Citrus Sinensis ID: 005841
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
ID ![]() | Alignment graph ![]() | Length ![]() |
Definition ![]() |
RBH(Q2H) ![]() |
RBH(H2Q) ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 674 | 2.2.26 [Sep-21-2011] | |||||||
| Q9FPR3 | 933 | Serine/threonine-protein | no | no | 0.267 | 0.192 | 0.583 | 4e-58 | |
| Q05609 | 821 | Serine/threonine-protein | no | no | 0.274 | 0.225 | 0.571 | 5e-56 | |
| Q54TM7 | 1288 | Probable serine/threonine | yes | no | 0.258 | 0.135 | 0.460 | 1e-41 | |
| Q7T6X2 | 1657 | Putative serine/threonine | N/A | no | 0.237 | 0.096 | 0.420 | 1e-39 | |
| Q54H46 | 642 | Probable serine/threonine | no | no | 0.235 | 0.247 | 0.465 | 3e-38 | |
| Q54TA1 | 749 | Probable serine/threonine | no | no | 0.252 | 0.226 | 0.430 | 1e-36 | |
| Q54H45 | 690 | Probable serine/threonine | no | no | 0.238 | 0.233 | 0.440 | 2e-36 | |
| Q55GU0 | 916 | Probable serine/threonine | no | no | 0.243 | 0.179 | 0.425 | 9e-36 | |
| Q54Y55 | 506 | Dual specificity protein | no | no | 0.256 | 0.341 | 0.451 | 4e-35 | |
| Q5UQG7 | 1651 | Putative serine/threonine | N/A | no | 0.240 | 0.098 | 0.426 | 1e-34 |
| >sp|Q9FPR3|EDR1_ARATH Serine/threonine-protein kinase EDR1 OS=Arabidopsis thaliana GN=EDR1 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 226 bits (576), Expect = 4e-58, Method: Compositional matrix adjust.
Identities = 105/180 (58%), Positives = 133/180 (73%)
Query: 494 DNDCLDYEILWEDLTIGEQIGQGSCGTVYHAVWYGSDVAVKVFSRQEYSDEVIHSFRQEV 553
D D + EI W DL I E+IG GS G VYHA W+G++VAVK F Q++S + FR EV
Sbjct: 656 DADVGECEIPWNDLVIAERIGLGSYGEVYHADWHGTEVAVKKFLDQDFSGAALAEFRSEV 715
Query: 554 SLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIA 613
+M+RLRHPNV+ F+GAVT P L IVTEFLPRGSL+R+L R + +D RRRI MALD+A
Sbjct: 716 RIMRRLRHPNVVFFLGAVTRPPNLSIVTEFLPRGSLYRILHRPKSHIDERRRIKMALDVA 775
Query: 614 RGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTVTYLA 673
G++ LH P I+HRDLK+ NLLVD +W VKVGDFGLSRLKH T+L++K+ GT ++A
Sbjct: 776 MGMNCLHTSTPTIVHRDLKTPNLLVDNNWNVKVGDFGLSRLKHNTFLSSKSTAGTPEWMA 835
|
MAPKKK serine/threonine-protein kinase involved in the regulation of a MAP kinase cascade (probably including MPK3 and MPK6) that negatively regulates salicylic acid- (SA-) dependent defense responses, abscisic acid (ABA) signaling, and ethylene-induced senescence. Modulates also stress response (e.g. drought) signaling and cell death, in an ORE9-dependent manner. Functions at a point of cross talk between ethylene, ABA and SA signaling that impinges on senescence and cell death. In another hand, confers sensitivity to various pathogens such as the fungus Erysiphe cichoracearum, the oomycete Hyaloperonospora parasitica and the bacteria Pseudomonas syringae pv. tomato DC3000. Required for the resistance to some hemibiotrophic/necrotrophic fungal pathogens (e.g. Colletotrichum gloeosporioides, Colletotrichum higginsianum and Alternaria brassicicola) through the induction of defensins expression, probably by repressing MYC2, an inhibitor of defensin genes (PDFs). Together with KEG, may regulate endocytic trafficking and/or the formation of signaling complexes on trans-Golgi network (TGN)/ early endosome (EE) vesicles during stress responses. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q05609|CTR1_ARATH Serine/threonine-protein kinase CTR1 OS=Arabidopsis thaliana GN=CTR1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 219 bits (558), Expect = 5e-56, Method: Compositional matrix adjust.
Identities = 108/189 (57%), Positives = 143/189 (75%), Gaps = 4/189 (2%)
Query: 487 AVNKVDLDNDCLDYEILWEDLTIGEQIGQGSCGTVYHAVWYGSDVAVKVFSRQEYSDEVI 546
A ++ LD D D +I W DL I E+IG GS GTV+ A W+GSDVAVK+ Q++ E +
Sbjct: 533 ANRELGLDGD--DMDIPWCDLNIKEKIGAGSFGTVHRAEWHGSDVAVKILMEQDFHAERV 590
Query: 547 HSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTK--LDWRR 604
+ F +EV++MKRLRHPN++LFMGAVT P L IVTE+L RGSL+RLL ++ + LD RR
Sbjct: 591 NEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERR 650
Query: 605 RILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKT 664
R+ MA D+A+G++YLH+ NPPI+HRDLKS NLLVDK +TVKV DFGLSRLK T+L++K+
Sbjct: 651 RLSMAYDVAKGMNYLHNRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKS 710
Query: 665 GKGTVTYLA 673
GT ++A
Sbjct: 711 AAGTPEWMA 719
|
Acts as a negative regulator in the ethylene response pathway. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q54TM7|DRKD_DICDI Probable serine/threonine-protein kinase drkD OS=Dictyostelium discoideum GN=drkD PE=2 SV=1 | Back alignment and function description |
|---|
Score = 171 bits (434), Expect = 1e-41, Method: Compositional matrix adjust.
Identities = 81/176 (46%), Positives = 115/176 (65%), Gaps = 2/176 (1%)
Query: 498 LDYEILWEDLTIGEQIGQGSCGTVYHAVWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMK 557
++E+ ++ IG +IG+G G V+ W G++VAVK+ + ++I R+EV L+
Sbjct: 842 FEWEVPLSEIAIGARIGRGGYGQVFRGSWRGTEVAVKMLFNDNVNLKLISDLRKEVDLLC 901
Query: 558 RLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVS 617
+LRHPN++LFMGA T P CIVTE+L RGSL +L + ++DW R+ + D ARG++
Sbjct: 902 KLRHPNIVLFMGACTEPSSPCIVTEYLSRGSLANILLDESIEMDWGLRLQLGFDCARGMT 961
Query: 618 YLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTVTYLA 673
YLH NP IIHRDLK+ NLLVD W VKV DFGL+ +K T+ KT GT ++A
Sbjct: 962 YLHSRNPIIIHRDLKTDNLLVDDSWQVKVADFGLATVKSHTF--AKTMCGTTGWVA 1015
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q7T6X2|YR826_MIMIV Putative serine/threonine-protein kinase/receptor R826 OS=Acanthamoeba polyphaga mimivirus GN=MIMI_R826 PE=4 SV=2 | Back alignment and function description |
|---|
Score = 165 bits (417), Expect = 1e-39, Method: Compositional matrix adjust.
Identities = 69/164 (42%), Positives = 113/164 (68%)
Query: 502 ILWEDLTIGEQIGQGSCGTVYHAVWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRH 561
I ++++ +GEQIG GS G VY W DVA+K F +Q+ + + R+E++ +K+L H
Sbjct: 1394 INYDEIKMGEQIGLGSYGVVYRGKWKNVDVAIKKFIKQKIDENHLLGIREEIAFLKKLHH 1453
Query: 562 PNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHH 621
PN++ +GA +CIVTE++ +G+L ++ T KL+W ++I + ++IA+G+SYLH
Sbjct: 1454 PNIITMVGASLKKPNICIVTEYMAKGNLRDAMRTCTPKLEWHQKIKILVNIAKGISYLHS 1513
Query: 622 CNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTG 665
+PPIIHRD+K SN+L+D++W VK+ DFG +R+K E + T+ G
Sbjct: 1514 FDPPIIHRDIKPSNILIDENWNVKIADFGFARIKEENAIMTRCG 1557
|
Acanthamoeba polyphaga (taxid: 5757) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q54H46|DRKA_DICDI Probable serine/threonine-protein kinase drkA OS=Dictyostelium discoideum GN=drkA PE=3 SV=1 | Back alignment and function description |
|---|
Score = 160 bits (405), Expect = 3e-38, Method: Compositional matrix adjust.
Identities = 74/159 (46%), Positives = 103/159 (64%)
Query: 507 LTIGEQIGQGSCGTVYHAVWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLL 566
+ IG +IG+G+ G VY W GS VAVK ++ ++ F +E++LMK LRHPNV+
Sbjct: 374 IKIGVRIGKGNYGEVYLGTWRGSQVAVKKLPAHNINENILKEFHREINLMKNLRHPNVIQ 433
Query: 567 FMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPI 626
F+G+ P +CI TE++PRGSL+ +L +L W I M +D A+GV YLH+ P I
Sbjct: 434 FLGSCLIPPDICICTEYMPRGSLYSILHDQALQLQWSLLIKMMIDAAKGVIYLHNSTPVI 493
Query: 627 IHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTG 665
+HRDLKS NLLVD++W VKV DFGLS ++ + T G
Sbjct: 494 LHRDLKSHNLLVDENWKVKVADFGLSTIEQQGATMTACG 532
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q54TA1|DRKC_DICDI Probable serine/threonine-protein kinase drkC OS=Dictyostelium discoideum GN=drkC PE=3 SV=1 | Back alignment and function description |
|---|
Score = 155 bits (391), Expect = 1e-36, Method: Compositional matrix adjust.
Identities = 77/179 (43%), Positives = 111/179 (62%), Gaps = 9/179 (5%)
Query: 499 DYEILWE-------DLTIGEQIGQGSCGTVYHAVWYGSDVAVKVFSRQEYSDE-VIHSFR 550
DY+ L+E ++ + +IG+GSC V+ W G VA+K DE ++
Sbjct: 476 DYKTLFEIKPIDISEIVVQNRIGRGSCAEVFTGTWRGIIVAIKKAKLLNEDDEDFLNELA 535
Query: 551 QEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMAL 610
QE ++M +LRHPN+ F+G +P + IV E++P GSL+R+L + LDW R MAL
Sbjct: 536 QEATIMSQLRHPNICQFLGTCNNPPEILIVMEYMPLGSLYRILHDPSISLDWPRMKSMAL 595
Query: 611 DIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTV 669
DIA+G++YLH C+P +IHRDLKS NLLVD+H+ VK+ DFGLS + + +L KT V
Sbjct: 596 DIAKGMNYLHCCDPIVIHRDLKSHNLLVDEHYRVKISDFGLST-RFKKHLDKKTAMTPV 653
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q54H45|DRKB_DICDI Probable serine/threonine-protein kinase drkB OS=Dictyostelium discoideum GN=drkB PE=3 SV=1 | Back alignment and function description |
|---|
Score = 154 bits (390), Expect = 2e-36, Method: Compositional matrix adjust.
Identities = 71/161 (44%), Positives = 101/161 (62%)
Query: 505 EDLTIGEQIGQGSCGTVYHAVWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNV 564
+ + IG +IG+G+ G VY W GS VAVK ++ ++ F +E++LMK LRHPNV
Sbjct: 389 QQIKIGVRIGKGNFGEVYLGTWRGSQVAVKKLPAHNINENILKEFHREINLMKNLRHPNV 448
Query: 565 LLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNP 624
+ F+G+ +CI TE++PRGSL+ +L K+ W M +D A+G+ YLH P
Sbjct: 449 IQFLGSCLISPDICICTEYMPRGSLYSILHNEKIKISWSLVKRMMIDAAKGIIYLHGSTP 508
Query: 625 PIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTG 665
I+HRDLKS NLLVD++W VKV DFGLS ++ + T G
Sbjct: 509 VILHRDLKSHNLLVDENWKVKVADFGLSTIEQQGATMTACG 549
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q55GU0|Y9955_DICDI Probable serine/threonine-protein kinase DDB_G0267514 OS=Dictyostelium discoideum GN=DDB_G0267514 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 152 bits (384), Expect = 9e-36, Method: Compositional matrix adjust.
Identities = 71/167 (42%), Positives = 114/167 (68%), Gaps = 3/167 (1%)
Query: 499 DYEILWEDLTIGEQIGQGSCGTVYHAVWYGSDVAVK-VFSRQEYSDEVIHSFRQEVSLMK 557
D EI + +L I ++G+G+ G VY +W GS VA+K + ++ +++V+ FR+E++++
Sbjct: 654 DIEISFSELKISSKLGEGTFGVVYKGLWRGSSVAIKQIKINEDVNNQVLEEFRKELTILS 713
Query: 558 RLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVS 617
RLRHPN++L M A T+P LC +TE+LP GSL+ L K++ + +A+ IA+G++
Sbjct: 714 RLRHPNIVLLMAACTAPPNLCFITEYLPGGSLYDALHSKKIKMNMQLYKKLAIQIAQGMN 773
Query: 618 YLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKT 664
YLH +IHRD+KS NLL+D+H VK+ DFGLS+LK ++ TK+
Sbjct: 774 YLHLSG--VIHRDIKSLNLLLDEHMNVKICDFGLSKLKSKSTEMTKS 818
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q54Y55|SHKC_DICDI Dual specificity protein kinase shkC OS=Dictyostelium discoideum GN=shkC PE=3 SV=1 | Back alignment and function description |
|---|
Score = 150 bits (378), Expect = 4e-35, Method: Compositional matrix adjust.
Identities = 79/175 (45%), Positives = 106/175 (60%), Gaps = 2/175 (1%)
Query: 501 EILWEDLTIGEQIGQGSCGTVYHAVWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLR 560
EI E++ E IG GS G VY VAVK+ +Q + + +FR+EV LM ++
Sbjct: 18 EIRPEEINFEELIGTGSFGKVYKGRCRQKAVAVKLLHKQNFDAATLSAFRKEVHLMSKIY 77
Query: 561 HPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLH 620
HPN+ LFMGA T P R IVTE +P+G+L LL +L R+ MA D A G+++LH
Sbjct: 78 HPNICLFMGACTIPGRCVIVTELVPKGNLETLLHDQKIQLPLYLRMRMARDAALGINWLH 137
Query: 621 HCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL--KHETYLTTKTGKGTVTYLA 673
NP +HRD+KSSNLLVD++ VK+ DFGLS L KH+ + KGT Y+A
Sbjct: 138 ESNPVFVHRDIKSSNLLVDENMRVKICDFGLSALKQKHKMLKDQSSAKGTPLYMA 192
|
Required for proper chemotaxis and phagocytosis; proper spatiotemporal control of F-actin levels in chemotaxing cells. Negative regulator of the PI3K (phosphatidylinositol 3 kinase) pathway. Predominantly phosphorylates serines and threonines and tyrosines at a lower level. Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q5UQG7|YR818_MIMIV Putative serine/threonine-protein kinase/receptor R818 OS=Acanthamoeba polyphaga mimivirus GN=MIMI_R818 PE=4 SV=1 | Back alignment and function description |
|---|
Score = 148 bits (373), Expect = 1e-34, Method: Compositional matrix adjust.
Identities = 70/164 (42%), Positives = 106/164 (64%), Gaps = 2/164 (1%)
Query: 502 ILWEDLTIGEQIGQGSCGTVYHAVWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRH 561
I ++D+ IG+QIG GS G V W +VAVK F +Q+ ++ + FR E++ + +LRH
Sbjct: 1389 INYDDIQIGKQIGVGSYGIVNMGKWKNINVAVKKFVKQKIDEKQMLEFRAEIAFLSQLRH 1448
Query: 562 PNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHH 621
P+++L +GA +CIVTEF+ GSL +++ TTK +W+ +I M A G+ YLH+
Sbjct: 1449 PHIILMIGACLKRPNICIVTEFMGNGSLRNVIK--TTKPEWKLKIKMLYQTALGIGYLHN 1506
Query: 622 CNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTG 665
+P IIHRD+K SN+LVD VK+ DFG +R+K E + T+ G
Sbjct: 1507 SDPIIIHRDIKPSNILVDDSMNVKIADFGFARIKEENSVMTRCG 1550
|
Acanthamoeba polyphaga (taxid: 5757) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST 
Original result of BLAST against Nonredundant Database
GI ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 674 | ||||||
| 224108736 | 781 | predicted protein [Populus trichocarpa] | 0.977 | 0.843 | 0.724 | 0.0 | |
| 224101557 | 759 | predicted protein [Populus trichocarpa] | 0.956 | 0.849 | 0.722 | 0.0 | |
| 255556394 | 796 | map3k delta-1 protein kinase, putative [ | 0.979 | 0.829 | 0.742 | 0.0 | |
| 225431966 | 771 | PREDICTED: uncharacterized protein LOC10 | 0.968 | 0.846 | 0.706 | 0.0 | |
| 356521762 | 770 | PREDICTED: uncharacterized protein LOC10 | 0.959 | 0.840 | 0.687 | 0.0 | |
| 356564864 | 771 | PREDICTED: uncharacterized protein LOC10 | 0.961 | 0.840 | 0.685 | 0.0 | |
| 296083240 | 732 | unnamed protein product [Vitis vinifera] | 0.913 | 0.841 | 0.674 | 0.0 | |
| 147827145 | 760 | hypothetical protein VITISV_034769 [Viti | 0.937 | 0.831 | 0.668 | 0.0 | |
| 449462150 | 774 | PREDICTED: LOW QUALITY PROTEIN: uncharac | 0.954 | 0.830 | 0.633 | 0.0 | |
| 357448913 | 744 | Protein kinase-like protein [Medicago tr | 0.919 | 0.833 | 0.639 | 0.0 |
| >gi|224108736|ref|XP_002314950.1| predicted protein [Populus trichocarpa] gi|222863990|gb|EEF01121.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 979 bits (2531), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 495/683 (72%), Positives = 564/683 (82%), Gaps = 24/683 (3%)
Query: 1 MDANTGPAEELLRKIQELEAGQEHLKQELSKLKISNDPKSETITTTTTTTHHQQRSHSVS 60
M++ AEELL+KIQ+LEAG HL+Q++SKLK+S +TTT QQRSHS+S
Sbjct: 1 MESTAPQAEELLKKIQQLEAGHHHLQQQMSKLKLS--------STTTDPKPTQQRSHSIS 52
Query: 61 PRRPRLAGPASRRKGGGTGPDAASAWKATNSASFRHSSPLQRESKGGDSGGSDAAGNSNS 120
P+R +GP +R GG TG +AWK SASFRHSSPLQRES+ +S + + G+SN
Sbjct: 53 PQR---SGPRNRVAGGPTGSSFEAAWK-KGSASFRHSSPLQRESRSLNSNNA-SDGHSNG 107
Query: 121 G----------PSAFNFTDRQYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEA 170
G PS+ FTD+QYLNILQS+GQSVHIFD S RIIYWNR+AE LYGYSA EA
Sbjct: 108 GGEGGDGNRGGPSSVKFTDKQYLNILQSVGQSVHIFDHSGRIIYWNRTAENLYGYSAAEA 167
Query: 171 LGQDAIELLTDGRDFDVAYDIVHRIKMGERWTGQFPAKTKTEERVLVVATNTPFYDDDGT 230
LGQDAIELL D RD+ VA IV R+ MGE+WTG+FP K K ER VVATNTP YDDDG
Sbjct: 168 LGQDAIELLIDSRDYAVANGIVQRVSMGEKWTGKFPVKNKMAERFTVVATNTPLYDDDGA 227
Query: 231 LVGIVCVSTDSRPFQETRAALWDTKNSDTDSNINRPRNTVTAKLGLDSQQPLQATIASKI 290
LVGI+CVS+DSRPFQE AL D++N + +S+ + PRN V +KLGLDSQQPLQA +ASKI
Sbjct: 228 LVGIICVSSDSRPFQEVGVALLDSRNLEAESSNSSPRNIVMSKLGLDSQQPLQAAVASKI 287
Query: 291 SNLATKVSNKVKSRIRTGDNFMDREGGSGDSHHSDHGFSDAALSDHREDGMSSGASTPRG 350
SNLA+KVSNKVKS+IR G+N MDREGGSGDSH+SDHG+SDAALSDHRED SSGASTPRG
Sbjct: 288 SNLASKVSNKVKSKIRPGENSMDREGGSGDSHYSDHGYSDAALSDHREDANSSGASTPRG 347
Query: 351 DVPPCPFGVFSHVDEKSPGKSVRDSGDESEGKPAIHKIITSKAEQWMGKKGLSWPWKGNE 410
DV P PFGVFSH+D++SP +S R+SGDESEGKPAIHKI TSKAE W+GKKGLSWPWKGNE
Sbjct: 348 DVHPSPFGVFSHLDDRSPAQSCRESGDESEGKPAIHKIFTSKAEAWIGKKGLSWPWKGNE 407
Query: 411 REGSDAKTARFAWPWSHGDQDNESVQQKSPSYGTKPESHMYEGNRSVNNEAWGSWSSSVN 470
+EGS+A+T RF WPW DQ++E+ Q+SPS G K ESH+ E NR NNEA GSWSSS+N
Sbjct: 408 KEGSEARTTRFGWPWLQNDQESETFHQRSPSSGAKSESHVSESNRPANNEASGSWSSSIN 467
Query: 471 VNSTSSVSSCGSTSSSAVNKVDLDNDCLDYEILWEDLTIGEQIGQGSCGTVYHAVWYGSD 530
VNSTSS SSC ++SS VNKVD D DCLDYEILWEDLTIGEQIGQGSCGTVYHA+WYGSD
Sbjct: 468 VNSTSSASSC-GSTSSTVNKVDPDTDCLDYEILWEDLTIGEQIGQGSCGTVYHALWYGSD 526
Query: 531 VAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLF 590
VAVKVFS+QEYSD+VI +F+QEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLF
Sbjct: 527 VAVKVFSKQEYSDDVILAFKQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLF 586
Query: 591 RLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFG 650
RLLQRNTTKLDWRRR MALDIARG++YLHH NPPIIHRDLKSSNLLVDK+WTVKVGDFG
Sbjct: 587 RLLQRNTTKLDWRRRAHMALDIARGMNYLHHYNPPIIHRDLKSSNLLVDKNWTVKVGDFG 646
Query: 651 LSRLKHETYLTTKTGKGTVTYLA 673
LSRLKHETYLTTKTGKGT ++A
Sbjct: 647 LSRLKHETYLTTKTGKGTPQWMA 669
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224101557|ref|XP_002312329.1| predicted protein [Populus trichocarpa] gi|222852149|gb|EEE89696.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 961 bits (2485), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 484/670 (72%), Positives = 548/670 (81%), Gaps = 25/670 (3%)
Query: 4 NTGPAEELLRKIQELEAGQEHLKQELSKLKISNDPKSETITTTTTTTHHQQRSHSVSPRR 63
+T PAEELL+KI+ELEAG HL+QE+SKLK+S +TTT QQRSHS+SP+R
Sbjct: 3 STAPAEELLKKIEELEAGHHHLQQEVSKLKLS--------STTTDPRSTQQRSHSISPQR 54
Query: 64 PRLAGPASRRKGGGTGPDAASAWKATNSASFRHSSPLQRESKGGDSGGSDAAGNSNSGPS 123
+GP R GG TG +AW SAS RHSSPLQ+E G+ NSGPS
Sbjct: 55 ---SGPRRRVSGGPTGSSFEAAWNK-GSASSRHSSPLQKER-----------GDGNSGPS 99
Query: 124 AFNFTDRQYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGR 183
A FTD+QYLNILQSMGQSVHIFD+S RIIYWNR+AE LYGYSA EALGQDAI LL D R
Sbjct: 100 AVKFTDKQYLNILQSMGQSVHIFDVSGRIIYWNRTAENLYGYSAAEALGQDAIGLLIDPR 159
Query: 184 DFDVAYDIVHRIKMGERWTGQFPAKTKTEERVLVVATNTPFYDDDGTLVGIVCVSTDSRP 243
D+ +A I+ R+ MGE+WTG+FP K K ER VATNTP YDDDG LVGI+CVS+DSRP
Sbjct: 160 DYALANGIIQRVSMGEKWTGKFPVKNKMAERFTAVATNTPLYDDDGALVGIICVSSDSRP 219
Query: 244 FQETRAALWDTKNSDTDSNINRPRNTVTAKLGLDSQQPLQATIASKISNLATKVSNKVKS 303
FQE AL D++N +T+S+ RP+NTV KLGLDSQQPLQ +ASKISNLA+KVSNKVKS
Sbjct: 220 FQEMEVALSDSRNLETESSHRRPKNTVMTKLGLDSQQPLQTAVASKISNLASKVSNKVKS 279
Query: 304 RIRTGDNFMDREGGSGDSHHSDHGFSDAALSDHREDGMSSGASTPRGDVPPCPFGVFSHV 363
+I G++ DRE GSGDSH+SDHG+SDAALSDHRED SSGASTPRGD+ P PFGVFS++
Sbjct: 280 KIHMGESNTDREVGSGDSHYSDHGYSDAALSDHREDANSSGASTPRGDLHPSPFGVFSNL 339
Query: 364 DEKSPGKSVRDSGDESEGKPAIHKIITSKAEQWMGKKGLSWPWKGNEREGSDAKTARFAW 423
D+KSP K RDSGDESEGKPAIHKIITSKAE W+GKKGLSWPWKGNE+EGS+A+T RF W
Sbjct: 340 DDKSPVKPSRDSGDESEGKPAIHKIITSKAEAWIGKKGLSWPWKGNEKEGSEARTTRFGW 399
Query: 424 PWSHGDQDNESVQQKSPSYGTKPESHMYEGNRSVNNEAWGSWSSSVNVNSTSSVSSCGST 483
PW DQ++E+ Q SPS G K ES + E R NEA GSW SS+NVNSTSS SS +
Sbjct: 400 PWLQNDQESETYHQTSPSSGAKSESQVSESIRPATNEASGSW-SSINVNSTSSASS-CGS 457
Query: 484 SSSAVNKVDLDNDCLDYEILWEDLTIGEQIGQGSCGTVYHAVWYGSDVAVKVFSRQEYSD 543
+SS VNKVD+D DCLDYEILWEDLTIGEQIGQGSCGTVYHA+WYGSDVAVKVFS+QEYSD
Sbjct: 458 TSSTVNKVDMDTDCLDYEILWEDLTIGEQIGQGSCGTVYHALWYGSDVAVKVFSKQEYSD 517
Query: 544 EVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWR 603
++I +FRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWR
Sbjct: 518 DIILAFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWR 577
Query: 604 RRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTK 663
RR+ MALDIARG++YLHHCNPPIIHRDLKSSNLLVDK+WTVKVGDFGLSRLKHETYLTTK
Sbjct: 578 RRVHMALDIARGMNYLHHCNPPIIHRDLKSSNLLVDKNWTVKVGDFGLSRLKHETYLTTK 637
Query: 664 TGKGTVTYLA 673
TGKGT ++A
Sbjct: 638 TGKGTPQWMA 647
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255556394|ref|XP_002519231.1| map3k delta-1 protein kinase, putative [Ricinus communis] gi|223541546|gb|EEF43095.1| map3k delta-1 protein kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 960 bits (2481), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 508/684 (74%), Positives = 563/684 (82%), Gaps = 24/684 (3%)
Query: 8 AEELLRKIQELEAGQEHLKQELSKLKISNDPKSET-----------ITTTTTTTHHQQRS 56
AEELL+KIQELEAGQ HLK+++SK K+++DP S++ QQRS
Sbjct: 7 AEELLKKIQELEAGQAHLKEQMSKFKLTSDPVSDSQLHHHHHHHHHHHRQQQQQQQQQRS 66
Query: 57 HSVSPRRPRLAGPASRRKGGGTGP---DAASAWKATNSASFRHSSPLQRESKGGDSGGSD 113
HS+SP+R +RR GGG G + +AWK S SFRHSSPLQRES+ + +
Sbjct: 67 HSISPQRT-----GTRRSGGGAGAGGFEVVAAWKK-GSTSFRHSSPLQRESRSSSADKIN 120
Query: 114 AA----GNSNSGPSAFNFTDRQYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEE 169
AA G + GPSA FTD+QYLNILQSMGQSVHIF LS RIIYWNR+AE LYGYS+ E
Sbjct: 121 AAVKEEGGNKCGPSAVKFTDKQYLNILQSMGQSVHIFYLSGRIIYWNRTAENLYGYSSAE 180
Query: 170 ALGQDAIELLTDGRDFDVAYDIVHRIKMGERWTGQFPAKTKTEERVLVVATNTPFYDDDG 229
ALGQDAIELL D RDF VA +IVHR+ MGERWTGQFP K K ER VATNTPFYDDDG
Sbjct: 181 ALGQDAIELLVDPRDFAVANNIVHRVAMGERWTGQFPVKNKMGERFTAVATNTPFYDDDG 240
Query: 230 TLVGIVCVSTDSRPFQETRAALWDTKNSDTDSNINRPRNTVTAKLGLDSQQPLQATIASK 289
TL+GI+CVS D RPFQETR AL KNS+ DS+ +RPR+TVT KLGLDSQQPLQA IASK
Sbjct: 241 TLIGIICVSGDVRPFQETRVALIGPKNSEADSSFSRPRSTVTTKLGLDSQQPLQAVIASK 300
Query: 290 ISNLATKVSNKVKSRIRTGDNFMDREGGSGDSHHSDHGFSDAALSDHREDGMSSGASTPR 349
I+NLA++VSNKVKS+IRTGDN MDREGGSGDSH SDHGFSDAALSDHRED SSGASTPR
Sbjct: 301 ITNLASRVSNKVKSKIRTGDNIMDREGGSGDSHQSDHGFSDAALSDHREDANSSGASTPR 360
Query: 350 GDVPPCPFGVFSHVDEKSPGKSVRDSGDESEGKPAIHKIITSKAEQWMGKKGLSWPWKGN 409
GD+ P FG FSHVDEKSP K++RDSG ESEGKP IHKIITSKAE W+GKKGLSWPWKG
Sbjct: 361 GDIHPSQFGTFSHVDEKSPMKAIRDSGYESEGKPGIHKIITSKAEAWIGKKGLSWPWKGI 420
Query: 410 EREGSDAKTARFAWPWSHGDQDNESVQQKSPSYGTKPESHMYEGNRSVNNEAWGSWSSSV 469
EREG D KT+RF WPW DQ++E + Q+SP G KPES + E NR NNEA GSWSSSV
Sbjct: 421 EREGPDTKTSRFVWPWLQNDQESELLHQRSPPAGAKPESQLNESNRPTNNEASGSWSSSV 480
Query: 470 NVNSTSSVSSCGSTSSSAVNKVDLDNDCLDYEILWEDLTIGEQIGQGSCGTVYHAVWYGS 529
NVNSTSS SSCGSTSSSA+NKVD+D DCLDYEILWEDLTIGEQIGQGSCGTVYHA+WYGS
Sbjct: 481 NVNSTSSASSCGSTSSSAINKVDMDIDCLDYEILWEDLTIGEQIGQGSCGTVYHALWYGS 540
Query: 530 DVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSL 589
DVAVKVFS+QEYSD+VI +FRQEVSLMKRLRHPNVLLFMGAVTSPQRLCI+TEFLPRGSL
Sbjct: 541 DVAVKVFSKQEYSDDVILAFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIITEFLPRGSL 600
Query: 590 FRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDF 649
FRLLQRNTTKLDWRRRI MALDI RG++YLHHCNPPIIHRDLKSSNLLVDK+WTVKVGDF
Sbjct: 601 FRLLQRNTTKLDWRRRIHMALDIVRGMNYLHHCNPPIIHRDLKSSNLLVDKNWTVKVGDF 660
Query: 650 GLSRLKHETYLTTKTGKGTVTYLA 673
GLSRLKHETYLTTKTGKGT ++A
Sbjct: 661 GLSRLKHETYLTTKTGKGTPQWMA 684
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225431966|ref|XP_002278360.1| PREDICTED: uncharacterized protein LOC100256793 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 919 bits (2376), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 477/675 (70%), Positives = 555/675 (82%), Gaps = 22/675 (3%)
Query: 4 NTGPAEELLRKIQELEAGQEHLKQELSKLKISNDPKSETITTTTTTTHHQQRSHSVSPRR 63
+T PAEELLRKIQELEAG HLK+E+SKL +S PKS+ H QRSHS SP+R
Sbjct: 2 DTPPAEELLRKIQELEAGHAHLKEEMSKLMVSG-PKSD---------HGHQRSHSTSPQR 51
Query: 64 PRLAGPA--SRRKGGGTGPDAASAWKATNSASFRHSSPLQRESKGGDSGGSDAAGNSNSG 121
R + PA S RKG G G D + W+ SASFRHSSPLQRES+ D + G
Sbjct: 52 SRFSSPATSSWRKGSG-GFDGPAGWR-RGSASFRHSSPLQRESRSRDPS---STAGGGGG 106
Query: 122 PSAFNFTDRQYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTD 181
P+A+ F D+QY NILQSMGQS+HIFDL+ R+IYWNR+AE LYGYSAEEALGQ AIELL+D
Sbjct: 107 PAAYKFNDKQYSNILQSMGQSIHIFDLNGRVIYWNRTAEKLYGYSAEEALGQQAIELLSD 166
Query: 182 GRDFDVAYDIVHRIKMGERWTGQFPAKTKTEERVLVVATNTPFYDDDGTLVGIVCVSTDS 241
+D+ +A +IV R+ GE WTGQFP K K ER L VATNTPFYDDDGTL+GI+CVS+DS
Sbjct: 167 VQDYAIANNIVDRVSRGESWTGQFPVKNKMGERFLAVATNTPFYDDDGTLIGIICVSSDS 226
Query: 242 RPFQETRAALWDTKNSDTDSNINRPRNTVTA-KLGLDSQQPLQATIASKISNLATKVSNK 300
+PFQE R A+ + + S+ +++ NR R++ + KLGLD QQP+QA IASKISNLA+KVSNK
Sbjct: 227 QPFQEIRVAMSNERQSEANASYNRSRSSSASAKLGLDPQQPIQAAIASKISNLASKVSNK 286
Query: 301 VKSRIRTGDNFMDREGGSGDSHHSDHGFSDAALSDHREDGMSSGASTPRGDVPPCPFGVF 360
V+ +I+ G+N + REGGSGDSHHSDHGFSDAA SDHRED SSGASTPRGDV P PFG+F
Sbjct: 287 VR-KIKAGENNVVREGGSGDSHHSDHGFSDAAFSDHREDATSSGASTPRGDVAPSPFGIF 345
Query: 361 SHV--DEKSPGKSVRDSGDESEGKPAIHKIITSKAEQWMGKKGLSWPWKGNEREGSDAKT 418
S DEKSPGK++RDSGDE+EGKP IH++ITSKAE W+GKK +SWPWKGNEREGS+ KT
Sbjct: 346 SQATADEKSPGKNLRDSGDENEGKPGIHRVITSKAEAWIGKKVMSWPWKGNEREGSEVKT 405
Query: 419 ARFAWPWSHGDQDNESVQQKSPSYGTKPESHMYEGNRSVNNEAWGSWSSSVNVNSTSSVS 478
RF WPW D +N+ VQ K+P++G K E+ + E NR NN+A GSWSS NVNSTSSVS
Sbjct: 406 NRFGWPWLQNDHENDMVQPKNPNFGAKTENLVSESNRHGNNDASGSWSS-FNVNSTSSVS 464
Query: 479 SCGSTSSSAVNKVDLDNDCLDYEILWEDLTIGEQIGQGSCGTVYHAVWYGSDVAVKVFSR 538
SCGSTSSSAVNKVD++ DCLDYEILWEDLTIGEQIGQGSCGTVYH +WYGSDVA+KVFS+
Sbjct: 465 SCGSTSSSAVNKVDMETDCLDYEILWEDLTIGEQIGQGSCGTVYHGLWYGSDVAIKVFSK 524
Query: 539 QEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTT 598
QEYSD+VI SFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNT+
Sbjct: 525 QEYSDDVILSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTS 584
Query: 599 KLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHET 658
+LDWRRR+ MALDIA+G++YLHH NPPIIHRDLKSSNLLVD++WTVKVGDFGLSRLKHET
Sbjct: 585 RLDWRRRVHMALDIAQGMNYLHHFNPPIIHRDLKSSNLLVDRNWTVKVGDFGLSRLKHET 644
Query: 659 YLTTKTGKGTVTYLA 673
YLTTKTGKGT ++A
Sbjct: 645 YLTTKTGKGTPQWMA 659
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356521762|ref|XP_003529520.1| PREDICTED: uncharacterized protein LOC100800867 [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 894 bits (2311), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 466/678 (68%), Positives = 533/678 (78%), Gaps = 31/678 (4%)
Query: 5 TGPAEELLRKIQELEAGQEHLKQELSKLKISNDPKSETITTTTTTTHHQQRSHSVSPRRP 64
T P +EL++KIQ+LE G HLKQE+SKLK+S+ HH+QRSHSVSP+R
Sbjct: 3 TPPTDELVKKIQQLEEGHAHLKQEMSKLKLSD----------VRHGHHRQRSHSVSPQRS 52
Query: 65 RLAGPASRRKGGGTGPDAASAWKATNSASFRHSSPLQRESKGGD------SGGSDAAGNS 118
RL P +R DA +AWK S SF+ SSPLQRES+GG GG +AA
Sbjct: 53 RLGAPPKKRS------DAPAAWK-RGSCSFKQSSPLQRESRGGGDPQIHGGGGEEAA--P 103
Query: 119 NSGPSAFNFTDRQYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIEL 178
GPSA NFT+RQYLNILQSMGQSVHI DL+ RIIYWNRSAE LYGY+AEEALGQD IEL
Sbjct: 104 RRGPSAVNFTERQYLNILQSMGQSVHILDLNCRIIYWNRSAENLYGYTAEEALGQDGIEL 163
Query: 179 LTDGRDFDVAYDIVHRIKMGERWTGQFPAKTKTEERVLVVATNTPFYDDDGTLVGIVCVS 238
L D RD D+A + V+R+ MGE WTGQFP K K E+ L VATNTPFYDDDG+LVG++CVS
Sbjct: 164 LVDPRDLDLANNTVNRVMMGESWTGQFPIKNKMGEKFLAVATNTPFYDDDGSLVGLICVS 223
Query: 239 TDSRPFQETRAALWDTKN--SDTDSNINRPRNTVTAKLGLDSQQPLQATIASKISNLATK 296
D RPF E + + +N SD+DS RPR+++T KLGLD+QQPLQA+IASKISNLA+K
Sbjct: 224 IDLRPFLEMKVPMPSVRNIESDSDSGGTRPRSSITNKLGLDTQQPLQASIASKISNLASK 283
Query: 297 VSNKVKSRIRTGDNFMDREGGSGDSHHSDHGFSDAALSDHREDGMSSGASTPRGDVPPCP 356
V NKVKSRI TG+N +DRE GSG+SHHS+H S++ + RED SSGASTPRGDVPP
Sbjct: 284 VGNKVKSRIWTGENNLDRESGSGESHHSEHSLSESVFLEQREDANSSGASTPRGDVPPSH 343
Query: 357 FGVFSHVDEKSPGKSVRDSGDESEGKPAIHKIITSKAEQWMGKKGLSWPWKGNEREGSDA 416
FG F HV+EKS GK++R+SGDESEGK +IHKII KAE W+ +K LSWPW+ +REGSDA
Sbjct: 344 FGAFPHVEEKSQGKALRESGDESEGK-SIHKIIP-KAEAWIQRKTLSWPWRTKDREGSDA 401
Query: 417 KTARFAWPWSHGDQDNESVQQKSPSYGTKPESHMYEGNRSVNNEAWGSWSSSVNVNSTSS 476
R A PW DQ+NESV QK S K ES E NR N+EA GSWSS NVNSTSS
Sbjct: 402 ANVRVAGPWRQNDQENESVNQKILSSSLKQESQAGESNRPTNHEASGSWSS-FNVNSTSS 460
Query: 477 VSSCGSTSSSAVN-KVDLDNDCLDYEILWEDLTIGEQIGQGSCGTVYHAVWYGSDVAVKV 535
SSCGS S AVN KVD+D DCLDYEILWEDLTIGEQIGQGSCGTVYHA+WYGSDVAVKV
Sbjct: 461 ASSCGSAGSGAVNNKVDVDTDCLDYEILWEDLTIGEQIGQGSCGTVYHALWYGSDVAVKV 520
Query: 536 FSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQR 595
FS+QEYSD+VI SFRQEVS+MKRLRHPN+LLFMGAVTSPQRLCIVTEFLPRGSL RLL R
Sbjct: 521 FSKQEYSDDVILSFRQEVSVMKRLRHPNILLFMGAVTSPQRLCIVTEFLPRGSLCRLLHR 580
Query: 596 NTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLK 655
NT+KLDWRRR+ MALDIARGV+YLHHCNPPIIHRDLKSSNLLVDK+WTVKVGDFGLSRLK
Sbjct: 581 NTSKLDWRRRVHMALDIARGVNYLHHCNPPIIHRDLKSSNLLVDKNWTVKVGDFGLSRLK 640
Query: 656 HETYLTTKTGKGTVTYLA 673
HET+LTTKTG+GT ++A
Sbjct: 641 HETFLTTKTGRGTPQWMA 658
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356564864|ref|XP_003550667.1| PREDICTED: uncharacterized protein LOC100785569 [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 890 bits (2299), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 465/678 (68%), Positives = 532/678 (78%), Gaps = 30/678 (4%)
Query: 5 TGPAEELLRKIQELEAGQEHLKQELSKLKISNDPKSETITTTTTTTHHQQRSHSVSPRRP 64
T P +EL++KIQ+LE G HLKQE+SKLK+S+ HH+QRSHSVSP+R
Sbjct: 3 TPPTDELVKKIQQLEEGHAHLKQEMSKLKLSD----------VRHGHHRQRSHSVSPQRS 52
Query: 65 RLAGPASRRKGGGTGPDAASAWKATNSASFRHSSPLQRESKGG-----DSGGSDAAGNSN 119
RL P +R A+AWK S SF+ SSPLQRES+GG GG +AA
Sbjct: 53 RLGAPPKKRSDA-----PAAAWK-RGSCSFKQSSPLQRESRGGGDPQIHGGGEEAA--PR 104
Query: 120 SGPSAFNFTDRQYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELL 179
GPSA NFT+RQYLNIL+SMGQSVHI DL+ RIIYWNRSAE LYGY+AEEALGQD IELL
Sbjct: 105 RGPSAVNFTERQYLNILRSMGQSVHILDLNCRIIYWNRSAENLYGYTAEEALGQDGIELL 164
Query: 180 TDGRDFDVAYDIVHRIKMGERWTGQFPAKTKTEERVLVVATNTPFYDDDGTLVGIVCVST 239
D RD D+A + V+R+ MGE WTGQFP K KT E+ L VATNTPFYDDDG+LVG++CVS
Sbjct: 165 VDPRDLDLANNTVNRVMMGESWTGQFPVKNKTGEKFLAVATNTPFYDDDGSLVGLICVSI 224
Query: 240 DSRPFQETRAAL-WDTKN--SDTDSNINRPRNTVTAKLGLDSQQPLQATIASKISNLATK 296
D RPF E + + +N SD+DS RPR+++T KLGLD+QQPLQA+IASKISNLA+K
Sbjct: 225 DLRPFLEMKVPMPTSVRNIESDSDSGGTRPRSSITNKLGLDTQQPLQASIASKISNLASK 284
Query: 297 VSNKVKSRIRTGDNFMDREGGSGDSHHSDHGFSDAALSDHREDGMSSGASTPRGDVPPCP 356
V NKVKSRI G+N +DRE GSG+SHHS+H ++ + RED SSGASTPRGDVPP
Sbjct: 285 VGNKVKSRIWMGENNLDRESGSGESHHSEHSLLESVFLEQREDANSSGASTPRGDVPPSH 344
Query: 357 FGVFSHVDEKSPGKSVRDSGDESEGKPAIHKIITSKAEQWMGKKGLSWPWKGNEREGSDA 416
FG FSHV+EKS GK++R+SGDESEGK +IHKII KAE W+ +K LSWPW+ +REGSDA
Sbjct: 345 FGAFSHVEEKSQGKALRESGDESEGK-SIHKIIP-KAEAWIQRKTLSWPWRTKDREGSDA 402
Query: 417 KTARFAWPWSHGDQDNESVQQKSPSYGTKPESHMYEGNRSVNNEAWGSWSSSVNVNSTSS 476
R A W DQ+NESV QK S G K ES E NR NNEA GSWSS NVNSTSS
Sbjct: 403 MNVRVAGSWRQNDQENESVNQKILSSGLKQESQAGESNRPTNNEASGSWSS-FNVNSTSS 461
Query: 477 VSSCGSTSSSAVN-KVDLDNDCLDYEILWEDLTIGEQIGQGSCGTVYHAVWYGSDVAVKV 535
SSCGS S AVN KVD+D DCLDYEILWEDLTIGEQIGQGSCGTVYHA+WYGSDVAVKV
Sbjct: 462 ASSCGSAGSGAVNNKVDVDTDCLDYEILWEDLTIGEQIGQGSCGTVYHALWYGSDVAVKV 521
Query: 536 FSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQR 595
FS+QEYSD+VI SFRQEVS+MKRLRHPN+LL+MGAVTSPQRLCIVTEFLPRGSL RLL R
Sbjct: 522 FSKQEYSDDVILSFRQEVSVMKRLRHPNILLYMGAVTSPQRLCIVTEFLPRGSLCRLLHR 581
Query: 596 NTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLK 655
NT+KLDWRRR+ MALDIARGV+YLHHCNPPIIHRDLKSSNLLVDK+WTVKVGDFGLSRLK
Sbjct: 582 NTSKLDWRRRVHMALDIARGVNYLHHCNPPIIHRDLKSSNLLVDKNWTVKVGDFGLSRLK 641
Query: 656 HETYLTTKTGKGTVTYLA 673
HETYLTTKTG+GT ++A
Sbjct: 642 HETYLTTKTGRGTPQWMA 659
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|296083240|emb|CBI22876.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 877 bits (2266), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 454/673 (67%), Positives = 530/673 (78%), Gaps = 57/673 (8%)
Query: 4 NTGPAEELLRKIQELEAGQEHLKQELSKLKISNDPKSETITTTTTTTHHQQRSHSVSPRR 63
+T PAEELLRKIQELEAG HLK+E+SKL +S PKS+ H QRSHS SP+R
Sbjct: 2 DTPPAEELLRKIQELEAGHAHLKEEMSKLMVSG-PKSD---------HGHQRSHSTSPQR 51
Query: 64 PRLAGPASRRKGGGTGPDAASAWKATNSASFRHSSPLQRESKGGDSGGSDAAGNSNSGPS 123
R + PA+ + GP+
Sbjct: 52 SRFSSPAT------------------------------------------STAGGGGGPA 69
Query: 124 AFNFTDRQYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGR 183
A+ F D+QY NILQSMGQS+HIFDL+ R+IYWNR+AE LYGYSAEEALGQ AIELL+D +
Sbjct: 70 AYKFNDKQYSNILQSMGQSIHIFDLNGRVIYWNRTAEKLYGYSAEEALGQQAIELLSDVQ 129
Query: 184 DFDVAYDIVHRIKMGERWTGQFPAKTKTEERVLVVATNTPFYDDDGTLVGIVCVSTDSRP 243
D+ +A +IV R+ GE WTGQFP K K ER L VATNTPFYDDDGTL+GI+CVS+DS+P
Sbjct: 130 DYAIANNIVDRVSRGESWTGQFPVKNKMGERFLAVATNTPFYDDDGTLIGIICVSSDSQP 189
Query: 244 FQETRAALWDTKNSDTDSNINRPRNTVTA-KLGLDSQQPLQATIASKISNLATKVSNKVK 302
FQE R A+ + + S+ +++ NR R++ + KLGLD QQP+QA IASKISNLA+KVSNKV+
Sbjct: 190 FQEIRVAMSNERQSEANASYNRSRSSSASAKLGLDPQQPIQAAIASKISNLASKVSNKVR 249
Query: 303 SRIRTGDNFMDREGGSGDSHHSDHGFSDAALSDHREDGMSSGASTPRGDVPPCPFGVFSH 362
+I+ G+N + REGGSGDSHHSDHGFSDAA SDHRED SSGASTPRGDV P PFG+FS
Sbjct: 250 -KIKAGENNVVREGGSGDSHHSDHGFSDAAFSDHREDATSSGASTPRGDVAPSPFGIFSQ 308
Query: 363 V--DEKSPGKSVRDSGDESEGKPAIHKIITSKAEQWMGKKGLSWPWKGNEREGSDAKTAR 420
DEKSPGK++RDSGDE+EGKP IH++ITSKAE W+GKK +SWPWKGNEREGS+ KT R
Sbjct: 309 ATADEKSPGKNLRDSGDENEGKPGIHRVITSKAEAWIGKKVMSWPWKGNEREGSEVKTNR 368
Query: 421 FAWPWSHGDQDNESVQQKSPSYGTKPESHMYEGNRSVNNEAWGSWSSSVNVNSTSSVSSC 480
F WPW D +N+ VQ K+P++G K E+ + E NR NN+A GSWSS NVNSTSSVSSC
Sbjct: 369 FGWPWLQNDHENDMVQPKNPNFGAKTENLVSESNRHGNNDASGSWSS-FNVNSTSSVSSC 427
Query: 481 GSTSSSAVNKVDLDNDCLDYEILWEDLTIGEQIGQGSCGTVYHAVWYGSDVAVKVFSRQE 540
GSTSSSAVNKVD++ DCLDYEILWEDLTIGEQIGQGSCGTVYH +WYGSDVA+KVFS+QE
Sbjct: 428 GSTSSSAVNKVDMETDCLDYEILWEDLTIGEQIGQGSCGTVYHGLWYGSDVAIKVFSKQE 487
Query: 541 YSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKL 600
YSD+VI SFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNT++L
Sbjct: 488 YSDDVILSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTSRL 547
Query: 601 DWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYL 660
DWRRR+ MALDIA+G++YLHH NPPIIHRDLKSSNLLVD++WTVKVGDFGLSRLKHETYL
Sbjct: 548 DWRRRVHMALDIAQGMNYLHHFNPPIIHRDLKSSNLLVDRNWTVKVGDFGLSRLKHETYL 607
Query: 661 TTKTGKGTVTYLA 673
TTKTGKGT ++A
Sbjct: 608 TTKTGKGTPQWMA 620
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147827145|emb|CAN70981.1| hypothetical protein VITISV_034769 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 860 bits (2223), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 458/685 (66%), Positives = 532/685 (77%), Gaps = 53/685 (7%)
Query: 4 NTGPAEELLRKIQELEAGQEHLKQELSKLKISNDPKSETITTTTTTTHHQQRSHSVSPRR 63
+T PAEELLRKIQELEAG HLK+E+SKL +S PKS+ H QR S
Sbjct: 2 DTPPAEELLRKIQELEAGHAHLKEEMSKLMVSG-PKSD---------HGHQRKGSGG--- 48
Query: 64 PRLAGPASRRKGGGTGPDAASAWKATNSASFRHSSPLQRESKGGDSGGSDAAGNSNSGPS 123
GPA R+G SASFRHSSPLQRES+ D + GP+
Sbjct: 49 --FDGPAGWRRG---------------SASFRHSSPLQRESRSRDPS---STAGGGGGPA 88
Query: 124 AFNFTDRQYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGR 183
A+ F D+QY NILQSMGQS+HIFDL+ R+IYWNR+AE LYGYSAEEALGQ AIELL+D +
Sbjct: 89 AYKFNDKQYSNILQSMGQSIHIFDLNGRVIYWNRTAEKLYGYSAEEALGQQAIELLSDVQ 148
Query: 184 DFDVAYDIVHRIKMGERWTGQFPAKTKTEERVLVVATNTPFYDDDGTLVGIVCVSTDSRP 243
D+ +A +IV R+ GE WTGQFP K K ER L VATNTPFYDDDGTL+GI+CVS+DS+P
Sbjct: 149 DYAIANNIVDRVSRGESWTGQFPVKNKMGERFLAVATNTPFYDDDGTLIGIICVSSDSQP 208
Query: 244 FQETRAALWDTKNSDTDSNIN-RPRNTVTAKLGLDSQQPLQATIASKISNLATKVSNKVK 302
FQE R A+ + + S+ +++ N ++ +AKLGLD QQP+QA IASKISNL VSNKV+
Sbjct: 209 FQEIRVAMSNERQSEANASYNRSRSSSASAKLGLDPQQPIQAAIASKISNL---VSNKVR 265
Query: 303 SRIRTGDNFMDREGGSGDSHHSDHGFSDAALSDHREDGMSSGASTPRGDVPPCPFGVFSH 362
+I+ G+N + REGGSGDSHHSDHGFSDAA SDHRED SSGASTPRGDV P PFG+FS
Sbjct: 266 -KIKAGENNVVREGGSGDSHHSDHGFSDAAFSDHREDATSSGASTPRGDVAPSPFGIFSQ 324
Query: 363 --VDEKSPGKSVRDSGDESEGKPAIHKIITSKAEQWMGKKGLSWPWKGNEREGSDAKTAR 420
DEKSPGK++RDSGDE+EGKP IH++ITSKAE W+GKK +SWPWKGNEREGS+ KT R
Sbjct: 325 ATADEKSPGKNLRDSGDENEGKPGIHRVITSKAEAWIGKKVMSWPWKGNEREGSEVKTNR 384
Query: 421 FAWPWSHGDQDNESVQQKSPSYGTKPESHMYEGNRSVNNEAWGSWSSSVNVNSTSSVSSC 480
F WPW D +N+ VQ K+P++G K E+ + E NR NN+A GSW SS NVNSTSSVSSC
Sbjct: 385 FGWPWLQNDHENDMVQPKNPNFGAKTENLVSESNRHGNNDASGSW-SSFNVNSTSSVSSC 443
Query: 481 GSTSSSAVNKVDLDNDCLDYEILWEDLTIGEQIGQGSCGTVYHAVWYGSDVAVKVFSRQE 540
GSTSSSAVNKVD++ DCLDYEILWEDLTIGEQIGQGSCGTVYH +WYGSDVA+KVFS+QE
Sbjct: 444 GSTSSSAVNKVDMETDCLDYEILWEDLTIGEQIGQGSCGTVYHGLWYGSDVAIKVFSKQE 503
Query: 541 YSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSL----------- 589
YSD+VI SFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPR L
Sbjct: 504 YSDDVILSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRCVLCFPIENFLKQA 563
Query: 590 -FRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGD 648
F L NT++LDWRRR+LMALDIA+G++YLHH NPPIIHRDLKSSNLLVD++WTVKVGD
Sbjct: 564 YFMCLALNTSRLDWRRRVLMALDIAQGMNYLHHFNPPIIHRDLKSSNLLVDRNWTVKVGD 623
Query: 649 FGLSRLKHETYLTTKTGKGTVTYLA 673
FGLSRLKHETYLTTKTGKGT ++A
Sbjct: 624 FGLSRLKHETYLTTKTGKGTPQWMA 648
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449462150|ref|XP_004148804.1| PREDICTED: LOW QUALITY PROTEIN: uncharacterized protein LOC101221874 [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 819 bits (2115), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 430/679 (63%), Positives = 509/679 (74%), Gaps = 36/679 (5%)
Query: 5 TGPAEELLRKIQELEAGQEHLKQELSKLKISNDPKSETITTTTTTTHHQQRSHSVSPRRP 64
T PAEELLRK+QELE GQ HLK+E+SKL +S + + + S+
Sbjct: 3 TPPAEELLRKVQELEEGQAHLKKEMSKLLLSVQ-----LRPPNPPSPPSPSTFSI----- 52
Query: 65 RLAGPASRRKGGGTGPDAASAWKATNSASFRHSSPLQRESK--------GGDSGGSDAAG 116
GG G AA+AWK S+SFRHSSPLQ+E+ +S D G
Sbjct: 53 -------HTTGGLDG--AAAAWK-RGSSSFRHSSPLQKEALPRFDISPLQRESRTRDPIG 102
Query: 117 NSNSGPSAFNFTDRQYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAI 176
S GP+A NFT++QYLNILQS+GQ V+IFDL+ IIYWNR+AE++YGYSA EALGQDAI
Sbjct: 103 CS--GPAAVNFTNKQYLNILQSLGQPVYIFDLNYHIIYWNRAAEIVYGYSAAEALGQDAI 160
Query: 177 ELLTDGRDFDVAYDIVHRIKMGERWTGQFPAKTKTEERVLVVATNTPFYDDDGTLVGIVC 236
ELL D DF + ++ R+ GE WTG P K K ++ +VVATNTPFYDD G L+GI+C
Sbjct: 161 ELLVDPEDFAITNHVILRVMAGENWTGHLPVKNKMGQKFVVVATNTPFYDD-GALIGIIC 219
Query: 237 VSTDSRPFQETRAAL-WDTKNSDTDSNINRPRNTVTAKLGLDSQQPLQATIASKISNLAT 295
+S+DSRPFQ+ + L +K D DS++ R R V+ KLGLD QQPLQ IASK+SNLA+
Sbjct: 220 ISSDSRPFQDLKIPLSIGSKQQDADSSMVRSRVPVSVKLGLDPQQPLQVAIASKLSNLAS 279
Query: 296 KVSNKVKSRIRTGDNFMDREGGSGDSHHSDHGFSDAALSDHREDGMSSGASTPRGDVPPC 355
KVSNKVKS+IRTG+N +DREGGSGD +HSDHG DA L D+R+D SSGASTPRGD
Sbjct: 280 KVSNKVKSKIRTGENSLDREGGSGDGYHSDHGHPDAVLCDNRDDANSSGASTPRGD--ST 337
Query: 356 PFGVFSHVDEKSPGKSVRDSGDESEGKPAIHKIITSKAEQWMGKKGLSWPWKGNEREG-S 414
G FS V+EK G+ VRDS DE +GKP I KI++SKAE+W+ KKGLSWPWKG E+EG S
Sbjct: 338 AHGAFSQVEEKLSGRLVRDSSDEGKGKPTIQKILSSKAEEWIAKKGLSWPWKGTEQEGGS 397
Query: 415 DAKTARFAWPWSHGDQDNESVQQKSPSYGTKPESHMYEGNRSVNNEAWGSWSSSVNVNST 474
+ + ARF WPW DQ+ E KS S K E +G+R+VNNEA GSWSS +++
Sbjct: 398 ETRAARFVWPWVQIDQEAEPANHKSSSISGKLEMQQNDGHRAVNNEASGSWSSININSTS 457
Query: 475 SSVSSCGSTSSSAVNKVDLDNDCLDYEILWEDLTIGEQIGQGSCGTVYHAVWYGSDVAVK 534
S S STSSSAVNKV+ D DCLD+EILWEDLTIGEQIGQGSCGTVYHA+WYGSDVAVK
Sbjct: 458 SVSSCG-STSSSAVNKVESDMDCLDHEILWEDLTIGEQIGQGSCGTVYHALWYGSDVAVK 516
Query: 535 VFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQ 594
VFS+QEYSD+VI SF+QEVSLMK+LRHPN+LLFMG VTSPQRLCIVTEFLPRGSLFRLLQ
Sbjct: 517 VFSKQEYSDDVILSFKQEVSLMKKLRHPNILLFMGVVTSPQRLCIVTEFLPRGSLFRLLQ 576
Query: 595 RNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL 654
RNT KLDWRRR+ MALDIARG++YLHHCNPPIIHRDLKSSNLL+DK+WTVKVGDFGLSRL
Sbjct: 577 RNTGKLDWRRRVHMALDIARGMNYLHHCNPPIIHRDLKSSNLLIDKNWTVKVGDFGLSRL 636
Query: 655 KHETYLTTKTGKGTVTYLA 673
KHETYLTTKTGKGT ++A
Sbjct: 637 KHETYLTTKTGKGTPQWMA 655
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357448913|ref|XP_003594732.1| Protein kinase-like protein [Medicago truncatula] gi|355483780|gb|AES64983.1| Protein kinase-like protein [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 811 bits (2095), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 431/674 (63%), Positives = 507/674 (75%), Gaps = 54/674 (8%)
Query: 7 PAEELLRKIQELEAGQEHLKQELSKLKISNDPKSETITTTTTTTHHQQRSHSVSPRRPRL 66
P ELL+KI+ LEAGQ HLKQE+SKLK+S ++RSHSVSP+R RL
Sbjct: 6 PEAELLKKIERLEAGQVHLKQEMSKLKLS----------------QRRRSHSVSPQRSRL 49
Query: 67 AGPASRRKGGGTGPDAASAWKATNSASFRHSSPLQRESKGG---DSGGSDAAGNSNSGPS 123
G A+SA A +++S SSPLQRES+ +GG
Sbjct: 50 ------------GASASSASSAASASSKGCSSPLQRESRSSHDPQNGGG----------- 86
Query: 124 AFNFTDRQYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGR 183
+YLNILQS+G SVHI DL RIIYWN SAE LYGY+AEE LG D IE+L D
Sbjct: 87 -------KYLNILQSIGHSVHILDLQCRIIYWNPSAENLYGYTAEEVLGLDGIEVLVDPS 139
Query: 184 DFDVAYDIVHRIKMGERWTGQFPAKTKTEERVLVVATNTPFYDDDGTLVGIVCVSTDSRP 243
+FD+A DI +R+KMGE WTGQFP K K +R +VVAT+TPFYDDDG+LVG++CV++DSRP
Sbjct: 140 EFDIANDIFNRVKMGESWTGQFPVKNKIGDRFVVVATDTPFYDDDGSLVGVICVTSDSRP 199
Query: 244 FQETRAALWDTKNSDTDSNINRPRNTVTAKLGLDSQQPLQATIASKISNLATKVSNKVKS 303
F E KN + DS +N PR +T KLGLD +QPLQ +ASKISNLATKVSNKVKS
Sbjct: 200 FLENIVPFSARKNEEKDSGVNFPRIAITNKLGLDPEQPLQNALASKISNLATKVSNKVKS 259
Query: 304 RIRTGDNFMDREGGSGDSHHSDHGFSDAALSDHREDG-MSSGASTPRGDVPPCPFGVFSH 362
+IRT +N ++ EGGS +SHHS+HGFSD SD REDG SSGASTP G+VPP PFG FS
Sbjct: 260 KIRTRENNVNGEGGSSESHHSEHGFSDYGHSDQREDGGNSSGASTPAGEVPPTPFGSFSR 319
Query: 363 VDEKSPGKSVRDSGDESEGKPAIHKIITSKAEQWMGKKGLSWPWKGNEREGSDAKTARFA 422
+E+S GK++R+SGDESE KP IHKIITS+AE W+ KK +SWPWK N+RE S+AK R +
Sbjct: 320 AEERSQGKTMRNSGDESEEKP-IHKIITSRAEAWIQKKTMSWPWKTNDREESEAKNVRVS 378
Query: 423 WPWSHGDQDNESVQQKSPSYGTKP-ESHMYEGNRSVNNEAWGSWSS--SVNVNSTSSVSS 479
WPW GDQD E QK+ S G KP ES E + V NEA GSWSS + + +STSS S
Sbjct: 379 WPWLQGDQDKEPANQKNASSGLKPPESRAVESYQPVQNEATGSWSSFNANSTSSTSSCGS 438
Query: 480 CGSTSSSAVNKVDLDNDCLDYEILWEDLTIGEQIGQGSCGTVYHAVWYGSDVAVKVFSRQ 539
+SS+A N+VD+D+DCLDYEILWEDLTIGE IGQGSCGTVYHA+WYGSDVAVKVFS+Q
Sbjct: 439 GSGSSSAANNRVDVDSDCLDYEILWEDLTIGESIGQGSCGTVYHALWYGSDVAVKVFSKQ 498
Query: 540 EYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTK 599
EYS++VI SFRQEVSLMKRLRHPN+LLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNT+K
Sbjct: 499 EYSEDVIQSFRQEVSLMKRLRHPNILLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTSK 558
Query: 600 LDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETY 659
DWRRR+ MA+DIARGV+YLHHCNPPIIHRDLK+SNLLVDK+WTVKVGDFGLSR+KHETY
Sbjct: 559 PDWRRRVHMAVDIARGVNYLHHCNPPIIHRDLKTSNLLVDKNWTVKVGDFGLSRIKHETY 618
Query: 660 LTTKTGKGTVTYLA 673
L TKTGKGT ++A
Sbjct: 619 LETKTGKGTPQWMA 632
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST 
Original result of BLAST against Gene Ontology (AMIGO)
ID ![]() |
Alignment graph ![]() |
Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 674 | ||||||
| TAIR|locus:2084314 | 773 | AT3G06620 [Arabidopsis thalian | 0.952 | 0.830 | 0.556 | 1.2e-193 | |
| TAIR|locus:2158019 | 831 | AT5G49470 [Arabidopsis thalian | 0.817 | 0.663 | 0.493 | 3e-181 | |
| TAIR|locus:2200296 | 765 | AT1G67890 [Arabidopsis thalian | 0.936 | 0.824 | 0.537 | 2.1e-178 | |
| TAIR|locus:2084304 | 671 | AT3G06630 [Arabidopsis thalian | 0.807 | 0.810 | 0.553 | 1.4e-170 | |
| TAIR|locus:2127228 | 736 | AT4G23050 [Arabidopsis thalian | 0.270 | 0.247 | 0.545 | 1.4e-76 | |
| TAIR|locus:2027794 | 1030 | AT1G73660 [Arabidopsis thalian | 0.272 | 0.178 | 0.610 | 1.3e-58 | |
| TAIR|locus:2194055 | 992 | AT1G18160 [Arabidopsis thalian | 0.265 | 0.180 | 0.592 | 6.7e-54 | |
| TAIR|locus:2143009 | 880 | AT5G11850 [Arabidopsis thalian | 0.258 | 0.197 | 0.591 | 7.2e-53 | |
| TAIR|locus:2025515 | 933 | EDR1 "ENHANCED DISEASE RESISTA | 0.267 | 0.192 | 0.583 | 5.9e-52 | |
| TAIR|locus:2144613 | 821 | CTR1 "CONSTITUTIVE TRIPLE RESP | 0.270 | 0.221 | 0.575 | 7e-52 |
| TAIR|locus:2084314 AT3G06620 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1876 (665.4 bits), Expect = 1.2e-193, P = 1.2e-193
Identities = 379/681 (55%), Positives = 467/681 (68%)
Query: 7 PAEELLRKIQELEAGQEHLKQELSKLKISNDPKSEXXXXXXXXXHHQQRSHSVSPRRPRL 66
PAEELL+KI ELE QEHLKQE+S+LK+S + + QRSHSVSP RP
Sbjct: 5 PAEELLKKILELEESQEHLKQEMSRLKVSTELR--------------QRSHSVSPHRP-- 48
Query: 67 AGPASRRKGGGTGPDAASAWKATNSASFRHSSPLQRESKXXXXXXXXXXXXXXXXPSAFN 126
+RR G + A +W+ + +ASFR++SPL++ES+ PSA
Sbjct: 49 ----ARRNIG----EGAPSWRKSGAASFRNASPLRKESRIQNSMRLRSEVGGGG-PSAGK 99
Query: 127 FTDRQYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFD 186
FTD+QYLNILQSM Q+VH FDL+ RII+WN AE +YGYSA EALG++ I ++ D RD
Sbjct: 100 FTDKQYLNILQSMAQAVHAFDLNMRIIFWNAMAEKVYGYSAAEALGENPINVIADDRDAA 159
Query: 187 VAYDIVHRIKMGERWTGQFPAKTKTEERVLVVATNTPFYDDDGTLVGIVCVSTDSRPFQE 246
A +I R GE WTG+FP K+K+ +R V T +PFYDDDG L+GI+C+++++ P+
Sbjct: 160 FAMNIARRCVRGESWTGEFPVKSKSGDRFSAVTTCSPFYDDDGALMGIICITSNTAPYLN 219
Query: 247 TRAALWDTKNSDTDSNINRP-RNT------------VTAKLGLDSQQPLQATIASKISNL 293
R +L K + + P RN+ V +KLGLDS QP+Q IASKIS+L
Sbjct: 220 PRISLAKLKAQEEGETSSIPARNSFASKLGLDSRGAVISKLGLDSDQPIQVAIASKISDL 279
Query: 294 ATKVSNKVKSRIRTGDNFMD-REXXXXXXXXXXXXXXXAALSDHREDGMSSGASTPRGDV 352
A+KVSNKV+S++R GDN E A L DHR+D SSGASTPRGD
Sbjct: 280 ASKVSNKVRSKMRAGDNSATLSEGGSGDSHQKDHNVFGATLVDHRDDAASSGASTPRGDF 339
Query: 353 PPCPFGVFSHVDEKSPGKSVRDSGDESEGKPAIHKIITSKAEQWMGKKGLSWPWKGNERE 412
PFGVF+ DEK K +DS DES+GKPAIHK++TSKAE+WM KKGLSWPWKGNE+E
Sbjct: 340 IQSPFGVFTCNDEKFVSKPFKDSSDESDGKPAIHKVLTSKAEEWMVKKGLSWPWKGNEQE 399
Query: 413 GSDAKTARFAWPWSHGDQDNESVQQKSPSYGTKPESHMYEGNRSVNNEXXXXXXXXXXXX 472
GS + WPW +Q E Q +PS G + ESH +E N+ +NNE
Sbjct: 400 GSKGRPTNSVWPWVQNEQKKERCHQINPSAGVQYESHAFESNKPINNEASSLWSSPINAN 459
Query: 473 XXXXXXXXXXXXXXXXNKVDLDNDCLDYEILWEDLTIGEQIGQGSCGTVYHAVWYGSDVA 532
NKVD D++ L+YEILW+DLTIGEQ+GQGSCGTVYH +W+GSDVA
Sbjct: 460 STSSASSCGSTSSSVMNKVDTDSEGLEYEILWDDLTIGEQVGQGSCGTVYHGLWFGSDVA 519
Query: 533 VKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRL 592
VKVFS+QEYS EVI SF+QEV LMKRLRHPNVLLFMGAVTSPQRLCIV+EFLPRGSLFRL
Sbjct: 520 VKVFSKQEYSAEVIESFKQEVLLMKRLRHPNVLLFMGAVTSPQRLCIVSEFLPRGSLFRL 579
Query: 593 LQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLS 652
LQ++T+KLDWRRRI MALDIARG++YLHHC+PPIIHRDLKSSNLLVDK+WTVKV DFGLS
Sbjct: 580 LQKSTSKLDWRRRIHMALDIARGMNYLHHCSPPIIHRDLKSSNLLVDKNWTVKVADFGLS 639
Query: 653 RLKHETYLTTKTGKGTVTYLA 673
R+KHETYLT+K+GKGT ++A
Sbjct: 640 RIKHETYLTSKSGKGTPQWMA 660
|
|
| TAIR|locus:2158019 AT5G49470 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1378 (490.1 bits), Expect = 3.0e-181, Sum P(3) = 3.0e-181
Identities = 288/584 (49%), Positives = 359/584 (61%)
Query: 23 EHLKQELSKLKISNDPKSEXXXXXXXXXHHQQRSHSVSPRRPRLAGPASRRKGGGTGPDA 82
E L +++ +L+ S + +QRSHS SP+RP R GT P
Sbjct: 9 EELLKKIRELEESQEHLKREMSRLKVSAEMKQRSHSASPQRP-----VRRNSNDGT-P-- 60
Query: 83 ASAWKATNSASFRHSSPLQRESKXXXXXXXXXXXXXXXXPSAFNFTDRQYLNILQSMGQS 142
W+ T +ASFRH+SPL++ES SA FTD+QYLNILQSM Q+
Sbjct: 61 --MWRKTGAASFRHASPLRKESHAKVAGGGGEGQ------SAGKFTDKQYLNILQSMAQA 112
Query: 143 VHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGERWT 202
VH+FDL+ +II+WN AE LYG+SA EALG+D I++L D +D VA +I R GE WT
Sbjct: 113 VHVFDLNGQIIFWNSMAEKLYGFSASEALGKDPIDILVDVQDASVAQNITRRCSSGESWT 172
Query: 203 GQFPAKTKTEERVLVVATNTPFYDDDGTLVGIVCVSTDSRPFQETRAALWDTKNS-DTDS 261
G+FP K K ER VV T +P YDDDG L+GI+C++ DS FQ+ R + T+ + ++
Sbjct: 173 GEFPVKNKAGERFSVVTTMSPSYDDDGCLIGIICITNDSALFQDPRGSPAKTRRGQEGET 232
Query: 262 NINR------------PRNTVTAKLGLDSQQPLQATIASKISNLATKVSNKVKSRIRTGD 309
+ +R + V +KLGLDSQQP+Q IASKIS+L V NKVKS++R GD
Sbjct: 233 SFSRVTSSVASKLGLDSKEAVVSKLGLDSQQPIQVAIASKISDL---VGNKVKSKMRAGD 289
Query: 310 N-FMDREXXXXXXXXXXXXXXXAALSDHREDGMSSGASTPRGDVPPCPFGVFSHVDEKSP 368
N + E AA +D RED +SGA TPRGD PFGVF DEK+
Sbjct: 290 NNAANLEGGSGDSHQSDQGFFDAAFADRREDAATSGADTPRGDFIQSPFGVFLRSDEKAS 349
Query: 369 GKSVRDSGDESEGKPAIHKIITSKAEQWMGKKGLSWPWKGNEREGSDAKTARFAWPWSHG 428
K RDS DES+G + K +TSKAE+WM KKGLSWPWKGNEREG + + + WPW
Sbjct: 350 TKPFRDSSDESDGNSVVPKTLTSKAEEWMVKKGLSWPWKGNEREGLEGRRSHSVWPWVRN 409
Query: 429 DQDNESVQQKSPSYGTKPESHMYEGNRSVNNEXXXXXXXXXXXXXXXXXXXXXXXXXXXX 488
+Q + Q + ++ K ES E ++ +NE
Sbjct: 410 EQQKQQAYQSNSNHSVKSESQACESIKASSNEPMGYWSSSVNVNSTSSSSSCGSTSSSVM 469
Query: 489 NKVDLDNDCLDYEILWEDLTIGEQIGQGSCGTVYHAVWYGSDVAVKVFSRQEYSDEVIHS 548
NKVD+D+DCLDYEILWEDLTIGEQIGQGSCGTVYH +W+GSDVAVKVFS+QEYS+E+I S
Sbjct: 470 NKVDMDSDCLDYEILWEDLTIGEQIGQGSCGTVYHGLWFGSDVAVKVFSKQEYSEEIITS 529
Query: 549 FRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRL 592
FRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPR L L
Sbjct: 530 FRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRFGLITL 573
|
|
| TAIR|locus:2200296 AT1G67890 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1732 (614.8 bits), Expect = 2.1e-178, P = 2.1e-178
Identities = 357/664 (53%), Positives = 434/664 (65%)
Query: 23 EHLKQELSKLKISNDPKSEXXXXXXXXXHHQQRSHSVSPRRPRLAGPASRRKGGGTGPDA 82
E L +++ +L+ S + ++RSHS SP+RP SRR G P
Sbjct: 9 EKLLKKIRELEESQEDLKREMSKLKVSAEIKRRSHSSSPKRP------SRRNSGEGTP-- 60
Query: 83 ASAWKATNSASFRHSSPLQRESKXXXXXXXXXXXXXXXXPSAFNFTDRQYLNILQSMGQS 142
W+ T +ASFRH+SPL++ES PSA FTD+QYLNILQSM Q+
Sbjct: 61 --LWRKTGAASFRHASPLRKESHSKDGVAGGGDG-----PSAGKFTDKQYLNILQSMAQA 113
Query: 143 VHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGERWT 202
VH+FDL+ +II+WN AE LYG+SA EALG+D+I +L DG+D VA +I R GE WT
Sbjct: 114 VHVFDLNGQIIFWNSMAEKLYGFSAAEALGKDSINILVDGQDAAVAKNIFQRCSSGESWT 173
Query: 203 GQFPAKTKTEERVLVVATNTPFYDDDGTLVGIVCVSTDSRPFQETRAALWDTKNSDTDSN 262
G+FP K K ER VV T +PFYDDDG L+GI+C++ DS FQ R + + DS+
Sbjct: 174 GEFPVKNKMGERFSVVTTISPFYDDDGLLIGIICITNDSALFQRPRVPPAKNRWQEGDSS 233
Query: 263 INRPRN------------TVTAKLGLDSQQPLQATIASKISNLATKVSNKVKSRIRTGDN 310
R N V +KLGLDSQQP+QA IASKIS+LA+KV NKV+S++R GDN
Sbjct: 234 FCRGTNGVASRLGFDSKEAVVSKLGLDSQQPIQAAIASKISDLASKVGNKVRSKMRAGDN 293
Query: 311 FMDR-EXXXXXXXXXXXXXXXAALSDHREDGMSSGASTPRGDVPPCPFGVFSHVDEKSPG 369
E AA SD RED ++ ASTPRG++ PFGVF D+KS
Sbjct: 294 NASHPEGGNGGSHQSDQGFFDAAFSDQREDAETNDASTPRGNLIQSPFGVFLCNDDKSSS 353
Query: 370 KSVRDSGDESEGKPAIHKIITSKAEQWMGKKGLSWPWKGNEREGSDAKTARFAWPWSHGD 429
K+ +S DE++ + K +TSK E+WM KKGLSWPWKGNEREG + + A WPW H +
Sbjct: 354 KASGESNDENDRNSVVPKKLTSKTEEWMVKKGLSWPWKGNEREGLERRNAHSVWPWVHNE 413
Query: 430 QDNESVQQKSPSYGTKPESHMYEGNRSVNNEXXXXXXXXXXXXXXXXXXXXXXXXXXXXN 489
Q E + K ES E N+ NNE N
Sbjct: 414 QQKEEAHHSNSYNSVKSESLASESNKPANNENMGSVNVNSASSASSCGSTSSSVM----N 469
Query: 490 KVDLDNDCLDYEILWEDLTIGEQIGQGSCGTVYHAVWYGSDVAVKVFSRQEYSDEVIHSF 549
KVD+D+DCLDYEILWEDLTIGEQIGQGSCGTVYH +W+GSDVAVKVFS+QEYS+E+I SF
Sbjct: 470 KVDMDSDCLDYEILWEDLTIGEQIGQGSCGTVYHGLWFGSDVAVKVFSKQEYSEEIITSF 529
Query: 550 RQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMA 609
+QEVSLMKRLRHPNVLLFMGAV SPQRLCIVTEFLPRGSLFRLLQRN +KLD RRRI MA
Sbjct: 530 KQEVSLMKRLRHPNVLLFMGAVASPQRLCIVTEFLPRGSLFRLLQRNKSKLDLRRRIHMA 589
Query: 610 LDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTV 669
DIARG++YLHHC+PPIIHRDLKSSNLLVD++WTVKV DFGLSR+KHETYLTT G+GT
Sbjct: 590 SDIARGMNYLHHCSPPIIHRDLKSSNLLVDRNWTVKVADFGLSRIKHETYLTTN-GRGTP 648
Query: 670 TYLA 673
++A
Sbjct: 649 QWMA 652
|
|
| TAIR|locus:2084304 AT3G06630 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1585 (563.0 bits), Expect = 1.4e-170, Sum P(2) = 1.4e-170
Identities = 306/553 (55%), Positives = 388/553 (70%)
Query: 122 PSAFNFTDRQYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTD 181
PS FTD+QYLNILQS+ QSVH+ DL+ RII+WN +E LYGYSA E +G++ + ++ D
Sbjct: 56 PSPGKFTDKQYLNILQSLAQSVHVLDLNTRIIFWNAMSEKLYGYSAAEVVGRNPVHVIVD 115
Query: 182 GRDFDVAYDIVHRIKMGERWTGQFPAKTKTEERVLVVATNTPFYDDDGTLVGIVCVSTDS 241
++ A ++ R GE WTG+FP KTK+ + V T +PFYDD+GT+VGI+ +++D
Sbjct: 116 DQNAAFALNVARRCANGESWTGEFPVKTKSGKIFSAVTTCSPFYDDNGTVVGIISITSDI 175
Query: 242 RPFQETRAALWDTKNSDTDSNINRP-RNTVTAKLGLDSQQPLQATIASKISNLATKVSNK 300
P+ R +L K + + + + V +K GLDS QP+Q +IASKIS+LA+K+SNK
Sbjct: 176 APYLNPRLSLPRLKPQEPERKLGLDSKGAVISKPGLDSDQPIQVSIASKISSLASKLSNK 235
Query: 301 VKSRIRTGDNFMDREXXXXXXXXXXXXXXXAALSDHREDGMSSGASTPRGDVPPCPFGVF 360
V+S++R GDN LSDHR+D SSGASTPRGD PFGVF
Sbjct: 236 VRSKMRAGDN-----SACGDSHHSDHDVFGDTLSDHRDDAASSGASTPRGDFIQSPFGVF 290
Query: 361 SHVDEKSPGKSVRDSGDESEGKPAIHKIITSKAEQWMGKKGLSWPWKGNEREGSDAKTAR 420
+ D+K P K +DS D KPAIHK+ TSKAE+WM KKGLS PWKGNE+EGS +
Sbjct: 291 TCYDDKFPSKPSKDSSDR---KPAIHKVPTSKAEEWMVKKGLSRPWKGNEQEGSRVRPTH 347
Query: 421 FAWPWSHGDQDNESVQQKSPSYGTKPESHMYEGNRSVNNEXXXXXXXXXXXXXXXXXXXX 480
W W +Q+ + Q PS G K ESH E N+ ++E
Sbjct: 348 SVWSWVENEQEKDKYHQIYPSAGVKSESHGSESNKPTDDEASNMWSSSINANSTNSASSC 407
Query: 481 XXXXXXXXNKVDLDNDCLDYEILWEDLTIGEQIGQGSCGTVYHAVWYGSDVAVKVFSRQE 540
+KVD+D+D L++EILW+DLTIGEQIG+GSCGTVYH +W+GSDVAVKVFS+QE
Sbjct: 408 GSTSRSVMDKVDIDSDPLEHEILWDDLTIGEQIGRGSCGTVYHGIWFGSDVAVKVFSKQE 467
Query: 541 YSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKL 600
YS+ VI SF +EVSLMKRLRHPNVLLFMGAVTSPQRLCIV+EF+PRGSLFRLLQR+ +KL
Sbjct: 468 YSESVIKSFEKEVSLMKRLRHPNVLLFMGAVTSPQRLCIVSEFVPRGSLFRLLQRSMSKL 527
Query: 601 DWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYL 660
DWRRRI MALDIARG++YLH C+PPIIHRDLKSSNLLVD++WTVKV DFGLSR+KH+TYL
Sbjct: 528 DWRRRINMALDIARGMNYLHCCSPPIIHRDLKSSNLLVDRNWTVKVADFGLSRIKHQTYL 587
Query: 661 TTKTGKGTVTYLA 673
T+K+GKGT ++A
Sbjct: 588 TSKSGKGTPQWMA 600
|
|
| TAIR|locus:2127228 AT4G23050 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 556 (200.8 bits), Expect = 1.4e-76, Sum P(2) = 1.4e-76
Identities = 101/185 (54%), Positives = 142/185 (76%)
Query: 489 NKVDLDNDCLDYEILWEDLTIGEQIGQGSCGTVYHAVWYGSDVAVKVFSRQEYSDEVIHS 548
N++ D+ C EI WEDL +GE++G+GS V+ VW GSDVA+KV+ +Y+ +
Sbjct: 453 NRLVTDSSC---EIRWEDLQLGEEVGRGSFAAVHRGVWNGSDVAIKVYFDGDYNAMTLTE 509
Query: 549 FRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILM 608
++E+++MK+LRHPNVLLFMGAV + ++ I+ E++PRGSLF++L LD +RR+ M
Sbjct: 510 CKKEINIMKKLRHPNVLLFMGAVCTEEKSAIIMEYMPRGSLFKILHNTNQPLDKKRRLRM 569
Query: 609 ALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGT 668
ALD+ARG++YLH NPPI+HRDLKSSNLLVDK+W VKVGDFGLS+ K+ T+L+TK+GKGT
Sbjct: 570 ALDVARGMNYLHRRNPPIVHRDLKSSNLLVDKNWNVKVGDFGLSKWKNATFLSTKSGKGT 629
Query: 669 VTYLA 673
++A
Sbjct: 630 PQWMA 634
|
|
| TAIR|locus:2027794 AT1G73660 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 597 (215.2 bits), Expect = 1.3e-58, Sum P(2) = 1.3e-58
Identities = 113/185 (61%), Positives = 142/185 (76%)
Query: 489 NKVDLDNDCLDYEILWEDLTIGEQIGQGSCGTVYHAVWYGSDVAVKVFSRQEYSDEVIHS 548
+K D D D D EILWE++T+GE+IG GS G VY W+G++VAVK F Q+ + E +
Sbjct: 731 SKSDCD-DVSDCEILWEEITVGERIGLGSYGEVYRGDWHGTEVAVKKFLDQDLTGEALEE 789
Query: 549 FRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILM 608
FR EV +MK+LRHPN++LFMGAVT P L IVTEFLPRGSL+RL+ R +LD RRR+ M
Sbjct: 790 FRSEVRIMKKLRHPNIVLFMGAVTRPPNLSIVTEFLPRGSLYRLIHRPNNQLDERRRLRM 849
Query: 609 ALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGT 668
ALD ARG++YLH CNP I+HRDLKS NLLVDK+W VKV DFGLSR+KH TYL++K+ GT
Sbjct: 850 ALDAARGMNYLHSCNPMIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHSTYLSSKSTAGT 909
Query: 669 VTYLA 673
++A
Sbjct: 910 AEWMA 914
|
|
| TAIR|locus:2194055 AT1G18160 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 565 (203.9 bits), Expect = 6.7e-54, P = 6.7e-54
Identities = 106/179 (59%), Positives = 136/179 (75%)
Query: 495 NDCLDYEILWEDLTIGEQIGQGSCGTVYHAVWYGSDVAVKVFSRQEYSDEVIHSFRQEVS 554
+D + EILWE++T+ E+IG GS G VY W+G+ VAVK F Q+ + E + FR EV
Sbjct: 703 DDVAECEILWEEITVAERIGLGSYGEVYRGDWHGTAVAVKKFIDQDITGEALEEFRSEVR 762
Query: 555 LMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIAR 614
+M+RLRHPN++LFMGAVT P L IVTEFLPRGSL+RL+ R +LD R+R+ MALD AR
Sbjct: 763 MMRRLRHPNIVLFMGAVTRPPNLSIVTEFLPRGSLYRLIHRPNNQLDERKRLRMALDAAR 822
Query: 615 GVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTVTYLA 673
G++YLH CNP I+HRDLKS NLLVDK+W VKV DFGLSR+K TYL++K+ GT ++A
Sbjct: 823 GMNYLHSCNPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKVSTYLSSKSTAGTAEWMA 881
|
|
| TAIR|locus:2143009 AT5G11850 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 553 (199.7 bits), Expect = 7.2e-53, P = 7.2e-53
Identities = 103/174 (59%), Positives = 135/174 (77%)
Query: 500 YEILWEDLTIGEQIGQGSCGTVYHAVWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRL 559
+EI+WEDL IGE+IG GS G VY A W G++VAVK F Q++S + + F+ E+ +M RL
Sbjct: 602 WEIMWEDLQIGERIGIGSYGEVYRAEWNGTEVAVKKFLDQDFSGDALTQFKSEIEIMLRL 661
Query: 560 RHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYL 619
RHPNV+LFMGAVT P I+TEFLPRGSL+RLL R +LD +RR+ MALD+A+G++YL
Sbjct: 662 RHPNVVLFMGAVTRPPNFSILTEFLPRGSLYRLLHRPNHQLDEKRRMRMALDVAKGMNYL 721
Query: 620 HHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTVTYLA 673
H +P ++HRDLKS NLLVDK+W VKV DFGLSR+KH TYL++K+ GT ++A
Sbjct: 722 HTSHPTVVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHHTYLSSKSTAGTPEWMA 775
|
|
| TAIR|locus:2025515 EDR1 "ENHANCED DISEASE RESISTANCE 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 546 (197.3 bits), Expect = 5.9e-52, P = 5.9e-52
Identities = 105/180 (58%), Positives = 133/180 (73%)
Query: 494 DNDCLDYEILWEDLTIGEQIGQGSCGTVYHAVWYGSDVAVKVFSRQEYSDEVIHSFRQEV 553
D D + EI W DL I E+IG GS G VYHA W+G++VAVK F Q++S + FR EV
Sbjct: 656 DADVGECEIPWNDLVIAERIGLGSYGEVYHADWHGTEVAVKKFLDQDFSGAALAEFRSEV 715
Query: 554 SLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIA 613
+M+RLRHPNV+ F+GAVT P L IVTEFLPRGSL+R+L R + +D RRRI MALD+A
Sbjct: 716 RIMRRLRHPNVVFFLGAVTRPPNLSIVTEFLPRGSLYRILHRPKSHIDERRRIKMALDVA 775
Query: 614 RGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTVTYLA 673
G++ LH P I+HRDLK+ NLLVD +W VKVGDFGLSRLKH T+L++K+ GT ++A
Sbjct: 776 MGMNCLHTSTPTIVHRDLKTPNLLVDNNWNVKVGDFGLSRLKHNTFLSSKSTAGTPEWMA 835
|
|
| TAIR|locus:2144613 CTR1 "CONSTITUTIVE TRIPLE RESPONSE 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 542 (195.9 bits), Expect = 7.0e-52, P = 7.0e-52
Identities = 107/186 (57%), Positives = 142/186 (76%)
Query: 490 KVDLDNDCLDYEILWEDLTIGEQIGQGSCGTVYHAVWYGSDVAVKVFSRQEYSDEVIHSF 549
++ LD D D +I W DL I E+IG GS GTV+ A W+GSDVAVK+ Q++ E ++ F
Sbjct: 536 ELGLDGD--DMDIPWCDLNIKEKIGAGSFGTVHRAEWHGSDVAVKILMEQDFHAERVNEF 593
Query: 550 RQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTK--LDWRRRIL 607
+EV++MKRLRHPN++LFMGAVT P L IVTE+L RGSL+RLL ++ + LD RRR+
Sbjct: 594 LREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLS 653
Query: 608 MALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKG 667
MA D+A+G++YLH+ NPPI+HRDLKS NLLVDK +TVKV DFGLSRLK T+L++K+ G
Sbjct: 654 MAYDVAKGMNYLHNRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAG 713
Query: 668 TVTYLA 673
T ++A
Sbjct: 714 TPEWMA 719
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries 
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server 
Original result from Ezypred Server
Fail to connect to Ezypred Server
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING 
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against CDD database part I
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 674 | |||
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 5e-51 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 7e-50 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 5e-49 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 2e-48 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 3e-48 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 5e-45 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 3e-42 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 9e-33 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 9e-30 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 1e-28 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 2e-27 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 2e-27 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 2e-26 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 2e-26 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 4e-26 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 9e-26 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 1e-25 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 1e-25 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 2e-25 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 4e-25 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 6e-25 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 1e-24 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 1e-24 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 1e-24 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 7e-24 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 7e-24 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 2e-23 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 4e-23 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 7e-23 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 1e-22 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 2e-22 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 3e-22 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 5e-22 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 1e-21 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 1e-21 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 2e-21 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 2e-21 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 3e-21 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 3e-21 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 3e-21 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 5e-21 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 6e-21 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 1e-20 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 3e-20 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 6e-20 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 8e-20 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 9e-20 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 1e-19 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 1e-19 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 2e-19 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 2e-19 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 3e-19 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 3e-19 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 3e-19 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 8e-19 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 1e-18 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 1e-18 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 2e-18 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 2e-18 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 2e-18 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 2e-18 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 3e-18 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 4e-18 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 4e-18 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 5e-18 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 8e-18 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 1e-17 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 1e-17 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 1e-17 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 1e-17 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 2e-17 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 2e-17 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 2e-17 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 3e-17 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 3e-17 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 4e-17 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 4e-17 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 9e-17 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 9e-17 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 1e-16 | |
| pfam13426 | 101 | pfam13426, PAS_9, PAS domain | 2e-16 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 2e-16 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 2e-16 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 2e-16 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 2e-16 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 3e-16 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 3e-16 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 3e-16 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 4e-16 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 4e-16 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 5e-16 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 5e-16 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 6e-16 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 7e-16 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 8e-16 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 8e-16 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 1e-15 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 1e-15 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 2e-15 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 2e-15 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 2e-15 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 2e-15 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 2e-15 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 3e-15 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 3e-15 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 4e-15 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 5e-15 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 5e-15 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 5e-15 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 5e-15 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 6e-15 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 6e-15 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 7e-15 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 7e-15 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 7e-15 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 1e-14 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 1e-14 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 1e-14 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 1e-14 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 2e-14 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 3e-14 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 6e-14 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 7e-14 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 7e-14 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 9e-14 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 9e-14 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 1e-13 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 1e-13 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 1e-13 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 1e-13 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 2e-13 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 2e-13 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 3e-13 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 4e-13 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 4e-13 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 4e-13 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 5e-13 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 5e-13 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 5e-13 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 6e-13 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 7e-13 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 8e-13 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 9e-13 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 9e-13 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 9e-13 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 1e-12 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 1e-12 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 1e-12 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 1e-12 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 2e-12 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 2e-12 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 2e-12 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 2e-12 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 2e-12 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 2e-12 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 3e-12 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 3e-12 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 3e-12 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 4e-12 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 4e-12 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 5e-12 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 5e-12 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 6e-12 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 6e-12 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 8e-12 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 1e-11 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 1e-11 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 1e-11 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 1e-11 | |
| pfam00989 | 113 | pfam00989, PAS, PAS fold | 2e-11 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 2e-11 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 2e-11 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 2e-11 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 2e-11 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 3e-11 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 3e-11 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 3e-11 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 3e-11 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 3e-11 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 4e-11 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 4e-11 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 5e-11 | |
| cd00130 | 103 | cd00130, PAS, PAS domain; PAS motifs appear in arc | 6e-11 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 6e-11 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 9e-11 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 9e-11 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 1e-10 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 1e-10 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 2e-10 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 2e-10 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 2e-10 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 3e-10 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 3e-10 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 3e-10 | |
| COG2202 | 232 | COG2202, AtoS, FOG: PAS/PAC domain [Signal transdu | 3e-10 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 5e-10 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 5e-10 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 5e-10 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 5e-10 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 6e-10 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 7e-10 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 8e-10 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 9e-10 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 9e-10 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 9e-10 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 9e-10 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 1e-09 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 1e-09 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 2e-09 | |
| TIGR00229 | 124 | TIGR00229, sensory_box, PAS domain S-box | 2e-09 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 2e-09 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 2e-09 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 2e-09 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 2e-09 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 2e-09 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 2e-09 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 3e-09 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 3e-09 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 3e-09 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 3e-09 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 4e-09 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 4e-09 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 4e-09 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 5e-09 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 7e-09 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 9e-09 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 1e-08 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 1e-08 | |
| smart00091 | 67 | smart00091, PAS, PAS domain | 1e-08 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 1e-08 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 1e-08 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 2e-08 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 2e-08 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 2e-08 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 2e-08 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 3e-08 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 3e-08 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 4e-08 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 4e-08 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 7e-08 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 8e-08 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 8e-08 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 9e-08 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 1e-07 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 1e-07 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 1e-07 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 3e-07 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 3e-07 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 4e-07 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 5e-07 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 6e-07 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 6e-07 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 8e-07 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 9e-07 | |
| pfam08448 | 110 | pfam08448, PAS_4, PAS fold | 1e-06 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 1e-06 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 1e-06 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 2e-06 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 2e-06 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 2e-06 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 2e-06 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 3e-06 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 3e-06 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 3e-06 | |
| COG3829 | 560 | COG3829, RocR, Transcriptional regulator containin | 5e-06 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 6e-06 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 7e-06 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 7e-06 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 8e-06 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 9e-06 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 9e-06 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 1e-05 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 1e-05 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 1e-05 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 1e-05 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 1e-05 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 1e-05 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 3e-05 | |
| pfam13188 | 64 | pfam13188, PAS_8, PAS domain | 3e-05 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 4e-05 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 5e-05 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 5e-05 | |
| PRK14879 | 211 | PRK14879, PRK14879, serine/threonine protein kinas | 8e-05 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 1e-04 | |
| PRK11360 | 607 | PRK11360, PRK11360, sensory histidine kinase AtoS; | 1e-04 | |
| COG3642 | 204 | COG3642, COG3642, Mn2+-dependent serine/threonine | 1e-04 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 1e-04 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 1e-04 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 2e-04 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 2e-04 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 3e-04 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 3e-04 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 4e-04 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 5e-04 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 0.001 | |
| pfam08447 | 90 | pfam08447, PAS_3, PAS fold | 0.001 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 0.001 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 0.001 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 0.002 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 0.002 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 0.002 | |
| TIGR03724 | 199 | TIGR03724, arch_bud32, Kae1-associated kinase Bud3 | 0.003 | |
| PRK11359 | 799 | PRK11359, PRK11359, cyclic-di-GMP phosphodiesteras | 0.003 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 0.003 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 0.004 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 0.004 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 177 bits (451), Expect = 5e-51
Identities = 64/167 (38%), Positives = 95/167 (56%), Gaps = 9/167 (5%)
Query: 507 LTIGEQIGQGSCGTVYHAVWYGS------DVAVKVFSRQEYSDEVIHSFRQEVSLMKRLR 560
L +G+++G+G+ G VY G VAVK ++ S+E F +E S+MK+L
Sbjct: 1 LELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTL-KEGASEEEREEFLEEASIMKKLS 59
Query: 561 HPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLH 620
HPN++ +G T + L IVTE++P G L L+++ KL + + MAL IA+G+ YL
Sbjct: 60 HPNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEYLE 119
Query: 621 HCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKG 667
N +HRDL + N LV ++ VK+ DFGLSR +E K G G
Sbjct: 120 SKN--FVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGG 164
|
Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 174 bits (443), Expect = 7e-50
Identities = 65/174 (37%), Positives = 99/174 (56%), Gaps = 10/174 (5%)
Query: 507 LTIGEQIGQGSCGTVYHAVWYGS------DVAVKVFSRQEYSDEVIHSFRQEVSLMKRLR 560
LT+G+++G+G+ G VY G +VAVK +++ S++ I F +E +M++L
Sbjct: 1 LTLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKT-LKEDASEQQIEEFLREARIMRKLD 59
Query: 561 HPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLH 620
HPNV+ +G T + L IV E++ G L L++N KL + AL IARG+ YL
Sbjct: 60 HPNVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEYLE 119
Query: 621 HCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSR-LKHETYLTTKTGKGTVTYLA 673
N IHRDL + N LV ++ VK+ DFGLSR L + Y + GK + ++A
Sbjct: 120 SKN--FIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWMA 171
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 172 bits (437), Expect = 5e-49
Identities = 59/169 (34%), Positives = 90/169 (53%), Gaps = 5/169 (2%)
Query: 507 LTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNV 564
+ ++G GS GTVY A G VAVK+ ++ + + R+E+ +++RL HPN+
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNI 60
Query: 565 LLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNP 624
+ + A L +V E+ G LF L R L +AL I RG+ YLH
Sbjct: 61 VRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRG-GPLSEDEAKKIALQILRGLEYLHSNG- 118
Query: 625 PIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTVTYLA 673
IIHRDLK N+L+D++ VK+ DFGL++ ++ + T GT Y+A
Sbjct: 119 -IIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFVGTPWYMA 166
|
Length = 260 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 170 bits (433), Expect = 2e-48
Identities = 65/175 (37%), Positives = 100/175 (57%), Gaps = 11/175 (6%)
Query: 507 LTIGEQIGQGSCGTVYHAVWYGS------DVAVKVFSRQEYSDEVIHSFRQEVSLMKRLR 560
LT+G+++G+G+ G VY G +VAVK +++ S++ I F +E +M++L
Sbjct: 1 LTLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKT-LKEDASEQQIEEFLREARIMRKLD 59
Query: 561 HPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNT-TKLDWRRRILMALDIARGVSYL 619
HPN++ +G T + L IV E++P G L L++N +L + AL IARG+ YL
Sbjct: 60 HPNIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYL 119
Query: 620 HHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSR-LKHETYLTTKTGKGTVTYLA 673
N IHRDL + N LV ++ VK+ DFGLSR L + Y K GK + ++A
Sbjct: 120 ESKN--FIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWMA 172
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 168 bits (427), Expect = 3e-48
Identities = 60/164 (36%), Positives = 87/164 (53%), Gaps = 6/164 (3%)
Query: 513 IGQGSCGTVYHAVWYGSD--VAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGA 570
+G+G GTVY A + VA+K+ +E S ++ +E+ ++K+L HPN++ G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIK-KEDSSSLLEELLREIEILKKLNHPNIVKLYGV 59
Query: 571 VTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRD 630
L +V E+ GSL LL+ N KL + + L I G+ YLH IIHRD
Sbjct: 60 FEDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNG--IIHRD 117
Query: 631 LKSSNLLVDK-HWTVKVGDFGLSRLKHETYLTTKTGKGTVTYLA 673
LK N+L+D + VK+ DFGLS+L KT GT Y+A
Sbjct: 118 LKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMA 161
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 160 bits (408), Expect = 5e-45
Identities = 55/169 (32%), Positives = 85/169 (50%), Gaps = 9/169 (5%)
Query: 508 TIGEQIGQGSCGTVYHAVWYGSD--VAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVL 565
I E++G+GS G VY A + VA+KV +++ + +E+ ++K+L+HPN++
Sbjct: 2 EILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRER-ILREIKILKKLKHPNIV 60
Query: 566 LFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTT-KLDWRRRILMALDIARGVSYLHHCNP 624
+L +V E+ G LF LL++ D R I + YLH
Sbjct: 61 RLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARFY--LRQILSALEYLHSKG- 117
Query: 625 PIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTVTYLA 673
I+HRDLK N+L+D+ VK+ DFGL+R T T GT Y+A
Sbjct: 118 -IVHRDLKPENILLDEDGHVKLADFGLARQLDPGEKLT-TFVGTPEYMA 164
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 153 bits (390), Expect = 3e-42
Identities = 54/171 (31%), Positives = 87/171 (50%), Gaps = 18/171 (10%)
Query: 511 EQIGQGSCGTVYHAVWYGS-----DVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVL 565
+++G+G+ G VY G +VAVK +++ S+E F +E +MK+L HPNV+
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKT-LKEDASEEERKDFLKEARVMKKLGHPNVV 59
Query: 566 LFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNT--------TKLDWRRRILMALDIARGVS 617
+G T + L +V E++ G L L+++ + L + + A+ IA+G+
Sbjct: 60 RLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGME 119
Query: 618 YLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL--KHETYLTTKTGK 666
YL +HRDL + N LV + VK+ DFGLSR + Y GK
Sbjct: 120 YLASKK--FVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGK 168
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 126 bits (320), Expect = 9e-33
Identities = 55/174 (31%), Positives = 92/174 (52%), Gaps = 9/174 (5%)
Query: 506 DLTIGEQIGQGSCGTVYHA--VWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPN 563
+ T GE +G+GS G+VY A G +AVK S+E + + +E+ ++ L+HPN
Sbjct: 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPN 60
Query: 564 VLLFMGAVTSPQR--LCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHH 621
++ + G+ ++ L I E++ GSL LL++ KL I G++YLH
Sbjct: 61 IVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFG-KLPEPVIRKYTRQILEGLAYLHS 119
Query: 622 CNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLT--TKTGKGTVTYLA 673
I+HRD+K +N+LVD VK+ DFG ++ + T + +GT ++A
Sbjct: 120 NG--IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMA 171
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 119 bits (299), Expect = 9e-30
Identities = 49/164 (29%), Positives = 84/164 (51%), Gaps = 14/164 (8%)
Query: 507 LTIGEQIGQGSCGTVYHAVW------YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLR 560
L +Q+G+G G V + G VAVK ++ F +E+ +++ L
Sbjct: 6 LKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSL-NHSGEEQHRSDFEREIEILRTLD 64
Query: 561 HPNVLLFMGAVTSPQR--LCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSY 618
H N++ + G P L ++ E+LP GSL LQR+ +++ +R +L + I +G+ Y
Sbjct: 65 HENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDY 124
Query: 619 LHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL---KHETY 659
L + IHRDL + N+LV+ VK+ DFGL+++ + Y
Sbjct: 125 LG--SQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYY 166
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 115 bits (289), Expect = 1e-28
Identities = 64/180 (35%), Positives = 94/180 (52%), Gaps = 10/180 (5%)
Query: 500 YEILWEDLTIGEQIGQGSCGTVYHAVWYGSD-----VAVKVFSRQEYSDEVIHSFRQEVS 554
YEI ED+T+G IG+G G VY V+ + VAVK + S V F QE
Sbjct: 1 YEIQREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTC-KNCTSPSVREKFLQEAY 59
Query: 555 LMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIAR 614
+M++ HP+++ +G V + + IV E P G L LQ N LD IL + ++
Sbjct: 60 IMRQFDHPHIVKLIG-VITENPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLST 118
Query: 615 GVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSR-LKHETYLTTKTGKGTVTYLA 673
++YL +HRD+ + N+LV VK+GDFGLSR L+ E+Y GK + ++A
Sbjct: 119 ALAYLESKR--FVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMA 176
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 2e-27
Identities = 59/168 (35%), Positives = 89/168 (52%), Gaps = 7/168 (4%)
Query: 500 YEILWEDLTIGEQIGQGSCGTVYHAVWYGS-DVAVKVFSRQEYSDEVIHSFRQEVSLMKR 558
+EI E L + ++G G G V+ W G+ VAVK S E +F QE +MK+
Sbjct: 1 WEIPRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPE---AFLQEAQIMKK 57
Query: 559 LRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNT-TKLDWRRRILMALDIARGVS 617
LRH ++ + + + IVTE++ +GSL L+ KL + + MA IA G++
Sbjct: 58 LRHDKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMA 117
Query: 618 YLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTG 665
YL N IHRDL + N+LV ++ K+ DFGL+RL + T + G
Sbjct: 118 YLESRN--YIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREG 163
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 111 bits (278), Expect = 2e-27
Identities = 58/164 (35%), Positives = 87/164 (53%), Gaps = 9/164 (5%)
Query: 500 YEILWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMK 557
+E+ D+T+ ++G G G VY VW Y VAVK + F +E ++MK
Sbjct: 1 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME---VEEFLKEAAVMK 57
Query: 558 RLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQR-NTTKLDWRRRILMALDIARGV 616
++HPN++ +G T I+TEF+ G+L L+ N +++ + MA I+ +
Sbjct: 58 EIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAM 117
Query: 617 SYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL-KHETY 659
YL N IHRDL + N LV ++ VKV DFGLSRL +TY
Sbjct: 118 EYLEKKN--FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY 159
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 2e-26
Identities = 53/150 (35%), Positives = 79/150 (52%), Gaps = 6/150 (4%)
Query: 505 EDLTIGEQIGQGSCGTVYHAVWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNV 564
++L +G IG+G G V + G VAVK +F E S+M LRHPN+
Sbjct: 6 KELKLGATIGKGEFGDVMLGDYRGQKVAVKCLKDDS---TAAQAFLAEASVMTTLRHPNL 62
Query: 565 LLFMGAVTSPQRLCIVTEFLPRGSLFRLLQ-RNTTKLDWRRRILMALDIARGVSYLHHCN 623
+ +G V L IVTE++ +GSL L+ R + +++ ALD+ G+ YL N
Sbjct: 63 VQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKN 122
Query: 624 PPIIHRDLKSSNLLVDKHWTVKVGDFGLSR 653
+HRDL + N+LV + KV DFGL++
Sbjct: 123 --FVHRDLAARNVLVSEDLVAKVSDFGLAK 150
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 2e-26
Identities = 56/186 (30%), Positives = 89/186 (47%), Gaps = 26/186 (13%)
Query: 499 DYEILWEDLTIGEQIGQGSCGTVYHA--VWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLM 556
YEI+ +QIG+GS G VY G +K S++ EV ++
Sbjct: 1 KYEII-------KQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKIL 53
Query: 557 KRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTK---------LDWRRRIL 607
K+L HPN++ + + +LCIV E+ G L + +++ + LDW ++
Sbjct: 54 KKLNHPNIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLC 113
Query: 608 MALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKG 667
+AL YLH I+HRD+K N+ + + VK+GDFG+S++ T KT G
Sbjct: 114 LALK------YLHSRK--ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVVG 165
Query: 668 TVTYLA 673
T YL+
Sbjct: 166 TPYYLS 171
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 4e-26
Identities = 55/174 (31%), Positives = 93/174 (53%), Gaps = 19/174 (10%)
Query: 510 GEQIGQGSCGTVYHAV--WYGSDVAVK---VFSRQEYSDEVIHSFRQEVSLMKRLRHPNV 564
GE +G GS G+VY + G AVK + + E + QE++L+ +L+HPN+
Sbjct: 5 GELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNI 64
Query: 565 LLFMGAVTSPQRLCIVTEFLPRGSLFRLLQR-----NTTKLDWRRRILMALDIARGVSYL 619
+ ++G L I E +P GSL +LL++ + R+IL+ G+ YL
Sbjct: 65 VQYLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILL------GLEYL 118
Query: 620 HHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTVTYLA 673
H N +HRD+K +N+LVD + VK+ DFG+++ + + K+ KG+ ++A
Sbjct: 119 HDRN--TVHRDIKGANILVDTNGVVKLADFGMAK-QVVEFSFAKSFKGSPYWMA 169
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 9e-26
Identities = 49/152 (32%), Positives = 82/152 (53%), Gaps = 19/152 (12%)
Query: 511 EQIGQGSCGTVYHAVWYGSD------VAVKVFSRQEYSDEVIHS--FRQEVSLMKRLRHP 562
E++G+G+ G VY A D VA+K R + +E I S R E+SL+K L+HP
Sbjct: 5 EKLGEGTYGVVYKAR----DKKTGEIVALKKI-RLDNEEEGIPSTALR-EISLLKELKHP 58
Query: 563 NVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLH-H 621
N++ + + + ++L +V E+ L + L + L + + RG++Y H H
Sbjct: 59 NIVKLLDVIHTERKLYLVFEYCDM-DLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSH 117
Query: 622 CNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSR 653
I+HRDLK N+L+++ +K+ DFGL+R
Sbjct: 118 R---ILHRDLKPQNILINRDGVLKLADFGLAR 146
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 1e-25
Identities = 60/184 (32%), Positives = 93/184 (50%), Gaps = 19/184 (10%)
Query: 500 YEILWEDLTIGEQIGQGSCGTVYHAVWYG-------SDVAVKVFSRQEYSDEVIHSFRQE 552
+E+ E +T+ ++GQGS G VY + G + VA+K + E I F E
Sbjct: 1 WELPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIE-FLNE 59
Query: 553 VSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQ------RNTTKLD---WR 603
S+MK +V+ +G V++ Q +V E + +G L L+ N L +
Sbjct: 60 ASVMKEFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQ 119
Query: 604 RRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTK 663
+ I MA +IA G++YL +HRDL + N +V + TVK+GDFG++R +ET K
Sbjct: 120 KFIQMAAEIADGMAYLAAKK--FVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRK 177
Query: 664 TGKG 667
GKG
Sbjct: 178 GGKG 181
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (265), Expect = 1e-25
Identities = 46/149 (30%), Positives = 87/149 (58%), Gaps = 5/149 (3%)
Query: 506 DLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPN 563
+ +G+ IG+G+ G VY + G VA+K S ++ +E + S QE+ L+K L+HPN
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60
Query: 564 VLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCN 623
++ ++G++ + L I+ E+ GSL +++++ + + +G++YLH
Sbjct: 61 IVKYIGSIETSDSLYIILEYAENGSLRQIIKKF-GPFPESLVAVYVYQVLQGLAYLH--E 117
Query: 624 PPIIHRDLKSSNLLVDKHWTVKVGDFGLS 652
+IHRD+K++N+L K VK+ DFG++
Sbjct: 118 QGVIHRDIKAANILTTKDGVVKLADFGVA 146
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 105 bits (265), Expect = 2e-25
Identities = 52/158 (32%), Positives = 80/158 (50%), Gaps = 24/158 (15%)
Query: 506 DLTIGEQIGQGSCGTVYHAVWY---GSDVAVKV--FSRQEYSDEVIHSFRQEVSLMKRLR 560
I E+IG+G G VY + G +VA+KV +E +++I E+ ++K+ +
Sbjct: 1 LFEILEKIGKGGFGEVY-KARHKRTGKEVAIKVIKLESKEKKEKII----NEIQILKKCK 55
Query: 561 HPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWR------RRILMALDIAR 614
HPN++ + G+ L IV EF GSL LL+ L + +L L+
Sbjct: 56 HPNIVKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLE--- 112
Query: 615 GVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLS 652
YLH IIHRD+K++N+L+ VK+ DFGLS
Sbjct: 113 ---YLHSNG--IIHRDIKAANILLTSDGEVKLIDFGLS 145
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 4e-25
Identities = 53/163 (32%), Positives = 85/163 (52%), Gaps = 7/163 (4%)
Query: 505 EDLTIGEQIGQGSCGTVYHAVWYGS-DVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPN 563
E+ T+ ++G G G V+ +W VA+K+ F++EV +KRLRH +
Sbjct: 6 EEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSD--DLLKQQDFQKEVQALKRLRHKH 63
Query: 564 VLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTK-LDWRRRILMALDIARGVSYLHHC 622
++ + + + I+TE + +GSL L+ + L I MA +A G++YL
Sbjct: 64 LISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQ 123
Query: 623 NPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL-KHETYLTTKT 664
N IHRDL + N+LV + KV DFGL+RL K + YL++
Sbjct: 124 N--SIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDK 164
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 6e-25
Identities = 56/172 (32%), Positives = 80/172 (46%), Gaps = 11/172 (6%)
Query: 505 EDLTIGEQIGQGSCGTVYHAV--WYGSDVAVKVFSRQEYSDEVI-HSFRQEVSLMKRLRH 561
DL + +GQGS G VY G A+K DE +E+ ++
Sbjct: 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKI--HVDGDEEFRKQLLRELKTLRSCES 58
Query: 562 PNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMAL--DIARGVSYL 619
P V+ GA + IV E++ GSL LL++ +L + I +G+ YL
Sbjct: 59 PYVVKCYGAFYKEGEISIVLEYMDGGSLADLLKKVGK---IPEPVLAYIARQILKGLDYL 115
Query: 620 HHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTVTY 671
H IIHRD+K SNLL++ VK+ DFG+S++ T T GTVTY
Sbjct: 116 HTKRH-IIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFVGTVTY 166
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 1e-24
Identities = 55/168 (32%), Positives = 82/168 (48%), Gaps = 7/168 (4%)
Query: 500 YEILWEDLTIGEQIGQGSCGTVYHAVWYGS-DVAVKVFSRQEYSDEVIHSFRQEVSLMKR 558
+EI + + ++G G G V+ +W + VAVK + F E +MK+
Sbjct: 1 WEIDRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPK---DFLAEAQIMKK 57
Query: 559 LRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNT-TKLDWRRRILMALDIARGVS 617
LRHP ++ T + + IVTE + GSL LQ L + I MA +A G++
Sbjct: 58 LRHPKLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMA 117
Query: 618 YLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTG 665
YL N IHRDL + N+LV ++ KV DFGL+R+ E + G
Sbjct: 118 YLEAQN--YIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREG 163
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 1e-24
Identities = 61/169 (36%), Positives = 86/169 (50%), Gaps = 12/169 (7%)
Query: 506 DLTIGEQIGQGSCGTVYHAVWYGS-----DVAVKVFSRQEYSDEVIHSFRQEVSLMKRLR 560
+TI + IG G G V DVA+K + SD+ F E S+M +
Sbjct: 5 YVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTL-KAGSSDKQRLDFLTEASIMGQFD 63
Query: 561 HPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLH 620
HPN++ G VT + + I+TE++ GSL + L+ N K + + M IA G+ YL
Sbjct: 64 HPNIIRLEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLS 123
Query: 621 HCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHE---TYLTTKTGK 666
N +HRDL + N+LV+ + KV DFGLSR + TY TTK GK
Sbjct: 124 EMN--YVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATY-TTKGGK 169
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 1e-24
Identities = 51/149 (34%), Positives = 76/149 (51%), Gaps = 6/149 (4%)
Query: 506 DLTIGEQIGQGSCGTVYHAVWYGS-DVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNV 564
+LT +++G G G V+ W G DVA+K+ S++ F +E +M +L HPN+
Sbjct: 5 ELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAMSED---DFIEEAKVMMKLSHPNL 61
Query: 565 LLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNP 624
+ G T + + IVTE++ G L L+ KL + M D+ + YL
Sbjct: 62 VQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNG- 120
Query: 625 PIIHRDLKSSNLLVDKHWTVKVGDFGLSR 653
IHRDL + N LV + VKV DFGL+R
Sbjct: 121 -FIHRDLAARNCLVGEDNVVKVSDFGLAR 148
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 7e-24
Identities = 55/160 (34%), Positives = 86/160 (53%), Gaps = 4/160 (2%)
Query: 511 EQIGQGSCGTVYHAVW-YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMG 569
E+IG+G+ G VY V ++VAVK R ++ F QE ++K+ HPN++ +G
Sbjct: 1 EKIGKGNFGDVYKGVLKGNTEVAVKT-CRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIG 59
Query: 570 AVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHR 629
Q + IV E +P GSL L++ +L ++ + M+LD A G+ YL N IHR
Sbjct: 60 VCVQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKN--CIHR 117
Query: 630 DLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTV 669
DL + N LV ++ +K+ DFG+SR + T G +
Sbjct: 118 DLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQI 157
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 100 bits (252), Expect = 7e-24
Identities = 55/156 (35%), Positives = 78/156 (50%), Gaps = 24/156 (15%)
Query: 511 EQIGQGSCGTVYHAVWYGS-----DVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVL 565
+++G GS G V W S VAVK + SD ++ F +E ++M L H N++
Sbjct: 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSD-IMDDFLKEAAIMHSLDHENLI 59
Query: 566 LFMGAV-TSPQRLCIVTEFLPRGSLFRLLQRN-------TTKLDWRRRILMALDIARGVS 617
G V T P L +VTE P GSL L+++ +T D+ A+ IA G+
Sbjct: 60 RLYGVVLTHP--LMMVTELAPLGSLLDRLRKDALGHFLISTLCDY------AVQIANGMR 111
Query: 618 YLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSR 653
YL IHRDL + N+L+ VK+GDFGL R
Sbjct: 112 YLESKR--FIHRDLAARNILLASDDKVKIGDFGLMR 145
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (252), Expect = 2e-23
Identities = 44/154 (28%), Positives = 75/154 (48%), Gaps = 8/154 (5%)
Query: 511 EQIGQGSCGTVYHA--VWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFM 568
+IG+G+ G VY A G VA+K + S+ + + +E+ L+K L HPN++ +
Sbjct: 5 GKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLL 64
Query: 569 GAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIH 628
L +V EF+ L++L++ L + +G+++ H I+H
Sbjct: 65 DVFRHKGDLYLVFEFM-DTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHG--ILH 121
Query: 629 RDLKSSNLLVDKHWTVKVGDFGLSRL---KHETY 659
RDLK NLL++ +K+ DFGL+R Y
Sbjct: 122 RDLKPENLLINTEGVLKLADFGLARSFGSPVRPY 155
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 99.0 bits (246), Expect = 4e-23
Identities = 62/168 (36%), Positives = 95/168 (56%), Gaps = 8/168 (4%)
Query: 500 YEILWEDLTIGEQIGQGSCGTVYHAVWYGS-DVAVKVFSRQEYSDEVIHSFRQEVSLMKR 558
+EI E L + ++GQG G V+ W G+ VA+K S E +F QE +MK+
Sbjct: 1 WEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE---AFLQEAQVMKK 57
Query: 559 LRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTK-LDWRRRILMALDIARGVS 617
LRH L+ + AV S + + IVTE++ +GSL L+ K L + + MA IA G++
Sbjct: 58 LRHEK-LVQLYAVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMA 116
Query: 618 YLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTG 665
Y+ N +HRDL+++N+LV ++ KV DFGL+RL + T + G
Sbjct: 117 YVERMN--YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQG 162
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 98.8 bits (247), Expect = 7e-23
Identities = 48/158 (30%), Positives = 88/158 (55%), Gaps = 12/158 (7%)
Query: 511 EQIGQGSCGTVYHA--VWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFM 568
E+IG+G+ G VY A G +VA+K ++ + E+I E+ +MK +HPN++ +
Sbjct: 25 EKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELI---INEILIMKDCKHPNIVDYY 81
Query: 569 GAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIH 628
+ L +V E++ GSL ++ +N +++ + + ++ +G+ YLH + +IH
Sbjct: 82 DSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLH--SQNVIH 139
Query: 629 RDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGK 666
RD+KS N+L+ K +VK+ DFG + LT + K
Sbjct: 140 RDIKSDNILLSKDGSVKLADFGFA-----AQLTKEKSK 172
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 97.4 bits (242), Expect = 1e-22
Identities = 62/168 (36%), Positives = 94/168 (55%), Gaps = 8/168 (4%)
Query: 500 YEILWEDLTIGEQIGQGSCGTVYHAVWYGS-DVAVKVFSRQEYSDEVIHSFRQEVSLMKR 558
+EI E L + ++GQG G V+ W G+ VA+K E +F QE +MK+
Sbjct: 1 WEIPRESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPE---AFLQEAQIMKK 57
Query: 559 LRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTK-LDWRRRILMALDIARGVS 617
LRH + L+ + AV S + + IVTEF+ +GSL L+ K L + + MA IA G++
Sbjct: 58 LRH-DKLVPLYAVVSEEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMA 116
Query: 618 YLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTG 665
Y+ N IHRDL+++N+LV + K+ DFGL+RL + T + G
Sbjct: 117 YIERMN--YIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQG 162
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 97.0 bits (241), Expect = 2e-22
Identities = 61/168 (36%), Positives = 93/168 (55%), Gaps = 8/168 (4%)
Query: 500 YEILWEDLTIGEQIGQGSCGTVYHAVWYG-SDVAVKVFSRQEYSDEVIHSFRQEVSLMKR 558
+EI E L + +++G G G V+ W G + VAVK S E SF +E +MK+
Sbjct: 1 WEIPRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPE---SFLEEAQIMKK 57
Query: 559 LRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTK-LDWRRRILMALDIARGVS 617
LRH + L+ + AV S + + IVTE++ +GSL L+ + L + MA +A G++
Sbjct: 58 LRH-DKLVQLYAVVSEEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMA 116
Query: 618 YLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTG 665
Y+ N IHRDL+S+N+LV K+ DFGL+RL + T + G
Sbjct: 117 YIERMN--YIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQG 162
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 97.1 bits (242), Expect = 3e-22
Identities = 60/178 (33%), Positives = 87/178 (48%), Gaps = 29/178 (16%)
Query: 501 EILWEDLTIGEQIGQGSCGTVYHAVWYG-------SDVAVKVFSRQEYSDEVIHSFRQEV 553
EI + E++G+G+ G VY G + VA+K ++ +V FRQE
Sbjct: 1 EIPLSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTL-KENAEPKVQQEFRQEA 59
Query: 554 SLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNT---------------T 598
LM L+HPN++ +G T Q C++ E+L G L L RN+ +
Sbjct: 60 ELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKS 119
Query: 599 KLDWRRRILMALDIARGVSYL--HHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL 654
LD + +A+ IA G+ YL HH +HRDL + N LV + TVK+ DFGLSR
Sbjct: 120 SLDCSDFLHIAIQIAAGMEYLSSHH----FVHRDLAARNCLVGEGLTVKISDFGLSRD 173
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 96.0 bits (239), Expect = 5e-22
Identities = 54/176 (30%), Positives = 89/176 (50%), Gaps = 15/176 (8%)
Query: 510 GEQIGQGSCGTVYHA--VWYGSDVAVKVFSRQEYSDE--------VIHSFRQEVSLMKRL 559
GE IG+G+ G VY A V G +AVK ++ + R E+ +K L
Sbjct: 6 GELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDL 65
Query: 560 RHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYL 619
H N++ ++G T+ + L I E++P GS+ L R + + + + G++YL
Sbjct: 66 DHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCL-RTYGRFEEQLVRFFTEQVLEGLAYL 124
Query: 620 HHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETY--LTTKTGKGTVTYLA 673
H + I+HRDLK+ NLLVD K+ DFG+S+ + Y + +G+V ++A
Sbjct: 125 H--SKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMA 178
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 95.2 bits (237), Expect = 1e-21
Identities = 52/177 (29%), Positives = 88/177 (49%), Gaps = 16/177 (9%)
Query: 507 LTIGEQIGQGSCGTVYHAVWYGS------DVAVKVFSRQEYSDEVIHSFRQEVSLMKRLR 560
L + +G G+ GTVY VW VA+KV R+E S + E +M +
Sbjct: 9 LEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVL-REETSPKANKEILDEAYVMASVD 67
Query: 561 HPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYL- 619
HP+V+ +G S Q + ++T+ +P G L ++ + + + + + IA+G+SYL
Sbjct: 68 HPHVVRLLGICLSSQ-VQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLE 126
Query: 620 -HHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL--KHETYLTTKTGKGTVTYLA 673
++HRDL + N+LV VK+ DFGL++L E + GK + ++A
Sbjct: 127 EKR----LVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMA 179
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 94.3 bits (235), Expect = 1e-21
Identities = 49/171 (28%), Positives = 85/171 (49%), Gaps = 8/171 (4%)
Query: 505 EDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHP 562
E I E++G+GS G+VY A+ G VA+KV +E + +E+S++K+ P
Sbjct: 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVP----VEEDLQEIIKEISILKQCDSP 58
Query: 563 NVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHC 622
++ + G+ L IV E+ GS+ +++ L + +G+ YLH
Sbjct: 59 YIVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSN 118
Query: 623 NPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTVTYLA 673
IHRD+K+ N+L+++ K+ DFG+S +T T GT ++A
Sbjct: 119 K--KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVIGTPFWMA 167
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 94.1 bits (234), Expect = 2e-21
Identities = 57/168 (33%), Positives = 95/168 (56%), Gaps = 8/168 (4%)
Query: 500 YEILWEDLTIGEQIGQGSCGTVYHAVWYG-SDVAVKVFSRQEYSDEVIHSFRQEVSLMKR 558
+E+ E L + +++G G G V+ + G + VA+K + S E +F E +LMK+
Sbjct: 1 WEVPRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPE---AFLAEANLMKQ 57
Query: 559 LRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNT-TKLDWRRRILMALDIARGVS 617
L+HP L+ + AV + + + I+TE++ GSL L+ KL + I MA IA G++
Sbjct: 58 LQHPR-LVRLYAVVTQEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMA 116
Query: 618 YLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTG 665
++ N IHRDL+++N+LV + K+ DFGL+RL + T + G
Sbjct: 117 FIERKN--YIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREG 162
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 93.9 bits (234), Expect = 2e-21
Identities = 58/184 (31%), Positives = 91/184 (49%), Gaps = 27/184 (14%)
Query: 499 DYEILWEDLTIGEQIGQGSCGTVYHAVWYGSD--VAVKVFSRQEYSDEVIHSFRQEVSLM 556
DYE++ ++IG G+ G VY A + VA+KV + + +QE+S++
Sbjct: 4 DYELI-------QRIGSGTYGDVYKARDIATGELVAIKVIKLEP--GDDFEIIQQEISML 54
Query: 557 KRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIA--- 613
K RHPN++ + G+ +L IV E+ GSL + Q R L L IA
Sbjct: 55 KECRHPNIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVT-------RGPLSELQIAYVC 107
Query: 614 ----RGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTV 669
+G++YLH IHRD+K +N+L+ + VK+ DFG+S T K+ GT
Sbjct: 108 RETLKGLAYLHETG--KIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFIGTP 165
Query: 670 TYLA 673
++A
Sbjct: 166 YWMA 169
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 93.4 bits (232), Expect = 3e-21
Identities = 51/150 (34%), Positives = 79/150 (52%), Gaps = 6/150 (4%)
Query: 505 EDLTIGEQIGQGSCGTVYHAVWYGS-DVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPN 563
+DLT +++G G G V + W G DVA+K+ S++ F +E +M +L H
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED---EFIEEAKVMMKLSHEK 60
Query: 564 VLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCN 623
++ G T + + IVTE++ G L L+ + + + + M D+ G++YL +
Sbjct: 61 LVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLE--S 118
Query: 624 PPIIHRDLKSSNLLVDKHWTVKVGDFGLSR 653
IHRDL + N LVD VKV DFGLSR
Sbjct: 119 KQFIHRDLAARNCLVDDQGCVKVSDFGLSR 148
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 93.5 bits (232), Expect = 3e-21
Identities = 54/162 (33%), Positives = 82/162 (50%), Gaps = 6/162 (3%)
Query: 505 EDLTIGEQIGQGSCGTVYHAVWYGSD-VAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPN 563
+LT+ ++IG G G V+ W VA+K S+E F +E +M +L HP
Sbjct: 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMSEE---DFIEEAQVMMKLSHPK 60
Query: 564 VLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCN 623
++ G T +C+V EF+ G L L+ K + M LD+ G++YL N
Sbjct: 61 LVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSN 120
Query: 624 PPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTG 665
+IHRDL + N LV ++ VKV DFG++R + T+ TG
Sbjct: 121 --VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTG 160
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 96.0 bits (237), Expect = 3e-21
Identities = 53/177 (29%), Positives = 82/177 (46%), Gaps = 14/177 (7%)
Query: 508 TIGEQIGQGSCGTVYHAVWYGSDVAVKVFSRQEYSDEVIH-SFRQEVSLMKRLRHP-NVL 565
I ++G+GS G VY A VA+KV +++ S F +E+ ++ L HP N++
Sbjct: 3 RILRKLGEGSFGEVYLAR-DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIV 61
Query: 566 LFMGAVTSPQRLCIVTEFLPRGSLFRLLQRN--TTKLDWRRRILMALDIARGVSYLHHCN 623
L +V E++ GSL LL++ L + + I + YLH
Sbjct: 62 KLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG 121
Query: 624 PPIIHRDLKSSNLLVDKH-WTVKVGDFGLSRL------KHETYLTTKTGKGTVTYLA 673
IIHRD+K N+L+D+ VK+ DFGL++L T GT Y+A
Sbjct: 122 --IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMA 176
|
Length = 384 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 92.8 bits (231), Expect = 5e-21
Identities = 53/170 (31%), Positives = 90/170 (52%), Gaps = 9/170 (5%)
Query: 510 GEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLF 567
G +IG G+ G VY AV G +AVK Q+ + I E+ +++ L+HPN++ +
Sbjct: 5 GNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKY 64
Query: 568 MGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPII 627
G +++ I E+ G+L LL + LD + L + G++YLH I+
Sbjct: 65 YGVEVHREKVYIFMEYCSGGTLEELL-EHGRILDEHVIRVYTLQLLEGLAYLHSHG--IV 121
Query: 628 HRDLKSSNLLVDKHWTVKVGDFGLS-RLKHETYLTTKTGK---GTVTYLA 673
HRD+K +N+ +D + +K+GDFG + +LK+ T + + GT Y+A
Sbjct: 122 HRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMA 171
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 92.6 bits (230), Expect = 6e-21
Identities = 57/173 (32%), Positives = 91/173 (52%), Gaps = 23/173 (13%)
Query: 510 GEQIGQGSCGTVY--HAVWYGSDVAVKVF----SRQEYSDEVIHSFRQEVSLMKRLRHPN 563
G+ +GQG+ G VY + V G ++AVK E EV ++ E+ L+K L+H
Sbjct: 7 GKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEV-NALECEIQLLKNLQHER 65
Query: 564 VLLFMGAVTSPQRLCIVTEFLPRGS------LFRLLQRNTTKLDWRRRILMALDIARGVS 617
++ + G + + L I E++P GS + L T+ + R+IL GV
Sbjct: 66 IVQYYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTR-KYTRQIL------EGVE 118
Query: 618 YLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTVT 670
YLH + I+HRD+K +N+L D VK+GDFG S+ + +T ++ TG +VT
Sbjct: 119 YLH--SNMIVHRDIKGANILRDSAGNVKLGDFGASK-RLQTICSSGTGMKSVT 168
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 92.1 bits (229), Expect = 1e-20
Identities = 58/174 (33%), Positives = 96/174 (55%), Gaps = 15/174 (8%)
Query: 511 EQIGQGSCGTVYHAVW------YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNV 564
+Q+G+G+ G+V + G VAVK Q + E + F +E+ ++K L+H N+
Sbjct: 10 QQLGKGNFGSVELCRYDPLQDNTGEVVAVKKL--QHSTAEHLRDFEREIEILKSLQHDNI 67
Query: 565 LLFMGAVTSPQR--LCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHC 622
+ + G S R L +V E+LP GSL LQ++ +LD R+ +L A I +G+ YL
Sbjct: 68 VKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLG-- 125
Query: 623 NPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL---KHETYLTTKTGKGTVTYLA 673
+ +HRDL + N+LV+ VK+GDFGL+++ E Y + G+ + + A
Sbjct: 126 SKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYA 179
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 91.5 bits (228), Expect = 3e-20
Identities = 54/161 (33%), Positives = 83/161 (51%), Gaps = 20/161 (12%)
Query: 500 YEILWEDLTIGEQIGQGSCGTVYHA--VWYGSDVAVKVFSRQEYSDE--VIHSFRQEVSL 555
YE + QIG+G+ G VY A G VA+K R E E I + R E+ L
Sbjct: 1 YEKI-------AQIGEGTYGQVYKARNKKTGELVALKKI-RMENEKEGFPITAIR-EIKL 51
Query: 556 MKRLRHPNVLLFMGAVTSPQR--LCIVTEFLPRGSLFRLLQRNTTKL-DWRRRILMALDI 612
+++LRHPN++ VTS + + +V E++ L LL K + + + M +
Sbjct: 52 LQKLRHPNIVRLKEIVTSKGKGSIYMVFEYMDH-DLTGLLDSPEVKFTESQIKCYM-KQL 109
Query: 613 ARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSR 653
G+ YLH I+HRD+K SN+L++ +K+ DFGL+R
Sbjct: 110 LEGLQYLHSNG--ILHRDIKGSNILINNDGVLKLADFGLAR 148
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 90.5 bits (225), Expect = 6e-20
Identities = 53/181 (29%), Positives = 87/181 (48%), Gaps = 25/181 (13%)
Query: 500 YEILWEDLTIGEQIGQGSCGTVYHA--VWYGSDVAVKVFSRQEYSDEVIH--SFRQEVSL 555
YE+L +G+G+ G V G VA+K F ++ DE + + R EV +
Sbjct: 3 YEVL-------GVVGEGAYGVVLKCRNKATGEIVAIKKF-KESEDDEDVKKTALR-EVKV 53
Query: 556 MKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWR--RRILMALDIA 613
+++LRH N++ A RL +V E++ R +L LL+ + L R + L
Sbjct: 54 LRQLRHENIVNLKEAFRRKGRLYLVFEYVER-TLLELLEASPGGLPPDAVRSYIWQL--L 110
Query: 614 RGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTVTYLA 673
+ ++Y H N IIHRD+K N+LV + +K+ DFG +R L + Y+A
Sbjct: 111 QAIAYCHSHN--IIHRDIKPENILVSESGVLKLCDFGFAR-----ALRARPASPLTDYVA 163
Query: 674 S 674
+
Sbjct: 164 T 164
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 89.2 bits (221), Expect = 8e-20
Identities = 50/150 (33%), Positives = 80/150 (53%), Gaps = 8/150 (5%)
Query: 505 EDLTIGEQIGQGSCGTVYHAVWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNV 564
+ LT+GE IG+G G V + G VAVK D +F +E ++M +L H N+
Sbjct: 6 QKLTLGEIIGEGEFGAVLQGEYTGQKVAVKNIK----CDVTAQAFLEETAVMTKLHHKNL 61
Query: 565 LLFMGAVTSPQRLCIVTEFLPRGSLFRLLQ-RNTTKLDWRRRILMALDIARGVSYLHHCN 623
+ +G + L IV E + +G+L L+ R + + + +LD+A G+ YL +
Sbjct: 62 VRLLGVILH-NGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLE--S 118
Query: 624 PPIIHRDLKSSNLLVDKHWTVKVGDFGLSR 653
++HRDL + N+LV + KV DFGL+R
Sbjct: 119 KKLVHRDLAARNILVSEDGVAKVSDFGLAR 148
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 90.7 bits (226), Expect = 9e-20
Identities = 51/151 (33%), Positives = 79/151 (52%), Gaps = 15/151 (9%)
Query: 512 QIGQGSCGTVYHAV--WYGSDVAVKVFSRQEYSDEVIHSFR--QEVSLMKRLRHPNVLLF 567
IG G+ G V AV G VA+K S D++I + R +E+ L++ LRH N++
Sbjct: 7 PIGSGAYGVVCSAVDKRTGRKVAIKKISN--VFDDLIDAKRILREIKLLRHLRHENIIGL 64
Query: 568 MGAVTSPQRLC-----IVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHC 622
+ + P IVTE + L ++++ D + + I RG+ YLH
Sbjct: 65 LDILRPPSPEDFNDVYIVTELME-TDLHKVIKSPQPLTDDHIQYFL-YQILRGLKYLHSA 122
Query: 623 NPPIIHRDLKSSNLLVDKHWTVKVGDFGLSR 653
N +IHRDLK SN+LV+ + +K+ DFGL+R
Sbjct: 123 N--VIHRDLKPSNILVNSNCDLKICDFGLAR 151
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 88.9 bits (220), Expect = 1e-19
Identities = 57/171 (33%), Positives = 89/171 (52%), Gaps = 11/171 (6%)
Query: 505 EDLTIGEQIGQGSCGTVYHAVWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNV 564
++L + + IG+G G V + G+ VAVK +D +F E S+M +LRH N+
Sbjct: 6 KELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIK----NDATAQAFLAEASVMTQLRHSNL 61
Query: 565 LLFMGAVTSPQ-RLCIVTEFLPRGSLFRLLQ-RNTTKLDWRRRILMALDIARGVSYLHHC 622
+ +G + + L IVTE++ +GSL L+ R + L + +LD+ + YL
Sbjct: 62 VQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEAN 121
Query: 623 NPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTVTYLA 673
N +HRDL + N+LV + KV DFGL++ E T TGK V + A
Sbjct: 122 N--FVHRDLAARNVLVSEDNVAKVSDFGLTK---EASSTQDTGKLPVKWTA 167
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 88.8 bits (220), Expect = 1e-19
Identities = 51/149 (34%), Positives = 75/149 (50%), Gaps = 6/149 (4%)
Query: 506 DLTIGEQIGQGSCGTVYHAVWYGS-DVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNV 564
+LT +++G G G V+ W VA+K + S+E F +E +M +L HP +
Sbjct: 5 ELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAMSEE---DFIEEAKVMMKLSHPKL 61
Query: 565 LLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNP 624
+ G T + L IVTEF+ G L L++ KL + M D+ G+ YL +
Sbjct: 62 VQLYGVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNS- 120
Query: 625 PIIHRDLKSSNLLVDKHWTVKVGDFGLSR 653
IHRDL + N LV VKV DFG++R
Sbjct: 121 -FIHRDLAARNCLVSSTGVVKVSDFGMTR 148
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 88.8 bits (221), Expect = 2e-19
Identities = 55/180 (30%), Positives = 90/180 (50%), Gaps = 25/180 (13%)
Query: 505 EDLTIGEQIGQGSCGTVYHAVWY---GSDVAVKVFSRQEY--SDEVIHSFRQEVSLMKRL 559
+D + +G GS G V V + G A+K+ S+ + +V H E +++ +
Sbjct: 1 DDFEFIKTLGTGSFGRV-MLVRHKGSGKYYALKILSKAKIVKLKQVEHVLN-EKRILQSI 58
Query: 560 RHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTT-KLDWRR----RILMALDIAR 614
RHP ++ G+ L +V E++P G LF L+++ R ++++AL+
Sbjct: 59 RHPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALE--- 115
Query: 615 GVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLS-RLKHETYLTTKTGKGTVTYLA 673
YLH + I++RDLK NLL+D +K+ DFG + R+K TY T GT YLA
Sbjct: 116 ---YLHSLD--IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGRTY----TLCGTPEYLA 166
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 87.9 bits (218), Expect = 2e-19
Identities = 52/178 (29%), Positives = 89/178 (50%), Gaps = 19/178 (10%)
Query: 506 DLTIGEQIGQGSCGTVYHAVWYGSD---VAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHP 562
D + +++G+GS G+VY V SD A+K S + E+ ++ + HP
Sbjct: 1 DFKVLKKLGKGSYGSVYK-VKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHP 59
Query: 563 NVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRN-------TTKLDWRRRILMALDIARG 615
N++ + A +LCIV E+ P G L + + + + WR + + + RG
Sbjct: 60 NIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWR----IFIQLLRG 115
Query: 616 VSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTVTYLA 673
+ LH I+HRDLKS+N+L+ + VK+GD G+S++ + T+ GT Y+A
Sbjct: 116 LQALHEQK--ILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAKTQI--GTPHYMA 169
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.6 bits (218), Expect = 3e-19
Identities = 55/172 (31%), Positives = 84/172 (48%), Gaps = 22/172 (12%)
Query: 513 IGQGSCGTVYHAV-------WYGSDVAVKVFSRQEYSD--EVIHSFRQEVSLMKRLRHPN 563
+G+GS G V V Y A+KV +++ EV H+ E +++ R+ HP
Sbjct: 1 LGKGSFGKVL-LVRKKDTGKLY----AMKVLKKKKIIKRKEVEHTLT-ERNILSRINHPF 54
Query: 564 V--LLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHH 621
+ L + A + ++L +V E+ P G LF L + + R R A +I + YLH
Sbjct: 55 IVKLHY--AFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAA-EIVLALEYLHS 111
Query: 622 CNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTVTYLA 673
II+RDLK N+L+D +K+ DFGL++ T T GT YLA
Sbjct: 112 LG--IIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTPEYLA 161
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 88.4 bits (220), Expect = 3e-19
Identities = 47/154 (30%), Positives = 83/154 (53%), Gaps = 14/154 (9%)
Query: 508 TIGEQIGQGSCGTVYHAVWYGSD--VAVK---VFSRQEYSDEVIHSFRQEVSLMKRLRHP 562
G+++G+G+ VY A + VA+K + R+E D + + +E+ L++ L+HP
Sbjct: 3 EKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHP 62
Query: 563 NVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKL---DWRRRILMALDIARGVSYL 619
N++ + + +V EF+ L ++++ + L D + +LM L RG+ YL
Sbjct: 63 NIIGLLDVFGHKSNINLVFEFME-TDLEKVIKDKSIVLTPADIKSYMLMTL---RGLEYL 118
Query: 620 HHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSR 653
H I+HRDLK +NLL+ +K+ DFGL+R
Sbjct: 119 HSNW--ILHRDLKPNNLLIASDGVLKLADFGLAR 150
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 88.0 bits (219), Expect = 3e-19
Identities = 48/156 (30%), Positives = 74/156 (47%), Gaps = 20/156 (12%)
Query: 508 TIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYS-DEVIHSFRQEVSLMKRLRHPNV 564
+ +Q+G G+ G+VY A G VA+K ++ YS +E + + R+ SL K HPN+
Sbjct: 2 KVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECM-NLREVKSLRKLNEHPNI 60
Query: 565 LLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKL-------DWRRRILMALDIARGVS 617
+ L V E++ G+L++L++ K +IL L
Sbjct: 61 VKLKEVFRENDELYFVFEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLA------ 113
Query: 618 YLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSR 653
++H HRDLK NLLV VK+ DFGL+R
Sbjct: 114 HIHKHG--FFHRDLKPENLLVSGPEVVKIADFGLAR 147
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 87.0 bits (215), Expect = 8e-19
Identities = 47/134 (35%), Positives = 74/134 (55%), Gaps = 14/134 (10%)
Query: 531 VAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLF 590
VAVK+ R + + + F +E+ +M RL++PN++ +G S LC++TE++ G L
Sbjct: 47 VAVKML-RADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLN 105
Query: 591 RLL-QR----------NTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVD 639
+ L QR N + + MA+ IA G+ YL N +HRDL + N LV
Sbjct: 106 QFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN--FVHRDLATRNCLVG 163
Query: 640 KHWTVKVGDFGLSR 653
H+T+K+ DFG+SR
Sbjct: 164 NHYTIKIADFGMSR 177
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.5 bits (215), Expect = 1e-18
Identities = 51/150 (34%), Positives = 81/150 (54%), Gaps = 7/150 (4%)
Query: 505 EDLTIGEQIGQGSCGTVYHAVWYGSD--VAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHP 562
E T+ E IG+GS G VY A+ ++ VA+KV +E DE I +QE+ + + R P
Sbjct: 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDE-IEDIQQEIQFLSQCRSP 59
Query: 563 NVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHC 622
+ + G+ +L I+ E+ GS LL+ KLD + ++ G+ YLH
Sbjct: 60 YITKYYGSFLKGSKLWIIMEYCGGGSCLDLLKPG--KLDETYIAFILREVLLGLEYLHEE 117
Query: 623 NPPIIHRDLKSSNLLVDKHWTVKVGDFGLS 652
IHRD+K++N+L+ + VK+ DFG+S
Sbjct: 118 GK--IHRDIKAANILLSEEGDVKLADFGVS 145
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 86.1 bits (214), Expect = 1e-18
Identities = 61/202 (30%), Positives = 93/202 (46%), Gaps = 53/202 (26%)
Query: 499 DYEILWEDLTIGEQIGQGSCGTVYHA---------VW----YGSDVAVKVFSRQEYSDEV 545
DYE+L E IG+GS GTV VW YG+ + +E V
Sbjct: 1 DYEVL-------ETIGKGSFGTVRKVRRKSDGKILVWKEIDYGN------MTEKEKQQLV 47
Query: 546 IHSFRQEVSLMKRLRHPNVLLFMG--AVTSPQRLCIVTEFLPRGSLFRLLQR---NTTKL 600
EV++++ L+HPN++ + S Q L IV E+ G L +L+Q+ +
Sbjct: 48 S-----EVNILRELKHPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYI 102
Query: 601 D----WRRRILMALDIARGVSYLHHC------NPPIIHRDLKSSNLLVDKHWTVKVGDFG 650
+ WR IL L +A L+ C ++HRDLK +N+ +D + VK+GDFG
Sbjct: 103 EEEFIWR--ILTQLLLA-----LYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFG 155
Query: 651 LSRLKHETYLTTKTGKGTVTYL 672
L+++ KT GT Y+
Sbjct: 156 LAKILGHDSSFAKTYVGTPYYM 177
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 85.5 bits (211), Expect = 2e-18
Identities = 52/168 (30%), Positives = 91/168 (54%), Gaps = 7/168 (4%)
Query: 500 YEILWEDLTIGEQIGQGSCGTVYHAVWYGS-DVAVKVFSRQEYSDEVIHSFRQEVSLMKR 558
+EI E + + +++G G G V+ + S VAVK S + +F +E +LMK
Sbjct: 1 WEIPRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMS---VQAFLEEANLMKT 57
Query: 559 LRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNT-TKLDWRRRILMALDIARGVS 617
L+H ++ VT + + I+TE++ +GSL L+ + K+ + I + IA G++
Sbjct: 58 LQHDKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMA 117
Query: 618 YLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTG 665
Y+ N IHRDL+++N+LV + K+ DFGL+R+ + T + G
Sbjct: 118 YIERKN--YIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREG 163
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 85.5 bits (212), Expect = 2e-18
Identities = 49/151 (32%), Positives = 77/151 (50%), Gaps = 16/151 (10%)
Query: 511 EQIGQGSCGTVYHAVWY---GS--DVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVL 565
+++G G+ G+V V+ G +VAVK QE+ F +E S+M +L HP ++
Sbjct: 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLK-QEHIAAGKKEFLREASVMAQLDHPCIV 59
Query: 566 LFMGAVTSPQRLCIVTEFLPRGSLFRLLQ--RNTTKLDWRRRILMALDIARGVSYLHHCN 623
+G L +V E P G L + L+ R D +A +A G++YL +
Sbjct: 60 RLIGVCKGEP-LMLVMELAPLGPLLKYLKKRREIPVSDL---KELAHQVAMGMAYLESKH 115
Query: 624 PPIIHRDLKSSN-LLVDKHWTVKVGDFGLSR 653
+HRDL + N LLV++H K+ DFG+SR
Sbjct: 116 --FVHRDLAARNVLLVNRHQ-AKISDFGMSR 143
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 85.5 bits (211), Expect = 2e-18
Identities = 58/184 (31%), Positives = 95/184 (51%), Gaps = 19/184 (10%)
Query: 500 YEILWEDLTIGEQIGQGSCGTVYHAVWYG-------SDVAVKVFSRQEYSDEVIHSFRQE 552
+E+ E +T+ ++GQGS G VY + G + VA+K + E I F E
Sbjct: 1 WEVAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIE-FLNE 59
Query: 553 VSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLD---------WR 603
S+MK +V+ +G V+ Q ++ E + RG L L+ +++ +
Sbjct: 60 ASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLK 119
Query: 604 RRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTK 663
+ I MA +IA G++YL+ +HRDL + N +V + +TVK+GDFG++R +ET K
Sbjct: 120 KMIQMAGEIADGMAYLNANK--FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRK 177
Query: 664 TGKG 667
GKG
Sbjct: 178 GGKG 181
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 84.9 bits (210), Expect = 2e-18
Identities = 50/187 (26%), Positives = 87/187 (46%), Gaps = 30/187 (16%)
Query: 499 DYEILWEDLTIGEQIGQGSCGTVYHA-------VWYGSDVAVKVFSRQEYSDEVIHSFRQ 551
D+EIL +IG+GS G V+ V+ + + +R+E + +
Sbjct: 1 DFEIL-------NKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAI-----D 48
Query: 552 EVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLL-----QRNTTKLDWRRRI 606
E ++ +L ++ + + +L IV E+ G L +LL + WR I
Sbjct: 49 EARVLAKLDSSYIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFI 108
Query: 607 LMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGK 666
+ L G+++LH + I+HRD+KS NL +D + VK+GD G+++L + T
Sbjct: 109 QILL----GLAHLH--SKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIV 162
Query: 667 GTVTYLA 673
GT YL+
Sbjct: 163 GTPYYLS 169
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 84.5 bits (209), Expect = 3e-18
Identities = 60/185 (32%), Positives = 98/185 (52%), Gaps = 30/185 (16%)
Query: 510 GEQIGQGSCGTVY---HAVWYGSDVAVKVF-------SRQEYSDEVIHSFRQEVSLMKRL 559
G IG GS G+VY +A G +AVK S ++ ++ + +E++L+K L
Sbjct: 5 GALIGSGSFGSVYLGMNAS-SGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKEL 63
Query: 560 RHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQR-----NTTKLDWRRRILMALDIAR 614
+H N++ ++G+ L I E++P GS+ LL T ++ R+IL +
Sbjct: 64 QHENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQIL------K 117
Query: 615 GVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGK------GT 668
G++YLH N IIHRD+K +N+LVD +K+ DFG+S+ L+TKT G+
Sbjct: 118 GLNYLH--NRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGS 175
Query: 669 VTYLA 673
V ++A
Sbjct: 176 VFWMA 180
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 85.1 bits (211), Expect = 4e-18
Identities = 55/175 (31%), Positives = 83/175 (47%), Gaps = 31/175 (17%)
Query: 507 LTIGEQIGQGSCGTVYHA----------------VWYGSD--VAVKVFSRQEYSDEVIHS 548
L E++G+G G V+ + VAVKV R + SD
Sbjct: 7 LNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVL-RPDASDNARED 65
Query: 549 FRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQR----------NTT 598
F +EV ++ RL PN+ +G T LC++ E++ G L + LQ+ N+
Sbjct: 66 FLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSK 125
Query: 599 KLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSR 653
L + + MA IA G+ YL N +HRDL + N LV K++T+K+ DFG+SR
Sbjct: 126 SLSFSTLLYMATQIASGMRYLESLN--FVHRDLATRNCLVGKNYTIKIADFGMSR 178
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 84.3 bits (209), Expect = 4e-18
Identities = 50/163 (30%), Positives = 78/163 (47%), Gaps = 24/163 (14%)
Query: 499 DYEILWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLM 556
DYE++ E IG G+ VY A+ VA+K ++ V R+EV M
Sbjct: 2 DYELI-------EVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSV-DELRKEVQAM 53
Query: 557 KRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIA--- 613
+ HPNV+ + + L +V +L GSL ++ K + R L IA
Sbjct: 54 SQCNHPNVVKYYTSFVVGDELWLVMPYLSGGSLLDIM-----KSSYPRGGLDEAIIATVL 108
Query: 614 ----RGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLS 652
+G+ YLH + IHRD+K+ N+L+ + +VK+ DFG+S
Sbjct: 109 KEVLKGLEYLH--SNGQIHRDIKAGNILLGEDGSVKIADFGVS 149
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 84.2 bits (208), Expect = 5e-18
Identities = 56/175 (32%), Positives = 86/175 (49%), Gaps = 13/175 (7%)
Query: 509 IGEQIGQGSCGTVY-----HAVWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPN 563
I E IG G G V VA+K + Y+++ F E S+M + HPN
Sbjct: 8 IEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTL-KSGYTEKQRRDFLSEASIMGQFDHPN 66
Query: 564 VLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCN 623
++ G VT + + I+TEF+ G+L L++N + + + M IA G+ YL N
Sbjct: 67 IIHLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMN 126
Query: 624 PPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHE-----TYLTTKTGKGTVTYLA 673
+HRDL + N+LV+ + KV DFGLSR + TY ++ GK + + A
Sbjct: 127 --YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTA 179
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 83.5 bits (207), Expect = 8e-18
Identities = 53/176 (30%), Positives = 91/176 (51%), Gaps = 16/176 (9%)
Query: 505 EDLTIGEQIGQGSCGTVYHA--VWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHP 562
+DL ++G G+ G V G +AVK R E ++ + +E+ ++ + P
Sbjct: 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTI-RLEINEAIQKQILRELDILHKCNSP 59
Query: 563 NVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRIL--MALDIARGVSYLH 620
++ F GA + + I E++ GSL ++L+ ++ RIL +A+ + +G++YLH
Sbjct: 60 YIVGFYGAFYNNGDISICMEYMDGGSLDKILKEVQGRIP--ERILGKIAVAVLKGLTYLH 117
Query: 621 HCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLT---TKTGKGTVTYLA 673
IIHRD+K SN+LV+ +K+ DFG+S L KT GT +Y+A
Sbjct: 118 E-KHKIIHRDVKPSNILVNSRGQIKLCDFGVS-----GQLVNSLAKTFVGTSSYMA 167
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 83.4 bits (206), Expect = 1e-17
Identities = 48/153 (31%), Positives = 82/153 (53%), Gaps = 20/153 (13%)
Query: 510 GEQIGQGSCGTVYHA--VWYGSDVAVKVFSRQEYS----DEVIHSFRQEVSLMKRLRHPN 563
G+Q+G G+ + Y A V G+ +AVK + + +EV+ + R+E+ LM RL HP+
Sbjct: 5 GQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPH 64
Query: 564 VLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQR-----NTTKLDWRRRILMALDIARGVSY 618
++ +GA + E++ GS+ LL + +++ ++L RG+SY
Sbjct: 65 IIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLL------RGLSY 118
Query: 619 LHHCNPPIIHRDLKSSNLLVDKH-WTVKVGDFG 650
LH IIHRD+K +NLL+D +++ DFG
Sbjct: 119 LH--ENQIIHRDVKGANLLIDSTGQRLRIADFG 149
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 83.3 bits (206), Expect = 1e-17
Identities = 53/152 (34%), Positives = 74/152 (48%), Gaps = 15/152 (9%)
Query: 511 EQIGQGSCGTVYHAVWYGSD-----VAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVL 565
IG+G G VYH SD AVK +R +EV F +E +MK HPNVL
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQ-FLKEGIIMKDFSHPNVL 59
Query: 566 LFMGAVTSPQRL-CIVTEFLPRGSL---FRLLQRNTTKLDWRRRILMALDIARGVSYLHH 621
+G + +V ++ G L R N T D I L +A+G+ YL
Sbjct: 60 SLLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDL---IGFGLQVAKGMEYL-- 114
Query: 622 CNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSR 653
+ +HRDL + N ++D+ +TVKV DFGL+R
Sbjct: 115 ASKKFVHRDLAARNCMLDESFTVKVADFGLAR 146
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 83.1 bits (205), Expect = 1e-17
Identities = 53/168 (31%), Positives = 93/168 (55%), Gaps = 8/168 (4%)
Query: 500 YEILWEDLTIGEQIGQGSCGTVYHAVWYG-SDVAVKVFSRQEYSDEVIHSFRQEVSLMKR 558
+EI E L + +++G G G V+ A + + VAVK S + +F E ++MK
Sbjct: 1 WEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMS---VEAFLAEANVMKT 57
Query: 559 LRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNT-TKLDWRRRILMALDIARGVS 617
L+H + L+ + AV + + + I+TEF+ +GSL L+ + +K + I + IA G++
Sbjct: 58 LQH-DKLVKLHAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMA 116
Query: 618 YLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTG 665
++ N IHRDL+++N+LV K+ DFGL+R+ + T + G
Sbjct: 117 FIEQRN--YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREG 162
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.5 bits (207), Expect = 1e-17
Identities = 56/148 (37%), Positives = 83/148 (56%), Gaps = 10/148 (6%)
Query: 511 EQIGQGSCGTVYHA--VWYGSDVAVKVFSRQEYSDEVIHSFR-QEVSLMKRLRHPNVLLF 567
E+IG+G+ G VY A G VA+K R E DE + S +E+SL+K L HPN++
Sbjct: 5 EKIGEGTYGVVYKARDKLTGEIVALKKI-RLETEDEGVPSTAIREISLLKELNHPNIVRL 63
Query: 568 MGAVTSPQRLCIVTEFLPRGSLFRLLQR-NTTKLDWRRRILMAL-DIARGVSYLHHCNPP 625
+ V S +L +V EFL L + + T LD I L + +G++Y H +
Sbjct: 64 LDVVHSENKLYLVFEFLDL-DLKKYMDSSPLTGLD-PPLIKSYLYQLLQGIAYCH--SHR 119
Query: 626 IIHRDLKSSNLLVDKHWTVKVGDFGLSR 653
++HRDLK NLL+D+ +K+ DFGL+R
Sbjct: 120 VLHRDLKPQNLLIDREGALKLADFGLAR 147
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 2e-17
Identities = 48/144 (33%), Positives = 79/144 (54%), Gaps = 4/144 (2%)
Query: 511 EQIGQGSCGTVYHAVWY-GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMG 569
E +G+G+ G V+ + VAVK +++ E+ F E ++K+ HPN++ +G
Sbjct: 1 ELLGKGNFGEVFKGTLKDKTPVAVKT-CKEDLPQELKIKFLSEARILKQYDHPNIVKLIG 59
Query: 570 AVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHR 629
T Q + IV E +P G L++ +L ++ + ALD A G++YL N IHR
Sbjct: 60 VCTQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKN--CIHR 117
Query: 630 DLKSSNLLVDKHWTVKVGDFGLSR 653
DL + N LV ++ +K+ DFG+SR
Sbjct: 118 DLAARNCLVGENNVLKISDFGMSR 141
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 82.3 bits (204), Expect = 2e-17
Identities = 52/178 (29%), Positives = 81/178 (45%), Gaps = 26/178 (14%)
Query: 513 IGQGSCGTVYHA--VWYGSDVAVKVFSRQEYSDE-VIHSFRQEVSLMKRLRHPNVLLFMG 569
I +G+ G V+ A G A+KV + + + + E ++ + + P V+
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYY 60
Query: 570 AVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLD--WRR----RILMALDIARGVSYLHHCN 623
+ + L +V E+LP G L LL N LD R I++AL+ YLH
Sbjct: 61 SFQGKKNLYLVMEYLPGGDLASLL-ENVGSLDEDVARIYIAEIVLALE------YLHSNG 113
Query: 624 PPIIHRDLKSSNLLVDKHWTVKVGDFGLS------RLKHETYLTTKTGK--GTVTYLA 673
IIHRDLK N+L+D + +K+ DFGLS R + + + GT Y+A
Sbjct: 114 --IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIA 169
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 83.0 bits (205), Expect = 2e-17
Identities = 44/133 (33%), Positives = 73/133 (54%), Gaps = 13/133 (9%)
Query: 531 VAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLF 590
VAVK+ R++ + + F +E+ +M RL+ PN++ + + LC++TE++ G L
Sbjct: 49 VAVKML-REDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLN 107
Query: 591 RLLQR----------NTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDK 640
+ L R + + + I MA IA G+ YL N +HRDL + N LV K
Sbjct: 108 QFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN--FVHRDLATRNCLVGK 165
Query: 641 HWTVKVGDFGLSR 653
++T+K+ DFG+SR
Sbjct: 166 NYTIKIADFGMSR 178
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 3e-17
Identities = 49/167 (29%), Positives = 84/167 (50%), Gaps = 23/167 (13%)
Query: 513 IGQGSCGTVYHAVWYGSD--VAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGA 570
+G+G+ G V+ V +K ++ + + + + E ++K L HPN++ +
Sbjct: 8 VGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYEN 67
Query: 571 VTSPQRLCIVTEFLPRGSLFRLLQR-------NTTKLDWRRRILMALDIARGVSYLHHCN 623
+ L IV E+ P G+L +Q+ T L + +IL+AL H
Sbjct: 68 FLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALH--------HVHT 119
Query: 624 PPIIHRDLKSSNLLVDKHWTV-KVGDFGLSRLKHETYLTTKTGKGTV 669
I+HRDLK+ N+L+DKH V K+GDFG+S++ L++K+ TV
Sbjct: 120 KLILHRDLKTQNILLDKHKMVVKIGDFGISKI-----LSSKSKAYTV 161
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 3e-17
Identities = 48/146 (32%), Positives = 74/146 (50%), Gaps = 7/146 (4%)
Query: 511 EQIGQGSCGTVYHAVWYGSDVAVKVFS-RQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMG 569
E+IG+G+ G V+ + V V S R+ ++ F QE ++K+ HPN++ +G
Sbjct: 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIG 60
Query: 570 AVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLH--HCNPPII 627
T Q + IV E + G L+ +L + I M + A G+ YL HC I
Sbjct: 61 VCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHC----I 116
Query: 628 HRDLKSSNLLVDKHWTVKVGDFGLSR 653
HRDL + N LV + +K+ DFG+SR
Sbjct: 117 HRDLAARNCLVTEKNVLKISDFGMSR 142
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 82.1 bits (203), Expect = 4e-17
Identities = 55/195 (28%), Positives = 90/195 (46%), Gaps = 34/195 (17%)
Query: 500 YEILWEDLTIGEQIGQGSCGTVYHAVWYGSD-------VAVKVF----SRQEYSDEVIHS 548
+E+ + LT+G+ +G+G+ G V A G D VAVK+ + ++ SD V
Sbjct: 7 WELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLV--- 63
Query: 549 FRQEVSLMKRL-RHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRN----------- 596
E+ +MK + +H N++ +G T L +V E+ G+L L+
Sbjct: 64 --SEMEMMKMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDD 121
Query: 597 ----TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLS 652
L + + A +ARG+ +L + IHRDL + N+LV + +K+ DFGL+
Sbjct: 122 PRPPEETLTQKDLVSFAYQVARGMEFL--ASKKCIHRDLAARNVLVTEDHVMKIADFGLA 179
Query: 653 RLKHETYLTTKTGKG 667
R H KT G
Sbjct: 180 RDIHHIDYYRKTTNG 194
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 81.9 bits (202), Expect = 4e-17
Identities = 50/151 (33%), Positives = 83/151 (54%), Gaps = 10/151 (6%)
Query: 528 GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSP--QRLCIVTEFLP 585
G VAVK R E + +++E++++K L H N++ + G + + L ++ E++P
Sbjct: 33 GEMVAVKTLKR-ECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLIMEYVP 91
Query: 586 RGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVK 645
GSL L ++ KL+ + +L A I G++YLH + IHRDL + N+L+D VK
Sbjct: 92 LGSLRDYLPKH--KLNLAQLLLFAQQICEGMAYLH--SQHYIHRDLAARNVLLDNDRLVK 147
Query: 646 VGDFGLSRL---KHETYLTTKTGKGTVTYLA 673
+GDFGL++ HE Y + G V + A
Sbjct: 148 IGDFGLAKAVPEGHEYYRVREDGDSPVFWYA 178
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 80.6 bits (199), Expect = 9e-17
Identities = 47/169 (27%), Positives = 80/169 (47%), Gaps = 19/169 (11%)
Query: 505 EDLTIGEQIGQGSCGTVYHAV--WYGSDVAVKVFSRQEYSDEVIHSFRQ----EVSLMKR 558
+ I ++IG+G VY A+ G VA+K E D RQ E+ L+K+
Sbjct: 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDA---KARQDCLKEIDLLKQ 58
Query: 559 LRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLL---QRNTTKLDWRRRILMALDIARG 615
L HPNV+ ++ + L IV E G L R++ ++ + R + +
Sbjct: 59 LDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSA 118
Query: 616 VSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKT 664
+ ++H + I+HRD+K +N+ + VK+GD GL R + ++KT
Sbjct: 119 LEHMH--SKRIMHRDIKPANVFITATGVVKLGDLGLGR-----FFSSKT 160
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 9e-17
Identities = 55/189 (29%), Positives = 93/189 (49%), Gaps = 22/189 (11%)
Query: 504 WEDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIH-SFRQEVSLMKRL- 559
WED+ + IG+G+ G V A+ G + + +E++ E H F E+ ++ +L
Sbjct: 1 WEDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLG 60
Query: 560 RHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRN---------------TTKLDWRR 604
HPN++ +GA + L I E+ P G+L L+++ + L ++
Sbjct: 61 HHPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQ 120
Query: 605 RILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKT 664
+ A D+A G+ YL IHRDL + N+LV ++ K+ DFGLSR E Y+
Sbjct: 121 LLQFASDVATGMQYL--SEKQFIHRDLAARNVLVGENLASKIADFGLSR-GEEVYVKKTM 177
Query: 665 GKGTVTYLA 673
G+ V ++A
Sbjct: 178 GRLPVRWMA 186
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 80.2 bits (198), Expect = 1e-16
Identities = 46/171 (26%), Positives = 79/171 (46%), Gaps = 27/171 (15%)
Query: 505 EDLTIGEQIGQGSCGTVYHAVWYG-------SDVAVKVFSRQEYSDEVIHSFRQEVSLMK 557
+ + + ++G+G+ G V+ Y VAVK ++ S++ F +E L+
Sbjct: 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTL-KETASNDARKDFEREAELLT 63
Query: 558 RLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRN-------------TTKLDWRR 604
+H N++ F G T +V E++ G L + L+ + +L +
Sbjct: 64 NFQHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQ 123
Query: 605 RILMALDIARGVSYL--HHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSR 653
+ +A+ IA G+ YL H +HRDL + N LV VK+GDFG+SR
Sbjct: 124 LLQIAVQIASGMVYLASQH----FVHRDLATRNCLVGYDLVVKIGDFGMSR 170
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|222120 pfam13426, PAS_9, PAS domain | Back alignment and domain information |
|---|
Score = 75.1 bits (185), Expect = 2e-16
Identities = 29/96 (30%), Positives = 47/96 (48%)
Query: 145 IFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGERWTGQ 204
+ D RI+Y N +A L GY+ EE LG+ +L G D + + ++ G +
Sbjct: 3 VLDPDGRIVYANDAALRLLGYTREELLGKSIRDLFGPGDDEEAVARLREALRNGGEVEVE 62
Query: 205 FPAKTKTEERVLVVATNTPFYDDDGTLVGIVCVSTD 240
+ K E V+ + +P D+DG +VGIV + D
Sbjct: 63 LELRRKDGEPFPVLVSASPVRDEDGEVVGIVGILRD 98
|
Length = 101 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 79.9 bits (197), Expect = 2e-16
Identities = 48/169 (28%), Positives = 82/169 (48%), Gaps = 31/169 (18%)
Query: 513 IGQGSCGTVYHAVWYG-------SDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVL 565
IGQG+ G V+ A G + VAVK+ ++E S ++ F++E +LM HPN++
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKML-KEEASADMQADFQREAALMAEFDHPNIV 71
Query: 566 LFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTK---------------------LDWRR 604
+G + +C++ E++ G L L+ + + L
Sbjct: 72 KLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTE 131
Query: 605 RILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSR 653
++ +A +A G++YL +HRDL + N LV ++ VK+ DFGLSR
Sbjct: 132 QLCIAKQVAAGMAYL--SERKFVHRDLATRNCLVGENMVVKIADFGLSR 178
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 79.6 bits (196), Expect = 2e-16
Identities = 49/146 (33%), Positives = 78/146 (53%), Gaps = 6/146 (4%)
Query: 531 VAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLF 590
VA+K + Y+++ F E S+M + HPN++ G VT + + IVTE++ GSL
Sbjct: 35 VAIKTL-KAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLD 93
Query: 591 RLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFG 650
L+++ + + + M IA G+ YL +HRDL + N+LV+ + KV DFG
Sbjct: 94 AFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMG--YVHRDLAARNILVNSNLVCKVSDFG 151
Query: 651 LSRLKH---ETYLTTKTGKGTVTYLA 673
LSR+ E TT+ GK + + A
Sbjct: 152 LSRVLEDDPEAAYTTRGGKIPIRWTA 177
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 2e-16
Identities = 61/180 (33%), Positives = 99/180 (55%), Gaps = 25/180 (13%)
Query: 505 EDLTIGEQIGQGSCGTVY--HAVWYGSDVAVKVF----SRQEYSDEVIHSFRQEVSLMKR 558
+ +G+ +G+G+ G VY + G ++AVK QE S EV ++ E+ L+K
Sbjct: 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEV-NALECEIQLLKN 60
Query: 559 LRHPNVLLFMGAVTSPQ--RLCIVTEFLPRGSL------FRLLQRNTTKLDWRRRILMAL 610
LRH ++ + G + P+ +L I E++P GS+ + L N T+ + R+IL
Sbjct: 61 LRHDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTR-RYTRQIL--- 116
Query: 611 DIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTVT 670
+GVSYLH + I+HRD+K +N+L D VK+GDFG S+ + +T + TG +VT
Sbjct: 117 ---QGVSYLH--SNMIVHRDIKGANILRDSAGNVKLGDFGASK-RIQTICMSGTGIKSVT 170
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 79.6 bits (196), Expect = 2e-16
Identities = 54/163 (33%), Positives = 79/163 (48%), Gaps = 18/163 (11%)
Query: 507 LTIGEQIGQGSCGTVYHAVWYGSD-----VAVKVFSRQEYSDEVIHSFRQEVSLMKRLRH 561
T+G +G+G G+V A D VAVK+ +S I F +E + MK H
Sbjct: 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH 60
Query: 562 PNVLLFMGAV---TSPQRLCI---VTEFLPRGSL--FRLLQR---NTTKLDWRRRILMAL 610
PNV+ +G + RL I + F+ G L F L+ R L + + +
Sbjct: 61 PNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMI 120
Query: 611 DIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSR 653
DIA G+ YL N IHRDL + N +++++ TV V DFGLS+
Sbjct: 121 DIASGMEYLSSKN--FIHRDLAARNCMLNENMTVCVADFGLSK 161
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 78.6 bits (194), Expect = 3e-16
Identities = 42/164 (25%), Positives = 80/164 (48%), Gaps = 5/164 (3%)
Query: 513 IGQGSCG--TVYHAVWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGA 570
+G+G+ G T+Y S V K + S++ E+ ++ L+HPN++ +
Sbjct: 8 LGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNH 67
Query: 571 VTSPQRLCIVTEFLPRGSLF-RLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHR 629
L I E+ G+L+ +++++ + + I VSY+H I+HR
Sbjct: 68 FMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAG--ILHR 125
Query: 630 DLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTVTYLA 673
D+K+ N+ + K +K+GDFG+S++ Y +T GT Y++
Sbjct: 126 DIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVVGTPYYMS 169
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 79.1 bits (195), Expect = 3e-16
Identities = 50/163 (30%), Positives = 76/163 (46%), Gaps = 18/163 (11%)
Query: 507 LTIGEQIGQGSCGTVYHAVWYGSD-----VAVKVFSRQEYSDEVIHSFRQEVSLMKRLRH 561
L +G+ +G+G G+V D VAVK ++ I F E + MK H
Sbjct: 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDH 60
Query: 562 PNVLLFMG------AVTSPQRLCIVTEFLPRGSL--FRLLQR---NTTKLDWRRRILMAL 610
PNV+ +G ++ + ++ F+ G L F L R KL + + +
Sbjct: 61 PNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMV 120
Query: 611 DIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSR 653
DIA G+ YL + N IHRDL + N ++ + TV V DFGLS+
Sbjct: 121 DIALGMEYLSNRN--FIHRDLAARNCMLREDMTVCVADFGLSK 161
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 79.3 bits (196), Expect = 3e-16
Identities = 41/151 (27%), Positives = 74/151 (49%), Gaps = 9/151 (5%)
Query: 508 TIGEQIGQGSCGTVYHAVWYGSD--VAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVL 565
I +IG+G+ G V+ A + VA+K + + + + +E+ ++ +HP V+
Sbjct: 3 KILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVV 62
Query: 566 LFMGAVTSPQRLCIVTEFLPRG--SLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCN 623
+ +V E++P + R +R + + + M L GV+Y+H
Sbjct: 63 KLLDVFPHGSGFVLVMEYMPSDLSEVLRDEERPLPEAQVKSYMRMLLK---GVAYMHANG 119
Query: 624 PPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL 654
I+HRDLK +NLL+ +K+ DFGL+RL
Sbjct: 120 --IMHRDLKPANLLISADGVLKIADFGLARL 148
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 4e-16
Identities = 57/165 (34%), Positives = 81/165 (49%), Gaps = 7/165 (4%)
Query: 513 IGQGSCGTVYHAVWYGSDV--AVKVFSRQEY--SDEVIHSFRQEVSLMKRLRHPNVLLFM 568
IG+GS G V A AVKV ++ E H + L+K ++HP ++
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLH 62
Query: 569 GAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIH 628
+ + +L V +++ G LF LQR + + R R A +IA + YLH N II+
Sbjct: 63 YSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRAR-FYAAEIASALGYLHSLN--IIY 119
Query: 629 RDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTVTYLA 673
RDLK N+L+D V + DFGL + E TT T GT YLA
Sbjct: 120 RDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFCGTPEYLA 164
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 4e-16
Identities = 56/191 (29%), Positives = 91/191 (47%), Gaps = 26/191 (13%)
Query: 504 WEDLTIGEQIGQGSCGTVYHAVWYGS----DVAVKVFSRQEYSDEVIH-SFRQEVSLMKR 558
W D+ + IG+G+ G V A D A+K +EY+ + H F E+ ++ +
Sbjct: 6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIK--RMKEYASKDDHRDFAGELEVLCK 63
Query: 559 L-RHPNVLLFMGAVTSPQRLCIVTEFLPRGSL---------------FRLLQRNTTKLDW 602
L HPN++ +GA L + E+ P G+L F + + L
Sbjct: 64 LGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSS 123
Query: 603 RRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTT 662
++ + A D+ARG+ YL IHRDL + N+LV +++ K+ DFGLSR E Y+
Sbjct: 124 QQLLHFAADVARGMDYLSQ--KQFIHRDLAARNILVGENYVAKIADFGLSR-GQEVYVKK 180
Query: 663 KTGKGTVTYLA 673
G+ V ++A
Sbjct: 181 TMGRLPVRWMA 191
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.6 bits (194), Expect = 5e-16
Identities = 53/174 (30%), Positives = 89/174 (51%), Gaps = 22/174 (12%)
Query: 511 EQIGQGSCGTVYHA--VWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRH---PNVL 565
E IG+G+ G VY V G VA+K+ + D+V ++EV+L+ +LR PN+
Sbjct: 7 ELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDV-SDIQREVALLSQLRQSQPPNIT 65
Query: 566 LFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWR------RRILMALDIARGVSYL 619
+ G+ RL I+ E+ GS+ L++ + + R +L+AL Y+
Sbjct: 66 KYYGSYLKGPRLWIIMEYAEGGSVRTLMK--AGPIAEKYISVIIREVLVAL------KYI 117
Query: 620 HHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTVTYLA 673
H +IHRD+K++N+LV VK+ DFG++ L ++ T GT ++A
Sbjct: 118 HKV--GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMA 169
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 78.9 bits (195), Expect = 5e-16
Identities = 57/193 (29%), Positives = 92/193 (47%), Gaps = 38/193 (19%)
Query: 499 DYEILWEDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFR------ 550
DYEIL ++G+G+ G VY A G VA+K ++H+ +
Sbjct: 9 DYEIL-------GKLGEGTFGEVYKARQIKTGRVVALKKI--------LMHNEKDGFPIT 53
Query: 551 --QEVSLMKRLRHPNV--LLFMGAVTSPQ----RLCI--VTEFLPRGSLFRLLQRNTTKL 600
+E+ ++K+L+HPNV L+ M + R + VT ++ L LL+ + KL
Sbjct: 54 ALREIKILKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDH-DLSGLLENPSVKL 112
Query: 601 DWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHE--T 658
+ L + G++YLH N I+HRD+K++N+L+D +K+ DFGL+R
Sbjct: 113 TESQIKCYMLQLLEGINYLH-ENH-ILHRDIKAANILIDNQGILKIADFGLARPYDGPPP 170
Query: 659 YLTTKTGKGTVTY 671
G GT Y
Sbjct: 171 NPKGGGGGGTRKY 183
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 6e-16
Identities = 59/184 (32%), Positives = 89/184 (48%), Gaps = 19/184 (10%)
Query: 500 YEILWEDLTIGEQIGQGSCGTVYHAVWYG-------SDVAVKVFSRQEYSDEVIHSFRQE 552
+E+ E +T+ ++GQGS G VY + VAVK + E I F E
Sbjct: 1 WEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIE-FLNE 59
Query: 553 VSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLL-------QRNTTKL--DWR 603
S+MK +V+ +G V+ Q +V E + G L L + N + +
Sbjct: 60 ASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQ 119
Query: 604 RRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTK 663
I MA +IA G++YL+ +HRDL + N +V +TVK+GDFG++R +ET K
Sbjct: 120 EMIQMAAEIADGMAYLN--AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRK 177
Query: 664 TGKG 667
GKG
Sbjct: 178 GGKG 181
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 7e-16
Identities = 47/131 (35%), Positives = 67/131 (51%), Gaps = 4/131 (3%)
Query: 543 DEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDW 602
DEV H+ E +++ RHP + + + RLC V E+ G LF L R +
Sbjct: 37 DEVAHTL-TESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSED 95
Query: 603 RRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTT 662
R R A +I + YLH C+ +++RDLK NL++DK +K+ DFGL + T
Sbjct: 96 RARFYGA-EIVSALGYLHSCD--VVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATM 152
Query: 663 KTGKGTVTYLA 673
KT GT YLA
Sbjct: 153 KTFCGTPEYLA 163
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 78.0 bits (192), Expect = 8e-16
Identities = 46/140 (32%), Positives = 76/140 (54%), Gaps = 7/140 (5%)
Query: 528 GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSP--QRLCIVTEFLP 585
G VAVK + E I ++E+ +++ L H N++ + G T + ++ EFLP
Sbjct: 33 GEQVAVKSL-KPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLP 91
Query: 586 RGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVK 645
GSL L RN K++ ++++ A+ I +G+ YL +HRDL + N+LV+ VK
Sbjct: 92 SGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQ--YVHRDLAARNVLVESEHQVK 149
Query: 646 VGDFGLSRL--KHETYLTTK 663
+GDFGL++ + Y T K
Sbjct: 150 IGDFGLTKAIETDKEYYTVK 169
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 79.1 bits (195), Expect = 8e-16
Identities = 60/201 (29%), Positives = 96/201 (47%), Gaps = 16/201 (7%)
Query: 475 SSVSSCGSTSSSAVNKVDLDNDCLDYEILWEDLTIGEQIGQGSCGTVYHAVWYGSD--VA 532
S SS S+SSSA L +L +IG G+ GTVY + + A
Sbjct: 50 PSSSSSSSSSSSASGSAPSAAKSL------SELERVNRIGSGAGGTVYKVIHRPTGRLYA 103
Query: 533 VKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRL 592
+KV + D V +E+ +++ + HPNV+ + ++ EF+ GSL
Sbjct: 104 LKVIY-GNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSL--- 159
Query: 593 LQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLS 652
T D + +A I G++YLH + I+HRD+K SNLL++ VK+ DFG+S
Sbjct: 160 --EGTHIADEQFLADVARQILSGIAYLHRRH--IVHRDIKPSNLLINSAKNVKIADFGVS 215
Query: 653 RLKHETYLTTKTGKGTVTYLA 673
R+ +T + GT+ Y++
Sbjct: 216 RILAQTMDPCNSSVGTIAYMS 236
|
Length = 353 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 78.2 bits (193), Expect = 1e-15
Identities = 53/147 (36%), Positives = 74/147 (50%), Gaps = 11/147 (7%)
Query: 513 IGQGSCGTVYHAVWYGSD--VAVK-VFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMG 569
IG+G+ G VY A S VA+K V E I S R E++L+ LRHPN++
Sbjct: 15 IGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLR-EITLLLNLRHPNIVELKE 73
Query: 570 AVTSPQ--RLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLH-HCNPPI 626
V + +V E+ + L LL T + + L + RG+ YLH + I
Sbjct: 74 VVVGKHLDSIFLVMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENF---I 129
Query: 627 IHRDLKSSNLLVDKHWTVKVGDFGLSR 653
IHRDLK SNLL+ +K+ DFGL+R
Sbjct: 130 IHRDLKVSNLLLTDKGCLKIADFGLAR 156
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 77.7 bits (191), Expect = 1e-15
Identities = 53/169 (31%), Positives = 85/169 (50%), Gaps = 33/169 (19%)
Query: 511 EQIGQGSCGTVYHAVWY--GSD----VAVKVF----SRQEYSDEVIHSFRQEVSLMKRLR 560
E++G+ + G +Y Y G D VA+K + Q++ + F+QE SLM L
Sbjct: 11 EELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGE-----FQQEASLMAELH 65
Query: 561 HPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLL--------------QRNTTK--LDWRR 604
HPN++ +G VT Q +C++ E+L +G L L + T K LD
Sbjct: 66 HPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGD 125
Query: 605 RILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSR 653
+ +A+ IA G+ YL + +H+DL + N+L+ + VK+ D GLSR
Sbjct: 126 FLHIAIQIAAGMEYL--SSHFFVHKDLAARNILIGEQLHVKISDLGLSR 172
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 77.1 bits (190), Expect = 2e-15
Identities = 45/146 (30%), Positives = 79/146 (54%), Gaps = 7/146 (4%)
Query: 511 EQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFR-QEVSLMKRLRHPNVLLF 567
E+IG+G+ GTV+ A VA+K R + DE + S +E+ L+K L+H N++
Sbjct: 6 EKIGEGTYGTVFKAKNRETHEIVALKRV-RLDDDDEGVPSSALREICLLKELKHKNIVRL 64
Query: 568 MGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPII 627
+ S ++L +V E+ + L + +D + +G+++ H N ++
Sbjct: 65 YDVLHSDKKLTLVFEYCDQ-DLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHN--VL 121
Query: 628 HRDLKSSNLLVDKHWTVKVGDFGLSR 653
HRDLK NLL++K+ +K+ DFGL+R
Sbjct: 122 HRDLKPQNLLINKNGELKLADFGLAR 147
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.9 bits (190), Expect = 2e-15
Identities = 53/165 (32%), Positives = 81/165 (49%), Gaps = 30/165 (18%)
Query: 509 IGEQIGQGSCGTVYHA--VWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLR---HPN 563
+IG+G+ GTVY A + G VA+K + + S +E++L+K+L HPN
Sbjct: 3 ELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPN 62
Query: 564 VLLFMGAVTSPQR-----LCIVTEFLPRGSLFRLLQR--------NTTKLDWRRRILMAL 610
++ + P+ L +V E + + L L + T K D R++L
Sbjct: 63 IVRLLDVCHGPRTDRELKLTLVFEHVDQ-DLATYLSKCPKPGLPPETIK-DLMRQLL--- 117
Query: 611 DIARGVSYLH-HCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL 654
RGV +LH H I+HRDLK N+LV VK+ DFGL+R+
Sbjct: 118 ---RGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLARI 156
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 2e-15
Identities = 49/167 (29%), Positives = 88/167 (52%), Gaps = 6/167 (3%)
Query: 511 EQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFM 568
++IG+GS G +Y A +K + + + ++EV L+ +++HPN++ F
Sbjct: 6 KKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFF 65
Query: 569 GAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRIL-MALDIARGVSYLHHCNPPII 627
+ RL IV E+ G L + + R L +IL + I+ G+ ++H + I+
Sbjct: 66 ASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIH--DRKIL 123
Query: 628 HRDLKSSNLLVDKHWTV-KVGDFGLSRLKHETYLTTKTGKGTVTYLA 673
HRD+KS N+ + K+ V K+GDFG++R +++ T GT YL+
Sbjct: 124 HRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCVGTPYYLS 170
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 77.3 bits (190), Expect = 2e-15
Identities = 60/165 (36%), Positives = 84/165 (50%), Gaps = 7/165 (4%)
Query: 513 IGQGSCGTVYHAVWY--GSDVAVKVFSRQEY--SDEVIHSFRQEVSLMKRLRHPNVLLFM 568
IG+GS G V A GS AVKV ++ E H + L+K L+HP ++
Sbjct: 3 IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLH 62
Query: 569 GAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIH 628
+ + ++L V +++ G LF LQR L+ R R A ++A + YLH N II+
Sbjct: 63 YSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRAR-FYAAEVASAIGYLHSLN--IIY 119
Query: 629 RDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTVTYLA 673
RDLK N+L+D V + DFGL + E TT T GT YLA
Sbjct: 120 RDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFCGTPEYLA 164
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.5 bits (189), Expect = 2e-15
Identities = 53/180 (29%), Positives = 88/180 (48%), Gaps = 21/180 (11%)
Query: 508 TIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRL-RHPNV 564
+ E IG+G+ G VY A G VA+K+ + ++ ++E +++++ HPN+
Sbjct: 9 ELVEVIGEGTYGKVYKARHKKTGQLVAIKI---MDIIEDEEEEIKEEYNILRKYSNHPNI 65
Query: 565 LLFMGA------VTSPQRLCIVTEFLPRGSLFRLLQR-----NTTKLDWRRRILMALDIA 613
F GA + +L +V E GS+ L++ K +W IL +
Sbjct: 66 ATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILR--ETL 123
Query: 614 RGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTVTYLA 673
RG++YLH +IHRD+K N+L+ K+ VK+ DFG+S T T GT ++A
Sbjct: 124 RGLAYLHENK--VIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFIGTPYWMA 181
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 3e-15
Identities = 53/170 (31%), Positives = 85/170 (50%), Gaps = 13/170 (7%)
Query: 513 IGQGSCGTVYHAVW-----YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLF 567
IG G G V+ + VA+K + Y+++ F E S+M + H N++
Sbjct: 13 IGAGEFGEVFRGILKMPGRKEVAVAIKTL-KPGYTEKQRQDFLSEASIMGQFSHHNIIRL 71
Query: 568 MGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPII 627
G VT + I+TE++ G+L + L+ + + + + M IA G+ YL N +
Sbjct: 72 EGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMN--YV 129
Query: 628 HRDLKSSNLLVDKHWTVKVGDFGLSRLKHE----TYLTTKTGKGTVTYLA 673
HRDL + N+LV+ + KV DFGLSR+ + TY TT GK + + A
Sbjct: 130 HRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTY-TTSGGKIPIRWTA 178
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 75.9 bits (186), Expect = 3e-15
Identities = 51/165 (30%), Positives = 90/165 (54%), Gaps = 7/165 (4%)
Query: 511 EQIGQGSCGTVYHAVWYGSD--VAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFM 568
E+IG+GS G VY + + VA+K+ +E DE I +QE++++ + P + +
Sbjct: 10 ERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDE-IEDIQQEITVLSQCDSPYITRYY 68
Query: 569 GAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIH 628
G+ +L I+ E+L GS LL+ + + IL +I +G+ YLH + IH
Sbjct: 69 GSYLKGTKLWIIMEYLGGGSALDLLKPGPLEETYIATILR--EILKGLDYLH--SERKIH 124
Query: 629 RDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTVTYLA 673
RD+K++N+L+ + VK+ DFG++ +T + T GT ++A
Sbjct: 125 RDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMA 169
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 75.9 bits (186), Expect = 4e-15
Identities = 52/165 (31%), Positives = 91/165 (55%), Gaps = 7/165 (4%)
Query: 511 EQIGQGSCGTVYHAVWYGSD--VAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFM 568
E+IG+GS G V+ + + VA+K+ +E DE I +QE++++ + P V +
Sbjct: 10 EKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDE-IEDIQQEITVLSQCDSPYVTKYY 68
Query: 569 GAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIH 628
G+ +L I+ E+L GS LL+ LD + + +I +G+ YLH + IH
Sbjct: 69 GSYLKDTKLWIIMEYLGGGSALDLLEPG--PLDETQIATILREILKGLDYLH--SEKKIH 124
Query: 629 RDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTVTYLA 673
RD+K++N+L+ +H VK+ DFG++ +T + T GT ++A
Sbjct: 125 RDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMA 169
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 75.5 bits (186), Expect = 5e-15
Identities = 52/159 (32%), Positives = 79/159 (49%), Gaps = 21/159 (13%)
Query: 506 DLTIGEQIGQGSCGTVYHAV--WYGSDVAVKVFSRQEYSDEVIHSFR-QEVSLMKRLRHP 562
D T E+IG+G+ G VY G VA+K R E +E + S +E+SL+K L+HP
Sbjct: 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKI-RLESEEEGVPSTAIREISLLKELQHP 59
Query: 563 NVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHH- 621
N++ + RL ++ EFL L + L ++ +D SYL+
Sbjct: 60 NIVCLQDVLMQESRLYLIFEFLSM-DLKKYL--DSLPKG------QYMDAELVKSYLYQI 110
Query: 622 ------CNPP-IIHRDLKSSNLLVDKHWTVKVGDFGLSR 653
C+ ++HRDLK NLL+D +K+ DFGL+R
Sbjct: 111 LQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLAR 149
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 76.4 bits (188), Expect = 5e-15
Identities = 57/178 (32%), Positives = 86/178 (48%), Gaps = 23/178 (12%)
Query: 506 DLTIGEQIGQGSCGTVYHAVWYGSD--VAVKVFSRQEY--SDEVIHSFRQEVSLMKRLRH 561
D +GE +G GS G V A G+ A+K ++E +V H QE S++ L H
Sbjct: 19 DFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQH-VAQEKSILMELSH 77
Query: 562 PNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQR-----NTTKLDWRRRILMALDIARGV 616
P ++ M + R+ + EF+ G LF L++ N + +++A +
Sbjct: 78 PFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFE----- 132
Query: 617 SYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLS-RLKHETYLTTKTGKGTVTYLA 673
YLH + II+RDLK NLL+D VKV DFG + ++ T+ T GT YLA
Sbjct: 133 -YLHSKD--IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRTF----TLCGTPEYLA 183
|
Length = 329 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 75.3 bits (185), Expect = 5e-15
Identities = 49/164 (29%), Positives = 81/164 (49%), Gaps = 5/164 (3%)
Query: 513 IGQGSCGTVYHAVWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVT 572
+G+G+ G VY A + V + + E + +E++L L+H N++ ++G+ +
Sbjct: 16 LGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDS 75
Query: 573 SPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRR--ILMALDIARGVSYLHHCNPPIIHRD 630
I E +P GSL LL+ L + I I G+ YLH + I+HRD
Sbjct: 76 ENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLH--DNQIVHRD 133
Query: 631 LKSSNLLVDKH-WTVKVGDFGLSRLKHETYLTTKTGKGTVTYLA 673
+K N+LV+ + VK+ DFG S+ T+T GT+ Y+A
Sbjct: 134 IKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETFTGTLQYMA 177
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 75.3 bits (186), Expect = 5e-15
Identities = 46/170 (27%), Positives = 78/170 (45%), Gaps = 17/170 (10%)
Query: 505 EDLTIGEQIGQGSCGTVYHAVWYGSD--VAVKVFSRQEYSDEV-IHSFRQEVSLMKRL-R 560
+D G+ IG+GS TV A ++ A+K+ +++ E + + E ++ RL
Sbjct: 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNG 60
Query: 561 HPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTK-LDWRR----RILMALDIARG 615
HP ++ + L V E+ P G L + +++ + R IL+AL+
Sbjct: 61 HPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALE---- 116
Query: 616 VSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTG 665
YLH IIHRDLK N+L+DK +K+ DFG +++
Sbjct: 117 --YLHSKG--IIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNK 162
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 76.3 bits (188), Expect = 6e-15
Identities = 41/163 (25%), Positives = 73/163 (44%), Gaps = 26/163 (15%)
Query: 509 IGEQIGQGSCGTVYHAV--WYGSDVAVKVFSRQEYSDEVIHSFRQ-------------EV 553
G +G+G+ G V A G VA+K E S++V RQ E+
Sbjct: 13 KGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKD-RQLVGMCGIHFTTLREL 71
Query: 554 SLMKRLRHPNVLLFMGAV---TSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMAL 610
+M ++H N+ MG V + +V + + L +++ R + + + ++ L
Sbjct: 72 KIMNEIKHENI---MGLVDVYVEGDFINLVMDIM-ASDLKKVVDRKIRLTESQVKCIL-L 126
Query: 611 DIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSR 653
I G++ LH +HRDL +N+ ++ K+ DFGL+R
Sbjct: 127 QILNGLNVLHKWY--FMHRDLSPANIFINSKGICKIADFGLAR 167
|
Length = 335 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 75.7 bits (186), Expect = 6e-15
Identities = 42/141 (29%), Positives = 71/141 (50%), Gaps = 21/141 (14%)
Query: 531 VAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLF 590
VAVK+ R + + + F +EV ++ RL+ PN++ +G LC++TE++ G L
Sbjct: 49 VAVKIL-RPDANKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLN 107
Query: 591 RLLQRNTTK------------------LDWRRRILMALDIARGVSYLHHCNPPIIHRDLK 632
+ L + + + + +AL IA G+ YL N +HRDL
Sbjct: 108 QFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN--FVHRDLA 165
Query: 633 SSNLLVDKHWTVKVGDFGLSR 653
+ N LV ++ T+K+ DFG+SR
Sbjct: 166 TRNCLVGENLTIKIADFGMSR 186
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 7e-15
Identities = 58/175 (33%), Positives = 91/175 (52%), Gaps = 23/175 (13%)
Query: 509 IGEQIGQGSCGTVY--HAVWYGSDVAVKVFSRQEYSDEV---IHSFRQEVSLMKRLRHPN 563
+G+ +GQG+ G VY + G ++AVK S E +++ E+ L+K L H
Sbjct: 6 LGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHER 65
Query: 564 VLLFMGAVTSPQR--LCIVTEFLPRGSL------FRLLQRNTTKLDWRRRILMALDIARG 615
++ + G + P L I E +P GS+ + L N T+ + R+IL G
Sbjct: 66 IVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTR-KYTRQIL------EG 118
Query: 616 VSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTVT 670
VSYLH + I+HRD+K +N+L D VK+GDFG S+ + +T + TG +VT
Sbjct: 119 VSYLH--SNMIVHRDIKGANILRDSVGNVKLGDFGASK-RLQTICLSGTGMKSVT 170
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 7e-15
Identities = 51/165 (30%), Positives = 88/165 (53%), Gaps = 7/165 (4%)
Query: 511 EQIGQGSCGTVYHAV--WYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFM 568
E+IG+GS G V+ + VA+K+ +E DE I +QE++++ + P V +
Sbjct: 10 ERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDE-IEDIQQEITVLSQCDSPYVTKYY 68
Query: 569 GAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIH 628
G+ +L I+ E+L GS LL+ D + M +I +G+ YLH + IH
Sbjct: 69 GSYLKGTKLWIIMEYLGGGSALDLLR--AGPFDEFQIATMLKEILKGLDYLH--SEKKIH 124
Query: 629 RDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTVTYLA 673
RD+K++N+L+ + VK+ DFG++ +T + T GT ++A
Sbjct: 125 RDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMA 169
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 75.1 bits (185), Expect = 7e-15
Identities = 47/143 (32%), Positives = 72/143 (50%), Gaps = 5/143 (3%)
Query: 513 IGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGA 570
+G+GS G V G VA+K F E V +E+ ++K+LRH N++ +
Sbjct: 9 VGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEV 68
Query: 571 VTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRD 630
+RL +V EF+ ++ L++ LD R I RG+ + H N IIHRD
Sbjct: 69 FRRKKRLYLVFEFVDH-TVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHN--IIHRD 125
Query: 631 LKSSNLLVDKHWTVKVGDFGLSR 653
+K N+LV + VK+ DFG +R
Sbjct: 126 IKPENILVSQSGVVKLCDFGFAR 148
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 1e-14
Identities = 56/165 (33%), Positives = 82/165 (49%), Gaps = 7/165 (4%)
Query: 513 IGQGSCGTVYHAVWYGSDV--AVKVFSRQEY--SDEVIHSFRQEVSLMKRLRHPNVLLFM 568
IG+GS G V A + AVKV ++ E H + L+K ++HP ++
Sbjct: 3 IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH 62
Query: 569 GAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIH 628
+ + +L V +++ G LF LQR L+ R R A +IA + YLH N I++
Sbjct: 63 FSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRAR-FYAAEIASALGYLHSLN--IVY 119
Query: 629 RDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTVTYLA 673
RDLK N+L+D + + DFGL + E TT T GT YLA
Sbjct: 120 RDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFCGTPEYLA 164
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 1e-14
Identities = 54/169 (31%), Positives = 86/169 (50%), Gaps = 16/169 (9%)
Query: 498 LDYEILWE----DLTIGEQIGQGSCGTVYHAVWYG---SD----VAVKVFSRQEYSDEVI 546
L Y++ WE +L+ G+ +G G+ G V A YG SD VAVK+ +S E
Sbjct: 24 LPYDLKWEFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSER- 82
Query: 547 HSFRQEVSLMKRL-RHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTK-LDWRR 604
+ E+ +M L H N++ +GA T + ++TE+ G L L+R L
Sbjct: 83 EALMSELKIMSHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLED 142
Query: 605 RILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSR 653
+ + +A+G+++L N IHRDL + N+L+ VK+ DFGL+R
Sbjct: 143 LLSFSYQVAKGMAFLASKN--CIHRDLAARNVLLTHGKIVKICDFGLAR 189
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 1e-14
Identities = 41/131 (31%), Positives = 71/131 (54%), Gaps = 15/131 (11%)
Query: 550 RQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLL--QRNT-----TKLDW 602
R+EV+++ ++HPN++ + + L IV ++ G L++ + QR LDW
Sbjct: 47 RKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDW 106
Query: 603 RRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTT 662
+I +AL H + I+HRD+KS N+ + K T+K+GDFG++R+ + T
Sbjct: 107 FVQICLALK--------HVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELA 158
Query: 663 KTGKGTVTYLA 673
+T GT YL+
Sbjct: 159 RTCIGTPYYLS 169
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 1e-14
Identities = 58/207 (28%), Positives = 98/207 (47%), Gaps = 34/207 (16%)
Query: 498 LDYEILWE----DLTIGEQIGQGSCGTVYHAVWYGSD---------VAVKVFSRQEYSDE 544
L + WE L +G+ +G+G G V A YG D VAVK+ + +D+
Sbjct: 1 LPLDPKWEFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKML-KDNATDK 59
Query: 545 VIHSFRQEVSLMKRL-RHPNVLLFMGAVTSPQRLCIVTEFLPRGSL-------------- 589
+ E+ LMK + +H N++ +G T L ++ E+ +G+L
Sbjct: 60 DLADLISEMELMKLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDY 119
Query: 590 -FRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGD 648
F + + +L ++ + A +ARG+ YL + IHRDL + N+LV + +K+ D
Sbjct: 120 TFDITKVPEEQLSFKDLVSCAYQVARGMEYLE--SRRCIHRDLAARNVLVTEDNVMKIAD 177
Query: 649 FGLSRLKHET--YLTTKTGKGTVTYLA 673
FGL+R H+ Y T G+ V ++A
Sbjct: 178 FGLARGVHDIDYYKKTSNGRLPVKWMA 204
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 73.4 bits (180), Expect = 2e-14
Identities = 48/158 (30%), Positives = 83/158 (52%), Gaps = 15/158 (9%)
Query: 503 LWEDLTIGEQIGQGSCGTVYHA-VWYGSDVAVKVF----SRQEYSDEVIHSFRQEVSLMK 557
W T GE +G+G+ GTVY G +AVK S +++ ++EV L+K
Sbjct: 1 EW---TKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLK 57
Query: 558 RLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQR--NTTKLDWRRRILMALDIARG 615
L+H N++ ++G + I EF+P GS+ +L R + + + LD G
Sbjct: 58 SLKHVNIVQYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILD---G 114
Query: 616 VSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSR 653
V+YLH+ ++HRD+K +N+++ + +K+ DFG +R
Sbjct: 115 VAYLHNNC--VVHRDIKGNNVMLMPNGIIKLIDFGCAR 150
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 73.2 bits (179), Expect = 3e-14
Identities = 52/171 (30%), Positives = 88/171 (51%), Gaps = 7/171 (4%)
Query: 505 EDLTIGEQIGQGSCGTVYHA--VWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHP 562
ED + ++IG G+ G VY A V G A+KV + D + +QE+ +MK +H
Sbjct: 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAV--VQQEIIMMKDCKHS 66
Query: 563 NVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHC 622
N++ + G+ +L I EF GSL + + T L + ++ + +G+ YLH
Sbjct: 67 NIVAYFGSYLRRDKLWICMEFCGGGSL-QDIYHVTGPLSESQIAYVSRETLQGLYYLH-- 123
Query: 623 NPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTVTYLA 673
+ +HRD+K +N+L+ + VK+ DFG+S T K+ GT ++A
Sbjct: 124 SKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFIGTPYWMA 174
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 6e-14
Identities = 48/147 (32%), Positives = 80/147 (54%), Gaps = 6/147 (4%)
Query: 511 EQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFM 568
E++G+GS TVY + G VA+KV S + + V + +E SL+K L+H N++L
Sbjct: 11 EKLGEGSYATVYKGISRINGQLVALKVIS-MKTEEGVPFTAIREASLLKGLKHANIVLLH 69
Query: 569 GAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIH 628
+ + + L V E++ L + + ++ L L + RG++Y+H + I+H
Sbjct: 70 DIIHTKETLTFVFEYM-HTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQH--ILH 126
Query: 629 RDLKSSNLLVDKHWTVKVGDFGLSRLK 655
RDLK NLL+ +K+ DFGL+R K
Sbjct: 127 RDLKPQNLLISYLGELKLADFGLARAK 153
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 72.2 bits (177), Expect = 7e-14
Identities = 55/182 (30%), Positives = 79/182 (43%), Gaps = 24/182 (13%)
Query: 513 IGQGSCGTVYHA-----VWYGSD---VAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNV 564
+G G+ G VY + GS VAVK + E F +E LM HPN+
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKK-EFLKEAHLMSNFNHPNI 61
Query: 565 LLFMGAVTSPQRLCIVTEFLPRGSLFRLLQ--RNTTK----LDWRRRILMALDIARGVSY 618
+ +G + I+ E + G L L+ R L + + + LD+A+G Y
Sbjct: 62 VKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVY 121
Query: 619 LHHCNPPIIHRDLKSSNLLV-----DKHWTVKVGDFGLSR--LKHETYLTTKTGKGTVTY 671
L + IHRDL + N LV D VK+GDFGL+R K + Y G V +
Sbjct: 122 LEQMH--FIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRW 179
Query: 672 LA 673
+A
Sbjct: 180 MA 181
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 7e-14
Identities = 45/147 (30%), Positives = 77/147 (52%), Gaps = 8/147 (5%)
Query: 511 EQIGQGSCGTVYHA--VWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFM 568
E+IG+G+ G VY A G VA+K ++ V + +E+SL+K L HPN++ +
Sbjct: 6 EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 65
Query: 569 GAVTSPQRLCIVTEFLPRG--SLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPI 626
+ + +L +V EFL + + L + L L +G+++ H + +
Sbjct: 66 DVIHTENKLYLVFEFLHQDLKKFMDASPLSGIPLPLIKSYLFQL--LQGLAFCH--SHRV 121
Query: 627 IHRDLKSSNLLVDKHWTVKVGDFGLSR 653
+HRDLK NLL++ +K+ DFGL+R
Sbjct: 122 LHRDLKPQNLLINTEGAIKLADFGLAR 148
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 72.2 bits (177), Expect = 9e-14
Identities = 47/144 (32%), Positives = 83/144 (57%), Gaps = 10/144 (6%)
Query: 511 EQIGQGSCGTVYHA--VWYGSDVAVKVFS-RQEYSDEVIHSFRQEVSLMKRLRHPNVLLF 567
E+IGQG+ GTVY A V G +VA+K + +Q+ E+I + E+ +M+ +HPN++ +
Sbjct: 25 EKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIIN---EILVMRENKHPNIVNY 81
Query: 568 MGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPII 627
+ + L +V E+L GSL ++ T +D + + + + + +LH + +I
Sbjct: 82 LDSYLVGDELWVVMEYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLH--SNQVI 137
Query: 628 HRDLKSSNLLVDKHWTVKVGDFGL 651
HRD+KS N+L+ +VK+ DFG
Sbjct: 138 HRDIKSDNILLGMDGSVKLTDFGF 161
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 72.0 bits (177), Expect = 9e-14
Identities = 45/151 (29%), Positives = 78/151 (51%), Gaps = 15/151 (9%)
Query: 511 EQIGQGSCGTVYHA--VWYGSDVAVKVFSRQEYSDEVIH--SFRQEVSLMKRLRHPNVLL 566
+IG+GS G V+ G VA+K F E D VI + R E+ ++K+L+HPN++
Sbjct: 7 SKIGEGSYGVVFKCRNRETGQIVAIKKFVESE-DDPVIKKIALR-EIRMLKQLKHPNLVN 64
Query: 567 FMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLD---WRRRILMALDIARGVSYLHHCN 623
+ ++L +V E+ ++ L++N + ++ I L V++ H N
Sbjct: 65 LIEVFRRKRKLHLVFEYCDH-TVLNELEKNPRGVPEHLIKKIIWQTLQ---AVNFCHKHN 120
Query: 624 PPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL 654
IHRD+K N+L+ K +K+ DFG +R+
Sbjct: 121 --CIHRDVKPENILITKQGQIKLCDFGFARI 149
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 72.3 bits (178), Expect = 1e-13
Identities = 54/180 (30%), Positives = 84/180 (46%), Gaps = 25/180 (13%)
Query: 501 EILWE---DLTIGEQIGQGSCGTVYHAVWYGSD--VAVKVFSRQEYSDEVIHSFR--QEV 553
+ +WE +G G+ G V A + VA+K SR S IH+ R +E+
Sbjct: 8 KTVWEVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQS--AIHAKRTYREL 65
Query: 554 SLMKRLRHPNVLLFMGAVTSPQRL------CIVTEFLPRGSLFRLLQRNTTKL-DWRRRI 606
L+K + H NV+ + T L +VT + L +++ KL D +
Sbjct: 66 RLLKHMDHENVIGLLDVFTPASSLEDFQDVYLVTHLMGA-DLNNIVK--CQKLSDDHIQF 122
Query: 607 LMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHE---TYLTTK 663
L I RG+ Y+H IIHRDLK SN+ V++ +K+ DFGL+R + Y+ T+
Sbjct: 123 L-VYQILRGLKYIHSAG--IIHRDLKPSNIAVNEDCELKILDFGLARHTDDEMTGYVATR 179
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 71.8 bits (176), Expect = 1e-13
Identities = 54/168 (32%), Positives = 83/168 (49%), Gaps = 25/168 (14%)
Query: 499 DYEILWEDLTIGEQIGQGSCGTVYHA--VWYGSDVAVKVFSRQ-EYSDEVIHSFRQEVSL 555
D E L+ DL +IG GS G VY A V VA+K S + S+E +EV
Sbjct: 12 DPEKLFTDLR---EIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRF 68
Query: 556 MKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIA-- 613
+++LRHPN + + G +V E+ L + L+ ++ L ++IA
Sbjct: 69 LQQLRHPNTIEYKGCYLREHTAWLVMEYC--------LGSASDILEVHKKPLQEVEIAAI 120
Query: 614 -----RGVSYLH-HCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLK 655
+G++YLH H IHRD+K+ N+L+ + TVK+ DFG + L
Sbjct: 121 CHGALQGLAYLHSHER---IHRDIKAGNILLTEPGTVKLADFGSASLV 165
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 1e-13
Identities = 56/181 (30%), Positives = 91/181 (50%), Gaps = 35/181 (19%)
Query: 513 IGQGSCGTVYHAVWYGSD--VAVK-VFSRQEYSDEVIHSFRQEVSLMKRLRHPNVL---- 565
+G GS G V+ AV D VAVK + S V H+ R E+ +++RL H N++
Sbjct: 13 LGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQS--VKHALR-EIKIIRRLDHDNIVKVYE 69
Query: 566 -LF---------MGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARG 615
L +G++T + IV E++ L +L++ + R L + RG
Sbjct: 70 VLGPSGSDLTEDVGSLTELNSVYIVQEYM-ETDLANVLEQGPLSEEHAR--LFMYQLLRG 126
Query: 616 VSYLHHCNPPIIHRDLKSSNLLVDKHWTV-KVGDFGLSRL-----KHETYLTTKTGKGTV 669
+ Y+H N ++HRDLK +N+ ++ V K+GDFGL+R+ H+ YL+ +G V
Sbjct: 127 LKYIHSAN--VLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLS----EGLV 180
Query: 670 T 670
T
Sbjct: 181 T 181
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 72.0 bits (177), Expect = 1e-13
Identities = 46/186 (24%), Positives = 82/186 (44%), Gaps = 47/186 (25%)
Query: 500 YEILWEDLTIGEQIGQGSCGTVYHAV--WYGSDVAVKVFSRQEYSDEVIHSFR--QEVSL 555
Y+ + E IG G+ G V A+ G VA+K D + R +E+ +
Sbjct: 7 YKPI-------ENIGSGAYGVVCSAIDTRSGKKVAIKKIPHA--FDVPTLAKRTLRELKI 57
Query: 556 MKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFR-------LLQRNTTKLDWRRRILM 608
++ +H N++ I P G+ F+ L++ + + + L
Sbjct: 58 LRHFKHDNII------------AIRDILRPPGADFKDVYVVMDLMESDLHHIIHSDQPLT 105
Query: 609 A-------LDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL------K 655
+ RG+ Y+H N +IHRDLK SNLLV++ +++GDFG++R +
Sbjct: 106 EEHIRYFLYQLLRGLKYIHSAN--VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTE 163
Query: 656 HETYLT 661
H+ ++T
Sbjct: 164 HKYFMT 169
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 71.1 bits (174), Expect = 2e-13
Identities = 55/177 (31%), Positives = 87/177 (49%), Gaps = 24/177 (13%)
Query: 505 EDLTIGEQIGQGSCGTVYHA--VWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHP 562
+D+ E +G G+ GTVY A + +AVKV + + E+ E+ ++ + P
Sbjct: 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIP-LDITVELQKQIMSELEILYKCDSP 59
Query: 563 NVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRI------LMALDIARGV 616
++ F GA R+ I TEF+ GSL D R+I +A+ + +G+
Sbjct: 60 YIIGFYGAFFVENRISICTEFMDGGSL-----------DVYRKIPEHVLGRIAVAVVKGL 108
Query: 617 SYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTVTYLA 673
+YL I+HRD+K SN+LV+ VK+ DFG+S + KT GT Y+A
Sbjct: 109 TYLWSLK--ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS--IAKTYVGTNAYMA 161
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 71.3 bits (174), Expect = 2e-13
Identities = 50/147 (34%), Positives = 78/147 (53%), Gaps = 6/147 (4%)
Query: 511 EQIGQGSCGTVYH--AVWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFM 568
E++G+GS TVY + G VA+KV QE + R E SL+K L+H N++L
Sbjct: 11 EKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIR-EASLLKGLKHANIVLLH 69
Query: 569 GAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIH 628
+ + + L +V E++ L + + ++ L L + RG+SY+H I+H
Sbjct: 70 DIIHTKETLTLVFEYV-HTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQ--RYILH 126
Query: 629 RDLKSSNLLVDKHWTVKVGDFGLSRLK 655
RDLK NLL+ +K+ DFGL+R K
Sbjct: 127 RDLKPQNLLISDTGELKLADFGLARAK 153
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 70.5 bits (172), Expect = 3e-13
Identities = 46/170 (27%), Positives = 83/170 (48%), Gaps = 19/170 (11%)
Query: 506 DLTIGEQIGQGSCGTVYHAVWYG-----SDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLR 560
++ + ++G+G+ G V+ A Y + V V + ++ SD F +E L+ L+
Sbjct: 6 NIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQ 65
Query: 561 HPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRN------------TTKLDWRRRILM 608
H +++ F G L +V E++ G L + L+ + +L + + +
Sbjct: 66 HEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHI 125
Query: 609 ALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHET 658
A IA G+ YL + +HRDL + N LV ++ VK+GDFG+SR + T
Sbjct: 126 AQQIAAGMVYL--ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYST 173
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 4e-13
Identities = 44/149 (29%), Positives = 76/149 (51%), Gaps = 10/149 (6%)
Query: 505 EDLTIGEQIGQGSCGTV--YHAVWYGSDVAVKVFS-RQEYSDEVIHSFRQEVSLMKRLRH 561
L +IG+GS G V G VAVK R++ E++ + EV +M+ +H
Sbjct: 19 SYLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFN---EVVIMRDYQH 75
Query: 562 PNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHH 621
PN++ + L +V EFL G+L ++ T+++ + + L + + +S+LH
Sbjct: 76 PNIVEMYSSYLVGDELWVVMEFLEGGALTDIVTH--TRMNEEQIATVCLAVLKALSFLH- 132
Query: 622 CNPPIIHRDLKSSNLLVDKHWTVKVGDFG 650
+IHRD+KS ++L+ VK+ DFG
Sbjct: 133 -AQGVIHRDIKSDSILLTSDGRVKLSDFG 160
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 70.5 bits (172), Expect = 4e-13
Identities = 47/168 (27%), Positives = 80/168 (47%), Gaps = 10/168 (5%)
Query: 513 IGQGSCGTVYHAVWYGSDVAVKVFSRQEYSDEVIH-----SFRQEVSLMKRLRHPNVLLF 567
+G G+ GTVY +W VK+ + +E F E +M + HP+++
Sbjct: 15 LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 74
Query: 568 MGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPII 627
+G SP + +VT+ +P G L + + + + + + IA+G+ YL ++
Sbjct: 75 LGVCLSPT-IQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERR--LV 131
Query: 628 HRDLKSSNLLVDKHWTVKVGDFGLSRLKH--ETYLTTKTGKGTVTYLA 673
HRDL + N+LV VK+ DFGL+RL E GK + ++A
Sbjct: 132 HRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMA 179
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 4e-13
Identities = 54/182 (29%), Positives = 89/182 (48%), Gaps = 26/182 (14%)
Query: 513 IGQGSCGTVYHAVWYGS----DVAVKVFSRQEYSDEVIH-SFRQEVSLMKRL-RHPNVLL 566
IG+G+ G V A D A+K +EY+ + H F E+ ++ +L HPN++
Sbjct: 3 IGEGNFGQVLKARIKKDGLRMDAAIKRM--KEYASKDDHRDFAGELEVLCKLGHHPNIIN 60
Query: 567 FMGAVTSPQRLCIVTEFLPRGSLFRLLQRN---------------TTKLDWRRRILMALD 611
+GA L + E+ P G+L L+++ + L ++ + A D
Sbjct: 61 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 120
Query: 612 IARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTVTY 671
+ARG+ YL IHRDL + N+LV +++ K+ DFGLSR E Y+ G+ V +
Sbjct: 121 VARGMDYLSQ--KQFIHRDLAARNILVGENYVAKIADFGLSR-GQEVYVKKTMGRLPVRW 177
Query: 672 LA 673
+A
Sbjct: 178 MA 179
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 5e-13
Identities = 54/170 (31%), Positives = 86/170 (50%), Gaps = 14/170 (8%)
Query: 513 IGQGSCGTVYHAVWY--GSD----VAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLL 566
+G G+ GTVY +W G + VA+KV R+ S + E +M + P V
Sbjct: 15 LGSGAFGTVYKGIWIPDGENVKIPVAIKVL-RENTSPKANKEILDEAYVMAGVGSPYVCR 73
Query: 567 FMG-AVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPP 625
+G +TS +L VT+ +P G L ++ N ++ + + + IA+G+SYL
Sbjct: 74 LLGICLTSTVQL--VTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVR-- 129
Query: 626 IIHRDLKSSNLLVDKHWTVKVGDFGLSRLK--HETYLTTKTGKGTVTYLA 673
++HRDL + N+LV VK+ DFGL+RL ET GK + ++A
Sbjct: 130 LVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMA 179
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 69.8 bits (170), Expect = 5e-13
Identities = 46/143 (32%), Positives = 80/143 (55%), Gaps = 8/143 (5%)
Query: 511 EQIGQGSCGTVYHA--VWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFM 568
E+IGQG+ GTV+ A V G +VA+K + Q+ + + E+ +MK L++PN++ F+
Sbjct: 25 EKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKEL--IINEILVMKELKNPNIVNFL 82
Query: 569 GAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIH 628
+ L +V E+L GSL ++ T +D + + + + + +LH +IH
Sbjct: 83 DSFLVGDELFVVMEYLAGGSLTDVVTE--TCMDEAQIAAVCRECLQALEFLHANQ--VIH 138
Query: 629 RDLKSSNLLVDKHWTVKVGDFGL 651
RD+KS N+L+ +VK+ DFG
Sbjct: 139 RDIKSDNVLLGMDGSVKLTDFGF 161
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 70.5 bits (172), Expect = 5e-13
Identities = 55/165 (33%), Positives = 81/165 (49%), Gaps = 8/165 (4%)
Query: 513 IGQGSCGTV--YHAVWYGSDVAVKVFSRQEY--SDEVIHSFRQEVSLMKRLRHPNVLLFM 568
+G+G+ G V G A+K+ ++ DEV H+ E ++K RHP +
Sbjct: 3 LGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTL-TESRVLKNTRHPFLTSLK 61
Query: 569 GAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIH 628
+ + RLC V E++ G LF L R + R R A +I + YLH + I++
Sbjct: 62 YSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGA-EIVSALDYLH--SGKIVY 118
Query: 629 RDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTVTYLA 673
RDLK NL++DK +K+ DFGL + T KT GT YLA
Sbjct: 119 RDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCGTPEYLA 163
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 69.3 bits (170), Expect = 6e-13
Identities = 41/165 (24%), Positives = 75/165 (45%), Gaps = 9/165 (5%)
Query: 513 IGQGSCGTVYHAVWY---GSDVAVKVFSRQEY-SDEVIHSFRQEVSLMKRLRHPNVLLFM 568
IG+G+ G V V A+K ++Q+ + + E +++ L HP ++
Sbjct: 8 IGKGAFGKVC-IVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLW 66
Query: 569 GAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIH 628
+ + + +V + L G L L + + + + + +I + YLH IIH
Sbjct: 67 YSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWIC-EIVLALEYLHSKG--IIH 123
Query: 629 RDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTVTYLA 673
RD+K N+L+D+ V + DF ++ LTT + GT Y+A
Sbjct: 124 RDIKPDNILLDEQGHVHITDFNIATKVTPDTLTT-STSGTPGYMA 167
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 7e-13
Identities = 46/174 (26%), Positives = 81/174 (46%), Gaps = 13/174 (7%)
Query: 509 IGEQIGQGSCGTVYHAVWYGSDVAVKVFSRQEYS------DEVIHSFRQEVSLMKRLRHP 562
+ +++G+GS GTVY + ++ +E +E + + QE L+ +L HP
Sbjct: 4 LQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQA-NQEAQLLSKLDHP 62
Query: 563 NVLLFMGAVTSPQRLCIVTEFLPRGSL---FRLLQRNTTKLDWRRRILMALDIARGVSYL 619
++ F + CI+TE+ L L+ L + + + GV Y+
Sbjct: 63 AIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYM 122
Query: 620 HHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTVTYLA 673
H I+HRDLK+ N+ + + +K+GDFG+SRL + T GT Y++
Sbjct: 123 HQRR--ILHRDLKAKNIFLKNN-LLKIGDFGVSRLLMGSCDLATTFTGTPYYMS 173
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 8e-13
Identities = 51/166 (30%), Positives = 77/166 (46%), Gaps = 13/166 (7%)
Query: 513 IGQGSCGTVYHA--VWYGSDVAVKVFSRQEY--SDEVIHSFRQEVSLMKRLRHPNVLLFM 568
I +G+ G+VY A G A+KV + + ++V + + +M + P V
Sbjct: 4 ISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLY 63
Query: 569 GAVTSPQRLCIVTEFLPRGSLFRLLQR-NTTKLDWRRRILMALDIARGVSYLHHCNPPII 627
+ S L +V E+L G L++ DW ++ ++ GV LH II
Sbjct: 64 YSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQ--YIAEVVLGVEDLHQRG--II 119
Query: 628 HRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTVTYLA 673
HRD+K NLL+D+ +K+ DFGLSR L K GT YLA
Sbjct: 120 HRDIKPENLLIDQTGHLKLTDFGLSRNG----LENKKFVGTPDYLA 161
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 9e-13
Identities = 46/131 (35%), Positives = 66/131 (50%), Gaps = 4/131 (3%)
Query: 543 DEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDW 602
DEV H+ E +++ RHP + A + RLC V E+ G LF L R +
Sbjct: 37 DEVAHTV-TESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEE 95
Query: 603 RRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTT 662
R R A +I + YLH + +++RD+K NL++DK +K+ DFGL + T
Sbjct: 96 RARFYGA-EIVSALEYLHSRD--VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATM 152
Query: 663 KTGKGTVTYLA 673
KT GT YLA
Sbjct: 153 KTFCGTPEYLA 163
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.9 bits (169), Expect = 9e-13
Identities = 43/147 (29%), Positives = 72/147 (48%), Gaps = 6/147 (4%)
Query: 511 EQIGQGSCGTVYHAVWYGSD--VAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFM 568
+++G+GS TVY + VA+K + + R E SL+K L+H N++
Sbjct: 11 DKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIR-EASLLKDLKHANIVTLH 69
Query: 569 GAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIH 628
+ + + L +V E+L L + + L L + RG++Y H ++H
Sbjct: 70 DIIHTKKTLTLVFEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRR--VLH 126
Query: 629 RDLKSSNLLVDKHWTVKVGDFGLSRLK 655
RDLK NLL+ + +K+ DFGL+R K
Sbjct: 127 RDLKPQNLLISERGELKLADFGLARAK 153
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 9e-13
Identities = 50/170 (29%), Positives = 84/170 (49%), Gaps = 25/170 (14%)
Query: 505 EDLTIGEQIGQGSCGTVY----HAVWYGSD---VAVKVFSRQEYSDEVIHSFRQEVSLMK 557
D+ + ++G+G+ G V+ H + D VAVK +E S+ F++E L+
Sbjct: 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKAL--KEASESARQDFQREAELLT 62
Query: 558 RLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRN--------------TTKLDWR 603
L+H +++ F G T + L +V E++ G L R L+ + +L
Sbjct: 63 VLQHQHIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLG 122
Query: 604 RRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSR 653
+ + +A IA G+ YL + +HRDL + N LV + VK+GDFG+SR
Sbjct: 123 QMLAIASQIASGMVYLASLH--FVHRDLATRNCLVGQGLVVKIGDFGMSR 170
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 1e-12
Identities = 52/159 (32%), Positives = 87/159 (54%), Gaps = 15/159 (9%)
Query: 513 IGQGSCGTVYHA--VWYGSDVAVKVFSRQEYSDEVI--HSFRQEVSLMKRLRHPNVLLFM 568
+G G+ G V A G +VA+K + +S V+ ++R E+ L+K LRH N++
Sbjct: 18 VGMGAFGLVCSARDQLTGQNVAIKKIMK-PFSTPVLAKRTYR-ELKLLKHLRHENIISLS 75
Query: 569 GAVTSP-QRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPII 627
SP + + VTE L L RLL + L+ + I RG+ Y+H ++
Sbjct: 76 DIFISPLEDIYFVTELLGT-DLHRLLT--SRPLEKQFIQYFLYQILRGLKYVHSAG--VV 130
Query: 628 HRDLKSSNLLVDKHWTVKVGDFGLSRLK--HET-YLTTK 663
HRDLK SN+L++++ +K+ DFGL+R++ T Y++T+
Sbjct: 131 HRDLKPSNILINENCDLKICDFGLARIQDPQMTGYVSTR 169
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 1e-12
Identities = 54/201 (26%), Positives = 98/201 (48%), Gaps = 30/201 (14%)
Query: 500 YEILWEDLTIGEQIGQGSCGTVYHAVWYGSD---------VAVKVFSRQEYSDEVIHSFR 550
+E+ + L +G+ +G+G G V A G D VAVK+ + + +++ +
Sbjct: 13 WEVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKML-KSDATEKDLSDLI 71
Query: 551 QEVSLMKRL-RHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRN------------- 596
E+ +MK + +H N++ +GA T L ++ E+ +G+L L+
Sbjct: 72 SEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQ 131
Query: 597 --TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL 654
+L ++ + A +ARG+ YL + IHRDL + N+LV + +K+ DFGL+R
Sbjct: 132 VPEEQLSFKDLVSCAYQVARGMEYL--ASKKCIHRDLAARNVLVTEDNVMKIADFGLARD 189
Query: 655 KH--ETYLTTKTGKGTVTYLA 673
H + Y T G+ V ++A
Sbjct: 190 IHHIDYYKKTTNGRLPVKWMA 210
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 1e-12
Identities = 53/162 (32%), Positives = 85/162 (52%), Gaps = 22/162 (13%)
Query: 513 IGQGSCGTV---YHAVWYGSDVAVKVFSRQEYSDEVIHSFR--QEVSLMKRLRHPNVLLF 567
IG G+ G V Y V G +VA+K SR V H+ R +E+ LMK + H N++
Sbjct: 24 IGSGAQGIVCAAYDTV-TGQNVAIKKLSRP--FQNVTHAKRAYRELVLMKLVNHKNIIGL 80
Query: 568 MGAVTSPQR-------LCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLH 620
+ T PQ+ + +V E + +L +++Q + LD R + + G+ +LH
Sbjct: 81 LNVFT-PQKSLEEFQDVYLVMELMD-ANLCQVIQMD---LDHERMSYLLYQMLCGIKHLH 135
Query: 621 HCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTT 662
+ IIHRDLK SN++V T+K+ DFGL+R +++ T
Sbjct: 136 --SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMT 175
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 68.2 bits (166), Expect = 1e-12
Identities = 56/177 (31%), Positives = 94/177 (53%), Gaps = 29/177 (16%)
Query: 510 GEQIGQGSCGTVYHAVWYGSDVAVKVFSRQ--------EYSDEVIHSFRQEVSLMKRLRH 561
G+ +GQG+ G VY + Y D ++ ++Q E S EV + E+ L+K L+H
Sbjct: 7 GKLLGQGAFGRVY--LCYDVDTGRELAAKQVQFDPESPETSKEV-SALECEIQLLKNLQH 63
Query: 562 PNVLLFMGAVT--SPQRLCIVTEFLPRGSL------FRLLQRNTTKLDWRRRILMALDIA 613
++ + G + + + L I E++P GS+ + L + T+ + R+IL
Sbjct: 64 ERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTR-KYTRQIL------ 116
Query: 614 RGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTVT 670
G+SYLH + I+HRD+K +N+L D VK+GDFG S+ + +T + TG +VT
Sbjct: 117 EGMSYLH--SNMIVHRDIKGANILRDSAGNVKLGDFGASK-RLQTICMSGTGIRSVT 170
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 68.2 bits (167), Expect = 2e-12
Identities = 46/173 (26%), Positives = 74/173 (42%), Gaps = 27/173 (15%)
Query: 501 EILWEDLTIGEQIGQGSCGTVYHAVWYGSD-------VAVK----VFSRQEYSDEVIHSF 549
E+ + +T+ +G G+ G VY ++ G D VAVK S Q+ SD F
Sbjct: 2 EVPRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESD-----F 56
Query: 550 RQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLL------QRNTTKLDWR 603
E +M + H N++ +G I+ E + G L L + L +
Sbjct: 57 LMEALIMSKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMK 116
Query: 604 RRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHW---TVKVGDFGLSR 653
+ A D+A+G YL + IHRD+ + N L+ K+ DFG++R
Sbjct: 117 DLLFCARDVAKGCKYLEENH--FIHRDIAARNCLLTCKGPGRVAKIADFGMAR 167
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.9 bits (169), Expect = 2e-12
Identities = 46/160 (28%), Positives = 77/160 (48%), Gaps = 19/160 (11%)
Query: 505 EDLTIGEQIGQGSCGTVYHAV--WYGSDVAVKV---FSRQEYSDEVIHSFRQEVSLMKRL 559
IG+G+ G V A G VA+K F Q + + R E+ +++R
Sbjct: 5 PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFC---QRTLR-EIKILRRF 60
Query: 560 RHPNVLLFMGAVTSP-----QRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIAR 614
+H N++ + + P + IV E + L++L++ T L I R
Sbjct: 61 KHENIIGILDIIRPPSFESFNDVYIVQELMET-DLYKLIK--TQHLSNDHIQYFLYQILR 117
Query: 615 GVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL 654
G+ Y+H N ++HRDLK SNLL++ + +K+ DFGL+R+
Sbjct: 118 GLKYIHSAN--VLHRDLKPSNLLLNTNCDLKICDFGLARI 155
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 2e-12
Identities = 43/149 (28%), Positives = 76/149 (51%), Gaps = 12/149 (8%)
Query: 513 IGQGSCGTVYHAVWYGSD------VAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLL 566
+G G+ GTVY +W VA+K R+ S + E +M + +P+V
Sbjct: 15 LGSGAFGTVYKGLWIPEGEKVKIPVAIKEL-REATSPKANKEILDEAYVMASVDNPHVCR 73
Query: 567 FMG-AVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPP 625
+G +TS +L +T+ +P G L ++ + + + + + IA+G++YL
Sbjct: 74 LLGICLTSTVQL--ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERR-- 129
Query: 626 IIHRDLKSSNLLVDKHWTVKVGDFGLSRL 654
++HRDL + N+LV VK+ DFGL++L
Sbjct: 130 LVHRDLAARNVLVKTPQHVKITDFGLAKL 158
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 2e-12
Identities = 57/201 (28%), Positives = 99/201 (49%), Gaps = 30/201 (14%)
Query: 500 YEILWEDLTIGEQIGQGSCGTVYHAVWYGSD---------VAVKVFSRQEYSDEVIHSFR 550
+E+ LT+G+ +G+G G V A G D VAVK+ + + +D+ +
Sbjct: 7 WELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKML-KDDATDKDLSDLV 65
Query: 551 QEVSLMKRL-RHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQ-RNTTKLDW------ 602
E+ +MK + +H N++ +GA T L ++ E+ +G+L L+ R +D+
Sbjct: 66 SEMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCK 125
Query: 603 --------RRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL 654
+ + A +ARG+ YL + IHRDL + N+LV + +K+ DFGL+R
Sbjct: 126 LPEEQLTFKDLVSCAYQVARGMEYL--ASQKCIHRDLAARNVLVTEDNVMKIADFGLARD 183
Query: 655 KH--ETYLTTKTGKGTVTYLA 673
H + Y T G+ V ++A
Sbjct: 184 VHNIDYYKKTTNGRLPVKWMA 204
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 2e-12
Identities = 55/201 (27%), Positives = 99/201 (49%), Gaps = 30/201 (14%)
Query: 500 YEILWEDLTIGEQIGQGSCGTVYHAVWYGSD---------VAVKVFSRQEYSDEVIHSFR 550
+E + LT+G+ +G+G G V A G D VAVK+ + + +++ +
Sbjct: 10 WEFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKML-KDDATEKDLSDLV 68
Query: 551 QEVSLMKRL-RHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQ-RNTTKLDWRRRILM 608
E+ +MK + +H N++ +GA T L ++ E+ +G+L L+ R +++ I
Sbjct: 69 SEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIAR 128
Query: 609 ALD--------------IARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL 654
D +ARG+ YL + IHRDL + N+LV ++ +K+ DFGL+R
Sbjct: 129 VPDEQMTFKDLVSCTYQVARGMEYL--ASQKCIHRDLAARNVLVTENNVMKIADFGLARD 186
Query: 655 KH--ETYLTTKTGKGTVTYLA 673
+ + Y T G+ V ++A
Sbjct: 187 VNNIDYYKKTTNGRLPVKWMA 207
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 2e-12
Identities = 57/165 (34%), Positives = 83/165 (50%), Gaps = 7/165 (4%)
Query: 513 IGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSD--EVIHSFRQEVSLMKRLRHPNVLLFM 568
IG+GS G V A G AVKV ++ + E H + L+K ++HP ++
Sbjct: 3 IGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLH 62
Query: 569 GAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIH 628
+ + ++L V +F+ G LF LQR + + R R A +IA + YLH N I++
Sbjct: 63 YSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAA-EIASALGYLHSIN--IVY 119
Query: 629 RDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTVTYLA 673
RDLK N+L+D V + DFGL + TT T GT YLA
Sbjct: 120 RDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFCGTPEYLA 164
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 3e-12
Identities = 51/151 (33%), Positives = 83/151 (54%), Gaps = 15/151 (9%)
Query: 511 EQIGQGSCGTVYHAV--WYGSDVAVKVFSRQEYSDEVIHSFR-QEVSLMKRLRHPNVLLF 567
E+IG+G+ G VY A +A+K R E DE + S +E+SL+K ++H N++
Sbjct: 8 EKIGEGTYGVVYKARDRVTNETIALKKI-RLEQEDEGVPSTAIREISLLKEMQHGNIVRL 66
Query: 568 MGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRR--RILMAL--DIARGVSYLHHCN 623
V S +RL +V E+L L + + D+ + R++ I RG++Y H +
Sbjct: 67 QDVVHSEKRLYLVFEYLD----LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCH--S 120
Query: 624 PPIIHRDLKSSNLLVDKHW-TVKVGDFGLSR 653
++HRDLK NLL+D+ +K+ DFGL+R
Sbjct: 121 HRVLHRDLKPQNLLIDRRTNALKLADFGLAR 151
|
Length = 294 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 3e-12
Identities = 50/172 (29%), Positives = 81/172 (47%), Gaps = 20/172 (11%)
Query: 513 IGQGSCGTVYHAVWYGSD---VAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMG 569
+G+GS G V V + +D +K + + S + QE L+ +L+HPN++ +
Sbjct: 8 VGKGSYGEV-SLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRE 66
Query: 570 AVTSPQ-RLCIVTEFLPRGSLFRLLQRNTTKL-------DWRRRILMALDIARGVSYLHH 621
+ L IV F G L+ L+ KL +W +I MAL YLH
Sbjct: 67 SWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMAL------QYLHE 120
Query: 622 CNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTVTYLA 673
+ I+HRDLK+ N+ + + +KVGD G++R+ T GT Y++
Sbjct: 121 KH--ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLIGTPYYMS 170
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 3e-12
Identities = 43/148 (29%), Positives = 77/148 (52%), Gaps = 10/148 (6%)
Query: 511 EQIGQGSCGTVYHAV--WYGSDVAVKVFSRQEYSDEVIHSFR-QEVSLMKRLRHPNVLLF 567
E++G+G+ TVY G VA+K ++E S +E+SLMK L+H N++
Sbjct: 6 EKLGEGTYATVYKGRNRTTGEIVALKEIHLD--AEEGTPSTAIREISLMKELKHENIVRL 63
Query: 568 MGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTK--LDWRRRILMALDIARGVSYLHHCNPP 625
+ + +L +V E++ L + + + + LD + +G+++ H
Sbjct: 64 HDVIHTENKLMLVFEYM-DKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR-- 120
Query: 626 IIHRDLKSSNLLVDKHWTVKVGDFGLSR 653
++HRDLK NLL++K +K+ DFGL+R
Sbjct: 121 VLHRDLKPQNLLINKRGELKLADFGLAR 148
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 4e-12
Identities = 49/177 (27%), Positives = 92/177 (51%), Gaps = 14/177 (7%)
Query: 499 DYEILWEDLTIGEQIGQGSCGTVYHA--VWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLM 556
DYE++ +++G G+ G VY A + G AVK+ + D + +QE+ ++
Sbjct: 10 DYELI-------QRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSL--IQQEIFMV 60
Query: 557 KRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGV 616
K +H N++ + G+ S ++L I E+ GSL + + T L + + + +G+
Sbjct: 61 KECKHCNIVAYFGSYLSREKLWICMEYCGGGSL-QDIYHVTGPLSELQIAYVCRETLQGL 119
Query: 617 SYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTVTYLA 673
+YLH + +HRD+K +N+L+ + VK+ DFG++ T K+ GT ++A
Sbjct: 120 AYLH--SKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFIGTPYWMA 174
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 4e-12
Identities = 52/162 (32%), Positives = 75/162 (46%), Gaps = 12/162 (7%)
Query: 511 EQIGQGSCGTVY----HAVWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLL 566
++IG G G V H + V VK DE + F QEV + L HPNVL
Sbjct: 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQL-LFLQEVQPYRELNHPNVLQ 59
Query: 567 FMGAVTSPQRLCIVTEFLPRGSLFRLLQRN--TTKLDWRRRIL--MALDIARGVSYLHHC 622
+G +V EF P G L L+ N ++ +L MA ++A G+ +LH
Sbjct: 60 CLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA 119
Query: 623 NPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKH-ETYLTTK 663
+ IH DL N + +VK+GD+GL+ ++ E Y TK
Sbjct: 120 D--FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITK 159
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 5e-12
Identities = 53/155 (34%), Positives = 79/155 (50%), Gaps = 9/155 (5%)
Query: 499 DYEILWEDLTIGEQIGQGSCGTVYHA--VWYGSDVAVKVFSRQ-EYSDEVIHSFRQEVSL 555
D E L+ DL +IG GS G VY A V VA+K S + S+E +EV
Sbjct: 12 DPEKLFSDL---REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRF 68
Query: 556 MKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARG 615
+++LRHPN + + G +V E+ GS LL+ + L + +G
Sbjct: 69 LQKLRHPNTIQYRGCYLREHTAWLVMEYC-LGSASDLLEVHKKPLQEVEIAAVTHGALQG 127
Query: 616 VSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFG 650
++YLH N +IHRD+K+ N+L+ + VK+GDFG
Sbjct: 128 LAYLHSHN--MIHRDVKAGNILLSEPGLVKLGDFG 160
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 67.4 bits (165), Expect = 5e-12
Identities = 49/159 (30%), Positives = 78/159 (49%), Gaps = 23/159 (14%)
Query: 513 IGQGSCGTVYHAV--WYGSDVAVK----VFSRQEYSDEVIHSFR--QEVSLMKRLRHPNV 564
IG+G+ G V A VA+K F D I + R +E+ L++ L H NV
Sbjct: 13 IGRGAYGIVCSAKNSETNEKVAIKKIANAF------DNRIDAKRTLREIKLLRHLDHENV 66
Query: 565 LLFMGAVTSPQR-----LCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYL 619
+ + P R + IV E L L ++++ + T D + + + RG+ Y+
Sbjct: 67 IAIKDIMPPPHREAFNDVYIVYE-LMDTDLHQIIRSSQTLSDDHCQYFL-YQLLRGLKYI 124
Query: 620 HHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHET 658
H N ++HRDLK SNLL++ + +K+ DFGL+R E
Sbjct: 125 HSAN--VLHRDLKPSNLLLNANCDLKICDFGLARTTSEK 161
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 6e-12
Identities = 57/175 (32%), Positives = 88/175 (50%), Gaps = 19/175 (10%)
Query: 511 EQIGQGSCGTVYHA--VWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRL-RHPNVLLF 567
E +G G+ G VY V G A+KV E +E I + E++++K+ H N+ +
Sbjct: 22 EVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEI---KLEINMLKKYSHHRNIATY 78
Query: 568 MGAVT--SP----QRLCIVTEFLPRGSLFRLLQR---NTTKLDWRRRILMALDIARGVSY 618
GA SP +L +V EF GS+ L++ N K DW I +I RG+++
Sbjct: 79 YGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYI--CREILRGLAH 136
Query: 619 LHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTVTYLA 673
LH +IHRD+K N+L+ ++ VK+ DFG+S T T GT ++A
Sbjct: 137 LHAHK--VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMA 189
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 6e-12
Identities = 49/178 (27%), Positives = 84/178 (47%), Gaps = 21/178 (11%)
Query: 511 EQIGQGSCGTVYHAVWY----GSDVAVK-VFSR-------QEYSDEVIHSFRQEVSLMK- 557
E +G G+ G VY V + +A+K + + D+ I EV+++K
Sbjct: 6 EHLGSGAFGCVY-KVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKE 64
Query: 558 RLRHPNVLLFMGAVTSPQRLCIVTEFL---PRGSLFRLLQRNTTKLDWRRRILMALDIAR 614
+LRHPN++ + RL IV + + P G F L+ + R + + +
Sbjct: 65 QLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVL 124
Query: 615 GVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKH-ETYLTTKTGKGTVTY 671
+ YLH I+HRDL +N+++ + V + DFGL++ K E+ LT+ GT+ Y
Sbjct: 125 ALRYLHK-EKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESKLTSVV--GTILY 179
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 8e-12
Identities = 53/174 (30%), Positives = 74/174 (42%), Gaps = 23/174 (13%)
Query: 506 DLTIGEQIGQGSCGTVYHAVWYGSD--VAVKVFSRQ--EYSDEVIHSFRQEVSLMKRLRH 561
D I Q+GQG G V+ A + VA+K + +EV H E ++ +
Sbjct: 2 DFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRH-VLTERDILTTTKS 60
Query: 562 PNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRR-RILMALDIARGVSYLH 620
++ + A + L + E++P G FR L N L R MA ++ V LH
Sbjct: 61 EWLVKLLYAFQDDEYLYLAMEYVPGGD-FRTLLNNLGVLSEDHARFYMA-EMFEAVDALH 118
Query: 621 HCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTVTYLAS 674
IHRDLK N L+D +K+ DFGLS KG VTY S
Sbjct: 119 ELG--YIHRDLKPENFLIDASGHIKLTDFGLS-------------KGIVTYANS 157
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 1e-11
Identities = 57/200 (28%), Positives = 94/200 (47%), Gaps = 35/200 (17%)
Query: 506 DLTIGEQIGQGSCGTVYHAVWYG-------SDVAVKVFSRQEYSDEVIHSFRQEVSLMKR 558
+L +G+ +G+G G V A + + VAVK+ S E + E +L+K+
Sbjct: 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSE-LRDLLSEFNLLKQ 59
Query: 559 LRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQ---------------RNTTKLD-- 601
+ HP+V+ GA + L ++ E+ GSL L+ RN++ LD
Sbjct: 60 VNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNP 119
Query: 602 ------WRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLK 655
I A I+RG+ YL ++HRDL + N+LV + +K+ DFGLSR
Sbjct: 120 DERALTMGDLISFAWQISRGMQYLAEMK--LVHRDLAARNVLVAEGRKMKISDFGLSRDV 177
Query: 656 HE--TYLTTKTGKGTVTYLA 673
+E +Y+ G+ V ++A
Sbjct: 178 YEEDSYVKRSKGRIPVKWMA 197
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 1e-11
Identities = 46/131 (35%), Positives = 66/131 (50%), Gaps = 3/131 (2%)
Query: 543 DEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDW 602
DEV H+ E +++ RHP + + + RLC V E+ G LF L R +
Sbjct: 37 DEVAHTL-TENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSED 95
Query: 603 RRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTT 662
R R A +I + YLH +++RDLK NL++DK +K+ DFGL + + T
Sbjct: 96 RARFYGA-EIVSALDYLH-SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATM 153
Query: 663 KTGKGTVTYLA 673
KT GT YLA
Sbjct: 154 KTFCGTPEYLA 164
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 1e-11
Identities = 50/164 (30%), Positives = 86/164 (52%), Gaps = 9/164 (5%)
Query: 511 EQIGQGSCGTVYHAVWYGSD--VAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFM 568
+++G+G+ TVY +D VA+K R E+ + + +EVSL+K L+H N++
Sbjct: 12 DKLGEGTYATVYKGRSKLTDNLVALKEI-RLEHEEGAPCTAIREVSLLKDLKHANIVTLH 70
Query: 569 GAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIH 628
+ + + L +V E+L + L + L ++ L + RG++Y H ++H
Sbjct: 71 DIIHTEKSLTLVFEYLDK-DLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHR--RKVLH 127
Query: 629 RDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTVTYL 672
RDLK NLL+++ +K+ DFGL+R K + TKT V L
Sbjct: 128 RDLKPQNLLINERGELKLADFGLARAKS---IPTKTYSNEVVTL 168
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 1e-11
Identities = 43/158 (27%), Positives = 73/158 (46%), Gaps = 20/158 (12%)
Query: 512 QIGQGSCGTVYHAVWYGSD-------VAVKVFSRQEYSDEVIHS-FRQEVSLMKRLRHPN 563
+G+G G V+ A G + V VK Q+ DE + S FR+E+ + ++L H N
Sbjct: 12 TLGRGEFGEVFLAKAKGIEEEGGETLVLVKAL--QKTKDENLQSEFRRELDMFRKLSHKN 69
Query: 564 VLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRR--------RILMALDIARG 615
V+ +G + ++ E+ G L + L+ +K + + ++ + IA G
Sbjct: 70 VVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALG 129
Query: 616 VSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSR 653
+ +L N +HRDL + N LV VKV LS+
Sbjct: 130 MDHLS--NARFVHRDLAARNCLVSSQREVKVSLLSLSK 165
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|216228 pfam00989, PAS, PAS fold | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 2e-11
Identities = 28/109 (25%), Positives = 48/109 (44%), Gaps = 1/109 (0%)
Query: 130 RQYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAY 189
IL+S+ + + D RI+Y N +AE L G S EE +G+ ++L+ + D +VA
Sbjct: 1 EDLRAILESLPDGIFVVDEDGRILYVNAAAEELLGLSREEVIGKSLLDLIPEDDDAEVAE 60
Query: 190 DIVHRIKMGERW-TGQFPAKTKTEERVLVVATNTPFYDDDGTLVGIVCV 237
+ + GE + + V +P D G + G + V
Sbjct: 61 LLRQALLQGEESRGFEVSFRVPDGRPRHVEVRASPVRDAGGEVRGFLGV 109
|
The PAS fold corresponds to the structural domain that has previously been defined as PAS and PAC motifs. The PAS fold appears in archaea, eubacteria and eukarya. Length = 113 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 65.1 bits (158), Expect = 2e-11
Identities = 45/144 (31%), Positives = 83/144 (57%), Gaps = 10/144 (6%)
Query: 511 EQIGQGSCGTVYHA--VWYGSDVAVKVFS-RQEYSDEVIHSFRQEVSLMKRLRHPNVLLF 567
E+IGQG+ GTVY A + G +VA+K + +Q+ E+I + E+ +M+ ++PN++ +
Sbjct: 25 EKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIIN---EILVMRENKNPNIVNY 81
Query: 568 MGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPII 627
+ + L +V E+L GSL ++ T +D + + + + + +LH + +I
Sbjct: 82 LDSYLVGDELWVVMEYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALDFLH--SNQVI 137
Query: 628 HRDLKSSNLLVDKHWTVKVGDFGL 651
HRD+KS N+L+ +VK+ DFG
Sbjct: 138 HRDIKSDNILLGMDGSVKLTDFGF 161
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 65.1 bits (159), Expect = 2e-11
Identities = 43/134 (32%), Positives = 60/134 (44%), Gaps = 14/134 (10%)
Query: 550 RQEV-SLM--KRL-------RHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTK 599
R EV SLM KR+ RHP ++ + +C V E+ G L + +
Sbjct: 40 RDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFVMEYAAGGDLMMHIHTDV-- 97
Query: 600 LDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETY 659
R + A + G+ YLH I++RDLK NLL+D VK+ DFGL +
Sbjct: 98 FSEPRAVFYAACVVLGLQYLHENK--IVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFG 155
Query: 660 LTTKTGKGTVTYLA 673
T T GT +LA
Sbjct: 156 DRTSTFCGTPEFLA 169
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 2e-11
Identities = 45/157 (28%), Positives = 78/157 (49%), Gaps = 10/157 (6%)
Query: 504 WEDLTIGEQIGQGSCGTVYHAVWYGSDV--AVKVFSRQEYSDEVIHSFRQEVSLMKRLRH 561
WE IGE +G G+ G VY A + + A K+ + S+E + F E+ ++ +H
Sbjct: 7 WE--IIGE-LGDGAFGKVYKAQHKETGLFAAAKIIQIE--SEEELEDFMVEIDILSECKH 61
Query: 562 PNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHH 621
PN++ A +L I+ EF G+L ++ L + + + +++LH
Sbjct: 62 PNIVGLYEAYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLH- 120
Query: 622 CNPPIIHRDLKSSNLLVDKHWTVKVGDFGLS-RLKHE 657
+ +IHRDLK+ N+L+ VK+ DFG+S + K
Sbjct: 121 -SHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKST 156
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 2e-11
Identities = 40/156 (25%), Positives = 73/156 (46%), Gaps = 12/156 (7%)
Query: 506 DLTIGEQIGQGSCGTVYHAVWYGSD------VAVKVFSRQEYSDEVIHSFRQEVSLMKRL 559
+L + +G G GTV+ +W VA+K + + + M L
Sbjct: 8 ELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRS-GRQTFQEITDHMLAMGSL 66
Query: 560 RHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYL 619
H ++ +G L +VT+ P GSL ++++ LD +R + + IA+G+ YL
Sbjct: 67 DHAYIVRLLGICPGAS-LQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYL 125
Query: 620 -HHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL 654
H ++HR+L + N+L+ V++ DFG++ L
Sbjct: 126 EEHR---MVHRNLAARNILLKSDSIVQIADFGVADL 158
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 3e-11
Identities = 45/144 (31%), Positives = 83/144 (57%), Gaps = 10/144 (6%)
Query: 511 EQIGQGSCGTVYHA--VWYGSDVAVKVFS-RQEYSDEVIHSFRQEVSLMKRLRHPNVLLF 567
E+IGQG+ GTVY A V G +VA++ + +Q+ E+I + E+ +M+ ++PN++ +
Sbjct: 26 EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIIN---EILVMRENKNPNIVNY 82
Query: 568 MGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPII 627
+ + L +V E+L GSL ++ T +D + + + + + +LH + +I
Sbjct: 83 LDSYLVGDELWVVMEYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLH--SNQVI 138
Query: 628 HRDLKSSNLLVDKHWTVKVGDFGL 651
HRD+KS N+L+ +VK+ DFG
Sbjct: 139 HRDIKSDNILLGMDGSVKLTDFGF 162
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 3e-11
Identities = 40/159 (25%), Positives = 80/159 (50%), Gaps = 15/159 (9%)
Query: 508 TIGEQIGQGSCGTVYHAVW----YGSDVAVKVFSRQEYSDEV-IHSFRQEVSLMKRLRHP 562
T+ + + +G+ G +++ + G + V V + ++++ E+ + QE L+ L H
Sbjct: 9 TLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQ 68
Query: 563 NVLLFMGAVTS-PQRLCIVTEFLPRGSLFRLLQR-------NTTKLDWRRRILMALDIAR 614
N+L + + ++ ++ G+L LQ+ N L ++ + MA+ IA
Sbjct: 69 NILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIAC 128
Query: 615 GVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSR 653
G+SYLH +IH+D+ + N ++D+ VK+ D LSR
Sbjct: 129 GMSYLHKRG--VIHKDIAARNCVIDEELQVKITDNALSR 165
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 3e-11
Identities = 49/164 (29%), Positives = 85/164 (51%), Gaps = 9/164 (5%)
Query: 511 EQIGQGSCGTVYHAVWYGSD--VAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFM 568
E++G+G+ TV+ ++ VA+K R E+ + + +EVSL+K L+H N++
Sbjct: 12 EKLGEGTYATVFKGRSKLTENLVALKEI-RLEHEEGAPCTAIREVSLLKDLKHANIVTLH 70
Query: 569 GAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIH 628
V + + L +V E+L + L + + + + I RG++Y H ++H
Sbjct: 71 DIVHTDKSLTLVFEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCH--RRKVLH 127
Query: 629 RDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTVTYL 672
RDLK NLL+++ +K+ DFGL+R K + TKT V L
Sbjct: 128 RDLKPQNLLINERGELKLADFGLARAKS---VPTKTYSNEVVTL 168
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 64.7 bits (158), Expect = 3e-11
Identities = 54/171 (31%), Positives = 82/171 (47%), Gaps = 19/171 (11%)
Query: 513 IGQGSCGTVYHAVWYGSD--VAVKVFSRQEYSDEVIHSFRQEV-SLM--KRL-----RHP 562
+G+GS G V A G+D AVKV + D ++ +V M KR+ +HP
Sbjct: 3 LGKGSFGKVLLAELKGTDELYAVKVLKK----DVILQ--DDDVECTMTEKRVLALAGKHP 56
Query: 563 NVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHC 622
+ + RL V E++ G L +QR + + D R A +I G+ +LH
Sbjct: 57 FLTQLHSCFQTKDRLFFVMEYVNGGDLMFHIQR-SGRFDEPRARFYAAEIVLGLQFLH-- 113
Query: 623 NPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTVTYLA 673
II+RDLK N+L+D +K+ DFG+ + +TT T GT Y+A
Sbjct: 114 ERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFCGTPDYIA 164
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 3e-11
Identities = 49/164 (29%), Positives = 84/164 (51%), Gaps = 9/164 (5%)
Query: 511 EQIGQGSCGTVY--HAVWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFM 568
+++G+G+ TV+ + + VA+K R E+ + + +EVSL+K L+H N++
Sbjct: 11 DKLGEGTYATVFKGRSKLTENLVALKEI-RLEHEEGAPCTAIREVSLLKNLKHANIVTLH 69
Query: 569 GAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIH 628
+ + + L +V E+L L + L + + + RG+SY H I+H
Sbjct: 70 DIIHTERCLTLVFEYL-DSDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHK--RKILH 126
Query: 629 RDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTVTYL 672
RDLK NLL+++ +K+ DFGL+R K + TKT V L
Sbjct: 127 RDLKPQNLLINEKGELKLADFGLARAKS---VPTKTYSNEVVTL 167
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 64.0 bits (155), Expect = 4e-11
Identities = 56/175 (32%), Positives = 87/175 (49%), Gaps = 19/175 (10%)
Query: 511 EQIGQGSCGTVYHA--VWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRL-RHPNVLLF 567
E +G G+ G VY V G A+KV +E I +QE++++K+ H N+ +
Sbjct: 12 ELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEI---KQEINMLKKYSHHRNIATY 68
Query: 568 MGAVTSPQ------RLCIVTEFLPRGSLFRLLQR---NTTKLDWRRRILMALDIARGVSY 618
GA +L +V EF GS+ L++ NT K +W I +I RG+S+
Sbjct: 69 YGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYI--CREILRGLSH 126
Query: 619 LHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTVTYLA 673
LH +IHRD+K N+L+ ++ VK+ DFG+S T T GT ++A
Sbjct: 127 LHQHK--VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMA 179
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 4e-11
Identities = 52/161 (32%), Positives = 74/161 (45%), Gaps = 12/161 (7%)
Query: 511 EQIGQGSCGTVY----HAVWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLL 566
++IG G G V ++ + + V VK E + F +E + L+H N+L
Sbjct: 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMK-FLEEAQPYRSLQHSNLLQ 59
Query: 567 FMGAVTSPQRLCIVTEFLPRGSLFRLLQ--RNTTKLDWRRRIL--MALDIARGVSYLHHC 622
+G T +V EF P G L L+ R + L MA +IA G+ +LH
Sbjct: 60 CLGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN 119
Query: 623 NPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKH-ETYLTT 662
N IH DL N L+ TVK+GD+GLS K+ E Y T
Sbjct: 120 N--FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVT 158
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 5e-11
Identities = 55/176 (31%), Positives = 80/176 (45%), Gaps = 14/176 (7%)
Query: 504 WEDLTIGEQIGQGSCGTVYHAVWYGSD---VAVKVFSRQEY--SDEVIHSFRQEVSLMKR 558
+ED +G GS G V A + D VA+K F + + +V H F E ++
Sbjct: 29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVF-SERKILNY 87
Query: 559 LRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSY 618
+ HP + G+ L +V EF+ G F L+RN + A I Y
Sbjct: 88 INHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNK-RFPNDVGCFYAAQIVLIFEY 146
Query: 619 LHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL-KHETYLTTKTGKGTVTYLA 673
L N I++RDLK NLL+DK +K+ DFG +++ TY T GT Y+A
Sbjct: 147 LQSLN--IVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTRTY----TLCGTPEYIA 196
|
Length = 340 |
| >gnl|CDD|238075 cd00130, PAS, PAS domain; PAS motifs appear in archaea, eubacteria and eukarya | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 6e-11
Identities = 30/103 (29%), Positives = 54/103 (52%), Gaps = 2/103 (1%)
Query: 139 MGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYD-IVHRIKM 197
+ V + DL RI+Y N +AE L GYS EE +G+ ++L+ D + + + + +
Sbjct: 1 LPDGVIVLDLDGRILYANPAAEQLLGYSPEELIGKSLLDLI-HPEDREELRERLENLLSG 59
Query: 198 GERWTGQFPAKTKTEERVLVVATNTPFYDDDGTLVGIVCVSTD 240
GE T + + K + V+ + TP D+ G ++G++ V D
Sbjct: 60 GEPVTLEVRLRRKDGSVIWVLVSLTPIRDEGGEVIGLLGVVRD 102
|
Probably the most surprising identification of a PAS domain was that in EAG-like K+-channels. PAS domains have been found to bind ligands, and to act as sensors for light and oxygen in signal transduction. Length = 103 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 6e-11
Identities = 46/159 (28%), Positives = 77/159 (48%), Gaps = 13/159 (8%)
Query: 499 DYEILWEDLTIGEQIGQGSCGTVYHAVWYGSD--VAVKVFSRQEYSDEVIHSFRQEVSLM 556
Y +L +G+GS G SD A+K R S + R+E L+
Sbjct: 1 QYNVL-------RVVGEGSFGRALLVQHVNSDQKYAMKEI-RLPKSSSAVEDSRKEAVLL 52
Query: 557 KRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILM-ALDIARG 615
+++HPN++ F + + L IV E+ G L + ++ KL IL + + G
Sbjct: 53 AKMKHPNIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLG 112
Query: 616 VSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL 654
V ++H ++HRD+KS N+ + ++ VK+GDFG +RL
Sbjct: 113 VQHIH--EKRVLHRDIKSKNIFLTQNGKVKLGDFGSARL 149
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 9e-11
Identities = 46/170 (27%), Positives = 78/170 (45%), Gaps = 26/170 (15%)
Query: 506 DLTIGEQIGQGSCGTVYHAVWYGSD-------VAVKVFSRQEYSDEVIHSFRQEVSLMKR 558
D+ + ++G+G+ G V+ A Y VAVK + F++E L+
Sbjct: 6 DIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAAR--KDFQREAELLTN 63
Query: 559 LRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQ---------------RNTTKLDWR 603
L+H +++ F G L +V E++ G L + L+ + +L
Sbjct: 64 LQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLS 123
Query: 604 RRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSR 653
+ + +A IA G+ YL + +HRDL + N LV + VK+GDFG+SR
Sbjct: 124 QMLHIASQIASGMVYL--ASQHFVHRDLATRNCLVGANLLVKIGDFGMSR 171
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 9e-11
Identities = 48/150 (32%), Positives = 78/150 (52%), Gaps = 11/150 (7%)
Query: 511 EQIGQGSCGTVYHAV--WYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFM 568
+Q+G G+ GTV A+ G+ VA+K R S+ +E+ L+K ++H NV+ +
Sbjct: 21 KQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLL 80
Query: 569 GAVTSPQRLCIVTEF---LP-RGS-LFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCN 623
T L +F +P G+ L +L++ KL R + + +G+ Y+H
Sbjct: 81 DVFTPDLSLDRFHDFYLVMPFMGTDLGKLMKHE--KLSEDRIQFLVYQMLKGLKYIHAAG 138
Query: 624 PPIIHRDLKSSNLLVDKHWTVKVGDFGLSR 653
IIHRDLK NL V++ +K+ DFGL+R
Sbjct: 139 --IIHRDLKPGNLAVNEDCELKILDFGLAR 166
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.1 bits (154), Expect = 1e-10
Identities = 45/165 (27%), Positives = 75/165 (45%), Gaps = 32/165 (19%)
Query: 512 QIGQGSCGTVYHAVWY----GSDVAVKVF-SRQEYSDEVIHSFRQEVSLMKRLRHPNVLL 566
IG+G+ G VY A G + A+K F +E + S +E++L++ L+H NV+
Sbjct: 7 CIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVS 66
Query: 567 FMGAVTSPQRLCI--VTEFLP----------RGSLFRLLQRNTTK-LDWRRRILMALDIA 613
+ + + ++ R + + + K L W+ I
Sbjct: 67 LVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQ--------IL 118
Query: 614 RGVSYLHHCNPPIIHRDLKSSNLLV----DKHWTVKVGDFGLSRL 654
GV YLH + ++HRDLK +N+LV + VK+GD GL+RL
Sbjct: 119 NGVHYLH--SNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARL 161
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.8 bits (153), Expect = 1e-10
Identities = 53/184 (28%), Positives = 89/184 (48%), Gaps = 33/184 (17%)
Query: 505 EDLTIGEQIGQGSCGTVYHA--VWYGSDVAVKVFS-------RQEYSDEVIHSFRQEVSL 555
+DL + +G G+ G V+ A+KV + +QE + +H+ E +
Sbjct: 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQE---QHVHN---EKRV 54
Query: 556 MKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQ-----RNTTKLDWRRRILMAL 610
+K + HP ++ + L ++ E++P G LF L+ N+T L + I+ AL
Sbjct: 55 LKEVSHPFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCAL 114
Query: 611 DIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSR-LKHETYLTTKTGKGTV 669
+ YLH I++RDLK N+L+DK +K+ DFG ++ L+ T+ T GT
Sbjct: 115 E------YLHSKE--IVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRTW----TLCGTP 162
Query: 670 TYLA 673
YLA
Sbjct: 163 EYLA 166
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 2e-10
Identities = 43/167 (25%), Positives = 73/167 (43%), Gaps = 29/167 (17%)
Query: 511 EQIGQGSCGTVYHAVWYGSD-------VAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPN 563
E++G+ G VY +G+ VA+K + + + F+ E + RL+HPN
Sbjct: 11 EELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTL-KDKAEGPLREEFKHEAMMRSRLQHPN 69
Query: 564 VLLFMGAVTSPQRLCIVTEFLPRGSLFRLL-----QRNTTKLDWRRRILMALD------- 611
++ +G VT Q L ++ + L L + D + + L+
Sbjct: 70 IVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHI 129
Query: 612 ---IARGVSYL--HHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSR 653
IA G+ +L HH ++H+DL + N+LV VK+ D GL R
Sbjct: 130 VTQIAAGMEFLSSHH----VVHKDLATRNVLVFDKLNVKISDLGLFR 172
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 2e-10
Identities = 34/108 (31%), Positives = 58/108 (53%), Gaps = 9/108 (8%)
Query: 551 QEVSLMKRLRHPNVLLFMGAVTSPQ--RLCIVTEFLPRGSLFRLLQRNTTKLDWR--RRI 606
+E+ + K + P ++ + GA + I E+ GSL + ++ K R ++
Sbjct: 48 RELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKK-VKKRGGRIGEKV 106
Query: 607 L--MALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLS 652
L +A + +G+SYLH IIHRD+K SN+L+ + VK+ DFG+S
Sbjct: 107 LGKIAESVLKGLSYLHSRK--IIHRDIKPSNILLTRKGQVKLCDFGVS 152
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 2e-10
Identities = 58/184 (31%), Positives = 92/184 (50%), Gaps = 21/184 (11%)
Query: 498 LDYEILWEDLTIGEQIGQGSCGTVYHAV--WYGSDVAVKVFSRQEYSDEVIHSFRQEVSL 555
LD +WE IGE +G G+ G VY A G+ A KV + S+E + + E+ +
Sbjct: 8 LDPNEVWE--IIGE-LGDGAFGKVYKAKNKETGALAAAKVIETK--SEEELEDYMVEIEI 62
Query: 556 MKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRL---LQRNTTKLDWR---RRILMA 609
+ HP ++ +GA +L I+ EF P G++ + L R T+ + R++L A
Sbjct: 63 LATCNHPYIVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEA 122
Query: 610 LDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTV 669
L YLH + IIHRDLK+ N+L+ +K+ DFG+S +T + GT
Sbjct: 123 L------QYLH--SMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFIGTP 174
Query: 670 TYLA 673
++A
Sbjct: 175 YWMA 178
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 3e-10
Identities = 46/143 (32%), Positives = 75/143 (52%), Gaps = 10/143 (6%)
Query: 512 QIGQGSCGTVYHAV--WYGSDVAVKVFS-RQEYSDEVIHSFRQEVSLMKRLRHPNVLLFM 568
+IG+GS G V A G VAVK R++ E++ + EV +M+ H NV+
Sbjct: 29 KIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFN---EVVIMRDYHHENVVDMY 85
Query: 569 GAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIH 628
+ L +V EFL G+L ++ T+++ + + L + R +SYLH N +IH
Sbjct: 86 NSYLVGDELWVVMEFLEGGALTDIVTH--TRMNEEQIATVCLSVLRALSYLH--NQGVIH 141
Query: 629 RDLKSSNLLVDKHWTVKVGDFGL 651
RD+KS ++L+ +K+ DFG
Sbjct: 142 RDIKSDSILLTSDGRIKLSDFGF 164
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 3e-10
Identities = 50/155 (32%), Positives = 77/155 (49%), Gaps = 9/155 (5%)
Query: 499 DYEILWEDLTIGEQIGQGSCGTVY--HAVWYGSDVAVKVFSRQ-EYSDEVIHSFRQEVSL 555
D E L+ DL +IG GS G VY V VA+K S + S+E +EV
Sbjct: 22 DPEKLFTDL---REIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKF 78
Query: 556 MKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARG 615
++R++HPN + + G +V E+ GS LL+ + L + +G
Sbjct: 79 LQRIKHPNSIEYKGCYLREHTAWLVMEYC-LGSASDLLEVHKKPLQEVEIAAITHGALQG 137
Query: 616 VSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFG 650
++YLH N +IHRD+K+ N+L+ + VK+ DFG
Sbjct: 138 LAYLHSHN--MIHRDIKAGNILLTEPGQVKLADFG 170
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 3e-10
Identities = 49/167 (29%), Positives = 81/167 (48%), Gaps = 22/167 (13%)
Query: 492 DLDNDCLDYEILWEDLTIGEQIGQGSCGTVYHA--VWYGSDVAVKVFSRQEYSDEVIHSF 549
DL N EDL +G G+ G+V + G+ +A KV V
Sbjct: 1 DLRN---------EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVV-HIGAKSSVRKQI 50
Query: 550 RQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQR-NTTKLDWRRRILM 608
+E+ +M R P ++ F GA + +C+ EF+ GSL R+ ++ ++ +I
Sbjct: 51 LRELQIMHECRSPYIVSFYGAFLNENNICMCMEFMDCGSLDRIYKKGGPIPVEILGKI-- 108
Query: 609 ALDIARGVSYL---HHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLS 652
A+ + G++YL H I+HRD+K SN+LV+ +K+ DFG+S
Sbjct: 109 AVAVVEGLTYLYNVHR----IMHRDIKPSNILVNSRGQIKLCDFGVS 151
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|225112 COG2202, AtoS, FOG: PAS/PAC domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Score = 60.6 bits (145), Expect = 3e-10
Identities = 29/113 (25%), Positives = 53/113 (46%), Gaps = 2/113 (1%)
Query: 130 RQYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAY 189
+ +L++ + + D RI+Y N +AE L GYS EE LG+ +L+ +
Sbjct: 112 ERLRALLEASPDGIWVLDEDGRILYANPAAEELLGYSPEEELGRGLSDLIHPEDEERREL 171
Query: 190 DIVHRIKMGER--WTGQFPAKTKTEERVLVVATNTPFYDDDGTLVGIVCVSTD 240
++ + G ++ + K ERV + + DDG +VG+V ++ D
Sbjct: 172 ELARALAEGRGGPLEIEYRVRRKDGERVRWILSRISPVRDDGEIVGVVGIARD 224
|
Length = 232 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 60.9 bits (148), Expect = 5e-10
Identities = 32/148 (21%), Positives = 73/148 (49%), Gaps = 9/148 (6%)
Query: 513 IGQGSCGTVYHAVWYGSDVAVKVFSR-QEYSDEVIHSFRQEVSLMKRLRHPNVL----LF 567
I + ++Y ++ +V ++ F + + +I E+ ++R+ N+L
Sbjct: 28 IKENDQNSIYKGIFNNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFI 87
Query: 568 MGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLH-HCNPPI 626
+ V RL ++ E+ RG L +L L ++ ++ MA+D +G+ L+ + N P
Sbjct: 88 IDIVDDLPRLSLILEYCTRGYLREVL-DKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKP- 145
Query: 627 IHRDLKSSNLLVDKHWTVKVGDFGLSRL 654
+++L S + LV +++ +K+ GL ++
Sbjct: 146 -YKNLTSVSFLVTENYKLKIICHGLEKI 172
|
Length = 283 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 5e-10
Identities = 39/139 (28%), Positives = 66/139 (47%), Gaps = 23/139 (16%)
Query: 528 GSDVAVKVFSRQEYSDEVIHSFRQ------EVSLMKRLRHPNVL-----LFMGAVTSPQR 576
GS+ V V ++ D V+ Q E L++ + HP+V+ L GA+T
Sbjct: 77 GSEGRVFVATKPGQPDPVVLKIGQKGTTLIEAMLLQNVNHPSVIRMKDTLVSGAIT---- 132
Query: 577 LCIVTEFLP--RGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSS 634
C+V LP L+ L + + L + +++ I G+ YLH IIHRD+K+
Sbjct: 133 -CMV---LPHYSSDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQR--IIHRDVKTE 186
Query: 635 NLLVDKHWTVKVGDFGLSR 653
N+ ++ V +GD G ++
Sbjct: 187 NIFINDVDQVCIGDLGAAQ 205
|
Length = 357 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 61.3 bits (148), Expect = 5e-10
Identities = 50/158 (31%), Positives = 77/158 (48%), Gaps = 14/158 (8%)
Query: 513 IGQGSCGTV---YHAVWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMG 569
IG G+ G V Y AV +VA+K SR + +E+ LMK + H N++ +
Sbjct: 25 IGSGAQGIVCAAYDAV-LDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLN 83
Query: 570 AVTSPQRLCIVTEFLPRGSLFRLLQRN-----TTKLDWRRRILMALDIARGVSYLHHCNP 624
T PQ+ + EF + L+ N +LD R + + G+ +LH
Sbjct: 84 VFT-PQK--SLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAG- 139
Query: 625 PIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTT 662
IIHRDLK SN++V T+K+ DFGL+R +++ T
Sbjct: 140 -IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMT 176
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 5e-10
Identities = 55/179 (30%), Positives = 84/179 (46%), Gaps = 15/179 (8%)
Query: 504 WEDLTIGEQIGQGSCGTVY--HAVWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLR- 560
WE I E IG+G+ G V+ GS AVK+ DE I + E +++K L
Sbjct: 20 WE---IIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEA---EYNILKALSD 73
Query: 561 HPNVLLFMGA-----VTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARG 615
HPNV+ F G V + +L +V E GS+ L++ + + ++A +
Sbjct: 74 HPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEA 133
Query: 616 VSYLHHC-NPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTVTYLA 673
+ L H IHRD+K +N+L+ VK+ DFG+S T L T GT ++A
Sbjct: 134 LMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMA 192
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 6e-10
Identities = 56/161 (34%), Positives = 82/161 (50%), Gaps = 28/161 (17%)
Query: 512 QIGQGSCGTVYHA--VWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLR---HPNVLL 566
+IG G+ GTVY A G VA+K Q D + S +EV+L+KRL HPN++
Sbjct: 7 EIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVR 66
Query: 567 FMGAVTSPQ-----RLCIVTEFLP---RGSLFRL----LQRNTTKLDWRRRILMALDIAR 614
M + + ++ +V E + R L ++ L T K D R+ L R
Sbjct: 67 LMDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPGLPAETIK-DLMRQFL------R 119
Query: 615 GVSYLH-HCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL 654
G+ +LH +C I+HRDLK N+LV VK+ DFGL+R+
Sbjct: 120 GLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLARI 157
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 59.9 bits (146), Expect = 7e-10
Identities = 45/173 (26%), Positives = 72/173 (41%), Gaps = 25/173 (14%)
Query: 513 IGQGSCGTVY--HAVWYGSDVAVKVFSRQEYSDEVI--HSFRQEVSLMKRLRHPNVLLFM 568
+G G G V A+K ++ + H F E +++ HP ++
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIF-SEKEILEECNHPFIVKLY 59
Query: 569 GAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIAR--------GVSYLH 620
+ + ++ E+ G L+ +L R R L AR YLH
Sbjct: 60 RTFKDKKYIYMLMEYCLGGELWTIL---------RDRGLFDEYTARFYIACVVLAFEYLH 110
Query: 621 HCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTVTYLA 673
+ II+RDLK NLL+D + VK+ DFG ++ K ++ T T GT Y+A
Sbjct: 111 NRG--IIYRDLKPENLLLDSNGYVKLVDFGFAK-KLKSGQKTWTFCGTPEYVA 160
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 8e-10
Identities = 49/165 (29%), Positives = 81/165 (49%), Gaps = 11/165 (6%)
Query: 492 DLDNDCLDYEILWEDLTIG-EQIGQGSCGTVYHAVWYGSDVAVKVFSRQEYSDEVIHSFR 550
D + L Y+ E++ +G +IG GS G VY A ++ V V + YS + +
Sbjct: 7 DPEIADLFYKDDPEEIFVGLHEIGHGSFGAVYFATNSHTNEVVAV-KKMSYSGKQTNEKW 65
Query: 551 Q----EVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRI 606
Q EV +++L+HPN + + G +V E+ GS LL+ + L
Sbjct: 66 QDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEYC-LGSASDLLEVHKKPLQEVEIA 124
Query: 607 LMALDIARGVSYLH-HCNPPIIHRDLKSSNLLVDKHWTVKVGDFG 650
+ +G++YLH H +IHRD+K+ N+L+ + VK+ DFG
Sbjct: 125 AITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFG 166
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 9e-10
Identities = 58/181 (32%), Positives = 84/181 (46%), Gaps = 19/181 (10%)
Query: 504 WEDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRL-R 560
WE I E IG+G+ G VY GS AVK+ DE I + E ++++ L
Sbjct: 24 WE---IIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEA---EYNILQSLPN 77
Query: 561 HPNVLLFMGAVTSPQR-----LCIVTEFLPRGSLFRLLQ---RNTTKLDWRRRILMALDI 612
HPNV+ F G + L +V E GS+ L++ +LD +
Sbjct: 78 HPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGA 137
Query: 613 ARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTVTYL 672
G+ +LH N IIHRD+K +N+L+ VK+ DFG+S T L T GT ++
Sbjct: 138 LLGLQHLH--NNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWM 195
Query: 673 A 673
A
Sbjct: 196 A 196
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 60.1 bits (146), Expect = 9e-10
Identities = 49/160 (30%), Positives = 72/160 (45%), Gaps = 9/160 (5%)
Query: 500 YEILWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMK 557
Y DL +IG G+CG VY + G +AVK R +E ++K
Sbjct: 10 YPADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLK 69
Query: 558 RLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRIL--MALDIARG 615
P ++ G + + I E L L +LL+R + IL M + I +
Sbjct: 70 SHDCPYIVKCYGYFITDSDVFICME-LMSTCLDKLLKR--IQGPIPEDILGKMTVAIVKA 126
Query: 616 VSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLS-RL 654
+ YL +IHRD+K SN+L+D VK+ DFG+S RL
Sbjct: 127 LHYLKE-KHGVIHRDVKPSNILLDASGNVKLCDFGISGRL 165
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 59.9 bits (146), Expect = 9e-10
Identities = 50/166 (30%), Positives = 88/166 (53%), Gaps = 28/166 (16%)
Query: 499 DYEILWEDLTIGEQIGQGSCGTVYHAVWYGSD--VAVKVFSRQEYSDEV----IHSFRQE 552
+YE L +I +G+ G VY A + VA+K + + E I S R E
Sbjct: 6 EYEKL-------NRIEEGTYGVVYRARDKKTGEIVALK---KLKMEKEKEGFPITSLR-E 54
Query: 553 VSLMKRLRHPNVL----LFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTK-LDWRRRIL 607
++++ +L+HPN++ + +G ++ ++ +V E++ L L++ L + L
Sbjct: 55 INILLKLQHPNIVTVKEVVVG--SNLDKIYMVMEYVEH-DLKSLMETMKQPFLQSEVKCL 111
Query: 608 MALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSR 653
M L + GV++LH I+HRDLK+SNLL++ +K+ DFGL+R
Sbjct: 112 M-LQLLSGVAHLHD--NWILHRDLKTSNLLLNNRGILKICDFGLAR 154
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 60.1 bits (146), Expect = 9e-10
Identities = 50/179 (27%), Positives = 81/179 (45%), Gaps = 28/179 (15%)
Query: 504 WEDLTIGEQIGQGSCGTVYHA--VWYGSDVAVK-VFSRQEYSDEVIHSFRQEVSLMKRLR 560
+E L IGQG+ G V+ A VA+K V E I + R E+ +++ L+
Sbjct: 14 YEKLAK---IGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALR-EIKILQLLK 69
Query: 561 HPNVLLFM---GAVTSPQRLC-----IVTEFLPRGSLFRLLQRNTTKLDW---RRRILMA 609
H NV+ + +P +V EF L LL K ++ + M
Sbjct: 70 HENVVNLIEICRTKATPYNRYKGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKML 128
Query: 610 LDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGT 668
L+ G+ Y+H I+HRD+K++N+L+ K +K+ DFGL+R + +K K
Sbjct: 129 LN---GLYYIHRNK--ILHRDMKAANILITKDGILKLADFGLAR----AFSLSKNSKPN 178
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 1e-09
Identities = 51/170 (30%), Positives = 74/170 (43%), Gaps = 33/170 (19%)
Query: 507 LTIGEQIGQGSCGTVYHAVWYGSD----VAVK-----VFSRQEYSDEVIHSFRQEVSLMK 557
L +G+ +G+G G+V D VAVK + +R E D F E MK
Sbjct: 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMED-----FLSEAVCMK 55
Query: 558 RLRHPNVLLFMG---------AVTSPQRLCIVTEFLPRGSL--FRLLQR---NTTKLDWR 603
HPNV+ +G SP ++ F+ G L F L R L +
Sbjct: 56 EFDHPNVMRLIGVCLQTVESEGYPSP---VVILPFMKHGDLHSFLLYSRLGDCPQYLPTQ 112
Query: 604 RRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSR 653
+ DIA G+ YL + IHRDL + N +++++ V V DFGLS+
Sbjct: 113 MLVKFMTDIASGMEYLSSKS--FIHRDLAARNCMLNENMNVCVADFGLSK 160
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 1e-09
Identities = 50/167 (29%), Positives = 84/167 (50%), Gaps = 9/167 (5%)
Query: 513 IGQGSCGTVYHAVWYGSD--VAVKVFSRQEY--SDEVIHSFRQEVSLMKRLRH--PNVLL 566
IG+G+ G VY + A+KV S++E EV H+ + L++ L P ++
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60
Query: 567 FMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPI 626
+ + L +VT+++ G LF LQ+ + R + +A ++ + +LH + I
Sbjct: 61 LKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIA-ELVLALEHLHKYD--I 117
Query: 627 IHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTVTYLA 673
++RDLK N+L+D + + DFGLS+ TT T GT YLA
Sbjct: 118 VYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFCGTTEYLA 164
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 59.5 bits (145), Expect = 2e-09
Identities = 49/164 (29%), Positives = 85/164 (51%), Gaps = 27/164 (16%)
Query: 500 YEILWEDLTIGEQIGQGSCGTVYHAVWYGSD------VAVK-VFSRQEYSDEVIHSFRQE 552
YEIL +++G+G+ Y VW D VA+K +F + + +FR E
Sbjct: 9 YEIL-------QKLGKGA----YGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFR-E 56
Query: 553 VSLMKRLR-HPNV--LLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMA 609
+ ++ L HPN+ LL + + + + +V E++ L +++ N + +R I+
Sbjct: 57 IMFLQELGDHPNIVKLLNVIKAENDKDIYLVFEYM-ETDLHAVIRANILEDVHKRYIMYQ 115
Query: 610 LDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSR 653
L + + Y+H N +IHRDLK SN+L++ VK+ DFGL+R
Sbjct: 116 L--LKALKYIHSGN--VIHRDLKPSNILLNSDCRVKLADFGLAR 155
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|232884 TIGR00229, sensory_box, PAS domain S-box | Back alignment and domain information |
|---|
Score = 55.8 bits (135), Expect = 2e-09
Identities = 30/125 (24%), Positives = 60/125 (48%), Gaps = 4/125 (3%)
Query: 129 DRQYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLT-DGRDFDV 187
+ +Y I +S ++ + DL I+Y N + E ++GYSAEE +G++ +EL+ + R+
Sbjct: 2 EERYRAIFESSPDAIIVIDLEGNILYVNPAFEEIFGYSAEELIGRNVLELIPEEDREEVR 61
Query: 188 AYDIVHRIKMGERWTGQ-FPAKTKTEERVLVVATNTPFYDDDGTLVGIVCVSTDSRPFQE 246
I R++ + + K + V + +P +G +G+V + D ++
Sbjct: 62 ER-IERRLEGEREPVSEERRVRRKDGSEIWVEVSVSP-IRTNGGELGVVGIVRDITERKQ 119
Query: 247 TRAAL 251
AL
Sbjct: 120 AEEAL 124
|
The PAS domain was previously described. This sensory box, or S-box domain occupies the central portion of the PAS domain but is more widely distributed. It is often tandemly repeated. Known prosthetic groups bound in the S-box domain include heme in the oxygen sensor FixL, FAD in the redox potential sensor NifL, and a 4-hydroxycinnamyl chromophore in photoactive yellow protein. Proteins containing the domain often contain other regulatory domains such as response regulator or sensor histidine kinase domains. Other S-box proteins include phytochromes and the aryl hydrocarbon receptor nuclear translocator [Regulatory functions, Small molecule interactions]. Length = 124 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 2e-09
Identities = 42/130 (32%), Positives = 66/130 (50%), Gaps = 4/130 (3%)
Query: 544 EVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWR 603
EV H+ E +++ ++ P ++ + SP++L +V F+ G LF LQR R
Sbjct: 36 EVTHTL-AERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGELFHHLQREGRFDLSR 94
Query: 604 RRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTK 663
R A ++ + LH N +I+RDLK N+L+D + + DFGL +L + T
Sbjct: 95 ARFYTA-ELLCALENLHKFN--VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTN 151
Query: 664 TGKGTVTYLA 673
T GT YLA
Sbjct: 152 TFCGTPEYLA 161
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 2e-09
Identities = 49/157 (31%), Positives = 75/157 (47%), Gaps = 12/157 (7%)
Query: 513 IGQGSCGTVYHAV--WYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGA 570
IG G+ G V A G +VAVK SR + +E+ L+K + H N++ +
Sbjct: 29 IGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNV 88
Query: 571 VTSPQRLCIVTEFLPRGSLFRLLQRNTTK-----LDWRRRILMALDIARGVSYLHHCNPP 625
T PQ+ + EF + L+ N + LD R + + G+ +LH
Sbjct: 89 FT-PQK--SLEEFQDVYLVMELMDANLCQVIHMELDHERMSYLLYQMLCGIKHLHSAG-- 143
Query: 626 IIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTT 662
IIHRDLK SN++V T+K+ DFGL+R ++ T
Sbjct: 144 IIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMMT 180
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 2e-09
Identities = 49/165 (29%), Positives = 78/165 (47%), Gaps = 7/165 (4%)
Query: 513 IGQGSCGTVYHAVWYGSD--VAVKVFSRQEY--SDEVIHSFRQEVSLMKRLRHPNVLLFM 568
+G+GS G V A G+D A+KV + D+V + ++ L +HP +
Sbjct: 3 LGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALH 62
Query: 569 GAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIH 628
+ RL V E++ G L +QR + K D R A ++ + +LH +I+
Sbjct: 63 CCFQTKDRLFFVMEYVNGGDLMFQIQR-SRKFDEPRSRFYAAEVTLALMFLHRHG--VIY 119
Query: 629 RDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTVTYLA 673
RDLK N+L+D K+ DFG+ + +TT T GT Y+A
Sbjct: 120 RDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCGTPDYIA 164
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 2e-09
Identities = 50/160 (31%), Positives = 81/160 (50%), Gaps = 18/160 (11%)
Query: 513 IGQGSCGTV---YHAVWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMG 569
IG G+ G V Y A+ +VA+K SR + +E+ LMK + H N++ +
Sbjct: 32 IGSGAQGIVCAAYDAI-LERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLN 90
Query: 570 AVTSPQR-------LCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHC 622
T PQ+ + IV E + +L +++Q +LD R + + G+ +LH
Sbjct: 91 VFT-PQKSLEEFQDVYIVMELMD-ANLCQVIQ---MELDHERMSYLLYQMLCGIKHLHSA 145
Query: 623 NPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTT 662
IIHRDLK SN++V T+K+ DFGL+R +++ T
Sbjct: 146 G--IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMT 183
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 2e-09
Identities = 45/174 (25%), Positives = 81/174 (46%), Gaps = 8/174 (4%)
Query: 506 DLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSD-EVIHSFRQEVSLMKRLRHP 562
+ I ++IG+G VY A VA+K E D + +E+ L+K+L HP
Sbjct: 3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHP 62
Query: 563 NVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQ--RNTTKLDWRRRILMA-LDIARGVSYL 619
NV+ ++ + L IV E G L ++++ + +L R + + + V ++
Sbjct: 63 NVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHM 122
Query: 620 HHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTVTYLA 673
H + ++HRD+K +N+ + VK+GD GL R + GT Y++
Sbjct: 123 H--SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMS 174
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 2e-09
Identities = 39/130 (30%), Positives = 67/130 (51%), Gaps = 15/130 (11%)
Query: 550 RQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQR------NTTKLDWR 603
+ E ++++ ++HP ++ + A + +L ++ E+L G LF L+R +T +
Sbjct: 48 KAERNILEAVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACF-YL 106
Query: 604 RRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTK 663
I +AL+ +LH II+RDLK N+L+D VK+ DFGL + T
Sbjct: 107 SEISLALE------HLHQQG--IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTH 158
Query: 664 TGKGTVTYLA 673
T GT+ Y+A
Sbjct: 159 TFCGTIEYMA 168
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 3e-09
Identities = 49/169 (28%), Positives = 82/169 (48%), Gaps = 15/169 (8%)
Query: 513 IGQGSCGTVYHAVWYGSD--VAVKVFSRQEYSDEVIHSFRQEVSLM-KRL-----RHPNV 564
+G+GS G V A G+D A+K+ + D +I E +++ KR+ + P +
Sbjct: 8 LGKGSFGKVMLAERKGTDELYAIKILKK----DVIIQDDDVECTMVEKRVLALPGKPPFL 63
Query: 565 LLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNP 624
+ RL V E++ G L +Q+ K + A +IA G+ +LH +
Sbjct: 64 TQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQ-VGKFKEPHAVFYAAEIAIGLFFLH--SK 120
Query: 625 PIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTVTYLA 673
II+RDLK N+++D +K+ DFG+ + TT+T GT Y+A
Sbjct: 121 GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRTFCGTPDYIA 169
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 58.0 bits (140), Expect = 3e-09
Identities = 39/144 (27%), Positives = 66/144 (45%), Gaps = 4/144 (2%)
Query: 531 VAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLF 590
VA+ R SD+ F E + + H N++ G +T + IVTE++ G+L
Sbjct: 36 VAIHTL-RAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALD 94
Query: 591 RLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFG 650
L+++ +L + + M +A G+ YL +H+ L + +LV+ K+ F
Sbjct: 95 SFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMG--YVHKGLAAHKVLVNSDLVCKISGFR 152
Query: 651 -LSRLKHETYLTTKTGKGTVTYLA 673
L K E TT +GK V + A
Sbjct: 153 RLQEDKSEAIYTTMSGKSPVLWAA 176
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 58.0 bits (140), Expect = 3e-09
Identities = 44/161 (27%), Positives = 78/161 (48%), Gaps = 12/161 (7%)
Query: 512 QIGQGSCGTVYHAVWYGS----DVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLF 567
++G G+ G V V+ DVA+KV + E V +E +M +L +P ++
Sbjct: 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVL-KNENEKSVRDEMMREAEIMHQLDNPYIVRM 60
Query: 568 MGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPII 627
+G V + L +V E G L + L ++ + + ++ G+ YL N +
Sbjct: 61 IG-VCEAEALMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKN--FV 117
Query: 628 HRDLKSSN-LLVDKHWTVKVGDFGLSRL--KHETYLTTKTG 665
HRDL + N LLV++H+ K+ DFGLS+ ++Y ++
Sbjct: 118 HRDLAARNVLLVNQHYA-KISDFGLSKALGADDSYYKARSA 157
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 58.2 bits (141), Expect = 3e-09
Identities = 50/182 (27%), Positives = 81/182 (44%), Gaps = 41/182 (22%)
Query: 497 CLD-YEILWEDLTIGEQIGQGSCGTVYHAV--WYGSDVAVK-VFSRQEYSDEVIHSFRQE 552
C+D ++I+ QIG+G+ G VY A G VA+K V E I + R E
Sbjct: 5 CVDKFDII-------GQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIR-E 56
Query: 553 VSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMAL-- 610
+ ++++L H N++ VT Q +F F L+ ++ LM L
Sbjct: 57 IKILRQLNHRNIVNLKEIVTDKQD---ALDFKKDKGAFYLV------FEYMDHDLMGLLE 107
Query: 611 ----------------DIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL 654
+ G++Y H N +HRD+K SN+L++ +K+ DFGL+RL
Sbjct: 108 SGLVHFSEDHIKSFMKQLLEGLNYCHKKN--FLHRDIKCSNILLNNKGQIKLADFGLARL 165
Query: 655 KH 656
+
Sbjct: 166 YN 167
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 4e-09
Identities = 52/167 (31%), Positives = 79/167 (47%), Gaps = 11/167 (6%)
Query: 513 IGQGSCGTVYHAVWYGSD--VAVKVFSR----QEYSDEVIHSFRQEVSLMKRLRHPNVLL 566
+G+GS G V A S AVKV + Q+ E + ++ +SL + HP +
Sbjct: 3 LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARN--HPFLTQ 60
Query: 567 FMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPI 626
+P RL V EF+ G L +Q+ + + D R A +I + +LH + I
Sbjct: 61 LYCCFQTPDRLFFVMEFVNGGDLMFHIQK-SRRFDEARARFYAAEITSALMFLH--DKGI 117
Query: 627 IHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTVTYLA 673
I+RDLK N+L+D K+ DFG+ + TT T GT Y+A
Sbjct: 118 IYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCGTPDYIA 164
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 4e-09
Identities = 44/174 (25%), Positives = 81/174 (46%), Gaps = 8/174 (4%)
Query: 506 DLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSD-EVIHSFRQEVSLMKRLRHP 562
+ I ++IG+G VY A G VA+K + D + +E+ L+K+L HP
Sbjct: 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 62
Query: 563 NVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQ--RNTTKLDWRRRILMA-LDIARGVSYL 619
NV+ + + L IV E G L R+++ + +L + + + + + ++
Sbjct: 63 NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHM 122
Query: 620 HHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTVTYLA 673
H + ++HRD+K +N+ + VK+GD GL R + GT Y++
Sbjct: 123 H--SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMS 174
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 4e-09
Identities = 51/151 (33%), Positives = 79/151 (52%), Gaps = 17/151 (11%)
Query: 513 IGQGSCGTVYHA--VWYGSDVAVKVFSRQEYSDEVIHSFR--QEVSLMKRLRHPNVLLFM 568
+G G+ G+V A G VAVK SR S +IH+ R +E+ L+K ++H NV+ +
Sbjct: 25 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS--IIHAKRTYRELRLLKHMKHENVIGLL 82
Query: 569 GAVTSPQRL------CIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHC 622
T + L +VT + G+ + + D + L+ I RG+ Y+H
Sbjct: 83 DVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLI-YQILRGLKYIHSA 139
Query: 623 NPPIIHRDLKSSNLLVDKHWTVKVGDFGLSR 653
+ IIHRDLK SNL V++ +K+ DFGL+R
Sbjct: 140 D--IIHRDLKPSNLAVNEDCELKILDFGLAR 168
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 5e-09
Identities = 55/181 (30%), Positives = 86/181 (47%), Gaps = 15/181 (8%)
Query: 498 LDYEILWEDLTIGEQIGQGSCGTVYHAVWYGSDV--AVKVFSRQEYSDEVIHSFRQEVSL 555
L+ E WE IGE +G G+ G VY A + V A KV + S+E + + E+ +
Sbjct: 1 LNPEEFWE--IIGE-LGDGAFGKVYKAQNKETGVLAAAKVIDTK--SEEELEDYMVEIDI 55
Query: 556 MKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRL---LQRNTTKLDWRRRILMALDI 612
+ HPN++ + A L I+ EF G++ + L+R T+ R L+
Sbjct: 56 LASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLE- 114
Query: 613 ARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTVTYL 672
++YLH IIHRDLK+ N+L +K+ DFG+S T + GT ++
Sbjct: 115 --ALNYLH--ENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWM 170
Query: 673 A 673
A
Sbjct: 171 A 171
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 7e-09
Identities = 49/170 (28%), Positives = 81/170 (47%), Gaps = 13/170 (7%)
Query: 512 QIGQGSCGTV----YHAVWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLF 567
++G G+ GTV Y VAVK+ + +E ++M++L +P ++
Sbjct: 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRM 61
Query: 568 MGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPII 627
+G + + +V E G L + LQ+N + + + ++ G+ YL N +
Sbjct: 62 IG-ICEAESWMLVMELAELGPLNKFLQKNKHVTE-KNITELVHQVSMGMKYLEETN--FV 117
Query: 628 HRDLKSSN-LLVDKHWTVKVGDFGLSRL--KHETYLTTKT-GKGTVTYLA 673
HRDL + N LLV +H+ K+ DFGLS+ E Y KT GK V + A
Sbjct: 118 HRDLAARNVLLVTQHYA-KISDFGLSKALGADENYYKAKTHGKWPVKWYA 166
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 9e-09
Identities = 47/167 (28%), Positives = 78/167 (46%), Gaps = 7/167 (4%)
Query: 511 EQIGQGSCGTVYHAVWYGSD--VAVKVFSRQE--YSDEVIHSFRQEVSLMKRLRHPNVLL 566
+ +G+GS G V+ A G++ A+K + D+V + ++ L HP +
Sbjct: 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 60
Query: 567 FMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPI 626
+ + L V E+L G L +Q + K D R A +I G+ +LH + I
Sbjct: 61 LYCTFQTKENLFFVMEYLNGGDLMFHIQ-SCHKFDLPRATFYAAEIICGLQFLH--SKGI 117
Query: 627 IHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTVTYLA 673
++RDLK N+L+D +K+ DFG+ + T T GT Y+A
Sbjct: 118 VYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFCGTPDYIA 164
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.9 bits (138), Expect = 1e-08
Identities = 44/152 (28%), Positives = 72/152 (47%), Gaps = 18/152 (11%)
Query: 511 EQIGQGSCGTVYHAVWYGSDV--AVKVFSRQEYS-DEVIHSFRQEVSLMKRLRHPNVLLF 567
+ +G+G G V+ G+ A+KV ++E + E ++ L HP +
Sbjct: 7 KLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTL 66
Query: 568 MGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKL---DWRR----RILMALDIARGVSYLH 620
+ + LC+V ++ P G LFRLLQR K + R +L+AL+ YLH
Sbjct: 67 YASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALE------YLH 120
Query: 621 HCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLS 652
I++RDLK N+L+ + + + DF LS
Sbjct: 121 --LLGIVYRDLKPENILLHESGHIMLSDFDLS 150
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 56.5 bits (137), Expect = 1e-08
Identities = 40/147 (27%), Positives = 70/147 (47%), Gaps = 10/147 (6%)
Query: 512 QIGQGSCGTVYHA--VWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLR-HPNVLLFM 568
+IG+G+ V A G A+K + S E +++ R E+ ++RL HPN+L +
Sbjct: 6 KIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLR-EIQALRRLSPHPNILRLI 64
Query: 569 GAV--TSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPI 626
+ RL +V E L +L+ L++ L +R + + + ++H I
Sbjct: 65 EVLFDRKTGRLALVFE-LMDMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNG--I 121
Query: 627 IHRDLKSSNLLVDKHWTVKVGDFGLSR 653
HRD+K N+L+ +K+ DFG R
Sbjct: 122 FHRDIKPENILIKDD-ILKLADFGSCR 147
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|214512 smart00091, PAS, PAS domain | Back alignment and domain information |
|---|
Score = 51.6 bits (124), Expect = 1e-08
Identities = 20/50 (40%), Positives = 31/50 (62%)
Query: 130 RQYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELL 179
+ IL+S+ + + DL RI+Y N +AE L GYS EE +G+ +EL+
Sbjct: 1 ERLRAILESLPDGIFVLDLDGRILYANPAAEELLGYSPEELIGKSLLELI 50
|
PAS motifs appear in archaea, eubacteria and eukarya. Probably the most surprising identification of a PAS domain was that in EAG-like K+-channels. Length = 67 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 1e-08
Identities = 50/169 (29%), Positives = 83/169 (49%), Gaps = 15/169 (8%)
Query: 513 IGQGSCGTVYHAVWYGSD--VAVKVFSRQEYSDEVIHSFRQEVSLM-KRL-----RHPNV 564
+G+GS G V A G+D A+K+ + D VI E +++ KR+ + P +
Sbjct: 8 LGKGSFGKVMLAERKGTDELYAIKILKK----DVVIQDDDVECTMVEKRVLALSGKPPFL 63
Query: 565 LLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNP 624
+ RL V E++ G L +Q+ + + A +IA G+ +LH +
Sbjct: 64 TQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQ-VGRFKEPHAVFYAAEIAIGLFFLH--SK 120
Query: 625 PIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTVTYLA 673
II+RDLK N+++D +K+ DFG+ + +TTKT GT Y+A
Sbjct: 121 GIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKTFCGTPDYIA 169
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 57.4 bits (138), Expect = 1e-08
Identities = 64/270 (23%), Positives = 105/270 (38%), Gaps = 58/270 (21%)
Query: 423 WPWSHGDQDNESVQQKSPSYGT----KPESHMYEGNRSVNNEAWGSWSSSVNVNSTSSVS 478
WP E K+ G+ + + E RS NN A +++ + S
Sbjct: 4 WPIDEDINIYEEKNHKANKGGSGKFEMNDKKLDEEERSHNNNAGEDEDEEKMIDNDINRS 63
Query: 479 SCGSTSSSAVNKVDLDNDCLDYEILWEDLTIGEQIGQGSCGTVYHAVWYGSD--VAVK-V 535
S +G IG GS G VY A+ + VA+K V
Sbjct: 64 PNKS------------------------YKLGNIIGNGSFGVVYEAICIDTSEKVAIKKV 99
Query: 536 FSRQEYSDEVIHSFRQEVSLMKRLRHPNVLL-----FMGAVTSPQR---LCIVTEFLPRG 587
+Y + +E+ +MK L H N++ + ++ L +V EF+P+
Sbjct: 100 LQDPQYKN-------RELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQT 152
Query: 588 --SLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVD-KHWTV 644
+ RN L L + + R ++Y+H + I HRDLK NLL+D T+
Sbjct: 153 VHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIH--SKFICHRDLKPQNLLIDPNTHTL 210
Query: 645 KVGDFGLSRLKHETYLTTKTGKGTVTYLAS 674
K+ DFG ++ G+ +V+Y+ S
Sbjct: 211 KLCDFGSAK-------NLLAGQRSVSYICS 233
|
Length = 440 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 2e-08
Identities = 33/106 (31%), Positives = 48/106 (45%), Gaps = 6/106 (5%)
Query: 570 AVTSPQRLCIVTEFLPRGSL-FRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIH 628
A + LC+V + G L + + R I A I G+ +LH I++
Sbjct: 61 AFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRR--IVY 118
Query: 629 RDLKSSNLLVDKHWTVKVGDFGLS-RLKHETYLTTKTGKGTVTYLA 673
RDLK N+L+D H V++ D GL+ LK K GT Y+A
Sbjct: 119 RDLKPENVLLDDHGNVRISDLGLAVELKGGK--KIKGRAGTPGYMA 162
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 56.2 bits (136), Expect = 2e-08
Identities = 31/134 (23%), Positives = 61/134 (45%), Gaps = 7/134 (5%)
Query: 509 IGEQIGQGSCGTVYHAVWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFM 568
IG+ + + VAVK + S E + +QE+ ++L+HPN+L ++
Sbjct: 6 IGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYV 65
Query: 569 GAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMAL---DIARGVSYLHHCNPP 625
+ L +V+ + GS LL+ + + + +A D+ + Y+H
Sbjct: 66 TSFIVDSELYVVSPLMAYGSCEDLLKTHFP--EGLPELAIAFILKDVLNALDYIHSKG-- 121
Query: 626 IIHRDLKSSNLLVD 639
IHR +K+S++L+
Sbjct: 122 FIHRSVKASHILLS 135
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 55.9 bits (135), Expect = 2e-08
Identities = 47/157 (29%), Positives = 76/157 (48%), Gaps = 19/157 (12%)
Query: 508 TIGEQIGQGSCGTVYHAV--WYGSDVAVK----VFSRQEYSDEVIHSFRQEVSLMKRLRH 561
I E IG+GS G V A+ G VA+K VF + SD +E+ L++ LRH
Sbjct: 3 KIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVF--EHVSDA--TRILREIKLLRLLRH 58
Query: 562 PNVLLFMGAVTSPQR-----LCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGV 616
P+++ + P R + +V E L L ++++ N + + + R +
Sbjct: 59 PDIVEIKHIMLPPSRREFKDIYVVFE-LMESDLHQVIKANDDLTPEHHQFFL-YQLLRAL 116
Query: 617 SYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSR 653
Y+H N + HRDLK N+L + +K+ DFGL+R
Sbjct: 117 KYIHTAN--VFHRDLKPKNILANADCKLKICDFGLAR 151
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 2e-08
Identities = 46/165 (27%), Positives = 81/165 (49%), Gaps = 7/165 (4%)
Query: 513 IGQGSCGTVYHAVWYGSD--VAVKVFSRQEY--SDEVIHSFRQEVSLMKRLRHPNVLLFM 568
+G+GS G V A G+D A+K+ + D+V + ++ L + + P +
Sbjct: 8 LGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLH 67
Query: 569 GAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIH 628
+ RL V E++ G L +Q+ K + + A +I+ G+ +LH II+
Sbjct: 68 SCFQTVDRLYFVMEYVNGGDLMYHIQQ-VGKFKEPQAVFYAAEISVGLFFLHRRG--IIY 124
Query: 629 RDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTVTYLA 673
RDLK N+++D +K+ DFG+ + +TT+T GT Y+A
Sbjct: 125 RDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRTFCGTPDYIA 169
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 3e-08
Identities = 43/143 (30%), Positives = 77/143 (53%), Gaps = 10/143 (6%)
Query: 512 QIGQGSCGTVYHA--VWYGSDVAVKVFS-RQEYSDEVIHSFRQEVSLMKRLRHPNVLLFM 568
+IG+GS G V A G VAVK+ R++ E++ + EV +M+ +H NV+
Sbjct: 28 KIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFN---EVVIMRDYQHQNVVEMY 84
Query: 569 GAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIH 628
+ + L ++ EFL G+L ++ + T+L+ + + + + + YLH + +IH
Sbjct: 85 KSYLVGEELWVLMEFLQGGALTDIVSQ--TRLNEEQIATVCESVLQALCYLH--SQGVIH 140
Query: 629 RDLKSSNLLVDKHWTVKVGDFGL 651
RD+KS ++L+ VK+ DFG
Sbjct: 141 RDIKSDSILLTLDGRVKLSDFGF 163
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 3e-08
Identities = 51/179 (28%), Positives = 80/179 (44%), Gaps = 20/179 (11%)
Query: 505 EDLTIGEQIGQGSCGTVYHAVWYGSD--VAVKVFSRQEY---SDEVIHSFRQEVSLMKRL 559
ED + + IG+G+ G V S A+K+ S+ E SD F +E +M
Sbjct: 43 EDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAF--FWEERDIMAFA 100
Query: 560 RHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRR----RILMALDIARG 615
P V+ A + L +V E++P G L L+ W + +++ALD
Sbjct: 101 NSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEKWAKFYTAEVVLALDAIHS 160
Query: 616 VSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLT-TKTGKGTVTYLA 673
+ +IHRD+K N+L+DKH +K+ DFG ET + T GT Y++
Sbjct: 161 MG--------LIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYIS 211
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 55.5 bits (134), Expect = 4e-08
Identities = 48/161 (29%), Positives = 74/161 (45%), Gaps = 33/161 (20%)
Query: 512 QIGQGSCGTVYHAV--WYGSDVAVK----VFSRQEYSDEVIHSFRQEVSLMKRLRHPNVL 565
IG G+ G V+ G VA+K VF V FR E+ ++ +H NVL
Sbjct: 7 PIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRV---FR-ELKMLCFFKHDNVL 62
Query: 566 LFMGAVTSP-----QRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMA-------LDIA 613
+ + P + + +VTE L+Q + K+ + L + I
Sbjct: 63 SALDILQPPHIDPFEEIYVVTE---------LMQSDLHKIIVSPQPLSSDHVKVFLYQIL 113
Query: 614 RGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL 654
RG+ YLH I+HRD+K NLLV+ + +K+ DFGL+R+
Sbjct: 114 RGLKYLHSAG--ILHRDIKPGNLLVNSNCVLKICDFGLARV 152
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 4e-08
Identities = 48/168 (28%), Positives = 82/168 (48%), Gaps = 12/168 (7%)
Query: 513 IGQGSCGTVYHA-VWYGSDV----AVKVFSRQ--EYSDEVIHSFRQEVSLMKRLRHPNVL 565
+GQGS G V+ G D A+KV + + D V + E ++ + HP ++
Sbjct: 4 LGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRV--RTKMERDILAEVNHPFIV 61
Query: 566 LFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPP 625
A + +L ++ +FL G LF L + + + +A ++A + +LH
Sbjct: 62 KLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLA-ELALALDHLHSLG-- 118
Query: 626 IIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTVTYLA 673
II+RDLK N+L+D+ +K+ DFGLS+ + + GTV Y+A
Sbjct: 119 IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMA 166
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 7e-08
Identities = 44/143 (30%), Positives = 74/143 (51%), Gaps = 10/143 (6%)
Query: 512 QIGQGSCGTVYHAV--WYGSDVAVKVFS-RQEYSDEVIHSFRQEVSLMKRLRHPNVLLFM 568
+IG+GS G V A G VAVK R++ E++ + EV +M+ +H NV+
Sbjct: 27 KIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFN---EVVIMRDYQHENVVEMY 83
Query: 569 GAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIH 628
+ L +V EFL G+L ++ T+++ + + L + + +S LH +IH
Sbjct: 84 NSYLVGDELWVVMEFLEGGALTDIVTH--TRMNEEQIAAVCLAVLKALSVLH--AQGVIH 139
Query: 629 RDLKSSNLLVDKHWTVKVGDFGL 651
RD+KS ++L+ VK+ DFG
Sbjct: 140 RDIKSDSILLTHDGRVKLSDFGF 162
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 8e-08
Identities = 46/148 (31%), Positives = 71/148 (47%), Gaps = 11/148 (7%)
Query: 513 IGQGSCGTVYHA--VWYGSDVAVKVFSRQEYSDEVIHSFR--QEVSLMKRLRHPNVLLFM 568
+G G+ G+V A VAVK SR S +IH+ R +E+ L+K ++H NV+ +
Sbjct: 23 VGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQS--LIHARRTYRELRLLKHMKHENVIGLL 80
Query: 569 GAVTSPQRLCIVTEFLPRGSLFRLLQRNTTK---LDWRRRILMALDIARGVSYLHHCNPP 625
T + E +L N K L + + RG+ Y+H
Sbjct: 81 DVFTPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQFLIYQLLRGLKYIHSAG-- 138
Query: 626 IIHRDLKSSNLLVDKHWTVKVGDFGLSR 653
IIHRDLK SN+ V++ +++ DFGL+R
Sbjct: 139 IIHRDLKPSNVAVNEDCELRILDFGLAR 166
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 8e-08
Identities = 48/163 (29%), Positives = 72/163 (44%), Gaps = 30/163 (18%)
Query: 511 EQIGQGSCGTVYHA--VWYGSDVAVKVFSRQEYSDEVIHSFR-QEVSLMKRLRHPNVLLF 567
E+IG+G+ G VY A G VA+K +R E +E I +E+SL++ L ++
Sbjct: 7 EKIGEGTYGKVYKARDKNTGKLVALKK-TRLEMDEEGIPPTALREISLLQMLSESIYIVR 65
Query: 568 MGAVTSPQR------LCIVTEFLP----------RGSLFRLLQRNTTKLDWRRRILMALD 611
+ V + L +V E+L R L T K
Sbjct: 66 LLDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKS-------FMYQ 118
Query: 612 IARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTV-KVGDFGLSR 653
+ +GV++ H ++HRDLK NLLVDK + K+ D GL R
Sbjct: 119 LLKGVAHCHKHG--VMHRDLKPQNLLVDKQKGLLKIADLGLGR 159
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 9e-08
Identities = 54/169 (31%), Positives = 78/169 (46%), Gaps = 21/169 (12%)
Query: 511 EQIGQGSCGTVYHAVWY----GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLL 566
++IG G G V + Y + V VK S E + F Q+ + L+HPN+L
Sbjct: 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQ-NEFLQQGDPYRILQHPNILQ 59
Query: 567 FMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRR---IL----MALDIARGVSYL 619
+G +V E+ G L L + W RR +L MA +IA GV+++
Sbjct: 60 CLGQCVEAIPYLLVFEYCELGDLKSYLSQE----QWHRRNSQLLLLQRMACEIAAGVTHM 115
Query: 620 HHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGL--SRLKHETYLTTKTGK 666
H N +H DL N + TVKVGD+G+ SR K E Y+ T+ K
Sbjct: 116 HKHN--FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYK-EDYIETEDDK 161
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 54.1 bits (130), Expect = 1e-07
Identities = 45/146 (30%), Positives = 72/146 (49%), Gaps = 6/146 (4%)
Query: 512 QIGQGSCGTVYHAV--WYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMG 569
Q+G G+ G+V A+ G VA+K SR S+ +E++L+K ++H NV+ +
Sbjct: 22 QVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLD 81
Query: 570 AVTSPQRLCIVTEF-LPRGSLFRLLQR-NTTKLDWRRRILMALDIARGVSYLHHCNPPII 627
TS +F L + LQ+ L + + + G+ Y+H II
Sbjct: 82 VFTSAVSGDEFQDFYLVMPYMQTDLQKIMGHPLSEDKVQYLVYQMLCGLKYIHSAG--II 139
Query: 628 HRDLKSSNLLVDKHWTVKVGDFGLSR 653
HRDLK NL V++ +K+ DFGL+R
Sbjct: 140 HRDLKPGNLAVNEDCELKILDFGLAR 165
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.8 bits (130), Expect = 1e-07
Identities = 41/159 (25%), Positives = 75/159 (47%), Gaps = 22/159 (13%)
Query: 505 EDLTIGEQIGQGSCGTVYHAVWYGSD---VAVKVFSRQEY--SDEVIHSFRQEVSLMKRL 559
+D + + IG+G+ G V+ V A+KV + + +++ H R E ++
Sbjct: 1 DDFEVIKVIGRGAFGEVW-LVRDKDTGQVYAMKVLRKSDMIKRNQIAH-VRAERDILADA 58
Query: 560 RHPNVL-LFMGAVTSPQRLCIVTEFLPRGSLFRLLQR-NTTKLDWRR----RILMALDIA 613
P ++ L+ + + L +V E++P G L LL R + + R +++ALD
Sbjct: 59 DSPWIVKLYY-SFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSV 117
Query: 614 RGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLS 652
+ + IHRD+K N+L+D +K+ DFGL
Sbjct: 118 HKLGF--------IHRDIKPDNILIDADGHIKLADFGLC 148
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 1e-07
Identities = 54/193 (27%), Positives = 86/193 (44%), Gaps = 22/193 (11%)
Query: 492 DLDNDCLDYEILWEDLTIGEQIGQGSCGTVYHAVWYGSD---VAVKVFSRQEY---SDEV 545
D N D + ED + + IG+G+ G V V + S A+K+ S+ E SD
Sbjct: 30 DTINKIRDLRMKAEDYEVVKVIGRGAFGEV-QLVRHKSTRKVYAMKLLSKFEMIKRSDSA 88
Query: 546 IHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRR- 604
F +E +M P V+ A + L +V E++P G L L+ W R
Sbjct: 89 F--FWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARF 146
Query: 605 ---RILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLS-RLKHETYL 660
+++ALD + + IHRD+K N+L+DK +K+ DFG ++ E +
Sbjct: 147 YTAEVVLALDAIHSMGF--------IHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMV 198
Query: 661 TTKTGKGTVTYLA 673
T GT Y++
Sbjct: 199 RCDTAVGTPDYIS 211
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 3e-07
Identities = 38/164 (23%), Positives = 66/164 (40%), Gaps = 29/164 (17%)
Query: 511 EQIGQGSCGTVYHAVW----------YGSDVAV--KVFSRQEYSDEVIHSFRQEVSLMKR 558
E +GQG+ +Y V G +V+V KV +F + SLM +
Sbjct: 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSL---AFFETASLMSQ 57
Query: 559 LRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTT--KLDWRRRILMALDIARGV 616
L H +++ G V +V E++ G L L R L W+ + L A +
Sbjct: 58 LSHKHLVKLYG-VCVRDENIMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQL--ASAL 114
Query: 617 SYLHHCNPPIIHRDLKSSNLLVDKHWT-------VKVGDFGLSR 653
YL + ++H ++ N+LV ++ +K+ D G+
Sbjct: 115 HYLE--DKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPI 156
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 3e-07
Identities = 43/134 (32%), Positives = 62/134 (46%), Gaps = 12/134 (8%)
Query: 528 GSDVAVKVFSRQEYSDE-VIHSFRQEVSLMKRLRHPN-VLLFMGAVTSPQRLCIVTEFLP 585
G +VA+K+ +E FR+E +L RL HPN V L P L V E++P
Sbjct: 3 GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVP 62
Query: 586 RGSLFRLLQRN--TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLV---DK 640
+L +L + + R +L LD ++ H N I+HRDLK N++V
Sbjct: 63 GRTLREVLAADGALPAGETGRLMLQVLD---ALACAH--NQGIVHRDLKPQNIMVSQTGV 117
Query: 641 HWTVKVGDFGLSRL 654
KV DFG+ L
Sbjct: 118 RPHAKVLDFGIGTL 131
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 4e-07
Identities = 49/171 (28%), Positives = 78/171 (45%), Gaps = 19/171 (11%)
Query: 513 IGQGSCGTVYHAVWYGSD--VAVKVFSRQEYSDEVIHSFRQEVSLMKR------LRHPNV 564
+G+GS G V A G++ A+K + D V+ E ++++R HP +
Sbjct: 3 LGKGSFGKVMLAELKGTNEFFAIKALKK----DVVLEDDDVECTMVERRVLALAWEHPFL 58
Query: 565 LLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNP 624
+ + L V E+L G L +Q ++ + D R A +I G+ +LH
Sbjct: 59 THLFCTFQTKEHLFFVMEYLNGGDLMFHIQ-SSGRFDEARARFYAAEIICGLQFLHKKG- 116
Query: 625 PIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGK--GTVTYLA 673
II+RDLK N+L+DK +K+ DFG+ K K GT Y+A
Sbjct: 117 -IIYRDLKLDNVLLDKDGHIKIADFGMC--KENMNGEGKASTFCGTPDYIA 164
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 51.6 bits (124), Expect = 5e-07
Identities = 45/158 (28%), Positives = 73/158 (46%), Gaps = 16/158 (10%)
Query: 505 EDLTIGEQIGQGSCGTVYHAVWYGSDV--AVKVFSRQEYSDEVIHSFRQEVSLMKRLRH- 561
EDL +IG+G+ GTV + S AVK R ++ ++ ++ R
Sbjct: 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRI-RSTVDEKEQKRLLMDLDVVMRSSDC 62
Query: 562 PNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWR--RRIL--MALDIARGVS 617
P ++ F GA+ I E L SL + + L IL +A+ + ++
Sbjct: 63 PYIVKFYGALFREGDCWICME-LMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALN 121
Query: 618 YL---HHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLS 652
YL IIHRD+K SN+L+D++ +K+ DFG+S
Sbjct: 122 YLKEELK----IIHRDVKPSNILLDRNGNIKLCDFGIS 155
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 6e-07
Identities = 19/45 (42%), Positives = 32/45 (71%), Gaps = 1/45 (2%)
Query: 608 MALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLS 652
+A+ I + + YLH +IHRD+K SN+L++++ VK+ DFG+S
Sbjct: 108 IAVSIVKALEYLHS-KLSVIHRDVKPSNVLINRNGQVKLCDFGIS 151
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 6e-07
Identities = 44/158 (27%), Positives = 76/158 (48%), Gaps = 21/158 (13%)
Query: 505 EDLTIGEQIGQGSCGTVYHAVWYGSDVAVKVFSRQEYSDEVIHSFRQ----EVSLMKRLR 560
+D ++G G+ G V + S + + +R+ E+ + R E+ ++
Sbjct: 1 DDFEKLGELGAGNGGVVTKVLHRPSGL---IMARKLIHLEIKPAIRNQIIRELKVLHECN 57
Query: 561 HPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRI----LMALDIA--R 614
P ++ F GA S + I E + GSL ++L++ RI L + IA R
Sbjct: 58 SPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKK-------AGRIPENILGKISIAVLR 110
Query: 615 GVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLS 652
G++YL I+HRD+K SN+LV+ +K+ DFG+S
Sbjct: 111 GLTYLRE-KHKIMHRDVKPSNILVNSRGEIKLCDFGVS 147
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 8e-07
Identities = 38/146 (26%), Positives = 74/146 (50%), Gaps = 11/146 (7%)
Query: 513 IGQGSCGTVYHAVWYGSD--VAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGA 570
+G+G+ G V + VA+K F E ++EV + +E+ +++ L+ N++ A
Sbjct: 9 VGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEA 68
Query: 571 VTSPQRLCIVTEFLPRGSLFRLLQR--NTTKLDWRRRILMALDIARGVSYLHHCNP-PII 627
+L +V E++ + ++ LL+ N + R + L + +H C+ I+
Sbjct: 69 FRRRGKLYLVFEYVEK-NMLELLEEMPNGVPPEKVRSYIYQL-----IKAIHWCHKNDIV 122
Query: 628 HRDLKSSNLLVDKHWTVKVGDFGLSR 653
HRD+K NLL+ + +K+ DFG +R
Sbjct: 123 HRDIKPENLLISHNDVLKLCDFGFAR 148
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 9e-07
Identities = 45/180 (25%), Positives = 77/180 (42%), Gaps = 20/180 (11%)
Query: 505 EDLTIGEQIGQGSCGTVYHAV---WYGSDVAVKVFSR-QEYSDEVIHSFRQEVSLMKRLR 560
+D + +G+G G V V G A+KV + + E + F +E ++
Sbjct: 1 KDFDVKSLVGRGHFGEV-QVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISN 59
Query: 561 HPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLD------WRRRILMALDIAR 614
P + A L +V E+ P G L LL R + D + +++A+
Sbjct: 60 SPWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVH 119
Query: 615 GVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLS-RLKHETYLTTKTGKGTVTYLA 673
+ Y +HRD+K N+L+D+ +K+ DFG + RL + +K GT Y+A
Sbjct: 120 QMGY--------VHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIA 171
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|219845 pfam08448, PAS_4, PAS fold | Back alignment and domain information |
|---|
Score = 47.4 bits (113), Expect = 1e-06
Identities = 30/107 (28%), Positives = 47/107 (43%), Gaps = 5/107 (4%)
Query: 136 LQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLT--DGRDFDVAYDIVH 193
L S+ ++ + D R+ Y N +A L+G EE LG+ ELL D + A
Sbjct: 1 LDSLPDALAVLDPDGRVRYANAAAAELFGLPPEELLGKTLAELLPPEDAARLERALRRA- 59
Query: 194 RIKMGERWTGQFPAKTKTEERVLVVATNTPFYDDDGTLVGIVCVSTD 240
++ E EER + TP D DG ++G++ +S D
Sbjct: 60 -LEGEEPIDFLEELLLNGEERHYEL-RLTPLRDPDGEVIGVLVISRD 104
|
The PAS fold corresponds to the structural domain that has previously been defined as PAS and PAC motifs. The PAS fold appears in archaea, eubacteria and eukarya. Length = 110 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 50.9 bits (122), Expect = 1e-06
Identities = 48/180 (26%), Positives = 80/180 (44%), Gaps = 22/180 (12%)
Query: 505 EDLTIGEQIGQGSCGTVYHAVWYGSD---VAVKVFSRQEY---SDEVIHSFRQEVSLMKR 558
ED + + IG+G+ G V V + S A+K+ S+ E SD F +E +M
Sbjct: 43 EDFDVIKVIGRGAFGEV-QLVRHKSSKQVYAMKLLSKFEMIKRSDSAF--FWEERDIMAH 99
Query: 559 LRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRR----RILMALDIAR 614
++ A + L +V E++P G L L+ W R +++ALD
Sbjct: 100 ANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLMSNYDIPEKWARFYTAEVVLALDAIH 159
Query: 615 GVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLS-RLKHETYLTTKTGKGTVTYLA 673
+ + IHRD+K N+L+DK +K+ DFG ++ + T GT Y++
Sbjct: 160 SMGF--------IHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAVGTPDYIS 211
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 1e-06
Identities = 30/107 (28%), Positives = 54/107 (50%), Gaps = 20/107 (18%)
Query: 552 EVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPR--GSLFRLLQRNTTKLDWRRRI--- 606
E +++ + HP+++ G T + C++ LPR L+ L +R I
Sbjct: 133 EAHILRAINHPSIIQLKGTFTYNKFTCLI---LPRYKTDLYCYLAA-------KRNIAIC 182
Query: 607 -LMALD--IARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFG 650
++A++ + R + YLH IIHRD+K+ N+ ++ V +GDFG
Sbjct: 183 DILAIERSVLRAIQYLH--ENRIIHRDIKAENIFINHPGDVCLGDFG 227
|
Length = 391 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 2e-06
Identities = 44/162 (27%), Positives = 75/162 (46%), Gaps = 13/162 (8%)
Query: 512 QIGQGSCGTVYHAVWY---GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLR---HPNVL 565
+IG+G+ G V+ A G VA+K Q + + S +EV++++ L HPNV+
Sbjct: 8 EIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVV 67
Query: 566 LFMGAVTSPQ-----RLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLH 620
T + +L +V E + + L + + M + RG+ +LH
Sbjct: 68 RLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH 127
Query: 621 HCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTT 662
+ ++HRDLK N+LV +K+ DFGL+R+ T
Sbjct: 128 --SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALT 167
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 2e-06
Identities = 35/123 (28%), Positives = 58/123 (47%), Gaps = 4/123 (3%)
Query: 552 EVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSL-FRLLQRNTTKLDWRRRILMAL 610
E +++++ V+ A + LC+V + G L F + + R + A
Sbjct: 50 EKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAA 109
Query: 611 DIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTVT 670
+I G+ LH I++RDLK N+L+D H +++ D GL+ E T K GTV
Sbjct: 110 EICCGLEDLHQ--ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ-TIKGRVGTVG 166
Query: 671 YLA 673
Y+A
Sbjct: 167 YMA 169
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 2e-06
Identities = 42/148 (28%), Positives = 75/148 (50%), Gaps = 10/148 (6%)
Query: 511 EQIGQGSCGTVYHAVWYGSDV--AVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFM 568
+++G+G+ G+VY + + V A+K R E + + E+ ++ + P ++ F
Sbjct: 7 DELGKGNYGSVYKVLHRPTGVTMAMKEI-RLELDESKFNQIIMELDILHKAVSPYIVDFY 65
Query: 569 GAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKL----DWRRRILMALDIARGVSYLHHCNP 624
GA + + E++ GSL +L D RRI A + +G+ +L
Sbjct: 66 GAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYA--VVKGLKFLKE-EH 122
Query: 625 PIIHRDLKSSNLLVDKHWTVKVGDFGLS 652
IIHRD+K +N+LV+ + VK+ DFG+S
Sbjct: 123 NIIHRDVKPTNVLVNGNGQVKLCDFGVS 150
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 2e-06
Identities = 47/165 (28%), Positives = 76/165 (46%), Gaps = 7/165 (4%)
Query: 513 IGQGSCGTVYHAVWYGSD--VAVKVFSRQEYS-DEVIHSFRQEVSLMKRL-RHPNVLLFM 568
IG+GS V + A+KV ++ + DE I + E + + HP ++
Sbjct: 3 IGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLH 62
Query: 569 GAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIH 628
+ RL V EF+ G L +QR KL + +I+ +++LH II+
Sbjct: 63 SCFQTESRLFFVIEFVSGGDLMFHMQRQR-KLPEEHARFYSAEISLALNFLHERG--IIY 119
Query: 629 RDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTVTYLA 673
RDLK N+L+D +K+ D+G+ + TT T GT Y+A
Sbjct: 120 RDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFCGTPNYIA 164
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 49.3 bits (118), Expect = 3e-06
Identities = 20/42 (47%), Positives = 28/42 (66%), Gaps = 2/42 (4%)
Query: 612 IARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSR 653
I G+ Y+H N ++HRDLK NLLV+ +K+ DFGL+R
Sbjct: 114 ILCGLKYIHSAN--VLHRDLKPGNLLVNADCELKICDFGLAR 153
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 3e-06
Identities = 42/154 (27%), Positives = 79/154 (51%), Gaps = 13/154 (8%)
Query: 505 EDLTIGEQIGQGSCGTVYHAVWYGSDVAVKVFSRQEYSDEVIHSFR----QEVSLMKRLR 560
+D ++G G+ G V+ S + + +R+ E+ + R +E+ ++
Sbjct: 5 DDFEKISELGAGNGGVVFKVSHKPSGL---IMARKLIHLEIKPAIRNQIIRELQVLHECN 61
Query: 561 HPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIA--RGVSY 618
P ++ F GA S + I E + GSL ++L++ ++ +IL + IA +G++Y
Sbjct: 62 SPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKK-AGRIP--EQILGKVSIAVIKGLTY 118
Query: 619 LHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLS 652
L I+HRD+K SN+LV+ +K+ DFG+S
Sbjct: 119 LRE-KHKIMHRDVKPSNILVNSRGEIKLCDFGVS 151
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 49.9 bits (119), Expect = 3e-06
Identities = 42/159 (26%), Positives = 73/159 (45%), Gaps = 16/159 (10%)
Query: 505 EDLTIGEQIGQGSCGTVYHA--VWYGSDVAVKVFSRQEYSDE-VIHSFRQEVSLMKRLRH 561
E+ I + I +G+ G VY AVKV + + ++ ++H + E + +
Sbjct: 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKS 63
Query: 562 PNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQ-----RNTTKLDWRRRILMALDIARGV 616
P ++ ++ S + +V E+L G + LL + + + +ALD
Sbjct: 64 PFIVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALD----- 118
Query: 617 SYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLK 655
YLH IIHRDLK N+L+ +K+ DFGLS++
Sbjct: 119 -YLHRHG--IIHRDLKPDNMLISNEGHIKLTDFGLSKVT 154
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|226350 COG3829, RocR, Transcriptional regulator containing PAS, AAA-type ATPase, and DNA-binding domains [Transcription / Signal transduction mechanisms] | Back alignment and domain information |
|---|
Score = 49.2 bits (118), Expect = 5e-06
Identities = 30/121 (24%), Positives = 49/121 (40%), Gaps = 16/121 (13%)
Query: 130 RQYL-NILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRD---F 185
RQ L IL S+ + + D IIY+N++ L G S EE LG+ +++++ G D
Sbjct: 116 RQRLEAILDSIDDGLLVVDEDGIIIYYNKAYAKLLGLSPEEVLGKHLLDVVSAGEDSTLL 175
Query: 186 DVAYDIVHRIKMGERWTGQFPAKTKTEERVLVVATNTPFYDDDGTLVGIVCVSTDSRPFQ 245
+V ++V N DG L+G+V +S D +
Sbjct: 176 EVLRTGKPIRD----------VVQTYNGNKIIV--NVAPVYADGQLIGVVGISKDVSELE 223
Query: 246 E 246
Sbjct: 224 R 224
|
Length = 560 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 6e-06
Identities = 44/157 (28%), Positives = 77/157 (49%), Gaps = 19/157 (12%)
Query: 505 EDLTIGEQIGQGSCGTVYHAVWYGSDVAVKVFSRQEYSDEVIHSFR----QEVSLMKRLR 560
+D ++G G+ G V S + + +R+ E+ + R +E+ ++
Sbjct: 5 DDFERISELGAGNGGVVTKVQHKPSGL---IMARKLIHLEIKPAIRNQIIRELQVLHECN 61
Query: 561 HPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRR---RILMALDIA--RG 615
P ++ F GA S + I E + GSL ++L+ + +R IL + IA RG
Sbjct: 62 SPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK------EAKRIPEEILGKVSIAVLRG 115
Query: 616 VSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLS 652
++YL I+HRD+K SN+LV+ +K+ DFG+S
Sbjct: 116 LAYLRE-KHQIMHRDVKPSNILVNSRGEIKLCDFGVS 151
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 48.2 bits (115), Expect = 7e-06
Identities = 33/102 (32%), Positives = 51/102 (50%), Gaps = 19/102 (18%)
Query: 561 HPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIAR------ 614
+P V+ + + + LC+V E++ G LL +N L +D+AR
Sbjct: 60 NPFVVSMFCSFETKRHLCMVMEYVEGGDCATLL-KNIGAL--------PVDMARMYFAET 110
Query: 615 --GVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL 654
+ YLH N I+HRDLK NLL+ +K+ DFGLS++
Sbjct: 111 VLALEYLH--NYGIVHRDLKPDNLLITSMGHIKLTDFGLSKI 150
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 48.3 bits (115), Expect = 7e-06
Identities = 45/159 (28%), Positives = 73/159 (45%), Gaps = 8/159 (5%)
Query: 505 EDLTIGEQIGQGSCGTV--YHAVWYGSDVAVKVFSRQEY--SDEVIHSFRQEVSLMKRLR 560
ED + IG+G+ G V G A+K + E D++ H + E ++
Sbjct: 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAH-VKAERDVLAESD 59
Query: 561 HPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLH 620
P V+ + Q L ++ EFLP G L +L + T + R MA + + +H
Sbjct: 60 SPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMA-ECVLAIEAVH 118
Query: 621 HCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETY 659
IHRD+K N+L+D+ +K+ DFGLS H+ +
Sbjct: 119 KLG--FIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQH 155
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 47.5 bits (114), Expect = 8e-06
Identities = 32/119 (26%), Positives = 57/119 (47%), Gaps = 10/119 (8%)
Query: 554 SLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIA 613
LMK +PN + +VT+ + ++ +++ G LF LL++ KL + +
Sbjct: 63 QLMKD--NPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEG-KLSEAEVKKIIRQLV 119
Query: 614 RGVSYLHHCNPPIIHRDLKSSNLLVDKH-WTVKVGDFGLSRLKHETYLTTKTGKGTVTY 671
++ LH N IIH D+K N+L D+ + + D+GL ++ T GT+ Y
Sbjct: 120 EALNDLHKHN--IIHNDIKLENVLYDRAKDRIYLCDYGLCKIIG----TPSCYDGTLDY 172
|
Length = 267 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 9e-06
Identities = 36/131 (27%), Positives = 65/131 (49%), Gaps = 15/131 (11%)
Query: 550 RQEVSLMKRLRH-PNVLLFMGAVTSPQRLCIVTEFLPRGSLF-RLLQRNTTKLDWRRRIL 607
R E +++ +R P ++ A + +L ++ +++ G LF L QR R+
Sbjct: 52 RTERQVLEAVRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTES-EVRVY 110
Query: 608 MALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGK- 666
+A +I + +LH II+RD+K N+L+D V + DFGLS+ +L + +
Sbjct: 111 IA-EIVLALDHLHQLG--IIYRDIKLENILLDSEGHVVLTDFGLSKE----FLAEEEERA 163
Query: 667 ----GTVTYLA 673
GT+ Y+A
Sbjct: 164 YSFCGTIEYMA 174
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 9e-06
Identities = 33/123 (26%), Positives = 59/123 (47%), Gaps = 4/123 (3%)
Query: 552 EVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSL-FRLLQRNTTKLDWRRRILMAL 610
E +++++ V+ A + LC+V + G L F + D R + A
Sbjct: 50 EKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAA 109
Query: 611 DIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTVT 670
+I G+ LH I++RDLK N+L+D + +++ D GL+ ++ T + GTV
Sbjct: 110 EITCGLEDLHRER--IVYRDLKPENILLDDYGHIRISDLGLA-VEIPEGETIRGRVGTVG 166
Query: 671 YLA 673
Y+A
Sbjct: 167 YMA 169
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 1e-05
Identities = 38/146 (26%), Positives = 72/146 (49%), Gaps = 9/146 (6%)
Query: 513 IGQGSCGTVY--HAVWYGSDVAVKVFSRQ----EYSDEVIHSFRQEVSLMKRLRHPNVLL 566
IG+G G VY G A+K ++ + + + + R +SL+ P ++
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61
Query: 567 FMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPI 626
A +P +LC + + + G L L ++ + R A +I G+ ++H N +
Sbjct: 62 MTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMR-FYATEIILGLEHMH--NRFV 118
Query: 627 IHRDLKSSNLLVDKHWTVKVGDFGLS 652
++RDLK +N+L+D+H V++ D GL+
Sbjct: 119 VYRDLKPANILLDEHGHVRISDLGLA 144
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.7 bits (114), Expect = 1e-05
Identities = 36/138 (26%), Positives = 62/138 (44%), Gaps = 6/138 (4%)
Query: 528 GSDVAVKVFSRQE--YSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLP 585
G A+K + E ++V H R E ++ +P V+ + L ++ E+LP
Sbjct: 26 GHIYAMKKLRKSEMLEKEQVAH-VRAERDILAEADNPWVVKLYYSFQDENYLYLIMEYLP 84
Query: 586 RGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVK 645
G + LL + T + R +A + + +H IHRD+K NLL+D +K
Sbjct: 85 GGDMMTLLMKKDTFTEEETRFYIA-ETILAIDSIHKLG--YIHRDIKPDNLLLDAKGHIK 141
Query: 646 VGDFGLSRLKHETYLTTK 663
+ DFGL +++ T
Sbjct: 142 LSDFGLCTGLKKSHRTEF 159
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 1e-05
Identities = 33/124 (26%), Positives = 60/124 (48%), Gaps = 6/124 (4%)
Query: 552 EVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSL-FRLLQRNTTKLDWRRRILMAL 610
E +++++ P ++ A S LC+V + G L + + L+ R I +
Sbjct: 43 EKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSA 102
Query: 611 DIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLS-RLKHETYLTTKTGKGTV 669
I G+ +LH + I++RD+K N+L+D ++ D GL+ LK +T + GT
Sbjct: 103 QITCGILHLHSMD--IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQRA--GTN 158
Query: 670 TYLA 673
Y+A
Sbjct: 159 GYMA 162
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 47.6 bits (113), Expect = 1e-05
Identities = 40/139 (28%), Positives = 62/139 (44%), Gaps = 13/139 (9%)
Query: 520 TVYHAVWYGSDVAVKVFSRQEYSDEVI------HSFRQEVSLMKRLRHPNVLLFMGAVTS 573
++ A+ GS+ V S +Y V+ S E L++RL HP VL +
Sbjct: 172 AIHRALTPGSEGCVFESSHPDYPQRVVVKAGWYASSVHEARLLRRLSHPAVLALLDVRVV 231
Query: 574 PQRLCIVTEFLP--RGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDL 631
C+V LP R L+ L L + +A + + Y+H IIHRD+
Sbjct: 232 GGLTCLV---LPKYRSDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIH--GEGIIHRDI 286
Query: 632 KSSNLLVDKHWTVKVGDFG 650
K+ N+LV+ + +GDFG
Sbjct: 287 KTENVLVNGPEDICLGDFG 305
|
Length = 461 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 1e-05
Identities = 47/170 (27%), Positives = 77/170 (45%), Gaps = 22/170 (12%)
Query: 512 QIGQGSCG--TVYHA--VWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLF 567
+IG+G C +VY A G+ V V++ + ++E + + + EV L RHPN++
Sbjct: 5 EIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTS 64
Query: 568 MGAVTSPQRLCIVTEFLPRGSLFRLLQR------NTTKLDWRRRILMALDIARGVSYLHH 621
T+ L +++ F+ GS LL+ + + IL RG++YLH
Sbjct: 65 WTVFTTGSWLWVISPFMAYGSANSLLKTYFPEGMSEALI---GNILFG--ALRGLNYLHQ 119
Query: 622 CNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTVTY 671
IHR++K+S++L+ G LS L H L K V Y
Sbjct: 120 NG--YIHRNIKASHILISGD-----GLVSLSGLSHLYSLVRNGQKAKVVY 162
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 47.4 bits (112), Expect = 1e-05
Identities = 47/165 (28%), Positives = 78/165 (47%), Gaps = 7/165 (4%)
Query: 513 IGQGSCGTVYHAVWYGSD--VAVKVFSRQEYSD-EVIHSFRQEVSLMKRL-RHPNVLLFM 568
IG+GS V ++ A+KV ++ +D E I + E + ++ HP ++
Sbjct: 3 IGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 62
Query: 569 GAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIH 628
+ RL V E++ G L +QR KL + +I+ ++YLH II+
Sbjct: 63 SCFQTESRLFFVIEYVNGGDLMFHMQRQR-KLPEEHARFYSAEISLALNYLHERG--IIY 119
Query: 629 RDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTVTYLA 673
RDLK N+L+D +K+ D+G+ + TT T GT Y+A
Sbjct: 120 RDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIA 164
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 47.2 bits (112), Expect = 3e-05
Identities = 26/89 (29%), Positives = 52/89 (58%), Gaps = 5/89 (5%)
Query: 552 EVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALD 611
E++ M +L+HPN++ +G S + ++ E++ +L +L RN L W RR +A+
Sbjct: 733 EIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVL-RN---LSWERRRKIAIG 788
Query: 612 IARGVSYLH-HCNPPIIHRDLKSSNLLVD 639
IA+ + +LH C+P ++ +L +++D
Sbjct: 789 IAKALRFLHCRCSPAVVVGNLSPEKIIID 817
|
Length = 968 |
| >gnl|CDD|221967 pfam13188, PAS_8, PAS domain | Back alignment and domain information |
|---|
Score = 42.2 bits (99), Expect = 3e-05
Identities = 12/57 (21%), Positives = 24/57 (42%), Gaps = 1/57 (1%)
Query: 130 RQYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFD 186
+ + ++ + + D DRI+Y N +A L GY L + ++ L +
Sbjct: 1 ERLRALFENAPDGILVLD-GDRILYANPAALELLGYELLGELLGELLDDLEALAEEA 56
|
Length = 64 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 45.7 bits (108), Expect = 4e-05
Identities = 41/145 (28%), Positives = 68/145 (46%), Gaps = 7/145 (4%)
Query: 513 IGQGSCGTVYHAVWYGSD--VAVKVFSRQEY--SDEVIHSFRQEVSLMKRLRHPNVLLFM 568
+G+GS G V A G AVK + D+V + ++ L +P +
Sbjct: 3 LGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLY 62
Query: 569 GAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIH 628
+ + L V EFL G L +Q + + D R A +I G+ +LH + II+
Sbjct: 63 CTFQTKEHLFFVMEFLNGGDLMFHIQ-DKGRFDLYRATFYAAEIVCGLQFLH--SKGIIY 119
Query: 629 RDLKSSNLLVDKHWTVKVGDFGLSR 653
RDLK N+++D+ +K+ DFG+ +
Sbjct: 120 RDLKLDNVMLDRDGHIKIADFGMCK 144
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 5e-05
Identities = 42/170 (24%), Positives = 77/170 (45%), Gaps = 39/170 (22%)
Query: 510 GEQIGQGSCGTVYHAVWYGSDVAVKVFSRQEYSDEVIHSFRQ------------EVSLMK 557
G ++G+G+ G VY A R++ DE ++ +Q E++L++
Sbjct: 6 GCKVGRGTYGHVYKA------------KRKDGKDEKEYALKQIEGTGISMSACREIALLR 53
Query: 558 RLRHPNVLLFMGAVT--SPQRLCIVTEFLPRG-----SLFRLLQRNTTKLDWRRRILMAL 610
L+HPNV+ S +++ ++ ++ R + N + R ++ +L
Sbjct: 54 ELKHPNVIALQKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSL 113
Query: 611 --DIARGVSYLHHCNPPIIHRDLKSSNLLV----DKHWTVKVGDFGLSRL 654
I G+ YLH ++HRDLK +N+LV + VK+ D G +RL
Sbjct: 114 LYQILDGIHYLH--ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARL 161
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 5e-05
Identities = 47/165 (28%), Positives = 78/165 (47%), Gaps = 7/165 (4%)
Query: 513 IGQGSCGTVYHAVWYGSD--VAVKVFSRQ-EYSDEVIHSFRQEVSLMKRLR-HPNVLLFM 568
IG+GS V +D A+KV ++ + DE I + E + ++ +P ++
Sbjct: 3 IGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLH 62
Query: 569 GAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIH 628
+ RL +V E++ G L +QR KL A +I +++LH II+
Sbjct: 63 SCFQTTSRLFLVIEYVNGGDLMFHMQRQR-KLPEEHARFYAAEICIALNFLHERG--IIY 119
Query: 629 RDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTVTYLA 673
RDLK N+L+D +K+ D+G+ + TT T GT Y+A
Sbjct: 120 RDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIA 164
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|237847 PRK14879, PRK14879, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 44.1 bits (105), Expect = 8e-05
Identities = 40/158 (25%), Positives = 64/158 (40%), Gaps = 28/158 (17%)
Query: 513 IGQGSCGTVYHAVWYGSDVAVKVFSRQEYS----DEVIHSFR--QEVSLMKRLRH----- 561
I +G+ +Y + G +K + Y DE I R +E +M R R
Sbjct: 4 IKRGAEAEIYLGDFLGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNV 63
Query: 562 PNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHH 621
P V P+ IV E++ L L+ N + ++ +I R V LH
Sbjct: 64 PAVYFV-----DPENFIIVMEYIEGEPLKDLINSNGMEELE-----LSREIGRLVGKLHS 113
Query: 622 CNPPIIHRDLKSSNLLV--DKHWTVKVGDFGLSRLKHE 657
IIH DL +SN+++ K + + DFGL+ +
Sbjct: 114 AG--IIHGDLTTSNMILSGGKIYLI---DFGLAEFSKD 146
|
Length = 211 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 44.7 bits (105), Expect = 1e-04
Identities = 40/150 (26%), Positives = 65/150 (43%), Gaps = 6/150 (4%)
Query: 505 EDLTIGEQIGQGSCGTV--YHAVWYGSDVAVKVFSRQEY-SDEVIHSFRQEVSLMKRLRH 561
ED + IG+G+ G V G A+K+ + + E + R E ++
Sbjct: 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADS 60
Query: 562 PNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHH 621
V+ + L ++ EFLP G + LL + T + + +A + + +H
Sbjct: 61 LWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIA-ETVLAIDSIHQ 119
Query: 622 CNPPIIHRDLKSSNLLVDKHWTVKVGDFGL 651
IHRD+K NLL+D VK+ DFGL
Sbjct: 120 LG--FIHRDIKPDNLLLDSKGHVKLSDFGL 147
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|236901 PRK11360, PRK11360, sensory histidine kinase AtoS; Provisional | Back alignment and domain information |
|---|
Score = 45.0 bits (107), Expect = 1e-04
Identities = 19/108 (17%), Positives = 43/108 (39%), Gaps = 4/108 (3%)
Query: 134 NILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVH 193
IL+S+ V D +I N +AE++ G E +G+ EL F +
Sbjct: 266 LILESIADGVIAIDRQGKITTMNPAAEVITGLQRHELVGKPYSELFPPNTPF---ASPLL 322
Query: 194 R-IKMGERWTGQFPAKTKTEERVLVVATNTPFYDDDGTLVGIVCVSTD 240
++ G + + + + + + ++ G ++G + + +D
Sbjct: 323 DTLEHGTEHVDLEISFPGRDRTIELSVSTSLLHNTHGEMIGALVIFSD 370
|
Length = 607 |
| >gnl|CDD|226168 COG3642, COG3642, Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Score = 43.4 bits (103), Expect = 1e-04
Identities = 33/151 (21%), Positives = 55/151 (36%), Gaps = 25/151 (16%)
Query: 513 IGQGSCGTVYHAVWYGSDVAVKVFSRQEYSDEVI------HSFRQEVSLMKRLRHPNV-- 564
I QG+ +Y + G VK + Y + R+E ++ + R V
Sbjct: 4 IKQGAEAIIYLTDFLGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPV 63
Query: 565 --LLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHC 622
+ P IV E++ G L + R + ++ R V LH
Sbjct: 64 PIVYD----VDPDNGLIVMEYIE-GELLK-------DALEEARPDLLREVGRLVGKLHKA 111
Query: 623 NPPIIHRDLKSSNLLVDKHWTVKVGDFGLSR 653
I+H DL +SN+++ + DFGL
Sbjct: 112 G--IVHGDLTTSNIILSGGRIYFI-DFGLGE 139
|
Length = 204 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 1e-04
Identities = 29/105 (27%), Positives = 56/105 (53%), Gaps = 7/105 (6%)
Query: 550 RQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSL-FRLLQRNT-TKLDWRRRIL 607
R +SL+ P ++ A +P +L + + + G L + L Q ++ + R
Sbjct: 45 RIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMR---F 101
Query: 608 MALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLS 652
A +I G+ ++H N +++RDLK +N+L+D+H V++ D GL+
Sbjct: 102 YAAEIILGLEHMH--NRFVVYRDLKPANILLDEHGHVRISDLGLA 144
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 1e-04
Identities = 32/123 (26%), Positives = 59/123 (47%), Gaps = 4/123 (3%)
Query: 552 EVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSL-FRLLQRNTTKLDWRRRILMAL 610
E +++++ V+ A + LC+V + G L F + + R + A
Sbjct: 50 EKQILEKVNSQFVVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAA 109
Query: 611 DIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTVT 670
+I G+ LH N ++RDLK N+L+D + +++ D GL+ +K + + GTV
Sbjct: 110 EILCGLEDLHREN--TVYRDLKPENILLDDYGHIRISDLGLA-VKIPEGESIRGRVGTVG 166
Query: 671 YLA 673
Y+A
Sbjct: 167 YMA 169
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 2e-04
Identities = 26/77 (33%), Positives = 40/77 (51%), Gaps = 3/77 (3%)
Query: 575 QRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSS 634
+ L ++ EFLP G + LL + T + + +A + + +H IHRD+K
Sbjct: 74 RNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIA-ETVLAIDAIHQLG--FIHRDIKPD 130
Query: 635 NLLVDKHWTVKVGDFGL 651
NLL+D VK+ DFGL
Sbjct: 131 NLLLDAKGHVKLSDFGL 147
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 2e-04
Identities = 38/127 (29%), Positives = 56/127 (44%), Gaps = 13/127 (10%)
Query: 482 STSSSAVNKVDLDNDCLDYEILWE----DLTIGEQIGQGSCGTVYHAVWYG-------SD 530
S SS + +D L Y+ WE +L +G +G G+ G V A +G
Sbjct: 10 SVSSDGHEYIYVDPMQLPYDSAWEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMK 69
Query: 531 VAVKVFSRQEYSDEVIHSFRQEVSLMKRL-RHPNVLLFMGAVTSPQRLCIVTEFLPRGSL 589
VAVK+ S E + E+ +M L H N++ +GA T + I+TE+ G L
Sbjct: 70 VAVKMLKSTARSSEK-QALMSELKIMSHLGPHLNIVNLLGACTKGGPIYIITEYCRYGDL 128
Query: 590 FRLLQRN 596
L RN
Sbjct: 129 VDYLHRN 135
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 3e-04
Identities = 41/170 (24%), Positives = 77/170 (45%), Gaps = 39/170 (22%)
Query: 510 GEQIGQGSCGTVYHAVWYGSDVAVKVFSRQEYSDEVIHSFRQ------------EVSLMK 557
G ++G+G+ G VY A R++ D+ ++ +Q E++L++
Sbjct: 6 GCKVGRGTYGHVYKA------------KRKDGKDDRDYALKQIEGTGISMSACREIALLR 53
Query: 558 RLRHPNVLLFMGAVTS--PQRLCIVTEFLPRG-----SLFRLLQRNTTKLDWRRRILMAL 610
L+HPNV+ S +++ ++ ++ R + N + R ++ +L
Sbjct: 54 ELKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSL 113
Query: 611 --DIARGVSYLHHCNPPIIHRDLKSSNLLV----DKHWTVKVGDFGLSRL 654
I G+ YLH ++HRDLK +N+LV + VK+ D G +RL
Sbjct: 114 LYQILDGIHYLH--ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARL 161
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 3e-04
Identities = 45/176 (25%), Positives = 79/176 (44%), Gaps = 12/176 (6%)
Query: 505 EDLTIGEQIGQGSCGTVYHAVWYGSD--VAVKVFSRQEYSDEV-IHSFRQEVSLMKRLRH 561
ED I + IG+G+ G V +D A+K+ ++ E FR+E ++ +
Sbjct: 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDN 60
Query: 562 PNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKL--DWRRRILMALDIA-RGVSY 618
+ A L +V ++ G L LL + +L D R L + IA V
Sbjct: 61 QWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQ 120
Query: 619 LHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLS-RLKHETYLTTKTGKGTVTYLA 673
LH+ +HRD+K N+L+D + +++ DFG +L + + + GT Y++
Sbjct: 121 LHY-----VHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYIS 171
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 4e-04
Identities = 23/75 (30%), Positives = 39/75 (52%), Gaps = 3/75 (4%)
Query: 577 LCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNL 636
L V +++P G + LL R + R +A ++ + +H IHRD+K N+
Sbjct: 76 LYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIA-ELTCAIESVH--KMGFIHRDIKPDNI 132
Query: 637 LVDKHWTVKVGDFGL 651
L+D+ +K+ DFGL
Sbjct: 133 LIDRDGHIKLTDFGL 147
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 5e-04
Identities = 30/98 (30%), Positives = 47/98 (47%), Gaps = 4/98 (4%)
Query: 577 LCIVTEFLPRGSL-FRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSN 635
LC+V + G L F + D +R I A ++ G+ L I++RDLK N
Sbjct: 75 LCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQR--ERIVYRDLKPEN 132
Query: 636 LLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTVTYLA 673
+L+D +++ D GL+ E T + GTV Y+A
Sbjct: 133 ILLDDRGHIRISDLGLAVQIPEGE-TVRGRVGTVGYMA 169
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 0.001
Identities = 30/110 (27%), Positives = 52/110 (47%), Gaps = 13/110 (11%)
Query: 498 LDYEILWE----DLTIGEQIGQGSCGTVYHAVWYG-------SDVAVKVFSRQEYSDEVI 546
L Y WE +L G+ +G G+ G V A +G VAVK+ ++DE
Sbjct: 27 LPYNEKWEFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDER- 85
Query: 547 HSFRQEVSLMKRL-RHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQR 595
+ E+ ++ L +H N++ +GA T + ++TE+ G L L++
Sbjct: 86 EALMSELKILSHLGQHKNIVNLLGACTHGGPVLVITEYCCYGDLLNFLRK 135
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|219844 pfam08447, PAS_3, PAS fold | Back alignment and domain information |
|---|
Score = 38.1 bits (89), Expect = 0.001
Identities = 26/100 (26%), Positives = 42/100 (42%), Gaps = 25/100 (25%)
Query: 152 IIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVH--------------RIKM 197
IIYW+ E + GY+ E EL + + D+VH +K
Sbjct: 1 IIYWSPRFEEILGYTPE--------ELKSSYEGW---LDLVHPEDRERVRRALQEFSLKK 49
Query: 198 GERWTGQFPAKTKTEERVLVVATNTPFYDDDGTLVGIVCV 237
GE ++G++ + K E V A P D++G V ++ V
Sbjct: 50 GEPYSGEYRIRRKDGEYRWVEARGRPIRDENGKPVRVIGV 89
|
The PAS fold corresponds to the structural domain that has previously been defined as PAS and PAC motifs. The PAS fold appears in archaea, eubacteria and eukarya. Length = 90 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 0.001
Identities = 37/131 (28%), Positives = 67/131 (51%), Gaps = 15/131 (11%)
Query: 550 RQEVSLMKRLRH-PNVLLFMGAVTSPQRLCIVTEFLPRGSLF-RLLQRNTTKLDWRR--- 604
R E ++++ +R P ++ A + +L ++ +++ G +F L QR+ D R
Sbjct: 52 RTERNVLEHVRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYS 111
Query: 605 -RILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSR-LKHETYLTT 662
I++AL+ +LH I++RD+K N+L+D V + DFGLS+ E T
Sbjct: 112 GEIILALE------HLHKLG--IVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERT 163
Query: 663 KTGKGTVTYLA 673
+ GT+ Y+A
Sbjct: 164 YSFCGTIEYMA 174
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 41.4 bits (97), Expect = 0.001
Identities = 47/188 (25%), Positives = 80/188 (42%), Gaps = 48/188 (25%)
Query: 478 SSCGSTSS----SAVNKVDLDNDCLDYEILWEDLTIGEQIGQGSCGTVYHAVWYGSD--- 530
C +TSS S V + Y IL + GS G V+ +G +
Sbjct: 76 EPCETTSSSDPASVVR--------MQYNIL-------SSLTPGSEGEVFVCTKHGDEQRK 120
Query: 531 -VAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLP--RG 587
V VK + + + +E+ ++K + H ++ + A +C+V +P +
Sbjct: 121 KVIVKAVTGGK-------TPGREIDILKTISHRAIINLIHAYRWKSTVCMV---MPKYKC 170
Query: 588 SLFRLLQRNT-----TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHW 642
LF + R+ + +RR+L AL +YLH IIHRD+K+ N+ +D+
Sbjct: 171 DLFTYVDRSGPLPLEQAITIQRRLLEAL------AYLH--GRGIIHRDVKTENIFLDEPE 222
Query: 643 TVKVGDFG 650
+GDFG
Sbjct: 223 NAVLGDFG 230
|
Length = 392 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 40.6 bits (95), Expect = 0.002
Identities = 28/100 (28%), Positives = 44/100 (44%), Gaps = 5/100 (5%)
Query: 577 LCIVTEFLPRGSL-FRL--LQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKS 633
LC+V + G L + + + R I G+ +LH II+RDLK
Sbjct: 68 LCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR--IIYRDLKP 125
Query: 634 SNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTVTYLA 673
N+L+D V++ D GL+ + TK GT ++A
Sbjct: 126 ENVLLDNDGNVRISDLGLAVELKDGQSKTKGYAGTPGFMA 165
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 40.6 bits (95), Expect = 0.002
Identities = 35/150 (23%), Positives = 73/150 (48%), Gaps = 21/150 (14%)
Query: 511 EQIGQGSCGTVYHAV---------WYGSDVAVKVF--SRQEYSDEVIHSFRQEVSLMKRL 559
E +GQG+ ++ + + ++V +KV S + YS+ SF + S+M +L
Sbjct: 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSE----SFFEAASMMSQL 56
Query: 560 RHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSY- 618
H +++L G +V E++ GSL L++N ++ I L++A+ +++
Sbjct: 57 SHKHLVLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLIN----ISWKLEVAKQLAWA 112
Query: 619 LHHC-NPPIIHRDLKSSNLLVDKHWTVKVG 647
LH + + H ++ + N+L+ + K G
Sbjct: 113 LHFLEDKGLTHGNVCAKNVLLIREEDRKTG 142
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 41.0 bits (96), Expect = 0.002
Identities = 23/59 (38%), Positives = 38/59 (64%), Gaps = 5/59 (8%)
Query: 619 LHHCNPP-IIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGK---GTVTYLA 673
+HH + +IHRD+KS+N+L+ + VK+GDFG S++ T ++ G+ GT Y+A
Sbjct: 156 VHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAAT-VSDDVGRTFCGTPYYVA 213
|
Length = 496 |
| >gnl|CDD|234331 TIGR03724, arch_bud32, Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Score = 39.1 bits (92), Expect = 0.003
Identities = 41/154 (26%), Positives = 60/154 (38%), Gaps = 31/154 (20%)
Query: 513 IGQGSCGTVYHAVWYGSDVAVKVFSRQEYS----DEVIHSFR--QEVSLMKRLRH----- 561
I +G+ +Y + G +K + Y DE I R E L+ R R
Sbjct: 2 IAKGAEAIIYLGDFLGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNT 61
Query: 562 PNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHH 621
P V P IV E++ G + + D R +I R V LH
Sbjct: 62 PVVYDV-----DPDNKTIVMEYIE-GKPLKDV--IEEGNDELLR-----EIGRLVGKLHK 108
Query: 622 CNPPIIHRDLKSSNLLV--DKHWTVKVGDFGLSR 653
I+H DL +SN++V DK + + DFGL +
Sbjct: 109 AG--IVHGDLTTSNIIVRDDKLYLI---DFGLGK 137
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine [Unknown function, General]. Length = 199 |
| >gnl|CDD|183097 PRK11359, PRK11359, cyclic-di-GMP phosphodiesterase; Provisional | Back alignment and domain information |
|---|
Score = 40.5 bits (95), Expect = 0.003
Identities = 24/99 (24%), Positives = 41/99 (41%), Gaps = 1/99 (1%)
Query: 143 VHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGERW- 201
V + D RI+ NR+ ++GY EA G LL + ++
Sbjct: 149 VIVLDPERRIVQCNRAFTEMFGYCISEASGMQPDTLLNIPEFPADNRIRLQQLLWKTARD 208
Query: 202 TGQFPAKTKTEERVLVVATNTPFYDDDGTLVGIVCVSTD 240
+F T+T E++ + A+ +P YD L +V +D
Sbjct: 209 QDEFLLLTRTGEKIWIKASISPVYDVLAHLQNLVMTFSD 247
|
Length = 799 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 39.9 bits (93), Expect = 0.003
Identities = 27/114 (23%), Positives = 57/114 (50%), Gaps = 7/114 (6%)
Query: 528 GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRG 587
G V V+ + + ++E++ + E+ + K HPN++ + + L +VT F+ G
Sbjct: 25 GEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYG 84
Query: 588 SLFRLLQRNTTKLDWRRRILMA---LDIARGVSYLHHCNPPIIHRDLKSSNLLV 638
S L+ T +D + +A + + + Y+HH +HR +K+S++L+
Sbjct: 85 SAKDLI--CTHFMDGMSELAIAYILQGVLKALDYIHHMG--YVHRSVKASHILI 134
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 0.004
Identities = 33/131 (25%), Positives = 65/131 (49%), Gaps = 15/131 (11%)
Query: 550 RQEVSLMKRLRH-PNVLLFMGAVTSPQRLCIVTEFLPRGSLF-RLLQRNTTKLDWRRRIL 607
R E +++ +R P ++ A + +L ++ +++ G LF L QR + + +
Sbjct: 52 RTERQVLEHIRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQR--ERFKEQEVQI 109
Query: 608 MALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGK- 666
+ +I + +LH II+RD+K N+L+D + V + DFGLS+ + + +
Sbjct: 110 YSGEIVLALEHLHKLG--IIYRDIKLENILLDSNGHVVLTDFGLSK----EFHEDEVERA 163
Query: 667 ----GTVTYLA 673
GT+ Y+A
Sbjct: 164 YSFCGTIEYMA 174
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 39.4 bits (92), Expect = 0.004
Identities = 19/48 (39%), Positives = 31/48 (64%), Gaps = 2/48 (4%)
Query: 606 ILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSR 653
I + +ARG+ +L + IHRDL + N+L+ ++ VK+ DFGL+R
Sbjct: 176 ISYSFQVARGMEFL--ASRKCIHRDLAARNILLSENNVVKICDFGLAR 221
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
Conserved Domains Detected by HHsearch 
Original result of HHsearch against CDD database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 674 | |||
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 99.98 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 99.97 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 99.97 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 99.97 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 99.97 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 99.97 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 99.97 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 99.96 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 99.96 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 99.96 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 99.96 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 99.96 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 99.96 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 99.96 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 99.96 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 99.96 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 99.95 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 99.95 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 99.95 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 99.95 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 99.95 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 99.95 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 99.95 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 99.95 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 99.95 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 99.95 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 99.95 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 99.95 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 99.95 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.95 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 99.95 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 99.95 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 99.95 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 99.95 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 99.95 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 99.95 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 99.95 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 99.95 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 99.95 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 99.95 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 99.95 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 99.95 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 99.95 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 99.95 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 99.95 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 99.95 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 99.95 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 99.94 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 99.94 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 99.94 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 99.94 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 99.94 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 99.94 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 99.94 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 99.94 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 99.94 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 99.94 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 99.94 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 99.94 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 99.94 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 99.94 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 99.94 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 99.94 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 99.94 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 99.94 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 99.94 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.94 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 99.94 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 99.94 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 99.94 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 99.94 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 99.94 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 99.94 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 99.94 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.94 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 99.94 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 99.94 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 99.94 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 99.94 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 99.94 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 99.94 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 99.93 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.93 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 99.93 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 99.93 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 99.93 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 99.93 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 99.93 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 99.93 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 99.93 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 99.93 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 99.93 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 99.93 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 99.93 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 99.93 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 99.93 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 99.93 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 99.93 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 99.93 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 99.93 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 99.93 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 99.93 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 99.93 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 99.93 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 99.93 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 99.93 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 99.93 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 99.93 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 99.93 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.93 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 99.93 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 99.93 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 99.93 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 99.93 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 99.93 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 99.92 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 99.92 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 99.92 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 99.92 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 99.92 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 99.92 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 99.92 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 99.92 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 99.92 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.92 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 99.92 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 99.92 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 99.92 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 99.92 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 99.92 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 99.92 | |
| PTZ00284 | 467 | protein kinase; Provisional | 99.92 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 99.92 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 99.92 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 99.92 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 99.92 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 99.92 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 99.92 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 99.92 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 99.92 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 99.92 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 99.92 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 99.92 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 99.92 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 99.92 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 99.92 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 99.92 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 99.92 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 99.92 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 99.92 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.92 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 99.92 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 99.92 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.92 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 99.92 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 99.92 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 99.92 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 99.92 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 99.92 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 99.92 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 99.92 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 99.92 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 99.92 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 99.92 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 99.92 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 99.92 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 99.91 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 99.91 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 99.91 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 99.91 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 99.91 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 99.91 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 99.91 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 99.91 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 99.91 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 99.91 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 99.91 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 99.91 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 99.91 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 99.91 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 99.91 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 99.91 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 99.91 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 99.91 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 99.91 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 99.91 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 99.91 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 99.91 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.91 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 99.91 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 99.91 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 99.91 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.91 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 99.91 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 99.91 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 99.91 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 99.91 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 99.91 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.91 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 99.91 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 99.91 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 99.91 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 99.91 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 99.91 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 99.91 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 99.91 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 99.91 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 99.91 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 99.91 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 99.91 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 99.91 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 99.91 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 99.91 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 99.91 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 99.91 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 99.91 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 99.91 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 99.91 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 99.91 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 99.91 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 99.91 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 99.91 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 99.91 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 99.91 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 99.91 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 99.91 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 99.91 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 99.91 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 99.91 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 99.91 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 99.91 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 99.91 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 99.91 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 99.9 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 99.9 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.9 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 99.9 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 99.9 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 99.9 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 99.9 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 99.9 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 99.9 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 99.9 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 99.9 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 99.9 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 99.9 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 99.9 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 99.9 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 99.9 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 99.9 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 99.9 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 99.9 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 99.9 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 99.9 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 99.9 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 99.9 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 99.9 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 99.9 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 99.9 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 99.9 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.9 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 99.9 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 99.9 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 99.9 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 99.9 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 99.9 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 99.9 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 99.9 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 99.9 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 99.9 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.9 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 99.9 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 99.9 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 99.9 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 99.9 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 99.9 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 99.9 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 99.9 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 99.9 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 99.9 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 99.9 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 99.9 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 99.9 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 99.9 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 99.9 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 99.9 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 99.9 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 99.9 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 99.9 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 99.9 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 99.9 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 99.9 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 99.9 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 99.9 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 99.9 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 99.89 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 99.89 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 99.89 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 99.89 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 99.89 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 99.89 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 99.89 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 99.89 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 99.89 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 99.89 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 99.89 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 99.89 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 99.89 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 99.89 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.89 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 99.89 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 99.89 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 99.89 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 99.89 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.89 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.89 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 99.89 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 99.89 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.89 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 99.89 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 99.89 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 99.89 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 99.89 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 99.89 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 99.89 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 99.89 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 99.89 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 99.89 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.89 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 99.89 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 99.89 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 99.89 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 99.89 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 99.89 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 99.88 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.88 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 99.88 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 99.88 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.88 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 99.88 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 99.88 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 99.88 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 99.88 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.88 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 99.88 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.88 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 99.88 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.88 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 99.88 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.88 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 99.88 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 99.87 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.87 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 99.87 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.87 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 99.87 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 99.87 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 99.87 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 99.87 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 99.87 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.87 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.87 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 99.87 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.87 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.87 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.87 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 99.87 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.87 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.86 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.86 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 99.86 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.86 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.85 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.85 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.85 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.85 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.85 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.85 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.84 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.84 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.84 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.82 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.82 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.82 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.81 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.81 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.81 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.8 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.8 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.8 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.79 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.79 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.79 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.77 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.77 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.77 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.77 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.76 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.76 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.75 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.73 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.73 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.71 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.71 | |
| PF13426 | 104 | PAS_9: PAS domain; PDB: 3ULF_B 3UE6_E 2Z6D_B 2Z6C_ | 99.7 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.67 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.66 | |
| PF08448 | 110 | PAS_4: PAS fold; InterPro: IPR013656 The PAS fold | 99.65 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.64 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.64 | |
| PF00989 | 113 | PAS: PAS fold; InterPro: IPR013767 PAS domains are | 99.63 | |
| PRK11091 | 779 | aerobic respiration control sensor protein ArcB; P | 99.6 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.58 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.58 | |
| COG3829 | 560 | RocR Transcriptional regulator containing PAS, AAA | 99.56 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.54 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.52 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.51 | |
| PRK13557 | 540 | histidine kinase; Provisional | 99.5 | |
| PRK13559 | 361 | hypothetical protein; Provisional | 99.49 | |
| PRK10060 | 663 | RNase II stability modulator; Provisional | 99.44 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.42 | |
| PRK10820 | 520 | DNA-binding transcriptional regulator TyrR; Provis | 99.39 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.37 | |
| PRK09776 | 1092 | putative diguanylate cyclase; Provisional | 99.36 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.34 | |
| TIGR02938 | 494 | nifL_nitrog nitrogen fixation negative regulator N | 99.33 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.32 | |
| TIGR00229 | 124 | sensory_box PAS domain S-box. The PAS domain was p | 99.32 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.3 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.3 | |
| PRK13560 | 807 | hypothetical protein; Provisional | 99.29 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.23 | |
| TIGR02040 | 442 | PpsR-CrtJ transcriptional regulator PpsR. This mod | 99.22 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.22 | |
| PRK13558 | 665 | bacterio-opsin activator; Provisional | 99.22 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.2 | |
| PRK09776 | 1092 | putative diguanylate cyclase; Provisional | 99.19 | |
| PRK11073 | 348 | glnL nitrogen regulation protein NR(II); Provision | 99.18 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.16 | |
| TIGR02966 | 333 | phoR_proteo phosphate regulon sensor kinase PhoR. | 99.15 | |
| PRK11360 | 607 | sensory histidine kinase AtoS; Provisional | 99.13 | |
| PF13596 | 106 | PAS_10: PAS domain; PDB: 3CAX_A 2QKP_D. | 99.09 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.09 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.08 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.07 | |
| PRK13560 | 807 | hypothetical protein; Provisional | 99.06 | |
| PRK11359 | 799 | cyclic-di-GMP phosphodiesterase; Provisional | 99.05 | |
| cd00130 | 103 | PAS PAS domain; PAS motifs appear in archaea, euba | 99.04 | |
| PRK11388 | 638 | DNA-binding transcriptional regulator DhaR; Provis | 99.03 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.03 | |
| PF08447 | 91 | PAS_3: PAS fold; InterPro: IPR013655 The PAS fold | 99.01 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 98.99 | |
| PF12860 | 115 | PAS_7: PAS fold | 98.89 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.89 | |
| PRK11086 | 542 | sensory histidine kinase DcuS; Provisional | 98.88 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 98.86 | |
| PRK11359 | 799 | cyclic-di-GMP phosphodiesterase; Provisional | 98.79 | |
| COG5002 | 459 | VicK Signal transduction histidine kinase [Signal | 98.79 | |
| TIGR02040 | 442 | PpsR-CrtJ transcriptional regulator PpsR. This mod | 98.75 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.75 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.74 | |
| PRK11006 | 430 | phoR phosphate regulon sensor protein; Provisional | 98.71 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.67 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 98.66 | |
| COG3283 | 511 | TyrR Transcriptional regulator of aromatic amino a | 98.63 | |
| TIGR02938 | 494 | nifL_nitrog nitrogen fixation negative regulator N | 98.59 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 98.59 | |
| COG3290 | 537 | CitA Signal transduction histidine kinase regulati | 98.52 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.5 | |
| COG5000 | 712 | NtrY Signal transduction histidine kinase involved | 98.48 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.46 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.44 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.42 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.38 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 98.38 | |
| PRK15053 | 545 | dpiB sensor histidine kinase DpiB; Provisional | 98.37 | |
| PF14598 | 111 | PAS_11: PAS domain; PDB: 1P97_A 3F1O_A 2A24_A 3H7W | 98.34 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.33 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.31 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.3 | |
| KOG0501 | 971 | consensus K+-channel KCNQ [Inorganic ion transport | 98.28 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.26 | |
| COG2202 | 232 | AtoS FOG: PAS/PAC domain [Signal transduction mech | 98.22 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.2 | |
| COG3852 | 363 | NtrB Signal transduction histidine kinase, nitroge | 98.2 | |
| PF13188 | 64 | PAS_8: PAS domain; PDB: 2JHE_D 3VOL_A. | 98.14 | |
| PRK09959 | 1197 | hybrid sensory histidine kinase in two-component r | 98.07 |
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-36 Score=309.25 Aligned_cols=167 Identities=27% Similarity=0.510 Sum_probs=153.3
Q ss_pred cCCeeEeeeecccCceEEEEEEE--cCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeEEEEE
Q 005841 504 WEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVT 581 (674)
Q Consensus 504 ~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 581 (674)
..+|.+.+.||.|+|++||+|++ ++..||||.+.+..+..+..+.+..||++|+.++|||||.+++++..++++||||
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM 88 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM 88 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence 46899999999999999999998 4678999999998888888899999999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCC------CcEEEEecCCcccc
Q 005841 582 EFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKH------WTVKVGDFGLSRLK 655 (674)
Q Consensus 582 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~------~~vkL~DFGla~~~ 655 (674)
|||+||+|.+||++. ..+++..+..++.||+.||++||+++ ||||||||.||||+.. -.+||+|||+|+.+
T Consensus 89 EyC~gGDLs~yi~~~-~~l~e~t~r~Fm~QLA~alq~L~~~~--IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L 165 (429)
T KOG0595|consen 89 EYCNGGDLSDYIRRR-GRLPEATARHFMQQLASALQFLHENN--IIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFL 165 (429)
T ss_pred EeCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCCcceEEeccCCCCCCCceEEecccchhhhC
Confidence 999999999999864 47999999999999999999999999 9999999999999754 45899999999998
Q ss_pred cCCccccccCCCCccccCC
Q 005841 656 HETYLTTKTGKGTVTYLAS 674 (674)
Q Consensus 656 ~~~~~~~~~~~GTp~YmAP 674 (674)
.... ...+.||+|.||||
T Consensus 166 ~~~~-~a~tlcGSplYMAP 183 (429)
T KOG0595|consen 166 QPGS-MAETLCGSPLYMAP 183 (429)
T ss_pred Cchh-HHHHhhCCccccCH
Confidence 8543 44568999999999
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=302.90 Aligned_cols=170 Identities=29% Similarity=0.470 Sum_probs=157.0
Q ss_pred cccCCeeEeeeecccCceEEEEEEE--cCCeEEEEEeecccCCH-HHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeEE
Q 005841 502 ILWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSD-EVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLC 578 (674)
Q Consensus 502 ~~~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 578 (674)
...++|+++++||+|+||+||.++. +++-||+|+++|..... ........|..||..++||+||.++..|++..++|
T Consensus 22 ~~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLy 101 (357)
T KOG0598|consen 22 VGPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLY 101 (357)
T ss_pred CChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEE
Confidence 4457899999999999999999986 57779999999887643 45677889999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccccCC
Q 005841 579 IVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHET 658 (674)
Q Consensus 579 lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~~ 658 (674)
||+||++||.|+.+|++ ...|++..+.+|+++|+.||.|||+.+ ||||||||+|||+|..|+|+|+|||||+.....
T Consensus 102 lVld~~~GGeLf~hL~~-eg~F~E~~arfYlaEi~lAL~~LH~~g--IiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~ 178 (357)
T KOG0598|consen 102 LVLDYLNGGELFYHLQR-EGRFSEDRARFYLAEIVLALGYLHSKG--IIYRDLKPENILLDEQGHIKLTDFGLCKEDLKD 178 (357)
T ss_pred EEEeccCCccHHHHHHh-cCCcchhHHHHHHHHHHHHHHHHHhCC--eeeccCCHHHeeecCCCcEEEeccccchhcccC
Confidence 99999999999999976 457999999999999999999999999 999999999999999999999999999988777
Q ss_pred ccccccCCCCccccCC
Q 005841 659 YLTTKTGKGTVTYLAS 674 (674)
Q Consensus 659 ~~~~~~~~GTp~YmAP 674 (674)
...+.++|||+.||||
T Consensus 179 ~~~t~tfcGT~eYmAP 194 (357)
T KOG0598|consen 179 GDATRTFCGTPEYMAP 194 (357)
T ss_pred CCccccccCCccccCh
Confidence 7788889999999999
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-34 Score=294.64 Aligned_cols=169 Identities=28% Similarity=0.457 Sum_probs=149.7
Q ss_pred cccCCeeEeeeecccCceEEEEEEE--cCCeEEEEEeecccCCH-----HHHHHHHHHHHHHhhCCCCCeeeEEEEEecC
Q 005841 502 ILWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSD-----EVIHSFRQEVSLMKRLRHPNVLLFMGAVTSP 574 (674)
Q Consensus 502 ~~~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~~~-----~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~ 574 (674)
...+.|.+.+.||+|+||.|.+|.. +++.||||+++++.... .....+.+|++||++|+|||||+++++|..+
T Consensus 169 s~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ 248 (475)
T KOG0615|consen 169 SFNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVP 248 (475)
T ss_pred hhcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecC
Confidence 3557799999999999999999986 67889999999876543 1223467999999999999999999999999
Q ss_pred CeEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCC---CcEEEEecCC
Q 005841 575 QRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKH---WTVKVGDFGL 651 (674)
Q Consensus 575 ~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~---~~vkL~DFGl 651 (674)
+..||||||+.||+|++.+-. +..+.+.....+++|++.||.|||+.| |+||||||+|||++.+ ..+||+|||+
T Consensus 249 ds~YmVlE~v~GGeLfd~vv~-nk~l~ed~~K~~f~Qll~avkYLH~~G--I~HRDiKPeNILl~~~~e~~llKItDFGl 325 (475)
T KOG0615|consen 249 DSSYMVLEYVEGGELFDKVVA-NKYLREDLGKLLFKQLLTAVKYLHSQG--IIHRDIKPENILLSNDAEDCLLKITDFGL 325 (475)
T ss_pred CceEEEEEEecCccHHHHHHh-ccccccchhHHHHHHHHHHHHHHHHcC--cccccCCcceEEeccCCcceEEEecccch
Confidence 999999999999999999865 446888999999999999999999999 9999999999999865 7899999999
Q ss_pred cccccCCccccccCCCCccccCC
Q 005841 652 SRLKHETYLTTKTGKGTVTYLAS 674 (674)
Q Consensus 652 a~~~~~~~~~~~~~~GTp~YmAP 674 (674)
|+...+.. .+.++||||.|.||
T Consensus 326 AK~~g~~s-fm~TlCGTpsYvAP 347 (475)
T KOG0615|consen 326 AKVSGEGS-FMKTLCGTPSYVAP 347 (475)
T ss_pred hhccccce-ehhhhcCCccccCh
Confidence 99987544 45679999999999
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-34 Score=283.42 Aligned_cols=167 Identities=30% Similarity=0.453 Sum_probs=153.5
Q ss_pred cccCCeeEeeeecccCceEEEEEEE--cCCeEEEEEeecccCC-HHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeEE
Q 005841 502 ILWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYS-DEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLC 578 (674)
Q Consensus 502 ~~~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 578 (674)
...++|+++..||.|+||+|.+++. .+..||+|+++++..- .+.++-..+|..+|+.+.||+++++++.+.+.+++|
T Consensus 41 ~~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~ly 120 (355)
T KOG0616|consen 41 YSLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLY 120 (355)
T ss_pred cchhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEE
Confidence 4457899999999999999999987 5677999999987753 367788899999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccccCC
Q 005841 579 IVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHET 658 (674)
Q Consensus 579 lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~~ 658 (674)
|||||++||.|+.+|++ .++|++..+.+|+.||+.||+|||.++ ||+|||||+|||||++|.+||+|||+|+.....
T Consensus 121 mvmeyv~GGElFS~Lrk-~~rF~e~~arFYAAeivlAleylH~~~--iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r 197 (355)
T KOG0616|consen 121 MVMEYVPGGELFSYLRK-SGRFSEPHARFYAAEIVLALEYLHSLD--IIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR 197 (355)
T ss_pred EEEeccCCccHHHHHHh-cCCCCchhHHHHHHHHHHHHHHHHhcC--eeeccCChHHeeeccCCcEEEEeccceEEecCc
Confidence 99999999999999976 458999999999999999999999999 999999999999999999999999999977654
Q ss_pred ccccccCCCCccccCC
Q 005841 659 YLTTKTGKGTVTYLAS 674 (674)
Q Consensus 659 ~~~~~~~~GTp~YmAP 674 (674)
+.+.||||.|+||
T Consensus 198 ---T~TlCGTPeYLAP 210 (355)
T KOG0616|consen 198 ---TWTLCGTPEYLAP 210 (355)
T ss_pred ---EEEecCCccccCh
Confidence 6678999999999
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=305.67 Aligned_cols=167 Identities=32% Similarity=0.475 Sum_probs=155.7
Q ss_pred CCeeEeeeecccCceEEEEEEE--cCCeEEEEEeecccC-CHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeEEEEE
Q 005841 505 EDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEY-SDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVT 581 (674)
Q Consensus 505 ~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 581 (674)
.+|+.++.||+|+|++||.+++ +|..||+|++.+... .....+++.+||+|.+.|+|||||+|+++|++.+++|||+
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 6799999999999999999987 688899999988665 3466788999999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccccCCccc
Q 005841 582 EFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLT 661 (674)
Q Consensus 582 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~~~~~ 661 (674)
|+|..++|..+++ .+..++|.++++|++||+.||.|||+++ |||||||..|||++++.+|||+|||||..+..+.-.
T Consensus 98 ELC~~~sL~el~K-rrk~ltEpEary~l~QIv~GlkYLH~~~--IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~Er 174 (592)
T KOG0575|consen 98 ELCHRGSLMELLK-RRKPLTEPEARYFLRQIVEGLKYLHSLG--IIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDGER 174 (592)
T ss_pred EecCCccHHHHHH-hcCCCCcHHHHHHHHHHHHHHHHHHhcC--ceecccchhheeecCcCcEEecccceeeeecCcccc
Confidence 9999999999997 5678999999999999999999999999 999999999999999999999999999998876666
Q ss_pred cccCCCCccccCC
Q 005841 662 TKTGKGTVTYLAS 674 (674)
Q Consensus 662 ~~~~~GTp~YmAP 674 (674)
..+.||||.|+||
T Consensus 175 k~TlCGTPNYIAP 187 (592)
T KOG0575|consen 175 KKTLCGTPNYIAP 187 (592)
T ss_pred cceecCCCcccCh
Confidence 7779999999999
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-33 Score=287.77 Aligned_cols=168 Identities=32% Similarity=0.456 Sum_probs=152.5
Q ss_pred ccccCCeeEeeeecccCceEEEEEEEc--CCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCe-E
Q 005841 501 EILWEDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQR-L 577 (674)
Q Consensus 501 ~~~~~~y~~~~~LG~G~fG~Vy~~~~~--~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~-~ 577 (674)
.+...+++.++.||+|..|+||+++++ +.-+|+|++. -.......+++.+|+++++.++||+||.+|++|..+.. +
T Consensus 75 ~i~~~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~-~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~i 153 (364)
T KOG0581|consen 75 GISLSDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVIL-LNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEI 153 (364)
T ss_pred ccCHHHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeec-ccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceE
Confidence 456678888999999999999999985 6679999994 34466777889999999999999999999999999995 9
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCeEEccCCCCCEEEcCCCcEEEEecCCccccc
Q 005841 578 CIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHH-CNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKH 656 (674)
Q Consensus 578 ~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~-~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~ 656 (674)
+|+||||++|+|.+++... +++++.....|+.+|++||.|||+ ++ ||||||||+||||+..|.|||||||.++.+.
T Consensus 154 sI~mEYMDgGSLd~~~k~~-g~i~E~~L~~ia~~VL~GL~YLh~~~~--IIHRDIKPsNlLvNskGeVKicDFGVS~~lv 230 (364)
T KOG0581|consen 154 SICMEYMDGGSLDDILKRV-GRIPEPVLGKIARAVLRGLSYLHEERK--IIHRDIKPSNLLVNSKGEVKICDFGVSGILV 230 (364)
T ss_pred EeehhhcCCCCHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhhccC--eeeccCCHHHeeeccCCCEEeccccccHHhh
Confidence 9999999999999999754 679999999999999999999995 77 9999999999999999999999999999998
Q ss_pred CCccccccCCCCccccCC
Q 005841 657 ETYLTTKTGKGTVTYLAS 674 (674)
Q Consensus 657 ~~~~~~~~~~GTp~YmAP 674 (674)
++ ...+++||..||||
T Consensus 231 nS--~a~tfvGT~~YMsP 246 (364)
T KOG0581|consen 231 NS--IANTFVGTSAYMSP 246 (364)
T ss_pred hh--hcccccccccccCh
Confidence 77 45568999999999
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-33 Score=299.02 Aligned_cols=176 Identities=51% Similarity=0.800 Sum_probs=159.9
Q ss_pred cccccccCCeeEeeeecccCceEEEEEEEcCCe-EEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCC-
Q 005841 498 LDYEILWEDLTIGEQIGQGSCGTVYHAVWYGSD-VAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQ- 575 (674)
Q Consensus 498 ~~~~~~~~~y~~~~~LG~G~fG~Vy~~~~~~~~-vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~- 575 (674)
..+.+...++.+.+.||.|+||+||++.+.+.. ||||++..........+.|.+|+.+|..++|||||+|+|++..+.
T Consensus 34 ~~~~i~~~~l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~ 113 (362)
T KOG0192|consen 34 PEEEIDPDELPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPG 113 (362)
T ss_pred cceecChHHhhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 445666777888888999999999999999999 999999988777666889999999999999999999999999888
Q ss_pred eEEEEEecCCCCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCC-cEEEEecCCcc
Q 005841 576 RLCIVTEFLPRGSLFRLLQR-NTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHW-TVKVGDFGLSR 653 (674)
Q Consensus 576 ~~~lV~E~~~ggsL~~~l~~-~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~-~vkL~DFGla~ 653 (674)
.++|||||+++|+|.++|.. ....+++..++.++.||+.||+|||++++ ||||||||+|||++.++ ++||+|||+++
T Consensus 114 ~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~-iIHrDLK~~NiLv~~~~~~~KI~DFGlsr 192 (362)
T KOG0192|consen 114 SLCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGP-IIHRDLKSDNILVDLKGKTLKIADFGLSR 192 (362)
T ss_pred ceEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCC-eeecccChhhEEEcCCCCEEEECCCccce
Confidence 79999999999999999987 37789999999999999999999999886 99999999999999998 99999999999
Q ss_pred cccCCccccccCCCCccccCC
Q 005841 654 LKHETYLTTKTGKGTVTYLAS 674 (674)
Q Consensus 654 ~~~~~~~~~~~~~GTp~YmAP 674 (674)
.............||+.||||
T Consensus 193 ~~~~~~~~~~~~~GT~~wMAP 213 (362)
T KOG0192|consen 193 EKVISKTSMTSVAGTYRWMAP 213 (362)
T ss_pred eeccccccccCCCCCccccCh
Confidence 887754444447899999999
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.7e-34 Score=280.88 Aligned_cols=172 Identities=27% Similarity=0.422 Sum_probs=153.2
Q ss_pred ccCCeeEeeeecccCceEEEEEEE--cCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEE-EEecCCe-EE
Q 005841 503 LWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMG-AVTSPQR-LC 578 (674)
Q Consensus 503 ~~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~-~~~~~~~-~~ 578 (674)
...+|+++++||.|.||.||++.. ++..||.|.++-...+.+..+.+..|+.+|++|+|||||++++ -|..... ++
T Consensus 17 ~l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evln 96 (375)
T KOG0591|consen 17 TLADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLN 96 (375)
T ss_pred cHHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhH
Confidence 346799999999999999999986 6888999999877777788889999999999999999999998 4444444 89
Q ss_pred EEEecCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCCCC--eEEccCCCCCEEEcCCCcEEEEecCCcc
Q 005841 579 IVTEFLPRGSLFRLLQR---NTTKLDWRRRILMALDIARGVSYLHHCNPP--IIHRDLKSSNLLVDKHWTVKVGDFGLSR 653 (674)
Q Consensus 579 lV~E~~~ggsL~~~l~~---~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~--IvHrDLKp~NILi~~~~~vkL~DFGla~ 653 (674)
||||||.+|+|..+++. ....|++..++.++.|+|.||.+||..-++ |+||||||.||+|+.+|.|||+|||+++
T Consensus 97 ivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r 176 (375)
T KOG0591|consen 97 IVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGR 176 (375)
T ss_pred HHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHh
Confidence 99999999999998864 456799999999999999999999983333 9999999999999999999999999999
Q ss_pred cccCCccccccCCCCccccCC
Q 005841 654 LKHETYLTTKTGKGTVTYLAS 674 (674)
Q Consensus 654 ~~~~~~~~~~~~~GTp~YmAP 674 (674)
.+........+++|||.||+|
T Consensus 177 ~l~s~~tfA~S~VGTPyYMSP 197 (375)
T KOG0591|consen 177 FLSSKTTFAHSLVGTPYYMSP 197 (375)
T ss_pred HhcchhHHHHhhcCCCcccCH
Confidence 998877777789999999998
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-31 Score=285.41 Aligned_cols=171 Identities=27% Similarity=0.458 Sum_probs=151.2
Q ss_pred ccccCCeeEeeeecccCceEEEEEEE--cCCeEEEEEeecccCC-HHHHHHHHHHHHHHhhC-CCCCeeeEEEEEecCCe
Q 005841 501 EILWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYS-DEVIHSFRQEVSLMKRL-RHPNVLLFMGAVTSPQR 576 (674)
Q Consensus 501 ~~~~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~~-~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~ 576 (674)
.....+|.+++.||+|+|.+|++|+. +++.||||++.+..+. +..+..+.+|-.+|.+| .||.|+++|..|++...
T Consensus 69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~s 148 (604)
T KOG0592|consen 69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEES 148 (604)
T ss_pred cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccc
Confidence 34457999999999999999999987 5778999999877653 34456677899999999 79999999999999999
Q ss_pred EEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCccccc
Q 005841 577 LCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKH 656 (674)
Q Consensus 577 ~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~ 656 (674)
+|+|+||+++|+|.++|++. +.|++..+.+|+.||+.||+|||.+| ||||||||+|||+|+++++||+|||.|+.+.
T Consensus 149 LYFvLe~A~nGdll~~i~K~-Gsfde~caR~YAAeIldAleylH~~G--IIHRDlKPENILLd~dmhikITDFGsAK~l~ 225 (604)
T KOG0592|consen 149 LYFVLEYAPNGDLLDLIKKY-GSFDETCARFYAAEILDALEYLHSNG--IIHRDLKPENILLDKDGHIKITDFGSAKILS 225 (604)
T ss_pred eEEEEEecCCCcHHHHHHHh-CcchHHHHHHHHHHHHHHHHHHHhcC--ceeccCChhheeEcCCCcEEEeeccccccCC
Confidence 99999999999999999875 58999999999999999999999999 9999999999999999999999999999875
Q ss_pred CCccc-----------c--ccCCCCccccCC
Q 005841 657 ETYLT-----------T--KTGKGTVTYLAS 674 (674)
Q Consensus 657 ~~~~~-----------~--~~~~GTp~YmAP 674 (674)
..... . .+|+||..|.+|
T Consensus 226 ~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSP 256 (604)
T KOG0592|consen 226 PSQKSQENPVDPNQASSRRSSFVGTAEYVSP 256 (604)
T ss_pred hhhccccCccCcccccCcccceeeeecccCH
Confidence 32221 1 458999999998
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4e-31 Score=285.72 Aligned_cols=171 Identities=30% Similarity=0.511 Sum_probs=152.3
Q ss_pred ccccCCeeEeeeecccCceEEEEEEE--cCCeEEEEEeecccCC---HHHHHHHHHHHHHHhhCC-CCCeeeEEEEEecC
Q 005841 501 EILWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYS---DEVIHSFRQEVSLMKRLR-HPNVLLFMGAVTSP 574 (674)
Q Consensus 501 ~~~~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~~---~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~ 574 (674)
....+.|.+++.||+|+||+|++|.+ ++..||+|++.++... ....+.+.+|+.+++.++ ||||++++.++...
T Consensus 13 ~~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~ 92 (370)
T KOG0583|consen 13 QLSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATP 92 (370)
T ss_pred ccccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecC
Confidence 34557899999999999999999987 5788999988775322 234556778999999999 99999999999999
Q ss_pred CeEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCC-CcEEEEecCCcc
Q 005841 575 QRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKH-WTVKVGDFGLSR 653 (674)
Q Consensus 575 ~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~-~~vkL~DFGla~ 653 (674)
..+|||||||.||+|++++.. ..++.+..+..+++|++.||+|||+++ |+||||||+|||++.+ +++||+|||++.
T Consensus 93 ~~~~ivmEy~~gGdL~~~i~~-~g~l~E~~ar~~F~Qlisav~y~H~~g--i~HRDLK~ENilld~~~~~~Kl~DFG~s~ 169 (370)
T KOG0583|consen 93 TKIYIVMEYCSGGDLFDYIVN-KGRLKEDEARKYFRQLISAVAYCHSRG--IVHRDLKPENILLDGNEGNLKLSDFGLSA 169 (370)
T ss_pred CeEEEEEEecCCccHHHHHHH-cCCCChHHHHHHHHHHHHHHHHHHhCC--EeeCCCCHHHEEecCCCCCEEEecccccc
Confidence 999999999999999999987 778999999999999999999999999 9999999999999999 999999999999
Q ss_pred cccCCccccccCCCCccccCC
Q 005841 654 LKHETYLTTKTGKGTVTYLAS 674 (674)
Q Consensus 654 ~~~~~~~~~~~~~GTp~YmAP 674 (674)
..........++||||.|+||
T Consensus 170 ~~~~~~~~l~t~cGsp~Y~aP 190 (370)
T KOG0583|consen 170 ISPGEDGLLKTFCGSPAYAAP 190 (370)
T ss_pred ccCCCCCcccCCCCCcccCCH
Confidence 874333455668999999998
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.1e-31 Score=289.50 Aligned_cols=170 Identities=28% Similarity=0.407 Sum_probs=153.1
Q ss_pred ccccCCeeEeeeecccCceEEEEEEEc--CCeEEEEEeecccC-CHHHHHHHHHHHHHHhhCC-CCCeeeEEEEEecCCe
Q 005841 501 EILWEDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEY-SDEVIHSFRQEVSLMKRLR-HPNVLLFMGAVTSPQR 576 (674)
Q Consensus 501 ~~~~~~y~~~~~LG~G~fG~Vy~~~~~--~~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~ 576 (674)
.+..++|.++++||+|+||+|+++..+ +..||||+++|... ..+.++.+..|.+|+.... ||+++.++..|++.++
T Consensus 364 ~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~ 443 (694)
T KOG0694|consen 364 PLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEH 443 (694)
T ss_pred cccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCe
Confidence 455689999999999999999999984 55699999998875 4466788888999998885 9999999999999999
Q ss_pred EEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCccccc
Q 005841 577 LCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKH 656 (674)
Q Consensus 577 ~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~ 656 (674)
+|+||||+.||+|..+. ....|++..+.+|+.+|+.||+|||+++ |||||||.+|||+|..|+|||+|||+|+...
T Consensus 444 l~fvmey~~Ggdm~~~~--~~~~F~e~rarfyaAev~l~L~fLH~~~--IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m 519 (694)
T KOG0694|consen 444 LFFVMEYVAGGDLMHHI--HTDVFSEPRARFYAAEVVLGLQFLHENG--IIYRDLKLDNLLLDTEGHVKIADFGLCKEGM 519 (694)
T ss_pred EEEEEEecCCCcEEEEE--ecccccHHHHHHHHHHHHHHHHHHHhcC--ceeeecchhheEEcccCcEEecccccccccC
Confidence 99999999999954443 3467999999999999999999999999 9999999999999999999999999999887
Q ss_pred CCccccccCCCCccccCC
Q 005841 657 ETYLTTKTGKGTVTYLAS 674 (674)
Q Consensus 657 ~~~~~~~~~~GTp~YmAP 674 (674)
-....+.++||||.||||
T Consensus 520 ~~g~~TsTfCGTpey~aP 537 (694)
T KOG0694|consen 520 GQGDRTSTFCGTPEFLAP 537 (694)
T ss_pred CCCCccccccCChhhcCh
Confidence 666788899999999999
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.9e-32 Score=270.92 Aligned_cols=167 Identities=25% Similarity=0.339 Sum_probs=149.7
Q ss_pred CCeeEeeeecccCceEEEEEEE--cCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeEEEEEe
Q 005841 505 EDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTE 582 (674)
Q Consensus 505 ~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E 582 (674)
+.|+.+.++|+|+||+||+|++ +|.-||||.|....-++...+-..+||++|++|+|+|+|.++++|....+++||+|
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 4688899999999999999997 57789999997766566667778899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccccCCcccc
Q 005841 583 FLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTT 662 (674)
Q Consensus 583 ~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~~~~~~ 662 (674)
||+. ++.+-|.+....++...+..|+.|++.|+.|||.++ ||||||||+||||+.+|.|||||||+|+.+..+...-
T Consensus 82 ~~dh-TvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n--~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pgd~Y 158 (396)
T KOG0593|consen 82 YCDH-TVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNN--CIHRDIKPENILITQNGVVKLCDFGFARTLSAPGDNY 158 (396)
T ss_pred ecch-HHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcC--eecccCChhheEEecCCcEEeccchhhHhhcCCcchh
Confidence 9966 666777788888999999999999999999999999 9999999999999999999999999999988554444
Q ss_pred ccCCCCccccCC
Q 005841 663 KTGKGTVTYLAS 674 (674)
Q Consensus 663 ~~~~GTp~YmAP 674 (674)
..++.|-.|.||
T Consensus 159 TDYVATRWYRaP 170 (396)
T KOG0593|consen 159 TDYVATRWYRAP 170 (396)
T ss_pred hhhhhhhhccCh
Confidence 446788889888
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-30 Score=276.05 Aligned_cols=170 Identities=27% Similarity=0.388 Sum_probs=150.6
Q ss_pred cccCCeeEeeeecccCceEEEEEEE--cCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecC--CeE
Q 005841 502 ILWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSP--QRL 577 (674)
Q Consensus 502 ~~~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~--~~~ 577 (674)
...+.|+.+++||+|+||.||++++ ++..||+|.+......+....-..+||.||++|.||||+++.++..+. ..+
T Consensus 114 r~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~si 193 (560)
T KOG0600|consen 114 RRADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSI 193 (560)
T ss_pred cchHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceE
Confidence 3456799999999999999999997 577799999988877777777788999999999999999999999887 689
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccccC
Q 005841 578 CIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHE 657 (674)
Q Consensus 578 ~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~ 657 (674)
|||+|||+. +|..++....-.|++.++.+|+.||+.||+|||.+| |+|||||.+|||||.+|.+||+|||||+++..
T Consensus 194 YlVFeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~g--vlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~ 270 (560)
T KOG0600|consen 194 YLVFEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRG--VLHRDIKGSNILIDNNGVLKIADFGLARFYTP 270 (560)
T ss_pred EEEEecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcC--eeeccccccceEEcCCCCEEeccccceeeccC
Confidence 999999966 999999877788999999999999999999999999 99999999999999999999999999998754
Q ss_pred Cccc-cccCCCCccccCC
Q 005841 658 TYLT-TKTGKGTVTYLAS 674 (674)
Q Consensus 658 ~~~~-~~~~~GTp~YmAP 674 (674)
.... ..+.+=|+.|.||
T Consensus 271 ~~~~~~T~rVvTLWYRpP 288 (560)
T KOG0600|consen 271 SGSAPYTSRVVTLWYRPP 288 (560)
T ss_pred CCCcccccceEEeeccCh
Confidence 3322 2234568999888
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4e-30 Score=274.92 Aligned_cols=150 Identities=27% Similarity=0.434 Sum_probs=138.4
Q ss_pred cccCCeeEeeeecccCceEEEEEEE--cCCeEEEEEeecccCC-HHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeEE
Q 005841 502 ILWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYS-DEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLC 578 (674)
Q Consensus 502 ~~~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 578 (674)
+..++|+++++||+|+||.||+|+. +|..||+|++++.... ...++-++.|-.||....+|.||++|..|++.+++|
T Consensus 138 ~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LY 217 (550)
T KOG0605|consen 138 LSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLY 217 (550)
T ss_pred CCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeE
Confidence 4568999999999999999999986 6778999999987763 356777888999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCccc
Q 005841 579 IVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL 654 (674)
Q Consensus 579 lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~ 654 (674)
|||||++||++..+|.+ ...|++..+.+|+.+++.||+-||+.| +|||||||+|+|||..|+|||+|||||.-
T Consensus 218 LiMEylPGGD~mTLL~~-~~~L~e~~arfYiaE~vlAI~~iH~~g--yIHRDIKPdNlLiD~~GHiKLSDFGLs~g 290 (550)
T KOG0605|consen 218 LIMEYLPGGDMMTLLMR-KDTLTEDWARFYIAETVLAIESIHQLG--YIHRDIKPDNLLIDAKGHIKLSDFGLSTG 290 (550)
T ss_pred EEEEecCCccHHHHHHh-cCcCchHHHHHHHHHHHHHHHHHHHcC--cccccCChhheeecCCCCEeeccccccch
Confidence 99999999999999976 457999999999999999999999999 99999999999999999999999999964
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.3e-31 Score=270.69 Aligned_cols=169 Identities=28% Similarity=0.482 Sum_probs=153.5
Q ss_pred cccCCeeEeeeecccCceEEEEEEE--cCCeEEEEEeecccCCH-HHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeEE
Q 005841 502 ILWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSD-EVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLC 578 (674)
Q Consensus 502 ~~~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 578 (674)
....+|++.+.||.|.||+|-++.. .++.||||.|.+..... .-+-.+.+||+||..|+||||+.+|.+|+..+.+.
T Consensus 50 nlkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIv 129 (668)
T KOG0611|consen 50 NLKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIV 129 (668)
T ss_pred chhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEE
Confidence 3457899999999999999999986 57889999999887754 44567889999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccccCC
Q 005841 579 IVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHET 658 (674)
Q Consensus 579 lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~~ 658 (674)
|||||..+|.|++|+.++ +.+++.++..|++||+.|+.|||.++ ++|||||.+|||+|.++++||+||||+-++.+.
T Consensus 130 ivMEYaS~GeLYDYiSer-~~LsErEaRhfFRQIvSAVhYCHknr--VvHRDLKLENILLD~N~NiKIADFGLSNly~~~ 206 (668)
T KOG0611|consen 130 IVMEYASGGELYDYISER-GSLSEREARHFFRQIVSAVHYCHKNR--VVHRDLKLENILLDQNNNIKIADFGLSNLYADK 206 (668)
T ss_pred EEEEecCCccHHHHHHHh-ccccHHHHHHHHHHHHHHHHHHhhcc--ceecccchhheeecCCCCeeeeccchhhhhccc
Confidence 999999999999999864 57999999999999999999999998 999999999999999999999999999988765
Q ss_pred ccccccCCCCccccCC
Q 005841 659 YLTTKTGKGTVTYLAS 674 (674)
Q Consensus 659 ~~~~~~~~GTp~YmAP 674 (674)
.+- .+|||+|-|.+|
T Consensus 207 kfL-qTFCGSPLYASP 221 (668)
T KOG0611|consen 207 KFL-QTFCGSPLYASP 221 (668)
T ss_pred cHH-HHhcCCcccCCc
Confidence 443 358999999988
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=278.49 Aligned_cols=166 Identities=33% Similarity=0.531 Sum_probs=153.0
Q ss_pred CCeeEeeeecccCceEEEEEEEc--CCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeEEEEEe
Q 005841 505 EDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTE 582 (674)
Q Consensus 505 ~~y~~~~~LG~G~fG~Vy~~~~~--~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E 582 (674)
++|.+.+.||+|+||+||+|+.+ ...||||++.|....++.++.+.+|++|+..++||||+.++++|++..++|+|+|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 57888999999999999999864 5569999999988888888999999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccccCCcccc
Q 005841 583 FLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTT 662 (674)
Q Consensus 583 ~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~~~~~~ 662 (674)
||.| +|+.+|.. ...++++.+..|+.|++.||.|||+.+ |+|||+||.|||++.++++|+||||+|+.........
T Consensus 82 ~a~g-~L~~il~~-d~~lpEe~v~~~a~~LVsaL~yLhs~r--ilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t~vl 157 (808)
T KOG0597|consen 82 YAVG-DLFTILEQ-DGKLPEEQVRAIAYDLVSALYYLHSNR--ILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNTSVL 157 (808)
T ss_pred hhhh-hHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHhcC--cccccCCcceeeecCCCceeechhhhhhhcccCceee
Confidence 9977 99999975 568999999999999999999999999 9999999999999999999999999999876655555
Q ss_pred ccCCCCccccCC
Q 005841 663 KTGKGTVTYLAS 674 (674)
Q Consensus 663 ~~~~GTp~YmAP 674 (674)
....|||.||||
T Consensus 158 tsikGtPlYmAP 169 (808)
T KOG0597|consen 158 TSIKGTPLYMAP 169 (808)
T ss_pred eeccCcccccCH
Confidence 667899999998
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-29 Score=272.16 Aligned_cols=171 Identities=40% Similarity=0.667 Sum_probs=146.4
Q ss_pred cccCCeeEeeeecccCceEEEEEEEcC-CeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCC-eEEE
Q 005841 502 ILWEDLTIGEQIGQGSCGTVYHAVWYG-SDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQ-RLCI 579 (674)
Q Consensus 502 ~~~~~y~~~~~LG~G~fG~Vy~~~~~~-~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~-~~~l 579 (674)
.-.++|.-..+||+|+||.||+|...+ ..||||.+....... ...|.+|+.++.+++|||+|+++|||.+.+ ..+|
T Consensus 72 ~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~--~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~~~~L 149 (361)
T KOG1187|consen 72 KATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQG--EREFLNEVEILSRLRHPNLVKLLGYCLEGGEHRLL 149 (361)
T ss_pred HHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcc--hhHHHHHHHHHhcCCCcCcccEEEEEecCCceEEE
Confidence 345788888899999999999999854 789999876554332 345999999999999999999999999998 4999
Q ss_pred EEecCCCCCHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHh-CCCCeEEccCCCCCEEEcCCCcEEEEecCCcccccC
Q 005841 580 VTEFLPRGSLFRLLQRNTT-KLDWRRRILMALDIARGVSYLHH-CNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHE 657 (674)
Q Consensus 580 V~E~~~ggsL~~~l~~~~~-~l~~~~~~~i~~qi~~~L~yLH~-~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~ 657 (674)
|+|||+.|+|.++|..... .++|..++.|+.+++.||+|||. +.++||||||||+|||+|.+++.||+|||+|+....
T Consensus 150 VYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFGLa~~~~~ 229 (361)
T KOG1187|consen 150 VYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFGLAKLGPE 229 (361)
T ss_pred EEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCccCcccCCc
Confidence 9999999999999987655 89999999999999999999997 556899999999999999999999999999976653
Q ss_pred -CccccccCCCCccccCC
Q 005841 658 -TYLTTKTGKGTVTYLAS 674 (674)
Q Consensus 658 -~~~~~~~~~GTp~YmAP 674 (674)
.........||..|+||
T Consensus 230 ~~~~~~~~~~gt~gY~~P 247 (361)
T KOG1187|consen 230 GDTSVSTTVMGTFGYLAP 247 (361)
T ss_pred cccceeeecCCCCccCCh
Confidence 21111111799999998
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.6e-29 Score=264.36 Aligned_cols=170 Identities=29% Similarity=0.456 Sum_probs=141.4
Q ss_pred cccCCeeEeeeecccCceEEEEEEE--cCCeEEEEEeecccCCHH------------HHHHHHHHHHHHhhCCCCCeeeE
Q 005841 502 ILWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDE------------VIHSFRQEVSLMKRLRHPNVLLF 567 (674)
Q Consensus 502 ~~~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~~~~------------~~~~~~~Ei~il~~l~HpnIv~l 567 (674)
.....|++.+.||+|.||+|.+++. .++.||||++.+...... -++...+||.||++|.|||||++
T Consensus 94 k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~L 173 (576)
T KOG0585|consen 94 KQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKL 173 (576)
T ss_pred eehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEE
Confidence 4457899999999999999999997 577799999987544221 23678999999999999999999
Q ss_pred EEEEecC--CeEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEE
Q 005841 568 MGAVTSP--QRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVK 645 (674)
Q Consensus 568 ~~~~~~~--~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vk 645 (674)
+.+..++ +.+|||+|||..|.+...-. ....+++.++++|+++++.||+|||.+| ||||||||+|+||+.+|+||
T Consensus 174 iEvLDDP~s~~~YlVley~s~G~v~w~p~-d~~els~~~Ar~ylrDvv~GLEYLH~Qg--iiHRDIKPsNLLl~~~g~VK 250 (576)
T KOG0585|consen 174 IEVLDDPESDKLYLVLEYCSKGEVKWCPP-DKPELSEQQARKYLRDVVLGLEYLHYQG--IIHRDIKPSNLLLSSDGTVK 250 (576)
T ss_pred EEeecCcccCceEEEEEeccCCccccCCC-CcccccHHHHHHHHHHHHHHHHHHHhcC--eeccccchhheEEcCCCcEE
Confidence 9999876 57999999999888744322 1223899999999999999999999999 99999999999999999999
Q ss_pred EEecCCcccccCC-----ccccccCCCCccccCC
Q 005841 646 VGDFGLSRLKHET-----YLTTKTGKGTVTYLAS 674 (674)
Q Consensus 646 L~DFGla~~~~~~-----~~~~~~~~GTp~YmAP 674 (674)
|+|||.+-..... .......+|||.||||
T Consensus 251 IsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~AP 284 (576)
T KOG0585|consen 251 ISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAP 284 (576)
T ss_pred eeccceeeecccCCccccHHHHhhcCCCccccch
Confidence 9999999865221 1122225799999999
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.2e-29 Score=259.17 Aligned_cols=173 Identities=27% Similarity=0.465 Sum_probs=154.0
Q ss_pred ccccccCCeeEeeeecccCceEEEEEEE--cCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCe
Q 005841 499 DYEILWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQR 576 (674)
Q Consensus 499 ~~~~~~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 576 (674)
.|....++|++.++||.|..++||+|+. ++..||||+++.+....+ +..+.+|+..|+.++||||++++..|..+..
T Consensus 20 ~~p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~-ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~ 98 (516)
T KOG0582|consen 20 EFPLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNND-LDALRKEVQTMSLIDHPNIVTYHCSFVVDSE 98 (516)
T ss_pred cCCCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhh-HHHHHHHHHHhhhcCCCCcceEEEEEEecce
Confidence 3456678999999999999999999987 577899999988776655 7889999999999999999999999999999
Q ss_pred EEEEEecCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccc
Q 005841 577 LCIVTEFLPRGSLFRLLQRN-TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLK 655 (674)
Q Consensus 577 ~~lV~E~~~ggsL~~~l~~~-~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~ 655 (674)
+|+||+||.+|++.++++.. ...|++..+..|+++++.||.|||++| .||||||+.||||+.+|.|||+|||.+..+
T Consensus 99 LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G--~IHRdvKAgnILi~~dG~VkLadFgvsa~l 176 (516)
T KOG0582|consen 99 LWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNG--HIHRDVKAGNILIDSDGTVKLADFGVSASL 176 (516)
T ss_pred eEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcC--ceecccccccEEEcCCCcEEEcCceeeeee
Confidence 99999999999999999763 445999999999999999999999999 999999999999999999999999988766
Q ss_pred cCCccc---c-ccCCCCccccCC
Q 005841 656 HETYLT---T-KTGKGTVTYLAS 674 (674)
Q Consensus 656 ~~~~~~---~-~~~~GTp~YmAP 674 (674)
.+.... . .+++|||.||||
T Consensus 177 ~~~G~R~~~rf~tfvgtp~wmAP 199 (516)
T KOG0582|consen 177 FDSGDRQVTRFNTFVGTPCWMAP 199 (516)
T ss_pred cccCceeeEeeccccCcccccCh
Confidence 433221 1 457899999999
|
|
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.4e-30 Score=260.29 Aligned_cols=171 Identities=31% Similarity=0.442 Sum_probs=155.7
Q ss_pred ccccCCeeEeeeecccCceEEEEEEE--cCCeEEEEEeecccC-CHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeE
Q 005841 501 EILWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEY-SDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRL 577 (674)
Q Consensus 501 ~~~~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 577 (674)
.+..++|.++++||+|.||+|.+|+. +++-||||++++... ..+.+.--..|-.+|+..+||++..+-..|+..+++
T Consensus 164 kvTm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drl 243 (516)
T KOG0690|consen 164 KVTMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRL 243 (516)
T ss_pred eeccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceE
Confidence 45567899999999999999999986 577799999988765 334455566799999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccccC
Q 005841 578 CIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHE 657 (674)
Q Consensus 578 ~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~ 657 (674)
|+||||.+||.|+-+|.+. ..|++....+|..+|+.||.|||+.+ ||+||||.+|+|+|++|++||+|||+|+.-..
T Consensus 244 CFVMeyanGGeLf~HLsre-r~FsE~RtRFYGaEIvsAL~YLHs~~--ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~ 320 (516)
T KOG0690|consen 244 CFVMEYANGGELFFHLSRE-RVFSEDRTRFYGAEIVSALGYLHSRN--IVYRDLKLENLLLDKDGHIKITDFGLCKEEIK 320 (516)
T ss_pred EEEEEEccCceEeeehhhh-hcccchhhhhhhHHHHHHhhhhhhCC--eeeeechhhhheeccCCceEeeecccchhccc
Confidence 9999999999999999764 47999999999999999999999999 99999999999999999999999999999888
Q ss_pred CccccccCCCCccccCC
Q 005841 658 TYLTTKTGKGTVTYLAS 674 (674)
Q Consensus 658 ~~~~~~~~~GTp~YmAP 674 (674)
...++.++||||.|+||
T Consensus 321 ~g~t~kTFCGTPEYLAP 337 (516)
T KOG0690|consen 321 YGDTTKTFCGTPEYLAP 337 (516)
T ss_pred ccceeccccCChhhcCc
Confidence 88899999999999998
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-29 Score=250.05 Aligned_cols=167 Identities=28% Similarity=0.415 Sum_probs=149.1
Q ss_pred CCeeEeeeecccCceEEEEEEE--cCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeEEEEEe
Q 005841 505 EDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTE 582 (674)
Q Consensus 505 ~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E 582 (674)
.+|...++||+|.||+||+|++ +++.||||.+......+.......+||++|+.++|+||+.++++|...+.+.||+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 4688889999999999999998 57889999998887666555677889999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccccCCcccc
Q 005841 583 FLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTT 662 (674)
Q Consensus 583 ~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~~~~~~ 662 (674)
|++- +|...++.....|+..++..++.+++.||+|||.+. |+||||||.|+||+.+|.+||+|||+|+.........
T Consensus 82 fm~t-dLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~--IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~~ 158 (318)
T KOG0659|consen 82 FMPT-DLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKW--ILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRIQ 158 (318)
T ss_pred eccc-cHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhh--hhcccCCccceEEcCCCcEEeecccchhccCCCCccc
Confidence 9955 999999988889999999999999999999999999 9999999999999999999999999999886544333
Q ss_pred ccCCCCccccCC
Q 005841 663 KTGKGTVTYLAS 674 (674)
Q Consensus 663 ~~~~GTp~YmAP 674 (674)
..-+-|-.|.||
T Consensus 159 ~~~V~TRWYRAP 170 (318)
T KOG0659|consen 159 THQVVTRWYRAP 170 (318)
T ss_pred ccceeeeeccCh
Confidence 333567888887
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.9e-29 Score=270.94 Aligned_cols=173 Identities=41% Similarity=0.703 Sum_probs=156.4
Q ss_pred cccccccCCeeEeeeecccCceEEEEEEEcCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeE
Q 005841 498 LDYEILWEDLTIGEQIGQGSCGTVYHAVWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRL 577 (674)
Q Consensus 498 ~~~~~~~~~y~~~~~LG~G~fG~Vy~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 577 (674)
.+|++..+.+.+++.||+|.||+||+|.|.| +||||+++.....++..+.|++|+.+|++-+|.||+.|+|++..+..
T Consensus 385 ~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG-dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~- 462 (678)
T KOG0193|consen 385 EEWEIPPEEVLLGERIGSGSFGTVYRGRWHG-DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL- 462 (678)
T ss_pred cccccCHHHhhccceeccccccceeeccccc-ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-
Confidence 6788999999999999999999999999984 58999999988888999999999999999999999999999988776
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccccC
Q 005841 578 CIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHE 657 (674)
Q Consensus 578 ~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~ 657 (674)
.||+-+|.|.+|+.+|+....+|.....+.|++||++||.|||.++ |||||||..|||+.++++|||+||||+.....
T Consensus 463 AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~--IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~ 540 (678)
T KOG0193|consen 463 AIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKN--IIHRDLKSNNIFLHEDLKVKIGDFGLATVKTR 540 (678)
T ss_pred eeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhh--hhhhhccccceEEccCCcEEEecccceeeeee
Confidence 9999999999999999988889999999999999999999999999 99999999999999999999999999976542
Q ss_pred C--ccccccCCCCccccCC
Q 005841 658 T--YLTTKTGKGTVTYLAS 674 (674)
Q Consensus 658 ~--~~~~~~~~GTp~YmAP 674 (674)
- ........|..-||||
T Consensus 541 w~g~~q~~qp~gsilwmAP 559 (678)
T KOG0193|consen 541 WSGEQQLEQPHGSLLWMAP 559 (678)
T ss_pred eccccccCCCccchhhhcH
Confidence 1 1111223588899998
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.7e-29 Score=259.92 Aligned_cols=166 Identities=32% Similarity=0.509 Sum_probs=144.8
Q ss_pred CCeeEeeeecccCceEEEEEEEc--CCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCC--eEEEE
Q 005841 505 EDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQ--RLCIV 580 (674)
Q Consensus 505 ~~y~~~~~LG~G~fG~Vy~~~~~--~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~--~~~lV 580 (674)
.+|..++.||+|+||.||++... +..+|||.+..... ...+.+.+|+.+|.+++|||||+++|...... .++|+
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~--~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~ 94 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDS--PTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIF 94 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecccc--hhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEee
Confidence 46888999999999999999985 57899999876522 22677899999999999999999999855544 69999
Q ss_pred EecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcC-CCcEEEEecCCcccccC--
Q 005841 581 TEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDK-HWTVKVGDFGLSRLKHE-- 657 (674)
Q Consensus 581 ~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~-~~~vkL~DFGla~~~~~-- 657 (674)
|||+++|+|.+++.+.+..|++..++.+.+||++||.|||+++ ||||||||+||||+. ++.+||+|||+++....
T Consensus 95 mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g--~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~ 172 (313)
T KOG0198|consen 95 MEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKG--IVHCDIKPANILLDPSNGDVKLADFGLAKKLESKG 172 (313)
T ss_pred eeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC--EeccCcccceEEEeCCCCeEEeccCcccccccccc
Confidence 9999999999999887668999999999999999999999999 999999999999999 79999999999987763
Q ss_pred -CccccccCCCCccccCC
Q 005841 658 -TYLTTKTGKGTVTYLAS 674 (674)
Q Consensus 658 -~~~~~~~~~GTp~YmAP 674 (674)
.........|||.||||
T Consensus 173 ~~~~~~~~~~Gtp~~maP 190 (313)
T KOG0198|consen 173 TKSDSELSVQGTPNYMAP 190 (313)
T ss_pred ccccccccccCCccccCc
Confidence 11223457899999999
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-29 Score=274.76 Aligned_cols=166 Identities=35% Similarity=0.526 Sum_probs=150.7
Q ss_pred CCeeEeeeecccCceEEEEEEE--cCCeEEEEEeecc-cCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeEEEEE
Q 005841 505 EDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQ-EYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVT 581 (674)
Q Consensus 505 ~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~-~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 581 (674)
+-|++++.||.|+.|.|.+|++ +|..+|||++.+. .........+.+||-||+.+.||||+++|+.++...++|+|+
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl 91 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL 91 (786)
T ss_pred cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence 5689999999999999999998 7889999999887 445556678899999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccccCCccc
Q 005841 582 EFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLT 661 (674)
Q Consensus 582 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~~~~~ 661 (674)
||++||.|+++|-+ .++|++.++.+++.||+.|+.|||..+ |+||||||+|+|+|.+++|||+|||+|.+.... ..
T Consensus 92 Eyv~gGELFdylv~-kG~l~e~eaa~ff~QIi~gv~yCH~~~--icHRDLKpENlLLd~~~nIKIADFGMAsLe~~g-kl 167 (786)
T KOG0588|consen 92 EYVPGGELFDYLVR-KGPLPEREAAHFFRQILDGVSYCHAFN--ICHRDLKPENLLLDVKNNIKIADFGMASLEVPG-KL 167 (786)
T ss_pred EecCCchhHHHHHh-hCCCCCHHHHHHHHHHHHHHHHHhhhc--ceeccCCchhhhhhcccCEeeeccceeecccCC-cc
Confidence 99999999999976 457999999999999999999999999 999999999999999999999999999865543 34
Q ss_pred cccCCCCccccCC
Q 005841 662 TKTGKGTVTYLAS 674 (674)
Q Consensus 662 ~~~~~GTp~YmAP 674 (674)
..+.||+|.|.||
T Consensus 168 LeTSCGSPHYA~P 180 (786)
T KOG0588|consen 168 LETSCGSPHYAAP 180 (786)
T ss_pred ccccCCCcccCCc
Confidence 4557999999998
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.6e-30 Score=249.18 Aligned_cols=170 Identities=34% Similarity=0.536 Sum_probs=151.3
Q ss_pred ccccCCeeEeeeecccCceEEEEEEEcCC--eEEEEEeecccCCH-HHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeE
Q 005841 501 EILWEDLTIGEQIGQGSCGTVYHAVWYGS--DVAVKVFSRQEYSD-EVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRL 577 (674)
Q Consensus 501 ~~~~~~y~~~~~LG~G~fG~Vy~~~~~~~--~vAvK~i~~~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 577 (674)
....++|++++.||+|-||.||.++.+.+ -||+|++.+..+.. .....+.+|++|...|+||||+++|++|-+..++
T Consensus 18 ~~~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~ri 97 (281)
T KOG0580|consen 18 TWTLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRI 97 (281)
T ss_pred ccchhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheecccee
Confidence 34558899999999999999999998544 59999998876543 4557799999999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCccccc
Q 005841 578 CIVTEFLPRGSLFRLLQRN-TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKH 656 (674)
Q Consensus 578 ~lV~E~~~ggsL~~~l~~~-~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~ 656 (674)
||++||..+|+|+..|+.. ..+|++.....|+.|++.||.|||.++ ||||||||+|+|++..+.+||+|||++....
T Consensus 98 yLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~--VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p 175 (281)
T KOG0580|consen 98 YLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKR--VIHRDIKPENLLLGSAGELKIADFGWSVHAP 175 (281)
T ss_pred EEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCC--cccCCCCHHHhccCCCCCeeccCCCceeecC
Confidence 9999999999999999843 356999999999999999999999988 9999999999999999999999999997654
Q ss_pred CCccccccCCCCccccCC
Q 005841 657 ETYLTTKTGKGTVTYLAS 674 (674)
Q Consensus 657 ~~~~~~~~~~GTp~YmAP 674 (674)
.....+.|||..|.+|
T Consensus 176 --~~kR~tlcgt~dyl~p 191 (281)
T KOG0580|consen 176 --SNKRKTLCGTLDYLPP 191 (281)
T ss_pred --CCCceeeecccccCCH
Confidence 4455668999999998
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.3e-29 Score=254.76 Aligned_cols=167 Identities=27% Similarity=0.356 Sum_probs=145.2
Q ss_pred CCeeEeeeecccCceEEEEEEEc--CCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEec--CCeEEEE
Q 005841 505 EDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTS--PQRLCIV 580 (674)
Q Consensus 505 ~~y~~~~~LG~G~fG~Vy~~~~~--~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~--~~~~~lV 580 (674)
+.|+.++.|++|+||.||+|+++ +..||+|.++-.....-+--...+||.+|.+++|||||.+-.+... -+.+|||
T Consensus 76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~V 155 (419)
T KOG0663|consen 76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIV 155 (419)
T ss_pred HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeee
Confidence 67899999999999999999984 5569999997665444344456789999999999999999887764 4679999
Q ss_pred EecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccccCCcc
Q 005841 581 TEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYL 660 (674)
Q Consensus 581 ~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~~~~ 660 (674)
||||+. +|..++.....+|...++..++.|++.||+|||.+. |+||||||+|+|++..|.+||+|||+|+.+..+..
T Consensus 156 Me~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~w--ilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp~k 232 (419)
T KOG0663|consen 156 MEYVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNW--ILHRDLKTSNLLLSHKGILKIADFGLAREYGSPLK 232 (419)
T ss_pred HHHHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhce--eEecccchhheeeccCCcEEecccchhhhhcCCcc
Confidence 999965 999999988889999999999999999999999999 99999999999999999999999999999887644
Q ss_pred ccccCCCCccccCC
Q 005841 661 TTKTGKGTVTYLAS 674 (674)
Q Consensus 661 ~~~~~~GTp~YmAP 674 (674)
.....+=|..|.||
T Consensus 233 ~~T~lVVTLWYRaP 246 (419)
T KOG0663|consen 233 PYTPLVVTLWYRAP 246 (419)
T ss_pred cCcceEEEeeecCH
Confidence 44445678888887
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.5e-30 Score=269.23 Aligned_cols=168 Identities=28% Similarity=0.413 Sum_probs=148.0
Q ss_pred cccCCeeEeeeecccCceEEEEEEE--cCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCC-CCCeeeEEEEEecCC-eE
Q 005841 502 ILWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLR-HPNVLLFMGAVTSPQ-RL 577 (674)
Q Consensus 502 ~~~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~-~~ 577 (674)
+.-++|.+.++||.|+||.||+|+. .+..||||.+++..+.-+... -.+|+..|++|+ ||||+++++++.+.+ .+
T Consensus 7 ~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~-nLREvksL~kln~hpniikL~Evi~d~~~~L 85 (538)
T KOG0661|consen 7 IFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECM-NLREVKSLRKLNPHPNIIKLKEVIRDNDRIL 85 (538)
T ss_pred hHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHH-HHHHHHHHHhcCCCCcchhhHHHhhccCceE
Confidence 3457899999999999999999986 577899999988777654433 346999999998 999999999999998 89
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccccC
Q 005841 578 CIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHE 657 (674)
Q Consensus 578 ~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~ 657 (674)
|+||||| ..+|+++++..+..|++..+..|+.||++||+|+|.+| +.||||||+||||..+..|||+|||+||....
T Consensus 86 ~fVfE~M-d~NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~G--fFHRDlKPENiLi~~~~~iKiaDFGLARev~S 162 (538)
T KOG0661|consen 86 YFVFEFM-DCNLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHG--FFHRDLKPENILISGNDVIKIADFGLAREVRS 162 (538)
T ss_pred eeeHHhh-hhhHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcC--cccccCChhheEecccceeEeccccccccccc
Confidence 9999999 45999999988889999999999999999999999999 99999999999999888999999999998754
Q ss_pred CccccccCCCCccccCC
Q 005841 658 TYLTTKTGKGTVTYLAS 674 (674)
Q Consensus 658 ~~~~~~~~~GTp~YmAP 674 (674)
..--+ .++.|-.|.||
T Consensus 163 kpPYT-eYVSTRWYRAP 178 (538)
T KOG0661|consen 163 KPPYT-EYVSTRWYRAP 178 (538)
T ss_pred CCCcc-hhhhcccccch
Confidence 33222 25789999998
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=7e-28 Score=261.44 Aligned_cols=148 Identities=26% Similarity=0.405 Sum_probs=134.0
Q ss_pred CCeeEeeeecccCceEEEEEEE--cCCeEEEEEeecccC-CHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeEEEEE
Q 005841 505 EDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEY-SDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVT 581 (674)
Q Consensus 505 ~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 581 (674)
++|++.+.||+|+||+||+|.+ ++..||||++.+... .......+.+|+.++..++||||+++++.+.+...+||||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 4799999999999999999987 467899999976543 2344567888999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccc
Q 005841 582 EFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLK 655 (674)
Q Consensus 582 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~ 655 (674)
|||++|+|.+++.+ ...+++..+..++.||+.||+|||+++ |+||||||+||||+.++++||+|||+|+..
T Consensus 81 E~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~lH~~g--ivHrDlKp~NILi~~~~~vkL~DFGla~~~ 151 (363)
T cd05628 81 EFLPGGDMMTLLMK-KDTLTEEETQFYIAETVLAIDSIHQLG--FIHRDIKPDNLLLDSKGHVKLSDFGLCTGL 151 (363)
T ss_pred cCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCC--eEecCCCHHHeEECCCCCEEEeeccCcccc
Confidence 99999999999975 457999999999999999999999999 999999999999999999999999999754
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.2e-28 Score=260.52 Aligned_cols=169 Identities=31% Similarity=0.498 Sum_probs=150.8
Q ss_pred ccccCCeeEeeeecccCceEEEEEEE--cCCeEEEEEeecccCCH-HHHHHHHHHHHHHhhCC-CCCeeeEEEEEecCCe
Q 005841 501 EILWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSD-EVIHSFRQEVSLMKRLR-HPNVLLFMGAVTSPQR 576 (674)
Q Consensus 501 ~~~~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~~~-~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~ 576 (674)
......|++.+.||.|.||+||+|+. ++..||+|++.+..... .....+.+|+.||+++. ||||+.++++|++...
T Consensus 31 ~~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~ 110 (382)
T KOG0032|consen 31 EDIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDS 110 (382)
T ss_pred ccccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCe
Confidence 33456799999999999999999997 47789999998877643 34567899999999998 9999999999999999
Q ss_pred EEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcC----CCcEEEEecCCc
Q 005841 577 LCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDK----HWTVKVGDFGLS 652 (674)
Q Consensus 577 ~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~----~~~vkL~DFGla 652 (674)
+|+|||+|.||.|++.+... .+++.++..++.|++.++.|||++| |+||||||+|||+.. ++.+|++|||+|
T Consensus 111 ~~lvmEL~~GGeLfd~i~~~--~~sE~da~~~~~~il~av~~lH~~g--vvHrDlKpEN~L~~~~~~~~~~ik~~DFGla 186 (382)
T KOG0032|consen 111 VYLVMELCEGGELFDRIVKK--HYSERDAAGIIRQILEAVKYLHSLG--VVHRDLKPENLLLASKDEGSGRIKLIDFGLA 186 (382)
T ss_pred EEEEEEecCCchHHHHHHHc--cCCHHHHHHHHHHHHHHHHHHHhCC--ceeccCCHHHeeeccccCCCCcEEEeeCCCc
Confidence 99999999999999999765 3999999999999999999999999 999999999999963 358999999999
Q ss_pred ccccCCccccccCCCCccccCC
Q 005841 653 RLKHETYLTTKTGKGTVTYLAS 674 (674)
Q Consensus 653 ~~~~~~~~~~~~~~GTp~YmAP 674 (674)
..... .......+|||.|+||
T Consensus 187 ~~~~~-~~~~~~~~Gtp~y~AP 207 (382)
T KOG0032|consen 187 KFIKP-GERLHTIVGTPEYVAP 207 (382)
T ss_pred eEccC-CceEeeecCCccccCc
Confidence 98877 4556668999999999
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.3e-28 Score=262.71 Aligned_cols=172 Identities=37% Similarity=0.609 Sum_probs=152.4
Q ss_pred cccccccCCeeEeeeecccCceEEEEEEEcCC-eEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCe
Q 005841 498 LDYEILWEDLTIGEQIGQGSCGTVYHAVWYGS-DVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQR 576 (674)
Q Consensus 498 ~~~~~~~~~y~~~~~LG~G~fG~Vy~~~~~~~-~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 576 (674)
..+++..+.+++++.||+|-||.||.|.+++. +||+|.+....... +.|.+|+.+|+.|+|+|||++++++..++.
T Consensus 199 d~wei~r~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m~~---~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~p 275 (468)
T KOG0197|consen 199 DPWEIPREELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGSMSP---EAFLREAQIMKKLRHEKLVKLYGVCTKQEP 275 (468)
T ss_pred CCeeecHHHHHHHHHhcCCccceEEEEEEcCCCcccceEEeccccCh---hHHHHHHHHHHhCcccCeEEEEEEEecCCc
Confidence 45677778889999999999999999999877 89999998765554 457799999999999999999999999899
Q ss_pred EEEEEecCCCCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccc
Q 005841 577 LCIVTEFLPRGSLFRLLQR-NTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLK 655 (674)
Q Consensus 577 ~~lV~E~~~ggsL~~~l~~-~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~ 655 (674)
+|||||||+.|+|.++|+. .+..+...+.+.|+.|||.||+||.+++ +|||||...||||+++..|||+|||||+..
T Consensus 276 iyIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~--~IHRDLAARNiLV~~~~~vKIsDFGLAr~~ 353 (468)
T KOG0197|consen 276 IYIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKN--YIHRDLAARNILVDEDLVVKISDFGLARLI 353 (468)
T ss_pred eEEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCC--ccchhhhhhheeeccCceEEEccccccccc
Confidence 9999999999999999986 5678999999999999999999999999 999999999999999999999999999976
Q ss_pred cCCcccccc-CCCCccccCC
Q 005841 656 HETYLTTKT-GKGTVTYLAS 674 (674)
Q Consensus 656 ~~~~~~~~~-~~GTp~YmAP 674 (674)
.++.++... ..=...|.||
T Consensus 354 ~d~~Y~~~~~~kfPIkWtAP 373 (468)
T KOG0197|consen 354 GDDEYTASEGGKFPIKWTAP 373 (468)
T ss_pred CCCceeecCCCCCCceecCH
Confidence 666555443 2345667777
|
|
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.9e-27 Score=258.38 Aligned_cols=170 Identities=29% Similarity=0.454 Sum_probs=155.7
Q ss_pred ccccCCeeEeeeecccCceEEEEEEE--cCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeEE
Q 005841 501 EILWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLC 578 (674)
Q Consensus 501 ~~~~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 578 (674)
......|.+...||.|.|++|.++++ ++..||||++.+........+.+.+|+++|+.|+|||||+++.+......+|
T Consensus 52 ~~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~ly 131 (596)
T KOG0586|consen 52 SNSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLY 131 (596)
T ss_pred cccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeE
Confidence 34457799999999999999999997 6888999999998888777778999999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccccCC
Q 005841 579 IVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHET 658 (674)
Q Consensus 579 lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~~ 658 (674)
+||||+.+|.++++|.++. ++.+..+..++.|++.+++|||+++ |||||||.+|||++.+.+|||+|||++.++..
T Consensus 132 lV~eya~~ge~~~yl~~~g-r~~e~~ar~~F~q~vsaveYcH~k~--ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~- 207 (596)
T KOG0586|consen 132 LVMEYASGGELFDYLVKHG-RMKEKEARAKFRQIVSAVEYCHSKN--IVHRDLKAENILLDENMNIKIADFGFSTFFDY- 207 (596)
T ss_pred EEEEeccCchhHHHHHhcc-cchhhhhhhhhHHHHHHHHHHhhcc--eeccccchhhcccccccceeeeccccceeecc-
Confidence 9999999999999997654 5667999999999999999999999 99999999999999999999999999998873
Q ss_pred ccccccCCCCccccCC
Q 005841 659 YLTTKTGKGTVTYLAS 674 (674)
Q Consensus 659 ~~~~~~~~GTp~YmAP 674 (674)
.....++||+|.|.||
T Consensus 208 ~~~lqt~cgsppyAaP 223 (596)
T KOG0586|consen 208 GLMLQTFCGSPPYAAP 223 (596)
T ss_pred cccccccCCCCCccCh
Confidence 4456678999999998
|
|
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.7e-27 Score=258.16 Aligned_cols=148 Identities=25% Similarity=0.401 Sum_probs=134.1
Q ss_pred CCeeEeeeecccCceEEEEEEE--cCCeEEEEEeecccC-CHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeEEEEE
Q 005841 505 EDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEY-SDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVT 581 (674)
Q Consensus 505 ~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 581 (674)
++|++.++||+|+||+||+|.+ ++..||||++.+... .......+.+|+.++..++||||+++++++.+.+.+||||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 4799999999999999999998 467899999976543 2344567888999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccc
Q 005841 582 EFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLK 655 (674)
Q Consensus 582 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~ 655 (674)
|||++++|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++.+
T Consensus 81 E~~~~g~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~lH~~~--ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~ 151 (364)
T cd05599 81 EYLPGGDMMTLLMKK-DTFTEEETRFYIAETILAIDSIHKLG--YIHRDIKPDNLLLDAKGHIKLSDFGLCTGL 151 (364)
T ss_pred CCCCCcHHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCCHHHeEECCCCCEEEeecccceec
Confidence 999999999999753 46999999999999999999999999 999999999999999999999999999764
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=99.95 E-value=2e-27 Score=253.71 Aligned_cols=161 Identities=30% Similarity=0.466 Sum_probs=141.2
Q ss_pred eeecccCceEEEEEEE--cCCeEEEEEeecccC-CHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeEEEEEecCCCC
Q 005841 511 EQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEY-SDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRG 587 (674)
Q Consensus 511 ~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg 587 (674)
++||+|+||.||+|.+ .+..||||++.+... .......+.+|+.+++.++||||+.+++++...+.+||||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 4699999999999987 567899999976543 2344566788999999999999999999999999999999999999
Q ss_pred CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccccCCccccccCCC
Q 005841 588 SLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKG 667 (674)
Q Consensus 588 sL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~~~~~~~~~~G 667 (674)
+|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++............+|
T Consensus 81 ~L~~~l~~-~~~~~~~~~~~~~~qi~~~L~~lH~~~--ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~g 157 (323)
T cd05571 81 ELFFHLSR-ERVFSEDRARFYGAEIVSALGYLHSCD--VVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCG 157 (323)
T ss_pred cHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCC--eEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCCcccceec
Confidence 99999975 457899999999999999999999999 999999999999999999999999999865444444445689
Q ss_pred CccccCC
Q 005841 668 TVTYLAS 674 (674)
Q Consensus 668 Tp~YmAP 674 (674)
|+.||||
T Consensus 158 t~~y~aP 164 (323)
T cd05571 158 TPEYLAP 164 (323)
T ss_pred CccccCh
Confidence 9999998
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.3e-27 Score=252.92 Aligned_cols=165 Identities=31% Similarity=0.480 Sum_probs=142.5
Q ss_pred cccCCeeEeeeecccCceEEEEEEE--cCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeEEE
Q 005841 502 ILWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCI 579 (674)
Q Consensus 502 ~~~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 579 (674)
....+|++.++||+|+||.||++.+ .+..||||++.... .......+.+|+.+++.++|+||+++++++...+.+|+
T Consensus 71 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 149 (353)
T PLN00034 71 KSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH-EDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQV 149 (353)
T ss_pred CCHHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCC-cHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEE
Confidence 3456788899999999999999987 46789999986543 34456778999999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccccCCc
Q 005841 580 VTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETY 659 (674)
Q Consensus 580 V~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~~~ 659 (674)
||||+++++|.... .+.+..+..++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++.+....
T Consensus 150 v~e~~~~~~L~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~ 222 (353)
T PLN00034 150 LLEFMDGGSLEGTH-----IADEQFLADVARQILSGIAYLHRRH--IVHRDIKPSNLLINSAKNVKIADFGVSRILAQTM 222 (353)
T ss_pred EEecCCCCcccccc-----cCCHHHHHHHHHHHHHHHHHHHHCC--EeecCCCHHHEEEcCCCCEEEcccccceeccccc
Confidence 99999999986532 3567888899999999999999999 9999999999999999999999999998776543
Q ss_pred cccccCCCCccccCC
Q 005841 660 LTTKTGKGTVTYLAS 674 (674)
Q Consensus 660 ~~~~~~~GTp~YmAP 674 (674)
.......||+.||||
T Consensus 223 ~~~~~~~gt~~y~aP 237 (353)
T PLN00034 223 DPCNSSVGTIAYMSP 237 (353)
T ss_pred ccccccccCccccCc
Confidence 333456799999998
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.2e-27 Score=254.10 Aligned_cols=167 Identities=31% Similarity=0.457 Sum_probs=147.5
Q ss_pred cccCCeeEeeeecccCceEEEEEEE--cCCeEEEEEeecccC-CHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeEE
Q 005841 502 ILWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEY-SDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLC 578 (674)
Q Consensus 502 ~~~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 578 (674)
....+|++.+.||+|+||.||+|.+ ++..||||++.+... .......+.+|+.+++.++||||+++++++...+.+|
T Consensus 15 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 94 (329)
T PTZ00263 15 WKLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVY 94 (329)
T ss_pred CCchheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEE
Confidence 3457899999999999999999998 467799999976543 2244567889999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccccCC
Q 005841 579 IVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHET 658 (674)
Q Consensus 579 lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~~ 658 (674)
+||||+++++|.+++.. ...+++..+..++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++.....
T Consensus 95 lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~ 171 (329)
T PTZ00263 95 FLLEFVVGGELFTHLRK-AGRFPNDVAKFYHAELVLAFEYLHSKD--IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR 171 (329)
T ss_pred EEEcCCCCChHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHEEECCCCCEEEeeccCceEcCCC
Confidence 99999999999999975 457899999999999999999999999 999999999999999999999999999876543
Q ss_pred ccccccCCCCccccCC
Q 005841 659 YLTTKTGKGTVTYLAS 674 (674)
Q Consensus 659 ~~~~~~~~GTp~YmAP 674 (674)
. ...+||+.||||
T Consensus 172 ~---~~~~gt~~y~aP 184 (329)
T PTZ00263 172 T---FTLCGTPEYLAP 184 (329)
T ss_pred c---ceecCChhhcCH
Confidence 2 235799999998
|
|
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2e-27 Score=247.12 Aligned_cols=153 Identities=25% Similarity=0.410 Sum_probs=140.0
Q ss_pred cccccCCeeEeeeecccCceEEEEEEEcC--CeEEEEEeecccCC-HHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCe
Q 005841 500 YEILWEDLTIGEQIGQGSCGTVYHAVWYG--SDVAVKVFSRQEYS-DEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQR 576 (674)
Q Consensus 500 ~~~~~~~y~~~~~LG~G~fG~Vy~~~~~~--~~vAvK~i~~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 576 (674)
..+...+|++++.||+|.-|+||+|...+ ..+|+|++.+..+. .+.+.+++-|-.||+.++||+++++|..|+...+
T Consensus 72 ~~l~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~ 151 (459)
T KOG0610|consen 72 GSLGLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKY 151 (459)
T ss_pred CccCHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccce
Confidence 45566789999999999999999999865 56999999988764 4567788889999999999999999999999999
Q ss_pred EEEEEecCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCccc
Q 005841 577 LCIVTEFLPRGSLFRLLQRNT-TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL 654 (674)
Q Consensus 577 ~~lV~E~~~ggsL~~~l~~~~-~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~ 654 (674)
.|+|||||+||+|+.++++.. ..|++..+.+|+.+|+.||+|||-.| ||+|||||+||||-++|+|.|+||.|+..
T Consensus 152 ~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlG--ivYRDLKPENILvredGHIMLsDFDLS~~ 228 (459)
T KOG0610|consen 152 SCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLG--IVYRDLKPENILVREDGHIMLSDFDLSLR 228 (459)
T ss_pred eEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhc--eeeccCCcceeEEecCCcEEeeecccccc
Confidence 999999999999999998754 56999999999999999999999999 99999999999999999999999999753
|
|
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.7e-27 Score=257.75 Aligned_cols=170 Identities=26% Similarity=0.396 Sum_probs=147.2
Q ss_pred ccccCCeeEeeeecccCceEEEEEEE--cCCeEEEEEeecccC-CHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeE
Q 005841 501 EILWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEY-SDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRL 577 (674)
Q Consensus 501 ~~~~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 577 (674)
....++|++.+.||+|+||.||++.+ ++..||+|++.+... .......+.+|+.+++.++||||+++++++.....+
T Consensus 39 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~ 118 (370)
T cd05621 39 QMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYL 118 (370)
T ss_pred CCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEE
Confidence 34457899999999999999999998 466799999976433 223345678899999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccccC
Q 005841 578 CIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHE 657 (674)
Q Consensus 578 ~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~ 657 (674)
|+|||||++|+|.+++.. ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+....
T Consensus 119 ~lv~Ey~~gg~L~~~l~~--~~~~~~~~~~~~~qil~aL~~LH~~~--IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~ 194 (370)
T cd05621 119 YMVMEYMPGGDLVNLMSN--YDVPEKWAKFYTAEVVLALDAIHSMG--LIHRDVKPDNMLLDKHGHLKLADFGTCMKMDE 194 (370)
T ss_pred EEEEcCCCCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHEEECCCCCEEEEecccceeccc
Confidence 999999999999999964 35899999999999999999999999 99999999999999999999999999987654
Q ss_pred Ccc-ccccCCCCccccCC
Q 005841 658 TYL-TTKTGKGTVTYLAS 674 (674)
Q Consensus 658 ~~~-~~~~~~GTp~YmAP 674 (674)
... .....+||+.||||
T Consensus 195 ~~~~~~~~~~gt~~Y~aP 212 (370)
T cd05621 195 TGMVRCDTAVGTPDYISP 212 (370)
T ss_pred CCceecccCCCCcccCCH
Confidence 322 23356799999998
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.8e-27 Score=257.95 Aligned_cols=147 Identities=26% Similarity=0.406 Sum_probs=133.1
Q ss_pred CCeeEeeeecccCceEEEEEEE--cCCeEEEEEeecccC-CHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeEEEEE
Q 005841 505 EDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEY-SDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVT 581 (674)
Q Consensus 505 ~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 581 (674)
++|.+.++||+|+||.||++.. .+..||||++.+... .......+.+|+.+++.++||||+++++++.+...+||||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 4789999999999999999987 567899999876443 3345677889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCccc
Q 005841 582 EFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL 654 (674)
Q Consensus 582 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~ 654 (674)
||+++++|.+++.. ...+++..+..++.|++.||+|||+++ |+||||||+||||+.++.+||+|||+++.
T Consensus 81 E~~~gg~L~~~l~~-~~~~~~~~~~~~~~ql~~aL~~LH~~g--ivHrDlkp~NIll~~~~~~kl~DfGla~~ 150 (377)
T cd05629 81 EFLPGGDLMTMLIK-YDTFSEDVTRFYMAECVLAIEAVHKLG--FIHRDIKPDNILIDRGGHIKLSDFGLSTG 150 (377)
T ss_pred eCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHEEECCCCCEEEeecccccc
Confidence 99999999999975 457899999999999999999999999 99999999999999999999999999964
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.5e-28 Score=261.85 Aligned_cols=165 Identities=29% Similarity=0.449 Sum_probs=149.2
Q ss_pred cCCeeEeeeecccCceEEEEEEE--cCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeEEEEE
Q 005841 504 WEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVT 581 (674)
Q Consensus 504 ~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 581 (674)
...|....+||+|+-|.||.+.. ++..||||.+.......+ +-+.+|+.+|+.++|+|||.++..|-..+.+|+||
T Consensus 272 ~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~k--eLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVM 349 (550)
T KOG0578|consen 272 RSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKK--ELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVM 349 (550)
T ss_pred hhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCch--hhhHHHHHHHHhccchHHHHHHHHhcccceeEEEE
Confidence 35688889999999999999987 566799999987654332 45788999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccccCCccc
Q 005841 582 EFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLT 661 (674)
Q Consensus 582 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~~~~~ 661 (674)
|||+||+|-+.+... .+++.++..|.++++.||+|||..+ |||||||.+|||++.+|.|||+|||+|..+......
T Consensus 350 Eym~ggsLTDvVt~~--~~~E~qIA~Icre~l~aL~fLH~~g--IiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~K 425 (550)
T KOG0578|consen 350 EYMEGGSLTDVVTKT--RMTEGQIAAICREILQGLKFLHARG--IIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQSK 425 (550)
T ss_pred eecCCCchhhhhhcc--cccHHHHHHHHHHHHHHHHHHHhcc--eeeeccccceeEeccCCcEEEeeeeeeeccccccCc
Confidence 999999999999653 4999999999999999999999999 999999999999999999999999999998877767
Q ss_pred cccCCCCccccCC
Q 005841 662 TKTGKGTVTYLAS 674 (674)
Q Consensus 662 ~~~~~GTp~YmAP 674 (674)
..+.+|||+||||
T Consensus 426 R~TmVGTPYWMAP 438 (550)
T KOG0578|consen 426 RSTMVGTPYWMAP 438 (550)
T ss_pred cccccCCCCccch
Confidence 7778999999998
|
|
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.4e-27 Score=252.86 Aligned_cols=168 Identities=22% Similarity=0.339 Sum_probs=146.4
Q ss_pred CCeeEeeeecccCceEEEEEEE--cCCeEEEEEeecccC-CHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeEEEEE
Q 005841 505 EDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEY-SDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVT 581 (674)
Q Consensus 505 ~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 581 (674)
++|++.+.||+|+||+||++.. .+..||||++.+... .......+.+|+.+++.++|+||+.+++++.+.+.+|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 4799999999999999999997 467899999976432 2234566888999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccccCCcc-
Q 005841 582 EFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYL- 660 (674)
Q Consensus 582 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~~~~- 660 (674)
||+++++|.+++.+....+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||++........
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 158 (331)
T cd05597 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLG--YVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTV 158 (331)
T ss_pred ecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eEECCCCHHHEEECCCCCEEEEECCceeecCCCCCc
Confidence 999999999999876678999999999999999999999999 99999999999999999999999999976543322
Q ss_pred ccccCCCCccccCC
Q 005841 661 TTKTGKGTVTYLAS 674 (674)
Q Consensus 661 ~~~~~~GTp~YmAP 674 (674)
......||+.||||
T Consensus 159 ~~~~~~gt~~y~aP 172 (331)
T cd05597 159 QSNVAVGTPDYISP 172 (331)
T ss_pred cccceeccccccCH
Confidence 22224699999998
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=9e-28 Score=254.04 Aligned_cols=162 Identities=33% Similarity=0.505 Sum_probs=144.6
Q ss_pred eeeecccCceEEEEEEE--cCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeEEEEEecCCCC
Q 005841 510 GEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRG 587 (674)
Q Consensus 510 ~~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg 587 (674)
.++||.|-||+||-|.+ +|+.||||+|.+-.+..+....+++|+.||+.+.||.||.+...|++++++|+|||.+.|.
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GD 648 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGD 648 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcch
Confidence 36899999999999987 6889999999998887766688999999999999999999999999999999999999664
Q ss_pred CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCC---CcEEEEecCCcccccCCcccccc
Q 005841 588 SLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKH---WTVKVGDFGLSRLKHETYLTTKT 664 (674)
Q Consensus 588 sL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~---~~vkL~DFGla~~~~~~~~~~~~ 664 (674)
-|.-+|....+++++....+++.||+.||.|||.++ |+|+||||+|||+... =+|||||||+|+++.+..+.. +
T Consensus 649 MLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~kn--IvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksFRr-s 725 (888)
T KOG4236|consen 649 MLEMILSSEKGRLPERITKFLVTQILVALRYLHFKN--IVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSFRR-S 725 (888)
T ss_pred HHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcc--eeeccCCchheeeccCCCCCceeeccccceeecchhhhhh-h
Confidence 455556667789999999999999999999999999 9999999999999754 379999999999998765554 4
Q ss_pred CCCCccccCC
Q 005841 665 GKGTVTYLAS 674 (674)
Q Consensus 665 ~~GTp~YmAP 674 (674)
.+|||.|+||
T Consensus 726 VVGTPAYLaP 735 (888)
T KOG4236|consen 726 VVGTPAYLAP 735 (888)
T ss_pred hcCCccccCH
Confidence 6899999998
|
|
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.3e-27 Score=256.94 Aligned_cols=146 Identities=21% Similarity=0.329 Sum_probs=132.6
Q ss_pred CeeEeeeecccCceEEEEEEE--cCCeEEEEEeecccC-CHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeEEEEEe
Q 005841 506 DLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEY-SDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTE 582 (674)
Q Consensus 506 ~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E 582 (674)
.|++++.||+|+||+||+|.+ ++..||||++.+... .......+.+|+.+++.++||||+++++++.+.+.+|||||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 589999999999999999987 466799999976543 33456778999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCccc
Q 005841 583 FLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL 654 (674)
Q Consensus 583 ~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~ 654 (674)
||++|+|.+++... ..+++..+..++.||+.||.|||..+ |+||||||+||||+.++++||+|||+++.
T Consensus 82 ~~~gg~L~~~l~~~-~~~~e~~~~~~~~qi~~aL~~LH~~g--ivHrDlKp~Nili~~~~~~kL~DFGl~~~ 150 (381)
T cd05626 82 YIPGGDMMSLLIRM-EVFPEVLARFYIAELTLAIESVHKMG--FIHRDIKPDNILIDLDGHIKLTDFGLCTG 150 (381)
T ss_pred cCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--eeecCCcHHHEEECCCCCEEEeeCcCCcc
Confidence 99999999999753 46899999999999999999999999 99999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=99.95 E-value=5e-27 Score=251.50 Aligned_cols=168 Identities=21% Similarity=0.322 Sum_probs=146.2
Q ss_pred CCeeEeeeecccCceEEEEEEE--cCCeEEEEEeecccC-CHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeEEEEE
Q 005841 505 EDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEY-SDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVT 581 (674)
Q Consensus 505 ~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 581 (674)
++|.+.+.||+|+||.||++.+ .+..||+|++.+... .......+.+|+.++..+.|+||+.+++++...+.+||||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 4799999999999999999987 456799999976432 2234456788999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccccCCcc-
Q 005841 582 EFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYL- 660 (674)
Q Consensus 582 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~~~~- 660 (674)
||+++|+|.+++.+....+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++.......
T Consensus 81 Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~--iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 158 (331)
T cd05624 81 DYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLH--YVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTV 158 (331)
T ss_pred eCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCchHHEEEcCCCCEEEEeccceeeccCCCce
Confidence 999999999999876678999999999999999999999999 99999999999999999999999999987654322
Q ss_pred ccccCCCCccccCC
Q 005841 661 TTKTGKGTVTYLAS 674 (674)
Q Consensus 661 ~~~~~~GTp~YmAP 674 (674)
.....+||+.||||
T Consensus 159 ~~~~~~gt~~y~aP 172 (331)
T cd05624 159 QSSVAVGTPDYISP 172 (331)
T ss_pred eeccccCCcccCCH
Confidence 22335799999998
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.7e-27 Score=251.65 Aligned_cols=164 Identities=26% Similarity=0.376 Sum_probs=145.5
Q ss_pred CCeeEeeeecccCceEEEEEEE--cCCeEEEEEeecccCCH-HHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeEEEEE
Q 005841 505 EDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSD-EVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVT 581 (674)
Q Consensus 505 ~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 581 (674)
++|++.+.||+|+||.||+|.+ .+..||||++.+..... .....+.+|+.++..++||||+++++++...+.+||||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 4699999999999999999998 46789999997654322 34567888999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccccCCccc
Q 005841 582 EFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLT 661 (674)
Q Consensus 582 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~~~~~ 661 (674)
||+++++|.+++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.... .
T Consensus 81 e~~~g~~L~~~l~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~---~ 154 (333)
T cd05600 81 EYVPGGDFRTLLNN-LGVLSEDHARFYMAEMFEAVDALHELG--YIHRDLKPENFLIDASGHIKLTDFGLSKGIVT---Y 154 (333)
T ss_pred eCCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEECCCCCEEEEeCcCCccccc---c
Confidence 99999999999965 446899999999999999999999999 99999999999999999999999999986654 2
Q ss_pred cccCCCCccccCC
Q 005841 662 TKTGKGTVTYLAS 674 (674)
Q Consensus 662 ~~~~~GTp~YmAP 674 (674)
....+||+.||||
T Consensus 155 ~~~~~gt~~y~aP 167 (333)
T cd05600 155 ANSVVGSPDYMAP 167 (333)
T ss_pred cCCcccCccccCh
Confidence 3346799999998
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.7e-27 Score=256.01 Aligned_cols=146 Identities=21% Similarity=0.335 Sum_probs=131.4
Q ss_pred CCeeEeeeecccCceEEEEEEE--cCCeEEEEEeecccCC-HHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeEEEEE
Q 005841 505 EDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYS-DEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVT 581 (674)
Q Consensus 505 ~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 581 (674)
.+|++++.||+|+||.||++.. ++..||||++.+.... ......+.+|+.++..+.||||+++++.+..++.+||||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 3699999999999999999987 4677999999754332 234566888999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcc
Q 005841 582 EFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSR 653 (674)
Q Consensus 582 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~ 653 (674)
|||++++|.+++.+. ..+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+|.
T Consensus 81 E~~~~g~L~~~i~~~-~~~~~~~~~~~~~qi~~al~~lH~~~--ivHrDlkp~Nill~~~~~ikL~DFG~a~ 149 (376)
T cd05598 81 DYIPGGDMMSLLIRL-GIFEEDLARFYIAELTCAIESVHKMG--FIHRDIKPDNILIDRDGHIKLTDFGLCT 149 (376)
T ss_pred eCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCCHHHEEECCCCCEEEEeCCCCc
Confidence 999999999999754 46899999999999999999999999 9999999999999999999999999985
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.3e-28 Score=259.67 Aligned_cols=168 Identities=27% Similarity=0.454 Sum_probs=153.8
Q ss_pred CCeeEeeeecccCceEEEEEEEc--CCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCe-EEEEE
Q 005841 505 EDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQR-LCIVT 581 (674)
Q Consensus 505 ~~y~~~~~LG~G~fG~Vy~~~~~--~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~-~~lV~ 581 (674)
++|++++++|+|+||.+++++++ ++.|++|.+..............+|+.++++++|||||.+.+.|..++. +||||
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm 83 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM 83 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence 67999999999999999999874 5569999998888777777788999999999999999999999999988 99999
Q ss_pred ecCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccccCCcc
Q 005841 582 EFLPRGSLFRLLQRNT-TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYL 660 (674)
Q Consensus 582 E~~~ggsL~~~l~~~~-~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~~~~ 660 (674)
+||+||+|.+.|.+.+ ..|+++.+..++.|++.||.|||+.+ |+|||||+.|||+++++.|||.|||+|+.+.....
T Consensus 84 ~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~--iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~~ 161 (426)
T KOG0589|consen 84 EYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENR--VLHRDLKCANIFLTKDKKVKLGDFGLAKILNPEDS 161 (426)
T ss_pred eecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhh--hhcccchhhhhhccccCceeecchhhhhhcCCchh
Confidence 9999999999998765 67999999999999999999999888 99999999999999999999999999999887664
Q ss_pred ccccCCCCccccCC
Q 005841 661 TTKTGKGTVTYLAS 674 (674)
Q Consensus 661 ~~~~~~GTp~YmAP 674 (674)
...+..|||.||.|
T Consensus 162 ~a~tvvGTp~YmcP 175 (426)
T KOG0589|consen 162 LASTVVGTPYYMCP 175 (426)
T ss_pred hhheecCCCcccCH
Confidence 55567899999998
|
|
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.3e-27 Score=256.23 Aligned_cols=146 Identities=21% Similarity=0.330 Sum_probs=132.1
Q ss_pred CeeEeeeecccCceEEEEEEE--cCCeEEEEEeecccC-CHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeEEEEEe
Q 005841 506 DLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEY-SDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTE 582 (674)
Q Consensus 506 ~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E 582 (674)
+|+++++||+|+||+||+|.. .+..||||++.+... .......+.+|+.+++.++||||+++++.+.+.+.+|||||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 589999999999999999987 466799999976543 23456678899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCccc
Q 005841 583 FLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL 654 (674)
Q Consensus 583 ~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~ 654 (674)
||++|+|.+++.+. ..+++..+..++.||+.||+|||+++ ||||||||+||||+.++.+||+|||+|+.
T Consensus 82 ~~~gg~L~~~l~~~-~~~~e~~~~~~~~qi~~al~~lH~~~--ivHrDlKp~NILl~~~g~~kL~DFGla~~ 150 (382)
T cd05625 82 YIPGGDMMSLLIRM-GIFPEDLARFYIAELTCAVESVHKMG--FIHRDIKPDNILIDRDGHIKLTDFGLCTG 150 (382)
T ss_pred CCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEECCCCCEEEeECCCCcc
Confidence 99999999999754 46899999999999999999999999 99999999999999999999999999853
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-27 Score=246.85 Aligned_cols=168 Identities=31% Similarity=0.409 Sum_probs=143.0
Q ss_pred cCCeeEeeeecccCceEEEEEEE--cCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCC-eeeEEEEEecCC-----
Q 005841 504 WEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPN-VLLFMGAVTSPQ----- 575 (674)
Q Consensus 504 ~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hpn-Iv~l~~~~~~~~----- 575 (674)
...|..+++||+|+||+||+|+. +|..||+|.+....-.+-.-....+|+.+++.|+|+| |+.+++++.+..
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~ 89 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI 89 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence 35577888999999999999987 5778999999766432223345678999999999999 999999998877
Q ss_pred -eEEEEEecCCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCC
Q 005841 576 -RLCIVTEFLPRGSLFRLLQRNT---TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGL 651 (674)
Q Consensus 576 -~~~lV~E~~~ggsL~~~l~~~~---~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGl 651 (674)
.+++||||++ .+|..++.... ..++...+..++.||+.||+|||+++ |+||||||.||||++.|.+||+|||+
T Consensus 90 ~~l~lvfe~~d-~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~--IlHRDLKPQNlLi~~~G~lKlaDFGl 166 (323)
T KOG0594|consen 90 GKLYLVFEFLD-RDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHG--ILHRDLKPQNLLISSSGVLKLADFGL 166 (323)
T ss_pred ceEEEEEEeec-ccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCC--eecccCCcceEEECCCCcEeeeccch
Confidence 8999999994 49999998766 45888999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCccccccCCCCccccCC
Q 005841 652 SRLKHETYLTTKTGKGTVTYLAS 674 (674)
Q Consensus 652 a~~~~~~~~~~~~~~GTp~YmAP 674 (674)
|+.+.-+..+-..-++|.-|.||
T Consensus 167 Ara~~ip~~~yt~evvTlWYRaP 189 (323)
T KOG0594|consen 167 ARAFSIPMRTYTPEVVTLWYRAP 189 (323)
T ss_pred HHHhcCCcccccccEEEeeccCH
Confidence 99766443333335789999988
|
|
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.2e-27 Score=253.24 Aligned_cols=168 Identities=30% Similarity=0.473 Sum_probs=147.2
Q ss_pred ccccCCeeEeeeecccCceEEEEEEEcC---CeEEEEEeecccC-CHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCe
Q 005841 501 EILWEDLTIGEQIGQGSCGTVYHAVWYG---SDVAVKVFSRQEY-SDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQR 576 (674)
Q Consensus 501 ~~~~~~y~~~~~LG~G~fG~Vy~~~~~~---~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 576 (674)
.+..++|.+.+.||+|+||.||+|.+.+ ..||+|++.+... .......+.+|+.+++.++||||+++++++...+.
T Consensus 26 ~~~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~ 105 (340)
T PTZ00426 26 KMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESY 105 (340)
T ss_pred CCChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCE
Confidence 4456789999999999999999998642 4699999976543 23445678899999999999999999999999999
Q ss_pred EEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCccccc
Q 005841 577 LCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKH 656 (674)
Q Consensus 577 ~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~ 656 (674)
+||||||+++++|.+++... ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 106 ~~lv~Ey~~~g~L~~~i~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~ 182 (340)
T PTZ00426 106 LYLVLEFVIGGEFFTFLRRN-KRFPNDVGCFYAAQIVLIFEYLQSLN--IVYRDLKPENLLLDKDGFIKMTDFGFAKVVD 182 (340)
T ss_pred EEEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eEccCCCHHHEEECCCCCEEEecCCCCeecC
Confidence 99999999999999999754 46999999999999999999999999 9999999999999999999999999998764
Q ss_pred CCccccccCCCCccccCC
Q 005841 657 ETYLTTKTGKGTVTYLAS 674 (674)
Q Consensus 657 ~~~~~~~~~~GTp~YmAP 674 (674)
.. ....+||+.||||
T Consensus 183 ~~---~~~~~gt~~y~aP 197 (340)
T PTZ00426 183 TR---TYTLCGTPEYIAP 197 (340)
T ss_pred CC---cceecCChhhcCH
Confidence 32 2346799999998
|
|
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.1e-27 Score=253.19 Aligned_cols=148 Identities=26% Similarity=0.410 Sum_probs=133.6
Q ss_pred CCeeEeeeecccCceEEEEEEE--cCCeEEEEEeecccC-CHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeEEEEE
Q 005841 505 EDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEY-SDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVT 581 (674)
Q Consensus 505 ~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 581 (674)
++|++.+.||+|+||+||++.. ++..||||++.+... .......+..|+.++..++||||+++++.+.+.+.+||||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 4689999999999999999987 467899999976433 2345667888999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccc
Q 005841 582 EFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLK 655 (674)
Q Consensus 582 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~ 655 (674)
|||++++|.+++.+ ...+++..+..++.|++.||.|||+++ |+||||||+||||+.++.+||+|||+++.+
T Consensus 81 E~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~~L~~lH~~g--ivHrDLkp~NIli~~~~~vkL~DfG~~~~~ 151 (360)
T cd05627 81 EFLPGGDMMTLLMK-KDTLSEEATQFYIAETVLAIDAIHQLG--FIHRDIKPDNLLLDAKGHVKLSDFGLCTGL 151 (360)
T ss_pred eCCCCccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCC--eEccCCCHHHEEECCCCCEEEeeccCCccc
Confidence 99999999999975 446899999999999999999999999 999999999999999999999999998754
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.1e-27 Score=248.27 Aligned_cols=164 Identities=28% Similarity=0.417 Sum_probs=145.0
Q ss_pred CCeeEeeeecccCceEEEEEEEc--CCeEEEEEeecccCC-HHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeEEEEE
Q 005841 505 EDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYS-DEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVT 581 (674)
Q Consensus 505 ~~y~~~~~LG~G~fG~Vy~~~~~--~~~vAvK~i~~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 581 (674)
++|++.+.||+|+||.||+|.+. +..||||++...... ......+.+|+.+++.++||||+++++++.+...+|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 46899999999999999999984 778999999765432 244567889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccccCCccc
Q 005841 582 EFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLT 661 (674)
Q Consensus 582 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~~~~~ 661 (674)
||+++++|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 81 e~~~~~~L~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~--- 154 (291)
T cd05612 81 EYVPGGELFSYLRN-SGRFSNSTGLFYASEIVCALEYLHSKE--IVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR--- 154 (291)
T ss_pred eCCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHeEECCCCCEEEEecCcchhccCC---
Confidence 99999999999975 447899999999999999999999999 999999999999999999999999999876543
Q ss_pred cccCCCCccccCC
Q 005841 662 TKTGKGTVTYLAS 674 (674)
Q Consensus 662 ~~~~~GTp~YmAP 674 (674)
....+||+.|+||
T Consensus 155 ~~~~~gt~~y~aP 167 (291)
T cd05612 155 TWTLCGTPEYLAP 167 (291)
T ss_pred cccccCChhhcCH
Confidence 2235799999998
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.9e-27 Score=250.19 Aligned_cols=161 Identities=30% Similarity=0.450 Sum_probs=140.7
Q ss_pred eeecccCceEEEEEEE--cCCeEEEEEeecccC-CHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeEEEEEecCCCC
Q 005841 511 EQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEY-SDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRG 587 (674)
Q Consensus 511 ~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg 587 (674)
++||+|+||.||++.. .+..||||++.+... .......+.+|+.+++.++||||+++++++...+.+||||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 4699999999999987 467899999976543 2345567888999999999999999999999999999999999999
Q ss_pred CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccccCCccccccCCC
Q 005841 588 SLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKG 667 (674)
Q Consensus 588 sL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~~~~~~~~~~G 667 (674)
+|.+++.. ...+++..+..++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++............+|
T Consensus 81 ~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~g 157 (328)
T cd05593 81 ELFFHLSR-ERVFSEDRTRFYGAEIVSALDYLHSGK--IVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCG 157 (328)
T ss_pred CHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCC--eEecccCHHHeEECCCCcEEEecCcCCccCCCcccccccccC
Confidence 99998865 347999999999999999999999999 999999999999999999999999999865433333445679
Q ss_pred CccccCC
Q 005841 668 TVTYLAS 674 (674)
Q Consensus 668 Tp~YmAP 674 (674)
|+.||||
T Consensus 158 t~~y~aP 164 (328)
T cd05593 158 TPEYLAP 164 (328)
T ss_pred CcCccCh
Confidence 9999998
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.9e-27 Score=249.49 Aligned_cols=168 Identities=24% Similarity=0.406 Sum_probs=148.1
Q ss_pred CCeeEeeeecccCceEEEEEEE--cCCeEEEEEeecccC-CHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeEEEEE
Q 005841 505 EDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEY-SDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVT 581 (674)
Q Consensus 505 ~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 581 (674)
++|.+.+.||+|+||.||++.+ .+..||||++.+... .......+.+|+.+++.++|+||+++++++...+.+||||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 4799999999999999999987 567899999986544 2345567889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccccCCcc-
Q 005841 582 EFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYL- 660 (674)
Q Consensus 582 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~~~~- 660 (674)
||+++++|.+++.+....+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||++..+.....
T Consensus 81 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~--i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~ 158 (330)
T cd05601 81 EYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMG--YVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMV 158 (330)
T ss_pred CCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEcccCchHheEECCCCCEEeccCCCCeECCCCCce
Confidence 999999999999877678999999999999999999999999 99999999999999999999999999987654322
Q ss_pred ccccCCCCccccCC
Q 005841 661 TTKTGKGTVTYLAS 674 (674)
Q Consensus 661 ~~~~~~GTp~YmAP 674 (674)
......||+.||||
T Consensus 159 ~~~~~~gt~~y~aP 172 (330)
T cd05601 159 NSKLPVGTPDYIAP 172 (330)
T ss_pred eeecccCCccccCH
Confidence 22335799999998
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.3e-27 Score=253.97 Aligned_cols=170 Identities=25% Similarity=0.366 Sum_probs=147.3
Q ss_pred ccccCCeeEeeeecccCceEEEEEEE--cCCeEEEEEeecccC-CHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeE
Q 005841 501 EILWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEY-SDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRL 577 (674)
Q Consensus 501 ~~~~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 577 (674)
.+..++|++.+.||+|+||.||+|.+ ++..||+|++.+... .......+.+|+.+++.++||||+++++++.....+
T Consensus 39 ~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~ 118 (371)
T cd05622 39 RMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYL 118 (371)
T ss_pred CcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEE
Confidence 45568999999999999999999998 466799999976433 223345678899999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccccC
Q 005841 578 CIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHE 657 (674)
Q Consensus 578 ~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~ 657 (674)
|+||||+++++|.+++... .+++..+..++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++....
T Consensus 119 ~lv~Ey~~gg~L~~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~ 194 (371)
T cd05622 119 YMVMEYMPGGDLVNLMSNY--DVPEKWARFYTAEVVLALDAIHSMG--FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNK 194 (371)
T ss_pred EEEEcCCCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHHCC--EEeCCCCHHHEEECCCCCEEEEeCCceeEcCc
Confidence 9999999999999999653 5899999999999999999999999 99999999999999999999999999987654
Q ss_pred Ccc-ccccCCCCccccCC
Q 005841 658 TYL-TTKTGKGTVTYLAS 674 (674)
Q Consensus 658 ~~~-~~~~~~GTp~YmAP 674 (674)
... .....+||+.||||
T Consensus 195 ~~~~~~~~~~gt~~y~aP 212 (371)
T cd05622 195 EGMVRCDTAVGTPDYISP 212 (371)
T ss_pred CCcccccCcccCccccCH
Confidence 322 23346799999998
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.1e-27 Score=250.01 Aligned_cols=161 Identities=29% Similarity=0.439 Sum_probs=140.3
Q ss_pred eeecccCceEEEEEEE--cCCeEEEEEeecccC-CHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeEEEEEecCCCC
Q 005841 511 EQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEY-SDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRG 587 (674)
Q Consensus 511 ~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg 587 (674)
+.||+|+||.||++.. .+..||+|++.+... .......+.+|+.+++.++||||+++++++...+.+||||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 4699999999999987 567899999976543 2344566788999999999999999999999999999999999999
Q ss_pred CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccccCCccccccCCC
Q 005841 588 SLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKG 667 (674)
Q Consensus 588 sL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~~~~~~~~~~G 667 (674)
+|..++... ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.............|
T Consensus 81 ~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~g 157 (323)
T cd05595 81 ELFFHLSRE-RVFTEERARFYGAEIVSALEYLHSRD--VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCG 157 (323)
T ss_pred cHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHEEEcCCCCEEecccHHhccccCCCCccccccC
Confidence 999988653 47899999999999999999999999 999999999999999999999999999864433333445679
Q ss_pred CccccCC
Q 005841 668 TVTYLAS 674 (674)
Q Consensus 668 Tp~YmAP 674 (674)
|+.||||
T Consensus 158 t~~y~aP 164 (323)
T cd05595 158 TPEYLAP 164 (323)
T ss_pred CcCcCCc
Confidence 9999998
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.7e-27 Score=252.90 Aligned_cols=167 Identities=25% Similarity=0.440 Sum_probs=147.3
Q ss_pred CCeeEeeeecccCceEEEEEEEc--CCeEEEEEeecccCCH-HHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeEEEEE
Q 005841 505 EDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSD-EVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVT 581 (674)
Q Consensus 505 ~~y~~~~~LG~G~fG~Vy~~~~~--~~~vAvK~i~~~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 581 (674)
++|.+.+.||+|+||+||+|.+. +..||||++.+..... .....+..|+.++..++||||+++++++.+.+.+|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 47999999999999999999985 7789999998654332 45567889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccccCCc--
Q 005841 582 EFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETY-- 659 (674)
Q Consensus 582 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~~~-- 659 (674)
||+++++|.+++.+. ..+++..+..++.||+.||.|||.++ |+||||||+||||+.++.+||+|||+++......
T Consensus 81 e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~g--iiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~ 157 (350)
T cd05573 81 EYMPGGDLMNLLIRK-DVFPEETARFYIAELVLALDSVHKLG--FIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDR 157 (350)
T ss_pred cCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHeEECCCCCEEeecCCCCccCcccCcc
Confidence 999999999999765 67999999999999999999999998 9999999999999999999999999998765433
Q ss_pred ---------------------------cccccCCCCccccCC
Q 005841 660 ---------------------------LTTKTGKGTVTYLAS 674 (674)
Q Consensus 660 ---------------------------~~~~~~~GTp~YmAP 674 (674)
.......||+.|+||
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP 199 (350)
T cd05573 158 EYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAP 199 (350)
T ss_pred cccccccccccccccccccccccccccccccccccCccccCH
Confidence 122335799999998
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.1e-27 Score=245.00 Aligned_cols=166 Identities=28% Similarity=0.404 Sum_probs=143.6
Q ss_pred CCeeEeeeecccCceEEEEEEE--cCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeEEEEEe
Q 005841 505 EDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTE 582 (674)
Q Consensus 505 ~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E 582 (674)
++|++.++||.|+||.||+|.. ++..||+|++...... .....+.+|+.+++.++||||+++++++.....+|+|||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEE-GAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFE 83 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccC-CcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEe
Confidence 6799999999999999999987 4677999998654322 223456789999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccccCCcccc
Q 005841 583 FLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTT 662 (674)
Q Consensus 583 ~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~~~~~~ 662 (674)
|+++ +|.+++......+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.........
T Consensus 84 ~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~~~ 160 (288)
T cd07871 84 YLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRK--ILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTY 160 (288)
T ss_pred CCCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEECCCCCEEECcCcceeeccCCCccc
Confidence 9975 999999776667899999999999999999999999 9999999999999999999999999998654433333
Q ss_pred ccCCCCccccCC
Q 005841 663 KTGKGTVTYLAS 674 (674)
Q Consensus 663 ~~~~GTp~YmAP 674 (674)
....||+.||||
T Consensus 161 ~~~~~~~~y~aP 172 (288)
T cd07871 161 SNEVVTLWYRPP 172 (288)
T ss_pred cCceecccccCh
Confidence 345789999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=99.95 E-value=1e-26 Score=248.25 Aligned_cols=161 Identities=30% Similarity=0.438 Sum_probs=139.5
Q ss_pred eeecccCceEEEEEEE--cCCeEEEEEeecccC-CHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeEEEEEecCCCC
Q 005841 511 EQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEY-SDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRG 587 (674)
Q Consensus 511 ~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg 587 (674)
+.||+|+||+||++.+ ++..||+|++.+... .......+.+|+.++..++||||+.+++++...+.+||||||++++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 4699999999999987 567899999986543 2234566788999999999999999999999999999999999999
Q ss_pred CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCeEEccCCCCCEEEcCCCcEEEEecCCcccccCCccccccCC
Q 005841 588 SLFRLLQRNTTKLDWRRRILMALDIARGVSYLHH-CNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGK 666 (674)
Q Consensus 588 sL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~-~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~~~~~~~~~~ 666 (674)
+|..++.. ...+++..+..++.||+.||.|||+ .+ |+||||||+||||+.++.+||+|||+++............+
T Consensus 81 ~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~lH~~~~--ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~ 157 (325)
T cd05594 81 ELFFHLSR-ERVFSEDRARFYGAEIVSALDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFC 157 (325)
T ss_pred cHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCC--EEecCCCCCeEEECCCCCEEEecCCCCeecCCCCccccccc
Confidence 99998865 3478999999999999999999997 78 99999999999999999999999999986543333344567
Q ss_pred CCccccCC
Q 005841 667 GTVTYLAS 674 (674)
Q Consensus 667 GTp~YmAP 674 (674)
||+.||||
T Consensus 158 gt~~y~aP 165 (325)
T cd05594 158 GTPEYLAP 165 (325)
T ss_pred CCcccCCH
Confidence 99999998
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.9e-29 Score=244.35 Aligned_cols=168 Identities=24% Similarity=0.387 Sum_probs=149.6
Q ss_pred ccCCeeEeeeecccCceEEEEEEE--cCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeEEEE
Q 005841 503 LWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIV 580 (674)
Q Consensus 503 ~~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 580 (674)
..+.|.+.++||+|.|+.||+|.+ +|..+|+|+++...+.....+.+.+|+.|...|+||||++++..+......|||
T Consensus 9 f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylv 88 (355)
T KOG0033|consen 9 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 88 (355)
T ss_pred cchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEE
Confidence 346799999999999999999987 677899999988777766678899999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEc---CCCcEEEEecCCcccccC
Q 005841 581 TEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVD---KHWTVKVGDFGLSRLKHE 657 (674)
Q Consensus 581 ~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~---~~~~vkL~DFGla~~~~~ 657 (674)
+|+|.|++|+.-|-.. ..+++..+-++++||+.+|.|||.++ |||||+||+|+|+- ..--|||+|||+|..+.
T Consensus 89 Fe~m~G~dl~~eIV~R-~~ySEa~aSH~~rQiLeal~yCH~n~--IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~- 164 (355)
T KOG0033|consen 89 FDLVTGGELFEDIVAR-EFYSEADASHCIQQILEALAYCHSNG--IVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN- 164 (355)
T ss_pred EecccchHHHHHHHHH-HHHHHHHHHHHHHHHHHHHHHHHhcC--ceeccCChhheeeeeccCCCceeecccceEEEeC-
Confidence 9999999997655332 46889999999999999999999999 99999999999995 34469999999999888
Q ss_pred CccccccCCCCccccCC
Q 005841 658 TYLTTKTGKGTVTYLAS 674 (674)
Q Consensus 658 ~~~~~~~~~GTp~YmAP 674 (674)
.......++|||+||||
T Consensus 165 ~g~~~~G~~GtP~fmaP 181 (355)
T KOG0033|consen 165 DGEAWHGFAGTPGYLSP 181 (355)
T ss_pred CccccccccCCCcccCH
Confidence 55666678999999998
|
|
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.3e-26 Score=248.40 Aligned_cols=168 Identities=22% Similarity=0.343 Sum_probs=145.5
Q ss_pred CCeeEeeeecccCceEEEEEEEc--CCeEEEEEeecccC-CHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeEEEEE
Q 005841 505 EDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEY-SDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVT 581 (674)
Q Consensus 505 ~~y~~~~~LG~G~fG~Vy~~~~~--~~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 581 (674)
++|++.++||+|+||.||++.+. +..||+|++.+... .......+.+|+.++..++|+||+.+++++...+.+||||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 47999999999999999999984 56699999975432 2233456788999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccccCCc-c
Q 005841 582 EFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETY-L 660 (674)
Q Consensus 582 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~~~-~ 660 (674)
||+++|+|.+++.+....+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++..+.... .
T Consensus 81 ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~--iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~~ 158 (332)
T cd05623 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLH--YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTV 158 (332)
T ss_pred eccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHEEECCCCCEEEeecchheecccCCcc
Confidence 999999999999876678999999999999999999999999 9999999999999999999999999997654322 2
Q ss_pred ccccCCCCccccCC
Q 005841 661 TTKTGKGTVTYLAS 674 (674)
Q Consensus 661 ~~~~~~GTp~YmAP 674 (674)
.....+||+.||||
T Consensus 159 ~~~~~~gt~~y~aP 172 (332)
T cd05623 159 QSSVAVGTPDYISP 172 (332)
T ss_pred eecccccCccccCH
Confidence 22335799999998
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=1e-26 Score=245.48 Aligned_cols=166 Identities=31% Similarity=0.457 Sum_probs=143.9
Q ss_pred CCeeEeeeecccCceEEEEEEE--cCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeEEEEEe
Q 005841 505 EDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTE 582 (674)
Q Consensus 505 ~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E 582 (674)
++|++.+.||+|+||.||+|.. ++..||||++....... ....+.+|+.+++.++||||+++++++......|+|||
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (303)
T cd07869 5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEG-TPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE 83 (303)
T ss_pred ccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccc-cchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence 6799999999999999999998 46789999987543222 22456789999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccccCCcccc
Q 005841 583 FLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTT 662 (674)
Q Consensus 583 ~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~~~~~~ 662 (674)
|++ ++|.+++......+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.........
T Consensus 84 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 160 (303)
T cd07869 84 YVH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRY--ILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTY 160 (303)
T ss_pred CCC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEECCCCCEEECCCCcceeccCCCccC
Confidence 995 6888888776677999999999999999999999999 9999999999999999999999999998654433333
Q ss_pred ccCCCCccccCC
Q 005841 663 KTGKGTVTYLAS 674 (674)
Q Consensus 663 ~~~~GTp~YmAP 674 (674)
....||+.||||
T Consensus 161 ~~~~~~~~y~aP 172 (303)
T cd07869 161 SNEVVTLWYRPP 172 (303)
T ss_pred CCCcccCCCCCh
Confidence 446789999998
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=99.94 E-value=7.4e-27 Score=250.40 Aligned_cols=172 Identities=28% Similarity=0.500 Sum_probs=142.3
Q ss_pred cccccCCeeEeeeecccCceEEEEEEEc-------CCeEEEEEeecccCCHHHHHHHHHHHHHHhhC-CCCCeeeEEEEE
Q 005841 500 YEILWEDLTIGEQIGQGSCGTVYHAVWY-------GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRL-RHPNVLLFMGAV 571 (674)
Q Consensus 500 ~~~~~~~y~~~~~LG~G~fG~Vy~~~~~-------~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~ 571 (674)
|.+..++|++.++||+|+||.||+|.+. +..||||++.... .......+.+|+.++..+ +||||+++++++
T Consensus 2 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~ 80 (338)
T cd05102 2 WEFPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGA-TASEHKALMSELKILIHIGNHLNVVNLLGAC 80 (338)
T ss_pred cccchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheecccccc-chHHHHHHHHHHHHHHHhccCcceeeEEeEe
Confidence 4667789999999999999999999752 3469999986433 334456788999999999 899999999988
Q ss_pred ecC-CeEEEEEecCCCCCHHHHHHhcC-----------------------------------------------------
Q 005841 572 TSP-QRLCIVTEFLPRGSLFRLLQRNT----------------------------------------------------- 597 (674)
Q Consensus 572 ~~~-~~~~lV~E~~~ggsL~~~l~~~~----------------------------------------------------- 597 (674)
... ..+|+||||+++|+|.+++....
T Consensus 81 ~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (338)
T cd05102 81 TKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPP 160 (338)
T ss_pred cCCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccc
Confidence 764 45899999999999999987532
Q ss_pred --------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccccCC--ccccccCCC
Q 005841 598 --------TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHET--YLTTKTGKG 667 (674)
Q Consensus 598 --------~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~~--~~~~~~~~G 667 (674)
..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++..... ........+
T Consensus 161 ~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~ 238 (338)
T cd05102 161 QETDDLWKSPLTMEDLICYSFQVARGMEFLASRK--CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARL 238 (338)
T ss_pred hhccccccCCCCHHHHHHHHHHHHHHHHHHHHCC--EECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCC
Confidence 24778899999999999999999998 999999999999999999999999999865332 122223456
Q ss_pred CccccCC
Q 005841 668 TVTYLAS 674 (674)
Q Consensus 668 Tp~YmAP 674 (674)
|+.||||
T Consensus 239 ~~~y~aP 245 (338)
T cd05102 239 PLKWMAP 245 (338)
T ss_pred CccccCc
Confidence 7899998
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.3e-28 Score=238.65 Aligned_cols=169 Identities=28% Similarity=0.469 Sum_probs=148.4
Q ss_pred cccCCeeEeeeecccCceEEEEEEE--cCCeEEEEEeecccC------CHHHHHHHHHHHHHHhhCC-CCCeeeEEEEEe
Q 005841 502 ILWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEY------SDEVIHSFRQEVSLMKRLR-HPNVLLFMGAVT 572 (674)
Q Consensus 502 ~~~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~------~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~ 572 (674)
-.+..|.-.+.||.|..++|.+|.+ ++..+|+|++..... ..+..+...+|+.||+++. ||+|+++.+.|+
T Consensus 14 ~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~ye 93 (411)
T KOG0599|consen 14 GFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYE 93 (411)
T ss_pred hHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeecc
Confidence 3456788889999999999999987 577899998864322 2256677889999999984 999999999999
Q ss_pred cCCeEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCc
Q 005841 573 SPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLS 652 (674)
Q Consensus 573 ~~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla 652 (674)
++..+|+|+|.|+.|.|+|+|.. ...++++....|++|++.|++|||.++ ||||||||+|||++++.+|||+|||+|
T Consensus 94 s~sF~FlVFdl~prGELFDyLts-~VtlSEK~tR~iMrqlfegVeylHa~~--IVHRDLKpENILlddn~~i~isDFGFa 170 (411)
T KOG0599|consen 94 SDAFVFLVFDLMPRGELFDYLTS-KVTLSEKETRRIMRQLFEGVEYLHARN--IVHRDLKPENILLDDNMNIKISDFGFA 170 (411)
T ss_pred CcchhhhhhhhcccchHHHHhhh-heeecHHHHHHHHHHHHHHHHHHHHhh--hhhcccChhheeeccccceEEecccee
Confidence 99999999999999999999964 557999999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCccccccCCCCccccCC
Q 005841 653 RLKHETYLTTKTGKGTVTYLAS 674 (674)
Q Consensus 653 ~~~~~~~~~~~~~~GTp~YmAP 674 (674)
..+... -.....||||.|+||
T Consensus 171 ~~l~~G-ekLrelCGTPgYLAP 191 (411)
T KOG0599|consen 171 CQLEPG-EKLRELCGTPGYLAP 191 (411)
T ss_pred eccCCc-hhHHHhcCCCcccCh
Confidence 987653 345568999999998
|
|
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=9.1e-27 Score=253.52 Aligned_cols=170 Identities=24% Similarity=0.348 Sum_probs=146.7
Q ss_pred ccccCCeeEeeeecccCceEEEEEEE--cCCeEEEEEeecccCC-HHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeE
Q 005841 501 EILWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYS-DEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRL 577 (674)
Q Consensus 501 ~~~~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 577 (674)
....++|++.++||+|+||.||++.+ ++..||+|++.+.... ......+.+|+.+++.++||||+++++++.+...+
T Consensus 39 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~ 118 (370)
T cd05596 39 RMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYL 118 (370)
T ss_pred CCCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 44567899999999999999999987 4677999999764332 23345577899999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccccC
Q 005841 578 CIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHE 657 (674)
Q Consensus 578 ~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~ 657 (674)
||||||+++|+|.+++.. ..+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||++.....
T Consensus 119 ~lv~Ey~~gg~L~~~l~~--~~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~ 194 (370)
T cd05596 119 YMVMEYMPGGDLVNLMSN--YDIPEKWARFYTAEVVLALDAIHSMG--FIHRDVKPDNMLLDKSGHLKLADFGTCMKMDA 194 (370)
T ss_pred EEEEcCCCCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHEEEcCCCCEEEEeccceeeccC
Confidence 999999999999999864 35889999999999999999999998 99999999999999999999999999987654
Q ss_pred Ccc-ccccCCCCccccCC
Q 005841 658 TYL-TTKTGKGTVTYLAS 674 (674)
Q Consensus 658 ~~~-~~~~~~GTp~YmAP 674 (674)
... .....+||+.||||
T Consensus 195 ~~~~~~~~~~gt~~y~aP 212 (370)
T cd05596 195 NGMVRCDTAVGTPDYISP 212 (370)
T ss_pred CCcccCCCCCCCcCeECH
Confidence 322 23346799999998
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.1e-26 Score=246.71 Aligned_cols=159 Identities=30% Similarity=0.429 Sum_probs=139.2
Q ss_pred ecccCceEEEEEEE--cCCeEEEEEeecccC-CHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeEEEEEecCCCCCH
Q 005841 513 IGQGSCGTVYHAVW--YGSDVAVKVFSRQEY-SDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSL 589 (674)
Q Consensus 513 LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL 589 (674)
||+|+||.||+|.+ ++..||+|++.+... .......+.+|+.+++.++||||+++++++...+.+|+||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 79999999999998 466799999976432 234456788899999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccccCCccccccCCCCc
Q 005841 590 FRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTV 669 (674)
Q Consensus 590 ~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~~~~~~~~~~GTp 669 (674)
.+++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++............+||+
T Consensus 81 ~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~ 157 (312)
T cd05585 81 FHHLQR-EGRFDLSRARFYTAELLCALENLHKFN--VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGTP 157 (312)
T ss_pred HHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCC--eEeCCCCHHHeEECCCCcEEEEECcccccCccCCCccccccCCc
Confidence 999975 457999999999999999999999999 99999999999999999999999999986544333344567999
Q ss_pred cccCC
Q 005841 670 TYLAS 674 (674)
Q Consensus 670 ~YmAP 674 (674)
.||||
T Consensus 158 ~y~aP 162 (312)
T cd05585 158 EYLAP 162 (312)
T ss_pred ccCCH
Confidence 99998
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.2e-28 Score=245.64 Aligned_cols=163 Identities=26% Similarity=0.419 Sum_probs=149.9
Q ss_pred CeeEeeeecccCceEEEEEEE--cCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeEEEEEec
Q 005841 506 DLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEF 583 (674)
Q Consensus 506 ~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~ 583 (674)
-|.++++||+|+||.||++.+ .|..||||.+.... -++.+.+||.||+++..|+||++|+.|.....++|||||
T Consensus 34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~s----DLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEY 109 (502)
T KOG0574|consen 34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDT----DLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEY 109 (502)
T ss_pred HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccc----hHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhh
Confidence 367888999999999999987 57789999885432 245677899999999999999999999999999999999
Q ss_pred CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccccCCccccc
Q 005841 584 LPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTK 663 (674)
Q Consensus 584 ~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~~~~~~~ 663 (674)
|..|++.++++..+..+++.++..+++..+.||+|||... -||||||..|||++.+|..||+|||.|..+.++-....
T Consensus 110 CGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~--KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMAKRN 187 (502)
T KOG0574|consen 110 CGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLK--KIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMAKRN 187 (502)
T ss_pred cCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHH--HHHhhcccccEEEcccchhhhhhccccchhhhhHHhhC
Confidence 9999999999988889999999999999999999999987 89999999999999999999999999999999888888
Q ss_pred cCCCCccccCC
Q 005841 664 TGKGTVTYLAS 674 (674)
Q Consensus 664 ~~~GTp~YmAP 674 (674)
+..|||.||||
T Consensus 188 TVIGTPFWMAP 198 (502)
T KOG0574|consen 188 TVIGTPFWMAP 198 (502)
T ss_pred ccccCcccccH
Confidence 88999999998
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.4e-26 Score=240.57 Aligned_cols=166 Identities=23% Similarity=0.329 Sum_probs=143.1
Q ss_pred CeeEeeeecccCceEEEEEEE--cCCeEEEEEeecccCCH-HHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeEEEEEe
Q 005841 506 DLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSD-EVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTE 582 (674)
Q Consensus 506 ~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E 582 (674)
.|++.+.||+|+||.||+|.+ ++..||+|++.+..... .....+.+|+.++..++|+||+.+++++.+.+.+|+|||
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 378899999999999999987 57789999987654332 333467789999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccccCCccc
Q 005841 583 FLPRGSLFRLLQRN-TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLT 661 (674)
Q Consensus 583 ~~~ggsL~~~l~~~-~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~~~~~ 661 (674)
|+++++|.+++... ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++....... .
T Consensus 81 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~-~ 157 (285)
T cd05631 81 IMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRER--IVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE-T 157 (285)
T ss_pred ecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--EEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC-e
Confidence 99999999888643 346899999999999999999999999 9999999999999999999999999998754322 2
Q ss_pred cccCCCCccccCC
Q 005841 662 TKTGKGTVTYLAS 674 (674)
Q Consensus 662 ~~~~~GTp~YmAP 674 (674)
.....||+.||||
T Consensus 158 ~~~~~g~~~y~aP 170 (285)
T cd05631 158 VRGRVGTVGYMAP 170 (285)
T ss_pred ecCCCCCCCccCH
Confidence 2345799999998
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.9e-26 Score=246.74 Aligned_cols=166 Identities=23% Similarity=0.365 Sum_probs=142.9
Q ss_pred CeeEeeeecccCceEEEEEEE-----cCCeEEEEEeecccCC--HHHHHHHHHHHHHHhhCC-CCCeeeEEEEEecCCeE
Q 005841 506 DLTIGEQIGQGSCGTVYHAVW-----YGSDVAVKVFSRQEYS--DEVIHSFRQEVSLMKRLR-HPNVLLFMGAVTSPQRL 577 (674)
Q Consensus 506 ~y~~~~~LG~G~fG~Vy~~~~-----~~~~vAvK~i~~~~~~--~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~ 577 (674)
+|++.+.||+|+||+||++.. ++..||+|++.+.... ....+.+..|+.++..++ |+||+.+++++...+.+
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 589999999999999999875 4667999999764332 234566888999999995 89999999999999999
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccccC
Q 005841 578 CIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHE 657 (674)
Q Consensus 578 ~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~ 657 (674)
|+||||+++++|.+++.. ...+++..+..++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++....
T Consensus 81 ~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~ 157 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQ-RDNFSEDEVRFYSGEIILALEHLHKLG--IVYRDIKLENILLDSEGHVVLTDFGLSKEFLS 157 (332)
T ss_pred EEEEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCC--cEecCCCHHHeEECCCCCEEEeeCcCCccccc
Confidence 999999999999999965 446899999999999999999999999 99999999999999999999999999986533
Q ss_pred C-ccccccCCCCccccCC
Q 005841 658 T-YLTTKTGKGTVTYLAS 674 (674)
Q Consensus 658 ~-~~~~~~~~GTp~YmAP 674 (674)
. .......+||+.||||
T Consensus 158 ~~~~~~~~~~gt~~y~aP 175 (332)
T cd05614 158 EEKERTYSFCGTIEYMAP 175 (332)
T ss_pred cCCCccccccCCccccCH
Confidence 2 2233346799999998
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.5e-26 Score=246.82 Aligned_cols=164 Identities=27% Similarity=0.417 Sum_probs=140.7
Q ss_pred eeEeeeecccCceEEEEEEE--cCCeEEEEEeecccC-CHHHHHHHHHHHHHH---hhCCCCCeeeEEEEEecCCeEEEE
Q 005841 507 LTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEY-SDEVIHSFRQEVSLM---KRLRHPNVLLFMGAVTSPQRLCIV 580 (674)
Q Consensus 507 y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~-~~~~~~~~~~Ei~il---~~l~HpnIv~l~~~~~~~~~~~lV 580 (674)
|++.+.||+|+||.||++.+ ++..||||++.+... .....+.+.+|+.++ ..++||||+++++++...+.+|+|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 67899999999999999987 467899999976543 223445677776665 456799999999999999999999
Q ss_pred EecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccccCCcc
Q 005841 581 TEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYL 660 (674)
Q Consensus 581 ~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~~~~ 660 (674)
|||+++++|..++.. ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 81 ~E~~~~~~L~~~~~~--~~l~~~~~~~~~~qi~~al~~lH~~~--ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~ 156 (324)
T cd05589 81 MEYAAGGDLMMHIHT--DVFSEPRAVFYAACVVLGLQYLHENK--IVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGD 156 (324)
T ss_pred EcCCCCCcHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCC--eEecCCCHHHeEECCCCcEEeCcccCCccCCCCCC
Confidence 999999999988854 46999999999999999999999999 99999999999999999999999999986544434
Q ss_pred ccccCCCCccccCC
Q 005841 661 TTKTGKGTVTYLAS 674 (674)
Q Consensus 661 ~~~~~~GTp~YmAP 674 (674)
.....+||+.||||
T Consensus 157 ~~~~~~g~~~y~aP 170 (324)
T cd05589 157 RTSTFCGTPEFLAP 170 (324)
T ss_pred cccccccCccccCH
Confidence 44457899999998
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.4e-26 Score=246.30 Aligned_cols=161 Identities=27% Similarity=0.391 Sum_probs=141.1
Q ss_pred eeecccCceEEEEEEE-----cCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeEEEEEecCC
Q 005841 511 EQIGQGSCGTVYHAVW-----YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLP 585 (674)
Q Consensus 511 ~~LG~G~fG~Vy~~~~-----~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ 585 (674)
+.||+|+||.||++.. .+..||+|++.+..........+.+|+.++++++||||+++++++...+.+|+||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 5799999999999875 46779999998755443444567789999999999999999999999999999999999
Q ss_pred CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccccCCccccccC
Q 005841 586 RGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTG 665 (674)
Q Consensus 586 ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~~~~~~~~~ 665 (674)
+++|.+++.+ ...+++..+..++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++............
T Consensus 82 ~~~L~~~l~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~ 158 (318)
T cd05582 82 GGDLFTRLSK-EVMFTEEDVKFYLAELALALDHLHSLG--IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSF 158 (318)
T ss_pred CCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHeEECCCCcEEEeeccCCcccCCCCCceecc
Confidence 9999999965 446899999999999999999999999 9999999999999999999999999998765443344456
Q ss_pred CCCccccCC
Q 005841 666 KGTVTYLAS 674 (674)
Q Consensus 666 ~GTp~YmAP 674 (674)
.||+.||||
T Consensus 159 ~g~~~y~aP 167 (318)
T cd05582 159 CGTVEYMAP 167 (318)
T ss_pred cCChhhcCH
Confidence 899999998
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.6e-26 Score=245.12 Aligned_cols=166 Identities=27% Similarity=0.368 Sum_probs=142.0
Q ss_pred CeeEeeeecccCceEEEEEEEc--CCeEEEEEeecccC-CHHHHHHHHHHHHHHhhCCCC-CeeeEEEEEecCCeEEEEE
Q 005841 506 DLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEY-SDEVIHSFRQEVSLMKRLRHP-NVLLFMGAVTSPQRLCIVT 581 (674)
Q Consensus 506 ~y~~~~~LG~G~fG~Vy~~~~~--~~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~Hp-nIv~l~~~~~~~~~~~lV~ 581 (674)
+|++.+.||+|+||.||+|.+. +..||||++.+... .....+.+..|+.++..+.|+ +|+.+++++...+.+|+||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 5899999999999999999874 55799999976543 234456778899999999764 6888999999999999999
Q ss_pred ecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccccCCccc
Q 005841 582 EFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLT 661 (674)
Q Consensus 582 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~~~~~ 661 (674)
||+++++|.+++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++........
T Consensus 81 E~~~~g~L~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~ 157 (324)
T cd05587 81 EYVNGGDLMYHIQQ-VGKFKEPHAVFYAAEIAIGLFFLHSKG--IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKT 157 (324)
T ss_pred cCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHeEEcCCCCEEEeecCcceecCCCCCc
Confidence 99999999999865 346899999999999999999999998 999999999999999999999999999754322233
Q ss_pred cccCCCCccccCC
Q 005841 662 TKTGKGTVTYLAS 674 (674)
Q Consensus 662 ~~~~~GTp~YmAP 674 (674)
....+||+.||||
T Consensus 158 ~~~~~gt~~y~aP 170 (324)
T cd05587 158 TRTFCGTPDYIAP 170 (324)
T ss_pred eeeecCCccccCh
Confidence 3446799999998
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.3e-26 Score=252.72 Aligned_cols=179 Identities=33% Similarity=0.495 Sum_probs=153.5
Q ss_pred CCCccccccccCCeeEeeeecccCceEEEEEEEcC-----Ce-EEEEEeecc-cCCHHHHHHHHHHHHHHhhCCCCCeee
Q 005841 494 DNDCLDYEILWEDLTIGEQIGQGSCGTVYHAVWYG-----SD-VAVKVFSRQ-EYSDEVIHSFRQEVSLMKRLRHPNVLL 566 (674)
Q Consensus 494 ~~~~~~~~~~~~~y~~~~~LG~G~fG~Vy~~~~~~-----~~-vAvK~i~~~-~~~~~~~~~~~~Ei~il~~l~HpnIv~ 566 (674)
+.....|++..++..+.++||+|+||.||+|...- .. ||||..... ....+.+..+.+|.++|++++|||||+
T Consensus 146 PI~r~~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr 225 (474)
T KOG0194|consen 146 PIPRQKWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVR 225 (474)
T ss_pred cccccccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEE
Confidence 34445678888999999999999999999998731 13 899988753 356778899999999999999999999
Q ss_pred EEEEEecCCeEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEE
Q 005841 567 FMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKV 646 (674)
Q Consensus 567 l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL 646 (674)
|||+......++||||+|+||+|.++|++....++..+.+.++.+.+.||+|||.++ +|||||..+|+|++.++.|||
T Consensus 226 ~yGVa~~~~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~--~IHRDIAARNcL~~~~~~vKI 303 (474)
T KOG0194|consen 226 FYGVAVLEEPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKN--CIHRDIAARNCLYSKKGVVKI 303 (474)
T ss_pred EEEEEcCCCccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCC--CcchhHhHHHheecCCCeEEe
Confidence 999999999999999999999999999988778999999999999999999999999 999999999999999999999
Q ss_pred EecCCcccccCCccccccCCCCccccCC
Q 005841 647 GDFGLSRLKHETYLTTKTGKGTVTYLAS 674 (674)
Q Consensus 647 ~DFGla~~~~~~~~~~~~~~GTp~YmAP 674 (674)
+|||+++...........-.-...|+||
T Consensus 304 SDFGLs~~~~~~~~~~~~~klPirWLAP 331 (474)
T KOG0194|consen 304 SDFGLSRAGSQYVMKKFLKKLPIRWLAP 331 (474)
T ss_pred CccccccCCcceeeccccccCcceecCh
Confidence 9999998765221111111245788888
|
|
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=2e-26 Score=245.96 Aligned_cols=161 Identities=27% Similarity=0.414 Sum_probs=139.0
Q ss_pred eeecccCceEEEEEEE-----cCCeEEEEEeecccCC--HHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeEEEEEec
Q 005841 511 EQIGQGSCGTVYHAVW-----YGSDVAVKVFSRQEYS--DEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEF 583 (674)
Q Consensus 511 ~~LG~G~fG~Vy~~~~-----~~~~vAvK~i~~~~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~ 583 (674)
++||+|+||.||++.. .+..||||++.+.... ......+..|+.+++.++||||+++++++...+.+|+||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 6799999999999975 3567999999764331 23345677899999999999999999999999999999999
Q ss_pred CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccccCCccccc
Q 005841 584 LPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTK 663 (674)
Q Consensus 584 ~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~~~~~~~ 663 (674)
+++++|.+++.. ...+.+..+..++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++..........
T Consensus 82 ~~~~~L~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 158 (323)
T cd05584 82 LSGGELFMHLER-EGIFMEDTACFYLSEISLALEHLHQQG--IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTH 158 (323)
T ss_pred CCCchHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEECCCCCEEEeeCcCCeecccCCCccc
Confidence 999999999975 446889999999999999999999999 99999999999999999999999999986544333344
Q ss_pred cCCCCccccCC
Q 005841 664 TGKGTVTYLAS 674 (674)
Q Consensus 664 ~~~GTp~YmAP 674 (674)
..+||+.||||
T Consensus 159 ~~~gt~~y~aP 169 (323)
T cd05584 159 TFCGTIEYMAP 169 (323)
T ss_pred ccCCCccccCh
Confidence 46799999998
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=99.94 E-value=3e-26 Score=244.51 Aligned_cols=166 Identities=27% Similarity=0.376 Sum_probs=142.3
Q ss_pred CeeEeeeecccCceEEEEEEEc--CCeEEEEEeecccCC-HHHHHHHHHHHHHHhhC-CCCCeeeEEEEEecCCeEEEEE
Q 005841 506 DLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYS-DEVIHSFRQEVSLMKRL-RHPNVLLFMGAVTSPQRLCIVT 581 (674)
Q Consensus 506 ~y~~~~~LG~G~fG~Vy~~~~~--~~~vAvK~i~~~~~~-~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lV~ 581 (674)
+|.+.+.||+|+||.||+|.+. +..||||++.+.... ......+..|..++..+ .|++|+.+++++...+.+||||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 5889999999999999999884 567999999865432 23345567788888777 4899999999999999999999
Q ss_pred ecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccccCCccc
Q 005841 582 EFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLT 661 (674)
Q Consensus 582 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~~~~~ 661 (674)
||+++++|.+++... ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++........
T Consensus 81 E~~~~g~L~~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~~~ 157 (323)
T cd05616 81 EYVNGGDLMYQIQQV-GRFKEPHAVFYAAEIAIGLFFLHSKG--IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVT 157 (323)
T ss_pred cCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--EEecCCCHHHeEECCCCcEEEccCCCceecCCCCCc
Confidence 999999999998654 46899999999999999999999999 999999999999999999999999999865433334
Q ss_pred cccCCCCccccCC
Q 005841 662 TKTGKGTVTYLAS 674 (674)
Q Consensus 662 ~~~~~GTp~YmAP 674 (674)
....+||+.||||
T Consensus 158 ~~~~~gt~~y~aP 170 (323)
T cd05616 158 TKTFCGTPDYIAP 170 (323)
T ss_pred cccCCCChhhcCH
Confidence 4456899999998
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.2e-26 Score=246.36 Aligned_cols=161 Identities=29% Similarity=0.384 Sum_probs=140.2
Q ss_pred eeecccCceEEEEEEE--cCCeEEEEEeecccCCH-HHHHHHHHHHHHHhhC-CCCCeeeEEEEEecCCeEEEEEecCCC
Q 005841 511 EQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSD-EVIHSFRQEVSLMKRL-RHPNVLLFMGAVTSPQRLCIVTEFLPR 586 (674)
Q Consensus 511 ~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~~~-~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lV~E~~~g 586 (674)
++||+|+||.||++.+ .+..||||++.+..... .....+..|+.++..+ +||||+.+++++.....+|||||||++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 3699999999999987 46679999998754432 4456688899999998 699999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccccCCccccccCC
Q 005841 587 GSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGK 666 (674)
Q Consensus 587 gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~~~~~~~~~~ 666 (674)
++|.+++.+. ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++............+
T Consensus 81 g~L~~~~~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~~~~~~~ 157 (329)
T cd05588 81 GDLMFHMQRQ-RKLPEEHARFYSAEISLALNFLHERG--IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFC 157 (329)
T ss_pred CCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHeEECCCCCEEECcCccccccccCCCcccccc
Confidence 9999988653 57999999999999999999999999 99999999999999999999999999976433333444568
Q ss_pred CCccccCC
Q 005841 667 GTVTYLAS 674 (674)
Q Consensus 667 GTp~YmAP 674 (674)
||+.||||
T Consensus 158 gt~~y~aP 165 (329)
T cd05588 158 GTPNYIAP 165 (329)
T ss_pred CCccccCH
Confidence 99999998
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.5e-28 Score=252.43 Aligned_cols=166 Identities=31% Similarity=0.454 Sum_probs=151.4
Q ss_pred CCeeEeeeecccCceEEEEEEE--cCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeEEEEEe
Q 005841 505 EDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTE 582 (674)
Q Consensus 505 ~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E 582 (674)
..|...+.||+|+||.||+|.+ +++.||||++...... +.++.+++|+.++.+++++||.++|+.+..+..++|+||
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~-deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMe 91 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAE-DEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIME 91 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhhcc-hhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHH
Confidence 3567779999999999999997 5777999999876543 446788999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccccCCcccc
Q 005841 583 FLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTT 662 (674)
Q Consensus 583 ~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~~~~~~ 662 (674)
||.||++.++|+. ...+.+..+..|+++++.||.|||..+ .+|||||+.|||+...|.|||+|||++..+..+....
T Consensus 92 y~~gGsv~~lL~~-~~~~~E~~i~~ilre~l~~l~ylH~~~--kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~rr 168 (467)
T KOG0201|consen 92 YCGGGSVLDLLKS-GNILDEFEIAVILREVLKGLDYLHSEK--KIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKRR 168 (467)
T ss_pred HhcCcchhhhhcc-CCCCccceeeeehHHHHHHhhhhhhcc--eecccccccceeEeccCcEEEEecceeeeeechhhcc
Confidence 9999999999964 445689999999999999999999999 9999999999999999999999999999998888888
Q ss_pred ccCCCCccccCC
Q 005841 663 KTGKGTVTYLAS 674 (674)
Q Consensus 663 ~~~~GTp~YmAP 674 (674)
.+++|||.||||
T Consensus 169 ~tfvGTPfwMAP 180 (467)
T KOG0201|consen 169 KTFVGTPFWMAP 180 (467)
T ss_pred ccccccccccch
Confidence 899999999999
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.2e-26 Score=240.06 Aligned_cols=170 Identities=28% Similarity=0.494 Sum_probs=142.3
Q ss_pred cccCCeeEeeeecccCceEEEEEEEc------------------CCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCC
Q 005841 502 ILWEDLTIGEQIGQGSCGTVYHAVWY------------------GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPN 563 (674)
Q Consensus 502 ~~~~~y~~~~~LG~G~fG~Vy~~~~~------------------~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hpn 563 (674)
+...+|.+.++||+|+||.||+|.+. +..||+|++.... .......+.+|+.++..++|||
T Consensus 2 ~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~n 80 (304)
T cd05096 2 FPRGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDA-NKNARNDFLKEVKILSRLKDPN 80 (304)
T ss_pred CchhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCC-CHHHHHHHHHHHHHHhhcCCCC
Confidence 34578999999999999999999752 2259999986543 3445667899999999999999
Q ss_pred eeeEEEEEecCCeEEEEEecCCCCCHHHHHHhcC------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCC
Q 005841 564 VLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNT------------------TKLDWRRRILMALDIARGVSYLHHCNPP 625 (674)
Q Consensus 564 Iv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~------------------~~l~~~~~~~i~~qi~~~L~yLH~~~~~ 625 (674)
|+++++++...+.+||||||+++++|.+++.... ..+++..+..++.||+.||.|||+++
T Consensus 81 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~-- 158 (304)
T cd05096 81 IIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN-- 158 (304)
T ss_pred eeEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC--
Confidence 9999999999999999999999999999986421 24678899999999999999999999
Q ss_pred eEEccCCCCCEEEcCCCcEEEEecCCcccccCCcc--ccccCCCCccccCC
Q 005841 626 IIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYL--TTKTGKGTVTYLAS 674 (674)
Q Consensus 626 IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~~~~--~~~~~~GTp~YmAP 674 (674)
|+||||||+|||++.++.+||+|||+++....... ......+|+.||||
T Consensus 159 ivH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aP 209 (304)
T cd05096 159 FVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAW 209 (304)
T ss_pred ccccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCH
Confidence 99999999999999999999999999986543221 12223568899998
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=7.5e-27 Score=246.61 Aligned_cols=167 Identities=27% Similarity=0.382 Sum_probs=151.5
Q ss_pred CCeeEeeeecccCceEEEEEEE--cCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeEEEEEe
Q 005841 505 EDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTE 582 (674)
Q Consensus 505 ~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E 582 (674)
.-|.+.+.||+|-|.+|.++++ +|..||||++.+..++.-....+.+|+.+|+.++|||||++|.+..++..+|||+|
T Consensus 18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLE 97 (864)
T KOG4717|consen 18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILE 97 (864)
T ss_pred eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEE
Confidence 4588889999999999999986 89999999999998877666678889999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEc-CCCcEEEEecCCcccccCCccc
Q 005841 583 FLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVD-KHWTVKVGDFGLSRLKHETYLT 661 (674)
Q Consensus 583 ~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~-~~~~vkL~DFGla~~~~~~~~~ 661 (674)
+-++|+|++||.+....+.+..+.+|++||+.|+.|||+.. +|||||||+|+++. +-|-|||.|||++-.+. +...
T Consensus 98 LGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLH--VVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~-PG~k 174 (864)
T KOG4717|consen 98 LGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLH--VVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQ-PGKK 174 (864)
T ss_pred ecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhh--hhcccCCcceeEEeeecCceEeeeccccccCC-Ccch
Confidence 99999999999998889999999999999999999999999 99999999999875 67899999999986443 3344
Q ss_pred cccCCCCccccCC
Q 005841 662 TKTGKGTVTYLAS 674 (674)
Q Consensus 662 ~~~~~GTp~YmAP 674 (674)
..++||++.|-||
T Consensus 175 L~TsCGSLAYSAP 187 (864)
T KOG4717|consen 175 LTTSCGSLAYSAP 187 (864)
T ss_pred hhcccchhhccCc
Confidence 5568999999998
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.4e-27 Score=244.81 Aligned_cols=171 Identities=29% Similarity=0.400 Sum_probs=149.6
Q ss_pred ccccCCeeEeeeecccCceEEEEEEEcCCe--EEEEEeecccCC-HHHHHHHHHHHHHHhhC-CCCCeeeEEEEEecCCe
Q 005841 501 EILWEDLTIGEQIGQGSCGTVYHAVWYGSD--VAVKVFSRQEYS-DEVIHSFRQEVSLMKRL-RHPNVLLFMGAVTSPQR 576 (674)
Q Consensus 501 ~~~~~~y~~~~~LG~G~fG~Vy~~~~~~~~--vAvK~i~~~~~~-~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~ 576 (674)
.+...+|.++.+||+|+||+|.++..+|+. ||||++++...- ++-++--..|-++|... +-|++++++.+|++.++
T Consensus 345 ~i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDR 424 (683)
T KOG0696|consen 345 RIKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDR 424 (683)
T ss_pred ceeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhh
Confidence 455678999999999999999999987665 999999887552 22223334466777665 46899999999999999
Q ss_pred EEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCccccc
Q 005841 577 LCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKH 656 (674)
Q Consensus 577 ~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~ 656 (674)
+|+||||+.||+|...++. -++|-+..+.+|+.+|+-||-|||+++ ||+||||.+|||++.+|+|||+|||+++.-.
T Consensus 425 LyFVMEyvnGGDLMyhiQQ-~GkFKEp~AvFYAaEiaigLFFLh~kg--IiYRDLKLDNvmLd~eGHiKi~DFGmcKEni 501 (683)
T KOG0696|consen 425 LYFVMEYVNGGDLMYHIQQ-VGKFKEPVAVFYAAEIAIGLFFLHSKG--IIYRDLKLDNVMLDSEGHIKIADFGMCKENI 501 (683)
T ss_pred eeeEEEEecCchhhhHHHH-hcccCCchhhhhhHHHHHHhhhhhcCC--eeeeeccccceEeccCCceEeeecccccccc
Confidence 9999999999999999976 457999999999999999999999999 9999999999999999999999999999887
Q ss_pred CCccccccCCCCccccCC
Q 005841 657 ETYLTTKTGKGTVTYLAS 674 (674)
Q Consensus 657 ~~~~~~~~~~GTp~YmAP 674 (674)
-...++.++||||.||||
T Consensus 502 ~~~~TTkTFCGTPdYiAP 519 (683)
T KOG0696|consen 502 FDGVTTKTFCGTPDYIAP 519 (683)
T ss_pred cCCcceeeecCCCccccc
Confidence 778889999999999998
|
|
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.7e-26 Score=243.82 Aligned_cols=161 Identities=29% Similarity=0.385 Sum_probs=139.3
Q ss_pred eeecccCceEEEEEEE--cCCeEEEEEeecccCC-HHHHHHHHHHHHHHhhC-CCCCeeeEEEEEecCCeEEEEEecCCC
Q 005841 511 EQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYS-DEVIHSFRQEVSLMKRL-RHPNVLLFMGAVTSPQRLCIVTEFLPR 586 (674)
Q Consensus 511 ~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~~-~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lV~E~~~g 586 (674)
++||+|+||+||++.+ ++..||+|++.+.... ......+..|+.++..+ +||||+.+++++...+.+||||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 3699999999999987 4667999999875432 34456678899988876 799999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccccCCccccccCC
Q 005841 587 GSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGK 666 (674)
Q Consensus 587 gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~~~~~~~~~~ 666 (674)
++|..++.. ...+++..+..++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++............+
T Consensus 81 ~~L~~~~~~-~~~l~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~~~~~~~ 157 (329)
T cd05618 81 GDLMFHMQR-QRKLPEEHARFYSAEISLALNYLHERG--IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFC 157 (329)
T ss_pred CCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCHHHEEECCCCCEEEeeCCccccccCCCCcccccc
Confidence 999998865 357999999999999999999999999 99999999999999999999999999986543333444568
Q ss_pred CCccccCC
Q 005841 667 GTVTYLAS 674 (674)
Q Consensus 667 GTp~YmAP 674 (674)
||+.||||
T Consensus 158 gt~~y~aP 165 (329)
T cd05618 158 GTPNYIAP 165 (329)
T ss_pred CCccccCH
Confidence 99999998
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.4e-26 Score=242.60 Aligned_cols=161 Identities=28% Similarity=0.402 Sum_probs=136.0
Q ss_pred eeecccCceEEEEEEEc--CCeEEEEEeecccC-CHHHHHHHHHHHHHHhhC-CCCCeeeEEEEEecCCeEEEEEecCCC
Q 005841 511 EQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEY-SDEVIHSFRQEVSLMKRL-RHPNVLLFMGAVTSPQRLCIVTEFLPR 586 (674)
Q Consensus 511 ~~LG~G~fG~Vy~~~~~--~~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lV~E~~~g 586 (674)
++||+|+||+||+|.+. +..||||++.+... .......+..|..++..+ .||||+++++++...+.+|+||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 36999999999999874 56799999976543 223344556677777654 799999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccccCCccccccCC
Q 005841 587 GSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGK 666 (674)
Q Consensus 587 gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~~~~~~~~~~ 666 (674)
++|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++............+
T Consensus 81 g~L~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~~~--ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~ 157 (316)
T cd05592 81 GDLMFHIQS-SGRFDEARARFYAAEIICGLQFLHKKG--IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFC 157 (316)
T ss_pred CcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCC--EEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCCcccccc
Confidence 999999875 447999999999999999999999998 99999999999999999999999999986543333344568
Q ss_pred CCccccCC
Q 005841 667 GTVTYLAS 674 (674)
Q Consensus 667 GTp~YmAP 674 (674)
||+.||||
T Consensus 158 gt~~y~aP 165 (316)
T cd05592 158 GTPDYIAP 165 (316)
T ss_pred CCccccCH
Confidence 99999998
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.3e-26 Score=242.75 Aligned_cols=166 Identities=27% Similarity=0.383 Sum_probs=142.5
Q ss_pred CeeEeeeecccCceEEEEEEE--cCCeEEEEEeecccC-CHHHHHHHHHHHHHHhhCC-CCCeeeEEEEEecCCeEEEEE
Q 005841 506 DLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEY-SDEVIHSFRQEVSLMKRLR-HPNVLLFMGAVTSPQRLCIVT 581 (674)
Q Consensus 506 ~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~lV~ 581 (674)
+|++.+.||+|+||+||+|.+ ++..||||++.+... .....+.+..|+.++..+. |++|+.+++++...+.+|+||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 478899999999999999987 467899999976533 2234456778899988886 577888999999999999999
Q ss_pred ecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccccCCccc
Q 005841 582 EFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLT 661 (674)
Q Consensus 582 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~~~~~ 661 (674)
||+++++|.+++... ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++........
T Consensus 81 Ey~~~g~L~~~i~~~-~~l~~~~~~~i~~qi~~al~~lH~~~--ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~~~ 157 (323)
T cd05615 81 EYVNGGDLMYHIQQV-GKFKEPQAVFYAAEISVGLFFLHRRG--IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVT 157 (323)
T ss_pred cCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHeEECCCCCEEEeccccccccCCCCcc
Confidence 999999999998653 46999999999999999999999998 999999999999999999999999999865444444
Q ss_pred cccCCCCccccCC
Q 005841 662 TKTGKGTVTYLAS 674 (674)
Q Consensus 662 ~~~~~GTp~YmAP 674 (674)
....+||+.||||
T Consensus 158 ~~~~~gt~~y~aP 170 (323)
T cd05615 158 TRTFCGTPDYIAP 170 (323)
T ss_pred ccCccCCccccCH
Confidence 4556799999998
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.3e-26 Score=243.06 Aligned_cols=161 Identities=29% Similarity=0.411 Sum_probs=138.6
Q ss_pred eeecccCceEEEEEEEc--CCeEEEEEeecccC-CHHHHHHHHHHHHHHhhC-CCCCeeeEEEEEecCCeEEEEEecCCC
Q 005841 511 EQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEY-SDEVIHSFRQEVSLMKRL-RHPNVLLFMGAVTSPQRLCIVTEFLPR 586 (674)
Q Consensus 511 ~~LG~G~fG~Vy~~~~~--~~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lV~E~~~g 586 (674)
++||+|+||.||+|.+. +..||||++.+... .......+..|+.++..+ +||||+.+++++...+.+||||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 36999999999999884 56799999976543 234456677889988866 799999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccccCCccccccCC
Q 005841 587 GSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGK 666 (674)
Q Consensus 587 gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~~~~~~~~~~ 666 (674)
++|..++... ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++............+
T Consensus 81 ~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~ 157 (321)
T cd05591 81 GDLMFQIQRS-RKFDEPRSRFYAAEVTLALMFLHRHG--VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFC 157 (321)
T ss_pred CcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHeEECCCCCEEEeecccceecccCCccccccc
Confidence 9999998654 46899999999999999999999999 99999999999999999999999999986544333444567
Q ss_pred CCccccCC
Q 005841 667 GTVTYLAS 674 (674)
Q Consensus 667 GTp~YmAP 674 (674)
||+.||||
T Consensus 158 gt~~y~aP 165 (321)
T cd05591 158 GTPDYIAP 165 (321)
T ss_pred cCccccCH
Confidence 99999998
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.3e-26 Score=242.57 Aligned_cols=161 Identities=35% Similarity=0.456 Sum_probs=136.2
Q ss_pred eeecccCceEEEEEEE--cCCeEEEEEeecccCCH-HHHHHHHHHHH-HHhhCCCCCeeeEEEEEecCCeEEEEEecCCC
Q 005841 511 EQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSD-EVIHSFRQEVS-LMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPR 586 (674)
Q Consensus 511 ~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~~~-~~~~~~~~Ei~-il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~g 586 (674)
++||+|+||+||+|.+ ++..||||++.+..... .....+..|.. +++.++||||+++++.+...+.+|+||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 4699999999999998 57789999997654322 22334445554 56789999999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccccCCccccccCC
Q 005841 587 GSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGK 666 (674)
Q Consensus 587 gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~~~~~~~~~~ 666 (674)
++|..++.. ...+++..+..++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++............+
T Consensus 81 g~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~g--ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 157 (323)
T cd05575 81 GELFFHLQR-ERSFPEPRARFYAAEIASALGYLHSLN--IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFC 157 (323)
T ss_pred CCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCCHHHeEECCCCcEEEeccCCCcccccCCCcccccc
Confidence 999999975 457899999999999999999999999 99999999999999999999999999986544333444567
Q ss_pred CCccccCC
Q 005841 667 GTVTYLAS 674 (674)
Q Consensus 667 GTp~YmAP 674 (674)
||+.||||
T Consensus 158 gt~~y~aP 165 (323)
T cd05575 158 GTPEYLAP 165 (323)
T ss_pred CChhhcCh
Confidence 99999998
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.2e-26 Score=243.23 Aligned_cols=161 Identities=31% Similarity=0.427 Sum_probs=138.4
Q ss_pred eeecccCceEEEEEEE--cCCeEEEEEeecccC-CHHHHHHHHHHHHHHhhC-CCCCeeeEEEEEecCCeEEEEEecCCC
Q 005841 511 EQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEY-SDEVIHSFRQEVSLMKRL-RHPNVLLFMGAVTSPQRLCIVTEFLPR 586 (674)
Q Consensus 511 ~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lV~E~~~g 586 (674)
++||+|+||+||+|.+ ++..||||++.+... .......+..|+.++..+ .||||+++++++...+.+||||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 3699999999999987 466799999976543 223456677888888876 699999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccccCCccccccCC
Q 005841 587 GSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGK 666 (674)
Q Consensus 587 gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~~~~~~~~~~ 666 (674)
++|.+++.+. ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.............
T Consensus 81 g~L~~~i~~~-~~l~~~~~~~~~~ql~~~L~~lH~~~--ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~~~~~~~ 157 (320)
T cd05590 81 GDLMFHIQKS-RRFDEARARFYAAEITSALMFLHDKG--IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFC 157 (320)
T ss_pred chHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCCcccccc
Confidence 9999998754 47999999999999999999999999 99999999999999999999999999986543333344567
Q ss_pred CCccccCC
Q 005841 667 GTVTYLAS 674 (674)
Q Consensus 667 GTp~YmAP 674 (674)
||+.||||
T Consensus 158 gt~~y~aP 165 (320)
T cd05590 158 GTPDYIAP 165 (320)
T ss_pred cCccccCH
Confidence 99999998
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.1e-26 Score=242.42 Aligned_cols=161 Identities=35% Similarity=0.452 Sum_probs=135.9
Q ss_pred eeecccCceEEEEEEE--cCCeEEEEEeecccCC-HHHHHHHHHHHH-HHhhCCCCCeeeEEEEEecCCeEEEEEecCCC
Q 005841 511 EQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYS-DEVIHSFRQEVS-LMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPR 586 (674)
Q Consensus 511 ~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~~-~~~~~~~~~Ei~-il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~g 586 (674)
++||+|+||+||+|.+ .+..||+|++.+.... ......+..|+. +++.++||||+++++++...+.+||||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 4799999999999998 4677999999765432 223344555554 67889999999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccccCCccccccCC
Q 005841 587 GSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGK 666 (674)
Q Consensus 587 gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~~~~~~~~~~ 666 (674)
++|..++.. ...+++..+..++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++............+
T Consensus 81 ~~L~~~l~~-~~~~~~~~~~~~~~qi~~~L~~lH~~~--ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 157 (321)
T cd05603 81 GELFFHLQR-ERCFLEPRARFYAAEVASAIGYLHSLN--IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFC 157 (321)
T ss_pred CCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCCHHHeEECCCCCEEEccCCCCccCCCCCCcccccc
Confidence 999998865 456899999999999999999999998 99999999999999999999999999986543333444568
Q ss_pred CCccccCC
Q 005841 667 GTVTYLAS 674 (674)
Q Consensus 667 GTp~YmAP 674 (674)
||+.||||
T Consensus 158 gt~~y~aP 165 (321)
T cd05603 158 GTPEYLAP 165 (321)
T ss_pred CCcccCCH
Confidence 99999998
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.1e-27 Score=272.92 Aligned_cols=170 Identities=25% Similarity=0.363 Sum_probs=151.1
Q ss_pred cccCCeeEeeeecccCceEEEEEEEc--CCeEEEEEeecccCC-HHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeEE
Q 005841 502 ILWEDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYS-DEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLC 578 (674)
Q Consensus 502 ~~~~~y~~~~~LG~G~fG~Vy~~~~~--~~~vAvK~i~~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 578 (674)
...++|+++++||+|+||.|.+++++ +..||+|++++.... .....-|+.|-.||-.-+.+=|+.++.+|++..++|
T Consensus 72 l~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LY 151 (1317)
T KOG0612|consen 72 LKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLY 151 (1317)
T ss_pred CCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceE
Confidence 45689999999999999999999984 556999999875443 223345888999999888999999999999999999
Q ss_pred EEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCccccc-C
Q 005841 579 IVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKH-E 657 (674)
Q Consensus 579 lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~-~ 657 (674)
+||||++||+|..+|.+.. ++++..+.+|+..|+.||.-||+.| +|||||||+|||||..|+|||+|||.|-... +
T Consensus 152 lVMdY~pGGDlltLlSk~~-~~pE~~ArFY~aEiVlAldslH~mg--yVHRDiKPDNvLld~~GHikLADFGsClkm~~d 228 (1317)
T KOG0612|consen 152 LVMDYMPGGDLLTLLSKFD-RLPEDWARFYTAEIVLALDSLHSMG--YVHRDIKPDNVLLDKSGHIKLADFGSCLKMDAD 228 (1317)
T ss_pred EEEecccCchHHHHHhhcC-CChHHHHHHHHHHHHHHHHHHHhcc--ceeccCCcceeEecccCcEeeccchhHHhcCCC
Confidence 9999999999999998766 8999999999999999999999999 9999999999999999999999999886655 5
Q ss_pred CccccccCCCCccccCC
Q 005841 658 TYLTTKTGKGTVTYLAS 674 (674)
Q Consensus 658 ~~~~~~~~~GTp~YmAP 674 (674)
..+.+...+|||.|++|
T Consensus 229 G~V~s~~aVGTPDYISP 245 (1317)
T KOG0612|consen 229 GTVRSSVAVGTPDYISP 245 (1317)
T ss_pred CcEEeccccCCCCccCH
Confidence 55566667899999998
|
|
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.4e-26 Score=242.14 Aligned_cols=161 Identities=34% Similarity=0.442 Sum_probs=136.1
Q ss_pred eeecccCceEEEEEEE--cCCeEEEEEeecccCC-HHHHHHHHHHHH-HHhhCCCCCeeeEEEEEecCCeEEEEEecCCC
Q 005841 511 EQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYS-DEVIHSFRQEVS-LMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPR 586 (674)
Q Consensus 511 ~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~~-~~~~~~~~~Ei~-il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~g 586 (674)
++||+|+||+||+|.+ ++..||||++.+.... ......+..|.. +++.++||||+++++++...+.+|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 4699999999999987 4778999999765332 233344555554 56778999999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccccCCccccccCC
Q 005841 587 GSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGK 666 (674)
Q Consensus 587 gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~~~~~~~~~~ 666 (674)
++|..++.. ...+++..+..++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++............+
T Consensus 81 ~~L~~~l~~-~~~~~~~~~~~~~~qi~~al~~lH~~g--ivH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~ 157 (325)
T cd05604 81 GELFFHLQR-ERSFPEPRARFYAAEIASALGYLHSIN--IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFC 157 (325)
T ss_pred CCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHeEECCCCCEEEeecCCcccCCCCCCCccccc
Confidence 999998865 457999999999999999999999999 99999999999999999999999999986543333344567
Q ss_pred CCccccCC
Q 005841 667 GTVTYLAS 674 (674)
Q Consensus 667 GTp~YmAP 674 (674)
||+.||||
T Consensus 158 gt~~y~aP 165 (325)
T cd05604 158 GTPEYLAP 165 (325)
T ss_pred CChhhCCH
Confidence 99999998
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=99.94 E-value=6e-26 Score=242.40 Aligned_cols=161 Identities=33% Similarity=0.424 Sum_probs=134.5
Q ss_pred eeecccCceEEEEEEEc--CCeEEEEEeecccCC-HHHHHHHHHHH-HHHhhCCCCCeeeEEEEEecCCeEEEEEecCCC
Q 005841 511 EQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYS-DEVIHSFRQEV-SLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPR 586 (674)
Q Consensus 511 ~~LG~G~fG~Vy~~~~~--~~~vAvK~i~~~~~~-~~~~~~~~~Ei-~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~g 586 (674)
+.||+|+||+||+|.+. +..||+|++.+.... ......+..|. .+++.++||||+++++++...+.+|+||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 46999999999999984 567999999764432 12223344444 456788999999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccccCCccccccCC
Q 005841 587 GSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGK 666 (674)
Q Consensus 587 gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~~~~~~~~~~ 666 (674)
++|.+++.. ...+.+..+..++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++............+
T Consensus 81 ~~L~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~g--iiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~~~~~~~ 157 (325)
T cd05602 81 GELFYHLQR-ERCFLEPRARFYAAEIASALGYLHSLN--IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFC 157 (325)
T ss_pred CcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHeEECCCCCEEEccCCCCcccccCCCCccccc
Confidence 999999975 456889999999999999999999999 99999999999999999999999999986544333444568
Q ss_pred CCccccCC
Q 005841 667 GTVTYLAS 674 (674)
Q Consensus 667 GTp~YmAP 674 (674)
||+.||||
T Consensus 158 gt~~y~aP 165 (325)
T cd05602 158 GTPEYLAP 165 (325)
T ss_pred CCccccCH
Confidence 99999998
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=99.94 E-value=8e-26 Score=236.08 Aligned_cols=160 Identities=23% Similarity=0.334 Sum_probs=138.6
Q ss_pred ecccCceEEEEEEE--cCCeEEEEEeecccCCH-HHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeEEEEEecCCCCCH
Q 005841 513 IGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSD-EVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSL 589 (674)
Q Consensus 513 LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL 589 (674)
||+|+||+||++.+ ++..||+|++.+..... ...+.+..|+.+++.++|+||+.+++++.....+|+||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 69999999999987 46789999997654332 3446678899999999999999999999999999999999999999
Q ss_pred HHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccccCCccccccCC
Q 005841 590 FRLLQR---NTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGK 666 (674)
Q Consensus 590 ~~~l~~---~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~~~~~~~~~~ 666 (674)
.+++.. ....+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++..............
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~ 158 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR--IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYA 158 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCCCCEEEeeCccceecCCCCccccccC
Confidence 988753 3356899999999999999999999999 99999999999999999999999999987654433444567
Q ss_pred CCccccCC
Q 005841 667 GTVTYLAS 674 (674)
Q Consensus 667 GTp~YmAP 674 (674)
||+.||||
T Consensus 159 g~~~y~aP 166 (280)
T cd05608 159 GTPGFMAP 166 (280)
T ss_pred CCcCccCH
Confidence 99999998
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=99.94 E-value=8.2e-26 Score=241.72 Aligned_cols=161 Identities=29% Similarity=0.374 Sum_probs=139.7
Q ss_pred eeecccCceEEEEEEE--cCCeEEEEEeecccCC-HHHHHHHHHHHHHHhhC-CCCCeeeEEEEEecCCeEEEEEecCCC
Q 005841 511 EQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYS-DEVIHSFRQEVSLMKRL-RHPNVLLFMGAVTSPQRLCIVTEFLPR 586 (674)
Q Consensus 511 ~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~~-~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lV~E~~~g 586 (674)
++||+|+||+||+|.. .+..||+|++.+.... ......+.+|+.++..+ +||||+.+++++...+.+||||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 3799999999999987 4567999999875443 34556788899999888 599999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccccCCccccccCC
Q 005841 587 GSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGK 666 (674)
Q Consensus 587 gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~~~~~~~~~~ 666 (674)
++|..++... ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++............+
T Consensus 81 ~~L~~~~~~~-~~l~~~~~~~~~~qi~~al~~lH~~~--ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 157 (327)
T cd05617 81 GDLMFHMQRQ-RKLPEEHARFYAAEICIALNFLHERG--IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFC 157 (327)
T ss_pred CcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHEEEeCCCCEEEeccccceeccCCCCceeccc
Confidence 9999988653 46999999999999999999999999 99999999999999999999999999986443333444578
Q ss_pred CCccccCC
Q 005841 667 GTVTYLAS 674 (674)
Q Consensus 667 GTp~YmAP 674 (674)
||+.||||
T Consensus 158 gt~~y~aP 165 (327)
T cd05617 158 GTPNYIAP 165 (327)
T ss_pred CCcccCCH
Confidence 99999998
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.5e-27 Score=256.47 Aligned_cols=166 Identities=26% Similarity=0.420 Sum_probs=149.7
Q ss_pred CCeeEeeeecccCceEEEEEEEcCCe--EEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeEEEEEe
Q 005841 505 EDLTIGEQIGQGSCGTVYHAVWYGSD--VAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTE 582 (674)
Q Consensus 505 ~~y~~~~~LG~G~fG~Vy~~~~~~~~--vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E 582 (674)
+.|+|+..||.|+||+||++..+... .|.|+|..+ ..+.++.+.-||.||..+.||+||++++.|...+.++|++|
T Consensus 32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetk--seEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliE 109 (1187)
T KOG0579|consen 32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETK--SEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIE 109 (1187)
T ss_pred HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhccc--chhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEe
Confidence 45788899999999999999875433 577887543 45667889999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccccCCcccc
Q 005841 583 FLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTT 662 (674)
Q Consensus 583 ~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~~~~~~ 662 (674)
||.||-+..++-.....+++.++..+++|+|.||.|||+.+ |||||||..|||++-+|.|+|+|||.+.....+....
T Consensus 110 FC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~--iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~qkR 187 (1187)
T KOG0579|consen 110 FCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQN--IIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTRQKR 187 (1187)
T ss_pred ecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcc--hhhhhccccceEEEecCcEeeecccccccchhHHhhh
Confidence 99999999888888889999999999999999999999999 9999999999999999999999999998776666677
Q ss_pred ccCCCCccccCC
Q 005841 663 KTGKGTVTYLAS 674 (674)
Q Consensus 663 ~~~~GTp~YmAP 674 (674)
.+|.|||+||||
T Consensus 188 DsFIGTPYWMAP 199 (1187)
T KOG0579|consen 188 DSFIGTPYWMAP 199 (1187)
T ss_pred ccccCCcccccc
Confidence 789999999999
|
|
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=7.1e-26 Score=255.52 Aligned_cols=174 Identities=24% Similarity=0.385 Sum_probs=144.3
Q ss_pred cccccccCCeeEeeeecccCceEEEEEEEc-C-CeEEEEEeecccCCHHHHHHHHHHHHHHhhCC-CCCeeeEEEE-Eec
Q 005841 498 LDYEILWEDLTIGEQIGQGSCGTVYHAVWY-G-SDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLR-HPNVLLFMGA-VTS 573 (674)
Q Consensus 498 ~~~~~~~~~y~~~~~LG~G~fG~Vy~~~~~-~-~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~-~~~ 573 (674)
..+.+...+++|.+.|.+|||+.||++... + ..||+|.+-.. +...++.+.+||.+|+.|. |+|||.+++. ...
T Consensus 30 ~~~~Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~--de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~ 107 (738)
T KOG1989|consen 30 QTFTVGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN--DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAIN 107 (738)
T ss_pred eEEEECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC--CHHHHHHHHHHHHHHHHhcCCCceeeEecccccc
Confidence 345677788999999999999999999983 3 78999987544 5677888999999999997 9999999993 221
Q ss_pred ------CCeEEEEEecCCCCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEE
Q 005841 574 ------PQRLCIVTEFLPRGSLFRLLQR-NTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKV 646 (674)
Q Consensus 574 ------~~~~~lV~E~~~ggsL~~~l~~-~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL 646 (674)
.-.++|+||||.||.|.+++.. ...+|++.+++.|++|+|+||.+||.+.+||||||||-|||||+.++++||
T Consensus 108 ~~~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~KL 187 (738)
T KOG1989|consen 108 RSSNNGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNYKL 187 (738)
T ss_pred ccCCCceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCEEe
Confidence 1358899999999999999864 345699999999999999999999999999999999999999999999999
Q ss_pred EecCCcccccCCccc----------cccCCCCccccCC
Q 005841 647 GDFGLSRLKHETYLT----------TKTGKGTVTYLAS 674 (674)
Q Consensus 647 ~DFGla~~~~~~~~~----------~~~~~GTp~YmAP 674 (674)
||||.|.......-. .. ..-||.|.||
T Consensus 188 CDFGSatt~~~~~~~~~e~~~ve~eI~-k~TTp~YRsP 224 (738)
T KOG1989|consen 188 CDFGSATTKILSPTSAQEVNYVEEEIE-KYTTPQYRSP 224 (738)
T ss_pred CcccccccccCCCccHHHHHHHHHHHH-hhCCccccCh
Confidence 999998654322100 11 1249999998
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.2e-25 Score=234.82 Aligned_cols=167 Identities=22% Similarity=0.327 Sum_probs=143.2
Q ss_pred CCeeEeeeecccCceEEEEEEEc--CCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeEEEEEe
Q 005841 505 EDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTE 582 (674)
Q Consensus 505 ~~y~~~~~LG~G~fG~Vy~~~~~--~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E 582 (674)
++|++.+.||+|+||.||+|++. +..||||++............+.+|+.+++.++||||+++++++...+.+|+|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 36999999999999999999984 5679999997655444556678889999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccccCCcc-c
Q 005841 583 FLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYL-T 661 (674)
Q Consensus 583 ~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~~~~-~ 661 (674)
|++++.|..+. .....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++....... .
T Consensus 81 ~~~~~~l~~~~-~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 157 (287)
T cd07848 81 YVEKNMLELLE-EMPNGVPPEKVRSYIYQLIKAIHWCHKND--IVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNAN 157 (287)
T ss_pred cCCCCHHHHHH-hcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEcCCCcEEEeeccCccccccccccc
Confidence 99887665444 44567999999999999999999999999 99999999999999999999999999987643222 2
Q ss_pred cccCCCCccccCC
Q 005841 662 TKTGKGTVTYLAS 674 (674)
Q Consensus 662 ~~~~~GTp~YmAP 674 (674)
.....||+.|+||
T Consensus 158 ~~~~~~~~~y~aP 170 (287)
T cd07848 158 YTEYVATRWYRSP 170 (287)
T ss_pred ccccccccccCCc
Confidence 2235799999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.5e-26 Score=231.92 Aligned_cols=174 Identities=26% Similarity=0.350 Sum_probs=155.6
Q ss_pred cccccccCCeeEeeeecccCceEEEEEEEc--CCeEEEEEeecccCCH-HHHHHHHHHHHHHhhC-CCCCeeeEEEEEec
Q 005841 498 LDYEILWEDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSD-EVIHSFRQEVSLMKRL-RHPNVLLFMGAVTS 573 (674)
Q Consensus 498 ~~~~~~~~~y~~~~~LG~G~fG~Vy~~~~~--~~~vAvK~i~~~~~~~-~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~ 573 (674)
..+.+...+|.++.+||+|+|++|..+++. .+-||+|++++....+ +-+.-.+.|-.++.+- +||++|-++.+|++
T Consensus 243 ~~~~l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqt 322 (593)
T KOG0695|consen 243 ISQGLGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQT 322 (593)
T ss_pred cccccccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcc
Confidence 344566689999999999999999999874 4459999998876643 4556677788888776 59999999999999
Q ss_pred CCeEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcc
Q 005841 574 PQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSR 653 (674)
Q Consensus 574 ~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~ 653 (674)
..++|+|.||++||+|..++++ ..+++++.+.+|-.+|+.||.|||++| ||+||||.+|+|+|..|++||+|+|+++
T Consensus 323 esrlffvieyv~ggdlmfhmqr-qrklpeeharfys~ei~lal~flh~rg--iiyrdlkldnvlldaeghikltdygmck 399 (593)
T KOG0695|consen 323 ESRLFFVIEYVNGGDLMFHMQR-QRKLPEEHARFYSAEICLALNFLHERG--IIYRDLKLDNVLLDAEGHIKLTDYGMCK 399 (593)
T ss_pred cceEEEEEEEecCcceeeehhh-hhcCcHHHhhhhhHHHHHHHHHHhhcC--eeeeeccccceEEccCCceeecccchhh
Confidence 9999999999999999998876 457999999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCccccccCCCCccccCC
Q 005841 654 LKHETYLTTKTGKGTVTYLAS 674 (674)
Q Consensus 654 ~~~~~~~~~~~~~GTp~YmAP 674 (674)
.-..+..++.++||||.|+||
T Consensus 400 e~l~~gd~tstfcgtpnyiap 420 (593)
T KOG0695|consen 400 EGLGPGDTTSTFCGTPNYIAP 420 (593)
T ss_pred cCCCCCcccccccCCCcccch
Confidence 988888899999999999998
|
|
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.7e-25 Score=238.00 Aligned_cols=167 Identities=25% Similarity=0.388 Sum_probs=146.4
Q ss_pred cccCCeeEeeeecccCceEEEEEEEc--CCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeEEE
Q 005841 502 ILWEDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCI 579 (674)
Q Consensus 502 ~~~~~y~~~~~LG~G~fG~Vy~~~~~--~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 579 (674)
+..++|++.+.||+|+||.||++.+. +..||+|++... ........+.+|+.+++.++||||+++++++...+.+++
T Consensus 2 l~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (331)
T cd06649 2 LKDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLE-IKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISI 80 (331)
T ss_pred CCcccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecc-cCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 34578999999999999999999984 667999998754 244556789999999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCeEEccCCCCCEEEcCCCcEEEEecCCcccccCC
Q 005841 580 VTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHC-NPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHET 658 (674)
Q Consensus 580 V~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~-~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~~ 658 (674)
||||+++++|.+++... ..+++..+..++.|++.||.|||+. + |+||||||+|||++.++.+||+|||+++.....
T Consensus 81 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~~--ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 157 (331)
T cd06649 81 CMEHMDGGSLDQVLKEA-KRIPEEILGKVSIAVLRGLAYLREKHQ--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 157 (331)
T ss_pred EeecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhhcCC--EEcCCCChhhEEEcCCCcEEEccCccccccccc
Confidence 99999999999999753 4689999999999999999999974 5 999999999999999999999999999866543
Q ss_pred ccccccCCCCccccCC
Q 005841 659 YLTTKTGKGTVTYLAS 674 (674)
Q Consensus 659 ~~~~~~~~GTp~YmAP 674 (674)
. .....||+.|+||
T Consensus 158 ~--~~~~~g~~~y~aP 171 (331)
T cd06649 158 M--ANSFVGTRSYMSP 171 (331)
T ss_pred c--cccCCCCcCcCCH
Confidence 2 2345799999998
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.3e-26 Score=252.14 Aligned_cols=166 Identities=31% Similarity=0.525 Sum_probs=144.2
Q ss_pred CeeEeeeecccCceEEEEEEE--cCCeEEEEEeecccC--CHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCe--EEE
Q 005841 506 DLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEY--SDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQR--LCI 579 (674)
Q Consensus 506 ~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~--~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~--~~l 579 (674)
-.++..+||+|+|-+||+|.+ +|-.||.-.++.... .++..++|..|+.+|+.|+||||++||..|.+..+ +.+
T Consensus 41 y~k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~ 120 (632)
T KOG0584|consen 41 YLKFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINF 120 (632)
T ss_pred eeehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeee
Confidence 346678999999999999998 455566544433332 34667899999999999999999999999988766 888
Q ss_pred EEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEc-CCCcEEEEecCCcccccCC
Q 005841 580 VTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVD-KHWTVKVGDFGLSRLKHET 658 (674)
Q Consensus 580 V~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~-~~~~vkL~DFGla~~~~~~ 658 (674)
|+|.+..|+|..|+++.+ +++.+.+..+++||+.||.|||.+.|||||||||.+||||+ ..|.|||+|+|||.++...
T Consensus 121 iTEL~TSGtLr~Y~kk~~-~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s 199 (632)
T KOG0584|consen 121 ITELFTSGTLREYRKKHR-RVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKS 199 (632)
T ss_pred eeecccCCcHHHHHHHhc-cCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHHhhcc
Confidence 999999999999998754 78999999999999999999999999999999999999998 5689999999999998887
Q ss_pred ccccccCCCCccccCC
Q 005841 659 YLTTKTGKGTVTYLAS 674 (674)
Q Consensus 659 ~~~~~~~~GTp~YmAP 674 (674)
.... ..|||.||||
T Consensus 200 ~aks--vIGTPEFMAP 213 (632)
T KOG0584|consen 200 HAKS--VIGTPEFMAP 213 (632)
T ss_pred ccce--eccCccccCh
Confidence 6655 5799999999
|
|
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.1e-25 Score=240.67 Aligned_cols=159 Identities=29% Similarity=0.419 Sum_probs=135.0
Q ss_pred ecccCceEEEEEEE--cCCeEEEEEeecccCC-HHHHHHHHHHHHHHhhC---CCCCeeeEEEEEecCCeEEEEEecCCC
Q 005841 513 IGQGSCGTVYHAVW--YGSDVAVKVFSRQEYS-DEVIHSFRQEVSLMKRL---RHPNVLLFMGAVTSPQRLCIVTEFLPR 586 (674)
Q Consensus 513 LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~~-~~~~~~~~~Ei~il~~l---~HpnIv~l~~~~~~~~~~~lV~E~~~g 586 (674)
||+|+||+||+|.+ .+..||||++.+.... ......+..|..++..+ .||||+.++..+.....+|+||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 79999999999987 4678999999764432 23334455677777665 699999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccccCCccccccCC
Q 005841 587 GSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGK 666 (674)
Q Consensus 587 gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~~~~~~~~~~ 666 (674)
++|..++.. ...+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++............+
T Consensus 81 g~L~~~l~~-~~~~~~~~~~~~~~qil~al~~LH~~~--ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 157 (330)
T cd05586 81 GELFWHLQK-EGRFSEDRAKFYIAELVLALEHLHKYD--IVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFC 157 (330)
T ss_pred ChHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCCCccCcc
Confidence 999999875 457999999999999999999999999 99999999999999999999999999976544333444568
Q ss_pred CCccccCC
Q 005841 667 GTVTYLAS 674 (674)
Q Consensus 667 GTp~YmAP 674 (674)
||+.||||
T Consensus 158 gt~~y~aP 165 (330)
T cd05586 158 GTTEYLAP 165 (330)
T ss_pred CCccccCH
Confidence 99999998
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.6e-25 Score=239.47 Aligned_cols=165 Identities=27% Similarity=0.435 Sum_probs=138.5
Q ss_pred CeeEeeeecccCceEEEEEEE--cCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecC-----CeEE
Q 005841 506 DLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSP-----QRLC 578 (674)
Q Consensus 506 ~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~-----~~~~ 578 (674)
+|++.++||+|+||.||+|.+ ++..||||.+............+.+|+.+++.++||||+++++++... ..+|
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 589999999999999999987 467899999875433333445788999999999999999999987543 3489
Q ss_pred EEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccccCC
Q 005841 579 IVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHET 658 (674)
Q Consensus 579 lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~~ 658 (674)
+|||||. ++|.+++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 81 lv~e~~~-~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~ 156 (338)
T cd07859 81 VVFELME-SDLHQVIKA-NDDLTPEHHQFFLYQLLRALKYIHTAN--VFHRDLKPKNILANADCKLKICDFGLARVAFND 156 (338)
T ss_pred EEEecCC-CCHHHHHHh-cccCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEECCCCcEEEccCccccccccc
Confidence 9999995 689998865 346999999999999999999999999 999999999999999999999999999864322
Q ss_pred c---cccccCCCCccccCC
Q 005841 659 Y---LTTKTGKGTVTYLAS 674 (674)
Q Consensus 659 ~---~~~~~~~GTp~YmAP 674 (674)
. .......||+.||||
T Consensus 157 ~~~~~~~~~~~~t~~y~aP 175 (338)
T cd07859 157 TPTAIFWTDYVATRWYRAP 175 (338)
T ss_pred cCccccccCCCCCCCcCCH
Confidence 1 112335799999998
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.7e-25 Score=250.84 Aligned_cols=172 Identities=24% Similarity=0.310 Sum_probs=147.5
Q ss_pred ccccCCeeEeeeecccCceEEEEEEE--cCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCC---
Q 005841 501 EILWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQ--- 575 (674)
Q Consensus 501 ~~~~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~--- 575 (674)
....++|.+.++||+|+||+||++.+ ++..||||++............+.+|+.++..++|+||++++..+...+
T Consensus 28 ~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~ 107 (496)
T PTZ00283 28 KEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRN 107 (496)
T ss_pred cccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccC
Confidence 34457999999999999999999987 5788999999877766666778899999999999999999988775432
Q ss_pred -----eEEEEEecCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEE
Q 005841 576 -----RLCIVTEFLPRGSLFRLLQRN---TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVG 647 (674)
Q Consensus 576 -----~~~lV~E~~~ggsL~~~l~~~---~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~ 647 (674)
.+++||||+++|+|.++|... ...+++..+..++.|++.||.|||+.+ |+||||||+||||+.++.+||+
T Consensus 108 ~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~--IiHrDLKP~NILl~~~~~vkL~ 185 (496)
T PTZ00283 108 PENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH--MIHRDIKSANILLCSNGLVKLG 185 (496)
T ss_pred cccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEEeCCCCEEEE
Confidence 378999999999999998642 346899999999999999999999998 9999999999999999999999
Q ss_pred ecCCcccccCCc--cccccCCCCccccCC
Q 005841 648 DFGLSRLKHETY--LTTKTGKGTVTYLAS 674 (674)
Q Consensus 648 DFGla~~~~~~~--~~~~~~~GTp~YmAP 674 (674)
|||+++.+.... ......+||+.||||
T Consensus 186 DFGls~~~~~~~~~~~~~~~~Gt~~Y~aP 214 (496)
T PTZ00283 186 DFGFSKMYAATVSDDVGRTFCGTPYYVAP 214 (496)
T ss_pred ecccCeeccccccccccccccCCcceeCH
Confidence 999998764321 123346799999998
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=99.93 E-value=2e-25 Score=231.00 Aligned_cols=170 Identities=23% Similarity=0.362 Sum_probs=144.9
Q ss_pred cccCCeeEeeeecccCceEEEEEEEc-----CCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCe
Q 005841 502 ILWEDLTIGEQIGQGSCGTVYHAVWY-----GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQR 576 (674)
Q Consensus 502 ~~~~~y~~~~~LG~G~fG~Vy~~~~~-----~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 576 (674)
+...+|++.+.||+|+||.||++.+. +..||+|.+.... .......+.+|+.++..++||||+++++++...+.
T Consensus 2 i~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 80 (266)
T cd05064 2 LDNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGC-SDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNT 80 (266)
T ss_pred CchHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCC-CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCC
Confidence 34567999999999999999999753 3469999987543 33445678899999999999999999999999999
Q ss_pred EEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCccccc
Q 005841 577 LCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKH 656 (674)
Q Consensus 577 ~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~ 656 (674)
+||||||+++++|.+++......+++..++.++.||+.||+|||+++ |+||||||+|||++.++.++|+|||.+....
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~--iiH~dikp~nili~~~~~~~l~dfg~~~~~~ 158 (266)
T cd05064 81 MMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMG--YVHKGLAAHKVLVNSDLVCKISGFRRLQEDK 158 (266)
T ss_pred cEEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC--EeeccccHhhEEEcCCCcEEECCCccccccc
Confidence 99999999999999999876667999999999999999999999998 9999999999999999999999999876543
Q ss_pred CCc-cccccCCCCccccCC
Q 005841 657 ETY-LTTKTGKGTVTYLAS 674 (674)
Q Consensus 657 ~~~-~~~~~~~GTp~YmAP 674 (674)
... .......+|+.|+||
T Consensus 159 ~~~~~~~~~~~~~~~y~aP 177 (266)
T cd05064 159 SEAIYTTMSGKSPVLWAAP 177 (266)
T ss_pred ccchhcccCCCCceeecCH
Confidence 221 222234567889998
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2e-26 Score=237.30 Aligned_cols=160 Identities=29% Similarity=0.461 Sum_probs=131.7
Q ss_pred CCeeEeeeecccCceEEEEEEE--cCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecC---C--eE
Q 005841 505 EDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSP---Q--RL 577 (674)
Q Consensus 505 ~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~---~--~~ 577 (674)
-.|.-.+++|.|+||.||.|.. .+..||||.+-.... --.+|+.+|+.+.|||||++..+|... + ++
T Consensus 24 i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r------~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~l 97 (364)
T KOG0658|consen 24 ISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR------YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYL 97 (364)
T ss_pred EEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC------cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHH
Confidence 3578889999999999999987 456799998754331 112599999999999999998888643 2 45
Q ss_pred EEEEecCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcC-CCcEEEEecCCcc
Q 005841 578 CIVTEFLPRGSLFRLLQR---NTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDK-HWTVKVGDFGLSR 653 (674)
Q Consensus 578 ~lV~E~~~ggsL~~~l~~---~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~-~~~vkL~DFGla~ 653 (674)
.+|||||+. +|.+.++. .+.+++...+..|..||++||.|||..+ |+||||||.|||+|. .|.+||||||.|+
T Consensus 98 nlVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~--IcHRDIKPqNlLvD~~tg~LKicDFGSAK 174 (364)
T KOG0658|consen 98 NLVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHG--ICHRDIKPQNLLVDPDTGVLKICDFGSAK 174 (364)
T ss_pred HHHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcC--cccCCCChheEEEcCCCCeEEeccCCcce
Confidence 789999966 99998874 3678999999999999999999999988 999999999999995 5999999999999
Q ss_pred cccCCccccccCCCCccccCC
Q 005841 654 LKHETYLTTKTGKGTVTYLAS 674 (674)
Q Consensus 654 ~~~~~~~~~~~~~GTp~YmAP 674 (674)
.+.....+.. +.=|-.|.||
T Consensus 175 ~L~~~epniS-YicSRyYRaP 194 (364)
T KOG0658|consen 175 VLVKGEPNIS-YICSRYYRAP 194 (364)
T ss_pred eeccCCCcee-EEEeccccCH
Confidence 8865544443 3347889888
|
|
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.6e-25 Score=238.47 Aligned_cols=167 Identities=24% Similarity=0.404 Sum_probs=145.6
Q ss_pred cccCCeeEeeeecccCceEEEEEEEc--CCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeEEE
Q 005841 502 ILWEDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCI 579 (674)
Q Consensus 502 ~~~~~y~~~~~LG~G~fG~Vy~~~~~--~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 579 (674)
+..++|++.+.||+|+||.||++.+. +..||+|++.... .......+.+|+.+++.++||||+++++++...+.+||
T Consensus 2 l~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (333)
T cd06650 2 LKDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISI 80 (333)
T ss_pred cchhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeeccc-CHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEE
Confidence 45578999999999999999999984 6679999886542 44556778999999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCeEEccCCCCCEEEcCCCcEEEEecCCcccccCC
Q 005841 580 VTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHH-CNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHET 658 (674)
Q Consensus 580 V~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~-~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~~ 658 (674)
||||+++++|.+++... ..+++..+..++.|++.||.|||+ .+ |+|+||||+|||++.++.+||+|||++......
T Consensus 81 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~~--ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~ 157 (333)
T cd06650 81 CMEHMDGGSLDQVLKKA-GRIPEQILGKVSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 157 (333)
T ss_pred EEecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhcCC--EEecCCChhhEEEcCCCCEEEeeCCcchhhhhh
Confidence 99999999999999753 468999999999999999999997 46 999999999999999999999999999765432
Q ss_pred ccccccCCCCccccCC
Q 005841 659 YLTTKTGKGTVTYLAS 674 (674)
Q Consensus 659 ~~~~~~~~GTp~YmAP 674 (674)
. .....||+.|+||
T Consensus 158 ~--~~~~~~~~~y~aP 171 (333)
T cd06650 158 M--ANSFVGTRSYMSP 171 (333)
T ss_pred c--cccCCCCccccCH
Confidence 2 2335799999998
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.2e-25 Score=249.47 Aligned_cols=166 Identities=20% Similarity=0.287 Sum_probs=142.1
Q ss_pred CCeeEeeeecccCceEEEEEEEc---CCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeEEEEE
Q 005841 505 EDLTIGEQIGQGSCGTVYHAVWY---GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVT 581 (674)
Q Consensus 505 ~~y~~~~~LG~G~fG~Vy~~~~~---~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 581 (674)
..|.+.+.||+|+||.||++... +..||+|.+... .......+.+|+.+++.++||||+++++++...+.+||||
T Consensus 67 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~--~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~ 144 (478)
T PTZ00267 67 HMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLN--DERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIM 144 (478)
T ss_pred eeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccC--CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEE
Confidence 45999999999999999999863 456888876443 2344456788999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccccCC
Q 005841 582 EFLPRGSLFRLLQR---NTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHET 658 (674)
Q Consensus 582 E~~~ggsL~~~l~~---~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~~ 658 (674)
||+++++|.++|.. ....+++..+..++.||+.||.|||+++ ||||||||+||||+.++.+||+|||+++.....
T Consensus 145 E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~--ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~ 222 (478)
T PTZ00267 145 EYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK--MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDS 222 (478)
T ss_pred ECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC--EEECCcCHHhEEECCCCcEEEEeCcCceecCCc
Confidence 99999999998854 2346899999999999999999999998 999999999999999999999999999876543
Q ss_pred cc--ccccCCCCccccCC
Q 005841 659 YL--TTKTGKGTVTYLAS 674 (674)
Q Consensus 659 ~~--~~~~~~GTp~YmAP 674 (674)
.. .....+||+.||||
T Consensus 223 ~~~~~~~~~~gt~~y~aP 240 (478)
T PTZ00267 223 VSLDVASSFCGTPYYLAP 240 (478)
T ss_pred cccccccccCCCccccCH
Confidence 21 23346799999998
|
|
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=3e-25 Score=232.38 Aligned_cols=166 Identities=24% Similarity=0.331 Sum_probs=143.0
Q ss_pred CeeEeeeecccCceEEEEEEE--cCCeEEEEEeecccCCH-HHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeEEEEEe
Q 005841 506 DLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSD-EVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTE 582 (674)
Q Consensus 506 ~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E 582 (674)
.|++.++||+|+||.||++.+ ++..||||++.+..... .....+.+|+.+++.++||||+.+++.+..++.+|+|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 488999999999999999987 46789999997654433 233557789999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccccCCccc
Q 005841 583 FLPRGSLFRLLQRN-TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLT 661 (674)
Q Consensus 583 ~~~ggsL~~~l~~~-~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~~~~~ 661 (674)
|+++++|.+++... ...+++..+..++.|++.||.|||+.+ |+||||||+|||+++++.++|+|||+++...... .
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~-~ 157 (285)
T cd05605 81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRER--IVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE-T 157 (285)
T ss_pred ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCC--cEecCCCHHHEEECCCCCEEEeeCCCceecCCCC-c
Confidence 99999999888653 346999999999999999999999998 9999999999999999999999999998754322 2
Q ss_pred cccCCCCccccCC
Q 005841 662 TKTGKGTVTYLAS 674 (674)
Q Consensus 662 ~~~~~GTp~YmAP 674 (674)
.....||+.||||
T Consensus 158 ~~~~~~~~~y~aP 170 (285)
T cd05605 158 IRGRVGTVGYMAP 170 (285)
T ss_pred cccccCCCCccCc
Confidence 2335799999998
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.9e-26 Score=253.50 Aligned_cols=165 Identities=27% Similarity=0.397 Sum_probs=140.6
Q ss_pred CeeEeeeecccCceEEEEEEE--cCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCC------eE
Q 005841 506 DLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQ------RL 577 (674)
Q Consensus 506 ~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~------~~ 577 (674)
-|...+.||+|+||.||++++ +|..||||.+++.. .....++..+|+++|++|+|+|||++++.-++.. ..
T Consensus 14 ~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~-~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~ 92 (732)
T KOG4250|consen 14 LWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKES-SLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLP 92 (732)
T ss_pred ceeehhhhcCCccceeeeecccccccchhHHhhhhhc-ccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccc
Confidence 356778999999999999997 58889999997654 3344577889999999999999999998765443 46
Q ss_pred EEEEecCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcC--CC--cEEEEecCC
Q 005841 578 CIVTEFLPRGSLFRLLQRN--TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDK--HW--TVKVGDFGL 651 (674)
Q Consensus 578 ~lV~E~~~ggsL~~~l~~~--~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~--~~--~vkL~DFGl 651 (674)
.+|||||.||+|...|.+. -..+++.+.+.++.+++.||.|||+++ ||||||||.||++-. +| ..||+|||.
T Consensus 93 vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~--IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~ 170 (732)
T KOG4250|consen 93 VLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENG--IVHRDLKPGNIVLQIGEDGQSIYKLTDFGA 170 (732)
T ss_pred eEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcC--ceeccCCCCcEEEeecCCCceEEeeecccc
Confidence 8999999999999999752 345999999999999999999999999 999999999999852 23 369999999
Q ss_pred cccccCCccccccCCCCccccCC
Q 005841 652 SRLKHETYLTTKTGKGTVTYLAS 674 (674)
Q Consensus 652 a~~~~~~~~~~~~~~GTp~YmAP 674 (674)
|+.+.+.. ...++.||+.|++|
T Consensus 171 Arel~d~s-~~~S~vGT~~YLhP 192 (732)
T KOG4250|consen 171 ARELDDNS-LFTSLVGTEEYLHP 192 (732)
T ss_pred cccCCCCC-eeeeecCchhhcCh
Confidence 99998766 44458999999998
|
|
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.2e-25 Score=236.02 Aligned_cols=166 Identities=28% Similarity=0.404 Sum_probs=143.2
Q ss_pred CCeeEeeeecccCceEEEEEEE--cCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeEEEEEe
Q 005841 505 EDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTE 582 (674)
Q Consensus 505 ~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E 582 (674)
++|.+.+.||+|+||.||+|.+ .+..||+|++...... .....+.+|+.+++.++||||+++++++...+..|+|||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 84 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEE-GAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFE 84 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccC-CcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEe
Confidence 6799999999999999999987 4667999998754322 223456789999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccccCCcccc
Q 005841 583 FLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTT 662 (674)
Q Consensus 583 ~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~~~~~~ 662 (674)
|+++ +|.+++......+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.........
T Consensus 85 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~--ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 161 (309)
T cd07872 85 YLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRK--VLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTY 161 (309)
T ss_pred CCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEECCCCCEEECccccceecCCCcccc
Confidence 9975 898888776667899999999999999999999999 9999999999999999999999999998654433333
Q ss_pred ccCCCCccccCC
Q 005841 663 KTGKGTVTYLAS 674 (674)
Q Consensus 663 ~~~~GTp~YmAP 674 (674)
....||+.|+||
T Consensus 162 ~~~~~~~~y~aP 173 (309)
T cd07872 162 SNEVVTLWYRPP 173 (309)
T ss_pred ccccccccccCC
Confidence 345689999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.5e-25 Score=238.63 Aligned_cols=161 Identities=28% Similarity=0.398 Sum_probs=136.0
Q ss_pred eeecccCceEEEEEEE--cCCeEEEEEeecccCC-HHHHHHHHHHHHHHhhC-CCCCeeeEEEEEecCCeEEEEEecCCC
Q 005841 511 EQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYS-DEVIHSFRQEVSLMKRL-RHPNVLLFMGAVTSPQRLCIVTEFLPR 586 (674)
Q Consensus 511 ~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~~-~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lV~E~~~g 586 (674)
++||+|+||.||+|.+ ++..||+|++.+.... ......+..|..++..+ +||||+++++++...+.+||||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 4799999999999998 4678999999765321 22344566788887754 899999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccccCCccccccCC
Q 005841 587 GSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGK 666 (674)
Q Consensus 587 gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~~~~~~~~~~ 666 (674)
++|..++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++............+
T Consensus 81 g~L~~~i~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 157 (316)
T cd05620 81 GDLMFHIQD-KGRFDLYRATFYAAEIVCGLQFLHSKG--IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFC 157 (316)
T ss_pred CcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHeEECCCCCEEeCccCCCeecccCCCceeccC
Confidence 999999875 457899999999999999999999999 99999999999999999999999999975432222334467
Q ss_pred CCccccCC
Q 005841 667 GTVTYLAS 674 (674)
Q Consensus 667 GTp~YmAP 674 (674)
||+.||||
T Consensus 158 gt~~y~aP 165 (316)
T cd05620 158 GTPDYIAP 165 (316)
T ss_pred CCcCccCH
Confidence 99999998
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=7.4e-27 Score=250.05 Aligned_cols=161 Identities=30% Similarity=0.435 Sum_probs=142.8
Q ss_pred eeEeeeecccCceEEEEEEE--cCCeEEEEEeecccC-CHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeEEEEEec
Q 005841 507 LTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEY-SDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEF 583 (674)
Q Consensus 507 y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~ 583 (674)
|.-+..||.|+||.||-+++ +...||||.++...- ..+..+.+.+|+..|.+++|||++.+-++|-.....||||||
T Consensus 28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEY 107 (948)
T KOG0577|consen 28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEY 107 (948)
T ss_pred HHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHH
Confidence 56677899999999999987 455699998865432 345667889999999999999999999999999999999999
Q ss_pred CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccccCCccccc
Q 005841 584 LPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTK 663 (674)
Q Consensus 584 ~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~~~~~~~ 663 (674)
| -|+-.|+|.-...++-+.++.-|..+.+.||.|||+.+ .||||||..|||+++.|.|||+|||.|.+... ..
T Consensus 108 C-lGSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~--~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P----An 180 (948)
T KOG0577|consen 108 C-LGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN--RIHRDIKAGNILLSEPGLVKLADFGSASIMAP----AN 180 (948)
T ss_pred H-hccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhh--HHhhhccccceEecCCCeeeeccccchhhcCc----hh
Confidence 9 66888888877788999999999999999999999999 99999999999999999999999999976542 45
Q ss_pred cCCCCccccCC
Q 005841 664 TGKGTVTYLAS 674 (674)
Q Consensus 664 ~~~GTp~YmAP 674 (674)
+|+|||+||||
T Consensus 181 sFvGTPywMAP 191 (948)
T KOG0577|consen 181 SFVGTPYWMAP 191 (948)
T ss_pred cccCCccccch
Confidence 68999999999
|
|
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.5e-25 Score=229.60 Aligned_cols=165 Identities=34% Similarity=0.518 Sum_probs=145.1
Q ss_pred eeEeeeecccCceEEEEEEEc--CCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeEEEEEecC
Q 005841 507 LTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFL 584 (674)
Q Consensus 507 y~~~~~LG~G~fG~Vy~~~~~--~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 584 (674)
|++.+.||+|+||+||++... +..||+|++..............+|+.+++.++||||+++++++.....+++||||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 789999999999999999985 446999999887655544445566999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccccCCcccccc
Q 005841 585 PRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKT 664 (674)
Q Consensus 585 ~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~~~~~~~~ 664 (674)
++++|.+++. ....+++..+..++.||+.||.|||+.+ |+|+||||+|||++.++.++|+|||.+............
T Consensus 81 ~~~~L~~~l~-~~~~~~~~~~~~~~~qi~~~L~~Lh~~~--i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~~~~~~ 157 (260)
T PF00069_consen 81 PGGSLQDYLQ-KNKPLSEEEILKIAYQILEALAYLHSKG--IVHRDIKPENILLDENGEVKLIDFGSSVKLSENNENFNP 157 (260)
T ss_dssp TTEBHHHHHH-HHSSBBHHHHHHHHHHHHHHHHHHHHTT--EEESSBSGGGEEESTTSEEEESSGTTTEESTSTTSEBSS
T ss_pred cccccccccc-cccccccccccccccccccccccccccc--ccccccccccccccccccccccccccccccccccccccc
Confidence 9999999997 3457899999999999999999999999 999999999999999999999999999864333344445
Q ss_pred CCCCccccCC
Q 005841 665 GKGTVTYLAS 674 (674)
Q Consensus 665 ~~GTp~YmAP 674 (674)
..||+.|+||
T Consensus 158 ~~~~~~y~aP 167 (260)
T PF00069_consen 158 FVGTPEYMAP 167 (260)
T ss_dssp SSSSGGGSCH
T ss_pred cccccccccc
Confidence 6799999998
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.9e-25 Score=237.86 Aligned_cols=161 Identities=28% Similarity=0.405 Sum_probs=136.2
Q ss_pred eeecccCceEEEEEEEc--CCeEEEEEeecccCC-HHHHHHHHHHHHHHhh-CCCCCeeeEEEEEecCCeEEEEEecCCC
Q 005841 511 EQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYS-DEVIHSFRQEVSLMKR-LRHPNVLLFMGAVTSPQRLCIVTEFLPR 586 (674)
Q Consensus 511 ~~LG~G~fG~Vy~~~~~--~~~vAvK~i~~~~~~-~~~~~~~~~Ei~il~~-l~HpnIv~l~~~~~~~~~~~lV~E~~~g 586 (674)
+.||+|+||+||+|.+. +..||||++.+.... ......+..|..++.. ++||||+++++++.+.+.+||||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999984 567999999765421 2233456667888876 4899999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccccCCccccccCC
Q 005841 587 GSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGK 666 (674)
Q Consensus 587 gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~~~~~~~~~~ 666 (674)
++|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++............+
T Consensus 81 g~L~~~l~~-~~~~~~~~~~~~~~qi~~al~~LH~~~--ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 157 (316)
T cd05619 81 GDLMFHIQS-CHKFDLPRATFYAAEIICGLQFLHSKG--IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFC 157 (316)
T ss_pred CcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCC--eEeCCCCHHHEEECCCCCEEEccCCcceECCCCCCceeeec
Confidence 999999975 346899999999999999999999998 99999999999999999999999999976433333344467
Q ss_pred CCccccCC
Q 005841 667 GTVTYLAS 674 (674)
Q Consensus 667 GTp~YmAP 674 (674)
||+.||||
T Consensus 158 gt~~y~aP 165 (316)
T cd05619 158 GTPDYIAP 165 (316)
T ss_pred CCccccCH
Confidence 99999998
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.6e-25 Score=244.25 Aligned_cols=173 Identities=28% Similarity=0.433 Sum_probs=143.5
Q ss_pred ccccccCCeeEeeeecccCceEEEEEEEc-------CCeEEEEEeecccCCHHHHHHHHHHHHHHhhC-CCCCeeeEEEE
Q 005841 499 DYEILWEDLTIGEQIGQGSCGTVYHAVWY-------GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRL-RHPNVLLFMGA 570 (674)
Q Consensus 499 ~~~~~~~~y~~~~~LG~G~fG~Vy~~~~~-------~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~ 570 (674)
.+.+..++|++.++||+|+||.||+|.+. +..||||++..... ....+.+.+|+.++..+ +||||++++++
T Consensus 29 ~~~~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~~Ei~il~~l~~HpnIv~l~~~ 107 (375)
T cd05104 29 KWEFPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAH-LTEREALMSELKVLSYLGNHINIVNLLGA 107 (375)
T ss_pred ccccchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcC-cHHHHHHHHHHHHHHHhcCCcceeeeeee
Confidence 34566678999999999999999999752 34699999865432 23446788999999999 89999999999
Q ss_pred EecCCeEEEEEecCCCCCHHHHHHhcC-----------------------------------------------------
Q 005841 571 VTSPQRLCIVTEFLPRGSLFRLLQRNT----------------------------------------------------- 597 (674)
Q Consensus 571 ~~~~~~~~lV~E~~~ggsL~~~l~~~~----------------------------------------------------- 597 (674)
+...+..|+|||||++|+|.+++....
T Consensus 108 ~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 187 (375)
T cd05104 108 CTVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRR 187 (375)
T ss_pred eccCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccc
Confidence 999999999999999999999986432
Q ss_pred ---------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCccccc
Q 005841 598 ---------------------TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKH 656 (674)
Q Consensus 598 ---------------------~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~ 656 (674)
..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 188 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~ 265 (375)
T cd05104 188 SVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN--CIHRDLAARNILLTHGRITKICDFGLARDIR 265 (375)
T ss_pred ccccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCchhhEEEECCCcEEEecCccceecc
Confidence 24788899999999999999999998 9999999999999999999999999998764
Q ss_pred CCccc--cccCCCCccccCC
Q 005841 657 ETYLT--TKTGKGTVTYLAS 674 (674)
Q Consensus 657 ~~~~~--~~~~~GTp~YmAP 674 (674)
..... .....+++.||||
T Consensus 266 ~~~~~~~~~~~~~~~~y~aP 285 (375)
T cd05104 266 NDSNYVVKGNARLPVKWMAP 285 (375)
T ss_pred CcccccccCCCCCCcceeCh
Confidence 43221 1123456789998
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.7e-25 Score=243.73 Aligned_cols=161 Identities=22% Similarity=0.349 Sum_probs=138.7
Q ss_pred cccCCeeEeeeecccCceEEEEEEE--cCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeEEE
Q 005841 502 ILWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCI 579 (674)
Q Consensus 502 ~~~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 579 (674)
+...+|++.+.||+|+||.||+|.+ ++..||||.... ..+.+|+.+++.++||||+++++++......|+
T Consensus 89 ~~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~--------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~l 160 (391)
T PHA03212 89 IEKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR--------GGTATEAHILRAINHPSIIQLKGTFTYNKFTCL 160 (391)
T ss_pred cccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh--------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEE
Confidence 4456899999999999999999997 467799996532 246789999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccccCCc
Q 005841 580 VTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETY 659 (674)
Q Consensus 580 V~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~~~ 659 (674)
|||++. ++|..++... ..+++..++.|+.||+.||.|||+++ ||||||||+||||+.++.+||+|||+|+......
T Consensus 161 v~e~~~-~~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~ylH~~~--IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~ 236 (391)
T PHA03212 161 ILPRYK-TDLYCYLAAK-RNIAICDILAIERSVLRAIQYLHENR--IIHRDIKAENIFINHPGDVCLGDFGAACFPVDIN 236 (391)
T ss_pred EEecCC-CCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCChHhEEEcCCCCEEEEeCCccccccccc
Confidence 999994 6898888653 46899999999999999999999998 9999999999999999999999999997643321
Q ss_pred -cccccCCCCccccCC
Q 005841 660 -LTTKTGKGTVTYLAS 674 (674)
Q Consensus 660 -~~~~~~~GTp~YmAP 674 (674)
......+||+.||||
T Consensus 237 ~~~~~~~~gt~~y~aP 252 (391)
T PHA03212 237 ANKYYGWAGTIATNAP 252 (391)
T ss_pred ccccccccCccCCCCh
Confidence 222345799999998
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.8e-25 Score=243.72 Aligned_cols=173 Identities=25% Similarity=0.441 Sum_probs=144.0
Q ss_pred ccccccCCeeEeeeecccCceEEEEEEEc-------CCeEEEEEeecccCCHHHHHHHHHHHHHHhhC-CCCCeeeEEEE
Q 005841 499 DYEILWEDLTIGEQIGQGSCGTVYHAVWY-------GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRL-RHPNVLLFMGA 570 (674)
Q Consensus 499 ~~~~~~~~y~~~~~LG~G~fG~Vy~~~~~-------~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~ 570 (674)
.+.+..++|++.+.||+|+||.||+|.+. ...||||++.... .......+.+|+.+++.+ +|+||++++++
T Consensus 32 ~~~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~il~~l~~h~nIv~~~~~ 110 (374)
T cd05106 32 KWEFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASA-HTDEREALMSELKILSHLGQHKNIVNLLGA 110 (374)
T ss_pred cccccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCC-CHHHHHHHHHHHHHHHhhccCCceeeEeeE
Confidence 34566778999999999999999999852 2359999997543 334456788999999999 89999999999
Q ss_pred EecCCeEEEEEecCCCCCHHHHHHhcC-----------------------------------------------------
Q 005841 571 VTSPQRLCIVTEFLPRGSLFRLLQRNT----------------------------------------------------- 597 (674)
Q Consensus 571 ~~~~~~~~lV~E~~~ggsL~~~l~~~~----------------------------------------------------- 597 (674)
+...+.+|+|||||++|+|.+++....
T Consensus 111 ~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 190 (374)
T cd05106 111 CTHGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSS 190 (374)
T ss_pred ecCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccc
Confidence 999999999999999999999986421
Q ss_pred ----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccccCCccc
Q 005841 598 ----------------TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLT 661 (674)
Q Consensus 598 ----------------~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~~~~~ 661 (674)
..+++..++.|+.||+.||.|||+++ |+||||||+|||+++++.+||+|||+++........
T Consensus 191 ~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g--iiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~ 268 (374)
T cd05106 191 SSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN--CIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNY 268 (374)
T ss_pred ccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC--EEeccCchheEEEeCCCeEEEeeceeeeeccCCcce
Confidence 24788899999999999999999998 999999999999999999999999999865433211
Q ss_pred --cccCCCCccccCC
Q 005841 662 --TKTGKGTVTYLAS 674 (674)
Q Consensus 662 --~~~~~GTp~YmAP 674 (674)
.....+++.||||
T Consensus 269 ~~~~~~~~~~~y~aP 283 (374)
T cd05106 269 VVKGNARLPVKWMAP 283 (374)
T ss_pred eeccCCCCccceeCH
Confidence 1122456789998
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.2e-26 Score=247.56 Aligned_cols=164 Identities=32% Similarity=0.527 Sum_probs=146.3
Q ss_pred cccccccCCeeEeeeecccCceEEEEEEEcCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeE
Q 005841 498 LDYEILWEDLTIGEQIGQGSCGTVYHAVWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRL 577 (674)
Q Consensus 498 ~~~~~~~~~y~~~~~LG~G~fG~Vy~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 577 (674)
..|++.++...-++-||.|+.|.||+|++.+..||||.++..+ ..+|+-|++|+||||+.|.|+|.....+
T Consensus 117 e~WeiPFe~IsELeWlGSGaQGAVF~Grl~netVAVKKV~elk---------ETdIKHLRkLkH~NII~FkGVCtqsPcy 187 (904)
T KOG4721|consen 117 ELWEIPFEEISELEWLGSGAQGAVFLGRLHNETVAVKKVRELK---------ETDIKHLRKLKHPNIITFKGVCTQSPCY 187 (904)
T ss_pred hhccCCHHHhhhhhhhccCcccceeeeeccCceehhHHHhhhh---------hhhHHHHHhccCcceeeEeeeecCCcee
Confidence 4567777777777889999999999999999999999875321 2378889999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccccC
Q 005841 578 CIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHE 657 (674)
Q Consensus 578 ~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~ 657 (674)
|||||||..|.|+..|+. +..++....+.+..+|+.||+|||.+. |||||||.-||||..+..|||+|||.++.+.+
T Consensus 188 CIiMEfCa~GqL~~VLka-~~~itp~llv~Wsk~IA~GM~YLH~hK--IIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~ 264 (904)
T KOG4721|consen 188 CIIMEFCAQGQLYEVLKA-GRPITPSLLVDWSKGIAGGMNYLHLHK--IIHRDLKSPNILISYDDVVKISDFGTSKELSD 264 (904)
T ss_pred EEeeeccccccHHHHHhc-cCccCHHHHHHHHHHhhhhhHHHHHhh--HhhhccCCCceEeeccceEEeccccchHhhhh
Confidence 999999999999999965 567889999999999999999999999 99999999999999999999999999998877
Q ss_pred CccccccCCCCccccCC
Q 005841 658 TYLTTKTGKGTVTYLAS 674 (674)
Q Consensus 658 ~~~~~~~~~GTp~YmAP 674 (674)
. .+.-+|+||..||||
T Consensus 265 ~-STkMSFaGTVaWMAP 280 (904)
T KOG4721|consen 265 K-STKMSFAGTVAWMAP 280 (904)
T ss_pred h-hhhhhhhhhHhhhCH
Confidence 6 344469999999998
|
|
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.2e-25 Score=237.37 Aligned_cols=161 Identities=30% Similarity=0.428 Sum_probs=138.7
Q ss_pred eeecccCceEEEEEEEc--CCeEEEEEeecccC-CHHHHHHHHHHHHHHhhC-CCCCeeeEEEEEecCCeEEEEEecCCC
Q 005841 511 EQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEY-SDEVIHSFRQEVSLMKRL-RHPNVLLFMGAVTSPQRLCIVTEFLPR 586 (674)
Q Consensus 511 ~~LG~G~fG~Vy~~~~~--~~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lV~E~~~g 586 (674)
++||+|+||+||++.+. +..||||++.+... .......+.+|+.++..+ +||||+++++++...+.+|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999884 56799999986543 223456677899999888 699999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccccCCccccccCC
Q 005841 587 GSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGK 666 (674)
Q Consensus 587 gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~~~~~~~~~~ 666 (674)
++|.+++.+. ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++............+
T Consensus 81 ~~L~~~~~~~-~~l~~~~~~~~~~qi~~~l~~LH~~~--ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 157 (318)
T cd05570 81 GDLMFHIQRS-GRFDEPRARFYAAEIVLGLQFLHERG--IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFC 157 (318)
T ss_pred CCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCC--eEccCCCHHHeEECCCCcEEecccCCCeecCcCCCccccee
Confidence 9999998754 47999999999999999999999999 99999999999999999999999999976443333344567
Q ss_pred CCccccCC
Q 005841 667 GTVTYLAS 674 (674)
Q Consensus 667 GTp~YmAP 674 (674)
||+.||||
T Consensus 158 g~~~y~aP 165 (318)
T cd05570 158 GTPDYIAP 165 (318)
T ss_pred cCccccCH
Confidence 99999998
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.7e-25 Score=243.14 Aligned_cols=174 Identities=28% Similarity=0.443 Sum_probs=146.2
Q ss_pred cccccccCCeeEeeeecccCceEEEEEEEcC-------CeEEEEEeecccCCHHHHHHHHHHHHHHhhCC-CCCeeeEEE
Q 005841 498 LDYEILWEDLTIGEQIGQGSCGTVYHAVWYG-------SDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLR-HPNVLLFMG 569 (674)
Q Consensus 498 ~~~~~~~~~y~~~~~LG~G~fG~Vy~~~~~~-------~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~ 569 (674)
..+++..++|.++++||+|+||.||+|.+.+ ..||||++.... .....+.+.+|+.+++.+. ||||+++++
T Consensus 30 ~~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~ 108 (400)
T cd05105 30 SRWEFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTA-RSSEKQALMSELKIMTHLGPHLNIVNLLG 108 (400)
T ss_pred CceeccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCCCeeeEEE
Confidence 4567778899999999999999999998632 249999986543 3344567899999999996 999999999
Q ss_pred EEecCCeEEEEEecCCCCCHHHHHHhcC----------------------------------------------------
Q 005841 570 AVTSPQRLCIVTEFLPRGSLFRLLQRNT---------------------------------------------------- 597 (674)
Q Consensus 570 ~~~~~~~~~lV~E~~~ggsL~~~l~~~~---------------------------------------------------- 597 (674)
++.....+|||||||++|+|.++|..+.
T Consensus 109 ~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 188 (400)
T cd05105 109 ACTKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQY 188 (400)
T ss_pred EEccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhccccccccccccccccc
Confidence 9999999999999999999999886431
Q ss_pred -------------------------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCC
Q 005841 598 -------------------------------------------TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSS 634 (674)
Q Consensus 598 -------------------------------------------~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~ 634 (674)
..+++..++.++.||+.||.|||+.+ |+||||||+
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivH~dikp~ 266 (400)
T cd05105 189 VPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN--CVHRDLAAR 266 (400)
T ss_pred chhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCChH
Confidence 24778889999999999999999998 999999999
Q ss_pred CEEEcCCCcEEEEecCCcccccCCcc--ccccCCCCccccCC
Q 005841 635 NLLVDKHWTVKVGDFGLSRLKHETYL--TTKTGKGTVTYLAS 674 (674)
Q Consensus 635 NILi~~~~~vkL~DFGla~~~~~~~~--~~~~~~GTp~YmAP 674 (674)
|||++.++.+||+|||+++....... ......+++.||||
T Consensus 267 Nill~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aP 308 (400)
T cd05105 267 NVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAP 308 (400)
T ss_pred hEEEeCCCEEEEEeCCcceeccccccccccCCcCCCcceECh
Confidence 99999999999999999986543221 22234578899998
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=6e-26 Score=233.38 Aligned_cols=166 Identities=28% Similarity=0.393 Sum_probs=143.0
Q ss_pred cCCeeEeeeecccCceEEEEEEE--cCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEec-----CCe
Q 005841 504 WEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTS-----PQR 576 (674)
Q Consensus 504 ~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~-----~~~ 576 (674)
...|...+.||.|+||.|+.+.+ ++..||||.+.......-..++..+|+++|+.++|+||+.+++++.. -..
T Consensus 21 ~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~D 100 (359)
T KOG0660|consen 21 PRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFND 100 (359)
T ss_pred cceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccce
Confidence 35566689999999999999987 57789999997666566667888999999999999999999999876 246
Q ss_pred EEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCccccc
Q 005841 577 LCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKH 656 (674)
Q Consensus 577 ~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~ 656 (674)
+|+|+|+| +.+|...|+. +..++...+.++++|++.||.|+|+.+ |+||||||.|+|++.++.+||||||+|+...
T Consensus 101 vYiV~elM-etDL~~iik~-~~~L~d~H~q~f~YQiLrgLKyiHSAn--ViHRDLKPsNll~n~~c~lKI~DFGLAR~~~ 176 (359)
T KOG0660|consen 101 VYLVFELM-ETDLHQIIKS-QQDLTDDHAQYFLYQILRGLKYIHSAN--VIHRDLKPSNLLLNADCDLKICDFGLARYLD 176 (359)
T ss_pred eEEehhHH-hhHHHHHHHc-CccccHHHHHHHHHHHHHhcchhhccc--ccccccchhheeeccCCCEEeccccceeecc
Confidence 99999999 6699999964 445999999999999999999999999 9999999999999999999999999999885
Q ss_pred C---CccccccCCCCccccCC
Q 005841 657 E---TYLTTKTGKGTVTYLAS 674 (674)
Q Consensus 657 ~---~~~~~~~~~GTp~YmAP 674 (674)
. ... ...++-|-.|.||
T Consensus 177 ~~~~~~~-mTeYVaTRWYRAP 196 (359)
T KOG0660|consen 177 KFFEDGF-MTEYVATRWYRAP 196 (359)
T ss_pred ccCcccc-hhcceeeeeecCH
Confidence 3 222 2235779999998
|
|
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.9e-25 Score=231.30 Aligned_cols=166 Identities=28% Similarity=0.412 Sum_probs=136.1
Q ss_pred CCeeEeeeecccCceEEEEEEEc---CCeEEEEEeecccCCHHHHHHHHHHHHHHhhC---CCCCeeeEEEEEe-----c
Q 005841 505 EDLTIGEQIGQGSCGTVYHAVWY---GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRL---RHPNVLLFMGAVT-----S 573 (674)
Q Consensus 505 ~~y~~~~~LG~G~fG~Vy~~~~~---~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l---~HpnIv~l~~~~~-----~ 573 (674)
.+|++.+.||+|+||+||+|.+. +..||+|++............+.+|+.+++.+ .||||+++++++. .
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 36899999999999999999872 45699999876544333334456677777765 6999999999885 3
Q ss_pred CCeEEEEEecCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCc
Q 005841 574 PQRLCIVTEFLPRGSLFRLLQRNT-TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLS 652 (674)
Q Consensus 574 ~~~~~lV~E~~~ggsL~~~l~~~~-~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla 652 (674)
...+++||||++ ++|.+++.... ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~--iiH~dlkp~Nil~~~~~~~kl~Dfg~~ 157 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR--VVHRDLKPQNILVTSSGQIKLADFGLA 157 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCHHHEEEcCCCCEEEccccce
Confidence 456899999996 58999887543 45899999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCccccccCCCCccccCC
Q 005841 653 RLKHETYLTTKTGKGTVTYLAS 674 (674)
Q Consensus 653 ~~~~~~~~~~~~~~GTp~YmAP 674 (674)
+..... .......||+.||||
T Consensus 158 ~~~~~~-~~~~~~~~~~~y~aP 178 (290)
T cd07862 158 RIYSFQ-MALTSVVVTLWYRAP 178 (290)
T ss_pred EeccCC-cccccccccccccCh
Confidence 876543 223345799999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=6.6e-25 Score=237.70 Aligned_cols=159 Identities=25% Similarity=0.358 Sum_probs=138.0
Q ss_pred cCCeeEeeeecccCceEEEEEEEc--CCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeEEEEE
Q 005841 504 WEDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVT 581 (674)
Q Consensus 504 ~~~y~~~~~LG~G~fG~Vy~~~~~--~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 581 (674)
..+|++.+.||+|+||.||+|.+. +..||+|+..+.. ...|+.+++.++||||+++++++......|+||
T Consensus 65 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~~--------~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 136 (357)
T PHA03209 65 SLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKGT--------TLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVL 136 (357)
T ss_pred hcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCccc--------cHHHHHHHHhCCCCCCcChhheEEeCCeeEEEE
Confidence 457999999999999999999984 4579999754332 245899999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccccCCccc
Q 005841 582 EFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLT 661 (674)
Q Consensus 582 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~~~~~ 661 (674)
||+. ++|.+++......+++..+..|+.||+.||.|||.++ ||||||||+|||++.++.+||+|||+++...... .
T Consensus 137 e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~-~ 212 (357)
T PHA03209 137 PHYS-SDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQR--IIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAP-A 212 (357)
T ss_pred EccC-CcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEECCCCCEEEecCccccccccCc-c
Confidence 9994 5899988777778999999999999999999999999 9999999999999999999999999998644322 2
Q ss_pred cccCCCCccccCC
Q 005841 662 TKTGKGTVTYLAS 674 (674)
Q Consensus 662 ~~~~~GTp~YmAP 674 (674)
.....||+.||||
T Consensus 213 ~~~~~gt~~y~aP 225 (357)
T PHA03209 213 FLGLAGTVETNAP 225 (357)
T ss_pred cccccccccccCC
Confidence 2345799999998
|
|
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.1e-25 Score=244.52 Aligned_cols=160 Identities=31% Similarity=0.498 Sum_probs=144.0
Q ss_pred eeecccCceEEEEEEEcCC--eEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeEEEEEecCCCCC
Q 005841 511 EQIGQGSCGTVYHAVWYGS--DVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGS 588 (674)
Q Consensus 511 ~~LG~G~fG~Vy~~~~~~~--~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggs 588 (674)
-+||+|.||+||-|++..+ ++|||.+.... ....+-+..||.+.++|+|.|||+++|.+..++++-|+||-++||+
T Consensus 581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpekd--sr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGS 658 (1226)
T KOG4279|consen 581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEKD--SREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGS 658 (1226)
T ss_pred EEeecCceeEEEeeccccceeEEEeeeccccc--chhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCc
Confidence 3799999999999998544 57899885432 3456778899999999999999999999999999999999999999
Q ss_pred HHHHHHhcCCCC--CHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEc-CCCcEEEEecCCcccccCCccccccC
Q 005841 589 LFRLLQRNTTKL--DWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVD-KHWTVKVGDFGLSRLKHETYLTTKTG 665 (674)
Q Consensus 589 L~~~l~~~~~~l--~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~-~~~~vkL~DFGla~~~~~~~~~~~~~ 665 (674)
|.++|+..=+++ .+..+-+|.+||++||.|||++. |||||||-+|+||+ -.|.+||+|||.++.+..-...+.+|
T Consensus 659 LSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~--IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~TETF 736 (1226)
T KOG4279|consen 659 LSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENK--IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPCTETF 736 (1226)
T ss_pred HHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcc--eeeccccCCcEEEeeccceEEecccccchhhccCCcccccc
Confidence 999998765566 88999999999999999999999 99999999999997 67899999999999998877788899
Q ss_pred CCCccccCC
Q 005841 666 KGTVTYLAS 674 (674)
Q Consensus 666 ~GTp~YmAP 674 (674)
.||++||||
T Consensus 737 TGTLQYMAP 745 (1226)
T KOG4279|consen 737 TGTLQYMAP 745 (1226)
T ss_pred ccchhhhCh
Confidence 999999999
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=6.5e-25 Score=256.04 Aligned_cols=168 Identities=26% Similarity=0.377 Sum_probs=149.9
Q ss_pred cCCeeEeeeecccCceEEEEEEEc--CCeEEEEEeecccC-CHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeEEEE
Q 005841 504 WEDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEY-SDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIV 580 (674)
Q Consensus 504 ~~~y~~~~~LG~G~fG~Vy~~~~~--~~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 580 (674)
.++|.+.++||.|+||+||+|.+. +..||||++.+... .......+..|+.++..++||||++++.++.....+|||
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lV 82 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLV 82 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEE
Confidence 468999999999999999999985 77899999976543 345567788999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccccCCcc
Q 005841 581 TEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYL 660 (674)
Q Consensus 581 ~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~~~~ 660 (674)
|||+.+++|.+++... ..+++..++.|+.||+.||.|||.++ ||||||||+||||+.++.+||+|||+++.......
T Consensus 83 mEy~~g~~L~~li~~~-~~l~~~~~~~i~~qil~aL~yLH~~g--IiHrDLKP~NILl~~~g~vkL~DFGls~~~~~~~~ 159 (669)
T cd05610 83 MEYLIGGDVKSLLHIY-GYFDEEMAVKYISEVALALDYLHRHG--IIHRDLKPDNMLISNEGHIKLTDFGLSKVTLNREL 159 (669)
T ss_pred EeCCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--EEeCCccHHHEEEcCCCCEEEEeCCCCccccCCcc
Confidence 9999999999999753 46899999999999999999999998 99999999999999999999999999998766555
Q ss_pred ccccCCCCccccCC
Q 005841 661 TTKTGKGTVTYLAS 674 (674)
Q Consensus 661 ~~~~~~GTp~YmAP 674 (674)
......||+.|+||
T Consensus 160 ~~~~~~~t~~~~~p 173 (669)
T cd05610 160 NMMDILTTPSMAKP 173 (669)
T ss_pred cccccccCccccCc
Confidence 55567899999987
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.1e-26 Score=239.79 Aligned_cols=169 Identities=24% Similarity=0.345 Sum_probs=148.7
Q ss_pred ccCCeeEeeeecccCceEEEEEEE--cCCeEEEEEeecccCCH-HHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeEEE
Q 005841 503 LWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSD-EVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCI 579 (674)
Q Consensus 503 ~~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 579 (674)
..+.|..-.+||+|+||.||-|.. +|+.||+|.+.++.... .......+|-.||..+..++||.+-.+|++++.+|+
T Consensus 183 t~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LCl 262 (591)
T KOG0986|consen 183 TKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCL 262 (591)
T ss_pred cccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEE
Confidence 346788889999999999999875 78889999998776644 333456789999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccccCC
Q 005841 580 VTEFLPRGSLFRLLQRNT-TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHET 658 (674)
Q Consensus 580 V~E~~~ggsL~~~l~~~~-~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~~ 658 (674)
||..|+||+|..+|.+.+ ..|++..+++|+.+|+.||++||+.+ ||+|||||+|||+|+.|+|+|+|.|||..+.+.
T Consensus 263 VLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~--iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g 340 (591)
T KOG0986|consen 263 VLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRR--IVYRDLKPENILLDDHGHVRISDLGLAVEIPEG 340 (591)
T ss_pred EEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcc--eeeccCChhheeeccCCCeEeeccceEEecCCC
Confidence 999999999999887654 46999999999999999999999988 999999999999999999999999999887664
Q ss_pred ccccccCCCCccccCC
Q 005841 659 YLTTKTGKGTVTYLAS 674 (674)
Q Consensus 659 ~~~~~~~~GTp~YmAP 674 (674)
.... ..+||.+||||
T Consensus 341 ~~~~-~rvGT~GYMAP 355 (591)
T KOG0986|consen 341 KPIR-GRVGTVGYMAP 355 (591)
T ss_pred Cccc-cccCcccccCH
Confidence 3332 34899999999
|
|
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=99.93 E-value=6.2e-25 Score=237.82 Aligned_cols=165 Identities=29% Similarity=0.423 Sum_probs=139.9
Q ss_pred ccCCeeEeeeecccCceEEEEEEE--cCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCC-----
Q 005841 503 LWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQ----- 575 (674)
Q Consensus 503 ~~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~----- 575 (674)
..++|++.+.||+|+||.||++.+ .+..||||++.+..........+.+|+.+++.++||||+++++++....
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence 347899999999999999999987 4678999999765544555667889999999999999999999986543
Q ss_pred -eEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCccc
Q 005841 576 -RLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL 654 (674)
Q Consensus 576 -~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~ 654 (674)
.+|+||||+++ +|...+.. .+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.
T Consensus 99 ~~~~lv~e~~~~-~l~~~~~~---~~~~~~~~~~~~qi~~~L~~LH~~~--ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~ 172 (359)
T cd07876 99 QDVYLVMELMDA-NLCQVIHM---ELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLART 172 (359)
T ss_pred ceeEEEEeCCCc-CHHHHHhc---cCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEECCCCCEEEecCCCccc
Confidence 57999999965 67666642 4889999999999999999999999 99999999999999999999999999986
Q ss_pred ccCCccccccCCCCccccCC
Q 005841 655 KHETYLTTKTGKGTVTYLAS 674 (674)
Q Consensus 655 ~~~~~~~~~~~~GTp~YmAP 674 (674)
...... .....||+.||||
T Consensus 173 ~~~~~~-~~~~~~t~~y~aP 191 (359)
T cd07876 173 ACTNFM-MTPYVVTRYYRAP 191 (359)
T ss_pred cccCcc-CCCCcccCCCCCc
Confidence 544322 2335799999998
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=9.7e-25 Score=255.93 Aligned_cols=173 Identities=24% Similarity=0.388 Sum_probs=145.9
Q ss_pred ccccCCeeEeeeecccCceEEEEEEEc--CCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEec--CCe
Q 005841 501 EILWEDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTS--PQR 576 (674)
Q Consensus 501 ~~~~~~y~~~~~LG~G~fG~Vy~~~~~--~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~--~~~ 576 (674)
+....+|++++.||.|+||+||+|.+. +..||+|++............+..|+.+++.|.||||++++++|.. ...
T Consensus 9 e~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~ 88 (1021)
T PTZ00266 9 ESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQK 88 (1021)
T ss_pred ccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCE
Confidence 556689999999999999999999984 5569999998766666667789999999999999999999998854 456
Q ss_pred EEEEEecCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC-----CCeEEccCCCCCEEEcC--------
Q 005841 577 LCIVTEFLPRGSLFRLLQRN---TTKLDWRRRILMALDIARGVSYLHHCN-----PPIIHRDLKSSNLLVDK-------- 640 (674)
Q Consensus 577 ~~lV~E~~~ggsL~~~l~~~---~~~l~~~~~~~i~~qi~~~L~yLH~~~-----~~IvHrDLKp~NILi~~-------- 640 (674)
+||||||+++++|.++|... ...+++..++.|+.||+.||.|||..+ .+||||||||+||||+.
T Consensus 89 lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i 168 (1021)
T PTZ00266 89 LYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKI 168 (1021)
T ss_pred EEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccc
Confidence 99999999999999998753 356999999999999999999999843 34999999999999964
Q ss_pred ---------CCcEEEEecCCcccccCCccccccCCCCccccCC
Q 005841 641 ---------HWTVKVGDFGLSRLKHETYLTTKTGKGTVTYLAS 674 (674)
Q Consensus 641 ---------~~~vkL~DFGla~~~~~~~~~~~~~~GTp~YmAP 674 (674)
.+.|||+|||++........ ....+||+.||||
T Consensus 169 ~~~~~n~ng~~iVKLsDFGlAr~l~~~s~-~~s~vGTp~YmAP 210 (1021)
T PTZ00266 169 TAQANNLNGRPIAKIGDFGLSKNIGIESM-AHSCVGTPYYWSP 210 (1021)
T ss_pred cccccccCCCCceEEccCCcccccccccc-ccccCCCccccCH
Confidence 23599999999987654322 2335799999998
|
|
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.93 E-value=9.1e-25 Score=255.18 Aligned_cols=168 Identities=23% Similarity=0.294 Sum_probs=142.5
Q ss_pred CCeeEeeeecccCceEEEEEEE--cCCeEEEEEeecccCC-HHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeEEEEE
Q 005841 505 EDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYS-DEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVT 581 (674)
Q Consensus 505 ~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 581 (674)
++|++.++||+|+||.||+|.+ ++..||||++...... .....++.+|+.+++.++||||+++++++.+.+..|+||
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 5799999999999999999987 4678999999764332 345567999999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHhc----------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCC
Q 005841 582 EFLPRGSLFRLLQRN----------TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGL 651 (674)
Q Consensus 582 E~~~ggsL~~~l~~~----------~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGl 651 (674)
||++|++|.+++... ...+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G--IIHRDLKPeNILLd~dg~vKLiDFGL 159 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG--VLHRDLKPDNILLGLFGEVVILDWGA 159 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC--ccccCCchheEEEcCCCCEEEEecCc
Confidence 999999999998642 123567788999999999999999998 99999999999999999999999999
Q ss_pred cccccCCc------------------cccccCCCCccccCC
Q 005841 652 SRLKHETY------------------LTTKTGKGTVTYLAS 674 (674)
Q Consensus 652 a~~~~~~~------------------~~~~~~~GTp~YmAP 674 (674)
++...... ......+||+.||||
T Consensus 160 Ak~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAP 200 (932)
T PRK13184 160 AIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAP 200 (932)
T ss_pred ceecccccccccccccccccccccccccCCCCCCCCCCCCH
Confidence 98652100 011124699999998
|
|
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.4e-24 Score=222.18 Aligned_cols=167 Identities=28% Similarity=0.393 Sum_probs=149.2
Q ss_pred CeeEeeeecccCceEEEEEEE--cCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeEEEEEec
Q 005841 506 DLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEF 583 (674)
Q Consensus 506 ~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~ 583 (674)
+|.+.+.||+|+||.||++.+ .+..|++|.+............+.+|+.+++.++||||+++++++...+..|+||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 588899999999999999987 567899999977665666677899999999999999999999999999999999999
Q ss_pred CCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccccCCcccc
Q 005841 584 LPRGSLFRLLQRN-TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTT 662 (674)
Q Consensus 584 ~~ggsL~~~l~~~-~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~~~~~~ 662 (674)
+++++|.+++... ...+++..+..++.|++.||.|||+.+ |+|+||||+|||++.++.++|+|||+++.........
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~--i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~~~ 158 (256)
T cd08529 81 AENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKK--ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFA 158 (256)
T ss_pred CCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCcceEEEeCCCCEEEcccccceeccCccchh
Confidence 9999999999764 457899999999999999999999998 9999999999999999999999999998776544444
Q ss_pred ccCCCCccccCC
Q 005841 663 KTGKGTVTYLAS 674 (674)
Q Consensus 663 ~~~~GTp~YmAP 674 (674)
....|++.|+||
T Consensus 159 ~~~~~~~~y~aP 170 (256)
T cd08529 159 NTIVGTPYYLSP 170 (256)
T ss_pred hccccCccccCH
Confidence 456789999998
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.1e-24 Score=225.13 Aligned_cols=168 Identities=36% Similarity=0.519 Sum_probs=145.2
Q ss_pred cCCeeEeeeecccCceEEEEEEEc-----CCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeEE
Q 005841 504 WEDLTIGEQIGQGSCGTVYHAVWY-----GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLC 578 (674)
Q Consensus 504 ~~~y~~~~~LG~G~fG~Vy~~~~~-----~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 578 (674)
.++|++.+.||+|+||+||+|.+. ...||||++.... .......+.+|+.+++.++||||+++++++...+..|
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 81 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS-SDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVM 81 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCC-ChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceE
Confidence 467999999999999999999874 2359999886543 3445567889999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCccccc--
Q 005841 579 IVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKH-- 656 (674)
Q Consensus 579 lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~-- 656 (674)
+||||+++++|.+++......+++..+..++.|++.||.|||+++ |+|+||||+|||++.++.++|+|||+++...
T Consensus 82 iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~--i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~ 159 (266)
T cd05033 82 IITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMN--YVHRDLAARNILVNSNLVCKVSDFGLSRRLEDS 159 (266)
T ss_pred EEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCcceEEEcCCCCEEECccchhhccccc
Confidence 999999999999999876678999999999999999999999998 9999999999999999999999999998774
Q ss_pred CCccccccCCCCccccCC
Q 005841 657 ETYLTTKTGKGTVTYLAS 674 (674)
Q Consensus 657 ~~~~~~~~~~GTp~YmAP 674 (674)
.....+....+++.|+||
T Consensus 160 ~~~~~~~~~~~~~~y~~P 177 (266)
T cd05033 160 EATYTTKGGKIPIRWTAP 177 (266)
T ss_pred ccceeccCCCCCccccCh
Confidence 222233334567889998
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.2e-24 Score=236.59 Aligned_cols=162 Identities=22% Similarity=0.326 Sum_probs=138.7
Q ss_pred cccCCeeEeeeecccCceEEEEEEEc----CCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeE
Q 005841 502 ILWEDLTIGEQIGQGSCGTVYHAVWY----GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRL 577 (674)
Q Consensus 502 ~~~~~y~~~~~LG~G~fG~Vy~~~~~----~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 577 (674)
+...+|++++.||+|+||.||+|... +..||+|.+.... .+.+|+.+++.++||||+++++++.....+
T Consensus 89 ~~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~~-------~~~~E~~il~~l~h~~iv~~~~~~~~~~~~ 161 (392)
T PHA03207 89 VVRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGGK-------TPGREIDILKTISHRAIINLIHAYRWKSTV 161 (392)
T ss_pred hccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEeccccc-------cHHHHHHHHHhcCCCCccceeeeEeeCCEE
Confidence 34568999999999999999999763 3468999876432 245799999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccccC
Q 005841 578 CIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHE 657 (674)
Q Consensus 578 ~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~ 657 (674)
|+||||+. ++|.+++. ....+++..++.|+.||+.||.|||+++ ||||||||+||||+.++.+||+|||+++.+..
T Consensus 162 ~lv~e~~~-~~l~~~l~-~~~~l~~~~~~~i~~ql~~aL~~LH~~g--ivHrDlkp~Nill~~~~~~~l~DfG~a~~~~~ 237 (392)
T PHA03207 162 CMVMPKYK-CDLFTYVD-RSGPLPLEQAITIQRRLLEALAYLHGRG--IIHRDVKTENIFLDEPENAVLGDFGAACKLDA 237 (392)
T ss_pred EEEehhcC-CCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEEcCCCCEEEccCccccccCc
Confidence 99999995 68989884 4567999999999999999999999999 99999999999999999999999999976544
Q ss_pred Ccc--ccccCCCCccccCC
Q 005841 658 TYL--TTKTGKGTVTYLAS 674 (674)
Q Consensus 658 ~~~--~~~~~~GTp~YmAP 674 (674)
... ......||+.||||
T Consensus 238 ~~~~~~~~~~~gt~~y~aP 256 (392)
T PHA03207 238 HPDTPQCYGWSGTLETNSP 256 (392)
T ss_pred ccccccccccccccCccCH
Confidence 322 22345799999998
|
|
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=99.92 E-value=2e-24 Score=221.33 Aligned_cols=167 Identities=25% Similarity=0.395 Sum_probs=148.1
Q ss_pred CeeEeeeecccCceEEEEEEE--cCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeEEEEEec
Q 005841 506 DLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEF 583 (674)
Q Consensus 506 ~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~ 583 (674)
+|++.+.||.|+||.||.+.. .+..|++|.+............+.+|+.++++++|+||+++++++...+.+++||||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 589999999999999988876 567799999887666666667888999999999999999999999999999999999
Q ss_pred CCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccccCCcccc
Q 005841 584 LPRGSLFRLLQRN-TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTT 662 (674)
Q Consensus 584 ~~ggsL~~~l~~~-~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~~~~~~ 662 (674)
+++++|.+++... ...+++..+..++.|++.+|.|||+.+ |+|+||||+||+++.++.+||+|||++..........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~~~ 158 (256)
T cd08221 81 ANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAG--ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMA 158 (256)
T ss_pred cCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCChHhEEEeCCCCEEECcCcceEEcccccccc
Confidence 9999999999764 456899999999999999999999998 9999999999999999999999999998765443333
Q ss_pred ccCCCCccccCC
Q 005841 663 KTGKGTVTYLAS 674 (674)
Q Consensus 663 ~~~~GTp~YmAP 674 (674)
....||+.|+||
T Consensus 159 ~~~~~~~~y~ap 170 (256)
T cd08221 159 ETVVGTPYYMSP 170 (256)
T ss_pred cccCCCccccCH
Confidence 445789999998
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=2e-24 Score=240.44 Aligned_cols=162 Identities=28% Similarity=0.425 Sum_probs=133.0
Q ss_pred ccCCeeEeeeecccCceEEEEEEE--cCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecC------
Q 005841 503 LWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSP------ 574 (674)
Q Consensus 503 ~~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~------ 574 (674)
...+|.++++||+|+||+||+|.+ .+..||||++.... ....+|+.+++.++||||+++++++...
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~------~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~ 137 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP------QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNE 137 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc------chHHHHHHHHHhcCCCCCcceeeeEeecccccCC
Confidence 456899999999999999999987 56789999885432 1234699999999999999998876432
Q ss_pred --CeEEEEEecCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCC-CcEEEEe
Q 005841 575 --QRLCIVTEFLPRGSLFRLLQR---NTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKH-WTVKVGD 648 (674)
Q Consensus 575 --~~~~lV~E~~~ggsL~~~l~~---~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~-~~vkL~D 648 (674)
..+++||||+++ +|.+++.. ....+++..+..|+.||+.||.|||+++ ||||||||+||||+.+ +.+||+|
T Consensus 138 ~~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~--IiHrDLKp~NILl~~~~~~vkL~D 214 (440)
T PTZ00036 138 KNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF--ICHRDLKPQNLLIDPNTHTLKLCD 214 (440)
T ss_pred CceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCcCHHHEEEcCCCCceeeec
Confidence 247899999975 77776643 3567999999999999999999999999 9999999999999965 4799999
Q ss_pred cCCcccccCCccccccCCCCccccCC
Q 005841 649 FGLSRLKHETYLTTKTGKGTVTYLAS 674 (674)
Q Consensus 649 FGla~~~~~~~~~~~~~~GTp~YmAP 674 (674)
||+|+.+.... ......||+.||||
T Consensus 215 FGla~~~~~~~-~~~~~~~t~~y~aP 239 (440)
T PTZ00036 215 FGSAKNLLAGQ-RSVSYICSRFYRAP 239 (440)
T ss_pred cccchhccCCC-CcccCCCCcCccCH
Confidence 99998765432 22345789999998
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=9.2e-25 Score=234.32 Aligned_cols=177 Identities=29% Similarity=0.506 Sum_probs=150.3
Q ss_pred CCccccccccCCeeEeeeecccCceEEEEEEEcC-CeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEec
Q 005841 495 NDCLDYEILWEDLTIGEQIGQGSCGTVYHAVWYG-SDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTS 573 (674)
Q Consensus 495 ~~~~~~~~~~~~y~~~~~LG~G~fG~Vy~~~~~~-~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~ 573 (674)
..+...++....+.+.++||+|-||.|++|...+ ..||||.++... .......|.+||++|.+|+||||+.++++|..
T Consensus 528 k~~al~EfPRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a-~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~ 606 (807)
T KOG1094|consen 528 KGPALVEFPRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDA-TKNARNDFLKEIKILSRLKHPNIVELLGVCVQ 606 (807)
T ss_pred cCcchhhcchhheehhhhhcCcccceeEEEEecCceEEEEeecCccc-chhHHHHHHHHHHHHhccCCCCeeEEEeeeec
Confidence 3445557888899999999999999999999876 789999997654 33456789999999999999999999999999
Q ss_pred CCeEEEEEecCCCCCHHHHHHhcCCC-CCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCc
Q 005841 574 PQRLCIVTEFLPRGSLFRLLQRNTTK-LDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLS 652 (674)
Q Consensus 574 ~~~~~lV~E~~~ggsL~~~l~~~~~~-l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla 652 (674)
++.+|+||||++.|+|.++|..+..+ +.-...+.|+.||+.||+||.+++ +|||||.+.|+|++.++++||+|||++
T Consensus 607 DePicmI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~n--fVHrd~a~rNcLv~~e~~iKiadfgms 684 (807)
T KOG1094|consen 607 DDPLCMITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLN--FVHRDLATRNCLVDGEFTIKIADFGMS 684 (807)
T ss_pred CCchHHHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhc--hhhccccccceeecCcccEEecCcccc
Confidence 99999999999999999999876433 355667779999999999999999 999999999999999999999999999
Q ss_pred cccc-CCccccc-cCCCCccccCC
Q 005841 653 RLKH-ETYLTTK-TGKGTVTYLAS 674 (674)
Q Consensus 653 ~~~~-~~~~~~~-~~~GTp~YmAP 674 (674)
+-+- .+++... .++-..+||||
T Consensus 685 R~lysg~yy~vqgr~vlpiRwmaw 708 (807)
T KOG1094|consen 685 RNLYSGDYYRVQGRAVLPIRWMAW 708 (807)
T ss_pred cccccCCceeeecceeeeeeehhH
Confidence 9553 3333322 23466789886
|
|
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.3e-24 Score=230.85 Aligned_cols=168 Identities=26% Similarity=0.471 Sum_probs=141.4
Q ss_pred ccCCeeEeeeecccCceEEEEEEE--cCC----eEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCe
Q 005841 503 LWEDLTIGEQIGQGSCGTVYHAVW--YGS----DVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQR 576 (674)
Q Consensus 503 ~~~~y~~~~~LG~G~fG~Vy~~~~--~~~----~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 576 (674)
...+|++.+.||+|+||+||+|.+ .+. .||||++... ......+.+.+|+.+++.+.||||+++++++... .
T Consensus 5 ~~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~ 82 (316)
T cd05108 5 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA-TSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-T 82 (316)
T ss_pred chhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEecccc-CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-C
Confidence 346799999999999999999986 333 3899998643 2344556788999999999999999999998764 5
Q ss_pred EEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCccccc
Q 005841 577 LCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKH 656 (674)
Q Consensus 577 ~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~ 656 (674)
.++|+||+++|+|.+++......+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 83 ~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~--iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~ 160 (316)
T cd05108 83 VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERR--LVHRDLAARNVLVKTPQHVKITDFGLAKLLG 160 (316)
T ss_pred ceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcC--eeccccchhheEecCCCcEEEcccccccccc
Confidence 78999999999999999877777999999999999999999999999 9999999999999999999999999998765
Q ss_pred CCcc--ccccCCCCccccCC
Q 005841 657 ETYL--TTKTGKGTVTYLAS 674 (674)
Q Consensus 657 ~~~~--~~~~~~GTp~YmAP 674 (674)
.... ......+|+.||||
T Consensus 161 ~~~~~~~~~~~~~~~~y~ap 180 (316)
T cd05108 161 ADEKEYHAEGGKVPIKWMAL 180 (316)
T ss_pred CCCcceeccCCccceeecCh
Confidence 3222 22223457789998
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.9e-24 Score=222.95 Aligned_cols=168 Identities=26% Similarity=0.425 Sum_probs=146.4
Q ss_pred CCeeEeeeecccCceEEEEEEE--cCCeEEEEEeecccC-CHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeEEEEE
Q 005841 505 EDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEY-SDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVT 581 (674)
Q Consensus 505 ~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 581 (674)
++|++.++||+|+||.||+|.+ ++..||||.+..... .......+.+|+.+++.++||||+++++++...+..++||
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 5799999999999999999987 577899998865433 3455667889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccccCC
Q 005841 582 EFLPRGSLFRLLQR---NTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHET 658 (674)
Q Consensus 582 E~~~ggsL~~~l~~---~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~~ 658 (674)
||+++++|.+++.. ....+++..+..++.||+.||.|||+++ |+|+||||+|||++.++.++|+|||++......
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~ 159 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR--VMHRDIKPANVFITATGVVKLGDLGLGRFFSSK 159 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCC--eeCCCCCHHHEEEcCCCCEEECccccceeccch
Confidence 99999999988853 2345889999999999999999999998 999999999999999999999999999876554
Q ss_pred ccccccCCCCccccCC
Q 005841 659 YLTTKTGKGTVTYLAS 674 (674)
Q Consensus 659 ~~~~~~~~GTp~YmAP 674 (674)
........|++.||||
T Consensus 160 ~~~~~~~~~~~~~~aP 175 (267)
T cd08228 160 TTAAHSLVGTPYYMSP 175 (267)
T ss_pred hHHHhcCCCCccccCh
Confidence 4333445789999998
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.5e-24 Score=222.62 Aligned_cols=165 Identities=32% Similarity=0.515 Sum_probs=141.7
Q ss_pred CCeeEeeeecccCceEEEEEEEc-CCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeEEEEEec
Q 005841 505 EDLTIGEQIGQGSCGTVYHAVWY-GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEF 583 (674)
Q Consensus 505 ~~y~~~~~LG~G~fG~Vy~~~~~-~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~ 583 (674)
.+|++.+.||+|+||.||++.+. +..+|+|.+...... ...+.+|+.+++.++||||+++++++.....+|+||||
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~ 80 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAMS---EEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEF 80 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCCcc---HHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEc
Confidence 56899999999999999999885 447999988654433 24678899999999999999999999999999999999
Q ss_pred CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccccCCccc-c
Q 005841 584 LPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLT-T 662 (674)
Q Consensus 584 ~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~~~~~-~ 662 (674)
+++++|.+++......+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+++........ .
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~~ 158 (256)
T cd05114 81 MENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNS--FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSS 158 (256)
T ss_pred CCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCC--ccccccCcceEEEcCCCeEEECCCCCccccCCCceecc
Confidence 9999999999765567899999999999999999999999 999999999999999999999999999865432222 2
Q ss_pred ccCCCCccccCC
Q 005841 663 KTGKGTVTYLAS 674 (674)
Q Consensus 663 ~~~~GTp~YmAP 674 (674)
....++..|+||
T Consensus 159 ~~~~~~~~y~aP 170 (256)
T cd05114 159 SGAKFPVKWSPP 170 (256)
T ss_pred CCCCCchhhCCh
Confidence 223466789998
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.1e-24 Score=226.27 Aligned_cols=164 Identities=29% Similarity=0.472 Sum_probs=145.9
Q ss_pred CCeeEeeeecccCceEEEEEEE--cCCeEEEEEeecccCC-HHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeEEEEE
Q 005841 505 EDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYS-DEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVT 581 (674)
Q Consensus 505 ~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 581 (674)
++|.+.+.||+|+||.||++.+ .+..||+|++.+.... ......+.+|+.+++++.||||+++++.+.....+|+||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 4689999999999999999987 4678999999765432 345677889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccccCCccc
Q 005841 582 EFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLT 661 (674)
Q Consensus 582 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~~~~~ 661 (674)
||+++++|.+++... ..+++..+..++.||+.||.|||+.+ |+|+||+|.||||+.++.+||+|||+++.....
T Consensus 81 e~~~~~~L~~~~~~~-~~l~~~~~~~~~~qil~~l~~lH~~~--i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~--- 154 (290)
T cd05580 81 EYVPGGELFSHLRKS-GRFPEPVARFYAAQVVLALEYLHSLD--IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR--- 154 (290)
T ss_pred ecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHEEECCCCCEEEeeCCCccccCCC---
Confidence 999999999999764 57999999999999999999999998 999999999999999999999999999876544
Q ss_pred cccCCCCccccCC
Q 005841 662 TKTGKGTVTYLAS 674 (674)
Q Consensus 662 ~~~~~GTp~YmAP 674 (674)
.....||+.|+||
T Consensus 155 ~~~~~~~~~y~aP 167 (290)
T cd05580 155 TYTLCGTPEYLAP 167 (290)
T ss_pred CCCCCCCccccCh
Confidence 2345799999998
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=7.5e-26 Score=211.26 Aligned_cols=166 Identities=29% Similarity=0.397 Sum_probs=143.9
Q ss_pred CeeEeeeecccCceEEEEEEE--cCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeEEEEEec
Q 005841 506 DLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEF 583 (674)
Q Consensus 506 ~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~ 583 (674)
.|.-.++||+|.||+||+++. ++..||+|.+....-++..-....+||.+++.++|.|||++++....+..+-+|+||
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~ 82 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence 466678999999999999987 455699999987765555556678899999999999999999999999999999999
Q ss_pred CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccccCCccccc
Q 005841 584 LPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTK 663 (674)
Q Consensus 584 ~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~~~~~~~ 663 (674)
|. .+|..++...++.++...+..++.|++.||.|||+++ ++||||||.|+||+.+|.+||+|||+|+...-+..+-.
T Consensus 83 cd-qdlkkyfdslng~~d~~~~rsfmlqllrgl~fchshn--vlhrdlkpqnllin~ngelkladfglarafgipvrcys 159 (292)
T KOG0662|consen 83 CD-QDLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHN--VLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCYS 159 (292)
T ss_pred hh-HHHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhh--hhhccCCcceEEeccCCcEEecccchhhhcCCceEeee
Confidence 95 4899999988999999999999999999999999999 99999999999999999999999999997765433333
Q ss_pred cCCCCccccCC
Q 005841 664 TGKGTVTYLAS 674 (674)
Q Consensus 664 ~~~GTp~YmAP 674 (674)
..+-|..|.+|
T Consensus 160 aevvtlwyrpp 170 (292)
T KOG0662|consen 160 AEVVTLWYRPP 170 (292)
T ss_pred ceeeeeeccCc
Confidence 33457777766
|
|
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.6e-24 Score=225.32 Aligned_cols=166 Identities=25% Similarity=0.349 Sum_probs=142.0
Q ss_pred CeeEeeeecccCceEEEEEEE--cCCeEEEEEeecccCCH-HHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeEEEEEe
Q 005841 506 DLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSD-EVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTE 582 (674)
Q Consensus 506 ~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E 582 (674)
.|++.++||+|+||.||++.+ ++..||||.+.+..... .....+.+|+.+++.++|+||+.+++.+.+.+.+|+|||
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence 377889999999999999987 46789999987654432 334567789999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccccCCccc
Q 005841 583 FLPRGSLFRLLQRN-TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLT 661 (674)
Q Consensus 583 ~~~ggsL~~~l~~~-~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~~~~~ 661 (674)
|+++++|.+++... ...+++..++.++.|++.||.|||+++ |+||||||+|||++.++.++|+|||++....... .
T Consensus 81 ~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~-~ 157 (285)
T cd05630 81 LMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQER--IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ-T 157 (285)
T ss_pred ecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC--EEeCCCCHHHEEECCCCCEEEeeccceeecCCCc-c
Confidence 99999999988643 345899999999999999999999998 9999999999999999999999999997654322 2
Q ss_pred cccCCCCccccCC
Q 005841 662 TKTGKGTVTYLAS 674 (674)
Q Consensus 662 ~~~~~GTp~YmAP 674 (674)
.....||+.||||
T Consensus 158 ~~~~~g~~~y~aP 170 (285)
T cd05630 158 IKGRVGTVGYMAP 170 (285)
T ss_pred ccCCCCCccccCh
Confidence 2234799999998
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.6e-24 Score=225.21 Aligned_cols=165 Identities=23% Similarity=0.321 Sum_probs=142.0
Q ss_pred eeEeeeecccCceEEEEEEE--cCCeEEEEEeecccCCH-HHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeEEEEEec
Q 005841 507 LTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSD-EVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEF 583 (674)
Q Consensus 507 y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~ 583 (674)
|+..+.||+|+||+||++.+ ++..||+|++.+..... .....+.+|+.+++.++|+||+.+++++...+.+|+||||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 67888999999999999988 46789999997654433 3345678899999999999999999999999999999999
Q ss_pred CCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccccCCcccc
Q 005841 584 LPRGSLFRLLQRN-TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTT 662 (674)
Q Consensus 584 ~~ggsL~~~l~~~-~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~~~~~~ 662 (674)
+++++|.+++... ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++....... ..
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~--iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~ 158 (285)
T cd05632 82 MNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHREN--TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE-SI 158 (285)
T ss_pred ccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecCCCHHHEEECCCCCEEEecCCcceecCCCC-cc
Confidence 9999999888653 346999999999999999999999998 9999999999999999999999999997654322 12
Q ss_pred ccCCCCccccCC
Q 005841 663 KTGKGTVTYLAS 674 (674)
Q Consensus 663 ~~~~GTp~YmAP 674 (674)
....||+.||||
T Consensus 159 ~~~~g~~~~~aP 170 (285)
T cd05632 159 RGRVGTVGYMAP 170 (285)
T ss_pred cCCCCCcCccCh
Confidence 235799999998
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.6e-24 Score=225.33 Aligned_cols=172 Identities=32% Similarity=0.508 Sum_probs=142.8
Q ss_pred cccccCCeeEeeeecccCceEEEEEEEcC-------CeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEe
Q 005841 500 YEILWEDLTIGEQIGQGSCGTVYHAVWYG-------SDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVT 572 (674)
Q Consensus 500 ~~~~~~~y~~~~~LG~G~fG~Vy~~~~~~-------~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~ 572 (674)
|++..++|++.+.||+|+||.||++.+.+ ..||||++.... .......+.+|+.+++.++||||+++++++.
T Consensus 1 ~~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~-~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~ 79 (277)
T cd05062 1 WEVAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAA-SMRERIEFLNEASVMKEFNCHHVVRLLGVVS 79 (277)
T ss_pred CcccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEc
Confidence 34566889999999999999999998642 459999886433 2234456889999999999999999999999
Q ss_pred cCCeEEEEEecCCCCCHHHHHHhcC---------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCc
Q 005841 573 SPQRLCIVTEFLPRGSLFRLLQRNT---------TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWT 643 (674)
Q Consensus 573 ~~~~~~lV~E~~~ggsL~~~l~~~~---------~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~ 643 (674)
.....++||||+++++|.+++.... ..+++..+..++.|++.||.|||+.+ ++|+||||+|||++.++.
T Consensus 80 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--~vH~dlkp~Nil~~~~~~ 157 (277)
T cd05062 80 QGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK--FVHRDLAARNCMVAEDFT 157 (277)
T ss_pred CCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCcchheEEEcCCCC
Confidence 9999999999999999999997532 23578889999999999999999988 999999999999999999
Q ss_pred EEEEecCCcccccCCccc--cccCCCCccccCC
Q 005841 644 VKVGDFGLSRLKHETYLT--TKTGKGTVTYLAS 674 (674)
Q Consensus 644 vkL~DFGla~~~~~~~~~--~~~~~GTp~YmAP 674 (674)
++|+|||+++........ .....+++.||||
T Consensus 158 ~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aP 190 (277)
T cd05062 158 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSP 190 (277)
T ss_pred EEECCCCCccccCCcceeecCCCCccCHhhcCh
Confidence 999999999765432221 1123568889998
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.8e-24 Score=225.38 Aligned_cols=166 Identities=31% Similarity=0.422 Sum_probs=141.8
Q ss_pred CeeEeeeecccCceEEEEEEE--cCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeEEEEEec
Q 005841 506 DLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEF 583 (674)
Q Consensus 506 ~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~ 583 (674)
+|++.+.||+|+||.||+|.. ++..||||++............+.+|+.+++.++||||+++++++..+..+|+||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 588999999999999999987 467899999875543333445678899999999999999999999999999999999
Q ss_pred CCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccccCCccc
Q 005841 584 LPRGSLFRLLQRNT--TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLT 661 (674)
Q Consensus 584 ~~ggsL~~~l~~~~--~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~~~~~ 661 (674)
++ ++|.+++.... ..+++..+..++.||+.||.|||+.+ |+|+||||+|||++.++.+||+|||++.........
T Consensus 81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~ 157 (285)
T cd07861 81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR--VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRV 157 (285)
T ss_pred CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCC--eeecCCCHHHEEEcCCCcEEECcccceeecCCCccc
Confidence 97 58988886533 56899999999999999999999998 999999999999999999999999999765433222
Q ss_pred cccCCCCccccCC
Q 005841 662 TKTGKGTVTYLAS 674 (674)
Q Consensus 662 ~~~~~GTp~YmAP 674 (674)
.....+++.|+||
T Consensus 158 ~~~~~~~~~y~aP 170 (285)
T cd07861 158 YTHEVVTLWYRAP 170 (285)
T ss_pred ccCCcccccccCh
Confidence 2334678999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.1e-24 Score=235.53 Aligned_cols=165 Identities=30% Similarity=0.412 Sum_probs=140.6
Q ss_pred ccCCeeEeeeecccCceEEEEEEE--cCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecC------
Q 005841 503 LWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSP------ 574 (674)
Q Consensus 503 ~~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~------ 574 (674)
..++|.+.+.||+|+||.||++.+ .+..||||++............+.+|+.+++.++||||+++++++...
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 94 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF 94 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence 457899999999999999999986 467799999976554555567788999999999999999999988644
Q ss_pred CeEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCccc
Q 005841 575 QRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL 654 (674)
Q Consensus 575 ~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~ 654 (674)
..+|+||||+++ +|.+.+.. .+++..+..++.|++.||.|||+.+ |+||||||+||||+.++.+||+|||+++.
T Consensus 95 ~~~~lv~e~~~~-~l~~~~~~---~l~~~~~~~~~~qi~~aL~~LH~~g--ivHrDikp~Nill~~~~~~kl~Dfg~~~~ 168 (355)
T cd07874 95 QDVYLVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLART 168 (355)
T ss_pred ceeEEEhhhhcc-cHHHHHhh---cCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCChHHEEECCCCCEEEeeCccccc
Confidence 357999999965 67777653 4889999999999999999999999 99999999999999999999999999987
Q ss_pred ccCCccccccCCCCccccCC
Q 005841 655 KHETYLTTKTGKGTVTYLAS 674 (674)
Q Consensus 655 ~~~~~~~~~~~~GTp~YmAP 674 (674)
..... ......||+.||||
T Consensus 169 ~~~~~-~~~~~~~t~~y~aP 187 (355)
T cd07874 169 AGTSF-MMTPYVVTRYYRAP 187 (355)
T ss_pred CCCcc-ccCCccccCCccCH
Confidence 65432 22346799999998
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=2e-24 Score=227.63 Aligned_cols=167 Identities=28% Similarity=0.410 Sum_probs=143.6
Q ss_pred cCCeeEeeeecccCceEEEEEEE--cCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeEEEEE
Q 005841 504 WEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVT 581 (674)
Q Consensus 504 ~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 581 (674)
.++|.+.+.||+|+||.||+|.+ ++..||+|.+...... .....+.+|+.+++.++||||+++++++.....+|+||
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~ 83 (301)
T cd07873 5 LETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEE-GAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVF 83 (301)
T ss_pred ccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEeccccc-CchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEE
Confidence 36799999999999999999987 4677999998654322 22345678999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccccCCccc
Q 005841 582 EFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLT 661 (674)
Q Consensus 582 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~~~~~ 661 (674)
||++ ++|..++......+++..+..++.||+.||.|||+.+ |+|+||||+|||++.++.+||+|||++.........
T Consensus 84 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~--i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~ 160 (301)
T cd07873 84 EYLD-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRK--VLHRDLKPQNLLINERGELKLADFGLARAKSIPTKT 160 (301)
T ss_pred eccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCCHHHEEECCCCcEEECcCcchhccCCCCCc
Confidence 9996 5999998876677999999999999999999999999 999999999999999999999999999865443333
Q ss_pred cccCCCCccccCC
Q 005841 662 TKTGKGTVTYLAS 674 (674)
Q Consensus 662 ~~~~~GTp~YmAP 674 (674)
.....+|+.|+||
T Consensus 161 ~~~~~~~~~y~~P 173 (301)
T cd07873 161 YSNEVVTLWYRPP 173 (301)
T ss_pred ccccceeecccCc
Confidence 3345689999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.2e-23 Score=236.03 Aligned_cols=163 Identities=18% Similarity=0.289 Sum_probs=131.3
Q ss_pred cccCCeeEeeeecccCceEEEEEEE--cCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCC------CCeeeEEEEEec
Q 005841 502 ILWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRH------PNVLLFMGAVTS 573 (674)
Q Consensus 502 ~~~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~H------pnIv~l~~~~~~ 573 (674)
....+|++.++||+|+||+||+|.+ .+..||||++.... .....+..|+.++..++| .+|+.++.++..
T Consensus 126 ~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~ 202 (467)
T PTZ00284 126 VSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP---KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQN 202 (467)
T ss_pred cCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch---hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEc
Confidence 3457899999999999999999987 46679999996422 223345567777776654 458888888876
Q ss_pred C-CeEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCeEEccCCCCCEEEcCCC---------
Q 005841 574 P-QRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHH-CNPPIIHRDLKSSNLLVDKHW--------- 642 (674)
Q Consensus 574 ~-~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~-~~~~IvHrDLKp~NILi~~~~--------- 642 (674)
. ..+|||||++ +++|.+++.+. ..+++..+..|+.||+.||.|||. ++ ||||||||+||||+.++
T Consensus 203 ~~~~~~iv~~~~-g~~l~~~l~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~g--IiHrDlKP~NILl~~~~~~~~~~~~~ 278 (467)
T PTZ00284 203 ETGHMCIVMPKY-GPCLLDWIMKH-GPFSHRHLAQIIFQTGVALDYFHTELH--LMHTDLKPENILMETSDTVVDPVTNR 278 (467)
T ss_pred CCceEEEEEecc-CCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhcCC--eecCCCCHHHEEEecCCccccccccc
Confidence 5 5789999988 77999988654 579999999999999999999997 58 99999999999998665
Q ss_pred -------cEEEEecCCcccccCCccccccCCCCccccCC
Q 005841 643 -------TVKVGDFGLSRLKHETYLTTKTGKGTVTYLAS 674 (674)
Q Consensus 643 -------~vkL~DFGla~~~~~~~~~~~~~~GTp~YmAP 674 (674)
.+||+|||++..... .....+||+.||||
T Consensus 279 ~~~~~~~~vkl~DfG~~~~~~~---~~~~~~gt~~Y~AP 314 (467)
T PTZ00284 279 ALPPDPCRVRICDLGGCCDERH---SRTAIVSTRHYRSP 314 (467)
T ss_pred ccCCCCceEEECCCCccccCcc---ccccccCCccccCc
Confidence 499999999864332 22346899999999
|
|
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.9e-24 Score=225.30 Aligned_cols=168 Identities=28% Similarity=0.426 Sum_probs=147.4
Q ss_pred ccCCeeEeeeecccCceEEEEEEE--cCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeEEEE
Q 005841 503 LWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIV 580 (674)
Q Consensus 503 ~~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 580 (674)
..+.|++.++||.|+||.||++.+ .+..|++|++... .....+.+.+|+.+++.++||||+++++.+.....+|+|
T Consensus 10 ~~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 87 (292)
T cd06644 10 PNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETK--SEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIM 87 (292)
T ss_pred cchhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEE
Confidence 346799999999999999999987 4677999998654 345567788999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccccCCcc
Q 005841 581 TEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYL 660 (674)
Q Consensus 581 ~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~~~~ 660 (674)
|||+++++|..++.+....+++..+..++.|++.+|.|||+.+ |+||||||+|||++.++.+||+|||++........
T Consensus 88 ~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~--i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~ 165 (292)
T cd06644 88 IEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMK--IIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQ 165 (292)
T ss_pred EecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCC--eeecCCCcceEEEcCCCCEEEccCccceecccccc
Confidence 9999999999888766677999999999999999999999998 99999999999999999999999999876544433
Q ss_pred ccccCCCCccccCC
Q 005841 661 TTKTGKGTVTYLAS 674 (674)
Q Consensus 661 ~~~~~~GTp~YmAP 674 (674)
......|++.|+||
T Consensus 166 ~~~~~~~~~~y~aP 179 (292)
T cd06644 166 RRDSFIGTPYWMAP 179 (292)
T ss_pred ccceecCCccccCc
Confidence 33445789999998
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.2e-24 Score=240.56 Aligned_cols=161 Identities=27% Similarity=0.345 Sum_probs=139.0
Q ss_pred ccCCeeEeeeecccCceEEEEEEEc--CCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeEEEE
Q 005841 503 LWEDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIV 580 (674)
Q Consensus 503 ~~~~y~~~~~LG~G~fG~Vy~~~~~--~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 580 (674)
....|.+.+.||+|+||.||+|.+. +..||||.... ..+.+|+.+++.|+|+||+++++++...+..|||
T Consensus 167 ~~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~--------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv 238 (461)
T PHA03211 167 AGLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY--------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLV 238 (461)
T ss_pred ccCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc--------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEE
Confidence 3457999999999999999999984 56799996422 2356799999999999999999999999999999
Q ss_pred EecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccccCCcc
Q 005841 581 TEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYL 660 (674)
Q Consensus 581 ~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~~~~ 660 (674)
||++. ++|..++......+++..++.|+.||+.||.|||+.+ ||||||||+||||+.++.+||+|||+++.......
T Consensus 239 ~e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g--IvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~ 315 (461)
T PHA03211 239 LPKYR-SDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEG--IIHRDIKTENVLVNGPEDICLGDFGAACFARGSWS 315 (461)
T ss_pred EEccC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--EEECcCCHHHEEECCCCCEEEcccCCceecccccc
Confidence 99994 6999988766667999999999999999999999999 99999999999999999999999999987643222
Q ss_pred c--cccCCCCccccCC
Q 005841 661 T--TKTGKGTVTYLAS 674 (674)
Q Consensus 661 ~--~~~~~GTp~YmAP 674 (674)
. ....+||+.||||
T Consensus 316 ~~~~~~~~GT~~Y~AP 331 (461)
T PHA03211 316 TPFHYGIAGTVDTNAP 331 (461)
T ss_pred cccccccCCCcCCcCH
Confidence 1 2235799999998
|
|
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.3e-24 Score=236.67 Aligned_cols=165 Identities=27% Similarity=0.423 Sum_probs=140.4
Q ss_pred CeeEeeeecccCceEEEEEEE--cCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCC-----eEE
Q 005841 506 DLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQ-----RLC 578 (674)
Q Consensus 506 ~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~-----~~~ 578 (674)
+|++.++||+|+||.||++.+ .+..||||.+............+.+|+.+++.++|+||+++++++.... .+|
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 478899999999999999986 5788999998654434445567889999999999999999999998776 799
Q ss_pred EEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccccCC
Q 005841 579 IVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHET 658 (674)
Q Consensus 579 lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~~ 658 (674)
+||||+. ++|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 81 lv~e~~~-~~l~~~~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~ 156 (372)
T cd07853 81 VVTELMQ-SDLHKIIVS-PQPLSSDHVKVFLYQILRGLKYLHSAG--ILHRDIKPGNLLVNSNCVLKICDFGLARVEEPD 156 (372)
T ss_pred EEeeccc-cCHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCChHHEEECCCCCEEeccccceeecccC
Confidence 9999996 588888754 457999999999999999999999999 999999999999999999999999999865432
Q ss_pred cc-ccccCCCCccccCC
Q 005841 659 YL-TTKTGKGTVTYLAS 674 (674)
Q Consensus 659 ~~-~~~~~~GTp~YmAP 674 (674)
.. ......||+.|+||
T Consensus 157 ~~~~~~~~~~~~~y~aP 173 (372)
T cd07853 157 ESKHMTQEVVTQYYRAP 173 (372)
T ss_pred ccccCCCCCcCCCcCCH
Confidence 21 22234689999998
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.2e-24 Score=219.34 Aligned_cols=167 Identities=32% Similarity=0.482 Sum_probs=147.3
Q ss_pred cCCeeEeeeecccCceEEEEEEE--cCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeEEEEE
Q 005841 504 WEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVT 581 (674)
Q Consensus 504 ~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 581 (674)
.++|++.+.||.|+||.||++.+ .+..+++|++..... .....+.+|+.+++.++||||+++++++.....+|++|
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~ 79 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPG--DDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVM 79 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCch--hhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEE
Confidence 36799999999999999999987 456799999975532 24577889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccccCCccc
Q 005841 582 EFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLT 661 (674)
Q Consensus 582 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~~~~~ 661 (674)
||+++++|.+++......+++..+..++.|++.||.|||+++ |+|+||||+||+++.++.+||+|||++.........
T Consensus 80 e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~--i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~ 157 (262)
T cd06613 80 EYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETG--KIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAK 157 (262)
T ss_pred eCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCC--ceecCCChhhEEECCCCCEEECccccchhhhhhhhc
Confidence 999999999999876578999999999999999999999998 999999999999999999999999999876543333
Q ss_pred cccCCCCccccCC
Q 005841 662 TKTGKGTVTYLAS 674 (674)
Q Consensus 662 ~~~~~GTp~YmAP 674 (674)
.....|++.|+||
T Consensus 158 ~~~~~~~~~y~~P 170 (262)
T cd06613 158 RKSFIGTPYWMAP 170 (262)
T ss_pred cccccCCccccCc
Confidence 3445789999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.2e-24 Score=222.72 Aligned_cols=167 Identities=28% Similarity=0.414 Sum_probs=144.5
Q ss_pred ccCCeeEeeeecccCceEEEEEEE--cCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeEEEE
Q 005841 503 LWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIV 580 (674)
Q Consensus 503 ~~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 580 (674)
...+|++.+.||+|+||.||++.+ .+..||+|++..... .....+.+|+.+++.++||||+++++.+...+.+|+|
T Consensus 7 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~--~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv 84 (267)
T cd06646 7 PQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPG--DDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWIC 84 (267)
T ss_pred chhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCcc--chHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEE
Confidence 346799999999999999999997 466799999865432 2234577899999999999999999999999999999
Q ss_pred EecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccccCCcc
Q 005841 581 TEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYL 660 (674)
Q Consensus 581 ~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~~~~ 660 (674)
|||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ |+|+||||+|||++.++.+||+|||+++.......
T Consensus 85 ~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~ 161 (267)
T cd06646 85 MEYCGGGSLQDIYHV-TGPLSELQIAYVCRETLQGLAYLHSKG--KMHRDIKGANILLTDNGDVKLADFGVAAKITATIA 161 (267)
T ss_pred EeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEECCCCCEEECcCccceeeccccc
Confidence 999999999999865 357899999999999999999999998 99999999999999999999999999987644333
Q ss_pred ccccCCCCccccCC
Q 005841 661 TTKTGKGTVTYLAS 674 (674)
Q Consensus 661 ~~~~~~GTp~YmAP 674 (674)
......|++.|+||
T Consensus 162 ~~~~~~~~~~y~~P 175 (267)
T cd06646 162 KRKSFIGTPYWMAP 175 (267)
T ss_pred ccCccccCccccCH
Confidence 33345789999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=99.92 E-value=5e-24 Score=218.48 Aligned_cols=166 Identities=25% Similarity=0.397 Sum_probs=144.9
Q ss_pred CeeEeeeecccCceEEEEEEE--cCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeEEEEEec
Q 005841 506 DLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEF 583 (674)
Q Consensus 506 ~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~ 583 (674)
+|++.+.||+|+||.||++.+ .+..||+|.+.... .....+.+.+|+.+++.++|+||+++++.+...+.+|+||||
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 79 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPK-SSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEY 79 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCc-chHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEee
Confidence 588999999999999999987 46779999986543 234456788899999999999999999999999999999999
Q ss_pred CCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccccCCcccc
Q 005841 584 LPRGSLFRLLQRN-TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTT 662 (674)
Q Consensus 584 ~~ggsL~~~l~~~-~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~~~~~~ 662 (674)
+++++|.+++... ...+++..++.++.||+.||.|||+++ |+|+||||+|||+++++.++|+|||++..........
T Consensus 80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~--i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~ 157 (255)
T cd08219 80 CDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKR--VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYA 157 (255)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCC--cccCCCCcceEEECCCCcEEEcccCcceeeccccccc
Confidence 9999999988653 345899999999999999999999999 9999999999999999999999999998765544333
Q ss_pred ccCCCCccccCC
Q 005841 663 KTGKGTVTYLAS 674 (674)
Q Consensus 663 ~~~~GTp~YmAP 674 (674)
....|++.||||
T Consensus 158 ~~~~~~~~~~aP 169 (255)
T cd08219 158 CTYVGTPYYVPP 169 (255)
T ss_pred ccccCCccccCH
Confidence 446799999998
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.4e-24 Score=226.05 Aligned_cols=167 Identities=28% Similarity=0.408 Sum_probs=147.7
Q ss_pred cCCeeEeeeecccCceEEEEEEE--cCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeEEEEE
Q 005841 504 WEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVT 581 (674)
Q Consensus 504 ~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 581 (674)
.++|++.+.||.|+||.||++.+ .+..||+|++... .......+..|+.+++.++||||+++++.+..+..+|+||
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIE--SEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILI 81 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeC--CHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEe
Confidence 35799999999999999999987 4677999998643 3445567889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccccCCccc
Q 005841 582 EFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLT 661 (674)
Q Consensus 582 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~~~~~ 661 (674)
||+++++|.+++......+++..+..++.|++.+|.|||+.+ |+|+||||+|||++.++.++|+|||++.........
T Consensus 82 e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~--i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~ 159 (280)
T cd06611 82 EFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHK--VIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQK 159 (280)
T ss_pred eccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCChhhEEECCCCCEEEccCccchhhcccccc
Confidence 999999999999876677999999999999999999999999 999999999999999999999999998766544434
Q ss_pred cccCCCCccccCC
Q 005841 662 TKTGKGTVTYLAS 674 (674)
Q Consensus 662 ~~~~~GTp~YmAP 674 (674)
.....||+.|+||
T Consensus 160 ~~~~~~~~~y~~P 172 (280)
T cd06611 160 RDTFIGTPYWMAP 172 (280)
T ss_pred cceeecchhhcCH
Confidence 4446799999998
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.1e-24 Score=237.28 Aligned_cols=173 Identities=28% Similarity=0.460 Sum_probs=145.0
Q ss_pred ccccccCCeeEeeeecccCceEEEEEEEcC-------CeEEEEEeecccCCHHHHHHHHHHHHHHhhCC-CCCeeeEEEE
Q 005841 499 DYEILWEDLTIGEQIGQGSCGTVYHAVWYG-------SDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLR-HPNVLLFMGA 570 (674)
Q Consensus 499 ~~~~~~~~y~~~~~LG~G~fG~Vy~~~~~~-------~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~ 570 (674)
.+++..++|.+.++||+|+||.||+|++.+ ..||||++.... .....+.+.+|+.++..+. ||||++++++
T Consensus 31 ~~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~~E~~~l~~l~~H~niv~~~~~ 109 (401)
T cd05107 31 AWEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTA-RSSEKQALMSELKIMSHLGPHLNIVNLLGA 109 (401)
T ss_pred cceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCC-ChhHHHHHHHHHHHHHhcCCCCCeEEEEEE
Confidence 367778899999999999999999998643 469999997543 2333457889999999997 9999999999
Q ss_pred EecCCeEEEEEecCCCCCHHHHHHhcC-----------------------------------------------------
Q 005841 571 VTSPQRLCIVTEFLPRGSLFRLLQRNT----------------------------------------------------- 597 (674)
Q Consensus 571 ~~~~~~~~lV~E~~~ggsL~~~l~~~~----------------------------------------------------- 597 (674)
+...+.+|||||||++|+|.+++.++.
T Consensus 110 ~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 189 (401)
T cd05107 110 CTKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADY 189 (401)
T ss_pred EccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCc
Confidence 999999999999999999999996532
Q ss_pred --------------------------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCC
Q 005841 598 --------------------------------------------TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKS 633 (674)
Q Consensus 598 --------------------------------------------~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp 633 (674)
..+++..++.|+.||+.||.|||+.+ |+||||||
T Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrdlkp 267 (401)
T cd05107 190 VPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN--CVHRDLAA 267 (401)
T ss_pred cchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC--cCcccCCc
Confidence 13677888999999999999999988 99999999
Q ss_pred CCEEEcCCCcEEEEecCCcccccCCc--cccccCCCCccccCC
Q 005841 634 SNLLVDKHWTVKVGDFGLSRLKHETY--LTTKTGKGTVTYLAS 674 (674)
Q Consensus 634 ~NILi~~~~~vkL~DFGla~~~~~~~--~~~~~~~GTp~YmAP 674 (674)
+|||++.++.+||+|||+++...... .......||+.||||
T Consensus 268 ~NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aP 310 (401)
T cd05107 268 RNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAP 310 (401)
T ss_pred ceEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeCh
Confidence 99999999999999999998653321 112234578899998
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.3e-24 Score=223.52 Aligned_cols=159 Identities=23% Similarity=0.352 Sum_probs=135.1
Q ss_pred ecccCceEEEEEEE--cCCeEEEEEeecccCCH-HHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeEEEEEecCCCCCH
Q 005841 513 IGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSD-EVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSL 589 (674)
Q Consensus 513 LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL 589 (674)
||+|+||.||++.. .+..||+|++.+..... .....+..|+.+++.++||||+++++++.....+|+||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 79999999999987 47789999997544322 2233456699999999999999999999999999999999999999
Q ss_pred HHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccccCCccccccCCCC
Q 005841 590 FRLLQRN-TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGT 668 (674)
Q Consensus 590 ~~~l~~~-~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~~~~~~~~~~GT 668 (674)
.+++... ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.++|+|||++........ .....||
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~-~~~~~~~ 157 (277)
T cd05607 81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHSMD--IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT-ITQRAGT 157 (277)
T ss_pred HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC--EEEccCChHhEEEcCCCCEEEeeceeeeecCCCce-eeccCCC
Confidence 9888643 345889999999999999999999999 99999999999999999999999999987654322 2235699
Q ss_pred ccccCC
Q 005841 669 VTYLAS 674 (674)
Q Consensus 669 p~YmAP 674 (674)
+.|+||
T Consensus 158 ~~y~aP 163 (277)
T cd05607 158 NGYMAP 163 (277)
T ss_pred CCccCH
Confidence 999998
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.92 E-value=3e-24 Score=222.05 Aligned_cols=168 Identities=32% Similarity=0.494 Sum_probs=143.3
Q ss_pred cCCeeEeeeecccCceEEEEEEEc--C---CeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeEE
Q 005841 504 WEDLTIGEQIGQGSCGTVYHAVWY--G---SDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLC 578 (674)
Q Consensus 504 ~~~y~~~~~LG~G~fG~Vy~~~~~--~---~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 578 (674)
..+|++.+.||+|+||.||+|.+. + ..||+|.+.... .......+.+|+.+++.++||||+++++++...+..|
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 81 (267)
T cd05066 3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGY-TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVM 81 (267)
T ss_pred HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccE
Confidence 467899999999999999999862 2 259999886543 3445678899999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccccCC
Q 005841 579 IVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHET 658 (674)
Q Consensus 579 lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~~ 658 (674)
+||||+++++|.+++......+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.++|+|||+++.....
T Consensus 82 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd05066 82 IVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMG--YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 159 (267)
T ss_pred EEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--EeehhhchhcEEECCCCeEEeCCCCcccccccc
Confidence 999999999999999876677899999999999999999999999 999999999999999999999999999876432
Q ss_pred cc---ccccCCCCccccCC
Q 005841 659 YL---TTKTGKGTVTYLAS 674 (674)
Q Consensus 659 ~~---~~~~~~GTp~YmAP 674 (674)
.. ......+++.|+||
T Consensus 160 ~~~~~~~~~~~~~~~y~~p 178 (267)
T cd05066 160 PEAAYTTRGGKIPIRWTAP 178 (267)
T ss_pred cceeeecCCCccceeecCH
Confidence 21 11223346789987
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.7e-24 Score=221.30 Aligned_cols=170 Identities=30% Similarity=0.539 Sum_probs=145.3
Q ss_pred cccccCCeeEeeeecccCceEEEEEEE-cCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeEE
Q 005841 500 YEILWEDLTIGEQIGQGSCGTVYHAVW-YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLC 578 (674)
Q Consensus 500 ~~~~~~~y~~~~~LG~G~fG~Vy~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 578 (674)
|++..++|++.++||+|+||.||++.. .+..||+|.+.... ...+.+.+|+.+++.++|+||+++++.+......|
T Consensus 1 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 77 (261)
T cd05072 1 WEIPRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT---MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIY 77 (261)
T ss_pred CcCchHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc---hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcE
Confidence 456778999999999999999999987 45669999876433 23467889999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccccC
Q 005841 579 IVTEFLPRGSLFRLLQRN-TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHE 657 (674)
Q Consensus 579 lV~E~~~ggsL~~~l~~~-~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~ 657 (674)
+||||+++++|.+++... ...+++..++.++.|++.||.|||+.+ ++|+||||+|||++.++.+||+|||++.....
T Consensus 78 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~--i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 155 (261)
T cd05072 78 IITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKN--YIHRDLRAANVLVSESLMCKIADFGLARVIED 155 (261)
T ss_pred EEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccccchhhEEecCCCcEEECCCccceecCC
Confidence 999999999999998753 456889999999999999999999988 99999999999999999999999999987654
Q ss_pred Ccccc-ccCCCCccccCC
Q 005841 658 TYLTT-KTGKGTVTYLAS 674 (674)
Q Consensus 658 ~~~~~-~~~~GTp~YmAP 674 (674)
..... ....++..||||
T Consensus 156 ~~~~~~~~~~~~~~y~aP 173 (261)
T cd05072 156 NEYTAREGAKFPIKWTAP 173 (261)
T ss_pred CceeccCCCccceecCCH
Confidence 33222 223467789998
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.92 E-value=6.1e-24 Score=217.72 Aligned_cols=167 Identities=27% Similarity=0.415 Sum_probs=145.0
Q ss_pred CeeEeeeecccCceEEEEEEE--cCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecC-CeEEEEEe
Q 005841 506 DLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSP-QRLCIVTE 582 (674)
Q Consensus 506 ~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~-~~~~lV~E 582 (674)
.|++.+.||.|+||.||.+.+ .+..||+|.+............+.+|+.+++.++|+||+++++.+... ..+|+|||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 489999999999999999987 456799999977665555667788999999999999999999987644 46899999
Q ss_pred cCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccccCCccc
Q 005841 583 FLPRGSLFRLLQRN-TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLT 661 (674)
Q Consensus 583 ~~~ggsL~~~l~~~-~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~~~~~ 661 (674)
|+++++|.+++... ...+++.++..++.|++.+|.|||+.+ |+|+||||+|||++.++.++|+|||++.........
T Consensus 81 ~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~--i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~ 158 (257)
T cd08223 81 FCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKH--ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDM 158 (257)
T ss_pred ccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCchhEEEecCCcEEEecccceEEecccCCc
Confidence 99999999999764 345899999999999999999999999 999999999999999999999999999876543333
Q ss_pred cccCCCCccccCC
Q 005841 662 TKTGKGTVTYLAS 674 (674)
Q Consensus 662 ~~~~~GTp~YmAP 674 (674)
.....|++.|+||
T Consensus 159 ~~~~~~~~~y~aP 171 (257)
T cd08223 159 ASTLIGTPYYMSP 171 (257)
T ss_pred cccccCCcCccCh
Confidence 4456799999998
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.1e-24 Score=226.90 Aligned_cols=166 Identities=27% Similarity=0.389 Sum_probs=143.6
Q ss_pred CeeEeeeecccCceEEEEEEE--cCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeEEEEEec
Q 005841 506 DLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEF 583 (674)
Q Consensus 506 ~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~ 583 (674)
+|++.+.||+|+||.||+|.+ ++..||+|.+............+.+|+.+++.++||||+++++++.+...+|+||||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 488999999999999999998 577899999976544333445677899999999999999999999999999999999
Q ss_pred CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccccCCccccc
Q 005841 584 LPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTK 663 (674)
Q Consensus 584 ~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~~~~~~~ 663 (674)
+. ++|.+++......+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++..........
T Consensus 81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~--i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~ 157 (284)
T cd07839 81 CD-QDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHN--VLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYS 157 (284)
T ss_pred CC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHEEEcCCCcEEECccchhhccCCCCCCcC
Confidence 96 5888888766677999999999999999999999999 99999999999999999999999999986654333333
Q ss_pred cCCCCccccCC
Q 005841 664 TGKGTVTYLAS 674 (674)
Q Consensus 664 ~~~GTp~YmAP 674 (674)
...+|+.|+||
T Consensus 158 ~~~~~~~y~aP 168 (284)
T cd07839 158 AEVVTLWYRPP 168 (284)
T ss_pred CCccccCCcCh
Confidence 34689999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.3e-24 Score=233.83 Aligned_cols=165 Identities=30% Similarity=0.408 Sum_probs=140.2
Q ss_pred ccCCeeEeeeecccCceEEEEEEE--cCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecC------
Q 005841 503 LWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSP------ 574 (674)
Q Consensus 503 ~~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~------ 574 (674)
..++|.+.+.||+|+||.||++.+ .+..||||++............+.+|+.+++.++||||+.+++++...
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 357899999999999999999987 467799999976554445566788899999999999999999987643
Q ss_pred CeEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCccc
Q 005841 575 QRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL 654 (674)
Q Consensus 575 ~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~ 654 (674)
..+|+||||+++ +|.+++.. .+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++.
T Consensus 102 ~~~~lv~e~~~~-~l~~~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~kL~DfG~a~~ 175 (364)
T cd07875 102 QDVYIVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLART 175 (364)
T ss_pred CeEEEEEeCCCC-CHHHHHHh---cCCHHHHHHHHHHHHHHHHHHhhCC--eecCCCCHHHEEECCCCcEEEEeCCCccc
Confidence 357999999965 78777753 4889999999999999999999998 99999999999999999999999999987
Q ss_pred ccCCccccccCCCCccccCC
Q 005841 655 KHETYLTTKTGKGTVTYLAS 674 (674)
Q Consensus 655 ~~~~~~~~~~~~GTp~YmAP 674 (674)
..... ......||+.|+||
T Consensus 176 ~~~~~-~~~~~~~t~~y~aP 194 (364)
T cd07875 176 AGTSF-MMTPYVVTRYYRAP 194 (364)
T ss_pred cCCCC-cccCCcccCCcCCH
Confidence 65432 22345799999998
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.4e-24 Score=224.14 Aligned_cols=166 Identities=31% Similarity=0.446 Sum_probs=145.3
Q ss_pred cCCeeEeeeecccCceEEEEEEE--cCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeEEEEE
Q 005841 504 WEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVT 581 (674)
Q Consensus 504 ~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 581 (674)
.++|.+.+.||+|+||.||++.+ .+..||+|++..... .....+.+|+.+++.++||||+++++.+...+.+|+||
T Consensus 8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~ 85 (267)
T cd06645 8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPG--EDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICM 85 (267)
T ss_pred HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCch--hHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEE
Confidence 45789999999999999999987 467799999865432 23356788999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccccCCccc
Q 005841 582 EFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLT 661 (674)
Q Consensus 582 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~~~~~ 661 (674)
||+++++|.+++.. ...+++..++.++.|++.||.|||+.+ |+|+||||+|||++.++.++|+|||++.........
T Consensus 86 e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~ 162 (267)
T cd06645 86 EFCGGGSLQDIYHV-TGPLSESQIAYVSRETLQGLYYLHSKG--KMHRDIKGANILLTDNGHVKLADFGVSAQITATIAK 162 (267)
T ss_pred eccCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEECCCCCEEECcceeeeEccCcccc
Confidence 99999999999865 447999999999999999999999999 999999999999999999999999999876544434
Q ss_pred cccCCCCccccCC
Q 005841 662 TKTGKGTVTYLAS 674 (674)
Q Consensus 662 ~~~~~GTp~YmAP 674 (674)
.....||+.||||
T Consensus 163 ~~~~~~~~~y~aP 175 (267)
T cd06645 163 RKSFIGTPYWMAP 175 (267)
T ss_pred cccccCcccccCh
Confidence 4456799999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.8e-24 Score=226.60 Aligned_cols=158 Identities=20% Similarity=0.392 Sum_probs=138.1
Q ss_pred eeecccCceEEEEEEEcCCeEEEEEeecccCCH-HHHHHHHHHHHHHhhCCCCCeeeEEEEEec----CCeEEEEEecCC
Q 005841 511 EQIGQGSCGTVYHAVWYGSDVAVKVFSRQEYSD-EVIHSFRQEVSLMKRLRHPNVLLFMGAVTS----PQRLCIVTEFLP 585 (674)
Q Consensus 511 ~~LG~G~fG~Vy~~~~~~~~vAvK~i~~~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~----~~~~~lV~E~~~ 585 (674)
..|++|++|.||+|.+++..||||++.+..... ...+.+.+|+.+|++++||||+++++++.+ ...+++||||++
T Consensus 26 ~~i~~g~~~~v~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~~ 105 (283)
T PHA02988 26 VLIKENDQNSIYKGIFNNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCT 105 (283)
T ss_pred eEEeeCCceEEEEEEECCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeCC
Confidence 578999999999999999999999997654433 446788899999999999999999999876 457899999999
Q ss_pred CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCeEEccCCCCCEEEcCCCcEEEEecCCcccccCCcccccc
Q 005841 586 RGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHC-NPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKT 664 (674)
Q Consensus 586 ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~-~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~~~~~~~~ 664 (674)
+|+|.+++... ..+++...+.++.|++.||.|||.. + ++||||||+|||+++++.+||+|||+++...... ..
T Consensus 106 ~g~L~~~l~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~--~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~---~~ 179 (283)
T PHA02988 106 RGYLREVLDKE-KDLSFKTKLDMAIDCCKGLYNLYKYTN--KPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP---FK 179 (283)
T ss_pred CCcHHHHHhhC-CCCChhHHHHHHHHHHHHHHHHHhcCC--CCCCcCChhhEEECCCCcEEEcccchHhhhcccc---cc
Confidence 99999999764 4789999999999999999999974 7 8899999999999999999999999998765432 23
Q ss_pred CCCCccccCC
Q 005841 665 GKGTVTYLAS 674 (674)
Q Consensus 665 ~~GTp~YmAP 674 (674)
..||+.||||
T Consensus 180 ~~~~~~y~aP 189 (283)
T PHA02988 180 NVNFMVYFSY 189 (283)
T ss_pred ccCcccccCH
Confidence 4689999998
|
|
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.1e-24 Score=224.82 Aligned_cols=169 Identities=34% Similarity=0.569 Sum_probs=143.4
Q ss_pred ccCCeeEeeeecccCceEEEEEEEcC-------CeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCC
Q 005841 503 LWEDLTIGEQIGQGSCGTVYHAVWYG-------SDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQ 575 (674)
Q Consensus 503 ~~~~y~~~~~LG~G~fG~Vy~~~~~~-------~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~ 575 (674)
...+|++.+.||+|+||.||+|...+ ..|++|.+.... .......+.+|+.++..++||||+++++++....
T Consensus 3 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~-~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~ 81 (283)
T cd05048 3 PLSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENA-EPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQ 81 (283)
T ss_pred ChHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCC-CHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCC
Confidence 34689999999999999999998643 349999886433 3455667899999999999999999999999999
Q ss_pred eEEEEEecCCCCCHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcC
Q 005841 576 RLCIVTEFLPRGSLFRLLQRNT---------------TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDK 640 (674)
Q Consensus 576 ~~~lV~E~~~ggsL~~~l~~~~---------------~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~ 640 (674)
..|++|||+++++|.+++.... ..+++..++.++.||+.||.|||+.+ |+|+||||+|||+++
T Consensus 82 ~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~--i~H~dlkp~Nil~~~ 159 (283)
T cd05048 82 PTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH--FVHRDLAARNCLVGE 159 (283)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccccccceEEEcC
Confidence 9999999999999999997532 45888999999999999999999999 999999999999999
Q ss_pred CCcEEEEecCCcccccCCc--cccccCCCCccccCC
Q 005841 641 HWTVKVGDFGLSRLKHETY--LTTKTGKGTVTYLAS 674 (674)
Q Consensus 641 ~~~vkL~DFGla~~~~~~~--~~~~~~~GTp~YmAP 674 (674)
++.+||+|||+++...... .......+|+.||||
T Consensus 160 ~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aP 195 (283)
T cd05048 160 GLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPP 195 (283)
T ss_pred CCcEEECCCcceeeccccccccccCCCcccccccCH
Confidence 9999999999998653322 122334678999998
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.3e-24 Score=224.51 Aligned_cols=172 Identities=33% Similarity=0.459 Sum_probs=142.2
Q ss_pred cccccCCeeEeeeecccCceEEEEEEEc-------CCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEe
Q 005841 500 YEILWEDLTIGEQIGQGSCGTVYHAVWY-------GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVT 572 (674)
Q Consensus 500 ~~~~~~~y~~~~~LG~G~fG~Vy~~~~~-------~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~ 572 (674)
|++..++|++.+.||+|+||.||+|..+ +..||+|.+.... .......+.+|+.+++.++||||+++++++.
T Consensus 1 ~~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~ 79 (288)
T cd05061 1 WEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESA-SLRERIEFLNEASVMKGFTCHHVVRLLGVVS 79 (288)
T ss_pred CcccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcC-CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEc
Confidence 4566789999999999999999998753 2369999886443 2333456788999999999999999999999
Q ss_pred cCCeEEEEEecCCCCCHHHHHHhcC---------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCc
Q 005841 573 SPQRLCIVTEFLPRGSLFRLLQRNT---------TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWT 643 (674)
Q Consensus 573 ~~~~~~lV~E~~~ggsL~~~l~~~~---------~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~ 643 (674)
.....|+||||+++++|.+++.... ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.
T Consensus 80 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--i~H~dikp~nili~~~~~ 157 (288)
T cd05061 80 KGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK--FVHRDLAARNCMVAHDFT 157 (288)
T ss_pred CCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--CcCCCCChheEEEcCCCc
Confidence 9999999999999999999997532 33567889999999999999999998 999999999999999999
Q ss_pred EEEEecCCcccccCCccc--cccCCCCccccCC
Q 005841 644 VKVGDFGLSRLKHETYLT--TKTGKGTVTYLAS 674 (674)
Q Consensus 644 vkL~DFGla~~~~~~~~~--~~~~~GTp~YmAP 674 (674)
++|+|||+++........ .....+++.||||
T Consensus 158 ~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~p 190 (288)
T cd05061 158 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 190 (288)
T ss_pred EEECcCCccccccccccccccCCCcccccccCH
Confidence 999999999865432221 1123467889998
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.92 E-value=7.1e-25 Score=236.39 Aligned_cols=146 Identities=21% Similarity=0.344 Sum_probs=130.6
Q ss_pred CCeeEeeeecccCceEEEEEEE--cCCeEEEEEeecccC-CHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeEEEEE
Q 005841 505 EDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEY-SDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVT 581 (674)
Q Consensus 505 ~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 581 (674)
.-|..++.||-|+||.|.+++. +...||+|.+.+... ....+.-++.|-.||..-..+-||+||..|++++.+|+||
T Consensus 629 SmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVM 708 (1034)
T KOG0608|consen 629 SMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVM 708 (1034)
T ss_pred cceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEE
Confidence 4577889999999999999975 445599999987654 2344556778999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcc
Q 005841 582 EFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSR 653 (674)
Q Consensus 582 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~ 653 (674)
+|++||++..+|-+. +.|.+..+.+|+.++..|++++|..| +|||||||+|||||.+|+|||+|||||.
T Consensus 709 dYIPGGDmMSLLIrm-gIFeE~LARFYIAEltcAiesVHkmG--FIHRDiKPDNILIDrdGHIKLTDFGLCT 777 (1034)
T KOG0608|consen 709 DYIPGGDMMSLLIRM-GIFEEDLARFYIAELTCAIESVHKMG--FIHRDIKPDNILIDRDGHIKLTDFGLCT 777 (1034)
T ss_pred eccCCccHHHHHHHh-ccCHHHHHHHHHHHHHHHHHHHHhcc--ceecccCccceEEccCCceeeeeccccc
Confidence 999999999998764 47999999999999999999999999 9999999999999999999999999995
|
|
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.5e-24 Score=220.48 Aligned_cols=166 Identities=33% Similarity=0.519 Sum_probs=142.1
Q ss_pred cCCeeEeeeecccCceEEEEEEEcCC-eEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeEEEEEe
Q 005841 504 WEDLTIGEQIGQGSCGTVYHAVWYGS-DVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTE 582 (674)
Q Consensus 504 ~~~y~~~~~LG~G~fG~Vy~~~~~~~-~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E 582 (674)
.++|++.+.||+|+||+||.+.+.+. .||||.+...... ...+.+|+.+++.++||||+++++++.....+|+|||
T Consensus 3 ~~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd05113 3 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS---EDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTE 79 (256)
T ss_pred hHHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCccc---HHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEE
Confidence 36799999999999999999987544 5999988654433 2458889999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccccCCcccc
Q 005841 583 FLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTT 662 (674)
Q Consensus 583 ~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~~~~~~ 662 (674)
|+.+++|.+++......+++..++.++.||+.||.|||+.+ |+|+||||+|||++.++.+||+|||+++.........
T Consensus 80 ~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~ 157 (256)
T cd05113 80 YMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQ--FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTS 157 (256)
T ss_pred cCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccccCcceEEEcCCCCEEECCCccceecCCCceee
Confidence 99999999999876667999999999999999999999998 9999999999999999999999999998664433222
Q ss_pred -ccCCCCccccCC
Q 005841 663 -KTGKGTVTYLAS 674 (674)
Q Consensus 663 -~~~~GTp~YmAP 674 (674)
....++..|+||
T Consensus 158 ~~~~~~~~~y~~p 170 (256)
T cd05113 158 SVGSKFPVRWSPP 170 (256)
T ss_pred cCCCccChhhCCH
Confidence 122356778887
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=6.4e-24 Score=224.93 Aligned_cols=164 Identities=25% Similarity=0.417 Sum_probs=143.4
Q ss_pred CCeeEeeeecccCceEEEEEEE--cCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeEEEEEe
Q 005841 505 EDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTE 582 (674)
Q Consensus 505 ~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E 582 (674)
++|++.+.||+|+||.||++.+ ++..||+|.+... ........+.+|+.+++.++||||+++++++..++.+|+|||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 79 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLE-IKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICME 79 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccc-cCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEee
Confidence 3689999999999999999987 4566899988643 234556678899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCeEEccCCCCCEEEcCCCcEEEEecCCcccccCCccc
Q 005841 583 FLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHH-CNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLT 661 (674)
Q Consensus 583 ~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~-~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~~~~~ 661 (674)
|+++++|.+++.+. ..+++..+..++.||+.||.|||+ ++ |+|+||||+|||++.++.+||+|||++.......
T Consensus 80 y~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~~--i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~-- 154 (308)
T cd06615 80 HMDGGSLDQVLKKA-GRIPENILGKISIAVLRGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM-- 154 (308)
T ss_pred ccCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhhCC--EEECCCChHHEEEecCCcEEEccCCCcccccccc--
Confidence 99999999999764 568999999999999999999997 57 9999999999999999999999999998664432
Q ss_pred cccCCCCccccCC
Q 005841 662 TKTGKGTVTYLAS 674 (674)
Q Consensus 662 ~~~~~GTp~YmAP 674 (674)
....+|++.|+||
T Consensus 155 ~~~~~~~~~~~aP 167 (308)
T cd06615 155 ANSFVGTRSYMSP 167 (308)
T ss_pred cccCCCCcCccCh
Confidence 2346789999998
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.3e-26 Score=243.05 Aligned_cols=170 Identities=23% Similarity=0.286 Sum_probs=153.5
Q ss_pred ccccCCeeEeeeecccCceEEEEEEEcCCe--EEEEEeecccC-CHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeE
Q 005841 501 EILWEDLTIGEQIGQGSCGTVYHAVWYGSD--VAVKVFSRQEY-SDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRL 577 (674)
Q Consensus 501 ~~~~~~y~~~~~LG~G~fG~Vy~~~~~~~~--vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 577 (674)
.....+++++..||-|+||.|-++...+.. +|+|++++... ..+..+-+..|-.||..++.|+||++|..|.+..++
T Consensus 416 ~v~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyv 495 (732)
T KOG0614|consen 416 QVKLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYV 495 (732)
T ss_pred ccchhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhh
Confidence 344577888999999999999999887666 89999988765 445667788899999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccccC
Q 005841 578 CIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHE 657 (674)
Q Consensus 578 ~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~ 657 (674)
|++||-|-||.|+..|++ ++.|+...+.+|+..+++|++|||++| ||+|||||+|+|++.+|-+||.|||+|+.+..
T Consensus 496 YmLmEaClGGElWTiLrd-Rg~Fdd~tarF~~acv~EAfeYLH~k~--iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~ 572 (732)
T KOG0614|consen 496 YMLMEACLGGELWTILRD-RGSFDDYTARFYVACVLEAFEYLHRKG--IIYRDLKPENLLLDNRGYLKLVDFGFAKKIGS 572 (732)
T ss_pred hhhHHhhcCchhhhhhhh-cCCcccchhhhhHHHHHHHHHHHHhcC--ceeccCChhheeeccCCceEEeehhhHHHhcc
Confidence 999999999999999975 568999999999999999999999999 99999999999999999999999999997765
Q ss_pred CccccccCCCCccccCC
Q 005841 658 TYLTTKTGKGTVTYLAS 674 (674)
Q Consensus 658 ~~~~~~~~~GTp~YmAP 674 (674)
...+++|||||.|.||
T Consensus 573 -g~KTwTFcGTpEYVAP 588 (732)
T KOG0614|consen 573 -GRKTWTFCGTPEYVAP 588 (732)
T ss_pred -CCceeeecCCcccccc
Confidence 4567789999999999
|
|
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.8e-24 Score=220.81 Aligned_cols=166 Identities=32% Similarity=0.506 Sum_probs=141.2
Q ss_pred cCCeeEeeeecccCceEEEEEEEc-CCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeEEEEEe
Q 005841 504 WEDLTIGEQIGQGSCGTVYHAVWY-GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTE 582 (674)
Q Consensus 504 ~~~y~~~~~LG~G~fG~Vy~~~~~-~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E 582 (674)
..+|++.+.||+|+||.||++.+. +..+|+|++.+..... ..+.+|+.+++.++||||+++++++...+..|+|||
T Consensus 3 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~~~---~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd05059 3 PSELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAMSE---DDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTE 79 (256)
T ss_pred hHHcchhhhhccCCCceEEEeEecCCccEEEEEeccCCCCH---HHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEe
Confidence 356889999999999999999875 4469999987554332 357789999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccccCCcccc
Q 005841 583 FLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTT 662 (674)
Q Consensus 583 ~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~~~~~~ 662 (674)
|+++++|.+++......+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++...+.....
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~ 157 (256)
T cd05059 80 YMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNG--FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTS 157 (256)
T ss_pred cCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC--cccccccHhhEEECCCCcEEECCcccceecccccccc
Confidence 99999999999876667999999999999999999999999 9999999999999999999999999998664432221
Q ss_pred c-cCCCCccccCC
Q 005841 663 K-TGKGTVTYLAS 674 (674)
Q Consensus 663 ~-~~~GTp~YmAP 674 (674)
. ...++..|+||
T Consensus 158 ~~~~~~~~~y~~P 170 (256)
T cd05059 158 SQGTKFPVKWAPP 170 (256)
T ss_pred cCCCCCCccccCH
Confidence 1 12345679987
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.9e-24 Score=219.51 Aligned_cols=170 Identities=33% Similarity=0.538 Sum_probs=143.8
Q ss_pred cccccCCeeEeeeecccCceEEEEEEEc-CCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeEE
Q 005841 500 YEILWEDLTIGEQIGQGSCGTVYHAVWY-GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLC 578 (674)
Q Consensus 500 ~~~~~~~y~~~~~LG~G~fG~Vy~~~~~-~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 578 (674)
|++..++|++.+.||+|+||.||+|.+. +..||+|.+...... ...+.+|+.+++.++||||+++++++.....+|
T Consensus 1 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 77 (261)
T cd05068 1 WEIDRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMD---PKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIY 77 (261)
T ss_pred CccchhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCccc---HHHHHHHHHHHHHCCCCCccceeEEEecCCCee
Confidence 3566788999999999999999999873 456999998654432 345788999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccccC
Q 005841 579 IVTEFLPRGSLFRLLQRNT-TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHE 657 (674)
Q Consensus 579 lV~E~~~ggsL~~~l~~~~-~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~ 657 (674)
+||||+++++|.+++.... ..+++..+..++.|++.||.|||+.+ |+|+||||+|||++.++.+||+|||+++....
T Consensus 78 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~ 155 (261)
T cd05068 78 IVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQN--YIHRDLAARNVLVGENNICKVADFGLARVIKE 155 (261)
T ss_pred eeeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeccCCcceEEEcCCCCEEECCcceEEEccC
Confidence 9999999999999997543 46899999999999999999999998 99999999999999999999999999987654
Q ss_pred Cccccc-cCCCCccccCC
Q 005841 658 TYLTTK-TGKGTVTYLAS 674 (674)
Q Consensus 658 ~~~~~~-~~~GTp~YmAP 674 (674)
...... ...++..||||
T Consensus 156 ~~~~~~~~~~~~~~y~aP 173 (261)
T cd05068 156 DIYEAREGAKFPIKWTAP 173 (261)
T ss_pred CcccccCCCcCceeccCc
Confidence 322211 12234579988
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.92 E-value=2e-24 Score=232.19 Aligned_cols=172 Identities=27% Similarity=0.470 Sum_probs=142.1
Q ss_pred cccccCCeeEeeeecccCceEEEEEEEc-------CCeEEEEEeecccCCHHHHHHHHHHHHHHhhC-CCCCeeeEEEEE
Q 005841 500 YEILWEDLTIGEQIGQGSCGTVYHAVWY-------GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRL-RHPNVLLFMGAV 571 (674)
Q Consensus 500 ~~~~~~~y~~~~~LG~G~fG~Vy~~~~~-------~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~ 571 (674)
|++..++|++.++||+|+||.||+|... ++.||+|++.... .......+..|+.++.++ +|+||+++++++
T Consensus 2 ~~~~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~ 80 (337)
T cd05054 2 WEFPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGA-TASEYKALMTELKILIHIGHHLNVVNLLGAC 80 (337)
T ss_pred cccCHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCC-CHHHHHHHHHHHHHHHhhccCcchhheeeeE
Confidence 5666789999999999999999999753 3569999986433 334456778899999999 799999999988
Q ss_pred ecC-CeEEEEEecCCCCCHHHHHHhcC-----------------------------------------------------
Q 005841 572 TSP-QRLCIVTEFLPRGSLFRLLQRNT----------------------------------------------------- 597 (674)
Q Consensus 572 ~~~-~~~~lV~E~~~ggsL~~~l~~~~----------------------------------------------------- 597 (674)
... ..++++|||+++++|.+++....
T Consensus 81 ~~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (337)
T cd05054 81 TKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDE 160 (337)
T ss_pred ecCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccch
Confidence 654 56899999999999999986421
Q ss_pred -------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccccCCc--cccccCCCC
Q 005841 598 -------TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETY--LTTKTGKGT 668 (674)
Q Consensus 598 -------~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~~~--~~~~~~~GT 668 (674)
..+++..+..++.||+.||.|||+++ |+||||||+|||++.++++||+|||+++.+.... .......++
T Consensus 161 ~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~--ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~ 238 (337)
T cd05054 161 EGDELYKEPLTLEDLISYSFQVARGMEFLASRK--CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP 238 (337)
T ss_pred hhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCC
Confidence 25789999999999999999999998 9999999999999999999999999998754321 222234567
Q ss_pred ccccCC
Q 005841 669 VTYLAS 674 (674)
Q Consensus 669 p~YmAP 674 (674)
+.||||
T Consensus 239 ~~y~aP 244 (337)
T cd05054 239 LKWMAP 244 (337)
T ss_pred ccccCc
Confidence 889998
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.6e-24 Score=233.00 Aligned_cols=164 Identities=29% Similarity=0.397 Sum_probs=139.9
Q ss_pred ccCCeeEeeeecccCceEEEEEEE--cCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecC------
Q 005841 503 LWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSP------ 574 (674)
Q Consensus 503 ~~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~------ 574 (674)
..++|.+.+.||.|+||+||+|.+ ++..||||++.+..........+.+|+.+++.++||||+++++++...
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07878 13 VPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENF 92 (343)
T ss_pred hhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccccc
Confidence 357899999999999999999987 466799999876543334456678899999999999999999887543
Q ss_pred CeEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCccc
Q 005841 575 QRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL 654 (674)
Q Consensus 575 ~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~ 654 (674)
..+|++|+++ +++|.+++.. ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 93 ~~~~~~~~~~-~~~l~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~--ivHrdikp~Nil~~~~~~~kl~Dfg~~~~ 167 (343)
T cd07878 93 NEVYLVTNLM-GADLNNIVKC--QKLSDEHVQFLIYQLLRGLKYIHSAG--IIHRDLKPSNVAVNEDCELRILDFGLARQ 167 (343)
T ss_pred CcEEEEeecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC--eecccCChhhEEECCCCCEEEcCCcccee
Confidence 3479999988 7899888753 46999999999999999999999999 99999999999999999999999999987
Q ss_pred ccCCccccccCCCCccccCC
Q 005841 655 KHETYLTTKTGKGTVTYLAS 674 (674)
Q Consensus 655 ~~~~~~~~~~~~GTp~YmAP 674 (674)
.... .....||+.|+||
T Consensus 168 ~~~~---~~~~~~t~~y~aP 184 (343)
T cd07878 168 ADDE---MTGYVATRWYRAP 184 (343)
T ss_pred cCCC---cCCccccccccCc
Confidence 6543 2345799999998
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=99.92 E-value=5.2e-24 Score=222.15 Aligned_cols=169 Identities=28% Similarity=0.482 Sum_probs=141.7
Q ss_pred ccCCeeEeeeecccCceEEEEEEE------cCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCe
Q 005841 503 LWEDLTIGEQIGQGSCGTVYHAVW------YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQR 576 (674)
Q Consensus 503 ~~~~y~~~~~LG~G~fG~Vy~~~~------~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 576 (674)
...+|++.+.||+|+||+||+|.+ .+..|++|.+.... .......+.+|+.+++.++||||+++++++.....
T Consensus 3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 81 (283)
T cd05090 3 PLSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDIN-NPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQP 81 (283)
T ss_pred ChhhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCC-CHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCc
Confidence 346799999999999999999985 23569999886433 34445678899999999999999999999999999
Q ss_pred EEEEEecCCCCCHHHHHHhc----------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcC
Q 005841 577 LCIVTEFLPRGSLFRLLQRN----------------TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDK 640 (674)
Q Consensus 577 ~~lV~E~~~ggsL~~~l~~~----------------~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~ 640 (674)
.|+||||+++++|.+++... ...+++..++.++.||+.||.|||+++ |+||||||+|||++.
T Consensus 82 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~--i~H~dlkp~nili~~ 159 (283)
T cd05090 82 VCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF--FVHKDLAARNILIGE 159 (283)
T ss_pred eEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC--eehhccccceEEEcC
Confidence 99999999999999998532 134788999999999999999999998 999999999999999
Q ss_pred CCcEEEEecCCcccccCCc--cccccCCCCccccCC
Q 005841 641 HWTVKVGDFGLSRLKHETY--LTTKTGKGTVTYLAS 674 (674)
Q Consensus 641 ~~~vkL~DFGla~~~~~~~--~~~~~~~GTp~YmAP 674 (674)
++.+||+|||+++...... .......++..|+||
T Consensus 160 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aP 195 (283)
T cd05090 160 QLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPP 195 (283)
T ss_pred CCcEEeccccccccccCCcceecccCCCccceecCh
Confidence 9999999999998653321 122334567789998
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.6e-24 Score=231.61 Aligned_cols=172 Identities=27% Similarity=0.438 Sum_probs=140.8
Q ss_pred cccccCCeeEeeeecccCceEEEEEEE-------cCCeEEEEEeecccCCHHHHHHHHHHHHHHhhC-CCCCeeeEEEEE
Q 005841 500 YEILWEDLTIGEQIGQGSCGTVYHAVW-------YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRL-RHPNVLLFMGAV 571 (674)
Q Consensus 500 ~~~~~~~y~~~~~LG~G~fG~Vy~~~~-------~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~ 571 (674)
|++..++|++.++||+|+||+||+|.+ .++.||||++.... .......+.+|+.++..+ +||||+++++++
T Consensus 2 ~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~ 80 (343)
T cd05103 2 WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLGAC 80 (343)
T ss_pred cccchhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCC-ChHHHHHHHHHHHHHHhccCCccHhhhccee
Confidence 566778999999999999999999974 34569999996543 234456788899999999 689999999987
Q ss_pred ecC-CeEEEEEecCCCCCHHHHHHhcC-----------------------------------------------------
Q 005841 572 TSP-QRLCIVTEFLPRGSLFRLLQRNT----------------------------------------------------- 597 (674)
Q Consensus 572 ~~~-~~~~lV~E~~~ggsL~~~l~~~~----------------------------------------------------- 597 (674)
... ..+++|||||++|+|.+++....
T Consensus 81 ~~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (343)
T cd05103 81 TKPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSD 160 (343)
T ss_pred ecCCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCcccc
Confidence 654 56899999999999999986432
Q ss_pred -------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccccCCcc--cc
Q 005841 598 -------------TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYL--TT 662 (674)
Q Consensus 598 -------------~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~~~~--~~ 662 (674)
..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++....... ..
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 238 (343)
T cd05103 161 VEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK--CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRK 238 (343)
T ss_pred chhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCccCeEEEcCCCcEEEEecccccccccCcchhhc
Confidence 23678888999999999999999998 99999999999999999999999999986533211 22
Q ss_pred ccCCCCccccCC
Q 005841 663 KTGKGTVTYLAS 674 (674)
Q Consensus 663 ~~~~GTp~YmAP 674 (674)
....+++.||||
T Consensus 239 ~~~~~~~~y~aP 250 (343)
T cd05103 239 GDARLPLKWMAP 250 (343)
T ss_pred CCCCCCcceECc
Confidence 223467789998
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.6e-24 Score=241.25 Aligned_cols=169 Identities=17% Similarity=0.272 Sum_probs=132.3
Q ss_pred ccCCeeEeeeecccCceEEEEEEEcCC---eEEEEE--------------eecc-cCCHHHHHHHHHHHHHHhhCCCCCe
Q 005841 503 LWEDLTIGEQIGQGSCGTVYHAVWYGS---DVAVKV--------------FSRQ-EYSDEVIHSFRQEVSLMKRLRHPNV 564 (674)
Q Consensus 503 ~~~~y~~~~~LG~G~fG~Vy~~~~~~~---~vAvK~--------------i~~~-~~~~~~~~~~~~Ei~il~~l~HpnI 564 (674)
...+|++++.||+|+||+||+|..... .+++|. +.+. .........+.+|+.+++.++||||
T Consensus 146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnI 225 (501)
T PHA03210 146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENI 225 (501)
T ss_pred hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCc
Confidence 347899999999999999999875321 122221 1111 1122345668899999999999999
Q ss_pred eeEEEEEecCCeEEEEEecCCCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcC
Q 005841 565 LLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNT----TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDK 640 (674)
Q Consensus 565 v~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~----~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~ 640 (674)
+++++++...+..|+||+++. ++|..++.... .......+..|+.||+.||.|||+++ ||||||||+||||+.
T Consensus 226 v~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g--IiHrDLKP~NILl~~ 302 (501)
T PHA03210 226 LKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK--LIHRDIKLENIFLNC 302 (501)
T ss_pred CcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEECC
Confidence 999999999999999999994 57877765421 22446678889999999999999999 999999999999999
Q ss_pred CCcEEEEecCCcccccCCcc-ccccCCCCccccCC
Q 005841 641 HWTVKVGDFGLSRLKHETYL-TTKTGKGTVTYLAS 674 (674)
Q Consensus 641 ~~~vkL~DFGla~~~~~~~~-~~~~~~GTp~YmAP 674 (674)
++.+||+|||+++.+..... .....+||+.||||
T Consensus 303 ~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aP 337 (501)
T PHA03210 303 DGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSP 337 (501)
T ss_pred CCCEEEEeCCCceecCcccccccccccCCcCCCCc
Confidence 99999999999987654322 22345799999998
|
|
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.5e-24 Score=236.24 Aligned_cols=162 Identities=29% Similarity=0.392 Sum_probs=140.6
Q ss_pred cCCeeEeeeecccCceEEEEEEE--cCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCC-C-----CCeeeEEEEEecCC
Q 005841 504 WEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLR-H-----PNVLLFMGAVTSPQ 575 (674)
Q Consensus 504 ~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~-H-----pnIv~l~~~~~~~~ 575 (674)
.-+|++.+.||+|+||+|.+|.+ ++..||||+++.. .........|+.||..|+ | -|||+++++|...+
T Consensus 185 ~~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~---k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~ 261 (586)
T KOG0667|consen 185 AYRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK---KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRN 261 (586)
T ss_pred EEEEEEEEEecccccceeEEEEecCCCcEEEEEeeccC---hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecccccc
Confidence 34899999999999999999998 5677999999764 355566777999999997 4 28999999999999
Q ss_pred eEEEEEecCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcC--CCcEEEEecCCc
Q 005841 576 RLCIVTEFLPRGSLFRLLQRNT-TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDK--HWTVKVGDFGLS 652 (674)
Q Consensus 576 ~~~lV~E~~~ggsL~~~l~~~~-~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~--~~~vkL~DFGla 652 (674)
++|||+|.+ .-+|+++|+.+. ..|+...+..|+.||+.||.+||+.+ |||+||||+||||.. ...|||+|||.|
T Consensus 262 HlciVfELL-~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~--IIHcDLKPENILL~~~~r~~vKVIDFGSS 338 (586)
T KOG0667|consen 262 HLCIVFELL-STNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELG--IIHCDLKPENILLKDPKRSRIKVIDFGSS 338 (586)
T ss_pred ceeeeehhh-hhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeccCChhheeeccCCcCceeEEecccc
Confidence 999999999 669999998653 56999999999999999999999999 999999999999963 447999999999
Q ss_pred ccccCCccccccCCCCccccCC
Q 005841 653 RLKHETYLTTKTGKGTVTYLAS 674 (674)
Q Consensus 653 ~~~~~~~~~~~~~~GTp~YmAP 674 (674)
.+..+... +++-+..|.||
T Consensus 339 c~~~q~vy---tYiQSRfYRAP 357 (586)
T KOG0667|consen 339 CFESQRVY---TYIQSRFYRAP 357 (586)
T ss_pred cccCCcce---eeeeccccccc
Confidence 98776544 46778889998
|
|
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.7e-24 Score=223.50 Aligned_cols=165 Identities=32% Similarity=0.408 Sum_probs=134.5
Q ss_pred CeeEeeeecccCceEEEEEEE--cCCeEEEEEeecccCCHHHHHHHHHHHHHHhhC---CCCCeeeEEEEEec-----CC
Q 005841 506 DLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRL---RHPNVLLFMGAVTS-----PQ 575 (674)
Q Consensus 506 ~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l---~HpnIv~l~~~~~~-----~~ 575 (674)
+|++.+.||+|+||.||+|.+ ++..||+|.+............+.+|+.+++.+ +||||+++++++.. ..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 489999999999999999987 467799999876443322223455677777665 69999999998864 34
Q ss_pred eEEEEEecCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCccc
Q 005841 576 RLCIVTEFLPRGSLFRLLQRNT-TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL 654 (674)
Q Consensus 576 ~~~lV~E~~~ggsL~~~l~~~~-~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~ 654 (674)
.+++||||+++ +|.+++.... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 81 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dikp~Nili~~~~~~kl~dfg~~~~ 157 (288)
T cd07863 81 KVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANC--IVHRDLKPENILVTSGGQVKLADFGLARI 157 (288)
T ss_pred eEEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEECCCCCEEECccCcccc
Confidence 58999999975 8988887543 45899999999999999999999999 99999999999999999999999999987
Q ss_pred ccCCccccccCCCCccccCC
Q 005841 655 KHETYLTTKTGKGTVTYLAS 674 (674)
Q Consensus 655 ~~~~~~~~~~~~GTp~YmAP 674 (674)
...... .....||+.|+||
T Consensus 158 ~~~~~~-~~~~~~~~~y~aP 176 (288)
T cd07863 158 YSCQMA-LTPVVVTLWYRAP 176 (288)
T ss_pred ccCccc-CCCccccccccCc
Confidence 654322 2235689999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.6e-24 Score=225.64 Aligned_cols=173 Identities=30% Similarity=0.543 Sum_probs=144.8
Q ss_pred ccccccCCeeEeeeecccCceEEEEEEEcC---------CeEEEEEeecccCCHHHHHHHHHHHHHHhhC-CCCCeeeEE
Q 005841 499 DYEILWEDLTIGEQIGQGSCGTVYHAVWYG---------SDVAVKVFSRQEYSDEVIHSFRQEVSLMKRL-RHPNVLLFM 568 (674)
Q Consensus 499 ~~~~~~~~y~~~~~LG~G~fG~Vy~~~~~~---------~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~ 568 (674)
.+++..++|.+.+.||+|+||.||++.+.+ ..||+|++.... .......+.+|+.+++.+ +||||++++
T Consensus 12 ~~~~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~e~~~l~~l~~h~~i~~~~ 90 (307)
T cd05098 12 RWEVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDA-TEKDLSDLISEMEMMKMIGKHKNIINLL 90 (307)
T ss_pred cceeehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCC-ChHHHHHHHHHHHHHHHhcCCCCEeeEE
Confidence 456777899999999999999999997632 359999987543 334456788899999999 799999999
Q ss_pred EEEecCCeEEEEEecCCCCCHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCC
Q 005841 569 GAVTSPQRLCIVTEFLPRGSLFRLLQRNT---------------TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKS 633 (674)
Q Consensus 569 ~~~~~~~~~~lV~E~~~ggsL~~~l~~~~---------------~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp 633 (674)
+++...+.+|+||||+++++|.+++.... ..+++..++.++.|++.||+|||+++ |+||||||
T Consensus 91 ~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g--i~H~dlkp 168 (307)
T cd05098 91 GACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK--CIHRDLAA 168 (307)
T ss_pred EEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC--cccccccH
Confidence 99999999999999999999999997532 24889999999999999999999998 99999999
Q ss_pred CCEEEcCCCcEEEEecCCcccccCCccc--cccCCCCccccCC
Q 005841 634 SNLLVDKHWTVKVGDFGLSRLKHETYLT--TKTGKGTVTYLAS 674 (674)
Q Consensus 634 ~NILi~~~~~vkL~DFGla~~~~~~~~~--~~~~~GTp~YmAP 674 (674)
+|||++.++.+||+|||+++........ .....+++.||||
T Consensus 169 ~Nill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aP 211 (307)
T cd05098 169 RNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAP 211 (307)
T ss_pred HheEEcCCCcEEECCCcccccccccchhhccccCCCccceeCh
Confidence 9999999999999999999765432211 2223456789998
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=99.92 E-value=8.1e-24 Score=217.87 Aligned_cols=168 Identities=27% Similarity=0.447 Sum_probs=146.2
Q ss_pred CCeeEeeeecccCceEEEEEEE--cCCeEEEEEeecccC-CHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeEEEEE
Q 005841 505 EDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEY-SDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVT 581 (674)
Q Consensus 505 ~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 581 (674)
++|++.+.||+|+||.||+|.. ++..||+|.+..... .......+.+|+.+++.++|+||+++++.+...+..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 5799999999999999999998 477899999875433 3344677899999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccccCC
Q 005841 582 EFLPRGSLFRLLQR---NTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHET 658 (674)
Q Consensus 582 E~~~ggsL~~~l~~---~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~~ 658 (674)
||+++++|..++.. ....+++..+..++.|++.||.|||+.+ |+|+||||+|||++.++.++|+|||++......
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~ 159 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR--IMHRDIKPANVFITATGVVKLGDLGLGRFFSSK 159 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCC--EecCCcChhhEEECCCCcEEEeccceeeeccCC
Confidence 99999999999864 2345899999999999999999999999 999999999999999999999999999876543
Q ss_pred ccccccCCCCccccCC
Q 005841 659 YLTTKTGKGTVTYLAS 674 (674)
Q Consensus 659 ~~~~~~~~GTp~YmAP 674 (674)
........|++.|+||
T Consensus 160 ~~~~~~~~~~~~y~ap 175 (267)
T cd08224 160 TTAAHSLVGTPYYMSP 175 (267)
T ss_pred CcccceecCCccccCH
Confidence 3333345689999998
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.8e-24 Score=223.16 Aligned_cols=166 Identities=28% Similarity=0.416 Sum_probs=141.5
Q ss_pred CCeeEeeeecccCceEEEEEEE--cCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeEEEEEe
Q 005841 505 EDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTE 582 (674)
Q Consensus 505 ~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E 582 (674)
++|++.+.||+|+||.||+|.. .+..||||.+....... ....+.+|+.+++.++|+||+++++++...+..|+|||
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEG-APFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFE 83 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccC-CchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEe
Confidence 6799999999999999999987 46789999987543221 22345679999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccccCCcccc
Q 005841 583 FLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTT 662 (674)
Q Consensus 583 ~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~~~~~~ 662 (674)
|+++ +|.+++......+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.........
T Consensus 84 ~~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~--i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~ 160 (291)
T cd07844 84 YLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRR--VLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTY 160 (291)
T ss_pred cCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eecccCCHHHEEEcCCCCEEECccccccccCCCCccc
Confidence 9975 999999876667899999999999999999999998 9999999999999999999999999997654322222
Q ss_pred ccCCCCccccCC
Q 005841 663 KTGKGTVTYLAS 674 (674)
Q Consensus 663 ~~~~GTp~YmAP 674 (674)
....+++.|+||
T Consensus 161 ~~~~~~~~~~aP 172 (291)
T cd07844 161 SNEVVTLWYRPP 172 (291)
T ss_pred cccccccccCCc
Confidence 234578889988
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=99.91 E-value=8.1e-24 Score=220.57 Aligned_cols=160 Identities=33% Similarity=0.471 Sum_probs=139.7
Q ss_pred CCeeEeeeecccCceEEEEEEE--cCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeEEEEEe
Q 005841 505 EDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTE 582 (674)
Q Consensus 505 ~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E 582 (674)
++|++.++||+|+||.||+|.+ ++..||+|++.... .......+.+|+.+++.++||||+++++++...+..++|||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 79 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDI-TVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTE 79 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCC-ChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEe
Confidence 4688899999999999999987 56779999987543 34455678899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccccCCcccc
Q 005841 583 FLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTT 662 (674)
Q Consensus 583 ~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~~~~~~ 662 (674)
|+++++|..+. .+++..+..++.|++.||.|||+.+ |+|+||||+|||++.++.++|+|||++....... .
T Consensus 80 ~~~~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~--~ 150 (279)
T cd06619 80 FMDGGSLDVYR-----KIPEHVLGRIAVAVVKGLTYLWSLK--ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI--A 150 (279)
T ss_pred cCCCCChHHhh-----cCCHHHHHHHHHHHHHHHHHHHHCC--EeeCCCCHHHEEECCCCCEEEeeCCcceeccccc--c
Confidence 99999996543 4788999999999999999999999 9999999999999999999999999998665432 2
Q ss_pred ccCCCCccccCC
Q 005841 663 KTGKGTVTYLAS 674 (674)
Q Consensus 663 ~~~~GTp~YmAP 674 (674)
....||+.|+||
T Consensus 151 ~~~~~~~~y~aP 162 (279)
T cd06619 151 KTYVGTNAYMAP 162 (279)
T ss_pred cCCCCChhhcCc
Confidence 235799999998
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.1e-24 Score=223.38 Aligned_cols=169 Identities=33% Similarity=0.534 Sum_probs=143.8
Q ss_pred ccCCeeEeeeecccCceEEEEEEEcC------------------CeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCe
Q 005841 503 LWEDLTIGEQIGQGSCGTVYHAVWYG------------------SDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNV 564 (674)
Q Consensus 503 ~~~~y~~~~~LG~G~fG~Vy~~~~~~------------------~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnI 564 (674)
...+|++.+.||+|+||.||++.+.. ..||+|++.... .......+.+|+.+++.++||||
T Consensus 3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i 81 (296)
T cd05051 3 PRQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDA-SDNAREDFLKEVKILSRLSDPNI 81 (296)
T ss_pred chhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCcc-CHHHHHHHHHHHHHHHhcCCCCE
Confidence 34689999999999999999987632 348999887543 33556788999999999999999
Q ss_pred eeEEEEEecCCeEEEEEecCCCCCHHHHHHhcC----------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCC
Q 005841 565 LLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNT----------TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSS 634 (674)
Q Consensus 565 v~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~----------~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~ 634 (674)
+++++++...+.+++||||+++++|.+++.... ..+++..++.++.|++.||.|||+++ |+|+||||+
T Consensus 82 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~--i~H~dlkp~ 159 (296)
T cd05051 82 ARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN--FVHRDLATR 159 (296)
T ss_pred eEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC--ccccccchh
Confidence 999999999999999999999999999997643 26899999999999999999999998 999999999
Q ss_pred CEEEcCCCcEEEEecCCcccccCCcc--ccccCCCCccccCC
Q 005841 635 NLLVDKHWTVKVGDFGLSRLKHETYL--TTKTGKGTVTYLAS 674 (674)
Q Consensus 635 NILi~~~~~vkL~DFGla~~~~~~~~--~~~~~~GTp~YmAP 674 (674)
|||++.++.++|+|||+++....... ......+|+.||||
T Consensus 160 Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aP 201 (296)
T cd05051 160 NCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAW 201 (296)
T ss_pred ceeecCCCceEEccccceeecccCcceeecCcCCCCceecCH
Confidence 99999999999999999986543221 22234578899998
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.7e-24 Score=217.66 Aligned_cols=161 Identities=30% Similarity=0.501 Sum_probs=136.9
Q ss_pred eeecccCceEEEEEEE--cCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeEEEEEecCCCCC
Q 005841 511 EQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGS 588 (674)
Q Consensus 511 ~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggs 588 (674)
+.||+|+||.||+|.+ .+..||+|.+... ...+....+.+|+.+++.+.||||+++++++.....+|+||||+++++
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 79 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRET-LPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGD 79 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCcc-CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCc
Confidence 4699999999999987 5778999988643 344556778999999999999999999999999999999999999999
Q ss_pred HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccccCCccccc--cCC
Q 005841 589 LFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTK--TGK 666 (674)
Q Consensus 589 L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~~~~~~~--~~~ 666 (674)
|.+++......+++..++.++.|++.||.|||+.+ |+|+||||+|||++.++.+||+|||++........... ...
T Consensus 80 L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 157 (252)
T cd05084 80 FLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKH--CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQ 157 (252)
T ss_pred HHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccccchheEEEcCCCcEEECccccCcccccccccccCCCCC
Confidence 99999766667899999999999999999999998 99999999999999999999999999986543221111 112
Q ss_pred CCccccCC
Q 005841 667 GTVTYLAS 674 (674)
Q Consensus 667 GTp~YmAP 674 (674)
++..|+||
T Consensus 158 ~~~~y~aP 165 (252)
T cd05084 158 IPVKWTAP 165 (252)
T ss_pred CceeecCc
Confidence 34679988
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=7.5e-24 Score=220.58 Aligned_cols=166 Identities=27% Similarity=0.388 Sum_probs=146.8
Q ss_pred CeeEeeeecccCceEEEEEEE--cCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeEEEEEec
Q 005841 506 DLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEF 583 (674)
Q Consensus 506 ~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~ 583 (674)
+|++.+.||+|+||.||+|.+ .+..|++|++............+.+|+.+++.++||||+++++++.....+|+||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 589999999999999999997 467899999987655455567788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccccCCcc-cc
Q 005841 584 LPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYL-TT 662 (674)
Q Consensus 584 ~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~~~~-~~ 662 (674)
+ +++|.+++......+++..+..++.||+.+|.|||+.+ |+|+||||+||+++.++.++|+|||++........ ..
T Consensus 81 ~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~ 157 (286)
T cd07832 81 M-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANG--IMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLY 157 (286)
T ss_pred c-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCCcc
Confidence 9 99999999876677999999999999999999999999 99999999999999999999999999987654321 12
Q ss_pred ccCCCCccccCC
Q 005841 663 KTGKGTVTYLAS 674 (674)
Q Consensus 663 ~~~~GTp~YmAP 674 (674)
....||+.|+||
T Consensus 158 ~~~~~~~~y~aP 169 (286)
T cd07832 158 SHQVATRWYRAP 169 (286)
T ss_pred ccccCcccccCc
Confidence 234689999998
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.3e-25 Score=222.35 Aligned_cols=160 Identities=27% Similarity=0.386 Sum_probs=136.7
Q ss_pred eeeecccCceEEEEEEE--cCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCC-CCCeeeEEEEEecCCeEEEEEecCCC
Q 005841 510 GEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLR-HPNVLLFMGAVTSPQRLCIVTEFLPR 586 (674)
Q Consensus 510 ~~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~lV~E~~~g 586 (674)
.+.||+|+|+.|-.|.. ++..||||++.++. .....++.+|+.++.+++ |+||++++++|+++.++|||||.|.|
T Consensus 83 ~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~--gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~G 160 (463)
T KOG0607|consen 83 SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQP--GHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRG 160 (463)
T ss_pred HHHhcCccceeeeeeeeeccchhhhhhhhhcCC--chHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccC
Confidence 35799999999999986 78889999998873 334567889999999996 99999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCC---cEEEEecCCcccccCCcc---
Q 005841 587 GSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHW---TVKVGDFGLSRLKHETYL--- 660 (674)
Q Consensus 587 gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~---~vkL~DFGla~~~~~~~~--- 660 (674)
|.|..+|++. .-|++.++..+..+|+.||.|||.+| |.||||||+|||..+.. -||||||.++.-.+....
T Consensus 161 GplLshI~~~-~~F~E~EAs~vvkdia~aLdFlH~kg--IAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~sp 237 (463)
T KOG0607|consen 161 GPLLSHIQKR-KHFNEREASRVVKDIASALDFLHTKG--IAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSP 237 (463)
T ss_pred chHHHHHHHh-hhccHHHHHHHHHHHHHHHHHHhhcC--cccccCCccceeecCCCCcCceeeeccccccccccCCCCCC
Confidence 9999999864 46999999999999999999999999 99999999999997544 489999999864321111
Q ss_pred ----ccccCCCCccccCC
Q 005841 661 ----TTKTGKGTVTYLAS 674 (674)
Q Consensus 661 ----~~~~~~GTp~YmAP 674 (674)
...+.+|+..||||
T Consensus 238 astP~L~tPvGSAEfMAP 255 (463)
T KOG0607|consen 238 ASTPELLTPVGSAEFMAP 255 (463)
T ss_pred CCCccccCcccchhhcch
Confidence 12235899999999
|
|
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=99.91 E-value=6.7e-24 Score=220.94 Aligned_cols=167 Identities=26% Similarity=0.351 Sum_probs=143.2
Q ss_pred CCeeEeeeecccCceEEEEEEE--cCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeEEEEEe
Q 005841 505 EDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTE 582 (674)
Q Consensus 505 ~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E 582 (674)
++|++...||+|+||.||++.+ .+..||+|++..........+.+.+|+.+++.++||||+++++++.....+|+|||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 4699999999999999999998 46789999987554333334567889999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccccCCcccc
Q 005841 583 FLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTT 662 (674)
Q Consensus 583 ~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~~~~~~ 662 (674)
|++++.|..++.. ...+++..++.++.||+.+|.|||+.+ |+|+||||+|||++.++.+||+|||++..........
T Consensus 81 ~~~~~~l~~~~~~-~~~~~~~~~~~~~~ql~~~l~~LH~~~--i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~ 157 (286)
T cd07847 81 YCDHTVLNELEKN-PRGVPEHLIKKIIWQTLQAVNFCHKHN--CIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDY 157 (286)
T ss_pred ccCccHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCChhhEEEcCCCcEEECccccceecCCCcccc
Confidence 9999888777653 446999999999999999999999998 9999999999999999999999999998775543233
Q ss_pred ccCCCCccccCC
Q 005841 663 KTGKGTVTYLAS 674 (674)
Q Consensus 663 ~~~~GTp~YmAP 674 (674)
....++..|+||
T Consensus 158 ~~~~~~~~~~aP 169 (286)
T cd07847 158 TDYVATRWYRAP 169 (286)
T ss_pred cCcccccccCCH
Confidence 345688889987
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=8.4e-24 Score=220.49 Aligned_cols=164 Identities=27% Similarity=0.417 Sum_probs=143.8
Q ss_pred eeEeeeecccCceEEEEEEEc--CCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeEEEEEecC
Q 005841 507 LTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFL 584 (674)
Q Consensus 507 y~~~~~LG~G~fG~Vy~~~~~--~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 584 (674)
|++.+.||+|+||.||++.+. +..+++|.+... .......+.+|+.+++.++||||+++++++......|+||||+
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~ 84 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTK--SEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 84 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCC--CHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEec
Confidence 678899999999999999984 556888888543 2345667889999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccccCCcccccc
Q 005841 585 PRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKT 664 (674)
Q Consensus 585 ~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~~~~~~~~ 664 (674)
++++|..++.+....+++..+..++.|++.||.|||+.+ |+|+||||+|||++.++.+||+|||++............
T Consensus 85 ~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~--i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~ 162 (282)
T cd06643 85 AGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENK--IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDS 162 (282)
T ss_pred CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCcccEEEccCCCEEEcccccccccccccccccc
Confidence 999999988765667999999999999999999999998 999999999999999999999999999876544333444
Q ss_pred CCCCccccCC
Q 005841 665 GKGTVTYLAS 674 (674)
Q Consensus 665 ~~GTp~YmAP 674 (674)
..||+.||||
T Consensus 163 ~~~~~~y~aP 172 (282)
T cd06643 163 FIGTPYWMAP 172 (282)
T ss_pred ccccccccCH
Confidence 6799999998
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=7.1e-24 Score=219.92 Aligned_cols=172 Identities=33% Similarity=0.490 Sum_probs=144.5
Q ss_pred cccccCCeeEeeeecccCceEEEEEEEcC-------CeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEe
Q 005841 500 YEILWEDLTIGEQIGQGSCGTVYHAVWYG-------SDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVT 572 (674)
Q Consensus 500 ~~~~~~~y~~~~~LG~G~fG~Vy~~~~~~-------~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~ 572 (674)
|++..++|.+.+.||+|+||.||++.+.+ ..||+|.+.... .......+.+|+.+++.+.||||+++++++.
T Consensus 1 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~ 79 (277)
T cd05032 1 WELPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENA-SMRERIEFLNEASVMKEFNCHHVVRLLGVVS 79 (277)
T ss_pred CccchHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCcc-CHHHHHHHHHHHHHHHhCCCCceeEEEEEEc
Confidence 35667899999999999999999998642 469999986443 3334467888999999999999999999999
Q ss_pred cCCeEEEEEecCCCCCHHHHHHhcC---------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCc
Q 005841 573 SPQRLCIVTEFLPRGSLFRLLQRNT---------TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWT 643 (674)
Q Consensus 573 ~~~~~~lV~E~~~ggsL~~~l~~~~---------~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~ 643 (674)
.....|+||||+++++|.+++.... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.
T Consensus 80 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~di~p~nill~~~~~ 157 (277)
T cd05032 80 TGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK--FVHRDLAARNCMVAEDLT 157 (277)
T ss_pred CCCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccccChheEEEcCCCC
Confidence 9999999999999999999986422 24688899999999999999999998 999999999999999999
Q ss_pred EEEEecCCcccccCCcc--ccccCCCCccccCC
Q 005841 644 VKVGDFGLSRLKHETYL--TTKTGKGTVTYLAS 674 (674)
Q Consensus 644 vkL~DFGla~~~~~~~~--~~~~~~GTp~YmAP 674 (674)
+||+|||+++....... ......+|+.|+||
T Consensus 158 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aP 190 (277)
T cd05032 158 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 190 (277)
T ss_pred EEECCcccchhhccCcccccCCCCCccccccCH
Confidence 99999999986543321 22234578899998
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=8.1e-24 Score=221.63 Aligned_cols=166 Identities=31% Similarity=0.432 Sum_probs=141.0
Q ss_pred CCeeEeeeecccCceEEEEEEE--cCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeEEEEEe
Q 005841 505 EDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTE 582 (674)
Q Consensus 505 ~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E 582 (674)
.+|.+.+.||+|+||.||+|.. .+..|++|++...... .....+.+|+.+++.++|+||+++++++...+..|+|||
T Consensus 5 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e 83 (291)
T cd07870 5 TSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEE-GVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFE 83 (291)
T ss_pred ceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcC-CCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEe
Confidence 5799999999999999999986 4778999998654322 222356789999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccccCCcccc
Q 005841 583 FLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTT 662 (674)
Q Consensus 583 ~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~~~~~~ 662 (674)
|+. ++|.+++......+.+..+..++.||+.||.|||+.+ |+|+||||+|||++.++.+||+|||+++.........
T Consensus 84 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~ 160 (291)
T cd07870 84 YMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQH--ILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTY 160 (291)
T ss_pred ccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCChHHEEEcCCCcEEEeccccccccCCCCCCC
Confidence 995 6887777665567889999999999999999999998 9999999999999999999999999998654433333
Q ss_pred ccCCCCccccCC
Q 005841 663 KTGKGTVTYLAS 674 (674)
Q Consensus 663 ~~~~GTp~YmAP 674 (674)
....+++.|+||
T Consensus 161 ~~~~~~~~y~aP 172 (291)
T cd07870 161 SSEVVTLWYRPP 172 (291)
T ss_pred CCccccccccCC
Confidence 344689999998
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.8e-24 Score=224.12 Aligned_cols=170 Identities=30% Similarity=0.529 Sum_probs=141.5
Q ss_pred cccCCeeEeeeecccCceEEEEEEEcC----------------CeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCee
Q 005841 502 ILWEDLTIGEQIGQGSCGTVYHAVWYG----------------SDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVL 565 (674)
Q Consensus 502 ~~~~~y~~~~~LG~G~fG~Vy~~~~~~----------------~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv 565 (674)
+...+|++.+.||+|+||.||+|.+.+ ..||+|++... ........+.+|+.+++.++|+||+
T Consensus 2 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~ei~~l~~l~h~~i~ 80 (295)
T cd05097 2 FPRQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRAD-VTKTARNDFLKEIKIMSRLKNPNII 80 (295)
T ss_pred CchHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCC-CCHHHHHHHHHHHHHHHhCCCCCcC
Confidence 345689999999999999999987532 13899998754 3445566789999999999999999
Q ss_pred eEEEEEecCCeEEEEEecCCCCCHHHHHHhcC-----------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCC
Q 005841 566 LFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNT-----------TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSS 634 (674)
Q Consensus 566 ~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~-----------~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~ 634 (674)
++++++......|+||||+++++|.+++.... ..+++..++.++.|++.||.|||+.+ |+|+||||+
T Consensus 81 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~--i~H~dlkp~ 158 (295)
T cd05097 81 RLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN--FVHRDLATR 158 (295)
T ss_pred eEEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC--eeccccChh
Confidence 99999999999999999999999999986432 23688999999999999999999999 999999999
Q ss_pred CEEEcCCCcEEEEecCCcccccCCccc--cccCCCCccccCC
Q 005841 635 NLLVDKHWTVKVGDFGLSRLKHETYLT--TKTGKGTVTYLAS 674 (674)
Q Consensus 635 NILi~~~~~vkL~DFGla~~~~~~~~~--~~~~~GTp~YmAP 674 (674)
|||++.++.+||+|||++......... .....+++.|+||
T Consensus 159 Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aP 200 (295)
T cd05097 159 NCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAW 200 (295)
T ss_pred hEEEcCCCcEEecccccccccccCcceeccCcCcCceeecCh
Confidence 999999999999999999765432211 1123457789998
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.2e-23 Score=216.29 Aligned_cols=167 Identities=30% Similarity=0.471 Sum_probs=143.9
Q ss_pred CCeeEeeeecccCceEEEEEEE--cCCeEEEEEeecccCCH---HHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeEEE
Q 005841 505 EDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSD---EVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCI 579 (674)
Q Consensus 505 ~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~~~---~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 579 (674)
++|.+.+.||+|+||.||.|.. .+..|++|++....... .....+.+|+.+++.++||||+++++++...+.+|+
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 5689999999999999999986 57789999987554322 345678899999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccccCCc
Q 005841 580 VTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETY 659 (674)
Q Consensus 580 V~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~~~ 659 (674)
||||+++++|.+++... ..+++..+..++.|++.||.|||+++ |+|+||||+|||++.++.++|+|||+++......
T Consensus 82 v~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~--i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~ 158 (263)
T cd06625 82 FMEYMPGGSVKDQLKAY-GALTETVTRKYTRQILEGVEYLHSNM--IVHRDIKGANILRDSAGNVKLGDFGASKRLQTIC 158 (263)
T ss_pred EEEECCCCcHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEEeecccceeccccc
Confidence 99999999999998754 46889999999999999999999999 9999999999999999999999999998654322
Q ss_pred ccc---ccCCCCccccCC
Q 005841 660 LTT---KTGKGTVTYLAS 674 (674)
Q Consensus 660 ~~~---~~~~GTp~YmAP 674 (674)
... ....|++.|+||
T Consensus 159 ~~~~~~~~~~~~~~y~aP 176 (263)
T cd06625 159 SSGTGMKSVTGTPYWMSP 176 (263)
T ss_pred cccccccCCCcCccccCc
Confidence 221 234688999998
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=99.91 E-value=6.5e-24 Score=222.95 Aligned_cols=166 Identities=28% Similarity=0.401 Sum_probs=143.7
Q ss_pred CeeEeeeecccCceEEEEEEE--cCCeEEEEEeecccCC---HHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeEEEE
Q 005841 506 DLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYS---DEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIV 580 (674)
Q Consensus 506 ~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 580 (674)
+|.+.+.||+|+||.||+|.+ .+..|+||.+...... ......+..|+.+++.++|+||+++++++.....+|+|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 488899999999999999987 4678999999765543 33445677899999999999999999999999999999
Q ss_pred EecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccccCCcc
Q 005841 581 TEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYL 660 (674)
Q Consensus 581 ~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~~~~ 660 (674)
|||+ +++|.+++......+++..+..++.||+.||.|||+++ |+|+||||+|||++.++.++|+|||+++.......
T Consensus 81 ~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~ 157 (298)
T cd07841 81 FEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNW--ILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNR 157 (298)
T ss_pred Eccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecCCChhhEEEcCCCCEEEccceeeeeccCCCc
Confidence 9999 88999999765447999999999999999999999999 99999999999999999999999999987654433
Q ss_pred ccccCCCCccccCC
Q 005841 661 TTKTGKGTVTYLAS 674 (674)
Q Consensus 661 ~~~~~~GTp~YmAP 674 (674)
......+++.|+||
T Consensus 158 ~~~~~~~~~~y~aP 171 (298)
T cd07841 158 KMTHQVVTRWYRAP 171 (298)
T ss_pred cccccccceeeeCH
Confidence 33334578889987
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.2e-23 Score=219.43 Aligned_cols=166 Identities=33% Similarity=0.588 Sum_probs=139.1
Q ss_pred CCeeEeeeecccCceEEEEEEE------cCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEec--CCe
Q 005841 505 EDLTIGEQIGQGSCGTVYHAVW------YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTS--PQR 576 (674)
Q Consensus 505 ~~y~~~~~LG~G~fG~Vy~~~~------~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~--~~~ 576 (674)
.+|++.+.||+|+||.||++.. .+..||+|.+... .......+.+|+.+++.++||||+++++++.. ...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 81 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHS--TAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRN 81 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCc
Confidence 5789999999999999999974 3567999998643 33445778899999999999999999998754 346
Q ss_pred EEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCccccc
Q 005841 577 LCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKH 656 (674)
Q Consensus 577 ~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~ 656 (674)
+|+||||+++++|.+++......+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 82 ~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~--i~H~dlkp~nili~~~~~~~l~dfg~~~~~~ 159 (284)
T cd05081 82 LRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKR--YVHRDLATRNILVESENRVKIGDFGLTKVLP 159 (284)
T ss_pred eEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCHhhEEECCCCeEEECCCccccccc
Confidence 89999999999999999876667999999999999999999999999 9999999999999999999999999998764
Q ss_pred CCcc---ccccCCCCccccCC
Q 005841 657 ETYL---TTKTGKGTVTYLAS 674 (674)
Q Consensus 657 ~~~~---~~~~~~GTp~YmAP 674 (674)
.... ......++..|+||
T Consensus 160 ~~~~~~~~~~~~~~~~~y~aP 180 (284)
T cd05081 160 QDKEYYKVREPGESPIFWYAP 180 (284)
T ss_pred CCCcceeecCCCCCceEeeCH
Confidence 3211 11222345568887
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=7.9e-24 Score=218.38 Aligned_cols=170 Identities=34% Similarity=0.587 Sum_probs=144.5
Q ss_pred cccccCCeeEeeeecccCceEEEEEEE--cCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeE
Q 005841 500 YEILWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRL 577 (674)
Q Consensus 500 ~~~~~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 577 (674)
|++...+|.+.+.||+|+||.||+|.+ .+..||+|++.... .....+.+|+.+++.++|+||+++++++...+.+
T Consensus 1 ~~~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 77 (263)
T cd05052 1 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT---MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPF 77 (263)
T ss_pred CCCchHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc---hHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCc
Confidence 355667899999999999999999987 46779999986432 2345688899999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCccccc
Q 005841 578 CIVTEFLPRGSLFRLLQRN-TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKH 656 (674)
Q Consensus 578 ~lV~E~~~ggsL~~~l~~~-~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~ 656 (674)
++||||+++++|.+++... ...+++..++.++.|++.||.|||+.+ |+||||||+|||+++++.+||+|||++....
T Consensus 78 ~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~--i~H~dlkp~nil~~~~~~~kl~df~~~~~~~ 155 (263)
T cd05052 78 YIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN--FIHRDLAARNCLVGENHLVKVADFGLSRLMT 155 (263)
T ss_pred EEEEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--EeecccCcceEEEcCCCcEEeCCCccccccc
Confidence 9999999999999999754 345899999999999999999999988 9999999999999999999999999998765
Q ss_pred CCccccc-cCCCCccccCC
Q 005841 657 ETYLTTK-TGKGTVTYLAS 674 (674)
Q Consensus 657 ~~~~~~~-~~~GTp~YmAP 674 (674)
....... ...+++.|+||
T Consensus 156 ~~~~~~~~~~~~~~~y~aP 174 (263)
T cd05052 156 GDTYTAHAGAKFPIKWTAP 174 (263)
T ss_pred cceeeccCCCCCccccCCH
Confidence 4332221 12346789998
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.9e-24 Score=220.88 Aligned_cols=169 Identities=31% Similarity=0.523 Sum_probs=145.6
Q ss_pred cccCCeeEeeeecccCceEEEEEEEc-CCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeEEEE
Q 005841 502 ILWEDLTIGEQIGQGSCGTVYHAVWY-GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIV 580 (674)
Q Consensus 502 ~~~~~y~~~~~LG~G~fG~Vy~~~~~-~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 580 (674)
....+|.+.++||.|+||.||+|.+. +..+++|++..... .....+..|+.+++.++|+||+++++++.....+|+|
T Consensus 3 ~~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (261)
T cd05148 3 RPREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDL--LKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYII 80 (261)
T ss_pred CcHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccch--hhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEE
Confidence 34467999999999999999999974 56799999865432 2345688899999999999999999999999999999
Q ss_pred EecCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccccCCc
Q 005841 581 TEFLPRGSLFRLLQRN-TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETY 659 (674)
Q Consensus 581 ~E~~~ggsL~~~l~~~-~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~~~ 659 (674)
|||+++++|.+++... ...+++..+..++.||+.||.|||+.+ |+|+||||+||||+.++.+||+|||++.......
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~--i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~ 158 (261)
T cd05148 81 TELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQN--SIHRDLAARNILVGEDLVCKVADFGLARLIKEDV 158 (261)
T ss_pred EeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccccCcceEEEcCCceEEEccccchhhcCCcc
Confidence 9999999999999763 346899999999999999999999998 9999999999999999999999999998776544
Q ss_pred cccccCCCCccccCC
Q 005841 660 LTTKTGKGTVTYLAS 674 (674)
Q Consensus 660 ~~~~~~~GTp~YmAP 674 (674)
.......+++.|+||
T Consensus 159 ~~~~~~~~~~~~~~P 173 (261)
T cd05148 159 YLSSDKKIPYKWTAP 173 (261)
T ss_pred ccccCCCCceEecCH
Confidence 444344577889987
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.91 E-value=7.7e-24 Score=223.49 Aligned_cols=173 Identities=28% Similarity=0.522 Sum_probs=145.3
Q ss_pred ccccccCCeeEeeeecccCceEEEEEEEc---------CCeEEEEEeecccCCHHHHHHHHHHHHHHhhC-CCCCeeeEE
Q 005841 499 DYEILWEDLTIGEQIGQGSCGTVYHAVWY---------GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRL-RHPNVLLFM 568 (674)
Q Consensus 499 ~~~~~~~~y~~~~~LG~G~fG~Vy~~~~~---------~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~ 568 (674)
.+++..++|.+.+.||+|+||.||++.+. +..||+|++.... .......+.+|+.+++.+ .||||++++
T Consensus 9 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~i~~~~ 87 (304)
T cd05101 9 RWEFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINLL 87 (304)
T ss_pred cccccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeeccccc-chHHHHHHHHHHHHHHhhccCCCchhee
Confidence 35677889999999999999999999752 2258999886432 334457788999999999 799999999
Q ss_pred EEEecCCeEEEEEecCCCCCHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCC
Q 005841 569 GAVTSPQRLCIVTEFLPRGSLFRLLQRNT---------------TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKS 633 (674)
Q Consensus 569 ~~~~~~~~~~lV~E~~~ggsL~~~l~~~~---------------~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp 633 (674)
+++......|+||||+++++|.+++.... ..+++..+..++.||+.||.|||+++ |+||||||
T Consensus 88 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g--ivH~dlkp 165 (304)
T cd05101 88 GACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK--CIHRDLAA 165 (304)
T ss_pred EEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC--eeeccccc
Confidence 99999999999999999999999997532 34788899999999999999999998 99999999
Q ss_pred CCEEEcCCCcEEEEecCCcccccCCcc--ccccCCCCccccCC
Q 005841 634 SNLLVDKHWTVKVGDFGLSRLKHETYL--TTKTGKGTVTYLAS 674 (674)
Q Consensus 634 ~NILi~~~~~vkL~DFGla~~~~~~~~--~~~~~~GTp~YmAP 674 (674)
+|||++.++.+||+|||+++....... ......+++.||||
T Consensus 166 ~Nili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aP 208 (304)
T cd05101 166 RNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAP 208 (304)
T ss_pred ceEEEcCCCcEEECCCccceecccccccccccCCCCCceeeCc
Confidence 999999999999999999987643221 22234567889998
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.91 E-value=9.3e-24 Score=221.24 Aligned_cols=173 Identities=31% Similarity=0.543 Sum_probs=145.8
Q ss_pred ccccccCCeeEeeeecccCceEEEEEEEcC-------CeEEEEEeecccCCHHHHHHHHHHHHHHhhC-CCCCeeeEEEE
Q 005841 499 DYEILWEDLTIGEQIGQGSCGTVYHAVWYG-------SDVAVKVFSRQEYSDEVIHSFRQEVSLMKRL-RHPNVLLFMGA 570 (674)
Q Consensus 499 ~~~~~~~~y~~~~~LG~G~fG~Vy~~~~~~-------~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~ 570 (674)
.+++...+|++.+.||+|+||.||++.+.+ ..||+|.+.... .......+.+|+.+++.+ +|+||++++++
T Consensus 6 ~~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~ 84 (293)
T cd05053 6 EWELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINLLGV 84 (293)
T ss_pred ccccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCC-CHHHHHHHHHHHHHHHhhcCCCCeeeEEEE
Confidence 356677889999999999999999998642 358999887543 334456788999999999 79999999999
Q ss_pred EecCCeEEEEEecCCCCCHHHHHHhc---------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCC
Q 005841 571 VTSPQRLCIVTEFLPRGSLFRLLQRN---------------TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSN 635 (674)
Q Consensus 571 ~~~~~~~~lV~E~~~ggsL~~~l~~~---------------~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~N 635 (674)
+...+.+|+||||+++++|..++... ...+++..++.++.|++.||.|||+.+ |+||||||+|
T Consensus 85 ~~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~--ivH~dlkp~N 162 (293)
T cd05053 85 CTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK--CIHRDLAARN 162 (293)
T ss_pred EcCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC--ccccccceee
Confidence 99999999999999999999999642 346899999999999999999999998 9999999999
Q ss_pred EEEcCCCcEEEEecCCcccccCCccc--cccCCCCccccCC
Q 005841 636 LLVDKHWTVKVGDFGLSRLKHETYLT--TKTGKGTVTYLAS 674 (674)
Q Consensus 636 ILi~~~~~vkL~DFGla~~~~~~~~~--~~~~~GTp~YmAP 674 (674)
||++.++.+||+|||+++........ .....+++.|+||
T Consensus 163 il~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aP 203 (293)
T cd05053 163 VLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAP 203 (293)
T ss_pred EEEcCCCeEEeCccccccccccccceeccCCCCCCccccCH
Confidence 99999999999999999876543221 2223456789998
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=1e-23 Score=216.30 Aligned_cols=165 Identities=35% Similarity=0.576 Sum_probs=144.0
Q ss_pred cccCCeeEeeeecccCceEEEEEEEcCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeEEEEE
Q 005841 502 ILWEDLTIGEQIGQGSCGTVYHAVWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVT 581 (674)
Q Consensus 502 ~~~~~y~~~~~LG~G~fG~Vy~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 581 (674)
+..++|++.+.||.|+||.||+|...+..||+|.+..... ....+.+|+.+++.++|+||+++++++......|+||
T Consensus 3 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~ 79 (256)
T cd05039 3 INSKELKLGATIGKGEFGDVMLGDYRGQKVAVKCLKDDST---AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVT 79 (256)
T ss_pred cChhhccceeeeecCCCceEEEEEecCcEEEEEEeccchh---HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEE
Confidence 4567899999999999999999999999999999965432 4567889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccccCCcc
Q 005841 582 EFLPRGSLFRLLQRNT-TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYL 660 (674)
Q Consensus 582 E~~~ggsL~~~l~~~~-~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~~~~ 660 (674)
||+++++|.+++.... ..+++..+..++.|++.||.|||+.+ |+|+||||+|||++.++.+||+|||+++.......
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~--i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~ 157 (256)
T cd05039 80 EYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKN--FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD 157 (256)
T ss_pred EecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccchhcccceEEEeCCCCEEEcccccccccccccc
Confidence 9999999999997543 26899999999999999999999999 99999999999999999999999999987643221
Q ss_pred ccccCCCCccccCC
Q 005841 661 TTKTGKGTVTYLAS 674 (674)
Q Consensus 661 ~~~~~~GTp~YmAP 674 (674)
...++..|+||
T Consensus 158 ---~~~~~~~~~ap 168 (256)
T cd05039 158 ---SGKLPVKWTAP 168 (256)
T ss_pred ---cCCCcccccCc
Confidence 23345668887
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.2e-23 Score=219.08 Aligned_cols=168 Identities=29% Similarity=0.508 Sum_probs=141.0
Q ss_pred ccCCeeEeeeecccCceEEEEEEE--cCC----eEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCe
Q 005841 503 LWEDLTIGEQIGQGSCGTVYHAVW--YGS----DVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQR 576 (674)
Q Consensus 503 ~~~~y~~~~~LG~G~fG~Vy~~~~--~~~----~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 576 (674)
...+|++.++||+|+||+||+|.+ ++. .||+|++.... .......+.+|+.++..+.||||+.+++++.. ..
T Consensus 5 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~ 82 (279)
T cd05109 5 KETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENT-SPKANKEILDEAYVMAGVGSPYVCRLLGICLT-ST 82 (279)
T ss_pred chhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCC-CHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CC
Confidence 456899999999999999999986 333 38999886543 34455678899999999999999999998875 45
Q ss_pred EEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCccccc
Q 005841 577 LCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKH 656 (674)
Q Consensus 577 ~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~ 656 (674)
.+++|||+++|+|.+++......+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 83 ~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~ 160 (279)
T cd05109 83 VQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVR--LVHRDLAARNVLVKSPNHVKITDFGLARLLD 160 (279)
T ss_pred cEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccccccceEEEcCCCcEEECCCCceeecc
Confidence 78999999999999999876677999999999999999999999999 9999999999999999999999999998764
Q ss_pred CCccc--cccCCCCccccCC
Q 005841 657 ETYLT--TKTGKGTVTYLAS 674 (674)
Q Consensus 657 ~~~~~--~~~~~GTp~YmAP 674 (674)
..... .....+++.||||
T Consensus 161 ~~~~~~~~~~~~~~~~y~~P 180 (279)
T cd05109 161 IDETEYHADGGKVPIKWMAL 180 (279)
T ss_pred cccceeecCCCccchhhCCH
Confidence 32211 2223457889998
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.7e-24 Score=220.04 Aligned_cols=168 Identities=25% Similarity=0.430 Sum_probs=145.8
Q ss_pred CCeeEeeeecccCceEEEEEEE--cCCeEEEEEeecccC-CHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeEEEEE
Q 005841 505 EDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEY-SDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVT 581 (674)
Q Consensus 505 ~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 581 (674)
.+|.+.+.||+|+||.||++.+ .+..|+||.+..... .......+.+|+.+++.+.|+||+++++++...+..++||
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 5788999999999999999986 577899998865443 2345567889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccccCC
Q 005841 582 EFLPRGSLFRLLQR---NTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHET 658 (674)
Q Consensus 582 E~~~ggsL~~~l~~---~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~~ 658 (674)
||+++++|.+++.. ....+++..+..++.||+.||.|||+++ |+|+||||+|||++.++.++|+|||++......
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR--VMHRDIKPANVFITATGVVKLGDLGLGRFFSSK 159 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEcCCCCEEECcchhhhccccC
Confidence 99999999998864 2346899999999999999999999999 999999999999999999999999999876544
Q ss_pred ccccccCCCCccccCC
Q 005841 659 YLTTKTGKGTVTYLAS 674 (674)
Q Consensus 659 ~~~~~~~~GTp~YmAP 674 (674)
........|++.|+||
T Consensus 160 ~~~~~~~~~~~~~~ap 175 (267)
T cd08229 160 TTAAHSLVGTPYYMSP 175 (267)
T ss_pred CcccccccCCcCccCH
Confidence 3333345789999998
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.5e-24 Score=223.13 Aligned_cols=167 Identities=26% Similarity=0.373 Sum_probs=144.2
Q ss_pred CCeeEeeeecccCceEEEEEEEc--CCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecC--CeEEEE
Q 005841 505 EDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSP--QRLCIV 580 (674)
Q Consensus 505 ~~y~~~~~LG~G~fG~Vy~~~~~--~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~--~~~~lV 580 (674)
++|++.+.||+|+||.||+|.+. +..|++|.+............+.+|+.++..++||||+++++++... ..+|||
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 57899999999999999999984 67799999976554444445677899999999999999999998877 889999
Q ss_pred EecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccccCCcc
Q 005841 581 TEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYL 660 (674)
Q Consensus 581 ~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~~~~ 660 (674)
|||+++ +|.+++......+++..++.++.||+.||.|||+++ |+|+||||+|||++.++.+||+|||++........
T Consensus 85 ~e~~~~-~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~ 161 (293)
T cd07843 85 MEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNW--ILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLK 161 (293)
T ss_pred ehhcCc-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCCHHHEEECCCCcEEEeecCceeeccCCcc
Confidence 999975 999998776667999999999999999999999999 99999999999999999999999999987655432
Q ss_pred ccccCCCCccccCC
Q 005841 661 TTKTGKGTVTYLAS 674 (674)
Q Consensus 661 ~~~~~~GTp~YmAP 674 (674)
......+++.||||
T Consensus 162 ~~~~~~~~~~~~aP 175 (293)
T cd07843 162 PYTQLVVTLWYRAP 175 (293)
T ss_pred ccccccccccccCc
Confidence 33334688999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.91 E-value=9.5e-24 Score=217.98 Aligned_cols=164 Identities=38% Similarity=0.628 Sum_probs=137.5
Q ss_pred eEeeeecccCceEEEEEEEc------CCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeEEEEE
Q 005841 508 TIGEQIGQGSCGTVYHAVWY------GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVT 581 (674)
Q Consensus 508 ~~~~~LG~G~fG~Vy~~~~~------~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 581 (674)
++.+.||.|.||.||+|.+. +..|+||.++. ....+..+.+.+|+.++++++||||+++++++...+.+++||
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~-~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~ 80 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKP-SSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVM 80 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEEST-TSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEE
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEecc-ccccccceeeeecccccccccccccccccccccccccccccc
Confidence 56789999999999999987 45699999954 334555788999999999999999999999999888899999
Q ss_pred ecCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccccCC--
Q 005841 582 EFLPRGSLFRLLQRN-TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHET-- 658 (674)
Q Consensus 582 E~~~ggsL~~~l~~~-~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~~-- 658 (674)
||+++|+|.++|... ...+++..+..|+.||+.||.|||+++ |+|+||+++|||++.++.+||+|||++......
T Consensus 81 e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~--iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~ 158 (259)
T PF07714_consen 81 EYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNN--IIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSK 158 (259)
T ss_dssp E--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTT--EEEST-SGGGEEEETTTEEEEESTTTGEETTTSSS
T ss_pred ccccccccccccccccccccccccccccccccccccccccccc--ccccccccccccccccccccccccccccccccccc
Confidence 999999999999876 567999999999999999999999998 999999999999999999999999999876321
Q ss_pred ccccccCCCCccccCC
Q 005841 659 YLTTKTGKGTVTYLAS 674 (674)
Q Consensus 659 ~~~~~~~~GTp~YmAP 674 (674)
........+...|+||
T Consensus 159 ~~~~~~~~~~~~~~aP 174 (259)
T PF07714_consen 159 YKNDSSQQLPLRYLAP 174 (259)
T ss_dssp EEESTTSESGGGGS-H
T ss_pred cccccccccccccccc
Confidence 1222223577889987
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1e-24 Score=233.85 Aligned_cols=167 Identities=25% Similarity=0.386 Sum_probs=143.6
Q ss_pred ccCCeeEeeeecccCceEEEEEEEcCC--eEEEEEeecccCCHH------HHHHHHHHHHHHhhCC---CCCeeeEEEEE
Q 005841 503 LWEDLTIGEQIGQGSCGTVYHAVWYGS--DVAVKVFSRQEYSDE------VIHSFRQEVSLMKRLR---HPNVLLFMGAV 571 (674)
Q Consensus 503 ~~~~y~~~~~LG~G~fG~Vy~~~~~~~--~vAvK~i~~~~~~~~------~~~~~~~Ei~il~~l~---HpnIv~l~~~~ 571 (674)
...+|..++.+|+|+||+|++|.++.. .|+||.|.|...-.+ .+-.+--||+||..|+ |+||++++.+|
T Consensus 559 k~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfF 638 (772)
T KOG1152|consen 559 KFSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFF 638 (772)
T ss_pred ccccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhhee
Confidence 456799999999999999999998543 489999987654221 1122345999999997 99999999999
Q ss_pred ecCCeEEEEEecC-CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecC
Q 005841 572 TSPQRLCIVTEFL-PRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFG 650 (674)
Q Consensus 572 ~~~~~~~lV~E~~-~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFG 650 (674)
++++++||+||-- +|.+|+++|.. ...+++.++..|++||+.|+++||+.+ |||||||-+|++++.+|.|||+|||
T Consensus 639 Eddd~yyl~te~hg~gIDLFd~IE~-kp~m~E~eAk~IFkQV~agi~hlh~~~--ivhrdikdenvivd~~g~~klidfg 715 (772)
T KOG1152|consen 639 EDDDYYYLETEVHGEGIDLFDFIEF-KPRMDEPEAKLIFKQVVAGIKHLHDQG--IVHRDIKDENVIVDSNGFVKLIDFG 715 (772)
T ss_pred ecCCeeEEEecCCCCCcchhhhhhc-cCccchHHHHHHHHHHHhccccccccC--ceecccccccEEEecCCeEEEeecc
Confidence 9999999999964 56799999965 457999999999999999999999999 9999999999999999999999999
Q ss_pred CcccccCCccccccCCCCccccCC
Q 005841 651 LSRLKHETYLTTKTGKGTVTYLAS 674 (674)
Q Consensus 651 la~~~~~~~~~~~~~~GTp~YmAP 674 (674)
.|.......+.. ++||..|.||
T Consensus 716 saa~~ksgpfd~--f~gtv~~aap 737 (772)
T KOG1152|consen 716 SAAYTKSGPFDV--FVGTVDYAAP 737 (772)
T ss_pred chhhhcCCCcce--eeeeccccch
Confidence 998766554443 7899999998
|
|
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.1e-23 Score=216.86 Aligned_cols=169 Identities=33% Similarity=0.556 Sum_probs=143.2
Q ss_pred cccccCCeeEeeeecccCceEEEEEEE-cCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeEE
Q 005841 500 YEILWEDLTIGEQIGQGSCGTVYHAVW-YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLC 578 (674)
Q Consensus 500 ~~~~~~~y~~~~~LG~G~fG~Vy~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 578 (674)
|++..++|++.++||+|+||.||+|.. .+..||+|.+....... ..+.+|+.+++.++|+||+++++++. .+..|
T Consensus 1 ~~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~~~---~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~ 76 (260)
T cd05067 1 WEVPRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSP---EAFLAEANLMKQLQHPRLVRLYAVVT-QEPIY 76 (260)
T ss_pred CccchHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCCcH---HHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcE
Confidence 466778999999999999999999987 46779999987654432 46788999999999999999998864 56799
Q ss_pred EEEecCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccccC
Q 005841 579 IVTEFLPRGSLFRLLQRN-TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHE 657 (674)
Q Consensus 579 lV~E~~~ggsL~~~l~~~-~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~ 657 (674)
+||||+.+++|.+++... ...+++..+..++.|++.||+|||+.+ |+|+||||+||++++++.++|+|||++.....
T Consensus 77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~--i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~ 154 (260)
T cd05067 77 IITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKN--YIHRDLRAANILVSETLCCKIADFGLARLIED 154 (260)
T ss_pred EEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC--eecccccHHhEEEcCCCCEEEccCcceeecCC
Confidence 999999999999998653 346899999999999999999999998 99999999999999999999999999987663
Q ss_pred Cccc-cccCCCCccccCC
Q 005841 658 TYLT-TKTGKGTVTYLAS 674 (674)
Q Consensus 658 ~~~~-~~~~~GTp~YmAP 674 (674)
.... .....++..|+||
T Consensus 155 ~~~~~~~~~~~~~~y~~p 172 (260)
T cd05067 155 NEYTAREGAKFPIKWTAP 172 (260)
T ss_pred CCcccccCCcccccccCH
Confidence 3222 2233467789987
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=9.1e-24 Score=215.92 Aligned_cols=161 Identities=32% Similarity=0.566 Sum_probs=141.5
Q ss_pred eeecccCceEEEEEEEc-----CCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeEEEEEecCC
Q 005841 511 EQIGQGSCGTVYHAVWY-----GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLP 585 (674)
Q Consensus 511 ~~LG~G~fG~Vy~~~~~-----~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ 585 (674)
++||+|+||.||+|.+. +..|++|++....... ....+.+|+.++..++|+||+++++++.....+++||||++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 79 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEE-ERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYME 79 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchh-HHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEecc
Confidence 46999999999999985 6679999997654433 46788999999999999999999999999999999999999
Q ss_pred CCCHHHHHHhc--------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccccC
Q 005841 586 RGSLFRLLQRN--------TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHE 657 (674)
Q Consensus 586 ggsL~~~l~~~--------~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~ 657 (674)
+++|.+++... ...+++..+..++.|++.||.|||+.+ |+|+||||+||+++.++.+||+|||++.....
T Consensus 80 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~--i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 80 GGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK--FVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC--cccCccCcceEEECCCCcEEEccccccccccc
Confidence 99999999875 467999999999999999999999988 99999999999999999999999999987654
Q ss_pred Cc--cccccCCCCccccCC
Q 005841 658 TY--LTTKTGKGTVTYLAS 674 (674)
Q Consensus 658 ~~--~~~~~~~GTp~YmAP 674 (674)
.. .......+++.|+||
T Consensus 158 ~~~~~~~~~~~~~~~y~aP 176 (262)
T cd00192 158 DDYYRKKTGGKLPIRWMAP 176 (262)
T ss_pred ccccccccCCCcCccccCH
Confidence 32 223345689999998
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.5e-23 Score=215.01 Aligned_cols=167 Identities=28% Similarity=0.424 Sum_probs=145.3
Q ss_pred CeeEeeeecccCceEEEEEEE--cCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEec--CCeEEEEE
Q 005841 506 DLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTS--PQRLCIVT 581 (674)
Q Consensus 506 ~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~--~~~~~lV~ 581 (674)
+|++.+.||.|+||.||++.+ .+..||+|++..........+.+..|+.+++.++|+||+++++++.. ...+|++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 588999999999999999987 56779999998766666667788999999999999999999997764 45689999
Q ss_pred ecCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHH-----hCCCCeEEccCCCCCEEEcCCCcEEEEecCCcc
Q 005841 582 EFLPRGSLFRLLQRN---TTKLDWRRRILMALDIARGVSYLH-----HCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSR 653 (674)
Q Consensus 582 E~~~ggsL~~~l~~~---~~~l~~~~~~~i~~qi~~~L~yLH-----~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~ 653 (674)
||+++++|.+++... ...+++..++.++.||+.||.||| ..+ |+|+||||+||+++.++.+||+|||++.
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~--i~h~dl~p~nili~~~~~~kl~d~g~~~ 158 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNT--VLHRDLKPANIFLDANNNVKLGDFGLAK 158 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCc--ceecCCCHHHEEEecCCCEEEecccccc
Confidence 999999999998653 467999999999999999999999 777 9999999999999999999999999998
Q ss_pred cccCCccccccCCCCccccCC
Q 005841 654 LKHETYLTTKTGKGTVTYLAS 674 (674)
Q Consensus 654 ~~~~~~~~~~~~~GTp~YmAP 674 (674)
.............|++.|+||
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~p 179 (265)
T cd08217 159 ILGHDSSFAKTYVGTPYYMSP 179 (265)
T ss_pred cccCCcccccccccCCCccCh
Confidence 876544323345789999998
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=9.2e-24 Score=236.42 Aligned_cols=166 Identities=31% Similarity=0.459 Sum_probs=147.1
Q ss_pred cCCeeEeeeecccCceEEEEEEE--cCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCC-CCCeeeEEEEEec-----CC
Q 005841 504 WEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLR-HPNVLLFMGAVTS-----PQ 575 (674)
Q Consensus 504 ~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~-----~~ 575 (674)
.+-|++.++||.|.+|+||+++. .++.+|+|+.....-.+ +.+..|..|++.+. |||++.++++|.. ++
T Consensus 18 ~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~d---eEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~D 94 (953)
T KOG0587|consen 18 ADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEE---EEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGD 94 (953)
T ss_pred CCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCcccc---HHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCC
Confidence 35689999999999999999976 67779999987654333 34556888888874 9999999999863 47
Q ss_pred eEEEEEecCCCCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCccc
Q 005841 576 RLCIVTEFLPRGSLFRLLQR-NTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL 654 (674)
Q Consensus 576 ~~~lV~E~~~ggsL~~~l~~-~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~ 654 (674)
.+|||||||.||+.-|+++. .+.++.|..+.+|++.++.||.+||... +||||||-.|||++.++.|||+|||++..
T Consensus 95 qLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nk--viHRDikG~NiLLT~e~~VKLvDFGvSaQ 172 (953)
T KOG0587|consen 95 QLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNK--VIHRDIKGQNVLLTENAEVKLVDFGVSAQ 172 (953)
T ss_pred eEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcc--eeeecccCceEEEeccCcEEEeeeeeeee
Confidence 89999999999999999875 3567999999999999999999999988 99999999999999999999999999999
Q ss_pred ccCCccccccCCCCccccCC
Q 005841 655 KHETYLTTKTGKGTVTYLAS 674 (674)
Q Consensus 655 ~~~~~~~~~~~~GTp~YmAP 674 (674)
++.+.....+++|||.||||
T Consensus 173 ldsT~grRnT~iGtP~WMAP 192 (953)
T KOG0587|consen 173 LDSTVGRRNTFIGTPYWMAP 192 (953)
T ss_pred eecccccccCcCCCcccccc
Confidence 99988888899999999998
|
|
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=8.7e-24 Score=218.66 Aligned_cols=160 Identities=29% Similarity=0.397 Sum_probs=131.5
Q ss_pred eecccCceEEEEEEEc----CCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeEEEEEecCCCC
Q 005841 512 QIGQGSCGTVYHAVWY----GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRG 587 (674)
Q Consensus 512 ~LG~G~fG~Vy~~~~~----~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg 587 (674)
.||+|+||.||+|... ...+++|.+.... .......+.+|+.+++.++|+||+++++.+.....+|+||||++++
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASA-TPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG 80 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccC-ChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence 6899999999999752 2357888765432 3344567888999999999999999999999999999999999999
Q ss_pred CHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccccCCc--cc
Q 005841 588 SLFRLLQRNT----TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETY--LT 661 (674)
Q Consensus 588 sL~~~l~~~~----~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~~~--~~ 661 (674)
+|.+++.... ..+++..++.++.||+.||+|||+++ |+||||||+|||++.++++||+|||+++...... ..
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~ 158 (269)
T cd05042 81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD--FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYIT 158 (269)
T ss_pred cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC--EecccccHhheEecCCCcEEEeccccccccccchheec
Confidence 9999997643 23467888999999999999999999 9999999999999999999999999997543221 12
Q ss_pred cccCCCCccccCC
Q 005841 662 TKTGKGTVTYLAS 674 (674)
Q Consensus 662 ~~~~~GTp~YmAP 674 (674)
.....+++.|+||
T Consensus 159 ~~~~~~~~~y~aP 171 (269)
T cd05042 159 KDCHAVPLRWLAP 171 (269)
T ss_pred cCCCCCcccccCH
Confidence 2233567889998
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.3e-23 Score=223.06 Aligned_cols=173 Identities=31% Similarity=0.554 Sum_probs=144.5
Q ss_pred ccccccCCeeEeeeecccCceEEEEEEEc---------CCeEEEEEeecccCCHHHHHHHHHHHHHHhhC-CCCCeeeEE
Q 005841 499 DYEILWEDLTIGEQIGQGSCGTVYHAVWY---------GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRL-RHPNVLLFM 568 (674)
Q Consensus 499 ~~~~~~~~y~~~~~LG~G~fG~Vy~~~~~---------~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~ 568 (674)
.+.+..++|.+.+.||+|+||.||++.+. ...||+|++.... .......+.+|+.+++.+ .||||++++
T Consensus 6 ~~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~ 84 (314)
T cd05099 6 KWEFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNA-TDKDLADLISEMELMKLIGKHKNIINLL 84 (314)
T ss_pred cccccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCC-ChHHHHHHHHHHHHHHhccCCCCeeeEE
Confidence 45677789999999999999999999752 2358999886543 344566788999999999 599999999
Q ss_pred EEEecCCeEEEEEecCCCCCHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCC
Q 005841 569 GAVTSPQRLCIVTEFLPRGSLFRLLQRNT---------------TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKS 633 (674)
Q Consensus 569 ~~~~~~~~~~lV~E~~~ggsL~~~l~~~~---------------~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp 633 (674)
+++.....+|+||||+++++|.+++.... ..+++..+..++.||+.||.|||+++ |+||||||
T Consensus 85 ~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g--i~H~dlkp 162 (314)
T cd05099 85 GVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR--CIHRDLAA 162 (314)
T ss_pred EEEccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC--eeeccccc
Confidence 99999999999999999999999997532 34889999999999999999999998 99999999
Q ss_pred CCEEEcCCCcEEEEecCCcccccCCcc--ccccCCCCccccCC
Q 005841 634 SNLLVDKHWTVKVGDFGLSRLKHETYL--TTKTGKGTVTYLAS 674 (674)
Q Consensus 634 ~NILi~~~~~vkL~DFGla~~~~~~~~--~~~~~~GTp~YmAP 674 (674)
+|||++.++.+||+|||+++....... ......+++.||||
T Consensus 163 ~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aP 205 (314)
T cd05099 163 RNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAP 205 (314)
T ss_pred eeEEEcCCCcEEEccccccccccccccccccccCCCCccccCH
Confidence 999999999999999999986643221 12223456789998
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=6.1e-24 Score=221.82 Aligned_cols=165 Identities=25% Similarity=0.458 Sum_probs=143.1
Q ss_pred CCeeEeeeecccCceEEEEEEEc--CCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeEEEEEe
Q 005841 505 EDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTE 582 (674)
Q Consensus 505 ~~y~~~~~LG~G~fG~Vy~~~~~--~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E 582 (674)
++|++++.||+|+||.||++.+. +..||+|.+... ........+.+|+.+++.++||||+++++.+...+.+|+|||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~-~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 79 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLE-LDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCME 79 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecc-cCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEe
Confidence 46889999999999999999984 778999988653 234445678899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHh-CCCCeEEccCCCCCEEEcCCCcEEEEecCCcccccCCc
Q 005841 583 FLPRGSLFRLLQRN--TTKLDWRRRILMALDIARGVSYLHH-CNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETY 659 (674)
Q Consensus 583 ~~~ggsL~~~l~~~--~~~l~~~~~~~i~~qi~~~L~yLH~-~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~~~ 659 (674)
|+++++|..++... ...+++..+..++.|++.||.|||+ ++ |+|+||||+|||++.++.+||+|||++.......
T Consensus 80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~--i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 157 (286)
T cd06622 80 YMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN--IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL 157 (286)
T ss_pred ecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCC--EeeCCCCHHHEEECCCCCEEEeecCCcccccCCc
Confidence 99999999988753 2368999999999999999999996 57 9999999999999999999999999997664332
Q ss_pred cccccCCCCccccCC
Q 005841 660 LTTKTGKGTVTYLAS 674 (674)
Q Consensus 660 ~~~~~~~GTp~YmAP 674 (674)
.....|++.|+||
T Consensus 158 --~~~~~~~~~y~aP 170 (286)
T cd06622 158 --AKTNIGCQSYMAP 170 (286)
T ss_pred --cccCCCccCccCc
Confidence 2235688999998
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.3e-23 Score=215.78 Aligned_cols=164 Identities=33% Similarity=0.535 Sum_probs=140.5
Q ss_pred cccCCeeEeeeecccCceEEEEEEEcCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEe-cCCeEEEE
Q 005841 502 ILWEDLTIGEQIGQGSCGTVYHAVWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVT-SPQRLCIV 580 (674)
Q Consensus 502 ~~~~~y~~~~~LG~G~fG~Vy~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~-~~~~~~lV 580 (674)
+..++|.+.+.||+|+||.||++...+..|++|.+.... ....+.+|+.+++.++|+||+++++++. .....|+|
T Consensus 3 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~k~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv 78 (256)
T cd05082 3 LNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIV 78 (256)
T ss_pred ccHHhCeeeeeecccCCCeEEEEEEcCCcEEEEEeCCCc----hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEE
Confidence 445789999999999999999999999999999985432 2456888999999999999999999764 45679999
Q ss_pred EecCCCCCHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccccCCc
Q 005841 581 TEFLPRGSLFRLLQRNTT-KLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETY 659 (674)
Q Consensus 581 ~E~~~ggsL~~~l~~~~~-~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~~~ 659 (674)
|||+++++|.+++..... .+++..++.++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+++......
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~ 156 (256)
T cd05082 79 TEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANN--FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ 156 (256)
T ss_pred EECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--EeccccchheEEEcCCCcEEecCCccceeccccC
Confidence 999999999999976443 4889999999999999999999998 9999999999999999999999999998654322
Q ss_pred cccccCCCCccccCC
Q 005841 660 LTTKTGKGTVTYLAS 674 (674)
Q Consensus 660 ~~~~~~~GTp~YmAP 674 (674)
....++..||||
T Consensus 157 ---~~~~~~~~y~aP 168 (256)
T cd05082 157 ---DTGKLPVKWTAP 168 (256)
T ss_pred ---CCCccceeecCH
Confidence 223456789988
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.2e-23 Score=219.40 Aligned_cols=169 Identities=29% Similarity=0.404 Sum_probs=141.7
Q ss_pred ccccCCeeEeeeecccCceEEEEEEE--cCCeEEEEEeecccCCHHHHHHHHHHHHHHhhC-CCCCeeeEEEEEe-----
Q 005841 501 EILWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRL-RHPNVLLFMGAVT----- 572 (674)
Q Consensus 501 ~~~~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~----- 572 (674)
....++|++.+.||+|+||.||++.+ .+..||+|++..... ....+.+|+.+++.+ +||||+++++++.
T Consensus 14 ~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~---~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~ 90 (286)
T cd06638 14 PDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHD---IDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVK 90 (286)
T ss_pred CCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccc---hHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccC
Confidence 34568899999999999999999987 467799998764322 224577899999999 6999999999874
Q ss_pred cCCeEEEEEecCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEec
Q 005841 573 SPQRLCIVTEFLPRGSLFRLLQR---NTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDF 649 (674)
Q Consensus 573 ~~~~~~lV~E~~~ggsL~~~l~~---~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DF 649 (674)
....+|+||||+++++|.+++.. ....+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+||
T Consensus 91 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~nili~~~~~~kl~df 168 (286)
T cd06638 91 NGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK--TIHRDVKGNNILLTTEGGVKLVDF 168 (286)
T ss_pred CCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCC--ccccCCCHHhEEECCCCCEEEccC
Confidence 34679999999999999998753 2356889999999999999999999998 999999999999999999999999
Q ss_pred CCcccccCCccccccCCCCccccCC
Q 005841 650 GLSRLKHETYLTTKTGKGTVTYLAS 674 (674)
Q Consensus 650 Gla~~~~~~~~~~~~~~GTp~YmAP 674 (674)
|+++.............||+.|+||
T Consensus 169 g~~~~~~~~~~~~~~~~~~~~y~aP 193 (286)
T cd06638 169 GVSAQLTSTRLRRNTSVGTPFWMAP 193 (286)
T ss_pred CceeecccCCCccccccCCCcccCh
Confidence 9998765433333445799999998
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.9e-24 Score=228.02 Aligned_cols=164 Identities=37% Similarity=0.569 Sum_probs=140.4
Q ss_pred cCCeeEeeeecccCceEEEEEEEcCCeEEEEEeecccCCHHHHHHHHHHHHHHhh--CCCCCeeeEEEEEecCC----eE
Q 005841 504 WEDLTIGEQIGQGSCGTVYHAVWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKR--LRHPNVLLFMGAVTSPQ----RL 577 (674)
Q Consensus 504 ~~~y~~~~~LG~G~fG~Vy~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~--l~HpnIv~l~~~~~~~~----~~ 577 (674)
.....+.++||+|.||.||+|...++.||||++..+ ..+.|+.|-.|+.. ++|+||++|+++-.... .+
T Consensus 209 l~pl~l~eli~~Grfg~V~KaqL~~~~VAVKifp~~-----~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~ey 283 (534)
T KOG3653|consen 209 LDPLQLLELIGRGRFGCVWKAQLDNRLVAVKIFPEQ-----EKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEY 283 (534)
T ss_pred CCchhhHHHhhcCccceeehhhccCceeEEEecCHH-----HHHHHHhHHHHHhccCccchhHHHhhchhccCCccccce
Confidence 355678899999999999999999999999999643 34678888888776 57999999999877665 79
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh-------CCCCeEEccCCCCCEEEcCCCcEEEEecC
Q 005841 578 CIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHH-------CNPPIIHRDLKSSNLLVDKHWTVKVGDFG 650 (674)
Q Consensus 578 ~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~-------~~~~IvHrDLKp~NILi~~~~~vkL~DFG 650 (674)
+||++|-+.|+|.+||.. ..++|.....|+.-|++||+|||+ ..++|+|||||..||||-.+++..|+|||
T Consensus 284 wLVt~fh~kGsL~dyL~~--ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFG 361 (534)
T KOG3653|consen 284 WLVTEFHPKGSLCDYLKA--NTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFG 361 (534)
T ss_pred eEEeeeccCCcHHHHHHh--ccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccc
Confidence 999999999999999975 468999999999999999999995 34679999999999999999999999999
Q ss_pred CcccccCCc--cccccCCCCccccCC
Q 005841 651 LSRLKHETY--LTTKTGKGTVTYLAS 674 (674)
Q Consensus 651 la~~~~~~~--~~~~~~~GTp~YmAP 674 (674)
||..+.... ..+..-+||.+||||
T Consensus 362 LAl~~~p~~~~~d~~~qVGT~RYMAP 387 (534)
T KOG3653|consen 362 LALRLEPGKPQGDTHGQVGTRRYMAP 387 (534)
T ss_pred eeEEecCCCCCcchhhhhhhhhhcCH
Confidence 998775322 122235799999998
|
|
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.2e-23 Score=219.65 Aligned_cols=167 Identities=29% Similarity=0.522 Sum_probs=141.5
Q ss_pred CCeeEeeeecccCceEEEEEEE------cCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecC--Ce
Q 005841 505 EDLTIGEQIGQGSCGTVYHAVW------YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSP--QR 576 (674)
Q Consensus 505 ~~y~~~~~LG~G~fG~Vy~~~~------~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~--~~ 576 (674)
.-|++.+.||+|+||.||+|.+ .+..||+|.+.... .......+.+|+.+++.+.||||+++++++... ..
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES-GGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG 82 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccc-cHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCc
Confidence 3478899999999999999974 35569999986543 344567799999999999999999999998875 56
Q ss_pred EEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCccccc
Q 005841 577 LCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKH 656 (674)
Q Consensus 577 ~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~ 656 (674)
.++||||+++++|.+++.+....+++..+..++.||+.||+|||+++ |+||||||+|||++.++.++|+|||+++.+.
T Consensus 83 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~g--i~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~ 160 (284)
T cd05079 83 IKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQ--YVHRDLAARNVLVESEHQVKIGDFGLTKAIE 160 (284)
T ss_pred eEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecccchheEEEcCCCCEEECCCccccccc
Confidence 89999999999999999766567899999999999999999999998 9999999999999999999999999998764
Q ss_pred CCcc---ccccCCCCccccCC
Q 005841 657 ETYL---TTKTGKGTVTYLAS 674 (674)
Q Consensus 657 ~~~~---~~~~~~GTp~YmAP 674 (674)
.... ......|+..|+||
T Consensus 161 ~~~~~~~~~~~~~~~~~y~ap 181 (284)
T cd05079 161 TDKEYYTVKDDLDSPVFWYAP 181 (284)
T ss_pred cCccceeecCCCCCCccccCH
Confidence 3221 12234577889988
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.6e-23 Score=216.64 Aligned_cols=167 Identities=33% Similarity=0.521 Sum_probs=141.8
Q ss_pred CCeeEeeeecccCceEEEEEEEc--C---CeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeEEE
Q 005841 505 EDLTIGEQIGQGSCGTVYHAVWY--G---SDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCI 579 (674)
Q Consensus 505 ~~y~~~~~LG~G~fG~Vy~~~~~--~---~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 579 (674)
.+|++.+.||+|+||.||+|.+. + ..||||++... ........|..|+.+++.+.||||+++++++......++
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~l 82 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSG-YTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMI 82 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCC-CCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEE
Confidence 56899999999999999999873 2 24999998653 345556789999999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccccCCc
Q 005841 580 VTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETY 659 (674)
Q Consensus 580 V~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~~~ 659 (674)
||||+++++|.+++......+++..++.++.|++.||.|||+++ ++|+||||+|||++.++.+||+|||++.......
T Consensus 83 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g--~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~ 160 (269)
T cd05065 83 ITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMN--YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT 160 (269)
T ss_pred EEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccChheEEEcCCCcEEECCCccccccccCc
Confidence 99999999999999876677999999999999999999999998 9999999999999999999999999998654322
Q ss_pred cc-----cccCCCCccccCC
Q 005841 660 LT-----TKTGKGTVTYLAS 674 (674)
Q Consensus 660 ~~-----~~~~~GTp~YmAP 674 (674)
.. ......+..|+||
T Consensus 161 ~~~~~~~~~~~~~~~~y~~P 180 (269)
T cd05065 161 SDPTYTSSLGGKIPIRWTAP 180 (269)
T ss_pred cccccccccCCCcceeecCH
Confidence 11 1111224578887
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.2e-23 Score=217.15 Aligned_cols=168 Identities=35% Similarity=0.598 Sum_probs=140.7
Q ss_pred ccccCCeeEeeeecccCceEEEEEEEcC-CeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeEEE
Q 005841 501 EILWEDLTIGEQIGQGSCGTVYHAVWYG-SDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCI 579 (674)
Q Consensus 501 ~~~~~~y~~~~~LG~G~fG~Vy~~~~~~-~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 579 (674)
.+..++|++.++||+|+||.||++.+.+ ..||+|++....... ..+.+|+.+++.++||||+++++.+. ....|+
T Consensus 2 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~~~---~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~l 77 (262)
T cd05071 2 EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP---EAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYI 77 (262)
T ss_pred CCChHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCccCH---HHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEE
Confidence 4556789999999999999999998743 469999987544322 46788999999999999999999874 466899
Q ss_pred EEecCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccccCC
Q 005841 580 VTEFLPRGSLFRLLQRN-TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHET 658 (674)
Q Consensus 580 V~E~~~ggsL~~~l~~~-~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~~ 658 (674)
||||+++++|.+++... ...+++..+..++.|++.||.|||+.+ |+|+||||+|||++.++.+||+|||+++.....
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~--i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~ 155 (262)
T cd05071 78 VTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN--YVHRDLRAANILVGENLVCKVADFGLARLIEDN 155 (262)
T ss_pred EEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCC--ccccccCcccEEEcCCCcEEeccCCceeecccc
Confidence 99999999999999753 345899999999999999999999998 999999999999999999999999999876543
Q ss_pred cccc-ccCCCCccccCC
Q 005841 659 YLTT-KTGKGTVTYLAS 674 (674)
Q Consensus 659 ~~~~-~~~~GTp~YmAP 674 (674)
.... ....+++.|+||
T Consensus 156 ~~~~~~~~~~~~~y~~P 172 (262)
T cd05071 156 EYTARQGAKFPIKWTAP 172 (262)
T ss_pred ccccccCCcccceecCH
Confidence 3222 123467789998
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.91 E-value=2e-23 Score=214.03 Aligned_cols=167 Identities=25% Similarity=0.422 Sum_probs=146.5
Q ss_pred CeeEeeeecccCceEEEEEEE--cCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeEEEEEec
Q 005841 506 DLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEF 583 (674)
Q Consensus 506 ~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~ 583 (674)
+|++.+.||+|+||.||.+.. .+..|++|.+............+.+|+.+++.++||||+++++++...+..|+||||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 589999999999999999987 467899999976555555566789999999999999999999999999999999999
Q ss_pred CCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccccCCcccc
Q 005841 584 LPRGSLFRLLQRNT-TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTT 662 (674)
Q Consensus 584 ~~ggsL~~~l~~~~-~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~~~~~~ 662 (674)
+++++|.+++.... ..+++..++.++.|++.||.|||+++ ++|+||+|+|||++.++.++|+|||++..........
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~ 158 (256)
T cd08218 81 CEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRK--ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELA 158 (256)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEEcCCCCEEEeeccceeecCcchhhh
Confidence 99999999987543 46889999999999999999999998 9999999999999999999999999998765543333
Q ss_pred ccCCCCccccCC
Q 005841 663 KTGKGTVTYLAS 674 (674)
Q Consensus 663 ~~~~GTp~YmAP 674 (674)
....|++.|+||
T Consensus 159 ~~~~~~~~~~~p 170 (256)
T cd08218 159 RTCIGTPYYLSP 170 (256)
T ss_pred hhccCCccccCH
Confidence 345689999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.3e-23 Score=219.19 Aligned_cols=167 Identities=25% Similarity=0.440 Sum_probs=138.9
Q ss_pred cCCeeEeeeecccCceEEEEEEE--cCC----eEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeE
Q 005841 504 WEDLTIGEQIGQGSCGTVYHAVW--YGS----DVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRL 577 (674)
Q Consensus 504 ~~~y~~~~~LG~G~fG~Vy~~~~--~~~----~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 577 (674)
..+|++.+.||+|+||+||+|.+ .+. .|++|.+... ........+..|+.++..+.||||+++++++. ....
T Consensus 6 ~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~~ 83 (279)
T cd05111 6 ETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDR-SGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GASL 83 (279)
T ss_pred HhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccc-cchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCcc
Confidence 46789999999999999999987 344 3777776432 22344567888999999999999999999875 4567
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccccC
Q 005841 578 CIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHE 657 (674)
Q Consensus 578 ~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~ 657 (674)
+++|||+++++|.+++......+++..+..++.||+.||.|||+.+ ++||||||+|||++.++.+||+|||+++....
T Consensus 84 ~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~ 161 (279)
T cd05111 84 QLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHR--MVHRNLAARNILLKSDSIVQIADFGVADLLYP 161 (279)
T ss_pred EEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC--EeccccCcceEEEcCCCcEEEcCCccceeccC
Confidence 8999999999999999877778999999999999999999999998 99999999999999999999999999986543
Q ss_pred Cc--cccccCCCCccccCC
Q 005841 658 TY--LTTKTGKGTVTYLAS 674 (674)
Q Consensus 658 ~~--~~~~~~~GTp~YmAP 674 (674)
.. .......|++.||||
T Consensus 162 ~~~~~~~~~~~~~~~y~~p 180 (279)
T cd05111 162 DDKKYFYSEHKTPIKWMAL 180 (279)
T ss_pred CCcccccCCCCCcccccCH
Confidence 21 122234577889998
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.5e-23 Score=215.15 Aligned_cols=170 Identities=29% Similarity=0.461 Sum_probs=141.8
Q ss_pred ccccCCeeEeeeecccCceEEEEEEE--cCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeEE
Q 005841 501 EILWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLC 578 (674)
Q Consensus 501 ~~~~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 578 (674)
++...++.....||+|+||.||++.+ .+..|++|.+.... ....+.+.+|+.+++.++|+||+++++++...+..+
T Consensus 4 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 81 (268)
T cd06624 4 EYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERD--SRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFK 81 (268)
T ss_pred ccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCC--HHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEE
Confidence 33444555556899999999999987 35669999886543 234567889999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHHhcCCCC--CHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcC-CCcEEEEecCCcccc
Q 005841 579 IVTEFLPRGSLFRLLQRNTTKL--DWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDK-HWTVKVGDFGLSRLK 655 (674)
Q Consensus 579 lV~E~~~ggsL~~~l~~~~~~l--~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~-~~~vkL~DFGla~~~ 655 (674)
+||||+++++|.+++......+ ++..+..++.||+.||.|||+.+ |+||||||+|||++. .+.++|+|||++...
T Consensus 82 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~ 159 (268)
T cd06624 82 IFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQ--IVHRDIKGDNVLVNTYSGVVKISDFGTSKRL 159 (268)
T ss_pred EEEecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCC--EeecCCCHHHEEEcCCCCeEEEecchhheec
Confidence 9999999999999997654455 88899999999999999999998 999999999999986 679999999999766
Q ss_pred cCCccccccCCCCccccCC
Q 005841 656 HETYLTTKTGKGTVTYLAS 674 (674)
Q Consensus 656 ~~~~~~~~~~~GTp~YmAP 674 (674)
...........|++.|+||
T Consensus 160 ~~~~~~~~~~~~~~~~~aP 178 (268)
T cd06624 160 AGINPCTETFTGTLQYMAP 178 (268)
T ss_pred ccCCCccccCCCCccccCh
Confidence 4433333345689999998
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.6e-23 Score=219.36 Aligned_cols=169 Identities=29% Similarity=0.489 Sum_probs=142.3
Q ss_pred cccCCeeEeeeecccCceEEEEEEEc-------CCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecC
Q 005841 502 ILWEDLTIGEQIGQGSCGTVYHAVWY-------GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSP 574 (674)
Q Consensus 502 ~~~~~y~~~~~LG~G~fG~Vy~~~~~-------~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~ 574 (674)
+.+.+|.+.+.||+|+||+||++... +..||+|.+... .......+.+|+.+++.+.||||+++++++...
T Consensus 2 ~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 79 (288)
T cd05093 2 IKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA--SDNARKDFHREAELLTNLQHEHIVKFYGVCVEG 79 (288)
T ss_pred CchHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCc--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecC
Confidence 34678999999999999999999752 234899988643 344556789999999999999999999999999
Q ss_pred CeEEEEEecCCCCCHHHHHHhcC------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCC
Q 005841 575 QRLCIVTEFLPRGSLFRLLQRNT------------TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHW 642 (674)
Q Consensus 575 ~~~~lV~E~~~ggsL~~~l~~~~------------~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~ 642 (674)
+.+|+||||+++++|.+++.... ..+++..++.++.||+.||+|||+++ |+||||||+|||+++++
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~--i~H~dlkp~Nili~~~~ 157 (288)
T cd05093 80 DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH--FVHRDLATRNCLVGENL 157 (288)
T ss_pred CccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecccCcceEEEccCC
Confidence 99999999999999999997432 24899999999999999999999998 99999999999999999
Q ss_pred cEEEEecCCcccccCCcc--ccccCCCCccccCC
Q 005841 643 TVKVGDFGLSRLKHETYL--TTKTGKGTVTYLAS 674 (674)
Q Consensus 643 ~vkL~DFGla~~~~~~~~--~~~~~~GTp~YmAP 674 (674)
.+||+|||+++....... ......+++.|+||
T Consensus 158 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aP 191 (288)
T cd05093 158 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPP 191 (288)
T ss_pred cEEeccCCccccccCCceeecCCCCCccccccCH
Confidence 999999999986543221 12223467889998
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.9e-23 Score=220.11 Aligned_cols=166 Identities=28% Similarity=0.423 Sum_probs=144.0
Q ss_pred ccCCeeEeeeecccCceEEEEEEE--cCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeEEEE
Q 005841 503 LWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIV 580 (674)
Q Consensus 503 ~~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 580 (674)
...+|++.+.||+|+||.||++.+ .+..|++|.+....... ...+.+|+.+++.+.|+||+++++.+......|+|
T Consensus 18 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~--~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv 95 (296)
T cd06654 18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK--KELIINEILVMRENKNPNIVNYLDSYLVGDELWVV 95 (296)
T ss_pred cccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcch--HHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEe
Confidence 346899999999999999999986 56789999987654332 35688899999999999999999999999999999
Q ss_pred EecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccccCCcc
Q 005841 581 TEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYL 660 (674)
Q Consensus 581 ~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~~~~ 660 (674)
|||+++++|.+++.. ..+++..+..++.|++.||.|||..+ |+|+||||+|||++.++.+||+|||++........
T Consensus 96 ~e~~~~~~L~~~~~~--~~~~~~~~~~i~~ql~~aL~~LH~~g--i~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~ 171 (296)
T cd06654 96 MEYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHSNQ--VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 171 (296)
T ss_pred ecccCCCCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEcCCCCEEECccccchhcccccc
Confidence 999999999999864 35899999999999999999999998 99999999999999999999999999886543322
Q ss_pred ccccCCCCccccCC
Q 005841 661 TTKTGKGTVTYLAS 674 (674)
Q Consensus 661 ~~~~~~GTp~YmAP 674 (674)
......|++.|+||
T Consensus 172 ~~~~~~~~~~y~aP 185 (296)
T cd06654 172 KRSTMVGTPYWMAP 185 (296)
T ss_pred ccCcccCCccccCH
Confidence 22335789999998
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.1e-23 Score=223.60 Aligned_cols=158 Identities=28% Similarity=0.446 Sum_probs=129.1
Q ss_pred eeeecccCceEEEEEEEc----CCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEec--CCeEEEEEec
Q 005841 510 GEQIGQGSCGTVYHAVWY----GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTS--PQRLCIVTEF 583 (674)
Q Consensus 510 ~~~LG~G~fG~Vy~~~~~----~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~--~~~~~lV~E~ 583 (674)
+++||+|+||.||+|.+. +..||+|.+...... ..+.+|+.+++.++||||+++++++.. ...+|+||||
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~ 81 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGIS----MSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDY 81 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCCc----HHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEec
Confidence 468999999999999863 456999998654332 346679999999999999999998854 4568999999
Q ss_pred CCCCCHHHHHHhc--------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEE----cCCCcEEEEecCC
Q 005841 584 LPRGSLFRLLQRN--------TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLV----DKHWTVKVGDFGL 651 (674)
Q Consensus 584 ~~ggsL~~~l~~~--------~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi----~~~~~vkL~DFGl 651 (674)
+. ++|.+++... ...+++..+..++.||+.||.|||+.+ |+||||||+|||+ +..+.+||+|||+
T Consensus 82 ~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~--ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~ 158 (317)
T cd07868 82 AE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW--VLHRDLKPANILVMGEGPERGRVKIADMGF 158 (317)
T ss_pred cC-CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC--EEcCCCCHHHEEEecCCCCcCcEEEeecCc
Confidence 95 5888887532 235889999999999999999999999 9999999999999 4567899999999
Q ss_pred cccccCCc---cccccCCCCccccCC
Q 005841 652 SRLKHETY---LTTKTGKGTVTYLAS 674 (674)
Q Consensus 652 a~~~~~~~---~~~~~~~GTp~YmAP 674 (674)
|+...... .......||+.||||
T Consensus 159 a~~~~~~~~~~~~~~~~~~t~~y~aP 184 (317)
T cd07868 159 ARLFNSPLKPLADLDPVVVTFWYRAP 184 (317)
T ss_pred eeccCCCCccccccCCccccccccCC
Confidence 98765332 122345799999999
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.8e-23 Score=214.43 Aligned_cols=167 Identities=31% Similarity=0.494 Sum_probs=141.2
Q ss_pred CCeeEeeeecccCceEEEEEEE--cCCeEEEEEeecccC---CHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecC--CeE
Q 005841 505 EDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEY---SDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSP--QRL 577 (674)
Q Consensus 505 ~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~---~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~--~~~ 577 (674)
.+|++.++||+|+||.||++.+ ++..||||++..... .......+.+|+.+++.+.||||+++++++.+. ..+
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 5799999999999999999987 467899998864322 234567889999999999999999999998764 568
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccccC
Q 005841 578 CIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHE 657 (674)
Q Consensus 578 ~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~ 657 (674)
|+||||+++++|.+++... ..+++..++.++.|++.+|.|||+++ |+|+||||+|||++.++.++|+|||+++....
T Consensus 82 ~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~--i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~ 158 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSY-GALTENVTRKYTRQILEGVSYLHSNM--IVHRDIKGANILRDSVGNVKLGDFGASKRLQT 158 (265)
T ss_pred EEEEEecCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEecCCCCEEECcCcccccccc
Confidence 8999999999999998754 45889999999999999999999999 99999999999999999999999999986543
Q ss_pred Ccc---ccccCCCCccccCC
Q 005841 658 TYL---TTKTGKGTVTYLAS 674 (674)
Q Consensus 658 ~~~---~~~~~~GTp~YmAP 674 (674)
... ......||..|+||
T Consensus 159 ~~~~~~~~~~~~~~~~y~aP 178 (265)
T cd06652 159 ICLSGTGMKSVTGTPYWMSP 178 (265)
T ss_pred ccccccccccCCCCccccCh
Confidence 211 12234689999998
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.6e-23 Score=220.30 Aligned_cols=170 Identities=29% Similarity=0.518 Sum_probs=140.3
Q ss_pred cccCCeeEeeeecccCceEEEEEEEc------------------CCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCC
Q 005841 502 ILWEDLTIGEQIGQGSCGTVYHAVWY------------------GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPN 563 (674)
Q Consensus 502 ~~~~~y~~~~~LG~G~fG~Vy~~~~~------------------~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hpn 563 (674)
+..++|++.+.||+|+||.||++.+. ...||+|++.... .......+.+|+.+++.++|+|
T Consensus 2 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~~~E~~~l~~l~~~~ 80 (296)
T cd05095 2 FPRKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDA-NKNARNDFLKEIKIMSRLKDPN 80 (296)
T ss_pred CChhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCC
Confidence 34568999999999999999998542 2248999886542 3445567889999999999999
Q ss_pred eeeEEEEEecCCeEEEEEecCCCCCHHHHHHhcC----------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCC
Q 005841 564 VLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNT----------TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKS 633 (674)
Q Consensus 564 Iv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~----------~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp 633 (674)
|+++++++...+..|+||||+++++|.+++.... ..+++..+..++.||+.||.|||+++ |+|+||||
T Consensus 81 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~--i~H~dlkp 158 (296)
T cd05095 81 IIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN--FVHRDLAT 158 (296)
T ss_pred cceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC--eecccCCh
Confidence 9999999999999999999999999999997532 23778899999999999999999999 99999999
Q ss_pred CCEEEcCCCcEEEEecCCcccccCCccc--cccCCCCccccCC
Q 005841 634 SNLLVDKHWTVKVGDFGLSRLKHETYLT--TKTGKGTVTYLAS 674 (674)
Q Consensus 634 ~NILi~~~~~vkL~DFGla~~~~~~~~~--~~~~~GTp~YmAP 674 (674)
+|||++.++.++|+|||+++........ .....+++.||||
T Consensus 159 ~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p 201 (296)
T cd05095 159 RNCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSW 201 (296)
T ss_pred heEEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCH
Confidence 9999999999999999999865432211 1112346788887
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=99.91 E-value=5e-24 Score=222.12 Aligned_cols=169 Identities=23% Similarity=0.422 Sum_probs=141.8
Q ss_pred ccCCeeEeeeecccCceEEEEEEEc-------CCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCC
Q 005841 503 LWEDLTIGEQIGQGSCGTVYHAVWY-------GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQ 575 (674)
Q Consensus 503 ~~~~y~~~~~LG~G~fG~Vy~~~~~-------~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~ 575 (674)
...+|.+.+.||+|+||.||+|.+. +..||||++.... .......+.+|+.++..++||||+++++++....
T Consensus 3 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~ 81 (283)
T cd05091 3 NLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA-EGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQ 81 (283)
T ss_pred CHHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCC-CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCC
Confidence 3456888999999999999999863 2469999987543 3445567889999999999999999999999999
Q ss_pred eEEEEEecCCCCCHHHHHHhc---------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcC
Q 005841 576 RLCIVTEFLPRGSLFRLLQRN---------------TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDK 640 (674)
Q Consensus 576 ~~~lV~E~~~ggsL~~~l~~~---------------~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~ 640 (674)
..++++||+++++|.+++... ...+++..+..++.|++.||.|||+++ |+||||||+|||+++
T Consensus 82 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g--i~H~dlkp~Nil~~~ 159 (283)
T cd05091 82 PLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH--VVHKDLATRNVLVFD 159 (283)
T ss_pred ceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC--ccccccchhheEecC
Confidence 999999999999999998521 234788899999999999999999999 999999999999999
Q ss_pred CCcEEEEecCCcccccCCccc--cccCCCCccccCC
Q 005841 641 HWTVKVGDFGLSRLKHETYLT--TKTGKGTVTYLAS 674 (674)
Q Consensus 641 ~~~vkL~DFGla~~~~~~~~~--~~~~~GTp~YmAP 674 (674)
++.+||+|||+++........ .....+|+.||||
T Consensus 160 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aP 195 (283)
T cd05091 160 KLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSP 195 (283)
T ss_pred CCceEecccccccccccchheeeccCccCCccccCH
Confidence 999999999999876433221 2233568899998
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.6e-23 Score=216.31 Aligned_cols=166 Identities=30% Similarity=0.452 Sum_probs=138.2
Q ss_pred eeEeeeecccCceEEEEEEEc-----CCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCe-----
Q 005841 507 LTIGEQIGQGSCGTVYHAVWY-----GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQR----- 576 (674)
Q Consensus 507 y~~~~~LG~G~fG~Vy~~~~~-----~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~----- 576 (674)
|.+.+.||+|+||.||+|... +..||||.+............+.+|+.+++.++||||+++++++.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 567899999999999999863 2569999997765555566789999999999999999999998876554
Q ss_pred -EEEEEecCCCCCHHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecC
Q 005841 577 -LCIVTEFLPRGSLFRLLQRN-----TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFG 650 (674)
Q Consensus 577 -~~lV~E~~~ggsL~~~l~~~-----~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFG 650 (674)
.++||||+++++|..++... ...+++..+..++.|++.||.|||+.+ |+||||||+|||+++++.+||+|||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~--i~H~dlkp~Nil~~~~~~~kl~dfg 158 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN--FIHRDLAARNCMLREDMTVCVADFG 158 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC--eeccccchheEEECCCCeEEECCcc
Confidence 79999999999999988542 246899999999999999999999998 9999999999999999999999999
Q ss_pred CcccccCCc--cccccCCCCccccCC
Q 005841 651 LSRLKHETY--LTTKTGKGTVTYLAS 674 (674)
Q Consensus 651 la~~~~~~~--~~~~~~~GTp~YmAP 674 (674)
+++...... .......+++.|+||
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~p 184 (273)
T cd05035 159 LSKKIYSGDYYRQGRIAKMPVKWIAI 184 (273)
T ss_pred ceeeccccccccccccccCCccccCH
Confidence 998654321 112223456788887
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=99.91 E-value=6.8e-24 Score=221.08 Aligned_cols=167 Identities=31% Similarity=0.387 Sum_probs=144.4
Q ss_pred CCeeEeeeecccCceEEEEEEE--cCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeEEEEEe
Q 005841 505 EDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTE 582 (674)
Q Consensus 505 ~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E 582 (674)
++|++.++||+|+||.||+|.+ .+..||+|++.+........+.+.+|+.+++.++||||+++++++..+..+|+|||
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 4689999999999999999998 46789999987654444455678889999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccccCCcccc
Q 005841 583 FLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTT 662 (674)
Q Consensus 583 ~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~~~~~~ 662 (674)
|+++++|..+... ...+++..++.++.||+.+|.|||+.+ |+|+||+|+||++++++.++|+|||++..........
T Consensus 81 ~~~~~~l~~~~~~-~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~ 157 (286)
T cd07846 81 FVDHTVLDDLEKY-PNGLDESRVRKYLFQILRGIEFCHSHN--IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVY 157 (286)
T ss_pred cCCccHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEECCCCcEEEEeeeeeeeccCCcccc
Confidence 9999888887654 445899999999999999999999998 9999999999999999999999999998765443333
Q ss_pred ccCCCCccccCC
Q 005841 663 KTGKGTVTYLAS 674 (674)
Q Consensus 663 ~~~~GTp~YmAP 674 (674)
....|++.|+||
T Consensus 158 ~~~~~~~~y~aP 169 (286)
T cd07846 158 TDYVATRWYRAP 169 (286)
T ss_pred CcccceeeccCc
Confidence 345688999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.6e-24 Score=211.11 Aligned_cols=169 Identities=25% Similarity=0.397 Sum_probs=144.8
Q ss_pred cccCCeeEeeeecccCceEEEEEEEc--CCeEEEEEeecccCCHHHHHHHHHHHHHHhhCC-CCCeeeEEEEEecCCeEE
Q 005841 502 ILWEDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLR-HPNVLLFMGAVTSPQRLC 578 (674)
Q Consensus 502 ~~~~~y~~~~~LG~G~fG~Vy~~~~~--~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~ 578 (674)
...++++++..||.|++|+|+++++. +.-+|||.+.+.... +..++++..+.++...+ .|+||+.+|+|..+..++
T Consensus 89 ~dindl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nk-ee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~ 167 (391)
T KOG0983|consen 89 ADINDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNK-EENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVF 167 (391)
T ss_pred cChHHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCH-HHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHH
Confidence 34456678889999999999999985 477999999876543 44567777888877765 899999999999999999
Q ss_pred EEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccccCC
Q 005841 579 IVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHET 658 (674)
Q Consensus 579 lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~~ 658 (674)
|.||.| ...+..+|++..+.+++..+-++..-++.||.||-++. +|||||+||+|||+|+.|+|||||||++..+.++
T Consensus 168 IcMelM-s~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH-~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdS 245 (391)
T KOG0983|consen 168 ICMELM-STCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKH-GVIHRDVKPSNILLDERGNIKLCDFGISGRLVDS 245 (391)
T ss_pred HHHHHH-HHHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhc-ceeecccCccceEEccCCCEEeecccccceeecc
Confidence 999998 55777788887888999999999999999999998643 3999999999999999999999999999988877
Q ss_pred ccccccCCCCccccCC
Q 005841 659 YLTTKTGKGTVTYLAS 674 (674)
Q Consensus 659 ~~~~~~~~GTp~YmAP 674 (674)
...+. -+|.+.||||
T Consensus 246 kAhtr-sAGC~~YMaP 260 (391)
T KOG0983|consen 246 KAHTR-SAGCAAYMAP 260 (391)
T ss_pred ccccc-ccCCccccCc
Confidence 66655 4799999998
|
|
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.9e-23 Score=220.07 Aligned_cols=165 Identities=29% Similarity=0.434 Sum_probs=143.9
Q ss_pred cCCeeEeeeecccCceEEEEEEE--cCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeEEEEE
Q 005841 504 WEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVT 581 (674)
Q Consensus 504 ~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 581 (674)
..+|.+.+.||+|+||.||++.. .+..||+|.+....... .+.+.+|+.+++.++|+||+++++++...+..|+||
T Consensus 18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~ 95 (297)
T cd06656 18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPK--KELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM 95 (297)
T ss_pred hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccch--HHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEee
Confidence 36899999999999999999986 57789999997654332 356788999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccccCCccc
Q 005841 582 EFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLT 661 (674)
Q Consensus 582 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~~~~~ 661 (674)
||+++++|.+++.+ ..+++..+..++.|++.+|.|||+.+ |+|+||||+|||++.++.++|+|||++.........
T Consensus 96 e~~~~~~L~~~~~~--~~~~~~~~~~~~~~l~~~L~~LH~~~--i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~ 171 (297)
T cd06656 96 EYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALDFLHSNQ--VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK 171 (297)
T ss_pred cccCCCCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCCCCEEECcCccceEccCCccC
Confidence 99999999999864 35889999999999999999999998 999999999999999999999999999865443333
Q ss_pred cccCCCCccccCC
Q 005841 662 TKTGKGTVTYLAS 674 (674)
Q Consensus 662 ~~~~~GTp~YmAP 674 (674)
.....|++.|+||
T Consensus 172 ~~~~~~~~~y~aP 184 (297)
T cd06656 172 RSTMVGTPYWMAP 184 (297)
T ss_pred cCcccCCccccCH
Confidence 3345689999998
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=2e-23 Score=214.66 Aligned_cols=170 Identities=34% Similarity=0.581 Sum_probs=144.2
Q ss_pred cccccCCeeEeeeecccCceEEEEEEEc-CCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeEE
Q 005841 500 YEILWEDLTIGEQIGQGSCGTVYHAVWY-GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLC 578 (674)
Q Consensus 500 ~~~~~~~y~~~~~LG~G~fG~Vy~~~~~-~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 578 (674)
|++..++|.+.++||+|+||.||++... +..||||.+...... ...+.+|+.+++.++|+||+++++++.....++
T Consensus 1 ~~~~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 77 (261)
T cd05034 1 WEIPRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMS---PEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIY 77 (261)
T ss_pred CccchhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCccC---HHHHHHHHHHHhhCCCCCEeeeeeeeecCCceE
Confidence 3566789999999999999999999874 456999998765433 346788999999999999999999999989999
Q ss_pred EEEecCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccccC
Q 005841 579 IVTEFLPRGSLFRLLQRNT-TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHE 657 (674)
Q Consensus 579 lV~E~~~ggsL~~~l~~~~-~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~ 657 (674)
+||||+++++|.+++.... ..+++..+..++.||+.||.|||+++ |+|+||||+||||+.++.+||+|||++.....
T Consensus 78 ~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~--i~h~di~p~nili~~~~~~~l~d~g~~~~~~~ 155 (261)
T cd05034 78 IVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRN--YIHRDLAARNILVGENLVCKIADFGLARLIED 155 (261)
T ss_pred EEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCcchheEEEcCCCCEEECccccceeccc
Confidence 9999999999999997643 46899999999999999999999998 99999999999999999999999999986653
Q ss_pred Cccc-cccCCCCccccCC
Q 005841 658 TYLT-TKTGKGTVTYLAS 674 (674)
Q Consensus 658 ~~~~-~~~~~GTp~YmAP 674 (674)
.... .....+++.|+||
T Consensus 156 ~~~~~~~~~~~~~~y~~P 173 (261)
T cd05034 156 DEYTAREGAKFPIKWTAP 173 (261)
T ss_pred hhhhhhhccCCCccccCH
Confidence 2211 1122356778887
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.7e-23 Score=221.20 Aligned_cols=169 Identities=31% Similarity=0.574 Sum_probs=139.5
Q ss_pred cccCCeeEeeeecccCceEEEEEEEc--CCe--EEEEEeecccCCHHHHHHHHHHHHHHhhC-CCCCeeeEEEEEecCCe
Q 005841 502 ILWEDLTIGEQIGQGSCGTVYHAVWY--GSD--VAVKVFSRQEYSDEVIHSFRQEVSLMKRL-RHPNVLLFMGAVTSPQR 576 (674)
Q Consensus 502 ~~~~~y~~~~~LG~G~fG~Vy~~~~~--~~~--vAvK~i~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~ 576 (674)
+.+.+|++.+.||+|+||.||+|.+. +.. +++|.+... ........+.+|+.++.++ +|+||+++++++...+.
T Consensus 4 ~~~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~-~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~ 82 (303)
T cd05088 4 LEWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY-ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGY 82 (303)
T ss_pred cchhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEeccc-CCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCC
Confidence 45678999999999999999999873 333 577766432 2344556788999999999 89999999999999999
Q ss_pred EEEEEecCCCCCHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCC
Q 005841 577 LCIVTEFLPRGSLFRLLQRNT---------------TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKH 641 (674)
Q Consensus 577 ~~lV~E~~~ggsL~~~l~~~~---------------~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~ 641 (674)
+|+||||+++++|.+++.... ..+++..++.++.||+.||+|||+++ |+||||||+|||++.+
T Consensus 83 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g--i~H~dlkp~Nili~~~ 160 (303)
T cd05088 83 LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ--FIHRDLAARNILVGEN 160 (303)
T ss_pred ceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC--ccccccchheEEecCC
Confidence 999999999999999997532 25789999999999999999999998 9999999999999999
Q ss_pred CcEEEEecCCcccccCCccccccCCCCccccCC
Q 005841 642 WTVKVGDFGLSRLKHETYLTTKTGKGTVTYLAS 674 (674)
Q Consensus 642 ~~vkL~DFGla~~~~~~~~~~~~~~GTp~YmAP 674 (674)
+.+||+|||+++..... .......+++.||||
T Consensus 161 ~~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aP 192 (303)
T cd05088 161 YVAKIADFGLSRGQEVY-VKKTMGRLPVRWMAI 192 (303)
T ss_pred CcEEeCccccCcccchh-hhcccCCCcccccCH
Confidence 99999999999743321 112223456779987
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.1e-23 Score=215.85 Aligned_cols=170 Identities=35% Similarity=0.576 Sum_probs=142.8
Q ss_pred ccccCCeeEeeeecccCceEEEEEEEcC-----CeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCC
Q 005841 501 EILWEDLTIGEQIGQGSCGTVYHAVWYG-----SDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQ 575 (674)
Q Consensus 501 ~~~~~~y~~~~~LG~G~fG~Vy~~~~~~-----~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~ 575 (674)
++...+|.+.++||+|+||.||+|.+.. ..|+||.+.... .....+.+.+|+.+++.+.||||+++++++.. .
T Consensus 2 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~-~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~ 79 (270)
T cd05056 2 EIQREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCT-SPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-N 79 (270)
T ss_pred eechhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcC-CHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-C
Confidence 4556789999999999999999998632 258999885433 34556788999999999999999999998875 5
Q ss_pred eEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccc
Q 005841 576 RLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLK 655 (674)
Q Consensus 576 ~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~ 655 (674)
..|+||||+++++|.+++......+++..++.++.||+.||.|||+++ ++|+||||+|||++.++.+||+|||+++..
T Consensus 80 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--~~H~dl~p~nili~~~~~~~l~d~g~~~~~ 157 (270)
T cd05056 80 PVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKR--FVHRDIAARNVLVSSPDCVKLGDFGLSRYL 157 (270)
T ss_pred CcEEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccccChheEEEecCCCeEEccCceeeec
Confidence 678999999999999999876667999999999999999999999998 999999999999999999999999999876
Q ss_pred cCCcc-ccccCCCCccccCC
Q 005841 656 HETYL-TTKTGKGTVTYLAS 674 (674)
Q Consensus 656 ~~~~~-~~~~~~GTp~YmAP 674 (674)
..... ......+++.|+||
T Consensus 158 ~~~~~~~~~~~~~~~~y~aP 177 (270)
T cd05056 158 EDESYYKASKGKLPIKWMAP 177 (270)
T ss_pred ccccceecCCCCccccccCh
Confidence 54322 12223456789998
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.6e-23 Score=216.67 Aligned_cols=166 Identities=28% Similarity=0.439 Sum_probs=135.8
Q ss_pred eeEeeeecccCceEEEEEEEcCC----eEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecC------Ce
Q 005841 507 LTIGEQIGQGSCGTVYHAVWYGS----DVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSP------QR 576 (674)
Q Consensus 507 y~~~~~LG~G~fG~Vy~~~~~~~----~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~------~~ 576 (674)
|.++++||+|+||.||+|.+... .||+|.+............+.+|+.+++.++|+||+++++++... ..
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 35678999999999999987432 489999876555556677889999999999999999999977432 24
Q ss_pred EEEEEecCCCCCHHHHHHh-----cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCC
Q 005841 577 LCIVTEFLPRGSLFRLLQR-----NTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGL 651 (674)
Q Consensus 577 ~~lV~E~~~ggsL~~~l~~-----~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGl 651 (674)
.++||||+++++|.+++.. ....+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~kl~Dfg~ 158 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS--FIHRDLAARNCMLNENMNVCVADFGL 158 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC--eeccccchhheEEcCCCCEEECCCCc
Confidence 7899999999999988742 2345899999999999999999999988 99999999999999999999999999
Q ss_pred cccccCCcc--ccccCCCCccccCC
Q 005841 652 SRLKHETYL--TTKTGKGTVTYLAS 674 (674)
Q Consensus 652 a~~~~~~~~--~~~~~~GTp~YmAP 674 (674)
++....... ......+++.|+||
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~p 183 (272)
T cd05075 159 SKKIYNGDYYRQGRIAKMPVKWIAI 183 (272)
T ss_pred ccccCcccceecCCcccCCcccCCH
Confidence 987643221 11223467789887
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.5e-23 Score=216.53 Aligned_cols=169 Identities=28% Similarity=0.517 Sum_probs=142.4
Q ss_pred cccCCeeEeeeecccCceEEEEEEEc--CC----eEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCC
Q 005841 502 ILWEDLTIGEQIGQGSCGTVYHAVWY--GS----DVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQ 575 (674)
Q Consensus 502 ~~~~~y~~~~~LG~G~fG~Vy~~~~~--~~----~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~ 575 (674)
+...+|++.+.||+|+||.||+|.+. +. .||+|.+..... ......+.+|+.+++.+.||||+++++++.. .
T Consensus 4 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~ 81 (279)
T cd05057 4 LKETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETS-PKANKEILDEAYVMASVDHPHVVRLLGICLS-S 81 (279)
T ss_pred cCHHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCC-HHHHHHHHHHHHHHHhCCCCCcceEEEEEec-C
Confidence 34578999999999999999999863 32 489998865543 4455678899999999999999999999887 7
Q ss_pred eEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccc
Q 005841 576 RLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLK 655 (674)
Q Consensus 576 ~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~ 655 (674)
..++||||+++++|.+++......+++..++.++.||+.||+|||+++ |+|+||||+|||++.++.+||+|||+++..
T Consensus 82 ~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--i~H~di~p~nil~~~~~~~kL~dfg~~~~~ 159 (279)
T cd05057 82 QVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKR--LVHRDLAARNVLVKTPQHVKITDFGLAKLL 159 (279)
T ss_pred ceEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC--EEecccCcceEEEcCCCeEEECCCcccccc
Confidence 899999999999999999877777999999999999999999999988 999999999999999999999999999876
Q ss_pred cCCcc--ccccCCCCccccCC
Q 005841 656 HETYL--TTKTGKGTVTYLAS 674 (674)
Q Consensus 656 ~~~~~--~~~~~~GTp~YmAP 674 (674)
..... ......+++.||||
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~P 180 (279)
T cd05057 160 DVDEKEYHAEGGKVPIKWMAL 180 (279)
T ss_pred cCcccceecCCCcccccccCH
Confidence 43221 11122346789988
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.1e-23 Score=219.96 Aligned_cols=149 Identities=28% Similarity=0.471 Sum_probs=134.7
Q ss_pred CCeeEeeeecccCceEEEEEEEc--CCeEEEEEeecccCCH-HHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeEEEEE
Q 005841 505 EDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSD-EVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVT 581 (674)
Q Consensus 505 ~~y~~~~~LG~G~fG~Vy~~~~~--~~~vAvK~i~~~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 581 (674)
++|++.+.||+|+||.||+|... +..||||.+.+..... .....+..|+.+++.+.|+||+++++.+......|+||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 47899999999999999999874 6789999998765443 45677889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccc
Q 005841 582 EFLPRGSLFRLLQRN-TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLK 655 (674)
Q Consensus 582 E~~~ggsL~~~l~~~-~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~ 655 (674)
||+.+++|.+++... ...+++..+..++.||+.||.|||..+ |+|+||||+||||+.++.++|+|||++...
T Consensus 81 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nili~~~~~~~l~dfg~~~~~ 153 (316)
T cd05574 81 DYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLG--IVYRDLKPENILLHESGHIMLSDFDLSKQS 153 (316)
T ss_pred EecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCC--eeccCCChHHeEEcCCCCEEEeecchhhcc
Confidence 999999999998753 356999999999999999999999998 999999999999999999999999998754
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.3e-24 Score=242.30 Aligned_cols=175 Identities=31% Similarity=0.548 Sum_probs=147.8
Q ss_pred ccccccccCCeeEeeeecccCceEEEEEEEcC-------CeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEE
Q 005841 497 CLDYEILWEDLTIGEQIGQGSCGTVYHAVWYG-------SDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMG 569 (674)
Q Consensus 497 ~~~~~~~~~~y~~~~~LG~G~fG~Vy~~~~~~-------~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~ 569 (674)
....++...+.++.+.||+|+||+||+|...+ .-||||.++... ..+..+.|++|++++..|+|||||+|+|
T Consensus 478 ~~~~~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a-~~~~~~dF~REaeLla~l~H~nIVrLlG 556 (774)
T KOG1026|consen 478 LKVLEIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKA-ENQARQDFRREAELLAELQHPNIVRLLG 556 (774)
T ss_pred cceeEechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccc-cHHHHHHHHHHHHHHHhccCCCeEEEEE
Confidence 34457788889999999999999999998632 239999986543 4557789999999999999999999999
Q ss_pred EEecCCeEEEEEecCCCCCHHHHHHhc-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCE
Q 005841 570 AVTSPQRLCIVTEFLPRGSLFRLLQRN-------------TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNL 636 (674)
Q Consensus 570 ~~~~~~~~~lV~E~~~ggsL~~~l~~~-------------~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NI 636 (674)
+|..++.+|+|+|||..|+|.++|.-+ +..++..+.+.|+.||+.||.||-++. +|||||..+|+
T Consensus 557 VC~~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~--FVHRDLATRNC 634 (774)
T KOG1026|consen 557 VCREGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH--FVHRDLATRNC 634 (774)
T ss_pred EEccCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc--ccccchhhhhc
Confidence 999999999999999999999999642 223889999999999999999999988 99999999999
Q ss_pred EEcCCCcEEEEecCCccccc-CCccccc-cCCCCccccCC
Q 005841 637 LVDKHWTVKVGDFGLSRLKH-ETYLTTK-TGKGTVTYLAS 674 (674)
Q Consensus 637 Li~~~~~vkL~DFGla~~~~-~~~~~~~-~~~GTp~YmAP 674 (674)
||.++..|||+||||+|..- .+++.-. .-.-..+||||
T Consensus 635 LVge~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMpp 674 (774)
T KOG1026|consen 635 LVGENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPP 674 (774)
T ss_pred eeccceEEEecccccchhhhhhhhhcccCCceeeeecCCH
Confidence 99999999999999998643 3333322 12246789987
|
|
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.2e-23 Score=215.76 Aligned_cols=161 Identities=30% Similarity=0.356 Sum_probs=133.5
Q ss_pred eeecccCceEEEEEEEc----CCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeEEEEEecCCC
Q 005841 511 EQIGQGSCGTVYHAVWY----GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPR 586 (674)
Q Consensus 511 ~~LG~G~fG~Vy~~~~~----~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~g 586 (674)
+.||+|+||.||+|.+. ...+|+|.+..... ......+.+|+.+++.++||||+++++++.....+|+||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 79 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSAS-VQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPL 79 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCC-hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCC
Confidence 36899999999999863 23589998865442 23345688899999999999999999999999999999999999
Q ss_pred CCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccccCCcc--
Q 005841 587 GSLFRLLQRNT----TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYL-- 660 (674)
Q Consensus 587 gsL~~~l~~~~----~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~~~~-- 660 (674)
++|.+++.... ..+++..++.++.|++.||.|||+.+ |+|+||||+|||++.++++||+|||+++.......
T Consensus 80 g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~ 157 (269)
T cd05087 80 GDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN--FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV 157 (269)
T ss_pred CcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC--EeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence 99999996532 24567788899999999999999998 99999999999999999999999999976543221
Q ss_pred ccccCCCCccccCC
Q 005841 661 TTKTGKGTVTYLAS 674 (674)
Q Consensus 661 ~~~~~~GTp~YmAP 674 (674)
......|++.||||
T Consensus 158 ~~~~~~~~~~y~aP 171 (269)
T cd05087 158 TPDQLWVPLRWIAP 171 (269)
T ss_pred cCCCcCCcccccCH
Confidence 22234678899998
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.91 E-value=2e-23 Score=220.56 Aligned_cols=173 Identities=28% Similarity=0.459 Sum_probs=145.2
Q ss_pred ccccccCCeeEeeeecccCceEEEEEEEc-------CCeEEEEEeecccCCHHHHHHHHHHHHHHhhC-CCCCeeeEEEE
Q 005841 499 DYEILWEDLTIGEQIGQGSCGTVYHAVWY-------GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRL-RHPNVLLFMGA 570 (674)
Q Consensus 499 ~~~~~~~~y~~~~~LG~G~fG~Vy~~~~~-------~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~ 570 (674)
.+.+..++|.+.+.||+|+||.||++.+. +..||+|++.... .....+.+.+|+.+++++ +||||++++++
T Consensus 29 ~~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~ 107 (302)
T cd05055 29 KWEFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTA-HSSEREALMSELKIMSHLGNHENIVNLLGA 107 (302)
T ss_pred cccccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccC-ChHHHHHHHHHHHHHHhccCCCCcceEEEE
Confidence 35667788999999999999999999752 2359999886543 234456789999999999 79999999999
Q ss_pred EecCCeEEEEEecCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEec
Q 005841 571 VTSPQRLCIVTEFLPRGSLFRLLQRNT-TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDF 649 (674)
Q Consensus 571 ~~~~~~~~lV~E~~~ggsL~~~l~~~~-~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DF 649 (674)
+...+.+|+||||+++++|.+++.... ..+++.++..++.||+.||.|||+.+ |+|+||||+|||++.++.++|+||
T Consensus 108 ~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~--ivH~dlkp~Nil~~~~~~~~l~df 185 (302)
T cd05055 108 CTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKN--CIHRDLAARNVLLTHGKIVKICDF 185 (302)
T ss_pred EecCCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eehhhhccceEEEcCCCeEEECCC
Confidence 999999999999999999999997543 34899999999999999999999998 999999999999999999999999
Q ss_pred CCcccccCCcc--ccccCCCCccccCC
Q 005841 650 GLSRLKHETYL--TTKTGKGTVTYLAS 674 (674)
Q Consensus 650 Gla~~~~~~~~--~~~~~~GTp~YmAP 674 (674)
|+++....... ......+++.|+||
T Consensus 186 g~~~~~~~~~~~~~~~~~~~~~~y~aP 212 (302)
T cd05055 186 GLARDIMNDSNYVVKGNARLPVKWMAP 212 (302)
T ss_pred cccccccCCCceeecCCCCcccccCCH
Confidence 99986543221 12223467889998
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=99.91 E-value=2e-23 Score=218.70 Aligned_cols=166 Identities=31% Similarity=0.539 Sum_probs=138.7
Q ss_pred CeeEeeeecccCceEEEEEEEcC-------CeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeEE
Q 005841 506 DLTIGEQIGQGSCGTVYHAVWYG-------SDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLC 578 (674)
Q Consensus 506 ~y~~~~~LG~G~fG~Vy~~~~~~-------~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 578 (674)
+|.+.+.||+|+||.||+|.... ..+++|++.... .......+.+|+.+++.+.||||+++++.+...+..|
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 79 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENA-SSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLL 79 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCC-CHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcE
Confidence 47889999999999999998632 348888886543 3344567889999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHHhcC-----------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCC
Q 005841 579 IVTEFLPRGSLFRLLQRNT-----------------------TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSN 635 (674)
Q Consensus 579 lV~E~~~ggsL~~~l~~~~-----------------------~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~N 635 (674)
+||||+++++|.+++.... ..+++..++.++.|++.||.|||+.+ |+||||||+|
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~--ivH~dikp~n 157 (290)
T cd05045 80 LIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK--LVHRDLAARN 157 (290)
T ss_pred EEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC--eehhhhhhhe
Confidence 9999999999999986421 24789999999999999999999998 9999999999
Q ss_pred EEEcCCCcEEEEecCCcccccCCc--cccccCCCCccccCC
Q 005841 636 LLVDKHWTVKVGDFGLSRLKHETY--LTTKTGKGTVTYLAS 674 (674)
Q Consensus 636 ILi~~~~~vkL~DFGla~~~~~~~--~~~~~~~GTp~YmAP 674 (674)
||+++++.+||+|||+++...... .......+++.|+||
T Consensus 158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~ap 198 (290)
T cd05045 158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAI 198 (290)
T ss_pred EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCH
Confidence 999999999999999998653221 122233567889997
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.2e-23 Score=215.68 Aligned_cols=165 Identities=27% Similarity=0.425 Sum_probs=136.2
Q ss_pred CCeeEeeeecccCceEEEEEEE--cCCeEEEEEeecccCCHHHHHHHHHHHHH-HhhCCCCCeeeEEEEEecCCeEEEEE
Q 005841 505 EDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSL-MKRLRHPNVLLFMGAVTSPQRLCIVT 581 (674)
Q Consensus 505 ~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~~~~~~~~~~~Ei~i-l~~l~HpnIv~l~~~~~~~~~~~lV~ 581 (674)
++|++.+.||+|+||.||++.+ ++..||||++......... ..+..|+.+ ++.+.||||+++++++.....+|+||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~-~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~ 79 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQ-KRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICM 79 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHH-HHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEh
Confidence 4789999999999999999998 4778999999765443333 344456554 66678999999999999999999999
Q ss_pred ecCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCeEEccCCCCCEEEcCCCcEEEEecCCcccccC
Q 005841 582 EFLPRGSLFRLLQR---NTTKLDWRRRILMALDIARGVSYLHHC-NPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHE 657 (674)
Q Consensus 582 E~~~ggsL~~~l~~---~~~~l~~~~~~~i~~qi~~~L~yLH~~-~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~ 657 (674)
||++ ++|.+++.. ....+++..++.++.||+.||.|||+. + |+||||||+|||++.++.+||+|||+++....
T Consensus 80 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~--i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~ 156 (283)
T cd06617 80 EVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS--VIHRDVKPSNVLINRNGQVKLCDFGISGYLVD 156 (283)
T ss_pred hhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCC--eecCCCCHHHEEECCCCCEEEeeccccccccc
Confidence 9996 588887754 235689999999999999999999986 7 99999999999999999999999999987644
Q ss_pred CccccccCCCCccccCC
Q 005841 658 TYLTTKTGKGTVTYLAS 674 (674)
Q Consensus 658 ~~~~~~~~~GTp~YmAP 674 (674)
.... ....||+.|+||
T Consensus 157 ~~~~-~~~~~~~~y~aP 172 (283)
T cd06617 157 SVAK-TIDAGCKPYMAP 172 (283)
T ss_pred cccc-ccccCCccccCh
Confidence 3222 224689999998
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.1e-23 Score=216.28 Aligned_cols=165 Identities=24% Similarity=0.374 Sum_probs=145.9
Q ss_pred CeeEeeeecccCceEEEEEEEc--CCeEEEEEeecccCCH-HHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeEEEEEe
Q 005841 506 DLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSD-EVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTE 582 (674)
Q Consensus 506 ~y~~~~~LG~G~fG~Vy~~~~~--~~~vAvK~i~~~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E 582 (674)
+|++.+.||.|+||.||+|.+. +..||+|++.+..... .....+.+|+.++++++||||+.+++.+.....+|+|||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 5899999999999999999984 7789999998655433 556789999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccccCCcccc
Q 005841 583 FLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTT 662 (674)
Q Consensus 583 ~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~~~~~~ 662 (674)
|+.+++|.+++... ..+++..+..++.||+.||.|||.++ |+|+||||+||++++++.++|+|||++....... ..
T Consensus 81 ~~~~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lh~~~--i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~-~~ 156 (258)
T cd05578 81 LLLGGDLRYHLSQK-VKFSEEQVKFWICEIVLALEYLHSKG--IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT-LT 156 (258)
T ss_pred CCCCCCHHHHHHhc-CCcCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHeEEcCCCCEEEeecccccccCCCc-cc
Confidence 99999999999764 57899999999999999999999999 9999999999999999999999999998765432 22
Q ss_pred ccCCCCccccCC
Q 005841 663 KTGKGTVTYLAS 674 (674)
Q Consensus 663 ~~~~GTp~YmAP 674 (674)
....|+..|+||
T Consensus 157 ~~~~~~~~y~~P 168 (258)
T cd05578 157 TSTSGTPGYMAP 168 (258)
T ss_pred cccCCChhhcCH
Confidence 335688999998
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.5e-23 Score=211.72 Aligned_cols=166 Identities=28% Similarity=0.429 Sum_probs=145.0
Q ss_pred CeeEeeeecccCceEEEEEEE--cCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeEEEEEec
Q 005841 506 DLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEF 583 (674)
Q Consensus 506 ~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~ 583 (674)
+|.+.+.||+|+||.||++.. .+..||||.+............+.+|+.+++.++||||+++++.+...+.+++||||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 588999999999999999987 566799999987666666678899999999999999999999999999999999999
Q ss_pred CCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCC-CcEEEEecCCcccccCCccc
Q 005841 584 LPRGSLFRLLQRN-TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKH-WTVKVGDFGLSRLKHETYLT 661 (674)
Q Consensus 584 ~~ggsL~~~l~~~-~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~-~~vkL~DFGla~~~~~~~~~ 661 (674)
+++++|.+++... ...+++..+..++.|++.+|.|||+++ |+|+||||+||+++.+ +.+||+|||++....... .
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~--i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~-~ 157 (256)
T cd08220 81 APGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKL--ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS-K 157 (256)
T ss_pred CCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc-c
Confidence 9999999999764 345899999999999999999999999 9999999999999854 568999999998765432 2
Q ss_pred cccCCCCccccCC
Q 005841 662 TKTGKGTVTYLAS 674 (674)
Q Consensus 662 ~~~~~GTp~YmAP 674 (674)
.....|++.|+||
T Consensus 158 ~~~~~~~~~y~aP 170 (256)
T cd08220 158 AYTVVGTPCYISP 170 (256)
T ss_pred ccccccCCcccCc
Confidence 2235689999998
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.7e-23 Score=214.07 Aligned_cols=159 Identities=26% Similarity=0.465 Sum_probs=133.4
Q ss_pred eecccCceEEEEEEEc----CCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeEEEEEecCCCC
Q 005841 512 QIGQGSCGTVYHAVWY----GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRG 587 (674)
Q Consensus 512 ~LG~G~fG~Vy~~~~~----~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg 587 (674)
.||+|+||.||+|.+. +..||+|++.... .....+.+.+|+.+++.++||||+++++++. ....++||||++++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~-~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~ 79 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNEN-EKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGG 79 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEccccc-ChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCC
Confidence 4899999999999763 3359999886543 3445567899999999999999999999875 45789999999999
Q ss_pred CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccccCCcc---cccc
Q 005841 588 SLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYL---TTKT 664 (674)
Q Consensus 588 sL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~~~~---~~~~ 664 (674)
+|.+++......+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++....... ....
T Consensus 80 ~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 157 (257)
T cd05115 80 PLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKN--FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSA 157 (257)
T ss_pred CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcC--eeecccchheEEEcCCCcEEeccCCccccccCCccceeccCC
Confidence 999999766678999999999999999999999998 99999999999999999999999999986543221 1112
Q ss_pred CCCCccccCC
Q 005841 665 GKGTVTYLAS 674 (674)
Q Consensus 665 ~~GTp~YmAP 674 (674)
..+++.||||
T Consensus 158 ~~~~~~y~aP 167 (257)
T cd05115 158 GKWPLKWYAP 167 (257)
T ss_pred CCCCcccCCH
Confidence 2346789998
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.3e-23 Score=218.28 Aligned_cols=168 Identities=27% Similarity=0.485 Sum_probs=142.5
Q ss_pred cCCeeEeeeecccCceEEEEEEEc-------CCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCe
Q 005841 504 WEDLTIGEQIGQGSCGTVYHAVWY-------GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQR 576 (674)
Q Consensus 504 ~~~y~~~~~LG~G~fG~Vy~~~~~-------~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 576 (674)
..+|.+.+.||+|+||.||+|.+. +..||||++.... ..+....+.+|+.+++.+.|+||+++++++.....
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 82 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETA-SNDARKDFEREAELLTNFQHENIVKFYGVCTEGDP 82 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccC-CHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCC
Confidence 467899999999999999999863 3469999986543 33456789999999999999999999999999999
Q ss_pred EEEEEecCCCCCHHHHHHhcC-------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCc
Q 005841 577 LCIVTEFLPRGSLFRLLQRNT-------------TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWT 643 (674)
Q Consensus 577 ~~lV~E~~~ggsL~~~l~~~~-------------~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~ 643 (674)
.|+||||+++++|.+++.... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.
T Consensus 83 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~--i~h~dlkp~nili~~~~~ 160 (280)
T cd05049 83 PIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH--FVHRDLATRNCLVGYDLV 160 (280)
T ss_pred eEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC--eeccccccceEEEcCCCe
Confidence 999999999999999997532 34788999999999999999999998 999999999999999999
Q ss_pred EEEEecCCcccccCCcc--ccccCCCCccccCC
Q 005841 644 VKVGDFGLSRLKHETYL--TTKTGKGTVTYLAS 674 (674)
Q Consensus 644 vkL~DFGla~~~~~~~~--~~~~~~GTp~YmAP 674 (674)
+||+|||+++....... ......+++.|+||
T Consensus 161 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aP 193 (280)
T cd05049 161 VKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPP 193 (280)
T ss_pred EEECCcccceecccCcceecCCCCcccceecCh
Confidence 99999999986533221 12233568899998
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.3e-23 Score=223.23 Aligned_cols=174 Identities=31% Similarity=0.530 Sum_probs=145.2
Q ss_pred cccccccCCeeEeeeecccCceEEEEEEEcC---------CeEEEEEeecccCCHHHHHHHHHHHHHHhhC-CCCCeeeE
Q 005841 498 LDYEILWEDLTIGEQIGQGSCGTVYHAVWYG---------SDVAVKVFSRQEYSDEVIHSFRQEVSLMKRL-RHPNVLLF 567 (674)
Q Consensus 498 ~~~~~~~~~y~~~~~LG~G~fG~Vy~~~~~~---------~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l 567 (674)
..|++...+|++++.||+|+||.||++.+.+ ..||+|++... ........+.+|+.+++++ +||||+++
T Consensus 5 ~~~~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~ 83 (334)
T cd05100 5 PKWELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDD-ATDKDLSDLVSEMEMMKMIGKHKNIINL 83 (334)
T ss_pred cccccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccc-cCHHHHHHHHHHHHHHHhhcCCCCeeee
Confidence 3567777889999999999999999997521 25899988643 3344567889999999999 79999999
Q ss_pred EEEEecCCeEEEEEecCCCCCHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCC
Q 005841 568 MGAVTSPQRLCIVTEFLPRGSLFRLLQRNT---------------TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLK 632 (674)
Q Consensus 568 ~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~---------------~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLK 632 (674)
++++...+.+|+||||+++++|.+++.+.. ..+++..++.++.||+.||.|||.++ |+|||||
T Consensus 84 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g--ivH~dlk 161 (334)
T cd05100 84 LGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK--CIHRDLA 161 (334)
T ss_pred eEEEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC--eeccccc
Confidence 999999999999999999999999997532 24788999999999999999999998 9999999
Q ss_pred CCCEEEcCCCcEEEEecCCcccccCCccc--cccCCCCccccCC
Q 005841 633 SSNLLVDKHWTVKVGDFGLSRLKHETYLT--TKTGKGTVTYLAS 674 (674)
Q Consensus 633 p~NILi~~~~~vkL~DFGla~~~~~~~~~--~~~~~GTp~YmAP 674 (674)
|+|||++.++.+||+|||+++........ .....+++.||||
T Consensus 162 p~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aP 205 (334)
T cd05100 162 ARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAP 205 (334)
T ss_pred cceEEEcCCCcEEECCcccceecccccccccccCCCcCceEcCH
Confidence 99999999999999999999866442211 2223456789998
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=99.91 E-value=2e-23 Score=223.06 Aligned_cols=164 Identities=20% Similarity=0.312 Sum_probs=138.6
Q ss_pred Eeeeeccc--CceEEEEEEE--cCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeEEEEEecC
Q 005841 509 IGEQIGQG--SCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFL 584 (674)
Q Consensus 509 ~~~~LG~G--~fG~Vy~~~~--~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 584 (674)
++++||+| +|++||++.. ++..||||.+............+.+|+.+++.++||||+++++++..++.+|+||||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 56789999 6889999987 5677999999776655666677888999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccccCCcc---
Q 005841 585 PRGSLFRLLQRN-TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYL--- 660 (674)
Q Consensus 585 ~ggsL~~~l~~~-~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~~~~--- 660 (674)
++++|.+++... ...+++..++.++.|++.||.|||+++ |+||||||+|||++.++.++|+||+.+........
T Consensus 82 ~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~~ 159 (327)
T cd08227 82 AYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMG--YVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLR 159 (327)
T ss_pred CCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCChhhEEEecCCcEEEcccchhhcccccccccc
Confidence 999999999754 345899999999999999999999999 99999999999999999999999987644322111
Q ss_pred ----ccccCCCCccccCC
Q 005841 661 ----TTKTGKGTVTYLAS 674 (674)
Q Consensus 661 ----~~~~~~GTp~YmAP 674 (674)
......++..||||
T Consensus 160 ~~~~~~~~~~~~~~y~aP 177 (327)
T cd08227 160 VVHDFPKYSVKVLPWLSP 177 (327)
T ss_pred ccccccccccceecccCh
Confidence 11223578889998
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.6e-23 Score=217.99 Aligned_cols=166 Identities=30% Similarity=0.436 Sum_probs=144.9
Q ss_pred ccCCeeEeeeecccCceEEEEEEE--cCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeEEEE
Q 005841 503 LWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIV 580 (674)
Q Consensus 503 ~~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 580 (674)
...+|.+.+.||.|+||.||++.+ .+..|++|.+...... ....+.+|+.+++.++||||+.+++++...+.+|+|
T Consensus 17 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 94 (296)
T cd06655 17 PKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQP--KKELIINEILVMKELKNPNIVNFLDSFLVGDELFVV 94 (296)
T ss_pred CcceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCc--hHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEE
Confidence 346799999999999999999986 5778999998754332 245688899999999999999999999999999999
Q ss_pred EecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccccCCcc
Q 005841 581 TEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYL 660 (674)
Q Consensus 581 ~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~~~~ 660 (674)
|||+++++|..++.. ..+++..+..++.|++.||.|||+.+ |+|+||||+|||++.++.+||+|||++........
T Consensus 95 ~e~~~~~~L~~~~~~--~~l~~~~~~~i~~~l~~al~~LH~~~--i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~ 170 (296)
T cd06655 95 MEYLAGGSLTDVVTE--TCMDEAQIAAVCRECLQALEFLHANQ--VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS 170 (296)
T ss_pred EEecCCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCCCCEEEccCccchhcccccc
Confidence 999999999999864 35899999999999999999999999 99999999999999999999999999987654433
Q ss_pred ccccCCCCccccCC
Q 005841 661 TTKTGKGTVTYLAS 674 (674)
Q Consensus 661 ~~~~~~GTp~YmAP 674 (674)
......|++.||||
T Consensus 171 ~~~~~~~~~~y~aP 184 (296)
T cd06655 171 KRSTMVGTPYWMAP 184 (296)
T ss_pred cCCCcCCCccccCc
Confidence 33345789999998
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=99.90 E-value=2e-23 Score=214.76 Aligned_cols=169 Identities=34% Similarity=0.588 Sum_probs=141.7
Q ss_pred cccccCCeeEeeeecccCceEEEEEEEc-CCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeEE
Q 005841 500 YEILWEDLTIGEQIGQGSCGTVYHAVWY-GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLC 578 (674)
Q Consensus 500 ~~~~~~~y~~~~~LG~G~fG~Vy~~~~~-~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 578 (674)
|++..++|++.+.||+|+||.||+|.+. +..||+|.+....... +.+.+|+.+++.++|+||+++++++. ....|
T Consensus 1 ~~~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~~~---~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~ 76 (260)
T cd05070 1 WEIPRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSP---ESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIY 76 (260)
T ss_pred CCCchHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCCCH---HHHHHHHHHHHhcCCCceEEEEeEEC-CCCcE
Confidence 3556678999999999999999999874 5679999987654433 45888999999999999999999875 46689
Q ss_pred EEEecCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccccC
Q 005841 579 IVTEFLPRGSLFRLLQRN-TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHE 657 (674)
Q Consensus 579 lV~E~~~ggsL~~~l~~~-~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~ 657 (674)
+||||+++++|.+++... ...+++..+..++.|++.||.|||+.+ |+||||||+|||+++++.++|+|||++.....
T Consensus 77 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~--i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~ 154 (260)
T cd05070 77 IVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMN--YIHRDLRSANILVGDGLVCKIADFGLARLIED 154 (260)
T ss_pred EEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCccceEEEeCCceEEeCCceeeeeccC
Confidence 999999999999999754 345899999999999999999999998 99999999999999999999999999987644
Q ss_pred Ccccc-ccCCCCccccCC
Q 005841 658 TYLTT-KTGKGTVTYLAS 674 (674)
Q Consensus 658 ~~~~~-~~~~GTp~YmAP 674 (674)
..... ....++..||||
T Consensus 155 ~~~~~~~~~~~~~~y~aP 172 (260)
T cd05070 155 NEYTARQGAKFPIKWTAP 172 (260)
T ss_pred cccccccCCCCCccccCh
Confidence 32221 123456789998
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.6e-23 Score=216.63 Aligned_cols=166 Identities=30% Similarity=0.432 Sum_probs=140.8
Q ss_pred cCCeeEeeeecccCceEEEEEEE--cCCeEEEEEeecccCCHHHHHHHHHHHHHHhhC-CCCCeeeEEEEEecC------
Q 005841 504 WEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRL-RHPNVLLFMGAVTSP------ 574 (674)
Q Consensus 504 ~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~------ 574 (674)
.+.|++.+.||+|+||.||+|.+ .+..||+|++..... ....+..|+.+++.+ +|+||+++++++...
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~---~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (272)
T cd06637 5 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD---EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD 81 (272)
T ss_pred hhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCc---cHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence 35688889999999999999987 466799999865432 224577899999998 699999999998753
Q ss_pred CeEEEEEecCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcc
Q 005841 575 QRLCIVTEFLPRGSLFRLLQRN-TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSR 653 (674)
Q Consensus 575 ~~~~lV~E~~~ggsL~~~l~~~-~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~ 653 (674)
..+|+||||+++++|.+++... ...+++..+..++.|++.||.|||+++ |+|+||||+|||++.++.+||+|||++.
T Consensus 82 ~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~--ivh~dl~~~nili~~~~~~~l~Dfg~~~ 159 (272)
T cd06637 82 DQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHK--VIHRDIKGQNVLLTENAEVKLVDFGVSA 159 (272)
T ss_pred cEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--CccCCCCHHHEEECCCCCEEEccCCCce
Confidence 4689999999999999999764 346899999999999999999999998 9999999999999999999999999998
Q ss_pred cccCCccccccCCCCccccCC
Q 005841 654 LKHETYLTTKTGKGTVTYLAS 674 (674)
Q Consensus 654 ~~~~~~~~~~~~~GTp~YmAP 674 (674)
.............||+.|+||
T Consensus 160 ~~~~~~~~~~~~~g~~~y~aP 180 (272)
T cd06637 160 QLDRTVGRRNTFIGTPYWMAP 180 (272)
T ss_pred ecccccccCCcccccccccCH
Confidence 765433334446799999998
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.3e-23 Score=223.76 Aligned_cols=160 Identities=18% Similarity=0.117 Sum_probs=125.5
Q ss_pred ccccCCeeEeeeecccCceEEEEEEEc---CCeEEEEEeecccC---CHHHHHHHHHHHHHHhhCCCCCeee-EEEEEec
Q 005841 501 EILWEDLTIGEQIGQGSCGTVYHAVWY---GSDVAVKVFSRQEY---SDEVIHSFRQEVSLMKRLRHPNVLL-FMGAVTS 573 (674)
Q Consensus 501 ~~~~~~y~~~~~LG~G~fG~Vy~~~~~---~~~vAvK~i~~~~~---~~~~~~~~~~Ei~il~~l~HpnIv~-l~~~~~~ 573 (674)
.....+|.+.++||+|+||+||+|.+. +..||||++..... .......+.+|+.+|+.+.|+||+. ++.+
T Consensus 14 ~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~--- 90 (365)
T PRK09188 14 PALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT--- 90 (365)
T ss_pred ccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc---
Confidence 455678999999999999999999873 45689998753321 2345567999999999999999985 4432
Q ss_pred CCeEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccC-CCCCEEEcCCCcEEEEecCCc
Q 005841 574 PQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDL-KSSNLLVDKHWTVKVGDFGLS 652 (674)
Q Consensus 574 ~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDL-Kp~NILi~~~~~vkL~DFGla 652 (674)
+..|||||||+|++|.. +.. .. ...++.|++.+|.|||+.+ |+|||| ||+|||++.++.+||+|||+|
T Consensus 91 -~~~~LVmE~~~G~~L~~-~~~----~~---~~~~~~~i~~aL~~lH~~g--IiHrDL~KP~NILv~~~~~ikLiDFGlA 159 (365)
T PRK09188 91 -GKDGLVRGWTEGVPLHL-ARP----HG---DPAWFRSAHRALRDLHRAG--ITHNDLAKPQNWLMGPDGEAAVIDFQLA 159 (365)
T ss_pred -CCcEEEEEccCCCCHHH-hCc----cc---hHHHHHHHHHHHHHHHHCC--CeeCCCCCcceEEEcCCCCEEEEECccc
Confidence 46899999999999963 211 11 1467889999999999999 999999 999999999999999999999
Q ss_pred ccccCCccc--------cccCCCCccccCC
Q 005841 653 RLKHETYLT--------TKTGKGTVTYLAS 674 (674)
Q Consensus 653 ~~~~~~~~~--------~~~~~GTp~YmAP 674 (674)
+.+...... ..+..||+.|+||
T Consensus 160 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~p 189 (365)
T PRK09188 160 SVFRRRGALYRIAAYEDLRHLLKHKRTYAP 189 (365)
T ss_pred eecccCcchhhhhhhhhhhhhhccCccCCc
Confidence 976433211 1235688999988
|
|
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.5e-23 Score=214.89 Aligned_cols=154 Identities=22% Similarity=0.377 Sum_probs=130.9
Q ss_pred eeecccCceEEEEEEEcCC------------eEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeEE
Q 005841 511 EQIGQGSCGTVYHAVWYGS------------DVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLC 578 (674)
Q Consensus 511 ~~LG~G~fG~Vy~~~~~~~------------~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 578 (674)
+.||+|+||.||++.+... .|++|++..... ....+.+|+.+++.++||||+++++++.. ...+
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~ 76 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHR---DSLAFFETASLMSQLSHKHLVKLYGVCVR-DENI 76 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchh---hHHHHHHHHHHHHcCCCcchhheeeEEec-CCcE
Confidence 4689999999999998433 277777654321 15678899999999999999999999988 7889
Q ss_pred EEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCC-------cEEEEecCC
Q 005841 579 IVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHW-------TVKVGDFGL 651 (674)
Q Consensus 579 lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~-------~vkL~DFGl 651 (674)
+||||+++++|.+++......+++..+..++.||+.||.|||+++ |+||||||+|||++.++ .+||+|||+
T Consensus 77 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~ 154 (259)
T cd05037 77 MVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKK--LVHGNVCGKNILVARYGLNEGYVPFIKLSDPGI 154 (259)
T ss_pred EEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCC--eecccCccceEEEecCccccCCceeEEeCCCCc
Confidence 999999999999999876657999999999999999999999998 99999999999999887 799999999
Q ss_pred cccccCCccccccCCCCccccCC
Q 005841 652 SRLKHETYLTTKTGKGTVTYLAS 674 (674)
Q Consensus 652 a~~~~~~~~~~~~~~GTp~YmAP 674 (674)
+..... .....+++.|+||
T Consensus 155 a~~~~~----~~~~~~~~~y~aP 173 (259)
T cd05037 155 PITVLS----REERVERIPWIAP 173 (259)
T ss_pred cccccc----ccccccCCCccCh
Confidence 986543 2224567788887
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.9e-23 Score=218.51 Aligned_cols=167 Identities=32% Similarity=0.574 Sum_probs=137.8
Q ss_pred cCCeeEeeeecccCceEEEEEEEc--CC--eEEEEEeecccCCHHHHHHHHHHHHHHhhC-CCCCeeeEEEEEecCCeEE
Q 005841 504 WEDLTIGEQIGQGSCGTVYHAVWY--GS--DVAVKVFSRQEYSDEVIHSFRQEVSLMKRL-RHPNVLLFMGAVTSPQRLC 578 (674)
Q Consensus 504 ~~~y~~~~~LG~G~fG~Vy~~~~~--~~--~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~ 578 (674)
+++|.+.++||+|+||.||+|... +. .+++|.+.. .......+.+.+|+.++.++ +||||+++++++...+.+|
T Consensus 1 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~-~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~ 79 (297)
T cd05089 1 WEDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKE-FASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLY 79 (297)
T ss_pred CccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccc-cCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcce
Confidence 468999999999999999999873 22 368887753 22334456788999999999 6999999999999999999
Q ss_pred EEEecCCCCCHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCc
Q 005841 579 IVTEFLPRGSLFRLLQRNT---------------TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWT 643 (674)
Q Consensus 579 lV~E~~~ggsL~~~l~~~~---------------~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~ 643 (674)
+||||+++++|.+++.... ..+++..++.++.|++.||+|||+++ |+||||||+|||++.++.
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~--ivH~dlkp~Nill~~~~~ 157 (297)
T cd05089 80 IAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ--FIHRDLAARNVLVGENLA 157 (297)
T ss_pred EEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCcCCcceEEECCCCe
Confidence 9999999999999996532 34889999999999999999999998 999999999999999999
Q ss_pred EEEEecCCcccccCCccccccCCCCccccCC
Q 005841 644 VKVGDFGLSRLKHETYLTTKTGKGTVTYLAS 674 (674)
Q Consensus 644 vkL~DFGla~~~~~~~~~~~~~~GTp~YmAP 674 (674)
+||+|||++...... ........+..||||
T Consensus 158 ~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aP 187 (297)
T cd05089 158 SKIADFGLSRGEEVY-VKKTMGRLPVRWMAI 187 (297)
T ss_pred EEECCcCCCccccce-eccCCCCcCccccCc
Confidence 999999998754321 122222345679988
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.8e-23 Score=212.95 Aligned_cols=168 Identities=35% Similarity=0.603 Sum_probs=140.0
Q ss_pred ccccCCeeEeeeecccCceEEEEEEEcC-CeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeEEE
Q 005841 501 EILWEDLTIGEQIGQGSCGTVYHAVWYG-SDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCI 579 (674)
Q Consensus 501 ~~~~~~y~~~~~LG~G~fG~Vy~~~~~~-~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 579 (674)
++..++|.+.+.||+|+||.||++.+.+ ..||+|.+..... ..+.+.+|+.+++.+.|+||+++++++. .+..|+
T Consensus 2 ~~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~~---~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~ 77 (260)
T cd05069 2 EIPRESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTM---MPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYI 77 (260)
T ss_pred cCChHHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCCc---cHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEE
Confidence 4556789999999999999999998754 4699998765432 2356788999999999999999998875 566899
Q ss_pred EEecCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccccCC
Q 005841 580 VTEFLPRGSLFRLLQRNT-TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHET 658 (674)
Q Consensus 580 V~E~~~ggsL~~~l~~~~-~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~~ 658 (674)
||||+++++|.+++.... ..+++..+..++.||+.||.|||+.+ |+|+||||+|||+++++.++|+|||+++.....
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~--i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~ 155 (260)
T cd05069 78 VTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMN--YIHRDLRAANILVGDNLVCKIADFGLARLIEDN 155 (260)
T ss_pred EEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--EeecccCcceEEEcCCCeEEECCCccceEccCC
Confidence 999999999999997543 35889999999999999999999998 999999999999999999999999999876443
Q ss_pred cccc-ccCCCCccccCC
Q 005841 659 YLTT-KTGKGTVTYLAS 674 (674)
Q Consensus 659 ~~~~-~~~~GTp~YmAP 674 (674)
.... ....+++.|+||
T Consensus 156 ~~~~~~~~~~~~~y~~P 172 (260)
T cd05069 156 EYTARQGAKFPIKWTAP 172 (260)
T ss_pred cccccCCCccchhhCCH
Confidence 2221 123467789988
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.8e-23 Score=215.79 Aligned_cols=168 Identities=30% Similarity=0.530 Sum_probs=142.3
Q ss_pred cCCeeEeeeecccCceEEEEEEEc------CCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEec--CC
Q 005841 504 WEDLTIGEQIGQGSCGTVYHAVWY------GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTS--PQ 575 (674)
Q Consensus 504 ~~~y~~~~~LG~G~fG~Vy~~~~~------~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~--~~ 575 (674)
.++|++.+.||+|+||.||++.+. +..||||++...... .....+.+|+.+++.+.|+||+++++++.. ..
T Consensus 3 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~ 81 (284)
T cd05038 3 KRHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE-QHRSDFEREIEILRTLDHENIVKYKGVCEKPGGR 81 (284)
T ss_pred hhhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch-HHHHHHHHHHHHHHhCCCCChheEEeeeecCCCC
Confidence 356888899999999999999863 457999999765433 456789999999999999999999999877 56
Q ss_pred eEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccc
Q 005841 576 RLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLK 655 (674)
Q Consensus 576 ~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~ 655 (674)
..++||||+++++|.+++......+++..+..++.||+.||+|||+.+ |+|+||||+|||++.++.++|+|||++...
T Consensus 82 ~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~--i~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 159 (284)
T cd05038 82 SLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQR--YIHRDLAARNILVESEDLVKISDFGLAKVL 159 (284)
T ss_pred ceEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHhEEEcCCCCEEEccccccccc
Confidence 799999999999999999876667999999999999999999999998 999999999999999999999999999876
Q ss_pred cCCcc---ccccCCCCccccCC
Q 005841 656 HETYL---TTKTGKGTVTYLAS 674 (674)
Q Consensus 656 ~~~~~---~~~~~~GTp~YmAP 674 (674)
..... ......++..|+||
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~P 181 (284)
T cd05038 160 PEDKDYYYVKEPGESPIFWYAP 181 (284)
T ss_pred ccCCcceeccCCCCCcccccCc
Confidence 53211 11123456668887
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=99.90 E-value=5e-23 Score=211.79 Aligned_cols=167 Identities=29% Similarity=0.465 Sum_probs=145.4
Q ss_pred CCeeEeeeecccCceEEEEEEE--cCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeEEEEEe
Q 005841 505 EDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTE 582 (674)
Q Consensus 505 ~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E 582 (674)
++|++.+.||.|+||+||++.. .+..|++|++....... ....+.+|+.+++.++|+||+++++.+......|+|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 79 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQT-SVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMP 79 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcch-HHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEe
Confidence 4799999999999999999987 46679999987654433 56778999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccccCCcc
Q 005841 583 FLPRGSLFRLLQRN--TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYL 660 (674)
Q Consensus 583 ~~~ggsL~~~l~~~--~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~~~~ 660 (674)
|+++++|.+++... ...+++..+..++.|++.||.|||+.+ |+|+||||+||++++++.++|+|||++..+.....
T Consensus 80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~--i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~ 157 (267)
T cd06610 80 YLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG--QIHRDIKAGNILLGEDGSVKIADFGVSASLADGGD 157 (267)
T ss_pred ccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHhEEEcCCCCEEEcccchHHHhccCcc
Confidence 99999999999764 246899999999999999999999999 99999999999999999999999999987654322
Q ss_pred c----cccCCCCccccCC
Q 005841 661 T----TKTGKGTVTYLAS 674 (674)
Q Consensus 661 ~----~~~~~GTp~YmAP 674 (674)
. .....|++.|+||
T Consensus 158 ~~~~~~~~~~~~~~y~~P 175 (267)
T cd06610 158 RTRKVRKTFVGTPCWMAP 175 (267)
T ss_pred ccccccccccCChhhcCh
Confidence 2 1334689999998
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.1e-23 Score=213.88 Aligned_cols=166 Identities=31% Similarity=0.530 Sum_probs=142.1
Q ss_pred CeeEeeeecccCceEEEEEEE--cCCeEEEEEeecccCC-------HHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCe
Q 005841 506 DLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYS-------DEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQR 576 (674)
Q Consensus 506 ~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~~-------~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 576 (674)
+|.+...||.|+||.||+|.+ .+..||+|.+...... .+..+.+.+|+.+++.++||||+++++++...+.
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 477889999999999999987 4678999988654332 1345678899999999999999999999999999
Q ss_pred EEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCccccc
Q 005841 577 LCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKH 656 (674)
Q Consensus 577 ~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~ 656 (674)
.++||||+++++|.+++... ..+++..+..++.|++.||.|||+++ |+|+||||+|||+++++.++|+|||+++...
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~l~~~l~~lH~~~--ivH~di~p~nil~~~~~~~~l~dfg~~~~~~ 157 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNY-GAFEETLVRNFVRQILKGLNYLHNRG--IIHRDIKGANILVDNKGGIKISDFGISKKLE 157 (267)
T ss_pred cEEEEEecCCCCHHHHHHhc-cCccHHHHHHHHHHHHHHHHHHHhcC--cccccCCHHHEEEcCCCCEEecccCCCcccc
Confidence 99999999999999999754 56899999999999999999999998 9999999999999999999999999998765
Q ss_pred CCcc------ccccCCCCccccCC
Q 005841 657 ETYL------TTKTGKGTVTYLAS 674 (674)
Q Consensus 657 ~~~~------~~~~~~GTp~YmAP 674 (674)
.... ......|++.|+||
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~y~~p 181 (267)
T cd06628 158 ANSLSTKTNGARPSLQGSVFWMAP 181 (267)
T ss_pred cccccCCccccccccCCCcCccCh
Confidence 2211 11234688999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.2e-23 Score=212.59 Aligned_cols=169 Identities=31% Similarity=0.544 Sum_probs=142.8
Q ss_pred cccccCCeeEeeeecccCceEEEEEEE-cCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeEE
Q 005841 500 YEILWEDLTIGEQIGQGSCGTVYHAVW-YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLC 578 (674)
Q Consensus 500 ~~~~~~~y~~~~~LG~G~fG~Vy~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 578 (674)
|++..++|.+.+.||+|+||.||++.+ .+..|++|.+.... .....+.+|+.+++.++|+||+++++.+.. ...|
T Consensus 1 ~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~ 76 (260)
T cd05073 1 WEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS---MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIY 76 (260)
T ss_pred CcccccceeEEeEecCccceEEEEEEecCCccEEEEecCCCh---hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeE
Confidence 467788999999999999999999986 45669999886432 234678889999999999999999999887 7889
Q ss_pred EEEecCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccccC
Q 005841 579 IVTEFLPRGSLFRLLQRN-TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHE 657 (674)
Q Consensus 579 lV~E~~~ggsL~~~l~~~-~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~ 657 (674)
+||||+++++|.+++... ...+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++.....
T Consensus 77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~--i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~ 154 (260)
T cd05073 77 IITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN--YIHRDLRAANILVSASLVCKIADFGLARVIED 154 (260)
T ss_pred EEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCC--ccccccCcceEEEcCCCcEEECCCcceeeccC
Confidence 999999999999999763 346788999999999999999999988 99999999999999999999999999986643
Q ss_pred Cccc-cccCCCCccccCC
Q 005841 658 TYLT-TKTGKGTVTYLAS 674 (674)
Q Consensus 658 ~~~~-~~~~~GTp~YmAP 674 (674)
.... .....++..|+||
T Consensus 155 ~~~~~~~~~~~~~~y~~P 172 (260)
T cd05073 155 NEYTAREGAKFPIKWTAP 172 (260)
T ss_pred CCcccccCCcccccccCH
Confidence 2222 2223466779887
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.6e-23 Score=210.24 Aligned_cols=167 Identities=29% Similarity=0.474 Sum_probs=149.2
Q ss_pred CeeEeeeecccCceEEEEEEEc--CCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeEEEEEec
Q 005841 506 DLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEF 583 (674)
Q Consensus 506 ~y~~~~~LG~G~fG~Vy~~~~~--~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~ 583 (674)
+|.+.+.||.|+||.||++.+. +..|++|++............+.+|+.+++.++|+|++++++.+......++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 5889999999999999999985 77899999987665556667788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccccCCcc
Q 005841 584 LPRGSLFRLLQRN---TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYL 660 (674)
Q Consensus 584 ~~ggsL~~~l~~~---~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~~~~ 660 (674)
+++++|.+++... ...+++..+..++.+++.||.|||+.+ ++|+||+|+|||++.++.++|+|||++........
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~--~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~ 158 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK--ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVD 158 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCC--EecccCChHHeEEcCCCcEEECCccceeecccCcc
Confidence 9999999999764 367999999999999999999999998 99999999999999999999999999987765543
Q ss_pred ccccCCCCccccCC
Q 005841 661 TTKTGKGTVTYLAS 674 (674)
Q Consensus 661 ~~~~~~GTp~YmAP 674 (674)
......|++.|+||
T Consensus 159 ~~~~~~~~~~y~~p 172 (258)
T cd08215 159 LAKTVVGTPYYLSP 172 (258)
T ss_pred eecceeeeecccCh
Confidence 34445789999998
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.4e-23 Score=220.32 Aligned_cols=169 Identities=31% Similarity=0.411 Sum_probs=141.9
Q ss_pred ccCCeeEeeeecccCceEEEEEEE--cCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecC--CeEE
Q 005841 503 LWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSP--QRLC 578 (674)
Q Consensus 503 ~~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~--~~~~ 578 (674)
..++|++.+.||+|+||.||+|.+ ++..||+|++............+.+|+.+++.++|+||+++++++... +.+|
T Consensus 5 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (309)
T cd07845 5 SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIF 84 (309)
T ss_pred cccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEE
Confidence 347899999999999999999997 477899999875543333333466799999999999999999998755 5689
Q ss_pred EEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccccCC
Q 005841 579 IVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHET 658 (674)
Q Consensus 579 lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~~ 658 (674)
+||||+.+ +|.+++......+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 85 lv~e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~ 161 (309)
T cd07845 85 LVMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENF--IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLP 161 (309)
T ss_pred EEEecCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEECCCCCEEECccceeeecCCc
Confidence 99999964 899988776677999999999999999999999999 999999999999999999999999999876543
Q ss_pred ccccccCCCCccccCC
Q 005841 659 YLTTKTGKGTVTYLAS 674 (674)
Q Consensus 659 ~~~~~~~~GTp~YmAP 674 (674)
........+++.|+||
T Consensus 162 ~~~~~~~~~~~~y~aP 177 (309)
T cd07845 162 AKPMTPKVVTLWYRAP 177 (309)
T ss_pred cCCCCcccccccccCh
Confidence 2222223468889998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=99.90 E-value=3e-23 Score=217.42 Aligned_cols=167 Identities=27% Similarity=0.352 Sum_probs=138.8
Q ss_pred CCeeEeeeecccCceEEEEEEE--cCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCC-CCCeeeEEEEEecCCe-----
Q 005841 505 EDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLR-HPNVLLFMGAVTSPQR----- 576 (674)
Q Consensus 505 ~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~----- 576 (674)
++|++.+.||+|+||.||+|.+ ++..||||++............+.+|+.+++.+. ||||+++++++...+.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 4689999999999999999997 4678999998665433333456788999999995 6999999999987766
Q ss_pred EEEEEecCCCCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcC-CCcEEEEecCC
Q 005841 577 LCIVTEFLPRGSLFRLLQRN----TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDK-HWTVKVGDFGL 651 (674)
Q Consensus 577 ~~lV~E~~~ggsL~~~l~~~----~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~-~~~vkL~DFGl 651 (674)
+|+||||+++ +|.+++... ...+++..++.++.||+.||.|||+.+ |+||||||+|||++. ++.+||+|||+
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~--i~H~dl~~~nil~~~~~~~~kl~dfg~ 157 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG--VMHRDLKPQNLLVDKQKGLLKIADLGL 157 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCChHHEEEecCCCeEEEeeccc
Confidence 8999999986 898887643 235899999999999999999999998 999999999999998 89999999999
Q ss_pred cccccCCccccccCCCCccccCC
Q 005841 652 SRLKHETYLTTKTGKGTVTYLAS 674 (674)
Q Consensus 652 a~~~~~~~~~~~~~~GTp~YmAP 674 (674)
++.............+++.|+||
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~aP 180 (295)
T cd07837 158 GRAFSIPVKSYTHEIVTLWYRAP 180 (295)
T ss_pred ceecCCCccccCCcccccCCCCh
Confidence 98654332222234578899998
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.4e-23 Score=210.66 Aligned_cols=161 Identities=30% Similarity=0.539 Sum_probs=137.1
Q ss_pred eeecccCceEEEEEEE-cCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeEEEEEecCCCCCH
Q 005841 511 EQIGQGSCGTVYHAVW-YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSL 589 (674)
Q Consensus 511 ~~LG~G~fG~Vy~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL 589 (674)
++||+|+||.||++.. .+..||+|++.... .......+.+|+.+++.++||||+++++++......++||||+++++|
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 79 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDL-PQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDF 79 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcC-CHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcH
Confidence 3689999999999986 45679999886543 344456788999999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccccCCccccc-cCCCC
Q 005841 590 FRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTK-TGKGT 668 (674)
Q Consensus 590 ~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~~~~~~~-~~~GT 668 (674)
.+++......+++..+..++.|++.+|.|||+.+ ++|+||||+||+++.++.+||+|||++........... ...++
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~ 157 (250)
T cd05085 80 LSFLRKKKDELKTKQLVKFALDAAAGMAYLESKN--CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIP 157 (250)
T ss_pred HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecccChheEEEcCCCeEEECCCccceeccccccccCCCCCCc
Confidence 9999766667899999999999999999999998 99999999999999999999999999976543322211 22456
Q ss_pred ccccCC
Q 005841 669 VTYLAS 674 (674)
Q Consensus 669 p~YmAP 674 (674)
+.|+||
T Consensus 158 ~~y~aP 163 (250)
T cd05085 158 IKWTAP 163 (250)
T ss_pred ccccCH
Confidence 779988
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.5e-23 Score=222.67 Aligned_cols=172 Identities=22% Similarity=0.312 Sum_probs=150.3
Q ss_pred ccccccCCeeEeeeecccCceEEEEEEEc-CCeEEEEEeecccCCHHHHHHHHHHHHHHhhCC-CCCeeeEEEEEecCCe
Q 005841 499 DYEILWEDLTIGEQIGQGSCGTVYHAVWY-GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLR-HPNVLLFMGAVTSPQR 576 (674)
Q Consensus 499 ~~~~~~~~y~~~~~LG~G~fG~Vy~~~~~-~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~ 576 (674)
.+.+....|+++++||.||-..||++... ...||+|.+.....+...+..|.+|+.+|.+|+ |.+|+++++|-..+++
T Consensus 355 ~i~Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~ 434 (677)
T KOG0596|consen 355 IIKVKGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGY 434 (677)
T ss_pred eEEECcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCce
Confidence 34677889999999999999999999874 456888888777778889999999999999996 8999999999999999
Q ss_pred EEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCccccc
Q 005841 577 LCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKH 656 (674)
Q Consensus 577 ~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~ 656 (674)
+||||||- ..+|..+|++....+....+.+|..||+.++.++|..| |||.||||.|||+-+ |.+||+|||+|....
T Consensus 435 lYmvmE~G-d~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~g--IVHSDLKPANFLlVk-G~LKLIDFGIA~aI~ 510 (677)
T KOG0596|consen 435 LYMVMECG-DIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHG--IVHSDLKPANFLLVK-GRLKLIDFGIANAIQ 510 (677)
T ss_pred EEEEeecc-cccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhc--eeecCCCcccEEEEe-eeEEeeeechhcccC
Confidence 99999975 56999999887666665689999999999999999999 999999999999987 599999999998764
Q ss_pred C--CccccccCCCCccccCC
Q 005841 657 E--TYLTTKTGKGTVTYLAS 674 (674)
Q Consensus 657 ~--~~~~~~~~~GTp~YmAP 674 (674)
. +.+...+-+||+.||+|
T Consensus 511 ~DTTsI~kdsQvGT~NYMsP 530 (677)
T KOG0596|consen 511 PDTTSIVKDSQVGTVNYMSP 530 (677)
T ss_pred ccccceeeccccCcccccCH
Confidence 3 33444456899999998
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.1e-23 Score=244.61 Aligned_cols=171 Identities=31% Similarity=0.568 Sum_probs=146.6
Q ss_pred ccccCCeeEeeeecccCceEEEEEEEc---CC----eEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEec
Q 005841 501 EILWEDLTIGEQIGQGSCGTVYHAVWY---GS----DVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTS 573 (674)
Q Consensus 501 ~~~~~~y~~~~~LG~G~fG~Vy~~~~~---~~----~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~ 573 (674)
++.....++...||+|+||.||+|... +. .||||.+.+. .+......|.+|..+|+.++|||||+++|++.+
T Consensus 688 ~v~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~-~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~ 766 (1025)
T KOG1095|consen 688 EVPRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRL-SSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLD 766 (1025)
T ss_pred cCChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEecccc-CCHHHHHHHHHHHHHHhcCCCcceeeEEEeecC
Confidence 355678899999999999999999873 22 2888888653 355667889999999999999999999999999
Q ss_pred CCeEEEEEecCCCCCHHHHHHhc------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEE
Q 005841 574 PQRLCIVTEFLPRGSLFRLLQRN------TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVG 647 (674)
Q Consensus 574 ~~~~~lV~E~~~ggsL~~~l~~~------~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~ 647 (674)
....+|++|||.||+|..+|++. ...++..+.+.|+.||+.|+.||++++ .|||||..+|+|++....|||+
T Consensus 767 ~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~--fvHRDLAaRNCLL~~~r~VKIa 844 (1025)
T KOG1095|consen 767 SGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH--FVHRDLAARNCLLDERRVVKIA 844 (1025)
T ss_pred CCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC--CcCcchhhhheeecccCcEEEc
Confidence 99999999999999999999987 667999999999999999999999999 9999999999999999999999
Q ss_pred ecCCccccc-CCccccccC-CCCccccCC
Q 005841 648 DFGLSRLKH-ETYLTTKTG-KGTVTYLAS 674 (674)
Q Consensus 648 DFGla~~~~-~~~~~~~~~-~GTp~YmAP 674 (674)
|||+|+.+. ..++..... .-...||||
T Consensus 845 DFGlArDiy~~~yyr~~~~a~lPvkWm~P 873 (1025)
T KOG1095|consen 845 DFGLARDIYDKDYYRKHGEAMLPVKWMPP 873 (1025)
T ss_pred ccchhHhhhhchheeccCccccceecCCH
Confidence 999999543 333333222 234689998
|
|
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.9e-23 Score=212.40 Aligned_cols=164 Identities=30% Similarity=0.483 Sum_probs=146.2
Q ss_pred CCeeEeeeecccCceEEEEEEEc--CCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeEEEEEe
Q 005841 505 EDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTE 582 (674)
Q Consensus 505 ~~y~~~~~LG~G~fG~Vy~~~~~--~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E 582 (674)
++|++.+.||.|+||.||++.+. +..|++|.+.... ....+.+|+.+++.++||||+++++.+.....+|++||
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~----~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e 78 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEE----DLQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVME 78 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHH----HHHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEe
Confidence 57899999999999999999984 5779999986432 15678999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccccCCcccc
Q 005841 583 FLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTT 662 (674)
Q Consensus 583 ~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~~~~~~ 662 (674)
|+++++|.+++......+++..+..++.|++.||.|||..+ |+|+||+|+||+++.++.++|+|||++..........
T Consensus 79 ~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~--i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~~~ 156 (256)
T cd06612 79 YCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNK--KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKR 156 (256)
T ss_pred cCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCcceEEECCCCcEEEcccccchhcccCcccc
Confidence 99999999999876778999999999999999999999998 9999999999999999999999999998766543333
Q ss_pred ccCCCCccccCC
Q 005841 663 KTGKGTVTYLAS 674 (674)
Q Consensus 663 ~~~~GTp~YmAP 674 (674)
....|++.|+||
T Consensus 157 ~~~~~~~~y~~P 168 (256)
T cd06612 157 NTVIGTPFWMAP 168 (256)
T ss_pred ccccCCccccCH
Confidence 345689999998
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.90 E-value=5.3e-23 Score=214.58 Aligned_cols=163 Identities=32% Similarity=0.547 Sum_probs=135.6
Q ss_pred eeEeeeecccCceEEEEEEE------cCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecC--CeEE
Q 005841 507 LTIGEQIGQGSCGTVYHAVW------YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSP--QRLC 578 (674)
Q Consensus 507 y~~~~~LG~G~fG~Vy~~~~------~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~--~~~~ 578 (674)
|++.+.||+|+||+||++.+ .+..||+|++.... .......+.+|+.+++.++||||+++++++... ..+|
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKREC-GQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQ 84 (283)
T ss_pred ceeceecccCCCcEEEEeeEccccCCCCceEEEEEecccc-ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEE
Confidence 48999999999999988763 35569999986543 233456788899999999999999999987653 4589
Q ss_pred EEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccccCC
Q 005841 579 IVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHET 658 (674)
Q Consensus 579 lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~~ 658 (674)
+||||+++++|.+++... .+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 85 lv~e~~~~~~l~~~~~~~--~l~~~~~~~i~~~l~~~l~~lH~~~--i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~ 160 (283)
T cd05080 85 LIMEYVPLGSLRDYLPKH--KLNLAQLLLFAQQICEGMAYLHSQH--YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEG 160 (283)
T ss_pred EEecCCCCCCHHHHHHHc--CCCHHHHHHHHHHHHHHHHHHHHCC--eeccccChheEEEcCCCcEEEeecccccccCCc
Confidence 999999999999999753 5999999999999999999999998 999999999999999999999999999876542
Q ss_pred ccc---cccCCCCccccCC
Q 005841 659 YLT---TKTGKGTVTYLAS 674 (674)
Q Consensus 659 ~~~---~~~~~GTp~YmAP 674 (674)
... .....+++.|+||
T Consensus 161 ~~~~~~~~~~~~~~~~~~P 179 (283)
T cd05080 161 HEYYRVREDGDSPVFWYAV 179 (283)
T ss_pred chhhccCCCCCCCceeeCH
Confidence 211 1223466778887
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.9e-23 Score=216.31 Aligned_cols=166 Identities=24% Similarity=0.398 Sum_probs=141.8
Q ss_pred CeeEeeeecccCceEEEEEEE-----cCCeEEEEEeecccCC--HHHHHHHHHHHHHHhhC-CCCCeeeEEEEEecCCeE
Q 005841 506 DLTIGEQIGQGSCGTVYHAVW-----YGSDVAVKVFSRQEYS--DEVIHSFRQEVSLMKRL-RHPNVLLFMGAVTSPQRL 577 (674)
Q Consensus 506 ~y~~~~~LG~G~fG~Vy~~~~-----~~~~vAvK~i~~~~~~--~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~ 577 (674)
+|++.+.||+|+||.||++.. ++..||+|++...... ....+.+.+|+.++..+ +|+||+.+++.+.....+
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 488999999999999999986 4677999998754322 13446678899999999 589999999999999999
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccccC
Q 005841 578 CIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHE 657 (674)
Q Consensus 578 ~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~ 657 (674)
|+||||+++++|.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 81 ~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~al~~lH~~~--i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~ 157 (290)
T cd05613 81 HLILDYINGGELFTHLSQR-ERFKEQEVQIYSGEIVLALEHLHKLG--IIYRDIKLENILLDSNGHVVLTDFGLSKEFHE 157 (290)
T ss_pred EEEEecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHeEECCCCCEEEeeCccceeccc
Confidence 9999999999999999754 46889999999999999999999998 99999999999999999999999999987643
Q ss_pred Ccc-ccccCCCCccccCC
Q 005841 658 TYL-TTKTGKGTVTYLAS 674 (674)
Q Consensus 658 ~~~-~~~~~~GTp~YmAP 674 (674)
... ......|++.|+||
T Consensus 158 ~~~~~~~~~~~~~~y~aP 175 (290)
T cd05613 158 DEVERAYSFCGTIEYMAP 175 (290)
T ss_pred ccccccccccCCcccCCh
Confidence 221 22345689999998
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.9e-23 Score=211.43 Aligned_cols=165 Identities=34% Similarity=0.544 Sum_probs=144.0
Q ss_pred CeeEeeeecccCceEEEEEEE--cCCeEEEEEeecccC---CHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeEEEE
Q 005841 506 DLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEY---SDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIV 580 (674)
Q Consensus 506 ~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~---~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 580 (674)
+|+..+.||+|+||+||+|.. .+..|++|.+..... ..+....+.+|+.+++.++|+||+++++++.....+|+|
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 477789999999999999987 477899999876442 235667899999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccccCCcc
Q 005841 581 TEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYL 660 (674)
Q Consensus 581 ~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~~~~ 660 (674)
|||+++++|.+++.+. ..+++..+..++.||+.||.|||+.+ |+|+||||+||+++.++.+||+|||++.......
T Consensus 81 ~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~- 156 (258)
T cd06632 81 LELVPGGSLAKLLKKY-GSFPEPVIRLYTRQILLGLEYLHDRN--TVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS- 156 (258)
T ss_pred EEecCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCCCCEEEccCccceeccccc-
Confidence 9999999999999754 46899999999999999999999998 9999999999999999999999999998765433
Q ss_pred ccccCCCCccccCC
Q 005841 661 TTKTGKGTVTYLAS 674 (674)
Q Consensus 661 ~~~~~~GTp~YmAP 674 (674)
......|++.|+||
T Consensus 157 ~~~~~~~~~~y~~p 170 (258)
T cd06632 157 FAKSFKGSPYWMAP 170 (258)
T ss_pred cccccCCCcceeCH
Confidence 22345689999998
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=99.90 E-value=6e-23 Score=216.93 Aligned_cols=167 Identities=27% Similarity=0.409 Sum_probs=141.7
Q ss_pred CCeeEeeeecccCceEEEEEEE--cCCeEEEEEeecccCC-HHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeEEEEE
Q 005841 505 EDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYS-DEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVT 581 (674)
Q Consensus 505 ~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 581 (674)
.+|.+.+.||+|+||.||++.+ .+..|++|.+.+.... ......+.+|+.+++.++||||+++++.+...+.+|+||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 3689999999999999999987 4567999998765432 234567889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccccCCc--
Q 005841 582 EFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETY-- 659 (674)
Q Consensus 582 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~~~-- 659 (674)
||+++++|.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 81 e~~~g~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~ 157 (305)
T cd05609 81 EYVEGGDCATLLKNI-GALPVDMARMYFAETVLALEYLHNYG--IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTT 157 (305)
T ss_pred ecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCchHHEEECCCCCEEEeeCCCccccCcCccc
Confidence 999999999999654 46899999999999999999999998 9999999999999999999999999987421110
Q ss_pred -------------cccccCCCCccccCC
Q 005841 660 -------------LTTKTGKGTVTYLAS 674 (674)
Q Consensus 660 -------------~~~~~~~GTp~YmAP 674 (674)
.......|++.|+||
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~y~aP 185 (305)
T cd05609 158 NLYEGHIEKDTREFLDKQVCGTPEYIAP 185 (305)
T ss_pred cccccccccchhhccccCCccCccccCc
Confidence 011124578899998
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.3e-23 Score=215.96 Aligned_cols=167 Identities=28% Similarity=0.365 Sum_probs=143.8
Q ss_pred CCeeEeeeecccCceEEEEEEE--cCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeEEEEEe
Q 005841 505 EDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTE 582 (674)
Q Consensus 505 ~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E 582 (674)
++|++.+.||+|+||.||+|.+ .+..|+||++............+.+|+.+++.+.|+||+++++++...+.+|+|||
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 3699999999999999999987 46679999987655444556778999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccccCCcc-c
Q 005841 583 FLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYL-T 661 (674)
Q Consensus 583 ~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~~~~-~ 661 (674)
|++++.|..++. ....+++..+..++.||+.||.|||..+ |+|+||||+||++++++.+||+|||++........ .
T Consensus 81 ~~~~~~l~~~~~-~~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~~ 157 (288)
T cd07833 81 YVERTLLELLEA-SPGGLPPDAVRSYIWQLLQAIAYCHSHN--IIHRDIKPENILVSESGVLKLCDFGFARALRARPASP 157 (288)
T ss_pred cCCCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEECCCCCEEEEeeecccccCCCcccc
Confidence 998866665554 4556899999999999999999999998 99999999999999999999999999987655432 2
Q ss_pred cccCCCCccccCC
Q 005841 662 TKTGKGTVTYLAS 674 (674)
Q Consensus 662 ~~~~~GTp~YmAP 674 (674)
.....|++.||||
T Consensus 158 ~~~~~~~~~~~~P 170 (288)
T cd07833 158 LTDYVATRWYRAP 170 (288)
T ss_pred ccCcccccCCcCC
Confidence 2335689999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.9e-23 Score=215.14 Aligned_cols=165 Identities=27% Similarity=0.415 Sum_probs=140.6
Q ss_pred CeeEeeeecccCceEEEEEEE--cCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeEEEEEec
Q 005841 506 DLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEF 583 (674)
Q Consensus 506 ~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~ 583 (674)
+|++.+.||.|++|.||+|++ ++..||||++...... .....+.+|+.+++.++|+||+++++++...+.+||||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 79 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEE-GTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEY 79 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccc-cchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEec
Confidence 589999999999999999998 4778999998765322 2234567899999999999999999999999999999999
Q ss_pred CCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccccCCccc
Q 005841 584 LPRGSLFRLLQRNT--TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLT 661 (674)
Q Consensus 584 ~~ggsL~~~l~~~~--~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~~~~~ 661 (674)
+++ +|.+++.... ..+++..+..++.||+.||.|||+.+ |+|+||||+||+++.++.++|+|||+++........
T Consensus 80 ~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~~ 156 (284)
T cd07836 80 MDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR--VLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNT 156 (284)
T ss_pred CCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCHHHEEECCCCcEEEeecchhhhhcCCccc
Confidence 975 8988886543 46899999999999999999999998 999999999999999999999999999865443322
Q ss_pred cccCCCCccccCC
Q 005841 662 TKTGKGTVTYLAS 674 (674)
Q Consensus 662 ~~~~~GTp~YmAP 674 (674)
.....+|+.|+||
T Consensus 157 ~~~~~~~~~y~~P 169 (284)
T cd07836 157 FSNEVVTLWYRAP 169 (284)
T ss_pred cccccccccccCh
Confidence 2334578899988
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=99.90 E-value=5.2e-23 Score=210.87 Aligned_cols=166 Identities=32% Similarity=0.562 Sum_probs=142.6
Q ss_pred cCCeeEeeeecccCceEEEEEEEc-CCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeEEEEEe
Q 005841 504 WEDLTIGEQIGQGSCGTVYHAVWY-GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTE 582 (674)
Q Consensus 504 ~~~y~~~~~LG~G~fG~Vy~~~~~-~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E 582 (674)
..+|++.+.||+|+||.||++.+. +..+|+|++....... ..+.+|+.+++.+.||||+++++++......|+|||
T Consensus 3 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~~~---~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e 79 (256)
T cd05112 3 PSELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMSE---EDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFE 79 (256)
T ss_pred hhHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCCCH---HHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEE
Confidence 357899999999999999999874 6789999987654433 357789999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccccCCccc-
Q 005841 583 FLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLT- 661 (674)
Q Consensus 583 ~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~~~~~- 661 (674)
|+++++|.+++......+++..+..++.|++.+|.|||+.+ |+|+||||+||+++.++.+||+|||+++........
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~ 157 (256)
T cd05112 80 FMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSN--VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTS 157 (256)
T ss_pred cCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCC--ccccccccceEEEcCCCeEEECCCcceeecccCcccc
Confidence 99999999999876667899999999999999999999998 999999999999999999999999999865433222
Q ss_pred cccCCCCccccCC
Q 005841 662 TKTGKGTVTYLAS 674 (674)
Q Consensus 662 ~~~~~GTp~YmAP 674 (674)
.....++..|+||
T Consensus 158 ~~~~~~~~~~~aP 170 (256)
T cd05112 158 STGTKFPVKWSSP 170 (256)
T ss_pred cCCCccchhhcCH
Confidence 1122356789988
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.90 E-value=5.7e-23 Score=211.21 Aligned_cols=166 Identities=31% Similarity=0.518 Sum_probs=145.9
Q ss_pred CeeEeeeecccCceEEEEEEE--cCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeEEEEEec
Q 005841 506 DLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEF 583 (674)
Q Consensus 506 ~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~ 583 (674)
+|.+.+.||+|+||.||++.. .+..|++|++............+..|+.+++.++|+||+++++.+...+.+++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 588999999999999999987 467899999987665555678899999999999999999999999999999999999
Q ss_pred CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccccCCccccc
Q 005841 584 LPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTK 663 (674)
Q Consensus 584 ~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~~~~~~~ 663 (674)
+++++|.+++... ..+++..+..++.|++.||.|||+.+ |+|+||||+||+++.++.+||+|||++...........
T Consensus 81 ~~~~~L~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~--i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~ 157 (264)
T cd06626 81 CSGGTLEELLEHG-RILDEHVIRVYTLQLLEGLAYLHSHG--IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMG 157 (264)
T ss_pred CCCCcHHHHHhhc-CCCChHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCCCCEEEcccccccccCCCCCccc
Confidence 9999999999753 45889999999999999999999999 99999999999999999999999999987654322211
Q ss_pred ----cCCCCccccCC
Q 005841 664 ----TGKGTVTYLAS 674 (674)
Q Consensus 664 ----~~~GTp~YmAP 674 (674)
...|++.|+||
T Consensus 158 ~~~~~~~~~~~~~~P 172 (264)
T cd06626 158 EEVQSLAGTPAYMAP 172 (264)
T ss_pred ccccCCcCCcCccCh
Confidence 24688999998
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=99.90 E-value=5.8e-23 Score=212.20 Aligned_cols=170 Identities=31% Similarity=0.472 Sum_probs=143.2
Q ss_pred cccCCeeEeeeecccCceEEEEEEEc--CC---eEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCe
Q 005841 502 ILWEDLTIGEQIGQGSCGTVYHAVWY--GS---DVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQR 576 (674)
Q Consensus 502 ~~~~~y~~~~~LG~G~fG~Vy~~~~~--~~---~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 576 (674)
+...+|+..+.||+|+||.||++... +. .+++|.+.... .....+.+..|+.+++.++||||+++++++...+.
T Consensus 2 i~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (268)
T cd05063 2 IHPSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGY-TEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKP 80 (268)
T ss_pred CChHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccC-CHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCC
Confidence 34467899999999999999999873 32 58999886432 34445678899999999999999999999999999
Q ss_pred EEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCccccc
Q 005841 577 LCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKH 656 (674)
Q Consensus 577 ~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~ 656 (674)
.|+||||+++++|.+++......+++..+..++.|++.||+|||+.+ |+|+||||+|||++.++.+||+|||++....
T Consensus 81 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~--i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~ 158 (268)
T cd05063 81 AMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMN--YVHRDLAARNILVNSNLECKVSDFGLSRVLE 158 (268)
T ss_pred cEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccccchhhEEEcCCCcEEECCCccceecc
Confidence 99999999999999999876678999999999999999999999998 9999999999999999999999999998664
Q ss_pred CCcccc---ccCCCCccccCC
Q 005841 657 ETYLTT---KTGKGTVTYLAS 674 (674)
Q Consensus 657 ~~~~~~---~~~~GTp~YmAP 674 (674)
...... .....++.|+||
T Consensus 159 ~~~~~~~~~~~~~~~~~y~~P 179 (268)
T cd05063 159 DDPEGTYTTSGGKIPIRWTAP 179 (268)
T ss_pred cccccceeccCCCcCceecCH
Confidence 322111 112345679987
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.6e-23 Score=211.93 Aligned_cols=159 Identities=26% Similarity=0.459 Sum_probs=134.6
Q ss_pred eecccCceEEEEEEE----cCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeEEEEEecCCCC
Q 005841 512 QIGQGSCGTVYHAVW----YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRG 587 (674)
Q Consensus 512 ~LG~G~fG~Vy~~~~----~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg 587 (674)
.||+|+||.||+|.+ ++..||+|++..........+.+.+|+.+++.+.||||+++++++. .+..++||||++++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 689999999999975 3566999998766555566778999999999999999999999875 55789999999999
Q ss_pred CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccccCCcc---cccc
Q 005841 588 SLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYL---TTKT 664 (674)
Q Consensus 588 sL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~~~~---~~~~ 664 (674)
+|.+++... ..+++..+..++.|++.||.|||+++ |+||||||.|||++.++.+||+|||+++....... ....
T Consensus 81 ~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~lH~~~--i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 157 (257)
T cd05116 81 PLNKFLQKN-KHVTEKNITELVHQVSMGMKYLEETN--FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTH 157 (257)
T ss_pred cHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecCC
Confidence 999999753 46899999999999999999999999 99999999999999999999999999987643221 1122
Q ss_pred CCCCccccCC
Q 005841 665 GKGTVTYLAS 674 (674)
Q Consensus 665 ~~GTp~YmAP 674 (674)
..+++.||||
T Consensus 158 ~~~~~~y~aP 167 (257)
T cd05116 158 GKWPVKWYAP 167 (257)
T ss_pred CCCCccccCH
Confidence 3456889998
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.2e-23 Score=220.52 Aligned_cols=167 Identities=35% Similarity=0.585 Sum_probs=140.9
Q ss_pred ccccCCeeEeeeecccCceEEEEEEEcCCeEEEEEeecccCCHHHHHHHHHHHHHHhh--CCCCCeeeEEEEEecC----
Q 005841 501 EILWEDLTIGEQIGQGSCGTVYHAVWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKR--LRHPNVLLFMGAVTSP---- 574 (674)
Q Consensus 501 ~~~~~~y~~~~~LG~G~fG~Vy~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~--l~HpnIv~l~~~~~~~---- 574 (674)
........+.+.||+|-||.||+|.|.|..||||+|.... .+.+.+|.+|++. |+|+||+.|++.-...
T Consensus 207 RTiarqI~L~e~IGkGRyGEVwrG~wrGe~VAVKiF~srd-----E~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~ 281 (513)
T KOG2052|consen 207 RTIARQIVLQEIIGKGRFGEVWRGRWRGEDVAVKIFSSRD-----ERSWFRETEIYQTVMLRHENILGFIAADNKDNGSW 281 (513)
T ss_pred HhhhheeEEEEEecCccccceeeccccCCceEEEEecccc-----hhhhhhHHHHHHHHHhccchhhhhhhccccCCCce
Confidence 4456778999999999999999999999999999996432 2457788888886 5899999999876543
Q ss_pred CeEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh------CCCCeEEccCCCCCEEEcCCCcEEEEe
Q 005841 575 QRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHH------CNPPIIHRDLKSSNLLVDKHWTVKVGD 648 (674)
Q Consensus 575 ~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~------~~~~IvHrDLKp~NILi~~~~~vkL~D 648 (674)
.+++||.+|-+.|||+|||.+ ..++....+.++.-++.||+|||. ..|.|.|||||..||||.+++.+.|+|
T Consensus 282 TQLwLvTdYHe~GSL~DyL~r--~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IAD 359 (513)
T KOG2052|consen 282 TQLWLVTDYHEHGSLYDYLNR--NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIAD 359 (513)
T ss_pred EEEEEeeecccCCcHHHHHhh--ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEee
Confidence 358999999999999999976 568999999999999999999994 335699999999999999999999999
Q ss_pred cCCcccccCC----ccccccCCCCccccCC
Q 005841 649 FGLSRLKHET----YLTTKTGKGTVTYLAS 674 (674)
Q Consensus 649 FGla~~~~~~----~~~~~~~~GTp~YmAP 674 (674)
+|||...... .......+||-+||||
T Consensus 360 LGLAv~h~~~t~~idi~~N~rVGTKRYMAP 389 (513)
T KOG2052|consen 360 LGLAVRHDSDTDTIDIPPNPRVGTKRYMAP 389 (513)
T ss_pred ceeeEEecccCCcccCCCCCccceeeccCh
Confidence 9999754332 2223345899999999
|
|
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.9e-23 Score=214.29 Aligned_cols=168 Identities=24% Similarity=0.415 Sum_probs=142.0
Q ss_pred cCCeeEeeeecccCceEEEEEEEc-------CCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCe
Q 005841 504 WEDLTIGEQIGQGSCGTVYHAVWY-------GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQR 576 (674)
Q Consensus 504 ~~~y~~~~~LG~G~fG~Vy~~~~~-------~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 576 (674)
.++|.+...||.|+||.||+|+.. ...|++|.+.... .......+.+|+.+++.++|+||+++++++.....
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 82 (275)
T cd05046 4 RSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTK-DENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEP 82 (275)
T ss_pred hHhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCcc-chHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCc
Confidence 367999999999999999999863 2458999886543 23356778999999999999999999999999999
Q ss_pred EEEEEecCCCCCHHHHHHhcC--------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEe
Q 005841 577 LCIVTEFLPRGSLFRLLQRNT--------TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGD 648 (674)
Q Consensus 577 ~~lV~E~~~ggsL~~~l~~~~--------~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~D 648 (674)
.|+||||+++++|.+++.... ..+++..+..++.||+.+|.|||+++ |+||||||+|||++.++.++|+|
T Consensus 83 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~--i~H~dlkp~Nili~~~~~~~l~~ 160 (275)
T cd05046 83 HYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR--FVHRDLAARNCLVSSQREVKVSL 160 (275)
T ss_pred ceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC--cccCcCccceEEEeCCCcEEEcc
Confidence 999999999999999997543 15899999999999999999999999 99999999999999999999999
Q ss_pred cCCcccccCC-ccccccCCCCccccCC
Q 005841 649 FGLSRLKHET-YLTTKTGKGTVTYLAS 674 (674)
Q Consensus 649 FGla~~~~~~-~~~~~~~~GTp~YmAP 674 (674)
||+++..... ........+++.|+||
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~y~~P 187 (275)
T cd05046 161 LSLSKDVYNSEYYKLRNALIPLRWLAP 187 (275)
T ss_pred cccccccCcccccccCCceeEEeecCh
Confidence 9998754322 2222334577889988
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=5.9e-23 Score=215.44 Aligned_cols=167 Identities=30% Similarity=0.413 Sum_probs=139.4
Q ss_pred CCeeEeeeecccCceEEEEEEE--cCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeEEEEEe
Q 005841 505 EDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTE 582 (674)
Q Consensus 505 ~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E 582 (674)
++|++.+.||+|+||.||++.+ .+..||+|.+............+.+|+.+++.++||||+++++++......|+|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 5799999999999999999987 46779999987654433445668889999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcC-CCcEEEEecCCcccccCCcc
Q 005841 583 FLPRGSLFRLLQRNT-TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDK-HWTVKVGDFGLSRLKHETYL 660 (674)
Q Consensus 583 ~~~ggsL~~~l~~~~-~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~-~~~vkL~DFGla~~~~~~~~ 660 (674)
|++ ++|.+++.... ..+++..+..++.||+.||+|||+++ |+|+||||+|||++. ++.+||+|||++........
T Consensus 82 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~~ 158 (294)
T PLN00009 82 YLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHR--VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVR 158 (294)
T ss_pred ccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCCcceEEEECCCCEEEEcccccccccCCCcc
Confidence 996 58888775533 33688899999999999999999998 999999999999985 56799999999976543322
Q ss_pred ccccCCCCccccCC
Q 005841 661 TTKTGKGTVTYLAS 674 (674)
Q Consensus 661 ~~~~~~GTp~YmAP 674 (674)
......|++.|+||
T Consensus 159 ~~~~~~~~~~y~~P 172 (294)
T PLN00009 159 TFTHEVVTLWYRAP 172 (294)
T ss_pred ccccCceeecccCH
Confidence 22334678999998
|
|
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.9e-23 Score=210.49 Aligned_cols=165 Identities=38% Similarity=0.651 Sum_probs=141.1
Q ss_pred eeEeeeecccCceEEEEEEEcC------CeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeEEEE
Q 005841 507 LTIGEQIGQGSCGTVYHAVWYG------SDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIV 580 (674)
Q Consensus 507 y~~~~~LG~G~fG~Vy~~~~~~------~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 580 (674)
+.+.+.||.|+||.||++.+.. ..||+|++.... .......+..|+.+++.++|+||+++++++...+..|++
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i 79 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDA-DEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIV 79 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCC-ChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEE
Confidence 3567899999999999999854 669999986543 333567888999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHHhcCCC-CCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccccCCc
Q 005841 581 TEFLPRGSLFRLLQRNTTK-LDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETY 659 (674)
Q Consensus 581 ~E~~~ggsL~~~l~~~~~~-l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~~~ 659 (674)
|||+++++|.+++...... +++..+..++.|++.||.|||+.+ |+|+||||+||+++.++.++|+|||+++......
T Consensus 80 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~--~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~ 157 (258)
T smart00219 80 MEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKN--FIHRDLAARNCLVGENLVVKISDFGLSRDLYDDD 157 (258)
T ss_pred EeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCC--eeecccccceEEEccCCeEEEcccCCceeccccc
Confidence 9999999999999765444 999999999999999999999998 9999999999999999999999999998765432
Q ss_pred cccc-cCCCCccccCC
Q 005841 660 LTTK-TGKGTVTYLAS 674 (674)
Q Consensus 660 ~~~~-~~~GTp~YmAP 674 (674)
.... ...+++.|+||
T Consensus 158 ~~~~~~~~~~~~y~~P 173 (258)
T smart00219 158 YYKKKGGKLPIRWMAP 173 (258)
T ss_pred ccccccCCCcccccCh
Confidence 2111 23478899998
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.90 E-value=6e-23 Score=211.73 Aligned_cols=166 Identities=30% Similarity=0.465 Sum_probs=142.0
Q ss_pred CeeEeeeecccCceEEEEEEE-cCCeEEEEEeecccCC----HHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeEEEE
Q 005841 506 DLTIGEQIGQGSCGTVYHAVW-YGSDVAVKVFSRQEYS----DEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIV 580 (674)
Q Consensus 506 ~y~~~~~LG~G~fG~Vy~~~~-~~~~vAvK~i~~~~~~----~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 580 (674)
+|++.+.||.|+||.||++.. .+..+|+|.+...... ......+.+|+.+++.++|+||+++++++...+.+|+|
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 478899999999999999987 5677999988754322 23456788999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccccCC--
Q 005841 581 TEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHET-- 658 (674)
Q Consensus 581 ~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~~-- 658 (674)
|||+++++|.+++.+. ..+++..+..++.|++.||+|||+.+ |+|+||||+||+++.++.++|+|||++......
T Consensus 81 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 157 (265)
T cd06631 81 MEFVPGGSISSILNRF-GPLPEPVFCKYTKQILDGVAYLHNNC--VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGL 157 (265)
T ss_pred EecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCcCHHhEEECCCCeEEeccchhhHhhhhccc
Confidence 9999999999999754 46889999999999999999999998 999999999999999999999999999765321
Q ss_pred ----ccccccCCCCccccCC
Q 005841 659 ----YLTTKTGKGTVTYLAS 674 (674)
Q Consensus 659 ----~~~~~~~~GTp~YmAP 674 (674)
........||+.|+||
T Consensus 158 ~~~~~~~~~~~~~~~~~~~p 177 (265)
T cd06631 158 HGTHSNMLKSMHGTPYWMAP 177 (265)
T ss_pred cccccccccccCCCccccCh
Confidence 1112235689999998
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=99.90 E-value=5.6e-23 Score=215.57 Aligned_cols=168 Identities=28% Similarity=0.464 Sum_probs=141.0
Q ss_pred ccCCeeEeeeecccCceEEEEEEEc-------CCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCC
Q 005841 503 LWEDLTIGEQIGQGSCGTVYHAVWY-------GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQ 575 (674)
Q Consensus 503 ~~~~y~~~~~LG~G~fG~Vy~~~~~-------~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~ 575 (674)
...+|.+.+.||+|+||.||++.+. ...+++|.+.... ......+.+|+.+++.++|+||+++++++...+
T Consensus 3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 80 (291)
T cd05094 3 KRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPT--LAARKDFQREAELLTNLQHEHIVKFYGVCGDGD 80 (291)
T ss_pred chHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCcc--HHHHHHHHHHHHHHhcCCCCCcceEEEEEccCC
Confidence 4567999999999999999999752 2348888875432 333467889999999999999999999999999
Q ss_pred eEEEEEecCCCCCHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcC
Q 005841 576 RLCIVTEFLPRGSLFRLLQRNT---------------TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDK 640 (674)
Q Consensus 576 ~~~lV~E~~~ggsL~~~l~~~~---------------~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~ 640 (674)
..++||||+++++|.+++.... ..+++..++.++.||+.||.|||+++ |+||||||+|||++.
T Consensus 81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~--i~H~dlkp~Nil~~~ 158 (291)
T cd05094 81 PLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH--FVHRDLATRNCLVGA 158 (291)
T ss_pred ceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecccCcceEEEcc
Confidence 9999999999999999996532 34889999999999999999999999 999999999999999
Q ss_pred CCcEEEEecCCcccccCCcc--ccccCCCCccccCC
Q 005841 641 HWTVKVGDFGLSRLKHETYL--TTKTGKGTVTYLAS 674 (674)
Q Consensus 641 ~~~vkL~DFGla~~~~~~~~--~~~~~~GTp~YmAP 674 (674)
++.++|+|||++........ ......|++.||||
T Consensus 159 ~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aP 194 (291)
T cd05094 159 NLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPP 194 (291)
T ss_pred CCcEEECCCCcccccCCCceeecCCCCCcceeecCh
Confidence 99999999999976543221 12224578899998
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=9.2e-23 Score=207.98 Aligned_cols=166 Identities=30% Similarity=0.556 Sum_probs=147.9
Q ss_pred CeeEeeeecccCceEEEEEEE--cCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeEEEEEec
Q 005841 506 DLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEF 583 (674)
Q Consensus 506 ~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~ 583 (674)
+|++.+.||+|++|.||++.+ .+..|++|.+............+.+|+.++..++|+||+++++++......|+||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 588999999999999999987 466799999987765556677899999999999999999999999999999999999
Q ss_pred CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccccCCccccc
Q 005841 584 LPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTK 663 (674)
Q Consensus 584 ~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~~~~~~~ 663 (674)
+++++|.+++... ..+++..+..++.|++.+|.|||+.+ |+|+||||+||+++.++.++|+|||++...........
T Consensus 81 ~~~~~L~~~~~~~-~~l~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~ 157 (254)
T cd06627 81 AENGSLRQIIKKF-GPFPESLVAVYVYQVLQGLAYLHEQG--VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDA 157 (254)
T ss_pred CCCCcHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHhhCC--cccCCCCHHHEEECCCCCEEEeccccceecCCCccccc
Confidence 9999999999754 57899999999999999999999998 99999999999999999999999999987765444334
Q ss_pred cCCCCccccCC
Q 005841 664 TGKGTVTYLAS 674 (674)
Q Consensus 664 ~~~GTp~YmAP 674 (674)
...|++.|+||
T Consensus 158 ~~~~~~~y~~p 168 (254)
T cd06627 158 SVVGTPYWMAP 168 (254)
T ss_pred ccccchhhcCH
Confidence 45789999998
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=99.90 E-value=5.8e-23 Score=213.74 Aligned_cols=170 Identities=25% Similarity=0.435 Sum_probs=140.2
Q ss_pred cccCCeeEeeeecccCceEEEEEEEcC-------CeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecC
Q 005841 502 ILWEDLTIGEQIGQGSCGTVYHAVWYG-------SDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSP 574 (674)
Q Consensus 502 ~~~~~y~~~~~LG~G~fG~Vy~~~~~~-------~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~ 574 (674)
+..++|.+.+.||+|+||.||+|.+.. ..|++|.+.... .......+.+|+.+++.++|+||+++++++...
T Consensus 3 ~~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 81 (277)
T cd05036 3 VPRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESC-SEQDESDFLMEALIMSKFNHQNIVRLIGVSFER 81 (277)
T ss_pred CCHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccC
Confidence 445789999999999999999998843 458889875433 333446688899999999999999999999999
Q ss_pred CeEEEEEecCCCCCHHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCC---cEE
Q 005841 575 QRLCIVTEFLPRGSLFRLLQRNT------TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHW---TVK 645 (674)
Q Consensus 575 ~~~~lV~E~~~ggsL~~~l~~~~------~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~---~vk 645 (674)
...|+||||+++++|.+++.... ..+++..++.++.||+.||.|||+++ ++|+||||+|||++.++ .+|
T Consensus 82 ~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivH~dlkp~nil~~~~~~~~~~k 159 (277)
T cd05036 82 LPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH--FIHRDIAARNCLLTCKGPGRVAK 159 (277)
T ss_pred CCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccchheEEEeccCCCcceE
Confidence 99999999999999999997643 25899999999999999999999998 99999999999998654 699
Q ss_pred EEecCCcccccCCcccc--ccCCCCccccCC
Q 005841 646 VGDFGLSRLKHETYLTT--KTGKGTVTYLAS 674 (674)
Q Consensus 646 L~DFGla~~~~~~~~~~--~~~~GTp~YmAP 674 (674)
|+|||+++......... ....+++.||||
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aP 190 (277)
T cd05036 160 IADFGMARDIYRASYYRKGGRAMLPIKWMPP 190 (277)
T ss_pred eccCccccccCCccceecCCCCCccHhhCCH
Confidence 99999998764322211 112345679988
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.90 E-value=8.2e-23 Score=211.17 Aligned_cols=167 Identities=29% Similarity=0.455 Sum_probs=140.9
Q ss_pred CCeeEeeeecccCceEEEEEEE--cCCeEEEEEeecccCC---HHHHHHHHHHHHHHhhCCCCCeeeEEEEEec--CCeE
Q 005841 505 EDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYS---DEVIHSFRQEVSLMKRLRHPNVLLFMGAVTS--PQRL 577 (674)
Q Consensus 505 ~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~--~~~~ 577 (674)
.+|.+.+.||+|+||.||++.. ++..|++|++...... .+....+.+|+.+++.++||||+++++++.. ...+
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 3688999999999999999987 5678999988754332 2455678899999999999999999998875 3678
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccccC
Q 005841 578 CIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHE 657 (674)
Q Consensus 578 ~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~ 657 (674)
+++|||+++++|.+++... ..+++..++.++.|++.||.|||+++ |+|+||||+|||++.++.+||+|||+++.+..
T Consensus 82 ~l~~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~LH~~~--i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~ 158 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAY-GALTESVTRKYTRQILEGMSYLHSNM--IVHRDIKGANILRDSAGNVKLGDFGASKRLQT 158 (266)
T ss_pred EEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHEEECCCCCEEEccCCCcccccc
Confidence 9999999999999999753 46899999999999999999999998 99999999999999999999999999986543
Q ss_pred Cc---cccccCCCCccccCC
Q 005841 658 TY---LTTKTGKGTVTYLAS 674 (674)
Q Consensus 658 ~~---~~~~~~~GTp~YmAP 674 (674)
.. .......|++.|+||
T Consensus 159 ~~~~~~~~~~~~~~~~y~aP 178 (266)
T cd06651 159 ICMSGTGIRSVTGTPYWMSP 178 (266)
T ss_pred ccccCCccccCCccccccCH
Confidence 11 112234689999998
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=8.7e-23 Score=210.75 Aligned_cols=167 Identities=31% Similarity=0.512 Sum_probs=141.3
Q ss_pred CCeeEeeeecccCceEEEEEEE--cCCeEEEEEeeccc---CCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecC--CeE
Q 005841 505 EDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQE---YSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSP--QRL 577 (674)
Q Consensus 505 ~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~---~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~--~~~ 577 (674)
.+|.+.+.||+|+||.||++.+ ++..||+|++.... ........+.+|+.+++.++|+||+++++++.+. ..+
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 4799999999999999999987 56789999875432 1234567889999999999999999999998764 468
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccccC
Q 005841 578 CIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHE 657 (674)
Q Consensus 578 ~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~ 657 (674)
++||||+++++|.+++... ..+++..+..++.||+.||.|||+++ |+|+||||+||+++.++.++|+|||+++....
T Consensus 82 ~~v~e~~~~~~L~~~~~~~-~~l~~~~~~~~~~~i~~al~~LH~~~--i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~ 158 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAY-GALTENVTRRYTRQILQGVSYLHSNM--IVHRDIKGANILRDSAGNVKLGDFGASKRIQT 158 (264)
T ss_pred EEEEEeCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEEcCCCCEEECcccccccccc
Confidence 9999999999999998754 35889999999999999999999999 99999999999999999999999999986543
Q ss_pred Cc---cccccCCCCccccCC
Q 005841 658 TY---LTTKTGKGTVTYLAS 674 (674)
Q Consensus 658 ~~---~~~~~~~GTp~YmAP 674 (674)
.. .......||+.|+||
T Consensus 159 ~~~~~~~~~~~~~~~~y~aP 178 (264)
T cd06653 159 ICMSGTGIKSVTGTPYWMSP 178 (264)
T ss_pred ccccCccccccCCcccccCH
Confidence 21 112235689999998
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.1e-23 Score=210.23 Aligned_cols=166 Identities=22% Similarity=0.345 Sum_probs=144.5
Q ss_pred ccccCCeeEeeeecccCceEEEEEEE--cCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCC-CCCeeeEEEEEecCCeE
Q 005841 501 EILWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLR-HPNVLLFMGAVTSPQRL 577 (674)
Q Consensus 501 ~~~~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~ 577 (674)
.+.+-.|+++++||+|+||.++.|.. ++.+||||.-...... ..+..|...++.|. .++|..+|.+..++.+-
T Consensus 24 ~~VG~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~A----PQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~N 99 (449)
T KOG1165|consen 24 LMVGPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSEA----PQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYN 99 (449)
T ss_pred eEecccceeccccccCcceeeecccccccCceEEEEeccccCCc----chHHHHHHHHHHHcCCCCCCceeeeccccchh
Confidence 45667899999999999999999986 7889999986554332 34667899999886 68999999999999999
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcC-----CCcEEEEecCCc
Q 005841 578 CIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDK-----HWTVKVGDFGLS 652 (674)
Q Consensus 578 ~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~-----~~~vkL~DFGla 652 (674)
.||||++ |.+|.|++.-|..+|+.+.++.|+.|++.-|+|+|+++ +|+|||||+||||.. ...|.|+|||+|
T Consensus 100 iLVidLL-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~--LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmA 176 (449)
T KOG1165|consen 100 ILVIDLL-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKD--LIYRDIKPDNFLIGRPGTKDANVIHIIDFGMA 176 (449)
T ss_pred hhhhhhh-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcc--eeecccCccceeecCCCCCCCceEEEEeccch
Confidence 9999998 99999999999999999999999999999999999999 999999999999963 346999999999
Q ss_pred ccccCC-------ccccccCCCCccccC
Q 005841 653 RLKHET-------YLTTKTGKGTVTYLA 673 (674)
Q Consensus 653 ~~~~~~-------~~~~~~~~GTp~YmA 673 (674)
+.+.++ +..-++..||.+||+
T Consensus 177 K~YrDp~TkqHIPYrE~KSLsGTARYMS 204 (449)
T KOG1165|consen 177 KEYRDPKTKQHIPYREHKSLSGTARYMS 204 (449)
T ss_pred hhhcCccccccCccccccccccceeeeE
Confidence 987543 334556789999996
|
|
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.3e-23 Score=215.88 Aligned_cols=166 Identities=28% Similarity=0.445 Sum_probs=142.0
Q ss_pred CeeEeeeecccCceEEEEEEE--cCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeEEEEEec
Q 005841 506 DLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEF 583 (674)
Q Consensus 506 ~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~ 583 (674)
+|++.+.||.|+||.||+|.+ ++..||||.+............+.+|+.+++.++||||+++++++...+..|+||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 488999999999999999987 467899999876544444445788899999999999999999999999999999999
Q ss_pred CCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccccCCcccc
Q 005841 584 LPRGSLFRLLQRN-TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTT 662 (674)
Q Consensus 584 ~~ggsL~~~l~~~-~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~~~~~~ 662 (674)
+. ++|..++... ...+++..+..++.||+.||+|||+.+ |+|+||+|+||+++.++.+||+|||++..........
T Consensus 81 ~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~--i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~~~ 157 (284)
T cd07860 81 LH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY 157 (284)
T ss_pred cc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEECCCCCEEEeeccchhhcccCcccc
Confidence 96 5898888653 356899999999999999999999998 9999999999999999999999999998654432223
Q ss_pred ccCCCCccccCC
Q 005841 663 KTGKGTVTYLAS 674 (674)
Q Consensus 663 ~~~~GTp~YmAP 674 (674)
....+++.|+||
T Consensus 158 ~~~~~~~~y~aP 169 (284)
T cd07860 158 THEVVTLWYRAP 169 (284)
T ss_pred ccccccccccCC
Confidence 334578999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.1e-23 Score=214.18 Aligned_cols=165 Identities=33% Similarity=0.494 Sum_probs=145.3
Q ss_pred CCeeEeeeecccCceEEEEEEE--cCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeEEEEEe
Q 005841 505 EDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTE 582 (674)
Q Consensus 505 ~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E 582 (674)
++|++.+.||.|+||.||++.+ .+..||+|++.... .......+.+|+.+++.++|+||+++++++.....+|+|+|
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEE-AEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIME 79 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccc-cchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEE
Confidence 3688899999999999999987 46779999987553 23344668899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccccCCcccc
Q 005841 583 FLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTT 662 (674)
Q Consensus 583 ~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~~~~~~ 662 (674)
|+++++|.+++... .+++..+..++.|++.+|.|||+.+ |+|+||+|+||+++.++.++|+|||+++.........
T Consensus 80 ~~~~~~L~~~~~~~--~~~~~~~~~~~~ql~~~l~~lh~~~--i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~ 155 (274)
T cd06609 80 YCGGGSCLDLLKPG--KLDETYIAFILREVLLGLEYLHEEG--KIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKR 155 (274)
T ss_pred eeCCCcHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEECCCCCEEEcccccceeeccccccc
Confidence 99999999999754 7899999999999999999999998 9999999999999999999999999998876543344
Q ss_pred ccCCCCccccCC
Q 005841 663 KTGKGTVTYLAS 674 (674)
Q Consensus 663 ~~~~GTp~YmAP 674 (674)
....|++.|+||
T Consensus 156 ~~~~~~~~y~~P 167 (274)
T cd06609 156 NTFVGTPFWMAP 167 (274)
T ss_pred ccccCCccccCh
Confidence 456789999998
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=99.90 E-value=5.3e-23 Score=214.50 Aligned_cols=169 Identities=30% Similarity=0.469 Sum_probs=141.6
Q ss_pred cccCCeeEeeeecccCceEEEEEEE-------cCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecC
Q 005841 502 ILWEDLTIGEQIGQGSCGTVYHAVW-------YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSP 574 (674)
Q Consensus 502 ~~~~~y~~~~~LG~G~fG~Vy~~~~-------~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~ 574 (674)
+.+.+|.+.++||+|+||.||++.. .+..+++|.+... .......+.+|+.+++.+.|+||+++++++...
T Consensus 2 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 79 (280)
T cd05092 2 IKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA--SESARQDFQREAELLTVLQHQHIVRFYGVCTEG 79 (280)
T ss_pred CChHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcC--CHHHHHHHHHHHHHHhcCCCCCCceEEEEEecC
Confidence 4567889999999999999999964 2346888987643 344556799999999999999999999999999
Q ss_pred CeEEEEEecCCCCCHHHHHHhcC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcC
Q 005841 575 QRLCIVTEFLPRGSLFRLLQRNT--------------TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDK 640 (674)
Q Consensus 575 ~~~~lV~E~~~ggsL~~~l~~~~--------------~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~ 640 (674)
...|+||||+++++|.+++.... ..+++..++.++.||+.||.|||+++ |+|+||||+|||+++
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~--i~H~dlkp~nil~~~ 157 (280)
T cd05092 80 RPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH--FVHRDLATRNCLVGQ 157 (280)
T ss_pred CceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC--eecccccHhhEEEcC
Confidence 99999999999999999997543 34889999999999999999999999 999999999999999
Q ss_pred CCcEEEEecCCcccccCCcc--ccccCCCCccccCC
Q 005841 641 HWTVKVGDFGLSRLKHETYL--TTKTGKGTVTYLAS 674 (674)
Q Consensus 641 ~~~vkL~DFGla~~~~~~~~--~~~~~~GTp~YmAP 674 (674)
++.+||+|||+++....... ......+++.|+||
T Consensus 158 ~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aP 193 (280)
T cd05092 158 GLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPP 193 (280)
T ss_pred CCCEEECCCCceeEcCCCceeecCCCccccccccCH
Confidence 99999999999976533211 11223467889998
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.4e-23 Score=213.24 Aligned_cols=156 Identities=21% Similarity=0.395 Sum_probs=132.0
Q ss_pred eeecccCceEEEEEEEc--------------CCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCe
Q 005841 511 EQIGQGSCGTVYHAVWY--------------GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQR 576 (674)
Q Consensus 511 ~~LG~G~fG~Vy~~~~~--------------~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 576 (674)
+.||+|+||.||+|.+. ...|++|++.... ......+.+|+.++..++||||+++++++.....
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~--~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~ 78 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSH--RDISLAFFETASMMRQVSHKHIVLLYGVCVRDVE 78 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhh--hhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCC
Confidence 46899999999999752 1248888875432 3345678889999999999999999999999999
Q ss_pred EEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCc-------EEEEec
Q 005841 577 LCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWT-------VKVGDF 649 (674)
Q Consensus 577 ~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~-------vkL~DF 649 (674)
.++||||+++++|..++......+++..++.++.||+.||.|||+.+ |+||||||+||||+.++. ++|+||
T Consensus 79 ~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~ 156 (262)
T cd05077 79 NIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKD--LVHGNVCTKNILLAREGIDGECGPFIKLSDP 156 (262)
T ss_pred CEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCC--eECCCCCcccEEEecCCccCCCCceeEeCCC
Confidence 99999999999999998776667999999999999999999999998 999999999999987664 899999
Q ss_pred CCcccccCCccccccCCCCccccCC
Q 005841 650 GLSRLKHETYLTTKTGKGTVTYLAS 674 (674)
Q Consensus 650 Gla~~~~~~~~~~~~~~GTp~YmAP 674 (674)
|++...... ....||+.||||
T Consensus 157 g~~~~~~~~----~~~~~~~~y~aP 177 (262)
T cd05077 157 GIPITVLSR----QECVERIPWIAP 177 (262)
T ss_pred CCCccccCc----ccccccccccCh
Confidence 998755322 224588899998
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.2e-23 Score=215.82 Aligned_cols=155 Identities=22% Similarity=0.369 Sum_probs=129.8
Q ss_pred eecccCceEEEEEEEc--------------------------CCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCee
Q 005841 512 QIGQGSCGTVYHAVWY--------------------------GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVL 565 (674)
Q Consensus 512 ~LG~G~fG~Vy~~~~~--------------------------~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv 565 (674)
.||+|+||.||+|.+. ...|++|++.... ......+.+|+.+++.+.||||+
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~--~~~~~~~~~~~~~~~~l~h~niv 79 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSH--RDIALAFFETASLMSQVSHIHLA 79 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHH--HHHHHHHHHHHHHHhcCCCCCee
Confidence 6999999999998641 1238888885432 23456788899999999999999
Q ss_pred eEEEEEecCCeEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCC---
Q 005841 566 LFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHW--- 642 (674)
Q Consensus 566 ~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~--- 642 (674)
++++++......|+||||+++++|..++.+....+++..+..++.||+.||+|||+.+ |+||||||+|||+++.+
T Consensus 80 ~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--iiH~dlkp~Nill~~~~~~~ 157 (274)
T cd05076 80 FVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKN--LVHGNVCAKNILLARLGLAE 157 (274)
T ss_pred eEEEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCC--ccCCCCCcccEEEeccCccc
Confidence 9999999999999999999999999999776678999999999999999999999988 99999999999997643
Q ss_pred ----cEEEEecCCcccccCCccccccCCCCccccCC
Q 005841 643 ----TVKVGDFGLSRLKHETYLTTKTGKGTVTYLAS 674 (674)
Q Consensus 643 ----~vkL~DFGla~~~~~~~~~~~~~~GTp~YmAP 674 (674)
.+||+|||++...... ....+++.||||
T Consensus 158 ~~~~~~kl~d~g~~~~~~~~----~~~~~~~~~~aP 189 (274)
T cd05076 158 GTSPFIKLSDPGVSFTALSR----EERVERIPWIAP 189 (274)
T ss_pred CccceeeecCCccccccccc----cccccCCcccCc
Confidence 4899999998643321 123578889998
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=6.8e-23 Score=212.15 Aligned_cols=166 Identities=31% Similarity=0.529 Sum_probs=141.8
Q ss_pred CeeEeeeecccCceEEEEEEE--cCCeEEEEEeecccCC--------HHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCC
Q 005841 506 DLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYS--------DEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQ 575 (674)
Q Consensus 506 ~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~~--------~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~ 575 (674)
+|.+.+.||.|+||.||+|.. .+..||+|.+...... ....+.+..|+.+++.++||||+++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 588899999999999999986 5778999988643211 123467888999999999999999999999999
Q ss_pred eEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccc
Q 005841 576 RLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLK 655 (674)
Q Consensus 576 ~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~ 655 (674)
.+++||||+++++|.+++.+. ..+++..+..++.||+.||.|||+.+ ++|+||||+||+++.++.++|+|||+++..
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~~~nil~~~~~~~~l~d~~~~~~~ 158 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTY-GRFEEQLVRFFTEQVLEGLAYLHSKG--ILHRDLKADNLLVDADGICKISDFGISKKS 158 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHhhCC--eeecCCChhhEEEcCCCeEEEeeccccccc
Confidence 999999999999999999765 57899999999999999999999998 999999999999999999999999999865
Q ss_pred cCCcc--ccccCCCCccccCC
Q 005841 656 HETYL--TTKTGKGTVTYLAS 674 (674)
Q Consensus 656 ~~~~~--~~~~~~GTp~YmAP 674 (674)
..... ......|++.|+||
T Consensus 159 ~~~~~~~~~~~~~~~~~y~~P 179 (272)
T cd06629 159 DDIYDNDQNMSMQGSVFWMAP 179 (272)
T ss_pred cccccccccccccCCccccCH
Confidence 43211 12234689999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=99.90 E-value=6e-23 Score=221.77 Aligned_cols=165 Identities=30% Similarity=0.420 Sum_probs=140.5
Q ss_pred ccCCeeEeeeecccCceEEEEEEE--cCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecC------
Q 005841 503 LWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSP------ 574 (674)
Q Consensus 503 ~~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~------ 574 (674)
..++|++.+.||+|+||.||++.+ ++..||||++.+..........+.+|+.+++.++||||+++++++...
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 457899999999999999999987 577899999876544445556778899999999999999999988644
Q ss_pred CeEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCccc
Q 005841 575 QRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL 654 (674)
Q Consensus 575 ~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~ 654 (674)
...|+||||+. ++|.+++... +++..+..++.|++.||.|||..+ |+||||||+|||++.++.+||+|||+++.
T Consensus 94 ~~~~lv~e~~~-~~l~~~~~~~---l~~~~~~~~~~ql~~aL~~LH~~g--i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~ 167 (353)
T cd07850 94 QDVYLVMELMD-ANLCQVIQMD---LDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLART 167 (353)
T ss_pred CcEEEEEeccC-CCHHHHHhhc---CCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHEEECCCCCEEEccCcccee
Confidence 35799999995 4888888542 889999999999999999999998 99999999999999999999999999987
Q ss_pred ccCCccccccCCCCccccCC
Q 005841 655 KHETYLTTKTGKGTVTYLAS 674 (674)
Q Consensus 655 ~~~~~~~~~~~~GTp~YmAP 674 (674)
...... .....||+.|+||
T Consensus 168 ~~~~~~-~~~~~~~~~y~aP 186 (353)
T cd07850 168 AGTSFM-MTPYVVTRYYRAP 186 (353)
T ss_pred CCCCCC-CCCCcccccccCH
Confidence 654332 2335689999998
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=99.90 E-value=6.9e-23 Score=215.86 Aligned_cols=169 Identities=24% Similarity=0.326 Sum_probs=140.5
Q ss_pred ccCCeeEeeeecccCceEEEEEEE--cCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCC-----
Q 005841 503 LWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQ----- 575 (674)
Q Consensus 503 ~~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~----- 575 (674)
..++|++.+.||+|+||.||+|.. ++..||||++............+.+|+.+++.++||||+++++++....
T Consensus 10 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 89 (310)
T cd07865 10 EVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNR 89 (310)
T ss_pred hhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccC
Confidence 346799999999999999999997 4678999998755433333345668999999999999999999887654
Q ss_pred ---eEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCc
Q 005841 576 ---RLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLS 652 (674)
Q Consensus 576 ---~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla 652 (674)
..|+||||+. ++|.+++......+++..+..++.||+.||.|||+.+ |+|+||||+|||++.++.+||+|||++
T Consensus 90 ~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--i~H~dl~p~nil~~~~~~~kl~dfg~~ 166 (310)
T cd07865 90 YKGSFYLVFEFCE-HDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNK--ILHRDMKAANILITKDGILKLADFGLA 166 (310)
T ss_pred CCceEEEEEcCCC-cCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHEEECCCCcEEECcCCCc
Confidence 4599999995 5888888766667999999999999999999999998 999999999999999999999999999
Q ss_pred ccccCCccc----cccCCCCccccCC
Q 005841 653 RLKHETYLT----TKTGKGTVTYLAS 674 (674)
Q Consensus 653 ~~~~~~~~~----~~~~~GTp~YmAP 674 (674)
......... .....+++.|+||
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~y~aP 192 (310)
T cd07865 167 RAFSLSKNSKPNRYTNRVVTLWYRPP 192 (310)
T ss_pred ccccCCcccCCCCccCcccCccccCc
Confidence 866432211 1234578999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=99.90 E-value=6.1e-23 Score=217.52 Aligned_cols=158 Identities=27% Similarity=0.441 Sum_probs=128.5
Q ss_pred eeeecccCceEEEEEEEc----CCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEec--CCeEEEEEec
Q 005841 510 GEQIGQGSCGTVYHAVWY----GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTS--PQRLCIVTEF 583 (674)
Q Consensus 510 ~~~LG~G~fG~Vy~~~~~----~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~--~~~~~lV~E~ 583 (674)
+.+||+|+||.||+|... +..||+|.+...... ..+.+|+.+++.++||||+++++++.. ...+|+||||
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~ 81 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGIS----MSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDY 81 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCCCc----HHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEee
Confidence 468999999999999863 356999988654332 346789999999999999999998854 5678999999
Q ss_pred CCCCCHHHHHHhc--------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEE----cCCCcEEEEecCC
Q 005841 584 LPRGSLFRLLQRN--------TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLV----DKHWTVKVGDFGL 651 (674)
Q Consensus 584 ~~ggsL~~~l~~~--------~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi----~~~~~vkL~DFGl 651 (674)
+. ++|.+++... ...+++..+..++.||+.||.|||+.+ |+||||||+|||+ +.++++||+|||+
T Consensus 82 ~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~ 158 (317)
T cd07867 82 AE-HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW--VLHRDLKPANILVMGEGPERGRVKIADMGF 158 (317)
T ss_pred eC-CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC--EEcCCCCHHHEEEccCCCCCCcEEEeeccc
Confidence 96 4888877421 234889999999999999999999998 9999999999999 5667999999999
Q ss_pred cccccCCcc---ccccCCCCccccCC
Q 005841 652 SRLKHETYL---TTKTGKGTVTYLAS 674 (674)
Q Consensus 652 a~~~~~~~~---~~~~~~GTp~YmAP 674 (674)
++....... ......||+.||||
T Consensus 159 a~~~~~~~~~~~~~~~~~~t~~y~aP 184 (317)
T cd07867 159 ARLFNSPLKPLADLDPVVVTFWYRAP 184 (317)
T ss_pred eeccCCCcccccccCcceecccccCc
Confidence 987644321 22335789999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.9e-23 Score=211.18 Aligned_cols=162 Identities=31% Similarity=0.539 Sum_probs=138.0
Q ss_pred ccCCeeEeeeecccCceEEEEEEEcCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeEEEEEe
Q 005841 503 LWEDLTIGEQIGQGSCGTVYHAVWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTE 582 (674)
Q Consensus 503 ~~~~y~~~~~LG~G~fG~Vy~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E 582 (674)
...+|++.+.||+|+||.||++...+..||+|.+.... ....+.+|+.+++.++||||+++++++... ..|+|||
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~iK~~~~~~----~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e 78 (254)
T cd05083 4 NLQKLTLGEIIGEGEFGAVLQGEYTGQKVAVKNIKCDV----TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVME 78 (254)
T ss_pred cHHHceeeeeeccCCCCceEecccCCCceEEEeecCcc----hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEE
Confidence 44679999999999999999999888999999986432 235688899999999999999999998654 5799999
Q ss_pred cCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccccCCccc
Q 005841 583 FLPRGSLFRLLQRNT-TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLT 661 (674)
Q Consensus 583 ~~~ggsL~~~l~~~~-~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~~~~~ 661 (674)
|+++++|.+++.... ..+++..+..++.|++.||.|||+++ ++||||||+|||++.++.+||+|||+++......
T Consensus 79 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~-- 154 (254)
T cd05083 79 LMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKK--LVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV-- 154 (254)
T ss_pred CCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccccCcceEEEcCCCcEEECCCccceeccccC--
Confidence 999999999997543 35899999999999999999999998 9999999999999999999999999997654321
Q ss_pred cccCCCCccccCC
Q 005841 662 TKTGKGTVTYLAS 674 (674)
Q Consensus 662 ~~~~~GTp~YmAP 674 (674)
.....++.|+||
T Consensus 155 -~~~~~~~~y~~p 166 (254)
T cd05083 155 -DNSKLPVKWTAP 166 (254)
T ss_pred -CCCCCCceecCH
Confidence 122345678887
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.1e-23 Score=227.10 Aligned_cols=173 Identities=33% Similarity=0.560 Sum_probs=150.7
Q ss_pred cccccccCCeeEeeeecccCceEEEEEEEcC----C--eEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEE
Q 005841 498 LDYEILWEDLTIGEQIGQGSCGTVYHAVWYG----S--DVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAV 571 (674)
Q Consensus 498 ~~~~~~~~~y~~~~~LG~G~fG~Vy~~~~~~----~--~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~ 571 (674)
.+|++..+...+.++||+|-||.||.|.++. . .||||+.+..- ..+..+.|..|..+|+.++||||++++|++
T Consensus 382 rnyel~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~-t~d~tekflqEa~iMrnfdHphIikLIGv~ 460 (974)
T KOG4257|consen 382 RNYELRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDC-TPDDTEKFLQEASIMRNFDHPHIIKLIGVC 460 (974)
T ss_pred CcceeehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCC-ChhhHHHHHHHHHHHHhCCCcchhheeeee
Confidence 3456666777788899999999999999742 2 39999886544 344478899999999999999999999999
Q ss_pred ecCCeEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCC
Q 005841 572 TSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGL 651 (674)
Q Consensus 572 ~~~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGl 651 (674)
.+ ...+||||+++.|.|..||+.+...++......|..||+.+|.|||+.. .|||||...|||+.....|||+|||+
T Consensus 461 ~e-~P~WivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkr--fVHRDIAaRNiLVsSp~CVKLaDFGL 537 (974)
T KOG4257|consen 461 VE-QPMWIVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKR--FVHRDIAARNILVSSPQCVKLADFGL 537 (974)
T ss_pred ec-cceeEEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhc--hhhhhhhhhheeecCcceeeecccch
Confidence 74 5799999999999999999999999999999999999999999999988 99999999999999999999999999
Q ss_pred cccccC-CccccccCCCCccccCC
Q 005841 652 SRLKHE-TYLTTKTGKGTVTYLAS 674 (674)
Q Consensus 652 a~~~~~-~~~~~~~~~GTp~YmAP 674 (674)
++.+.+ .++......-...||||
T Consensus 538 SR~~ed~~yYkaS~~kLPIKWmaP 561 (974)
T KOG4257|consen 538 SRYLEDDAYYKASRGKLPIKWMAP 561 (974)
T ss_pred hhhccccchhhccccccceeecCc
Confidence 998754 45555556677889998
|
|
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.90 E-value=5.1e-23 Score=212.26 Aligned_cols=166 Identities=30% Similarity=0.502 Sum_probs=141.6
Q ss_pred CeeEeeeecccCceEEEEEEE--cCCeEEEEEeecccCC----HHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeEEE
Q 005841 506 DLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYS----DEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCI 579 (674)
Q Consensus 506 ~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~~----~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 579 (674)
+|+..+.||+|+||.||++.. ++..||+|++...... ......+.+|+.+++.++|+||+++++++...+.+++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 478889999999999999986 5778999998754321 2356788999999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCC-cEEEEecCCcccccCC
Q 005841 580 VTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHW-TVKVGDFGLSRLKHET 658 (674)
Q Consensus 580 V~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~-~vkL~DFGla~~~~~~ 658 (674)
||||+++++|.+++.+. ..+++..+..++.||+.||.|||+++ |+|+||||+||+++.++ .+||+|||++......
T Consensus 81 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~ql~~al~~LH~~~--i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~ 157 (268)
T cd06630 81 FVEWMAGGSVSHLLSKY-GAFKEAVIINYTEQLLRGLSYLHENQ--IIHRDVKGANLLIDSTGQRLRIADFGAAARLAAK 157 (268)
T ss_pred EEeccCCCcHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEEEcccccccccccc
Confidence 99999999999999753 46899999999999999999999999 99999999999998765 6999999999876543
Q ss_pred cc----ccccCCCCccccCC
Q 005841 659 YL----TTKTGKGTVTYLAS 674 (674)
Q Consensus 659 ~~----~~~~~~GTp~YmAP 674 (674)
.. ......||+.|+||
T Consensus 158 ~~~~~~~~~~~~~~~~~~~P 177 (268)
T cd06630 158 GTGAGEFQGQLLGTIAFMAP 177 (268)
T ss_pred cccCCccccccccccceeCH
Confidence 11 11234688999998
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.90 E-value=6.6e-23 Score=212.40 Aligned_cols=160 Identities=28% Similarity=0.391 Sum_probs=130.6
Q ss_pred eecccCceEEEEEEE-cCC---eEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeEEEEEecCCCC
Q 005841 512 QIGQGSCGTVYHAVW-YGS---DVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRG 587 (674)
Q Consensus 512 ~LG~G~fG~Vy~~~~-~~~---~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg 587 (674)
.||+|+||.||++.. .+. .+++|.+.... .......+.+|+.++..++||||+++++.+......|+||||++++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 80 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANA-SSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG 80 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCC-ChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence 699999999999975 222 35666654432 2344567899999999999999999999999999999999999999
Q ss_pred CHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccccCC-c-ccc
Q 005841 588 SLFRLLQRNT---TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHET-Y-LTT 662 (674)
Q Consensus 588 sL~~~l~~~~---~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~~-~-~~~ 662 (674)
+|.+++.+.. ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++...... . ...
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~--i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~ 158 (268)
T cd05086 81 DLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN--FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETE 158 (268)
T ss_pred cHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC--eeccCCccceEEEcCCccEEecccccccccCcchhhhcc
Confidence 9999997532 34667788899999999999999998 999999999999999999999999998643221 1 122
Q ss_pred ccCCCCccccCC
Q 005841 663 KTGKGTVTYLAS 674 (674)
Q Consensus 663 ~~~~GTp~YmAP 674 (674)
....|++.|+||
T Consensus 159 ~~~~~~~~y~aP 170 (268)
T cd05086 159 DDKCVPLRWLAP 170 (268)
T ss_pred cCCcCcccccCc
Confidence 235688999998
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=5.1e-23 Score=213.69 Aligned_cols=164 Identities=29% Similarity=0.473 Sum_probs=143.0
Q ss_pred CeeEeeeecccCceEEEEEEE--cCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCC---CCCeeeEEEEEecCCeEEEE
Q 005841 506 DLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLR---HPNVLLFMGAVTSPQRLCIV 580 (674)
Q Consensus 506 ~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~---HpnIv~l~~~~~~~~~~~lV 580 (674)
.|++.+.||.|+||.||+|.+ .+..|++|++.... .......+.+|+.+++.+. ||||+++++++......|+|
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv 80 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDT-PDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWII 80 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCC-CchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEE
Confidence 477889999999999999997 56789999986543 2334567888999999997 99999999999999999999
Q ss_pred EecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccccCCcc
Q 005841 581 TEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYL 660 (674)
Q Consensus 581 ~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~~~~ 660 (674)
|||+++++|.+++.. ..+++..++.++.|++.+|.|||+.+ |+|+||+|+||+++.++.++|+|||++........
T Consensus 81 ~e~~~~~~L~~~~~~--~~l~~~~~~~i~~~i~~~l~~lh~~~--i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06917 81 MEYAEGGSVRTLMKA--GPIAEKYISVIIREVLVALKYIHKVG--VIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSS 156 (277)
T ss_pred EecCCCCcHHHHHHc--cCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCcCHHHEEEcCCCCEEEccCCceeecCCCcc
Confidence 999999999999865 36899999999999999999999999 99999999999999999999999999987655443
Q ss_pred ccccCCCCccccCC
Q 005841 661 TTKTGKGTVTYLAS 674 (674)
Q Consensus 661 ~~~~~~GTp~YmAP 674 (674)
......|++.|+||
T Consensus 157 ~~~~~~~~~~y~aP 170 (277)
T cd06917 157 KRSTFVGTPYWMAP 170 (277)
T ss_pred ccccccCCcceeCH
Confidence 34445799999998
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.4e-22 Score=212.19 Aligned_cols=167 Identities=32% Similarity=0.434 Sum_probs=141.6
Q ss_pred ccCCeeEeeeecccCceEEEEEEE--cCCeEEEEEeecccCCHHHHHHHHHHHHHHhhC-CCCCeeeEEEEEecC-----
Q 005841 503 LWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRL-RHPNVLLFMGAVTSP----- 574 (674)
Q Consensus 503 ~~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~----- 574 (674)
..++|.+.+.||+|+||.||++.. .+..||+|++.... .....+.+|+.++..+ +||||+++++++...
T Consensus 20 ~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~---~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 96 (291)
T cd06639 20 PTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS---DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVG 96 (291)
T ss_pred CCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc---cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCC
Confidence 357899999999999999999987 46789999986532 2234567899999998 799999999998754
Q ss_pred CeEEEEEecCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCC
Q 005841 575 QRLCIVTEFLPRGSLFRLLQR---NTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGL 651 (674)
Q Consensus 575 ~~~~lV~E~~~ggsL~~~l~~---~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGl 651 (674)
...|+||||+++++|.+++.. ....+++..++.++.|++.||.|||+.+ |+|+||||+|||++.++.+||+|||+
T Consensus 97 ~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dlkp~nili~~~~~~kl~dfg~ 174 (291)
T cd06639 97 GQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR--IIHRDVKGNNILLTTEGGVKLVDFGV 174 (291)
T ss_pred CeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHEEEcCCCCEEEeeccc
Confidence 358999999999999998863 3457899999999999999999999998 99999999999999999999999999
Q ss_pred cccccCCccccccCCCCccccCC
Q 005841 652 SRLKHETYLTTKTGKGTVTYLAS 674 (674)
Q Consensus 652 a~~~~~~~~~~~~~~GTp~YmAP 674 (674)
++.............|++.|+||
T Consensus 175 ~~~~~~~~~~~~~~~~~~~y~aP 197 (291)
T cd06639 175 SAQLTSTRLRRNTSVGTPFWMAP 197 (291)
T ss_pred chhcccccccccCccCCccccCh
Confidence 98765443333345789999998
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=99.90 E-value=9.3e-23 Score=212.19 Aligned_cols=164 Identities=31% Similarity=0.492 Sum_probs=142.4
Q ss_pred CeeEeeeecccCceEEEEEEE--cCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeEEEEEec
Q 005841 506 DLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEF 583 (674)
Q Consensus 506 ~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~ 583 (674)
-|.+.+.||.|+||.||+|.+ .+..||||++..... ......+.+|+.++..++||||+++++++......|+||||
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA-EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY 83 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccc-hHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEe
Confidence 367888999999999999987 466799998865432 34456788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccccCCccccc
Q 005841 584 LPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTK 663 (674)
Q Consensus 584 ~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~~~~~~~ 663 (674)
+++++|.+++.. ..+++..+..++.|++.+|.|||+.+ |+|+||||+||+++.++.++|+|||++...........
T Consensus 84 ~~~~~l~~~i~~--~~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~~~~ 159 (277)
T cd06641 84 LGGGSALDLLEP--GPLDETQIATILREILKGLDYLHSEK--KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRN 159 (277)
T ss_pred CCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHccCC--eecCCCCHHhEEECCCCCEEEeecccceecccchhhhc
Confidence 999999999864 46899999999999999999999998 99999999999999999999999999987654433334
Q ss_pred cCCCCccccCC
Q 005841 664 TGKGTVTYLAS 674 (674)
Q Consensus 664 ~~~GTp~YmAP 674 (674)
...|++.|+||
T Consensus 160 ~~~~~~~y~~P 170 (277)
T cd06641 160 TFVGTPFWMAP 170 (277)
T ss_pred cccCCccccCh
Confidence 45789999998
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=6e-23 Score=217.14 Aligned_cols=166 Identities=27% Similarity=0.426 Sum_probs=138.3
Q ss_pred CeeEeeeecccCceEEEEEEE----cCCeEEEEEeecccC-CHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecC--CeEE
Q 005841 506 DLTIGEQIGQGSCGTVYHAVW----YGSDVAVKVFSRQEY-SDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSP--QRLC 578 (674)
Q Consensus 506 ~y~~~~~LG~G~fG~Vy~~~~----~~~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~--~~~~ 578 (674)
.|.+.++||+|+||.||+|.+ .+..||+|++..... .......+.+|+.+++.++||||+++++++... ..+|
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 488999999999999999997 357799999976431 123345677899999999999999999999988 8899
Q ss_pred EEEecCCCCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcC----CCcEEEEecC
Q 005841 579 IVTEFLPRGSLFRLLQRN----TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDK----HWTVKVGDFG 650 (674)
Q Consensus 579 lV~E~~~ggsL~~~l~~~----~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~----~~~vkL~DFG 650 (674)
+||||+++ +|.+++... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++. ++.+||+|||
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg 157 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW--VLHRDLKPANILVMGEGPERGVVKIGDLG 157 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC--EeeCCCCHHHEEEcCCCCccceEEECCCc
Confidence 99999965 777766432 236899999999999999999999998 999999999999999 9999999999
Q ss_pred CcccccCCcc---ccccCCCCccccCC
Q 005841 651 LSRLKHETYL---TTKTGKGTVTYLAS 674 (674)
Q Consensus 651 la~~~~~~~~---~~~~~~GTp~YmAP 674 (674)
+++....... .....++|+.|+||
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~y~aP 184 (316)
T cd07842 158 LARLFNAPLKPLADLDPVVVTIWYRAP 184 (316)
T ss_pred cccccCCCcccccccCCccccccccCH
Confidence 9987643322 23345789999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=99.90 E-value=5.4e-23 Score=215.04 Aligned_cols=169 Identities=27% Similarity=0.500 Sum_probs=141.3
Q ss_pred ccCCeeEeeeecccCceEEEEEEEc-------CCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCC
Q 005841 503 LWEDLTIGEQIGQGSCGTVYHAVWY-------GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQ 575 (674)
Q Consensus 503 ~~~~y~~~~~LG~G~fG~Vy~~~~~-------~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~ 575 (674)
...+|++.+.||+|+||.||++.+. +..||+|++.... .......+.+|+.+++.+.||||+++++++...+
T Consensus 3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~ 81 (288)
T cd05050 3 PRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMAEFDHPNIVKLLGVCAVGK 81 (288)
T ss_pred ChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCc-CHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCC
Confidence 4568999999999999999999863 4569999886533 3445567889999999999999999999999999
Q ss_pred eEEEEEecCCCCCHHHHHHhcC---------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCC
Q 005841 576 RLCIVTEFLPRGSLFRLLQRNT---------------------TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSS 634 (674)
Q Consensus 576 ~~~lV~E~~~ggsL~~~l~~~~---------------------~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~ 634 (674)
.+|+||||+++++|.+++.... ..+++..++.++.|++.||.|||+.+ ++||||||+
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~--i~H~dl~p~ 159 (288)
T cd05050 82 PMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK--FVHRDLATR 159 (288)
T ss_pred ccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC--eecccccHh
Confidence 9999999999999999997432 24788899999999999999999998 999999999
Q ss_pred CEEEcCCCcEEEEecCCcccccCCcc--ccccCCCCccccCC
Q 005841 635 NLLVDKHWTVKVGDFGLSRLKHETYL--TTKTGKGTVTYLAS 674 (674)
Q Consensus 635 NILi~~~~~vkL~DFGla~~~~~~~~--~~~~~~GTp~YmAP 674 (674)
|||++.++.++|+|||+++....... ......+++.|+||
T Consensus 160 nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aP 201 (288)
T cd05050 160 NCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPP 201 (288)
T ss_pred heEecCCCceEECccccceecccCccccccCCCccChhhcCH
Confidence 99999999999999999976543221 11223456779987
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=6.7e-23 Score=211.52 Aligned_cols=167 Identities=31% Similarity=0.444 Sum_probs=143.2
Q ss_pred ccCCeeEeeeecccCceEEEEEEE--cCCeEEEEEeecccCCHHHHHHHHHHHHHHhhC-CCCCeeeEEEEEecCC----
Q 005841 503 LWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRL-RHPNVLLFMGAVTSPQ---- 575 (674)
Q Consensus 503 ~~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~---- 575 (674)
..++|++.+.||+|+||.||+|.+ .+..|++|++..... ....+.+|+.+++.+ .|+||+++++++....
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~ 80 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED---EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGN 80 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch---hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCc
Confidence 347899999999999999999998 456799999875432 335688999999999 6999999999997544
Q ss_pred --eEEEEEecCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecC
Q 005841 576 --RLCIVTEFLPRGSLFRLLQRN---TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFG 650 (674)
Q Consensus 576 --~~~lV~E~~~ggsL~~~l~~~---~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFG 650 (674)
.+|+||||+++++|.+++... ...+++..+..++.|++.||.|||+.+ |+|+||+|+||+++.++.+||+|||
T Consensus 81 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~--i~H~~l~p~ni~~~~~~~~~l~d~~ 158 (275)
T cd06608 81 DDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK--VIHRDIKGQNILLTKNAEVKLVDFG 158 (275)
T ss_pred ceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC--cccCCCCHHHEEEccCCeEEECCCc
Confidence 489999999999999988653 367999999999999999999999998 9999999999999999999999999
Q ss_pred CcccccCCccccccCCCCccccCC
Q 005841 651 LSRLKHETYLTTKTGKGTVTYLAS 674 (674)
Q Consensus 651 la~~~~~~~~~~~~~~GTp~YmAP 674 (674)
++..............||+.|+||
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~y~aP 182 (275)
T cd06608 159 VSAQLDSTLGRRNTFIGTPYWMAP 182 (275)
T ss_pred cceecccchhhhcCccccccccCH
Confidence 998765444344446789999998
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.9e-23 Score=213.72 Aligned_cols=165 Identities=28% Similarity=0.466 Sum_probs=145.0
Q ss_pred CCeeEeeeecccCceEEEEEEEc--CCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeEEEEEe
Q 005841 505 EDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTE 582 (674)
Q Consensus 505 ~~y~~~~~LG~G~fG~Vy~~~~~--~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E 582 (674)
++|++.+.||.|+||.||++.+. +..|++|.+..... ......+.+|+.+++.+.||||+++++.+.....+|+|||
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 79 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEIN-EAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICME 79 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccC-hHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEE
Confidence 36788899999999999999984 67799999876543 3455678899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCeEEccCCCCCEEEcCCCcEEEEecCCcccccCCccc
Q 005841 583 FLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHH-CNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLT 661 (674)
Q Consensus 583 ~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~-~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~~~~~ 661 (674)
|+++++|.+++......+++..+..++.|++.+|.|||+ .+ ++|+||||+||+++.++.++|+|||++.........
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~--i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~ 157 (265)
T cd06605 80 YMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHK--IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAK 157 (265)
T ss_pred ecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCC--eecCCCCHHHEEECCCCCEEEeecccchhhHHHHhh
Confidence 999999999998765789999999999999999999999 88 999999999999999999999999999766433222
Q ss_pred cccCCCCccccCC
Q 005841 662 TKTGKGTVTYLAS 674 (674)
Q Consensus 662 ~~~~~GTp~YmAP 674 (674)
...|++.|+||
T Consensus 158 --~~~~~~~y~~P 168 (265)
T cd06605 158 --TFVGTSSYMAP 168 (265)
T ss_pred --cccCChhccCH
Confidence 26789999998
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=1e-22 Score=208.04 Aligned_cols=161 Identities=34% Similarity=0.569 Sum_probs=137.8
Q ss_pred eeecccCceEEEEEEEc-CCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeEEEEEecCCCCCH
Q 005841 511 EQIGQGSCGTVYHAVWY-GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSL 589 (674)
Q Consensus 511 ~~LG~G~fG~Vy~~~~~-~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL 589 (674)
++||+|+||.||++.+. +..|++|++...... .....+.+|+.+++.+.|+||+.+++++......|+||||+++++|
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l 79 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPP-DLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSL 79 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCH-HHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcH
Confidence 46999999999999875 778999988765433 4556789999999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccccCCcccc--ccCCC
Q 005841 590 FRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTT--KTGKG 667 (674)
Q Consensus 590 ~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~~~~~~--~~~~G 667 (674)
.+++......+++..++.++.+++.+|.|||+.+ |+||||||+|||++.++.+||+|||+++......... ....+
T Consensus 80 ~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~--i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~ 157 (251)
T cd05041 80 LTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKN--CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQI 157 (251)
T ss_pred HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--EehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCcc
Confidence 9999776667899999999999999999999998 9999999999999999999999999998654322111 12234
Q ss_pred CccccCC
Q 005841 668 TVTYLAS 674 (674)
Q Consensus 668 Tp~YmAP 674 (674)
+..|+||
T Consensus 158 ~~~y~~P 164 (251)
T cd05041 158 PIKWTAP 164 (251)
T ss_pred eeccCCh
Confidence 6678887
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=99.90 E-value=6.1e-23 Score=210.13 Aligned_cols=167 Identities=28% Similarity=0.466 Sum_probs=143.8
Q ss_pred CeeEeeeecccCceEEEEEEE--cCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeEEEEEec
Q 005841 506 DLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEF 583 (674)
Q Consensus 506 ~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~ 583 (674)
+|.+.+.||.|+||.||++.. .+..||+|.+............+.+|+.+++.++|+||+++++.+......|+||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 588999999999999999998 467799999977554444456788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCC-cEEEEecCCcccccCCccc
Q 005841 584 LPRGSLFRLLQRNT-TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHW-TVKVGDFGLSRLKHETYLT 661 (674)
Q Consensus 584 ~~ggsL~~~l~~~~-~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~-~vkL~DFGla~~~~~~~~~ 661 (674)
+++++|.+++.... ..+++..+..++.||+.||.|||+++ |+|+||||+|||++.++ .+||+|||++.........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~~ 158 (257)
T cd08225 81 CDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRK--ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMEL 158 (257)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccccCCHHHEEEcCCCCeEEecccccchhccCCccc
Confidence 99999999987543 35899999999999999999999998 99999999999999775 5799999999876544333
Q ss_pred cccCCCCccccCC
Q 005841 662 TKTGKGTVTYLAS 674 (674)
Q Consensus 662 ~~~~~GTp~YmAP 674 (674)
.....|++.|+||
T Consensus 159 ~~~~~~~~~~~ap 171 (257)
T cd08225 159 AYTCVGTPYYLSP 171 (257)
T ss_pred ccccCCCccccCH
Confidence 3334689999998
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.6e-23 Score=215.27 Aligned_cols=166 Identities=30% Similarity=0.456 Sum_probs=144.2
Q ss_pred ccCCeeEeeeecccCceEEEEEEEc--CCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeEEEE
Q 005841 503 LWEDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIV 580 (674)
Q Consensus 503 ~~~~y~~~~~LG~G~fG~Vy~~~~~--~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 580 (674)
...+|++.+.||+|+||+||++.+. +..||+|++.... .......+.+|+.+++.++||||+++++++.....+|+|
T Consensus 3 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 81 (284)
T cd06620 3 RNEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGA-KSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMC 81 (284)
T ss_pred cHHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecC-cchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEE
Confidence 3467999999999999999999974 7789999886543 344567789999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCeEEccCCCCCEEEcCCCcEEEEecCCcccccCCc
Q 005841 581 TEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHH-CNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETY 659 (674)
Q Consensus 581 ~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~-~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~~~ 659 (674)
|||+++++|.+++.+ ...+++..+..++.+++.+|.|||+ .+ |+|+||||+|||++.++.++|+|||++......
T Consensus 82 ~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~i~~~l~~LH~~~~--i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~- 157 (284)
T cd06620 82 MEFMDCGSLDRIYKK-GGPIPVEILGKIAVAVVEGLTYLYNVHR--IMHRDIKPSNILVNSRGQIKLCDFGVSGELINS- 157 (284)
T ss_pred EecCCCCCHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHHhcC--eeccCCCHHHEEECCCCcEEEccCCcccchhhh-
Confidence 999999999999875 3468999999999999999999996 57 999999999999999999999999998755332
Q ss_pred cccccCCCCccccCC
Q 005841 660 LTTKTGKGTVTYLAS 674 (674)
Q Consensus 660 ~~~~~~~GTp~YmAP 674 (674)
......||+.|+||
T Consensus 158 -~~~~~~~~~~~~aP 171 (284)
T cd06620 158 -IADTFVGTSTYMSP 171 (284)
T ss_pred -ccCccccCcccCCH
Confidence 22345789999998
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.2e-22 Score=208.69 Aligned_cols=166 Identities=34% Similarity=0.481 Sum_probs=146.2
Q ss_pred CCeeEeeeecccCceEEEEEEEc--CCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeEEEEEe
Q 005841 505 EDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTE 582 (674)
Q Consensus 505 ~~y~~~~~LG~G~fG~Vy~~~~~--~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E 582 (674)
.+|++.+.||+|+||.||++.+. +..|+||++...... .....+.+|+.++..++|+||+++++++.....+|+|||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 79 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDE-EFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLE 79 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcch-HHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEE
Confidence 36889999999999999999884 778999998765432 456778999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCeEEccCCCCCEEEcCCCcEEEEecCCcccccCCccc
Q 005841 583 FLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHH-CNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLT 661 (674)
Q Consensus 583 ~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~-~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~~~~~ 661 (674)
|+++++|.+++... ..+++..++.++.|++.+|.|||. .+ ++|+||+|+||+++.++.++|+|||++.........
T Consensus 80 ~~~~~~L~~~l~~~-~~l~~~~~~~~~~~l~~~l~~lh~~~~--~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~ 156 (264)
T cd06623 80 YMDGGSLADLLKKV-GKIPEPVLAYIARQILKGLDYLHTKRH--IIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQ 156 (264)
T ss_pred ecCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhccCC--CccCCCCHHHEEECCCCCEEEccCccceecccCCCc
Confidence 99999999999754 578999999999999999999999 88 999999999999999999999999999876554433
Q ss_pred cccCCCCccccCC
Q 005841 662 TKTGKGTVTYLAS 674 (674)
Q Consensus 662 ~~~~~GTp~YmAP 674 (674)
.....|++.|+||
T Consensus 157 ~~~~~~~~~y~~p 169 (264)
T cd06623 157 CNTFVGTVTYMSP 169 (264)
T ss_pred ccceeecccccCH
Confidence 3345688999987
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=99.89 E-value=5.9e-23 Score=215.93 Aligned_cols=170 Identities=26% Similarity=0.388 Sum_probs=142.1
Q ss_pred cccCCeeEeeeecccCceEEEEEEE--cCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCC----
Q 005841 502 ILWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQ---- 575 (674)
Q Consensus 502 ~~~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~---- 575 (674)
...++|++.+.||+|+||.||+|.+ .+..||+|++............+.+|+.+++.++||||+++++++.+..
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 4457899999999999999999998 4678999999765433333456778999999999999999999987655
Q ss_pred ------eEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEec
Q 005841 576 ------RLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDF 649 (674)
Q Consensus 576 ------~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DF 649 (674)
.+|+||||+++ +|..++......+++..+..++.||+.||.|||+.+ |+|+||||+||+++.++.+||+||
T Consensus 84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--i~H~dl~p~nili~~~~~~kl~df 160 (302)
T cd07864 84 FKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKN--FLHRDIKCSNILLNNKGQIKLADF 160 (302)
T ss_pred ccccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEECCCCcEEeCcc
Confidence 79999999976 788877765567999999999999999999999998 999999999999999999999999
Q ss_pred CCcccccCCcccc-ccCCCCccccCC
Q 005841 650 GLSRLKHETYLTT-KTGKGTVTYLAS 674 (674)
Q Consensus 650 Gla~~~~~~~~~~-~~~~GTp~YmAP 674 (674)
|++.......... ....+++.|+||
T Consensus 161 g~~~~~~~~~~~~~~~~~~~~~y~~P 186 (302)
T cd07864 161 GLARLYNSEESRPYTNKVITLWYRPP 186 (302)
T ss_pred cccccccCCcccccccceeccCccCh
Confidence 9998765433211 123467889988
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=99.89 E-value=9.3e-23 Score=209.75 Aligned_cols=161 Identities=32% Similarity=0.493 Sum_probs=132.6
Q ss_pred eeecccCceEEEEEEEc-----CCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEe-cCCeEEEEEecC
Q 005841 511 EQIGQGSCGTVYHAVWY-----GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVT-SPQRLCIVTEFL 584 (674)
Q Consensus 511 ~~LG~G~fG~Vy~~~~~-----~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~-~~~~~~lV~E~~ 584 (674)
+.||+|+||.||+|.+. ...||||.+.... .......+.+|+.+++.++||||+++++++. .+...|+||||+
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~ 79 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRIT-DLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYM 79 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccC-CHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecC
Confidence 36899999999999862 2359999875432 3344577889999999999999999999765 455689999999
Q ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccccCCcc----
Q 005841 585 PRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYL---- 660 (674)
Q Consensus 585 ~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~~~~---- 660 (674)
++++|.+++......+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 80 ~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~ 157 (262)
T cd05058 80 KHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKK--FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVH 157 (262)
T ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccccCcceEEEcCCCcEEECCccccccccCCcceeec
Confidence 999999999876666788899999999999999999998 99999999999999999999999999986543211
Q ss_pred ccccCCCCccccCC
Q 005841 661 TTKTGKGTVTYLAS 674 (674)
Q Consensus 661 ~~~~~~GTp~YmAP 674 (674)
......+++.||||
T Consensus 158 ~~~~~~~~~~y~aP 171 (262)
T cd05058 158 NHTGAKLPVKWMAL 171 (262)
T ss_pred ccccCcCCccccCh
Confidence 11123567889998
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=99.89 E-value=8.4e-23 Score=215.74 Aligned_cols=168 Identities=29% Similarity=0.542 Sum_probs=139.4
Q ss_pred ccCCeeEeeeecccCceEEEEEEE--cCC----eEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCe
Q 005841 503 LWEDLTIGEQIGQGSCGTVYHAVW--YGS----DVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQR 576 (674)
Q Consensus 503 ~~~~y~~~~~LG~G~fG~Vy~~~~--~~~----~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 576 (674)
...+|+..+.||+|+||.||++.+ .+. .||+|.+.... .......+.+|+.+++.+.||||+++++++... .
T Consensus 5 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~ 82 (303)
T cd05110 5 KETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETT-GPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-T 82 (303)
T ss_pred chhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-C
Confidence 346789999999999999999986 333 47888876443 233445688899999999999999999998754 5
Q ss_pred EEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCccccc
Q 005841 577 LCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKH 656 (674)
Q Consensus 577 ~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~ 656 (674)
.++|+||+++|+|.+++......+++..+..++.||+.||.|||+++ |+|+||||+|||++.++.+||+|||+++...
T Consensus 83 ~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~--ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~ 160 (303)
T cd05110 83 IQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERR--LVHRDLAARNVLVKSPNHVKITDFGLARLLE 160 (303)
T ss_pred ceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcC--eeccccccceeeecCCCceEEcccccccccc
Confidence 78999999999999999876667899999999999999999999998 9999999999999999999999999998764
Q ss_pred CCcc--ccccCCCCccccCC
Q 005841 657 ETYL--TTKTGKGTVTYLAS 674 (674)
Q Consensus 657 ~~~~--~~~~~~GTp~YmAP 674 (674)
.... ......+++.||||
T Consensus 161 ~~~~~~~~~~~~~~~~y~~P 180 (303)
T cd05110 161 GDEKEYNADGGKMPIKWMAL 180 (303)
T ss_pred CcccccccCCCccccccCCH
Confidence 3222 22223467889987
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=99.89 E-value=8e-23 Score=209.63 Aligned_cols=160 Identities=32% Similarity=0.517 Sum_probs=137.3
Q ss_pred eeecccCceEEEEEEEcC---C--eEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeEEEEEecCC
Q 005841 511 EQIGQGSCGTVYHAVWYG---S--DVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLP 585 (674)
Q Consensus 511 ~~LG~G~fG~Vy~~~~~~---~--~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ 585 (674)
++||+|+||.||++.+.. . .||||.+...... .....+.+|+.++++++||||+++++.+.. ..+++||||++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~ 78 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS-DIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAP 78 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH-HHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecC
Confidence 468999999999998732 2 5899999776544 566789999999999999999999999988 88999999999
Q ss_pred CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccccCCc---cc
Q 005841 586 RGSLFRLLQRNT-TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETY---LT 661 (674)
Q Consensus 586 ggsL~~~l~~~~-~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~~~---~~ 661 (674)
+++|.+++.... ..+++..+..++.|++.||.|||..+ |+|+||||+|||++.++.+||+|||+++...... ..
T Consensus 79 ~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 156 (257)
T cd05040 79 LGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKR--FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVM 156 (257)
T ss_pred CCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCC--ccccccCcccEEEecCCEEEeccccccccccccccceec
Confidence 999999997654 56899999999999999999999998 9999999999999999999999999998764321 11
Q ss_pred cccCCCCccccCC
Q 005841 662 TKTGKGTVTYLAS 674 (674)
Q Consensus 662 ~~~~~GTp~YmAP 674 (674)
.....++..|+||
T Consensus 157 ~~~~~~~~~y~~p 169 (257)
T cd05040 157 EEHLKVPFAWCAP 169 (257)
T ss_pred ccCCCCCceecCH
Confidence 2234678889988
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.89 E-value=3.2e-23 Score=215.49 Aligned_cols=165 Identities=30% Similarity=0.484 Sum_probs=143.2
Q ss_pred CCeeEeeeecccCceEEEEEEE--cCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeEEEEEe
Q 005841 505 EDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTE 582 (674)
Q Consensus 505 ~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E 582 (674)
+.|...+.||+|+||.||+|.+ .+..||+|++.... .......+.+|+.+++.++||||+++++.+......|+|||
T Consensus 4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (277)
T cd06642 4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEE-AEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIME 82 (277)
T ss_pred HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEecccc-chHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEE
Confidence 3466778899999999999987 46679999886543 23455778999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccccCCcccc
Q 005841 583 FLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTT 662 (674)
Q Consensus 583 ~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~~~~~~ 662 (674)
|+++++|.+++.. ..+++..+..++.||+.||.|||+.+ |+|+||+|+||+++.++.++|+|||++..........
T Consensus 83 ~~~~~~L~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~--ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~ 158 (277)
T cd06642 83 YLGGGSALDLLKP--GPLEETYIATILREILKGLDYLHSER--KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKR 158 (277)
T ss_pred ccCCCcHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhcCC--eeccCCChheEEEeCCCCEEEccccccccccCcchhh
Confidence 9999999998864 46899999999999999999999988 9999999999999999999999999998765544344
Q ss_pred ccCCCCccccCC
Q 005841 663 KTGKGTVTYLAS 674 (674)
Q Consensus 663 ~~~~GTp~YmAP 674 (674)
....|+..|+||
T Consensus 159 ~~~~~~~~y~aP 170 (277)
T cd06642 159 NTFVGTPFWMAP 170 (277)
T ss_pred hcccCcccccCH
Confidence 445789999998
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.9e-22 Score=209.91 Aligned_cols=170 Identities=25% Similarity=0.385 Sum_probs=141.8
Q ss_pred cccCCeeEeeeecccCceEEEEEEEcC------CeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEec-C
Q 005841 502 ILWEDLTIGEQIGQGSCGTVYHAVWYG------SDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTS-P 574 (674)
Q Consensus 502 ~~~~~y~~~~~LG~G~fG~Vy~~~~~~------~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~-~ 574 (674)
+..++|.+.++||+|+||.||+|.+.. ..|++|.+... ........+.+|+.+++.+.||||+++++++.. .
T Consensus 3 ~~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~-~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~ 81 (280)
T cd05043 3 ISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDH-ASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDG 81 (280)
T ss_pred cchhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCC-CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCC
Confidence 456789999999999999999999743 56899987533 344556778899999999999999999998765 5
Q ss_pred CeEEEEEecCCCCCHHHHHHhcC-------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEE
Q 005841 575 QRLCIVTEFLPRGSLFRLLQRNT-------TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVG 647 (674)
Q Consensus 575 ~~~~lV~E~~~ggsL~~~l~~~~-------~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~ 647 (674)
...++++||+++++|.+++.... ..+++..+..++.||+.||.|||+.+ |+|+||||+|||++.++.+||+
T Consensus 82 ~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~--i~H~di~p~nil~~~~~~~kl~ 159 (280)
T cd05043 82 EPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG--VIHKDIAARNCVIDEELQVKIT 159 (280)
T ss_pred CCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccCHhhEEEcCCCcEEEC
Confidence 67899999999999999997542 45899999999999999999999998 9999999999999999999999
Q ss_pred ecCCcccccCCcc--ccccCCCCccccCC
Q 005841 648 DFGLSRLKHETYL--TTKTGKGTVTYLAS 674 (674)
Q Consensus 648 DFGla~~~~~~~~--~~~~~~GTp~YmAP 674 (674)
|||+++.+..... ......++..||||
T Consensus 160 d~g~~~~~~~~~~~~~~~~~~~~~~y~ap 188 (280)
T cd05043 160 DNALSRDLFPMDYHCLGDNENRPVKWMAL 188 (280)
T ss_pred CCCCcccccCCceEEeCCCCCcchhccCH
Confidence 9999986533211 11223467789998
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.2e-22 Score=211.73 Aligned_cols=167 Identities=29% Similarity=0.426 Sum_probs=141.0
Q ss_pred ccCCeeEeeeecccCceEEEEEEE--cCCeEEEEEeecccCCHHHHHHHHHHHHHHhhC-CCCCeeeEEEEEec------
Q 005841 503 LWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRL-RHPNVLLFMGAVTS------ 573 (674)
Q Consensus 503 ~~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~------ 573 (674)
..+.|++.+.||.|+||.||++.+ .+..||+|++.... .....+..|+.+++.+ +|+||+++++++..
T Consensus 14 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~---~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~ 90 (282)
T cd06636 14 PAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE---DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGH 90 (282)
T ss_pred hhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh---HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCC
Confidence 346799999999999999999998 46679999986532 3345678899999998 69999999999853
Q ss_pred CCeEEEEEecCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCc
Q 005841 574 PQRLCIVTEFLPRGSLFRLLQRN-TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLS 652 (674)
Q Consensus 574 ~~~~~lV~E~~~ggsL~~~l~~~-~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla 652 (674)
...+|+||||+++++|.+++... ...+++..+..++.||+.||.|||+.+ |+|+||||+||+++.++.++|+|||++
T Consensus 91 ~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~--ivH~dl~~~nili~~~~~~~l~dfg~~ 168 (282)
T cd06636 91 DDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHK--VIHRDIKGQNVLLTENAEVKLVDFGVS 168 (282)
T ss_pred CCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCCCCEEEeeCcch
Confidence 46789999999999999999753 345889999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCccccccCCCCccccCC
Q 005841 653 RLKHETYLTTKTGKGTVTYLAS 674 (674)
Q Consensus 653 ~~~~~~~~~~~~~~GTp~YmAP 674 (674)
..............|++.|+||
T Consensus 169 ~~~~~~~~~~~~~~~~~~y~aP 190 (282)
T cd06636 169 AQLDRTVGRRNTFIGTPYWMAP 190 (282)
T ss_pred hhhhccccCCCcccccccccCH
Confidence 8665433333446799999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.5e-22 Score=208.45 Aligned_cols=158 Identities=24% Similarity=0.329 Sum_probs=139.0
Q ss_pred ecccCceEEEEEEEc--CCeEEEEEeecccCC-HHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeEEEEEecCCCCCH
Q 005841 513 IGQGSCGTVYHAVWY--GSDVAVKVFSRQEYS-DEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSL 589 (674)
Q Consensus 513 LG~G~fG~Vy~~~~~--~~~vAvK~i~~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL 589 (674)
||.|+||.||++.+. +..|++|++.+.... ......+.+|+.+++.++||||+++++.+..+..+|+||||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 689999999999985 778999999765543 34557799999999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccccCCccccccCCCCc
Q 005841 590 FRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTV 669 (674)
Q Consensus 590 ~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~~~~~~~~~~GTp 669 (674)
.+++.+. ..+++..+..++.||+.||.|||+++ ++|+||||+||+++.++.++|+|||++....... ......|++
T Consensus 81 ~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lH~~~--~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~ 156 (262)
T cd05572 81 WTILRDR-GLFDEYTARFYIACVVLAFEYLHNRG--IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ-KTWTFCGTP 156 (262)
T ss_pred HHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhhCC--cccCCCCHHHEEEcCCCCEEEeeCCcccccCccc-ccccccCCc
Confidence 9999764 46899999999999999999999998 9999999999999999999999999998765432 223357899
Q ss_pred cccCC
Q 005841 670 TYLAS 674 (674)
Q Consensus 670 ~YmAP 674 (674)
.||||
T Consensus 157 ~~~~P 161 (262)
T cd05572 157 EYVAP 161 (262)
T ss_pred CccCh
Confidence 99998
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.4e-22 Score=210.98 Aligned_cols=165 Identities=31% Similarity=0.485 Sum_probs=143.5
Q ss_pred CCeeEeeeecccCceEEEEEEE--cCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeEEEEEe
Q 005841 505 EDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTE 582 (674)
Q Consensus 505 ~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E 582 (674)
..|+..+.||.|+||.||+|.+ .+..||||++.... .......+.+|+.+++.+.||||+++++.+......|+|||
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEE-AEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIME 82 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccc-cHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEe
Confidence 3577888999999999999987 46779999987543 23445788899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccccCCcccc
Q 005841 583 FLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTT 662 (674)
Q Consensus 583 ~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~~~~~~ 662 (674)
|+++++|.+++.. ..+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++..........
T Consensus 83 ~~~~~~L~~~i~~--~~l~~~~~~~~~~~l~~~l~~lh~~~--ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~ 158 (277)
T cd06640 83 YLGGGSALDLLRA--GPFDEFQIATMLKEILKGLDYLHSEK--KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKR 158 (277)
T ss_pred cCCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC--ccCcCCChhhEEEcCCCCEEEcccccceeccCCcccc
Confidence 9999999999864 46899999999999999999999998 9999999999999999999999999997765443333
Q ss_pred ccCCCCccccCC
Q 005841 663 KTGKGTVTYLAS 674 (674)
Q Consensus 663 ~~~~GTp~YmAP 674 (674)
....+|..|+||
T Consensus 159 ~~~~~~~~y~ap 170 (277)
T cd06640 159 NTFVGTPFWMAP 170 (277)
T ss_pred ccccCcccccCH
Confidence 345688999998
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.2e-22 Score=212.77 Aligned_cols=164 Identities=30% Similarity=0.412 Sum_probs=142.6
Q ss_pred cCCeeEeeeecccCceEEEEEEE--cCCeEEEEEeecccC-CHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeEEEE
Q 005841 504 WEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEY-SDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIV 580 (674)
Q Consensus 504 ~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 580 (674)
.+.|.+.+.||+|+||.||++.. .+..||+|++..... ..+....+.+|+.+++.++||||+++++++...+..|+|
T Consensus 14 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv 93 (307)
T cd06607 14 EKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLV 93 (307)
T ss_pred chhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEE
Confidence 35689999999999999999987 477899999865433 334556788999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccccCCcc
Q 005841 581 TEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYL 660 (674)
Q Consensus 581 ~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~~~~ 660 (674)
|||++ ++|.+++......+++..+..++.||+.||.|||..+ |+|+||+|+||+++.++.++|+|||++......
T Consensus 94 ~e~~~-g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~--i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~-- 168 (307)
T cd06607 94 MEYCL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHE--RIHRDIKAGNILLTEPGTVKLADFGSASLVSPA-- 168 (307)
T ss_pred HHhhC-CCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCcccEEECCCCCEEEeecCcceecCCC--
Confidence 99996 5888877666667999999999999999999999998 999999999999999999999999999765432
Q ss_pred ccccCCCCccccCC
Q 005841 661 TTKTGKGTVTYLAS 674 (674)
Q Consensus 661 ~~~~~~GTp~YmAP 674 (674)
....|++.|+||
T Consensus 169 --~~~~~~~~y~aP 180 (307)
T cd06607 169 --NSFVGTPYWMAP 180 (307)
T ss_pred --CCccCCccccCc
Confidence 235688999998
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.4e-22 Score=213.19 Aligned_cols=165 Identities=30% Similarity=0.442 Sum_probs=143.4
Q ss_pred cCCeeEeeeecccCceEEEEEEE--cCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeEEEEE
Q 005841 504 WEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVT 581 (674)
Q Consensus 504 ~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 581 (674)
.++|.+.+.||+|+||.||++.. .+..|++|.+.... ....+.+.+|+.+++.++||||+++++.+......|+||
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~ 95 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQ--QPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVM 95 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEecccc--chHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEE
Confidence 47899999999999999999986 56779999986433 223466888999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccccCCccc
Q 005841 582 EFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLT 661 (674)
Q Consensus 582 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~~~~~ 661 (674)
||+++++|.+++.+ ..+++..+..++.|++.||.|||+.+ |+|+||||+||+++.++.++|+|||++.........
T Consensus 96 e~~~~~~L~~~~~~--~~l~~~~~~~i~~~l~~al~~LH~~g--i~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~~ 171 (293)
T cd06647 96 EYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHSNQ--VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK 171 (293)
T ss_pred ecCCCCcHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHhCC--EeeccCCHHHEEEcCCCCEEEccCcceecccccccc
Confidence 99999999999964 35889999999999999999999999 999999999999999999999999998766544333
Q ss_pred cccCCCCccccCC
Q 005841 662 TKTGKGTVTYLAS 674 (674)
Q Consensus 662 ~~~~~GTp~YmAP 674 (674)
.....|++.|+||
T Consensus 172 ~~~~~~~~~y~~P 184 (293)
T cd06647 172 RSTMVGTPYWMAP 184 (293)
T ss_pred cccccCChhhcCc
Confidence 3345689999998
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=99.89 E-value=3.7e-23 Score=217.46 Aligned_cols=164 Identities=30% Similarity=0.429 Sum_probs=141.0
Q ss_pred CCeeEeeeecccCceEEEEEEE--cCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeEEEEEe
Q 005841 505 EDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTE 582 (674)
Q Consensus 505 ~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E 582 (674)
+.|.....||+|+||.||++.. ++..||||.+.... ......+.+|+.+++.++|+||+++++.+...+..|+|||
T Consensus 22 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e 99 (292)
T cd06658 22 EYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRK--QQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVME 99 (292)
T ss_pred HHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecch--HHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEe
Confidence 4566677899999999999987 56789999886432 2345668899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccccCCcccc
Q 005841 583 FLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTT 662 (674)
Q Consensus 583 ~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~~~~~~ 662 (674)
|+++++|.+++.. ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.++|+|||++..........
T Consensus 100 ~~~~~~L~~~~~~--~~l~~~~~~~~~~qi~~~l~~LH~~~--ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~~~ 175 (292)
T cd06658 100 FLEGGALTDIVTH--TRMNEEQIATVCLSVLRALSYLHNQG--VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKR 175 (292)
T ss_pred CCCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC--EeecCCCHHHEEEcCCCCEEEccCcchhhcccccccC
Confidence 9999999998853 36899999999999999999999998 9999999999999999999999999997654433333
Q ss_pred ccCCCCccccCC
Q 005841 663 KTGKGTVTYLAS 674 (674)
Q Consensus 663 ~~~~GTp~YmAP 674 (674)
....||+.|+||
T Consensus 176 ~~~~~~~~y~aP 187 (292)
T cd06658 176 KSLVGTPYWMAP 187 (292)
T ss_pred ceeecCccccCH
Confidence 345689999998
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.7e-22 Score=207.62 Aligned_cols=159 Identities=28% Similarity=0.500 Sum_probs=132.6
Q ss_pred eeecccCceEEEEEEEc--C---CeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeEEEEEecCC
Q 005841 511 EQIGQGSCGTVYHAVWY--G---SDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLP 585 (674)
Q Consensus 511 ~~LG~G~fG~Vy~~~~~--~---~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ 585 (674)
++||+|+||.||+|.+. + ..||+|.+...... .....+.+|+.+++.+.|+||+++++++. .+..++||||++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~ 78 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA-AGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAP 78 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccch-HHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCC
Confidence 47999999999999863 2 46999998765543 44567889999999999999999999876 556899999999
Q ss_pred CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccccCCccc---c
Q 005841 586 RGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLT---T 662 (674)
Q Consensus 586 ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~~~~~---~ 662 (674)
+++|.+++.... .+++..+..++.|++.+|.|||..+ |+|+||||+|||++.++.+||+|||+++........ .
T Consensus 79 ~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lh~~~--i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~ 155 (257)
T cd05060 79 LGPLLKYLKKRR-EIPVSDLKELAHQVAMGMAYLESKH--FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRAT 155 (257)
T ss_pred CCcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHhhcC--eeccCcccceEEEcCCCcEEeccccccceeecCCcccccc
Confidence 999999997644 7899999999999999999999998 999999999999999999999999999866432211 1
Q ss_pred ccCCCCccccCC
Q 005841 663 KTGKGTVTYLAS 674 (674)
Q Consensus 663 ~~~~GTp~YmAP 674 (674)
....++..|+||
T Consensus 156 ~~~~~~~~y~aP 167 (257)
T cd05060 156 TAGRWPLKWYAP 167 (257)
T ss_pred cCccccccccCH
Confidence 122345789988
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.3e-22 Score=211.07 Aligned_cols=159 Identities=25% Similarity=0.352 Sum_probs=136.2
Q ss_pred ecccCceEEEEEEE--cCCeEEEEEeecccCCH-HHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeEEEEEecCCCCCH
Q 005841 513 IGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSD-EVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSL 589 (674)
Q Consensus 513 LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL 589 (674)
||+|+||+||+|.. .+..||+|++.+..... .....+..|+.+++.++||||+++++.+...+..|+||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 68999999999986 47789999997654322 3345667899999999999999999999999999999999999999
Q ss_pred HHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccccCCccccccCCCC
Q 005841 590 FRLLQRNT-TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGT 668 (674)
Q Consensus 590 ~~~l~~~~-~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~~~~~~~~~~GT 668 (674)
.+++.... ..+++..+..++.|++.||.|||+++ |+|+||||+|||++.++.++|+|||++...... .......|+
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~--i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~ 157 (277)
T cd05577 81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRR--IVYRDLKPENVLLDDHGNVRISDLGLAVELKGG-KKIKGRAGT 157 (277)
T ss_pred HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEECCCCCEEEccCcchhhhccC-CccccccCC
Confidence 99987644 36899999999999999999999999 999999999999999999999999999866432 222334688
Q ss_pred ccccCC
Q 005841 669 VTYLAS 674 (674)
Q Consensus 669 p~YmAP 674 (674)
+.|+||
T Consensus 158 ~~y~~P 163 (277)
T cd05577 158 PGYMAP 163 (277)
T ss_pred CCcCCH
Confidence 899988
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=9.9e-24 Score=219.70 Aligned_cols=173 Identities=27% Similarity=0.425 Sum_probs=145.2
Q ss_pred ccccCCeeEeeeecccCceEEEEEEE--cCCeEEEEEeeccc-CCH----HHHHHHHHHHHHHhhCCCCCeeeEEEEEec
Q 005841 501 EILWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQE-YSD----EVIHSFRQEVSLMKRLRHPNVLLFMGAVTS 573 (674)
Q Consensus 501 ~~~~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~-~~~----~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~ 573 (674)
..+.++|-++.+||+|+|+.||++.+ ..+.||||+-.... +.+ ...+-..+|..|.+.|.||.||++|++|.-
T Consensus 459 ptLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfsl 538 (775)
T KOG1151|consen 459 PTLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSL 538 (775)
T ss_pred cchHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeee
Confidence 34567899999999999999999987 45669999754322 222 244557789999999999999999999974
Q ss_pred -CCeEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcC---CCcEEEEec
Q 005841 574 -PQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDK---HWTVKVGDF 649 (674)
Q Consensus 574 -~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~---~~~vkL~DF 649 (674)
.+.+|-|+|||+|.+|..||+.+ ..++++++..|+.||+.||.||.+..+||||=||||.|||+-. -|.|||+||
T Consensus 539 DtdsFCTVLEYceGNDLDFYLKQh-klmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDF 617 (775)
T KOG1151|consen 539 DTDSFCTVLEYCEGNDLDFYLKQH-KLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDF 617 (775)
T ss_pred ccccceeeeeecCCCchhHHHHhh-hhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeec
Confidence 46689999999999999999764 4689999999999999999999999999999999999999954 578999999
Q ss_pred CCcccccCCccc-------cccCCCCccccCC
Q 005841 650 GLSRLKHETYLT-------TKTGKGTVTYLAS 674 (674)
Q Consensus 650 Gla~~~~~~~~~-------~~~~~GTp~YmAP 674 (674)
||+++..+..+. +..++||..|++|
T Consensus 618 GLSKIMdddSy~~vdGmeLTSQgAGTYWYLPP 649 (775)
T KOG1151|consen 618 GLSKIMDDDSYNSVDGMELTSQGAGTYWYLPP 649 (775)
T ss_pred chhhhccCCccCcccceeeecccCceeeecCc
Confidence 999987655443 4457899999988
|
|
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.9e-22 Score=209.03 Aligned_cols=160 Identities=31% Similarity=0.553 Sum_probs=131.4
Q ss_pred eeecccCceEEEEEEEcC--C--eEEEEEeecccCCHHHHHHHHHHHHHHhhC-CCCCeeeEEEEEecCCeEEEEEecCC
Q 005841 511 EQIGQGSCGTVYHAVWYG--S--DVAVKVFSRQEYSDEVIHSFRQEVSLMKRL-RHPNVLLFMGAVTSPQRLCIVTEFLP 585 (674)
Q Consensus 511 ~~LG~G~fG~Vy~~~~~~--~--~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lV~E~~~ 585 (674)
+.||+|+||.||++.+.. . .+++|.+... ......+.+.+|+.++..+ .||||+++++++.....+|+||||++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~ 79 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY-ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAP 79 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEcccc-CCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCC
Confidence 368999999999998743 3 3688877532 2344556788999999999 79999999999999999999999999
Q ss_pred CCCHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecC
Q 005841 586 RGSLFRLLQRNT---------------TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFG 650 (674)
Q Consensus 586 ggsL~~~l~~~~---------------~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFG 650 (674)
+++|.+++.... ..+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||
T Consensus 80 ~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~--i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 80 HGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ--FIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccccceEEEcCCCeEEECCCC
Confidence 999999997532 24789999999999999999999998 9999999999999999999999999
Q ss_pred CcccccCCccccccCCCCccccCC
Q 005841 651 LSRLKHETYLTTKTGKGTVTYLAS 674 (674)
Q Consensus 651 la~~~~~~~~~~~~~~GTp~YmAP 674 (674)
++...... ........++.|+||
T Consensus 158 l~~~~~~~-~~~~~~~~~~~y~ap 180 (270)
T cd05047 158 LSRGQEVY-VKKTMGRLPVRWMAI 180 (270)
T ss_pred Cccccchh-hhccCCCCccccCCh
Confidence 98643221 112223446779987
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.89 E-value=3.9e-23 Score=212.74 Aligned_cols=156 Identities=21% Similarity=0.362 Sum_probs=132.3
Q ss_pred eeecccCceEEEEEEEc---------CCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeEEEEE
Q 005841 511 EQIGQGSCGTVYHAVWY---------GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVT 581 (674)
Q Consensus 511 ~~LG~G~fG~Vy~~~~~---------~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 581 (674)
+.||.|+||.||+|.+. ...|++|.+.... ....+.+..|+.+++.+.||||+++++++..++..++||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 78 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSH--RNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQ 78 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchh--HHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEE
Confidence 46999999999999863 2238888775432 344567888999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCc--------EEEEecCCcc
Q 005841 582 EFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWT--------VKVGDFGLSR 653 (674)
Q Consensus 582 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~--------vkL~DFGla~ 653 (674)
||+++++|..++......+++..++.++.||+.||.|||+++ |+||||||+|||++.++. ++|+|||++.
T Consensus 79 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~ 156 (258)
T cd05078 79 EYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKG--LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISI 156 (258)
T ss_pred ecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCccceEEEecccccccCCCceEEeccccccc
Confidence 999999999999876667899999999999999999999999 999999999999987654 6999999986
Q ss_pred cccCCccccccCCCCccccCC
Q 005841 654 LKHETYLTTKTGKGTVTYLAS 674 (674)
Q Consensus 654 ~~~~~~~~~~~~~GTp~YmAP 674 (674)
.... .....||+.||||
T Consensus 157 ~~~~----~~~~~~~~~y~aP 173 (258)
T cd05078 157 TVLP----KEILLERIPWVPP 173 (258)
T ss_pred ccCC----chhccccCCccCc
Confidence 5432 2235688999998
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.6e-22 Score=211.07 Aligned_cols=158 Identities=24% Similarity=0.372 Sum_probs=129.5
Q ss_pred eecccCceEEEEEEE--cCCeEEEEEeecccCCH-HHHHHHHHHHHH---HhhCCCCCeeeEEEEEecCCeEEEEEecCC
Q 005841 512 QIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSD-EVIHSFRQEVSL---MKRLRHPNVLLFMGAVTSPQRLCIVTEFLP 585 (674)
Q Consensus 512 ~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~~~-~~~~~~~~Ei~i---l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ 585 (674)
+||+|+||.||++.. ++..||+|++.+..... .....+.+|..+ +....||||+.+++.+...+..|+||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 489999999999987 46789999997654432 112223344433 334479999999999999999999999999
Q ss_pred CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccccCCccccccC
Q 005841 586 RGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTG 665 (674)
Q Consensus 586 ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~~~~~~~~~ 665 (674)
+++|.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.++|+|||++....... ....
T Consensus 81 ~~~L~~~i~~~-~~l~~~~~~~i~~qi~~al~~lH~~~--ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~--~~~~ 155 (279)
T cd05633 81 GGDLHYHLSQH-GVFSEKEMRFYATEIILGLEHMHNRF--VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK--PHAS 155 (279)
T ss_pred CCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--cCCCCCCHHHEEECCCCCEEEccCCcceeccccC--ccCc
Confidence 99999998654 46999999999999999999999999 9999999999999999999999999997654322 2234
Q ss_pred CCCccccCC
Q 005841 666 KGTVTYLAS 674 (674)
Q Consensus 666 ~GTp~YmAP 674 (674)
.||+.||||
T Consensus 156 ~~~~~y~aP 164 (279)
T cd05633 156 VGTHGYMAP 164 (279)
T ss_pred CCCcCccCH
Confidence 699999998
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.3e-22 Score=211.27 Aligned_cols=165 Identities=33% Similarity=0.447 Sum_probs=140.8
Q ss_pred eeEeeeecccCceEEEEEEE--cCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeEEEEEecC
Q 005841 507 LTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFL 584 (674)
Q Consensus 507 y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 584 (674)
|++.+.||.|++|.||+|.+ .+..||+|++............+.+|+.+++.++||||+++++++...+..|+||||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 67788999999999999987 5788999998765544444456788999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccccCCccccc
Q 005841 585 PRGSLFRLLQRNT-TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTK 663 (674)
Q Consensus 585 ~ggsL~~~l~~~~-~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~~~~~~~ 663 (674)
+ ++|.+++.... ..+++..+..++.|++.||+|||+.+ ++|+||+|+|||++.++.++|+|||+++..........
T Consensus 81 ~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~--~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~ 157 (283)
T cd07835 81 D-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHR--VLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYT 157 (283)
T ss_pred C-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeCCCCCHHHEEEcCCCcEEEeecccccccCCCccccC
Confidence 5 68999887544 46899999999999999999999988 99999999999999999999999999976543322222
Q ss_pred cCCCCccccCC
Q 005841 664 TGKGTVTYLAS 674 (674)
Q Consensus 664 ~~~GTp~YmAP 674 (674)
...+++.||||
T Consensus 158 ~~~~~~~~~aP 168 (283)
T cd07835 158 HEVVTLWYRAP 168 (283)
T ss_pred ccccccCCCCC
Confidence 33578999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.89 E-value=1e-22 Score=210.96 Aligned_cols=167 Identities=28% Similarity=0.501 Sum_probs=145.1
Q ss_pred CCeeEeeeecccCceEEEEEEE--cCCeEEEEEeecccC-CHHHHHHHHHHHHHHhhCC-CCCeeeEEEEEecCCeEEEE
Q 005841 505 EDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEY-SDEVIHSFRQEVSLMKRLR-HPNVLLFMGAVTSPQRLCIV 580 (674)
Q Consensus 505 ~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~lV 580 (674)
++|.+.+.||.|+||.||++.. .+..|++|++.+... .......+.+|+.++.++. ||||+++++++...+..|+|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 4799999999999999999987 577899999976443 3344567888999999998 99999999999999999999
Q ss_pred EecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccccCCc-
Q 005841 581 TEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETY- 659 (674)
Q Consensus 581 ~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~~~- 659 (674)
|||+++++|.+++.+. ..+++..+..++.|++.||.|||+++ ++|+||||+||+++.++.++|+|||++.......
T Consensus 81 ~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~ql~~~l~~Lh~~~--~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~ 157 (280)
T cd05581 81 LEYAPNGELLQYIRKY-GSLDEKCTRFYAAEILLALEYLHSKG--IIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSS 157 (280)
T ss_pred EcCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHeEECCCCCEEecCCccccccCCccc
Confidence 9999999999999764 47999999999999999999999999 9999999999999999999999999998664332
Q ss_pred -------------------cccccCCCCccccCC
Q 005841 660 -------------------LTTKTGKGTVTYLAS 674 (674)
Q Consensus 660 -------------------~~~~~~~GTp~YmAP 674 (674)
.....+.|++.|+||
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~P 191 (280)
T cd05581 158 PESNKGDATNIDSQIEKNRRRFASFVGTAEYVSP 191 (280)
T ss_pred cccCCCCCccccccccccccccccccCCccccCH
Confidence 222335688999988
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=4e-23 Score=206.86 Aligned_cols=161 Identities=31% Similarity=0.397 Sum_probs=134.1
Q ss_pred cCCeeEe-eeecccCceEEEEEEE--cCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCC-CCCeeeEEEEEec----CC
Q 005841 504 WEDLTIG-EQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLR-HPNVLLFMGAVTS----PQ 575 (674)
Q Consensus 504 ~~~y~~~-~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~----~~ 575 (674)
.++|.+. ++||-|-.|+|..|.+ ++..+|+|++... ...++|+++..... |||||.++++|.. ..
T Consensus 60 tedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-------~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rk 132 (400)
T KOG0604|consen 60 TEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-------PKARREVELHWMASGHPHIVSIIDVYENSYQGRK 132 (400)
T ss_pred hhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-------HHHHhHhhhhhhhcCCCceEEeehhhhhhccCce
Confidence 4566654 5789999999999987 5677999988432 34667888877774 9999999998864 35
Q ss_pred eEEEEEecCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEc---CCCcEEEEecCC
Q 005841 576 RLCIVTEFLPRGSLFRLLQRNT-TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVD---KHWTVKVGDFGL 651 (674)
Q Consensus 576 ~~~lV~E~~~ggsL~~~l~~~~-~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~---~~~~vkL~DFGl 651 (674)
.+.||||.|+||.|+..++..+ ..|+++++..|+.||+.|+.|||+.+ |.||||||+|+|.. .+..+||+|||+
T Consensus 133 cLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~n--IAHRDlKpENLLyt~t~~na~lKLtDfGF 210 (400)
T KOG0604|consen 133 CLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMN--IAHRDLKPENLLYTTTSPNAPLKLTDFGF 210 (400)
T ss_pred eeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcc--hhhccCChhheeeecCCCCcceEeccccc
Confidence 6889999999999999998754 46999999999999999999999999 99999999999996 456799999999
Q ss_pred cccccCCccccccCCCCccccCC
Q 005841 652 SRLKHETYLTTKTGKGTVTYLAS 674 (674)
Q Consensus 652 a~~~~~~~~~~~~~~GTp~YmAP 674 (674)
|+..... ....+.|-||+|.||
T Consensus 211 AK~t~~~-~~L~TPc~TPyYvaP 232 (400)
T KOG0604|consen 211 AKETQEP-GDLMTPCFTPYYVAP 232 (400)
T ss_pred ccccCCC-ccccCCcccccccCH
Confidence 9976542 334446779999998
|
|
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.4e-22 Score=209.63 Aligned_cols=158 Identities=25% Similarity=0.355 Sum_probs=130.0
Q ss_pred eecccCceEEEEEEE--cCCeEEEEEeecccCCH-HHHHHHHHH---HHHHhhCCCCCeeeEEEEEecCCeEEEEEecCC
Q 005841 512 QIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSD-EVIHSFRQE---VSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLP 585 (674)
Q Consensus 512 ~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~~~-~~~~~~~~E---i~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ 585 (674)
+||+|+||.||++.+ .+..||+|++.+..... .....+..| +.++....||+|+.+++++...+.+|+||||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 489999999999987 46789999997754432 111223333 344455679999999999999999999999999
Q ss_pred CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccccCCccccccC
Q 005841 586 RGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTG 665 (674)
Q Consensus 586 ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~~~~~~~~~ 665 (674)
|++|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++....... ....
T Consensus 81 g~~L~~~l~~-~~~l~~~~~~~~~~ql~~~l~~lH~~~--i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~--~~~~ 155 (278)
T cd05606 81 GGDLHYHLSQ-HGVFSEAEMRFYAAEIILGLEHMHNRF--VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK--PHAS 155 (278)
T ss_pred CCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCC--EEcCCCCHHHEEECCCCCEEEccCcCccccCccC--CcCc
Confidence 9999998865 457999999999999999999999998 9999999999999999999999999997654322 2335
Q ss_pred CCCccccCC
Q 005841 666 KGTVTYLAS 674 (674)
Q Consensus 666 ~GTp~YmAP 674 (674)
.||+.||||
T Consensus 156 ~~~~~y~aP 164 (278)
T cd05606 156 VGTHGYMAP 164 (278)
T ss_pred CCCcCCcCc
Confidence 799999998
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=99.89 E-value=7.2e-23 Score=215.81 Aligned_cols=163 Identities=28% Similarity=0.389 Sum_probs=140.1
Q ss_pred CeeEeeeecccCceEEEEEEE--cCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeEEEEEec
Q 005841 506 DLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEF 583 (674)
Q Consensus 506 ~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~ 583 (674)
.|.....||+|+||.||++.. .+..||+|++...... ....+.+|+.++..+.||||+++++.+...+..|+||||
T Consensus 22 ~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~--~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~ 99 (297)
T cd06659 22 LLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQ--RRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEF 99 (297)
T ss_pred hHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccc--hHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEec
Confidence 344556899999999999987 5778999998654322 235678899999999999999999999999999999999
Q ss_pred CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccccCCccccc
Q 005841 584 LPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTK 663 (674)
Q Consensus 584 ~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~~~~~~~ 663 (674)
+++++|..++.. ..+++..+..++.|++.||.|||+.+ |+|+||||+|||++.++.+||+|||++...........
T Consensus 100 ~~~~~L~~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~--ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~~~~ 175 (297)
T cd06659 100 LQGGALTDIVSQ--TRLNEEQIATVCESVLQALCYLHSQG--VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRK 175 (297)
T ss_pred CCCCCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHeEEccCCcEEEeechhHhhccccccccc
Confidence 999999998854 46899999999999999999999999 99999999999999999999999999976554433334
Q ss_pred cCCCCccccCC
Q 005841 664 TGKGTVTYLAS 674 (674)
Q Consensus 664 ~~~GTp~YmAP 674 (674)
...|++.|+||
T Consensus 176 ~~~~~~~y~aP 186 (297)
T cd06659 176 SLVGTPYWMAP 186 (297)
T ss_pred ceecCccccCH
Confidence 46799999998
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.5e-22 Score=216.31 Aligned_cols=164 Identities=30% Similarity=0.425 Sum_probs=140.3
Q ss_pred ccCCeeEeeeecccCceEEEEEEE--cCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCC-----
Q 005841 503 LWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQ----- 575 (674)
Q Consensus 503 ~~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~----- 575 (674)
..++|.+.+.||+|+||.||++.. .+..||||++.+..........+.+|+.+++.++||||+++++++....
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07880 13 VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRF 92 (343)
T ss_pred cccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccccc
Confidence 457899999999999999999987 4678999998654434445567889999999999999999999987654
Q ss_pred -eEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCccc
Q 005841 576 -RLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL 654 (674)
Q Consensus 576 -~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~ 654 (674)
.+|+||||+ +++|.+++.. ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++..
T Consensus 93 ~~~~lv~e~~-~~~l~~~~~~--~~l~~~~~~~i~~qi~~al~~LH~~g--i~H~dlkp~Nill~~~~~~kl~dfg~~~~ 167 (343)
T cd07880 93 HDFYLVMPFM-GTDLGKLMKH--EKLSEDRIQFLVYQMLKGLKYIHAAG--IIHRDLKPGNLAVNEDCELKILDFGLARQ 167 (343)
T ss_pred ceEEEEEecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEEeecccccc
Confidence 469999999 7799888853 46899999999999999999999999 99999999999999999999999999986
Q ss_pred ccCCccccccCCCCccccCC
Q 005841 655 KHETYLTTKTGKGTVTYLAS 674 (674)
Q Consensus 655 ~~~~~~~~~~~~GTp~YmAP 674 (674)
.... .....+|+.|+||
T Consensus 168 ~~~~---~~~~~~~~~y~aP 184 (343)
T cd07880 168 TDSE---MTGYVVTRWYRAP 184 (343)
T ss_pred cccC---ccccccCCcccCH
Confidence 5432 2234689999998
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.2e-22 Score=210.16 Aligned_cols=167 Identities=29% Similarity=0.459 Sum_probs=146.1
Q ss_pred ccCCeeEeeeecccCceEEEEEEEc--CCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeEEEE
Q 005841 503 LWEDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIV 580 (674)
Q Consensus 503 ~~~~y~~~~~LG~G~fG~Vy~~~~~--~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 580 (674)
..+.|++.+.||+|+||.||++.+. +..|++|++..... ....+.+|+.+++.++|+||+++++.+......|+|
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 93 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ---NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVV 93 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch---hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEE
Confidence 3466888999999999999999985 77899999975433 456788899999999999999999999999999999
Q ss_pred EecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccccCCcc
Q 005841 581 TEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYL 660 (674)
Q Consensus 581 ~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~~~~ 660 (674)
|||+++++|.+++......+++..+..++.|++.||.|||..+ |+|+||||+||+++.++.++|+|||++........
T Consensus 94 ~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~g--i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 171 (286)
T cd06614 94 MEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQN--VIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKS 171 (286)
T ss_pred EeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCChhhEEEcCCCCEEECccchhhhhccchh
Confidence 9999999999999876557999999999999999999999988 99999999999999999999999999876654333
Q ss_pred ccccCCCCccccCC
Q 005841 661 TTKTGKGTVTYLAS 674 (674)
Q Consensus 661 ~~~~~~GTp~YmAP 674 (674)
......|++.|+||
T Consensus 172 ~~~~~~~~~~y~~P 185 (286)
T cd06614 172 KRNSVVGTPYWMAP 185 (286)
T ss_pred hhccccCCcccCCH
Confidence 33345688999988
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=3.7e-23 Score=228.49 Aligned_cols=171 Identities=34% Similarity=0.519 Sum_probs=150.9
Q ss_pred ccccCCeeEeeeecccCceEEEEEEEc--CC---eEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCC
Q 005841 501 EILWEDLTIGEQIGQGSCGTVYHAVWY--GS---DVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQ 575 (674)
Q Consensus 501 ~~~~~~y~~~~~LG~G~fG~Vy~~~~~--~~---~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~ 575 (674)
++.....+|.++||.|.||.||.|+.+ ++ .||||.++ ..+.++....|+.|..||-++.||||+++.|+.....
T Consensus 625 EId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK-~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~ 703 (996)
T KOG0196|consen 625 EIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLK-AGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSK 703 (996)
T ss_pred hcChhheEEEEEEecccccceecccccCCCCcceeEEEeeec-cCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCc
Confidence 455567789999999999999999873 32 39999995 4567778889999999999999999999999999999
Q ss_pred eEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccc
Q 005841 576 RLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLK 655 (674)
Q Consensus 576 ~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~ 655 (674)
.+.||.|||++|+|..+|+++.+.|++.+..-|++.|+.||.||-+++ +|||||...|||||.+..+||+||||+|.+
T Consensus 704 PvMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~--YVHRDLAARNILVNsnLvCKVsDFGLSRvl 781 (996)
T KOG0196|consen 704 PVMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMN--YVHRDLAARNILVNSNLVCKVSDFGLSRVL 781 (996)
T ss_pred eeEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcC--chhhhhhhhheeeccceEEEeccccceeec
Confidence 999999999999999999999999999999999999999999999999 999999999999999999999999999988
Q ss_pred cCCc---cccccCCCCccccCC
Q 005841 656 HETY---LTTKTGKGTVTYLAS 674 (674)
Q Consensus 656 ~~~~---~~~~~~~GTp~YmAP 674 (674)
.++. +++..+.=..+|.||
T Consensus 782 edd~~~~ytt~GGKIPiRWTAP 803 (996)
T KOG0196|consen 782 EDDPEAAYTTLGGKIPIRWTAP 803 (996)
T ss_pred ccCCCccccccCCccceeecCh
Confidence 5543 333334445678877
|
|
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.89 E-value=4.2e-22 Score=202.90 Aligned_cols=166 Identities=33% Similarity=0.505 Sum_probs=147.1
Q ss_pred CeeEeeeecccCceEEEEEEEc--CCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecC--CeEEEEE
Q 005841 506 DLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSP--QRLCIVT 581 (674)
Q Consensus 506 ~y~~~~~LG~G~fG~Vy~~~~~--~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~--~~~~lV~ 581 (674)
+|.+.+.||+|++|.||+|... +..|++|++..........+.+.+|+.++++++||||+++++.+... ..+++||
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 4788899999999999999985 77899999977665556678899999999999999999999999988 8899999
Q ss_pred ecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccccCCcc-
Q 005841 582 EFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYL- 660 (674)
Q Consensus 582 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~~~~- 660 (674)
||+++++|.+++.... .+++..+..++.|++.+|.|||+.+ ++|+||+|+||+++.++.++|+|||.+........
T Consensus 81 e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~~~--~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~ 157 (260)
T cd06606 81 EYVSGGSLSSLLKKFG-KLPEPVIRKYTRQILEGLAYLHSNG--IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETG 157 (260)
T ss_pred EecCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEEcCCCCEEEcccccEEeccccccc
Confidence 9999999999997654 8999999999999999999999988 99999999999999999999999999987765432
Q ss_pred -ccccCCCCccccCC
Q 005841 661 -TTKTGKGTVTYLAS 674 (674)
Q Consensus 661 -~~~~~~GTp~YmAP 674 (674)
......+++.|+||
T Consensus 158 ~~~~~~~~~~~y~~p 172 (260)
T cd06606 158 EGTGSVRGTPYWMAP 172 (260)
T ss_pred ccccCCCCCccccCH
Confidence 12335689999987
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=4.9e-22 Score=201.54 Aligned_cols=164 Identities=34% Similarity=0.524 Sum_probs=145.0
Q ss_pred CeeEeeeecccCceEEEEEEEc--CCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeEEEEEec
Q 005841 506 DLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEF 583 (674)
Q Consensus 506 ~y~~~~~LG~G~fG~Vy~~~~~--~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~ 583 (674)
+|.+.+.||+|++|.||++.+. +..|++|++..... .....+.+|+.+++.++|+||+++++.+......+++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~ 78 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK--EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEF 78 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch--hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEec
Confidence 4888999999999999999984 67799999876543 3456788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccccCCccccc
Q 005841 584 LPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTK 663 (674)
Q Consensus 584 ~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~~~~~~~ 663 (674)
+++++|.+++......+++..+..++.|++.+|.|||..+ ++|+||+|+||+++.++.++|+|||++........ ..
T Consensus 79 ~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~--i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-~~ 155 (253)
T cd05122 79 CSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNG--IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA-RN 155 (253)
T ss_pred CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCC--EecCCCCHHHEEEccCCeEEEeecccccccccccc-cc
Confidence 9999999999776567999999999999999999999988 99999999999999999999999999987654332 23
Q ss_pred cCCCCccccCC
Q 005841 664 TGKGTVTYLAS 674 (674)
Q Consensus 664 ~~~GTp~YmAP 674 (674)
...|+..|+||
T Consensus 156 ~~~~~~~~~~P 166 (253)
T cd05122 156 TMVGTPYWMAP 166 (253)
T ss_pred ceecCCcccCH
Confidence 45689999988
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=4.9e-24 Score=246.31 Aligned_cols=167 Identities=30% Similarity=0.451 Sum_probs=145.5
Q ss_pred CCeeEeeeecccCceEEEEEEE--cCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeEEEEEe
Q 005841 505 EDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTE 582 (674)
Q Consensus 505 ~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E 582 (674)
-+|.-+..||.|.||.||.|.. +|.-.|+|.+..+.........+.+|..++..|+|||+|++|++-...+.++|.||
T Consensus 1235 ~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFME 1314 (1509)
T KOG4645|consen 1235 FRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFME 1314 (1509)
T ss_pred eeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHH
Confidence 3566778899999999999986 67779999987776666666778899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccccCCccc-
Q 005841 583 FLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLT- 661 (674)
Q Consensus 583 ~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~~~~~- 661 (674)
||++|+|.+++.. ....++.....|..|++.|+.|||+.| ||||||||.|||++.+|-+|++|||.|..+.....+
T Consensus 1315 yC~~GsLa~ll~~-gri~dE~vt~vyt~qll~gla~LH~~g--IVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~ 1391 (1509)
T KOG4645|consen 1315 YCEGGSLASLLEH-GRIEDEMVTRVYTKQLLEGLAYLHEHG--IVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTM 1391 (1509)
T ss_pred HhccCcHHHHHHh-cchhhhhHHHHHHHHHHHHHHHHHhcC--ceecCCCccceeeecCCcEEeecccceeEecCchhcC
Confidence 9999999999964 446778888888899999999999999 999999999999999999999999999876544212
Q ss_pred ---cccCCCCccccCC
Q 005841 662 ---TKTGKGTVTYLAS 674 (674)
Q Consensus 662 ---~~~~~GTp~YmAP 674 (674)
.....|||.||||
T Consensus 1392 ~~el~~~~GT~~YMAP 1407 (1509)
T KOG4645|consen 1392 PGELQSMMGTPMYMAP 1407 (1509)
T ss_pred CHHHHhhcCCchhcCc
Confidence 2335799999999
|
|
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=99.89 E-value=7.7e-24 Score=212.76 Aligned_cols=167 Identities=28% Similarity=0.427 Sum_probs=136.7
Q ss_pred CCeeEeeeecccCceEEEEEEEc------CCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEec-CCeE
Q 005841 505 EDLTIGEQIGQGSCGTVYHAVWY------GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTS-PQRL 577 (674)
Q Consensus 505 ~~y~~~~~LG~G~fG~Vy~~~~~------~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~-~~~~ 577 (674)
..|++.+.||+|.||.||++..+ ...+|||.|+-+.-..-......+|+.+++.++||||+.+..+|-. +..+
T Consensus 24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v 103 (438)
T KOG0666|consen 24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKV 103 (438)
T ss_pred HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceE
Confidence 46899999999999999999642 2259999987653322334556789999999999999999888876 7789
Q ss_pred EEEEecCCCCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCC----CcEEEEec
Q 005841 578 CIVTEFLPRGSLFRLLQRN----TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKH----WTVKVGDF 649 (674)
Q Consensus 578 ~lV~E~~~ggsL~~~l~~~----~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~----~~vkL~DF 649 (674)
++++||.+. +|+.+|+-. ...++...+..|+.||+.||.|||++- |+||||||.||||.-+ |+|||+||
T Consensus 104 ~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW--vlHRDLKPaNIlvmgdgperG~VKIaDl 180 (438)
T KOG0666|consen 104 WLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW--VLHRDLKPANILVMGDGPERGRVKIADL 180 (438)
T ss_pred EEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh--eeeccCCcceEEEeccCCccCeeEeecc
Confidence 999999965 898888643 235889999999999999999999999 9999999999999866 99999999
Q ss_pred CCcccccCCccc---cccCCCCccccCC
Q 005841 650 GLSRLKHETYLT---TKTGKGTVTYLAS 674 (674)
Q Consensus 650 Gla~~~~~~~~~---~~~~~GTp~YmAP 674 (674)
|+|+++..+-.. ....+-|.-|.||
T Consensus 181 GlaR~~~~plkpl~s~d~VVVTiWYRAP 208 (438)
T KOG0666|consen 181 GLARLFNNPLKPLASLDPVVVTIWYRAP 208 (438)
T ss_pred cHHHHhhccccccccCCceEEEEEecCh
Confidence 999988754322 2233568888887
|
|
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=99.89 E-value=3e-22 Score=208.13 Aligned_cols=162 Identities=26% Similarity=0.354 Sum_probs=136.3
Q ss_pred eeEeeeecccCceEEEEEEE--cCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCC-CCCeeeEEEEEecC--CeEEEEE
Q 005841 507 LTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLR-HPNVLLFMGAVTSP--QRLCIVT 581 (674)
Q Consensus 507 y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~--~~~~lV~ 581 (674)
|++.+.||+|+||.||++.. .+..||+|++.+........ ...+|+.++.++. |+||+++++++.+. +.+++||
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~-~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~ 79 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQV-NNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVF 79 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhh-hHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEE
Confidence 67889999999999999987 56779999987643333222 3446888898885 99999999999988 8899999
Q ss_pred ecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccccCCccc
Q 005841 582 EFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLT 661 (674)
Q Consensus 582 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~~~~~ 661 (674)
||++ ++|.+++......+++..+..++.||+.||.|||..+ |+||||||+||+++. +.+||+|||+++........
T Consensus 80 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~--i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~~ 155 (282)
T cd07831 80 ELMD-MNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNG--IFHRDIKPENILIKD-DILKLADFGSCRGIYSKPPY 155 (282)
T ss_pred ecCC-ccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecccCHHHEEEcC-CCeEEEecccccccccCCCc
Confidence 9996 5888888765667999999999999999999999998 999999999999999 99999999999876543222
Q ss_pred cccCCCCccccCC
Q 005841 662 TKTGKGTVTYLAS 674 (674)
Q Consensus 662 ~~~~~GTp~YmAP 674 (674)
....+|+.|+||
T Consensus 156 -~~~~~~~~y~aP 167 (282)
T cd07831 156 -TEYISTRWYRAP 167 (282)
T ss_pred -CCCCCCcccCCh
Confidence 224689999998
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=99.89 E-value=3.6e-22 Score=212.44 Aligned_cols=163 Identities=29% Similarity=0.420 Sum_probs=141.6
Q ss_pred CCeeEeeeecccCceEEEEEEE--cCCeEEEEEeecccC-CHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeEEEEE
Q 005841 505 EDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEY-SDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVT 581 (674)
Q Consensus 505 ~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 581 (674)
..|...+.||+|+||.||++.+ .+..||+|++..... ..+....+.+|+.+++.++||||+++++++......|+||
T Consensus 25 ~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 104 (317)
T cd06635 25 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVM 104 (317)
T ss_pred hhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEE
Confidence 4578889999999999999987 467799999875533 3355667889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccccCCccc
Q 005841 582 EFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLT 661 (674)
Q Consensus 582 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~~~~~ 661 (674)
||+++ +|.+++......+++..+..++.||+.||.|||..+ |+|+||+|+||+++.++.+||+|||++.....
T Consensus 105 e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~--i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~---- 177 (317)
T cd06635 105 EYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN--MIHRDIKAGNILLTEPGQVKLADFGSASIASP---- 177 (317)
T ss_pred eCCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCcccEEECCCCCEEEecCCCccccCC----
Confidence 99975 888888766677999999999999999999999998 99999999999999999999999999875443
Q ss_pred cccCCCCccccCC
Q 005841 662 TKTGKGTVTYLAS 674 (674)
Q Consensus 662 ~~~~~GTp~YmAP 674 (674)
.....|++.|+||
T Consensus 178 ~~~~~~~~~y~aP 190 (317)
T cd06635 178 ANSFVGTPYWMAP 190 (317)
T ss_pred cccccCCccccCh
Confidence 2234689999998
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.9e-22 Score=208.31 Aligned_cols=165 Identities=29% Similarity=0.417 Sum_probs=141.5
Q ss_pred eeEeeeecccCceEEEEEEEc--CCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecC--CeEEEEEe
Q 005841 507 LTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSP--QRLCIVTE 582 (674)
Q Consensus 507 y~~~~~LG~G~fG~Vy~~~~~--~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~--~~~~lV~E 582 (674)
|++.+.||.|+||.||++.+. +..||+|++............+.+|+.+++.+.|+||+++++++... +..|+|||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 678899999999999999984 57799999987643344456688899999999999999999999988 88999999
Q ss_pred cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccccCCccc-
Q 005841 583 FLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLT- 661 (674)
Q Consensus 583 ~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~~~~~- 661 (674)
|+++ +|..++......+++..++.++.||+.||+|||+.+ ++|+||||+|||+++++.+||+|||++.........
T Consensus 81 ~~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~--~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~~ 157 (287)
T cd07840 81 YMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNG--ILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSAD 157 (287)
T ss_pred cccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCcHHHeEEcCCCCEEEccccceeeccCCCccc
Confidence 9975 899988765567999999999999999999999998 999999999999999999999999999876544311
Q ss_pred cccCCCCccccCC
Q 005841 662 TKTGKGTVTYLAS 674 (674)
Q Consensus 662 ~~~~~GTp~YmAP 674 (674)
.....+++.|+||
T Consensus 158 ~~~~~~~~~y~~P 170 (287)
T cd07840 158 YTNRVITLWYRPP 170 (287)
T ss_pred ccccccccccCCc
Confidence 1123578889998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=3.7e-23 Score=197.48 Aligned_cols=171 Identities=25% Similarity=0.371 Sum_probs=141.9
Q ss_pred cccccCCeeEeeeecccCceEEEEEEE--cCCeEEEEEeecccCCHHHHHHHHHHHHHHhhC-CCCCeeeEEEEEecCCe
Q 005841 500 YEILWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRL-RHPNVLLFMGAVTSPQR 576 (674)
Q Consensus 500 ~~~~~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~ 576 (674)
+++..+++..+..||+|+||.|-+-++ .|.-.|+|.+.... ..+...++..|+.+..+. ..|++|.|||.+.....
T Consensus 41 ~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tv-n~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regd 119 (282)
T KOG0984|consen 41 FEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATV-NSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGD 119 (282)
T ss_pred cccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhc-ChHHHHHHHHhhhhhccCCCCCeEEEeehhhhcccc
Confidence 456667778888999999999877665 67889999986544 344556788899887765 58999999999999999
Q ss_pred EEEEEecCCCCCHHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcc
Q 005841 577 LCIVTEFLPRGSLFRLLQ---RNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSR 653 (674)
Q Consensus 577 ~~lV~E~~~ggsL~~~l~---~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~ 653 (674)
++|+||.|. .+|..+-. +.+..+++..+-+|+.-|+.||.|||++- .|||||+||+|||||..|+|||||||++.
T Consensus 120 vwIcME~M~-tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL-~vIHRDvKPsNiLIn~~GqVKiCDFGIsG 197 (282)
T KOG0984|consen 120 VWICMELMD-TSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKL-SVIHRDVKPSNILINYDGQVKICDFGISG 197 (282)
T ss_pred EEEeHHHhh-hhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHh-hhhhccCCcceEEEccCCcEEEcccccce
Confidence 999999994 47765543 35678999999999999999999999742 39999999999999999999999999999
Q ss_pred cccCCccccccCCCCccccCC
Q 005841 654 LKHETYLTTKTGKGTVTYLAS 674 (674)
Q Consensus 654 ~~~~~~~~~~~~~GTp~YmAP 674 (674)
.+.++-..+- -+|.-.||||
T Consensus 198 ~L~dSiAkt~-daGCkpYmaP 217 (282)
T KOG0984|consen 198 YLVDSIAKTM-DAGCKPYMAP 217 (282)
T ss_pred eehhhhHHHH-hcCCCccCCh
Confidence 8887654442 4688999998
|
|
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.2e-22 Score=215.85 Aligned_cols=165 Identities=28% Similarity=0.460 Sum_probs=137.8
Q ss_pred cCCeeEeeeecccCceEEEEEEE--cCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecC-----Ce
Q 005841 504 WEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSP-----QR 576 (674)
Q Consensus 504 ~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~-----~~ 576 (674)
.++|++.++||+|+||.||+|.+ ++..||||++.... .......+.+|+.+++.++|+||+++++++... ..
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 82 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFE-HQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFND 82 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccc-cchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccce
Confidence 36899999999999999999987 57789999986432 234456678899999999999999999887654 35
Q ss_pred EEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCccccc
Q 005841 577 LCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKH 656 (674)
Q Consensus 577 ~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~ 656 (674)
+|+||||+. ++|.+++.. ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 83 ~~lv~e~~~-~~l~~~~~~--~~l~~~~~~~i~~ql~~aL~~LH~~~--ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~ 157 (336)
T cd07849 83 VYIVQELME-TDLYKLIKT--QHLSNDHIQYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLNTNCDLKICDFGLARIAD 157 (336)
T ss_pred EEEEehhcc-cCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHEEECCCCCEEECcccceeecc
Confidence 899999996 488888853 46999999999999999999999999 9999999999999999999999999998654
Q ss_pred CCcc---ccccCCCCccccCC
Q 005841 657 ETYL---TTKTGKGTVTYLAS 674 (674)
Q Consensus 657 ~~~~---~~~~~~GTp~YmAP 674 (674)
.... ......||+.||||
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aP 178 (336)
T cd07849 158 PEHDHTGFLTEYVATRWYRAP 178 (336)
T ss_pred ccccccCCcCCcCcCCCccCh
Confidence 3221 11234689999998
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=6.5e-22 Score=207.09 Aligned_cols=165 Identities=27% Similarity=0.408 Sum_probs=139.9
Q ss_pred CCeeEeeeecccCceEEEEEEE--cCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecC--CeEEEE
Q 005841 505 EDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSP--QRLCIV 580 (674)
Q Consensus 505 ~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~--~~~~lV 580 (674)
++|+..+.||.|++|.||++.+ .+..||+|++..... ......+.+|+.+++.++||||+++++++... ..+|+|
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 79 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPN-PDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIA 79 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCc-hHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEE
Confidence 4689999999999999999998 467799999875432 34557788999999999999999999988654 478999
Q ss_pred EecCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccccC
Q 005841 581 TEFLPRGSLFRLLQR---NTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHE 657 (674)
Q Consensus 581 ~E~~~ggsL~~~l~~---~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~ 657 (674)
|||+++++|.+++.. ....+++..+..++.||+.||.|||..+ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 80 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~--i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 157 (287)
T cd06621 80 MEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK--IIHRDIKPSNILLTRKGQVKLCDFGVSGELVN 157 (287)
T ss_pred EEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence 999999999988753 3456899999999999999999999999 99999999999999999999999999876543
Q ss_pred CccccccCCCCccccCC
Q 005841 658 TYLTTKTGKGTVTYLAS 674 (674)
Q Consensus 658 ~~~~~~~~~GTp~YmAP 674 (674)
... ....++..|+||
T Consensus 158 ~~~--~~~~~~~~y~~p 172 (287)
T cd06621 158 SLA--GTFTGTSFYMAP 172 (287)
T ss_pred ccc--ccccCCccccCH
Confidence 322 134678889987
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.6e-22 Score=205.05 Aligned_cols=165 Identities=29% Similarity=0.492 Sum_probs=144.8
Q ss_pred CeeEeeeecccCceEEEEEEE--cCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeEEEEEec
Q 005841 506 DLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEF 583 (674)
Q Consensus 506 ~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~ 583 (674)
+|++.+.||+|+||.||++.+ .+..|++|.+............+.+|+.+++.++|+||+++++++......|+||||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 588999999999999999987 466799999977655555567788899999999999999999999999999999999
Q ss_pred CCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccccCCcc
Q 005841 584 LPRGSLFRLLQRN---TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYL 660 (674)
Q Consensus 584 ~~ggsL~~~l~~~---~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~~~~ 660 (674)
+++++|..++.+. ...+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.+||+|||++......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~--i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~-- 156 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK--ILHRDLKSANILLVANDLVKIGDLGISKVLKKN-- 156 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC--cccCCCCcceEEEecCCcEEEeeccchhhhccC--
Confidence 9999999988652 356899999999999999999999999 999999999999999999999999999877654
Q ss_pred ccccCCCCccccCC
Q 005841 661 TTKTGKGTVTYLAS 674 (674)
Q Consensus 661 ~~~~~~GTp~YmAP 674 (674)
......|++.|+||
T Consensus 157 ~~~~~~~~~~~~~P 170 (256)
T cd08530 157 MAKTQIGTPHYMAP 170 (256)
T ss_pred CcccccCCccccCH
Confidence 22234688999987
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.1e-22 Score=216.21 Aligned_cols=167 Identities=27% Similarity=0.368 Sum_probs=140.6
Q ss_pred cCCeeEeeeecccCceEEEEEEE--cCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecC-----Ce
Q 005841 504 WEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSP-----QR 576 (674)
Q Consensus 504 ~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~-----~~ 576 (674)
..+|.+.+.||+|+||+||++.+ ++..||||.+............+.+|+.+++.++|+||+++++++... ..
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 35799999999999999999987 477899999876433333445677899999999999999999987654 34
Q ss_pred EEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCccccc
Q 005841 577 LCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKH 656 (674)
Q Consensus 577 ~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~ 656 (674)
+||||||+. ++|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 84 ~~lv~e~~~-~~L~~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~--i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~ 159 (337)
T cd07858 84 VYIVYELMD-TDLHQIIRS-SQTLSDDHCQYFLYQLLRGLKYIHSAN--VLHRDLKPSNLLLNANCDLKICDFGLARTTS 159 (337)
T ss_pred EEEEEeCCC-CCHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEEcCCCCEEECcCccccccC
Confidence 899999995 689988865 457999999999999999999999998 9999999999999999999999999998765
Q ss_pred CCccccccCCCCccccCC
Q 005841 657 ETYLTTKTGKGTVTYLAS 674 (674)
Q Consensus 657 ~~~~~~~~~~GTp~YmAP 674 (674)
..........||..|+||
T Consensus 160 ~~~~~~~~~~~~~~y~aP 177 (337)
T cd07858 160 EKGDFMTEYVVTRWYRAP 177 (337)
T ss_pred CCcccccccccccCccCh
Confidence 432223345689999998
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.4e-22 Score=217.43 Aligned_cols=167 Identities=25% Similarity=0.407 Sum_probs=140.2
Q ss_pred ccCCeeEeeeecccCceEEEEEEE--cCCeEEEEEeecccCCHHHHHHHHHHHHHHhhC-CCCCeeeEEEEEecC--CeE
Q 005841 503 LWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRL-RHPNVLLFMGAVTSP--QRL 577 (674)
Q Consensus 503 ~~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~--~~~ 577 (674)
..++|++.+.||+|+||.||+|.+ .+..||||.+.+..........+.+|+.++..+ +||||+++++++... ..+
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 84 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI 84 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence 346899999999999999999987 467799998865433334445677899999999 999999999998654 368
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccccC
Q 005841 578 CIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHE 657 (674)
Q Consensus 578 ~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~ 657 (674)
|+||||++ ++|..++... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 85 ~lv~e~~~-~~L~~~~~~~--~~~~~~~~~i~~qi~~~L~~LH~~~--i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~ 159 (337)
T cd07852 85 YLVFEYME-TDLHAVIRAN--ILEDVHKRYIMYQLLKALKYIHSGN--VIHRDLKPSNILLNSDCRVKLADFGLARSLSE 159 (337)
T ss_pred EEEecccc-cCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEcCCCcEEEeeccchhcccc
Confidence 99999997 5999988653 7889999999999999999999998 99999999999999999999999999987643
Q ss_pred Ccc-----ccccCCCCccccCC
Q 005841 658 TYL-----TTKTGKGTVTYLAS 674 (674)
Q Consensus 658 ~~~-----~~~~~~GTp~YmAP 674 (674)
... ....+.||+.||||
T Consensus 160 ~~~~~~~~~~~~~~~~~~y~aP 181 (337)
T cd07852 160 LEENPENPVLTDYVATRWYRAP 181 (337)
T ss_pred ccccccCcchhcccccccccCc
Confidence 221 22235689999998
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.4e-22 Score=206.85 Aligned_cols=166 Identities=31% Similarity=0.468 Sum_probs=136.7
Q ss_pred eeEeeeecccCceEEEEEEEc-----CCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCC------
Q 005841 507 LTIGEQIGQGSCGTVYHAVWY-----GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQ------ 575 (674)
Q Consensus 507 y~~~~~LG~G~fG~Vy~~~~~-----~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~------ 575 (674)
|.+.++||+|+||.||+|.+. +..||||++..........+.+.+|+.+++.++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 577889999999999999862 467999999776666666778899999999999999999999886542
Q ss_pred eEEEEEecCCCCCHHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecC
Q 005841 576 RLCIVTEFLPRGSLFRLLQRN-----TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFG 650 (674)
Q Consensus 576 ~~~lV~E~~~ggsL~~~l~~~-----~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFG 650 (674)
..++++||+.+++|.+++... ...+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~--i~H~dikp~nili~~~~~~kl~dfg 158 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN--FIHRDLAARNCMLNENMTVCVADFG 158 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--EeecccchhhEEEcCCCCEEECccc
Confidence 247899999999999887432 224788999999999999999999998 9999999999999999999999999
Q ss_pred CcccccCCc--cccccCCCCccccCC
Q 005841 651 LSRLKHETY--LTTKTGKGTVTYLAS 674 (674)
Q Consensus 651 la~~~~~~~--~~~~~~~GTp~YmAP 674 (674)
+++...... .......+++.|++|
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~p 184 (273)
T cd05074 159 LSKKIYSGDYYRQGCASKLPVKWLAL 184 (273)
T ss_pred ccccccCCcceecCCCccCchhhcCH
Confidence 998654321 122233466788877
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.5e-23 Score=239.51 Aligned_cols=167 Identities=31% Similarity=0.457 Sum_probs=137.7
Q ss_pred CCeeEeeeecccCceEEEEEEE--cCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEe----------
Q 005841 505 EDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVT---------- 572 (674)
Q Consensus 505 ~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~---------- 572 (674)
.+|+.++.||+|+||.||++++ .|..||||.|.... +.....++.+|+.++.+|+|||||++|..|.
T Consensus 479 ~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~-s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~e 557 (1351)
T KOG1035|consen 479 NDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA-SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLE 557 (1351)
T ss_pred hhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch-HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccccc
Confidence 5678889999999999999997 69999999997765 6677788999999999999999999887420
Q ss_pred --------------------------------------------------------------------c-----------
Q 005841 573 --------------------------------------------------------------------S----------- 573 (674)
Q Consensus 573 --------------------------------------------------------------------~----------- 573 (674)
+
T Consensus 558 i~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e 637 (1351)
T KOG1035|consen 558 IVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSE 637 (1351)
T ss_pred ccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccC
Confidence 0
Q ss_pred ----------------------C--------CeEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 005841 574 ----------------------P--------QRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCN 623 (674)
Q Consensus 574 ----------------------~--------~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ 623 (674)
. ..+||-||||+...|.+++.++...-.....+.++++|+.||.|+|+.|
T Consensus 638 ~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~~g 717 (1351)
T KOG1035|consen 638 GSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHDQG 717 (1351)
T ss_pred CccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHhCc
Confidence 0 2368999999998888888764322147788999999999999999999
Q ss_pred CCeEEccCCCCCEEEcCCCcEEEEecCCccccc------------------CCccccccCCCCccccCC
Q 005841 624 PPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKH------------------ETYLTTKTGKGTVTYLAS 674 (674)
Q Consensus 624 ~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~------------------~~~~~~~~~~GTp~YmAP 674 (674)
||||||||.||+++..+.|||+|||+|.... .........+||.-|+||
T Consensus 718 --iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAP 784 (1351)
T KOG1035|consen 718 --IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAP 784 (1351)
T ss_pred --eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecH
Confidence 9999999999999999999999999998721 001123346899999999
|
|
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.3e-22 Score=217.32 Aligned_cols=166 Identities=25% Similarity=0.409 Sum_probs=139.8
Q ss_pred CCeeEeeeecccCceEEEEEEE--cCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEec----CCeEE
Q 005841 505 EDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTS----PQRLC 578 (674)
Q Consensus 505 ~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~----~~~~~ 578 (674)
.+|++.+.||+|+||.||+|.. ++..||+|++............+.+|+.+++.++||||+++++++.. ...+|
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 84 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVY 84 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEE
Confidence 6899999999999999999987 57789999987654333455677889999999999999999988753 35689
Q ss_pred EEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccccCC
Q 005841 579 IVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHET 658 (674)
Q Consensus 579 lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~~ 658 (674)
+||||+. ++|.+++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++......
T Consensus 85 lv~e~~~-~~l~~~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 160 (334)
T cd07855 85 VVMDLME-SDLHHIIHS-DQPLTEEHIRYFLYQLLRGLKYIHSAN--VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSS 160 (334)
T ss_pred EEEehhh-hhHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEcCCCcEEecccccceeeccc
Confidence 9999995 589888864 446999999999999999999999998 999999999999999999999999999765432
Q ss_pred ccc----cccCCCCccccCC
Q 005841 659 YLT----TKTGKGTVTYLAS 674 (674)
Q Consensus 659 ~~~----~~~~~GTp~YmAP 674 (674)
... .....||+.|+||
T Consensus 161 ~~~~~~~~~~~~~~~~y~~P 180 (334)
T cd07855 161 PTEHKYFMTEYVATRWYRAP 180 (334)
T ss_pred CcCCCcccccccccccccCh
Confidence 221 1234689999998
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.3e-22 Score=206.12 Aligned_cols=159 Identities=30% Similarity=0.458 Sum_probs=137.5
Q ss_pred ecccCceEEEEEEEc--CCeEEEEEeecccCC-HHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeEEEEEecCCCCCH
Q 005841 513 IGQGSCGTVYHAVWY--GSDVAVKVFSRQEYS-DEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSL 589 (674)
Q Consensus 513 LG~G~fG~Vy~~~~~--~~~vAvK~i~~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL 589 (674)
||.|+||.||++.+. +..|++|++...... ......+.+|+.+++.++||||+++++.+......|+||||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 689999999999984 778999998765432 34567788999999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccccCCcc--------c
Q 005841 590 FRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYL--------T 661 (674)
Q Consensus 590 ~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~~~~--------~ 661 (674)
.+++.+.. .+++..+..++.||+.||.|||+.+ |+|+||+|+|||++.++.++|+|||++........ .
T Consensus 81 ~~~l~~~~-~~~~~~~~~i~~qi~~~L~~lH~~~--i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~ 157 (265)
T cd05579 81 ASLLENVG-SLDEDVARIYIAEIVLALEYLHSNG--IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKE 157 (265)
T ss_pred HHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHcC--eecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccccccc
Confidence 99997644 7899999999999999999999998 99999999999999999999999999876543311 2
Q ss_pred cccCCCCccccCC
Q 005841 662 TKTGKGTVTYLAS 674 (674)
Q Consensus 662 ~~~~~GTp~YmAP 674 (674)
.....+++.|+||
T Consensus 158 ~~~~~~~~~~~~P 170 (265)
T cd05579 158 DKRIVGTPDYIAP 170 (265)
T ss_pred ccCcccCccccCH
Confidence 2334688999988
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.3e-22 Score=211.92 Aligned_cols=168 Identities=29% Similarity=0.434 Sum_probs=138.7
Q ss_pred cCCeeEeeeecccCceEEEEEEE--cCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecC-------
Q 005841 504 WEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSP------- 574 (674)
Q Consensus 504 ~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~------- 574 (674)
.++|.+.++||+|+||.||++.+ ++..||||++............+.+|+.+++.++||||+++++++...
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 47899999999999999999997 467799999876543333334567899999999999999999887543
Q ss_pred -CeEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcc
Q 005841 575 -QRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSR 653 (674)
Q Consensus 575 -~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~ 653 (674)
..+|+||||+.+ +|...+......+++..+..++.||+.||.|||+.+ |+|+||||+|||+++++.+||+|||+++
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~--i~H~dl~p~nil~~~~~~~~l~dfg~~~ 163 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENH--ILHRDIKAANILIDNQGILKIADFGLAR 163 (311)
T ss_pred CceEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEECCCCCEEECcCccch
Confidence 347999999964 788877665667999999999999999999999999 9999999999999999999999999998
Q ss_pred cccCCccc-----------cccCCCCccccCC
Q 005841 654 LKHETYLT-----------TKTGKGTVTYLAS 674 (674)
Q Consensus 654 ~~~~~~~~-----------~~~~~GTp~YmAP 674 (674)
........ .....||+.|+||
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aP 195 (311)
T cd07866 164 PYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPP 195 (311)
T ss_pred hccCCCcccccCCcccccccccceeccCcCCh
Confidence 65432211 1123578899998
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.88 E-value=6.7e-22 Score=206.99 Aligned_cols=163 Identities=29% Similarity=0.426 Sum_probs=140.1
Q ss_pred CeeEeeeecccCceEEEEEEE--cCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeEEEEEec
Q 005841 506 DLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEF 583 (674)
Q Consensus 506 ~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~ 583 (674)
.|...+.||+|++|.||++.. .+..|++|++.... ......+.+|+.+++.+.||||+++++++...++.|+|+||
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~ 97 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRK--QQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEF 97 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccc--hhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEec
Confidence 455567999999999999986 46779999886432 23345678899999999999999999999999999999999
Q ss_pred CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccccCCccccc
Q 005841 584 LPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTK 663 (674)
Q Consensus 584 ~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~~~~~~~ 663 (674)
+++++|.+++.. ..+++..+..++.|++.+|+|||+++ |+||||||+||+++.++.++|+|||++...........
T Consensus 98 ~~~~~L~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~~~~ 173 (285)
T cd06648 98 LEGGALTDIVTH--TRMNEEQIATVCLAVLKALSFLHAQG--VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRK 173 (285)
T ss_pred cCCCCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCChhhEEEcCCCcEEEcccccchhhccCCcccc
Confidence 999999999976 46899999999999999999999999 99999999999999999999999999876544333333
Q ss_pred cCCCCccccCC
Q 005841 664 TGKGTVTYLAS 674 (674)
Q Consensus 664 ~~~GTp~YmAP 674 (674)
...|++.|+||
T Consensus 174 ~~~~~~~y~aP 184 (285)
T cd06648 174 SLVGTPYWMAP 184 (285)
T ss_pred cccCCccccCH
Confidence 45689999998
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=99.88 E-value=4.8e-22 Score=207.87 Aligned_cols=166 Identities=23% Similarity=0.348 Sum_probs=140.7
Q ss_pred CeeEeeeecccCceEEEEEEE-----cCCeEEEEEeecccCC--HHHHHHHHHHHHHHhhC-CCCCeeeEEEEEecCCeE
Q 005841 506 DLTIGEQIGQGSCGTVYHAVW-----YGSDVAVKVFSRQEYS--DEVIHSFRQEVSLMKRL-RHPNVLLFMGAVTSPQRL 577 (674)
Q Consensus 506 ~y~~~~~LG~G~fG~Vy~~~~-----~~~~vAvK~i~~~~~~--~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~ 577 (674)
+|.+.+.||+|+||.||++.. .+..||||++.+.... ......+.+|+.++..+ +||||+.+++.+.....+
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 488999999999999999875 3567999998754322 23446688899999999 599999999999999999
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccccC
Q 005841 578 CIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHE 657 (674)
Q Consensus 578 ~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~ 657 (674)
|+||||+++++|.+++... ..+++..+..++.|++.+|.|||+.+ ++|+||||.|||++.++.++|+|||+++....
T Consensus 81 ~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~--~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 157 (288)
T cd05583 81 HLILDYVNGGELFTHLYQR-EHFTESEVRVYIAEIVLALDHLHQLG--IIYRDIKLENILLDSEGHVVLTDFGLSKEFLA 157 (288)
T ss_pred EEEEecCCCCcHHHHHhhc-CCcCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHeEECCCCCEEEEECcccccccc
Confidence 9999999999999998753 46899999999999999999999988 99999999999999999999999999986543
Q ss_pred Ccc-ccccCCCCccccCC
Q 005841 658 TYL-TTKTGKGTVTYLAS 674 (674)
Q Consensus 658 ~~~-~~~~~~GTp~YmAP 674 (674)
... ......|++.|+||
T Consensus 158 ~~~~~~~~~~~~~~y~aP 175 (288)
T cd05583 158 EEEERAYSFCGTIEYMAP 175 (288)
T ss_pred ccccccccccCCccccCH
Confidence 322 22235689999998
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=99.88 E-value=6.5e-22 Score=204.49 Aligned_cols=166 Identities=25% Similarity=0.437 Sum_probs=139.9
Q ss_pred CeeEeeeecccCceEEEEEEEcC---CeEEEEEeeccc--------CCHHHHHHHHHHHHHHhh-CCCCCeeeEEEEEec
Q 005841 506 DLTIGEQIGQGSCGTVYHAVWYG---SDVAVKVFSRQE--------YSDEVIHSFRQEVSLMKR-LRHPNVLLFMGAVTS 573 (674)
Q Consensus 506 ~y~~~~~LG~G~fG~Vy~~~~~~---~~vAvK~i~~~~--------~~~~~~~~~~~Ei~il~~-l~HpnIv~l~~~~~~ 573 (674)
+|++.+.||+|+||.||++.+.. ..+|+|.+.... ........+..|+.++.. ++||||+++++++..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 47888999999999999999843 669999886432 223455667789988875 789999999999999
Q ss_pred CCeEEEEEecCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCeEEccCCCCCEEEcCCCcEEEEec
Q 005841 574 PQRLCIVTEFLPRGSLFRLLQR---NTTKLDWRRRILMALDIARGVSYLHH-CNPPIIHRDLKSSNLLVDKHWTVKVGDF 649 (674)
Q Consensus 574 ~~~~~lV~E~~~ggsL~~~l~~---~~~~l~~~~~~~i~~qi~~~L~yLH~-~~~~IvHrDLKp~NILi~~~~~vkL~DF 649 (674)
.+..|+||||+++++|.+++.. ....+++..++.++.|++.+|.|||. .+ |+|+||||+|||++.++.+||+||
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~--i~H~dl~~~nil~~~~~~~~l~df 158 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKR--IVHRDLTPNNIMLGEDDKVTITDF 158 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCc--eeecCCCHHHEEECCCCcEEEecc
Confidence 9999999999999999998743 34568999999999999999999995 66 999999999999999999999999
Q ss_pred CCcccccCCccccccCCCCccccCC
Q 005841 650 GLSRLKHETYLTTKTGKGTVTYLAS 674 (674)
Q Consensus 650 Gla~~~~~~~~~~~~~~GTp~YmAP 674 (674)
|++....... ......|++.|+||
T Consensus 159 g~~~~~~~~~-~~~~~~~~~~~~~P 182 (269)
T cd08528 159 GLAKQKQPES-KLTSVVGTILYSCP 182 (269)
T ss_pred cceeeccccc-ccccccCcccCcCh
Confidence 9998765543 33345789999998
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.7e-22 Score=207.28 Aligned_cols=165 Identities=28% Similarity=0.397 Sum_probs=143.3
Q ss_pred eeEeeeecccCceEEEEEEE--cCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeEEEEEecC
Q 005841 507 LTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFL 584 (674)
Q Consensus 507 y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 584 (674)
|++.+.||+|++|.||++.. .+..+++|.+............+.+|+.+++.++|+||+++++++..+..+|+||||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 56788999999999999987 4677999998766555445577888999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccccCCcccccc
Q 005841 585 PRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKT 664 (674)
Q Consensus 585 ~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~~~~~~~~ 664 (674)
++ +|.+++......+++..+..++.||+.||.|||..+ |+|+||||+||+++.++.++|+|||++............
T Consensus 81 ~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~~~~~ 157 (283)
T cd05118 81 DT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHG--ILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTH 157 (283)
T ss_pred CC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCC--eeecCcCHHHEEECCCCcEEEeeeeeeEecCCCcccccC
Confidence 75 898888776668999999999999999999999999 999999999999999999999999999877654322223
Q ss_pred CCCCccccCC
Q 005841 665 GKGTVTYLAS 674 (674)
Q Consensus 665 ~~GTp~YmAP 674 (674)
..+++.|+||
T Consensus 158 ~~~~~~~~~P 167 (283)
T cd05118 158 YVVTRWYRAP 167 (283)
T ss_pred ccCcccccCc
Confidence 4588889988
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.88 E-value=6.8e-22 Score=211.63 Aligned_cols=165 Identities=25% Similarity=0.326 Sum_probs=136.4
Q ss_pred CeeEeeeecccCceEEEEEEEc----CCeEEEEEeecccCCHHHHHHHHHHHHHHhhC-CCCCeeeEEEEEecC----Ce
Q 005841 506 DLTIGEQIGQGSCGTVYHAVWY----GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRL-RHPNVLLFMGAVTSP----QR 576 (674)
Q Consensus 506 ~y~~~~~LG~G~fG~Vy~~~~~----~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~----~~ 576 (674)
+|++.+.||+|+||.||++.+. +..||||++............+.+|+.+++.+ .||||+++++.+... ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 4889999999999999999985 45799999875433334456778899999999 499999999875432 45
Q ss_pred EEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCccccc
Q 005841 577 LCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKH 656 (674)
Q Consensus 577 ~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~ 656 (674)
+|++|||+. ++|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+.
T Consensus 81 ~~~~~e~~~-~~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~g--ivH~dlkp~Nili~~~~~~kl~Dfg~a~~~~ 156 (332)
T cd07857 81 LYLYEELME-ADLHQIIRS-GQPLTDAHFQSFIYQILCGLKYIHSAN--VLHRDLKPGNLLVNADCELKICDFGLARGFS 156 (332)
T ss_pred EEEEEeccc-CCHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHeEEcCCCCEEeCcCCCceecc
Confidence 789999985 689998864 457999999999999999999999999 9999999999999999999999999998664
Q ss_pred CCccc----cccCCCCccccCC
Q 005841 657 ETYLT----TKTGKGTVTYLAS 674 (674)
Q Consensus 657 ~~~~~----~~~~~GTp~YmAP 674 (674)
..... .....||+.|+||
T Consensus 157 ~~~~~~~~~~~~~~g~~~y~aP 178 (332)
T cd07857 157 ENPGENAGFMTEYVATRWYRAP 178 (332)
T ss_pred cccccccccccCcccCccccCc
Confidence 32221 2235799999998
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=99.88 E-value=4e-22 Score=211.11 Aligned_cols=166 Identities=21% Similarity=0.260 Sum_probs=140.2
Q ss_pred eeEeeeecccCceEEEEEEEcCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeEEEEEecCCC
Q 005841 507 LTIGEQIGQGSCGTVYHAVWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPR 586 (674)
Q Consensus 507 y~~~~~LG~G~fG~Vy~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~g 586 (674)
|.+++.+|.|+++.||++..++..||||++............+.+|+.+++.++|+||+++++++...+..|++|||+++
T Consensus 4 ~~i~~~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~ 83 (314)
T cd08216 4 TLIGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAY 83 (314)
T ss_pred hhhhHhhcCCceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCC
Confidence 44556667777777777777889999999987655556677899999999999999999999999999999999999999
Q ss_pred CCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccccCCcc-----
Q 005841 587 GSLFRLLQRN-TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYL----- 660 (674)
Q Consensus 587 gsL~~~l~~~-~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~~~~----- 660 (674)
++|.+++... ...+++..+..++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||.+........
T Consensus 84 ~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~--ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~ 161 (314)
T cd08216 84 GSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKG--FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVV 161 (314)
T ss_pred CCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCcceEEEecCCceEEecCccceeecccccccccc
Confidence 9999999753 346899999999999999999999999 99999999999999999999999999875532211
Q ss_pred --ccccCCCCccccCC
Q 005841 661 --TTKTGKGTVTYLAS 674 (674)
Q Consensus 661 --~~~~~~GTp~YmAP 674 (674)
......++..|+||
T Consensus 162 ~~~~~~~~~~~~y~aP 177 (314)
T cd08216 162 HDFPKSSVKNLPWLSP 177 (314)
T ss_pred ccccccccccccccCH
Confidence 12234578889998
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.1e-21 Score=211.41 Aligned_cols=165 Identities=31% Similarity=0.403 Sum_probs=139.3
Q ss_pred cccCCeeEeeeecccCceEEEEEEE--cCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecC-----
Q 005841 502 ILWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSP----- 574 (674)
Q Consensus 502 ~~~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~----- 574 (674)
...++|.+.+.||+|+||.||++.. ++..||+|++.+........+.+.+|+.+++.++||||+++++++...
T Consensus 14 ~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~ 93 (345)
T cd07877 14 EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEE 93 (345)
T ss_pred hccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecccccc
Confidence 3458899999999999999999986 567899999876543444456788899999999999999999988643
Q ss_pred -CeEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcc
Q 005841 575 -QRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSR 653 (674)
Q Consensus 575 -~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~ 653 (674)
...|++++++ +++|.+++.. ..+++..+..++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||+++
T Consensus 94 ~~~~~lv~~~~-~~~L~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~NIll~~~~~~kl~dfg~~~ 168 (345)
T cd07877 94 FNDVYLVTHLM-GADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLAR 168 (345)
T ss_pred cccEEEEehhc-ccCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCChHHEEEcCCCCEEEecccccc
Confidence 3478888887 7899888854 35899999999999999999999999 9999999999999999999999999998
Q ss_pred cccCCccccccCCCCccccCC
Q 005841 654 LKHETYLTTKTGKGTVTYLAS 674 (674)
Q Consensus 654 ~~~~~~~~~~~~~GTp~YmAP 674 (674)
..... .....||+.|+||
T Consensus 169 ~~~~~---~~~~~~~~~y~aP 186 (345)
T cd07877 169 HTDDE---MTGYVATRWYRAP 186 (345)
T ss_pred ccccc---ccccccCCCccCH
Confidence 65432 2235689999998
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.2e-22 Score=213.48 Aligned_cols=165 Identities=31% Similarity=0.414 Sum_probs=141.7
Q ss_pred CeeEeeeecccCceEEEEEEEc--CCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCC-----eEE
Q 005841 506 DLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQ-----RLC 578 (674)
Q Consensus 506 ~y~~~~~LG~G~fG~Vy~~~~~--~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~-----~~~ 578 (674)
+|.+.+.||.|+||.||+|... +..|+||++..........+.+.+|+.+++.++|+||+++++++.... .+|
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 5899999999999999999973 678999998765433445577889999999999999999999988775 789
Q ss_pred EEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccccCC
Q 005841 579 IVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHET 658 (674)
Q Consensus 579 lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~~ 658 (674)
+||||++ ++|.+++... ..+++..+..++.||+.||.|||+.+ |+|+||||+|||++.++.++|+|||++......
T Consensus 81 lv~e~~~-~~l~~~l~~~-~~l~~~~~~~i~~~l~~~l~~LH~~g--i~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~ 156 (330)
T cd07834 81 IVTELME-TDLHKVIKSP-QPLTDDHIQYFLYQILRGLKYLHSAN--VIHRDLKPSNILVNSNCDLKICDFGLARGVDPD 156 (330)
T ss_pred EEecchh-hhHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEEcccCceEeeccc
Confidence 9999997 4898888653 47999999999999999999999999 999999999999999999999999999876554
Q ss_pred c---cccccCCCCccccCC
Q 005841 659 Y---LTTKTGKGTVTYLAS 674 (674)
Q Consensus 659 ~---~~~~~~~GTp~YmAP 674 (674)
. .......+|+.|+||
T Consensus 157 ~~~~~~~~~~~~~~~y~aP 175 (330)
T cd07834 157 EDEKGFLTEYVVTRWYRAP 175 (330)
T ss_pred ccccccccccccccCcCCc
Confidence 3 122334689999998
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.5e-23 Score=205.32 Aligned_cols=176 Identities=26% Similarity=0.350 Sum_probs=145.0
Q ss_pred CCCccccccccCCeeEeeeecccCceEEEEEEEc--CCeEEEEEeecccCCHHHHHHHHHHHHHHhhC-CCCCeeeEEEE
Q 005841 494 DNDCLDYEILWEDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRL-RHPNVLLFMGA 570 (674)
Q Consensus 494 ~~~~~~~~~~~~~y~~~~~LG~G~fG~Vy~~~~~--~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~ 570 (674)
+.+...+.+..++++-+..||.|+||+|++-.++ +..+|||.+..... ....++|+.|.++..+- +.||||+|||+
T Consensus 53 p~~~~~~~F~~~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~-~keq~rll~e~d~~mks~~cp~IVkfyGa 131 (361)
T KOG1006|consen 53 PDDAHLHTFTSDNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNI-EKEQKRLLMEHDTVMKSSNCPNIVKFYGA 131 (361)
T ss_pred CCcccccccccchHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccc-hHHHHHHHHHHHHHHhhcCCcHHHHHhhh
Confidence 3444556778888899999999999999999884 67799999976654 34456777788766554 58999999999
Q ss_pred EecCCeEEEEEecCCCCCHHHHHH----hcCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCeEEccCCCCCEEEcCCCcEE
Q 005841 571 VTSPQRLCIVTEFLPRGSLFRLLQ----RNTTKLDWRRRILMALDIARGVSYLHH-CNPPIIHRDLKSSNLLVDKHWTVK 645 (674)
Q Consensus 571 ~~~~~~~~lV~E~~~ggsL~~~l~----~~~~~l~~~~~~~i~~qi~~~L~yLH~-~~~~IvHrDLKp~NILi~~~~~vk 645 (674)
+..++..||.||+|+ .+|..+.+ .....+++..+-.|....+.||+||-. .+ |||||+||+|||++..|.||
T Consensus 132 ~F~EGdcWiCMELMd-~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lk--iIHRDvKPSNILldr~G~vK 208 (361)
T KOG1006|consen 132 LFSEGDCWICMELMD-ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELK--IIHRDVKPSNILLDRHGDVK 208 (361)
T ss_pred hhcCCceeeeHHHHh-hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhh--hhhccCChhheEEecCCCEe
Confidence 999999999999994 46654432 135578999999999999999999975 45 99999999999999999999
Q ss_pred EEecCCcccccCCccccccCCCCccccCC
Q 005841 646 VGDFGLSRLKHETYLTTKTGKGTVTYLAS 674 (674)
Q Consensus 646 L~DFGla~~~~~~~~~~~~~~GTp~YmAP 674 (674)
|||||++..+.++...+. -+|...||||
T Consensus 209 LCDFGIcGqLv~SiAkT~-daGCrpYmAP 236 (361)
T KOG1006|consen 209 LCDFGICGQLVDSIAKTV-DAGCRPYMAP 236 (361)
T ss_pred eecccchHhHHHHHHhhh-ccCCccccCh
Confidence 999999998887766554 5799999999
|
|
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.1e-21 Score=201.62 Aligned_cols=157 Identities=32% Similarity=0.426 Sum_probs=131.2
Q ss_pred eeecccCceEEEEEEE--cCCeEEEEEeecccCCH-HHHHHHHHHHHHH-hhCCCCCeeeEEEEEecCCeEEEEEecCCC
Q 005841 511 EQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSD-EVIHSFRQEVSLM-KRLRHPNVLLFMGAVTSPQRLCIVTEFLPR 586 (674)
Q Consensus 511 ~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~~~-~~~~~~~~Ei~il-~~l~HpnIv~l~~~~~~~~~~~lV~E~~~g 586 (674)
+.||+|+||.||+|.. .+..||||++.+..... .....+..|..++ ..+.|+||+++++++...+.+|+||||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 5799999999999987 56789999987654322 2233445555544 455899999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccccCCccccccCC
Q 005841 587 GSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGK 666 (674)
Q Consensus 587 gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~~~~~~~~~~ 666 (674)
++|.+++... ..+++..+..++.||+.||.|||+.+ |+|+||+|+|||++.++.+||+|||+++.... .....
T Consensus 82 ~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~lH~~~--i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~----~~~~~ 154 (260)
T cd05611 82 GDCASLIKTL-GGLPEDWAKQYIAEVVLGVEDLHQRG--IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE----NKKFV 154 (260)
T ss_pred CCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEECCCCcEEEeecccceeccc----cccCC
Confidence 9999999754 46899999999999999999999998 99999999999999999999999999876443 22356
Q ss_pred CCccccCC
Q 005841 667 GTVTYLAS 674 (674)
Q Consensus 667 GTp~YmAP 674 (674)
|++.|+||
T Consensus 155 ~~~~y~~p 162 (260)
T cd05611 155 GTPDYLAP 162 (260)
T ss_pred CCcCccCh
Confidence 88999998
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=7.9e-24 Score=230.48 Aligned_cols=167 Identities=29% Similarity=0.447 Sum_probs=151.8
Q ss_pred ccCCeeEeeeecccCceEEEEEEE--cCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeEEEE
Q 005841 503 LWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIV 580 (674)
Q Consensus 503 ~~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 580 (674)
..++|+++..+|.|+||.||++++ ++...|+|+++...- +.+..+++|+-+++.++||||+-+++-+...+.++|+
T Consensus 13 P~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~--dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwic 90 (829)
T KOG0576|consen 13 PQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPG--DDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWIC 90 (829)
T ss_pred CccchhheeeecCCcccchhhhcccccCchhhheeeeccCC--ccccccccceeeeecCCCcChHHHHhhhhhhcCcEEE
Confidence 347899999999999999999997 567799999975432 3345677899999999999999999999999999999
Q ss_pred EecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccccCCcc
Q 005841 581 TEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYL 660 (674)
Q Consensus 581 ~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~~~~ 660 (674)
||||.||+|.+.-+ -.+.+++.++.++.++.++||+|||..+ -+|||||-.|||+++.|.||++|||.+..+..+..
T Consensus 91 MEycgggslQdiy~-~TgplselqiayvcRetl~gl~ylhs~g--k~hRdiKGanilltd~gDvklaDfgvsaqitati~ 167 (829)
T KOG0576|consen 91 MEYCGGGSLQDIYH-VTGPLSELQIAYVCRETLQGLKYLHSQG--KIHRDIKGANILLTDEGDVKLADFGVSAQITATIA 167 (829)
T ss_pred EEecCCCcccceee-ecccchhHHHHHHHhhhhccchhhhcCC--cccccccccceeecccCceeecccCchhhhhhhhh
Confidence 99999999998765 3568999999999999999999999998 89999999999999999999999999999998888
Q ss_pred ccccCCCCccccCC
Q 005841 661 TTKTGKGTVTYLAS 674 (674)
Q Consensus 661 ~~~~~~GTp~YmAP 674 (674)
..+++.|||+||||
T Consensus 168 KrksfiGtpywmap 181 (829)
T KOG0576|consen 168 KRKSFIGTPYWMAP 181 (829)
T ss_pred hhhcccCCccccch
Confidence 89999999999998
|
|
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.88 E-value=5.7e-22 Score=207.13 Aligned_cols=165 Identities=26% Similarity=0.372 Sum_probs=136.4
Q ss_pred CCeeEeeeecccCceEEEEEEE--cCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCC-CCCeeeEEEEEecCCeEEEEE
Q 005841 505 EDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLR-HPNVLLFMGAVTSPQRLCIVT 581 (674)
Q Consensus 505 ~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~lV~ 581 (674)
++|...++||+|+||.||++.+ .+..||+|.+...... .....+.+|+.++.++. |+||+++++++..+...+++|
T Consensus 4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~ 82 (288)
T cd06616 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDE-KEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICM 82 (288)
T ss_pred HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccCh-HHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEE
Confidence 4677788999999999999998 4677999998765433 44567888999999996 999999999999999999999
Q ss_pred ecCCCCCHHHHHH---h-cCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCeEEccCCCCCEEEcCCCcEEEEecCCccccc
Q 005841 582 EFLPRGSLFRLLQ---R-NTTKLDWRRRILMALDIARGVSYLHH-CNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKH 656 (674)
Q Consensus 582 E~~~ggsL~~~l~---~-~~~~l~~~~~~~i~~qi~~~L~yLH~-~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~ 656 (674)
||+.. +|.++.. . ....+++..+..++.|++.||+|||+ .+ |+||||||+|||++.++.+||+|||+++...
T Consensus 83 e~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~--i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 159 (288)
T cd06616 83 ELMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELK--IIHRDVKPSNILLDRNGNIKLCDFGISGQLV 159 (288)
T ss_pred ecccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCC--eeccCCCHHHEEEccCCcEEEeecchhHHhc
Confidence 99854 5554432 2 23579999999999999999999997 47 9999999999999999999999999998765
Q ss_pred CCccccccCCCCccccCC
Q 005841 657 ETYLTTKTGKGTVTYLAS 674 (674)
Q Consensus 657 ~~~~~~~~~~GTp~YmAP 674 (674)
..... ....||+.|+||
T Consensus 160 ~~~~~-~~~~~~~~y~aP 176 (288)
T cd06616 160 DSIAK-TRDAGCRPYMAP 176 (288)
T ss_pred cCCcc-ccccCccCccCH
Confidence 43322 224689999998
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=99.87 E-value=1e-21 Score=206.49 Aligned_cols=170 Identities=27% Similarity=0.414 Sum_probs=141.7
Q ss_pred cccccCCeeEeeeecccCceEEEEEEEc--CCeEEEEEeecccCCHHHHHHHHHHHHHHhhCC-CCCeeeEEEEEecCCe
Q 005841 500 YEILWEDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLR-HPNVLLFMGAVTSPQR 576 (674)
Q Consensus 500 ~~~~~~~y~~~~~LG~G~fG~Vy~~~~~--~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~ 576 (674)
+.+..++|++.+.||+|+||.||++.+. +..||||.+.+..... ....+..|+.++..+. ||||+++++++.....
T Consensus 10 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~-~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~ 88 (296)
T cd06618 10 YPADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKE-ENKRILMDLDVVLKSHDCPYIVKCYGYFITDSD 88 (296)
T ss_pred ccCCcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChH-HHHHHHHHHHHHHhccCCCchHhhheeeecCCe
Confidence 4566788999999999999999999985 7789999997654332 3445666777676665 9999999999999999
Q ss_pred EEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCeEEccCCCCCEEEcCCCcEEEEecCCcccc
Q 005841 577 LCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHH-CNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLK 655 (674)
Q Consensus 577 ~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~-~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~ 655 (674)
+|+||||+. ++|.+++......+++..+..++.||+.||.|||+ ++ |+||||+|+|||++.++.+||+|||++..+
T Consensus 89 ~~~v~e~~~-~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~--i~H~dl~p~nill~~~~~~kL~dfg~~~~~ 165 (296)
T cd06618 89 VFICMELMS-TCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHG--VIHRDVKPSNILLDASGNVKLCDFGISGRL 165 (296)
T ss_pred EEEEeeccC-cCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCC--EecCCCcHHHEEEcCCCCEEECccccchhc
Confidence 999999984 57888877656689999999999999999999997 57 999999999999999999999999999876
Q ss_pred cCCccccccCCCCccccCC
Q 005841 656 HETYLTTKTGKGTVTYLAS 674 (674)
Q Consensus 656 ~~~~~~~~~~~GTp~YmAP 674 (674)
....... ...|++.|+||
T Consensus 166 ~~~~~~~-~~~~~~~y~aP 183 (296)
T cd06618 166 VDSKAKT-RSAGCAAYMAP 183 (296)
T ss_pred cCCCccc-CCCCCccccCH
Confidence 5433222 23588899998
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.2e-21 Score=206.06 Aligned_cols=161 Identities=30% Similarity=0.436 Sum_probs=139.6
Q ss_pred eeEeeeecccCceEEEEEEE--cCCeEEEEEeecccC-CHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeEEEEEec
Q 005841 507 LTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEY-SDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEF 583 (674)
Q Consensus 507 y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~ 583 (674)
|...+.||+|+||.||+|.. .+..|++|++..... .......+.+|+.+++.++||||+++++++.+....|+||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 67778899999999999987 567899999876543 334556788899999999999999999999999999999999
Q ss_pred CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccccCCccccc
Q 005841 584 LPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTK 663 (674)
Q Consensus 584 ~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~~~~~~~ 663 (674)
+. ++|.+++......+++..+..++.||+.+|.|||+.+ |+|+||||+||+++.++.+||+|||++..... ..
T Consensus 103 ~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~g--i~H~dl~p~nili~~~~~~kL~dfg~~~~~~~----~~ 175 (313)
T cd06633 103 CL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN--MIHRDIKAGNILLTEPGQVKLADFGSASKSSP----AN 175 (313)
T ss_pred CC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCChhhEEECCCCCEEEeecCCCcccCC----CC
Confidence 95 5888888766677999999999999999999999998 99999999999999999999999999864332 22
Q ss_pred cCCCCccccCC
Q 005841 664 TGKGTVTYLAS 674 (674)
Q Consensus 664 ~~~GTp~YmAP 674 (674)
...|++.|+||
T Consensus 176 ~~~~~~~y~aP 186 (313)
T cd06633 176 SFVGTPYWMAP 186 (313)
T ss_pred CccccccccCh
Confidence 35689999998
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=99.87 E-value=5.4e-22 Score=204.91 Aligned_cols=160 Identities=31% Similarity=0.511 Sum_probs=132.7
Q ss_pred eecccCceEEEEEEEcC--------CeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeEEEEEec
Q 005841 512 QIGQGSCGTVYHAVWYG--------SDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEF 583 (674)
Q Consensus 512 ~LG~G~fG~Vy~~~~~~--------~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~ 583 (674)
.||+|+||.||+|.+.. ..|+||.+.+.. .......+.+|+.+++.++||||+++++++...+..|+||||
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGA-TDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred ccccccceeEEeeeecccccCcccceeehhhhhhccc-chhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 68999999999998642 458999886543 223456788899999999999999999999999999999999
Q ss_pred CCCCCHHHHHHhc------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCC-----cEEEEecCCc
Q 005841 584 LPRGSLFRLLQRN------TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHW-----TVKVGDFGLS 652 (674)
Q Consensus 584 ~~ggsL~~~l~~~------~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~-----~vkL~DFGla 652 (674)
+++++|.+++... ...+++..++.++.||+.||.|||+.+ |+|+||||+|||++.++ .++|+|||++
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~ 158 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH--FIHRDLAARNCLVSEKGYDADRVVKIGDFGLA 158 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC--cccCCCChheEEEecCCCCCCcceEECCcccc
Confidence 9999999999652 234789999999999999999999988 99999999999999877 8999999999
Q ss_pred ccccCCcc--ccccCCCCccccCC
Q 005841 653 RLKHETYL--TTKTGKGTVTYLAS 674 (674)
Q Consensus 653 ~~~~~~~~--~~~~~~GTp~YmAP 674 (674)
+....... ......+++.|+||
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~y~aP 182 (269)
T cd05044 159 RDIYKSDYYRKEGEGLLPVRWMAP 182 (269)
T ss_pred cccccccccccCcccCCCccccCH
Confidence 76543221 11223467889988
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.87 E-value=4.8e-22 Score=206.35 Aligned_cols=165 Identities=28% Similarity=0.432 Sum_probs=142.2
Q ss_pred eeEeeeecccCceEEEEEEEc--CCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeEEEEEecC
Q 005841 507 LTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFL 584 (674)
Q Consensus 507 y~~~~~LG~G~fG~Vy~~~~~--~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 584 (674)
|++.+.||+|.||.||+|... +..|++|++............+..|+.+++.++|+||+++++++.....+|+||||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 567889999999999999984 678999999876534444566788999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccccCCcccccc
Q 005841 585 PRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKT 664 (674)
Q Consensus 585 ~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~~~~~~~~ 664 (674)
+ ++|.+++......+++..+..++.|++.||.|||+.+ |+|+||+|+||+++.++.++|+|||+++...........
T Consensus 81 ~-~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~~~~ 157 (282)
T cd07829 81 D-MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHR--ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTH 157 (282)
T ss_pred C-cCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCChheEEEcCCCCEEEecCCcccccCCCccccCc
Confidence 7 5999999876567999999999999999999999998 999999999999999999999999999876543322223
Q ss_pred CCCCccccCC
Q 005841 665 GKGTVTYLAS 674 (674)
Q Consensus 665 ~~GTp~YmAP 674 (674)
..+++.|+||
T Consensus 158 ~~~~~~~~aP 167 (282)
T cd07829 158 EVVTLWYRAP 167 (282)
T ss_pred cccCcCcCCh
Confidence 4567889988
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.7e-21 Score=205.04 Aligned_cols=170 Identities=18% Similarity=0.191 Sum_probs=126.2
Q ss_pred ccccCCeeEeeeecccCceEEEEEEEcCC-----eEEEEEeecccCCH--HH-------HHHHHHHHHHHhhCCCCCeee
Q 005841 501 EILWEDLTIGEQIGQGSCGTVYHAVWYGS-----DVAVKVFSRQEYSD--EV-------IHSFRQEVSLMKRLRHPNVLL 566 (674)
Q Consensus 501 ~~~~~~y~~~~~LG~G~fG~Vy~~~~~~~-----~vAvK~i~~~~~~~--~~-------~~~~~~Ei~il~~l~HpnIv~ 566 (674)
++..++|++.++||+|+||+||+|.+.+. .+|+|+........ +. ......++..+..+.|+||+.
T Consensus 8 ~i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~ 87 (294)
T PHA02882 8 DITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPK 87 (294)
T ss_pred ccCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCc
Confidence 56668899999999999999999987543 46777643322111 10 011223444566678999999
Q ss_pred EEEEEecCC----eEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCC
Q 005841 567 FMGAVTSPQ----RLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHW 642 (674)
Q Consensus 567 l~~~~~~~~----~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~ 642 (674)
+++++.... ..|++|+++ ..++.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++
T Consensus 88 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~--iiHrDiKp~Nill~~~~ 163 (294)
T PHA02882 88 YYGCGSFKRCRMYYRFILLEKL-VENTKEIFKRI-KCKNKKLIKNIMKDMLTTLEYIHEHG--ISHGDIKPENIMVDGNN 163 (294)
T ss_pred EEEeeeEecCCceEEEEEEehh-ccCHHHHHHhh-ccCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCC
Confidence 998776543 457888987 44777776543 34678889999999999999999998 99999999999999999
Q ss_pred cEEEEecCCcccccCCc-------cccccCCCCccccCC
Q 005841 643 TVKVGDFGLSRLKHETY-------LTTKTGKGTVTYLAS 674 (674)
Q Consensus 643 ~vkL~DFGla~~~~~~~-------~~~~~~~GTp~YmAP 674 (674)
.++|+|||+|+...... .......||+.||||
T Consensus 164 ~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ap 202 (294)
T PHA02882 164 RGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGL 202 (294)
T ss_pred cEEEEEcCCceeeccCCcccccccccccccCCCccccCH
Confidence 99999999998653211 111224699999997
|
|
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.2e-21 Score=201.90 Aligned_cols=164 Identities=31% Similarity=0.425 Sum_probs=137.0
Q ss_pred eeEeeeecccCceEEEEEEEc--CCeEEEEEeecccCCHHHHHHHHHHHHHHhhC---CCCCeeeEEEEEecCCe-----
Q 005841 507 LTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRL---RHPNVLLFMGAVTSPQR----- 576 (674)
Q Consensus 507 y~~~~~LG~G~fG~Vy~~~~~--~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l---~HpnIv~l~~~~~~~~~----- 576 (674)
|++.+.||+|+||.||++.+. +..||+|++............+.+|+.+++++ .|+||+++++++...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 678999999999999999984 67899999975543333345566788877766 59999999999998877
Q ss_pred EEEEEecCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccc
Q 005841 577 LCIVTEFLPRGSLFRLLQRNT-TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLK 655 (674)
Q Consensus 577 ~~lV~E~~~ggsL~~~l~~~~-~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~ 655 (674)
++++|||+++ +|.+++.... ..+++..++.++.||+.||.|||+.+ |+|+||||+|||++.++.+||+|||++...
T Consensus 81 ~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~--i~h~~l~~~nili~~~~~~~l~dfg~~~~~ 157 (287)
T cd07838 81 LTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHR--IVHRDLKPQNILVTSDGQVKIADFGLARIY 157 (287)
T ss_pred eEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCChhhEEEccCCCEEEeccCcceec
Confidence 9999999975 8999887643 36899999999999999999999998 999999999999999999999999999876
Q ss_pred cCCccccccCCCCccccCC
Q 005841 656 HETYLTTKTGKGTVTYLAS 674 (674)
Q Consensus 656 ~~~~~~~~~~~GTp~YmAP 674 (674)
...... ....+++.|+||
T Consensus 158 ~~~~~~-~~~~~~~~~~~P 175 (287)
T cd07838 158 SFEMAL-TSVVVTLWYRAP 175 (287)
T ss_pred cCCccc-ccccccccccCh
Confidence 443222 223578899998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.7e-21 Score=202.08 Aligned_cols=156 Identities=22% Similarity=0.366 Sum_probs=129.7
Q ss_pred CCeeEeeee--cccCceEEEEEEE--cCCeEEEEEeecccCCHHHHHHHHHHHHHHhhC-CCCCeeeEEEEEecCCeEEE
Q 005841 505 EDLTIGEQI--GQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRL-RHPNVLLFMGAVTSPQRLCI 579 (674)
Q Consensus 505 ~~y~~~~~L--G~G~fG~Vy~~~~--~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~l 579 (674)
++|.+.+.+ |+|+||.||++.. .+..+|+|++.+...... |+.+...+ +||||+++++.+...+.+|+
T Consensus 14 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-------e~~~~~~~~~h~~iv~~~~~~~~~~~~~i 86 (267)
T PHA03390 14 KNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-------EPMVHQLMKDNPNFIKLYYSVTTLKGHVL 86 (267)
T ss_pred HhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-------hHHHHHHhhcCCCEEEEEEEEecCCeeEE
Confidence 456666666 9999999999987 467799999876543321 22222222 69999999999999999999
Q ss_pred EEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCC-cEEEEecCCcccccCC
Q 005841 580 VTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHW-TVKVGDFGLSRLKHET 658 (674)
Q Consensus 580 V~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~-~vkL~DFGla~~~~~~ 658 (674)
||||+++++|.+++.... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++ .++|+|||+++.....
T Consensus 87 v~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~ 163 (267)
T PHA03390 87 IMDYIKDGDLFDLLKKEG-KLSEAEVKKIIRQLVEALNDLHKHN--IIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTP 163 (267)
T ss_pred EEEcCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHEEEeCCCCeEEEecCccceecCCC
Confidence 999999999999997654 7999999999999999999999999 99999999999999888 9999999999765432
Q ss_pred ccccccCCCCccccCC
Q 005841 659 YLTTKTGKGTVTYLAS 674 (674)
Q Consensus 659 ~~~~~~~~GTp~YmAP 674 (674)
....||+.|+||
T Consensus 164 ----~~~~~~~~y~aP 175 (267)
T PHA03390 164 ----SCYDGTLDYFSP 175 (267)
T ss_pred ----ccCCCCCcccCh
Confidence 234689999998
|
|
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=99.87 E-value=9.1e-22 Score=210.32 Aligned_cols=162 Identities=23% Similarity=0.351 Sum_probs=135.0
Q ss_pred eeeccc--CceEEEEEEE--cCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeEEEEEecCCC
Q 005841 511 EQIGQG--SCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPR 586 (674)
Q Consensus 511 ~~LG~G--~fG~Vy~~~~--~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~g 586 (674)
..||.| +||+||++.+ .++.||+|++..........+.+.+|+.+++.++||||+++++++..++.+|+||||+.+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 356666 9999999987 678899999987665556668899999999999999999999999999999999999999
Q ss_pred CCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccccCCccc----
Q 005841 587 GSLFRLLQRN-TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLT---- 661 (674)
Q Consensus 587 gsL~~~l~~~-~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~~~~~---- 661 (674)
++|.+++.+. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.++|+||+.+.........
T Consensus 84 ~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~--ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (328)
T cd08226 84 GSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNG--YIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVV 161 (328)
T ss_pred CCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccccc
Confidence 9999998764 345899999999999999999999998 999999999999999999999999865433211111
Q ss_pred ---cccCCCCccccCC
Q 005841 662 ---TKTGKGTVTYLAS 674 (674)
Q Consensus 662 ---~~~~~GTp~YmAP 674 (674)
.....++..||||
T Consensus 162 ~~~~~~~~~~~~y~aP 177 (328)
T cd08226 162 YDFPQFSTSVLPWLSP 177 (328)
T ss_pred ccccccccCccCccCh
Confidence 1112356779988
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.8e-22 Score=196.43 Aligned_cols=154 Identities=23% Similarity=0.304 Sum_probs=135.5
Q ss_pred cccccCCeeEeeeecccCceEEEEEEE--cCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecC---
Q 005841 500 YEILWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSP--- 574 (674)
Q Consensus 500 ~~~~~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~--- 574 (674)
..+..++|.+.++||+|+|..||++.. ++.-||+|.+.... .+.++...+|++..++++||||++++++...+
T Consensus 16 v~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~--~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D 93 (302)
T KOG2345|consen 16 VIINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHS--QEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKD 93 (302)
T ss_pred EEEcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccc--hHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhcc
Confidence 356778999999999999999999985 56679999987654 45567888999999999999999998876443
Q ss_pred --CeEEEEEecCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEec
Q 005841 575 --QRLCIVTEFLPRGSLFRLLQRN---TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDF 649 (674)
Q Consensus 575 --~~~~lV~E~~~ggsL~~~l~~~---~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DF 649 (674)
...||+++|...|+|.+.+.+. +..+++.+++.|+.+|++||++||+..+++.||||||.|||+.+.+.++|.||
T Consensus 94 ~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~vl~D~ 173 (302)
T KOG2345|consen 94 GKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPVLMDL 173 (302)
T ss_pred CceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceEEEec
Confidence 3499999999999999988653 44699999999999999999999999999999999999999999999999999
Q ss_pred CCcccc
Q 005841 650 GLSRLK 655 (674)
Q Consensus 650 Gla~~~ 655 (674)
|.+...
T Consensus 174 GS~~~a 179 (302)
T KOG2345|consen 174 GSATQA 179 (302)
T ss_pred cCcccc
Confidence 998754
|
|
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.3e-21 Score=207.59 Aligned_cols=164 Identities=29% Similarity=0.434 Sum_probs=139.0
Q ss_pred ccCCeeEeeeecccCceEEEEEEE--cCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEec-CCeEEE
Q 005841 503 LWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTS-PQRLCI 579 (674)
Q Consensus 503 ~~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~-~~~~~l 579 (674)
..++|.+.+.||.|+||.||++.. ++..||||++.+..........+.+|+.+++.++||||+++++++.. ....|+
T Consensus 8 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~l 87 (328)
T cd07856 8 ITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYF 87 (328)
T ss_pred cccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEE
Confidence 456799999999999999999986 56779999886654444455678889999999999999999999876 467899
Q ss_pred EEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccccCCc
Q 005841 580 VTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETY 659 (674)
Q Consensus 580 V~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~~~ 659 (674)
||||+ +++|..++.. ..+++..+..++.||+.||.|||+.+ |+|+||||+|||++.++.++|+|||++......
T Consensus 88 v~e~~-~~~L~~~~~~--~~~~~~~~~~~~~ql~~aL~~LH~~~--iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~~- 161 (328)
T cd07856 88 VTELL-GTDLHRLLTS--RPLEKQFIQYFLYQILRGLKYVHSAG--VVHRDLKPSNILINENCDLKICDFGLARIQDPQ- 161 (328)
T ss_pred Eeehh-ccCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEeECCCCCEEeCccccccccCCC-
Confidence 99999 5689888863 35888999999999999999999999 999999999999999999999999999754332
Q ss_pred cccccCCCCccccCC
Q 005841 660 LTTKTGKGTVTYLAS 674 (674)
Q Consensus 660 ~~~~~~~GTp~YmAP 674 (674)
.....+++.|+||
T Consensus 162 --~~~~~~~~~y~aP 174 (328)
T cd07856 162 --MTGYVSTRYYRAP 174 (328)
T ss_pred --cCCCcccccccCc
Confidence 2234678899998
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.8e-21 Score=198.41 Aligned_cols=159 Identities=31% Similarity=0.463 Sum_probs=139.1
Q ss_pred ecccCceEEEEEEEc--CCeEEEEEeecccCC-HHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeEEEEEecCCCCCH
Q 005841 513 IGQGSCGTVYHAVWY--GSDVAVKVFSRQEYS-DEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSL 589 (674)
Q Consensus 513 LG~G~fG~Vy~~~~~--~~~vAvK~i~~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL 589 (674)
||+|+||.||++.+. +..|++|++.+.... ......+..|+.+++.++||||+++++.+......|+||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 689999999999984 678999999776543 24567788999999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccccCCccccccCCCCc
Q 005841 590 FRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTV 669 (674)
Q Consensus 590 ~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~~~~~~~~~~GTp 669 (674)
.+++... ..+++..+..++.|++.||.|||+++ ++|+||||+||+++.++.++|+|||++..............|+.
T Consensus 81 ~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lh~~~--~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~ 157 (250)
T cd05123 81 FSHLSKE-GRFSEERARFYAAEIVLALEYLHSLG--IIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTP 157 (250)
T ss_pred HHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCcceEEEcCCCcEEEeecCcceecccCCCcccCCcCCc
Confidence 9999764 36899999999999999999999988 99999999999999999999999999987654323334457899
Q ss_pred cccCC
Q 005841 670 TYLAS 674 (674)
Q Consensus 670 ~YmAP 674 (674)
.|+||
T Consensus 158 ~~~~P 162 (250)
T cd05123 158 EYLAP 162 (250)
T ss_pred cccCh
Confidence 99988
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.2e-21 Score=206.20 Aligned_cols=160 Identities=29% Similarity=0.398 Sum_probs=137.1
Q ss_pred EeeeecccCceEEEEEEE--cCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeEEEEEecCCC
Q 005841 509 IGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPR 586 (674)
Q Consensus 509 ~~~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~g 586 (674)
...+||+|+||.||++.. ++..||||.+.... ......+.+|+.+++.++|+||+++++.+...+..|+||||+++
T Consensus 24 ~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 101 (292)
T cd06657 24 NFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRK--QQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEG 101 (292)
T ss_pred hHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccc--hhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCC
Confidence 346899999999999987 56779999875432 23456688999999999999999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccccCCccccccCC
Q 005841 587 GSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGK 666 (674)
Q Consensus 587 gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~~~~~~~~~~ 666 (674)
++|.+++.. ..+++..+..++.|++.+|+|||+.+ |+|+||||+||+++.++.++|+|||++..............
T Consensus 102 ~~L~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~g--ivH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~~~~~~ 177 (292)
T cd06657 102 GALTDIVTH--TRMNEEQIAAVCLAVLKALSVLHAQG--VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLV 177 (292)
T ss_pred CcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEECCCCCEEEcccccceecccccccccccc
Confidence 999998753 36899999999999999999999998 99999999999999999999999999876544332333456
Q ss_pred CCccccCC
Q 005841 667 GTVTYLAS 674 (674)
Q Consensus 667 GTp~YmAP 674 (674)
||+.|+||
T Consensus 178 ~~~~y~~p 185 (292)
T cd06657 178 GTPYWMAP 185 (292)
T ss_pred cCccccCH
Confidence 89999998
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.4e-21 Score=203.29 Aligned_cols=163 Identities=29% Similarity=0.414 Sum_probs=138.0
Q ss_pred eeEeeeecccCceEEEEEEE--cCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCC-CCCeeeEEEEEecCCeEEEEEec
Q 005841 507 LTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLR-HPNVLLFMGAVTSPQRLCIVTEF 583 (674)
Q Consensus 507 y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~lV~E~ 583 (674)
|.+.+.||+|+||.||+|.. .+..|+||.+........ .....+|+..++.++ |+||+.+++++..++..|+||||
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~-~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~ 79 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWE-ECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEY 79 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchh-HHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEec
Confidence 67889999999999999998 466799998865433222 233456899999999 99999999999999999999999
Q ss_pred CCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccccCCcccc
Q 005841 584 LPRGSLFRLLQRNT-TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTT 662 (674)
Q Consensus 584 ~~ggsL~~~l~~~~-~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~~~~~~ 662 (674)
+ +++|.+++.... ..+++..+..++.|++.+|.|||+++ |+|+||||+||+++.++.++|+|||++.........
T Consensus 80 ~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~--i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~~- 155 (283)
T cd07830 80 M-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHG--FFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPY- 155 (283)
T ss_pred C-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCChhhEEEcCCCCEEEeecccceeccCCCCc-
Confidence 9 789999887643 57899999999999999999999999 999999999999999999999999999866543222
Q ss_pred ccCCCCccccCC
Q 005841 663 KTGKGTVTYLAS 674 (674)
Q Consensus 663 ~~~~GTp~YmAP 674 (674)
....||..|+||
T Consensus 156 ~~~~~~~~~~aP 167 (283)
T cd07830 156 TDYVSTRWYRAP 167 (283)
T ss_pred CCCCCcccccCc
Confidence 224688999998
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.6e-21 Score=208.82 Aligned_cols=166 Identities=24% Similarity=0.378 Sum_probs=136.4
Q ss_pred CCee-EeeeecccCceEEEEEEE--cCCeEEEEEeecccCCHH------------HHHHHHHHHHHHhhCCCCCeeeEEE
Q 005841 505 EDLT-IGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDE------------VIHSFRQEVSLMKRLRHPNVLLFMG 569 (674)
Q Consensus 505 ~~y~-~~~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~~~~------------~~~~~~~Ei~il~~l~HpnIv~l~~ 569 (674)
++|. +.+.||.|+||+||++.+ .+..||||++........ ....+.+|+.+++.++|+||+.+++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence 4454 567899999999999986 467899999865433210 0124678999999999999999999
Q ss_pred EEecCCeEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEec
Q 005841 570 AVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDF 649 (674)
Q Consensus 570 ~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DF 649 (674)
++...+..|+||||+. ++|.+++.. ...+++..+..++.||+.||.|||+.+ |+|+||||+|||++.++.++|+||
T Consensus 88 ~~~~~~~~~lv~e~~~-~~l~~~l~~-~~~~~~~~~~~~~~ql~~aL~~LH~~~--i~H~dl~~~nill~~~~~~kl~df 163 (335)
T PTZ00024 88 VYVEGDFINLVMDIMA-SDLKKVVDR-KIRLTESQVKCILLQILNGLNVLHKWY--FMHRDLSPANIFINSKGICKIADF 163 (335)
T ss_pred EEecCCcEEEEEeccc-cCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCC--eecccccHHHeEECCCCCEEECCc
Confidence 9999999999999996 589998864 456899999999999999999999999 999999999999999999999999
Q ss_pred CCcccccCC--------------ccccccCCCCccccCC
Q 005841 650 GLSRLKHET--------------YLTTKTGKGTVTYLAS 674 (674)
Q Consensus 650 Gla~~~~~~--------------~~~~~~~~GTp~YmAP 674 (674)
|+++..... ........+++.|+||
T Consensus 164 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aP 202 (335)
T PTZ00024 164 GLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAP 202 (335)
T ss_pred cceeecccccccccccccccccccccccccccccCCCCC
Confidence 999765411 1112223578889998
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.87 E-value=9.9e-22 Score=211.53 Aligned_cols=164 Identities=29% Similarity=0.408 Sum_probs=141.0
Q ss_pred ccCCeeEeeeecccCceEEEEEEE--cCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCe----
Q 005841 503 LWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQR---- 576 (674)
Q Consensus 503 ~~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~---- 576 (674)
..++|.+...||+|+||.||+|.+ .+..||||++............+.+|+.+++.+.||||+.+++++...+.
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF 92 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence 467899999999999999999998 46779999987654444455677889999999999999999988776554
Q ss_pred --EEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCccc
Q 005841 577 --LCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL 654 (674)
Q Consensus 577 --~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~ 654 (674)
+|+|+||+ +++|.+++.. ..+++..+..++.||+.||.|||+.+ |+|+||||+|||++.++.+||+|||++..
T Consensus 93 ~~~~lv~e~~-~~~L~~~~~~--~~l~~~~~~~~~~ql~~aL~~LH~~g--i~H~dlkp~Nill~~~~~~kL~dfg~~~~ 167 (343)
T cd07851 93 QDVYLVTHLM-GADLNNIVKC--QKLSDDHIQFLVYQILRGLKYIHSAG--IIHRDLKPSNIAVNEDCELKILDFGLARH 167 (343)
T ss_pred ccEEEEEecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEECCCCCEEEcccccccc
Confidence 89999999 6799999864 46999999999999999999999998 99999999999999999999999999986
Q ss_pred ccCCccccccCCCCccccCC
Q 005841 655 KHETYLTTKTGKGTVTYLAS 674 (674)
Q Consensus 655 ~~~~~~~~~~~~GTp~YmAP 674 (674)
.... .....+|+.|+||
T Consensus 168 ~~~~---~~~~~~~~~y~aP 184 (343)
T cd07851 168 TDDE---MTGYVATRWYRAP 184 (343)
T ss_pred cccc---ccCCcccccccCH
Confidence 6443 2335689999998
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.8e-22 Score=215.79 Aligned_cols=172 Identities=33% Similarity=0.561 Sum_probs=147.6
Q ss_pred cccccccCCeeEeeeecccCceEEEEEEEcC--CeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCC
Q 005841 498 LDYEILWEDLTIGEQIGQGSCGTVYHAVWYG--SDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQ 575 (674)
Q Consensus 498 ~~~~~~~~~y~~~~~LG~G~fG~Vy~~~~~~--~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~ 575 (674)
..|+....+..+..+||-|-||.||.|.|+. .-||||.++... ..++.|+.|..+|+.++|||+|+++++|....
T Consensus 260 DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDt---MeveEFLkEAAvMKeikHpNLVqLLGVCT~Ep 336 (1157)
T KOG4278|consen 260 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT---MEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEP 336 (1157)
T ss_pred chhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcc---hhHHHHHHHHHHHHhhcCccHHHHhhhhccCC
Confidence 4466667778888999999999999999964 459999986543 34678999999999999999999999999999
Q ss_pred eEEEEEecCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCccc
Q 005841 576 RLCIVTEFLPRGSLFRLLQRNT-TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL 654 (674)
Q Consensus 576 ~~~lV~E~~~ggsL~~~l~~~~-~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~ 654 (674)
.+|||+|||..|+|.+||++++ ..++.-..++|+.||..||+||..++ +|||||...|+|+.++..|||+||||+++
T Consensus 337 PFYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkkn--FIHRDLAARNCLVgEnhiVKvADFGLsRl 414 (1157)
T KOG4278|consen 337 PFYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKN--FIHRDLAARNCLVGENHIVKVADFGLSRL 414 (1157)
T ss_pred CeEEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhh--hhhhhhhhhhccccccceEEeeccchhhh
Confidence 9999999999999999999865 34677788899999999999999999 99999999999999999999999999999
Q ss_pred ccCCccccccCCC-CccccCC
Q 005841 655 KHETYLTTKTGKG-TVTYLAS 674 (674)
Q Consensus 655 ~~~~~~~~~~~~G-Tp~YmAP 674 (674)
...+.++...++- ...|.||
T Consensus 415 MtgDTYTAHAGAKFPIKWTAP 435 (1157)
T KOG4278|consen 415 MTGDTYTAHAGAKFPIKWTAP 435 (1157)
T ss_pred hcCCceecccCccCcccccCc
Confidence 8877666554332 3345555
|
|
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.87 E-value=1e-21 Score=201.95 Aligned_cols=166 Identities=28% Similarity=0.440 Sum_probs=137.3
Q ss_pred CeeEeeeecccCceEEEEEEEcC--CeEEEEEeeccc---CCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeEEEE
Q 005841 506 DLTIGEQIGQGSCGTVYHAVWYG--SDVAVKVFSRQE---YSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIV 580 (674)
Q Consensus 506 ~y~~~~~LG~G~fG~Vy~~~~~~--~~vAvK~i~~~~---~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 580 (674)
+|.+.+.||+|+||.||++.+.. ..+++|+++... ........+..|+.+++.++||||+++++++......++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 58899999999999999998743 346666654322 2223334567799999999999999999999999999999
Q ss_pred EecCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccccC
Q 005841 581 TEFLPRGSLFRLLQR---NTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHE 657 (674)
Q Consensus 581 ~E~~~ggsL~~~l~~---~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~ 657 (674)
|||+++++|.+++.. ....+++..++.++.|++.||.|||+.+ |+|+||||+||+++. +.++|+|||+++....
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~ 157 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR--ILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMG 157 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcC--ccccCCChhheEeec-CCEeecccCceeecCC
Confidence 999999999998864 3456899999999999999999999998 999999999999986 5799999999987655
Q ss_pred CccccccCCCCccccCC
Q 005841 658 TYLTTKTGKGTVTYLAS 674 (674)
Q Consensus 658 ~~~~~~~~~GTp~YmAP 674 (674)
.........|++.|+||
T Consensus 158 ~~~~~~~~~~~~~~~~p 174 (260)
T cd08222 158 SCDLATTFTGTPYYMSP 174 (260)
T ss_pred CcccccCCCCCcCccCH
Confidence 43344446789999987
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.1e-21 Score=208.96 Aligned_cols=162 Identities=30% Similarity=0.420 Sum_probs=136.5
Q ss_pred cCCeeEeeeecccCceEEEEEEE--cCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCC------
Q 005841 504 WEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQ------ 575 (674)
Q Consensus 504 ~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~------ 575 (674)
..+|.+.+.||+|+||.||+|.+ ++..||||++.+..........+.+|+.+++.+.||||+++++++....
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 46899999999999999999987 5778999998765434444566888999999999999999999987543
Q ss_pred eEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccc
Q 005841 576 RLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLK 655 (674)
Q Consensus 576 ~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~ 655 (674)
.+|+||||+. .+|..++ ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 94 ~~~lv~e~~~-~~l~~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~--i~H~dlkp~NIll~~~~~~kL~dfg~~~~~ 167 (342)
T cd07879 94 DFYLVMPYMQ-TDLQKIM---GHPLSEDKVQYLVYQMLCGLKYIHSAG--IIHRDLKPGNLAVNEDCELKILDFGLARHA 167 (342)
T ss_pred eEEEEecccc-cCHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCCCCEEEeeCCCCcCC
Confidence 4699999995 4776665 236899999999999999999999998 999999999999999999999999999865
Q ss_pred cCCccccccCCCCccccCC
Q 005841 656 HETYLTTKTGKGTVTYLAS 674 (674)
Q Consensus 656 ~~~~~~~~~~~GTp~YmAP 674 (674)
... .....||+.||||
T Consensus 168 ~~~---~~~~~~~~~y~aP 183 (342)
T cd07879 168 DAE---MTGYVVTRWYRAP 183 (342)
T ss_pred CCC---CCCceeeecccCh
Confidence 332 2235688999998
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.1e-21 Score=204.37 Aligned_cols=163 Identities=31% Similarity=0.433 Sum_probs=140.5
Q ss_pred CCeeEeeeecccCceEEEEEEE--cCCeEEEEEeecccC-CHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeEEEEE
Q 005841 505 EDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEY-SDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVT 581 (674)
Q Consensus 505 ~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 581 (674)
..|...+.||+|+||.||++.. .+..|++|.+..... .......+.+|+.+++.++|+||+++++++......|+||
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 94 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEE
Confidence 4577788999999999999997 466799999875432 3345567888999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccccCCccc
Q 005841 582 EFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLT 661 (674)
Q Consensus 582 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~~~~~ 661 (674)
||+. ++|.+++......+++..+..++.|++.||.|||+.+ ++|+||||+|||++.++.++|+|||++......
T Consensus 95 e~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~--i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~--- 168 (308)
T cd06634 95 EYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN--MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA--- 168 (308)
T ss_pred EccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHhEEECCCCcEEECCcccceeecCc---
Confidence 9996 5888887666667899999999999999999999998 999999999999999999999999998765432
Q ss_pred cccCCCCccccCC
Q 005841 662 TKTGKGTVTYLAS 674 (674)
Q Consensus 662 ~~~~~GTp~YmAP 674 (674)
....||+.|+||
T Consensus 169 -~~~~~~~~y~aP 180 (308)
T cd06634 169 -NXFVGTPYWMAP 180 (308)
T ss_pred -ccccCCccccCH
Confidence 235689999998
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.7e-22 Score=217.90 Aligned_cols=170 Identities=33% Similarity=0.498 Sum_probs=142.8
Q ss_pred ccccCCeeEeeeecccCceEEEEEEEc---CC--eEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCC
Q 005841 501 EILWEDLTIGEQIGQGSCGTVYHAVWY---GS--DVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQ 575 (674)
Q Consensus 501 ~~~~~~y~~~~~LG~G~fG~Vy~~~~~---~~--~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~ 575 (674)
.|..++.++.++||+|+||+|++|.|+ |+ .||||++....... ....|.+|+.+|.+|+|+|++++||++.+ .
T Consensus 106 lIpee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~-~mddflrEas~M~~L~H~hliRLyGvVl~-q 183 (1039)
T KOG0199|consen 106 LIPEEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNA-IMDDFLREASHMLKLQHPHLIRLYGVVLD-Q 183 (1039)
T ss_pred eccHHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccch-hHHHHHHHHHHHHhccCcceeEEeeeecc-c
Confidence 344566788899999999999999995 22 39999998766554 56789999999999999999999999987 7
Q ss_pred eEEEEEecCCCCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCccc
Q 005841 576 RLCIVTEFLPRGSLFRLLQR-NTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL 654 (674)
Q Consensus 576 ~~~lV~E~~~ggsL~~~l~~-~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~ 654 (674)
.+.||||+++.|+|.+.|++ ....|.......|+.||+.||.||-.++ +|||||...|||+-....||||||||++-
T Consensus 184 p~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskr--lvHRDLAARNlllasprtVKI~DFGLmRa 261 (1039)
T KOG0199|consen 184 PAMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKR--LVHRDLAARNLLLASPRTVKICDFGLMRA 261 (1039)
T ss_pred hhhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhh--hhhhhhhhhhheecccceeeeecccceec
Confidence 78999999999999999987 5567888999999999999999999988 99999999999999999999999999998
Q ss_pred ccC--Cccc-cccCCCCccccCC
Q 005841 655 KHE--TYLT-TKTGKGTVTYLAS 674 (674)
Q Consensus 655 ~~~--~~~~-~~~~~GTp~YmAP 674 (674)
+.. +.+. .....-...|+||
T Consensus 262 Lg~ned~Yvm~p~rkvPfAWCaP 284 (1039)
T KOG0199|consen 262 LGENEDMYVMAPQRKVPFAWCAP 284 (1039)
T ss_pred cCCCCcceEecCCCcCcccccCH
Confidence 743 2222 2222334556666
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.7e-21 Score=188.54 Aligned_cols=166 Identities=23% Similarity=0.349 Sum_probs=141.6
Q ss_pred ccccCCeeEeeeecccCceEEEEEEE--cCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCC-CCeeeEEEEEecCCeE
Q 005841 501 EILWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRH-PNVLLFMGAVTSPQRL 577 (674)
Q Consensus 501 ~~~~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~H-pnIv~l~~~~~~~~~~ 577 (674)
.+....|+++++||.|+||.+|.+.. .|..||||+-+...-.+ .+..|..++..|++ ..|..+..++.+..+-
T Consensus 11 ~iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~hp----qL~yEskvY~iL~~g~GiP~i~~y~~e~~yn 86 (341)
T KOG1163|consen 11 LIVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKHP----QLLYESKVYRILQGGVGIPHIRHYGTEKDYN 86 (341)
T ss_pred heeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCCc----chhHHHHHHHHhccCCCCchhhhhccccccc
Confidence 56778999999999999999999987 68889999876544333 35568999999975 7888899899999999
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEc---CCCcEEEEecCCccc
Q 005841 578 CIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVD---KHWTVKVGDFGLSRL 654 (674)
Q Consensus 578 ~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~---~~~~vkL~DFGla~~ 654 (674)
.+||+++ |.+|.+++.-+...|+.++++.++-|++.-|+|+|.++ .|||||||+|+|+. ....+.|+|||+|+.
T Consensus 87 vlVMdLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~--fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKk 163 (341)
T KOG1163|consen 87 VLVMDLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRN--FIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKK 163 (341)
T ss_pred eeeeecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhc--cccccCCccceeeccccccceEEEEeccchhh
Confidence 9999998 99999999988899999999999999999999999999 99999999999986 335699999999986
Q ss_pred ccC-------CccccccCCCCccccC
Q 005841 655 KHE-------TYLTTKTGKGTVTYLA 673 (674)
Q Consensus 655 ~~~-------~~~~~~~~~GTp~YmA 673 (674)
+.+ ++.......||..|.+
T Consensus 164 y~d~~t~~HIpyre~r~ltGTaRYAS 189 (341)
T KOG1163|consen 164 YRDIRTRQHIPYREDRNLTGTARYAS 189 (341)
T ss_pred hccccccccCccccCCccceeeeehh
Confidence 532 2333445679999864
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.8e-21 Score=192.02 Aligned_cols=142 Identities=20% Similarity=0.219 Sum_probs=109.6
Q ss_pred eeeecccCceEEEEEEE-cCCeEEEEEeecccCCHHH------------------------HHHHHHHHHHHhhCCCCCe
Q 005841 510 GEQIGQGSCGTVYHAVW-YGSDVAVKVFSRQEYSDEV------------------------IHSFRQEVSLMKRLRHPNV 564 (674)
Q Consensus 510 ~~~LG~G~fG~Vy~~~~-~~~~vAvK~i~~~~~~~~~------------------------~~~~~~Ei~il~~l~HpnI 564 (674)
.+.||+|+||.||+|.. +|..||||++......... .....+|+.++..+.+++|
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 46799999999999987 5889999999765321110 1223459999999987776
Q ss_pred eeEEEEEecCCeEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH-HhCCCCeEEccCCCCCEEEcCCCc
Q 005841 565 LLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYL-HHCNPPIIHRDLKSSNLLVDKHWT 643 (674)
Q Consensus 565 v~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yL-H~~~~~IvHrDLKp~NILi~~~~~ 643 (674)
.....+.. ...+|||||++|++|...+.. ...+++..+..++.|++.+|.|| |+.+ |+||||||+|||++ ++.
T Consensus 82 ~~p~~~~~--~~~~iVmE~i~g~~l~~~~~~-~~~~~~~~~~~i~~qi~~~L~~l~H~~g--iiHrDlkP~NIli~-~~~ 155 (190)
T cd05147 82 PCPEPILL--KSHVLVMEFIGDDGWAAPRLK-DAPLSESKARELYLQVIQIMRILYQDCR--LVHADLSEYNLLYH-DGK 155 (190)
T ss_pred CCCcEEEe--cCCEEEEEEeCCCCCcchhhh-cCCCCHHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEEE-CCc
Confidence 44333222 224899999998877655332 35789999999999999999999 6888 99999999999998 478
Q ss_pred EEEEecCCcccccC
Q 005841 644 VKVGDFGLSRLKHE 657 (674)
Q Consensus 644 vkL~DFGla~~~~~ 657 (674)
|+|+|||+|.....
T Consensus 156 v~LiDFG~a~~~~~ 169 (190)
T cd05147 156 LYIIDVSQSVEHDH 169 (190)
T ss_pred EEEEEccccccCCC
Confidence 99999999975543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=9.3e-21 Score=211.98 Aligned_cols=172 Identities=20% Similarity=0.258 Sum_probs=128.4
Q ss_pred ccccCCeeEeeeecccCceEEEEEEE------------------cCCeEEEEEeecccCC--HH----------HHHHHH
Q 005841 501 EILWEDLTIGEQIGQGSCGTVYHAVW------------------YGSDVAVKVFSRQEYS--DE----------VIHSFR 550 (674)
Q Consensus 501 ~~~~~~y~~~~~LG~G~fG~Vy~~~~------------------~~~~vAvK~i~~~~~~--~~----------~~~~~~ 550 (674)
.+..++|.+.++||+|+||+||+|.. .+..||||.+...... .+ ..+...
T Consensus 141 r~~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~ 220 (507)
T PLN03224 141 RWSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGM 220 (507)
T ss_pred CccccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhH
Confidence 34567899999999999999999964 2346999998643211 01 012233
Q ss_pred HHHHHHhhCCCCCe-----eeEEEEEec--------CCeEEEEEecCCCCCHHHHHHhcC--------------------
Q 005841 551 QEVSLMKRLRHPNV-----LLFMGAVTS--------PQRLCIVTEFLPRGSLFRLLQRNT-------------------- 597 (674)
Q Consensus 551 ~Ei~il~~l~HpnI-----v~l~~~~~~--------~~~~~lV~E~~~ggsL~~~l~~~~-------------------- 597 (674)
.|+.++.+++|.++ +.++++|.. ....||||||+++++|.++|....
T Consensus 221 vE~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~ 300 (507)
T PLN03224 221 VEAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDN 300 (507)
T ss_pred HHHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhh
Confidence 46777777766554 566666643 356899999999999999886421
Q ss_pred ---CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccccCCc-cccccCCCCccccC
Q 005841 598 ---TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETY-LTTKTGKGTVTYLA 673 (674)
Q Consensus 598 ---~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~~~-~~~~~~~GTp~YmA 673 (674)
..+++..+..++.|++.+|.|||+.+ |+||||||+|||++.++.+||+|||+++...... .......+||.|+|
T Consensus 301 ~~~~~~~~~~~~~i~~ql~~aL~~lH~~~--ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~a 378 (507)
T PLN03224 301 MPQDKRDINVIKGVMRQVLTGLRKLHRIG--IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSP 378 (507)
T ss_pred cccccCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeC
Confidence 12467788899999999999999998 9999999999999999999999999997653321 22223456899999
Q ss_pred C
Q 005841 674 S 674 (674)
Q Consensus 674 P 674 (674)
|
T Consensus 379 P 379 (507)
T PLN03224 379 P 379 (507)
T ss_pred h
Confidence 8
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=6e-21 Score=197.31 Aligned_cols=165 Identities=27% Similarity=0.378 Sum_probs=139.4
Q ss_pred ccccCCeeEeeeecccCceEEEEEEEc--CCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCC--C----CeeeEEEEEe
Q 005841 501 EILWEDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRH--P----NVLLFMGAVT 572 (674)
Q Consensus 501 ~~~~~~y~~~~~LG~G~fG~Vy~~~~~--~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~H--p----nIv~l~~~~~ 572 (674)
++...+|++..++|+|.||+|..|.+. +..||||+++. -....++.+-|+.+++++.+ | -++++.++|.
T Consensus 85 D~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~---V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFd 161 (415)
T KOG0671|consen 85 DILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKN---VDKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFD 161 (415)
T ss_pred cccccceehhhhhcCCcccceEEEeecCCCceehHHHHHH---HHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhh
Confidence 566789999999999999999999874 56799999853 23556677789999999942 3 3678888899
Q ss_pred cCCeEEEEEecCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEc------------
Q 005841 573 SPQRLCIVTEFLPRGSLFRLLQRNT-TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVD------------ 639 (674)
Q Consensus 573 ~~~~~~lV~E~~~ggsL~~~l~~~~-~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~------------ 639 (674)
-.++.|||+|.+ |.+++++|..++ ..|+...+..|++|++.+|+|||+.+ ++|.||||+|||+.
T Consensus 162 yrghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~k--l~HTDLKPENILfvss~~~~~~~~k~ 238 (415)
T KOG0671|consen 162 YRGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLK--LTHTDLKPENILFVSSEYFKTYNPKK 238 (415)
T ss_pred ccCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcc--eeecCCChheEEEeccceEEEeccCC
Confidence 999999999988 779999998744 56999999999999999999999999 99999999999982
Q ss_pred --------CCCcEEEEecCCcccccCCccccccCCCCccccCC
Q 005841 640 --------KHWTVKVGDFGLSRLKHETYLTTKTGKGTVTYLAS 674 (674)
Q Consensus 640 --------~~~~vkL~DFGla~~~~~~~~~~~~~~GTp~YmAP 674 (674)
++..|||+|||.|...++... +.+.|-.|.||
T Consensus 239 ~~~~~r~~ks~~I~vIDFGsAtf~~e~hs---~iVsTRHYRAP 278 (415)
T KOG0671|consen 239 KVCFIRPLKSTAIKVIDFGSATFDHEHHS---TIVSTRHYRAP 278 (415)
T ss_pred ccceeccCCCcceEEEecCCcceeccCcc---eeeeccccCCc
Confidence 134699999999998777653 35679999998
|
|
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.85 E-value=6.1e-21 Score=205.29 Aligned_cols=164 Identities=27% Similarity=0.459 Sum_probs=135.1
Q ss_pred cCCeeEeeeecccCceEEEEEEE--cCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecC-------
Q 005841 504 WEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSP------- 574 (674)
Q Consensus 504 ~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~------- 574 (674)
..+|.+.+.||.|+||.||+|.. ++..||+|++..... ...+.+.+|+.+++.++||||+++++.+...
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~--~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 81 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP--QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTED 81 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC--chHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccc
Confidence 36899999999999999999987 467899999866543 3346688899999999999999998766543
Q ss_pred -------CeEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEc-CCCcEEE
Q 005841 575 -------QRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVD-KHWTVKV 646 (674)
Q Consensus 575 -------~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~-~~~~vkL 646 (674)
..+|+||||++ ++|.+++.. ..+++..+..++.||+.||.|||+.+ |+||||||+|||++ .++.+||
T Consensus 82 ~~~~~~~~~~~lv~e~~~-~~L~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~g--ivH~dikp~Nili~~~~~~~kl 156 (342)
T cd07854 82 VGSLTELNSVYIVQEYME-TDLANVLEQ--GPLSEEHARLFMYQLLRGLKYIHSAN--VLHRDLKPANVFINTEDLVLKI 156 (342)
T ss_pred cccccccceEEEEeeccc-ccHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEEcCCCceEEE
Confidence 35899999996 589888853 36899999999999999999999999 99999999999997 5567999
Q ss_pred EecCCcccccCCccc---cccCCCCccccCC
Q 005841 647 GDFGLSRLKHETYLT---TKTGKGTVTYLAS 674 (674)
Q Consensus 647 ~DFGla~~~~~~~~~---~~~~~GTp~YmAP 674 (674)
+|||+++.+...... .....||+.|+||
T Consensus 157 ~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aP 187 (342)
T cd07854 157 GDFGLARIVDPHYSHKGYLSEGLVTKWYRSP 187 (342)
T ss_pred CCcccceecCCccccccccccccccccccCH
Confidence 999999865432211 1123578899998
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=7.5e-21 Score=217.21 Aligned_cols=166 Identities=19% Similarity=0.225 Sum_probs=118.6
Q ss_pred ccccCCeeEeeeecccCceEEEEEEEc------CCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEE----
Q 005841 501 EILWEDLTIGEQIGQGSCGTVYHAVWY------GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGA---- 570 (674)
Q Consensus 501 ~~~~~~y~~~~~LG~G~fG~Vy~~~~~------~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~---- 570 (674)
.+..++|.+.++||+|+||.||+|.+. +..||||.+........ ...+ .+....+.++..++..
T Consensus 128 ~~~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~e~----~~~e--~l~~~~~~~~~~~~~~~~~~ 201 (566)
T PLN03225 128 SFKKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAVEI----WMNE--RVRRACPNSCADFVYGFLEP 201 (566)
T ss_pred CCccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchhHH----HHHH--HHHhhchhhHHHHHHhhhcc
Confidence 445688999999999999999999974 56799998764321111 1111 1111112222221111
Q ss_pred --EecCCeEEEEEecCCCCCHHHHHHhcCCC-------------------CCHHHHHHHHHHHHHHHHHHHhCCCCeEEc
Q 005841 571 --VTSPQRLCIVTEFLPRGSLFRLLQRNTTK-------------------LDWRRRILMALDIARGVSYLHHCNPPIIHR 629 (674)
Q Consensus 571 --~~~~~~~~lV~E~~~ggsL~~~l~~~~~~-------------------l~~~~~~~i~~qi~~~L~yLH~~~~~IvHr 629 (674)
......++|||||+++++|.+++...... .....+..|+.||+.||.|||+.+ ||||
T Consensus 202 ~~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g--IiHR 279 (566)
T PLN03225 202 VSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG--IVHR 279 (566)
T ss_pred cccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC--EEeC
Confidence 24567799999999999999998753211 123446689999999999999998 9999
Q ss_pred cCCCCCEEEcC-CCcEEEEecCCcccccCC-ccccccCCCCccccCC
Q 005841 630 DLKSSNLLVDK-HWTVKVGDFGLSRLKHET-YLTTKTGKGTVTYLAS 674 (674)
Q Consensus 630 DLKp~NILi~~-~~~vkL~DFGla~~~~~~-~~~~~~~~GTp~YmAP 674 (674)
||||+|||++. ++.+||+|||+|+.+... ......++|||.||||
T Consensus 280 DLKP~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~AP 326 (566)
T PLN03225 280 DVKPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAP 326 (566)
T ss_pred cCCHHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccCh
Confidence 99999999985 689999999999865432 2334457899999998
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.85 E-value=2.5e-23 Score=203.65 Aligned_cols=169 Identities=24% Similarity=0.362 Sum_probs=134.4
Q ss_pred ccCCeeEeeeecccCceEEEEEEE--cCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecC------
Q 005841 503 LWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSP------ 574 (674)
Q Consensus 503 ~~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~------ 574 (674)
....|+-+.+||+|.||.||+++. +++.||+|++.-......+-....+|+++|..|+|+|++.++..|...
T Consensus 15 ~~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r 94 (376)
T KOG0669|consen 15 EVSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNR 94 (376)
T ss_pred cchHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccc
Confidence 346788888999999999999986 466688886543222222334566799999999999999998877543
Q ss_pred --CeEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCc
Q 005841 575 --QRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLS 652 (674)
Q Consensus 575 --~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla 652 (674)
..+|+||.+|.. +|..+|.....+|+..++..++.+++.||.|+|+.. |+|||+||.|+||+.+|.+||+|||++
T Consensus 95 ~r~t~ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~k--ilHRDmKaaNvLIt~dgilklADFGla 171 (376)
T KOG0669|consen 95 DRATFYLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNK--ILHRDMKAANVLITKDGILKLADFGLA 171 (376)
T ss_pred ccceeeeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhh--HHhhcccHhhEEEcCCceEEeeccccc
Confidence 348999999955 999999877789999999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCccccc----cCCCCccccCC
Q 005841 653 RLKHETYLTTK----TGKGTVTYLAS 674 (674)
Q Consensus 653 ~~~~~~~~~~~----~~~GTp~YmAP 674 (674)
+.+........ ..+-|+.|.+|
T Consensus 172 r~fs~~~n~~kprytnrvvTLwYrpp 197 (376)
T KOG0669|consen 172 RAFSTSKNVVKPRYTNRVVTLWYRPP 197 (376)
T ss_pred cceecccccCCCCcccceeeeecCCH
Confidence 76542211111 12347777765
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.84 E-value=2.1e-20 Score=190.37 Aligned_cols=146 Identities=16% Similarity=0.188 Sum_probs=123.2
Q ss_pred cCceEEEEEEE--cCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeEEEEEecCCCCCHHHHH
Q 005841 516 GSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLL 593 (674)
Q Consensus 516 G~fG~Vy~~~~--~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l 593 (674)
|.||.||++.+ ++..||+|.+.+.. .+.+|...+....||||+++++++...+..|+||||+++++|.+++
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-------~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l 76 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-------EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHI 76 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-------hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHH
Confidence 89999999998 56779999986543 1223445555567999999999999999999999999999999998
Q ss_pred HhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccccCCccccccCCCCccccC
Q 005841 594 QRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTVTYLA 673 (674)
Q Consensus 594 ~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~~~~~~~~~~GTp~YmA 673 (674)
.+. ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.++|+|||++...... .....+++.|||
T Consensus 77 ~~~-~~l~~~~~~~~~~ql~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~---~~~~~~~~~y~a 150 (237)
T cd05576 77 SKF-LNIPEECVKRWAAEMVVALDALHREG--IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS---CDGEAVENMYCA 150 (237)
T ss_pred HHh-cCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHEEEcCCCCEEEecccchhccccc---cccCCcCccccC
Confidence 754 35899999999999999999999998 999999999999999999999999988765442 223456788999
Q ss_pred C
Q 005841 674 S 674 (674)
Q Consensus 674 P 674 (674)
|
T Consensus 151 P 151 (237)
T cd05576 151 P 151 (237)
T ss_pred C
Confidence 8
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.84 E-value=2.5e-20 Score=184.02 Aligned_cols=142 Identities=20% Similarity=0.207 Sum_probs=112.6
Q ss_pred eeeecccCceEEEEEEE-cCCeEEEEEeecccCC----------------------H--HHHHHHHHHHHHHhhCCCCCe
Q 005841 510 GEQIGQGSCGTVYHAVW-YGSDVAVKVFSRQEYS----------------------D--EVIHSFRQEVSLMKRLRHPNV 564 (674)
Q Consensus 510 ~~~LG~G~fG~Vy~~~~-~~~~vAvK~i~~~~~~----------------------~--~~~~~~~~Ei~il~~l~HpnI 564 (674)
...||+|+||+||+|.+ +|..||||++...... . .....+.+|+..+.++.|++|
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 46899999999999987 4889999999865321 0 112335679999999999987
Q ss_pred eeEEEEEecCCeEEEEEecCCCCCHHHH-HHhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCeEEccCCCCCEEEcCCC
Q 005841 565 LLFMGAVTSPQRLCIVTEFLPRGSLFRL-LQRNTTKLDWRRRILMALDIARGVSYLHH-CNPPIIHRDLKSSNLLVDKHW 642 (674)
Q Consensus 565 v~l~~~~~~~~~~~lV~E~~~ggsL~~~-l~~~~~~l~~~~~~~i~~qi~~~L~yLH~-~~~~IvHrDLKp~NILi~~~~ 642 (674)
.....+... ..||||||++|+++... +. ...++...+..++.|++.+|.|||+ .| |+||||||+|||++ ++
T Consensus 82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~--~~~~~~~~~~~i~~~l~~~l~~lH~~~g--ivHrDlkP~NIll~-~~ 154 (190)
T cd05145 82 PVPEPILLK--KNVLVMEFIGDDGSPAPRLK--DVPLEEEEAEELYEQVVEQMRRLYQEAG--LVHGDLSEYNILYH-DG 154 (190)
T ss_pred CCceEEEec--CCEEEEEEecCCCchhhhhh--hccCCHHHHHHHHHHHHHHHHHHHHhCC--EecCCCChhhEEEE-CC
Confidence 544443332 24899999998865443 43 3457888999999999999999999 88 99999999999999 78
Q ss_pred cEEEEecCCcccccCC
Q 005841 643 TVKVGDFGLSRLKHET 658 (674)
Q Consensus 643 ~vkL~DFGla~~~~~~ 658 (674)
.++|+|||+|+....+
T Consensus 155 ~~~liDFG~a~~~~~~ 170 (190)
T cd05145 155 KPYIIDVSQAVELDHP 170 (190)
T ss_pred CEEEEEcccceecCCC
Confidence 9999999999876543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=2.2e-20 Score=215.28 Aligned_cols=173 Identities=32% Similarity=0.591 Sum_probs=148.3
Q ss_pred ccccccCCeeEeeeecccCceEEEEEEEc---------CCeEEEEEeecccCCHHHHHHHHHHHHHHhhCC-CCCeeeEE
Q 005841 499 DYEILWEDLTIGEQIGQGSCGTVYHAVWY---------GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLR-HPNVLLFM 568 (674)
Q Consensus 499 ~~~~~~~~y~~~~~LG~G~fG~Vy~~~~~---------~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~ 568 (674)
.|++..+++.+.+.||+|.||+|+++... ...||||.++..... ...+.+..|+.+|+.+. |+||+.++
T Consensus 290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~-~~~~~~~~El~~m~~~g~H~niv~ll 368 (609)
T KOG0200|consen 290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASS-SEKKDLMSELNVLKELGKHPNIVNLL 368 (609)
T ss_pred ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCc-HHHHHHHHHHHHHHHhcCCcchhhhe
Confidence 67888888899999999999999999742 234999988765544 66788999999999995 99999999
Q ss_pred EEEecCCeEEEEEecCCCCCHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCC
Q 005841 569 GAVTSPQRLCIVTEFLPRGSLFRLLQRNT---------------TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKS 633 (674)
Q Consensus 569 ~~~~~~~~~~lV~E~~~ggsL~~~l~~~~---------------~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp 633 (674)
+++.....+++|+||+..|+|..+|+.++ ..++..+.+.++.||+.||+||++.. +|||||..
T Consensus 369 G~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~--~vHRDLAa 446 (609)
T KOG0200|consen 369 GACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP--CVHRDLAA 446 (609)
T ss_pred eeeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC--ccchhhhh
Confidence 99999999999999999999999998766 34899999999999999999999988 99999999
Q ss_pred CCEEEcCCCcEEEEecCCcccc-cCCccccccCCCC--ccccCC
Q 005841 634 SNLLVDKHWTVKVGDFGLSRLK-HETYLTTKTGKGT--VTYLAS 674 (674)
Q Consensus 634 ~NILi~~~~~vkL~DFGla~~~-~~~~~~~~~~~GT--p~YmAP 674 (674)
+||||.++..+||+|||+|+.. +..++......|| ..||||
T Consensus 447 RNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmAp 490 (609)
T KOG0200|consen 447 RNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAP 490 (609)
T ss_pred hhEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCH
Confidence 9999999999999999999864 3344443333443 349998
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.82 E-value=3e-19 Score=174.60 Aligned_cols=159 Identities=38% Similarity=0.607 Sum_probs=137.6
Q ss_pred ecccCceEEEEEEEc--CCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeEEEEEecCCCCCHH
Q 005841 513 IGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLF 590 (674)
Q Consensus 513 LG~G~fG~Vy~~~~~--~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~ 590 (674)
||+|.+|.||++... +..+++|++....... ....+.+|+.+++.+.|++|+++++++......+++|||+++++|.
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~-~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~ 79 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS-LLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLK 79 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchh-HHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHH
Confidence 689999999999986 7889999997654332 3467889999999999999999999999999999999999999999
Q ss_pred HHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcC-CCcEEEEecCCcccccCCccccccCCCCc
Q 005841 591 RLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDK-HWTVKVGDFGLSRLKHETYLTTKTGKGTV 669 (674)
Q Consensus 591 ~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~-~~~vkL~DFGla~~~~~~~~~~~~~~GTp 669 (674)
+++......+++..+..++.+++.+|.|||..+ ++|+||+|.||+++. ++.++|+|||.+..............++.
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~ 157 (215)
T cd00180 80 DLLKENEGKLSEDEILRILLQILEGLEYLHSNG--IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTP 157 (215)
T ss_pred HHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcchhhcccCCC
Confidence 999765456899999999999999999999998 999999999999999 89999999999987655432223345778
Q ss_pred cccCC
Q 005841 670 TYLAS 674 (674)
Q Consensus 670 ~YmAP 674 (674)
.|++|
T Consensus 158 ~~~~p 162 (215)
T cd00180 158 AYMAP 162 (215)
T ss_pred CccCh
Confidence 88877
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.82 E-value=2.3e-19 Score=178.99 Aligned_cols=165 Identities=36% Similarity=0.594 Sum_probs=141.9
Q ss_pred eeEeeeecccCceEEEEEEEc--CCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeEEEEEecC
Q 005841 507 LTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFL 584 (674)
Q Consensus 507 y~~~~~LG~G~fG~Vy~~~~~--~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 584 (674)
|.+.+.||.|++|.||++... +..+++|.+...... .....+.+|+..+..++|+||+++++++......++++||+
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 79 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE-KQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYC 79 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch-HHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEecc
Confidence 567889999999999999984 578999999765433 24578889999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccccCCc-cccc
Q 005841 585 PRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETY-LTTK 663 (674)
Q Consensus 585 ~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~~~-~~~~ 663 (674)
++++|.+++......+++..+..++.+++.+|.|||.++ ++|+||+|.||+++.++.++|+|||++....... ....
T Consensus 80 ~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~~~ 157 (225)
T smart00221 80 EGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLG--IVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAALLK 157 (225)
T ss_pred CCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEEeeCceeeEecCccccccc
Confidence 999999999764433899999999999999999999998 9999999999999999999999999998775532 1122
Q ss_pred cCCCCccccCC
Q 005841 664 TGKGTVTYLAS 674 (674)
Q Consensus 664 ~~~GTp~YmAP 674 (674)
...++..|++|
T Consensus 158 ~~~~~~~~~~p 168 (225)
T smart00221 158 TVKGTPFYLAP 168 (225)
T ss_pred ceeccCCcCCH
Confidence 34678888887
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.5e-20 Score=208.45 Aligned_cols=163 Identities=31% Similarity=0.536 Sum_probs=137.7
Q ss_pred eeEeeeecccCceEEEEEEE--cC----CeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeEEEE
Q 005841 507 LTIGEQIGQGSCGTVYHAVW--YG----SDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIV 580 (674)
Q Consensus 507 y~~~~~LG~G~fG~Vy~~~~--~~----~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 580 (674)
++..++||.|+||+||+|.| ++ -+||||++.... ..+....+..|.-+|..|+|||++++++++.... +.||
T Consensus 698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t-~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlv 775 (1177)
T KOG1025|consen 698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFT-SPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLV 775 (1177)
T ss_pred hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccC-CchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHH
Confidence 34567999999999999998 33 359999986544 3344567888999999999999999999998665 8899
Q ss_pred EecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccccCC--
Q 005841 581 TEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHET-- 658 (674)
Q Consensus 581 ~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~~-- 658 (674)
++|+++|+|.++++.++..+..++.+.+..||++||.|||... +|||||..+||||..-.+|||.|||+|+.+..+
T Consensus 776 tq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qr--lVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~ 853 (1177)
T KOG1025|consen 776 TQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQR--LVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEK 853 (1177)
T ss_pred HHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcc--hhhhhhhhhheeecCCCeEEEEecchhhccCcccc
Confidence 9999999999999999999999999999999999999999988 999999999999999999999999999987543
Q ss_pred ccccccCCCCccccC
Q 005841 659 YLTTKTGKGTVTYLA 673 (674)
Q Consensus 659 ~~~~~~~~GTp~YmA 673 (674)
.+....+.-.+.|||
T Consensus 854 ey~~~~gK~pikwma 868 (1177)
T KOG1025|consen 854 EYSAPGGKVPIKWMA 868 (1177)
T ss_pred cccccccccCcHHHH
Confidence 233333344455554
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=7.5e-22 Score=195.10 Aligned_cols=163 Identities=29% Similarity=0.446 Sum_probs=129.9
Q ss_pred eEeeeecccCceEEEEEEE--cCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecC-----CeEEEE
Q 005841 508 TIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSP-----QRLCIV 580 (674)
Q Consensus 508 ~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~-----~~~~lV 580 (674)
+-.+-||-|+||+||.+++ .++.||+|.+..-...-...+++.+|+++|..++|.||+..+++.+-. ..+|+|
T Consensus 56 ~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~ 135 (449)
T KOG0664|consen 56 QPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVL 135 (449)
T ss_pred CCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHH
Confidence 3345799999999999987 688899998754332334557888999999999999999988887654 247889
Q ss_pred EecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccccCC-c
Q 005841 581 TEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHET-Y 659 (674)
Q Consensus 581 ~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~~-~ 659 (674)
+|+|+ .+|..+|- ....++...+.-+++||++||.|||+.+ |+||||||.|+|++.+..+||||||+|+..... .
T Consensus 136 TELmQ-SDLHKIIV-SPQ~Ls~DHvKVFlYQILRGLKYLHsA~--ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~~ 211 (449)
T KOG0664|consen 136 TELMQ-SDLHKIIV-SPQALTPDHVKVFVYQILRGLKYLHTAN--ILHRDIKPGNLLVNSNCILKICDFGLARTWDQRDR 211 (449)
T ss_pred HHHHH-hhhhheec-cCCCCCcchhhhhHHHHHhhhHHHhhcc--hhhccCCCccEEeccCceEEecccccccccchhhh
Confidence 99884 47877774 4667999999999999999999999999 999999999999999999999999999865322 1
Q ss_pred cccccCCCCccccCC
Q 005841 660 LTTKTGKGTVTYLAS 674 (674)
Q Consensus 660 ~~~~~~~GTp~YmAP 674 (674)
......+-|-+|.||
T Consensus 212 ~hMTqEVVTQYYRAP 226 (449)
T KOG0664|consen 212 LNMTHEVVTQYYRAP 226 (449)
T ss_pred hhhHHHHHHHHhccH
Confidence 111122346677776
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=4.1e-20 Score=206.50 Aligned_cols=159 Identities=32% Similarity=0.451 Sum_probs=128.8
Q ss_pred eEeeeecccCceE-EEEEEEcCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCC-CCCeeeEEEEEecCCeEEEEEecCC
Q 005841 508 TIGEQIGQGSCGT-VYHAVWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLR-HPNVLLFMGAVTSPQRLCIVTEFLP 585 (674)
Q Consensus 508 ~~~~~LG~G~fG~-Vy~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~lV~E~~~ 585 (674)
.-.+++|.|+-|+ ||+|.+.++.||||.+-. +......+||.+|+.-+ |||||++|+.-.+...+||++|.|
T Consensus 512 ~~~eilG~Gs~Gt~Vf~G~ye~R~VAVKrll~-----e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC- 585 (903)
T KOG1027|consen 512 SPKEILGYGSNGTVVFRGVYEGREVAVKRLLE-----EFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC- 585 (903)
T ss_pred ccHHHcccCCCCcEEEEEeeCCceehHHHHhh-----HhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh-
Confidence 3446789999876 899999999999997743 34456778999999885 999999999999999999999999
Q ss_pred CCCHHHHHHhcCCC---CCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcC---C--CcEEEEecCCcccccC
Q 005841 586 RGSLFRLLQRNTTK---LDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDK---H--WTVKVGDFGLSRLKHE 657 (674)
Q Consensus 586 ggsL~~~l~~~~~~---l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~---~--~~vkL~DFGla~~~~~ 657 (674)
..+|.+++...... ......+.++.|++.||++||.++ ||||||||.||||+. + .+++|+|||+|+.+..
T Consensus 586 ~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~--iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~ 663 (903)
T KOG1027|consen 586 ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLK--IVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAG 663 (903)
T ss_pred hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcc--cccccCCCceEEEEccCCCcceeEEecccccccccCC
Confidence 55999999763111 111456788999999999999999 999999999999975 2 5789999999998743
Q ss_pred C--cc-ccccCCCCccccCC
Q 005841 658 T--YL-TTKTGKGTVTYLAS 674 (674)
Q Consensus 658 ~--~~-~~~~~~GTp~YmAP 674 (674)
. .+ ...+..||-+|+||
T Consensus 664 ~~sS~~r~s~~sGt~GW~AP 683 (903)
T KOG1027|consen 664 GKSSFSRLSGGSGTSGWQAP 683 (903)
T ss_pred CcchhhcccCCCCcccccCH
Confidence 2 22 23345799999998
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.81 E-value=2.3e-19 Score=218.84 Aligned_cols=155 Identities=23% Similarity=0.401 Sum_probs=128.2
Q ss_pred CCeeEeeeecccCceEEEEEEE--cCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeEEEEEe
Q 005841 505 EDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTE 582 (674)
Q Consensus 505 ~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E 582 (674)
..|....+||+|+||.||+|.+ .+..||||.+...... ...|+.++++++||||+++++++...+..|+|||
T Consensus 690 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~------~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~E 763 (968)
T PLN00113 690 SSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI------PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHE 763 (968)
T ss_pred hhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc------cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEe
Confidence 3466677899999999999986 5778999988643321 1236889999999999999999999999999999
Q ss_pred cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCeEEccCCCCCEEEcCCCcEEEEecCCcccccCCccc
Q 005841 583 FLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHC-NPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLT 661 (674)
Q Consensus 583 ~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~-~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~~~~~ 661 (674)
|+++|+|.++++ .++|..+..|+.||+.||+|||.. .++|+||||||+|||++.++.+++. ||........
T Consensus 764 y~~~g~L~~~l~----~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~--- 835 (968)
T PLN00113 764 YIEGKNLSEVLR----NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD--- 835 (968)
T ss_pred CCCCCcHHHHHh----cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccC---
Confidence 999999999995 388999999999999999999943 3349999999999999998888876 7766543221
Q ss_pred cccCCCCccccCC
Q 005841 662 TKTGKGTVTYLAS 674 (674)
Q Consensus 662 ~~~~~GTp~YmAP 674 (674)
....||+.||||
T Consensus 836 -~~~~~t~~y~aP 847 (968)
T PLN00113 836 -TKCFISSAYVAP 847 (968)
T ss_pred -CCccccccccCc
Confidence 123689999999
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=1.5e-19 Score=198.01 Aligned_cols=159 Identities=24% Similarity=0.379 Sum_probs=134.1
Q ss_pred ccCCeeEeeeecccCceEEEEEEE--cCCeEEEEEeecccCCHHHHHHHHHHHHHHhhC-CCCCeeeEEEEEecCCeEEE
Q 005841 503 LWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRL-RHPNVLLFMGAVTSPQRLCI 579 (674)
Q Consensus 503 ~~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~l 579 (674)
..+.|++...+|.|+|+.|..|.+ ++..+++|++.+.... ..+|+.++... .||||+++++.+.++.+.|+
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~~------~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~ 393 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRADD------NQDEIPISLLVRDHPNIVKSHDVYEDGKEIYL 393 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheeccccccc------cccccchhhhhcCCCcceeecceecCCceeee
Confidence 457889999999999999999987 4667999999876322 23467666655 69999999999999999999
Q ss_pred EEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEE-cCCCcEEEEecCCcccccCC
Q 005841 580 VTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLV-DKHWTVKVGDFGLSRLKHET 658 (674)
Q Consensus 580 V~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi-~~~~~vkL~DFGla~~~~~~ 658 (674)
|||++.|+.|.+.+.... .+. ..+..|+++|+.+|.|||++| ||||||||+|||+ +..++++|+|||.++.+...
T Consensus 394 v~e~l~g~ell~ri~~~~-~~~-~e~~~w~~~lv~Av~~LH~~g--vvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~ 469 (612)
T KOG0603|consen 394 VMELLDGGELLRRIRSKP-EFC-SEASQWAAELVSAVDYLHEQG--VVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS 469 (612)
T ss_pred eehhccccHHHHHHHhcc-hhH-HHHHHHHHHHHHHHHHHHhcC--eeecCCChhheeecCCCCcEEEEEechhhhCchh
Confidence 999999999988886533 233 788889999999999999988 9999999999999 58999999999999988766
Q ss_pred ccccccCCCCccccCC
Q 005841 659 YLTTKTGKGTVTYLAS 674 (674)
Q Consensus 659 ~~~~~~~~GTp~YmAP 674 (674)
..+.|-|..|.||
T Consensus 470 ---~~tp~~t~~y~AP 482 (612)
T KOG0603|consen 470 ---CDTPALTLQYVAP 482 (612)
T ss_pred ---hcccchhhcccCh
Confidence 2234669999998
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=4.8e-19 Score=189.27 Aligned_cols=164 Identities=24% Similarity=0.341 Sum_probs=132.9
Q ss_pred CeeEeeeecccCceEEEEEEEcCC---eEEEEEeecccCCHHHHHHHHHHHHHHhhCCC----CCeeeEEEEE-ecCCeE
Q 005841 506 DLTIGEQIGQGSCGTVYHAVWYGS---DVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRH----PNVLLFMGAV-TSPQRL 577 (674)
Q Consensus 506 ~y~~~~~LG~G~fG~Vy~~~~~~~---~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~H----pnIv~l~~~~-~~~~~~ 577 (674)
.|++.++||+|+||.||.|..... .+|+|+......... ..+..|+.++..+.. +++..++..+ ....+.
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~--~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~ 96 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKP--SVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFN 96 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCC--ccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCcee
Confidence 799999999999999999998543 589998765432211 146678888888862 5889999998 578889
Q ss_pred EEEEecCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCC-----CcEEEEecCC
Q 005841 578 CIVTEFLPRGSLFRLLQRNT-TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKH-----WTVKVGDFGL 651 (674)
Q Consensus 578 ~lV~E~~~ggsL~~~l~~~~-~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~-----~~vkL~DFGl 651 (674)
||||+.+ |.+|.++..... ..|+..+++.|+.|++.+|++||+.| +|||||||.|+++... ..+.|+|||+
T Consensus 97 ~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G--~iHRDiKp~N~~~g~~~~~~~~~~~llDfGl 173 (322)
T KOG1164|consen 97 FIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKG--FIHRDIKPENFVVGQSSRSEVRTLYLLDFGL 173 (322)
T ss_pred EEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcC--cccCCcCHHHeeecCCCCcccceEEEEecCC
Confidence 9999988 889999886655 78999999999999999999999999 9999999999999754 4699999999
Q ss_pred cc--cccCCc-------cc-cccCCCCccccCC
Q 005841 652 SR--LKHETY-------LT-TKTGKGTVTYLAS 674 (674)
Q Consensus 652 a~--~~~~~~-------~~-~~~~~GTp~YmAP 674 (674)
|+ ...... .. ...+.||..|+++
T Consensus 174 ar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~ 206 (322)
T KOG1164|consen 174 ARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASI 206 (322)
T ss_pred CccccccCCCCcccccCCCCccCCCCccccccH
Confidence 98 321111 11 2235699999875
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.80 E-value=3e-20 Score=180.01 Aligned_cols=143 Identities=20% Similarity=0.453 Sum_probs=125.0
Q ss_pred cCCeeEeeeecccCceEEEEEEE--cCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCC-CCCeeeEEEEEecCC--eEE
Q 005841 504 WEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLR-HPNVLLFMGAVTSPQ--RLC 578 (674)
Q Consensus 504 ~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~--~~~ 578 (674)
.++|++..++|+|.|+.||.|.. ++..++||++++- ..+.+.+|+.||..|. ||||+++++...++. ...
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV-----kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Sktpa 111 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV-----KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPS 111 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechH-----HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCch
Confidence 47899999999999999999985 5677999998643 3466889999999997 999999999998764 478
Q ss_pred EEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcC-CCcEEEEecCCcccccC
Q 005841 579 IVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDK-HWTVKVGDFGLSRLKHE 657 (674)
Q Consensus 579 lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~-~~~vkL~DFGla~~~~~ 657 (674)
||+||++..+...+.. .++..++..++.+++.||.|||++| |+|||+||.|+|||. ...++|+|+|+|.+.+.
T Consensus 112 LiFE~v~n~Dfk~ly~----tl~d~dIryY~~elLkALdyCHS~G--ImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp 185 (338)
T KOG0668|consen 112 LIFEYVNNTDFKQLYP----TLTDYDIRYYIYELLKALDYCHSMG--IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP 185 (338)
T ss_pred hHhhhhccccHHHHhh----hhchhhHHHHHHHHHHHHhHHHhcC--cccccCCcceeeechhhceeeeeecchHhhcCC
Confidence 9999999888766664 4788999999999999999999999 999999999999995 45799999999998764
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.79 E-value=1.3e-18 Score=174.81 Aligned_cols=153 Identities=35% Similarity=0.530 Sum_probs=132.9
Q ss_pred CceEEEEEEEc--CCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeEEEEEecCCCCCHHHHHH
Q 005841 517 SCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQ 594 (674)
Q Consensus 517 ~fG~Vy~~~~~--~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~ 594 (674)
+||.||+|.+. +..|++|++........ ...+.+|+.+++.++|+||+++++.+......+++|||+++++|..++.
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~ 79 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKK-RERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLK 79 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccH-HHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHH
Confidence 58999999984 57899999876543322 5778899999999999999999999999999999999999999999997
Q ss_pred hcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccccCCccccccCCCCccccCC
Q 005841 595 RNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTVTYLAS 674 (674)
Q Consensus 595 ~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~~~~~~~~~~GTp~YmAP 674 (674)
... .+++..+..++.+++.+|.|||..+ |+|+||+|.||+++.++.++|+|||++....... ......|++.|+||
T Consensus 80 ~~~-~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~~~p 155 (244)
T smart00220 80 KRG-RLSEDEARFYARQILSALEYLHSNG--IIHRDLKPENILLDEDGHVKLADFGLARQLDPGG-LLTTFVGTPEYMAP 155 (244)
T ss_pred hcc-CCCHHHHHHHHHHHHHHHHHHHHcC--eecCCcCHHHeEECCCCcEEEccccceeeecccc-ccccccCCcCCCCH
Confidence 644 3899999999999999999999998 9999999999999999999999999998776542 22335688999987
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.79 E-value=1.3e-18 Score=173.81 Aligned_cols=137 Identities=17% Similarity=0.268 Sum_probs=105.5
Q ss_pred EeeeecccCceEEEEEEEcCCeEEEEEeecccCCHHHHHHHHHHHHHHhhC-----CCCCeeeEEEEEecCC---eEE-E
Q 005841 509 IGEQIGQGSCGTVYHAVWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRL-----RHPNVLLFMGAVTSPQ---RLC-I 579 (674)
Q Consensus 509 ~~~~LG~G~fG~Vy~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l-----~HpnIv~l~~~~~~~~---~~~-l 579 (674)
-..+||+|+||.||.-..... .+||++...... ....+.+|+.+++.+ .||||+++++++.+.. .+| +
T Consensus 6 ~~~~LG~G~~~~Vy~hp~~~~-k~IKv~~~~~~~--~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~ 82 (210)
T PRK10345 6 EQSPLGTGRHRKCYAHPEDAQ-RCIKIVYHRGDG--GDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDV 82 (210)
T ss_pred CcceecCCCceEEEECCCCcC-eEEEEEeccccc--hHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEE
Confidence 346899999999996222333 468888654322 345689999999999 5799999999999874 444 7
Q ss_pred EEec--CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHH-HHHHhCCCCeEEccCCCCCEEEcC----CCcEEEEe-cCC
Q 005841 580 VTEF--LPRGSLFRLLQRNTTKLDWRRRILMALDIARGV-SYLHHCNPPIIHRDLKSSNLLVDK----HWTVKVGD-FGL 651 (674)
Q Consensus 580 V~E~--~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L-~yLH~~~~~IvHrDLKp~NILi~~----~~~vkL~D-FGl 651 (674)
|||| +.+++|.+++.+. .+++. ..++.|++.++ +|||+.+ ||||||||+|||++. +++++|+| ||.
T Consensus 83 I~e~~G~~~~tL~~~l~~~--~~~e~--~~~~~~~L~~l~~yLh~~~--IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~ 156 (210)
T PRK10345 83 IADFDGKPSITLTEFAEQC--RYEED--VAQLRQLLKKLKRYLLDNR--IVTMELKPQNILCQRISESEVIPVVCDNIGE 156 (210)
T ss_pred EecCCCCcchhHHHHHHcc--cccHh--HHHHHHHHHHHHHHHHHCC--EeecCCCHHHEEEeccCCCCCcEEEEECCCC
Confidence 8999 5579999999653 46655 35677888777 9999999 999999999999974 34899999 554
Q ss_pred ccc
Q 005841 652 SRL 654 (674)
Q Consensus 652 a~~ 654 (674)
...
T Consensus 157 ~~~ 159 (210)
T PRK10345 157 STF 159 (210)
T ss_pred cce
Confidence 443
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.79 E-value=1.1e-19 Score=180.04 Aligned_cols=145 Identities=26% Similarity=0.411 Sum_probs=122.5
Q ss_pred cCCeeEeeeecccCceEEEEEEEcC--CeEEEEEeecccCCHHHHHHHHHHHHHHhhCC-CCCeeeEEE-EEecCCeEEE
Q 005841 504 WEDLTIGEQIGQGSCGTVYHAVWYG--SDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLR-HPNVLLFMG-AVTSPQRLCI 579 (674)
Q Consensus 504 ~~~y~~~~~LG~G~fG~Vy~~~~~~--~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~-~~~~~~~~~l 579 (674)
.+.|.+.+.||+|.||.+.+|.+++ +.+++|.+.+.. ..+..|.+|...--.|. |.||+.-|+ +|++.+.+++
T Consensus 23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~---tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF 99 (378)
T KOG1345|consen 23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQ---TTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVF 99 (378)
T ss_pred hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcch---hhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEE
Confidence 4679999999999999999999964 569999987654 33567888888766664 889986554 5778889999
Q ss_pred EEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEc--CCCcEEEEecCCcccc
Q 005841 580 VTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVD--KHWTVKVGDFGLSRLK 655 (674)
Q Consensus 580 V~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~--~~~~vkL~DFGla~~~ 655 (674)
+|||++.|+|..-+.. ..+.+.....++.|++.||.|||+.+ +||||||.+||||. +..+|||||||+.+..
T Consensus 100 ~qE~aP~gdL~snv~~--~GigE~~~K~v~~ql~SAi~fMHskn--lVHRdlK~eNiLif~~df~rvKlcDFG~t~k~ 173 (378)
T KOG1345|consen 100 VQEFAPRGDLRSNVEA--AGIGEANTKKVFAQLLSAIEFMHSKN--LVHRDLKAENILIFDADFYRVKLCDFGLTRKV 173 (378)
T ss_pred eeccCccchhhhhcCc--ccccHHHHHHHHHHHHHHHHHhhccc--hhhcccccceEEEecCCccEEEeeeccccccc
Confidence 9999999999887754 45789999999999999999999999 99999999999995 4558999999998754
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.77 E-value=2.6e-19 Score=181.43 Aligned_cols=163 Identities=29% Similarity=0.389 Sum_probs=136.1
Q ss_pred cCCeeEeeeecccCceEEEEEEE--cCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecC------C
Q 005841 504 WEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSP------Q 575 (674)
Q Consensus 504 ~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~------~ 575 (674)
..+|.-+..+|.|+- .|..+.+ .+.+||+|.+........-.++..+|+.+++.+.|+||+.++.+|.-. .
T Consensus 16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~ 94 (369)
T KOG0665|consen 16 PKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQ 94 (369)
T ss_pred eeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHH
Confidence 356888888999988 6666654 688999998876643334456788899999999999999999998644 3
Q ss_pred eEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccc
Q 005841 576 RLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLK 655 (674)
Q Consensus 576 ~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~ 655 (674)
.+|+||||| ..+|...+. ..++-+.+.+++.|++.|+.|||+.+ |+||||||+||+++.++.+||+|||+|+..
T Consensus 95 e~y~v~e~m-~~nl~~vi~---~elDH~tis~i~yq~~~~ik~lhs~~--IihRdLkPsnivv~~~~~lKi~dfg~ar~e 168 (369)
T KOG0665|consen 95 EVYLVMELM-DANLCQVIL---MELDHETISYILYQMLCGIKHLHSAG--IIHRDLKPSNIVVNSDCTLKILDFGLARTE 168 (369)
T ss_pred hHHHHHHhh-hhHHHHHHH---HhcchHHHHHHHHHHHHHHHHHHhcc--eeecccCcccceecchhheeeccchhhccc
Confidence 479999999 458888876 35788999999999999999999999 999999999999999999999999999876
Q ss_pred cCCccccccCCCCccccCC
Q 005841 656 HETYLTTKTGKGTVTYLAS 674 (674)
Q Consensus 656 ~~~~~~~~~~~GTp~YmAP 674 (674)
..+ .....++.|-.|.||
T Consensus 169 ~~~-~~mtpyVvtRyyrap 186 (369)
T KOG0665|consen 169 DTD-FMMTPYVVTRYYRAP 186 (369)
T ss_pred Ccc-cccCchhheeeccCc
Confidence 655 344456789999998
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.77 E-value=2.9e-18 Score=172.35 Aligned_cols=144 Identities=13% Similarity=0.134 Sum_probs=119.5
Q ss_pred ccccCCeeEeeeecccCceEEEEEEEcCCeEEEEEeecccCCH-HHHHH------HHHHHHHHhhCCCCCeeeEEEEEec
Q 005841 501 EILWEDLTIGEQIGQGSCGTVYHAVWYGSDVAVKVFSRQEYSD-EVIHS------FRQEVSLMKRLRHPNVLLFMGAVTS 573 (674)
Q Consensus 501 ~~~~~~y~~~~~LG~G~fG~Vy~~~~~~~~vAvK~i~~~~~~~-~~~~~------~~~Ei~il~~l~HpnIv~l~~~~~~ 573 (674)
.++..+|++.++||.|+||.||+....+..+|||++....... ..... +.+|+..+.++.|++|..+..++..
T Consensus 27 ~~l~~~y~~~~~l~~~~f~~v~l~~~~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~ 106 (232)
T PRK10359 27 DFLSYNIKTIKVFRNIDDTKVSLIDTDYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLL 106 (232)
T ss_pred HHhhCceEEEEEecCCCceEEEEEecCCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeee
Confidence 4667899999999999999999987777789999997665433 33333 5789999999999999999888664
Q ss_pred C--------CeEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEE
Q 005841 574 P--------QRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVK 645 (674)
Q Consensus 574 ~--------~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vk 645 (674)
. ...+|||||++|.+|.++.. +++ ....+|+.+|..||+.| |+|+||||+|||++.++ |+
T Consensus 107 ~~~~~~~~~~~~~lvmEyi~G~tL~~~~~-----~~~----~~~~~i~~~l~~lH~~g--i~H~Dikp~Nili~~~g-i~ 174 (232)
T PRK10359 107 AERKTLRYAHTYIMLIEYIEGVELNDMPE-----ISE----DVKAKIKASIESLHQHG--MVSGDPHKGNFIVSKNG-LR 174 (232)
T ss_pred cccccccccCCeEEEEEEECCccHHHhhh-----ccH----HHHHHHHHHHHHHHHcC--CccCCCChHHEEEeCCC-EE
Confidence 3 35899999999999988742 333 24569999999999999 99999999999999988 99
Q ss_pred EEecCCccccc
Q 005841 646 VGDFGLSRLKH 656 (674)
Q Consensus 646 L~DFGla~~~~ 656 (674)
|+|||..+...
T Consensus 175 liDfg~~~~~~ 185 (232)
T PRK10359 175 IIDLSGKRCTA 185 (232)
T ss_pred EEECCCccccc
Confidence 99999887653
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.77 E-value=3.6e-18 Score=170.71 Aligned_cols=137 Identities=26% Similarity=0.390 Sum_probs=116.8
Q ss_pred eeecccCceEEEEEEEcCCeEEEEEeecccCCHH------HHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeEEEEEecC
Q 005841 511 EQIGQGSCGTVYHAVWYGSDVAVKVFSRQEYSDE------VIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFL 584 (674)
Q Consensus 511 ~~LG~G~fG~Vy~~~~~~~~vAvK~i~~~~~~~~------~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 584 (674)
+.||+|++|.||+|.+.+..|++|+......... ....+.+|+.++..+.|++|.....++......++||||+
T Consensus 2 ~~l~~G~~~~vy~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 81 (211)
T PRK14879 2 KLIKRGAEAEIYLGDFLGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEYI 81 (211)
T ss_pred cccccCceEEEEEEeeCCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEEe
Confidence 5799999999999999889999998765443221 2245788999999999999887777777778899999999
Q ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccc
Q 005841 585 PRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLK 655 (674)
Q Consensus 585 ~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~ 655 (674)
+|++|.+++.... . ....++.+++.+|.+||..+ ++|+||+|.|||++ ++.++|+|||+++..
T Consensus 82 ~G~~L~~~~~~~~----~-~~~~i~~~i~~~l~~lH~~~--i~H~Dl~p~Nil~~-~~~~~liDf~~a~~~ 144 (211)
T PRK14879 82 EGEPLKDLINSNG----M-EELELSREIGRLVGKLHSAG--IIHGDLTTSNMILS-GGKIYLIDFGLAEFS 144 (211)
T ss_pred CCcCHHHHHHhcc----H-HHHHHHHHHHHHHHHHHhCC--cccCCCCcccEEEE-CCCEEEEECCcccCC
Confidence 9999999986432 2 78889999999999999999 99999999999999 789999999999864
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.77 E-value=4.1e-18 Score=168.05 Aligned_cols=136 Identities=18% Similarity=0.235 Sum_probs=108.5
Q ss_pred eEeeeecccCceEEEEEEEcCCeEEEEEeecccC--CHHHHHHHHHHHHHHhhCC-CCCeeeEEEEEecCCeEEEEEecC
Q 005841 508 TIGEQIGQGSCGTVYHAVWYGSDVAVKVFSRQEY--SDEVIHSFRQEVSLMKRLR-HPNVLLFMGAVTSPQRLCIVTEFL 584 (674)
Q Consensus 508 ~~~~~LG~G~fG~Vy~~~~~~~~vAvK~i~~~~~--~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~lV~E~~ 584 (674)
.+...|+.|+||+||.+...+.+++.+.+..... ..-....+.+|+.+|++|. |++|+.++++ ...|++|||+
T Consensus 5 ~~~~~l~~~~f~~v~~~~~~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI 80 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRGGERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYL 80 (218)
T ss_pred ccceeecCCCcceEEEeecCCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeee
Confidence 3467899999999998877777888776654332 1112235789999999996 5889999886 4579999999
Q ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccC-CCCCEEEcCCCcEEEEecCCcccccC
Q 005841 585 PRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDL-KSSNLLVDKHWTVKVGDFGLSRLKHE 657 (674)
Q Consensus 585 ~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDL-Kp~NILi~~~~~vkL~DFGla~~~~~ 657 (674)
.|.+|...+.. ....++.|++.+|.+||++| |+|||| ||+|||++.++.++|+|||+|.....
T Consensus 81 ~G~~L~~~~~~--------~~~~~~~qi~~~L~~lH~~G--IvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~ 144 (218)
T PRK12274 81 AGAAMYQRPPR--------GDLAYFRAARRLLQQLHRCG--VAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNP 144 (218)
T ss_pred cCccHHhhhhh--------hhHHHHHHHHHHHHHHHHCc--CccCCCCCcceEEEcCCCCEEEEECCCceecCC
Confidence 99998765421 12357789999999999999 999999 79999999999999999999986543
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.76 E-value=1.4e-18 Score=184.87 Aligned_cols=166 Identities=25% Similarity=0.343 Sum_probs=137.6
Q ss_pred ccccCCeeEeeeecccCceEEEEEEE--cCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCC------CCCeeeEEEEEe
Q 005841 501 EILWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLR------HPNVLLFMGAVT 572 (674)
Q Consensus 501 ~~~~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~------HpnIv~l~~~~~ 572 (674)
+++-.+|.+....|+|-|++|.+|.+ .+..||||+|...... .+.=+.|+.||+.|+ --+++.|+-.|.
T Consensus 428 E~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M---~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~ 504 (752)
T KOG0670|consen 428 ELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVM---HKTGLKELEILKKLNDADPEDKFHCLRLFRHFK 504 (752)
T ss_pred hhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHH---hhhhhHHHHHHHHhhccCchhhhHHHHHHHHhh
Confidence 56678999999999999999999987 4678999999765433 344557999999996 237889999999
Q ss_pred cCCeEEEEEecCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCC-CcEEEEec
Q 005841 573 SPQRLCIVTEFLPRGSLFRLLQRNT--TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKH-WTVKVGDF 649 (674)
Q Consensus 573 ~~~~~~lV~E~~~ggsL~~~l~~~~--~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~-~~vkL~DF 649 (674)
..+++|||+|-+ ..+|.++|++.+ ..|....+..|+.|+..||..|-.|+ |+|.||||+||||+.+ ..+|||||
T Consensus 505 hknHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~--vlHaDIKPDNiLVNE~k~iLKLCDf 581 (752)
T KOG0670|consen 505 HKNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCG--VLHADIKPDNILVNESKNILKLCDF 581 (752)
T ss_pred hcceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcC--eeecccCccceEeccCcceeeeccC
Confidence 999999999988 669999998754 34788999999999999999999999 9999999999999965 56899999
Q ss_pred CCcccccCCccccccCCCCccccCC
Q 005841 650 GLSRLKHETYLTTKTGKGTVTYLAS 674 (674)
Q Consensus 650 Gla~~~~~~~~~~~~~~GTp~YmAP 674 (674)
|.|....+..++.. .-+-.|.||
T Consensus 582 GSA~~~~eneitPY--LVSRFYRaP 604 (752)
T KOG0670|consen 582 GSASFASENEITPY--LVSRFYRAP 604 (752)
T ss_pred ccccccccccccHH--HHHHhccCc
Confidence 99988776555432 234556666
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.76 E-value=6e-18 Score=167.60 Aligned_cols=134 Identities=25% Similarity=0.353 Sum_probs=110.6
Q ss_pred eecccCceEEEEEEEcCCeEEEEEeecccCCH------HHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeEEEEEecCC
Q 005841 512 QIGQGSCGTVYHAVWYGSDVAVKVFSRQEYSD------EVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLP 585 (674)
Q Consensus 512 ~LG~G~fG~Vy~~~~~~~~vAvK~i~~~~~~~------~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ 585 (674)
.||+|+||.||++.+.+..|++|+........ .....+.+|+.++..+.|++|.....++......++||||++
T Consensus 1 ~ig~G~~~~vy~~~~~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~~ 80 (199)
T TIGR03724 1 LIAKGAEAIIYLGDFLGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYIE 80 (199)
T ss_pred CCCCCceEEEEEeecCCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEEC
Confidence 48999999999999999999999865443321 123567889999999998876655555556677899999999
Q ss_pred CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCccccc
Q 005841 586 RGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKH 656 (674)
Q Consensus 586 ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~ 656 (674)
|++|.+++..... .++.+++.+|.+||+.+ ++|+||+|.|||++ ++.++|+|||+++...
T Consensus 81 g~~l~~~~~~~~~--------~~~~~i~~~l~~lH~~g--i~H~Dl~~~Nil~~-~~~~~liDfg~a~~~~ 140 (199)
T TIGR03724 81 GKPLKDVIEEGND--------ELLREIGRLVGKLHKAG--IVHGDLTTSNIIVR-DDKLYLIDFGLGKYSD 140 (199)
T ss_pred CccHHHHHhhcHH--------HHHHHHHHHHHHHHHCC--eecCCCCcceEEEE-CCcEEEEECCCCcCCC
Confidence 9999998854211 78899999999999999 99999999999999 7899999999998643
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.75 E-value=4.2e-17 Score=168.89 Aligned_cols=165 Identities=32% Similarity=0.485 Sum_probs=143.1
Q ss_pred eeEeeeecccCceEEEEEEEcCCeEEEEEeecccCCHH-HHHHHHHHHHHHhhCCCC-CeeeEEEEEecCCeEEEEEecC
Q 005841 507 LTIGEQIGQGSCGTVYHAVWYGSDVAVKVFSRQEYSDE-VIHSFRQEVSLMKRLRHP-NVLLFMGAVTSPQRLCIVTEFL 584 (674)
Q Consensus 507 y~~~~~LG~G~fG~Vy~~~~~~~~vAvK~i~~~~~~~~-~~~~~~~Ei~il~~l~Hp-nIv~l~~~~~~~~~~~lV~E~~ 584 (674)
|.+...||.|+||.||++.+. ..+++|.+........ ....+.+|+.++..+.|+ +|+.++..+......+++++|+
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~-~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 80 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR-KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEYV 80 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec-cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEecC
Confidence 788899999999999999988 7789999977665443 677899999999999988 7999999998888899999999
Q ss_pred CCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCC-cEEEEecCCcccccCCcc-
Q 005841 585 PRGSLFRLLQRNT--TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHW-TVKVGDFGLSRLKHETYL- 660 (674)
Q Consensus 585 ~ggsL~~~l~~~~--~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~-~vkL~DFGla~~~~~~~~- 660 (674)
.+++|.+++.... ..+.......++.|++.++.|+|..+ ++||||||+|||++..+ .++++|||+++.......
T Consensus 81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~--~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~ 158 (384)
T COG0515 81 DGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG--IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGST 158 (384)
T ss_pred CCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHeeecCCCCeEEEeccCcceecCCCCcc
Confidence 9999997776543 26899999999999999999999999 99999999999999888 799999999986654332
Q ss_pred -----ccccCCCCccccCC
Q 005841 661 -----TTKTGKGTVTYLAS 674 (674)
Q Consensus 661 -----~~~~~~GTp~YmAP 674 (674)
......||+.|+||
T Consensus 159 ~~~~~~~~~~~~t~~~~~p 177 (384)
T COG0515 159 SSIPALPSTSVGTPGYMAP 177 (384)
T ss_pred ccccccccccccccccCCH
Confidence 23456899999998
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.73 E-value=2.1e-17 Score=188.56 Aligned_cols=139 Identities=23% Similarity=0.316 Sum_probs=116.5
Q ss_pred CeeEeeeecccCceEEEEEEEcCCeEEEEEeecccCCH------HHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeEEE
Q 005841 506 DLTIGEQIGQGSCGTVYHAVWYGSDVAVKVFSRQEYSD------EVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCI 579 (674)
Q Consensus 506 ~y~~~~~LG~G~fG~Vy~~~~~~~~vAvK~i~~~~~~~------~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 579 (674)
.|...+.||+|+||+||++.+.+..+++|+........ ...+.+.+|+.++..++|++|+....++......++
T Consensus 334 ~~~~~~~iG~G~~g~Vy~~~~~~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~l 413 (535)
T PRK09605 334 RKIPDHLIGKGAEADIKKGEYLGRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEKTI 413 (535)
T ss_pred ccCccceeccCCcEEEEEEeecCccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCEE
Confidence 34667899999999999999887777777644332221 123568899999999999999988877777778899
Q ss_pred EEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCccccc
Q 005841 580 VTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKH 656 (674)
Q Consensus 580 V~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~ 656 (674)
||||++|++|.+++. ....++.+++.+|.|||+.+ |+||||||+|||+ .++.++|+|||+|+...
T Consensus 414 v~E~~~g~~L~~~l~---------~~~~~~~~i~~~L~~lH~~g--iiHrDlkp~NILl-~~~~~~liDFGla~~~~ 478 (535)
T PRK09605 414 VMEYIGGKDLKDVLE---------GNPELVRKVGEIVAKLHKAG--IVHGDLTTSNFIV-RDDRLYLIDFGLGKYSD 478 (535)
T ss_pred EEEecCCCcHHHHHH---------HHHHHHHHHHHHHHHHHhCC--CccCCCChHHEEE-ECCcEEEEeCcccccCC
Confidence 999999999999885 34678899999999999999 9999999999999 57799999999998754
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.73 E-value=2.1e-17 Score=168.71 Aligned_cols=146 Identities=23% Similarity=0.229 Sum_probs=113.7
Q ss_pred CeeEeeeecccCceEEEEEE-E--cCCeEEEEEeecccCC--------------------H--HHHHHHHHHHHHHhhCC
Q 005841 506 DLTIGEQIGQGSCGTVYHAV-W--YGSDVAVKVFSRQEYS--------------------D--EVIHSFRQEVSLMKRLR 560 (674)
Q Consensus 506 ~y~~~~~LG~G~fG~Vy~~~-~--~~~~vAvK~i~~~~~~--------------------~--~~~~~~~~Ei~il~~l~ 560 (674)
-|.+.+.||+|+||.||+|. + ++..||||++...... . .....+.+|+.+++++.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 58899999999999999998 3 6788999998754321 0 11234678999999997
Q ss_pred CC--CeeeEEEEEecCCeEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEE
Q 005841 561 HP--NVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLV 638 (674)
Q Consensus 561 Hp--nIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi 638 (674)
+. .+..++.+ ...||||||++|.+|..++.. ...+....+..++.||+.+|.|||..+ .|+||||||+|||+
T Consensus 109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~g-~iiH~Dikp~NIli 182 (237)
T smart00090 109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLK-DVEPEEEEEFELYDDILEEMRKLYKEG-ELVHGDLSEYNILV 182 (237)
T ss_pred hcCCCCCeeeEe----cCceEEEEEecCCcccccccc-cCCcchHHHHHHHHHHHHHHHHHHhcC-CEEeCCCChhhEEE
Confidence 53 33444543 245899999999888765432 234666778899999999999999865 49999999999999
Q ss_pred cCCCcEEEEecCCcccccCC
Q 005841 639 DKHWTVKVGDFGLSRLKHET 658 (674)
Q Consensus 639 ~~~~~vkL~DFGla~~~~~~ 658 (674)
+ ++.++|+|||+|.....+
T Consensus 183 ~-~~~i~LiDFg~a~~~~~~ 201 (237)
T smart00090 183 H-DGKVVIIDVSQSVELDHP 201 (237)
T ss_pred E-CCCEEEEEChhhhccCCc
Confidence 9 889999999999866544
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.71 E-value=2.6e-16 Score=167.13 Aligned_cols=134 Identities=25% Similarity=0.395 Sum_probs=113.7
Q ss_pred cccCCeeEeeeecccCceEEEEEEEc--CCeEEEEEeecccCCHHHHHHHHHHHHHHhhCC-----C---CCeeeEEEEE
Q 005841 502 ILWEDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLR-----H---PNVLLFMGAV 571 (674)
Q Consensus 502 ~~~~~y~~~~~LG~G~fG~Vy~~~~~--~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~-----H---pnIv~l~~~~ 571 (674)
+...+|.+.++||=|-|++||+|.++ .+.||+|+++.. ..+.+....||.+|++++ | ..||+|++.|
T Consensus 75 F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA---qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~F 151 (590)
T KOG1290|consen 75 FNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA---QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHF 151 (590)
T ss_pred ccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh---hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccc
Confidence 44589999999999999999999884 556999998643 345677888999999984 3 2699999998
Q ss_pred ec----CCeEEEEEecCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHh-CCCCeEEccCCCCCEEEcCC
Q 005841 572 TS----PQRLCIVTEFLPRGSLFRLLQRNT-TKLDWRRRILMALDIARGVSYLHH-CNPPIIHRDLKSSNLLVDKH 641 (674)
Q Consensus 572 ~~----~~~~~lV~E~~~ggsL~~~l~~~~-~~l~~~~~~~i~~qi~~~L~yLH~-~~~~IvHrDLKp~NILi~~~ 641 (674)
.. +.++|||+|++ |.+|..+|...+ ..++...+..|++||+.||.|||+ |+ |||-||||+|||+..+
T Consensus 152 khsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecg--IIHTDlKPENvLl~~~ 224 (590)
T KOG1290|consen 152 KHSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECG--IIHTDLKPENVLLCST 224 (590)
T ss_pred eecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcC--ccccCCCcceeeeecc
Confidence 74 45799999999 889999998754 458999999999999999999995 78 9999999999999644
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.71 E-value=5e-17 Score=161.33 Aligned_cols=138 Identities=24% Similarity=0.222 Sum_probs=108.6
Q ss_pred eeEeeeecccCceEEEEEEE-cCCeEEEEEeecccCCH--------------------HHHHHHHHHHHHHhhCCCCC--
Q 005841 507 LTIGEQIGQGSCGTVYHAVW-YGSDVAVKVFSRQEYSD--------------------EVIHSFRQEVSLMKRLRHPN-- 563 (674)
Q Consensus 507 y~~~~~LG~G~fG~Vy~~~~-~~~~vAvK~i~~~~~~~--------------------~~~~~~~~Ei~il~~l~Hpn-- 563 (674)
|.+.+.||+|+||.||++.. ++..||||++....... .....+.+|+.++..+.|++
T Consensus 17 ~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~ 96 (198)
T cd05144 17 ESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGFP 96 (198)
T ss_pred hhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCCC
Confidence 77889999999999999987 58899999976533110 01123677899999988774
Q ss_pred eeeEEEEEecCCeEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCc
Q 005841 564 VLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWT 643 (674)
Q Consensus 564 Iv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~ 643 (674)
++.++. ....++||||++|++|..+... .....++.+++.++.++|+.+ |+|+||||+|||++.++.
T Consensus 97 v~~~~~----~~~~~lv~e~~~g~~L~~~~~~-------~~~~~~~~~i~~~l~~lh~~g--i~H~Dl~p~Nill~~~~~ 163 (198)
T cd05144 97 VPKPID----WNRHAVVMEYIDGVELYRVRVL-------EDPEEVLDEILEEIVKAYKHG--IIHGDLSEFNILVDDDEK 163 (198)
T ss_pred CCceee----cCCceEEEEEeCCcchhhcccc-------ccHHHHHHHHHHHHHHHHHCC--CCcCCCCcccEEEcCCCc
Confidence 444443 2456999999999998765421 345678889999999999988 999999999999999999
Q ss_pred EEEEecCCcccccC
Q 005841 644 VKVGDFGLSRLKHE 657 (674)
Q Consensus 644 vkL~DFGla~~~~~ 657 (674)
++|+|||+|.....
T Consensus 164 ~~liDfg~~~~~~~ 177 (198)
T cd05144 164 IYIIDWPQMVSTDH 177 (198)
T ss_pred EEEEECCccccCCC
Confidence 99999999965543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PF13426 PAS_9: PAS domain; PDB: 3ULF_B 3UE6_E 2Z6D_B 2Z6C_B 3P7N_B 1LL8_A 3MJQ_A 3BWL_A 4EET_B 4EEP_A | Back alignment and domain information |
|---|
Probab=99.70 E-value=2.5e-16 Score=137.52 Aligned_cols=104 Identities=27% Similarity=0.522 Sum_probs=95.7
Q ss_pred cceeEEEcCCCcEEeecHHHHHHhCCChhhHcCCCccccccccccchhHHHHHHHHHhCceeEEEEEEEcCCCCEEEEEE
Q 005841 140 GQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGERWTGQFPAKTKTEERVLVVA 219 (674)
Q Consensus 140 ~d~I~v~D~~GrIi~~N~a~e~llGys~eEviG~~~~~l~~~~~~~~~~~~i~~~l~~g~~~~~e~~~~~kdG~~~~v~~ 219 (674)
|++|+++|.+|+|++||+++++++||+.++++|+++.+++++.........+.+.+..+..+..++.+.+++|..+|+.+
T Consensus 1 p~~i~i~d~~g~i~~~N~~~~~~~g~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~g~~~~~~~ 80 (104)
T PF13426_consen 1 PDGIFILDPDGRILYVNPAFERLFGYSREELIGKSISDFFPEEDRPEFEEQIERALEEGGSWSGEVRLRRKDGETFWVEV 80 (104)
T ss_dssp -SEEEEEETTSBEEEE-HHHHHHHTS-HHHHTTSBGGGGCSTTSCHHHHHHHHHHHHHTSSEEEEEEEEETTSEEEEEEE
T ss_pred CEEEEEECCcCcEEehhHHHHHHHCcCHHHHcCCCcccccCcccchhhHHHHHHHHhcCCceeEEEEEEcCCCCEEEEEE
Confidence 68999999999999999999999999999999999999998777777778888889999999999999999999999999
Q ss_pred EEEEEECCCCCEEEEEEEEEchHH
Q 005841 220 TNTPFYDDDGTLVGIVCVSTDSRP 243 (674)
Q Consensus 220 s~sPi~d~dG~ivg~i~i~rDITe 243 (674)
+++|+++++|++.+++++++|||+
T Consensus 81 ~~~~i~~~~g~~~~~i~~~~DiTe 104 (104)
T PF13426_consen 81 SASPIRDEDGEITGIIGIFRDITE 104 (104)
T ss_dssp EEEEEEETTSSEEEEEEEEEEEHH
T ss_pred EEEEEECCCCCEEEEEEEEEECCC
Confidence 999999999999999999999996
|
... |
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.67 E-value=6.1e-17 Score=169.84 Aligned_cols=144 Identities=24% Similarity=0.374 Sum_probs=126.1
Q ss_pred cccccCCeeEeeeecccCceEEEEEEEc-----CCeEEEEEeecccCCHHHHHHHHHHHHHHhhCC-CCCeeeEEEEEec
Q 005841 500 YEILWEDLTIGEQIGQGSCGTVYHAVWY-----GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLR-HPNVLLFMGAVTS 573 (674)
Q Consensus 500 ~~~~~~~y~~~~~LG~G~fG~Vy~~~~~-----~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~ 573 (674)
.......|.+.++||+|+|++||++++. ...||+|.+..... ..++.+|+++|..+. +.||+.+.+++..
T Consensus 31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~----p~ri~~El~~L~~~gG~~ni~~~~~~~rn 106 (418)
T KOG1167|consen 31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSS----PSRILNELEMLYRLGGSDNIIKLNGCFRN 106 (418)
T ss_pred hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccC----chHHHHHHHHHHHhccchhhhcchhhhcc
Confidence 3455678999999999999999999763 34599998865432 245778999999996 8999999999999
Q ss_pred CCeEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEc-CCCcEEEEecCCc
Q 005841 574 PQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVD-KHWTVKVGDFGLS 652 (674)
Q Consensus 574 ~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~-~~~~vkL~DFGla 652 (674)
++..++||||++..+..+++.. ++...+..|++.++.||.++|.+| ||||||||.|||.+ ..+.-.|+|||+|
T Consensus 107 nd~v~ivlp~~~H~~f~~l~~~----l~~~~i~~Yl~~ll~Al~~~h~~G--IvHRDiKpsNFL~n~~t~rg~LvDFgLA 180 (418)
T KOG1167|consen 107 NDQVAIVLPYFEHDRFRDLYRS----LSLAEIRWYLRNLLKALAHLHKNG--IVHRDIKPSNFLYNRRTQRGVLVDFGLA 180 (418)
T ss_pred CCeeEEEecccCccCHHHHHhc----CCHHHHHHHHHHHHHHhhhhhccC--ccccCCCccccccccccCCceEEechhH
Confidence 9999999999999998888864 678999999999999999999999 99999999999998 5678899999999
Q ss_pred c
Q 005841 653 R 653 (674)
Q Consensus 653 ~ 653 (674)
.
T Consensus 181 ~ 181 (418)
T KOG1167|consen 181 Q 181 (418)
T ss_pred H
Confidence 7
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.66 E-value=4.6e-16 Score=152.40 Aligned_cols=139 Identities=25% Similarity=0.237 Sum_probs=100.0
Q ss_pred eeeecccCceEEEEEEEc-CCeEEEEEeecccCCHHHHHH----------------------HHHHHHHHhhCCCC--Ce
Q 005841 510 GEQIGQGSCGTVYHAVWY-GSDVAVKVFSRQEYSDEVIHS----------------------FRQEVSLMKRLRHP--NV 564 (674)
Q Consensus 510 ~~~LG~G~fG~Vy~~~~~-~~~vAvK~i~~~~~~~~~~~~----------------------~~~Ei~il~~l~Hp--nI 564 (674)
.+.||+|+||+||+|.+. +..||||++............ ...|...+..+.+. .+
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 467999999999999885 888999998764322111111 13566666666443 24
Q ss_pred eeEEEEEecCCeEEEEEecCCCCCHHH-HHHhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCeEEccCCCCCEEEcCCC
Q 005841 565 LLFMGAVTSPQRLCIVTEFLPRGSLFR-LLQRNTTKLDWRRRILMALDIARGVSYLHH-CNPPIIHRDLKSSNLLVDKHW 642 (674)
Q Consensus 565 v~l~~~~~~~~~~~lV~E~~~ggsL~~-~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~-~~~~IvHrDLKp~NILi~~~~ 642 (674)
..++++ ...++||||++++.+.. .+.... . ...+..++.+++.++.++|. ++ |+|+||||+|||++ ++
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~--~-~~~~~~~~~~~~~~l~~lh~~~~--ivH~Dl~p~Nili~-~~ 151 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR--L-LEDPEELYDQILELMRKLYREAG--LVHGDLSEYNILVD-DG 151 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhhh--h-cccHHHHHHHHHHHHHHHhhccC--cCcCCCChhhEEEE-CC
Confidence 445443 24699999999854321 222111 1 16678899999999999999 88 99999999999999 88
Q ss_pred cEEEEecCCcccccCC
Q 005841 643 TVKVGDFGLSRLKHET 658 (674)
Q Consensus 643 ~vkL~DFGla~~~~~~ 658 (674)
.++|+|||.+.....+
T Consensus 152 ~~~liDfg~a~~~~~~ 167 (187)
T cd05119 152 KVYIIDVPQAVEIDHP 167 (187)
T ss_pred cEEEEECcccccccCc
Confidence 9999999999866553
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PF08448 PAS_4: PAS fold; InterPro: IPR013656 The PAS fold corresponds to the structural domain that has previously been defined as PAS and PAC motifs [] | Back alignment and domain information |
|---|
Probab=99.65 E-value=2.3e-15 Score=132.94 Aligned_cols=110 Identities=24% Similarity=0.357 Sum_probs=98.2
Q ss_pred HHHhcceeEEEcCCCcEEeecHHHHHHhCCChhhHcCCCccccccccccchhHHHHHHHHHhCceeEEEEEEEcCCCCEE
Q 005841 136 LQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGERWTGQFPAKTKTEERV 215 (674)
Q Consensus 136 lds~~d~I~v~D~~GrIi~~N~a~e~llGys~eEviG~~~~~l~~~~~~~~~~~~i~~~l~~g~~~~~e~~~~~kdG~~~ 215 (674)
|++++++|+++|.+|+|++||+++++++|++.++++|+++.+++++.........+.+++..+.....+..... +|...
T Consensus 1 l~~~p~~i~v~D~~~~i~~~N~~~~~~~~~~~~~~~G~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~ 79 (110)
T PF08448_consen 1 LDSSPDGIFVIDPDGRIVYANQAAAELFGVSPEELIGRSLFDLLPPEDREEFQAALRRALAGGEPVFFEEILLR-DGEER 79 (110)
T ss_dssp HHHCSSEEEEEETTSBEEEE-HHHHHHHTSTHHHHTTSBHHHHSCCGCHHHHHHHHHHHHHHTSEEEEEEEECT-TSCEE
T ss_pred CCCCCceeEEECCCCEEEEEHHHHHHHhCCCHHHHhhccchhccccchhhhhHHHHHHhhccCceEEEEEEEee-cCCcE
Confidence 68999999999999999999999999999999999999999999887666666677777888887776666655 89999
Q ss_pred EEEEEEEEEECCCCCEEEEEEEEEchHHHHH
Q 005841 216 LVVATNTPFYDDDGTLVGIVCVSTDSRPFQE 246 (674)
Q Consensus 216 ~v~~s~sPi~d~dG~ivg~i~i~rDITe~k~ 246 (674)
|+.++++|++|.+|++.|++++++|||++|+
T Consensus 80 ~~~~~~~Pi~~~~g~~~g~~~~~~DiT~~rr 110 (110)
T PF08448_consen 80 WFEVSISPIFDEDGEVVGVLVIIRDITERRR 110 (110)
T ss_dssp EEEEEEEEEECTTTCEEEEEEEEEEECCHHH
T ss_pred EEEEEEEEeEcCCCCEEEEEEEEEECchhhC
Confidence 9999999999999999999999999999875
|
The PAS fold appears in archaea, eubacteria and eukarya. ; PDB: 3K3D_A 3K3C_B 3KX0_X 3FC7_B 3LUQ_D 3MXQ_A 3BWL_C 3FG8_A. |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.64 E-value=2.2e-15 Score=154.15 Aligned_cols=138 Identities=20% Similarity=0.240 Sum_probs=106.8
Q ss_pred eeec-ccCceEEEEEEEcCCeEEEEEeecccC-----------CHHHHHHHHHHHHHHhhCCCCCe--eeEEEEEecCC-
Q 005841 511 EQIG-QGSCGTVYHAVWYGSDVAVKVFSRQEY-----------SDEVIHSFRQEVSLMKRLRHPNV--LLFMGAVTSPQ- 575 (674)
Q Consensus 511 ~~LG-~G~fG~Vy~~~~~~~~vAvK~i~~~~~-----------~~~~~~~~~~Ei~il~~l~HpnI--v~l~~~~~~~~- 575 (674)
..|| .|+.|+||.+...+..++||.+..... ......++.+|+.++..|.|++| +..+++.....
T Consensus 37 ~~lg~~~g~gtv~~v~~~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~~ 116 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTPGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRHG 116 (239)
T ss_pred ceeecCCCCccEEEEEeCCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeecC
Confidence 3576 788888888888888999998865332 11223567889999999998775 56666543322
Q ss_pred ---eEEEEEecCCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCC
Q 005841 576 ---RLCIVTEFLPR-GSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGL 651 (674)
Q Consensus 576 ---~~~lV~E~~~g-gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGl 651 (674)
..+|||||++| .+|.+++.. ..++... +.+|+.+|.+||+.| |+||||||.|||++.++.|+|+|||.
T Consensus 117 ~~~~~~lV~e~l~G~~~L~~~l~~--~~l~~~~----~~~i~~~l~~lH~~G--I~HrDlkp~NILv~~~~~v~LIDfg~ 188 (239)
T PRK01723 117 LFYRADILIERIEGARDLVALLQE--APLSEEQ----WQAIGQLIARFHDAG--VYHADLNAHNILLDPDGKFWLIDFDR 188 (239)
T ss_pred cceeeeEEEEecCCCCCHHHHHhc--CCCCHHH----HHHHHHHHHHHHHCC--CCCCCCCchhEEEcCCCCEEEEECCC
Confidence 23599999997 689988864 2455443 568999999999999 99999999999999988999999999
Q ss_pred ccccc
Q 005841 652 SRLKH 656 (674)
Q Consensus 652 a~~~~ 656 (674)
+....
T Consensus 189 ~~~~~ 193 (239)
T PRK01723 189 GELRT 193 (239)
T ss_pred cccCC
Confidence 98654
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.64 E-value=1.6e-15 Score=141.22 Aligned_cols=136 Identities=18% Similarity=0.165 Sum_probs=114.3
Q ss_pred EeeeecccCceEEEEEEEcCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCC--CCeeeEEEEEecCCeEEEEEecCCC
Q 005841 509 IGEQIGQGSCGTVYHAVWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRH--PNVLLFMGAVTSPQRLCIVTEFLPR 586 (674)
Q Consensus 509 ~~~~LG~G~fG~Vy~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~H--pnIv~l~~~~~~~~~~~lV~E~~~g 586 (674)
+.+.||.|.++.||++...+..+++|++..... ...+..|+.++..+.| .++++++.++...+..+++|||+++
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~~~~~iK~~~~~~~----~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g 77 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKDEDYVLKINPSREK----GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEG 77 (155)
T ss_pred cceecccccccceEEEEecCCeEEEEecCCCCc----hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCC
Confidence 356899999999999999888899999865432 3567889999999976 5889999988888889999999988
Q ss_pred CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC-CCeEEccCCCCCEEEcCCCcEEEEecCCccccc
Q 005841 587 GSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCN-PPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKH 656 (674)
Q Consensus 587 gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~-~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~ 656 (674)
..+..+ +......++.+++.+|.+||... .+++|+||+|.|||+++.+.++|+|||+++...
T Consensus 78 ~~~~~~--------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~~~ 140 (155)
T cd05120 78 ETLDEV--------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGYGP 140 (155)
T ss_pred eecccC--------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccCCC
Confidence 777543 45666778899999999999742 249999999999999998999999999998544
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >PF00989 PAS: PAS fold; InterPro: IPR013767 PAS domains are involved in many signalling proteins where they are used as a signal sensor domain [] | Back alignment and domain information |
|---|
Probab=99.63 E-value=3.1e-15 Score=132.81 Aligned_cols=112 Identities=25% Similarity=0.438 Sum_probs=95.8
Q ss_pred HHHHHHHHHhcceeEEEcCCCcEEeecHHHHHHhCCChhhHcCCCccccccccccchhHHHHHHHHHhCcee-EEEEEEE
Q 005841 130 RQYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGERW-TGQFPAK 208 (674)
Q Consensus 130 ~~l~~ilds~~d~I~v~D~~GrIi~~N~a~e~llGys~eEviG~~~~~l~~~~~~~~~~~~i~~~l~~g~~~-~~e~~~~ 208 (674)
++|+++|++++++|+++|.+|+|+|||+++++++||+.++++|+++.+++++++.......+.+.+..++.. .......
T Consensus 1 e~~~~i~~~~~~~i~~~d~~g~I~~~N~a~~~l~g~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 80 (113)
T PF00989_consen 1 ERYRAILENSPDGIFVIDEDGRILYVNQAAEELLGYSREELIGKSLFDLIHPEDRRELRERLRQALSQGESGESFEVRFR 80 (113)
T ss_dssp HHHHHHHHCSSSEEEEEETTSBEEEECHHHHHHHSS-HHHHTTSBGGGGCSGGGHHHHHHHHHHHHHHCCHECEEEEEEE
T ss_pred CHHHHHHhcCCceEEEEeCcCeEEEECHHHHHHHccCHHHHcCCcHHHhcCchhhHHHHHHHHHHHHcCCCceeEEEEEE
Confidence 479999999999999999999999999999999999999999999999998876555566677777776653 3344444
Q ss_pred cCCCCEEEEEEEEEEEECCCCCEEEEEEEEEch
Q 005841 209 TKTEERVLVVATNTPFYDDDGTLVGIVCVSTDS 241 (674)
Q Consensus 209 ~kdG~~~~v~~s~sPi~d~dG~ivg~i~i~rDI 241 (674)
.++|..+|+.+..+|+++.+|++.|++++++||
T Consensus 81 ~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~DI 113 (113)
T PF00989_consen 81 LRDGRPRWVEVRASPVRDEDGQIIGILVIFRDI 113 (113)
T ss_dssp ETTSCEEEEEEEEEEEEETTEEEEEEEEEEEE-
T ss_pred ecCCcEEEEEEEEEEEEeCCCCEEEEEEEEEeC
Confidence 479999999999999999999999999999997
|
PAS domains appear in archaea, bacteria and eukaryotes. Several PAS-domain proteins are known to detect their signal by way of an associated cofactor. Haeme, flavin, and a 4-hydroxycinnamyl chromophore are used in different proteins. The PAS domain was named after three proteins that it occurs in: Per- period circadian protein Arnt- Ah receptor nuclear translocator protein Sim- single-minded protein. PAS domains are often associated with PAC domains IPR001610 from INTERPRO. It appears that these domains are directly linked, and that together they form the conserved 3D PAS fold. The division between the PAS and PAC domains is caused by major differences in sequences in the region connecting these two motifs []. In human PAS kinase, this region has been shown to be very flexible, and adopts different conformations depending on the bound ligand []. Probably the most surprising identification of a PAS domain was that in EAG-like K+-channels [].; GO: 0006355 regulation of transcription, DNA-dependent; PDB: 2GJ3_A 4F3L_B 1XFN_A 1OTD_A 2PYR_A 1KOU_A 1XFQ_A 2ZOI_A 2ZOH_A 1OTA_A .... |
| >PRK11091 aerobic respiration control sensor protein ArcB; Provisional | Back alignment and domain information |
|---|
Probab=99.60 E-value=2.6e-14 Score=170.53 Aligned_cols=154 Identities=16% Similarity=0.165 Sum_probs=133.3
Q ss_pred ccccHHHHHHHHHHhcceeEEEcCCCcEEeecHHHHHHhCCChhhHcCCCccccccccccchhHHHHHHHHHhCceeEEE
Q 005841 125 FNFTDRQYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGERWTGQ 204 (674)
Q Consensus 125 ~~~se~~l~~ilds~~d~I~v~D~~GrIi~~N~a~e~llGys~eEviG~~~~~l~~~~~~~~~~~~i~~~l~~g~~~~~e 204 (674)
+...++.++.++++++++|+++|.+|+|++||+++++++||+.++++|+++.+++++.............+..+..+..+
T Consensus 150 l~~~~~~l~~il~~~~~~i~~~D~~g~i~~~N~a~~~l~G~~~~eliG~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~e 229 (779)
T PRK11091 150 LEQQSSLLRSFLDASPDLVYYRNEDGEFSGCNRAMELLTGKSEKQLIGLTPKDVYSPEAAEKVIETDEKVFRHNVSLTYE 229 (779)
T ss_pred HHHHHHHHHHHHhcCcceEEEECCCCcEEeEcHHHHHHhCcCHHHHcCCChHHhCCHHHHHHHHHHHHHHHhcCCCeEEE
Confidence 33566789999999999999999999999999999999999999999999999988765444444455567778888888
Q ss_pred EEEEcCCCCEEEEEEEEEEEECCCCCEEEEEEEEEchHHHHHHHHHHHHhhhcCCccCcCCchhHHHHHhcCCccchhhH
Q 005841 205 FPAKTKTEERVLVVATNTPFYDDDGTLVGIVCVSTDSRPFQETRAALWDTKNSDTDSNINRPRNTVTAKLGLDSQQPLQA 284 (674)
Q Consensus 205 ~~~~~kdG~~~~v~~s~sPi~d~dG~ivg~i~i~rDITe~k~~e~~L~~la~~d~lt~~nr~~~~~~~kl~~~~~qpl~~ 284 (674)
.++..++|..+|+.++..|+++.+|.+.|++++++|||+++++++++++.. +.+..++..++|+.+.|++.
T Consensus 230 ~~~~~~~G~~~~~~~~~~pi~~~~g~~~g~v~~~~DITe~k~~e~~l~~a~---------~~~~~~~a~isHelrtPL~~ 300 (779)
T PRK11091 230 QWLDYPDGRKACFELRKVPFYDRVGKRHGLMGFGRDITERKRYQDALEKAS---------RDKTTFISTISHELRTPLNG 300 (779)
T ss_pred EEEEcCCCCEEEEEEEeeeEEcCCCCEEEEEEEEeehhHHHHHHHHHHHHH---------HHHHHHHHHhhHhhcCcHHH
Confidence 889999999999999999999999999999999999999999999887652 25567888899999999988
Q ss_pred HHH
Q 005841 285 TIA 287 (674)
Q Consensus 285 ~ia 287 (674)
+++
T Consensus 301 I~g 303 (779)
T PRK11091 301 IVG 303 (779)
T ss_pred HHH
Confidence 554
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.58 E-value=7.4e-15 Score=152.30 Aligned_cols=171 Identities=23% Similarity=0.330 Sum_probs=136.0
Q ss_pred ccccCCeeEeeeecccCceEEEEEEEcCC-------eEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEec
Q 005841 501 EILWEDLTIGEQIGQGSCGTVYHAVWYGS-------DVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTS 573 (674)
Q Consensus 501 ~~~~~~y~~~~~LG~G~fG~Vy~~~~~~~-------~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~ 573 (674)
.+...++++..++-+|.||.||+|.|... .|-+|.++ +..++-.+..+..|--++..+.|||+..+.++..+
T Consensus 280 ~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk-~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie 358 (563)
T KOG1024|consen 280 TVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVK-QHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIE 358 (563)
T ss_pred hhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHH-hcccHHHHHHHHHHHHHHhcCcCCCccceeEEEee
Confidence 34456788889999999999999987432 36677764 44466667788889999999999999999988754
Q ss_pred -CCeEEEEEecCCCCCHHHHHHhc-------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEE
Q 005841 574 -PQRLCIVTEFLPRGSLFRLLQRN-------TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVK 645 (674)
Q Consensus 574 -~~~~~lV~E~~~ggsL~~~l~~~-------~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vk 645 (674)
....++++.++.-|+|..+|..+ .+.++..+...++.|++.||+|||+++ |||.||...|.+|++..+||
T Consensus 359 ~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~--ViHkDiAaRNCvIdd~LqVk 436 (563)
T KOG1024|consen 359 DYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG--VIHKDIAARNCVIDDQLQVK 436 (563)
T ss_pred ccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC--cccchhhhhcceehhheeEE
Confidence 46678999999999999999843 234778889999999999999999999 99999999999999999999
Q ss_pred EEecCCcccccCCcccc--ccCCCCccccCC
Q 005841 646 VGDFGLSRLKHETYLTT--KTGKGTVTYLAS 674 (674)
Q Consensus 646 L~DFGla~~~~~~~~~~--~~~~GTp~YmAP 674 (674)
|+|=-+++.+-...+.. ..-.....||+|
T Consensus 437 ltDsaLSRDLFP~DYhcLGDnEnRPvkWMsl 467 (563)
T KOG1024|consen 437 LTDSALSRDLFPGDYHCLGDNENRPVKWMSL 467 (563)
T ss_pred eccchhccccCcccccccCCCCCCcccccCH
Confidence 99999998763222211 112345677775
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.58 E-value=3.4e-15 Score=174.44 Aligned_cols=148 Identities=30% Similarity=0.429 Sum_probs=117.4
Q ss_pred ccccccCCeeEeeeecccCceEEEEEEE-cCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCC---CCCeeeEEEEEecC
Q 005841 499 DYEILWEDLTIGEQIGQGSCGTVYHAVW-YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLR---HPNVLLFMGAVTSP 574 (674)
Q Consensus 499 ~~~~~~~~y~~~~~LG~G~fG~Vy~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~---HpnIv~l~~~~~~~ 574 (674)
++++..+.|.|.+.||+|+||+||+|.. ++..||+|+-+....=+ |.-=.+++.+|+ -+-|+.++.++...
T Consensus 692 ~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WE-----fYI~~q~~~RLk~~~~~~~~~~~~a~~~~ 766 (974)
T KOG1166|consen 692 EFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWE-----FYICLQVMERLKPQMLPSIMHISSAHVFQ 766 (974)
T ss_pred eeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCcee-----eeehHHHHHhhchhhhcchHHHHHHHccC
Confidence 3456678899999999999999999987 57779999876543211 000122233333 24566777777778
Q ss_pred CeEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEc-------CCCcEEEE
Q 005841 575 QRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVD-------KHWTVKVG 647 (674)
Q Consensus 575 ~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~-------~~~~vkL~ 647 (674)
+--+||+||.+.|+|.+++. ....+++..+.++.+|++..|++||.++ |||+||||+|+||. ..--++|+
T Consensus 767 ~~S~lv~ey~~~Gtlld~~N-~~~~m~e~lv~~~~~qml~ive~lH~~~--IIHgDiKPDNfll~~~~~~~~~~~~l~lI 843 (974)
T KOG1166|consen 767 NASVLVSEYSPYGTLLDLIN-TNKVMDEYLVMFFSCQMLRIVEHLHAMG--IIHGDIKPDNFLLRREICADSDSKGLYLI 843 (974)
T ss_pred CcceeeeeccccccHHHhhc-cCCCCCchhhhHHHHHHHHHHHHHHhcc--eecccCCcceeEeecccCCCCcccceEEE
Confidence 88999999999999999997 5667999999999999999999999999 99999999999994 23458999
Q ss_pred ecCCccc
Q 005841 648 DFGLSRL 654 (674)
Q Consensus 648 DFGla~~ 654 (674)
|||.+-.
T Consensus 844 DfG~siD 850 (974)
T KOG1166|consen 844 DFGRSID 850 (974)
T ss_pred eccccee
Confidence 9999854
|
|
| >COG3829 RocR Transcriptional regulator containing PAS, AAA-type ATPase, and DNA-binding domains [Transcription / Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.56 E-value=2.6e-14 Score=155.46 Aligned_cols=167 Identities=21% Similarity=0.376 Sum_probs=128.8
Q ss_pred HHHHHHHHHHhcceeEEEcCCCcEEeecHHHHHHhCCChhhHcCCCccccccccccchhHHHHHHHHHhCceeEEEEEEE
Q 005841 129 DRQYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGERWTGQFPAK 208 (674)
Q Consensus 129 e~~l~~ilds~~d~I~v~D~~GrIi~~N~a~e~llGys~eEviG~~~~~l~~~~~~~~~~~~i~~~l~~g~~~~~e~~~~ 208 (674)
...|+.||+.+.++|+++|.+|+|+++|+++..++|++.++++|+++.+++..... ....+++.++++.......+
T Consensus 116 ~~~l~~il~~~~~~l~vvD~~G~~i~~N~~~~~~~gl~~e~~~gk~~~~v~~~~~~----s~~l~vl~~~kp~~~~~~~~ 191 (560)
T COG3829 116 RQRLEAILDSIDDGLLVVDEDGIIIYYNKAYAKLLGLSPEEVLGKHLLDVVSAGED----STLLEVLRTGKPIRDVVQTY 191 (560)
T ss_pred HHHHHHHHhhccCceEEEcCCCcEEEEcHHHHHHhCCCHHHHcCCcHHHHHhccCC----ceehhhhhcCCcceeeeeee
Confidence 35789999999999999999999999999999999999999999999998711110 12677889999987766655
Q ss_pred cCCCCEEEEEEEEEEEECCCCCEEEEEEEEEchHHHHHHHHHHHHhhhcCCccCcCCchhHHHHHhcCCccchhhHHHHH
Q 005841 209 TKTEERVLVVATNTPFYDDDGTLVGIVCVSTDSRPFQETRAALWDTKNSDTDSNINRPRNTVTAKLGLDSQQPLQATIAS 288 (674)
Q Consensus 209 ~kdG~~~~v~~s~sPi~d~dG~ivg~i~i~rDITe~k~~e~~L~~la~~d~lt~~nr~~~~~~~kl~~~~~qpl~~~ias 288 (674)
..+.. ..+..|++ .+|.++|+|.+++|+++...+..++........ ...++.|+.-..-+..|..
T Consensus 192 ~~~~~----i~~~~pv~-~~g~l~G~v~~~~~~~~l~~l~~~~~~~~~~~~----------~~a~y~f~~Iig~S~~m~~ 256 (560)
T COG3829 192 NGNKI----IVNVAPVY-ADGQLIGVVGISKDVSELERLTRELEESEGLLR----------LKAKYTFDDIIGESPAMLR 256 (560)
T ss_pred cCCce----eEeeccEe-cCCcEEEEEEeecchHHHHHHHHHHHHHhhhhc----------cccccchhhhccCCHHHHH
Confidence 44332 56777887 477999999999999999999998876633111 1223334322222333333
Q ss_pred HHHHHHHHHHhhhccccccCCCCCccC
Q 005841 289 KISNLATKVSNKVKSRIRTGDNFMDRE 315 (674)
Q Consensus 289 si~~LA~kva~~~~svLi~Gesg~~~~ 315 (674)
+..+|.++|.++++|||.|||||+||
T Consensus 257 -~~~~akr~A~tdstVLi~GESGTGKE 282 (560)
T COG3829 257 -VLELAKRIAKTDSTVLILGESGTGKE 282 (560)
T ss_pred -HHHHHHhhcCCCCcEEEecCCCccHH
Confidence 88999999999999999999999997
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.54 E-value=4.9e-16 Score=170.66 Aligned_cols=156 Identities=26% Similarity=0.341 Sum_probs=133.2
Q ss_pred eecccCceEEEEEEE-----cCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCC-CCCeeeEEEEEecCCeEEEEEecCC
Q 005841 512 QIGQGSCGTVYHAVW-----YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLR-HPNVLLFMGAVTSPQRLCIVTEFLP 585 (674)
Q Consensus 512 ~LG~G~fG~Vy~~~~-----~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~lV~E~~~ 585 (674)
++|+|+||.|+++.- .+.-||+|+..+.............|-.++..++ ||.+++++.+++.+..++++++|+.
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 479999999998753 3555999998776554322224556788888887 9999999999999999999999999
Q ss_pred CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccccCCccccccC
Q 005841 586 RGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTG 665 (674)
Q Consensus 586 ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~~~~~~~~~ 665 (674)
||.|+..+.+ ...+++.....+...++.+++++|..+ |+|||+|++||+++.+|++++.|||++++..+....
T Consensus 81 gg~lft~l~~-~~~f~~~~~~~~~aelaLald~lh~l~--iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~---- 153 (612)
T KOG0603|consen 81 GGDLFTRLSK-EVMFDELDVAFYLAELALALDHLHKLG--IAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA---- 153 (612)
T ss_pred cchhhhcccc-CCchHHHHHHHHHHHHHHHHhhcchhH--HHHhcccccceeecccCccccCCchhhhHhHhhhhc----
Confidence 9999998865 446888888999999999999999999 999999999999999999999999999987654333
Q ss_pred CCCccccCC
Q 005841 666 KGTVTYLAS 674 (674)
Q Consensus 666 ~GTp~YmAP 674 (674)
|||..||||
T Consensus 154 cgt~eymAp 162 (612)
T KOG0603|consen 154 CGTYEYRAP 162 (612)
T ss_pred ccchhhhhh
Confidence 899999998
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.52 E-value=6.5e-15 Score=175.88 Aligned_cols=88 Identities=17% Similarity=0.131 Sum_probs=69.0
Q ss_pred CCC-CCeeeEEEEE-------ecCCeEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEcc
Q 005841 559 LRH-PNVLLFMGAV-------TSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRD 630 (674)
Q Consensus 559 l~H-pnIv~l~~~~-------~~~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrD 630 (674)
+.| .||..++++| .....++++|||+ +++|.++|......+++..++.|+.||+.||.|||+++ |||||
T Consensus 29 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~g--IvHrD 105 (793)
T PLN00181 29 LSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQG--IVVHN 105 (793)
T ss_pred hhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCC--eeecc
Confidence 344 4677777766 2234578888987 66999999765667999999999999999999999999 99999
Q ss_pred CCCCCEEEcCCCcEEEEec
Q 005841 631 LKSSNLLVDKHWTVKVGDF 649 (674)
Q Consensus 631 LKp~NILi~~~~~vkL~DF 649 (674)
|||+||||+..+.+|++||
T Consensus 106 lKP~NiLl~~~~~~k~~d~ 124 (793)
T PLN00181 106 VRPSCFVMSSFNHVSFIES 124 (793)
T ss_pred CCchhEEEcccCcEEEeec
Confidence 9999999965444443333
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.51 E-value=1.2e-14 Score=166.45 Aligned_cols=163 Identities=28% Similarity=0.365 Sum_probs=126.9
Q ss_pred eEeeeecccCceEEEEEEE--cCCeEEEEEee----cccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeEEEEE
Q 005841 508 TIGEQIGQGSCGTVYHAVW--YGSDVAVKVFS----RQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVT 581 (674)
Q Consensus 508 ~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~i~----~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 581 (674)
....++|.|++|.|+.+.. ....++.|.+. ...........+..|+.+-..+.||||+..+..+......+-+|
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m 400 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM 400 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence 4567899999997777654 22224444332 22222233334777888888999999988877777777666679
Q ss_pred ecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccccCCc--
Q 005841 582 EFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETY-- 659 (674)
Q Consensus 582 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~~~-- 659 (674)
|||++ +|+.++... .++...++-.++.|++.||+|||..| |.||||||+|+|++.+|.+||+|||.+....-..
T Consensus 401 E~~~~-Dlf~~~~~~-~~~~~~e~~c~fKqL~~Gv~y~h~~G--iahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e~ 476 (601)
T KOG0590|consen 401 EYCPY-DLFSLVMSN-GKLTPLEADCFFKQLLRGVKYLHSMG--LAHRDLKLENLLVTENGILKIIDFGAASVFRYPWEK 476 (601)
T ss_pred hcccH-HHHHHHhcc-cccchhhhhHHHHHHHHHHHHHHhcC--ceeccCccccEEEecCCceEEeecCcceeeccCcch
Confidence 99999 999999653 47899999999999999999999999 9999999999999999999999999997654322
Q ss_pred --cccccCCCCccccCC
Q 005841 660 --LTTKTGKGTVTYLAS 674 (674)
Q Consensus 660 --~~~~~~~GTp~YmAP 674 (674)
.....++|+-.|+||
T Consensus 477 ~~~~~~g~~gS~pY~ap 493 (601)
T KOG0590|consen 477 NIHESSGIVGSDPYLAP 493 (601)
T ss_pred hhhhhcCcccCCcCcCc
Confidence 345557899999998
|
|
| >PRK13557 histidine kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.50 E-value=3.6e-13 Score=153.04 Aligned_cols=128 Identities=18% Similarity=0.230 Sum_probs=114.8
Q ss_pred ccHHHHHHHHHHhcceeEEEcC---CCcEEeecHHHHHHhCCChhhHcCCCccccccccccchhHHHHHHHHHhCceeEE
Q 005841 127 FTDRQYLNILQSMGQSVHIFDL---SDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGERWTG 203 (674)
Q Consensus 127 ~se~~l~~ilds~~d~I~v~D~---~GrIi~~N~a~e~llGys~eEviG~~~~~l~~~~~~~~~~~~i~~~l~~g~~~~~ 203 (674)
.....|..+++.++++|+++|. +|+|+|+|++|++++||+.+|++|+++.+++++.........+...+..+..+..
T Consensus 27 ~~~~~~~~~~~~~~~~i~v~d~~~~~g~i~~~N~a~~~~~G~~~~e~~g~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 106 (540)
T PRK13557 27 HRSDIFFAAVETTRMPMIVTDPNQPDNPIVFANRAFLEMTGYAAEEIIGNNCRFLQGPETDRATVAEVRDAIAERREIAT 106 (540)
T ss_pred hhhHHHHHHHHhCcCcEEEEcCCCCCCCEEEEcHHHHHHhCCCHHHhcCCChHhhcCCCCCHHHHHHHHHHHHcCCCceE
Confidence 3466899999999999999995 8999999999999999999999999999988777666666677778888888888
Q ss_pred EEEEEcCCCCEEEEEEEEEEEECCCCCEEEEEEEEEchHHHHHHHHHHHHh
Q 005841 204 QFPAKTKTEERVLVVATNTPFYDDDGTLVGIVCVSTDSRPFQETRAALWDT 254 (674)
Q Consensus 204 e~~~~~kdG~~~~v~~s~sPi~d~dG~ivg~i~i~rDITe~k~~e~~L~~l 254 (674)
++...+++|..+|+.+++.|+++.+|.+++++++.+|||+++++++++.+.
T Consensus 107 ~~~~~~~~G~~~~~~~~~~~i~~~~g~~~~~~~~~~dit~~~~~e~~l~~~ 157 (540)
T PRK13557 107 EILNYRKDGSSFWNALFVSPVYNDAGDLVYFFGSQLDVSRRRDAEDALRQA 157 (540)
T ss_pred EEEEEeCCCCEEEEEEEEEEeECCCCCEEEEEEEecChHHHHHHHHHHHHH
Confidence 888889999999999999999999999999999999999999998877654
|
|
| >PRK13559 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.49 E-value=5.8e-13 Score=144.23 Aligned_cols=125 Identities=21% Similarity=0.179 Sum_probs=108.0
Q ss_pred cHHHHHHHHHHhcceeEEEcC---CCcEEeecHHHHHHhCCChhhHcCCCccccccccccchhHHHHHHHHHhCceeEEE
Q 005841 128 TDRQYLNILQSMGQSVHIFDL---SDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGERWTGQ 204 (674)
Q Consensus 128 se~~l~~ilds~~d~I~v~D~---~GrIi~~N~a~e~llGys~eEviG~~~~~l~~~~~~~~~~~~i~~~l~~g~~~~~e 204 (674)
+...|+.+|+.++++|+++|. +|+|++||+++++++||+.++++|+.+.++..+.........+...+..+..+..+
T Consensus 41 ~~~~~~~~~e~~~~~i~i~D~~~~~g~i~~~N~a~~~l~G~~~~e~iG~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~e 120 (361)
T PRK13559 41 SGRLFEQAMEQTRMAMCITDPHQPDLPIVLANQAFLDLTGYAAEEVVGRNCRFLQGAATDPIAVAKIRAAIAAEREIVVE 120 (361)
T ss_pred hhhHHHHHHHhCCCcEEEecCCCCCCcEEEEchHHHHHhCCCHHHHcCCChhhhcCCCCCHHHHHHHHHHhccCCceEEE
Confidence 456799999999999999997 67899999999999999999999999877766554444455566677788888888
Q ss_pred EEEEcCCCCEEEEEEEEEEEECCCCCEEEEEEEEEchHHHHHHHHHHH
Q 005841 205 FPAKTKTEERVLVVATNTPFYDDDGTLVGIVCVSTDSRPFQETRAALW 252 (674)
Q Consensus 205 ~~~~~kdG~~~~v~~s~sPi~d~dG~ivg~i~i~rDITe~k~~e~~L~ 252 (674)
....+++|..+|+.++..|+++.+|.+++++++++|||+++++++.++
T Consensus 121 ~~~~~~dG~~~~~~~~~~~i~d~~G~~~~~v~~~~DITerk~~e~~~~ 168 (361)
T PRK13559 121 LLNYRKDGEPFWNALHLGPVYGEDGRLLYFFGSQWDVTDIRAVRALEA 168 (361)
T ss_pred EEEEcCCCCEEEEEEEEEEEEcCCCCEEEeeeeeeehhcchhhHHHHH
Confidence 888899999999999999999999999999999999999998876543
|
|
| >PRK10060 RNase II stability modulator; Provisional | Back alignment and domain information |
|---|
Probab=99.44 E-value=1.3e-12 Score=152.84 Aligned_cols=137 Identities=16% Similarity=0.210 Sum_probs=113.1
Q ss_pred HHHHHHHHHHhcceeEEEcCCCcEEeecHHHHHHhCCChhhHcCCCcccccccccc-chhHHHHHHHHHhCceeEEEEEE
Q 005841 129 DRQYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRD-FDVAYDIVHRIKMGERWTGQFPA 207 (674)
Q Consensus 129 e~~l~~ilds~~d~I~v~D~~GrIi~~N~a~e~llGys~eEviG~~~~~l~~~~~~-~~~~~~i~~~l~~g~~~~~e~~~ 207 (674)
..+++.+++.++++|+++|.+|+|+++|+++++++||+.++++|+++.+++.++.. ......+...+..+..|..+.++
T Consensus 110 ~~~~~~v~~~~~~gI~i~D~~g~I~~~N~a~~~l~Gy~~~eliG~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~ 189 (663)
T PRK10060 110 LSFAEQVVSEANSVIVILDSRGNIQRFNRLCEEYTGLKEHDVIGQSVFKLFMSRREAAASRRNIRGFFRSGNAYEVERWI 189 (663)
T ss_pred HHHHHHHHhhCCceEEEEeCCCCEEEEcHHHHHHHCcCHHHHcCCCHHHHhCChhhHHHHHHHHHHHHhcCCceEEEEEE
Confidence 45678899999999999999999999999999999999999999998887755443 23333455667788889999999
Q ss_pred EcCCCCEEEEEEEEEEEECCCCCEEEEEEEEEchHHHHHHHHHHHHhhhcCCccCcCC
Q 005841 208 KTKTEERVLVVATNTPFYDDDGTLVGIVCVSTDSRPFQETRAALWDTKNSDTDSNINR 265 (674)
Q Consensus 208 ~~kdG~~~~v~~s~sPi~d~dG~ivg~i~i~rDITe~k~~e~~L~~la~~d~lt~~nr 265 (674)
.+++|..+|+.....+..+.++...+++++++|||++++.+++|++++.+|++|++.+
T Consensus 190 ~~~~G~~~~~~~~~~~~~~~g~~~~~~i~~~~DITe~k~~e~~l~~~a~~D~LTGL~N 247 (663)
T PRK10060 190 KTRKGQRLFLFRNKFVHSGSGKNEIFLICSGTDITEERRAQERLRILANTDSITGLPN 247 (663)
T ss_pred EeCCCCEEEEEeeeEEEcCCCCceEEEEEEEEechHHHHHHHHHHHHhhcCccCCCcC
Confidence 9999999988766544333333456788999999999999999999999999999444
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.42 E-value=9.4e-13 Score=146.11 Aligned_cols=142 Identities=23% Similarity=0.246 Sum_probs=97.3
Q ss_pred eeecccCceEEEEEEE-cCCeEEEEEeecccCCH--------------------------------HHHH------HHHH
Q 005841 511 EQIGQGSCGTVYHAVW-YGSDVAVKVFSRQEYSD--------------------------------EVIH------SFRQ 551 (674)
Q Consensus 511 ~~LG~G~fG~Vy~~~~-~~~~vAvK~i~~~~~~~--------------------------------~~~~------~~~~ 551 (674)
+.||.|++|+||+|+. .|..||||+..+..... +... .+.+
T Consensus 123 ~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~ 202 (437)
T TIGR01982 123 KPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRR 202 (437)
T ss_pred cceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHH
Confidence 5799999999999997 68899999986542110 0000 2334
Q ss_pred HHHHHhhCC-----CCCeeeEEEEEecCCeEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHH-HHHHHHhCCCC
Q 005841 552 EVSLMKRLR-----HPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIAR-GVSYLHHCNPP 625 (674)
Q Consensus 552 Ei~il~~l~-----HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~-~L~yLH~~~~~ 625 (674)
|...+.++. +++|.-..-+.......+|||||++|++|.++.......++ ...++.+++. .+..+|..|
T Consensus 203 Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~~---~~~ia~~~~~~~l~ql~~~g-- 277 (437)
T TIGR01982 203 EAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGLD---RKALAENLARSFLNQVLRDG-- 277 (437)
T ss_pred HHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCCC---HHHHHHHHHHHHHHHHHhCC--
Confidence 555555442 34333222122223457999999999999887653222222 3345555555 467889988
Q ss_pred eEEccCCCCCEEEcCCCcEEEEecCCcccccC
Q 005841 626 IIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHE 657 (674)
Q Consensus 626 IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~ 657 (674)
++|+|+||.|||++.+++++|+|||++..+..
T Consensus 278 ~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 278 FFHADLHPGNIFVLKDGKIIALDFGIVGRLSE 309 (437)
T ss_pred ceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence 99999999999999999999999999987653
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >PRK10820 DNA-binding transcriptional regulator TyrR; Provisional | Back alignment and domain information |
|---|
Probab=99.39 E-value=2.7e-12 Score=145.55 Aligned_cols=161 Identities=16% Similarity=0.206 Sum_probs=115.7
Q ss_pred ccHHHHHHHHHHhcceeEEEcCCCcEEeecHHHHHHhCCChhhHcCCCccccccccccchhHHHHHHHHHhCceeEEEEE
Q 005841 127 FTDRQYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGERWTGQFP 206 (674)
Q Consensus 127 ~se~~l~~ilds~~d~I~v~D~~GrIi~~N~a~e~llGys~eEviG~~~~~l~~~~~~~~~~~~i~~~l~~g~~~~~e~~ 206 (674)
.....+.+||++|+++|+++|.+|+|+++|++++++||++.++++|+++.++++... +...+.++...... .
T Consensus 77 ~e~~~L~aIL~sm~eGVi~vD~~G~I~~iN~aA~~Llg~~~eel~Gk~i~eli~~~~-------l~~~le~~~~~~~~-~ 148 (520)
T PRK10820 77 REHRALSALLEALPEPVLSIDMKGKVELANPASCQLFGQSEEKLRNHTAAQLINGFN-------FLRWLESEPQDSHN-E 148 (520)
T ss_pred HHHHHHHHHHHhCCCcEEEECCCCeeeHhHHHHHHHHCcCHHHHCCCcHHHHcCcch-------HHHHHHcCCCccce-E
Confidence 345679999999999999999999999999999999999999999999999988654 44456666542111 1
Q ss_pred EEcCCCCEEEEEEEEEEEE--CCCCCE--EEEEEEEEchHHHHHHHHHHHHhhhcCCccCcCCchhHHHHHhcCCccchh
Q 005841 207 AKTKTEERVLVVATNTPFY--DDDGTL--VGIVCVSTDSRPFQETRAALWDTKNSDTDSNINRPRNTVTAKLGLDSQQPL 282 (674)
Q Consensus 207 ~~~kdG~~~~v~~s~sPi~--d~dG~i--vg~i~i~rDITe~k~~e~~L~~la~~d~lt~~nr~~~~~~~kl~~~~~qpl 282 (674)
.+..+|..++ +...|++ |++|.. +|+|.+++|+++..+ ++..+.. .....|+.-..-
T Consensus 149 ~v~~~g~~~~--v~~~PI~~~d~~g~~~~~GaVivlrd~~~l~~---~~~~~~~--------------~~~~~f~~~ig~ 209 (520)
T PRK10820 149 HVVINGQDFL--MEITPVYLQDENDQHVLVGAVVMLRSTARMGR---QLQNLAV--------------NDDSAFSQIVAV 209 (520)
T ss_pred EEEECCEEEE--EEEEeeeecCCCCceeEEEEEEEeccHHHHHH---HHHhhhc--------------cccccccceeEC
Confidence 2234566554 5677887 666654 899999999998643 2222211 111223322222
Q ss_pred hHHHHHHHHHHHHHHHhhhccccccCCCCCccC
Q 005841 283 QATIASKISNLATKVSNKVKSRIRTGDNFMDRE 315 (674)
Q Consensus 283 ~~~iassi~~LA~kva~~~~svLi~Gesg~~~~ 315 (674)
+..+.. +...|.++|.....+||+||+||+|+
T Consensus 210 s~~~~~-~~~~~~~~A~~~~pvlI~GE~GtGK~ 241 (520)
T PRK10820 210 SPKMRQ-VVEQARKLAMLDAPLLITGDTGTGKD 241 (520)
T ss_pred CHHHHH-HHHHHHHHhCCCCCEEEECCCCccHH
Confidence 333333 88889999999999999999999996
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.37 E-value=1.8e-12 Score=124.54 Aligned_cols=131 Identities=16% Similarity=0.114 Sum_probs=97.3
Q ss_pred eeeecccCceEEEEEEEcCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCe-eeEEEEEecCCeEEEEEecCCCCC
Q 005841 510 GEQIGQGSCGTVYHAVWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNV-LLFMGAVTSPQRLCIVTEFLPRGS 588 (674)
Q Consensus 510 ~~~LG~G~fG~Vy~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnI-v~l~~~~~~~~~~~lV~E~~~ggs 588 (674)
.+.|+.|.++.||++...+..|++|+...... ....+.+|+.+++.+.+.++ .+++.+. ....++||||++|.+
T Consensus 3 ~~~l~~G~~~~vy~~~~~~~~~~lK~~~~~~~---~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~ 77 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVANKKYVVRIPGNGTE---LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSE 77 (170)
T ss_pred eeecCCcccCceEEEEECCeEEEEEeCCCCcc---cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCc
Confidence 35788999999999998888999998754421 11245678889988865444 3555443 334589999999987
Q ss_pred HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCC---CeEEccCCCCCEEEcCCCcEEEEecCCcccc
Q 005841 589 LFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNP---PIIHRDLKSSNLLVDKHWTVKVGDFGLSRLK 655 (674)
Q Consensus 589 L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~---~IvHrDLKp~NILi~~~~~vkL~DFGla~~~ 655 (674)
+.... .....++.+++.+|..||..+. .++|+|++|.|||++ ++.++|+|||.+...
T Consensus 78 l~~~~---------~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~~ 137 (170)
T cd05151 78 LLTED---------FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGMN 137 (170)
T ss_pred ccccc---------ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccCC
Confidence 75430 1113356789999999998761 249999999999999 668999999998753
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >PRK09776 putative diguanylate cyclase; Provisional | Back alignment and domain information |
|---|
Probab=99.36 E-value=4.7e-12 Score=156.58 Aligned_cols=141 Identities=19% Similarity=0.195 Sum_probs=117.6
Q ss_pred ccccHHHHHHHHHHhcceeEEEcCCCcEEeecHHHHHHhCCChhhHcCCCccccccccc--cchhHHHHHHHHHhCce--
Q 005841 125 FNFTDRQYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGR--DFDVAYDIVHRIKMGER-- 200 (674)
Q Consensus 125 ~~~se~~l~~ilds~~d~I~v~D~~GrIi~~N~a~e~llGys~eEviG~~~~~l~~~~~--~~~~~~~i~~~l~~g~~-- 200 (674)
+...+++++.++++++++|+++|.+|+|+++|+++++++||+.+|++|+++.++++... .......+......+..
T Consensus 531 L~~~~~~l~~~l~~~~~~i~~~D~~g~i~~~N~a~~~l~G~~~~e~iG~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 610 (1092)
T PRK09776 531 LFQEKERLHITLDSIGEAVVCTDMAMKVTFMNPVAEKMTGWTQEEALGVPLLTVLHITFGDNGPLMENIYSCLTSRSAAY 610 (1092)
T ss_pred HHHHHHHHHHHHhccccEEEEECCCCeEEEEcHHHHHHhCCCHHHHcCCCHHHHcccccCCcchhhHHHHHHHhcCCCcc
Confidence 34456778999999999999999999999999999999999999999999888765322 22222234444444433
Q ss_pred eEEEEEEEcCCCCEEEEEEEEEEEECCCCCEEEEEEEEEchHHHHHHHHHHHHhhhcCCccCcCC
Q 005841 201 WTGQFPAKTKTEERVLVVATNTPFYDDDGTLVGIVCVSTDSRPFQETRAALWDTKNSDTDSNINR 265 (674)
Q Consensus 201 ~~~e~~~~~kdG~~~~v~~s~sPi~d~dG~ivg~i~i~rDITe~k~~e~~L~~la~~d~lt~~nr 265 (674)
+..+....+++|..+|+.++..|+++.+|+++|++++++|||++|+++++|..++.+|++|++.+
T Consensus 611 ~~~~~~~~~~~G~~~~~~~~~~pi~~~~g~~~g~v~~~~DITe~k~~e~~L~~~a~~D~lTgl~n 675 (1092)
T PRK09776 611 LEQDVVLHCRSGGSYDVHYSITPLSTLDGENIGSVLVIQDVTESRKMLRQLSYSASHDALTHLAN 675 (1092)
T ss_pred ccceEEEEeCCCcEEEEEEEeeeeecCCCCEEEEEEEEEecchHHHHHHHHHhhcCCCcccCCcc
Confidence 45567778899999999999999999999999999999999999999999999999999999544
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.34 E-value=1.2e-11 Score=118.37 Aligned_cols=135 Identities=24% Similarity=0.339 Sum_probs=110.4
Q ss_pred eeecccCceEEEEEEEcCCeEEEEEeecccCCHH------HHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeEEEEEecC
Q 005841 511 EQIGQGSCGTVYHAVWYGSDVAVKVFSRQEYSDE------VIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFL 584 (674)
Q Consensus 511 ~~LG~G~fG~Vy~~~~~~~~vAvK~i~~~~~~~~------~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 584 (674)
..+.+|+-+.+|.+.+.+.++++|.-.++.+... ...+..+|..++..++--.|...+-+..+++...|+|||+
T Consensus 2 ~~i~~GAEa~i~~~~~~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~I 81 (204)
T COG3642 2 DLIKQGAEAIIYLTDFLGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEYI 81 (204)
T ss_pred chhhCCcceeEEeeeccCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEEe
Confidence 3578999999999999888888887666655432 2245678999999998777777777778889999999999
Q ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCccccc
Q 005841 585 PRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKH 656 (674)
Q Consensus 585 ~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~ 656 (674)
+|..|.+++... ...++..|-.-+.-||..+ |||+||.++||++..++ +.++||||+.+..
T Consensus 82 ~G~~lkd~l~~~--------~~~~~r~vG~~vg~lH~~g--ivHGDLTtsNiIl~~~~-i~~IDfGLg~~s~ 142 (204)
T COG3642 82 EGELLKDALEEA--------RPDLLREVGRLVGKLHKAG--IVHGDLTTSNIILSGGR-IYFIDFGLGEFSD 142 (204)
T ss_pred CChhHHHHHHhc--------chHHHHHHHHHHHHHHhcC--eecCCCccceEEEeCCc-EEEEECCcccccc
Confidence 999999888653 2456677777788999999 99999999999998764 9999999998643
|
|
| >TIGR02938 nifL_nitrog nitrogen fixation negative regulator NifL | Back alignment and domain information |
|---|
Probab=99.33 E-value=6.5e-12 Score=140.59 Aligned_cols=126 Identities=18% Similarity=0.298 Sum_probs=110.7
Q ss_pred HHHHHHHHHHhcceeEEEcCCCcEEeecHHHHHHhCCChhhHcCCCccccccccccchhHHHHHHHHHhCceeEEEEEEE
Q 005841 129 DRQYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGERWTGQFPAK 208 (674)
Q Consensus 129 e~~l~~ilds~~d~I~v~D~~GrIi~~N~a~e~llGys~eEviG~~~~~l~~~~~~~~~~~~i~~~l~~g~~~~~e~~~~ 208 (674)
.+.|+.+++.++++|+++|.+|+++|||+++++++||+.++++|+....+..+.........+...+..+..+..++...
T Consensus 3 ~~~~~~i~~~~~~~i~~~d~~g~~~~~N~~~~~~~G~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (494)
T TIGR02938 3 PEAYRQTVDQAPLAISITDLKANILYANDAFTRITGYTKEEIIGKNESVLSNHTTPPEVYQALWGSLAEQKPWAGKLLNR 82 (494)
T ss_pred hHHHHHHHHhCCceEEEECCCCcEEEEchhheeecCCCHHHHhCCCchhhcCCCCCHHHHHHHHHHHHhCCcccceeecc
Confidence 45799999999999999999999999999999999999999999987766655554555556677777888888888888
Q ss_pred cCCCCEEEEEEEEEEEECCCCCEEEEEEEEEchHHHHHHHHHHHHh
Q 005841 209 TKTEERVLVVATNTPFYDDDGTLVGIVCVSTDSRPFQETRAALWDT 254 (674)
Q Consensus 209 ~kdG~~~~v~~s~sPi~d~dG~ivg~i~i~rDITe~k~~e~~L~~l 254 (674)
+++|..+|+.+...|+++.+|.+.+++++++|||++++++++|++.
T Consensus 83 ~~~g~~~~~~~~~~~~~~~~g~~~~~~~~~~DIt~~k~~e~~l~~~ 128 (494)
T TIGR02938 83 RKDGELYLAELTVAPVLNEAGETTHFLGMHRDITELHRLEQVVANQ 128 (494)
T ss_pred CCCccchhhheeeEEEECCCCCEEEEEEehhhhhHHHHHHHHHHHH
Confidence 9999999999999999999999999999999999999998887644
|
NifL is a modulator of the nitrogen fixation positive regulator protein NifA, and is therefore a negative regulator. It binds NifA. NifA and NifL are encoded by adjacent genes. |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.32 E-value=2.4e-12 Score=144.86 Aligned_cols=146 Identities=19% Similarity=0.208 Sum_probs=94.7
Q ss_pred cccCCeeEeeeecccCceEEEEEEEc--CCeEEEEEeecccC---------------------------CH-----HHHH
Q 005841 502 ILWEDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEY---------------------------SD-----EVIH 547 (674)
Q Consensus 502 ~~~~~y~~~~~LG~G~fG~Vy~~~~~--~~~vAvK~i~~~~~---------------------------~~-----~~~~ 547 (674)
..+.+|.. +.||.|++|+||+|+.. |+.||||+..+... .. +..+
T Consensus 117 ~~F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~ 195 (537)
T PRK04750 117 EWFDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEK 195 (537)
T ss_pred HHHHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHH
Confidence 34566776 78999999999999973 78999999975421 00 1112
Q ss_pred H------HHHHHHHHhhCC----CCCeeeEEEEEec-CCeEEEEEecCCCCCHHHH--HHhcCC---CCCHHHHHHHHHH
Q 005841 548 S------FRQEVSLMKRLR----HPNVLLFMGAVTS-PQRLCIVTEFLPRGSLFRL--LQRNTT---KLDWRRRILMALD 611 (674)
Q Consensus 548 ~------~~~Ei~il~~l~----HpnIv~l~~~~~~-~~~~~lV~E~~~ggsL~~~--l~~~~~---~l~~~~~~~i~~q 611 (674)
. +.+|...+.++. +.+.+.+-.++.+ ....+|||||+.|+.|.++ +...+. .+....+..++.|
T Consensus 196 ~l~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Q 275 (537)
T PRK04750 196 TLHDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQ 275 (537)
T ss_pred HHHHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHH
Confidence 2 233443343332 3333333222222 3456899999999999774 322221 2333344444444
Q ss_pred HHHHHHHHHhCCCCeEEccCCCCCEEEcCCC----cEEEEecCCcccccC
Q 005841 612 IARGVSYLHHCNPPIIHRDLKSSNLLVDKHW----TVKVGDFGLSRLKHE 657 (674)
Q Consensus 612 i~~~L~yLH~~~~~IvHrDLKp~NILi~~~~----~vkL~DFGla~~~~~ 657 (674)
| +..| ++|+|+||.||+++.++ +++++|||++..+..
T Consensus 276 i-------f~~G--ffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 276 V-------FRDG--FFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred H-------HhCC--eeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 4 3467 99999999999999888 999999999987653
|
|
| >TIGR00229 sensory_box PAS domain S-box | Back alignment and domain information |
|---|
Probab=99.32 E-value=3e-11 Score=102.92 Aligned_cols=120 Identities=23% Similarity=0.400 Sum_probs=96.5
Q ss_pred HHHHHHHHHhcceeEEEcCCCcEEeecHHHHHHhCCChhhHcCCCccccccccccchhHHHHHHHHHhCce-eEEEEEEE
Q 005841 130 RQYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGER-WTGQFPAK 208 (674)
Q Consensus 130 ~~l~~ilds~~d~I~v~D~~GrIi~~N~a~e~llGys~eEviG~~~~~l~~~~~~~~~~~~i~~~l~~g~~-~~~e~~~~ 208 (674)
+.++.+++.++++++++|.+|+|+++|+++++++|++..+++|+.+.+++++.........+...+..+.. ....+.+.
T Consensus 3 ~~~~~~~~~~~~~~~~~d~~~~i~~~n~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (124)
T TIGR00229 3 ERYRAIFESSPDAIIVIDLEGNILYVNPAFEEIFGYSAEELIGRNVLELIPEEDREEVRERIERLLEGEREPVSEERRVR 82 (124)
T ss_pred hHHHHHHhhCCceEEEEcCCCcEEEEchHHHHHhCCChHHhcCcchhhhcChhhhHHHHHHHHHHHcCCCCCcceEeeeE
Confidence 46889999999999999999999999999999999999999999988877655443333334444442222 33444555
Q ss_pred cCCCCEEEEEEEEEEEECCCCCEEEEEEEEEchHHHHHHHHH
Q 005841 209 TKTEERVLVVATNTPFYDDDGTLVGIVCVSTDSRPFQETRAA 250 (674)
Q Consensus 209 ~kdG~~~~v~~s~sPi~d~dG~ivg~i~i~rDITe~k~~e~~ 250 (674)
..+|..+|+.++..|+. .+|...++++++.|||++++.+++
T Consensus 83 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~dit~~~~~~~~ 123 (124)
T TIGR00229 83 RKDGSEIWVEVSVSPIR-TNGGELGVVGIVRDITERKQAEEA 123 (124)
T ss_pred cCCCCEEEEEEEEeehh-hCCCeeEEEEEeeehhHHHHHHhc
Confidence 78999999999999998 788899999999999999887764
|
The PAS domain was previously described. This sensory box, or S-box domain occupies the central portion of the PAS domain but is more widely distributed. It is often tandemly repeated. Known prosthetic groups bound in the S-box domain include heme in the oxygen sensor FixL, FAD in the redox potential sensor NifL, and a 4-hydroxycinnamyl chromophore in photoactive yellow protein. Proteins containing the domain often contain other regulatory domains such as response regulator or sensor histidine kinase domains. Other S-box proteins include phytochromes and the aryl hydrocarbon receptor nuclear translocator. |
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.30 E-value=1.6e-11 Score=121.05 Aligned_cols=139 Identities=20% Similarity=0.183 Sum_probs=101.3
Q ss_pred eeeecccCceEEEEEEEc--------CCeEEEEEeecccC----------------------CH--HHHHHHHHHHHHHh
Q 005841 510 GEQIGQGSCGTVYHAVWY--------GSDVAVKVFSRQEY----------------------SD--EVIHSFRQEVSLMK 557 (674)
Q Consensus 510 ~~~LG~G~fG~Vy~~~~~--------~~~vAvK~i~~~~~----------------------~~--~~~~~~~~Ei~il~ 557 (674)
...||.|--+.||.|... +..+|||+...... .. .......+|+..|+
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 357899999999999754 36799998852111 00 11122348999999
Q ss_pred hCCC--CCeeeEEEEEecCCeEEEEEecCCCCCHHH-HHHhcCCCCCHHHHHHHHHHHHHHHHHH-HhCCCCeEEccCCC
Q 005841 558 RLRH--PNVLLFMGAVTSPQRLCIVTEFLPRGSLFR-LLQRNTTKLDWRRRILMALDIARGVSYL-HHCNPPIIHRDLKS 633 (674)
Q Consensus 558 ~l~H--pnIv~l~~~~~~~~~~~lV~E~~~ggsL~~-~l~~~~~~l~~~~~~~i~~qi~~~L~yL-H~~~~~IvHrDLKp 633 (674)
++.. -++..++.+ ...+|||||+.+..+.. .+.. ..++......+..+++.+|.+| |.++ |||+||++
T Consensus 82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd--~~~~~~~~~~i~~~i~~~l~~l~H~~g--lVHGDLs~ 153 (197)
T cd05146 82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD--AKLNDEEMKNAYYQVLSMMKQLYKECN--LVHADLSE 153 (197)
T ss_pred HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc--cccCHHHHHHHHHHHHHHHHHHHHhCC--eecCCCCH
Confidence 9863 466677754 56899999997654422 2322 2355666778889999999999 8888 99999999
Q ss_pred CCEEEcCCCcEEEEecCCcccccC
Q 005841 634 SNLLVDKHWTVKVGDFGLSRLKHE 657 (674)
Q Consensus 634 ~NILi~~~~~vkL~DFGla~~~~~ 657 (674)
.|||+.. +.++|+|||.|.....
T Consensus 154 ~NIL~~~-~~v~iIDF~qav~~~h 176 (197)
T cd05146 154 YNMLWHD-GKVWFIDVSQSVEPTH 176 (197)
T ss_pred HHEEEEC-CcEEEEECCCceeCCC
Confidence 9999974 6899999999976643
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.30 E-value=3e-11 Score=115.08 Aligned_cols=145 Identities=23% Similarity=0.213 Sum_probs=114.9
Q ss_pred EeeeecccCceEEEEEEEcCCeEEEEEeecccCCHH------HHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeEEEEEe
Q 005841 509 IGEQIGQGSCGTVYHAVWYGSDVAVKVFSRQEYSDE------VIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTE 582 (674)
Q Consensus 509 ~~~~LG~G~fG~Vy~~~~~~~~vAvK~i~~~~~~~~------~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E 582 (674)
.+..|-+|+-+.|+++.+.|+.+.||.-..+.+... ...+.++|++++.++.--.|.-..-++.+...-+|+||
T Consensus 11 ~l~likQGAEArv~~~~~~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ME 90 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFSGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYME 90 (229)
T ss_pred cceeeeccceeeEeeeccCCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEEE
Confidence 567888999999999999999999997655555432 33567889999999886677766667777888899999
Q ss_pred cCCC-CCHHHHHHhcCCCCCH-HHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCC---cEEEEecCCcccc
Q 005841 583 FLPR-GSLFRLLQRNTTKLDW-RRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHW---TVKVGDFGLSRLK 655 (674)
Q Consensus 583 ~~~g-gsL~~~l~~~~~~l~~-~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~---~vkL~DFGla~~~ 655 (674)
|++| .++.+++......-.. .....++.+|-..|.-||..+ |||+||..+|||+..++ .+.|+|||++...
T Consensus 91 ~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~nd--iiHGDLTTSNill~~~~~~~~~~lIdfgls~~s 166 (229)
T KOG3087|consen 91 FIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDND--IIHGDLTTSNILLRSDGNQITPILIDFGLSSVS 166 (229)
T ss_pred eccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCC--eecccccccceEEecCCCcCceEEEeecchhcc
Confidence 9987 5788887654333223 333788889999999999999 99999999999997543 4589999998754
|
|
| >PRK13560 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.29 E-value=2.4e-11 Score=145.03 Aligned_cols=130 Identities=15% Similarity=0.125 Sum_probs=107.2
Q ss_pred ccccHHHHHHHHHHhcceeEEEcCCCcEEeecHHHHHHhCCChhhHcCCCccccccccccchhHHHHHHHHHhCceeEEE
Q 005841 125 FNFTDRQYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGERWTGQ 204 (674)
Q Consensus 125 ~~~se~~l~~ilds~~d~I~v~D~~GrIi~~N~a~e~llGys~eEviG~~~~~l~~~~~~~~~~~~i~~~l~~g~~~~~e 204 (674)
+..+++.|+.++++++++|+++|.+|+|++||+++++++||+.+|++|+++.+++++.............+..+.....+
T Consensus 199 l~~~~~~l~~l~e~~~~~i~~~d~~g~i~~~N~~~~~~~G~~~~e~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e 278 (807)
T PRK13560 199 IDEALHFLQQLLDNIADPAFWKDEDAKVFGCNDAACLACGFRREEIIGMSIHDFAPAQPADDYQEADAAKFDADGSQIIE 278 (807)
T ss_pred HHHHHHHHHHHHhhCCCeEEEEcCCCCEEEEhHHHHHHhCCCHHHHcCCcchhcCCcchhHHHHHHHHHHhccCCceEEE
Confidence 34455678999999999999999999999999999999999999999999999887654333222334445566677788
Q ss_pred EEEEcCCCCEEEEEEE--EEEEECCCCCEEEEEEEEEchHHHHHHHHHHHHh
Q 005841 205 FPAKTKTEERVLVVAT--NTPFYDDDGTLVGIVCVSTDSRPFQETRAALWDT 254 (674)
Q Consensus 205 ~~~~~kdG~~~~v~~s--~sPi~d~dG~ivg~i~i~rDITe~k~~e~~L~~l 254 (674)
..+.+++|..+|+.+. ..|+.+.+|.+.|++++++|||++++++++|+..
T Consensus 279 ~~~~~~dG~~~~~~~~~~~~~~~~~~g~~~g~~~~~~DITerk~~e~~L~~s 330 (807)
T PRK13560 279 AEFQNKDGRTRPVDVIFNHAEFDDKENHCAGLVGAITDISGRRAAERELLEK 330 (807)
T ss_pred EEEEcCCCCEEEEEEEecceEEEcCCCCEEEEEEEEEechHHHHHHHHHHHH
Confidence 8899999999966554 4567889999999999999999999999988754
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.23 E-value=2.2e-12 Score=128.36 Aligned_cols=165 Identities=25% Similarity=0.548 Sum_probs=134.4
Q ss_pred CCeeEeeeecccCceEEEEEEEcCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeEEEEEecC
Q 005841 505 EDLTIGEQIGQGSCGTVYHAVWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFL 584 (674)
Q Consensus 505 ~~y~~~~~LG~G~fG~Vy~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 584 (674)
.++.+..+|.+...|..|+|+|.+.++++|++............|..|.-.|+.+.||||+.+++.|..+.++.++..||
T Consensus 190 ~~lnl~tkl~e~hsgelwrgrwqgndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~m 269 (448)
T KOG0195|consen 190 SSLNLITKLAESHSGELWRGRWQGNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYM 269 (448)
T ss_pred hhhhhhhhhccCCCcccccccccCcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeec
Confidence 45566778889999999999999999999999888777777788999999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccccCCccccc
Q 005841 585 PRGSLFRLLQRNT-TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTK 663 (674)
Q Consensus 585 ~ggsL~~~l~~~~-~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~~~~~~~ 663 (674)
+.|+|+..|+... -..+..++..++.+|+.||.|||+..+-|.---|....++||++.+.+|. .+-+++ .+...
T Consensus 270 p~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltaris-mad~kf----sfqe~ 344 (448)
T KOG0195|consen 270 PFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARIS-MADTKF----SFQEV 344 (448)
T ss_pred cchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhhee-ccccee----eeecc
Confidence 9999999998643 34678899999999999999999987544445688899999998887664 122221 11222
Q ss_pred cCCCCccccCC
Q 005841 664 TGKGTVTYLAS 674 (674)
Q Consensus 664 ~~~GTp~YmAP 674 (674)
...-.|.||+|
T Consensus 345 gr~y~pawmsp 355 (448)
T KOG0195|consen 345 GRAYSPAWMSP 355 (448)
T ss_pred ccccCcccCCH
Confidence 23457889987
|
|
| >TIGR02040 PpsR-CrtJ transcriptional regulator PpsR | Back alignment and domain information |
|---|
Probab=99.22 E-value=1.9e-10 Score=128.33 Aligned_cols=114 Identities=15% Similarity=0.030 Sum_probs=90.6
Q ss_pred HHHHHHHHhcceeEEEcCCCcEEeecHHHHHHhCCC-hhhHcCCCccccccccccchhHHHHHHHH-HhCceeEEEEEEE
Q 005841 131 QYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYS-AEEALGQDAIELLTDGRDFDVAYDIVHRI-KMGERWTGQFPAK 208 (674)
Q Consensus 131 ~l~~ilds~~d~I~v~D~~GrIi~~N~a~e~llGys-~eEviG~~~~~l~~~~~~~~~~~~i~~~l-~~g~~~~~e~~~~ 208 (674)
.|+.+|++++++|+++|.+|+|++||++|++++||+ .++++|+++.+++.+... . ...+...+ ..|.....+..+.
T Consensus 253 ~~~~l~e~~~d~I~v~D~~G~I~~~N~a~~~l~G~~~~~~l~G~~~~~~~~~~~~-~-~~~~~~~~~~~g~~~~~~~~~~ 330 (442)
T TIGR02040 253 NLARLYHEAPDAIVFSDADGTIRGANEAFLELTDSSSLEAVRGRTLDRWLGRGGV-D-LRVLLSNVRRTGQVRLYATTLT 330 (442)
T ss_pred HHHHHHHhCCceEEEEcCCCcEEehhHHHHHHhCCCChHHHcCCCHHHHhCCCcc-c-HHHHHHHHhhcCceEEEEEEEE
Confidence 689999999999999999999999999999999997 578999998877764322 1 12233333 3444455566778
Q ss_pred cCCCCEEEEEEEEEEEECCCCCEEEEEEEEEchHHHHHHH
Q 005841 209 TKTEERVLVVATNTPFYDDDGTLVGIVCVSTDSRPFQETR 248 (674)
Q Consensus 209 ~kdG~~~~v~~s~sPi~d~dG~ivg~i~i~rDITe~k~~e 248 (674)
+++|..+|++++++|+.+.++ ..++++++|||++++.+
T Consensus 331 ~~~G~~~~ve~s~~~i~~~~~--~~~~~v~rDITeR~~~~ 368 (442)
T TIGR02040 331 GEFGAQTEVEISAAWVDQGER--PLIVLVIRDISRRLTMR 368 (442)
T ss_pred cCCCCEEEEEEEEEEeccCCc--eEEEEEEecchhhccCC
Confidence 999999999999999986544 45788999999988764
|
This model represents the transcriptional regulator PpsR which is strictly associated with photosynthetic proteobacteria and found in photosynthetic operons. PpsR has been reported to be a repressor. These proteins contain a Helix-Turn_Helix motif of the "fis" type (pfam02954). |
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.22 E-value=1.2e-11 Score=129.16 Aligned_cols=151 Identities=27% Similarity=0.440 Sum_probs=107.7
Q ss_pred cccccccCCeeEeeeecccCceEEEEEEEcC---------C----------------------------eEEEEEeeccc
Q 005841 498 LDYEILWEDLTIGEQIGQGSCGTVYHAVWYG---------S----------------------------DVAVKVFSRQE 540 (674)
Q Consensus 498 ~~~~~~~~~y~~~~~LG~G~fG~Vy~~~~~~---------~----------------------------~vAvK~i~~~~ 540 (674)
.+..+..++|+|++.||+|+...||.+.... . +.|||.+..-.
T Consensus 150 ~dskFtiddyeiG~~igkGC~AaVY~A~~~~dg~~le~~~~t~~~pgf~p~ts~p~e~~q~~~p~~~aFPLAiKmMfN~~ 229 (598)
T KOG4158|consen 150 IDSKFTIDDYEIGEFIGKGCNAAVYSARLANDGSDLESSGNTHYGPGFNPVTSIPAEIPQVSKPAQKAFPLAIKMMFNFE 229 (598)
T ss_pred hhcccchhhhcccchhhccchhhhhhhhcCCCcccccccCCCCcCCCcCCCcCCcccCCcccCccccccchHHHHhcccc
Confidence 4446777999999999999999999875310 0 15666553222
Q ss_pred C---CHHHHHHHHHHHH--------------HHhh--------CCCCCeeeEEEEEec----------------------
Q 005841 541 Y---SDEVIHSFRQEVS--------------LMKR--------LRHPNVLLFMGAVTS---------------------- 573 (674)
Q Consensus 541 ~---~~~~~~~~~~Ei~--------------il~~--------l~HpnIv~l~~~~~~---------------------- 573 (674)
. ....++...+|+- ..+. -+|||||.++.+|.+
T Consensus 230 ~~s~~~~iL~sM~~ElvPa~~~a~~~e~~~~t~R~l~nqtvhLa~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p 309 (598)
T KOG4158|consen 230 HDSGDAHILKSMGNELVPAPNAAKLLEGQMGTFRPLPNQTVHLAKHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYP 309 (598)
T ss_pred cCCchHHHHHHhhhhccCcchhhhhcccccceeeeCCCCCcccCCCCCEEeehhhhhhhhccCCchhhhCcccccceecc
Confidence 1 1123333333321 1111 259999999988743
Q ss_pred -----CCeEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEc--CCC--cE
Q 005841 574 -----PQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVD--KHW--TV 644 (674)
Q Consensus 574 -----~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~--~~~--~v 644 (674)
+..+|+||.-.+ .+|..++..+ ..+......|+.|+++|+.|||++| |.|||||.+||||. +++ .+
T Consensus 310 ~g~g~~~tlylvMkrY~-~tLr~yl~~~--~~s~r~~~~~laQlLEav~hL~~hg--vAhRDlKSDNiL~ElddD~~P~L 384 (598)
T KOG4158|consen 310 SGAGEPKTLYLVMKRYR-QTLREYLWTR--HRSYRTGRVILAQLLEAVTHLHKHG--VAHRDLKSDNILLELDDDEIPQL 384 (598)
T ss_pred cccCCCceEEEehhcch-hhHHHHHhcC--CCchHHHHHHHHHHHHHHHHHHHcc--chhhcccccceEEEecCCCCcEE
Confidence 235899999774 4999999643 4567778888899999999999999 99999999999984 444 47
Q ss_pred EEEecCCcc
Q 005841 645 KVGDFGLSR 653 (674)
Q Consensus 645 kL~DFGla~ 653 (674)
.|+|||+|-
T Consensus 385 VvaDFGCcL 393 (598)
T KOG4158|consen 385 VVADFGCCL 393 (598)
T ss_pred EEcccceee
Confidence 899999874
|
|
| >PRK13558 bacterio-opsin activator; Provisional | Back alignment and domain information |
|---|
Probab=99.22 E-value=1.8e-10 Score=135.22 Aligned_cols=125 Identities=22% Similarity=0.255 Sum_probs=110.6
Q ss_pred HHHHHHHHHhcceeEEEcC---CCcEEeecHHHHHHhCCChhhHcCCCccccccccccchhHHHHHHHHHhCceeEEEEE
Q 005841 130 RQYLNILQSMGQSVHIFDL---SDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGERWTGQFP 206 (674)
Q Consensus 130 ~~l~~ilds~~d~I~v~D~---~GrIi~~N~a~e~llGys~eEviG~~~~~l~~~~~~~~~~~~i~~~l~~g~~~~~e~~ 206 (674)
..++.+++..+++|++.|. +|+|+|||+++++++||+.++++|+++.+++++.........+...+..+..+..++.
T Consensus 148 r~~~~~~~~~~~gi~~~d~~~~dg~i~~~N~~~~~l~G~~~eel~g~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~e~~ 227 (665)
T PRK13558 148 RLKERALDEAPVGITIADATLPDEPLIYINDAFERITGYSPDEVLGRNCRFLQGEDTNEERVAELREAIDEERPTSVELR 227 (665)
T ss_pred HHHHHHHhcCCccEEEEcCCCCCCcEEEEcHHHHHHhCcCHHHHcCCCHHHhcCCCccHHHHHHHHHHHhcCCCeEEEEE
Confidence 3467899999999999984 8999999999999999999999999988887766555555556677778888888999
Q ss_pred EEcCCCCEEEEEEEEEEEECCCCCEEEEEEEEEchHHHHHHHHHHHHh
Q 005841 207 AKTKTEERVLVVATNTPFYDDDGTLVGIVCVSTDSRPFQETRAALWDT 254 (674)
Q Consensus 207 ~~~kdG~~~~v~~s~sPi~d~dG~ivg~i~i~rDITe~k~~e~~L~~l 254 (674)
..+++|..+|+.++..|+++.+|.+.+++++++|||++|+.+++|++.
T Consensus 228 ~~~~dG~~~~~~~~~~pi~d~~G~~~~~vgi~~DITerk~~E~~L~~~ 275 (665)
T PRK13558 228 NYRKDGSTFWNQVDIAPIRDEDGTVTHYVGFQTDVTERKEAELALQRE 275 (665)
T ss_pred EECCCCCEEEEEEEEEEEECCCCCEEEEEEEEEeCcHHHHHHHHHHHH
Confidence 999999999999999999999999999999999999999999988754
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.20 E-value=9.3e-11 Score=121.75 Aligned_cols=150 Identities=23% Similarity=0.327 Sum_probs=98.3
Q ss_pred CeeEeeeecccCceEEEEEEE--cCCeEEEEEeecccC-CHHHHHHHHHHHHHHhhCCC----------CCeeeEEEEEe
Q 005841 506 DLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEY-SDEVIHSFRQEVSLMKRLRH----------PNVLLFMGAVT 572 (674)
Q Consensus 506 ~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~H----------pnIv~l~~~~~ 572 (674)
.+.....||.|+++.||.+++ ++.++|+|++.-... ....++.+++|.-....+.+ -.++..++...
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~ 92 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR 92 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence 467889999999999999999 568899999865442 22456777777755555332 12333333322
Q ss_pred c---------C---C-----eEEEEEecCCCCCHHHHHHh---cCCC---CCHHHHHHHHHHHHHHHHHHHhCCCCeEEc
Q 005841 573 S---------P---Q-----RLCIVTEFLPRGSLFRLLQR---NTTK---LDWRRRILMALDIARGVSYLHHCNPPIIHR 629 (674)
Q Consensus 573 ~---------~---~-----~~~lV~E~~~ggsL~~~l~~---~~~~---l~~~~~~~i~~qi~~~L~yLH~~~~~IvHr 629 (674)
. . . +.+++|+-+ -++|.+++.. .... +.....+.+..|+++.+++||..| |||+
T Consensus 93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G--lVHg 169 (288)
T PF14531_consen 93 IPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYG--LVHG 169 (288)
T ss_dssp ETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT--EEES
T ss_pred EcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcc--eEec
Confidence 1 1 1 247788877 5588877542 2211 223344566689999999999999 9999
Q ss_pred cCCCCCEEEcCCCcEEEEecCCcccccCC
Q 005841 630 DLKSSNLLVDKHWTVKVGDFGLSRLKHET 658 (674)
Q Consensus 630 DLKp~NILi~~~~~vkL~DFGla~~~~~~ 658 (674)
||||+|||++.+|.++|+||+......+.
T Consensus 170 di~~~nfll~~~G~v~Lg~F~~~~r~g~~ 198 (288)
T PF14531_consen 170 DIKPENFLLDQDGGVFLGDFSSLVRAGTR 198 (288)
T ss_dssp T-SGGGEEE-TTS-EEE--GGGEEETTEE
T ss_pred ccceeeEEEcCCCCEEEcChHHHeecCce
Confidence 99999999999999999999987665543
|
|
| >PRK09776 putative diguanylate cyclase; Provisional | Back alignment and domain information |
|---|
Probab=99.19 E-value=9e-11 Score=145.26 Aligned_cols=129 Identities=16% Similarity=0.124 Sum_probs=110.5
Q ss_pred cccHHHHHHHHHHhcceeEEEcCCCcEEeecHHHHHHhCCChhhHcCCCccccccccccchhHHHHHHHHHhCc--eeEE
Q 005841 126 NFTDRQYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGE--RWTG 203 (674)
Q Consensus 126 ~~se~~l~~ilds~~d~I~v~D~~GrIi~~N~a~e~llGys~eEviG~~~~~l~~~~~~~~~~~~i~~~l~~g~--~~~~ 203 (674)
..++++++.+++.++++|+++|.+|+|++||+++++++||+.+|++|+++.+++++++...... ....+..++ .+..
T Consensus 279 ~~~e~r~~~l~e~~~~~i~~~d~dG~i~~~N~~~~~l~G~~~~el~g~~~~~~~~~~d~~~~~~-~~~~~~~~~~~~~~~ 357 (1092)
T PRK09776 279 SESETRFRNAMEYSAIGMALVGTEGQWLQVNKALCQFLGYSQEELRGLTFQQLTWPEDLNKDLQ-QVEKLLSGEINSYSM 357 (1092)
T ss_pred HHHHHHHHHHHHhCCceEEEEcCCCcEEehhHHHHHHhCCCHHHHccCCceeccCcchhHhHHH-HHHHHHcCCccceee
Confidence 3567789999999999999999999999999999999999999999999998887765443332 333334443 3677
Q ss_pred EEEEEcCCCCEEEEEEEEEEEECCCCCEEEEEEEEEchHHHHHHHHHHHHhh
Q 005841 204 QFPAKTKTEERVLVVATNTPFYDDDGTLVGIVCVSTDSRPFQETRAALWDTK 255 (674)
Q Consensus 204 e~~~~~kdG~~~~v~~s~sPi~d~dG~ivg~i~i~rDITe~k~~e~~L~~la 255 (674)
+.++.+++|..+|+.++..|+++.+|.+.+++++++|||++|++|++++++.
T Consensus 358 e~~~~~~dG~~~~~~~~~~~~~~~~g~~~~~i~~~~DITerk~~e~~l~~~~ 409 (1092)
T PRK09776 358 EKRYYRRDGEVVWALLAVSLVRDTDGTPLYFIAQIEDINELKRTEQVNERLM 409 (1092)
T ss_pred eeEEEcCCCCEEEEEEEEEEEECCCCCEeeehhhHHhhHHHHHHHHHHHHHH
Confidence 8889999999999999999999999999999999999999999999887654
|
|
| >PRK11073 glnL nitrogen regulation protein NR(II); Provisional | Back alignment and domain information |
|---|
Probab=99.18 E-value=2.4e-10 Score=122.99 Aligned_cols=144 Identities=15% Similarity=0.072 Sum_probs=110.7
Q ss_pred HHHHHHHHHHhcceeEEEcCCCcEEeecHHHHHHhCCChhhHcCCCccccccccccchhHHHHHHHHHhCceeEEEEEEE
Q 005841 129 DRQYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGERWTGQFPAK 208 (674)
Q Consensus 129 e~~l~~ilds~~d~I~v~D~~GrIi~~N~a~e~llGys~eEviG~~~~~l~~~~~~~~~~~~i~~~l~~g~~~~~e~~~~ 208 (674)
...+.++|++++++++++|.+|+|++||+++++++||+.++++|+++.++++.... ....+...+..+..+......+
T Consensus 6 ~~~~~~il~~~~~gi~~~d~~~~i~~~N~a~~~~~g~~~~~~~g~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 83 (348)
T PRK11073 6 LPDAGQILNSLINSILLLDDDLAIHYANPAAQQLLAQSSRKLFGTPLPELLSYFSL--NIELMRESLQAGQGFTDNEVTL 83 (348)
T ss_pred cchHHHHHhcCcCeEEEECCCCeEeeEcHHHHHHhCCCHHHHcCCCHHHHcCcchh--hHHHHHHHHHcCCcccccceEE
Confidence 34689999999999999999999999999999999999999999999998865321 1223445566666554444455
Q ss_pred cCCCCEEEEEEEEEEEECCCCCEEEEEEEEEchHHHHHHHHHHHHhhhcCCccCcCCchhHHHHHhcCCccchhhHHH
Q 005841 209 TKTEERVLVVATNTPFYDDDGTLVGIVCVSTDSRPFQETRAALWDTKNSDTDSNINRPRNTVTAKLGLDSQQPLQATI 286 (674)
Q Consensus 209 ~kdG~~~~v~~s~sPi~d~dG~ivg~i~i~rDITe~k~~e~~L~~la~~d~lt~~nr~~~~~~~kl~~~~~qpl~~~i 286 (674)
..+|..+|+.++.+|+. + .+++..++|||+++++++++.+.+.. .....+...++|+.+.||+.+.
T Consensus 84 ~~~g~~~~~~~~~~~~~--~---~~~~~~~~dit~~~~~~~~~~~~~~~-------~~~~~~~~~iaHelr~pL~~i~ 149 (348)
T PRK11073 84 VIDGRSHILSLTAQRLP--E---GMILLEMAPMDNQRRLSQEQLQHAQQ-------VAARDLVRGLAHEIKNPLGGLR 149 (348)
T ss_pred EECCceEEEEEEEEEcc--C---ceeEEEEechhHHHHHHHHHHHHHHH-------HHHHHHHHhhhHhhcChHHHHH
Confidence 67999999999999997 2 24567899999999988877654331 1224567778888888888743
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.16 E-value=1.7e-10 Score=115.47 Aligned_cols=142 Identities=21% Similarity=0.245 Sum_probs=107.7
Q ss_pred eeecccCceEEEEEEEcC-CeEEEEEeecccCCHHHHHHHHHHHHHHhhCCC--CCeeeEEEEEecCC---eEEEEEecC
Q 005841 511 EQIGQGSCGTVYHAVWYG-SDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRH--PNVLLFMGAVTSPQ---RLCIVTEFL 584 (674)
Q Consensus 511 ~~LG~G~fG~Vy~~~~~~-~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~H--pnIv~l~~~~~~~~---~~~lV~E~~ 584 (674)
+.|+.|.++.||++...+ ..|++|+....... .....+.+|+.+++.+.+ .++.+++.+..... ..++||||+
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~-~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i 82 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALL-PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERV 82 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccC-cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEe
Confidence 568999999999998765 78999987654321 123467889999999975 44667777766542 678999999
Q ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC------------------------------------------
Q 005841 585 PRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHC------------------------------------------ 622 (674)
Q Consensus 585 ~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~------------------------------------------ 622 (674)
+|.+|.+.+.. ..+++.....++.+++..|.+||+.
T Consensus 83 ~G~~l~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (223)
T cd05154 83 DGRVLRDRLLR--PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERL 160 (223)
T ss_pred CCEecCCCCCC--CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHH
Confidence 99887665431 3466777777788888888888742
Q ss_pred ------------CCCeEEccCCCCCEEEcC--CCcEEEEecCCcccc
Q 005841 623 ------------NPPIIHRDLKSSNLLVDK--HWTVKVGDFGLSRLK 655 (674)
Q Consensus 623 ------------~~~IvHrDLKp~NILi~~--~~~vkL~DFGla~~~ 655 (674)
...++|+|+.|.|||++. ++.+.|+||+.+...
T Consensus 161 ~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~g 207 (223)
T cd05154 161 LRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATLG 207 (223)
T ss_pred HHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEeccccccC
Confidence 124799999999999998 667899999998754
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >TIGR02966 phoR_proteo phosphate regulon sensor kinase PhoR | Back alignment and domain information |
|---|
Probab=99.15 E-value=4.2e-10 Score=119.17 Aligned_cols=128 Identities=17% Similarity=0.263 Sum_probs=97.5
Q ss_pred cHHHHHHHHHHhcceeEEEcCCCcEEeecHHHHHHhCCChhhHcCCCccccccccccchhHHHHHHHHHhCceeEEEEEE
Q 005841 128 TDRQYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGERWTGQFPA 207 (674)
Q Consensus 128 se~~l~~ilds~~d~I~v~D~~GrIi~~N~a~e~llGys~eEviG~~~~~l~~~~~~~~~~~~i~~~l~~g~~~~~e~~~ 207 (674)
..+.|+.++++++++|+++|.+|+|++||+++++++||+.++++|+++.+++.++. +...+..+.. ...+.+
T Consensus 4 ~~~~l~~~~~~~~~~i~~~d~~g~i~~~N~~~~~~~g~~~~~~~g~~~~~~~~~~~-------~~~~l~~~~~-~~~~~~ 75 (333)
T TIGR02966 4 LLSRFRAAAQALPDAVVVLDEEGQIEWCNPAAERLLGLRWPDDLGQRITNLIRHPE-------FVEYLAAGRF-SEPLEL 75 (333)
T ss_pred HHHHHHHHHHhCcCcEEEECCCCcEEEEcHHHHHHhCCChHHHcCCcHHHHccCHH-------HHHHHHhccc-CCCeEe
Confidence 45679999999999999999999999999999999999999999999988876532 3333433332 222445
Q ss_pred EcCCCCEEEEEEEEEEEECCCCCEEEEEEEEEchHHHHHHHHHHHHhhhcCCccCcCCchhHHHHHhcCCccchhhH
Q 005841 208 KTKTEERVLVVATNTPFYDDDGTLVGIVCVSTDSRPFQETRAALWDTKNSDTDSNINRPRNTVTAKLGLDSQQPLQA 284 (674)
Q Consensus 208 ~~kdG~~~~v~~s~sPi~d~dG~ivg~i~i~rDITe~k~~e~~L~~la~~d~lt~~nr~~~~~~~kl~~~~~qpl~~ 284 (674)
..++|..+|+.+...|+.+.+ ++++++|||+++++++.... +...++|+...|++.
T Consensus 76 ~~~~~~~~~~~~~~~p~~~~~-----~~~~~~dit~~~~~~~~~~~----------------~~~~l~h~l~~pL~~ 131 (333)
T TIGR02966 76 PSPINSERVLEIRIAPYGEEQ-----KLLVARDVTRLRRLEQMRRD----------------FVANVSHELRTPLTV 131 (333)
T ss_pred ecCCCCceEEEEEEEEcCCCc-----eEEEEeCchHHHHHHHHHHH----------------HHHhhhhhhcccHHH
Confidence 557888999999999997532 67889999999988765433 344455566666655
|
Members of this protein family are the regulatory histidine kinase PhoR associated with the phosphate ABC transporter in most Proteobacteria. Related proteins from Gram-positive organisms are not included in this model. The phoR gene usually is adjacent to the response regulator phoB gene (TIGR02154). |
| >PRK11360 sensory histidine kinase AtoS; Provisional | Back alignment and domain information |
|---|
Probab=99.13 E-value=7.5e-10 Score=127.06 Aligned_cols=148 Identities=16% Similarity=0.216 Sum_probs=114.4
Q ss_pred ccHHHHHHHHHHhcceeEEEcCCCcEEeecHHHHHHhCCChhhHcCCCccccccccccchhHHHHHHHHHhCce-eEEEE
Q 005841 127 FTDRQYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGER-WTGQF 205 (674)
Q Consensus 127 ~se~~l~~ilds~~d~I~v~D~~GrIi~~N~a~e~llGys~eEviG~~~~~l~~~~~~~~~~~~i~~~l~~g~~-~~~e~ 205 (674)
..+..++.+++.++++++++|.+|+|+++|+++++++||+.++++|+++.+++++.. .....+...+..+.. ...++
T Consensus 259 ~~~~~~~~i~~~~~~~i~~~d~~g~i~~~N~~~~~l~g~~~~~~~g~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~ 336 (607)
T PRK11360 259 ETRSLNELILESIADGVIAIDRQGKITTMNPAAEVITGLQRHELVGKPYSELFPPNT--PFASPLLDTLEHGTEHVDLEI 336 (607)
T ss_pred HHHHHHHHHHHhccCeEEEEcCCCCEEEECHHHHHHhCCChHHhcCCcHHHHcCCch--hHHHHHHHHHhcCCCccceEE
Confidence 344577889999999999999999999999999999999999999999998887543 223334455555554 33456
Q ss_pred EEEcCCCCEEEEEEEEEEEECCCCCEEEEEEEEEchHHHHHHHHHHHHhhhcCCccCcCCchhHHHHHhcCCccchhhH
Q 005841 206 PAKTKTEERVLVVATNTPFYDDDGTLVGIVCVSTDSRPFQETRAALWDTKNSDTDSNINRPRNTVTAKLGLDSQQPLQA 284 (674)
Q Consensus 206 ~~~~kdG~~~~v~~s~sPi~d~dG~ivg~i~i~rDITe~k~~e~~L~~la~~d~lt~~nr~~~~~~~kl~~~~~qpl~~ 284 (674)
.+..++|... +.++..|+++.+|++.|++++++|||+++++++++++..... ....+...++|+...|++.
T Consensus 337 ~~~~~~~~~~-~~~~~~~i~~~~g~~~~~i~~~~Dite~~~~e~~l~~~~~~~-------~l~~~~~~~~hel~~~l~~ 407 (607)
T PRK11360 337 SFPGRDRTIE-LSVSTSLLHNTHGEMIGALVIFSDLTERKRLQRRVARQERLA-------ALGELVAGVAHEIRNPLTA 407 (607)
T ss_pred EEEcCCCcEE-EEEEEeeEEcCCCCEEEEEEEEeechHHHHHHHHHHHHHHHH-------HHHHHHHHHHHHhhhHHHH
Confidence 6677778776 899999999999999999999999999999999887763311 1123455566666666655
|
|
| >PF13596 PAS_10: PAS domain; PDB: 3CAX_A 2QKP_D | Back alignment and domain information |
|---|
Probab=99.09 E-value=4.2e-10 Score=99.99 Aligned_cols=106 Identities=22% Similarity=0.326 Sum_probs=77.7
Q ss_pred HHHHHHHhcceeEEEcCCCcEEeecHHHHHHhCCChhhHcCCCccccccccccchhHHHHHHHHHhCceeEEEEEEEcCC
Q 005841 132 YLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGERWTGQFPAKTKT 211 (674)
Q Consensus 132 l~~ilds~~d~I~v~D~~GrIi~~N~a~e~llGys~eEviG~~~~~l~~~~~~~~~~~~i~~~l~~g~~~~~e~~~~~kd 211 (674)
++++|++++.+++++|.+++|.|+|+++.+++++.. ..+|+++.++.++ ........+.+.+..|+....+.... .+
T Consensus 1 L~~il~s~~~~i~~vD~~~~I~~~n~~a~~~f~~~~-~~iGr~l~~~~~~-~~~~~l~~~i~~~~~~~~~~~~~~~~-~~ 77 (106)
T PF13596_consen 1 LNNILDSMPIGIIFVDRNLRIRYFNPAAARLFNLSP-SDIGRPLFDIHPP-LSYPNLKKIIEQVRSGKEEEFEIVIP-NG 77 (106)
T ss_dssp HHHHHHHSSSEEEEEETTSBEEEE-SCGC-SS---G-GGTTSBCCCSS-H-HHHHHHHHHHHHHHTTSBSEEEEEEE-ET
T ss_pred ChHHHhcCCCCEEEEcCCCeEEEeChhHhhhcCCCh-HHCCCCHHHcCCc-cchHHHHHHHHHHHcCCCceEEEEec-CC
Confidence 578999999999999999999999999999999765 5689999988766 33444555667778888644443333 34
Q ss_pred CCEEEEEEEEEEEECCCCCEEEEEEEEEchH
Q 005841 212 EERVLVVATNTPFYDDDGTLVGIVCVSTDSR 242 (674)
Q Consensus 212 G~~~~v~~s~sPi~d~dG~ivg~i~i~rDIT 242 (674)
| .|+.+...|++|++|++.|++.++.|||
T Consensus 78 ~--~~~~~~~~P~~~~~g~~~G~v~~~~DIT 106 (106)
T PF13596_consen 78 G--RWYLVRYRPYRDEDGEYAGAVITFQDIT 106 (106)
T ss_dssp T--EEEEEEEEEEE-TTS-EEEEEEEEEE-G
T ss_pred C--EEEEEEEEEEECCCCCEEEEEEEEEecC
Confidence 4 5567899999999999999999999998
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.09 E-value=2.5e-11 Score=140.10 Aligned_cols=143 Identities=21% Similarity=0.286 Sum_probs=118.8
Q ss_pred CeeEeeeecccCceEEEEEEEcCCeEEEEEeecccCC--HHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeEEEEEec
Q 005841 506 DLTIGEQIGQGSCGTVYHAVWYGSDVAVKVFSRQEYS--DEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEF 583 (674)
Q Consensus 506 ~y~~~~~LG~G~fG~Vy~~~~~~~~vAvK~i~~~~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~ 583 (674)
+|...+.||.+.|=+|.+|++....|+||++-++... -.-..+...|++ +..+++||++.+.-+.......|||-+|
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRqy 102 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGLVVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQY 102 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCceEEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHHHH
Confidence 6888999999999999999987677999999876532 222333444666 6677899999998888888888999999
Q ss_pred CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcc
Q 005841 584 LPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSR 653 (674)
Q Consensus 584 ~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~ 653 (674)
+ .-+|+|.|.. +..+..-+...|+.|++.||.-||..| |+|+|||.+||||+.=.=+.|+||---+
T Consensus 103 v-khnLyDRlST-RPFL~~iEKkWiaFQLL~al~qcH~~g--VcHGDIKsENILiTSWNW~~LtDFAsFK 168 (1431)
T KOG1240|consen 103 V-KHNLYDRLST-RPFLVLIEKKWIAFQLLKALSQCHKLG--VCHGDIKSENILITSWNWLYLTDFASFK 168 (1431)
T ss_pred H-hhhhhhhhcc-chHHHHHHHHHHHHHHHHHHHHHHHcC--ccccccccceEEEeeechhhhhcccccC
Confidence 9 5599999975 446778889999999999999999999 9999999999999976668999997644
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.08 E-value=1e-11 Score=142.39 Aligned_cols=167 Identities=26% Similarity=0.371 Sum_probs=135.2
Q ss_pred CeeEeeeecccCceEEEEEEEc---CCeEEEEEeecccCCHHHHHHHHHHHHHHhhCC-CCCeeeEEEEEecCCeEEEEE
Q 005841 506 DLTIGEQIGQGSCGTVYHAVWY---GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLR-HPNVLLFMGAVTSPQRLCIVT 581 (674)
Q Consensus 506 ~y~~~~~LG~G~fG~Vy~~~~~---~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~lV~ 581 (674)
.|.+...||+|+|+.|-..... ...+|+|.+...............|..+-+.+. |.|++.+++........++++
T Consensus 21 ~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~ 100 (601)
T KOG0590|consen 21 QYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLSL 100 (601)
T ss_pred cccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccccc
Confidence 4667777999999999887652 233677766654433344555666888888887 999999999999999999999
Q ss_pred ecCCCCCHHHHH-HhcCCCCCHHHHHHHHHHHHHHHHHHH-hCCCCeEEccCCCCCEEEcCCC-cEEEEecCCcccccC-
Q 005841 582 EFLPRGSLFRLL-QRNTTKLDWRRRILMALDIARGVSYLH-HCNPPIIHRDLKSSNLLVDKHW-TVKVGDFGLSRLKHE- 657 (674)
Q Consensus 582 E~~~ggsL~~~l-~~~~~~l~~~~~~~i~~qi~~~L~yLH-~~~~~IvHrDLKp~NILi~~~~-~vkL~DFGla~~~~~- 657 (674)
+|..|+++++.+ .......+...+..++.|+..++.|+| ..+ +.||||||+|.+++..+ .+++.|||+|..+..
T Consensus 101 ~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~--~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~~ 178 (601)
T KOG0590|consen 101 SYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENG--VTHRDIKPSNSLLDESGSALKIADFGLATAYRNK 178 (601)
T ss_pred CcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccc--cccCCCCCccchhccCCCcccCCCchhhcccccc
Confidence 999999999988 433336778889999999999999999 888 99999999999999999 999999999977644
Q ss_pred --CccccccCCC-CccccCC
Q 005841 658 --TYLTTKTGKG-TVTYLAS 674 (674)
Q Consensus 658 --~~~~~~~~~G-Tp~YmAP 674 (674)
........+| ++.|+||
T Consensus 179 ~g~~~~~~~~~g~s~~y~a~ 198 (601)
T KOG0590|consen 179 NGAERSLKDRCGSSPPYGAP 198 (601)
T ss_pred CCcceeeecccCCCCCCCCc
Confidence 2223334578 9999998
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.07 E-value=1.1e-10 Score=134.96 Aligned_cols=128 Identities=33% Similarity=0.467 Sum_probs=89.1
Q ss_pred CCeeEeeeecccCceEEEEEEEc--CCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeEEEEEe
Q 005841 505 EDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTE 582 (674)
Q Consensus 505 ~~y~~~~~LG~G~fG~Vy~~~~~--~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E 582 (674)
.+|..+++|-.|+||.||.++++ ..++|+| ++++.+-. ++ |+.....|++|
T Consensus 83 ~df~~IklisngAygavylvrh~~trqrfa~k-iNkq~lil------Rn---ilt~a~npfvv----------------- 135 (1205)
T KOG0606|consen 83 SDFNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQNLIL------RN---ILTFAGNPFVV----------------- 135 (1205)
T ss_pred cccceeEeeccCCCCceeeeeccccccchhhc-ccccchhh------hc---cccccCCccee-----------------
Confidence 56888999999999999999875 6779994 55443211 11 23333334433
Q ss_pred cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCccccc------
Q 005841 583 FLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKH------ 656 (674)
Q Consensus 583 ~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~------ 656 (674)
|+-..+++. -+.++. +++.+++|||+.+ |+|||+||+|+||+.-|++|+.|||+++...
T Consensus 136 ----gDc~tllk~-~g~lPv--------dmvla~Eylh~yg--ivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atn 200 (1205)
T KOG0606|consen 136 ----GDCATLLKN-IGPLPV--------DMVLAVEYLHSYG--IVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATN 200 (1205)
T ss_pred ----chhhhhccc-CCCCcc--------hhhHHhHhhccCC--eecCCCCCCcceeeecccccccchhhhhhhhhhccch
Confidence 344444533 222322 3478999999999 9999999999999999999999999997632
Q ss_pred --CCcc-------ccccCCCCccccCC
Q 005841 657 --ETYL-------TTKTGKGTVTYLAS 674 (674)
Q Consensus 657 --~~~~-------~~~~~~GTp~YmAP 674 (674)
+.++ ..+..||||.|+||
T Consensus 201 l~eg~I~k~t~Ef~dKqvcgTPeyiaP 227 (1205)
T KOG0606|consen 201 LKEGHIEKDTHEFQDKQVCGTPEYIAP 227 (1205)
T ss_pred hhhcchHHHHHHhhhccccCCccccCh
Confidence 1111 12335899999998
|
|
| >PRK13560 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.06 E-value=9.2e-10 Score=131.46 Aligned_cols=131 Identities=18% Similarity=0.218 Sum_probs=104.6
Q ss_pred cccccHHHHHHHHHHhcceeEEEcCCCcEEee-cHHHHHHhCCChhhHcCCCccccccccccch----------------
Q 005841 124 AFNFTDRQYLNILQSMGQSVHIFDLSDRIIYW-NRSAELLYGYSAEEALGQDAIELLTDGRDFD---------------- 186 (674)
Q Consensus 124 ~~~~se~~l~~ilds~~d~I~v~D~~GrIi~~-N~a~e~llGys~eEviG~~~~~l~~~~~~~~---------------- 186 (674)
++..+++.|+.++++++++|+++|.+|+|+++ |+++++++||+.++++|+++..+.+......
T Consensus 326 ~L~~se~~l~~l~~~~~~~i~~~d~~g~i~~~nn~~~~~~~G~~~~e~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 405 (807)
T PRK13560 326 ELLEKEDMLRAIIEAAPIAAIGLDADGNICFVNNNAAERMLGWSAAEVMGKPLPGMDPELNEEFWCGDFQEWYPDGRPMA 405 (807)
T ss_pred HHHHHHHHHHHHHHhCcccEEEEcCCCCEEEecCHHHHHHhCCCHHHHcCCCccccChhhhhhhhhchhhhcCCcCCcch
Confidence 34456678999999999999999999999987 6788889999999999998776544221100
Q ss_pred -hHHHHHHHHHhCceeE-EEEEEEcCCCCEEEEEEEEEEEECCCCCEEEEEEEEEchHHHHHHHHHHHHh
Q 005841 187 -VAYDIVHRIKMGERWT-GQFPAKTKTEERVLVVATNTPFYDDDGTLVGIVCVSTDSRPFQETRAALWDT 254 (674)
Q Consensus 187 -~~~~i~~~l~~g~~~~-~e~~~~~kdG~~~~v~~s~sPi~d~dG~ivg~i~i~rDITe~k~~e~~L~~l 254 (674)
..+.+...+..+..+. .++.+.+++|..+|+.++..|++|.+|+++|++++++|||++|++|++|++.
T Consensus 406 ~~~~~~~~~~~~~~~~~~~e~~~~~~~g~~~~~~~~~~p~~d~~g~~~~~~~~~~DITerk~~E~~L~~~ 475 (807)
T PRK13560 406 FDACPMAKTIKGGKIFDGQEVLIEREDDGPADCSAYAEPLHDADGNIIGAIALLVDITERKQVEEQLLLA 475 (807)
T ss_pred hhhhhHHHHHhcCCcccCceEEEEcCCCCeEEEEEEEeeeECCCCCEEEEEEEeehhhhHHHHHHHHHHH
Confidence 0111233456666543 4677888999999999999999999999999999999999999999998765
|
|
| >PRK11359 cyclic-di-GMP phosphodiesterase; Provisional | Back alignment and domain information |
|---|
Probab=99.05 E-value=1.4e-09 Score=130.10 Aligned_cols=125 Identities=23% Similarity=0.263 Sum_probs=104.7
Q ss_pred cHHHHHHHHHHhcceeEEEcCCCcEEeecHHHHHHhCCChhhHcCCCccccccccccc-hhHHHHHHHHHhCceeEEEEE
Q 005841 128 TDRQYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDF-DVAYDIVHRIKMGERWTGQFP 206 (674)
Q Consensus 128 se~~l~~ilds~~d~I~v~D~~GrIi~~N~a~e~llGys~eEviG~~~~~l~~~~~~~-~~~~~i~~~l~~g~~~~~e~~ 206 (674)
..+.+..+++.++++|+++|.+|+|+++|+++++++||+.++++|+.+.++++.+... .....+...+..+..+..++.
T Consensus 134 ~~~~~~~~~~~~~~~i~~~d~~g~i~~~N~~~~~l~G~~~~e~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~ 213 (799)
T PRK11359 134 QTRQLIIAVDHLDRPVIVLDPERRIVQCNRAFTEMFGYCISEASGMQPDTLLNIPEFPADNRIRLQQLLWKTARDQDEFL 213 (799)
T ss_pred HHHHHHHHHhcCCCcEEEEcCCCcEEEEChhhHhhhCCCHHHHCCCChHHhcCCCCCcHHHHHHHHHhhccCCCCcceeE
Confidence 3456677899999999999999999999999999999999999999988877644333 333344455666666777888
Q ss_pred EEcCCCCEEEEEEEEEEEECCCCCEEEEEEEEEchHHHHHHHHHHH
Q 005841 207 AKTKTEERVLVVATNTPFYDDDGTLVGIVCVSTDSRPFQETRAALW 252 (674)
Q Consensus 207 ~~~kdG~~~~v~~s~sPi~d~dG~ivg~i~i~rDITe~k~~e~~L~ 252 (674)
..+++|..+|+.++..|+++.+|.+.+++++++|||+++++++..+
T Consensus 214 ~~~~dG~~~~~~~~~~~v~d~~g~~~~~~~~~~DITerk~~e~~~~ 259 (799)
T PRK11359 214 LLTRTGEKIWIKASISPVYDVLAHLQNLVMTFSDITEERQIRQLEG 259 (799)
T ss_pred EeCCCCCEEEEEeeeeeeecCCCceeEEEEEeehhhhHHHHHHHHH
Confidence 8999999999999999999999999999999999999998876443
|
|
| >cd00130 PAS PAS domain; PAS motifs appear in archaea, eubacteria and eukarya | Back alignment and domain information |
|---|
Probab=99.04 E-value=6.2e-09 Score=84.04 Aligned_cols=103 Identities=28% Similarity=0.460 Sum_probs=86.0
Q ss_pred hcceeEEEcCCCcEEeecHHHHHHhCCChhhHcCCCccccccccccchhHHHHHHHHHhCceeEEEEEEEcCCCCEEEEE
Q 005841 139 MGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGERWTGQFPAKTKTEERVLVV 218 (674)
Q Consensus 139 ~~d~I~v~D~~GrIi~~N~a~e~llGys~eEviG~~~~~l~~~~~~~~~~~~i~~~l~~g~~~~~e~~~~~kdG~~~~v~ 218 (674)
++++++++|.+|.++++|.++++++|++.++++|+.+.+++++.........+...+..+.....++.+...+|...|+.
T Consensus 1 ~~~~i~~~d~~~~~~~~n~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 80 (103)
T cd00130 1 LPDGVIVLDLDGRILYANPAAEQLLGYSPEELIGKSLLDLIHPEDREELRERLENLLSGGEPVTLEVRLRRKDGSVIWVL 80 (103)
T ss_pred CCceEEEECCCCcEEEECHHHHHHhCCCHHHHcCccHHHhcCCccchHHHHHHHHHHhcCcCeEEEEEEEccCCCEEEEE
Confidence 36789999999999999999999999999999999988888776654444444444555556777788888889999999
Q ss_pred EEEEEEECCCCCEEEEEEEEEch
Q 005841 219 ATNTPFYDDDGTLVGIVCVSTDS 241 (674)
Q Consensus 219 ~s~sPi~d~dG~ivg~i~i~rDI 241 (674)
+...|+.+.+|...+++++++||
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~di 103 (103)
T cd00130 81 VSLTPIRDEGGEVIGLLGVVRDI 103 (103)
T ss_pred EEEEEEecCCCCEEEEEEEEecC
Confidence 99999998888999999999886
|
Probably the most surprising identification of a PAS domain was that in EAG-like K+-channels. PAS domains have been found to bind ligands, and to act as sensors for light and oxygen in signal transduction. |
| >PRK11388 DNA-binding transcriptional regulator DhaR; Provisional | Back alignment and domain information |
|---|
Probab=99.03 E-value=2e-09 Score=125.71 Aligned_cols=158 Identities=14% Similarity=0.159 Sum_probs=110.7
Q ss_pred HHHHHHHhcceeEEEcCCCcEEeecHHHHHHhCCChhhHcCCCccccccccccchhHHHHHHHHHhCceeEEEEEEEcCC
Q 005841 132 YLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGERWTGQFPAKTKT 211 (674)
Q Consensus 132 l~~ilds~~d~I~v~D~~GrIi~~N~a~e~llGys~eEviG~~~~~l~~~~~~~~~~~~i~~~l~~g~~~~~e~~~~~kd 211 (674)
+..+++++.++|+++|.+|+|+++|+++++++|++.++++|+++.+++.... .+..++.+++...........+
T Consensus 205 ~~~il~~~~~gVl~vD~~G~I~~~N~aa~~llg~s~~~l~G~~i~~l~~~~~------~l~~vl~~~~~~~~~~~~l~~~ 278 (638)
T PRK11388 205 LNALLESMDDGVIAWDEQGNLQFLNAQAARLLRLDATASQGRAITELLTLPA------VLQQAIKQAHPLKHVEVTFESQ 278 (638)
T ss_pred HHHHHhccCCcEEEECCCCeEehhhHHHHHHhCcCHHHHCCCcHHHHhccch------HHHHHHhcCCceeeEEEEEecC
Confidence 4458899999999999999999999999999999999999999999885322 2445667776554433333446
Q ss_pred CCEEEEEEEEEEEECCCCCEEEEEEEEEchHHHHHHHHHHHHhhhcCCccCcCCchhHHHHHhcCCccchhhHHHHHHHH
Q 005841 212 EERVLVVATNTPFYDDDGTLVGIVCVSTDSRPFQETRAALWDTKNSDTDSNINRPRNTVTAKLGLDSQQPLQATIASKIS 291 (674)
Q Consensus 212 G~~~~v~~s~sPi~d~dG~ivg~i~i~rDITe~k~~e~~L~~la~~d~lt~~nr~~~~~~~kl~~~~~qpl~~~iassi~ 291 (674)
|..+++.+++.|+.+..| .+++.+++|++..++.... ... +. ...++.-..-+..+.. +.
T Consensus 279 g~~~~~~v~~~Pi~~~~g--~~~v~~l~~~~~~~~~~~~--~~~---------~~------~~~~~~l~g~s~~~~~-~~ 338 (638)
T PRK11388 279 GQFIDAVITLKPIIEGQG--TSFILLLHPVEQMRQLMTS--QLG---------KV------SHTFDHMPQDSPQMRR-LI 338 (638)
T ss_pred CceEEEEEEEEeecccCc--eEEEEEehhhHHHHHHHHH--hhc---------cc------cccccceEECCHHHHH-HH
Confidence 777788999999975444 3456667888876543111 110 00 0011111111223333 88
Q ss_pred HHHHHHHhhhccccccCCCCCccC
Q 005841 292 NLATKVSNKVKSRIRTGDNFMDRE 315 (674)
Q Consensus 292 ~LA~kva~~~~svLi~Gesg~~~~ 315 (674)
..|.++|....+|||+||+||+|+
T Consensus 339 ~~~~~~a~~~~pvli~Ge~GtGK~ 362 (638)
T PRK11388 339 HFGRQAAKSSFPVLLCGEEGVGKA 362 (638)
T ss_pred HHHHHHhCcCCCEEEECCCCcCHH
Confidence 899999999999999999999996
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.03 E-value=3.9e-09 Score=109.56 Aligned_cols=140 Identities=19% Similarity=0.143 Sum_probs=100.8
Q ss_pred eecccCceEEEEEEEcCCeEEEEEeecccCCHHHHH----------HHHHHHHHHhhCCCCCe--eeEEEEEec-----C
Q 005841 512 QIGQGSCGTVYHAVWYGSDVAVKVFSRQEYSDEVIH----------SFRQEVSLMKRLRHPNV--LLFMGAVTS-----P 574 (674)
Q Consensus 512 ~LG~G~fG~Vy~~~~~~~~vAvK~i~~~~~~~~~~~----------~~~~Ei~il~~l~HpnI--v~l~~~~~~-----~ 574 (674)
.+-+-....|+++.+.|..|.||........ +..+ .+.+|...+..|...+| +.++.++.. .
T Consensus 29 ~v~~~~~rrvvr~~~~g~~~~vKr~~~~~~~-~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~ 107 (268)
T PRK15123 29 VFRELEGRRTLRFELAGKSYFLKWHRGTGWG-EIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPAT 107 (268)
T ss_pred EEecCCCceEEEEEECCEEEEEEEecCCcHH-HHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCcc
Confidence 3433344456677778888999976433311 1111 36788888888753333 344444432 2
Q ss_pred CeEEEEEecCCCC-CHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcC-------CCcEE
Q 005841 575 QRLCIVTEFLPRG-SLFRLLQRN-TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDK-------HWTVK 645 (674)
Q Consensus 575 ~~~~lV~E~~~gg-sL~~~l~~~-~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~-------~~~vk 645 (674)
...+||||++++. +|.+++... ....+......++.+++..+.-||..| |+|+||++.||||+. +..+.
T Consensus 108 ~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~G--i~HgDL~~~NiLl~~~~~~~~~~~~~~ 185 (268)
T PRK15123 108 RTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAG--INHRDCYICHFLLHLPFPGREEDLKLS 185 (268)
T ss_pred ceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCc--CccCCCChhhEEEeccccCCCCCceEE
Confidence 3578999999886 899988532 234566778899999999999999999 999999999999975 46899
Q ss_pred EEecCCccc
Q 005841 646 VGDFGLSRL 654 (674)
Q Consensus 646 L~DFGla~~ 654 (674)
|+||+.++.
T Consensus 186 LIDl~r~~~ 194 (268)
T PRK15123 186 VIDLHRAQI 194 (268)
T ss_pred EEECCcccc
Confidence 999999864
|
|
| >PF08447 PAS_3: PAS fold; InterPro: IPR013655 The PAS fold corresponds to the structural domain that has previously been defined as PAS and PAC motifs [] | Back alignment and domain information |
|---|
Probab=99.01 E-value=3.7e-09 Score=90.53 Aligned_cols=86 Identities=26% Similarity=0.471 Sum_probs=71.9
Q ss_pred EEeecHHHHHHhCCChhhHcCCC----ccccccccccchhHHHHHH-HHHhCceeEEEEEEEcCCCCEEEEEEEEEEEEC
Q 005841 152 IIYWNRSAELLYGYSAEEALGQD----AIELLTDGRDFDVAYDIVH-RIKMGERWTGQFPAKTKTEERVLVVATNTPFYD 226 (674)
Q Consensus 152 Ii~~N~a~e~llGys~eEviG~~----~~~l~~~~~~~~~~~~i~~-~l~~g~~~~~e~~~~~kdG~~~~v~~s~sPi~d 226 (674)
|+|||+.+++++||+++++ +.. +..++++++...+...+.. ....+..+..++++++++|+.+|+.++..+++|
T Consensus 1 ~i~~s~~~~~i~G~~~~~~-~~~~~~~~~~~ihpdD~~~~~~~~~~~~~~~~~~~~~e~R~~~~~G~~~wi~~~~~~~~d 79 (91)
T PF08447_consen 1 IIYWSDNFYEIFGYSPEEI-GKPDFEEWLERIHPDDRERVRQAIQQAALQNGEPFEIEYRIRRKDGEYRWIEVRGRPIFD 79 (91)
T ss_dssp -EEE-THHHHHHTS-HHHH-TCBEHHHHHHHB-TTTHHHHHHHHHHHHHHTT-EEEEEEEEEGTTSTEEEEEEEEEEEET
T ss_pred CEEEeHHHHHHhCCCHHHh-ccCCHHHHHhhcCHHHHHHHHHHHHHHhhccCcceEEEEEEECCCCCEEEEEEEEEEEEC
Confidence 7899999999999999999 777 7778888887777777777 677788999999999999999999999999999
Q ss_pred CCCCEEEEEEEE
Q 005841 227 DDGTLVGIVCVS 238 (674)
Q Consensus 227 ~dG~ivg~i~i~ 238 (674)
++|+++.++|+.
T Consensus 80 ~~g~~~~~~Gv~ 91 (91)
T PF08447_consen 80 ENGKPIRIIGVI 91 (91)
T ss_dssp TTS-EEEEEEEE
T ss_pred CCCCEEEEEEEC
Confidence 999999999874
|
The PAS fold appears in archaea, eubacteria and eukarya. The PAS domain contains a sensory box, or S-box domain that occupies the central portion of the PAS domain but is more widely distributed. It is often tandemly repeated. Known prosthetic groups bound in the S-box domain include haem in the oxygen sensor FixL [], FAD in the redox potential sensor NifL [], and a 4-hydroxycinnamyl chromophore in photoactive yellow protein []. Proteins containing the domain often contain other regulatory domains such as response regulator or sensor histidine kinase domains. Other S-box proteins include phytochromes and the aryl hydrocarbon receptor nuclear translocator. This domain has been found in the gene product of the madA gene of the filamentous zygomycete fungus Phycomyces blakesleeanus. It has been shown that MadA encodes a blue-light photoreceptor for phototropism and other light responses. The gene is involved in the phototropic responses associated with sporangiophore growth; they exhibit phototropism by bending toward near-UV and blue wavelengths and away from far-UV wavelengths in a manner that is physiologically similar to plant phototropic responses [].; GO: 0005515 protein binding; PDB: 3NJA_D 3H9W_A 3GDI_B 3ICY_A 3EEH_A 3MR0_B. |
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=98.99 E-value=1e-09 Score=106.05 Aligned_cols=73 Identities=22% Similarity=0.201 Sum_probs=64.3
Q ss_pred CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccccCCccccccCC
Q 005841 587 GSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGK 666 (674)
Q Consensus 587 gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~~~~~~~~~~ 666 (674)
|+|.+++......+++..++.|+.||+.||.|||+.+ ||+|||++.++.+|+ ||+++...... ..
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~--------kp~Nil~~~~~~~~~--fG~~~~~~~~~-----~~ 65 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA--------KSGNILLTWDGLLKL--DGSVAFKTPEQ-----SR 65 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC--------CcccEeEcCccceee--ccceEeecccc-----CC
Confidence 6899999876667999999999999999999999876 999999999999999 99998765421 26
Q ss_pred CCccccCC
Q 005841 667 GTVTYLAS 674 (674)
Q Consensus 667 GTp~YmAP 674 (674)
||+.||||
T Consensus 66 g~~~y~aP 73 (176)
T smart00750 66 VDPYFMAP 73 (176)
T ss_pred CcccccCh
Confidence 89999998
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >PF12860 PAS_7: PAS fold | Back alignment and domain information |
|---|
Probab=98.89 E-value=4.9e-09 Score=94.49 Aligned_cols=105 Identities=23% Similarity=0.362 Sum_probs=75.5
Q ss_pred HHHhcceeEEEcCCCcEEeecHHHHHHhCCChhhH-cCCCccccccc---------cccchhHHHHHHHHHhCceeEEEE
Q 005841 136 LQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEA-LGQDAIELLTD---------GRDFDVAYDIVHRIKMGERWTGQF 205 (674)
Q Consensus 136 lds~~d~I~v~D~~GrIi~~N~a~e~llGys~eEv-iG~~~~~l~~~---------~~~~~~~~~i~~~l~~g~~~~~e~ 205 (674)
|++|++||+++|.+|++++||+.|.+|+|++.+.+ .|.++.+++.. .............+........
T Consensus 1 Ld~l~~Gv~v~D~~~rl~~~N~~~~~l~~~~~~~~~~G~~~~~l~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~-- 78 (115)
T PF12860_consen 1 LDSLPQGVAVFDSDGRLVFWNQRFRELFGLPPEMLRPGASFRDLLRRLAERGEFPPGDPEAWVRQRLARLRRRQPRSF-- 78 (115)
T ss_pred CCCcCceEEEEcCCCeEEeEcHHHHHHhCCCHHHhcCCCCHHHHHHHHHHcCCCCCCCHHHHHHHHHHHHhcCCCcee--
Confidence 57899999999999999999999999999999998 89888777531 1112222233333334333333
Q ss_pred EEEcCCCCEEEEEEEEEEEECCCCCEEEEEEEEEchHHHHHHHH
Q 005841 206 PAKTKTEERVLVVATNTPFYDDDGTLVGIVCVSTDSRPFQETRA 249 (674)
Q Consensus 206 ~~~~kdG~~~~v~~s~sPi~d~dG~ivg~i~i~rDITe~k~~e~ 249 (674)
.....||. |+.++..|+ ++| |+|.++.|||++++.|+
T Consensus 79 ~~~~~dgr--~l~~~~~~~--~~G---g~v~~~~DVT~~~~~E~ 115 (115)
T PF12860_consen 79 ELRLPDGR--WLEVRAQPL--PDG---GFVLTFTDVTERRRAEE 115 (115)
T ss_pred EEECCCCE--EEEEEeEEC--CCC---CEEEEEEeCCHHHHhcC
Confidence 34456774 557788888 456 67889999999998764
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.89 E-value=9e-09 Score=101.11 Aligned_cols=128 Identities=29% Similarity=0.307 Sum_probs=84.5
Q ss_pred EEEEEEE-cCCeEEEEEeecccC-----------------------C-HHHHHHHHHHHHHHhhCCCC--CeeeEEEEEe
Q 005841 520 TVYHAVW-YGSDVAVKVFSRQEY-----------------------S-DEVIHSFRQEVSLMKRLRHP--NVLLFMGAVT 572 (674)
Q Consensus 520 ~Vy~~~~-~~~~vAvK~i~~~~~-----------------------~-~~~~~~~~~Ei~il~~l~Hp--nIv~l~~~~~ 572 (674)
.||.|.. .+..+|||+...... . ........+|...|..+..- ++..++.+.
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 4899987 577899998743100 0 12335677899999999755 566776543
Q ss_pred cCCeEEEEEecCC--CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHH-HHhCCCCeEEccCCCCCEEEcCCCcEEEEec
Q 005841 573 SPQRLCIVTEFLP--RGSLFRLLQRNTTKLDWRRRILMALDIARGVSY-LHHCNPPIIHRDLKSSNLLVDKHWTVKVGDF 649 (674)
Q Consensus 573 ~~~~~~lV~E~~~--ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~y-LH~~~~~IvHrDLKp~NILi~~~~~vkL~DF 649 (674)
..+|||||++ |..+..+.... ++......++.+++..+.. +|..| |||+||.+.|||++.+ .+.|+||
T Consensus 80 ---~~~ivME~I~~~G~~~~~l~~~~---~~~~~~~~~~~~il~~~~~~~~~~g--ivHGDLs~~NIlv~~~-~~~iIDf 150 (188)
T PF01163_consen 80 ---RNVIVMEYIGEDGVPLPRLKDVD---LSPEEPKELLEEILEEIIKMLHKAG--IVHGDLSEYNILVDDG-KVYIIDF 150 (188)
T ss_dssp ---TTEEEEE--EETTEEGGCHHHCG---GGGSTHHHHHHHHHHHHHHHHHCTT--EEESS-STTSEEEETT-CEEE--G
T ss_pred ---CCEEEEEecCCCccchhhHHhcc---ccchhHHHHHHHHHHHHHHHHHhcC--ceecCCChhhEEeecc-eEEEEec
Confidence 4589999998 65554443321 2234556677788886666 57888 9999999999999988 9999999
Q ss_pred CCcccccC
Q 005841 650 GLSRLKHE 657 (674)
Q Consensus 650 Gla~~~~~ 657 (674)
|.+.....
T Consensus 151 ~qav~~~~ 158 (188)
T PF01163_consen 151 GQAVDSSH 158 (188)
T ss_dssp TTEEETTS
T ss_pred CcceecCC
Confidence 99876543
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PRK11086 sensory histidine kinase DcuS; Provisional | Back alignment and domain information |
|---|
Probab=98.88 E-value=3.9e-08 Score=112.16 Aligned_cols=136 Identities=17% Similarity=0.250 Sum_probs=100.4
Q ss_pred HHHHHHHHHhcceeEEEcCCCcEEeecHHHHHHhCCC---hhhHcCCCccccccccccchhHHHHHHHHHhCceeEEEEE
Q 005841 130 RQYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYS---AEEALGQDAIELLTDGRDFDVAYDIVHRIKMGERWTGQFP 206 (674)
Q Consensus 130 ~~l~~ilds~~d~I~v~D~~GrIi~~N~a~e~llGys---~eEviG~~~~~l~~~~~~~~~~~~i~~~l~~g~~~~~e~~ 206 (674)
+.+++++++++++|+++|.+|+|++||+++++++|+. ..+.+|+.+.++.+... +...+..+........
T Consensus 221 ~~~~~il~~~~~gIi~~D~~g~I~~~N~~a~~llg~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~ 293 (542)
T PRK11086 221 EQRQAMLQSIKEGVIAVDDRGEVTLINDEAKRLFNYKKGLEDDPLGTDVESWMPVSR-------LKEVLRTGTPRRDEEI 293 (542)
T ss_pred HHHHHHHHHhcCcEEEECCCCeEEEEhHHHHHHhCCCcCCcccccCCcHHHhCCchh-------HHHHHhcCCCccceEE
Confidence 5578999999999999999999999999999999875 45778887776665322 4455666665433222
Q ss_pred EEcCCCCEEEEEEEEEEEECCCCCEEEEEEEEEchHHHHHHHHHHHHhhhcCCccCcCCchhHHHHHhcCCccchhhHHH
Q 005841 207 AKTKTEERVLVVATNTPFYDDDGTLVGIVCVSTDSRPFQETRAALWDTKNSDTDSNINRPRNTVTAKLGLDSQQPLQATI 286 (674)
Q Consensus 207 ~~~kdG~~~~v~~s~sPi~d~dG~ivg~i~i~rDITe~k~~e~~L~~la~~d~lt~~nr~~~~~~~kl~~~~~qpl~~~i 286 (674)
. .+|. ++.++..|+++ +|.++|++++++|+|+.+++++++..+.. ..+.+...+|+...|++.+.
T Consensus 294 ~--~~g~--~~~~~~~pi~~-~g~~~g~v~~~rDite~~~l~~~l~~~~~----------~~~~l~~~sHel~npL~~I~ 358 (542)
T PRK11086 294 N--INGR--LLLTNTVPVRV-NGEIIGAIATFRDKTEVRQLAQRLDGMVN----------YADALRAQSHEFMNKLHVIL 358 (542)
T ss_pred E--ECCE--EEEEEEEEEeE-CCEEEEEEEEEEEchHHHHHHHHHHHHHH----------HHHHHHhhchhhcCHHHHHH
Confidence 2 2454 34567789998 89999999999999999999888876532 12334556788888887755
Q ss_pred H
Q 005841 287 A 287 (674)
Q Consensus 287 a 287 (674)
+
T Consensus 359 g 359 (542)
T PRK11086 359 G 359 (542)
T ss_pred H
Confidence 4
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.86 E-value=2.8e-09 Score=117.63 Aligned_cols=99 Identities=38% Similarity=0.669 Sum_probs=92.1
Q ss_pred HhhCCCCCeeeEEEEEecCCeEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCe-EEccCCCC
Q 005841 556 MKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPI-IHRDLKSS 634 (674)
Q Consensus 556 l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~I-vHrDLKp~ 634 (674)
|+.+.|.|+.+|++.+.++..+++|.+||..|+|.+.+......+++.-...++++|+.||.|||.-- | +|+.|+..
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~--i~~hg~l~s~ 78 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSP--IGYHGALKSS 78 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCc--ceeeeeeccc
Confidence 46788999999999999999999999999999999999887788999999999999999999999755 4 99999999
Q ss_pred CEEEcCCCcEEEEecCCccccc
Q 005841 635 NLLVDKHWTVKVGDFGLSRLKH 656 (674)
Q Consensus 635 NILi~~~~~vkL~DFGla~~~~ 656 (674)
|.+++..+.+||+|||+..+..
T Consensus 79 nClvd~~w~lklt~~Gl~~~~~ 100 (484)
T KOG1023|consen 79 NCLVDSRWVLKLTDFGLNSLLE 100 (484)
T ss_pred cceeeeeEEEEechhhhccccc
Confidence 9999999999999999988764
|
|
| >PRK11359 cyclic-di-GMP phosphodiesterase; Provisional | Back alignment and domain information |
|---|
Probab=98.79 E-value=3.5e-08 Score=118.23 Aligned_cols=126 Identities=16% Similarity=0.227 Sum_probs=99.0
Q ss_pred ccHHHHHHHHHHhcceeEEEcCCCcEEeecHHHHHHhCCChhhHcCCCccccccccccchhHHHHHHHHHhCc----eeE
Q 005841 127 FTDRQYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGE----RWT 202 (674)
Q Consensus 127 ~se~~l~~ilds~~d~I~v~D~~GrIi~~N~a~e~llGys~eEviG~~~~~l~~~~~~~~~~~~i~~~l~~g~----~~~ 202 (674)
..+..+..+++.++++++++|.+|+|++||+++++++||+.+|++|+++.+++++.........+......+. .+.
T Consensus 9 ~~~~~~~~~le~~~~~i~~~d~~g~i~~~N~~~~~l~G~s~eeliG~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 88 (799)
T PRK11359 9 AADGIFFPALEQNMMGAVLINENDEVLFFNPAAEKLWGYKREEVIGNNIDMLIPRDLRPAHPEYIRHNREGGKARVEGMS 88 (799)
T ss_pred hhhhhHHHHHHhhcCcEEEEcCCCeEEEEcHHHHHHhCCCHHHHcCCCHHHhcCccccccchHHHhhhhccCCccccccc
Confidence 3455677889999999999999999999999999999999999999999998877654333333333333332 244
Q ss_pred EEEEEEcCCCCEEEEEEEEEEEECCCCCEEEEEEEEEchHHHHHHHHHHHHh
Q 005841 203 GQFPAKTKTEERVLVVATNTPFYDDDGTLVGIVCVSTDSRPFQETRAALWDT 254 (674)
Q Consensus 203 ~e~~~~~kdG~~~~v~~s~sPi~d~dG~ivg~i~i~rDITe~k~~e~~L~~l 254 (674)
.++++.+++|..+|+.++..|+. .+|. .+++++.+|||++++++++++.+
T Consensus 89 ~e~~~~~~dG~~~~v~~~~~~~~-~~g~-~~~~~~~~DiT~~~~~~~~~~~~ 138 (799)
T PRK11359 89 RELQLEKKDGSKIWTRFALSKVS-AEGK-VYYLALVRDASVEMAQKEQTRQL 138 (799)
T ss_pred eeeEEecCCcCEEEEEEEeeeec-cCCc-eEEEEEEeeccchhhhHHHHHHH
Confidence 57888999999999999998884 4565 46788999999998887776554
|
|
| >COG5002 VicK Signal transduction histidine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.79 E-value=1.3e-07 Score=97.68 Aligned_cols=119 Identities=20% Similarity=0.271 Sum_probs=95.4
Q ss_pred HHHHHHHHHHhcceeEEEcCCCcEEeecHHHHHHhCCChhhHcCCCccccccccccchhHHHHHHHHHhCceeEEEEEEE
Q 005841 129 DRQYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGERWTGQFPAK 208 (674)
Q Consensus 129 e~~l~~ilds~~d~I~v~D~~GrIi~~N~a~e~llGys~eEviG~~~~~l~~~~~~~~~~~~i~~~l~~g~~~~~e~~~~ 208 (674)
.+++..+|-.|.|||+.+|..|+|+.+|..+.+++|.+.++++|+++.+++.-.+...+ .+.+........+ .
T Consensus 110 r~kL~SvlayMtDGViATdRrG~iI~iN~~A~k~L~~~~E~~~~~~i~elL~i~d~y~~----~dL~e~~~s~lld---~ 182 (459)
T COG5002 110 RRKLDSVLAYMTDGVIATDRRGKIILINKPALKMLGVSKEDALGRSILELLKIEDTYTF----EDLVEKNDSLLLD---S 182 (459)
T ss_pred HHHHHHHHHHHcCceEeecCCCcEEEeccHHHHHhCcCHHHHhcccHHHHhCCccceeH----HHHHhcCCcEEEe---e
Confidence 34799999999999999999999999999999999999999999999999876554332 2223222222222 2
Q ss_pred cCCCCEEEEEEEEEEEECCCCCEEEEEEEEEchHHHHHHHHHHHHh
Q 005841 209 TKTEERVLVVATNTPFYDDDGTLVGIVCVSTDSRPFQETRAALWDT 254 (674)
Q Consensus 209 ~kdG~~~~v~~s~sPi~d~dG~ivg~i~i~rDITe~k~~e~~L~~l 254 (674)
...++...+.++.+.+.-+.|-+-|+|++.+|+|++.+.|++.+..
T Consensus 183 ~~~~E~~~lrv~Fs~i~rEsGfisGlIaVlhDvTEqek~e~ErRef 228 (459)
T COG5002 183 SDEEEGYVLRVNFSVIQRESGFISGLIAVLHDVTEQEKVERERREF 228 (459)
T ss_pred cCCCccEEEEEEEEEEeecccccceeEEEEecccHHHHHHHHHHHH
Confidence 2367778888999999888999999999999999999998876543
|
|
| >TIGR02040 PpsR-CrtJ transcriptional regulator PpsR | Back alignment and domain information |
|---|
Probab=98.75 E-value=5e-08 Score=109.01 Aligned_cols=122 Identities=16% Similarity=0.233 Sum_probs=89.2
Q ss_pred ccccHHHHHHHHHHhcceeEEEcC-CCcEEeecHHHHHHhCCChhhHcCCCccccccccccchhHHHHHHHHHhCceeEE
Q 005841 125 FNFTDRQYLNILQSMGQSVHIFDL-SDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGERWTG 203 (674)
Q Consensus 125 ~~~se~~l~~ilds~~d~I~v~D~-~GrIi~~N~a~e~llGys~eEviG~~~~~l~~~~~~~~~~~~i~~~l~~g~~~~~ 203 (674)
++..++.|+.+++.++++|+++|. +|+|+++|+++++++||+.++++|+++.++++++........+......|.....
T Consensus 128 l~~~e~r~~~l~e~~~~~i~~~d~~~g~i~~~N~a~~~l~G~~~~el~g~~~~~~~~~~~~~~~~~~l~~~~~~g~~~~~ 207 (442)
T TIGR02040 128 LREMETRYRVVLEVSSDAVLLVDMSTGRIVEANSAAAALLGGVGQSLVGRAFPQEFEGRRREELMLTLRNVRATGSAAPV 207 (442)
T ss_pred HHHHHHHHHHHHhhCCceEEEEECCCCEEEEEcHHHHHHhCcCHHHHcCCCHHHhCCHHHHHHHHHHHHHHHhcCCCcce
Confidence 334567899999999999999998 8999999999999999999999999999888776544444444455556665544
Q ss_pred EEEEEcCCCCEEEEEEEEEEEECCCCCEEEEEEEEEchHHHHHHHHHH
Q 005841 204 QFPAKTKTEERVLVVATNTPFYDDDGTLVGIVCVSTDSRPFQETRAAL 251 (674)
Q Consensus 204 e~~~~~kdG~~~~v~~s~sPi~d~dG~ivg~i~i~rDITe~k~~e~~L 251 (674)
++. .++|...| .+..+++.. +|. ..+++.+.|||+++++++++
T Consensus 208 ~~~--~~~~~~~~-~~~~~~~~~-~~~-~~~l~~~~dit~~~~~e~~~ 250 (442)
T TIGR02040 208 RIL--LRRSQKRL-LVVVSVFRQ-DGE-SLFLCQLSPAGATQPVGDEL 250 (442)
T ss_pred EEE--EcCCCeEE-EEEEEEEEe-CCc-eEEEEEEcccchhhhhhHHH
Confidence 443 23344344 445666653 443 35677889999998776544
|
This model represents the transcriptional regulator PpsR which is strictly associated with photosynthetic proteobacteria and found in photosynthetic operons. PpsR has been reported to be a repressor. These proteins contain a Helix-Turn_Helix motif of the "fis" type (pfam02954). |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.75 E-value=1.9e-08 Score=111.26 Aligned_cols=168 Identities=23% Similarity=0.188 Sum_probs=129.0
Q ss_pred cCCeeEeeeecc--cCceEEEEEEE----cCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCC-CCCeeeEEEEEecCCe
Q 005841 504 WEDLTIGEQIGQ--GSCGTVYHAVW----YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLR-HPNVLLFMGAVTSPQR 576 (674)
Q Consensus 504 ~~~y~~~~~LG~--G~fG~Vy~~~~----~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~ 576 (674)
...+.+...+|. |.+|.||.+.. .+..+|+|.-+...........-.+|+.-..+++ |+|.+..+..+...+.
T Consensus 113 ~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~ 192 (524)
T KOG0601|consen 113 DQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGI 192 (524)
T ss_pred hhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCc
Confidence 345667788999 99999998876 3445888863322221111122334666666665 9999999999999999
Q ss_pred EEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHH----HHHHHHhCCCCeEEccCCCCCEEEcCC-CcEEEEecCC
Q 005841 577 LCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIAR----GVSYLHHCNPPIIHRDLKSSNLLVDKH-WTVKVGDFGL 651 (674)
Q Consensus 577 ~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~----~L~yLH~~~~~IvHrDLKp~NILi~~~-~~vkL~DFGl 651 (674)
+|+-+|+| +.+|..+.......++...++.++.+... ||.++|..+ |+|-|+||.||++..+ ...+++|||+
T Consensus 193 lfiqtE~~-~~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~--~~~~~~kp~~i~~~~~~~s~~~~df~~ 269 (524)
T KOG0601|consen 193 LFIQTELC-GESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNN--IVHDDLKPANIFTTSDWTSCKLTDFGL 269 (524)
T ss_pred ceeeeccc-cchhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCc--ccccccchhheecccccceeecCCcce
Confidence 99999999 57888887665555888888889989888 999999999 9999999999999988 7899999999
Q ss_pred cccccCCccccccC-----CCCccccCC
Q 005841 652 SRLKHETYLTTKTG-----KGTVTYLAS 674 (674)
Q Consensus 652 a~~~~~~~~~~~~~-----~GTp~YmAP 674 (674)
...+....+..... -|...|++|
T Consensus 270 v~~i~~~~~~~~~~~~~r~~~~~~Y~~k 297 (524)
T KOG0601|consen 270 VSKISDGNFSSVFKVSKRPEGDCIYAAK 297 (524)
T ss_pred eEEccCCccccceeeeecCCCCceEeCh
Confidence 98776554332222 578889886
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.74 E-value=1.2e-07 Score=94.86 Aligned_cols=107 Identities=29% Similarity=0.303 Sum_probs=84.4
Q ss_pred HHHHHHHHHHhhCCCC--CeeeEEEEEecC----CeEEEEEecCCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH
Q 005841 547 HSFRQEVSLMKRLRHP--NVLLFMGAVTSP----QRLCIVTEFLPRG-SLFRLLQRNTTKLDWRRRILMALDIARGVSYL 619 (674)
Q Consensus 547 ~~~~~Ei~il~~l~Hp--nIv~l~~~~~~~----~~~~lV~E~~~gg-sL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yL 619 (674)
.+..+|...+..|... .+..++++.... ...+||+|++++. +|.+++..... ++......++.+++..+.-|
T Consensus 56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~-~~~~~~~~ll~~l~~~i~~l 134 (206)
T PF06293_consen 56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ-LDPSQRRELLRALARLIAKL 134 (206)
T ss_pred hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc-cchhhHHHHHHHHHHHHHHH
Confidence 3567788887777533 344556655543 2468999999884 79998875332 66778889999999999999
Q ss_pred HhCCCCeEEccCCCCCEEEcCCC---cEEEEecCCccccc
Q 005841 620 HHCNPPIIHRDLKSSNLLVDKHW---TVKVGDFGLSRLKH 656 (674)
Q Consensus 620 H~~~~~IvHrDLKp~NILi~~~~---~vkL~DFGla~~~~ 656 (674)
|..| |+|+|+++.|||++.+. .+.|+||+-++...
T Consensus 135 H~~g--i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~~ 172 (206)
T PF06293_consen 135 HDAG--IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFRP 172 (206)
T ss_pred HHCc--CCCCCCCcccEEEeCCCCceeEEEEcchhceeCC
Confidence 9999 99999999999999887 89999999887644
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >PRK11006 phoR phosphate regulon sensor protein; Provisional | Back alignment and domain information |
|---|
Probab=98.71 E-value=9e-08 Score=106.46 Aligned_cols=127 Identities=17% Similarity=0.252 Sum_probs=90.4
Q ss_pred ccHHHHHHHHHHhcceeEEEcCCCcEEeecHHHHHHhCCChhhHcCCCccccccccccchhHHHHHHHHHhCceeEEEEE
Q 005841 127 FTDRQYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGERWTGQFP 206 (674)
Q Consensus 127 ~se~~l~~ilds~~d~I~v~D~~GrIi~~N~a~e~llGys~eEviG~~~~~l~~~~~~~~~~~~i~~~l~~g~~~~~e~~ 206 (674)
...++|+.++++++++|+++|.+|+|++||+++++++||+.++++|+++.+++..++ +...+.... ......
T Consensus 95 ~~~~~~~~~~~~~~~~i~~~d~~g~i~~~N~~a~~l~g~~~~~~~g~~~~~~~~~~~-------~~~~~~~~~-~~~~~~ 166 (430)
T PRK11006 95 NLIKRFRSGAESLPDAVVLTTEEGNIFWCNGLAQQLLGFRWPEDNGQNILNLLRYPE-------FTQYLKTRD-FSRPLT 166 (430)
T ss_pred HHHHHHHHHHHhCCCeEEEEcCCCceeHHHHHHHHHhCCCChHhCCCcHHHHhcCHH-------HHHHHHhcc-cCCCeE
Confidence 456789999999999999999999999999999999999999999999888876443 222222221 111222
Q ss_pred EEcCCCCEEEEEEEEEEEECCCCCEEEEEEEEEchHHHHHHHHHHHHhhhcCCccCcCCchhHHHHHhcCCccchhhH
Q 005841 207 AKTKTEERVLVVATNTPFYDDDGTLVGIVCVSTDSRPFQETRAALWDTKNSDTDSNINRPRNTVTAKLGLDSQQPLQA 284 (674)
Q Consensus 207 ~~~kdG~~~~v~~s~sPi~d~dG~ivg~i~i~rDITe~k~~e~~L~~la~~d~lt~~nr~~~~~~~kl~~~~~qpl~~ 284 (674)
....+|. ++.+...|+. ++ +++.+++|||+++++++..+ .+...++|+.+.||+.
T Consensus 167 ~~~~~~~--~~~~~~~~~~--~~---~~~~~~~dit~~~~~e~~~~----------------~~~~~isHelrtPL~~ 221 (430)
T PRK11006 167 LVLNNGR--HLEIRVMPYT--EG---QLLMVARDVTQMHQLEGARR----------------NFFANVSHELRTPLTV 221 (430)
T ss_pred EEcCCCC--EEEEEEEEcC--CC---cEEEEEehhhHHHHHHHHHH----------------HHHHHhHHHhcchHHH
Confidence 3344554 4456666764 33 24678999999998876543 2455667777777776
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.67 E-value=1.4e-07 Score=95.69 Aligned_cols=138 Identities=27% Similarity=0.252 Sum_probs=100.5
Q ss_pred eeEeeeecccCceEEEEEEE-cCCeEEEEEeecccC------------------C--HHHHHHHHHHHHHHhhCCCC--C
Q 005841 507 LTIGEQIGQGSCGTVYHAVW-YGSDVAVKVFSRQEY------------------S--DEVIHSFRQEVSLMKRLRHP--N 563 (674)
Q Consensus 507 y~~~~~LG~G~fG~Vy~~~~-~~~~vAvK~i~~~~~------------------~--~~~~~~~~~Ei~il~~l~Hp--n 563 (674)
+.++.+||-|--+.||.|.. .+.++|||+=..... + .-.....++|..+|.+|... .
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~ 172 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK 172 (304)
T ss_pred HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence 35778999999999999998 588999995421110 0 12235577899999998644 6
Q ss_pred eeeEEEEEecCCeEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCc
Q 005841 564 VLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWT 643 (674)
Q Consensus 564 Iv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~ 643 (674)
|...+++ ++..+||||++|-.|...- ++.+..-.++..|+.-+.-+-..| |||+|+.+-|||++++|.
T Consensus 173 VP~P~~~----nRHaVvMe~ieG~eL~~~r------~~~en~~~il~~il~~~~~~~~~G--iVHGDlSefNIlV~~dg~ 240 (304)
T COG0478 173 VPKPIAW----NRHAVVMEYIEGVELYRLR------LDVENPDEILDKILEEVRKAYRRG--IVHGDLSEFNILVTEDGD 240 (304)
T ss_pred CCCcccc----ccceeeeehcccceeeccc------CcccCHHHHHHHHHHHHHHHHHcC--ccccCCchheEEEecCCC
Confidence 6666653 6789999999996664432 123344445555555555555678 999999999999999999
Q ss_pred EEEEecCCccccc
Q 005841 644 VKVGDFGLSRLKH 656 (674)
Q Consensus 644 vkL~DFGla~~~~ 656 (674)
+.|+||--+....
T Consensus 241 ~~vIDwPQ~v~~~ 253 (304)
T COG0478 241 IVVIDWPQAVPIS 253 (304)
T ss_pred EEEEeCcccccCC
Confidence 9999998776543
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.66 E-value=1.3e-07 Score=105.86 Aligned_cols=119 Identities=28% Similarity=0.437 Sum_probs=98.8
Q ss_pred cCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeEEEEEecCCCCCHHHHHHhcCCCCCHHHHH
Q 005841 527 YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRI 606 (674)
Q Consensus 527 ~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~ 606 (674)
.+.+|.|.+.+...- .......+-++.|+.|+||||++++..++..+.+|||+|-+. -|..++.+ +....+.
T Consensus 36 ~~~~vsVF~~~~~~~--~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~----l~~~~v~ 107 (690)
T KOG1243|consen 36 DGGPVSVFVYKRSNG--EVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKE----LGKEEVC 107 (690)
T ss_pred cCCceEEEEEeCCCc--hhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHH----hHHHHHH
Confidence 567788877765443 444556778899999999999999999999999999999873 45666654 3367778
Q ss_pred HHHHHHHHHHHHHH-hCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccc
Q 005841 607 LMALDIARGVSYLH-HCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLK 655 (674)
Q Consensus 607 ~i~~qi~~~L~yLH-~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~ 655 (674)
..+.||+.||.||| +++ ++|++|.-..|+|+..|.+||++|.++...
T Consensus 108 ~Gl~qIl~AL~FL~~d~~--lvHgNv~~~SVfVn~~GeWkLggle~v~~~ 155 (690)
T KOG1243|consen 108 LGLFQILAALSFLNDDCN--LVHGNVCKDSVFVNESGEWKLGGLELVSKA 155 (690)
T ss_pred HHHHHHHHHHHHHhccCC--eeeccEeeeeEEEcCCCcEEEeeeEEEecc
Confidence 88899999999998 577 999999999999999999999999988544
|
|
| >COG3283 TyrR Transcriptional regulator of aromatic amino acids metabolism [Transcription / Amino acid transport and metabolism] | Back alignment and domain information |
|---|
Probab=98.63 E-value=1.5e-07 Score=97.73 Aligned_cols=156 Identities=16% Similarity=0.236 Sum_probs=102.9
Q ss_pred HHHHHHHHhcceeEEEcCCCcEEeecHHHHHHhCCChhhHcCCCccccccccccchhHHHHHHHHHhCce-eEEEEEEEc
Q 005841 131 QYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGER-WTGQFPAKT 209 (674)
Q Consensus 131 ~l~~ilds~~d~I~v~D~~GrIi~~N~a~e~llGys~eEviG~~~~~l~~~~~~~~~~~~i~~~l~~g~~-~~~e~~~~~ 209 (674)
.+.++|++|+++|+-+|..|.|...|+|+++++|.+.+++.|+.+..++.... +.+.+..+.. ...+.. .
T Consensus 81 ~L~aLL~al~~pVlsvd~kg~v~~aNpAa~~l~~~~~~~~~g~~~~~l~~~~n-------f~~~l~~~~~~~~~~~V--~ 151 (511)
T COG3283 81 ALSALLEALPEPVLSVDMKGKVDMANPAACQLFGRKEDRLRGHTAAQLINGFN-------FLRWLEGEPQRSHNEHV--V 151 (511)
T ss_pred HHHHHHHhCCCceEEecccCceeecCHHHHHHhCCChhhhcCccHHHhcCcCC-------HHHHHhcCCCcCCCceE--E
Confidence 58899999999999999999999999999999999999999999988887655 3344443322 222222 2
Q ss_pred CCCCEEEEEEEEEEEECCCC----CEEEEEEEEEchHHHHHHHHHHHHhhhcCCccCcCCchhHHHHHhcCCccchhhHH
Q 005841 210 KTEERVLVVATNTPFYDDDG----TLVGIVCVSTDSRPFQETRAALWDTKNSDTDSNINRPRNTVTAKLGLDSQQPLQAT 285 (674)
Q Consensus 210 kdG~~~~v~~s~sPi~d~dG----~ivg~i~i~rDITe~k~~e~~L~~la~~d~lt~~nr~~~~~~~kl~~~~~qpl~~~ 285 (674)
-+|..+.+ -++||+-.++ .+.|.+.+.+. -.++-+++..+...+.. +|+.-...+..
T Consensus 152 ~~gq~~lm--eitPv~~~~~~~e~~lagav~~L~~---~~r~ge~~~~~~~~~~~--------------~F~~~v~~S~~ 212 (511)
T COG3283 152 INGQNFLM--EITPVYLQDENDEHVLAGAVVMLRS---TNRMGEQLQNVAAQDVS--------------GFEQIVAVSPK 212 (511)
T ss_pred Ecchhhee--eccceeecCCcchhheeheeeeehh---hhhHHHHHhhccccccc--------------chHHHhhccHH
Confidence 35766755 4557764433 25555544432 22233333333211111 11111111233
Q ss_pred HHHHHHHHHHHHHhhhccccccCCCCCccC
Q 005841 286 IASKISNLATKVSNKVKSRIRTGDNFMDRE 315 (674)
Q Consensus 286 iassi~~LA~kva~~~~svLi~Gesg~~~~ 315 (674)
+.+ +..-|.|+|-.+..-||+||+||+|+
T Consensus 213 mk~-~v~qA~k~AmlDAPLLI~GeTGTGKd 241 (511)
T COG3283 213 MKH-VVEQAQKLAMLDAPLLITGETGTGKD 241 (511)
T ss_pred HHH-HHHHHHHhhccCCCeEEecCCCchHH
Confidence 333 88889999999999999999999997
|
|
| >TIGR02938 nifL_nitrog nitrogen fixation negative regulator NifL | Back alignment and domain information |
|---|
Probab=98.59 E-value=4.3e-08 Score=109.78 Aligned_cols=155 Identities=8% Similarity=-0.003 Sum_probs=101.1
Q ss_pred cccHHHHHHHHHHhcceeEEEcCCCcEEeecHHHHHHhCCChhhHcCCCccccccccccchhHHHHHHHHHhCceeE-EE
Q 005841 126 NFTDRQYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGERWT-GQ 204 (674)
Q Consensus 126 ~~se~~l~~ilds~~d~I~v~D~~GrIi~~N~a~e~llGys~eEviG~~~~~l~~~~~~~~~~~~i~~~l~~g~~~~-~e 204 (674)
...+..++.++++++++|+++|.+|+|+++|++|++++|+...+..+..+.+++.+..... +......+..+. .+
T Consensus 126 ~~~~~~~~~~~~~~~~~i~~~d~~~~i~~~N~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~ 201 (494)
T TIGR02938 126 ANQKLLIESVVDAAPVAFVLLDPTGRVILDNQEYKKLATDLRVKEPAHTVLDLLREAWREA----LAENWPQQLAFSNRE 201 (494)
T ss_pred HHHHHHHHHHHhcccceEEEEcCCCCEEEechhHHHhhchhhhhHHHHHHHHHhhHHhhhh----hhhcchhhhccccce
Confidence 3455678999999999999999999999999999999999988887766555544322111 111111222222 23
Q ss_pred EEEEcCCCC-EEEEEEEEEEEECCCCCE---------EEEEEEEEchHHHHHHHHHHHHhhhcCCccCcC--CchhHHHH
Q 005841 205 FPAKTKTEE-RVLVVATNTPFYDDDGTL---------VGIVCVSTDSRPFQETRAALWDTKNSDTDSNIN--RPRNTVTA 272 (674)
Q Consensus 205 ~~~~~kdG~-~~~v~~s~sPi~d~dG~i---------vg~i~i~rDITe~k~~e~~L~~la~~d~lt~~n--r~~~~~~~ 272 (674)
......+|. .+|+.....|+.+.+|.+ .+++++++|||++|+.+++++..+..+.+.... +.....+.
T Consensus 202 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~DITe~k~~ee~l~~~al~~~~~~~~~~~~l~~~~~ 281 (494)
T TIGR02938 202 ARFDRGGGRPARWLSCTGSVIGMESDCADSFFCAAEQPYLLLTIADISNLREEQERARLSALQALMAEEERLEAIRETLS 281 (494)
T ss_pred eeeccCCCceeeEEEecCceEEeecchhhheeccCCCchheehHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Confidence 333444444 789998888887665543 445678999999999998876554433332211 12223444
Q ss_pred HhcCCccchhhH
Q 005841 273 KLGLDSQQPLQA 284 (674)
Q Consensus 273 kl~~~~~qpl~~ 284 (674)
...|+.+.|++.
T Consensus 282 ~~~h~lr~pL~~ 293 (494)
T TIGR02938 282 AAIHRLQGPMNL 293 (494)
T ss_pred HHHHHHhcHHHH
Confidence 555777777776
|
NifL is a modulator of the nitrogen fixation positive regulator protein NifA, and is therefore a negative regulator. It binds NifA. NifA and NifL are encoded by adjacent genes. |
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=98.59 E-value=1.6e-08 Score=110.06 Aligned_cols=95 Identities=27% Similarity=0.396 Sum_probs=78.8
Q ss_pred CeEEEEEecCCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCc
Q 005841 575 QRLCIVTEFLPRGSLFRLLQR--NTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLS 652 (674)
Q Consensus 575 ~~~~lV~E~~~ggsL~~~l~~--~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla 652 (674)
.++||.|++|...+|.++|.+ .....++...+.++.|++.+++| ++ .+|||+||.||++..+..+||.|||+.
T Consensus 329 ~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~--~ihrdlkp~nif~~~d~q~kIgDFgl~ 403 (516)
T KOG1033|consen 329 VYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KG--LIHRDLKPSNIFFSDDDQLKIGDFGLV 403 (516)
T ss_pred cchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---cc--chhhhccccccccccchhhhhhhhhhe
Confidence 358999999999999999963 23457788899999999999999 66 899999999999999999999999998
Q ss_pred ccccCCc------cccccCCCCccccCC
Q 005841 653 RLKHETY------LTTKTGKGTVTYLAS 674 (674)
Q Consensus 653 ~~~~~~~------~~~~~~~GTp~YmAP 674 (674)
....... ......+||+-||+|
T Consensus 404 ts~~~~~~~~~~~a~~t~~~gt~~YmsP 431 (516)
T KOG1033|consen 404 TSQDKDETVAPAAASHTQQVGTLLYMSP 431 (516)
T ss_pred eecccCCcccchhhhhhhcccccccCCH
Confidence 7654433 112234799999998
|
|
| >COG3290 CitA Signal transduction histidine kinase regulating citrate/malate metabolism [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.52 E-value=4.7e-07 Score=99.42 Aligned_cols=114 Identities=21% Similarity=0.310 Sum_probs=94.6
Q ss_pred HHHHHHHHHhcceeEEEcCCCcEEeecHHHHHHhCCChh--hHcCCCccccccccccchhHHHHHHHHHhCceeEEEEEE
Q 005841 130 RQYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAE--EALGQDAIELLTDGRDFDVAYDIVHRIKMGERWTGQFPA 207 (674)
Q Consensus 130 ~~l~~ilds~~d~I~v~D~~GrIi~~N~a~e~llGys~e--EviG~~~~~l~~~~~~~~~~~~i~~~l~~g~~~~~e~~~ 207 (674)
+...++|+++.+||+.+|..|.|..+|.++++|+|+... +++|+++.+++++..+ +...+.++++...+...
T Consensus 215 ~er~A~l~si~EGviAvd~~G~It~~N~~A~~ll~~~~~~~~~ig~~i~~v~~p~~~------l~~vl~~~~~~~~~e~~ 288 (537)
T COG3290 215 EERQAMLQSIKEGVIAVDKKGVITLINQAAQKLLGLRQPSGDPIGRSIVEVLPPDSD------LPEVLETGKPQHDEEIR 288 (537)
T ss_pred HHHHHHHHHhhceEEEECCCCeEeehhHHHHHHhcccCcCcccccccceEeeccccC------cHHHHhcCCcccchhhh
Confidence 456788999999999999999999999999999999865 7999999999997432 56668888876655443
Q ss_pred EcCCCCEEEEEEEEEEEECCCCCEEEEEEEEEchHHHHHHHHHHHHh
Q 005841 208 KTKTEERVLVVATNTPFYDDDGTLVGIVCVSTDSRPFQETRAALWDT 254 (674)
Q Consensus 208 ~~kdG~~~~v~~s~sPi~d~dG~ivg~i~i~rDITe~k~~e~~L~~l 254 (674)
+ +| .++.++..||+ .+|+++|+|.+|||-|+.+++-++|...
T Consensus 289 ~--ng--~~~i~nr~pI~-~~~~~~GaI~tFRdktei~~L~eqLt~v 330 (537)
T COG3290 289 I--NG--RLLVANRVPIR-SGGQIVGAIITFRDKTEIKKLTEQLTGV 330 (537)
T ss_pred c--CC--eEEEEEeccEE-ECCEEeEEEEEEecHHHHHHHHHHHHHH
Confidence 3 34 45577888998 4899999999999999999999988654
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.50 E-value=1.8e-06 Score=86.07 Aligned_cols=142 Identities=15% Similarity=0.147 Sum_probs=96.0
Q ss_pred ccccCCeeEeeeecccCceEEEEEEEcCCeEEEEEeecccCCH-HHHHH------HHHHHHHHhhC---CCCCeeeEEEE
Q 005841 501 EILWEDLTIGEQIGQGSCGTVYHAVWYGSDVAVKVFSRQEYSD-EVIHS------FRQEVSLMKRL---RHPNVLLFMGA 570 (674)
Q Consensus 501 ~~~~~~y~~~~~LG~G~fG~Vy~~~~~~~~vAvK~i~~~~~~~-~~~~~------~~~Ei~il~~l---~HpnIv~l~~~ 570 (674)
.+...+|++.+++-......|.+....+..+++|......... ..... ..+.+..+..+ .-..+..++.+
T Consensus 27 ~i~~~~~~~~kv~k~~~r~~ValIei~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~ 106 (229)
T PF06176_consen 27 KILDNNYKIIKVFKNTKRNYVALIEIDGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLA 106 (229)
T ss_pred HHHhCCceEEEeecCCCccEEEEEEECCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceee
Confidence 4566789999999988888899888899999999886543222 11111 12233323333 22233333333
Q ss_pred Eec-----CCeEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEE
Q 005841 571 VTS-----PQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVK 645 (674)
Q Consensus 571 ~~~-----~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vk 645 (674)
..- ....+|||||++|..|.++.. +++ .+...+..+|.-||..| ++|+|+.|.||+++.+ .|+
T Consensus 107 ~ekk~~~~~~~~~ll~EYIeG~~l~d~~~-----i~e----~~~~ki~~~ikqlH~~G--~~HGD~hpgNFlv~~~-~i~ 174 (229)
T PF06176_consen 107 AEKKIFRYTSSYVLLMEYIEGVELNDIED-----IDE----DLAEKIVEAIKQLHKHG--FYHGDPHPGNFLVSNN-GIR 174 (229)
T ss_pred eeeeeccceeEEEEEEEEecCeecccchh-----cCH----HHHHHHHHHHHHHHHcC--CccCCCCcCcEEEECC-cEE
Confidence 221 234578999999988866542 222 24456778899999999 9999999999999965 599
Q ss_pred EEecCCccc
Q 005841 646 VGDFGLSRL 654 (674)
Q Consensus 646 L~DFGla~~ 654 (674)
++||+..+.
T Consensus 175 iID~~~k~~ 183 (229)
T PF06176_consen 175 IIDTQGKRM 183 (229)
T ss_pred EEECccccc
Confidence 999998754
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >COG5000 NtrY Signal transduction histidine kinase involved in nitrogen fixation and metabolism regulation [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.48 E-value=1.5e-06 Score=96.00 Aligned_cols=131 Identities=17% Similarity=0.126 Sum_probs=93.3
Q ss_pred HHHHHHHHhcceeEEEcCCCcEEeecHHHHHHhCCChhhHcCCCccccccccccchhHHHHHHHHH-hCce-eEEEEEEE
Q 005841 131 QYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIK-MGER-WTGQFPAK 208 (674)
Q Consensus 131 ~l~~ilds~~d~I~v~D~~GrIi~~N~a~e~llGys~eEviG~~~~~l~~~~~~~~~~~~i~~~l~-~g~~-~~~e~~~~ 208 (674)
+++++|+.++.||+.+|.+|+|..+|+++|+|||.+.++++|+++..+.+.- ...+.... .+.+ ...+..+.
T Consensus 371 f~E~VLsgvtaGVi~~d~~g~i~t~N~~ae~~l~~~~~~~~G~~lsa~ap~~------~~vf~~~~a~~~~~~~~ev~~~ 444 (712)
T COG5000 371 FLEAVLSGLTAGVIGFDNRGCITTVNPSAEQILGKPFDQLLGQSLSAIAPEL------EEVFAEAGAAARTDKRVEVKLA 444 (712)
T ss_pred HHHHHHhcCceeEEEEcCCCeeEeecchHHHHhcCChhHhhcchhhhhhhHH------HHHHHHhhhhcCCCccceeecc
Confidence 7999999999999999999999999999999999999999999877665431 11222221 2222 33444444
Q ss_pred cCCCCEEEEEEEEEEEECCCCCEEEEEEEEEchHHHHHHHHHHHHhhhcCCccCcCCchhHHHHHhcCCccchhhH
Q 005841 209 TKTEERVLVVATNTPFYDDDGTLVGIVCVSTDSRPFQETRAALWDTKNSDTDSNINRPRNTVTAKLGLDSQQPLQA 284 (674)
Q Consensus 209 ~kdG~~~~v~~s~sPi~d~dG~ivg~i~i~rDITe~k~~e~~L~~la~~d~lt~~nr~~~~~~~kl~~~~~qpl~~ 284 (674)
+ .|+...+.+..+-... | +--|+|.++-|||+...+++... ...+..+++|+...||.-
T Consensus 445 r-~g~~rtl~Vq~t~~~~-d-~~~gyVvt~DDITdLV~AQRs~A--------------W~dVArRIAHEIKNPLTP 503 (712)
T COG5000 445 R-EGEERTLNVQATREPE-D-NGNGYVVTFDDITDLVIAQRSAA--------------WGDVARRIAHEIKNPLTP 503 (712)
T ss_pred c-CCCceeeeeeeeeccc-c-cCCceEEEecchHHHHHHHHHHH--------------HHHHHHHHHHHhcCCCch
Confidence 4 4555555666655533 2 23478999999999998776432 246777888888887776
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.46 E-value=8.5e-08 Score=106.20 Aligned_cols=149 Identities=21% Similarity=0.170 Sum_probs=117.9
Q ss_pred ccCCeeEeeeecccCceEEEEEEEc---CCeEEEEEeecccCCHHHHHHHHHHHHHHhhCC-CCCeeeEEEEEecCCeEE
Q 005841 503 LWEDLTIGEQIGQGSCGTVYHAVWY---GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLR-HPNVLLFMGAVTSPQRLC 578 (674)
Q Consensus 503 ~~~~y~~~~~LG~G~fG~Vy~~~~~---~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~ 578 (674)
...+|..+..||.|.|+.|+.+..+ +..|++|-+.+..+.......-..|+.+...+. |.+++..+..|....+.|
T Consensus 263 ~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ 342 (524)
T KOG0601|consen 263 KLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGY 342 (524)
T ss_pred ecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccccc
Confidence 4467888999999999999988743 456899987665554422223334666665554 888888888887788889
Q ss_pred EEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCC-CcEEEEecCCccc
Q 005841 579 IVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKH-WTVKVGDFGLSRL 654 (674)
Q Consensus 579 lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~-~~vkL~DFGla~~ 654 (674)
|-.|||.++++...+ .....+++...+.+..|++.++.++|+.. ++|+|+||+||++..+ +..++.|||+...
T Consensus 343 ip~e~~~~~s~~l~~-~~~~~~d~~~~~~~~~q~~~~l~~i~s~~--~~~~d~~psni~i~~~~~~~~~~~~~~~t~ 416 (524)
T KOG0601|consen 343 IPLEFCEGGSSSLRS-VTSQMLDEDPRLRLTAQILTALNVIHSKL--FVHLDVKPSNILISNDGFFSKLGDFGCWTR 416 (524)
T ss_pred CchhhhcCcchhhhh-HHHHhcCcchhhhhHHHHHhccccccchh--hhcccccccceeeccchhhhhccccccccc
Confidence 999999999887666 33445788889999999999999999988 9999999999999875 7789999998863
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.44 E-value=3e-06 Score=86.07 Aligned_cols=138 Identities=14% Similarity=0.205 Sum_probs=86.4
Q ss_pred eeecccCceEEEEEEEcCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCC--CeeeEEEEEecCCeEEEEEecCCCCC
Q 005841 511 EQIGQGSCGTVYHAVWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHP--NVLLFMGAVTSPQRLCIVTEFLPRGS 588 (674)
Q Consensus 511 ~~LG~G~fG~Vy~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp--nIv~l~~~~~~~~~~~lV~E~~~ggs 588 (674)
..||+|..+.||+. .+..+++|+..... .. ..+.+|.+++..+..- .+.+++.+....+...+|||+++|..
T Consensus 7 ~~i~~G~t~~~y~~--~~~~~VlR~~~~~~-~~---~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~ 80 (226)
T TIGR02172 7 TQTGEGGNGESYTH--KTGKWMLKLYNPGF-DK---ETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKR 80 (226)
T ss_pred eeecCCCCcceeEe--cCCCEEEEeCCCCC-CH---HHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCcc
Confidence 57899999999984 35678899886533 22 3457799999888643 34677888878888899999999863
Q ss_pred -HHHHH---------------------HhcC-CCCCHHH-HHHHHH----------HHHH-HHHHHH--hCCCCeEEccC
Q 005841 589 -LFRLL---------------------QRNT-TKLDWRR-RILMAL----------DIAR-GVSYLH--HCNPPIIHRDL 631 (674)
Q Consensus 589 -L~~~l---------------------~~~~-~~l~~~~-~~~i~~----------qi~~-~L~yLH--~~~~~IvHrDL 631 (674)
+...+ +... ....... ...+.. .+.. ...+|. ...+.++|+|+
T Consensus 81 ~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~ 160 (226)
T TIGR02172 81 SFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDF 160 (226)
T ss_pred chhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCC
Confidence 21111 1000 0111110 000100 0111 122222 22234789999
Q ss_pred CCCCEEEcCCCcEEEEecCCcccc
Q 005841 632 KSSNLLVDKHWTVKVGDFGLSRLK 655 (674)
Q Consensus 632 Kp~NILi~~~~~vkL~DFGla~~~ 655 (674)
.|.|||++.++ +.|+||+.+..-
T Consensus 161 ~~~Nii~~~~~-~~iIDwe~a~~G 183 (226)
T TIGR02172 161 QIGNLITSGKG-TYWIDLGDFGYG 183 (226)
T ss_pred CCCcEEEcCCC-cEEEechhcCcC
Confidence 99999999888 999999998743
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.42 E-value=2.2e-06 Score=86.10 Aligned_cols=142 Identities=18% Similarity=0.228 Sum_probs=85.3
Q ss_pred eeeecccCceEEEEEEEcCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCC--CeeeEEEEEe---cCCeEEEEEecC
Q 005841 510 GEQIGQGSCGTVYHAVWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHP--NVLLFMGAVT---SPQRLCIVTEFL 584 (674)
Q Consensus 510 ~~~LG~G~fG~Vy~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp--nIv~l~~~~~---~~~~~~lV~E~~ 584 (674)
++.|+.|..+.||++...+..+++|+.... .....+.+|..++..+... .+..++.... .....+++|+++
T Consensus 2 i~~l~~G~~n~~~~v~~~~~~~vlK~~~~~----~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i 77 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDDGRYVLKFYRPP----DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYI 77 (239)
T ss_dssp EEEEEESSSSEEEEEEETTSEEEEEEESSH----HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEE
T ss_pred CccCCCCCeeeEEEEEECCcEEEEEEeCCC----CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEe
Confidence 467899999999999987789999987543 3445677888888887532 3556665432 234579999999
Q ss_pred CCCCHHH----------------HHH---hc--C-CCCCHHHH--HHH-------------------HHHHHH-HHHHHH
Q 005841 585 PRGSLFR----------------LLQ---RN--T-TKLDWRRR--ILM-------------------ALDIAR-GVSYLH 620 (674)
Q Consensus 585 ~ggsL~~----------------~l~---~~--~-~~l~~~~~--~~i-------------------~~qi~~-~L~yLH 620 (674)
+|..+.. .+. .. . ..+..... ... ...+.. .+..++
T Consensus 78 ~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (239)
T PF01636_consen 78 PGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELE 157 (239)
T ss_dssp SSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHH
Confidence 9988777 111 11 0 11110000 000 011222 233333
Q ss_pred h-----CCCCeEEccCCCCCEEEc-CCCcEEEEecCCcccc
Q 005841 621 H-----CNPPIIHRDLKSSNLLVD-KHWTVKVGDFGLSRLK 655 (674)
Q Consensus 621 ~-----~~~~IvHrDLKp~NILi~-~~~~vkL~DFGla~~~ 655 (674)
+ ....++|+|+.|.|||++ .++.|.|+||+.+...
T Consensus 158 ~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~~ 198 (239)
T PF01636_consen 158 ALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGWG 198 (239)
T ss_dssp HHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EEE
T ss_pred hhhccCCCcEEEEeccccccceeeeccceeEEEecccceEC
Confidence 2 223489999999999999 6777899999998754
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.38 E-value=4e-06 Score=83.30 Aligned_cols=139 Identities=17% Similarity=0.090 Sum_probs=101.4
Q ss_pred cccCceEEEEEEEcCCeEEEEEeecccC---C-HHHHHHHHHHHHHHhhCCCC--CeeeEEEEEe--c--CCeEEEEEec
Q 005841 514 GQGSCGTVYHAVWYGSDVAVKVFSRQEY---S-DEVIHSFRQEVSLMKRLRHP--NVLLFMGAVT--S--PQRLCIVTEF 583 (674)
Q Consensus 514 G~G~fG~Vy~~~~~~~~vAvK~i~~~~~---~-~~~~~~~~~Ei~il~~l~Hp--nIv~l~~~~~--~--~~~~~lV~E~ 583 (674)
|+|+-+-|+.....|..|-+|.-..... . +--...|.+|+..+..|... .+..+..... . .-+-+||+|-
T Consensus 27 ~rgG~SgV~r~~~~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVTe~ 106 (216)
T PRK09902 27 RRNGMSGVQCVERNGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVTED 106 (216)
T ss_pred CCCCcceEEEEEeCCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEEEe
Confidence 5588888998887777777775531111 1 11235788999999988532 2444442221 1 1347899998
Q ss_pred CCC-CCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCc--EEEEecCCccc
Q 005841 584 LPR-GSLFRLLQRN-TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWT--VKVGDFGLSRL 654 (674)
Q Consensus 584 ~~g-gsL~~~l~~~-~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~--vkL~DFGla~~ 654 (674)
+.+ .+|.+++... -.+.+......++.+|+..|.-||+.| +.|+|+-+.|||++.++. |+++||.-++.
T Consensus 107 L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~G--v~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 107 MAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVN--RQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred CCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCC--CcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 864 6898888543 234577778899999999999999999 999999999999986667 99999998765
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.38 E-value=2.6e-07 Score=95.22 Aligned_cols=94 Identities=31% Similarity=0.550 Sum_probs=82.3
Q ss_pred HHHhhCCCCCeeeEEEEEecCC-----eEEEEEecCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCCCC
Q 005841 554 SLMKRLRHPNVLLFMGAVTSPQ-----RLCIVTEFLPRGSLFRLLQR---NTTKLDWRRRILMALDIARGVSYLHHCNPP 625 (674)
Q Consensus 554 ~il~~l~HpnIv~l~~~~~~~~-----~~~lV~E~~~ggsL~~~l~~---~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~ 625 (674)
.-+.++.|.|||+++.++.+.+ +..++.||+.-|+|..+|++ +...+......+++-||+.||.|||++.++
T Consensus 119 dnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~Pp 198 (458)
T KOG1266|consen 119 DNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPP 198 (458)
T ss_pred HHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCc
Confidence 4455567999999999997654 47899999999999999975 345688899999999999999999999999
Q ss_pred eEEccCCCCCEEEcCCCcEEEE
Q 005841 626 IIHRDLKSSNLLVDKHWTVKVG 647 (674)
Q Consensus 626 IvHrDLKp~NILi~~~~~vkL~ 647 (674)
|+|++|..+-|++..+|-|||.
T Consensus 199 iihgnlTc~tifiq~ngLIkig 220 (458)
T KOG1266|consen 199 IIHGNLTCDTIFIQHNGLIKIG 220 (458)
T ss_pred cccCCcchhheeecCCceEEec
Confidence 9999999999999999988874
|
|
| >PRK15053 dpiB sensor histidine kinase DpiB; Provisional | Back alignment and domain information |
|---|
Probab=98.37 E-value=4e-06 Score=96.11 Aligned_cols=113 Identities=19% Similarity=0.186 Sum_probs=83.3
Q ss_pred HHHHHHHHHHhcceeEEEcCCCcEEeecHHHHHHhCCCh--hhHcCCCccccccccccchhHHHHHHHHHhCceeEEEEE
Q 005841 129 DRQYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSA--EEALGQDAIELLTDGRDFDVAYDIVHRIKMGERWTGQFP 206 (674)
Q Consensus 129 e~~l~~ilds~~d~I~v~D~~GrIi~~N~a~e~llGys~--eEviG~~~~~l~~~~~~~~~~~~i~~~l~~g~~~~~e~~ 206 (674)
...++.+++++.++|+++|.+|+|+++|+++++++|+.. ++++|+++.+++++... +...... .....
T Consensus 221 ~~~~~~il~~~~egii~~D~~g~I~~~N~~a~~ll~~~~~~~~~~g~~~~~~~~~~~~------~~~~~~~-~~~~~--- 290 (545)
T PRK15053 221 VRQQEALFSSVYEGLIAVDPHGYITAINRNARKMLGLSSPGRQWLGKPIAEVVRPADF------FTEQIDE-KRQDV--- 290 (545)
T ss_pred HHHHHHHHHHhCceEEEECCCCeEEeecHHHHHHhCCCCcchhhcCCcHHHhCCCchh------hhhhcCC-cccce---
Confidence 355778999999999999999999999999999999975 57999999888865421 1111111 11111
Q ss_pred EEcCCCCEEEEEEEEEEEECCCCCEEEEEEEEEchHHHHHHHHHHHHh
Q 005841 207 AKTKTEERVLVVATNTPFYDDDGTLVGIVCVSTDSRPFQETRAALWDT 254 (674)
Q Consensus 207 ~~~kdG~~~~v~~s~sPi~d~dG~ivg~i~i~rDITe~k~~e~~L~~l 254 (674)
....+| ..+.++..|++. +|+++|++.+++|+|+.+++++++.++
T Consensus 291 ~~~~~~--~~~~~~~~~i~~-~~~~~G~v~~~~d~te~~~l~~~l~~~ 335 (545)
T PRK15053 291 VANFNG--LSVIANREAIRS-GDDLLGAIISFRSKDEISTLNAQLTQI 335 (545)
T ss_pred EEEECC--EEEEEEeeeEEE-CCeEEEEEEEEEchHHHHHHHHHHHHH
Confidence 112234 334567889875 667899999999999999988887665
|
|
| >PF14598 PAS_11: PAS domain; PDB: 1P97_A 3F1O_A 2A24_A 3H7W_A 3F1P_A 3H82_A 3F1N_A 4F3L_B 4DJ3_A 2KDK_A | Back alignment and domain information |
|---|
Probab=98.34 E-value=8.5e-06 Score=73.18 Aligned_cols=97 Identities=22% Similarity=0.299 Sum_probs=80.3
Q ss_pred eEEEcCCCcEEeecHH-HHHHhCCChhhHcCCCccccccccccch-hHHHHHHHHHhCceeEEEEEEEcCCCCEEEEEEE
Q 005841 143 VHIFDLSDRIIYWNRS-AELLYGYSAEEALGQDAIELLTDGRDFD-VAYDIVHRIKMGERWTGQFPAKTKTEERVLVVAT 220 (674)
Q Consensus 143 I~v~D~~GrIi~~N~a-~e~llGys~eEviG~~~~~l~~~~~~~~-~~~~i~~~l~~g~~~~~e~~~~~kdG~~~~v~~s 220 (674)
+...+.+|+|+++-.. ...++||.++|++|+.+.+++++++... ......+.+..|+.....++++.++|..+|+...
T Consensus 5 ~trhs~dgki~~~d~~~v~~~lgy~~~eLvG~s~y~~~H~~D~~~~~~~~~~~~~~~g~~~~~~yR~~~k~g~~vwvqt~ 84 (111)
T PF14598_consen 5 TTRHSLDGKITYVDSRAVSSLLGYLPEELVGRSIYDFVHPDDLQRVLKQHHREVLQKGQSVSPYYRFRTKNGGYVWVQTK 84 (111)
T ss_dssp EEEEETTSBEEEEETTHHHHHHSS-HHHHTTSBGGGGBSCCTHHHHHHHHHHHHHHHSSEEEEEEEEE-TTSSEEEEEEE
T ss_pred EEEECCCcEEEEEcCccChhhcCCCcHHHcCCchHHhCCHhhhhhHHHHHHHHHhhCCCcCcceEEEEecCCcEEEEEEE
Confidence 3457889999999999 5999999999999999999999988765 5555667788999888889999999999999999
Q ss_pred EEEEECC-CCCEEEEEEEEE
Q 005841 221 NTPFYDD-DGTLVGIVCVST 239 (674)
Q Consensus 221 ~sPi~d~-dG~ivg~i~i~r 239 (674)
..+++++ .+++..++++-+
T Consensus 85 ~~~~~n~~~~~~~~Iv~~n~ 104 (111)
T PF14598_consen 85 ATLFYNPWTSKPEFIVCTNT 104 (111)
T ss_dssp EEEEEETTTTCEEEEEEEEE
T ss_pred EEEEECCCCCCccEEEEEEE
Confidence 9999875 456677777654
|
... |
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.33 E-value=3e-06 Score=92.38 Aligned_cols=136 Identities=18% Similarity=0.232 Sum_probs=105.2
Q ss_pred eEEEEEEE--cCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecC----CeEEEEEecCCC-CCHHH
Q 005841 519 GTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSP----QRLCIVTEFLPR-GSLFR 591 (674)
Q Consensus 519 G~Vy~~~~--~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~----~~~~lV~E~~~g-gsL~~ 591 (674)
.+.|+|.. +|..|++|.++-...... ...-.-++.++++.|+|||.|..+|.+. ..+++|++|.++ ++|++
T Consensus 290 ~Ttyk~~s~~DG~~YvLkRlhg~r~~~~--nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d 367 (655)
T KOG3741|consen 290 ITTYKATSNVDGNAYVLKRLHGDRDQST--NKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYD 367 (655)
T ss_pred ceeEeeeeccCCceeeeeeeccccccCc--ccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHH
Confidence 46788875 688899998843322111 1112347788999999999999888743 458999999986 67887
Q ss_pred HHHh--------------cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccccC
Q 005841 592 LLQR--------------NTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHE 657 (674)
Q Consensus 592 ~l~~--------------~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~ 657 (674)
+.-. .+.+.++..++.|+.|+..||.++|+.| +..+-|.|.+||++.+-+|+|.-+|+..++..
T Consensus 368 ~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG--LAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~ 445 (655)
T KOG3741|consen 368 LYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG--LACKTLDLKKILVTGKMRIRISGCGIMDVLQE 445 (655)
T ss_pred HHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC--ceeecccHhHeEeeCcceEEEecccceeeecC
Confidence 6532 1234678999999999999999999999 88899999999999888999999998876644
Q ss_pred C
Q 005841 658 T 658 (674)
Q Consensus 658 ~ 658 (674)
+
T Consensus 446 d 446 (655)
T KOG3741|consen 446 D 446 (655)
T ss_pred C
Confidence 3
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.31 E-value=4.6e-06 Score=84.11 Aligned_cols=139 Identities=22% Similarity=0.163 Sum_probs=93.8
Q ss_pred eeeecccCceEEEEEEE-cCCeEEEEEeecccCCH---------------------H-HHHHHHHHHHHHhhCC--CCCe
Q 005841 510 GEQIGQGSCGTVYHAVW-YGSDVAVKVFSRQEYSD---------------------E-VIHSFRQEVSLMKRLR--HPNV 564 (674)
Q Consensus 510 ~~~LG~G~fG~Vy~~~~-~~~~vAvK~i~~~~~~~---------------------~-~~~~~~~Ei~il~~l~--HpnI 564 (674)
...|..|-.+.||+|.. .+..||+|++......- + ...-..+|+.-|+++. +-.+
T Consensus 53 ~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrv 132 (268)
T COG1718 53 VGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRV 132 (268)
T ss_pred EeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCC
Confidence 34667788888999886 57889999985432110 0 1122345777777664 3445
Q ss_pred eeEEEEEecCCeEEEEEecCCCCC-HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCeEEccCCCCCEEEcCCC
Q 005841 565 LLFMGAVTSPQRLCIVTEFLPRGS-LFRLLQRNTTKLDWRRRILMALDIARGVSYLHH-CNPPIIHRDLKSSNLLVDKHW 642 (674)
Q Consensus 565 v~l~~~~~~~~~~~lV~E~~~ggs-L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~-~~~~IvHrDLKp~NILi~~~~ 642 (674)
.+.+.+. ...|||||+.... -.-.|+. ..+...++..+..++++.|.-|-. ++ +||+||..-|||+. ++
T Consensus 133 P~Pi~~~----~nVLvMEfIg~~g~pAP~LkD--v~~e~~e~~~~~~~~v~~~~~l~~~a~--LVHgDLSEyNiL~~-~~ 203 (268)
T COG1718 133 PEPIAFR----NNVLVMEFIGDDGLPAPRLKD--VPLELEEAEGLYEDVVEYMRRLYKEAG--LVHGDLSEYNILVH-DG 203 (268)
T ss_pred CCceeec----CCeEEEEeccCCCCCCCCccc--CCcCchhHHHHHHHHHHHHHHHHHhcC--cccccchhhheEEE-CC
Confidence 5555543 3579999995431 1111221 223344677788889999888876 77 99999999999999 78
Q ss_pred cEEEEecCCcccccC
Q 005841 643 TVKVGDFGLSRLKHE 657 (674)
Q Consensus 643 ~vkL~DFGla~~~~~ 657 (674)
.+.|+|||-|.....
T Consensus 204 ~p~iID~~QaV~~~h 218 (268)
T COG1718 204 EPYIIDVSQAVTIDH 218 (268)
T ss_pred eEEEEECccccccCC
Confidence 999999999876553
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.30 E-value=6.9e-06 Score=84.07 Aligned_cols=139 Identities=18% Similarity=0.153 Sum_probs=85.8
Q ss_pred eecccCc-eEEEEEEEcCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCC-CCCeeeEEEEEecCCeEEEEEecCCCCCH
Q 005841 512 QIGQGSC-GTVYHAVWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLR-HPNVLLFMGAVTSPQRLCIVTEFLPRGSL 589 (674)
Q Consensus 512 ~LG~G~f-G~Vy~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~lV~E~~~ggsL 589 (674)
.|-.|.. ..||+....+..+.||+..... ...+.+|+.+++.+. +--+.+++++....+..++|||+++|.+|
T Consensus 5 ~~~~g~~~~~v~~~~~~~~~~~vk~~~~~~-----~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l 79 (244)
T cd05150 5 RVTEGQSGATVYRLDGKNPGLYLKIAPSGP-----TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPA 79 (244)
T ss_pred ecCCCCCcCeEEEEcCCCCcEEEEecCCCc-----ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccH
Confidence 3445555 7899987766778889875432 224566888888874 34466788877777778999999999776
Q ss_pred HHHH-------------------HhcC---CCCCHH--HHHHHHHH--------------------HHHHHHHHHh----
Q 005841 590 FRLL-------------------QRNT---TKLDWR--RRILMALD--------------------IARGVSYLHH---- 621 (674)
Q Consensus 590 ~~~l-------------------~~~~---~~l~~~--~~~~i~~q--------------------i~~~L~yLH~---- 621 (674)
.... +... ..+... ........ +...+..|-.
T Consensus 80 ~~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 159 (244)
T cd05150 80 AALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPA 159 (244)
T ss_pred hHhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCC
Confidence 5431 0000 011100 00000000 1111122211
Q ss_pred -CCCCeEEccCCCCCEEEcCCCcEEEEecCCcccc
Q 005841 622 -CNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLK 655 (674)
Q Consensus 622 -~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~ 655 (674)
..+.++|+|+.|.|||++.++.+.|+||+.|..-
T Consensus 160 ~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~~g 194 (244)
T cd05150 160 EEDLVVTHGDACLPNIIVDPGKFSGFIDLGRLGVA 194 (244)
T ss_pred cCceEEECCCCCCccEEEeCCcEEEEEEccccccc
Confidence 1234899999999999999877899999998753
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >KOG0501 consensus K+-channel KCNQ [Inorganic ion transport and metabolism] | Back alignment and domain information |
|---|
Probab=98.28 E-value=3.9e-06 Score=91.29 Aligned_cols=118 Identities=14% Similarity=0.178 Sum_probs=95.9
Q ss_pred HHHHHHHHHHhc--ceeEEEc-C---CCcEEeecHHHHHHhCCChhhHcCCCcccc--ccccccchhHHHHHHHHHhCce
Q 005841 129 DRQYLNILQSMG--QSVHIFD-L---SDRIIYWNRSAELLYGYSAEEALGQDAIEL--LTDGRDFDVAYDIVHRIKMGER 200 (674)
Q Consensus 129 e~~l~~ilds~~--d~I~v~D-~---~GrIi~~N~a~e~llGys~eEviG~~~~~l--~~~~~~~~~~~~i~~~l~~g~~ 200 (674)
.-++++|+.-.. |.-|++- + |.-|+|+|..||++.||.+.|++-+.+.-- ..+-.+......+.+.+.+-+.
T Consensus 13 NTFLENiiRRsn~~dtsFlL~NAQiVD~PiVY~NdgFcKlsGY~RAevMQKs~tc~FMyGEltdk~ti~k~~~t~eN~~~ 92 (971)
T KOG0501|consen 13 NTFLENIIRRSNNADTSFLLANAQIVDWPIVYCNDGFCKLSGYHRAEVMQKSCTCSFMYGELTDKGTIEKVRQTLENYET 92 (971)
T ss_pred hhHHHHHHhhccCCCcceeeccceeeccceEEecCcchhccCccHHHHhcccceeeeeeccccchhhHHHHHHHHHhhhh
Confidence 347888876554 6555543 3 788999999999999999999999886432 3333445556677778888888
Q ss_pred eEEEEEEEcCCCCEEEEEEEEEEEECCCCCEEEEEEEEEchHHHHH
Q 005841 201 WTGQFPAKTKTEERVLVVATNTPFYDDDGTLVGIVCVSTDSRPFQE 246 (674)
Q Consensus 201 ~~~e~~~~~kdG~~~~v~~s~sPi~d~dG~ivg~i~i~rDITe~k~ 246 (674)
-..|+-+++|+...+|+.+.+.||+++...++-++|.|+|||..|+
T Consensus 93 ~qfEillyKKN~TPvW~~vqiAPIrNe~d~VVLfLctFkDIT~~KQ 138 (971)
T KOG0501|consen 93 NQFEILLYKKNRTPVWLLVQIAPIRNEKDKVVLFLCTFKDITALKQ 138 (971)
T ss_pred cceeeEeeecCCCceEEEEEeecccCCCceEEEEEeecccchhhcC
Confidence 8889999999999999999999999999999999999999999874
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.26 E-value=2.9e-06 Score=95.45 Aligned_cols=143 Identities=21% Similarity=0.221 Sum_probs=93.5
Q ss_pred eeecccCceEEEEEEEc-CCeEEEEEeeccc---------------------------CCH-----HHHHH------HHH
Q 005841 511 EQIGQGSCGTVYHAVWY-GSDVAVKVFSRQE---------------------------YSD-----EVIHS------FRQ 551 (674)
Q Consensus 511 ~~LG~G~fG~Vy~~~~~-~~~vAvK~i~~~~---------------------------~~~-----~~~~~------~~~ 551 (674)
+-|+.++-|+||+|+.. |+.||||+..+.- +.. +..+. +.+
T Consensus 131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~ 210 (517)
T COG0661 131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR 210 (517)
T ss_pred CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence 57899999999999985 8999999985421 111 11111 223
Q ss_pred HHHHHhhCC-----CCCeeeEEEEEecCCeEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCe
Q 005841 552 EVSLMKRLR-----HPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPI 626 (674)
Q Consensus 552 Ei~il~~l~-----HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~I 626 (674)
|..-+.+++ .++|.-..-+++--..-.|+|||++|-.+.+........++.+.+...+.++.--.-+ ..| +
T Consensus 211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g~d~k~ia~~~~~~f~~q~~--~dg--f 286 (517)
T COG0661 211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAGIDRKELAELLVRAFLRQLL--RDG--F 286 (517)
T ss_pred HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhcCCCHHHHHHHHHHHHHHHHH--hcC--c
Confidence 333333332 3444333333333456789999999988888753333456655554444443332223 357 9
Q ss_pred EEccCCCCCEEEcCCCcEEEEecCCcccccC
Q 005841 627 IHRDLKSSNLLVDKHWTVKVGDFGLSRLKHE 657 (674)
Q Consensus 627 vHrDLKp~NILi~~~~~vkL~DFGla~~~~~ 657 (674)
+|.|..|.||+++.++++.+.|||+...+.+
T Consensus 287 fHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 287 FHADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred cccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 9999999999999999999999999876653
|
|
| >COG2202 AtoS FOG: PAS/PAC domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.22 E-value=2.3e-05 Score=72.96 Aligned_cols=118 Identities=25% Similarity=0.427 Sum_probs=90.4
Q ss_pred HHHHHHHHHHhcceeEEEcCCCcEEeecHHHHHHhCCChhhHcCCCccccccccccchhHHHHHHH--HHhCceeEEEEE
Q 005841 129 DRQYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHR--IKMGERWTGQFP 206 (674)
Q Consensus 129 e~~l~~ilds~~d~I~v~D~~GrIi~~N~a~e~llGys~eEviG~~~~~l~~~~~~~~~~~~i~~~--l~~g~~~~~e~~ 206 (674)
...+..+++.++++++++|.+|+++++|+++++++|++..+.++....++................ .........++.
T Consensus 111 ~~~~~~~~~~~~~~~~~~d~~~~~~~~n~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 190 (232)
T COG2202 111 EERLRALLEASPDGIWVLDEDGRILYANPAAEELLGYSPEEELGRGLSDLIHPEDEERRELELARALAEGRGGPLEIEYR 190 (232)
T ss_pred HHHHHHHHhhCCceEEEEeCCCCEEEeCHHHHHHhCCChHHhcCCChhheEecCCCchhhHHHHHHhhccCCCCcceEEE
Confidence 344788999999999999999999999999999999998888888777666544332111122222 233334677888
Q ss_pred EEcCCCCE-EEEEEEEEEEECCCCCEEEEEEEEEchHHHHHH
Q 005841 207 AKTKTEER-VLVVATNTPFYDDDGTLVGIVCVSTDSRPFQET 247 (674)
Q Consensus 207 ~~~kdG~~-~~v~~s~sPi~d~dG~ivg~i~i~rDITe~k~~ 247 (674)
...++|.. .++.....+... +|.+.+++....|+++.++.
T Consensus 191 ~~~~~g~~~~~~~~~~~~~~~-~~~~~~~~~~~~d~~~~~~~ 231 (232)
T COG2202 191 VRRKDGERVRWILSRISPVRD-DGEIVGVVGIARDITERKQA 231 (232)
T ss_pred EEecCCCEEEEEEeeeeEecC-CCceEEEEEEEechHHHhhc
Confidence 88899996 888888888764 78899999999999998753
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.20 E-value=7.3e-06 Score=78.48 Aligned_cols=136 Identities=20% Similarity=0.256 Sum_probs=94.6
Q ss_pred eeEeeeecccCceEEEEEEEcCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCee-eEEEEEecCCeEEEEEecCC
Q 005841 507 LTIGEQIGQGSCGTVYHAVWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVL-LFMGAVTSPQRLCIVTEFLP 585 (674)
Q Consensus 507 y~~~~~LG~G~fG~Vy~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv-~l~~~~~~~~~~~lV~E~~~ 585 (674)
..+.+.|++|.++.||+|.+.+..+|+|+-..+. -...+..|.++|..+.-.++. +++.+. ..++.|||+.
T Consensus 24 ~~v~~~L~KG~~s~Vyl~~~~~~~~a~Kvrr~ds----~r~~l~kEakiLeil~g~~~~p~vy~yg----~~~i~me~i~ 95 (201)
T COG2112 24 LRVEKELAKGTTSVVYLGEWRGGEVALKVRRRDS----PRRNLEKEAKILEILAGEGVTPEVYFYG----EDFIRMEYID 95 (201)
T ss_pred hhhhhhhhcccccEEEEeeccCceEEEEEecCCc----chhhHHHHHHHHHHhhhcCCCceEEEec----hhhhhhhhhc
Confidence 3456789999999999999999999999865443 235688899999998866655 455443 3456699999
Q ss_pred CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCC-CCCEEEcCCCcEEEEecCCcccccCCcc
Q 005841 586 RGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLK-SSNLLVDKHWTVKVGDFGLSRLKHETYL 660 (674)
Q Consensus 586 ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLK-p~NILi~~~~~vkL~DFGla~~~~~~~~ 660 (674)
|..|....... +...+. .++..-.-|-..| |-|.-|. |..++|-.++.+.|+||.-|++...+..
T Consensus 96 G~~L~~~~~~~----~rk~l~----~vlE~a~~LD~~G--I~H~El~~~~k~vlv~~~~~~iIDFd~At~k~~p~N 161 (201)
T COG2112 96 GRPLGKLEIGG----DRKHLL----RVLEKAYKLDRLG--IEHGELSRPWKNVLVNDRDVYIIDFDSATFKKKPRN 161 (201)
T ss_pred Ccchhhhhhcc----cHHHHH----HHHHHHHHHHHhc--cchhhhcCCceeEEecCCcEEEEEccchhhccCCch
Confidence 98887765421 222222 3444433344556 8888776 5555555555999999999997665543
|
|
| >COG3852 NtrB Signal transduction histidine kinase, nitrogen specific [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.20 E-value=1.5e-05 Score=81.74 Aligned_cols=160 Identities=18% Similarity=0.155 Sum_probs=115.4
Q ss_pred HHHHHHhcceeEEEcCCCcEEeecHHHHHHhCCChhhHcCCCccccccccccchhHHHHHHHHHhCceeEE-EEEEEcCC
Q 005841 133 LNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGERWTG-QFPAKTKT 211 (674)
Q Consensus 133 ~~ilds~~d~I~v~D~~GrIi~~N~a~e~llGys~eEviG~~~~~l~~~~~~~~~~~~i~~~l~~g~~~~~-e~~~~~kd 211 (674)
..+|+++...|+++|.+|.|.|+|++|+.+||.+...+.|..+.++++... .....+.+....+..... +..+. .+
T Consensus 10 ~~~Ln~~~~pVl~vd~~~~i~yaN~aAe~~~~~Sa~~L~~~~l~~l~~~gs--~ll~ll~q~~~~~~~~~~~~v~l~-~~ 86 (363)
T COG3852 10 GAILNNLINPVLLVDDELAIHYANPAAEQLLAVSARRLAGTRLSELLPFGS--LLLSLLDQVLERGQPVTEYEVTLV-IL 86 (363)
T ss_pred HhHHhccCCceEEEcCCCcEEecCHHHHHHHHHHHHHHhcCChHHHcCCCc--HHHHHHHHHHHhcCCcccceeeee-ec
Confidence 468999999999999999999999999999999999999999999988654 223334455666666432 23333 78
Q ss_pred CCEEEEEEEEEEEECCCCCEEEEEEEEEchHHHHHHHHHHHHhhhcCCccCcCCchhHHHHHhcCCccchhhHHHHHHHH
Q 005841 212 EERVLVVATNTPFYDDDGTLVGIVCVSTDSRPFQETRAALWDTKNSDTDSNINRPRNTVTAKLGLDSQQPLQATIASKIS 291 (674)
Q Consensus 212 G~~~~v~~s~sPi~d~dG~ivg~i~i~rDITe~k~~e~~L~~la~~d~lt~~nr~~~~~~~kl~~~~~qpl~~~iassi~ 291 (674)
|....+.+++.|+-...|- ++..+..+....++.+++.+.+. +|.-..+...++|+...||.- |.
T Consensus 87 g~~~~v~~~v~~v~~~~G~---vlle~~~~~~~~ridre~~q~a~-------~~a~~~L~r~LAHEIKNPL~G-----iR 151 (363)
T COG3852 87 GRSHIVDLTVAPVPEEPGS---VLLEFHPRDMQRRLDREQTQHAQ-------QRAVKGLVRGLAHEIKNPLGG-----IR 151 (363)
T ss_pred CccceEEEEEeeccCCCCe---EEEEechhHHHhHhhHHHHHHHH-------HHHHHHHHHHHHHHhcCcccc-----hh
Confidence 9999999999999765664 35667888887777777655543 233345677788888888877 44
Q ss_pred HHHHHHHhhhc-------cccccCCC
Q 005841 292 NLATKVSNKVK-------SRIRTGDN 310 (674)
Q Consensus 292 ~LA~kva~~~~-------svLi~Ges 310 (674)
.-|+.++..+. +.||.-|+
T Consensus 152 GAAQLLe~~lpd~~~~~lt~lIieE~ 177 (363)
T COG3852 152 GAAQLLERALPDEALRELTQLIIEEA 177 (363)
T ss_pred hHHHHHHhhCCChHHHHHHHHHHHHH
Confidence 44444444433 34666554
|
|
| >PF13188 PAS_8: PAS domain; PDB: 2JHE_D 3VOL_A | Back alignment and domain information |
|---|
Probab=98.14 E-value=2.5e-06 Score=68.23 Aligned_cols=48 Identities=35% Similarity=0.605 Sum_probs=40.2
Q ss_pred HHHHHHHHHhcceeEEEcCCCcEEeecHHHHHHhCCChhhHcCCCccccccc
Q 005841 130 RQYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTD 181 (674)
Q Consensus 130 ~~l~~ilds~~d~I~v~D~~GrIi~~N~a~e~llGys~eEviG~~~~~l~~~ 181 (674)
++|+.+|++++++|+++| +++|+++|+++++++||+ +.|+.+..+++.
T Consensus 1 e~~~~l~~~~~~~i~i~d-~~~i~~~N~~~~~l~g~~---~~~~~~~~~~~~ 48 (64)
T PF13188_consen 1 ERYRSLFDNSPDGILIID-GGRIIYVNPAFEELFGYS---LEGEDIGQLFPD 48 (64)
T ss_dssp HHHHHHHCCSSSEEEEEE-TSBEEEE-HHHHHHHCS----HTCCCHHCTSTT
T ss_pred CHHHHHHHcCccceEEEE-CCChHHhhHHHHHHhCCC---CCCCCHHHhCcc
Confidence 479999999999999999 889999999999999999 777776655543
|
|
| >PRK09959 hybrid sensory histidine kinase in two-component regulatory system with EvgA; Provisional | Back alignment and domain information |
|---|
Probab=98.07 E-value=2.4e-05 Score=98.30 Aligned_cols=156 Identities=12% Similarity=0.014 Sum_probs=91.6
Q ss_pred ccHHHHHHHHHHhcceeEEEcCCCcEEeecHHHHHHhCCChhhHcCCCccccccccccchhHHHHH---HHHHhCce-eE
Q 005841 127 FTDRQYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIV---HRIKMGER-WT 202 (674)
Q Consensus 127 ~se~~l~~ilds~~d~I~v~D~~GrIi~~N~a~e~llGys~eEviG~~~~~l~~~~~~~~~~~~i~---~~l~~g~~-~~ 202 (674)
....+++.++++++++|+++|.+|+|+++|+++++++|+...+..+........+ ......... ........ +.
T Consensus 573 ~~~~~~~~i~~~~~~~i~~~d~~g~i~~~N~~~~~~~g~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 650 (1197)
T PRK09959 573 NQISFRKALSDSLPNPTYVVNWQGNVISHNSAFEHYFTADYYKNAMLPLENSDSP--FKDVFSNAHEVTAETKENRTIYT 650 (1197)
T ss_pred HHHHHHHHHHhhCCCcEEEEcCCCcEEEehHHHHHHhCcccccccccccccccCc--hhhhHhHHHHHHHHHhhccccce
Confidence 4456788999999999999999999999999999999987544333222111111 011111111 11111111 22
Q ss_pred EEEEEEcCCCCEEE-EEEEEEEEECCCCCEEEEEEEEEchHHHHHHHHHHHHhhhcCCccCcCCchhHHHHHhcCCccch
Q 005841 203 GQFPAKTKTEERVL-VVATNTPFYDDDGTLVGIVCVSTDSRPFQETRAALWDTKNSDTDSNINRPRNTVTAKLGLDSQQP 281 (674)
Q Consensus 203 ~e~~~~~kdG~~~~-v~~s~sPi~d~dG~ivg~i~i~rDITe~k~~e~~L~~la~~d~lt~~nr~~~~~~~kl~~~~~qp 281 (674)
..+. ..+|.... +.....+.....+...++++.++|||++++++++|+..... ....++.+..++..++|+.+.|
T Consensus 651 ~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dite~~~~~~~l~~~~~~--~~~~~~~~~~~~~~isHelrtP 726 (1197)
T PRK09959 651 QVFE--IDNGIEKRCINHWHTLCNLPASDHAVYICGWQDITETRDLIHALEVERNK--AINATVAKSQFLATMSHEIRTP 726 (1197)
T ss_pred eeEe--eecCccceeeeeeeeeeccCCCCceEEEEEEEehhHHHHHHHHHHHHHHH--HHHHHHHHHHHHHhcChhhCcc
Confidence 2222 22333222 22222232233455667889999999999998887654221 1112334567788899999999
Q ss_pred hhHHHHH
Q 005841 282 LQATIAS 288 (674)
Q Consensus 282 l~~~ias 288 (674)
|..++..
T Consensus 727 L~~i~~~ 733 (1197)
T PRK09959 727 ISSIMGF 733 (1197)
T ss_pred HHHHHHH
Confidence 9885543
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST 
Original result of BLAST against Protein Data Bank
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() | |
| Query | 674 | ||||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 8e-56 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 3e-55 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 4e-29 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 5e-29 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 8e-29 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 1e-27 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 1e-27 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 1e-27 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 1e-27 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 2e-27 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 2e-27 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 2e-27 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 4e-27 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 4e-27 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 6e-27 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 3e-26 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 1e-22 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 1e-21 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 4e-21 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 9e-21 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 2e-20 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 2e-20 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 2e-20 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 2e-20 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 3e-20 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 4e-20 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 6e-20 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 7e-20 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 8e-20 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 8e-20 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 9e-20 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 9e-20 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 9e-20 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 1e-19 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 1e-19 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 1e-19 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-19 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 1e-19 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 1e-19 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 1e-19 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 1e-19 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-19 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 2e-19 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 2e-19 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 2e-19 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 2e-19 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 2e-19 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 2e-19 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-19 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-19 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 2e-19 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-19 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 2e-19 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 2e-19 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-19 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 2e-19 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 2e-19 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 3e-19 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 3e-19 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 3e-19 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 3e-19 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 4e-19 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 6e-19 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 8e-19 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 9e-19 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 9e-19 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 9e-19 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 9e-19 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 1e-18 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 1e-18 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 2e-18 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 2e-18 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 2e-18 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 2e-18 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 3e-18 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 3e-18 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 3e-18 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 3e-18 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 4e-18 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 5e-18 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 5e-18 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 6e-18 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 6e-18 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 7e-18 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 8e-18 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 8e-18 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 8e-18 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 8e-18 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 9e-18 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 9e-18 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 9e-18 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 1e-17 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 1e-17 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 1e-17 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 1e-17 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-17 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 1e-17 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 1e-17 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 1e-17 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 1e-17 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 1e-17 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 1e-17 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 1e-17 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 1e-17 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 1e-17 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-17 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-17 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-17 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 1e-17 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 2e-17 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 2e-17 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 2e-17 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 2e-17 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-17 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 2e-17 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 2e-17 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-17 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 3e-17 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 3e-17 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 3e-17 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 3e-17 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 4e-17 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 4e-17 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 4e-17 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 4e-17 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 4e-17 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 5e-17 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 5e-17 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 5e-17 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 5e-17 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 5e-17 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 5e-17 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 6e-17 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 6e-17 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 7e-17 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 7e-17 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 8e-17 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 1e-16 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 1e-16 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 1e-16 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 1e-16 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 1e-16 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 1e-16 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 2e-16 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 2e-16 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 2e-16 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 2e-16 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 2e-16 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 2e-16 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 2e-16 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 2e-16 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 2e-16 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 2e-16 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 2e-16 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 2e-16 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 2e-16 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 2e-16 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 3e-16 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 3e-16 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 3e-16 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 3e-16 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 5e-16 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 5e-16 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 5e-16 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 7e-16 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 8e-16 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 8e-16 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 8e-16 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 8e-16 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 9e-16 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 1e-15 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 1e-15 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 1e-15 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 1e-15 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 1e-15 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 1e-15 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 1e-15 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 1e-15 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 1e-15 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 1e-15 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 1e-15 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 1e-15 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 1e-15 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 1e-15 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 1e-15 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 2e-15 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 2e-15 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 2e-15 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 2e-15 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 2e-15 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 2e-15 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 2e-15 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 2e-15 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 2e-15 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 3e-15 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 3e-15 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 3e-15 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 3e-15 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 3e-15 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 4e-15 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 4e-15 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 4e-15 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 5e-15 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 5e-15 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 5e-15 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 5e-15 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 5e-15 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 6e-15 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 7e-15 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 7e-15 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 8e-15 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 1e-14 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 1e-14 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 1e-14 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-14 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 2e-14 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 2e-14 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 2e-14 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 2e-14 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 2e-14 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 2e-14 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-14 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 2e-14 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 2e-14 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 2e-14 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 3e-14 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 3e-14 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 3e-14 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 3e-14 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 4e-14 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 4e-14 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 4e-14 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-14 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 4e-14 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 5e-14 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 6e-14 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 6e-14 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 6e-14 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 7e-14 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 8e-14 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 8e-14 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 8e-14 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 8e-14 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 8e-14 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 8e-14 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 8e-14 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 9e-14 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 9e-14 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 9e-14 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 1e-13 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 1e-13 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 2e-13 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 2e-13 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 2e-13 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 2e-13 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 2e-13 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 3e-13 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 3e-13 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 3e-13 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 3e-13 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 3e-13 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 3e-13 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 3e-13 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 3e-13 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 3e-13 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 3e-13 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 3e-13 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 4e-13 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 4e-13 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 4e-13 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 4e-13 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 4e-13 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 4e-13 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 4e-13 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 4e-13 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-13 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 5e-13 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 5e-13 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 6e-13 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 6e-13 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 6e-13 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 6e-13 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 6e-13 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 6e-13 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 6e-13 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 6e-13 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 6e-13 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 6e-13 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 7e-13 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 7e-13 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 7e-13 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 8e-13 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 8e-13 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 8e-13 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 9e-13 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 9e-13 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 9e-13 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 9e-13 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 1e-12 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 1e-12 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 1e-12 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 1e-12 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-12 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 1e-12 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 3e-12 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 3e-12 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 3e-12 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 3e-12 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-12 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 4e-12 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 4e-12 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 4e-12 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-12 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 5e-12 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 5e-12 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 5e-12 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 6e-12 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 6e-12 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 6e-12 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 8e-12 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 9e-12 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 9e-12 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 1e-11 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 1e-11 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 1e-11 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 1e-11 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-11 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-11 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 1e-11 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 1e-11 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 1e-11 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 1e-11 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-11 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 1e-11 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-11 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 2e-11 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 2e-11 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 2e-11 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 2e-11 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 2e-11 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 3e-11 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 3e-11 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-11 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 3e-11 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-11 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 3e-11 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 3e-11 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 3e-11 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 3e-11 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 3e-11 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 3e-11 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-11 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 3e-11 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 3e-11 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 3e-11 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 3e-11 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 3e-11 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 3e-11 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 3e-11 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 3e-11 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 3e-11 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 3e-11 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 3e-11 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 3e-11 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 3e-11 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 3e-11 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 3e-11 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 3e-11 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 3e-11 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 3e-11 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 4e-11 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 4e-11 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 4e-11 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 4e-11 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 4e-11 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 4e-11 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 4e-11 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 4e-11 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 4e-11 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-11 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 4e-11 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 4e-11 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 4e-11 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 4e-11 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 4e-11 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 4e-11 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 4e-11 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 5e-11 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 5e-11 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 5e-11 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 5e-11 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 5e-11 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 5e-11 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-11 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 5e-11 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 5e-11 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 6e-11 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 6e-11 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 6e-11 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 6e-11 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 7e-11 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 8e-11 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 8e-11 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 9e-11 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 9e-11 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 1e-10 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 1e-10 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-10 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 1e-10 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 1e-10 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 1e-10 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-10 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 1e-10 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 1e-10 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 1e-10 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 2e-10 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 2e-10 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-10 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-10 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 2e-10 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 3e-10 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 3e-10 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-10 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 3e-10 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-10 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 4e-10 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 4e-10 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 5e-10 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 5e-10 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 5e-10 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 5e-10 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 5e-10 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 5e-10 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 6e-10 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 6e-10 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 6e-10 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 6e-10 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 6e-10 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 6e-10 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 6e-10 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 6e-10 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 6e-10 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 7e-10 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 7e-10 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 7e-10 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 8e-10 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 8e-10 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 8e-10 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 8e-10 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 8e-10 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 9e-10 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 1e-09 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-09 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 1e-09 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 1e-09 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 1e-09 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 1e-09 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-09 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 1e-09 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 1e-09 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 1e-09 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 1e-09 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 1e-09 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-09 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 1e-09 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 1e-09 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 1e-09 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-09 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 1e-09 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 1e-09 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 1e-09 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-09 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 1e-09 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 1e-09 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 1e-09 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-09 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 1e-09 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 1e-09 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 1e-09 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 1e-09 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 1e-09 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 1e-09 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 1e-09 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-09 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 1e-09 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-09 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 2e-09 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 2e-09 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 2e-09 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-09 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 2e-09 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 2e-09 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 2e-09 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 2e-09 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-09 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 2e-09 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 2e-09 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 2e-09 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 2e-09 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 2e-09 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 2e-09 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 2e-09 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 2e-09 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 2e-09 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 2e-09 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 2e-09 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-09 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 2e-09 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 2e-09 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 2e-09 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 2e-09 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-09 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 2e-09 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-09 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 2e-09 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 2e-09 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 2e-09 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 2e-09 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-09 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 2e-09 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-09 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 2e-09 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 2e-09 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 2e-09 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-09 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 2e-09 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 2e-09 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-09 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 2e-09 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 3e-09 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 3e-09 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 3e-09 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 3e-09 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 3e-09 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-09 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 3e-09 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 3e-09 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 3e-09 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 3e-09 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 3e-09 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 3e-09 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-09 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 4e-09 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 4e-09 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 4e-09 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 4e-09 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-09 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 4e-09 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 4e-09 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 4e-09 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 4e-09 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-09 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 4e-09 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 4e-09 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 4e-09 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 5e-09 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-09 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 5e-09 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 5e-09 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 5e-09 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 5e-09 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 5e-09 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 5e-09 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 5e-09 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 5e-09 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 5e-09 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 5e-09 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 5e-09 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 5e-09 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 5e-09 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 5e-09 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 5e-09 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 6e-09 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 6e-09 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 6e-09 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 6e-09 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 6e-09 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 6e-09 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 6e-09 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 6e-09 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 6e-09 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 6e-09 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 6e-09 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 6e-09 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 6e-09 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 6e-09 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 7e-09 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 7e-09 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 7e-09 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 7e-09 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 7e-09 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 7e-09 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 7e-09 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 7e-09 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 7e-09 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 7e-09 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 7e-09 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 7e-09 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 7e-09 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 7e-09 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 7e-09 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 7e-09 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 7e-09 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 7e-09 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 7e-09 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 7e-09 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 7e-09 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 7e-09 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 7e-09 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 7e-09 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 7e-09 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 7e-09 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 7e-09 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 8e-09 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 8e-09 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 8e-09 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 8e-09 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 8e-09 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 8e-09 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 8e-09 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 8e-09 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 8e-09 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 8e-09 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 8e-09 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 9e-09 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 9e-09 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 9e-09 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 9e-09 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 1e-08 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-08 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 1e-08 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 1e-08 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 1e-08 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-08 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 1e-08 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 1e-08 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 1e-08 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 1e-08 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 1e-08 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 1e-08 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 1e-08 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 1e-08 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-08 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 1e-08 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 1e-08 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-08 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 1e-08 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 1e-08 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 1e-08 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-08 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 2e-08 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 2e-08 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 2e-08 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 2e-08 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-08 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 2e-08 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 2e-08 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-08 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 2e-08 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 2e-08 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-08 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-08 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-08 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 3e-08 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 3e-08 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 3e-08 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 3e-08 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 4e-08 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 4e-08 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 4e-08 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 4e-08 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 4e-08 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 4e-08 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 5e-08 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 5e-08 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 5e-08 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 5e-08 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 5e-08 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 5e-08 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 6e-08 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 6e-08 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 6e-08 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 6e-08 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 6e-08 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 7e-08 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 7e-08 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 7e-08 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 7e-08 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 7e-08 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 7e-08 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 8e-08 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 8e-08 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 8e-08 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 8e-08 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 8e-08 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 8e-08 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 8e-08 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 8e-08 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 8e-08 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 8e-08 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 8e-08 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 8e-08 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 9e-08 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 9e-08 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 9e-08 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 9e-08 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 1e-07 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 1e-07 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 1e-07 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 1e-07 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 1e-07 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 1e-07 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 1e-07 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-07 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-07 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 1e-07 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-07 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-07 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 1e-07 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 2e-07 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 2e-07 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 2e-07 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 2e-07 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 2e-07 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 2e-07 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 2e-07 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 2e-07 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 2e-07 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 2e-07 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 2e-07 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 2e-07 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-07 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-07 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 2e-07 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 2e-07 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 2e-07 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 2e-07 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 2e-07 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-07 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 2e-07 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 2e-07 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 2e-07 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 2e-07 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 3e-07 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 3e-07 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 3e-07 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 3e-07 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 3e-07 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 3e-07 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 3e-07 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 3e-07 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 3e-07 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 3e-07 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 3e-07 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 3e-07 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 3e-07 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 3e-07 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 3e-07 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 3e-07 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 3e-07 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 4e-07 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 4e-07 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 4e-07 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 4e-07 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 4e-07 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 4e-07 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 4e-07 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 4e-07 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 4e-07 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 4e-07 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 4e-07 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 4e-07 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 5e-07 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 5e-07 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 5e-07 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 5e-07 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 5e-07 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 5e-07 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 5e-07 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 5e-07 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 5e-07 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 5e-07 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 5e-07 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 5e-07 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 6e-07 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 6e-07 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 6e-07 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 6e-07 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 6e-07 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 6e-07 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 6e-07 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 6e-07 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 6e-07 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 6e-07 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 7e-07 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 7e-07 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 7e-07 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 8e-07 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 8e-07 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 9e-07 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 9e-07 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 1e-06 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 1e-06 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-06 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 1e-06 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 1e-06 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 1e-06 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 2e-06 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-06 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 2e-06 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-06 | ||
| 3lyx_A | 124 | Crystal Structure Of The Pas Domain Of The Protein | 2e-06 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 2e-06 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 2e-06 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 2e-06 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 2e-06 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 2e-06 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 2e-06 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 2e-06 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 2e-06 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 2e-06 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 2e-06 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 2e-06 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 2e-06 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 2e-06 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 2e-06 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 3e-06 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 3e-06 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 3e-06 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 3e-06 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 3e-06 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 3e-06 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 3e-06 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 3e-06 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 4e-06 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 4e-06 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 4e-06 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 4e-06 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 4e-06 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 4e-06 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 4e-06 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 5e-06 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 5e-06 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 5e-06 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 5e-06 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 5e-06 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 5e-06 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 5e-06 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 5e-06 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 5e-06 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 5e-06 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 6e-06 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 6e-06 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 6e-06 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 6e-06 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 6e-06 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 6e-06 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 6e-06 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 7e-06 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 7e-06 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 8e-06 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 8e-06 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 8e-06 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 8e-06 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 8e-06 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 8e-06 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 9e-06 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 9e-06 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 9e-06 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 9e-06 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 9e-06 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 9e-06 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 1e-05 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 1e-05 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 1e-05 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 1e-05 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 1e-05 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 1e-05 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-05 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 1e-05 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 1e-05 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 1e-05 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 2e-05 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-05 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 2e-05 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 2e-05 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 2e-05 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 2e-05 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 2e-05 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 3e-05 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 4e-05 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 7e-05 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 7e-05 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 8e-05 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 9e-05 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 1e-04 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-04 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 2e-04 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 2e-04 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-04 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 2e-04 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 2e-04 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 2e-04 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 2e-04 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 2e-04 | ||
| 3gni_B | 389 | Structure Of Strad And Mo25 Length = 389 | 2e-04 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 2e-04 | ||
| 2wtk_B | 373 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 2e-04 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 2e-04 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 2e-04 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 2e-04 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 2e-04 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 2e-04 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 2e-04 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 2e-04 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 3e-04 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-04 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 3e-04 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 4e-04 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 4e-04 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 4e-04 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 4e-04 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 4e-04 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 4e-04 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 4e-04 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 5e-04 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 5e-04 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 5e-04 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 5e-04 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 5e-04 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 6e-04 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 6e-04 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 6e-04 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 6e-04 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 6e-04 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 6e-04 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 6e-04 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 6e-04 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 7e-04 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 7e-04 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 7e-04 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 7e-04 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 7e-04 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 8e-04 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 8e-04 |
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3LYX|A Chain A, Crystal Structure Of The Pas Domain Of The Protein Cps_1291 From Colwellia Psychrerythraea. Northeast Structural Genomics Consortium Target Id Csr222b Length = 124 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST 
Original result of RPS-BLAST against PDB70 database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 674 | |||
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 1e-97 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 1e-87 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 4e-87 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 1e-86 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 8e-86 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 2e-85 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 4e-84 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 3e-82 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 1e-80 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 6e-77 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 5e-74 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 5e-72 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 3e-71 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 4e-71 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 1e-69 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 2e-47 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 2e-45 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 1e-43 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 2e-43 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 5e-43 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 7e-43 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 1e-42 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 2e-42 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 2e-42 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 2e-42 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 4e-42 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 6e-42 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 8e-42 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 1e-41 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 1e-41 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 1e-41 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 1e-41 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 2e-41 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 3e-41 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 6e-41 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 8e-41 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 1e-40 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 2e-40 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 2e-40 | |
| 3zzw_A | 289 | Tyrosine-protein kinase transmembrane receptor RO; | 2e-40 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 3e-40 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 9e-40 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 1e-39 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 2e-39 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 2e-39 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 2e-39 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 4e-39 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 5e-39 | |
| 3v5q_A | 297 | NT-3 growth factor receptor; kinase domain, kinase | 6e-39 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 2e-38 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 3e-38 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 6e-38 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 8e-38 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 1e-37 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 2e-37 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 2e-37 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 2e-37 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 3e-37 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 5e-37 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 5e-37 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 6e-37 | |
| 4apc_A | 350 | Serine/threonine-protein kinase NEK1; transferase; | 1e-36 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 2e-36 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 2e-36 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 3e-36 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 3e-36 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 3e-36 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 4e-36 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 5e-36 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 5e-36 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 7e-36 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 7e-36 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 9e-36 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 2e-35 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 2e-35 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 2e-35 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 3e-35 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 9e-35 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 9e-35 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 1e-34 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 3e-34 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 7e-34 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 2e-33 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 3e-33 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 3e-33 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 1e-32 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 2e-32 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 2e-32 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 4e-32 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 8e-32 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 3e-30 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 4e-30 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 2e-29 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 4e-29 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 5e-29 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 5e-29 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 6e-29 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 6e-29 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 6e-29 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 7e-29 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 8e-29 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 9e-29 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 1e-28 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 2e-28 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 2e-28 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 3e-28 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 3e-28 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 1e-27 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 2e-27 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 2e-27 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 4e-27 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 5e-27 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 1e-26 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 1e-26 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 1e-26 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 1e-26 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 2e-26 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 2e-26 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 4e-26 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 8e-26 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 8e-26 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 2e-25 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 2e-25 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 3e-25 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 3e-25 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 3e-25 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 3e-25 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 3e-25 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 5e-25 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 6e-25 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 6e-25 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 7e-25 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 7e-25 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 8e-25 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 9e-25 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 1e-24 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 1e-24 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 1e-24 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 1e-24 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 2e-24 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 2e-24 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 2e-24 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 2e-24 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 2e-24 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 2e-24 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 2e-24 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 3e-24 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 3e-24 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 3e-24 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 3e-24 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 6e-24 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 7e-24 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 8e-24 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 1e-23 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 1e-23 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 1e-23 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 1e-23 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 2e-23 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 2e-23 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 3e-23 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 4e-23 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 4e-23 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 4e-23 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 5e-23 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 6e-23 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 7e-23 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 8e-23 | |
| 1uu3_A | 310 | HPDK1, 3-phosphoinositide dependent protein kinase | 1e-22 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 2e-22 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 2e-22 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 2e-22 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 3e-22 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 4e-22 | |
| 3lyx_A | 124 | Sensory BOX/ggdef domain protein; structural genom | 5e-22 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 7e-22 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 1e-21 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 2e-21 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 4e-21 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 7e-21 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 2e-20 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 2e-20 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 3e-20 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 3e-20 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 3e-20 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 4e-20 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 6e-20 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 7e-20 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 8e-20 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 1e-19 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 1e-19 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 3e-19 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 3e-19 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 1e-18 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 1e-18 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 2e-18 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 4e-18 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 4e-18 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 5e-18 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 5e-18 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 6e-18 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 9e-18 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 1e-17 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 2e-17 | |
| 3g51_A | 325 | Ribosomal protein S6 kinase alpha-3; N-terminal ki | 4e-17 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 5e-17 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 5e-17 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 7e-17 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 8e-17 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 9e-17 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 1e-16 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 1e-16 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 2e-16 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 2e-16 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 2e-16 | |
| 3ewk_A | 227 | Sensor protein; PAS domain, alpha/beta fold, kinas | 2e-16 | |
| 3ewk_A | 227 | Sensor protein; PAS domain, alpha/beta fold, kinas | 7e-15 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 3e-16 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 4e-16 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 6e-16 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 6e-16 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 1e-15 | |
| 3pvu_A | 695 | Beta-adrenergic receptor kinase 1; transferase, se | 1e-15 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 5e-15 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 1e-14 | |
| 3a0s_A | 96 | Sensor protein; PAS-fold, kinase, phosphoprotein, | 2e-13 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 1e-12 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 2e-12 | |
| 3a0r_A | 349 | Sensor protein; four helix bundle, PAS fold, kinas | 3e-12 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 5e-12 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 2e-11 | |
| 3b33_A | 115 | Sensor protein; structural genomics, PAS domain, n | 3e-11 | |
| 3mjq_A | 126 | Uncharacterized protein; NESG, structural genomics | 7e-11 | |
| 3luq_A | 114 | Sensor protein; PAS, histidine, kinase, PSI, MCSG, | 1e-10 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 5e-10 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 7e-10 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 8e-10 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 4e-09 | |
| 3mxq_A | 152 | Sensor protein; PSI2, MCSG, structural genomics, p | 6e-09 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 1e-08 | |
| 2r78_A | 117 | Sensor protein; sensory box sensor histidine kinas | 1e-08 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 2e-08 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 3e-08 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 4e-08 | |
| 3mqq_A | 120 | Transcriptional regulator, LUXR family; PAS domain | 4e-08 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 4e-08 | |
| 3fc7_A | 125 | HTR-like protein, sensor protein; APC87712.1, HTR- | 5e-08 | |
| 3bwl_A | 126 | Sensor protein; structural genomics, APC87707.1, P | 5e-08 | |
| 2gj3_A | 120 | Nitrogen fixation regulatory protein; PAS domain, | 6e-08 | |
| 3olo_A | 118 | Two-component sensor histidine kinase; structural | 6e-08 | |
| 2jhe_A | 190 | Transcription regulator TYRR; aromatic hydrocarbon | 9e-08 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 1e-07 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 3e-07 | |
| 3mfx_A | 129 | Sensory BOX/ggdef family protein; alpha-beta prote | 4e-07 | |
| 1d06_A | 130 | Nitrogen fixation regulatory protein FIXL; oxygen | 1e-06 | |
| 1vt4_I | 1221 | APAF-1 related killer DARK; drosophila apoptosome, | 3e-06 | |
| 2vv6_A | 119 | FIXL, sensor protein FIXL; signaling protein, tran | 3e-06 | |
| 1v9y_A | 167 | Heme PAS sensor protein; signaling protein; HET: H | 6e-06 | |
| 1ll8_A | 114 | PAS kinase; PAS domain, ligand binding, ligand scr | 6e-06 | |
| 3p7n_A | 258 | Sensor histidine kinase; LOV domain, light-activat | 1e-05 | |
| 3t50_A | 128 | Blue-light-activated histidine kinase; PAS superfa | 1e-05 | |
| 3fg8_A | 118 | Uncharacterized protein RHA05790; PAS domain, stru | 2e-05 | |
| 3vol_A | 233 | Aerotaxis transducer AER2; heme, oxygen sensor pro | 3e-05 | |
| 3k3c_A | 158 | Protein RV1364C/MT1410; sensor, PAS, signal transd | 3e-05 | |
| 3kx0_X | 185 | Uncharacterized protein RV1364C/MT1410; PAS domain | 3e-05 | |
| 3sw1_A | 162 | Sensory box protein; light-oxygen-voltage, LOV, PA | 4e-05 | |
| 2pr5_A | 132 | Blue-light photoreceptor; light-oxygen-voltage, LO | 8e-05 | |
| 2qkp_A | 151 | Uncharacterized protein; structural genomics, unkn | 9e-05 | |
| 2vlg_A | 111 | Sporulation kinase A; histidine kinase, two-compon | 2e-04 | |
| 3cax_A | 369 | Uncharacterized protein PF0695; structural genomic | 3e-04 | |
| 2w0n_A | 118 | Sensor protein DCUS; signal transduction, two-comp | 3e-04 | |
| 3ue6_A | 166 | Aureochrome1; PAS/LOV domain, FMN-binding blue-lig | 3e-04 | |
| 2v0u_A | 146 | NPH1-1, LOV2; kinase, transferase, ATP-binding, se | 6e-04 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 7e-04 |
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 301 bits (774), Expect = 1e-97
Identities = 104/194 (53%), Positives = 140/194 (72%), Gaps = 2/194 (1%)
Query: 482 STSSSAVNKVDLDNDCLDYEILWEDLTIGEQIGQGSCGTVYHAVWYGSDVAVKVFSRQEY 541
++ D D +I W DL I E+IG GS GTV+ A W+GSDVAVK+ Q++
Sbjct: 14 DIPTTENLYFQGAMDGDDMDIPWCDLNIKEKIGAGSFGTVHRAEWHGSDVAVKILMEQDF 73
Query: 542 SDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTK-- 599
E ++ F +EV++MKRLRHPN++LFMGAVT P L IVTE+L RGSL+RLL ++ +
Sbjct: 74 HAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQ 133
Query: 600 LDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETY 659
LD RRR+ MA D+A+G++YLH+ NPPI+HR+LKS NLLVDK +TVKV DFGLSRLK T+
Sbjct: 134 LDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTF 193
Query: 660 LTTKTGKGTVTYLA 673
L++K+ GT ++A
Sbjct: 194 LSSKSAAGTPEWMA 207
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 272 bits (699), Expect = 4e-87
Identities = 44/176 (25%), Positives = 83/176 (47%), Gaps = 8/176 (4%)
Query: 501 EILWEDLTIGEQIGQGSCGTVYHAVWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLR 560
I ++ L ++ + G ++ W G+D+ VKV +++S F +E ++
Sbjct: 6 GIDFKQLNFLTKLNENHSGELWKGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFS 65
Query: 561 HPNVLLFMGAVTSP--QRLCIVTEFLPRGSLFRLLQRNTT-KLDWRRRILMALDIARGVS 617
HPNVL +GA SP ++T ++P GSL+ +L T +D + + ALD+ARG++
Sbjct: 66 HPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMA 125
Query: 618 YLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTVTYLA 673
+LH P I L S ++++D+ T ++ + ++A
Sbjct: 126 FLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQSP-----GRMYAPAWVA 176
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 272 bits (697), Expect = 1e-86
Identities = 71/177 (40%), Positives = 111/177 (62%), Gaps = 6/177 (3%)
Query: 499 DYEILWEDLTIGEQIGQGSCGTVYHAVWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKR 558
D+EI +T+G++IG GS GTVY W+G DVAVK+ + + + + +F+ EV ++++
Sbjct: 18 DWEIPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRK 76
Query: 559 LRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSY 618
RH N+LLFMG T+PQ L IVT++ SL+ L + TK + ++ I +A ARG+ Y
Sbjct: 77 TRHVNILLFMGYSTAPQ-LAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDY 135
Query: 619 LHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYL--TTKTGKGTVTYLA 673
LH + IIHRDLKS+N+ + + TVK+GDFGL+ K + G++ ++A
Sbjct: 136 LHAKS--IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMA 190
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 271 bits (694), Expect = 8e-86
Identities = 63/205 (30%), Positives = 109/205 (53%), Gaps = 13/205 (6%)
Query: 474 TSSVSSCGSTSSSAVNKVDLDNDCLDYEILWEDLTIGEQIGQGSCGTVYHAVWYGSDVAV 533
S +S+ ++ + L +++I +E L IGE IG+G G VYH W+G +VA+
Sbjct: 6 LSLLSARSFPRKASQTSIFLQ----EWDIPFEQLEIGELIGKGRFGQVYHGRWHG-EVAI 60
Query: 534 KVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLL 593
++ + +++ + +F++EV ++ RH NV+LFMGA SP L I+T +L+ ++
Sbjct: 61 RLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVV 120
Query: 594 QRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSR 653
+ LD + +A +I +G+ YLH I+H+DLKS N+ D + V + DFGL
Sbjct: 121 RDAKIVLDVNKTRQIAQEIVKGMGYLH--AKGILHKDLKSKNVFYD-NGKVVITDFGLFS 177
Query: 654 LKHETYLTTKTGK-----GTVTYLA 673
+ + K G + +LA
Sbjct: 178 ISGVLQAGRREDKLRIQNGWLCHLA 202
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 268 bits (687), Expect = 2e-85
Identities = 69/184 (37%), Positives = 96/184 (52%), Gaps = 15/184 (8%)
Query: 501 EILWEDLTIGEQIGQGSCGTVYHAVWYGSDVAVKVF--SRQEYSDEVIHSFRQEVSLMKR 558
EI + +LT+ E IG G G VY A W G +VAVK E + I + RQE L
Sbjct: 3 EIDFAELTLEEIIGIGGFGKVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAM 62
Query: 559 LRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSY 618
L+HPN++ G LC+V EF G L R+L ++ + A+ IARG++Y
Sbjct: 63 LKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGK--RIPPDILVNWAVQIARGMNY 120
Query: 619 LHHCNP-PIIHRDLKSSNLLVDK--------HWTVKVGDFGLSRLKHETYLTTKTGKGTV 669
LH PIIHRDLKSSN+L+ + + +K+ DFGL+R H T T + G
Sbjct: 121 LHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRT--TKMSAAGAY 178
Query: 670 TYLA 673
++A
Sbjct: 179 AWMA 182
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 265 bits (680), Expect = 4e-84
Identities = 54/187 (28%), Positives = 87/187 (46%), Gaps = 17/187 (9%)
Query: 499 DYEILWEDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSD-----EVIHSFRQ 551
+ ++ +QIG+G G V+ S VA+K + E F++
Sbjct: 13 LPTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQR 72
Query: 552 EVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALD 611
EV +M L HPN++ G + +P +V EF+P G L+ L + W ++ + LD
Sbjct: 73 EVFIMSNLNHPNIVKLYGLMHNP--PRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLD 130
Query: 612 IARGVSYLHHCNPPIIHRDLKSSNLLVDK-----HWTVKVGDFGLSRLKHETYLTTKTGK 666
IA G+ Y+ + NPPI+HRDL+S N+ + KV DFGLS+ +
Sbjct: 131 IALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVH---SVSGLL 187
Query: 667 GTVTYLA 673
G ++A
Sbjct: 188 GNFQWMA 194
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 261 bits (670), Expect = 3e-82
Identities = 55/168 (32%), Positives = 88/168 (52%), Gaps = 2/168 (1%)
Query: 501 EILWEDLTIGEQIGQGSCGTVYHAVWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLR 560
DL GE +G+G G + + + + +E +F +EV +M+ L
Sbjct: 6 IFRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLE 65
Query: 561 HPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLH 620
HPNVL F+G + +RL +TE++ G+L +++ ++ W +R+ A DIA G++YLH
Sbjct: 66 HPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLH 125
Query: 621 HCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGT 668
N IIHRDL S N LV ++ V V DFGL+RL + + +
Sbjct: 126 SMN--IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSL 171
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 257 bits (658), Expect = 1e-80
Identities = 53/178 (29%), Positives = 86/178 (48%), Gaps = 13/178 (7%)
Query: 500 YEILWEDLTIGEQIGQGSCGTVYHAVWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRL 559
+ I ++++ + E +G+G+ G V A W DVA+K + F E+ + R+
Sbjct: 3 HMIDYKEIEVEEVVGRGAFGVVCKAKWRAKDVAIKQIESESERKA----FIVELRQLSRV 58
Query: 560 RHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLL--QRNTTKLDWRRRILMALDIARGVS 617
HPN++ GA +P +C+V E+ GSL+ +L + L ++GV+
Sbjct: 59 NHPNIVKLYGACLNP--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVA 116
Query: 618 YLHHCNP-PIIHRDLKSSNLLVDKHWTV-KVGDFGLSRLKHETYLTTKTGKGTVTYLA 673
YLH P +IHRDLK NLL+ TV K+ DFG + KG+ ++A
Sbjct: 117 YLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQT---HMTNNKGSAAWMA 171
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 248 bits (636), Expect = 6e-77
Identities = 61/215 (28%), Positives = 93/215 (43%), Gaps = 26/215 (12%)
Query: 473 STSSVSSCGSTSSSAVNKVDLDNDCLDYEILWEDLTIGEQIGQGSCGTVYHAVWYGSDVA 532
S S S S + L + + + + +QIG+G G V+ W G VA
Sbjct: 12 RDLIEQSQSSGSGSGLPL-------LVQRTIAKQIQMVKQIGKGRYGEVWMGKWRGEKVA 64
Query: 533 VKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQ----RLCIVTEFLPRGS 588
VKVF E + E+ +RH N+L F+ A +L ++T++ GS
Sbjct: 65 VKVFFTTEEASWF---RETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGS 121
Query: 589 LFRLLQRNTTKLDWRRRILMALDIARGVSYLH------HCNPPIIHRDLKSSNLLVDKHW 642
L+ L+ T LD + + +A G+ +LH P I HRDLKS N+LV K+
Sbjct: 122 LYDYLKSTT--LDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNG 179
Query: 643 TVKVGDFGLSRL----KHETYLTTKTGKGTVTYLA 673
T + D GL+ +E + T GT Y+
Sbjct: 180 TCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMP 214
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 239 bits (613), Expect = 5e-74
Identities = 58/187 (31%), Positives = 91/187 (48%), Gaps = 19/187 (10%)
Query: 501 EILWEDLTIGEQIGQGSCGTVYHAVWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLR 560
+ D+T+ E +G+G G V+ W G +VAVK+FS ++ E+ LR
Sbjct: 4 RTVARDITLLECVGKGRYGEVWRGSWQGENVAVKIFSSRDEKSWF---RETELYNTVMLR 60
Query: 561 HPNVLLFMGAVT----SPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGV 616
H N+L F+ + S +L ++T + GSL+ LQ T LD + + L IA G+
Sbjct: 61 HENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTT--LDTVSCLRIVLSIASGL 118
Query: 617 SYLH------HCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETY----LTTKTGK 666
++LH P I HRDLKS N+LV K+ + D GL+ + ++ +
Sbjct: 119 AHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRV 178
Query: 667 GTVTYLA 673
GT Y+A
Sbjct: 179 GTKRYMA 185
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 233 bits (595), Expect = 3e-71
Identities = 60/207 (28%), Positives = 90/207 (43%), Gaps = 21/207 (10%)
Query: 481 GSTSSSAVNKVDLDNDCLDYEILWEDLTIGEQIGQGSCGTVYHAVWYGSDVAVKVFSRQE 540
G + VDL + L L + E +G G V+ A VAVK+F Q+
Sbjct: 2 GHHHHHHSSGVDLGTENL--YFQSMPLQLLEVKARGRFGCVWKAQLLNEYVAVKIFPIQD 59
Query: 541 YSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSP----QRLCIVTEFLPRGSLFRLLQRN 596
EV + ++H N+L F+GA L ++T F +GSL L+ N
Sbjct: 60 KQSWQ---NEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKAN 116
Query: 597 TTKLDWRRRILMALDIARGVSYLHH--------CNPPIIHRDLKSSNLLVDKHWTVKVGD 648
+ W +A +ARG++YLH P I HRD+KS N+L+ + T + D
Sbjct: 117 V--VSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIAD 174
Query: 649 FGLSRLKH--ETYLTTKTGKGTVTYLA 673
FGL+ ++ T GT Y+A
Sbjct: 175 FGLALKFEAGKSAGDTHGQVGTRRYMA 201
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 233 bits (596), Expect = 4e-71
Identities = 61/192 (31%), Positives = 88/192 (45%), Gaps = 19/192 (9%)
Query: 496 DCLDYEILWEDLTIGEQIGQGSCGTVYHAVWYGSDVAVKVFSRQEYSDEVIHSFRQEVSL 555
L + + + E IG+G G V+ W G +VAVK+FS +E E+
Sbjct: 33 PLLVQRTIARTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSREERSWF---REAEIYQ 89
Query: 556 MKRLRHPNVLLFMGAVT----SPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALD 611
LRH N+L F+ A + +L +V+++ GSLF L R T + I +AL
Sbjct: 90 TVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT--VTVEGMIKLALS 147
Query: 612 IARGVSYLH------HCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTT--- 662
A G+++LH P I HRDLKS N+LV K+ T + D GL+ T
Sbjct: 148 TASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIA 207
Query: 663 -KTGKGTVTYLA 673
GT Y+A
Sbjct: 208 PNHRVGTKRYMA 219
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 229 bits (585), Expect = 1e-69
Identities = 58/203 (28%), Positives = 85/203 (41%), Gaps = 29/203 (14%)
Query: 493 LDNDCLDYEILWEDLTIGEQIGQGSCGTVYHAVWYGSDVAVKVFSRQEYSDEVIHSFRQE 552
++ + + ++L + E IG+G G VY VAVKVFS +F E
Sbjct: 1 MEAAASEPSLDLDNLKLLELIGRGRYGAVYKGSLDERPVAVKVFSFANR-----QNFINE 55
Query: 553 --VSLMKRLRHPNVLLFMGA-----VTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRR 605
+ + + H N+ F+ +V E+ P GSL + L +T DW
Sbjct: 56 KNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHT--SDWVSS 113
Query: 606 ILMALDIARGVSYLH-------HCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHET 658
+A + RG++YLH H P I HRDL S N+LV T + DFGLS
Sbjct: 114 CRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGN 173
Query: 659 YL--------TTKTGKGTVTYLA 673
L + GT+ Y+A
Sbjct: 174 RLVRPGEEDNAAISEVGTIRYMA 196
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 168 bits (427), Expect = 2e-47
Identities = 54/197 (27%), Positives = 93/197 (47%), Gaps = 15/197 (7%)
Query: 489 NKVDLDNDCLDYEILWEDLT-----IGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEY 541
N+ D + L+ + + +IG+GS TVY + +VA ++
Sbjct: 5 NQQQDDIEELETKAVGMSNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL 64
Query: 542 SDEVIHSFRQEVSLMKRLRHPNVLLFMGA----VTSPQRLCIVTEFLPRGSLFRLLQRNT 597
+ F++E ++K L+HPN++ F + V + + +VTE + G+L L+R
Sbjct: 65 TKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFK 124
Query: 598 TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVD-KHWTVKVGDFGLSRLKH 656
+ + I +G+ +LH PPIIHRDLK N+ + +VK+GD GL+ LK
Sbjct: 125 -VMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 183
Query: 657 ETYLTTKTGKGTVTYLA 673
+ K GT ++A
Sbjct: 184 AS--FAKAVIGTPEFMA 198
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 165 bits (420), Expect = 2e-45
Identities = 53/171 (30%), Positives = 82/171 (47%), Gaps = 5/171 (2%)
Query: 499 DYEILWEDLTIGEQIGQGSCGTVYHAVWYGS--DVAVKVFSRQEYSDEVIHSFRQEVSLM 556
+ + EDL +GEQIG+G+ G V+ VAVK R+ ++ F QE ++
Sbjct: 108 KWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSC-RETLPPDLKAKFLQEARIL 166
Query: 557 KRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGV 616
K+ HPN++ +G T Q + IV E + G L+ +L + + M D A G+
Sbjct: 167 KQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGM 226
Query: 617 SYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKG 667
YL IHRDL + N LV + +K+ DFG+SR + + G
Sbjct: 227 EYLESKC--CIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLR 275
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 1e-43
Identities = 51/168 (30%), Positives = 82/168 (48%), Gaps = 6/168 (3%)
Query: 499 DYEILWEDLTIGEQIGQGSCGTVYHAVWYGS-DVAVKVFSRQEYSDEVIHSFRQEVSLMK 557
+EI +DLT +++G G G V + W G DVA+K+ ++ E F +E +M
Sbjct: 18 SWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMI-KEGSMSE--DEFIEEAKVMM 74
Query: 558 RLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVS 617
L H ++ G T + + I+TE++ G L L+ + ++ + M D+ +
Sbjct: 75 NLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAME 134
Query: 618 YLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTG 665
YL +HRDL + N LV+ VKV DFGLSR + T+ G
Sbjct: 135 YLESKQ--FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVG 180
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 2e-43
Identities = 52/167 (31%), Positives = 81/167 (48%), Gaps = 6/167 (3%)
Query: 500 YEILWEDLTIGEQIGQGSCGTVYHAVWYGS-DVAVKVFSRQEYSDEVIHSFRQEVSLMKR 558
+ I +LT ++IG G G V+ W VA+K R+ E F +E +M +
Sbjct: 3 WVIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTI-REGAMSE--EDFIEEAEVMMK 59
Query: 559 LRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSY 618
L HP ++ G +C+VTEF+ G L L+ + M LD+ G++Y
Sbjct: 60 LSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAY 119
Query: 619 LHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTG 665
L +IHRDL + N LV ++ +KV DFG++R + T+ TG
Sbjct: 120 LEEAC--VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTG 164
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 155 bits (395), Expect = 5e-43
Identities = 54/174 (31%), Positives = 85/174 (48%), Gaps = 10/174 (5%)
Query: 499 DYEILWEDLTIGEQIGQGSCGTVYHAVWYGSD-----VAVKVFSRQEYSDEVIHSFRQEV 553
Y I ED+ + +G+G G VY V+ VAVK +++ + + F E
Sbjct: 6 QYGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTC-KKDCTLDNKEKFMSEA 64
Query: 554 SLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIA 613
+MK L HP+++ +G + + I+ E P G L L+RN L +L +L I
Sbjct: 65 VIMKNLDHPHIVKLIGIIEE-EPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQIC 123
Query: 614 RGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSR-LKHETYLTTKTGK 666
+ ++YL N +HRD+ N+LV VK+GDFGLSR ++ E Y +
Sbjct: 124 KAMAYLESIN--CVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTR 175
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 7e-43
Identities = 53/166 (31%), Positives = 85/166 (51%), Gaps = 6/166 (3%)
Query: 501 EILWEDLTIGEQIGQGSCGTVYHAVWYGS-DVAVKVFSRQEYSDEVIHSFRQEVSLMKRL 559
E+ E++T+ +++G G G V W G DVAVK+ ++ E F QE M +L
Sbjct: 4 ELKREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMI-KEGSMSE--DEFFQEAQTMMKL 60
Query: 560 RHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYL 619
HP ++ F G + + IVTE++ G L L+ + L+ + + M D+ G+++L
Sbjct: 61 SHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFL 120
Query: 620 HHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTG 665
IHRDL + N LVD+ VKV DFG++R + + G
Sbjct: 121 ESHQ--FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVG 164
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 1e-42
Identities = 51/212 (24%), Positives = 78/212 (36%), Gaps = 27/212 (12%)
Query: 473 STSSVSSCGSTSSSAVNKVDLDNDCLDYEILWEDLTIGEQIGQGSCGTVYHAVWYGSD-- 530
S S NK++ D I L +G+ +G+G G+V D
Sbjct: 8 HHHSSGLVPRGSEELQNKLE------DVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGT 61
Query: 531 ---VAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVT-----SPQRLCIVTE 582
VAVK S I F E + MK HPNV+ +G + ++
Sbjct: 62 SLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILP 121
Query: 583 FLPRGSLFRLLQR-----NTTKLDWRRRILMALDIARGVSYL--HHCNPPIIHRDLKSSN 635
F+ G L L + + + +DIA G+ YL + +HRDL + N
Sbjct: 122 FMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNF----LHRDLAARN 177
Query: 636 LLVDKHWTVKVGDFGLSRLKHETYLTTKTGKG 667
++ TV V DFGLS+ + +
Sbjct: 178 CMLRDDMTVCVADFGLSKKIYSGDYYRQGRIA 209
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 154 bits (392), Expect = 2e-42
Identities = 49/177 (27%), Positives = 82/177 (46%), Gaps = 14/177 (7%)
Query: 501 EILWEDLTIGEQIGQGSCGTVYHAVW------YGSDVAVKVFSRQEYSDEVIHSFRQEVS 554
L +G+G G V + G VAVK + E I ++E+
Sbjct: 17 HFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSL-KPESGGNHIADLKKEIE 75
Query: 555 LMKRLRHPNVLLFMGAVTSPQR--LCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDI 612
+++ L H N++ + G T + ++ EFLP GSL L +N K++ ++++ A+ I
Sbjct: 76 ILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQI 135
Query: 613 ARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL---KHETYLTTKTGK 666
+G+ YL +HRDL + N+LV+ VK+GDFGL++ E Y
Sbjct: 136 CKGMDYLGSRQ--YVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRD 190
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 153 bits (390), Expect = 2e-42
Identities = 57/174 (32%), Positives = 87/174 (50%), Gaps = 10/174 (5%)
Query: 499 DYEILWEDLTIGEQIGQGSCGTVYHAVWYGSD-----VAVKVFSRQEYSDEVIHSFRQEV 553
DYEI E + +G IG+G G V+ ++ + VA+K + SD V F QE
Sbjct: 9 DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTC-KNCTSDSVREKFLQEA 67
Query: 554 SLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIA 613
M++ HP+++ +G +T + I+ E G L LQ LD IL A ++
Sbjct: 68 LTMRQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLS 126
Query: 614 RGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSR-LKHETYLTTKTGK 666
++YL +HRD+ + N+LV + VK+GDFGLSR ++ TY GK
Sbjct: 127 TALAYLESKR--FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGK 178
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 2e-42
Identities = 51/194 (26%), Positives = 77/194 (39%), Gaps = 22/194 (11%)
Query: 492 DLDNDCLDYEILWEDLTIGEQIGQGSCGTVYHAVWYGSD-----VAVKVFSRQEYSDEVI 546
+L D I + T+G +G+G G+V A D VAVK+ + I
Sbjct: 10 ELKEKLEDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDI 69
Query: 547 HSFRQEVSLMKRLRHPNVLLFMGAVT------SPQRLCIVTEFLPRGSLFRLLQ-----R 595
F +E + MK HP+V +G ++ F+ G L L
Sbjct: 70 EEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGE 129
Query: 596 NTTKLDWRRRILMALDIARGVSYL--HHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSR 653
N L + + +DIA G+ YL + IHRDL + N ++ + TV V DFGLSR
Sbjct: 130 NPFNLPLQTLVRFMVDIACGMEYLSSRNF----IHRDLAARNCMLAEDMTVCVADFGLSR 185
Query: 654 LKHETYLTTKTGKG 667
+ +
Sbjct: 186 KIYSGDYYRQGCAS 199
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 154 bits (392), Expect = 4e-42
Identities = 51/175 (29%), Positives = 85/175 (48%), Gaps = 9/175 (5%)
Query: 500 YEILWEDLTIGEQIGQGSCGTVYHAVWYGS------DVAVKVFSRQEYSDEVIHSFRQEV 553
EI +T + IG G G VY + S VA+K + Y+++ F E
Sbjct: 39 TEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTL-KAGYTEKQRVDFLGEA 97
Query: 554 SLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIA 613
+M + H N++ G ++ + + I+TE++ G+L + L+ + + + M IA
Sbjct: 98 GIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIA 157
Query: 614 RGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGT 668
G+ YL + N +HRDL + N+LV+ + KV DFGLSR+ + T T G
Sbjct: 158 AGMKYLANMN--YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGG 210
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 6e-42
Identities = 52/192 (27%), Positives = 84/192 (43%), Gaps = 21/192 (10%)
Query: 492 DLDNDCL----DYEIL--WEDLTIGEQIGQGSCGTVYHAVWYGSD-----VAVKVFSRQE 540
DLD+ L D I IG+G G VYH + A+K +
Sbjct: 2 DLDSALLAEVKDVLIPHERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSL-SRI 60
Query: 541 YSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQ-RLCIVTEFLPRGSLFRLLQRNTTK 599
+ + +F +E LM+ L HPNVL +G + P+ ++ ++ G L + ++
Sbjct: 61 TEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRN 120
Query: 600 LDWRRRILMALDIARGVSYL--HHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHE 657
+ I L +ARG+ YL +HRDL + N ++D+ +TVKV DFGL+R +
Sbjct: 121 PTVKDLISFGLQVARGMEYLAEQKF----VHRDLAARNCMLDESFTVKVADFGLARDILD 176
Query: 658 T--YLTTKTGKG 667
Y +
Sbjct: 177 REYYSVQQHRHA 188
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 8e-42
Identities = 54/174 (31%), Positives = 81/174 (46%), Gaps = 11/174 (6%)
Query: 501 EILWEDLTIGEQIGQGSCGTVYHAVWYGS-----DVAVKVFSRQEYSDEVIHSFRQEVSL 555
EI + I + IG G G V + VA+K + Y++ F E S+
Sbjct: 45 EIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKAL-KAGYTERQRRDFLSEASI 103
Query: 556 MKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARG 615
M + HPN++ G VT + IVTE++ GSL L+ + + + + M + G
Sbjct: 104 MGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAG 163
Query: 616 VSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL---KHETYLTTKTGK 666
+ YL +HRDL + N+LVD + KV DFGLSR+ + TT GK
Sbjct: 164 MRYLSDLG--YVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGK 215
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 1e-41
Identities = 52/177 (29%), Positives = 91/177 (51%), Gaps = 15/177 (8%)
Query: 501 EILWEDLTIGEQIGQGSCGTVYHAVWYGSD------VAVKVFSRQEYSDEVIHSFRQEVS 554
+ L +Q+G+G+ G+V + VAVK Q ++E + F +E+
Sbjct: 6 QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKL--QHSTEEHLRDFEREIE 63
Query: 555 LMKRLRHPNVLLFMGAVTSPQR--LCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDI 612
++K L+H N++ + G S R L ++ E+LP GSL LQ++ ++D + + I
Sbjct: 64 ILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQI 123
Query: 613 ARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL---KHETYLTTKTGK 666
+G+ YL IHRDL + N+LV+ VK+GDFGL+++ E + + G+
Sbjct: 124 CKGMEYLGTKR--YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGE 178
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 1e-41
Identities = 53/178 (29%), Positives = 91/178 (51%), Gaps = 15/178 (8%)
Query: 500 YEILWEDLTIGEQIGQGSCGTVYHAVWYGSD------VAVKVFSRQEYSDEVIHSFRQEV 553
+ L +Q+G+G+ G+V + VAVK Q ++E + F +E+
Sbjct: 36 TQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKL--QHSTEEHLRDFEREI 93
Query: 554 SLMKRLRHPNVLLFMGAVTSPQR--LCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALD 611
++K L+H N++ + G S R L ++ E+LP GSL LQ++ ++D + +
Sbjct: 94 EILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQ 153
Query: 612 IARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL---KHETYLTTKTGK 666
I +G+ YL IHRDL + N+LV+ VK+GDFGL+++ E Y + G+
Sbjct: 154 ICKGMEYLGTKR--YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGE 209
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 1e-41
Identities = 45/180 (25%), Positives = 83/180 (46%), Gaps = 12/180 (6%)
Query: 495 NDCLDYEILWEDLTIGEQIGQGSCGTVYHAVWYGSD------VAVKVFSRQEYSDEVIHS 548
N L + + + +G G+ GTVY +W VA+K R+ S +
Sbjct: 5 NQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL-REATSPKANKE 63
Query: 549 FRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILM 608
E +M + +P+V +G + + ++T+ +P G L ++ + + + +
Sbjct: 64 ILDEAYVMASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNW 122
Query: 609 ALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL--KHETYLTTKTGK 666
+ IA+G++YL ++HRDL + N+LV VK+ DFGL++L E + GK
Sbjct: 123 CVQIAKGMNYLEDRR--LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGK 180
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 152 bits (387), Expect = 1e-41
Identities = 58/187 (31%), Positives = 90/187 (48%), Gaps = 23/187 (12%)
Query: 499 DYEILWEDLTIGEQIGQGSCGTVYHAVWYGSD-------VAVKVFSRQEYSDEVIHSFRQ 551
++E+ E +T+ ++GQGS G VY V G VA+K + S F
Sbjct: 19 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTV-NEAASMRERIEFLN 77
Query: 552 EVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRN---------TTKLDW 602
E S+MK +V+ +G V+ Q ++ E + RG L L+
Sbjct: 78 EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSL 137
Query: 603 RRRILMALDIARGVSYL--HHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYL 660
+ I MA +IA G++YL + +HRDL + N +V + +TVK+GDFG++R +ET
Sbjct: 138 SKMIQMAGEIADGMAYLNANKF----VHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDY 193
Query: 661 TTKTGKG 667
K GKG
Sbjct: 194 YRKGGKG 200
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 2e-41
Identities = 54/170 (31%), Positives = 90/170 (52%), Gaps = 11/170 (6%)
Query: 499 DYEILWEDLTIGEQIGQGSCGTVYHAVWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKR 558
+ + ++L + + IG+G G V + G+ VAVK + + + + +F E S+M +
Sbjct: 15 GWALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCI-KNDATAQ---AFLAEASVMTQ 70
Query: 559 LRHPNVLLFMGAVTSPQ-RLCIVTEFLPRGSLFRLLQ-RNTTKLDWRRRILMALDIARGV 616
LRH N++ +G + + L IVTE++ +GSL L+ R + L + +LD+ +
Sbjct: 71 LRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAM 130
Query: 617 SYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGK 666
YL N +HRDL + N+LV + KV DFGL++ E T TGK
Sbjct: 131 EYLEGNN--FVHRDLAARNVLVSEDNVAKVSDFGLTK---EASSTQDTGK 175
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 152 bits (385), Expect = 3e-41
Identities = 52/177 (29%), Positives = 85/177 (48%), Gaps = 15/177 (8%)
Query: 501 EILWEDLTIGEQIGQGSCGTVYHAVWYGSD------VAVKVFSRQEYSDEVIHSFRQEVS 554
L Q+G+G+ G+V + VAVK Q + F++E+
Sbjct: 19 IFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQL--QHSGPDQQRDFQREIQ 76
Query: 555 LMKRLRHPNVLLFMGAVTSPQR--LCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDI 612
++K L ++ + G P R L +V E+LP G L LQR+ +LD R +L + I
Sbjct: 77 ILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQI 136
Query: 613 ARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL---KHETYLTTKTGK 666
+G+ YL +HRDL + N+LV+ VK+ DFGL++L + Y+ + G+
Sbjct: 137 CKGMEYLGSRR--CVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQ 191
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 6e-41
Identities = 50/218 (22%), Positives = 87/218 (39%), Gaps = 21/218 (9%)
Query: 466 SSSVNVNSTSSVSSCGSTSSSAVNKVDLDNDCLDY------EILWEDLTIGEQIGQGSCG 519
S+S+ + S ++ ++ L+ + + + E IG+G G
Sbjct: 44 STSLYKKAGSENLYFQGANTVHIDLSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFG 103
Query: 520 TVYHAVWYGSD-----VAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSP 574
VYH +D AVK + + F E +MK HPNVL +G
Sbjct: 104 CVYHGTLLDNDGKKIHCAVKSL-NRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS 162
Query: 575 QR-LCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYL--HHCNPPIIHRDL 631
+ +V ++ G L ++ T + I L +A+G+ +L +HRDL
Sbjct: 163 EGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKF----VHRDL 218
Query: 632 KSSNLLVDKHWTVKVGDFGLSRLKHET--YLTTKTGKG 667
+ N ++D+ +TVKV DFGL+R ++
Sbjct: 219 AARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGA 256
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 150 bits (382), Expect = 8e-41
Identities = 63/172 (36%), Positives = 101/172 (58%), Gaps = 17/172 (9%)
Query: 513 IGQGSCGTVYHAV-WYGSDVAVKV---FSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFM 568
+G+G G VY G+ VAVK Q + F+ EV ++ H N+L
Sbjct: 38 LGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQ----FQTEVEMISMAVHRNLLRLR 93
Query: 569 G-AVTSPQRLCIVTEFLPRGSL-FRLLQRNTTK--LDWRRRILMALDIARGVSYLH-HCN 623
G +T +RL +V ++ GS+ L +R ++ LDW +R +AL ARG++YLH HC+
Sbjct: 94 GFCMTPTERL-LVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCD 152
Query: 624 PPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL--KHETYLTTKTGKGTVTYLA 673
P IIHRD+K++N+L+D+ + VGDFGL++L +T++TT +GT+ ++A
Sbjct: 153 PKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAV-RGTIGHIA 203
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 1e-40
Identities = 52/174 (29%), Positives = 86/174 (49%), Gaps = 11/174 (6%)
Query: 501 EILWEDLTIGEQIGQGSCGTVYHAVWYGSD-----VAVKVFSRQEYSDEVIHSFRQEVSL 555
E+ +++I + +G G G V VA+K + Y+++ F E S+
Sbjct: 41 ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTL-KVGYTEKQRRDFLGEASI 99
Query: 556 MKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARG 615
M + HPN++ G VT + + IVTE++ GSL L+++ + + + M IA G
Sbjct: 100 MGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASG 159
Query: 616 VSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL---KHETYLTTKTGK 666
+ YL +HRDL + N+L++ + KV DFGL R+ E TT+ GK
Sbjct: 160 MKYLSDMG--YVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGK 211
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 2e-40
Identities = 50/188 (26%), Positives = 77/188 (40%), Gaps = 17/188 (9%)
Query: 492 DLDNDCLDYEIL--WEDLTIGEQIGQGSCGTVYHAVWYGSD-----VAVKVFSRQEYSDE 544
+L I + E IG+G G VYH +D AVK +
Sbjct: 10 ELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL-NRITDIG 68
Query: 545 VIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQR-LCIVTEFLPRGSLFRLLQRNTTKLDWR 603
+ F E +MK HPNVL +G + +V ++ G L ++ T +
Sbjct: 69 EVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVK 128
Query: 604 RRILMALDIARGVSYL--HHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHET--Y 659
I L +A+G+ YL +HRDL + N ++D+ +TVKV DFGL+R ++ Y
Sbjct: 129 DLIGFGLQVAKGMKYLASKKF----VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYY 184
Query: 660 LTTKTGKG 667
Sbjct: 185 SVHNKTGA 192
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 2e-40
Identities = 49/177 (27%), Positives = 84/177 (47%), Gaps = 16/177 (9%)
Query: 501 EILWEDLTIGEQIGQGSCGTVYHAVWYGSD------VAVKVFSRQEYSDEVIHSFRQEVS 554
L +G+G G V + ++ VAVK + + + ++QE+
Sbjct: 27 VFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKAL-KADAGPQHRSGWKQEID 85
Query: 555 LMKRLRHPNVLLFMGAVTSPQR--LCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDI 612
+++ L H +++ + G L +V E++P GSL L R+ + + +L A I
Sbjct: 86 ILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRH--SIGLAQLLLFAQQI 143
Query: 613 ARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL---KHETYLTTKTGK 666
G++YLH + IHRDL + N+L+D VK+GDFGL++ HE Y + G
Sbjct: 144 CEGMAYLHAQH--YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGD 198
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 2e-40
Identities = 50/191 (26%), Positives = 76/191 (39%), Gaps = 29/191 (15%)
Query: 501 EILWEDLTIGEQIGQGSCGTVYHAVWYGSD-------VAVKVFSRQEYSDEVIHSFRQEV 553
EI + E++G+ G VY +G VA+K + + + FR E
Sbjct: 5 EISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTL-KDKAEGPLREEFRHEA 63
Query: 554 SLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRN---------------TT 598
L RL+HPNV+ +G VT Q L ++ + G L L +
Sbjct: 64 MLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKS 123
Query: 599 KLDWRRRILMALDIARGVSYL--HHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKH 656
L+ + + IA G+ YL HH +H+DL + N+LV VK+ D GL R +
Sbjct: 124 ALEPPDFVHLVAQIAAGMEYLSSHHV----VHKDLATRNVLVYDKLNVKISDLGLFREVY 179
Query: 657 ETYLTTKTGKG 667
G
Sbjct: 180 AADYYKLLGNS 190
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 3e-40
Identities = 57/170 (33%), Positives = 87/170 (51%), Gaps = 8/170 (4%)
Query: 499 DYEILWEDLTIGEQIGQGSCGTVYHAVWYGS--DVAVKVFSRQEYSDEVIHSFRQEVSLM 556
+E+ D+T+ ++G G G VY VW VAVK +++ + F +E ++M
Sbjct: 7 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEV--EEFLKEAAVM 63
Query: 557 KRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQ-RNTTKLDWRRRILMALDIARG 615
K ++HPN++ +G T I+TEF+ G+L L+ N ++ + MA I+
Sbjct: 64 KEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSA 123
Query: 616 VSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTG 665
+ YL N IHRDL + N LV ++ VKV DFGLSRL T G
Sbjct: 124 MEYLEKKN--FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAG 171
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 9e-40
Identities = 55/169 (32%), Positives = 92/169 (54%), Gaps = 8/169 (4%)
Query: 499 DYEILWEDLTIGEQIGQGSCGTVYHAVWYGS-DVAVKVFSRQEYSDEVIHSFRQEVSLMK 557
++E+ E L + E++G G G V+ + G VAVK +Q +F E +LMK
Sbjct: 7 EWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSL-KQGSMSP--DAFLAEANLMK 63
Query: 558 RLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNT-TKLDWRRRILMALDIARGV 616
+L+H ++ VT + + I+TE++ GSL L+ + KL + + MA IA G+
Sbjct: 64 QLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGM 122
Query: 617 SYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTG 665
+++ N IHRDL+++N+LV + K+ DFGL+RL + T + G
Sbjct: 123 AFIEERN--YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREG 169
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 154 bits (390), Expect = 1e-39
Identities = 57/174 (32%), Positives = 87/174 (50%), Gaps = 10/174 (5%)
Query: 499 DYEILWEDLTIGEQIGQGSCGTVYHAVWYGSD-----VAVKVFSRQEYSDEVIHSFRQEV 553
DYEI E + +G IG+G G V+ ++ + VA+K + SD V F QE
Sbjct: 384 DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTC-KNCTSDSVREKFLQEA 442
Query: 554 SLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIA 613
M++ HP+++ +G +T + I+ E G L LQ LD IL A ++
Sbjct: 443 LTMRQFDHPHIVKLIGVITENP-VWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLS 501
Query: 614 RGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSR-LKHETYLTTKTGK 666
++YL +HRD+ + N+LV + VK+GDFGLSR ++ TY GK
Sbjct: 502 TALAYLESKR--FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGK 553
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 2e-39
Identities = 56/224 (25%), Positives = 96/224 (42%), Gaps = 33/224 (14%)
Query: 471 VNSTSSVSSCGSTSSSAVNKVDLDNDCLDYEILWE----DLTIGEQIGQGSCGTVYHAVW 526
+ S SS+S S + + + D+ + ++G+G+ G V+ A
Sbjct: 3 MGSGSSLSPTEGKGSGLQGHIIENPQYFSDACVHHIKRRDIVLKWELGEGAFGKVFLAEC 62
Query: 527 YGSD-------VAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCI 579
+ VAVK +E S+ F++E L+ L+H +++ F G T + L +
Sbjct: 63 HNLLPEQDKMLVAVKAL--KEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLM 120
Query: 580 VTEFLPRGSLFRLLQRN--------------TTKLDWRRRILMALDIARGVSYL--HHCN 623
V E++ G L R L+ + L + + +A +A G+ YL H
Sbjct: 121 VFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHF- 179
Query: 624 PPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKG 667
+HRDL + N LV + VK+GDFG+SR + T G+
Sbjct: 180 ---VHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRT 220
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 2e-39
Identities = 43/176 (24%), Positives = 76/176 (43%), Gaps = 12/176 (6%)
Query: 499 DYEILWEDLTIGE-QIGQGSCGTVYHAVWYGS----DVAVKVFSRQEYSDEVIHSFRQEV 553
+ ++L I + ++G G+ G+V V+ DVA+KV +Q +E
Sbjct: 3 KLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVL-KQGTEKADTEEMMREA 61
Query: 554 SLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIA 613
+M +L +P ++ +G + L +V E G L + L ++ + ++
Sbjct: 62 QIMHQLDNPYIVRLIGVCQAEA-LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVS 120
Query: 614 RGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL---KHETYLTTKTGK 666
G+ YL N +HRDL + N+L+ K+ DFGLS+ Y GK
Sbjct: 121 MGMKYLEEKN--FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGK 174
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 2e-39
Identities = 45/180 (25%), Positives = 83/180 (46%), Gaps = 12/180 (6%)
Query: 495 NDCLDYEILWEDLTIGEQIGQGSCGTVYHAVWYGSD------VAVKVFSRQEYSDEVIHS 548
N L + + + +G G+ GTVY +W VA+K R+ S +
Sbjct: 5 NQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL-REATSPKANKE 63
Query: 549 FRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILM 608
E +M + +P+V +G + + ++T+ +P G L ++ + + + +
Sbjct: 64 ILDEAYVMASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNW 122
Query: 609 ALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL--KHETYLTTKTGK 666
+ IA+G++YL ++HRDL + N+LV VK+ DFGL++L E + GK
Sbjct: 123 CVQIAKGMNYLEDRR--LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGK 180
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 4e-39
Identities = 57/182 (31%), Positives = 83/182 (45%), Gaps = 14/182 (7%)
Query: 495 NDCLDYEILWEDLTIGEQIGQGSCGTVYHAVWYGSD-----VAVKVFSRQEY--SDEVIH 547
L I +DL + E++G GS G V W VAVK + + E +
Sbjct: 8 LQSLTCLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCL-KPDVLSQPEAMD 66
Query: 548 SFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRIL 607
F +EV+ M L H N++ G V +P + +VTE P GSL L+++
Sbjct: 67 DFIREVNAMHSLDHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSR 125
Query: 608 MALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL---KHETYLTTKT 664
A+ +A G+ YL IHRDL + NLL+ VK+GDFGL R + Y+ +
Sbjct: 126 YAVQVAEGMGYLESKR--FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEH 183
Query: 665 GK 666
K
Sbjct: 184 RK 185
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 5e-39
Identities = 41/178 (23%), Positives = 78/178 (43%), Gaps = 16/178 (8%)
Query: 501 EILWE----DLTIGEQIGQGSCGTVYHAVWYGSD------VAVKVFSRQEYSDEVIHSFR 550
+ +L + +G G GTV+ VW V +KV + + +
Sbjct: 5 VLARIFKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVI-EDKSGRQSFQAVT 63
Query: 551 QEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMAL 610
+ + L H +++ +G L +VT++LP GSL ++++ L + + +
Sbjct: 64 DHMLAIGSLDHAHIVRLLGLCPGSS-LQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGV 122
Query: 611 DIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL--KHETYLTTKTGK 666
IA+G+ YL ++HR+L + N+L+ V+V DFG++ L + L K
Sbjct: 123 QIAKGMYYLEEHG--MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAK 178
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 6e-39
Identities = 50/191 (26%), Positives = 84/191 (43%), Gaps = 30/191 (15%)
Query: 501 EILWEDLTIGEQIGQGSCGTVYHAVWYGSD-------VAVKVFSRQEYSDEVIHSFRQEV 553
I D+ + ++G+G+ G V+ A Y VAVK ++ + F++E
Sbjct: 11 HIKRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKAL--KDPTLAARKDFQREA 68
Query: 554 SLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRN---------------TT 598
L+ L+H +++ F G L +V E++ G L + L+ +
Sbjct: 69 ELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKG 128
Query: 599 KLDWRRRILMALDIARGVSYL--HHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKH 656
+L + + +A IA G+ YL H +HRDL + N LV + VK+GDFG+SR +
Sbjct: 129 ELGLSQMLHIASQIASGMVYLASQHF----VHRDLATRNCLVGANLLVKIGDFGMSRDVY 184
Query: 657 ETYLTTKTGKG 667
T G
Sbjct: 185 STDYYRVGGHT 195
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 143 bits (364), Expect = 2e-38
Identities = 46/185 (24%), Positives = 76/185 (41%), Gaps = 23/185 (12%)
Query: 501 EILWEDLTIGEQIGQGSCGTVYHAVWYGSD-------VAVKVFSRQEYSDEVIHSFRQEV 553
E+ +++T+ +G G+ G VY G VAVK + S++ F E
Sbjct: 26 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL-PEVCSEQDELDFLMEA 84
Query: 554 SLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRN------TTKLDWRRRIL 607
++ + H N++ +G I+ E + G L L+ + L +
Sbjct: 85 LIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLH 144
Query: 608 MALDIARGVSYL--HHCNPPIIHRDLKSSNLLVDKHW---TVKVGDFGLSRLKHETYLTT 662
+A DIA G YL +H IHRD+ + N L+ K+GDFG++R +
Sbjct: 145 VARDIACGCQYLEENHF----IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYR 200
Query: 663 KTGKG 667
K G
Sbjct: 201 KGGCA 205
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 3e-38
Identities = 39/174 (22%), Positives = 75/174 (43%), Gaps = 25/174 (14%)
Query: 500 YEILWEDLTIGEQIGQGSCGTVYHAVWYGSD---------VAVKVFSRQEYSDEVIHSFR 550
++I EDL E +GQG+ ++ V V +KV + SF
Sbjct: 3 HKIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVL--DKAHRNYSESFF 60
Query: 551 QEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMAL 610
+ S+M +L H +++L G +V EF+ GSL L++N ++ ++ +A
Sbjct: 61 EAASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAK 120
Query: 611 DIARGVSYL--HHCNPPIIHRDLKSSNLLVDKHWT--------VKVGDFGLSRL 654
+A + +L + IH ++ + N+L+ + +K+ D G+S
Sbjct: 121 QLAAAMHFLEENTL----IHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISIT 170
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 6e-38
Identities = 50/209 (23%), Positives = 87/209 (41%), Gaps = 41/209 (19%)
Query: 493 LDNDCLDYEILWEDLTIGEQIGQGSCGTVYHAVWYGSD-------VAVKVFSRQEYSDEV 545
L+ L E ++ IG+G+ G V+ A G VAVK+ ++E S ++
Sbjct: 35 LNPKLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKML-KEEASADM 93
Query: 546 IHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRR 605
F++E +LM +PN++ +G + +C++ E++ G L L+ +
Sbjct: 94 QADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLS 153
Query: 606 -----------------------ILMALDIARGVSYL--HHCNPPIIHRDLKSSNLLVDK 640
+ +A +A G++YL +HRDL + N LV +
Sbjct: 154 HSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKF----VHRDLATRNCLVGE 209
Query: 641 HWTVKVGDFGLSRLKHET--YLTTKTGKG 667
+ VK+ DFGLSR + Y G
Sbjct: 210 NMVVKIADFGLSRNIYSADYY--KADGND 236
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 8e-38
Identities = 54/170 (31%), Positives = 90/170 (52%), Gaps = 11/170 (6%)
Query: 499 DYEILWEDLTIGEQIGQGSCGTVYHAVWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKR 558
+ + ++L + + IG+G G V + G+ VAVK + + + + +F E S+M +
Sbjct: 187 GWALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCI-KNDATAQ---AFLAEASVMTQ 242
Query: 559 LRHPNVLLFMGAVTSPQ-RLCIVTEFLPRGSLFRLLQ-RNTTKLDWRRRILMALDIARGV 616
LRH N++ +G + + L IVTE++ +GSL L+ R + L + +LD+ +
Sbjct: 243 LRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAM 302
Query: 617 SYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGK 666
YL N +HRDL + N+LV + KV DFGL++ E T TGK
Sbjct: 303 EYLEGNN--FVHRDLAARNVLVSEDNVAKVSDFGLTK---EASSTQDTGK 347
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 1e-37
Identities = 46/185 (24%), Positives = 76/185 (41%), Gaps = 23/185 (12%)
Query: 501 EILWEDLTIGEQIGQGSCGTVYHAVWYGSD-------VAVKVFSRQEYSDEVIHSFRQEV 553
E+ +++T+ +G G+ G VY G VAVK + S++ F E
Sbjct: 67 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL-PEVCSEQDELDFLMEA 125
Query: 554 SLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRN------TTKLDWRRRIL 607
++ + H N++ +G I+ E + G L L+ + L +
Sbjct: 126 LIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLH 185
Query: 608 MALDIARGVSYL--HHCNPPIIHRDLKSSNLLVDKHW---TVKVGDFGLSRLKHETYLTT 662
+A DIA G YL +H IHRD+ + N L+ K+GDFG++R +
Sbjct: 186 VARDIACGCQYLEENHF----IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYR 241
Query: 663 KTGKG 667
K G
Sbjct: 242 KGGCA 246
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 2e-37
Identities = 59/195 (30%), Positives = 94/195 (48%), Gaps = 10/195 (5%)
Query: 474 TSSVSSCGSTSSSAVNKVDLDNDCLDYEILWEDLTIGEQIGQGSCGTVYHAVWYGS--DV 531
T+ + + V + D +E+ D+T+ ++G G G VY VW V
Sbjct: 191 TTLHYPAPKRNKPTIYGVSPNYD--KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTV 248
Query: 532 AVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFR 591
AVK +++ + F +E ++MK ++HPN++ +G T I+TEF+ G+L
Sbjct: 249 AVKTL-KEDTMEV--EEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLD 305
Query: 592 LLQ-RNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFG 650
L+ N ++ + MA I+ + YL N IHR+L + N LV ++ VKV DFG
Sbjct: 306 YLRECNRQEVSAVVLLYMATQISSAMEYLEKKN--FIHRNLAARNCLVGENHLVKVADFG 363
Query: 651 LSRLKHETYLTTKTG 665
LSRL T G
Sbjct: 364 LSRLMTGDTYTAHAG 378
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 2e-37
Identities = 53/201 (26%), Positives = 91/201 (45%), Gaps = 29/201 (14%)
Query: 489 NKVDLDNDCLDY-EILWEDLTIGEQIGQGSCGTVYHAVWYGSD----VAVKVFSRQEYSD 543
+ + D Y + W D+ + IG+G+ G V A A+K ++ S
Sbjct: 8 HHGKNNPDPTIYPVLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRM-KEYASK 66
Query: 544 EVIHSFRQEVSLMKRL-RHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRN------ 596
+ F E+ ++ +L HPN++ +GA L + E+ P G+L L+++
Sbjct: 67 DDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETD 126
Query: 597 ---------TTKLDWRRRILMALDIARGVSYL--HHCNPPIIHRDLKSSNLLVDKHWTVK 645
+ L ++ + A D+ARG+ YL IHRDL + N+LV +++ K
Sbjct: 127 PAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQF----IHRDLAARNILVGENYVAK 182
Query: 646 VGDFGLSRLKHETYLTTKTGK 666
+ DFGLSR E Y+ G+
Sbjct: 183 IADFGLSR-GQEVYVKKTMGR 202
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 2e-37
Identities = 47/196 (23%), Positives = 78/196 (39%), Gaps = 32/196 (16%)
Query: 499 DYEILWEDLTIGEQIGQGSCGTVYHAVWYG-------SDVAVKVFSRQEYSDEVIHSFRQ 551
+E L+ G+ +G G+ G V A YG VAVK+ + +
Sbjct: 17 KWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKML-KPSAHLTEREALMS 75
Query: 552 EVSLMKRL-RHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRN-------------- 596
E+ ++ L H N++ +GA T ++TE+ G L L+R
Sbjct: 76 ELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIM 135
Query: 597 ---TTKLDWRRRILMALDIARGVSYL--HHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGL 651
LD + + +A+G+++L +C IHRDL + N+L+ K+ DFGL
Sbjct: 136 EDDELALDLEDLLSFSYQVAKGMAFLASKNC----IHRDLAARNILLTHGRITKICDFGL 191
Query: 652 SRLKHETYLTTKTGKG 667
+R G
Sbjct: 192 ARDIKNDSNYVVKGNA 207
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 3e-37
Identities = 50/201 (24%), Positives = 86/201 (42%), Gaps = 37/201 (18%)
Query: 499 DYEILWEDLTIGEQIGQGSCGTVYHAVWYGSD-------VAVKVFSRQEYSDEVIHSFRQ 551
+E ++L +G+ +G+G G V A + VAVK+ ++ S +
Sbjct: 17 KWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKML-KENASPSELRDLLS 75
Query: 552 EVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRN--------------- 596
E +++K++ HP+V+ GA + L ++ E+ GSL L+ +
Sbjct: 76 EFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRN 135
Query: 597 --------TTKLDWRRRILMALDIARGVSYL--HHCNPPIIHRDLKSSNLLVDKHWTVKV 646
L I A I++G+ YL +HRDL + N+LV + +K+
Sbjct: 136 SSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKL----VHRDLAARNILVAEGRKMKI 191
Query: 647 GDFGLSRLKHETYLTTKTGKG 667
DFGLSR +E K +G
Sbjct: 192 SDFGLSRDVYEEDSYVKRSQG 212
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 5e-37
Identities = 54/208 (25%), Positives = 99/208 (47%), Gaps = 33/208 (15%)
Query: 487 AVNKVDLDNDCLDYEILWEDLTIGEQIGQGSCGTVYHAVWYGSD---------VAVKVFS 537
V++ +L D +E + LT+G+ +G+G+ G V A G D VAVK+
Sbjct: 18 GVSEYELPED-PKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKML- 75
Query: 538 RQEYSDEVIHSFRQEVSLMKRL-RHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRN 596
+ + +++ + E+ +MK + +H N++ +GA T L ++ E+ +G+L L+
Sbjct: 76 KDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRAR 135
Query: 597 ---------------TTKLDWRRRILMALDIARGVSYL--HHCNPPIIHRDLKSSNLLVD 639
++ ++ + +ARG+ YL C IHRDL + N+LV
Sbjct: 136 RPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKC----IHRDLAARNVLVT 191
Query: 640 KHWTVKVGDFGLSRLKHETYLTTKTGKG 667
++ +K+ DFGL+R + KT G
Sbjct: 192 ENNVMKIADFGLARDINNIDYYKKTTNG 219
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 5e-37
Identities = 55/168 (32%), Positives = 92/168 (54%), Gaps = 12/168 (7%)
Query: 513 IGQGSCGTVYHAVWY-GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAV 571
IG G G VY V G+ VA+K + + S + I F E+ + RHP+++ +G
Sbjct: 47 IGHGVFGKVYKGVLRDGAKVALKRRTPE--SSQGIEEFETEIETLSFCRHPHLVSLIGFC 104
Query: 572 TSPQRLCIVTEFLPRGSLFRLL---QRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIH 628
+ ++ +++ G+L R L T + W +R+ + + ARG+ YLH IIH
Sbjct: 105 DERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLH--TRAIIH 162
Query: 629 RDLKSSNLLVDKHWTVKVGDFGLSRLKHE---TYLTTKTGKGTVTYLA 673
RD+KS N+L+D+++ K+ DFG+S+ E T+L+T KGT+ Y+
Sbjct: 163 RDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTVV-KGTLGYID 209
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 6e-37
Identities = 56/221 (25%), Positives = 103/221 (46%), Gaps = 33/221 (14%)
Query: 474 TSSVSSCGSTSSSAVNKVDLDNDCLDYEILWEDLTIGEQIGQGSCGTVYHAVWYGSD--- 530
T S+ + + V++ +L D +E + LT+G+ +G+G G V A G D
Sbjct: 51 TRLSSTADTPMLAGVSEYELPED-PKWEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDK 109
Query: 531 ------VAVKVFSRQEYSDEVIHSFRQEVSLMKRL-RHPNVLLFMGAVTSPQRLCIVTEF 583
VAVK+ + + +++ + E+ +MK + +H N++ +GA T L ++ E+
Sbjct: 110 PKEAVTVAVKML-KDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEY 168
Query: 584 LPRGSLFRLLQRN---------------TTKLDWRRRILMALDIARGVSYL--HHCNPPI 626
+G+L L+ ++ ++ + +ARG+ YL C
Sbjct: 169 ASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKC---- 224
Query: 627 IHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKG 667
IHRDL + N+LV ++ +K+ DFGL+R + KT G
Sbjct: 225 IHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 265
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 1e-36
Identities = 52/194 (26%), Positives = 93/194 (47%), Gaps = 18/194 (9%)
Query: 489 NKVDLDNDCLDYEILWEDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVI 546
+ VDL + L ++ + E ++IG+GS G G +K + S +
Sbjct: 9 SGVDLGTENLYFQSM-EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKER 67
Query: 547 HSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTK------- 599
R+EV+++ ++HPN++ + + L IV ++ G LF+ +
Sbjct: 68 EESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQI 127
Query: 600 LDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETY 659
LDW +I +AL ++H I+HRD+KS N+ + K TV++GDFG++R+ + T
Sbjct: 128 LDWFVQICLALK------HVHDRK--ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTV 179
Query: 660 LTTKTGKGTVTYLA 673
+ GT YL+
Sbjct: 180 ELARACIGTPYYLS 193
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 2e-36
Identities = 51/169 (30%), Positives = 88/169 (52%), Gaps = 8/169 (4%)
Query: 499 DYEILWEDLTIGEQIGQGSCGTVYHAVWYGS-DVAVKVFSRQEYSDEVIHSFRQEVSLMK 557
+EI E L + +++G G G V+ A + VAVK + +F E ++MK
Sbjct: 182 AWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTM-KPGSMSV--EAFLAEANVMK 238
Query: 558 RLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRN-TTKLDWRRRILMALDIARGV 616
L+H ++ VT + + I+TEF+ +GSL L+ + +K + I + IA G+
Sbjct: 239 TLQHDKLVKLHAVVTK-EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGM 297
Query: 617 SYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTG 665
+++ N IHRDL+++N+LV K+ DFGL+R+ + T + G
Sbjct: 298 AFIEQRN--YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREG 344
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 136 bits (346), Expect = 2e-36
Identities = 55/172 (31%), Positives = 83/172 (48%), Gaps = 8/172 (4%)
Query: 505 EDLTIGEQIGQGSCGTVYHA--VWYGSDVAVKVFSRQE-YSDEVIHSFRQEVSLMKRLRH 561
ED IG +G+G G VY A +A+KV + + V H R+EV + LRH
Sbjct: 9 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 68
Query: 562 PNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHH 621
PN+L G R+ ++ E+ P G+++R LQ+ + + R + +A +SY H
Sbjct: 69 PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITE-LANALSYCHS 127
Query: 622 CNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTVTYLA 673
+IHRD+K NLL+ +K+ DFG S H GT+ YL
Sbjct: 128 KR--VIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTDLCGTLDYLP 175
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 3e-36
Identities = 49/217 (22%), Positives = 90/217 (41%), Gaps = 29/217 (13%)
Query: 474 TSSVSSCGSTSSSAVNKVDLDNDCLDYEILWEDLTIGEQIGQGSCGTVYHAVWYG----- 528
+ S S + ++ L + +E +L G+ +G G+ G V A +G
Sbjct: 16 WKIIESYEGNSYTFIDPTQLPYN-EKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKED 74
Query: 529 --SDVAVKVFSRQEYSDEVIHSFRQEVSLMKRL-RHPNVLLFMGAVTSPQRLCIVTEFLP 585
VAVK+ + + + E+ +M L +H N++ +GA T + ++TE+
Sbjct: 75 AVLKVAVKML-KSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCC 133
Query: 586 RGSLFRLLQRN-------------TTKLDWRRRILMALDIARGVSYL--HHCNPPIIHRD 630
G L L+R + R + + +A+G+++L +C IHRD
Sbjct: 134 YGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNC----IHRD 189
Query: 631 LKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKG 667
+ + N+L+ K+GDFGL+R G
Sbjct: 190 VAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNA 226
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 136 bits (346), Expect = 3e-36
Identities = 43/176 (24%), Positives = 80/176 (45%), Gaps = 12/176 (6%)
Query: 499 DYEILWEDLTIGEQ-IGQGSCGTVYHAVWYGS----DVAVKVFSRQEYSDEVIHSFRQEV 553
+ + + LT+ ++ +G G+ GTV + VAVK+ + + E
Sbjct: 10 EVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEA 69
Query: 554 SLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIA 613
++M++L +P ++ +G + + +V E G L + LQ+N + + I + ++
Sbjct: 70 NVMQQLDNPYIVRMIGICEA-ESWMLVMEMAELGPLNKYLQQNR-HVKDKNIIELVHQVS 127
Query: 614 RGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL---KHETYLTTKTGK 666
G+ YL N +HRDL + N+L+ K+ DFGLS+ Y GK
Sbjct: 128 MGMKYLEESN--FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGK 181
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 3e-36
Identities = 49/191 (25%), Positives = 82/191 (42%), Gaps = 29/191 (15%)
Query: 499 DYEILWEDLTIGEQIGQGSCGTVYHA--VWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLM 556
DYE+L IG GS G G + K ++ EV+L+
Sbjct: 7 DYEVL-------YTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLL 59
Query: 557 KRLRHPNVLLFMGAV--TSPQRLCIVTEFLPRGSLFRLLQRNTTK---------LDWRRR 605
+ L+HPN++ + + + L IV E+ G L ++ + T + L +
Sbjct: 60 RELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQ 119
Query: 606 ILMALDIARGVSYLHHCNPP---IIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTT 662
+ +AL H + ++HRDLK +N+ +D VK+GDFGL+R+ +
Sbjct: 120 LTLALK------ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFA 173
Query: 663 KTGKGTVTYLA 673
KT GT Y++
Sbjct: 174 KTFVGTPYYMS 184
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 4e-36
Identities = 58/169 (34%), Positives = 93/169 (55%), Gaps = 8/169 (4%)
Query: 500 YEILWEDLTIGEQIGQGSCGTVYHAVWYGS-DVAVKVFSRQEYSDEVIHSFRQEVSLMKR 558
+EI E L + ++GQG G V+ W G+ VA+K + +F QE +MK+
Sbjct: 179 WEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSP--EAFLQEAQVMKK 235
Query: 559 LRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTK-LDWRRRILMALDIARGVS 617
LRH ++ V+ + + IVTE++ +GSL L+ T K L + + MA IA G++
Sbjct: 236 LRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMA 294
Query: 618 YLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGK 666
Y+ N +HRDL+++N+LV ++ KV DFGL+RL + T + G
Sbjct: 295 YVERMN--YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGA 341
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 136 bits (346), Expect = 5e-36
Identities = 57/168 (33%), Positives = 93/168 (55%), Gaps = 10/168 (5%)
Query: 513 IGQGSCGTVYHAVWYGSDVAVKVFSRQEY--SDEVIHSFRQEVSLMKRLRHPNVLLFMGA 570
+G+G G VY + VAVK + ++E+ F QE+ +M + +H N++ +G
Sbjct: 39 MGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGF 98
Query: 571 VTSPQRLCIVTEFLPRGSL-FRLLQRNTTK-LDWRRRILMALDIARGVSYLHHCNPPIIH 628
+ LC+V ++P GSL RL + T L W R +A A G+++LH IH
Sbjct: 99 SSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLH--ENHHIH 156
Query: 629 RDLKSSNLLVDKHWTVKVGDFGLSRLKHE---TYLTTKTGKGTVTYLA 673
RD+KS+N+L+D+ +T K+ DFGL+R + T +T++ GT Y+A
Sbjct: 157 RDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRI-VGTTAYMA 203
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 5e-36
Identities = 50/198 (25%), Positives = 87/198 (43%), Gaps = 31/198 (15%)
Query: 496 DCLDYEILWEDLTIGEQIGQGSCGTVYHAVWYGSD-------VAVKVFSRQEYSDEVIHS 548
D +E + L +G+ +G+G+ G V A +G D VAVK+ ++ + +
Sbjct: 18 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKML-KEGATHSEHRA 76
Query: 549 FRQEVSLMKRL-RHPNVLLFMGAVTSPQR-LCIVTEFLPRGSLFRLLQRN---------- 596
E+ ++ + H NV+ +GA T P L ++ EF G+L L+
Sbjct: 77 LMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVA 136
Query: 597 -----TTKLDWRRRILMALDIARGVSYL--HHCNPPIIHRDLKSSNLLVDKHWTVKVGDF 649
L I + +A+G+ +L C IHRDL + N+L+ + VK+ DF
Sbjct: 137 PEDLYKDFLTLEHLICYSFQVAKGMEFLASRKC----IHRDLAARNILLSEKNVVKICDF 192
Query: 650 GLSRLKHETYLTTKTGKG 667
GL+R ++ + G
Sbjct: 193 GLARDIYKDPDYVRKGDA 210
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 7e-36
Identities = 51/195 (26%), Positives = 94/195 (48%), Gaps = 9/195 (4%)
Query: 484 SSSAVNKVDLDNDCLDYEILWEDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEY 541
S + + D ++D L+Y+ +++ +G+G+ G VY +A+K +
Sbjct: 1 SMRSTEEGDCESDLLEYDYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPER-- 58
Query: 542 SDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLD 601
+E++L K L+H N++ ++G+ + + I E +P GSL LL+ L
Sbjct: 59 DSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLK 118
Query: 602 WRRRILM--ALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHW-TVKVGDFGLSRLKHET 658
+ + I G+ YLH I+HRD+K N+L++ + +K+ DFG S+
Sbjct: 119 DNEQTIGFYTKQILEGLKYLHDNQ--IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGI 176
Query: 659 YLTTKTGKGTVTYLA 673
T+T GT+ Y+A
Sbjct: 177 NPCTETFTGTLQYMA 191
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 7e-36
Identities = 56/172 (32%), Positives = 87/172 (50%), Gaps = 8/172 (4%)
Query: 505 EDLTIGEQIGQGSCGTVYHA--VWYGSDVAVKVFSRQE-YSDEVIHSFRQEVSLMKRLRH 561
+D IG +G+G G VY A +A+KV + + + V H R+E+ + LRH
Sbjct: 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH 73
Query: 562 PNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHH 621
PN+L +R+ ++ EF PRG L++ LQ++ + R M ++A + Y H
Sbjct: 74 PNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFME-ELADALHYCHE 132
Query: 622 CNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTVTYLA 673
+IHRD+K NLL+ +K+ DFG S H L +T GT+ YL
Sbjct: 133 RK--VIHRDIKPENLLMGYKGELKIADFGWS--VHAPSLRRRTMCGTLDYLP 180
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 9e-36
Identities = 53/200 (26%), Positives = 90/200 (45%), Gaps = 40/200 (20%)
Query: 499 DYEILWEDLTIGEQIGQGSCGTVYHAVWYG---------SDVAVKV----FSRQEYSDEV 545
+E+ + L +G+ +G+G+ G V A G + VAVK+ + ++ SD
Sbjct: 63 RWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSD-- 120
Query: 546 IHSFRQEVSLMKRL-RHPNVLLFMGAVTSPQRLCIVTEFLPRGSL--------------- 589
E+ +MK + +H N++ +GA T L ++ E+ +G+L
Sbjct: 121 ---LISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYS 177
Query: 590 FRLLQRNTTKLDWRRRILMALDIARGVSYL--HHCNPPIIHRDLKSSNLLVDKHWTVKVG 647
+ +L + + A +ARG+ YL C IHRDL + N+LV + +K+
Sbjct: 178 YNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKC----IHRDLAARNVLVTEDNVMKIA 233
Query: 648 DFGLSRLKHETYLTTKTGKG 667
DFGL+R H KT G
Sbjct: 234 DFGLARDIHHIDYYKKTTNG 253
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 2e-35
Identities = 42/221 (19%), Positives = 85/221 (38%), Gaps = 27/221 (12%)
Query: 476 SVSSCGSTSSSAVNKVDLDNDCLDYEILWEDLTIGEQIGQGSCGTVYHAVWYGSDVAVKV 535
+ S S+ N + L+ + + D I + QG + A+K
Sbjct: 2 PLGSMKDILSNYSNLIYLNKYVKEKDKYINDYRIIRTLNQGKFNKIILCEKDNKFYALKK 61
Query: 536 FSRQE---------------YSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIV 580
+ + F+ E+ ++ +++ L G +T+ + I+
Sbjct: 62 YEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEGIITNYDEVYII 121
Query: 581 TEFLPRGSLFRLLQRNTTKLDWRRRILMALDIAR--------GVSYLHHCNPPIIHRDLK 632
E++ S+ + + LD + + + + SY+H+ I HRD+K
Sbjct: 122 YEYMENDSILKFDEYFF-VLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKN-ICHRDVK 179
Query: 633 SSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTVTYLA 673
SN+L+DK+ VK+ DFG S ++ K +GT ++
Sbjct: 180 PSNILMDKNGRVKLSDFGES--EYMVDKKIKGSRGTYEFMP 218
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 2e-35
Identities = 49/179 (27%), Positives = 83/179 (46%), Gaps = 14/179 (7%)
Query: 499 DYEILWEDLTIGEQIGQGSCGTVYHA--VWYGSDVAVKVFSRQE-YSDEVIHSFRQEVSL 555
D+++ G +G+GS VY A + G +VA+K+ ++ Y ++ + EV +
Sbjct: 12 DFKV-------GNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKI 64
Query: 556 MKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLD-WRRRILMALDIAR 614
+L+HP++L + +V E G + R L+ R M I
Sbjct: 65 HCQLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMH-QIIT 123
Query: 615 GVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTVTYLA 673
G+ YLH I+HRDL SNLL+ ++ +K+ DFGL+ + T GT Y++
Sbjct: 124 GMLYLHSHG--ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLCGTPNYIS 180
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 2e-35
Identities = 45/168 (26%), Positives = 67/168 (39%), Gaps = 6/168 (3%)
Query: 509 IGEQIGQGSCGTVYHA--VWYGSDVAVKVFSRQE-YSDEVIHSFRQEVSLMKRLRHPNVL 565
G +G+G + A K+ + E+S+ + L H +V+
Sbjct: 19 RGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVV 78
Query: 566 LFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPP 625
F G + +V E R SL L +R + R + I G YLH
Sbjct: 79 GFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLR-QIVLGCQYLHRNR-- 135
Query: 626 IIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTVTYLA 673
+IHRDLK NL +++ VK+GDFGL+ K GT Y+A
Sbjct: 136 VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIA 183
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 3e-35
Identities = 51/212 (24%), Positives = 87/212 (41%), Gaps = 38/212 (17%)
Query: 488 VNKVDLDNDCLDYEILWEDLTIGEQIGQGSCGTVYHAVWYG-------SDVAVKVFSRQE 540
V+ + + D L +E E+L G+ +G G+ G V +A YG VAVK+ +++
Sbjct: 29 VDFREYEYD-LKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKML-KEK 86
Query: 541 YSDEVIHSFRQEVSLMKRL-RHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRN--- 596
+ E+ +M +L H N++ +GA T + ++ E+ G L L+
Sbjct: 87 ADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREK 146
Query: 597 -------------------TTKLDWRRRILMALDIARGVSYL--HHCNPPIIHRDLKSSN 635
L + + A +A+G+ +L C +HRDL + N
Sbjct: 147 FSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSC----VHRDLAARN 202
Query: 636 LLVDKHWTVKVGDFGLSRLKHETYLTTKTGKG 667
+LV VK+ DFGL+R G
Sbjct: 203 VLVTHGKVVKICDFGLARDIMSDSNYVVRGNA 234
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 9e-35
Identities = 45/168 (26%), Positives = 67/168 (39%), Gaps = 6/168 (3%)
Query: 509 IGEQIGQGSCGTVYHA--VWYGSDVAVKVFSRQE-YSDEVIHSFRQEVSLMKRLRHPNVL 565
G +G+G + A K+ + E+S+ + L H +V+
Sbjct: 45 RGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVV 104
Query: 566 LFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPP 625
F G + +V E R SL L +R + R + I G YLH
Sbjct: 105 GFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLR-QIVLGCQYLHRNR-- 161
Query: 626 IIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTVTYLA 673
+IHRDLK NL +++ VK+GDFGL+ K GT Y+A
Sbjct: 162 VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIA 209
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 138 bits (348), Expect = 9e-35
Identities = 58/169 (34%), Positives = 93/169 (55%), Gaps = 8/169 (4%)
Query: 500 YEILWEDLTIGEQIGQGSCGTVYHAVWYGS-DVAVKVFSRQEYSDEVIHSFRQEVSLMKR 558
+EI E L + ++GQG G V+ W G+ VA+K + +F QE +MK+
Sbjct: 262 WEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSP--EAFLQEAQVMKK 318
Query: 559 LRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTK-LDWRRRILMALDIARGVS 617
LRH ++ V+ + + IVTE++ +GSL L+ T K L + + MA IA G++
Sbjct: 319 LRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMA 377
Query: 618 YLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGK 666
Y+ N +HRDL+++N+LV ++ KV DFGL+RL + T + G
Sbjct: 378 YVERMN--YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGA 424
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 1e-34
Identities = 41/175 (23%), Positives = 79/175 (45%), Gaps = 11/175 (6%)
Query: 499 DYEILWEDLTIGE-QIGQGSCGTVYHAVWYGS----DVAVKVFSRQEYSDEVIHSFRQEV 553
+ ++L I + ++G G+ G+V V+ DVA+KV +Q +E
Sbjct: 329 KLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVL-KQGTEKADTEEMMREA 387
Query: 554 SLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIA 613
+M +L +P ++ +G + L +V E G L + L ++ + ++
Sbjct: 388 QIMHQLDNPYIVRLIGVCQAEA-LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVS 446
Query: 614 RGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL--KHETYLTTKTGK 666
G+ YL N +HR+L + N+L+ K+ DFGLS+ ++Y T ++
Sbjct: 447 MGMKYLEEKN--FVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAG 499
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 3e-34
Identities = 45/181 (24%), Positives = 78/181 (43%), Gaps = 20/181 (11%)
Query: 505 EDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEV-IHSFRQEVSLMKRLRH 561
+ I ++IG+G VY A G VA+K + D +E+ L+K+L H
Sbjct: 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91
Query: 562 PNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTK---------LDWRRRILMALDI 612
PNV+ + + L IV E G L R+++ + + ++ AL+
Sbjct: 92 PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALE- 150
Query: 613 ARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTVTYL 672
++H ++HRD+K +N+ + VK+GD GL R + GT Y+
Sbjct: 151 -----HMHSRR--VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYM 203
Query: 673 A 673
+
Sbjct: 204 S 204
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 7e-34
Identities = 38/173 (21%), Positives = 77/173 (44%), Gaps = 14/173 (8%)
Query: 508 TIGEQIGQGSCGTVYHAV-WYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPN--- 563
+I +QIG G V+ + A+K + +E ++ + S+R E++ + +L+ +
Sbjct: 31 SILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKI 90
Query: 564 VLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTT-KLDWRRRILMALDIARGVSYLHHC 622
+ L+ + Q + +V E L L++ + R+ ++ V +H
Sbjct: 91 IRLY-DYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWK--NMLEAVHTIHQH 146
Query: 623 NPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL--KHETYLTTKTGKGTVTYLA 673
I+H DLK +N L+ +K+ DFG++ T + + GTV Y+
Sbjct: 147 G--IVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMP 196
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 2e-33
Identities = 44/234 (18%), Positives = 88/234 (37%), Gaps = 23/234 (9%)
Query: 447 ESHMYEGNRSVNNEAWGSWSSSVNVNSTSSVSSCGSTSSSAVNKVDLDNDCLDYEILWED 506
S + + A + + SSSA + + Y I
Sbjct: 7 SSGLVPRGSGMKETAAAKFERQHMDSPDLGTDDDDKASSSANECISVKGR--IYSI---- 60
Query: 507 LTIGEQIGQGSCGTVYHAV-WYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPN-- 563
+QIG G V+ + A+K + +E ++ + S+R E++ + +L+ +
Sbjct: 61 ---LKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDK 117
Query: 564 -VLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTT-KLDWRRRILMALDIARGVSYLHH 621
+ L+ + Q + +V E L L++ + R+ ++ V +H
Sbjct: 118 IIRLY-DYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWK--NMLEAVHTIHQ 173
Query: 622 CNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL--KHETYLTTKTGKGTVTYLA 673
I+H DLK +N L+ +K+ DFG++ T + + G V Y+
Sbjct: 174 HG--IVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMP 224
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 3e-33
Identities = 38/173 (21%), Positives = 77/173 (44%), Gaps = 14/173 (8%)
Query: 508 TIGEQIGQGSCGTVYHAV-WYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPN--- 563
+I +QIG G V+ + A+K + +E ++ + S+R E++ + +L+ +
Sbjct: 12 SILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKI 71
Query: 564 VLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTT-KLDWRRRILMALDIARGVSYLHHC 622
+ L+ + Q + +V E L L++ + R+ ++ V +H
Sbjct: 72 IRLY-DYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWK--NMLEAVHTIHQH 127
Query: 623 NPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL--KHETYLTTKTGKGTVTYLA 673
I+H DLK +N L+ +K+ DFG++ T + + GTV Y+
Sbjct: 128 G--IVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMP 177
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 3e-33
Identities = 54/204 (26%), Positives = 79/204 (38%), Gaps = 46/204 (22%)
Query: 505 EDLTIGEQIGQGSCGTVYHAV--WYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHP 562
D +GQG+ G V A A+K ++E + + EV L+ L H
Sbjct: 6 SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRH---TEEKLSTILSEVMLLASLNHQ 62
Query: 563 NVLLFMGA-------------VTSPQRLCIVTEFLPRGSLFRLLQRNTTKLD----WR-- 603
V+ + A V L I E+ G+L+ L+ WR
Sbjct: 63 YVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLF 122
Query: 604 RRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTT- 662
R+IL AL Y+H IIHRDLK N+ +D+ VK+GDFGL++ H +
Sbjct: 123 RQILEALS------YIHSQG--IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILK 174
Query: 663 -------------KTGKGTVTYLA 673
+ GT Y+A
Sbjct: 175 LDSQNLPGSSDNLTSAIGTAMYVA 198
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 1e-32
Identities = 44/179 (24%), Positives = 81/179 (45%), Gaps = 20/179 (11%)
Query: 508 TIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNV- 564
+ + +GQG+ V+ G A+KVF+ + V +E ++K+L H N+
Sbjct: 12 LLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPV-DVQMREFEVLKKLNHKNIV 70
Query: 565 -LLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWR----RRILMALDIARGVSYL 619
L + T+ + ++ EF P GSL+ +L+ + +L D+ G+++L
Sbjct: 71 KLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLR--DVVGGMNHL 128
Query: 620 HHCNPPIIHRDLKSSNLLV----DKHWTVKVGDFGLSR-LKHETYLTTKTGKGTVTYLA 673
I+HR++K N++ D K+ DFG +R L+ + + GT YL
Sbjct: 129 RENG--IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSL--YGTEEYLH 183
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 2e-32
Identities = 38/187 (20%), Positives = 73/187 (39%), Gaps = 22/187 (11%)
Query: 505 EDLTIGEQIGQGSCGTVYHA--VWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHP 562
+ +++G+G V + G A+K E D ++E + + HP
Sbjct: 29 KHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDR--EEAQREADMHRLFNHP 86
Query: 563 NVLLFMGA----VTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDW--RRRIL-MALDIARG 615
N+L + + ++ F RG+L+ ++R K ++ +IL + L I RG
Sbjct: 87 NILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRG 146
Query: 616 VSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTK---------TGK 666
+ +H HRDLK +N+L+ + D G ++ +
Sbjct: 147 LEAIHA--KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQR 204
Query: 667 GTVTYLA 673
T++Y A
Sbjct: 205 CTISYRA 211
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 2e-32
Identities = 40/230 (17%), Positives = 72/230 (31%), Gaps = 13/230 (5%)
Query: 447 ESHMYEGNRSVNNEAWGSWSSSVNVNSTSSVSSCGSTSSSAVNKVDLDNDCLDYEILWED 506
H + N + S + + + S + + +
Sbjct: 5 HHHSSGVDLGTENLYFQSMHQLQPRRVSFRGEASETLQSPGYDPSRPE------SFFQQS 58
Query: 507 LTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSD-EVIHSFRQEVSLMKRLRHPN 563
++G GS G V+ G AVK + + S K +HP
Sbjct: 59 FQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPC 118
Query: 564 VLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCN 623
+ A L + TE SL + + L + D +++LH
Sbjct: 119 CVRLEQAWEEGGILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQG 177
Query: 624 PPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTVTYLA 673
++H D+K +N+ + K+GDFGL + +G Y+A
Sbjct: 178 --LVHLDVKPANIFLGPRGRCKLGDFGLLVELGTA-GAGEVQEGDPRYMA 224
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 4e-32
Identities = 47/201 (23%), Positives = 81/201 (40%), Gaps = 49/201 (24%)
Query: 499 DYEILWEDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVSLM 556
D++ + E IG G G V+ A G +K +EV +
Sbjct: 12 DFKEI-------ELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN------EKAEREVKAL 58
Query: 557 KRLRHPNVLLFMGA----------------VTSPQRLCIVTEFLPRGSLFRLLQRNTTK- 599
+L H N++ + G + + L I EF +G+L + +++ +
Sbjct: 59 AKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEK 118
Query: 600 ------LDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSR 653
L+ +I +D Y+H +I+RDLK SN+ + VK+GDFGL
Sbjct: 119 LDKVLALELFEQITKGVD------YIHSKK--LINRDLKPSNIFLVDTKQVKIGDFGLVT 170
Query: 654 -LKHETYLTTKTGKGTVTYLA 673
LK++ T GT+ Y++
Sbjct: 171 SLKNDGKRTRSK--GTLRYMS 189
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 8e-32
Identities = 44/179 (24%), Positives = 81/179 (45%), Gaps = 20/179 (11%)
Query: 508 TIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNV- 564
+ + +GQG+ V+ G A+KVF+ + V +E ++K+L H N+
Sbjct: 12 LLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPV-DVQMREFEVLKKLNHKNIV 70
Query: 565 -LLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWR----RRILMALDIARGVSYL 619
L + T+ + ++ EF P GSL+ +L+ + +L D+ G+++L
Sbjct: 71 KLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLR--DVVGGMNHL 128
Query: 620 HHCNPPIIHRDLKSSNLLV----DKHWTVKVGDFGLSR-LKHETYLTTKTGKGTVTYLA 673
I+HR++K N++ D K+ DFG +R L+ + + GT YL
Sbjct: 129 RENG--IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSL--YGTEEYLH 183
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 119 bits (302), Expect = 3e-30
Identities = 46/173 (26%), Positives = 80/173 (46%), Gaps = 16/173 (9%)
Query: 508 TIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVL 565
E +G G+ V+ G A+K + + S E++++K+++H N++
Sbjct: 12 IFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRD--SSLENEIAVLKKIKHENIV 69
Query: 566 LFMGAVTSPQRLCIVTEFLPRGSLF-RLLQRNT-TKLDWRRRILMALDIARGVSYLHHCN 623
S +V + + G LF R+L+R T+ D I + V YLH
Sbjct: 70 TLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQ---VLSAVKYLHENG 126
Query: 624 PPIIHRDLKSSNLLV---DKHWTVKVGDFGLSRLKHETYLTTKTGKGTVTYLA 673
I+HRDLK NLL +++ + + DFGLS+++ ++T GT Y+A
Sbjct: 127 --IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMSTAC--GTPGYVA 175
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 4e-30
Identities = 45/199 (22%), Positives = 74/199 (37%), Gaps = 35/199 (17%)
Query: 505 EDLTIGEQIGQGSCGTVYHA--VWYGSDVAVKV--FSRQEYSDEVIHSFRQEVSLMKRLR 560
D + +G+G G V+ A + A+K +E + E +EV + +L
Sbjct: 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELARE---KVMREVKALAKLE 61
Query: 561 HPNVLLFMGA------------VTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILM 608
HP ++ + A + L I + + +L + T + R + +
Sbjct: 62 HPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCL 121
Query: 609 --ALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKT-- 664
L IA V +LH ++HRDLK SN+ VKVGDFGL +
Sbjct: 122 HIFLQIAEAVEFLHSKG--LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLT 179
Query: 665 ----------GKGTVTYLA 673
GT Y++
Sbjct: 180 PMPAYARHTGQVGTKLYMS 198
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 2e-29
Identities = 48/179 (26%), Positives = 84/179 (46%), Gaps = 20/179 (11%)
Query: 508 TIGEQIGQGSCGTVYHAV--WYGSDVAVKVFSRQEYS------DEVIHSFRQEVSLMKRL 559
+ + +G G+CG V A VA+++ S+++++ + + E+ ++K+L
Sbjct: 138 IMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKL 197
Query: 560 RHPNVLLFMGAVTSPQRLCIVTEFLPRGSLF-RLLQRNTTKLDWRRRILMALDIARGVSY 618
HP ++ + IV E + G LF +++ +L L + V Y
Sbjct: 198 NHPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGNK--RLKEATCKLYFYQMLLAVQY 254
Query: 619 LHHCNPPIIHRDLKSSNLLV---DKHWTVKVGDFGLSR-LKHETYLTTKTGKGTVTYLA 673
LH IIHRDLK N+L+ ++ +K+ DFG S+ L + + T GT TYLA
Sbjct: 255 LHENG--IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLC--GTPTYLA 309
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 4e-29
Identities = 42/174 (24%), Positives = 77/174 (44%), Gaps = 15/174 (8%)
Query: 508 TIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVL 565
+ E++G+G+ V V G + A K+ + ++ S +E + ++L+HPN++
Sbjct: 9 DVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIV 68
Query: 566 LFMGAVTSPQRLCIVTEFLPRGSLF-RLLQRNT-TKLDWRRRILMALDIARGVSYLHHCN 623
++ +V + + G LF ++ R ++ D I ++Y H
Sbjct: 69 RLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASH---CIQQILESIAYCHSNG 125
Query: 624 PPIIHRDLKSSNLLV---DKHWTVKVGDFGLSR-LKHETYLTTKTGKGTVTYLA 673
I+HR+LK NLL+ K VK+ DFGL+ + GT YL+
Sbjct: 126 --IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFA--GTPGYLS 175
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 5e-29
Identities = 51/172 (29%), Positives = 77/172 (44%), Gaps = 14/172 (8%)
Query: 509 IGEQIGQGSCGTVYHA--VWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLL 566
+ + +G+G+ G V A VAVK+ + D + + E+ + K L H NV+
Sbjct: 11 LVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKK-EICINKMLNHENVVK 69
Query: 567 FMGAVTSPQRLCIVTEFLPRGSLF-RLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPP 625
F G + E+ G LF R+ +R L +A GV YLH
Sbjct: 70 FYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQL-MA-GVVYLHGIG-- 125
Query: 626 IIHRDLKSSNLLVDKHWTVKVGDFGLSRL----KHETYLTTKTGKGTVTYLA 673
I HRD+K NLL+D+ +K+ DFGL+ + E L GT+ Y+A
Sbjct: 126 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLL--NKMCGTLPYVA 175
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 5e-29
Identities = 51/178 (28%), Positives = 83/178 (46%), Gaps = 18/178 (10%)
Query: 508 TIGEQIGQGSCGTVYHAV--WYGSDVAVKVFSRQ------EYSDEVIHSFRQEVSLMKRL 559
+ + +G G+CG V A VA+K+ S++ + + E+ ++K+L
Sbjct: 13 IMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKL 72
Query: 560 RHPNVLLFMGAVTSPQRLCIVTEFLPRGSLF-RLLQRNTTKLDWRRRILMALDIARGVSY 618
HP ++ + IV E + G LF +++ +L L + V Y
Sbjct: 73 NHPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGN--KRLKEATCKLYFYQMLLAVQY 129
Query: 619 LHHCNPPIIHRDLKSSNLLV---DKHWTVKVGDFGLSRLKHETYLTTKTGKGTVTYLA 673
LH IIHRDLK N+L+ ++ +K+ DFG S++ ET L +T GT TYLA
Sbjct: 130 LHENG--IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL-MRTLCGTPTYLA 184
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 6e-29
Identities = 52/195 (26%), Positives = 84/195 (43%), Gaps = 34/195 (17%)
Query: 508 TIGEQIGQGSCGTVYHA--VWYGSDVAVKVFSRQ------------------------EY 541
T+ ++IG+GS G V A + A+KV S++
Sbjct: 16 TLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQ 75
Query: 542 SDEVIHSFRQEVSLMKRLRHPNVL-LF--MGAVTSPQRLCIVTEFLPRGSLFRLLQRNTT 598
I QE++++K+L HPNV+ L + L +V E + +G + +
Sbjct: 76 PRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNE-DHLYMVFELVNQGPVMEVPTLKPL 134
Query: 599 KLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHET 658
D R D+ +G+ YLH+ IIHRD+K SNLLV + +K+ DFG+S +
Sbjct: 135 SEDQARFYFQ--DLIKGIEYLHYQK--IIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGS 190
Query: 659 YLTTKTGKGTVTYLA 673
GT ++A
Sbjct: 191 DALLSNTVGTPAFMA 205
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 6e-29
Identities = 52/182 (28%), Positives = 80/182 (43%), Gaps = 23/182 (12%)
Query: 508 TIGEQIGQGSCGTVYHAV--WYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVL 565
+ E++G G G V + G VA+K RQE S + + E+ +MK+L HPNV+
Sbjct: 17 EMKERLGTGGFGYVLRWIHQDTGEQVAIKQC-RQELSPKNRERWCLEIQIMKKLNHPNVV 75
Query: 566 -LF-----MGAVTSPQRLCIVTEFLPRGSLFRLLQR--NTTKL--DWRRRILMALDIARG 615
+ + + E+ G L + L + N L R +L DI+
Sbjct: 76 SAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLS--DISSA 133
Query: 616 VSYLHHCNPPIIHRDLKSSNLLVD---KHWTVKVGDFGLSR-LKHETYLTTKTGKGTVTY 671
+ YLH IIHRDLK N+++ + K+ D G ++ L T GT+ Y
Sbjct: 134 LRYLHENR--IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEF--VGTLQY 189
Query: 672 LA 673
LA
Sbjct: 190 LA 191
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 6e-29
Identities = 51/174 (29%), Positives = 85/174 (48%), Gaps = 15/174 (8%)
Query: 508 TIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVL 565
I +G+GS G V + AVKV ++ ++ + +EV L+K+L HPN++
Sbjct: 25 NIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIM 84
Query: 566 LFMGAVTSPQRLCIVTEFLPRGSLF-RLLQRNT-TKLDWRRRILMALDIARGVSYLHHCN 623
+ IV E G LF +++R ++ D R + + G++Y+H N
Sbjct: 85 KLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAAR---IIKQVFSGITYMHKHN 141
Query: 624 PPIIHRDLKSSNLLV---DKHWTVKVGDFGLSR-LKHETYLTTKTGKGTVTYLA 673
I+HRDLK N+L+ +K +K+ DFGLS + T + + GT Y+A
Sbjct: 142 --IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRI--GTAYYIA 191
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 119 bits (299), Expect = 7e-29
Identities = 45/203 (22%), Positives = 81/203 (39%), Gaps = 20/203 (9%)
Query: 481 GSTSSSAVNKVDLDNDCLDYEILWEDLTIGEQIGQGSCGTVYHA-VWYGSDVAVKVFSRQ 539
GS+ S + D + + + + +G G+ GT+ + ++ DVAVK +
Sbjct: 2 GSSPSLEQDDGDEETSVVIVGKI--SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPE 59
Query: 540 EYSDEVIHSFRQEVSLMKRL-RHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTT 598
+S +EV L++ HPNV+ + Q I E +L +++
Sbjct: 60 CFSFA-----DREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCA-ATLQEYVEQKDF 113
Query: 599 KLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLV-----DKHWTVKVGDFGLSR 653
I + G+++LH N I+HRDLK N+L+ + DFGL +
Sbjct: 114 AHLGLEPITLLQQTTSGLAHLHSLN--IVHRDLKPHNILISMPNAHGKIKAMISDFGLCK 171
Query: 654 L---KHETYLTTKTGKGTVTYLA 673
++ GT ++A
Sbjct: 172 KLAVGRHSFSRRSGVPGTEGWIA 194
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 8e-29
Identities = 51/220 (23%), Positives = 86/220 (39%), Gaps = 23/220 (10%)
Query: 462 WGSWSSSVNVNSTSSVSSCGSTSSSAVNKVDLDNDCLDYEILWEDLTIGEQIGQGSCGTV 521
W S S+ + + + G + + VD + Y +T ++G+GS G V
Sbjct: 20 WSSGSAKLQRLGPETEDNEGVLLTEKLKPVDYE-----YREEVHWMTHQPRVGRGSFGEV 74
Query: 522 YHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCI 579
+ G AVK + + +E+ L P ++ GAV + I
Sbjct: 75 HRMKDKQTGFQCAVKKVRLEVFRV-------EELVACAGLSSPRIVPLYGAVREGPWVNI 127
Query: 580 VTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVD 639
E L GSL +L+ + L R + G+ YLH I+H D+K+ N+L+
Sbjct: 128 FMELLEGGSLGQLI-KQMGCLPEDRALYYLGQALEGLEYLHTRR--ILHGDVKADNVLLS 184
Query: 640 KH-WTVKVGDFGLSR-----LKHETYLTTKTGKGTVTYLA 673
+ DFG + ++ LT GT T++A
Sbjct: 185 SDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMA 224
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 9e-29
Identities = 53/195 (27%), Positives = 78/195 (40%), Gaps = 24/195 (12%)
Query: 472 NSTSSVSSCGSTSSSAVNKVDLDNDCLDYEILWEDLTIGEQIGQGSCGTVYHA--VWYGS 529
S + G S V + E+ L + + +G VY A V G
Sbjct: 3 GPGSLGGASGRDQSDFVGQT--------VELGELRLRVRRVLAEGGFAFVYEAQDVGSGR 54
Query: 530 DVAVKVFSRQEYSDEVIHSFRQEVSLMKRLR-HPNVLLFMGA-------VTSPQRLCIVT 581
+ A+K E + QEV MK+L HPN++ F A + Q ++
Sbjct: 55 EYALKRLLSNEEEKN--RAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLL 112
Query: 582 EFLPRGSLFRLL--QRNTTKLDWRRRIL-MALDIARGVSYLHHCNPPIIHRDLKSSNLLV 638
L +G L L + L +L + R V ++H PPIIHRDLK NLL+
Sbjct: 113 TELCKGQLVEFLKKMESRGPLS-CDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLL 171
Query: 639 DKHWTVKVGDFGLSR 653
T+K+ DFG +
Sbjct: 172 SNQGTIKLCDFGSAT 186
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 1e-28
Identities = 43/168 (25%), Positives = 79/168 (47%), Gaps = 12/168 (7%)
Query: 494 DNDCLDYEILWEDLTIGEQIGQGSCGTVYHA--VWYGSDVAVKVFSRQEYSDEVIHSFRQ 551
D+ L + I +D + E IG G+ V A VA+K + ++ + +
Sbjct: 4 DSSALPWSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTS-MDELLK 62
Query: 552 EVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALD 611
E+ M + HPN++ + + L +V + L GS+ +++ K + + +L
Sbjct: 63 EIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDEST 122
Query: 612 IA-------RGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLS 652
IA G+ YLH IHRD+K+ N+L+ + +V++ DFG+S
Sbjct: 123 IATILREVLEGLEYLHKNG--QIHRDVKAGNILLGEDGSVQIADFGVS 168
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 2e-28
Identities = 48/178 (26%), Positives = 86/178 (48%), Gaps = 19/178 (10%)
Query: 508 TIGEQIGQGSCGTVYHAV--WYGSDVAVKVFSR------QEYSDEVIHSFRQEVSLMKRL 559
+ IG+G V V G + AVK+ E +EV + R+E +++++
Sbjct: 97 DPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQV 156
Query: 560 R-HPNVLLFMGAVTSPQRLCIVTEFLPRGSLF-RLLQRNT-TKLDWRRRILMALDIARGV 616
HP+++ + + S + +V + + +G LF L ++ ++ + R + + V
Sbjct: 157 AGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRS---IMRSLLEAV 213
Query: 617 SYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSR-LKHETYLTTKTGKGTVTYLA 673
S+LH N I+HRDLK N+L+D + +++ DFG S L+ L GT YLA
Sbjct: 214 SFLHANN--IVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLRELC--GTPGYLA 267
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 2e-28
Identities = 45/179 (25%), Positives = 80/179 (44%), Gaps = 20/179 (11%)
Query: 508 TIGEQIGQGSCGTVYHAV--WYGSDVAVKVFSR-------QEYSDEVIHSFRQEVSLMKR 558
E +G+G V + + AVK+ E E+ + +EV ++++
Sbjct: 20 EPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRK 79
Query: 559 L-RHPNVLLFMGAVTSPQRLCIVTEFLPRGSLF-RLLQRNT-TKLDWRRRILMALDIARG 615
+ HPN++ + +V + + +G LF L ++ T ++ + R+ + +
Sbjct: 80 VSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRK---IMRALLEV 136
Query: 616 VSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSR-LKHETYLTTKTGKGTVTYLA 673
+ LH N I+HRDLK N+L+D +K+ DFG S L L GT +YLA
Sbjct: 137 ICALHKLN--IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVC--GTPSYLA 191
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 3e-28
Identities = 44/159 (27%), Positives = 73/159 (45%), Gaps = 8/159 (5%)
Query: 508 TIGEQIGQGSCGTVYHA--VWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVL 565
+ + IG+G+ V A + G +VA+K+ + + + + +EV +MK L HPN++
Sbjct: 18 RLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIV 77
Query: 566 LFMGAVTSPQRLCIVTEFLPRGSLF-RLLQRNTTKLDWRRRILMALDIARGVSYLHHCNP 624
+ + + L ++ E+ G +F L+ K R I V Y H
Sbjct: 78 KLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFR--QIVSAVQYCHQKR- 134
Query: 625 PIIHRDLKSSNLLVDKHWTVKVGDFGLSRL-KHETYLTT 662
I+HRDLK+ NLL+D +K+ DFG S L
Sbjct: 135 -IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDA 172
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 3e-28
Identities = 51/172 (29%), Positives = 77/172 (44%), Gaps = 14/172 (8%)
Query: 509 IGEQIGQGSCGTVYHA--VWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLL 566
+ + +G+G+ G V A VAVK+ + D + + E+ + K L H NV+
Sbjct: 11 LVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKK-EICINKMLNHENVVK 69
Query: 567 FMGAVTSPQRLCIVTEFLPRGSLF-RLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPP 625
F G + E+ G LF R+ +R L +A GV YLH
Sbjct: 70 FYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQL-MA-GVVYLHGIG-- 125
Query: 626 IIHRDLKSSNLLVDKHWTVKVGDFGLSRL----KHETYLTTKTGKGTVTYLA 673
I HRD+K NLL+D+ +K+ DFGL+ + E L GT+ Y+A
Sbjct: 126 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLL--NKMCGTLPYVA 175
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 1e-27
Identities = 40/200 (20%), Positives = 71/200 (35%), Gaps = 34/200 (17%)
Query: 499 DYEILWEDLTIGEQIGQGSCGTVYHAV--WYGSDVAVKVFSRQEYSDEVIHSFRQEVSLM 556
Y + E+IG G G+V+ V G A+K + + +EV
Sbjct: 8 RYTTEFH---ELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAH 64
Query: 557 KRL-RHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQ---RNTTKLDWRRRILMALDI 612
L +H +V+ + A + I E+ GSL + R + + L +
Sbjct: 65 AVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQV 124
Query: 613 ARGVSYLHHCNPPIIHRDLKSSNLLVDKH-------------------WTVKVGDFGLSR 653
RG+ Y+H + ++H D+K SN+ + + K+GD G
Sbjct: 125 GRGLRYIHSMS--LVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVT 182
Query: 654 LKHETYLTTKTGKGTVTYLA 673
+ +G +LA
Sbjct: 183 RISS----PQVEEGDSRFLA 198
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 2e-27
Identities = 47/192 (24%), Positives = 74/192 (38%), Gaps = 35/192 (18%)
Query: 508 TIGEQIGQGSCGTVYHA-VWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRL-RHPNVL 565
+ +G GS GTV + G VAVK E+ L+ HPNV+
Sbjct: 18 VSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDFC-----DIALMEIKLLTESDDHPNVI 72
Query: 566 LFMGAVTSPQRLCIVTEFLPRGSLF-RLLQRNTTKLDWRR------RILMALDIARGVSY 618
+ + T+ + L I E +L + +N + + + L+ IA GV++
Sbjct: 73 RYYCSETTDRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLL-RQIASGVAH 130
Query: 619 LHHCNPPIIHRDLKSSNLLVD-------------KHWTVKVGDFGLSRL----KHETYLT 661
LH IIHRDLK N+LV ++ + + DFGL + +
Sbjct: 131 LHSLK--IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTN 188
Query: 662 TKTGKGTVTYLA 673
GT + A
Sbjct: 189 LNNPSGTSGWRA 200
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 2e-27
Identities = 52/178 (29%), Positives = 74/178 (41%), Gaps = 27/178 (15%)
Query: 508 TIGEQIGQGSCGTVYHA--VWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVL 565
+ IG G+ G VAVK R DE + ++E+ + LRHPN++
Sbjct: 23 DFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENV---QREIINHRSLRHPNIV 79
Query: 566 LFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIAR--------GVS 617
F + +P L I+ E+ G L+ + R + D AR GVS
Sbjct: 80 RFKEVILTPTHLAIIMEYASGGELYERICNA------GR---FSEDEARFFFQQLLSGVS 130
Query: 618 YLHHCNPPIIHRDLKSSNLLVDKHWT--VKVGDFGLSRLKHETYLTTKTGKGTVTYLA 673
Y H I HRDLK N L+D +K+ DFG S+ K+ GT Y+A
Sbjct: 131 YCHSMQ--ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-PKSTVGTPAYIA 185
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 4e-27
Identities = 42/174 (24%), Positives = 77/174 (44%), Gaps = 15/174 (8%)
Query: 508 TIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVL 565
+ E++G+G+ V V G + A K+ + ++ S +E + ++L+HPN++
Sbjct: 32 DVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIV 91
Query: 566 LFMGAVTSPQRLCIVTEFLPRGSLF-RLLQRNT-TKLDWRRRILMALDIARGVSYLHHCN 623
++ +V + + G LF ++ R ++ D I ++Y H
Sbjct: 92 RLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASH---CIQQILESIAYCHSNG 148
Query: 624 PPIIHRDLKSSNLLV---DKHWTVKVGDFGLSR-LKHETYLTTKTGKGTVTYLA 673
I+HR+LK NLL+ K VK+ DFGL+ + GT YL+
Sbjct: 149 --IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFA--GTPGYLS 198
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 5e-27
Identities = 39/176 (22%), Positives = 76/176 (43%), Gaps = 16/176 (9%)
Query: 509 IGEQIGQGSCGTVYHA--VWYGSDVAVKVFSRQEYSD--EVIHSFRQEVSLMKRLRHPNV 564
+G+ +G+GS G V AVK+ +++ + ++E+ L++RLRH NV
Sbjct: 9 MGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNV 68
Query: 565 L-LF--MGAVTSPQRLCIVTEFLPRGS--LFRLLQRNTTKLDWRRRILMALDIARGVSYL 619
+ L + Q++ +V E+ G + + + + G+ YL
Sbjct: 69 IQLVDVLYNEE-KQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFC--QLIDGLEYL 125
Query: 620 HHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTT--KTGKGTVTYLA 673
H I+H+D+K NLL+ T+K+ G++ H +T +G+ +
Sbjct: 126 HSQG--IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQP 179
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 1e-26
Identities = 48/160 (30%), Positives = 81/160 (50%), Gaps = 9/160 (5%)
Query: 508 TIGEQIGQGSCGTVYHA--VWYGSDVAVKVFSRQE-YSDEVIHSFRQEVSLMKRLRHPNV 564
+G+ +G G+ G V G VAVK+ +RQ+ S +V+ ++E+ +K RHP++
Sbjct: 14 VLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHI 73
Query: 565 LLFMGAVTSPQRLCIVTEFLPRGSLF-RLLQRNTTKLDWRRRILMALDIARGVSYLHHCN 623
+ +++P +V E++ G LF + + + RR+ I V Y H
Sbjct: 74 IKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQ--QILSAVDYCHRHM 131
Query: 624 PPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL-KHETYLTT 662
++HRDLK N+L+D H K+ DFGLS + +L T
Sbjct: 132 --VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRT 169
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 111 bits (278), Expect = 1e-26
Identities = 30/200 (15%), Positives = 61/200 (30%), Gaps = 28/200 (14%)
Query: 498 LDYEILWEDLTIGEQIGQGSCGTVYHAVWYGSD-------VAVKVFSRQEYSDEVIHSFR 550
++++ + + + +G+G+ VY A + +KV + +
Sbjct: 58 TEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWE--FYIGT 115
Query: 551 QEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQR----NTTKLDWRRRI 606
Q + +K + F A +V E G+L + + I
Sbjct: 116 QLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVI 175
Query: 607 LMALDIARGVSYLHHCNPPIIHRDLKSSNLLV-----------DKHWTVKVGDFGLSRLK 655
A+ + + +H C IIH D+K N ++ D + + D G S
Sbjct: 176 SFAMRMLYMIEQVHDCE--IIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDM 233
Query: 656 --HETYLTTKTGKGTVTYLA 673
T +
Sbjct: 234 KLFPKGTIFTAKCETSGFQC 253
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 1e-26
Identities = 53/173 (30%), Positives = 87/173 (50%), Gaps = 10/173 (5%)
Query: 482 STSSSAVNKVDLDNDCLDYEILWEDLTIGEQIGQGSCGTVYHAV--WYGSDVAVKVFSRQ 539
+ S + N D E L+ L E+IG+GS G V+ + VA+K+ +
Sbjct: 2 AHSPVQSGLPGMQNLKADPEELFTKL---EKIGKGSFGEVFKGIDNRTQKVVAIKIIDLE 58
Query: 540 EYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTK 599
E DE I +QE++++ + P V + G+ +L I+ E+L GS LL+
Sbjct: 59 EAEDE-IEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLD 117
Query: 600 LDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLS 652
IL +I +G+ YLH IHRD+K++N+L+ +H VK+ DFG++
Sbjct: 118 ETQIATILR--EILKGLDYLHSEK--KIHRDIKAANVLLSEHGEVKLADFGVA 166
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 1e-26
Identities = 45/181 (24%), Positives = 86/181 (47%), Gaps = 17/181 (9%)
Query: 500 YEILWEDLTIGEQIGQGSCGTVYHA--VWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMK 557
E+ +D ++G G+ G V+ G +A K+ E + + +E+ ++
Sbjct: 28 GELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLI-HLEIKPAIRNQIIRELQVLH 86
Query: 558 RLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRIL--MALDIARG 615
P ++ F GA S + I E + GSL ++L++ +IL +++ + +G
Sbjct: 87 ECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR---IPEQILGKVSIAVIKG 143
Query: 616 VSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLT---TKTGKGTVTYL 672
++YL I+HRD+K SN+LV+ +K+ DFG+S L + GT +Y+
Sbjct: 144 LTYLRE-KHKIMHRDVKPSNILVNSRGEIKLCDFGVS-----GQLIDSMANSFVGTRSYM 197
Query: 673 A 673
+
Sbjct: 198 S 198
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 2e-26
Identities = 39/173 (22%), Positives = 74/173 (42%), Gaps = 12/173 (6%)
Query: 508 TIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVL 565
+ E++G+G+ V V G + A + + ++ S +E + + L+HPN++
Sbjct: 14 QLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIV 73
Query: 566 LFMGAVTSPQRLCIVTEFLPRGSLF-RLLQRNT-TKLDWRRRILMALDIARGVSYLHHCN 623
+++ ++ + + G LF ++ R ++ D I V + H
Sbjct: 74 RLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASH---CIQQILEAVLHCHQMG 130
Query: 624 PPIIHRDLKSSNLLV---DKHWTVKVGDFGLSRLKHETYLTTKTGKGTVTYLA 673
++HR+LK NLL+ K VK+ DFGL+ GT YL+
Sbjct: 131 --VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLS 181
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 2e-26
Identities = 56/230 (24%), Positives = 101/230 (43%), Gaps = 23/230 (10%)
Query: 452 EGNRSVNNEAWGSWSSSVNVNSTSSVSSCGSTSSSAVNKVDLDNDCLDYEILWEDLTIGE 511
+ S + +++S ++ ++ G+ S +D N + L + +
Sbjct: 4 HHHHSSGVDLGTENLYFQSMSSVTASAAPGTASLVPDYWIDGSN----RDALSDFFEVES 59
Query: 512 QIGQGSCGTVYHAVWYGSD--VAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMG 569
++G+G+ VY G+ A+KV + R E+ ++ RL HPN++
Sbjct: 60 ELGRGATSIVYRCKQKGTQKPYALKVLKKTV----DKKIVRTEIGVLLRLSHPNIIKLKE 115
Query: 570 AVTSPQRLCIVTEFLPRGSLF-RLLQRNT-TKLDWRRRILMALDIARGVSYLHHCNPPII 627
+P + +V E + G LF R++++ ++ D I V+YLH I+
Sbjct: 116 IFETPTEISLVLELVTGGELFDRIVEKGYYSERDAAD---AVKQILEAVAYLHENG--IV 170
Query: 628 HRDLKSSNLLV---DKHWTVKVGDFGLSR-LKHETYLTTKTGKGTVTYLA 673
HRDLK NLL +K+ DFGLS+ ++H+ + T GT Y A
Sbjct: 171 HRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVC--GTPGYCA 218
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 4e-26
Identities = 43/178 (24%), Positives = 70/178 (39%), Gaps = 18/178 (10%)
Query: 508 TIGEQIGQGSCGTVYHAV--WYGSDVAVKVFS----RQEYSDEVIHSFRQEVSLMKRLRH 561
IGE++G G V G + A K R +EVS+++++ H
Sbjct: 15 DIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLH 74
Query: 562 PNVLLFMGAVTSPQRLCIVTEFLPRGSLF-RLLQRNTTKLDWRRRILMALDIARGVSYLH 620
NV+ + + ++ E + G LF L Q+ L I GV+YLH
Sbjct: 75 HNVITLHDVYENRTDVVLILELVSGGELFDFLAQKE--SLSEEEATSFIKQILDGVNYLH 132
Query: 621 HCNPPIIHRDLKSSNLLV----DKHWTVKVGDFGLSR-LKHETYLTTKTGKGTVTYLA 673
I H DLK N+++ +K+ DFGL+ ++ GT ++A
Sbjct: 133 TKK--IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIF--GTPEFVA 186
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 8e-26
Identities = 43/179 (24%), Positives = 74/179 (41%), Gaps = 17/179 (9%)
Query: 508 TIGEQIGQGSCGTVYHAV--WYGSDVAVKV-----FSRQEYSDEVIHSFRQEVSLMKRLR 560
+ E IG+G V + G AVK+ F+ ++E S+ L+
Sbjct: 27 ELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLS--TEDLKREASICHMLK 84
Query: 561 HPNVLLFMGAVTSPQRLCIVTEFLPRGSLF-RLLQRNTTKLDW--RRRILMALDIARGVS 617
HP+++ + +S L +V EF+ L +++R + I +
Sbjct: 85 HPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALR 144
Query: 618 YLHHCNPPIIHRDLKSSNLLV---DKHWTVKVGDFGLSRLKHETYLTTKTGKGTVTYLA 673
Y H N IIHRD+K +L+ + VK+G FG++ E+ L GT ++A
Sbjct: 145 YCHDNN--IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMA 201
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 8e-26
Identities = 39/178 (21%), Positives = 70/178 (39%), Gaps = 18/178 (10%)
Query: 508 TIGEQIGQGSCGTVYHAV--WYGSDVAVKVFS----RQEYSDEVIHSFRQEVSLMKRLRH 561
+GE++G G V G + A K +EV++++ +RH
Sbjct: 8 EMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRH 67
Query: 562 PNVLLFMGAVTSPQRLCIVTEFLPRGSLF-RLLQRNTTKLDWRRRILMALDIARGVSYLH 620
PN++ + + ++ E + G LF L ++ L I GV YLH
Sbjct: 68 PNIITLHDIFENKTDVVLILELVSGGELFDFLAEKE--SLTEDEATQFLKQILDGVHYLH 125
Query: 621 HCNPPIIHRDLKSSNLLV----DKHWTVKVGDFGLSR-LKHETYLTTKTGKGTVTYLA 673
I H DLK N+++ + +K+ DFG++ ++ GT ++A
Sbjct: 126 SKR--IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIF--GTPEFVA 179
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 2e-25
Identities = 46/160 (28%), Positives = 77/160 (48%), Gaps = 18/160 (11%)
Query: 499 DYEILWEDLTIGEQIGQGSCGTVYHAV--WYGSDVAVKVFSRQEYSDEVIHS--FRQEVS 554
YE + +IG+GS G V+ G VA+K F + D VI R E+
Sbjct: 4 KYEKI-------GKIGEGSYGVVFKCRNRDTGQIVAIKKF-LESEDDPVIKKIALR-EIR 54
Query: 555 LMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRR-RILMALDIA 613
++K+L+HPN++ + +RL +V E+ ++ L R + + +
Sbjct: 55 MLKQLKHPNLVNLLEVFRRKRRLHLVFEYCDH-TVLHELDRYQRGVPEHLVKSIT-WQTL 112
Query: 614 RGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSR 653
+ V++ H N IHRD+K N+L+ KH +K+ DFG +R
Sbjct: 113 QAVNFCHKHN--CIHRDVKPENILITKHSVIKLCDFGFAR 150
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 2e-25
Identities = 52/174 (29%), Positives = 77/174 (44%), Gaps = 17/174 (9%)
Query: 508 TIGEQIGQGSCGTVYHAV--WYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVL 565
T+ IG+GS G V AV A K + D + F+QE+ +MK L HPN++
Sbjct: 12 TLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVED--VDRFKQEIEIMKSLDHPNII 69
Query: 566 LFMGAVTSPQRLCIVTEFLPRGSLF-RLLQRNT-TKLDWRRRILMALDIARGVSYLHHCN 623
+ +V E G LF R++ + + D R + D+ V+Y H N
Sbjct: 70 RLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAAR---IMKDVLSAVAYCHKLN 126
Query: 624 PPIIHRDLKSSNLLV---DKHWTVKVGDFGLSR-LKHETYLTTKTGKGTVTYLA 673
+ HRDLK N L +K+ DFGL+ K + TK GT Y++
Sbjct: 127 --VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKV--GTPYYVS 176
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 3e-25
Identities = 34/155 (21%), Positives = 65/155 (41%), Gaps = 11/155 (7%)
Query: 505 EDLTIGEQIGQG--SCGTVYHA--VWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLR 560
+ IG+G TV A G V V+ + + S+E++ + E+ + K
Sbjct: 25 GCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFN 84
Query: 561 HPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKL---DWRRRILMALDIARGVS 617
HPN++ + + L +VT F+ GS L+ + IL + + +
Sbjct: 85 HPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYIL--QGVLKALD 142
Query: 618 YLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLS 652
Y+HH +HR +K+S++L+ V + +
Sbjct: 143 YIHHMG--YVHRSVKASHILISVDGKVYLSGLRSN 175
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 3e-25
Identities = 50/159 (31%), Positives = 82/159 (51%), Gaps = 9/159 (5%)
Query: 509 IGEQIGQGSCGTVYHA--VWYGSDVAVKVFSRQE-YSDEVIHSFRQEVSLMKRLRHPNVL 565
+G+ +G G+ G V G VAVK+ +RQ+ S +V+ R+E+ +K RHP+++
Sbjct: 20 LGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHII 79
Query: 566 LFMGAVTSPQRLCIVTEFLPRGSLF-RLLQRNTTKLDWRRRILMALDIARGVSYLHHCNP 624
+++P + +V E++ G LF + + RR+ I GV Y H
Sbjct: 80 KLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQ--QILSGVDYCHRHM- 136
Query: 625 PIIHRDLKSSNLLVDKHWTVKVGDFGLSRL-KHETYLTT 662
++HRDLK N+L+D H K+ DFGLS + +L T
Sbjct: 137 -VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRT 174
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 3e-25
Identities = 42/182 (23%), Positives = 74/182 (40%), Gaps = 18/182 (9%)
Query: 500 YEILWEDLTIGEQIGQGSCGTVYHAV--WYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMK 557
Y + +++G+G V + G + A K ++ + E+++++
Sbjct: 30 YILT------SKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLE 83
Query: 558 RLRH-PNVLLFMGAVTSPQRLCIVTEFLPRGSLF-RLLQRNTTKLDWRRRILMALDIARG 615
+ P V+ + + ++ E+ G +F L + I + I G
Sbjct: 84 LAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEG 143
Query: 616 VSYLHHCNPPIIHRDLKSSNLLV---DKHWTVKVGDFGLSR-LKHETYLTTKTGKGTVTY 671
V YLH N I+H DLK N+L+ +K+ DFG+SR + H L GT Y
Sbjct: 144 VYYLHQNN--IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIM--GTPEY 199
Query: 672 LA 673
LA
Sbjct: 200 LA 201
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 3e-25
Identities = 50/201 (24%), Positives = 87/201 (43%), Gaps = 20/201 (9%)
Query: 484 SSSAVNKVDLDNDCLDYEILWEDLTIGEQIGQGSCGTVYHA--VWYGSDVAVKVFSRQEY 541
S + K+ + + ++ EDL +IG+G+ G+V G +AVK R
Sbjct: 2 SIESSGKLKISPE-QHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRI-RSTV 59
Query: 542 SDEVIHSFRQEVS-LMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKL 600
++ ++ +M+ P ++ F GA+ I E + S + + + L
Sbjct: 60 DEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMS-TSFDKFYKYVYSVL 118
Query: 601 DWR--RRIL--MALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKH 656
D IL + L + +++L N IIHRD+K SN+L+D+ +K+ DFG+S
Sbjct: 119 DDVIPEEILGKITLATVKALNHLKE-NLKIIHRDIKPSNILLDRSGNIKLCDFGIS---- 173
Query: 657 ETYLTTKTGK----GTVTYLA 673
L K G Y+A
Sbjct: 174 -GQLVDSIAKTRDAGCRPYMA 193
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 5e-25
Identities = 46/201 (22%), Positives = 82/201 (40%), Gaps = 17/201 (8%)
Query: 481 GSTSSSAVNKVDLDNDCLDYEILWEDLTIGEQIGQGSCGTVYHA--VWYGSDVAVKVFSR 538
GS+ SS L Y+ DL ++G G+CG V+ G +AVK R
Sbjct: 1 GSSGSSGKQTGYLTIGGQRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQM-R 59
Query: 539 QEYSDEVIHSFRQEVS-LMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSL-FRLLQRN 596
+ + E ++ ++K P ++ G + + I E + + + +
Sbjct: 60 RSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQG 119
Query: 597 TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKH 656
++ + I + + YL + +IHRD+K SN+L+D+ +K+ DFG+S
Sbjct: 120 PIPERILGKM--TVAIVKALYYLKEKHG-VIHRDVKPSNILLDERGQIKLCDFGIS---- 172
Query: 657 ETYLTTKTGK----GTVTYLA 673
L K G Y+A
Sbjct: 173 -GRLVDDKAKDRSAGCAAYMA 192
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 6e-25
Identities = 48/160 (30%), Positives = 78/160 (48%), Gaps = 18/160 (11%)
Query: 499 DYEILWEDLTIGEQIGQGSCGTVYHAV--WYGSDVAVKVFSRQEYSDEVIHS--FRQEVS 554
YE L +G+GS G V G VA+K F + D+++ R E+
Sbjct: 26 KYENL-------GLVGEGSYGMVMKCRNKDTGRIVAIKKF-LESDDDKMVKKIAMR-EIK 76
Query: 555 LMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRR-RILMALDIA 613
L+K+LRH N++ + +R +V EF+ ++ L+ LD++ + + I
Sbjct: 77 LLKQLRHENLVNLLEVCKKKKRWYLVFEFVDH-TILDDLELFPNGLDYQVVQKYL-FQII 134
Query: 614 RGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSR 653
G+ + H N IIHRD+K N+LV + VK+ DFG +R
Sbjct: 135 NGIGFCHSHN--IIHRDIKPENILVSQSGVVKLCDFGFAR 172
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 6e-25
Identities = 54/176 (30%), Positives = 85/176 (48%), Gaps = 11/176 (6%)
Query: 482 STSSSAVNKVDLDNDCL--DYEILWEDLTIGEQIGQGSCGTVYHA--VWYGSDVAVKVFS 537
+ ++ D+ D E L+ DL +IG GS G VY A V VA+K S
Sbjct: 32 GGRAGSLKDPDVAELFFKDDPEKLFSDL---REIGHGSFGAVYFARDVRNSEVVAIKKMS 88
Query: 538 -RQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRN 596
+ S+E +EV +++LRHPN + + G +V E+ GS LL+ +
Sbjct: 89 YSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCL-GSASDLLEVH 147
Query: 597 TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLS 652
L + +G++YLH N +IHRD+K+ N+L+ + VK+GDFG +
Sbjct: 148 KKPLQEVEIAAVTHGALQGLAYLHSHN--MIHRDVKAGNILLSEPGLVKLGDFGSA 201
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 7e-25
Identities = 48/210 (22%), Positives = 79/210 (37%), Gaps = 18/210 (8%)
Query: 466 SSSVNVNSTSSVSSCGSTSSSAVNKVDLDND-CLDYEILWEDLTIGEQIGQGSCGTVYHA 524
SS + + +S + GS + + + E L +G +G G G+VY
Sbjct: 3 SSHHHHHHSSGLVPRGSHMAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSG 62
Query: 525 --VWYGSDVAVKVFSRQEYSDEVIHSF----RQEVSLMKRLRH--PNVLLFMGAVTSPQR 576
V VA+K + SD EV L+K++ V+ + P
Sbjct: 63 IRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS 122
Query: 577 LCIVTEF-LPRGSLFRLLQRNTTKLDWR--RRILMALDIARGVSYLHHCNPPIIHRDLKS 633
++ E P LF + L R + V + H+C ++HRD+K
Sbjct: 123 FVLILERPEPVQDLFDFITERG-ALQEELARSFFW--QVLEAVRHCHNCG--VLHRDIKD 177
Query: 634 SNLLVD-KHWTVKVGDFGLSRLKHETYLTT 662
N+L+D +K+ DFG L +T T
Sbjct: 178 ENILIDLNRGELKLIDFGSGALLKDTVYTD 207
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 7e-25
Identities = 43/178 (24%), Positives = 71/178 (39%), Gaps = 18/178 (10%)
Query: 508 TIGEQIGQGSCGTVYHAV--WYGSDVAVKVFS----RQEYSDEVIHSFRQEVSLMKRLRH 561
IGE++G G V G + A K R +EVS+++++ H
Sbjct: 15 DIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLH 74
Query: 562 PNVLLFMGAVTSPQRLCIVTEFLPRGSLF-RLLQRNTTKLDWRRRILMALDIARGVSYLH 620
PN++ + + ++ E + G LF L Q+ L I GV+YLH
Sbjct: 75 PNIITLHDVYENRTDVVLILELVSGGELFDFLAQKE--SLSEEEATSFIKQILDGVNYLH 132
Query: 621 HCNPPIIHRDLKSSNLLV----DKHWTVKVGDFGLSR-LKHETYLTTKTGKGTVTYLA 673
I H DLK N+++ +K+ DFGL+ ++ GT ++A
Sbjct: 133 TKK--IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIF--GTPEFVA 186
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 8e-25
Identities = 47/173 (27%), Positives = 86/173 (49%), Gaps = 11/173 (6%)
Query: 482 STSSSAVNKVDLDNDCLDYEILWEDLTIGEQIGQGSCGTVYHA--VWYGSDVAVKVFSRQ 539
+ + K+D D+ E +++ L E++G+GS G+VY A G VA+K +
Sbjct: 9 NPPRRQLKKLDEDSLTKQPEEVFDVL---EKLGEGSYGSVYKAIHKETGQIVAIKQVPVE 65
Query: 540 EYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTK 599
E+I +E+S+M++ P+V+ + G+ L IV E+ GS+ +++
Sbjct: 66 SDLQEII----KEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKT 121
Query: 600 LDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLS 652
L + +G+ YLH IHRD+K+ N+L++ K+ DFG++
Sbjct: 122 LTEDEIATILQSTLKGLEYLHFMR--KIHRDIKAGNILLNTEGHAKLADFGVA 172
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 9e-25
Identities = 43/157 (27%), Positives = 79/157 (50%), Gaps = 9/157 (5%)
Query: 498 LDYEILWEDLTIGEQIGQGSCGTVYHA--VWYGSDVAVKVFSRQEYSDEVIHSFRQEVSL 555
LD +WE + ++G G+ G VY A G+ A KV + S+E + + E+ +
Sbjct: 15 LDPNEVWEIV---GELGDGAFGKVYKAKNKETGALAAAKVIETK--SEEELEDYIVEIEI 69
Query: 556 MKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARG 615
+ HP ++ +GA +L I+ EF P G++ ++ L + ++ +
Sbjct: 70 LATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEA 129
Query: 616 VSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLS 652
+++LH IIHRDLK+ N+L+ +++ DFG+S
Sbjct: 130 LNFLHSKR--IIHRDLKAGNVLMTLEGDIRLADFGVS 164
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 1e-24
Identities = 49/160 (30%), Positives = 83/160 (51%), Gaps = 18/160 (11%)
Query: 499 DYEILWEDLTIGEQIGQGSCGTVYHA--VWYGSDVAVKVFSRQEYSDEVIHS--FRQEVS 554
YE L E+IG+G+ GTV+ A VA+K R + DE + S R E+
Sbjct: 3 KYEKL-------EKIGEGTYGTVFKAKNRETHEIVALKRV-RLDDDDEGVPSSALR-EIC 53
Query: 555 LMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRR-RILMALDIA 613
L+K L+H N++ + S ++L +V EF + L + LD + + +
Sbjct: 54 LLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFL-FQLL 111
Query: 614 RGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSR 653
+G+ + H N ++HRDLK NLL++++ +K+ +FGL+R
Sbjct: 112 KGLGFCHSRN--VLHRDLKPQNLLINRNGELKLANFGLAR 149
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 1e-24
Identities = 51/174 (29%), Positives = 85/174 (48%), Gaps = 15/174 (8%)
Query: 508 TIGEQIGQGSCGTVYHAV--WYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVL 565
I +G+GS G V + AVKV ++ ++ + +EV L+K+L HPN++
Sbjct: 25 NIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIM 84
Query: 566 LFMGAVTSPQRLCIVTEFLPRGSLF-RLLQRNT-TKLDWRRRILMALDIARGVSYLHHCN 623
+ IV E G LF +++R ++ D R + + G++Y+H N
Sbjct: 85 KLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAAR---IIKQVFSGITYMHKHN 141
Query: 624 PPIIHRDLKSSNLLV---DKHWTVKVGDFGLSRL-KHETYLTTKTGKGTVTYLA 673
I+HRDLK N+L+ +K +K+ DFGLS + T + + GT Y+A
Sbjct: 142 --IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRI--GTAYYIA 191
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 1e-24
Identities = 42/178 (23%), Positives = 77/178 (43%), Gaps = 19/178 (10%)
Query: 508 TIGEQIGQGSCGTVYHA--VWYGSDVAVKVFSRQE------YSDEVIHSFRQEVSLMKRL 559
+ +G G+ G V+ A +V VK +++ D + E++++ R+
Sbjct: 27 STMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRV 86
Query: 560 RHPNVLLFMGAVTSPQRLCIVTEFLPRGS-LFRLLQRNTTKLDWR--RRILMALDIARGV 616
H N++ + + +V E G LF + R+ +LD I + V
Sbjct: 87 EHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHP-RLDEPLASYIFR--QLVSAV 143
Query: 617 SYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL-KHETYLTTKTGKGTVTYLA 673
YL + IIHRD+K N+++ + +T+K+ DFG + + T GT+ Y A
Sbjct: 144 GYLRLKD--IIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLF--YTFCGTIEYCA 197
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 2e-24
Identities = 53/159 (33%), Positives = 80/159 (50%), Gaps = 10/159 (6%)
Query: 509 IGEQIGQGSCGTVYHA--VWYGSDVAVKVFSRQE-YSDEVIHSFRQEVSLMKRLRHPNVL 565
I E +G+GS G V A VA+K SRQ ++ +E+S +K LRHP+++
Sbjct: 13 IRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHII 72
Query: 566 LFMGAVTSPQRLCIVTEFLPRGSLF-RLLQRNTTKLDWRRRILMALDIARGVSYLHHCNP 624
+T+P + +V E+ G LF ++++ D RR I + Y H
Sbjct: 73 KLYDVITTPTDIVMVIEYAG-GELFDYIVEKKRMTEDEGRRFFQ--QIICAIEYCHRHK- 128
Query: 625 PIIHRDLKSSNLLVDKHWTVKVGDFGLSRL-KHETYLTT 662
I+HRDLK NLL+D + VK+ DFGLS + +L T
Sbjct: 129 -IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKT 166
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 2e-24
Identities = 40/169 (23%), Positives = 68/169 (40%), Gaps = 19/169 (11%)
Query: 508 TIGEQIGQGSCGTVYHA--VWYGSDVAVKVFSR----QEYSDEVIHSFRQEVSLMKRLR- 560
+G +G+G GTV+ + VA+KV R + EV+L+ ++
Sbjct: 34 RLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGA 93
Query: 561 ---HPNVLLFMGAVTSPQRLCIVTEF-LPRGSLFRLLQRNTTKLDWR--RRILMALDIAR 614
HP V+ + + + +V E LP LF + L R +
Sbjct: 94 GGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKG-PLGEGPSRCFFG--QVVA 150
Query: 615 GVSYLHHCNPPIIHRDLKSSNLLVD-KHWTVKVGDFGLSRLKHETYLTT 662
+ + H ++HRD+K N+L+D + K+ DFG L H+ T
Sbjct: 151 AIQHCHSRG--VVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTD 197
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 2e-24
Identities = 44/172 (25%), Positives = 77/172 (44%), Gaps = 13/172 (7%)
Query: 508 TIGEQIGQGSCGTVYHAV--WYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVL 565
I E++G G+ G V+ V G K + D ++ + E+S+M +L HP ++
Sbjct: 54 DILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLD--KYTVKNEISIMNQLHHPKLI 111
Query: 566 LFMGAVTSPQRLCIVTEFLPRGSLF-RLLQRNTTKLDWRRRILMALDIARGVSYLHHCNP 624
A + ++ EFL G LF R+ + K+ I G+ ++H +
Sbjct: 112 NLHDAFEDKYEMVLILEFLSGGELFDRIAAED-YKMSEAEVINYMRQACEGLKHMHEHS- 169
Query: 625 PIIHRDLKSSNLLV--DKHWTVKVGDFGLSR-LKHETYLTTKTGKGTVTYLA 673
I+H D+K N++ K +VK+ DFGL+ L + + T T + A
Sbjct: 170 -IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTT--ATAEFAA 218
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 102 bits (258), Expect = 2e-24
Identities = 54/159 (33%), Positives = 84/159 (52%), Gaps = 17/159 (10%)
Query: 499 DYEILWEDLTIGEQIGQGSCGTVYHAV-WYGSDVAVKVFSRQEYSDEVIHS--FRQEVSL 555
Y L E+IG+G+ G VY A YG A+K R E DE I S R E+S+
Sbjct: 3 KYHGL-------EKIGEGTYGVVYKAQNNYGETFALKKI-RLEKEDEGIPSTTIR-EISI 53
Query: 556 MKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRR-RILMALDIAR 614
+K L+H N++ + + +RL +V E L + L +LL L+ + + L +
Sbjct: 54 LKELKHSNIVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFL-LQLLN 111
Query: 615 GVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSR 653
G++Y H ++HRDLK NLL+++ +K+ DFGL+R
Sbjct: 112 GIAYCHDRR--VLHRDLKPQNLLINREGELKIADFGLAR 148
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 2e-24
Identities = 48/187 (25%), Positives = 82/187 (43%), Gaps = 24/187 (12%)
Query: 500 YEILWEDLTIGEQIGQGSCGTVYHA--VWYGSDVAVKVFSRQEYSDEVIHSFRQEVS-LM 556
E+ +DL ++G+G+ G V V G +AVK R + + ++ M
Sbjct: 2 MEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRI-RATVNSQEQKRLLMDLDISM 60
Query: 557 KRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRI------LMAL 610
+ + P + F GA+ + I E + SL + ++ K + I +A+
Sbjct: 61 RTVDCPFTVTFYGALFREGDVWICMELMD-TSLDKFYKQVIDK---GQTIPEDILGKIAV 116
Query: 611 DIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGK---- 666
I + + +LH +IHRD+K SN+L++ VK+ DFG+S YL K
Sbjct: 117 SIVKALEHLHS-KLSVIHRDVKPSNVLINALGQVKMCDFGISG-----YLVDDVAKDIDA 170
Query: 667 GTVTYLA 673
G Y+A
Sbjct: 171 GCKPYMA 177
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 104 bits (260), Expect = 2e-24
Identities = 23/203 (11%), Positives = 44/203 (21%), Gaps = 41/203 (20%)
Query: 506 DLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDE-VIHSFRQEVSLMKRLRHP 562
L + E + G V+ D A+KVF+ + + + RL
Sbjct: 63 KLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGE 122
Query: 563 NVLLFMGA--------------------------VTSPQRLCIVTEFLPRGSLFRLLQR- 595
+ + ++ L L
Sbjct: 123 SPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMP-AASVDLELLFSTL 181
Query: 596 -----NTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFG 650
++ + R + L ++H NL + + +GD
Sbjct: 182 DFVYVFRGDEGILALHILTAQLIRLAANLQSKG--LVHGHFTPDNLFIMPDGRLMLGDVS 239
Query: 651 LSRLKHETYLTTKTGKGTVTYLA 673
VTY
Sbjct: 240 ALWKVGT---RGPASSVPVTYAP 259
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 2e-24
Identities = 44/178 (24%), Positives = 70/178 (39%), Gaps = 18/178 (10%)
Query: 508 TIGEQIGQGSCGTVYHAV--WYGSDVAVKVFS----RQEYSDEVIHSFRQEVSLMKRLRH 561
GE++G G V G A K + +EVS++K ++H
Sbjct: 14 DTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQH 73
Query: 562 PNVLLFMGAVTSPQRLCIVTEFLPRGSLF-RLLQRNTTKLDWRRRILMALDIARGVSYLH 620
PNV+ + + ++ E + G LF L ++ L I GV YLH
Sbjct: 74 PNVITLHEVYENKTDVILILELVAGGELFDFLAEKE--SLTEEEATEFLKQILNGVYYLH 131
Query: 621 HCNPPIIHRDLKSSN-LLVDKHW---TVKVGDFGLSR-LKHETYLTTKTGKGTVTYLA 673
I H DLK N +L+D++ +K+ DFGL+ + GT ++A
Sbjct: 132 SLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF--GTPEFVA 185
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 3e-24
Identities = 47/173 (27%), Positives = 82/173 (47%), Gaps = 13/173 (7%)
Query: 508 TIGEQIGQGSCGTVYHAV--WYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVL 565
+++G G+ G V + A+K+ + S +EV+++K L HPN++
Sbjct: 40 QRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIM 99
Query: 566 LFMGAVTSPQRLCIVTEFLPRGSLF-RLLQRNTTKLDWRRRILMALDIARGVSYLHHCNP 624
+ +V E G LF ++ R K + ++ + GV+YLH N
Sbjct: 100 KLYDFFEDKRNYYLVMECYKGGELFDEIIHRM--KFNEVDAAVIIKQVLSGVTYLHKHN- 156
Query: 625 PIIHRDLKSSNLLV---DKHWTVKVGDFGLSRL-KHETYLTTKTGKGTVTYLA 673
I+HRDLK NLL+ +K +K+ DFGLS + +++ + + GT Y+A
Sbjct: 157 -IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERL--GTAYYIA 206
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 3e-24
Identities = 38/172 (22%), Positives = 72/172 (41%), Gaps = 14/172 (8%)
Query: 508 TIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVL 565
I E +G+G G V+ V K + ++ ++E+S++ RH N+L
Sbjct: 8 MIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLV---KKEISILNIARHRNIL 64
Query: 566 LFMGAVTSPQRLCIVTEFLPRGSLF-RLLQRNTTKLDWRRRILMALDIARGVSYLHHCNP 624
+ S + L ++ EF+ +F R+ +L+ R + + + +LH N
Sbjct: 65 HLHESFESMEELVMIFEFISGLDIFERINTSA-FELNEREIVSYVHQVCEALQFLHSHN- 122
Query: 625 PIIHRDLKSSNLLV--DKHWTVKVGDFGLSR-LKHETYLTTKTGKGTVTYLA 673
I H D++ N++ + T+K+ +FG +R LK Y A
Sbjct: 123 -IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLF--TAPEYYA 171
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 3e-24
Identities = 57/159 (35%), Positives = 88/159 (55%), Gaps = 17/159 (10%)
Query: 499 DYEILWEDLTIGEQIGQGSCGTVYHAV-WYGSDVAVKVFSRQEYSDEVIHS--FRQEVSL 555
Y+ L E++G+G+ G VY A G VA+K R + DE I S R E+SL
Sbjct: 22 KYQKL-------EKVGEGTYGVVYKAKDSQGRIVALKRI-RLDAEDEGIPSTAIR-EISL 72
Query: 556 MKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRR-RILMALDIAR 614
+K L HPN++ + + S + L +V EF+ + L ++L N T L + +I + + R
Sbjct: 73 LKELHHPNIVSLIDVIHSERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYL-YQLLR 130
Query: 615 GVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSR 653
GV++ H I+HRDLK NLL++ +K+ DFGL+R
Sbjct: 131 GVAHCHQHR--ILHRDLKPQNLLINSDGALKLADFGLAR 167
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 3e-24
Identities = 39/175 (22%), Positives = 71/175 (40%), Gaps = 14/175 (8%)
Query: 508 TIGEQIGQGSCGTVYHAV--WYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVL 565
++G G+ G V+ G + +K ++ + E+ ++K L HPN++
Sbjct: 25 IFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVP-MEQIEAEIEVLKSLDHPNII 83
Query: 566 LFMGAVTSPQRLCIVTEFLPRGSLF-RLLQRNTTK--LDWRRRILMALDIARGVSYLHHC 622
+ IV E G L R++ L + + ++Y H
Sbjct: 84 KIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ 143
Query: 623 NPPIIHRDLKSSNLLV---DKHWTVKVGDFGLSR-LKHETYLTTKTGKGTVTYLA 673
+ ++H+DLK N+L H +K+ DFGL+ K + + T GT Y+A
Sbjct: 144 H--VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAA--GTALYMA 194
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 6e-24
Identities = 38/175 (21%), Positives = 75/175 (42%), Gaps = 20/175 (11%)
Query: 508 TIGEQIGQGSCGTVYHAV--WYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRL-RHPNV 564
+ E IG GS + + AVK+ + + +E+ ++ R +HPN+
Sbjct: 25 EVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSK------RDPTEEIEILLRYGQHPNI 78
Query: 565 LLFMGAVTSPQRLCIVTEFLPRGSLF-RLLQRNT-TKLDWRRRILMALDIARGVSYLHHC 622
+ + + +VTE + G L ++L++ ++ + + I + V YLH
Sbjct: 79 ITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASA---VLFTITKTVEYLHAQ 135
Query: 623 NPPIIHRDLKSSNLLV----DKHWTVKVGDFGLSRLKHETYLTTKTGKGTVTYLA 673
++HRDLK SN+L ++++ DFG ++ T T ++A
Sbjct: 136 G--VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVA 188
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 7e-24
Identities = 50/176 (28%), Positives = 83/176 (47%), Gaps = 15/176 (8%)
Query: 509 IGEQIGQGSCGTVYHAV--WYGSDVAVKVFSRQEYSD--EVIHSFRQEVSLMKRLRHPN- 563
+GE +G G V+ A DVAVKV R + + FR+E L HP
Sbjct: 16 LGEILGFGGMSEVHLARDLRDHRDVAVKVL-RADLARDPSFYLRFRREAQNAAALNHPAI 74
Query: 564 VLLF-MGAVTSPQRLC--IVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLH 620
V ++ G +P IV E++ +L ++ + +R I + D + +++ H
Sbjct: 75 VAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG-PMTPKRAIEVIADACQALNFSH 133
Query: 621 HCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLT-TKTGK--GTVTYLA 673
IIHRD+K +N+++ VKV DFG++R ++ + T+T GT YL+
Sbjct: 134 QNG--IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLS 187
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 8e-24
Identities = 49/162 (30%), Positives = 82/162 (50%), Gaps = 19/162 (11%)
Query: 499 DYEILWEDLTIGEQIGQGSCGTVYHA--VWYGSDVA---VKVFSRQEYSDEV-IHSFRQE 552
YE L + +G+G TVY A VA +K+ R E D + + R E
Sbjct: 11 RYEKL-------DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALR-E 62
Query: 553 VSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRR-RILMALD 611
+ L++ L HPN++ + A + +V +F+ L +++ N+ L + M L
Sbjct: 63 IKLLQELSHPNIIGLLDAFGHKSNISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYM-LM 120
Query: 612 IARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSR 653
+G+ YLH I+HRDLK +NLL+D++ +K+ DFGL++
Sbjct: 121 TLQGLEYLHQHW--ILHRDLKPNNLLLDENGVLKLADFGLAK 160
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 1e-23
Identities = 47/171 (27%), Positives = 78/171 (45%), Gaps = 11/171 (6%)
Query: 509 IGEQIGQGSCGTVYHAV--WYGSDVAVKVFSRQEYSD--EVIHSFRQEVSLMKRLRHPNV 564
I +++G G TVY A VA+K + E + F +EV +L H N+
Sbjct: 15 IVDKLGGGGMSTVYLAEDTILNIKVAIKAI-FIPPREKEETLKRFEREVHNSSQLSHQNI 73
Query: 565 LLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNP 624
+ + +V E++ +L ++ + L I I G+ + H
Sbjct: 74 VSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHG-PLSVDTAINFTNQILDGIKHAHDMR- 131
Query: 625 PIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGK--GTVTYLA 673
I+HRD+K N+L+D + T+K+ DFG+++ ET LT T GTV Y +
Sbjct: 132 -IVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQ-TNHVLGTVQYFS 180
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 1e-23
Identities = 42/156 (26%), Positives = 76/156 (48%), Gaps = 11/156 (7%)
Query: 499 DYEILWEDLTIGEQIGQGSCGTVYHA--VWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLM 556
D + + E+IGQG+ GTVY A V G +VA++ + Q+ E+ +M
Sbjct: 17 DPKKKYTRF---EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQ--QPKKELIINEILVM 71
Query: 557 KRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGV 616
+ ++PN++ ++ + L +V E+L GSL ++ + + + +
Sbjct: 72 RENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVC--RECLQAL 129
Query: 617 SYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLS 652
+LH +IHRD+KS N+L+ +VK+ DFG
Sbjct: 130 EFLHSNQ--VIHRDIKSDNILLGMDGSVKLTDFGFC 163
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 1e-23
Identities = 49/216 (22%), Positives = 80/216 (37%), Gaps = 52/216 (24%)
Query: 508 TIGEQIGQGSCGTVYHAV--WYGSDVAVKVFSR---QEYSDEVIHSFRQEVSLMKRLRHP 562
+ IGQGS G V A+ + A+K+ ++ ++ + + + + EV LMK+L HP
Sbjct: 29 HLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHP 88
Query: 563 NVLLFMGAVTSPQRLCIVTEFLPRGSLF-RLLQRNTTKLDWRRRILMAL----------- 610
N+ Q +C+V E G L +L ++
Sbjct: 89 NIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEE 148
Query: 611 ---------------------------DIARGVSYLHHCNPPIIHRDLKSSNLLV--DKH 641
I + YLH+ I HRD+K N L +K
Sbjct: 149 AINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQG--ICHRDIKPENFLFSTNKS 206
Query: 642 WTVKVGDFGLSRL----KHETYLTTKTGKGTVTYLA 673
+ +K+ DFGLS+ + Y T GT ++A
Sbjct: 207 FEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVA 242
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 1e-23
Identities = 48/174 (27%), Positives = 77/174 (44%), Gaps = 13/174 (7%)
Query: 506 DLTIGEQIGQGSCGTVYHAV--WYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPN 563
++ E +G G G V+ G +A K+ + D + E+S+M +L H N
Sbjct: 90 TVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKD--KEEVKNEISVMNQLDHAN 147
Query: 564 VLLFMGAVTSPQRLCIVTEFLPRGSLF-RLLQRNTTKLDWRRRILMALDIARGVSYLHHC 622
++ A S + +V E++ G LF R++ + L IL I G+ ++H
Sbjct: 148 LIQLYDAFESKNDIVLVMEYVDGGELFDRIIDES-YNLTELDTILFMKQICEGIRHMHQM 206
Query: 623 NPPIIHRDLKSSNLLVDKHWT--VKVGDFGLSR-LKHETYLTTKTGKGTVTYLA 673
I+H DLK N+L +K+ DFGL+R K L GT +LA
Sbjct: 207 Y--ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNF--GTPEFLA 256
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 2e-23
Identities = 47/161 (29%), Positives = 84/161 (52%), Gaps = 19/161 (11%)
Query: 499 DYEILWEDLTIGEQIGQGSCGTVYHA--VWYGSDVAVKVFSRQEYSDEVIHS--FRQEVS 554
+++ + E+IG+G+ G VY A G VA+K R + E + S R E+S
Sbjct: 4 NFQKV-------EKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIR-EIS 54
Query: 555 LMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLL-QRNTTKLDWRR-RILMALDI 612
L+K L HPN++ + + + +L +V EFL + L + + T + + + +
Sbjct: 55 LLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYL-FQL 112
Query: 613 ARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSR 653
+G+++ H ++HRDLK NLL++ +K+ DFGL+R
Sbjct: 113 LQGLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLAR 151
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 2e-23
Identities = 49/174 (28%), Positives = 78/174 (44%), Gaps = 14/174 (8%)
Query: 508 TIGEQIGQGSCGTVYHAV--WYGSDVAVKVFSRQEYSDEV-IHSFRQEVSLMKRLRHPNV 564
+G+GS G V G + AVKV S+++ + S +EV L+K+L HPN+
Sbjct: 29 KGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNI 88
Query: 565 LLFMGAVTSPQRLCIVTEFLPRGSLF-RLLQRNTTKLDWRRRILMALDIARGVSYLHHCN 623
+ +V E G LF ++ R + + + G++Y+H
Sbjct: 89 MKLYEFFEDKGYFYLVGEVYTGGELFDEIISRK--RFSEVDAARIIRQVLSGITYMHKNK 146
Query: 624 PPIIHRDLKSSNLLV---DKHWTVKVGDFGLSRL-KHETYLTTKTGKGTVTYLA 673
I+HRDLK NLL+ K +++ DFGLS + + K GT Y+A
Sbjct: 147 --IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKI--GTAYYIA 196
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 101 bits (252), Expect = 3e-23
Identities = 29/203 (14%), Positives = 62/203 (30%), Gaps = 41/203 (20%)
Query: 506 DLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEY-SDEVIHSFRQEVSLMKRLR-- 560
L G +GQ A G V V E I ++EV ++ LR
Sbjct: 74 TLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGI 133
Query: 561 --------------------HPNVLLFMGAVTSPQRLCIVTEFL----PRGSLFRLLQ-- 594
P + + + +++ F + +L +
Sbjct: 134 KNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVL 193
Query: 595 ----RNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFG 650
L R+ + L + R ++ LHH ++H L+ ++++D+ V + F
Sbjct: 194 LSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG--LVHTYLRPVDIVLDQRGGVFLTGFE 251
Query: 651 LSRLKHETYLTTKTGKGTVTYLA 673
+++ + +
Sbjct: 252 HLVRDGARVVSS----VSRGFEP 270
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 4e-23
Identities = 40/150 (26%), Positives = 69/150 (46%), Gaps = 8/150 (5%)
Query: 505 EDLTIGEQIGQGSCGTVYHA--VWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHP 562
L +IG+GS G V A G VAVK+ ++ EV +M+ +H
Sbjct: 45 LLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRR--ELLFNEVVIMRDYQHF 102
Query: 563 NVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHC 622
NV+ + + L ++ EFL G+L ++ + + + + + ++YLH
Sbjct: 103 NVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQVRLNEEQIATVC--EAVLQALAYLHAQ 160
Query: 623 NPPIIHRDLKSSNLLVDKHWTVKVGDFGLS 652
+IHRD+KS ++L+ VK+ DFG
Sbjct: 161 G--VIHRDIKSDSILLTLDGRVKLSDFGFC 188
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 4e-23
Identities = 46/186 (24%), Positives = 73/186 (39%), Gaps = 28/186 (15%)
Query: 499 DYEILWEDLTIGEQIGQGSCGTVYHAV--WYGSDVAVKVFSRQEYSDEVIHSFRQEVSLM 556
DY++ + +G G G V G A+K+ RQEV
Sbjct: 29 DYQLS------KQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP-------KARQEVDHH 75
Query: 557 KRL-RHPNVLLFMGA----VTSPQRLCIVTEFLPRGSLF-RLLQRNTTKLDWRRRILMAL 610
+ P+++ + + L I+ E + G LF R+ +R R +
Sbjct: 76 WQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMR 135
Query: 611 DIARGVSYLHHCNPPIIHRDLKSSNLLV---DKHWTVKVGDFGLSRLKHETYLTTKTGKG 667
DI + +LH N I HRD+K NLL +K +K+ DFG ++ + L T
Sbjct: 136 DIGTAIQFLHSHN--IAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQTPC--Y 191
Query: 668 TVTYLA 673
T Y+A
Sbjct: 192 TPYYVA 197
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 99.6 bits (249), Expect = 4e-23
Identities = 44/149 (29%), Positives = 81/149 (54%), Gaps = 10/149 (6%)
Query: 511 EQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEV-IHSFRQEVSLMKRLRHPNVLLF 567
+++G+G+ TVY + VA+K R E+ + + R EVSL+K L+H N++
Sbjct: 8 DKLGEGTYATVYKGKSKLTDNLVALKEI-RLEHEEGAPCTAIR-EVSLLKDLKHANIVTL 65
Query: 568 MGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRR-RILMALDIARGVSYLHHCNPPI 626
+ + + L +V E+L + L + L ++ ++ + + RG++Y H +
Sbjct: 66 HDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNIINMHNVKLFL-FQLLRGLAYCHRQK--V 121
Query: 627 IHRDLKSSNLLVDKHWTVKVGDFGLSRLK 655
+HRDLK NLL+++ +K+ DFGL+R K
Sbjct: 122 LHRDLKPQNLLINERGELKLADFGLARAK 150
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 5e-23
Identities = 55/254 (21%), Positives = 84/254 (33%), Gaps = 37/254 (14%)
Query: 432 NESVQQKSPSYGTKPESHMYEGNRSVNNEAWGSWSSSVNVNSTSSVSSCGSTSSSAVNKV 491
+ S Q P P ++ + V S +A+
Sbjct: 3 SNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIID- 61
Query: 492 DLDNDCLDYEILWEDLTIGEQIGQGSCGTVYHAV--WYGSDVAVKVFSRQEYSDEVIHSF 549
DY++ + +G G G V A+K+
Sbjct: 62 -------DYKVT------SQVLGLGINGKVLQIFNKRTQEKFALKMLQDCP-------KA 101
Query: 550 RQEVSLMKRL-RHPNVLLFMGA----VTSPQRLCIVTEFLPRGSLF-RLLQRNTTKLDWR 603
R+EV L R + P+++ + + L IV E L G LF R+ R R
Sbjct: 102 RREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTER 161
Query: 604 RRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLV---DKHWTVKVGDFGLSR-LKHETY 659
+ I + YLH N I HRD+K NLL + +K+ DFG ++
Sbjct: 162 EASEIMKSIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS 219
Query: 660 LTTKTGKGTVTYLA 673
LTT T Y+A
Sbjct: 220 LTTPC--YTPYYVA 231
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 6e-23
Identities = 44/183 (24%), Positives = 80/183 (43%), Gaps = 22/183 (12%)
Query: 499 DYEILWEDLTIGEQIGQGSCGTVYHAV--WYGSDVAVKVFSRQEYSDEVIHSFRQEVSLM 556
Y++ + +G+GS V AVK+ S++ ++ ++E++ +
Sbjct: 9 HYDLD----LKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEAN-----TQKEITAL 59
Query: 557 KRLR-HPNVLLFMGAVTSPQRLCIVTEFLPRGSLF-RLLQRNT-TKLDWRRRILMALDIA 613
K HPN++ +V E L G LF R+ ++ ++ + + +
Sbjct: 60 KLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASY---IMRKLV 116
Query: 614 RGVSYLHHCNPPIIHRDLKSSNLLV---DKHWTVKVGDFGLSRLKHETYLTTKTGKGTVT 670
VS++H ++HRDLK NLL + + +K+ DFG +RLK KT T+
Sbjct: 117 SAVSHMHDVG--VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLH 174
Query: 671 YLA 673
Y A
Sbjct: 175 YAA 177
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 99.4 bits (248), Expect = 7e-23
Identities = 55/200 (27%), Positives = 94/200 (47%), Gaps = 23/200 (11%)
Query: 482 STSSSAVNKVDLDNDCL-DYEILWEDLTIGEQIGQGSCGTVYHAV--WYGSDVAVKVFSR 538
++ S A + ++D L D ++E + E +G G+ G VY G A+KV
Sbjct: 3 ASDSPARSLDEIDLSALRDPAGIFELV---ELVGNGTYGQVYKGRHVKTGQLAAIKV--- 56
Query: 539 QEYSDEVIHSFRQEVSLMKRL-RHPNVLLFMGA------VTSPQRLCIVTEFLPRGSLFR 591
+ + + +QE++++K+ H N+ + GA +L +V EF GS+
Sbjct: 57 MDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTD 116
Query: 592 LLQRNTTKL---DWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGD 648
L++ +W I +I RG+S+LH +IHRD+K N+L+ ++ VK+ D
Sbjct: 117 LIKNTKGNTLKEEWIAYIC--REILRGLSHLHQHK--VIHRDIKGQNVLLTENAEVKLVD 172
Query: 649 FGLSRLKHETYLTTKTGKGT 668
FG+S T T GT
Sbjct: 173 FGVSAQLDRTVGRRNTFIGT 192
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 98.8 bits (247), Expect = 8e-23
Identities = 46/166 (27%), Positives = 79/166 (47%), Gaps = 22/166 (13%)
Query: 499 DYEILWEDLTIGEQIGQGSCGTVYHA--VWYGSDVAVKVFSRQEYSDEV-IHSFRQEVSL 555
++ L E++G G+ TVY G VA+K + + + + R E+SL
Sbjct: 6 QFKQL-------EKLGNGTYATVYKGLNKTTGVYVALKEV-KLDSEEGTPSTAIR-EISL 56
Query: 556 MKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRR------RILMA 609
MK L+H N++ + + +L +V EF+ L + + T R +
Sbjct: 57 MKELKHENIVRLYDVIHTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQ- 114
Query: 610 LDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLK 655
+ +G+++ H I+HRDLK NLL++K +K+GDFGL+R
Sbjct: 115 WQLLQGLAFCHENK--ILHRDLKPQNLLINKRGQLKLGDFGLARAF 158
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 1e-22
Identities = 43/180 (23%), Positives = 81/180 (45%), Gaps = 20/180 (11%)
Query: 505 EDLTIGEQIGQGSCGTVYHAVWYGSD--VAVKVFSRQE--YSDEVIHSFRQEVSLMKRLR 560
ED G+ +G+GS TV A + A+K+ ++ ++V + +E +M RL
Sbjct: 30 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYV-TRERDVMSRLD 88
Query: 561 HPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRR-----ILMALDIARG 615
HP + ++L + G L + +++ + + R I+ AL+
Sbjct: 89 HPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALE---- 144
Query: 616 VSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL--KHETYLTTKTGKGTVTYLA 673
YLH IIHRDLK N+L+++ +++ DFG +++ + GT Y++
Sbjct: 145 --YLHGKG--IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVS 200
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 101 bits (252), Expect = 2e-22
Identities = 43/172 (25%), Positives = 78/172 (45%), Gaps = 13/172 (7%)
Query: 508 TIGEQIGQGSCGTVYHAV--WYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVL 565
I E++G G+ G V+ G++ A K SD + R+E+ M LRHP ++
Sbjct: 160 DIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESD--KETVRKEIQTMSVLRHPTLV 217
Query: 566 LFMGAVTSPQRLCIVTEFLPRGSLF-RLLQRNTTKLDWRRRILMALDIARGVSYLHHCNP 624
A + ++ EF+ G LF ++ + K+ + + +G+ ++H N
Sbjct: 218 NLHDAFEDDNEMVMIYEFMSGGELFEKVADEH-NKMSEDEAVEYMRQVCKGLCHMHENN- 275
Query: 625 PIIHRDLKSSNLLV--DKHWTVKVGDFGLSR-LKHETYLTTKTGKGTVTYLA 673
+H DLK N++ + +K+ DFGL+ L + + T GT + A
Sbjct: 276 -YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT--GTAEFAA 324
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 99.4 bits (247), Expect = 2e-22
Identities = 31/203 (15%), Positives = 62/203 (30%), Gaps = 38/203 (18%)
Query: 507 LTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEY-SDEVIHSFRQEVSLMKRLR--- 560
L G +GQ A G V V E I ++EV ++ LR
Sbjct: 80 LVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIK 139
Query: 561 -------------------HPNVLLFMGAVTSPQRLCIVTEFL----PRGSLFRLLQ--- 594
P + + + +++ F + +L +
Sbjct: 140 NQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLL 199
Query: 595 ---RNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGL 651
L R+ + L + R ++ LHH ++H L+ ++++D+ V + F
Sbjct: 200 SHSSTHKSLVHHARLQLTLQVIRLLASLHHYG--LVHTYLRPVDIVLDQRGGVFLTGFEH 257
Query: 652 SRLKHETYLT-TKTGKGTVTYLA 673
+ ++ G A
Sbjct: 258 LVRDGASAVSPIGRGFAPPETTA 280
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 2e-22
Identities = 51/214 (23%), Positives = 87/214 (40%), Gaps = 27/214 (12%)
Query: 481 GSTSSSAVNKVDLDNDCL---DYEILWEDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKV 535
+ + ++ + E ++G G+ G V S+ A+KV
Sbjct: 9 SGRENLYFQGIAINPGMYVRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKV 68
Query: 536 FSRQ-----------EYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFL 584
+ + ++ E+SL+K L HPN++ + +VTEF
Sbjct: 69 IKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFY 128
Query: 585 PRGSLF-RLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLV---DK 640
G LF +++ R+ K D + I G+ YLH N I+HRD+K N+L+ +
Sbjct: 129 EGGELFEQIINRH--KFDECDAANIMKQILSGICYLHKHN--IVHRDIKPENILLENKNS 184
Query: 641 HWTVKVGDFGLSR-LKHETYLTTKTGKGTVTYLA 673
+K+ DFGLS + L + GT Y+A
Sbjct: 185 LLNIKIVDFGLSSFFSKDYKLRDRL--GTAYYIA 216
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 97.3 bits (242), Expect = 3e-22
Identities = 37/212 (17%), Positives = 71/212 (33%), Gaps = 27/212 (12%)
Query: 487 AVNKVDLDNDCLDYEILWEDLTIGEQIGQGSCGTVYHA-----------VWYGSDVAVKV 535
A+ ++ L N L E + ++ ++ ++A + +
Sbjct: 35 AIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEMDEIWLKDES 94
Query: 536 FSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQR 595
S + + ++ M N + + + L I + + +L + R
Sbjct: 95 TDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNR 154
Query: 596 NTTKLDWRRRILMAL--DIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSR 653
+ D + + + IA V +LH ++HRDLK SN+ VKVGDFGL
Sbjct: 155 RCSLEDREHGVCLHIFIQIAEAVEFLHSKG--LMHRDLKPSNIFFTMDDVVKVGDFGLVT 212
Query: 654 LKHETYLTTKT------------GKGTVTYLA 673
+ GT Y++
Sbjct: 213 AMDQDEEEQTVLTPMPAYATHTGQVGTKLYMS 244
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 96.9 bits (242), Expect = 4e-22
Identities = 45/164 (27%), Positives = 75/164 (45%), Gaps = 22/164 (13%)
Query: 499 DYEILWEDLTIGEQIGQGSCGTVYHA--VWYGSDVAVKVFSRQEYSDEVIHS--FRQEVS 554
Y + ++G+G+ G VY A VA+K R E+ +E + R EVS
Sbjct: 35 RYRRI-------TKLGEGTYGEVYKAIDTVTNETVAIKRI-RLEHEEEGVPGTAIR-EVS 85
Query: 555 LMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIAR 614
L+K L+H N++ + RL ++ E+ L + + +N + + +
Sbjct: 86 LLKELQHRNIIELKSVIHHNHRLHLIFEYAEN-DLKKYMDKNPDVSMRVIKSFL-YQLIN 143
Query: 615 GVSYLHHCNPPIIHRDLKSSNLLVDKHWT-----VKVGDFGLSR 653
GV++ H +HRDLK NLL+ +K+GDFGL+R
Sbjct: 144 GVNFCHSRR--CLHRDLKPQNLLLSVSDASETPVLKIGDFGLAR 185
|
| >3lyx_A Sensory BOX/ggdef domain protein; structural genomics, PSI- 2, protein structure initiative, northeast structural genomics consortium; 2.00A {Colwellia psychrerythraea} Length = 124 | Back alignment and structure |
|---|
Score = 91.0 bits (227), Expect = 5e-22
Identities = 28/112 (25%), Positives = 55/112 (49%), Gaps = 2/112 (1%)
Query: 130 RQYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAY 189
+Q + ++ + DL II WN+ +E LYGYS E+A+GQ + +L D +
Sbjct: 7 KQRAKAFDYVFDAIVVTDLQGFIIDWNKGSETLYGYSKEQAIGQP-VNMLHVPGDTEHIT 65
Query: 190 -DIVHRIKMGERWTGQFPAKTKTEERVLVVATNTPFYDDDGTLVGIVCVSTD 240
+++ ++ +WTG+ K + + P Y ++ +VG + ++ D
Sbjct: 66 SEVISAVENQGKWTGEIRMLHKDGHIGWIESMCVPIYGENYQMVGALGINRD 117
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 7e-22
Identities = 40/178 (22%), Positives = 73/178 (41%), Gaps = 22/178 (12%)
Query: 511 EQIGQGSCGTVYHAV--WYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLR-HPNVLLF 567
+ +G+G+ V + + AVK+ +Q +EV ++ + + H NVL
Sbjct: 19 DVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIR--SRVFREVEMLYQCQGHRNVLEL 76
Query: 568 MGAVTSPQRLCIVTEFLPRGSLF-RLLQRNT-TKLDWRRRILMALDIARGVSYLHHCNPP 625
+ R +V E + GS+ + +R +L+ + D+A + +LH+
Sbjct: 77 IEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASV---VVQDVASALDFLHNKG-- 131
Query: 626 IIHRDLKSSNLLV---DKHWTVKVGDFGLSRLKHETYLTTKTGK-------GTVTYLA 673
I HRDLK N+L ++ VK+ DF L + G+ Y+A
Sbjct: 132 IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMA 189
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 1e-21
Identities = 39/175 (22%), Positives = 67/175 (38%), Gaps = 17/175 (9%)
Query: 508 TIGEQIGQGSCGTVYHA--VWYGSDVAVKVFSRQEYSD--EVIHSFRQEVSLMKRLRHPN 563
+ +G+G G VY A VA+K+ + S ++E RL+ P+
Sbjct: 37 RLRRLVGRGGMGDVYEAEDTVRERIVALKLM-SETLSSDPVFRTRMQREARTAGRLQEPH 95
Query: 564 VLLFMGAV----TSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYL 619
V+ + +L + + L +L+R L R + + I +
Sbjct: 96 VV----PIHDFGEIDGQLYVDMRLINGVDLAAMLRRQG-PLAPPRAVAIVRQIGSALDAA 150
Query: 620 HHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLT-TKTGKGTVTYLA 673
H HRD+K N+LV + DFG++ + LT GT+ Y+A
Sbjct: 151 HAAG--ATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMA 203
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 96.3 bits (240), Expect = 2e-21
Identities = 42/164 (25%), Positives = 74/164 (45%), Gaps = 33/164 (20%)
Query: 508 TIGEQIGQGSCGTVYHAVWY--GSDVAVK-VFSRQEYSDEVIHSFRQEVSLMKRLRHPNV 564
T + IG GS G VY A G VA+K V + + R E+ +M++L H N+
Sbjct: 57 TDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFK------NR-ELQIMRKLDHCNI 109
Query: 565 LLFMGAVTSPQR------LCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALD------- 611
+ S L +V +++P +++R+ + R + + +
Sbjct: 110 VRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVA-----RHYSRAKQTLPVIYVKLYMY 163
Query: 612 -IARGVSYLHHCNPPIIHRDLKSSNLLVDKH-WTVKVGDFGLSR 653
+ R ++Y+H I HRD+K NLL+D +K+ DFG ++
Sbjct: 164 QLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAK 205
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 4e-21
Identities = 40/167 (23%), Positives = 69/167 (41%), Gaps = 33/167 (19%)
Query: 508 TIGEQIGQGSCGTVYHAVWY--GSDVAVK-VFSRQEYSDEVIHSFR--QEVSLMKRLRHP 562
+ GQG+ GTV G VA+K V + R Q + + L HP
Sbjct: 26 QVERMAGQGTFGTVQLGKEKSTGMSVAIKKVI------QDPRFRNRELQIMQDLAVLHHP 79
Query: 563 NVLLFMGAVTSPQR-------LCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALD---- 611
N++ + L +V E++P +L R + +RR++
Sbjct: 80 NIVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCC-----RNYYRRQVAPPPILIKV 133
Query: 612 ----IARGVSYLHHCNPPIIHRDLKSSNLLVDKH-WTVKVGDFGLSR 653
+ R + LH + + HRD+K N+LV++ T+K+ DFG ++
Sbjct: 134 FLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAK 180
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 7e-21
Identities = 44/163 (26%), Positives = 75/163 (46%), Gaps = 32/163 (19%)
Query: 508 TIGEQIGQGSCGTVYHAVWYGSD-VAVK-VFSRQEYSDEVIHSFRQEVSLMKRLRHPNVL 565
T + IG GS G V+ A SD VA+K V + + R E+ +M+ ++HPNV+
Sbjct: 43 TNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRFK------NR-ELQIMRIVKHPNVV 95
Query: 566 LFMGAVTSPQR------LCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALD-------- 611
S L +V E++P +++R + + + M +
Sbjct: 96 DLKAFFYSNGDKKDEVFLNLVLEYVPE-TVYRASRHY-----AKLKQTMPMLLIKLYMYQ 149
Query: 612 IARGVSYLHHCNPPIIHRDLKSSNLLVDKH-WTVKVGDFGLSR 653
+ R ++Y+H I HRD+K NLL+D +K+ DFG ++
Sbjct: 150 LLRSLAYIHSIG--ICHRDIKPQNLLLDPPSGVLKLIDFGSAK 190
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 92.3 bits (230), Expect = 2e-20
Identities = 45/167 (26%), Positives = 74/167 (44%), Gaps = 24/167 (14%)
Query: 499 DYEILWEDLTIGEQIGQGSCGTVYHA--VWYGSDVAVKVFSRQEYSDE--VIHSFRQEVS 554
YE L +IGQG+ G V+ A G VA+K E E I + R E+
Sbjct: 18 KYEKL-------AKIGQGTFGEVFKARHRKTGQKVALKKV-LMENEKEGFPITALR-EIK 68
Query: 555 LMKRLRHPNVLLFMGAVTSPQRLC--------IVTEFLPRGSLFRLLQRNTTKLDWRRRI 606
+++ L+H NV+ + + +V +F L LL K
Sbjct: 69 ILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIK 127
Query: 607 LMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSR 653
+ + G+ Y+H I+HRD+K++N+L+ + +K+ DFGL+R
Sbjct: 128 RVMQMLLNGLYYIHRNK--ILHRDMKAANVLITRDGVLKLADFGLAR 172
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 93.2 bits (232), Expect = 2e-20
Identities = 48/178 (26%), Positives = 79/178 (44%), Gaps = 18/178 (10%)
Query: 505 EDLTIGEQIGQGSCGTVYHAVWYGSD--VAVKVFSRQE--YSDEVIHSFRQEVSLMKRLR 560
ED + + IG+G+ G V + A+K+ S+ E + F +E +M
Sbjct: 69 EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAF-FWEERDIMAFAN 127
Query: 561 HPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRR----RILMALDIARGV 616
P V+ A + L +V E++P G L L+ W R +++ALD
Sbjct: 128 SPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALD----- 182
Query: 617 SYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLS-RLKHETYLTTKTGKGTVTYLA 673
+H IHRD+K N+L+DK +K+ DFG ++ E + T GT Y++
Sbjct: 183 -AIHSMG--FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYIS 237
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 92.9 bits (231), Expect = 3e-20
Identities = 36/166 (21%), Positives = 70/166 (42%), Gaps = 8/166 (4%)
Query: 513 IGQGSCGTVYHAVWYGSD--VAVKVFSRQE--YSDEVIHSFRQEVSLMKRLRHPNVLLFM 568
IG+G+ V + A+K+ ++ + EV FR+E ++ +
Sbjct: 69 IGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSC-FREERDVLVNGDRRWITQLH 127
Query: 569 GAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIH 628
A L +V E+ G L LL + ++ +I + +H +H
Sbjct: 128 FAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLG--YVH 185
Query: 629 RDLKSSNLLVDKHWTVKVGDFGLS-RLKHETYLTTKTGKGTVTYLA 673
RD+K N+L+D+ +++ DFG +L+ + + + GT YL+
Sbjct: 186 RDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLS 231
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 3e-20
Identities = 43/178 (24%), Positives = 78/178 (43%), Gaps = 21/178 (11%)
Query: 505 EDLTIGEQIGQGSCGTVYHAVWYGSD--VAVKVFSRQE--YSDEVIHSFRQEVSLMKRLR 560
+ + +G GS G V S A+K+ +Q+ ++ H+ E +++ +
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHT-LNEKRILQAVN 99
Query: 561 HPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRR-----ILMALDIARG 615
P ++ + L +V E++ G +F L+R + R I++ +
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFE---- 155
Query: 616 VSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTVTYLA 673
YLH + +I+RDLK NLL+D+ ++V DFG ++ T T GT LA
Sbjct: 156 --YLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAK---RVKGRTWTLCGTPEALA 206
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 92.9 bits (231), Expect = 3e-20
Identities = 42/180 (23%), Positives = 80/180 (44%), Gaps = 20/180 (11%)
Query: 505 EDLTIGEQIGQGSCGTVYHAVWYGSD--VAVKVFSRQE--YSDEVIHSFRQEVSLMKRLR 560
ED I + IG+G+ G V +D A+K+ ++ E E FR+E ++
Sbjct: 74 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETAC-FREERDVLVNGD 132
Query: 561 HPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKL--DWRR----RILMALDIAR 614
+ A L +V ++ G L LL + +L + R +++A+D
Sbjct: 133 SKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAID--- 189
Query: 615 GVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLS-RLKHETYLTTKTGKGTVTYLA 673
+H + +HRD+K N+L+D + +++ DFG +L + + + GT Y++
Sbjct: 190 ---SVHQLH--YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYIS 244
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 92.5 bits (230), Expect = 4e-20
Identities = 58/232 (25%), Positives = 99/232 (42%), Gaps = 18/232 (7%)
Query: 446 PESHMYEGNRSVNNEAWGSWSSSVNVNSTSSVSSCGSTSSSAVNKVDLDNDCLDYEILWE 505
+ + A S + + S + + ++V ++ ++E L
Sbjct: 100 TTAIQTVADGLKKQAAAEMDFRSGSPSDNSGAEEMEVSLAKPKHRVTMN----EFEYL-- 153
Query: 506 DLTIGEQIGQGSCGTVYHAVWYGSDV--AVKVFSRQE--YSDEVIHSFRQEVSLMKRLRH 561
+ +G+G+ G V + A+K+ ++ DEV H+ E +++ RH
Sbjct: 154 -----KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHT-LTENRVLQNSRH 207
Query: 562 PNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHH 621
P + + + RLC V E+ G LF L R + R R A +I + YLH
Sbjct: 208 PFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGA-EIVSALDYLHS 266
Query: 622 CNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTVTYLA 673
+++RDLK NL++DK +K+ DFGL + + T KT GT YLA
Sbjct: 267 EKN-VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLA 317
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 91.8 bits (228), Expect = 6e-20
Identities = 39/164 (23%), Positives = 74/164 (45%), Gaps = 25/164 (15%)
Query: 509 IGEQIGQGSCGTVYHA----VWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNV 564
G ++G+G+ G VY A D A+K S +E++L++ L+HPNV
Sbjct: 25 EGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSAC----REIALLRELKHPNV 80
Query: 565 LLFMGAVTSPQ--RLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALD--------IAR 614
+ S ++ ++ ++ L+ +++ + ++ + + I
Sbjct: 81 ISLQKVFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILD 139
Query: 615 GVSYLHHCNPPIIHRDLKSSNLLV----DKHWTVKVGDFGLSRL 654
G+ YLH ++HRDLK +N+LV + VK+ D G +RL
Sbjct: 140 GIHYLHANW--VLHRDLKPANILVMGEGPERGRVKIADMGFARL 181
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 7e-20
Identities = 42/164 (25%), Positives = 62/164 (37%), Gaps = 26/164 (15%)
Query: 499 DYEILWEDLTIGEQIGQGSCGTVYHAV--WYGSDVAVKVFSRQEYSDEVIHSFRQEVSLM 556
DY++ + +G G G V A+K+ R+EV L
Sbjct: 18 DYKVT------SQVLGLGINGKVLQIFNKRTQEKFALKMLQDCP-------KARREVELH 64
Query: 557 KRL-RHPNVLLFMGA----VTSPQRLCIVTEFLPRGSLF-RLLQRNTTKLDWRRRILMAL 610
R + P+++ + + L IV E L G LF R+ R R +
Sbjct: 65 WRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMK 124
Query: 611 DIARGVSYLHHCNPPIIHRDLKSSNLLV---DKHWTVKVGDFGL 651
I + YLH N I HRD+K NLL + +K+ DFG
Sbjct: 125 SIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFGF 166
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 89.6 bits (223), Expect = 8e-20
Identities = 52/171 (30%), Positives = 75/171 (43%), Gaps = 28/171 (16%)
Query: 499 DYEILWEDLTIGEQIGQGSCGTVYHA--VWYGSDVAVKVFSRQEYSDEVIHSF-----RQ 551
YE + +IG G+ GTVY A G VA+K R R
Sbjct: 10 RYEPV-------AEIGVGAYGTVYKARDPHSGHFVALKSV-RVPNGGGGGGGLPISTVR- 60
Query: 552 EVSLMKRLR---HPNVLLFMGAVTSPQ-----RLCIVTEFLPRGSLFRLL-QRNTTKLDW 602
EV+L++RL HPNV+ M + + ++ +V E + + L L + L
Sbjct: 61 EVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPA 119
Query: 603 RRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSR 653
+ RG+ +LH I+HRDLK N+LV TVK+ DFGL+R
Sbjct: 120 ETIKDLMRQFLRGLDFLHANC--IVHRDLKPENILVTSGGTVKLADFGLAR 168
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 89.1 bits (222), Expect = 1e-19
Identities = 47/178 (26%), Positives = 87/178 (48%), Gaps = 21/178 (11%)
Query: 505 EDLTIGEQIGQGSCGTVYHAVWYGSD--VAVKVFSRQE--YSDEVIHSFRQEVSLMKRLR 560
+D I +G GS G V+ + A+KV ++ +V H+ E ++ +
Sbjct: 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHT-NDERLMLSIVT 64
Query: 561 HPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRR-----ILMALDIARG 615
HP ++ G Q++ ++ +++ G LF LL+++ + + + +AL+
Sbjct: 65 HPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALE---- 120
Query: 616 VSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTVTYLA 673
YLH + II+RDLK N+L+DK+ +K+ DFG ++ + T T GT Y+A
Sbjct: 121 --YLHSKD--IIYRDLKPENILLDKNGHIKITDFGFAKYVPD---VTYTLCGTPDYIA 171
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 92.2 bits (229), Expect = 1e-19
Identities = 40/175 (22%), Positives = 62/175 (35%), Gaps = 23/175 (13%)
Query: 509 IGEQIGQGSCGTVYHA---VWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPN-V 564
+ I G G +Y A G V +K E E + + HP+ V
Sbjct: 84 VKGCIAHGGLGWIYLALDRNVNGRPVVLKGL-VHSGDAEAQAMAMAERQFLAEVVHPSIV 142
Query: 565 LLF----MGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLH 620
+F IV E++ SL R + KL I L+I +SYLH
Sbjct: 143 QIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQ---KLPVAEAIAYLLEILPALSYLH 199
Query: 621 HCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGK--GTVTYLA 673
+++ DLK N+++ + +K+ D G G GT + A
Sbjct: 200 SIG--LVYNDLKPENIMLTEE-QLKLIDLGAVS------RINSFGYLYGTPGFQA 245
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 3e-19
Identities = 49/170 (28%), Positives = 85/170 (50%), Gaps = 19/170 (11%)
Query: 513 IGQGSCGTVYHA------VWYGSDVAVKVFSRQE--YSDEVIHSFRQEVSLMKRLRHPNV 564
IG+GS G V Y A+K ++Q+ +EV + F+ E+ +M+ L HP +
Sbjct: 23 IGKGSFGKVCIVQKNDTKKMY----AMKYMNKQKCVERNEVRNVFK-ELQIMQGLEHPFL 77
Query: 565 LLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNP 624
+ + + + +V + L G L LQ+N + ++ + ++ + YL +
Sbjct: 78 VNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFIC-ELVMALDYLQNQR- 135
Query: 625 PIIHRDLKSSNLLVDKHWTVKVGDFGLS-RLKHETYLTTKTGKGTVTYLA 673
IIHRD+K N+L+D+H V + DF ++ L ET +TT GT Y+A
Sbjct: 136 -IIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITTMA--GTKPYMA 182
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 3e-19
Identities = 38/179 (21%), Positives = 62/179 (34%), Gaps = 27/179 (15%)
Query: 500 YEILWEDLTIGEQIGQGSCGTVYHAV-WYGSDVAVKVFSRQEYSDEVIHSFRQ------- 551
Y + I GS G V V G VA+K ++
Sbjct: 24 YTVQ-------RFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRV 76
Query: 552 --EVSLMKRLRHPNVLLFMGAVTSPQR-----LCIVTEFLPRGSLFRLLQRNTTKL-DWR 603
E+ L+ HPN+L + L +VTE + L +++ +
Sbjct: 77 LREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVIHDQRIVISPQH 135
Query: 604 RRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTT 662
+ M I G+ LH ++HRDL N+L+ + + + DF L+R T
Sbjct: 136 IQYFM-YHILLGLHVLHEAG--VVHRDLHPGNILLADNNDITICDFNLAREDTADANKT 191
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 1e-18
Identities = 44/183 (24%), Positives = 79/183 (43%), Gaps = 26/183 (14%)
Query: 500 YEILWEDLTIGEQIGQGSCGTVYHAV--WYGSDVAVK---VFSRQEYSDEVIHSFRQEVS 554
+++ +G+G+ G V A G VA+K F + ++ + + R E+
Sbjct: 13 FQLK-------SLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFA---LRTLR-EIK 61
Query: 555 LMKRLRHPNVLLFMGAVTSPQR-----LCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMA 609
++K +H N++ + I+ E + L R++ D + +
Sbjct: 62 ILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQT-DLHRVISTQMLSDDHIQYFI-- 118
Query: 610 LDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTV 669
R V LH N +IHRDLK SNLL++ + +KV DFGL+R+ E+ G
Sbjct: 119 YQTLRAVKVLHGSN--VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQ 176
Query: 670 TYL 672
+ +
Sbjct: 177 SGM 179
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 86.5 bits (215), Expect = 1e-18
Identities = 47/169 (27%), Positives = 77/169 (45%), Gaps = 26/169 (15%)
Query: 499 DYEILWEDLTIGEQIGQGSCGTVYHAVWY---GSDVAVKVFSRQEYSDEVIHS--FRQEV 553
YE + +IG+G+ G V+ A G VA+K R + +E + R EV
Sbjct: 12 QYECV-------AEIGEGAYGKVFKARDLKNGGRFVALKRV-RVQTGEEGMPLSTIR-EV 62
Query: 554 SLMKRLR---HPNVLLFMGAVTSPQ-----RLCIVTEFLPRGSLFRLL-QRNTTKLDWRR 604
++++ L HPNV+ T + +L +V E + + L L + +
Sbjct: 63 AVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTET 121
Query: 605 RILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSR 653
M + RG+ +LH ++HRDLK N+LV +K+ DFGL+R
Sbjct: 122 IKDMMFQLLRGLDFLHSHR--VVHRDLKPQNILVTSSGQIKLADFGLAR 168
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 86.5 bits (215), Expect = 2e-18
Identities = 52/165 (31%), Positives = 80/165 (48%), Gaps = 8/165 (4%)
Query: 513 IGQGSCGTVYHAVWYGSD--VAVKVFSRQE--YSDEVIHSFRQEVSLMKRLRHPNVLLFM 568
+G+G+ G V + A+K+ ++ DEV H+ E +++ RHP +
Sbjct: 13 LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHT-VTESRVLQNTRHPFLTALK 71
Query: 569 GAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIH 628
A + RLC V E+ G LF L R + R R A +I + YLH + +++
Sbjct: 72 YAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGA-EIVSALEYLHSRD--VVY 128
Query: 629 RDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTVTYLA 673
RD+K NL++DK +K+ DFGL + T KT GT YLA
Sbjct: 129 RDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLA 173
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 86.8 bits (215), Expect = 4e-18
Identities = 49/204 (24%), Positives = 81/204 (39%), Gaps = 20/204 (9%)
Query: 461 AWGSWSSSVNVNSTSSVSSCGSTSSSAVNKVDLDNDCLDYEILWEDLTIGEQIGQGSCGT 520
+ + V+ + S+ + D++I + I IG GS G
Sbjct: 10 QQHNSGTQHTVSGSQQEGQQRKQHHSSKPTASMPRPHSDWQIP-DRYEIRHLIGTGSYGH 68
Query: 521 VYHAV--WYGSDVAVK----VFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSP 574
V A VA+K VF R E++++ RL H +V+ + V
Sbjct: 69 VCEAYDKLEKRVVAIKKILRVFEDLIDC---KRILR-EIAILNRLNHDHVVKVLDIVIPK 124
Query: 575 QRLC-----IVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHR 629
+V E +L + + + L+ ++ GV Y+H I+HR
Sbjct: 125 DVEKFDELYVVLEIADS-DFKKLFRTPVYLTELHIKTLL-YNLLVGVKYVHSAG--ILHR 180
Query: 630 DLKSSNLLVDKHWTVKVGDFGLSR 653
DLK +N LV++ +VKV DFGL+R
Sbjct: 181 DLKPANCLVNQDCSVKVCDFGLAR 204
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 85.9 bits (213), Expect = 4e-18
Identities = 48/167 (28%), Positives = 79/167 (47%), Gaps = 22/167 (13%)
Query: 508 TIGEQIGQGSCGTVYHAV--WYGSDVAVK----VFSRQEYSDEVIHSFRQEVSLMKRLRH 561
+ IG G+ G V A +VA+K F Q ++ ++R E+ LMK + H
Sbjct: 28 QNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHA---KRAYR-ELVLMKCVNH 83
Query: 562 PNVLLFMGAVTSPQRLC------IVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARG 615
N++ + T + L IV E + +L +++Q R L+ + G
Sbjct: 84 KNIIGLLNVFTPQKSLEEFQDVYIVMELMD-ANLCQVIQMELD--HERMSYLL-YQMLCG 139
Query: 616 VSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTT 662
+ +LH IIHRDLK SN++V T+K+ DFGL+R +++ T
Sbjct: 140 IKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMT 184
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 86.3 bits (214), Expect = 5e-18
Identities = 43/165 (26%), Positives = 72/165 (43%), Gaps = 26/165 (15%)
Query: 500 YEILWEDLTIGEQIGQGSCGTVYHAV--WYGSDVAVK----VFSRQEYSDEVIHSFRQEV 553
Y I IG+GS G VY A +VA+K +F R E+
Sbjct: 28 YIIK-------HLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDC---KRILR-EI 76
Query: 554 SLMKRLRHPNVLLFMGAVTSPQRLC-----IVTEFLPRGSLFRLLQRNTTKLDWRRRILM 608
+++ RL+ ++ + L IV E L +L + + + ++
Sbjct: 77 TILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIADS-DLKKLFKTPIFLTEEHIKTIL 135
Query: 609 ALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSR 653
++ G +++H IIHRDLK +N L+++ +VKV DFGL+R
Sbjct: 136 -YNLLLGENFIHESG--IIHRDLKPANCLLNQDCSVKVCDFGLAR 177
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 87.4 bits (216), Expect = 5e-18
Identities = 54/261 (20%), Positives = 102/261 (39%), Gaps = 23/261 (8%)
Query: 417 KTARFAWPWSHGDQDNESVQQKSPSYGTKPESHMYEGNRSVNNEAWGSWSSSVNVNSTSS 476
K W ++ E P G++ + + + ++
Sbjct: 269 KAGVDGWFKLLSQEEGEYFNVPVPPEGSEGNEELRQKFERAKIG-----QGTKAPEEKTA 323
Query: 477 VSSCGSTSSSAVNKVDLDNDCLDYEILWEDLTIGEQIGQGSCGTVYHAVWYGSD--VAVK 534
+ ++ +++ L D+ L +G+GS G V + G+D AVK
Sbjct: 324 NTISKFDNNGNRDRMKLT----DFNFL-------MVLGKGSFGKVMLSERKGTDELYAVK 372
Query: 535 VFSRQE--YSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRL 592
+ + D+V + ++ L + P + + RL V E++ G L
Sbjct: 373 ILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYH 432
Query: 593 LQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLS 652
+Q+ + + A +IA G+ +L II+RDLK N+++D +K+ DFG+
Sbjct: 433 IQQ-VGRFKEPHAVFYAAEIAIGLFFLQSKG--IIYRDLKLDNVMLDSEGHIKIADFGMC 489
Query: 653 RLKHETYLTTKTGKGTVTYLA 673
+ +TTKT GT Y+A
Sbjct: 490 KENIWDGVTTKTFCGTPDYIA 510
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 6e-18
Identities = 42/170 (24%), Positives = 80/170 (47%), Gaps = 25/170 (14%)
Query: 508 TIGEQIGQGSCGTVYHAV--WYGSDVAVK----VFSRQEYSDEVIHSFRQEVSLMKRLRH 561
+G G+ G+V A+ G VA+K F + ++ ++R E+ L+K ++H
Sbjct: 27 VSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFA---KRAYR-ELLLLKHMQH 82
Query: 562 PNVLLFMGAVTSPQRLC------IVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARG 615
NV+ + T L +V F+ L +++ + + + + L+ + +G
Sbjct: 83 ENVIGLLDVFTPASSLRNFYDFYLVMPFMQT-DLQKIMGLKFS--EEKIQYLV-YQMLKG 138
Query: 616 VSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHET---YLTT 662
+ Y+H ++HRDLK NL V++ +K+ DFGL+R Y+ T
Sbjct: 139 LKYIHSAG--VVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVT 186
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 85.7 bits (212), Expect = 9e-18
Identities = 47/167 (28%), Positives = 79/167 (47%), Gaps = 22/167 (13%)
Query: 508 TIGEQIGQGSCGTVYHAV--WYGSDVAVK----VFSRQEYSDEVIHSFRQEVSLMKRLRH 561
+ IG G+ G V A +VA+K F Q ++ ++R E+ LMK + H
Sbjct: 65 QNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHA---KRAYR-ELVLMKCVNH 120
Query: 562 PNVLLFMGAVTSPQRLC------IVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARG 615
N++ + T + L +V E + +L +++Q R L+ + G
Sbjct: 121 KNIISLLNVFTPQKTLEEFQDVYLVMELMD-ANLCQVIQMELD--HERMSYLL-YQMLCG 176
Query: 616 VSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTT 662
+ +LH IIHRDLK SN++V T+K+ DFGL+R +++ T
Sbjct: 177 IKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMT 221
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 82.9 bits (205), Expect = 1e-17
Identities = 20/145 (13%), Positives = 39/145 (26%), Gaps = 8/145 (5%)
Query: 509 IGEQIGQGSCGTVYHAV--WYGSDVAVKVFSRQEYSDEVIHS-FRQEVSLMKRLRHPNVL 565
+ G + A+ VA+ Q + + + R+ P V
Sbjct: 35 LLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVA 94
Query: 566 LFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPP 625
+ V + +V E++ GSL + + I +A H
Sbjct: 95 RVLDVVHTRAGGLVVAEWIRGGSLQEVADTS---PSPVGAIRAMQSLAAAADAAHRAG-- 149
Query: 626 IIHRDLKSSNLLVDKHWTVKVGDFG 650
+ S + V V +
Sbjct: 150 VALSIDHPSRVRVSIDGDVVLAYPA 174
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 83.0 bits (206), Expect = 2e-17
Identities = 43/169 (25%), Positives = 84/169 (49%), Gaps = 12/169 (7%)
Query: 513 IGQGSCGTVY---HAVWYGSDV--AVKVFSRQ---EYSDEVIHSFRQEVSLMKRLRHPNV 564
+G+G G V+ + A+KV + + + H+ + E ++++ ++HP +
Sbjct: 25 LGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHT-KAERNILEEVKHPFI 83
Query: 565 LLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNP 624
+ + A + +L ++ E+L G LF L+R ++ +A +I+ + +LH
Sbjct: 84 VDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLA-EISMALGHLHQKG- 141
Query: 625 PIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTVTYLA 673
II+RDLK N++++ VK+ DFGL + T T GT+ Y+A
Sbjct: 142 -IIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFCGTIEYMA 189
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 81.8 bits (203), Expect = 4e-17
Identities = 48/198 (24%), Positives = 88/198 (44%), Gaps = 21/198 (10%)
Query: 482 STSSSAVNKVDLDNDCLDYEILWEDLTIGEQIGQGSCGTVY---HAVWYGSDV--AVKVF 536
K D +E+L + +GQGS G V+ + A+KV
Sbjct: 12 HHVKEGHEKADPS----QFELL-------KVLGQGSFGKVFLVKKISGSDARQLYAMKVL 60
Query: 537 SRQE-YSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQR 595
+ + + + + E ++ + HP ++ A + +L ++ +FL G LF L +
Sbjct: 61 KKATLKVRDRVRT-KMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSK 119
Query: 596 NTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLK 655
+ + +A ++A + +LH II+RDLK N+L+D+ +K+ DFGLS+
Sbjct: 120 EVMFTEEDVKFYLA-ELALALDHLHSLG--IIYRDLKPENILLDEEGHIKLTDFGLSKES 176
Query: 656 HETYLTTKTGKGTVTYLA 673
+ + GTV Y+A
Sbjct: 177 IDHEKKAYSFCGTVEYMA 194
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 81.9 bits (203), Expect = 5e-17
Identities = 42/172 (24%), Positives = 77/172 (44%), Gaps = 23/172 (13%)
Query: 499 DYEIL---WE---DLTIGEQIGQGSCGTVYHAV--WYGSDVAVKVFSRQEYSDEVIHSFR 550
DYE W D + ++G+G V+ A+ V VK+ + ++
Sbjct: 24 DYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKIL-KPVKKKKIK---- 78
Query: 551 QEVSLMKRLR-HPNVLLFMGAVTSPQ--RLCIVTEFLPRGSLFRLLQRNTTKLDWRRRIL 607
+E+ +++ LR PN++ V P +V E + +L Q T D+ R
Sbjct: 79 REIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLT---DYDIRFY 135
Query: 608 MALDIARGVSYLHHCNPPIIHRDLKSSNLLVD-KHWTVKVGDFGLSRLKHET 658
M +I + + Y H I+HRD+K N+++D +H +++ D+GL+ H
Sbjct: 136 M-YEILKALDYCHSMG--IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG 184
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 5e-17
Identities = 46/155 (29%), Positives = 76/155 (49%), Gaps = 21/155 (13%)
Query: 511 EQIGQGSCGTVYHAV--WYGSDVAVK----VFSRQEYSDEVIHSFRQEVSLMKRLRHPNV 564
+G G+ G+V A G VAVK F ++ ++R E+ L+K ++H NV
Sbjct: 35 SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHA---KRTYR-ELRLLKHMKHENV 90
Query: 565 LLFMGAVTSPQRLC------IVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSY 618
+ + T + L +VT + L +++ D + ++ I RG+ Y
Sbjct: 91 IGLLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIVKCQKLTDDHVQFLIY--QILRGLKY 147
Query: 619 LHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSR 653
+H + IIHRDLK SNL V++ +K+ DFGL+R
Sbjct: 148 IHSAD--IIHRDLKPSNLAVNEDCELKILDFGLAR 180
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 7e-17
Identities = 44/173 (25%), Positives = 76/173 (43%), Gaps = 35/173 (20%)
Query: 500 YEILWEDLTIGEQIGQGSCGTVYHAV--WYGSDVAVK--VFSRQEYSDEVIHSFRQEVSL 555
Y L + +G G G V+ AV VA+K V + + H+ R E+ +
Sbjct: 13 YMDL-------KPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSV---KHALR-EIKI 61
Query: 556 MKRLRHPNVLLFMGAVTSPQRLC--------------IVTEFLPRGSLFRLLQRNTTKLD 601
++RL H N++ + IV E++ L +L++ +
Sbjct: 62 IRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYME-TDLANVLEQGPLLEE 120
Query: 602 WRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHW-TVKVGDFGLSR 653
R + + RG+ Y+H N ++HRDLK +NL ++ +K+GDFGL+R
Sbjct: 121 HARLFMY--QLLRGLKYIHSAN--VLHRDLKPANLFINTEDLVLKIGDFGLAR 169
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 8e-17
Identities = 47/155 (30%), Positives = 78/155 (50%), Gaps = 21/155 (13%)
Query: 511 EQIGQGSCGTVYHAV--WYGSDVAVK----VFSRQEYSDEVIHSFRQEVSLMKRLRHPNV 564
+ +G G+ G V AV G+ VA+K F + ++ ++R E+ L+K +RH NV
Sbjct: 31 QPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFA---KRAYR-ELRLLKHMRHENV 86
Query: 565 LLFMGAVTSPQRLC------IVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSY 618
+ + T + L +V F+ L +L++ KL R + + +G+ Y
Sbjct: 87 IGLLDVFTPDETLDDFTDFYLVMPFMGT-DLGKLMKHE--KLGEDRIQFLVYQMLKGLRY 143
Query: 619 LHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSR 653
+H IIHRDLK NL V++ +K+ DFGL+R
Sbjct: 144 IHAAG--IIHRDLKPGNLAVNEDCELKILDFGLAR 176
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 9e-17
Identities = 48/156 (30%), Positives = 74/156 (47%), Gaps = 19/156 (12%)
Query: 508 TIGEQIGQGSCGTVYHAV--WYGSDVAVK---VFSRQEYSDEVIHSFRQEVSLMKRLRHP 562
T IG+G+ G V A VA+K F Q Y + R E+ ++ R RH
Sbjct: 30 TNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYC---QRTLR-EIKILLRFRHE 85
Query: 563 NVLLFMGAVTSPQR-----LCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVS 617
N++ + +P + IV + + L++LL+ D L I RG+
Sbjct: 86 NIIGINDIIRAPTIEQMKDVYIVQDLME-TDLYKLLKTQHLSNDHICYFLY--QILRGLK 142
Query: 618 YLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSR 653
Y+H N ++HRDLK SNLL++ +K+ DFGL+R
Sbjct: 143 YIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLAR 176
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 81.5 bits (201), Expect = 1e-16
Identities = 36/170 (21%), Positives = 65/170 (38%), Gaps = 17/170 (10%)
Query: 493 LDNDCLDYEILWEDLTIGEQIGQGSCGTVYHAVWYGSD-------VAVKVFSRQEYSDEV 545
L D +E + L +G+ +G+G+ G V A +G D VAVK+ ++ +
Sbjct: 10 LPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKM-LKEGATHSE 68
Query: 546 IHSFRQEVSLMKRL-RHPNVLLFMGAVT-SPQRLCIVTEFLPRGSLFRLLQRNTTKLDWR 603
+ E+ ++ + H NV+ +GA T L ++ EF G+L L+ +
Sbjct: 69 HRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEF--V 126
Query: 604 RRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSR 653
+G Y+ I DLK + + F +
Sbjct: 127 PYKTKGARFRQGKDYVG-----AIPVDLKRRLDSITSSQSSASSGFVEEK 171
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 80.7 bits (200), Expect = 1e-16
Identities = 54/202 (26%), Positives = 88/202 (43%), Gaps = 18/202 (8%)
Query: 476 SVSSCGSTSSSAVNKVDLDNDCLDYEILWEDLTIGEQIGQGSCGTVYHAVWYGSD--VAV 533
S ++ N++ +D ++E + +G+GS G V A + AV
Sbjct: 5 SSKEGNGIGVNSSNRLGID----NFEFI-------RVLGKGSFGKVMLARVKETGDLYAV 53
Query: 534 KVFSRQE--YSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFR 591
KV + D+V + ++ L HP + +P RL V EF+ G L
Sbjct: 54 KVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMF 113
Query: 592 LLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGL 651
+Q+ + + D R A +I + +LH II+RDLK N+L+D K+ DFG+
Sbjct: 114 HIQK-SRRFDEARARFYAAEIISALMFLHDKG--IIYRDLKLDNVLLDHEGHCKLADFGM 170
Query: 652 SRLKHETYLTTKTGKGTVTYLA 673
+ +TT T GT Y+A
Sbjct: 171 CKEGICNGVTTATFCGTPDYIA 192
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 80.7 bits (200), Expect = 2e-16
Identities = 52/205 (25%), Positives = 93/205 (45%), Gaps = 20/205 (9%)
Query: 473 STSSVSSCGSTSSSAVNKVDLDNDCLDYEILWEDLTIGEQIGQGSCGTVYHAVWYGSD-- 530
+T++VS ++ +++ L D+ L +G+GS G V + G+D
Sbjct: 1 TTNTVSK--FDNNGNRDRMKLT----DFNFL-------MVLGKGSFGKVMLSERKGTDEL 47
Query: 531 VAVKVFSRQE--YSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGS 588
AVK+ + D+V + ++ L + P + + RL V E++ G
Sbjct: 48 YAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGD 107
Query: 589 LFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGD 648
L +Q+ + + A +IA G+ +L II+RDLK N+++D +K+ D
Sbjct: 108 LMYHIQQ-VGRFKEPHAVFYAAEIAIGLFFLQSKG--IIYRDLKLDNVMLDSEGHIKIAD 164
Query: 649 FGLSRLKHETYLTTKTGKGTVTYLA 673
FG+ + +TTKT GT Y+A
Sbjct: 165 FGMCKENIWDGVTTKTFCGTPDYIA 189
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 2e-16
Identities = 62/212 (29%), Positives = 94/212 (44%), Gaps = 18/212 (8%)
Query: 466 SSSVNVNSTSSVSSCGSTSSSAVNKVDLDNDCLDYEILWEDLTIGEQIGQGSCGTVYHAV 525
+ N + S + S+ D+ L + IG+GS G V A
Sbjct: 10 LMNANPAPPPAPSQQINLGPSSNPHAKPS----DFHFL-------KVIGKGSFGKVLLAR 58
Query: 526 WYGSDV--AVKVFSRQE--YSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVT 581
+V AVKV ++ E H + L+K ++HP ++ + + +L V
Sbjct: 59 HKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVL 118
Query: 582 EFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKH 641
+++ G LF LQR L+ R R A +IA + YLH N I++RDLK N+L+D
Sbjct: 119 DYINGGELFYHLQRERCFLEPRARFYAA-EIASALGYLHSLN--IVYRDLKPENILLDSQ 175
Query: 642 WTVKVGDFGLSRLKHETYLTTKTGKGTVTYLA 673
+ + DFGL + E TT T GT YLA
Sbjct: 176 GHIVLTDFGLCKENIEHNSTTSTFCGTPEYLA 207
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 2e-16
Identities = 44/165 (26%), Positives = 75/165 (45%), Gaps = 7/165 (4%)
Query: 513 IGQGSCGTVYHAVWYGSDV--AVKVFSRQE--YSDEVIHSFRQEVSLMKRLRHPNVLLFM 568
IG+GS V +D A+KV ++ +++ ++ + HP ++
Sbjct: 17 IGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 76
Query: 569 GAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIH 628
+ RL V E++ G L +QR + R A +I+ ++YLH II+
Sbjct: 77 SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSA-EISLALNYLHERG--IIY 133
Query: 629 RDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTVTYLA 673
RDLK N+L+D +K+ D+G+ + TT T GT Y+A
Sbjct: 134 RDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIA 178
|
| >3ewk_A Sensor protein; PAS domain, alpha/beta fold, kinase, phosphoprotein, transfe flavoprotein; HET: FAD; 2.34A {Methylococcus capsulatus} Length = 227 | Back alignment and structure |
|---|
Score = 77.8 bits (192), Expect = 2e-16
Identities = 28/98 (28%), Positives = 41/98 (41%)
Query: 143 VHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGERWT 202
V I DL RI+Y N + + Y EE +GQD + + D+ I G W
Sbjct: 2 VSITDLQGRILYANDNFCAVSRYGREELVGQDHRIVNSGYHGKAYIRDMWRTISRGNIWQ 61
Query: 203 GQFPAKTKTEERVLVVATNTPFYDDDGTLVGIVCVSTD 240
G+F + K R V +T P D+ G + + D
Sbjct: 62 GEFCNRRKDGTRYWVDSTIVPLMDNAGKPRQYISIRRD 99
|
| >3ewk_A Sensor protein; PAS domain, alpha/beta fold, kinase, phosphoprotein, transfe flavoprotein; HET: FAD; 2.34A {Methylococcus capsulatus} Length = 227 | Back alignment and structure |
|---|
Score = 73.6 bits (181), Expect = 7e-15
Identities = 25/122 (20%), Positives = 46/122 (37%), Gaps = 8/122 (6%)
Query: 126 NFTDRQYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDF 185
+ + + + + + D + RIIY N + G + E LGQ +L
Sbjct: 107 EAQLARLKQAMDANSEMILLTDRAGRIIYANPALCRFSGMAEGELLGQS-PSILDSPLAD 165
Query: 186 DVAY-DIVHRIKMGERWTGQFPAKTKTE------ERVLVVATNTPFYDDDGTLVGIVCVS 238
+ ++ G+ W+G+ + +T E + TP + D LVG V +
Sbjct: 166 QETLAAMQEALQAGQPWSGRLLNRRRTGPAPHDAEDYWAEISTTPIHTDGNGLVGYVQIQ 225
Query: 239 TD 240
D
Sbjct: 226 HD 227
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 3e-16
Identities = 47/165 (28%), Positives = 76/165 (46%), Gaps = 7/165 (4%)
Query: 513 IGQGSCGTVYHAVWYGSD--VAVKVFSRQE--YSDEVIHSFRQEVSLMKRLRHPNVLLFM 568
+G+GS G V+ A + ++ A+K + D+V + ++ L HP +
Sbjct: 25 LGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMF 84
Query: 569 GAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIH 628
+ + L V E+L G L +Q K D R A +I G+ +LH I++
Sbjct: 85 CTFQTKENLFFVMEYLNGGDLMYHIQSCH-KFDLSRATFYAAEIILGLQFLHSKG--IVY 141
Query: 629 RDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTVTYLA 673
RDLK N+L+DK +K+ DFG+ + T T GT Y+A
Sbjct: 142 RDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIA 186
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 79.8 bits (197), Expect = 4e-16
Identities = 43/196 (21%), Positives = 71/196 (36%), Gaps = 65/196 (33%)
Query: 508 TIGEQIGQGSCGTVYHAVWY--GSDVAVK-VFSRQEYSDEVIHSFRQEVSLMKRLRHPNV 564
++G+ +G GS G V G A+K V Y R E+ +MK L H N+
Sbjct: 10 SLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYK------NR-ELDIMKVLDHVNI 62
Query: 565 ---------------------------------LLFMGAVTSPQR-----LCIVTEFLPR 586
+ L ++ E++P
Sbjct: 63 IKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP- 121
Query: 587 GSLFRLLQRNTTKLDWRRRILMALD--------IARGVSYLHHCNPPIIHRDLKSSNLLV 638
+L ++L K R + ++ + R V ++H I HRD+K NLLV
Sbjct: 122 DTLHKVL-----KSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLG--ICHRDIKPQNLLV 174
Query: 639 D-KHWTVKVGDFGLSR 653
+ K T+K+ DFG ++
Sbjct: 175 NSKDNTLKLCDFGSAK 190
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 6e-16
Identities = 49/231 (21%), Positives = 93/231 (40%), Gaps = 19/231 (8%)
Query: 447 ESHMYEGNRSVNNEAWGSWSSSVNVNSTSSVSSCGSTSSSAVNKVDLDNDCLDYEILWED 506
H ++ + + + + + S A + + L D+++L
Sbjct: 6 HHHHHDYDIPTTENLYFQGAMGSGIEEEKEAMN-TRESGKASSSLGLQ----DFDLL--- 57
Query: 507 LTIGEQIGQGSCGTVYHAVWYGSDV--AVKVFSRQE--YSDEVIHSFRQEVSLMKRLRHP 562
IG+GS V +D A++V ++ +++ ++ + HP
Sbjct: 58 ----RVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHP 113
Query: 563 NVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHC 622
++ + RL V E++ G L +QR + R A +I+ ++YLH
Sbjct: 114 FLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSA-EISLALNYLHER 172
Query: 623 NPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTVTYLA 673
II+RDLK N+L+D +K+ D+G+ + TT T GT Y+A
Sbjct: 173 G--IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIA 221
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 6e-16
Identities = 40/163 (24%), Positives = 83/163 (50%), Gaps = 25/163 (15%)
Query: 500 YEILWEDLTIGEQIGQGSCGTVYHAV--WYGSDVAVK----VFSRQEYSDEVIHSFRQEV 553
YE++ +++G+G+ G V+ ++ G VAVK F + +FR E+
Sbjct: 11 YELV-------KKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDA---QRTFR-EI 59
Query: 554 SLMKRLR-HPNVLLFMGAVTSP--QRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMAL 610
++ L H N++ + + + + + +V +++ L +++ N + ++ ++
Sbjct: 60 MILTELSGHENIVNLLNVLRADNDRDVYLVFDYME-TDLHAVIRANILEPVHKQYVV--Y 116
Query: 611 DIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSR 653
+ + + YLH ++HRD+K SN+L++ VKV DFGLSR
Sbjct: 117 QLIKVIKYLHSGG--LLHRDMKPSNILLNAECHVKVADFGLSR 157
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 1e-15
Identities = 46/241 (19%), Positives = 97/241 (40%), Gaps = 29/241 (12%)
Query: 448 SHMYEGNRSVNNEAWGSWSSSVNVNSTSSVSSCGSTSSSAVN------KVDLDNDCLDYE 501
+H + + + G+ +S + N KV ++ ++E
Sbjct: 2 AHHHHHHEEEGGSSGGAAGTSADGGDGGEQLLTVKHELRTANLTGHAEKVGIE----NFE 57
Query: 502 ILWEDLTIGEQIGQGSCGTVY---HAVWYGSDV--AVKVFSRQ---EYSDEVIHSFRQEV 553
+L + +G G+ G V+ + + A+KV + + + H+ +
Sbjct: 58 LL-------KVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQ 110
Query: 554 SLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIA 613
L + P ++ A + +L ++ +++ G LF L + + +I + +I
Sbjct: 111 VLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVG-EIV 169
Query: 614 RGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLK-HETYLTTKTGKGTVTYL 672
+ +LH II+RD+K N+L+D + V + DFGLS+ + GT+ Y+
Sbjct: 170 LALEHLHKLG--IIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYM 227
Query: 673 A 673
A
Sbjct: 228 A 228
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 79.5 bits (196), Expect = 1e-15
Identities = 38/167 (22%), Positives = 72/167 (43%), Gaps = 11/167 (6%)
Query: 513 IGQGSCGTVYHAVWYGSDV--AVKVFSRQE--YSDEVIHSF--RQEVSLMKRLRHPNVLL 566
IG+G G VY + A+K ++ + R +SL+ P ++
Sbjct: 197 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 256
Query: 567 FMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPI 626
A +P +L + + + G L L ++ A +I G+ ++H+ +
Sbjct: 257 MSYAFHTPDKLSFILDLMNGGDLHYHLSQHG-VFSEADMRFYAAEIILGLEHMHNRF--V 313
Query: 627 IHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTVTYLA 673
++RDLK +N+L+D+H V++ D GL+ + GT Y+A
Sbjct: 314 VYRDLKPANILLDEHGHVRISDLGLACDFSKK--KPHASVGTHGYMA 358
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 77.1 bits (190), Expect = 5e-15
Identities = 37/168 (22%), Positives = 66/168 (39%), Gaps = 10/168 (5%)
Query: 513 IGQGSCGTVYHAVWYGSDV--AVKVFSRQE--YSDEVIHSFRQEVSLMKRLRHPNVLLFM 568
+G+G G V+ + A K +++ + E ++ ++ ++
Sbjct: 193 LGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGA-MVEKKILAKVHSRFIVSLA 251
Query: 569 GAVTSPQRLCIVTEFLPRGSLFRLLQRNTTK---LDWRRRILMALDIARGVSYLHHCNPP 625
A + LC+V + G + + R I I G+ +LH N
Sbjct: 252 YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN-- 309
Query: 626 IIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTVTYLA 673
II+RDLK N+L+D V++ D GL+ TK GT ++A
Sbjct: 310 IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMA 357
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 76.0 bits (187), Expect = 1e-14
Identities = 40/167 (23%), Positives = 68/167 (40%), Gaps = 11/167 (6%)
Query: 513 IGQGSCGTVYHAVWYGSDV--AVKVFSRQE--YSDEVIHSFRQEVSLMKRLRHPNVLLFM 568
+G+G G V + A K ++ + E +++++ V+
Sbjct: 192 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMA-LNEKQILEKVNSRFVVSLA 250
Query: 569 GAVTSPQRLCIVTEFLPRGSLFRLLQR-NTTKLDWRRRILMALDIARGVSYLHHCNPPII 627
A + LC+V + G L + R + A +I G+ LH I+
Sbjct: 251 YAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRER--IV 308
Query: 628 HRDLKSSNLLVDKHWTVKVGDFGLSRLKHETY-LTTKTGKGTVTYLA 673
+RDLK N+L+D H +++ D GL+ H T K GTV Y+A
Sbjct: 309 YRDLKPENILLDDHGHIRISDLGLA--VHVPEGQTIKGRVGTVGYMA 353
|
| >3a0s_A Sensor protein; PAS-fold, kinase, phosphoprotein, transferase, two-component regulatory system; HET: PG4 PGE; 1.47A {Thermotoga maritima} PDB: 3a0v_A* Length = 96 | Back alignment and structure |
|---|
Score = 66.0 bits (161), Expect = 2e-13
Identities = 23/102 (22%), Positives = 38/102 (37%), Gaps = 7/102 (6%)
Query: 139 MGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMG 198
M ++ RI WN+ AE L+G E LG+ +L ++ +
Sbjct: 1 METAIITLSKDGRITEWNKKAEQLFGLKKENVLGRRLKDLPDFE---EIGSVAESVFENK 57
Query: 199 ERWTGQFPAKTKTEERVLVVATNTPFYDDDGTLVGIVCVSTD 240
E F K ER + +PF + L+ V ++ D
Sbjct: 58 EPVFLNF---YKFGERYFNI-RFSPFRNAKTQLLEGVIITID 95
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 69.0 bits (169), Expect = 1e-12
Identities = 51/203 (25%), Positives = 86/203 (42%), Gaps = 37/203 (18%)
Query: 483 TSSSAVNKVDLDNDCLDY-----EILWEDLTIGEQIGQGSCGTVYHAV--WYGSDVAVKV 535
+ N D+D Y + + + + IG+GS G V A VA+K+
Sbjct: 70 GMTGGPNNGGYDDDQGSYVQVPHDHVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKM 129
Query: 536 F-SRQEYSDEVIHSFRQ---EVSLMKRLRH------PNVLLFMGAVTSPQRLCIVTEFLP 585
+ + + RQ E+ +++ LR NV+ + T +C+ E L
Sbjct: 130 VRNEKRF-------HRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHICMTFELL- 181
Query: 586 RGSLFRLLQRNTTK---LDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLV--DK 640
+L+ L+++N + L R+ A I + + LH IIH DLK N+L+
Sbjct: 182 SMNLYELIKKNKFQGFSLPLVRKF--AHSILQCLDALHKNR--IIHCDLKPENILLKQQG 237
Query: 641 HWTVKVGDFGLSRLKHE---TYL 660
+KV DFG S +H+ TY+
Sbjct: 238 RSGIKVIDFGSSCYEHQRVYTYI 260
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 68.6 bits (168), Expect = 2e-12
Identities = 39/188 (20%), Positives = 76/188 (40%), Gaps = 44/188 (23%)
Query: 500 YEILWEDLTIGEQIGQGSCGTVYHAV--WYGSDVAVKVF-SRQEYSDEVIHSFRQEVSLM 556
Y ++ ++G G TV+ A + VA+K+ + Y++ E+ L+
Sbjct: 21 YILV-------RKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAED----EIKLL 69
Query: 557 KRLR--------HPNV-----LL--FMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTK-- 599
+R+ LL F + + +V E L +L L+++ +
Sbjct: 70 QRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGI 128
Query: 600 -LDWRRRILMALDIARGVSYLH-HCNPPIIHRDLKSSNLLVD------KHWTVKVGDFGL 651
L + ++I + + G+ Y+H C IIH D+K N+L++ +K+ D G
Sbjct: 129 PLIYVKQI--SKQLLLGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGN 184
Query: 652 SRLKHETY 659
+ E Y
Sbjct: 185 ACWYDEHY 192
|
| >3a0r_A Sensor protein; four helix bundle, PAS fold, kinase, phosphoprotein, transfe two-component regulatory system; 3.80A {Thermotoga maritima} Length = 349 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 3e-12
Identities = 25/112 (22%), Positives = 43/112 (38%), Gaps = 7/112 (6%)
Query: 130 RQYL-NILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVA 188
R + +IL+S+ ++ RI WN+ AE L+G E LG+ +L DF+
Sbjct: 7 RNFSESILESLETAIITLSKDGRITEWNKKAEQLFGLKKENVLGRRLKDLP----DFEEI 62
Query: 189 YDIVHRIKMGERWTGQFPAKTKTEERVLVVATNTPFYDDDGTLVGIVCVSTD 240
+ + + F K ER + + L G++ D
Sbjct: 63 GSVAESVFENKE--PVFLNFYKFGERYFNIRFSPFRNAKTQLLEGVIITIDD 112
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 66.4 bits (161), Expect = 5e-12
Identities = 32/194 (16%), Positives = 53/194 (27%), Gaps = 48/194 (24%)
Query: 505 EDLTIGEQIGQGSCGTVYHAVWYGSDVAVKV------FSRQEYSDEVIHSFRQEVSLMKR 558
E L E+IG+G G V+ + + VA+K+ + E+ + K
Sbjct: 20 EKLQRCEKIGEGVFGEVFQTIADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKE 79
Query: 559 L---------RHPNVLLFMGA------------------------------VTSPQRLCI 579
L R + +L I
Sbjct: 80 LSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFI 139
Query: 580 VTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVD 639
V EF G L Q T + + ++ + HRDL N+L+
Sbjct: 140 VLEFEFGGID--LEQMRTKLSSLATAKSILHQLTASLAVAEA-SLRFEHRDLHWGNVLLK 196
Query: 640 KHWTVKVGDFGLSR 653
K K+ +
Sbjct: 197 KTSLKKLHYTLNGK 210
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 65.5 bits (160), Expect = 2e-11
Identities = 46/191 (24%), Positives = 80/191 (41%), Gaps = 29/191 (15%)
Query: 494 DNDCLDY-----EILWEDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVF-SRQEYSDEV 545
D+D DY E + I IG+GS G V A VA+K+ +++ + ++
Sbjct: 38 DDDNYDYIVKNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQA 97
Query: 546 IHSFRQEVSLMKRLRHP------NVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTK 599
+ EV L++ + ++ LC+V E L +L+ LL+ +
Sbjct: 98 ----QIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEML-SYNLYDLLRNTNFR 152
Query: 600 ---LDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLV--DKHWTVKVGDFGLSRL 654
L+ R+ A + + +L IIH DLK N+L+ K +K+ DFG S
Sbjct: 153 GVSLNLTRKF--AQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQ 210
Query: 655 KHE---TYLTT 662
+ Y+ +
Sbjct: 211 LGQRIYQYIQS 221
|
| >3b33_A Sensor protein; structural genomics, PAS domain, nitrogen regulation protein APC91440.4, PSI-2; HET: MSE; 1.83A {Vibrio parahaemolyticus rimd 2210633} Length = 115 | Back alignment and structure |
|---|
Score = 59.8 bits (145), Expect = 3e-11
Identities = 20/99 (20%), Positives = 38/99 (38%), Gaps = 2/99 (2%)
Query: 134 NILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVH 193
IL +M + I D I Y N +AELL+ SA+ + Q +L+ +
Sbjct: 11 AILNNMVTATLILDDGLAIRYANPAAELLFSQSAKRIVEQSLSQLIQHASLDLAL--LTQ 68
Query: 194 RIKMGERWTGQFPAKTKTEERVLVVATNTPFYDDDGTLV 232
++ G+ T +++ T +P ++
Sbjct: 69 PLQSGQSITDSDVTFVVDGRPLMLEVTVSPITWQRQLML 107
|
| >3mjq_A Uncharacterized protein; NESG, structural genomics, PSI-2, protein structure initiati northeast structural genomics consortium; 2.60A {Desulfitobacterium hafniense} Length = 126 | Back alignment and structure |
|---|
Score = 59.2 bits (144), Expect = 7e-11
Identities = 18/103 (17%), Positives = 40/103 (38%), Gaps = 2/103 (1%)
Query: 134 NILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVH 193
N L+++ + I + R++Y N + GY+ EE + I +T I+
Sbjct: 3 NFLETIEDMILIINREGRLLYANTAVPKKLGYTHEELMSMH-ILTITSAGKMAEGEKILA 61
Query: 194 RIKMGERWTGQFPAKTKTEERVLVVATNTPF-YDDDGTLVGIV 235
+ G++ + + K + A + ++ L I+
Sbjct: 62 ELFAGKKESLPLSLEKKEGTSIPAKARIWQGKWHNEPCLFAII 104
|
| >3luq_A Sensor protein; PAS, histidine, kinase, PSI, MCSG, structural genomics, midwest center for structural genomics; HET: PGE; 2.49A {Geobacter sulfurreducens} Length = 114 | Back alignment and structure |
|---|
Score = 58.0 bits (141), Expect = 1e-10
Identities = 17/112 (15%), Positives = 38/112 (33%), Gaps = 3/112 (2%)
Query: 130 RQYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAY 189
+ + ++ +FD R + +R YG + LG ++ + + +
Sbjct: 3 ERLRLFTEHAPAALAMFDREMRYLAVSRRWREDYGLGDGDILGMSHYDIFPEIGEEWKSV 62
Query: 190 DIVHRIKMGERWTG-QFPAKTKTEERVLVVATNTPFYDDDGTLVGIVCVSTD 240
R GE + + P+Y+ +G + G+V + D
Sbjct: 63 H--RRGLAGEVIRVEEDCFVRADGRTQWLRWEVRPWYEGEGRVGGVVIFTED 112
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 60.5 bits (147), Expect = 5e-10
Identities = 43/186 (23%), Positives = 70/186 (37%), Gaps = 33/186 (17%)
Query: 509 IGEQIGQGSCGTVYHA--VWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRH----P 562
+G++IG G+ G + ++ VA+K+ E E K+L P
Sbjct: 13 VGKKIGCGNFGELRLGKNLYTNEYVAIKL----EPMKSRAPQLHLEYRFYKQLGSGDGIP 68
Query: 563 NVLLFMGAVTSPQRL--CIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLH 620
V F P +V E L SL L + +++A+ + + Y+H
Sbjct: 69 QVYYF-----GPCGKYNAMVLELLGP-SLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVH 122
Query: 621 HCNPPIIHRDLKSSNLLVDKHWTVKVG-----DFGLSRL-------KHETYLTTKTGKGT 668
N +I+RD+K N L+ + DF L++ KH Y K+ GT
Sbjct: 123 SKN--LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGT 180
Query: 669 VTYLAS 674
Y S
Sbjct: 181 ARY-MS 185
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 59.7 bits (145), Expect = 7e-10
Identities = 45/184 (24%), Positives = 70/184 (38%), Gaps = 29/184 (15%)
Query: 509 IGEQIGQGSCGTVYHA--VWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRH----P 562
+G +IG+GS G ++ + VA+K E R E K L P
Sbjct: 14 VGRRIGEGSFGVIFEGTNLLNNQQVAIK----FEPRRSDAPQLRDEYRTYKLLAGCTGIP 69
Query: 563 NVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHC 622
NV F G +V + L SL LL K + + A + V +H
Sbjct: 70 NVYYF-G--QEGLHNVLVIDLLGP-SLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEK 125
Query: 623 NPPIIHRDLKSSNLLVDKHWT-----VKVGDFGLSRL-------KHETYLTTKTGKGTVT 670
+ +++RD+K N L+ + + + V DFG+ + +H Y K GT
Sbjct: 126 S--LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTAR 183
Query: 671 YLAS 674
Y S
Sbjct: 184 Y-MS 186
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 59.7 bits (145), Expect = 8e-10
Identities = 49/182 (26%), Positives = 73/182 (40%), Gaps = 27/182 (14%)
Query: 509 IGEQIGQGSCGTVYHA--VWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRH----P 562
+G +IG GS G +Y + G +VA+K E E + K ++ P
Sbjct: 13 LGRKIGSGSFGDIYLGTDIAAGEEVAIK----LECVKTKHPQLHIESKIYKMMQGGVGIP 68
Query: 563 NVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHC 622
+ G +V E L SL L + K + +L+A + + Y+H
Sbjct: 69 TIRWC-G--AEGDYNVMVMELLGP-SLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSK 124
Query: 623 NPPIIHRDLKSSNLLV---DKHWTVKVGDFGLSRL-------KHETYLTTKTGKGTVTYL 672
N IHRD+K N L+ K V + DFGL++ +H Y K GT Y
Sbjct: 125 N--FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARY- 181
Query: 673 AS 674
AS
Sbjct: 182 AS 183
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 57.8 bits (140), Expect = 4e-09
Identities = 37/194 (19%), Positives = 67/194 (34%), Gaps = 34/194 (17%)
Query: 509 IGEQIGQGSCGTVYHA--VWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLL 566
+G++IG G G +Y A A V + + + S E+ +R+ + +
Sbjct: 41 LGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFS---ELKFYQRVAKKDCIK 97
Query: 567 FMGAVTSPQRLCIVT-----EFLPRGSLFR-----LLQRNTTKL-DWRRR-----ILM-A 609
L I +G +R L + K+ +L
Sbjct: 98 KWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDLQKISGQNGTFKKSTVLQLG 157
Query: 610 LDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKV--GDFGLSRL-------KHETYL 660
+ + + Y+H +H D+K++NLL+ +V D+GLS K
Sbjct: 158 IRMLDVLEYIHENE--YVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQEN 215
Query: 661 TTKTGKGTVTYLAS 674
K GT+ + S
Sbjct: 216 PRKGHNGTIEF-TS 228
|
| >3mxq_A Sensor protein; PSI2, MCSG, structural genomics, protein structure initiativ midwest center for structural genomics; 2.78A {Vibrio cholerae o1 biovar el tor} Length = 152 | Back alignment and structure |
|---|
Score = 54.6 bits (131), Expect = 6e-09
Identities = 21/128 (16%), Positives = 41/128 (32%), Gaps = 11/128 (8%)
Query: 124 AFNFTDRQYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGR 183
A + +L + ++ I I+ N E + E G++ +EL +
Sbjct: 16 AMAKSRLLLSELLDQLSFALCIVRNDYVIVKVNEYFESRVIFDGETMQGKNILELFPESA 75
Query: 184 DF------DVAYDIVHRIKMGERWTGQFPAK-----TKTEERVLVVATNTPFYDDDGTLV 232
D+ E+ P K + EE++ P + +DGT+
Sbjct: 76 DYLKRKIDTALVIESSSFSSWEQKPHLLPFKSSRPVSGEEEQMYQNLEVIPIHSEDGTIE 135
Query: 233 GIVCVSTD 240
+ D
Sbjct: 136 HVCLCVYD 143
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 56.8 bits (137), Expect = 1e-08
Identities = 37/157 (23%), Positives = 71/157 (45%), Gaps = 28/157 (17%)
Query: 501 EILWEDLTIGEQIGQGSCGTVYHA--VWYGSDVAVKVF-SRQEYSDEVIHSFRQEVSLMK 557
++ + ++G G TV+ + + VA+KV S + Y++ + E+ L+K
Sbjct: 33 DLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALD----EIRLLK 88
Query: 558 RLR-----HPN-----VLLFMGAVTSP--QRLCIVTEFLPRGSLFRLLQRNTTK---LDW 602
+R PN LL ++ +C+V E L L + + ++ + L
Sbjct: 89 SVRNSDPNDPNREMVVQLLDDFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPC 147
Query: 603 RRRILMALDIARGVSYLH-HCNPPIIHRDLKSSNLLV 638
++I+ + +G+ YLH C IIH D+K N+L+
Sbjct: 148 VKKIIQ--QVLQGLDYLHTKCR--IIHTDIKPENILL 180
|
| >2r78_A Sensor protein; sensory box sensor histidine kinase/response regulator, structural genomics, PSI, MCSG; 1.60A {Geobacter sulfurreducens pca} Length = 117 | Back alignment and structure |
|---|
Score = 52.5 bits (127), Expect = 1e-08
Identities = 23/106 (21%), Positives = 41/106 (38%), Gaps = 3/106 (2%)
Query: 130 RQYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAY 189
Y + + + I D + N + GY+ +E L D +L+ G D A
Sbjct: 11 NAYRALFEHAIDGIFIMDAEGHYLDVNPAICSAIGYTRDEFLALD-WGVLSRGVDSGWAA 69
Query: 190 DIVHRIKMGERWTGQFPAKTKTEERVLVVATNTPFYDDDGTLVGIV 235
+ RI GE + T+ +++ V + DG ++GI
Sbjct: 70 ASLARIVGGEPLREERTVWTRNGDQLTVELSAHLL--PDGKILGIA 113
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 55.8 bits (134), Expect = 2e-08
Identities = 42/179 (23%), Positives = 70/179 (39%), Gaps = 21/179 (11%)
Query: 509 IGEQIGQGSCGTVYHA--VWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLR-HPNVL 565
+G +IG GS G +Y + +VA+K E E + + L+ +
Sbjct: 11 LGRKIGSGSFGEIYLGTNIQTNEEVAIK----LENVKTKHPQLLYESKIYRILQGGTGIP 66
Query: 566 LFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPP 625
+V + L SL L + KL + +++A + V ++H +
Sbjct: 67 NVRWFGVEGDYNVLVMDLLGP-SLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS-- 123
Query: 626 IIHRDLKSSNLLVDKHWT---VKVGDFGLSRL-------KHETYLTTKTGKGTVTYLAS 674
+HRD+K N L+ V + DFGL++ +H Y K GT Y AS
Sbjct: 124 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARY-AS 181
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 3e-08
Identities = 39/209 (18%), Positives = 84/209 (40%), Gaps = 57/209 (27%)
Query: 495 NDCLD--YEILWEDLTIGEQIGQGSCGTVYHAV--WYGSDVAVKVF-SRQEYSDEVIHSF 549
L+ + ++ ++G G+ G V AVKV + ++Y+ S
Sbjct: 30 GMLLNNAFLVI-------RKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTR----SA 78
Query: 550 RQEVSLMKRLRH-----PNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTK---LD 601
+ E ++K++++ N++ + G +C++ E L SL+ ++ RN ++
Sbjct: 79 KIEADILKKIQNDDINNNNIVKYHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIE 137
Query: 602 WRRRILMALDIARGVSYLHHCNPPIIHRDLKSSN-LLVDKHWT----------------- 643
+ ++I + ++YL + + H DLK N LL D ++
Sbjct: 138 DIKLY--CIEILKALNYLRKMS--LTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQI 193
Query: 644 -------VKVGDFGLSRLKHE---TYLTT 662
+K+ DFG + K + + + T
Sbjct: 194 YRTKSTGIKLIDFGCATFKSDYHGSIINT 222
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 4e-08
Identities = 46/205 (22%), Positives = 80/205 (39%), Gaps = 53/205 (25%)
Query: 495 NDCLD--YEILWEDLTIGEQIGQGSCGTVYHAV---WYGSDVAVKVF-SRQEYSDEVIHS 548
D L YEI+ +G+G+ G V + S VA+K+ + +Y +
Sbjct: 14 GDWLQERYEIV-------GNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAA--- 63
Query: 549 FRQEVSLMKRLRHP------NVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTK--- 599
R E++++K+++ +L +CI E L + F L+ N +
Sbjct: 64 -RLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHMCIAFELL-GKNTFEFLKENNFQPYP 121
Query: 600 LDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSN-LLVD------------------K 640
L R + A + + +LH + H DLK N L V+ K
Sbjct: 122 LPHVRHM--AYQLCHALRFLHENQ--LTHTDLKPENILFVNSEFETLYNEHKSCEEKSVK 177
Query: 641 HWTVKVGDFGLSRLKHE---TYLTT 662
+ +++V DFG + HE T + T
Sbjct: 178 NTSIRVADFGSATFDHEHHTTIVAT 202
|
| >3mqq_A Transcriptional regulator, LUXR family; PAS domain, PSI, MCSG, structural genomics, center for structural genomics; 1.65A {Burkholderia thailandensis} PDB: 3mqo_A Length = 120 | Back alignment and structure |
|---|
Score = 51.0 bits (123), Expect = 4e-08
Identities = 13/91 (14%), Positives = 24/91 (26%), Gaps = 2/91 (2%)
Query: 151 RIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYD-IVHRIKMGERWTGQFPAKT 209
I N ++ + + +G+ L +F+ + I + + K
Sbjct: 23 VIEDCNDELAAIFRCARADLIGRSFEVLYPSSDEFERIGERISPVMIAHGSYADDRIMKR 82
Query: 210 KTEERVLVVATNTPFYDDDGTLVGIVCVSTD 240
E T D L V D
Sbjct: 83 AGGELFWCHVTGRAL-DRTAPLAAGVWTFED 112
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 54.6 bits (132), Expect = 4e-08
Identities = 49/205 (23%), Positives = 80/205 (39%), Gaps = 53/205 (25%)
Query: 495 NDCLD--YEILWEDLTIGEQIGQGSCGTVYHAVWY---GSDVAVKVF-SRQEYSDEVIHS 548
D L YEI+ + +G+G+ G V + + G VAVK+ + Y +
Sbjct: 9 GDVLSARYEIV-------DTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAA--- 58
Query: 549 FRQEVSLMKRLRHP------NVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTK--- 599
R E+ +++ L + + +CIV E L S + ++ N
Sbjct: 59 -RSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHICIVFELL-GLSTYDFIKENGFLPFR 116
Query: 600 LDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSN-LLVDKHWT--------------- 643
LD R++ A I + V++LH + H DLK N L V +T
Sbjct: 117 LDHIRKM--AYQICKSVNFLHSNK--LTHTDLKPENILFVQSDYTEAYNPKIKRDERTLI 172
Query: 644 ---VKVGDFGLSRLKHE---TYLTT 662
+KV DFG + E T ++T
Sbjct: 173 NPDIKVVDFGSATYDDEHHSTLVST 197
|
| >3fc7_A HTR-like protein, sensor protein; APC87712.1, HTR-like protein,haloarcula marismortui ATCC 430 structural genomics, PSI-2; 2.65A {Haloarcula marismortui} Length = 125 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 5e-08
Identities = 13/111 (11%), Positives = 29/111 (26%), Gaps = 6/111 (5%)
Query: 130 RQYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAY 189
+++ +++ + + I+ N S G + +GQ ++
Sbjct: 19 KKFESLVSDSPDGIVHLTTNGTILSVNPSMAGRLGADPDTLVGQQLSAVMDSEAANQRLE 78
Query: 190 DIVHRIKMGERWTGQFPAKTKTEERVLVVATNTPFYDDDGTLVGIVCVSTD 240
++ G + R P D VS D
Sbjct: 79 AGKSAVENGTATRSE----DAVGGRHYHN-QYIPV-DSHRKSDTFQLVSRD 123
|
| >3bwl_A Sensor protein; structural genomics, APC87707.1, PAS domain, HTR-like protei protein structure initiative; HET: MSE I3A; 1.73A {Haloarcula marismortui atcc 43049} Length = 126 | Back alignment and structure |
|---|
Score = 51.0 bits (123), Expect = 5e-08
Identities = 16/111 (14%), Positives = 34/111 (30%), Gaps = 3/111 (2%)
Query: 130 RQYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAY 189
+ + ++ + + D I N+ GY E LG+ E D +
Sbjct: 17 SRLEALFENSPDMIDVLDADGTICEVNQRFCAELGYDESEVLGRSIWEFDLM-FDAEDVQ 75
Query: 190 DIVHRIKMGERWTGQFPAKTKTEERVLVVATNTPFYDDDGTLVGIVCVSTD 240
+ + ER + + + + V F + + +S D
Sbjct: 76 TQLSGFSVDERRKFEGLYERRDGSTMSVEVHLLRFNLEGEDR--FLAISRD 124
|
| >2gj3_A Nitrogen fixation regulatory protein; PAS domain, FAD, redox sensor, atomic resolution, transferase; HET: FAD; 1.04A {Azotobacter vinelandii} Length = 120 | Back alignment and structure |
|---|
Score = 50.6 bits (122), Expect = 6e-08
Identities = 25/112 (22%), Positives = 50/112 (44%), Gaps = 2/112 (1%)
Query: 130 RQYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGR-DFDVA 188
+ ++ ++ I DL I+Y NR+ + GY +EE LG++ +L++G V
Sbjct: 5 EIFRQTVEHAPIAISITDLKANILYANRAFRTITGYGSEEVLGKNE-SILSNGTTPRLVY 63
Query: 189 YDIVHRIKMGERWTGQFPAKTKTEERVLVVATNTPFYDDDGTLVGIVCVSTD 240
+ R+ + W+G + K + L T P ++ G + + + D
Sbjct: 64 QALWGRLAQKKPWSGVLVNRRKDKTLYLAELTVAPVLNEAGETIYYLGMHRD 115
|
| >3olo_A Two-component sensor histidine kinase; structural genomics, PSI-2, protein structure initiative, MI center for structural genomics, MCSG, TRA; 2.09A {Nostoc SP} Length = 118 | Back alignment and structure |
|---|
Score = 50.7 bits (122), Expect = 6e-08
Identities = 15/111 (13%), Positives = 40/111 (36%), Gaps = 7/111 (6%)
Query: 130 RQYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAY 189
+ ++ + ++ + + +Y N + + YS E+ L + ++ D D A
Sbjct: 13 KFAHYLINNAVEASFCLGDNWQFLYVNDATCRMTEYSREQLLSMNLQDI-----DVDFAL 67
Query: 190 DIVHRIKMGERWTGQFPAKTKTEERVLVVATNTPFYDDDGTLVGIVCVSTD 240
I+ +T + ++++ LV + T D + +
Sbjct: 68 HDWEEIRQKNNYTFKTRYRSQSGRIFLVEMSLTFLEDQERRF--SCVFVRE 116
|
| >2jhe_A Transcription regulator TYRR; aromatic hydrocarbons catabolism, TYRR protei nucleotide-binding, transcription regulation, activator; HET: PG4; 2.30A {Escherichia coli} Length = 190 | Back alignment and structure |
|---|
Score = 51.8 bits (124), Expect = 9e-08
Identities = 21/116 (18%), Positives = 41/116 (35%), Gaps = 22/116 (18%)
Query: 130 RQYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAY 189
+L+++ + V D+ ++ N ++ L+G + A +L+ F+
Sbjct: 80 LALSALLEALPEPVLSVDMKSKVDMANPASCQLFGQKLDRLRNHTAAQLI---NGFNF-- 134
Query: 190 DIVHRIKMGERWTGQFPAKTKTEERVL----VVATNTPFY----DDDGTLVGIVCV 237
RW P + E V+ + TP Y +D L G V +
Sbjct: 135 ---------LRWLESEPQDSHNEHVVINGQNFLMEITPVYLQDENDQHVLTGAVVM 181
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 53.6 bits (129), Expect = 1e-07
Identities = 36/199 (18%), Positives = 67/199 (33%), Gaps = 41/199 (20%)
Query: 509 IGEQIGQGSCGTVYHAVWY-GSDVAVKVFSRQEYSDEVIHS----FRQEVSLMKRLRHPN 563
+G IGQG G +Y A V +V S E+ +R P
Sbjct: 39 VGLPIGQGGFGCIYLADMNSSESVGSD----APCVVKVEPSDNGPLFTELKFYQRAAKPE 94
Query: 564 VLLFMGAVTSPQRLCI-------------------VTEFLPRGSLFRLLQRNTTKLDWRR 604
+ + L + + + L ++ + N + +
Sbjct: 95 QIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGS-DLQKIYEANAKRFSRKT 153
Query: 605 RILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKV--GDFGLSRL-------K 655
+ ++L I + Y+H +H D+K+SNLL++ +V D+GL+ K
Sbjct: 154 VLQLSLRILDILEYIHEHE--YVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHK 211
Query: 656 HETYLTTKTGKGTVTYLAS 674
+ GT+ + S
Sbjct: 212 AYAADPKRCHDGTIEF-TS 229
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 3e-07
Identities = 34/197 (17%), Positives = 67/197 (34%), Gaps = 37/197 (18%)
Query: 509 IGEQIGQGSCGTVYHAV----------WYGSDVAVKVFSRQ-----EYSDEVIHSFRQEV 553
+ + + G +Y A ++K+ ++ E + + +V
Sbjct: 46 LKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQV 105
Query: 554 SLMKRLRH------PNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRIL 607
+ K+L P + F G R +V L R SL L + + R +L
Sbjct: 106 NKWKKLYSTPLLAIPTCMGF-GVHQDKYR-FLVLPSLGR-SLQSALDVSPKHVLSERSVL 162
Query: 608 M-ALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKV--GDFGLSRL-----KHETY 659
A + + +LH +H ++ + N+ VD +V +G + KH Y
Sbjct: 163 QVACRLLDALEFLHENE--YVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAY 220
Query: 660 LTTKTGK--GTVTYLAS 674
+ G + + S
Sbjct: 221 VEGSRSPHEGDLEF-IS 236
|
| >3mfx_A Sensory BOX/ggdef family protein; alpha-beta protein, structural genomics, PSI-2, protein structure initiative; 2.40A {Shewanella oneidensis} Length = 129 | Back alignment and structure |
|---|
Score = 48.6 bits (116), Expect = 4e-07
Identities = 16/119 (13%), Positives = 40/119 (33%), Gaps = 11/119 (9%)
Query: 126 NFTDRQYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDF 185
+ + +Q + +++ + + + I N+ + L GQD LT+
Sbjct: 3 HSSLETIELFIQHLTEAMILVNANGFIRSCNQRSAELLDCPQVSLKGQDWRNFLTEHHQA 62
Query: 186 DVAYDIVHRIKMGERWTGQFPAKTKTEERVL---------VVATNTPFYDDDGTLVGIV 235
+ H +++G P + +E L V + + + V ++
Sbjct: 63 RYDNLLSHDVQLGTN--CGQPVQHPAQETTLICASGKAKDVELSISYIPGHEPMFVMVM 119
|
| >1d06_A Nitrogen fixation regulatory protein FIXL; oxygen sensor, histidine kinase, PAS, high-resolution, two-C system, signaling protein; HET: HEM; 1.40A {Sinorhizobium meliloti} SCOP: d.110.3.2 PDB: 1ew0_A* Length = 130 | Back alignment and structure |
|---|
Score = 46.8 bits (112), Expect = 1e-06
Identities = 12/45 (26%), Positives = 25/45 (55%), Gaps = 1/45 (2%)
Query: 135 ILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELL 179
IL ++ + + I+ +N +A +GY+ EE +GQ+ + +L
Sbjct: 21 ILDTVPDATVVSATDGTIVSFNAAAVRQFGYAEEEVIGQN-LRIL 64
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 49.9 bits (118), Expect = 3e-06
Identities = 55/386 (14%), Positives = 109/386 (28%), Gaps = 106/386 (27%)
Query: 312 MDREGGSGDSHHSD--HGFSDAALSDHREDGMSSGASTPRGDVPPCPFGVFS--HVDEKS 367
MD E G + D F DA + + D DV P + S +D
Sbjct: 7 MDFETGEHQYQYKDILSVFEDAFVDNF--DCK---------DVQDMPKSILSKEEIDH-- 53
Query: 368 PGKSVRDSGDESEGKPAIHKIITSK----AEQWMG---KKGLSW---PWKGNEREGSDAK 417
+ S D G + + SK ++++ + + P K E+
Sbjct: 54 ----IIMSKDAVSGTLRLFWTLLSKQEEMVQKFVEEVLRINYKFLMSPIK-TEQRQPSMM 108
Query: 418 TARFAWPWSHGDQDNESVQQKSPSYGTKPESHMY--EGNRSVNNEAWGSWSSSVNVNSTS 475
T + D+ Q + ++ + ++ + + V ++
Sbjct: 109 TRMYI---EQRDRLYNDNQVFAKYNVSRLQPYLKLRQALLELRPAKN------VLIDG-- 157
Query: 476 SVSSCGSTS--SSAVNKVDLDNDCLDYEILWEDLTIGEQIGQGSCGTVYHAVWYGSDVAV 533
V G T + +D++I W L + + + + Y D
Sbjct: 158 -VLGSGKTWVALDVCLSYKVQ-CKMDFKIFW--LNLKNCNSPETVLEMLQKLLYQIDPNW 213
Query: 534 KVFSRQEYSDEV-IHSFRQEVS-LMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFR 591
S + ++ IHS + E+ L+K + N LL +
Sbjct: 214 TSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLL------------V------------ 249
Query: 592 LLQRNTTKLD--WRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLL---VDKHWTVKV 646
L + A ++ C + R + ++ L H ++
Sbjct: 250 --------LLNVQNAKAWNAFNL--------SCKILLTTRFKQVTDFLSAATTTHISLDH 293
Query: 647 GDFGLSRLKHET------YLTTKTGK 666
L+ E YL +
Sbjct: 294 HSMTLT--PDEVKSLLLKYLDCRPQD 317
|
| >2vv6_A FIXL, sensor protein FIXL; signaling protein, transferase, phosphoprotein, nitrogen FIX PER-ARNT-SIM, metal-binding, PAS, iron, heme; HET: HEM; 1.5A {Bradyrhizobium japonicum} PDB: 1xj6_A* 1xj4_A* 2vv7_A* 2vv8_A* 1lsw_A* 1dp8_A* 1dp9_A* 1drm_A* 1lsv_A* 1dp6_A* 1lsx_A* 1lt0_A* 1y28_A* 2cmn_A* 1xj3_A* 1xj2_A* 2owh_A* 2owj_A* Length = 119 | Back alignment and structure |
|---|
Score = 45.6 bits (109), Expect = 3e-06
Identities = 12/35 (34%), Positives = 22/35 (62%), Gaps = 1/35 (2%)
Query: 145 IFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELL 179
+ D I ++ +AE L+G+S EA+GQ+ + +L
Sbjct: 8 VIDGHGIIQLFSTAAERLFGWSELEAIGQN-VNIL 41
|
| >1v9y_A Heme PAS sensor protein; signaling protein; HET: HEM; 1.32A {Escherichia coli} SCOP: d.110.3.2 PDB: 1v9z_A* 1vb6_A* 1s67_L* 1s66_L* Length = 167 | Back alignment and structure |
|---|
Score = 46.1 bits (110), Expect = 6e-06
Identities = 16/56 (28%), Positives = 31/56 (55%), Gaps = 1/56 (1%)
Query: 124 AFNFTDRQYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELL 179
A N D + L+ + + +D ++++N +AE L+GY EE +G + I++L
Sbjct: 34 ADNAADGIFFPALEQNMMGAVLINENDEVMFFNPAAEKLWGYKREEVIGNN-IDML 88
|
| >1ll8_A PAS kinase; PAS domain, ligand binding, ligand screening, kinase regulation, transferase; NMR {Homo sapiens} SCOP: d.110.3.5 Length = 114 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 6e-06
Identities = 13/103 (12%), Positives = 31/103 (30%), Gaps = 5/103 (4%)
Query: 135 ILQSMGQSVHIFDLSD-RIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVH 193
+ +++ D I+ N A L GYS+++ +GQ + V
Sbjct: 3 MDPEFNKAIFTVDAKTTEILVANDKACGLLGYSSQDLIGQKLTQFFLRSDSDVVEALSEE 62
Query: 194 RIKMGERWT----GQFPAKTKTEERVLVVATNTPFYDDDGTLV 232
++ +++ E++ V +
Sbjct: 63 HMEADGHAAVVFGTVVDIISRSGEKIPVSVWMKRMRQERRLCC 105
|
| >3p7n_A Sensor histidine kinase; LOV domain, light-activated transcription factor, DNA bindin; HET: FMN; 2.10A {Erythrobacter litoralis} Length = 258 | Back alignment and structure |
|---|
Score = 46.1 bits (109), Expect = 1e-05
Identities = 26/163 (15%), Positives = 56/163 (34%), Gaps = 2/163 (1%)
Query: 152 IIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGERWTGQFPAKTKT 211
+I N++ L GYS EE +G++ L G + + I ++ + + K
Sbjct: 88 LIAINQAFTDLTGYSEEECVGRNCRFLAGSGTEPWLTDKIRQGVREHKPVLVEILNYKKD 147
Query: 212 EERVLVVATNTPFYDDDGTLVGIVCVSTDSRPFQETRAALWDTKNSDTDSNINRPRNTVT 271
P YDDD L+ + + Q + ++ ++ + VT
Sbjct: 148 GTPFRNAVLVAPIYDDDDELLYFLGSQVEVDDDQPNMGMARRERAAEMLKTLSPRQLEVT 207
Query: 272 AKLGLDSQQPLQATI--ASKISNLATKVSNKVKSRIRTGDNFM 312
+ + A S+ + + K ++T + +
Sbjct: 208 TLVASGLRNKEVAARLGLSEKTVKMHRGLVMEKLNLKTSADLV 250
|
| >3t50_A Blue-light-activated histidine kinase; PAS superfamily, blue-light photoreceptor, FMN binding, TRAN; HET: FMN; 1.64A {Brucella melitensis} Length = 128 | Back alignment and structure |
|---|
Score = 44.1 bits (105), Expect = 1e-05
Identities = 20/90 (22%), Positives = 33/90 (36%)
Query: 151 RIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGERWTGQFPAKTK 210
I++ N + L GY A+E +G++ L G D I I + K
Sbjct: 21 PIVFANPAFLKLTGYEADEVMGRNCRFLQGHGTDPAHVRAIKSAIAAEKPIDIDIINYKK 80
Query: 211 TEERVLVVATNTPFYDDDGTLVGIVCVSTD 240
+ E +P ++ +G L V D
Sbjct: 81 SGEAFWNRLHISPVHNANGRLQHFVSSQLD 110
|
| >3fg8_A Uncharacterized protein RHA05790; PAS domain, structural genomics, PS protein structure initiative, midwest center for structural genomics, MCSG; HET: 3PB; 1.80A {Rhodococcus SP} Length = 118 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 2e-05
Identities = 18/62 (29%), Positives = 22/62 (35%), Gaps = 2/62 (3%)
Query: 130 RQYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELL--TDGRDFDV 187
N+ G D RIIY N S +E LG+ E+L T G FD
Sbjct: 12 SGRENLYFQGGLGFMALDEDLRIIYVNSGCLRHVRRSRDELLGRVVTEVLPETQGSYFDA 71
Query: 188 AY 189
Sbjct: 72 LC 73
|
| >3vol_A Aerotaxis transducer AER2; heme, oxygen sensor protein, PAS, HAMP, cyanoMet, CN-bound, protein; HET: HEM; 2.40A {Pseudomonas aeruginosa} Length = 233 | Back alignment and structure |
|---|
Score = 44.9 bits (105), Expect = 3e-05
Identities = 28/180 (15%), Positives = 61/180 (33%), Gaps = 7/180 (3%)
Query: 134 NILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTD---GRDFDVAY- 189
+ L ++ +V I D IIY NR+ + G + + + + G + DV +
Sbjct: 26 SALDNVSANVMIADNDLNIIYMNRTVSEMLGRAEAD-IRKQLPNFDAGRLMGANIDVFHK 84
Query: 190 DIVHRIKMGERWTGQFPAKTKTEERVLVVATNTPFYDDDGTLVGIVCVSTDSRPFQETRA 249
+ H+ + TG A+ R + P ++D +G TD
Sbjct: 85 NPAHQRHLLANLTGVHKAELNLGGRRFSL-DVVPVFNDANERLGSAVQWTDRTEEHRAEQ 143
Query: 250 ALWDTKNSDTDSNINRPRNTVTAKLGLDSQQPLQATIASKISNLATKVSNKVKSRIRTGD 309
+ + + ++ R K G + ++ + +++ + GD
Sbjct: 144 EVSQLVQAAAAGDFSK-RVEEAGKEGFFLRLAKDLNSLVDTADRGLRDVSRMLGALAQGD 202
|
| >3k3c_A Protein RV1364C/MT1410; sensor, PAS, signal transduction, fatty-acid binding, sigma regulator, signaling protein; HET: PLM; 1.62A {Mycobacterium tuberculosis} PDB: 3k3d_A Length = 158 | Back alignment and structure |
|---|
Score = 43.8 bits (104), Expect = 3e-05
Identities = 19/118 (16%), Positives = 39/118 (33%), Gaps = 10/118 (8%)
Query: 130 RQYLNILQSMGQSVHIFDLSD-RIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVA 188
I + + + + D R + N + + +GQ A E+ + +
Sbjct: 17 EDVRRIFEHIPAILVGLEGPDHRFVAVNAAYRGFSP--LLDTVGQPAREVYPELEGQQIY 74
Query: 189 YDIVHRI------KMGERWTGQFPAKTKTEERVLVVATNTPFYDDDGTLVGIVCVSTD 240
+++ R+ + G W Q E TP DG++ G+ + D
Sbjct: 75 -EMLDRVYQTGEPQSGSEWRLQTDYDGSGVEERYFDFVVTPRRRADGSIEGVQLIVDD 131
|
| >3kx0_X Uncharacterized protein RV1364C/MT1410; PAS domain, sensory domain, mycobacteium tuberculos molecule binding domain; 2.30A {Mycobacterium tuberculosis} Length = 185 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 3e-05
Identities = 19/118 (16%), Positives = 39/118 (33%), Gaps = 10/118 (8%)
Query: 130 RQYLNILQSMGQSVHIFDLSD-RIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVA 188
I + + + + D R + N + + +GQ A E+ + +
Sbjct: 37 EDVRRIFEHIPAILVGLEGPDHRFVAVNAAYRGFSP--LLDTVGQPAREVYPELEGQQIY 94
Query: 189 YDIVHRI------KMGERWTGQFPAKTKTEERVLVVATNTPFYDDDGTLVGIVCVSTD 240
+++ R+ + G W Q E TP DG++ G+ + D
Sbjct: 95 -EMLDRVYQTGEPQSGSEWRLQTDYDGSGVEERYFDFVVTPRRRADGSIEGVQLIVDD 151
|
| >3sw1_A Sensory box protein; light-oxygen-voltage, LOV, PAS, signaling protein; HET: FMN; 2.63A {Pseudomonas putida} Length = 162 | Back alignment and structure |
|---|
Score = 43.8 bits (104), Expect = 4e-05
Identities = 23/90 (25%), Positives = 30/90 (33%)
Query: 151 RIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGERWTGQFPAKTK 210
+IY N + E L GYS +E L QD L D RD I + G K
Sbjct: 49 ILIYVNAAFEYLTGYSRDEILYQDCRFLQGDDRDQLGRARIRKAMAEGRPCREVLRNYRK 108
Query: 211 TEERVLVVATNTPFYDDDGTLVGIVCVSTD 240
+ TP D + + D
Sbjct: 109 DGSAFWNELSITPVKSDFDQRTYFIGIQKD 138
|
| >2pr5_A Blue-light photoreceptor; light-oxygen-voltage, LOV, PER-ARNT-SIM, PAS, flavoprotein, protein; HET: FMN; 1.45A {Bacillus subtilis} PDB: 2pr6_A* Length = 132 | Back alignment and structure |
|---|
Score = 41.7 bits (99), Expect = 8e-05
Identities = 22/85 (25%), Positives = 31/85 (36%), Gaps = 1/85 (1%)
Query: 151 RIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGERWTGQFPAKTK 210
I+Y N+ + GY EE LG++ L D +I ++ E T Q K
Sbjct: 23 PIVYVNQGFVQMTGYETEEILGKNCRFLQGKHTDPAEVDNIRTALQNKEPVTVQIQNYKK 82
Query: 211 TEERVLVVATNTPFYDDDGTL-VGI 234
P +D T VGI
Sbjct: 83 DGTMFWNELNIDPMEIEDKTYFVGI 107
|
| >2qkp_A Uncharacterized protein; structural genomics, unknown function, PSI-2, protein struct initiative; 1.75A {Streptococcus mutans} Length = 151 | Back alignment and structure |
|---|
Score = 42.4 bits (100), Expect = 9e-05
Identities = 21/128 (16%), Positives = 47/128 (36%), Gaps = 6/128 (4%)
Query: 127 FTDRQYLNILQSMGQSVHIFDLSDRIIYWNRSA---ELLYGYSAEEALGQDAIELLTDGR 183
+ Q IL + + + D Y+N S E+++ + +G++ +
Sbjct: 16 LSVEQANLILNHLPLEITFVNKDDIFQYYNDSVPAAEMVFKRT-PSQVGRNVELCHPP-K 73
Query: 184 DFDVAYDIVHRIKMGERWTGQFPAKTKTEERVLVVATNTPFYDDDGTLVGIVCVSTDSRP 243
D + ++ G+R +++ + + V T D G G++ D +P
Sbjct: 74 VLDKVKKVFELLRNGQRDKVNMWFQSERLGKFVYV-TYAAVRDQAGDFQGVLEYVQDIKP 132
Query: 244 FQETRAAL 251
F E +
Sbjct: 133 FFELDSEF 140
|
| >2vlg_A Sporulation kinase A; histidine kinase, two-component regulatory system, two-component signal transduction, transferase, phosphorylation, SCOD; 1.7A {Bacillus subtilis} Length = 111 | Back alignment and structure |
|---|
Score = 40.5 bits (95), Expect = 2e-04
Identities = 18/107 (16%), Positives = 30/107 (28%), Gaps = 5/107 (4%)
Query: 135 ILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELL-TDGRDFDVAYDIVH 193
LQ+ + + RIIY + +++L GY E +G L + D +
Sbjct: 4 PLQTKTDIHAVLASNGRIIYISANSKLHLGYLQGEMIGSFLKTFLHEE----DQFLVESY 59
Query: 194 RIKMGERWTGQFPAKTKTEERVLVVATNTPFYDDDGTLVGIVCVSTD 240
F K V V A + +
Sbjct: 60 FYNEHHLMPCTFRFIKKDHTIVWVEAAVEIVTTRAERTEREIILKMK 106
|
| >3cax_A Uncharacterized protein PF0695; structural genomics, unknown function, PSI-2, protein struct initiative; 2.43A {Pyrococcus furiosus dsm 3638} Length = 369 | Back alignment and structure |
|---|
Score = 42.8 bits (100), Expect = 3e-04
Identities = 24/167 (14%), Positives = 58/167 (34%), Gaps = 10/167 (5%)
Query: 80 PDAASAWKATNSASFRHSSPLQRESKGGDSGGSDAAGNSNSGPSAFNFTDRQYLNILQSM 139
P+ T + + Q + + +G + I +++
Sbjct: 193 PELNVEQLLTLPKEVQQALRGQPLEFDKTQLKREEDIDLGTG----YLNIEELKAIFEAL 248
Query: 140 GQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGE 199
V D DR+ +++ E ++ + LG+ + V I+ K G
Sbjct: 249 PVDVTFIDKDDRVRFFSP-GERIFTRT-PSVLGRPVQLCHPP-KSVYVVNKILKAFKEGR 305
Query: 200 RWTGQFPAKTKTEERVLVVATNTPFYDDDGTLVGIVCVSTDSRPFQE 246
+ F + E+ V + P +++ G +G + ++ D P+++
Sbjct: 306 KKEATFWLR-LREKYVYI--KYVPLFNEKGEYIGTLEMTMDIAPYKK 349
|
| >2w0n_A Sensor protein DCUS; signal transduction, two-component regulatory system, PAS, kinase, membrane, transferase, solid state cell inner membrane; NMR {Escherichia coli} Length = 118 | Back alignment and structure |
|---|
Score = 40.0 bits (94), Expect = 3e-04
Identities = 18/106 (16%), Positives = 39/106 (36%), Gaps = 15/106 (14%)
Query: 135 ILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAE---EALGQDAIELLTDGRDFDVAYDI 191
+LQS+ + V D + N +A+ L Y E L + +V
Sbjct: 20 MLQSIKEGVVAVDDRGEVTLINDAAQELLNYRKSQDDEKLSTLSHSWSQVVDVSEV---- 75
Query: 192 VHRIKMGERWTGQFPAKTKTEERVLVVATNTPFYDDDGTLVGIVCV 237
++ G + + ++R+L++ P +G ++G +
Sbjct: 76 ---LRDGTPRRDE---EITIKDRLLLI-NTVPVR-SNGVIIGAIST 113
|
| >3ue6_A Aureochrome1; PAS/LOV domain, FMN-binding blue-light photoreceptor, signal protein; HET: FMN; 2.75A {Vaucheria frigida} PDB: 3ulf_A* Length = 166 | Back alignment and structure |
|---|
Score = 40.8 bits (96), Expect = 3e-04
Identities = 26/115 (22%), Positives = 40/115 (34%), Gaps = 3/115 (2%)
Query: 129 DRQYLNILQSMGQSVHIFDLSD---RIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDF 185
D + LQ Q+ I D S I+Y +R L GYS ++ LG++ L D
Sbjct: 34 DYSLVKALQMAQQNFVITDASLPDNPIVYASRGFLTLTGYSLDQILGRNCRFLQGPETDP 93
Query: 186 DVAYDIVHRIKMGERWTGQFPAKTKTEERVLVVATNTPFYDDDGTLVGIVCVSTD 240
I + I G + + + D G +V V V +
Sbjct: 94 RAVDKIRNAITKGVDTSVCLLNYRQDGTTFWNLFFVAGLRDSKGNIVNYVGVQSK 148
|
| >2v0u_A NPH1-1, LOV2; kinase, transferase, ATP-binding, serine/threonine-protein kinase, light-induced signal trans phototropin1, nucleotide-binding; HET: FMN; 1.40A {Avena sativa} PDB: 2v0w_A* 2v1b_A* 2v1a_A* 1jnu_A* 1g28_A* Length = 146 | Back alignment and structure |
|---|
Score = 39.5 bits (93), Expect = 6e-04
Identities = 23/90 (25%), Positives = 33/90 (36%)
Query: 151 RIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGERWTGQFPAKTK 210
II+ + S L YS EE LG++ L D I I T Q TK
Sbjct: 26 PIIFASDSFLQLTEYSREEILGRNCRFLQGPETDRATVRKIRDAIDNQTEVTVQLINYTK 85
Query: 211 TEERVLVVATNTPFYDDDGTLVGIVCVSTD 240
+ ++ + P D G + + V D
Sbjct: 86 SGKKFWNLFHLQPMRDQKGDVQYFIGVQLD 115
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* Length = 282 | Back alignment and structure |
|---|
Score = 41.1 bits (96), Expect = 7e-04
Identities = 33/183 (18%), Positives = 61/183 (33%), Gaps = 38/183 (20%)
Query: 491 VDLDNDCLDYEILWEDL------TIGEQIGQGSCGTVYHAV-WYGSDVAVKVF------- 536
L L + IG+ +G+G V++ + VK
Sbjct: 70 STFTFIGLSLYSLHRLVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSF 129
Query: 537 ----SRQEYSD-----EVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRG 587
+++Y D I S R E +++L+ V + ++ E +
Sbjct: 130 KKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW----EGNAVLMELIDAK 185
Query: 588 SLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVG 647
L+R+ N ++ I V+ +H I+H DL N+LV + +
Sbjct: 186 ELYRVRVENPDEVLD--------MILEEVAKFYHRG--IVHGDLSQYNVLVS-EEGIWII 234
Query: 648 DFG 650
DF
Sbjct: 235 DFP 237
|
Structure Templates Detected by HHsearch 
Original result of HHsearch against PDB70 database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 674 | |||
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 99.98 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 99.98 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 99.97 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 99.97 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 99.97 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 99.97 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 99.97 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 99.96 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 99.96 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 99.96 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 99.96 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 99.96 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 99.96 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 99.96 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 99.96 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 99.96 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 99.96 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 99.96 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 99.96 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 99.96 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 99.96 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 99.96 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 99.96 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 99.96 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 99.96 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 99.96 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 99.96 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 99.96 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 99.96 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 99.96 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 99.96 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 99.96 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 99.96 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 99.96 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 99.96 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 99.96 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 99.96 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 99.96 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 99.96 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 99.96 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 99.96 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 99.96 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 99.96 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 99.95 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 99.95 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 99.95 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 99.95 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 99.95 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 99.95 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 99.95 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 99.95 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 99.95 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 99.95 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 99.95 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 99.95 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 99.95 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 99.95 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 99.95 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 99.95 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 99.95 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 99.95 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 99.95 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 99.95 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 99.95 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 99.95 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 99.95 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 99.95 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 99.95 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 99.95 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 99.95 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 99.95 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 99.95 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 99.95 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 99.95 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 99.95 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 99.95 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 99.95 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 99.95 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 99.95 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 99.95 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 99.95 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 99.95 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 99.95 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 99.95 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 99.95 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 99.95 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 99.95 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 99.95 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 99.95 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 99.95 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 99.95 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 99.95 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 99.95 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 99.95 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 99.95 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 99.95 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 99.95 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 99.95 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 99.95 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 99.95 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 99.95 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 99.95 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 99.95 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 99.95 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 99.95 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 99.95 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 99.95 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 99.95 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 99.95 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 99.95 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 99.95 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 99.95 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 99.95 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 99.95 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 99.95 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 99.95 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 99.95 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 99.95 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 99.95 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 99.95 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 99.95 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 99.95 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 99.95 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 99.95 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 99.95 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 99.95 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 99.94 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 99.94 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 99.94 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 99.94 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 99.94 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 99.94 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 99.94 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 99.94 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 99.94 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 99.94 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 99.94 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 99.94 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 99.94 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 99.94 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 99.94 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 99.94 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 99.94 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 99.94 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 99.94 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 99.94 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 99.94 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 99.94 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 99.94 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 99.94 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 99.94 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 99.94 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 99.94 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 99.94 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 99.94 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 99.94 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 99.94 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 99.94 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 99.94 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 99.94 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 99.94 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 99.94 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 99.94 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 99.94 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 99.94 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 99.94 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 99.94 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 99.94 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 99.94 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 99.94 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 99.94 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 99.94 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 99.94 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 99.94 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 99.94 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 99.94 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 99.94 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 99.94 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.94 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 99.94 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 99.94 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 99.94 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 99.94 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 99.94 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 99.94 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 99.94 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 99.94 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 99.94 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 99.94 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 99.94 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 99.94 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 99.94 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 99.94 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 99.94 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 99.94 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 99.94 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 99.94 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 99.94 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 99.94 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 99.93 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 99.93 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 99.93 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 99.93 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 99.93 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 99.93 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 99.93 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 99.93 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 99.93 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 99.93 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 99.93 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 99.93 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 99.93 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 99.93 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 99.93 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 99.93 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 99.93 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 99.93 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 99.93 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 99.93 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 99.93 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 99.93 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 99.93 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 99.93 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 99.93 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 99.92 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 99.92 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 99.92 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 99.92 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 99.92 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 99.91 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.91 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 99.91 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 99.91 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 99.91 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 99.89 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.85 | |
| 4hia_A | 176 | LOV protein; PAS, HTH, signaling protein; HET: FMN | 99.82 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.81 | |
| 2gj3_A | 120 | Nitrogen fixation regulatory protein; PAS domain, | 99.79 | |
| 2pr5_A | 132 | Blue-light photoreceptor; light-oxygen-voltage, LO | 99.76 | |
| 3p7n_A | 258 | Sensor histidine kinase; LOV domain, light-activat | 99.75 | |
| 3ue6_A | 166 | Aureochrome1; PAS/LOV domain, FMN-binding blue-lig | 99.72 | |
| 1n9l_A | 109 | PHOT-LOV1, putative blue light receptor; phototrop | 99.72 | |
| 3t50_A | 128 | Blue-light-activated histidine kinase; PAS superfa | 99.71 | |
| 3sw1_A | 162 | Sensory box protein; light-oxygen-voltage, LOV, PA | 99.71 | |
| 3k3c_A | 158 | Protein RV1364C/MT1410; sensor, PAS, signal transd | 99.68 | |
| 3f1p_B | 121 | ARYL hydrocarbon receptor nuclear translocator; PA | 99.68 | |
| 2wkq_A | 332 | NPH1-1, RAS-related C3 botulinum toxin substrate 1 | 99.68 | |
| 3mr0_A | 142 | Sensory box histidine kinase/response regulator; P | 99.67 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.67 | |
| 2vv6_A | 119 | FIXL, sensor protein FIXL; signaling protein, tran | 99.66 | |
| 4eet_B | 115 | Phototropin-2; LOV, blue light photoreceptor, sign | 99.66 | |
| 3lyx_A | 124 | Sensory BOX/ggdef domain protein; structural genom | 99.66 | |
| 2r78_A | 117 | Sensor protein; sensory box sensor histidine kinas | 99.65 | |
| 2z6d_A | 130 | Phototropin-2; PAS-fold, LOV-fold, alternative spl | 99.65 | |
| 3nja_A | 125 | Probable ggdef family protein; structural genomics | 99.65 | |
| 3f1p_A | 117 | Endothelial PAS domain-containing protein 1; PAS d | 99.64 | |
| 3mqq_A | 120 | Transcriptional regulator, LUXR family; PAS domain | 99.64 | |
| 3mxq_A | 152 | Sensor protein; PSI2, MCSG, structural genomics, p | 99.64 | |
| 3luq_A | 114 | Sensor protein; PAS, histidine, kinase, PSI, MCSG, | 99.63 | |
| 3ewk_A | 227 | Sensor protein; PAS domain, alpha/beta fold, kinas | 99.62 | |
| 3kx0_X | 185 | Uncharacterized protein RV1364C/MT1410; PAS domain | 99.61 | |
| 1d06_A | 130 | Nitrogen fixation regulatory protein FIXL; oxygen | 99.59 | |
| 2v0u_A | 146 | NPH1-1, LOV2; kinase, transferase, ATP-binding, se | 99.56 | |
| 2qkp_A | 151 | Uncharacterized protein; structural genomics, unkn | 99.56 | |
| 3ewk_A | 227 | Sensor protein; PAS domain, alpha/beta fold, kinas | 99.54 | |
| 3icy_A | 118 | Sensor protein; sensory box histidine kinase/respo | 99.54 | |
| 3mjq_A | 126 | Uncharacterized protein; NESG, structural genomics | 99.54 | |
| 3h9w_A | 115 | Diguanylate cyclase with PAS/PAC sensor; alpha-bet | 99.53 | |
| 3eeh_A | 125 | Putative light and redox sensing histidine kinase; | 99.52 | |
| 3vol_A | 233 | Aerotaxis transducer AER2; heme, oxygen sensor pro | 99.52 | |
| 3olo_A | 118 | Two-component sensor histidine kinase; structural | 99.52 | |
| 1v9y_A | 167 | Heme PAS sensor protein; signaling protein; HET: H | 99.52 | |
| 2l0w_A | 138 | Potassium voltage-gated channel, subfamily H (EAG | 99.49 | |
| 2kdk_A | 121 | ARYL hydrocarbon receptor nuclear translocator-LI | 99.48 | |
| 1byw_A | 110 | Protein (human ERG potassium channel); PAS domain, | 99.46 | |
| 4hi4_A | 121 | Aerotaxis transducer AER2; PAS domain, diatomic GA | 99.45 | |
| 3d72_A | 149 | Vivid PAS protein VVD; circadian, photoreceptor, b | 99.45 | |
| 3mfx_A | 129 | Sensory BOX/ggdef family protein; alpha-beta prote | 99.45 | |
| 3bwl_A | 126 | Sensor protein; structural genomics, APC87707.1, P | 99.44 | |
| 3b33_A | 115 | Sensor protein; structural genomics, PAS domain, n | 99.4 | |
| 3fc7_A | 125 | HTR-like protein, sensor protein; APC87712.1, HTR- | 99.37 | |
| 3fg8_A | 118 | Uncharacterized protein RHA05790; PAS domain, stru | 99.36 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.34 | |
| 4eho_A | 635 | Bacteriophytochrome, PAS/PAC sensor; photoreceptor | 99.32 | |
| 3cax_A | 369 | Uncharacterized protein PF0695; structural genomic | 99.3 | |
| 3a0r_A | 349 | Sensor protein; four helix bundle, PAS fold, kinas | 99.25 | |
| 2vlg_A | 111 | Sporulation kinase A; histidine kinase, two-compon | 99.25 | |
| 4f3l_A | 361 | Mclock, circadian locomoter output cycles protein | 99.25 | |
| 1nwz_A | 125 | PYP, photoactive yellow protein; PAS, LOV, GAF, do | 99.17 | |
| 3a0s_A | 96 | Sensor protein; PAS-fold, kinase, phosphoprotein, | 99.16 | |
| 2w0n_A | 118 | Sensor protein DCUS; signal transduction, two-comp | 99.15 | |
| 4f3l_B | 387 | BMAL1B; BHLH, PAS, circadian rhythm proteins, tran | 99.15 | |
| 1ll8_A | 114 | PAS kinase; PAS domain, ligand binding, ligand scr | 99.15 | |
| 1mzu_A | 129 | PPR; photoactive yellow protein, PAS, PYP, signali | 99.14 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.11 | |
| 2jhe_A | 190 | Transcription regulator TYRR; aromatic hydrocarbon | 99.11 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.1 | |
| 3rty_A | 339 | Period circadian protein; PAS domain, signalling, | 98.84 | |
| 2ykf_A | 305 | Pdtas, probable sensor histidine kinase pdtas; tra | 98.2 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.71 | |
| 4dj3_A | 317 | Period circadian protein homolog 3; PAS domain, ci | 98.64 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.6 | |
| 3gdi_A | 309 | Period circadian protein homolog 2; tandem PAS dom | 98.59 | |
| 4dj2_A | 320 | Period circadian protein homolog 1; PAS domains, c | 98.54 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.54 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.44 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.4 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.2 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.19 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.17 | |
| 4f3l_A | 361 | Mclock, circadian locomoter output cycles protein | 98.04 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.97 | |
| 4f3l_B | 387 | BMAL1B; BHLH, PAS, circadian rhythm proteins, tran | 97.88 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.75 | |
| 3rty_A | 339 | Period circadian protein; PAS domain, signalling, | 97.65 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.64 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.38 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.38 | |
| 1oj5_A | 132 | Steroid receptor coactivator 1A; transcriptional c | 97.34 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.33 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.24 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.02 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.82 | |
| 4dj2_A | 320 | Period circadian protein homolog 1; PAS domains, c | 96.73 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 96.72 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.67 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.63 | |
| 4dj3_A | 317 | Period circadian protein homolog 3; PAS domain, ci | 96.49 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.41 | |
| 3gdi_A | 309 | Period circadian protein homolog 2; tandem PAS dom | 96.24 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.6 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 95.19 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 92.9 | |
| 4dah_A | 217 | Sporulation kinase D; alpha-beta-alpha structure, | 92.74 | |
| 2ool_A | 337 | Sensor protein; bacteriophytochrome, photoconversi | 92.59 | |
| 1p0z_A | 131 | Sensor kinase CITA; transferase; HET: FLC MO7; 1.6 | 91.84 | |
| 3ra3_B | 28 | P2F; coiled coil domain, fiber, KIH interactions, | 89.58 | |
| 3by8_A | 142 | Sensor protein DCUS; histidine kinase sensor domai | 89.19 | |
| 3lif_A | 254 | Putative diguanylate cyclase (ggdef) with PAS/PAC; | 84.55 | |
| 4e04_A | 327 | Bacteriophytochrome (light-regulated signal trans | 81.62 | |
| 1dip_A | 78 | Delta-sleep-inducing peptide immunoreactive peptid | 81.42 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 81.3 |
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=339.65 Aligned_cols=169 Identities=25% Similarity=0.418 Sum_probs=148.7
Q ss_pred cCCeeEeeeecccCceEEEEEEE--cCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeEEEEE
Q 005841 504 WEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVT 581 (674)
Q Consensus 504 ~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 581 (674)
.++|+++++||+|+||+||+|++ +++.||||++.+........+.+.+|+.+|+.|+|||||++++++.+.+.+||||
T Consensus 23 me~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVm 102 (350)
T 4b9d_A 23 MEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVM 102 (350)
T ss_dssp CCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEE
Confidence 36899999999999999999998 4778999999988777777889999999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccccCCcc
Q 005841 582 EFLPRGSLFRLLQRNT-TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYL 660 (674)
Q Consensus 582 E~~~ggsL~~~l~~~~-~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~~~~ 660 (674)
|||+||+|.++|...+ ..+++..++.|+.||+.||+|||+++ ||||||||+||||+.+++|||+|||+|+.+.....
T Consensus 103 Ey~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~--IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~ 180 (350)
T 4b9d_A 103 DYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRK--ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVE 180 (350)
T ss_dssp ECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT--CEETTCCGGGEEECTTCCEEECSTTEESCCCHHHH
T ss_pred eCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCCHHHEEECCCCCEEEcccccceeecCCcc
Confidence 9999999999997543 45799999999999999999999999 99999999999999999999999999998765444
Q ss_pred ccccCCCCccccCC
Q 005841 661 TTKTGKGTVTYLAS 674 (674)
Q Consensus 661 ~~~~~~GTp~YmAP 674 (674)
...+.+|||.||||
T Consensus 181 ~~~~~~GT~~YmAP 194 (350)
T 4b9d_A 181 LARACIGTPYYLSP 194 (350)
T ss_dssp HHHHHHSCCTTCCH
T ss_pred cccccCCCccccCH
Confidence 44557899999998
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=333.95 Aligned_cols=168 Identities=24% Similarity=0.415 Sum_probs=150.2
Q ss_pred cCCeeEeeeecccCceEEEEEEE--cCCeEEEEEeecccCC-HHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeEEEE
Q 005841 504 WEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYS-DEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIV 580 (674)
Q Consensus 504 ~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 580 (674)
.++|+++++||+|+||+||+|++ ++..||||++.+.... ....+.+.+|+.+|+.|+|||||+++++|.+.+.+|||
T Consensus 31 ~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yiv 110 (311)
T 4aw0_A 31 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFG 110 (311)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 36799999999999999999998 4778999999875432 23456789999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccccCC--
Q 005841 581 TEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHET-- 658 (674)
Q Consensus 581 ~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~~-- 658 (674)
||||+||+|.++|.+. ..+++..+..|+.||+.||+|||+++ ||||||||+||||+.+++|||+|||+|+.+...
T Consensus 111 mEy~~gG~L~~~i~~~-~~l~e~~~~~~~~qi~~al~ylH~~~--IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~ 187 (311)
T 4aw0_A 111 LSYAKNGELLKYIRKI-GSFDETCTRFYTAEIVSALEYLHGKG--IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK 187 (311)
T ss_dssp ECCCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTSCEEECCCTTCEECCTTTT
T ss_pred EecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--CccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCC
Confidence 9999999999999764 47999999999999999999999999 999999999999999999999999999987532
Q ss_pred ccccccCCCCccccCC
Q 005841 659 YLTTKTGKGTVTYLAS 674 (674)
Q Consensus 659 ~~~~~~~~GTp~YmAP 674 (674)
.....+++|||.||||
T Consensus 188 ~~~~~~~~GTp~YmAP 203 (311)
T 4aw0_A 188 QARANSFVGTAQYVSP 203 (311)
T ss_dssp CCCBCCCCSCGGGCCH
T ss_pred cccccCcccCcccCCH
Confidence 2334567999999998
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-38 Score=337.66 Aligned_cols=165 Identities=28% Similarity=0.378 Sum_probs=149.6
Q ss_pred cCCeeEeeeecccCceEEEEEEE--cCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeEEEEE
Q 005841 504 WEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVT 581 (674)
Q Consensus 504 ~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 581 (674)
.+.|+++++||+|+||+||+|++ ++..||||++.+..... .+.+.+|+.+|+.++|||||+++++|.+.+.+||||
T Consensus 73 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~--~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivm 150 (346)
T 4fih_A 73 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQR--RELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVM 150 (346)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSS--GGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hHhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhH--HHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 35699999999999999999998 47789999997654332 345788999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccccCCccc
Q 005841 582 EFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLT 661 (674)
Q Consensus 582 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~~~~~ 661 (674)
|||+||+|.+++.+ ..+++..+..|+.||+.||+|||+++ ||||||||+||||+.+++|||+|||+|+.+......
T Consensus 151 Ey~~gg~L~~~l~~--~~l~e~~~~~~~~qi~~aL~ylH~~~--IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~ 226 (346)
T 4fih_A 151 EFLEGGALTDIVTH--TRMNEEQIAAVCLAVLQALSVLHAQG--VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR 226 (346)
T ss_dssp CCCTTEEHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCC
T ss_pred eCCCCCcHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC--cccccCCHHHEEECCCCCEEEecCcCceecCCCCCc
Confidence 99999999999975 46999999999999999999999999 999999999999999999999999999988765555
Q ss_pred cccCCCCccccCC
Q 005841 662 TKTGKGTVTYLAS 674 (674)
Q Consensus 662 ~~~~~GTp~YmAP 674 (674)
..+.+|||.||||
T Consensus 227 ~~~~~GTp~YmAP 239 (346)
T 4fih_A 227 RKSLVGTPYWMAP 239 (346)
T ss_dssp BCCCCSCGGGCCH
T ss_pred ccccccCcCcCCH
Confidence 6678999999998
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=326.63 Aligned_cols=173 Identities=39% Similarity=0.653 Sum_probs=151.0
Q ss_pred cccccccCCeeEeeeecccCceEEEEEEEcCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeE
Q 005841 498 LDYEILWEDLTIGEQIGQGSCGTVYHAVWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRL 577 (674)
Q Consensus 498 ~~~~~~~~~y~~~~~LG~G~fG~Vy~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 577 (674)
..|++..++|++.++||+|+||+||+|++.+ .||||+++......+..+.|.+|+.+|++++|||||++++++. .+.+
T Consensus 29 ~~Wei~~~~l~l~~~iG~G~fG~Vy~~~~~~-~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~-~~~~ 106 (307)
T 3omv_A 29 YYWEIEASEVMLSTRIGSGSFGTVYKGKWHG-DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMT-KDNL 106 (307)
T ss_dssp CCCBCCTTSCCEEEECCCCSSSEEEEEESSS-EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSC
T ss_pred cCcEEcHHHeEEeeEEeeCCCcEEEEEEECC-cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE-CCeE
Confidence 3578889999999999999999999998754 6999999876667777889999999999999999999999875 4678
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccccC
Q 005841 578 CIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHE 657 (674)
Q Consensus 578 ~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~ 657 (674)
|||||||++|+|.++|......+++..++.|+.||+.||+|||+++ ||||||||+||||+.++++||+|||+|+....
T Consensus 107 ~iVmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~--IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~ 184 (307)
T 3omv_A 107 AIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKN--IIHRDMKSNNIFLHEGLTVKIGDFGLATVKSR 184 (307)
T ss_dssp EEEEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTT--CBCSCCCSSSEEEETTEEEEECCCSSCBC---
T ss_pred EEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--ccCCccCHHHEEECCCCcEEEeeccCceeccc
Confidence 9999999999999999877778999999999999999999999998 99999999999999999999999999987653
Q ss_pred C--ccccccCCCCccccCC
Q 005841 658 T--YLTTKTGKGTVTYLAS 674 (674)
Q Consensus 658 ~--~~~~~~~~GTp~YmAP 674 (674)
. .......+|||.||||
T Consensus 185 ~~~~~~~~~~~GT~~ymAP 203 (307)
T 3omv_A 185 WSGSQQVEQPTGSVLWMAP 203 (307)
T ss_dssp ---------CCCCTTSCCH
T ss_pred CCcceeecccccCCCccCH
Confidence 2 2234456899999998
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=318.29 Aligned_cols=165 Identities=32% Similarity=0.537 Sum_probs=147.2
Q ss_pred eeEeeeecccCceEEEEEEEc--CCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEec----CCeEEEE
Q 005841 507 LTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTS----PQRLCIV 580 (674)
Q Consensus 507 y~~~~~LG~G~fG~Vy~~~~~--~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~----~~~~~lV 580 (674)
|++.++||+|+||+||+|.+. +..||||++.+........+.|.+|+.+|+.|+|||||+++++|.+ ...+|||
T Consensus 28 ~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lv 107 (290)
T 3fpq_A 28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 107 (290)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEE
Confidence 578889999999999999984 6679999998877777777889999999999999999999999865 3568999
Q ss_pred EecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEc-CCCcEEEEecCCcccccCCc
Q 005841 581 TEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVD-KHWTVKVGDFGLSRLKHETY 659 (674)
Q Consensus 581 ~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~-~~~~vkL~DFGla~~~~~~~ 659 (674)
||||+||+|.++|.+. ..+++..+..|+.||+.||+|||+++++||||||||+||||+ .++.|||+|||+|+......
T Consensus 108 mEy~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~~~ 186 (290)
T 3fpq_A 108 TELMTSGTLKTYLKRF-KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASF 186 (290)
T ss_dssp EECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCTTS
T ss_pred EeCCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCCEeCCCCc
Confidence 9999999999999764 479999999999999999999999887899999999999998 47999999999998765433
Q ss_pred cccccCCCCccccCC
Q 005841 660 LTTKTGKGTVTYLAS 674 (674)
Q Consensus 660 ~~~~~~~GTp~YmAP 674 (674)
..+.+|||.||||
T Consensus 187 --~~~~~GTp~YmAP 199 (290)
T 3fpq_A 187 --AKAVIGTPEFMAP 199 (290)
T ss_dssp --BEESCSSCCCCCG
T ss_pred --cCCcccCccccCH
Confidence 3457899999999
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-37 Score=335.26 Aligned_cols=165 Identities=28% Similarity=0.378 Sum_probs=149.5
Q ss_pred cCCeeEeeeecccCceEEEEEEE--cCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeEEEEE
Q 005841 504 WEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVT 581 (674)
Q Consensus 504 ~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 581 (674)
.+.|+++++||+|+||+||+|++ ++..||||++....... .+.+.+|+.+|+.|+|||||+++++|.+.+.+||||
T Consensus 150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~--~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVm 227 (423)
T 4fie_A 150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQR--RELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVM 227 (423)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSS--GGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhH--HHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEE
Confidence 35799999999999999999998 47789999997654332 346789999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccccCCccc
Q 005841 582 EFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLT 661 (674)
Q Consensus 582 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~~~~~ 661 (674)
|||+||+|.+++.. ..+++..+..|+.||+.||+|||+++ ||||||||+||||+.+|+|||+|||+|+.+......
T Consensus 228 Ey~~gG~L~~~i~~--~~l~e~~~~~~~~qil~aL~ylH~~~--IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~~ 303 (423)
T 4fie_A 228 EFLEGGALTDIVTH--TRMNEEQIAAVCLAVLQALSVLHAQG--VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR 303 (423)
T ss_dssp ECCTTEEHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSTTTEEECTTCCEEECCCTTCEECCSSCCC
T ss_pred eCCCCCcHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHHCC--eecccCCHHHEEEcCCCCEEEecCccceECCCCCcc
Confidence 99999999999965 36999999999999999999999999 999999999999999999999999999987765555
Q ss_pred cccCCCCccccCC
Q 005841 662 TKTGKGTVTYLAS 674 (674)
Q Consensus 662 ~~~~~GTp~YmAP 674 (674)
..+.+|||.||||
T Consensus 304 ~~~~~GTp~YmAP 316 (423)
T 4fie_A 304 RKSLVGTPYWMAP 316 (423)
T ss_dssp BCCCEECTTTCCH
T ss_pred ccccccCcCcCCH
Confidence 6678999999998
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=327.56 Aligned_cols=168 Identities=26% Similarity=0.353 Sum_probs=141.6
Q ss_pred cCCeeEeeeecccCceEEEEEEE-----cCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeEE
Q 005841 504 WEDLTIGEQIGQGSCGTVYHAVW-----YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLC 578 (674)
Q Consensus 504 ~~~y~~~~~LG~G~fG~Vy~~~~-----~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 578 (674)
.++|+++++||+|+||+||+|++ ++..||||++.+..........+.+|+.+|+.++|||||++++++.+.+.+|
T Consensus 23 p~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ 102 (304)
T 3ubd_A 23 PSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLY 102 (304)
T ss_dssp GGGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEE
T ss_pred ccccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEE
Confidence 36899999999999999999987 2456999999876543322345778999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccccCC
Q 005841 579 IVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHET 658 (674)
Q Consensus 579 lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~~ 658 (674)
||||||+||+|.++|.+. ..+++..+..|+.||+.||+|||+++ ||||||||+|||++.+++|||+|||+|+.....
T Consensus 103 ivmEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~ylH~~~--IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~ 179 (304)
T 3ubd_A 103 LILDFLRGGDLFTRLSKE-VMFTEEDVKFYLAELALALDHLHSLG--IIYRDLKPENILLDEEGHIKLTDFGLSKESIDH 179 (304)
T ss_dssp EEECCCTTCEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSSCCGGGEEECTTSCEEEESSEEEEC----
T ss_pred EEEEcCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--CcCCCCCHHHeEEcCCCCEEecccccceeccCC
Confidence 999999999999999764 47999999999999999999999999 999999999999999999999999999976655
Q ss_pred ccccccCCCCccccCC
Q 005841 659 YLTTKTGKGTVTYLAS 674 (674)
Q Consensus 659 ~~~~~~~~GTp~YmAP 674 (674)
.....+.+|||.||||
T Consensus 180 ~~~~~~~~GT~~YmAP 195 (304)
T 3ubd_A 180 EKKAYSFCGTVEYMAP 195 (304)
T ss_dssp -CCCCSCCCCGGGCCH
T ss_pred CccccccccCcccCCH
Confidence 4455568999999998
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-36 Score=319.71 Aligned_cols=164 Identities=27% Similarity=0.301 Sum_probs=142.5
Q ss_pred ccccCCeeEeeeecccCceEEEEEEE--cCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeEE
Q 005841 501 EILWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLC 578 (674)
Q Consensus 501 ~~~~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 578 (674)
....+.|++.++||+|+||+||+|++ ++..||||+++++... .+|+.+++.|+|||||++++++.+.+.+|
T Consensus 54 ~~~~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~~-------~~E~~il~~l~HpnIV~l~~~~~~~~~~~ 126 (336)
T 4g3f_A 54 REEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR-------VEELVACAGLSSPRIVPLYGAVREGPWVN 126 (336)
T ss_dssp CBTTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC-------THHHHTTTTCCCTTBCCEEEEEEETTEEE
T ss_pred hcchhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHhH-------HHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 34456799999999999999999998 4778999999876433 35999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCC-cEEEEecCCcccccC
Q 005841 579 IVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHW-TVKVGDFGLSRLKHE 657 (674)
Q Consensus 579 lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~-~vkL~DFGla~~~~~ 657 (674)
||||||+||+|.++|.+. ..|++..+..|+.||+.||+|||+++ ||||||||+||||+.++ +|||+|||+|+.+..
T Consensus 127 ivmEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~ylH~~~--IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~ 203 (336)
T 4g3f_A 127 IFMELLEGGSLGQLIKQM-GCLPEDRALYYLGQALEGLEYLHTRR--ILHGDVKADNVLLSSDGSRAALCDFGHALCLQP 203 (336)
T ss_dssp EEECCCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTTT--EECSCCCGGGEEECTTSCCEEECCCTTCEEC--
T ss_pred EEEeccCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--ceecccCHHHEEEeCCCCEEEEeeCCCCeEccC
Confidence 999999999999999764 47999999999999999999999999 99999999999999887 699999999997654
Q ss_pred Cc-----cccccCCCCccccCC
Q 005841 658 TY-----LTTKTGKGTVTYLAS 674 (674)
Q Consensus 658 ~~-----~~~~~~~GTp~YmAP 674 (674)
.. .+...++|||.||||
T Consensus 204 ~~~~~~~~~~~~~~GT~~YmAP 225 (336)
T 4g3f_A 204 DGLGKSLLTGDYIPGTETHMAP 225 (336)
T ss_dssp ----------CCCCCCGGGCCH
T ss_pred CCcccceecCCccccCccccCH
Confidence 32 223346899999998
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-36 Score=313.30 Aligned_cols=165 Identities=30% Similarity=0.521 Sum_probs=133.1
Q ss_pred CCeeEeeeecccCceEEEEEEE--cCCeEEEEEeecccCCH-HHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeEEEEE
Q 005841 505 EDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSD-EVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVT 581 (674)
Q Consensus 505 ~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 581 (674)
++|++.+.||+|+||+||+|.+ ++..||||++.+..... .....+.+|+.+++.++|||||++++++.+.+.+||||
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 92 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI 92 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 6899999999999999999997 47789999998766543 44567899999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccccCCccc
Q 005841 582 EFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLT 661 (674)
Q Consensus 582 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~~~~~ 661 (674)
||| +|+|.+++.+ ...+++..+..|+.||+.||+|||+++ ||||||||+||||+.+++|||+|||+|+...... .
T Consensus 93 Ey~-~g~L~~~l~~-~~~l~e~~~~~~~~qi~~al~ylH~~~--IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~-~ 167 (275)
T 3hyh_A 93 EYA-GNELFDYIVQ-RDKMSEQEARRFFQQIISAVEYCHRHK--IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGN-F 167 (275)
T ss_dssp ECC-CEEHHHHHHH-SCSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCTTTEEECTTCCEEECCSSCC---------
T ss_pred eCC-CCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCC--cccccCChHHeEECCCCCEEEeecCCCeecCCCC-c
Confidence 999 6799999976 457999999999999999999999999 9999999999999999999999999998765433 2
Q ss_pred cccCCCCccccCC
Q 005841 662 TKTGKGTVTYLAS 674 (674)
Q Consensus 662 ~~~~~GTp~YmAP 674 (674)
..+.+|||.||||
T Consensus 168 ~~~~~GT~~Y~AP 180 (275)
T 3hyh_A 168 LKTSCGSPNYAAP 180 (275)
T ss_dssp -------CTTSCH
T ss_pred cCCeeECcccCCh
Confidence 3357899999998
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-36 Score=317.32 Aligned_cols=170 Identities=29% Similarity=0.456 Sum_probs=142.2
Q ss_pred ccccCCeeEeeeecccCceEEEEEEEc-------CCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEec
Q 005841 501 EILWEDLTIGEQIGQGSCGTVYHAVWY-------GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTS 573 (674)
Q Consensus 501 ~~~~~~y~~~~~LG~G~fG~Vy~~~~~-------~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~ 573 (674)
.+..++|.+.++||+|+||+||+|++. +..||||+++.. .....+.|.+|+.+|++++|||||++++++.+
T Consensus 37 ~i~~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~--~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~ 114 (329)
T 4aoj_A 37 HIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA--SESARQDFQREAELLTMLQHQHIVRFFGVCTE 114 (329)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCC--SHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS
T ss_pred ccCHHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcC--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEE
Confidence 456688999999999999999999874 456999999643 45566789999999999999999999999999
Q ss_pred CCeEEEEEecCCCCCHHHHHHhcC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEc
Q 005841 574 PQRLCIVTEFLPRGSLFRLLQRNT--------------TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVD 639 (674)
Q Consensus 574 ~~~~~lV~E~~~ggsL~~~l~~~~--------------~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~ 639 (674)
.+.+|||||||++|+|.++|.... ..+++.+++.|+.||+.||.|||+++ ||||||||+||||+
T Consensus 115 ~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~--iiHRDLKp~NILl~ 192 (329)
T 4aoj_A 115 GRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH--FVHRDLATRNCLVG 192 (329)
T ss_dssp SSSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEE
T ss_pred CCEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCC--eecccccHhhEEEC
Confidence 999999999999999999997532 45899999999999999999999998 99999999999999
Q ss_pred CCCcEEEEecCCcccccCCc--cccccCCCCccccCC
Q 005841 640 KHWTVKVGDFGLSRLKHETY--LTTKTGKGTVTYLAS 674 (674)
Q Consensus 640 ~~~~vkL~DFGla~~~~~~~--~~~~~~~GTp~YmAP 674 (674)
.++++||+|||+|+...... ......+||+.||||
T Consensus 193 ~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAP 229 (329)
T 4aoj_A 193 QGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPP 229 (329)
T ss_dssp TTTEEEECCCC----------------CCCCGGGCCH
T ss_pred CCCcEEEcccccceeccCCCcceecCcccccccccCh
Confidence 99999999999998764332 223346799999998
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-36 Score=314.38 Aligned_cols=170 Identities=29% Similarity=0.489 Sum_probs=147.7
Q ss_pred ccccCCeeEeeeecccCceEEEEEEEc-------CCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEec
Q 005841 501 EILWEDLTIGEQIGQGSCGTVYHAVWY-------GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTS 573 (674)
Q Consensus 501 ~~~~~~y~~~~~LG~G~fG~Vy~~~~~-------~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~ 573 (674)
.+..++|.+.+.||+|+||+||+|++. +..||||+++.. .....+.|.+|+.+|++|+|||||++++++.+
T Consensus 9 ~I~r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~--~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~ 86 (299)
T 4asz_A 9 HIKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA--SDNARKDFHREAELLTNLQHEHIVKFYGVCVE 86 (299)
T ss_dssp BCCGGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS
T ss_pred ccCHHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCC--ChHHHHHHHHHHHHHHhCCCCCCccEEEEEee
Confidence 566789999999999999999999873 456999999653 45566789999999999999999999999999
Q ss_pred CCeEEEEEecCCCCCHHHHHHhc------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCC
Q 005841 574 PQRLCIVTEFLPRGSLFRLLQRN------------TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKH 641 (674)
Q Consensus 574 ~~~~~lV~E~~~ggsL~~~l~~~------------~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~ 641 (674)
.+.+|||||||++|+|.++|... ...+++..++.|+.||+.||.|||+++ ||||||||+||||+.+
T Consensus 87 ~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~--iiHRDlKp~NILl~~~ 164 (299)
T 4asz_A 87 GDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH--FVHRDLATRNCLVGEN 164 (299)
T ss_dssp SSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECGG
T ss_pred CCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCccCHhhEEECCC
Confidence 99999999999999999999753 246999999999999999999999998 9999999999999999
Q ss_pred CcEEEEecCCcccccCCccc--cccCCCCccccCC
Q 005841 642 WTVKVGDFGLSRLKHETYLT--TKTGKGTVTYLAS 674 (674)
Q Consensus 642 ~~vkL~DFGla~~~~~~~~~--~~~~~GTp~YmAP 674 (674)
+++||+|||+|+........ ....+||+.||||
T Consensus 165 ~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAP 199 (299)
T 4asz_A 165 LLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPP 199 (299)
T ss_dssp GCEEECCCSCHHHHTGGGCEEETTTEEECGGGCCH
T ss_pred CcEEECCcccceecCCCCceeecCceecChhhcCH
Confidence 99999999999876543322 2234699999998
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-35 Score=312.56 Aligned_cols=171 Identities=28% Similarity=0.477 Sum_probs=147.9
Q ss_pred ccccCCeeEeeeecccCceEEEEEEEc-------CCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEec
Q 005841 501 EILWEDLTIGEQIGQGSCGTVYHAVWY-------GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTS 573 (674)
Q Consensus 501 ~~~~~~y~~~~~LG~G~fG~Vy~~~~~-------~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~ 573 (674)
++...++++.++||+|+||+||+|.+. +..||||+++... .....+.|.+|+.++++++|||||++++++..
T Consensus 22 ei~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~-~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~ 100 (308)
T 4gt4_A 22 EISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKA-EGPLREEFRHEAMLRARLQHPNVVCLLGVVTK 100 (308)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-C-CC-CHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cCCHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECccc-ChHHHHHHHHHHHHHHhCCCCCCCCcceEEEE
Confidence 556678999999999999999999873 4569999996543 33445789999999999999999999999999
Q ss_pred CCeEEEEEecCCCCCHHHHHHhc---------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEE
Q 005841 574 PQRLCIVTEFLPRGSLFRLLQRN---------------TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLV 638 (674)
Q Consensus 574 ~~~~~lV~E~~~ggsL~~~l~~~---------------~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi 638 (674)
.+.+|||||||++|+|.++|... ...+++..++.|+.||+.||+|||+++ ||||||||+||||
T Consensus 101 ~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~--iiHRDLK~~NILl 178 (308)
T 4gt4_A 101 DQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH--VVHKDLATRNVLV 178 (308)
T ss_dssp SSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEE
T ss_pred CCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC--CCCCCccccceEE
Confidence 99999999999999999999643 235899999999999999999999999 9999999999999
Q ss_pred cCCCcEEEEecCCcccccCC--ccccccCCCCccccCC
Q 005841 639 DKHWTVKVGDFGLSRLKHET--YLTTKTGKGTVTYLAS 674 (674)
Q Consensus 639 ~~~~~vkL~DFGla~~~~~~--~~~~~~~~GTp~YmAP 674 (674)
+.++++||+|||+|+..... .......+||+.||||
T Consensus 179 ~~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAP 216 (308)
T 4gt4_A 179 YDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAP 216 (308)
T ss_dssp CGGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCH
T ss_pred CCCCCEEECCcccceeccCCCceeEecccccCCcccCH
Confidence 99999999999999876432 2223446899999998
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-35 Score=308.50 Aligned_cols=167 Identities=25% Similarity=0.365 Sum_probs=134.3
Q ss_pred CCeeEeeeecccCceEEEEEEE--cCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCC-------
Q 005841 505 EDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQ------- 575 (674)
Q Consensus 505 ~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~------- 575 (674)
.+|++++.||+|+||+||+|++ ++..||||++.... .....+.+.+|+.+|+.|+|||||+++++|.+.+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~-~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~ 83 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPN-RELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQP 83 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECS-SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC-------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccC-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccc
Confidence 4699999999999999999998 47789999997654 4455678999999999999999999999987544
Q ss_pred -----eEEEEEecCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEe
Q 005841 576 -----RLCIVTEFLPRGSLFRLLQRNT--TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGD 648 (674)
Q Consensus 576 -----~~~lV~E~~~ggsL~~~l~~~~--~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~D 648 (674)
++|||||||++|+|.+++.... ...++..++.|+.||+.||+|||+++ ||||||||+||||+.++.|||+|
T Consensus 84 ~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~--IiHRDlKp~NILl~~~~~vKl~D 161 (299)
T 4g31_A 84 SSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKG--LMHRDLKPSNIFFTMDDVVKVGD 161 (299)
T ss_dssp ---CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTCCEEECC
T ss_pred cCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCc--CccccCcHHHeEECCCCcEEEcc
Confidence 4799999999999999997543 23456778999999999999999999 99999999999999999999999
Q ss_pred cCCcccccCCcc------------ccccCCCCccccCC
Q 005841 649 FGLSRLKHETYL------------TTKTGKGTVTYLAS 674 (674)
Q Consensus 649 FGla~~~~~~~~------------~~~~~~GTp~YmAP 674 (674)
||+|+.+..... ...+.+|||.||||
T Consensus 162 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAP 199 (299)
T 4g31_A 162 FGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSP 199 (299)
T ss_dssp CCCC--------------------------CCCTTSCH
T ss_pred CccceecCCCccccccccccccccccCCcccCccccCH
Confidence 999987654221 12335899999998
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-34 Score=315.26 Aligned_cols=167 Identities=26% Similarity=0.412 Sum_probs=146.2
Q ss_pred cCCeeEeeeecccCceEEEEEEE--cCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEec------CC
Q 005841 504 WEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTS------PQ 575 (674)
Q Consensus 504 ~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~------~~ 575 (674)
.++|+++++||+|+||+||+|.+ ++..||||++.+........+.+.+|+.+|+.|+|||||++++++.. .+
T Consensus 53 ~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 132 (398)
T 4b99_A 53 GDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFK 132 (398)
T ss_dssp CSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCC
T ss_pred CCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCC
Confidence 46899999999999999999998 47789999998766666667788999999999999999999998764 36
Q ss_pred eEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccc
Q 005841 576 RLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLK 655 (674)
Q Consensus 576 ~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~ 655 (674)
.+|||||||+ |+|.+++.. ...+++..+..|+.||+.||.|||+++ ||||||||+|||++.++.+||+|||+|+.+
T Consensus 133 ~~~ivmE~~~-g~L~~~i~~-~~~l~~~~~~~~~~qil~al~ylH~~~--iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~ 208 (398)
T 4b99_A 133 SVYVVLDLME-SDLHQIIHS-SQPLTLEHVRYFLYQLLRGLKYMHSAQ--VIHRDLKPSNLLVNENCELKIGDFGMARGL 208 (398)
T ss_dssp CEEEEEECCS-EEHHHHHTS-SSCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTCCEEECCCTTCBCC
T ss_pred EEEEEEeCCC-CCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCc--CcCCCcCccccccCCCCCEEEeecceeeec
Confidence 7999999995 689999965 457999999999999999999999999 999999999999999999999999999876
Q ss_pred cCC----ccccccCCCCccccCC
Q 005841 656 HET----YLTTKTGKGTVTYLAS 674 (674)
Q Consensus 656 ~~~----~~~~~~~~GTp~YmAP 674 (674)
... .....+.+||+.||||
T Consensus 209 ~~~~~~~~~~~~~~~GT~~Y~AP 231 (398)
T 4b99_A 209 CTSPAEHQYFMTEYVATRWYRAP 231 (398)
T ss_dssp -------CCCCCSSCCCCTTCCH
T ss_pred ccCccccccccccceeChHhcCH
Confidence 432 2233457899999998
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-34 Score=309.90 Aligned_cols=176 Identities=28% Similarity=0.490 Sum_probs=150.7
Q ss_pred CccccccccCCeeEeeeecccCceEEEEEEEcC-------CeEEEEEeecccCCHHHHHHHHHHHHHHhhCCC-CCeeeE
Q 005841 496 DCLDYEILWEDLTIGEQIGQGSCGTVYHAVWYG-------SDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRH-PNVLLF 567 (674)
Q Consensus 496 ~~~~~~~~~~~y~~~~~LG~G~fG~Vy~~~~~~-------~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~H-pnIv~l 567 (674)
+...|++..++|++.++||+|+||+||+|.+.+ +.||||++.... .....+.|.+|+.+|.++.| ||||++
T Consensus 55 ~~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~-~~~~~~~~~~E~~il~~l~hhpnIV~l 133 (353)
T 4ase_A 55 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNL 133 (353)
T ss_dssp CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CCcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEcccc-ChHHHHHHHHHHHHHHHcCCCCcEEEE
Confidence 334578899999999999999999999999754 359999997543 44456789999999999975 899999
Q ss_pred EEEEecC-CeEEEEEecCCCCCHHHHHHhc---------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccC
Q 005841 568 MGAVTSP-QRLCIVTEFLPRGSLFRLLQRN---------------TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDL 631 (674)
Q Consensus 568 ~~~~~~~-~~~~lV~E~~~ggsL~~~l~~~---------------~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDL 631 (674)
+++|... ..+|||||||++|+|.++|+.. ...+++..++.|+.||+.||+|||+++ ||||||
T Consensus 134 ~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~--iiHRDL 211 (353)
T 4ase_A 134 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK--CIHRDL 211 (353)
T ss_dssp EEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT--CCCSCC
T ss_pred EEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC--eecCcc
Confidence 9998764 5799999999999999999753 234899999999999999999999999 999999
Q ss_pred CCCCEEEcCCCcEEEEecCCcccccCC--ccccccCCCCccccCC
Q 005841 632 KSSNLLVDKHWTVKVGDFGLSRLKHET--YLTTKTGKGTVTYLAS 674 (674)
Q Consensus 632 Kp~NILi~~~~~vkL~DFGla~~~~~~--~~~~~~~~GTp~YmAP 674 (674)
||+|||++.+++|||+|||+|+.+... .......+||+.||||
T Consensus 212 K~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAP 256 (353)
T 4ase_A 212 AARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAP 256 (353)
T ss_dssp SGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCH
T ss_pred CccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCH
Confidence 999999999999999999999976432 2334456799999998
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-34 Score=301.24 Aligned_cols=165 Identities=36% Similarity=0.541 Sum_probs=137.1
Q ss_pred CCeeEeeeecccCceEEEEEEEcCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCC----eEEEE
Q 005841 505 EDLTIGEQIGQGSCGTVYHAVWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQ----RLCIV 580 (674)
Q Consensus 505 ~~y~~~~~LG~G~fG~Vy~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~----~~~lV 580 (674)
++|.+.++||+|+||+||+|++++..||||+++... .....+..|+.++..++|||||++++++...+ .+|||
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~~g~~VAvK~l~~~~---~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV 79 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLV 79 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEECCEEEEEEEECccc---hhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEE
Confidence 578999999999999999999999999999996543 21223345777778899999999999998654 58999
Q ss_pred EecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC------CCCeEEccCCCCCEEEcCCCcEEEEecCCccc
Q 005841 581 TEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHC------NPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL 654 (674)
Q Consensus 581 ~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~------~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~ 654 (674)
||||++|+|.++|+.. .+++..+..|+.|++.||+|||+. .++||||||||+||||+.++++||+|||+|+.
T Consensus 80 ~Ey~~~gsL~~~l~~~--~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~ 157 (303)
T 3hmm_A 80 SDYHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVR 157 (303)
T ss_dssp EECCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred ecCCCCCcHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCcc
Confidence 9999999999999753 589999999999999999999976 22499999999999999999999999999987
Q ss_pred ccCCcc----ccccCCCCccccCC
Q 005841 655 KHETYL----TTKTGKGTVTYLAS 674 (674)
Q Consensus 655 ~~~~~~----~~~~~~GTp~YmAP 674 (674)
...... .....+||+.||||
T Consensus 158 ~~~~~~~~~~~~~~~~GT~~ymAP 181 (303)
T 3hmm_A 158 HDSATDTIDIAPNHRVGTKRYMAP 181 (303)
T ss_dssp EETTTTEESCC-----CCGGGCCH
T ss_pred ccCCCCceeeecccccccccccCH
Confidence 654322 22345799999998
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-33 Score=322.14 Aligned_cols=167 Identities=24% Similarity=0.374 Sum_probs=146.3
Q ss_pred ccCCeeEeeeecccCceEEEEEEE--cCCeEEEEEeecccCC----HHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCe
Q 005841 503 LWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYS----DEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQR 576 (674)
Q Consensus 503 ~~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~~----~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 576 (674)
..++|+++++||+|+||+||+|++ ++..||||++.+.... .........++.+++.++|||||+++++|.+.+.
T Consensus 187 slddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~ 266 (689)
T 3v5w_A 187 TMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDK 266 (689)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSE
T ss_pred chHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCE
Confidence 347899999999999999999998 5778999999865432 2233344456778888899999999999999999
Q ss_pred EEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCccccc
Q 005841 577 LCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKH 656 (674)
Q Consensus 577 ~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~ 656 (674)
+|||||||+||+|+++|.+. ..|++..+..|+.||+.||+|||+++ ||||||||+||||+.+|+|||+|||+|+...
T Consensus 267 lylVmEy~~GGdL~~~l~~~-~~l~E~~a~~y~~qIl~aL~yLH~~g--IiHRDLKPeNILld~~G~vKL~DFGlA~~~~ 343 (689)
T 3v5w_A 267 LSFILDLMNGGDLHYHLSQH-GVFSEADMRFYAAEIILGLEHMHNRF--VVYRDLKPANILLDEHGHVRISDLGLACDFS 343 (689)
T ss_dssp EEEEECCCCSCBHHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred EEEEEecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCchHHeEEeCCCCEEecccceeeecC
Confidence 99999999999999999764 57999999999999999999999999 9999999999999999999999999998776
Q ss_pred CCccccccCCCCccccCC
Q 005841 657 ETYLTTKTGKGTVTYLAS 674 (674)
Q Consensus 657 ~~~~~~~~~~GTp~YmAP 674 (674)
... +.+.+|||.||||
T Consensus 344 ~~~--~~t~~GTp~YmAP 359 (689)
T 3v5w_A 344 KKK--PHASVGTHGYMAP 359 (689)
T ss_dssp SCC--CCSCCSCGGGCCH
T ss_pred CCC--CCCccCCcCccCH
Confidence 543 4457999999998
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=3.2e-32 Score=293.63 Aligned_cols=162 Identities=23% Similarity=0.352 Sum_probs=139.0
Q ss_pred ccCCeeEeeeecccCceEEEEEEEc-----CCeEEEEEeecccCCHHHHHHHHHHHHHHhhC-CCCCeeeEEEEEecCCe
Q 005841 503 LWEDLTIGEQIGQGSCGTVYHAVWY-----GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRL-RHPNVLLFMGAVTSPQR 576 (674)
Q Consensus 503 ~~~~y~~~~~LG~G~fG~Vy~~~~~-----~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~ 576 (674)
..++|++.++||+|+||+||+|+++ +..||||++.+... ...+.+|+.+|+.+ .||||++++++|.+.++
T Consensus 19 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~----~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~ 94 (361)
T 4f9c_A 19 LSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSH----PIRIAAELQCLTVAGGQDNVMGVKYCFRKNDH 94 (361)
T ss_dssp GGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSC----HHHHHHHHHHHHHTCSBTTBCCCSEEEEETTE
T ss_pred ccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccC----HHHHHHHHHHHHHhcCCCCCceEEEEEEECCE
Confidence 4578999999999999999999863 45699999865432 23577899999998 59999999999999999
Q ss_pred EEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCC-CcEEEEecCCcccc
Q 005841 577 LCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKH-WTVKVGDFGLSRLK 655 (674)
Q Consensus 577 ~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~-~~vkL~DFGla~~~ 655 (674)
+|||||||++++|.+++. .+++.++..|+.||+.||+|||++| ||||||||+||||+.+ +.+||+|||+|+..
T Consensus 95 ~~lvmE~~~g~~L~~~~~----~l~~~~~~~~~~qll~al~ylH~~g--IiHRDiKPeNiLl~~~~~~~kl~DFGla~~~ 168 (361)
T 4f9c_A 95 VVIAMPYLEHESFLDILN----SLSFQEVREYMLNLFKALKRIHQFG--IVHRDVKPSNFLYNRRLKKYALVDFGLAQGT 168 (361)
T ss_dssp EEEEEECCCCCCHHHHHT----TCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred EEEEEeCCCcccHHHHHc----CCCHHHHHHHHHHHHHHHHHHHHCC--eEeCcCCHHHeEEeCCCCeEEECcCCCCccc
Confidence 999999999999999994 4899999999999999999999999 9999999999999876 89999999999865
Q ss_pred cCCcc----------------------------ccccCCCCccccCC
Q 005841 656 HETYL----------------------------TTKTGKGTVTYLAS 674 (674)
Q Consensus 656 ~~~~~----------------------------~~~~~~GTp~YmAP 674 (674)
..... ...+.+|||.||||
T Consensus 169 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~AP 215 (361)
T 4f9c_A 169 HDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAP 215 (361)
T ss_dssp TTCSCGGGGGC--------------------------CCCCGGGCCH
T ss_pred CCccccccccccccccccccccccccccccccccccccccCccccCH
Confidence 43221 12235799999998
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=99.98 E-value=3.3e-32 Score=310.64 Aligned_cols=166 Identities=24% Similarity=0.423 Sum_probs=148.4
Q ss_pred cCCeeEeeeecccCceEEEEEEE--cCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeEEEEE
Q 005841 504 WEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVT 581 (674)
Q Consensus 504 ~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 581 (674)
.++|++++.||+|+||+||+|.+ ++..||||++.+.. ....+.+.+|+.+|+.|+|||||+++++|.+...+||||
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~--~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~ 233 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH--ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIY 233 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccc--hhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEE
Confidence 46899999999999999999998 57789999997653 333467889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcC--CCcEEEEecCCcccccCCc
Q 005841 582 EFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDK--HWTVKVGDFGLSRLKHETY 659 (674)
Q Consensus 582 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~--~~~vkL~DFGla~~~~~~~ 659 (674)
|||+||+|+++|......|++..+..|+.||+.||.|||+++ ||||||||+||||+. .+.|||+|||+|+.+....
T Consensus 234 E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~--iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~ 311 (573)
T 3uto_A 234 EFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN--YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ 311 (573)
T ss_dssp ECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTS
T ss_pred eecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCChhhccccCCCCCCEEEeeccceeEccCCC
Confidence 999999999999766678999999999999999999999999 999999999999985 4899999999999876543
Q ss_pred cccccCCCCccccCC
Q 005841 660 LTTKTGKGTVTYLAS 674 (674)
Q Consensus 660 ~~~~~~~GTp~YmAP 674 (674)
.....+|||.||||
T Consensus 312 -~~~~~~GT~~y~AP 325 (573)
T 3uto_A 312 -SVKVTTGTAEFAAP 325 (573)
T ss_dssp -EEEEECSSGGGCCH
T ss_pred -ceeeeEECccccCH
Confidence 33446899999998
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.1e-30 Score=275.48 Aligned_cols=177 Identities=58% Similarity=0.963 Sum_probs=147.4
Q ss_pred cccccccCCeeEeeeecccCceEEEEEEEcCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeE
Q 005841 498 LDYEILWEDLTIGEQIGQGSCGTVYHAVWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRL 577 (674)
Q Consensus 498 ~~~~~~~~~y~~~~~LG~G~fG~Vy~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 577 (674)
..+++...+|++.+.||+|+||+||+|.+.+..||||++............+.+|+.+++.++||||+++++++.....+
T Consensus 30 ~~~~i~~~~y~i~~~lG~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 109 (309)
T 3p86_A 30 DDMDIPWCDLNIKEKIGAGSFGTVHRAEWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNL 109 (309)
T ss_dssp --CBCCGGGEEEEEEEEECSSEEEEEEEETTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCC
T ss_pred ccccCChhHceeeeEeecCCCeEEEEEEECCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCce
Confidence 34567788999999999999999999999999999999988777777778899999999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccc
Q 005841 578 CIVTEFLPRGSLFRLLQRNTT--KLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLK 655 (674)
Q Consensus 578 ~lV~E~~~ggsL~~~l~~~~~--~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~ 655 (674)
|+||||+++++|.+++..... .+++..++.++.||+.||.|||+.+++|+||||||+|||++.++.+||+|||+++..
T Consensus 110 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~ 189 (309)
T 3p86_A 110 SIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLK 189 (309)
T ss_dssp EEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCEEECCCC-----
T ss_pred EEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCcEEECCCCCCccc
Confidence 999999999999999975432 389999999999999999999998877999999999999999999999999999876
Q ss_pred cCCccccccCCCCccccCC
Q 005841 656 HETYLTTKTGKGTVTYLAS 674 (674)
Q Consensus 656 ~~~~~~~~~~~GTp~YmAP 674 (674)
...........||+.|+||
T Consensus 190 ~~~~~~~~~~~gt~~y~aP 208 (309)
T 3p86_A 190 ASTFLSSKSAAGTPEWMAP 208 (309)
T ss_dssp ------------CCTTSCH
T ss_pred cccccccccCCCCccccCh
Confidence 6555455557899999998
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=99.97 E-value=4.4e-30 Score=273.37 Aligned_cols=170 Identities=26% Similarity=0.423 Sum_probs=154.1
Q ss_pred ccccCCeeEeeeecccCceEEEEEEE--cCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeEE
Q 005841 501 EILWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLC 578 (674)
Q Consensus 501 ~~~~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 578 (674)
....++|++.+.||+|+||+||+|.+ ++..||||++.+........+.+.+|+.+++.++||||+++++++...+.+|
T Consensus 11 ~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~ 90 (328)
T 3fe3_A 11 QPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLY 90 (328)
T ss_dssp CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred CCccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEE
Confidence 44557899999999999999999998 5788999999887777777788999999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccccCC
Q 005841 579 IVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHET 658 (674)
Q Consensus 579 lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~~ 658 (674)
+||||+++++|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 91 lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~al~~lH~~~--ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 167 (328)
T 3fe3_A 91 LIMEYASGGEVFDYLVAH-GRMKEKEARSKFRQIVSAVQYCHQKR--IVHRDLKAENLLLDADMNIKIADFGFSNEFTVG 167 (328)
T ss_dssp EEECCCTTCBHHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTSCEEECSTTCCGGGSSS
T ss_pred EEEECCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--EeccCCCHHHEEEcCCCCEEEeeccCceecCCC
Confidence 999999999999999764 46999999999999999999999999 999999999999999999999999999876543
Q ss_pred ccccccCCCCccccCC
Q 005841 659 YLTTKTGKGTVTYLAS 674 (674)
Q Consensus 659 ~~~~~~~~GTp~YmAP 674 (674)
. .....+||+.|+||
T Consensus 168 ~-~~~~~~gt~~y~aP 182 (328)
T 3fe3_A 168 G-KLDAFCGAPPYAAP 182 (328)
T ss_dssp C-GGGTTSSSGGGCCH
T ss_pred C-ccccccCCcceeCc
Confidence 3 33457899999998
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=3.4e-30 Score=275.36 Aligned_cols=169 Identities=28% Similarity=0.419 Sum_probs=149.7
Q ss_pred ccCCeeEeeeecccCceEEEEEEE--cCCeEEEEEeecccC-CHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeEEE
Q 005841 503 LWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEY-SDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCI 579 (674)
Q Consensus 503 ~~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 579 (674)
..++|++.++||+|+||+||+|.+ ++..||||++.+... .......+.+|+.+++.++||||+++++++...+.+||
T Consensus 3 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~l 82 (337)
T 1o6l_A 3 TMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCF 82 (337)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEE
T ss_pred ChHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEE
Confidence 457899999999999999999998 477899999976532 11234568889999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccccCCc
Q 005841 580 VTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETY 659 (674)
Q Consensus 580 V~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~~~ 659 (674)
||||+++++|..++... ..+++..+..++.||+.||.|||+++ |+||||||+||||+.++++||+|||+|+......
T Consensus 83 v~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~ 159 (337)
T 1o6l_A 83 VMEYANGGELFFHLSRE-RVFTEERARFYGAEIVSALEYLHSRD--VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG 159 (337)
T ss_dssp EEECCTTCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT
T ss_pred EEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCcCCHHHEEECCCCCEEEeeccchhhcccCC
Confidence 99999999999999764 47999999999999999999999999 9999999999999999999999999998765544
Q ss_pred cccccCCCCccccCC
Q 005841 660 LTTKTGKGTVTYLAS 674 (674)
Q Consensus 660 ~~~~~~~GTp~YmAP 674 (674)
......+||+.||||
T Consensus 160 ~~~~~~~gt~~y~aP 174 (337)
T 1o6l_A 160 ATMKTFCGTPEYLAP 174 (337)
T ss_dssp CCBCCCEECGGGCCG
T ss_pred CcccccccChhhCCh
Confidence 455667899999998
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=3.4e-30 Score=277.11 Aligned_cols=171 Identities=29% Similarity=0.409 Sum_probs=143.0
Q ss_pred ccccCCeeEeeeecccCceEEEEEEE--cCCeEEEEEeecccC-CHHHHHHHHHHHHHHhhC-CCCCeeeEEEEEecCCe
Q 005841 501 EILWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEY-SDEVIHSFRQEVSLMKRL-RHPNVLLFMGAVTSPQR 576 (674)
Q Consensus 501 ~~~~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~ 576 (674)
.+..++|++.++||+|+||+||+|++ ++..||||++.+... .......+.+|+.++..+ +||||+++++++.+.+.
T Consensus 19 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~ 98 (353)
T 3txo_A 19 RLGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDR 98 (353)
T ss_dssp ----CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred CCchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCE
Confidence 34557899999999999999999998 467899999976532 223346678899999988 69999999999999999
Q ss_pred EEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCccccc
Q 005841 577 LCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKH 656 (674)
Q Consensus 577 ~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~ 656 (674)
+|||||||+|++|.+++.+. ..+++..+..|+.||+.||.|||+++ ||||||||+||||+.++++||+|||+|+...
T Consensus 99 ~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~g--ivHrDlkp~NILl~~~g~ikL~DFG~a~~~~ 175 (353)
T 3txo_A 99 LFFVMEFVNGGDLMFHIQKS-RRFDEARARFYAAEIISALMFLHDKG--IIYRDLKLDNVLLDHEGHCKLADFGMCKEGI 175 (353)
T ss_dssp EEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred EEEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--CcccCCCHHHEEECCCCCEEEccccceeecc
Confidence 99999999999999999764 46999999999999999999999999 9999999999999999999999999998765
Q ss_pred CCccccccCCCCccccCC
Q 005841 657 ETYLTTKTGKGTVTYLAS 674 (674)
Q Consensus 657 ~~~~~~~~~~GTp~YmAP 674 (674)
.......+.+||+.||||
T Consensus 176 ~~~~~~~~~~gt~~y~aP 193 (353)
T 3txo_A 176 CNGVTTATFCGTPDYIAP 193 (353)
T ss_dssp C---------CCGGGCCH
T ss_pred cCCccccccCCCcCeECh
Confidence 555556667899999998
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.97 E-value=5.1e-30 Score=279.86 Aligned_cols=170 Identities=28% Similarity=0.375 Sum_probs=149.6
Q ss_pred cccCCeeEeeeecccCceEEEEEEEc--CCeEEEEEeecccCCH-HHHHHHHHHHHHHhhC-CCCCeeeEEEEEecCCeE
Q 005841 502 ILWEDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSD-EVIHSFRQEVSLMKRL-RHPNVLLFMGAVTSPQRL 577 (674)
Q Consensus 502 ~~~~~y~~~~~LG~G~fG~Vy~~~~~--~~~vAvK~i~~~~~~~-~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~ 577 (674)
+..++|+++++||+|+||+||+|++. +..||||++.+..... .....+..|+.++..+ +||||+++++++.+...+
T Consensus 49 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~ 128 (396)
T 4dc2_A 49 LGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRL 128 (396)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEE
T ss_pred CChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEE
Confidence 44578999999999999999999984 5679999998765433 3445678899999877 899999999999999999
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccccC
Q 005841 578 CIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHE 657 (674)
Q Consensus 578 ~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~ 657 (674)
|||||||++|+|..++.+. ..+++..+..|+.||+.||.|||+++ ||||||||+||||+.++++||+|||+|+....
T Consensus 129 ~lV~E~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~LH~~g--ivHrDLKp~NILl~~~g~ikL~DFGla~~~~~ 205 (396)
T 4dc2_A 129 FFVIEYVNGGDLMFHMQRQ-RKLPEEHARFYSAEISLALNYLHERG--IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR 205 (396)
T ss_dssp EEEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred EEEEEcCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--EEeccCCHHHEEECCCCCEEEeecceeeeccc
Confidence 9999999999999999764 47999999999999999999999999 99999999999999999999999999987555
Q ss_pred CccccccCCCCccccCC
Q 005841 658 TYLTTKTGKGTVTYLAS 674 (674)
Q Consensus 658 ~~~~~~~~~GTp~YmAP 674 (674)
......+.+||+.||||
T Consensus 206 ~~~~~~~~~gt~~Y~aP 222 (396)
T 4dc2_A 206 PGDTTSTFCGTPNYIAP 222 (396)
T ss_dssp TTCCBCCCCBCGGGCCH
T ss_pred CCCccccccCCcccCCc
Confidence 55556678999999998
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=99.96 E-value=1.1e-29 Score=274.56 Aligned_cols=173 Identities=29% Similarity=0.528 Sum_probs=149.9
Q ss_pred ccccccCCeeEeeeecccCceEEEEEEEcC---------CeEEEEEeecccCCHHHHHHHHHHHHHHhhC-CCCCeeeEE
Q 005841 499 DYEILWEDLTIGEQIGQGSCGTVYHAVWYG---------SDVAVKVFSRQEYSDEVIHSFRQEVSLMKRL-RHPNVLLFM 568 (674)
Q Consensus 499 ~~~~~~~~y~~~~~LG~G~fG~Vy~~~~~~---------~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~ 568 (674)
.+++..++|++.+.||+|+||.||+|.+.+ ..||||++.... .......+.+|+.+++.+ +||||++++
T Consensus 75 ~~~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hpnIv~~~ 153 (370)
T 2psq_A 75 KWEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINLL 153 (370)
T ss_dssp TTBCCGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTC-BHHHHHHHHHHHHHHHHSCCCTTBCCEE
T ss_pred cccccHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCc-CHHHHHHHHHHHHHHHHhcCCCCEeeEE
Confidence 346677899999999999999999998732 249999997543 445667899999999999 899999999
Q ss_pred EEEecCCeEEEEEecCCCCCHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCC
Q 005841 569 GAVTSPQRLCIVTEFLPRGSLFRLLQRNT---------------TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKS 633 (674)
Q Consensus 569 ~~~~~~~~~~lV~E~~~ggsL~~~l~~~~---------------~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp 633 (674)
+++...+.+||||||+++|+|.+++.... ..+++..++.++.||+.||.|||+++ ||||||||
T Consensus 154 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp 231 (370)
T 2psq_A 154 GACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK--CIHRDLAA 231 (370)
T ss_dssp EEECSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCG
T ss_pred EEEccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC--eeccccch
Confidence 99999999999999999999999997643 35899999999999999999999999 99999999
Q ss_pred CCEEEcCCCcEEEEecCCcccccCCc--cccccCCCCccccCC
Q 005841 634 SNLLVDKHWTVKVGDFGLSRLKHETY--LTTKTGKGTVTYLAS 674 (674)
Q Consensus 634 ~NILi~~~~~vkL~DFGla~~~~~~~--~~~~~~~GTp~YmAP 674 (674)
+||||+.++.+||+|||+++...... .......||+.||||
T Consensus 232 ~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aP 274 (370)
T 2psq_A 232 RNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAP 274 (370)
T ss_dssp GGEEECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCH
T ss_pred hhEEECCCCCEEEccccCCcccCcccceecccCCCcccceECH
Confidence 99999999999999999998765432 223345789999998
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.5e-29 Score=271.29 Aligned_cols=170 Identities=28% Similarity=0.376 Sum_probs=151.5
Q ss_pred cccCCeeEeeeecccCceEEEEEEEc--CCeEEEEEeecccCC-HHHHHHHHHHHHHHhhC-CCCCeeeEEEEEecCCeE
Q 005841 502 ILWEDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYS-DEVIHSFRQEVSLMKRL-RHPNVLLFMGAVTSPQRL 577 (674)
Q Consensus 502 ~~~~~y~~~~~LG~G~fG~Vy~~~~~--~~~vAvK~i~~~~~~-~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~ 577 (674)
+..++|++.+.||+|+||+||+|++. +..||||++.+.... ......+.+|+.++..+ +||||+++++++.+...+
T Consensus 6 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~ 85 (345)
T 3a8x_A 6 LGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRL 85 (345)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred CchhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEE
Confidence 34578999999999999999999984 667999999876543 45667788999999988 899999999999999999
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccccC
Q 005841 578 CIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHE 657 (674)
Q Consensus 578 ~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~ 657 (674)
||||||+++++|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+||||+.++++||+|||+|+....
T Consensus 86 ~lv~e~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~ 162 (345)
T 3a8x_A 86 FFVIEYVNGGDLMFHMQRQ-RKLPEEHARFYSAEISLALNYLHERG--IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR 162 (345)
T ss_dssp EEEECCCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTSCEEECCGGGCBCSCC
T ss_pred EEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCHHHEEECCCCCEEEEeccccccccC
Confidence 9999999999999999764 47999999999999999999999999 99999999999999999999999999987554
Q ss_pred CccccccCCCCccccCC
Q 005841 658 TYLTTKTGKGTVTYLAS 674 (674)
Q Consensus 658 ~~~~~~~~~GTp~YmAP 674 (674)
........+||+.||||
T Consensus 163 ~~~~~~~~~gt~~y~aP 179 (345)
T 3a8x_A 163 PGDTTSTFCGTPNYIAP 179 (345)
T ss_dssp TTCCBCCCCSCGGGCCH
T ss_pred CCCcccccCCCccccCc
Confidence 44455567899999998
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=8.3e-30 Score=276.15 Aligned_cols=170 Identities=31% Similarity=0.396 Sum_probs=141.5
Q ss_pred cccCCeeEeeeecccCceEEEEEEEc--CCeEEEEEeecccCCH-HHHHHHHHHHHH-HhhCCCCCeeeEEEEEecCCeE
Q 005841 502 ILWEDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSD-EVIHSFRQEVSL-MKRLRHPNVLLFMGAVTSPQRL 577 (674)
Q Consensus 502 ~~~~~y~~~~~LG~G~fG~Vy~~~~~--~~~vAvK~i~~~~~~~-~~~~~~~~Ei~i-l~~l~HpnIv~l~~~~~~~~~~ 577 (674)
...++|++.++||+|+||+||+|++. +..||||++.+..... .....+..|..+ ++.++||||+++++++.+.+.+
T Consensus 35 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~ 114 (373)
T 2r5t_A 35 AKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKL 114 (373)
T ss_dssp CCGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEE
T ss_pred CChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEE
Confidence 44578999999999999999999984 5679999998765432 344556677776 5678999999999999999999
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccccC
Q 005841 578 CIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHE 657 (674)
Q Consensus 578 ~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~ 657 (674)
||||||++||+|.+++.+. ..+++..+..|+.||+.||.|||+++ ||||||||+||||+.++++||+|||+|+....
T Consensus 115 ~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~g--ivHrDlkp~NIll~~~g~ikL~DFG~a~~~~~ 191 (373)
T 2r5t_A 115 YFVLDYINGGELFYHLQRE-RCFLEPRARFYAAEIASALGYLHSLN--IVYRDLKPENILLDSQGHIVLTDFGLCKENIE 191 (373)
T ss_dssp EEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTSCEEECCCCBCGGGBC
T ss_pred EEEEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCHHHEEECCCCCEEEeeCcccccccc
Confidence 9999999999999999764 46899999999999999999999999 99999999999999999999999999987555
Q ss_pred CccccccCCCCccccCC
Q 005841 658 TYLTTKTGKGTVTYLAS 674 (674)
Q Consensus 658 ~~~~~~~~~GTp~YmAP 674 (674)
........+||+.||||
T Consensus 192 ~~~~~~~~~gt~~y~aP 208 (373)
T 2r5t_A 192 HNSTTSTFCGTPEYLAP 208 (373)
T ss_dssp CCCCCCSBSCCCCCCCH
T ss_pred CCCccccccCCccccCH
Confidence 44455667899999998
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=4.8e-30 Score=281.60 Aligned_cols=172 Identities=21% Similarity=0.315 Sum_probs=150.8
Q ss_pred ccccCCeeEeeeecccCceEEEEEEE--cCCeEEEEEeecccCC-HHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeE
Q 005841 501 EILWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYS-DEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRL 577 (674)
Q Consensus 501 ~~~~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 577 (674)
.+..++|++.++||+|+||+||+|++ ++..||||++.+.... ......+.+|+.++..++||||+++++++.+.+.+
T Consensus 57 ~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~ 136 (412)
T 2vd5_A 57 RLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYL 136 (412)
T ss_dssp SCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEE
T ss_pred cCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEE
Confidence 45568999999999999999999998 4778999999764321 12234578899999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccccC
Q 005841 578 CIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHE 657 (674)
Q Consensus 578 ~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~ 657 (674)
|||||||+||+|.+++.+....+++..+..|+.||+.||.|||+++ ||||||||+||||+.++++||+|||+|+....
T Consensus 137 ~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~g--iiHrDLKp~NILld~~g~vkL~DFGla~~~~~ 214 (412)
T 2vd5_A 137 YLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLG--YVHRDIKPDNILLDRCGHIRLADFGSCLKLRA 214 (412)
T ss_dssp EEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecccCHHHeeecCCCCEEEeechhheeccC
Confidence 9999999999999999876668999999999999999999999999 99999999999999999999999999987654
Q ss_pred Ccc-ccccCCCCccccCC
Q 005841 658 TYL-TTKTGKGTVTYLAS 674 (674)
Q Consensus 658 ~~~-~~~~~~GTp~YmAP 674 (674)
... .....+||+.||||
T Consensus 215 ~~~~~~~~~~Gt~~Y~AP 232 (412)
T 2vd5_A 215 DGTVRSLVAVGTPDYLSP 232 (412)
T ss_dssp TSCEECSSCCSCGGGCCH
T ss_pred CCccccceeccccCcCCH
Confidence 332 33456899999998
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=4.9e-30 Score=283.58 Aligned_cols=172 Identities=22% Similarity=0.329 Sum_probs=149.4
Q ss_pred ccccCCeeEeeeecccCceEEEEEEEc--CCeEEEEEeecccCCH-HHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeE
Q 005841 501 EILWEDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSD-EVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRL 577 (674)
Q Consensus 501 ~~~~~~y~~~~~LG~G~fG~Vy~~~~~--~~~vAvK~i~~~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 577 (674)
.+..++|++.++||+|+||+||+|++. +..||||++.+..... .....+.+|+.++..++||||+++++++.+.+.+
T Consensus 70 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~ 149 (437)
T 4aw2_A 70 RLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNL 149 (437)
T ss_dssp SCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEE
T ss_pred cCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEE
Confidence 455689999999999999999999984 5679999997632211 1123377899999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccccC
Q 005841 578 CIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHE 657 (674)
Q Consensus 578 ~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~ 657 (674)
|||||||++|+|.+++.+....+++..+..|+.||+.||.|||+++ ||||||||+||||+.++.+||+|||+|+....
T Consensus 150 ~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g--iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~ 227 (437)
T 4aw2_A 150 YLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLH--YVHRDIKPDNILMDMNGHIRLADFGSCLKLME 227 (437)
T ss_dssp EEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCC--eEecccCHHHeeEcCCCCEEEcchhhhhhccc
Confidence 9999999999999999876678999999999999999999999999 99999999999999999999999999987654
Q ss_pred Cc-cccccCCCCccccCC
Q 005841 658 TY-LTTKTGKGTVTYLAS 674 (674)
Q Consensus 658 ~~-~~~~~~~GTp~YmAP 674 (674)
.. ......+||+.||||
T Consensus 228 ~~~~~~~~~~GT~~Y~AP 245 (437)
T 4aw2_A 228 DGTVQSSVAVGTPDYISP 245 (437)
T ss_dssp TSCEECCSCCSCGGGCCH
T ss_pred CCCcccccccCCcCeeCh
Confidence 32 233446899999998
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=4.2e-29 Score=262.40 Aligned_cols=169 Identities=36% Similarity=0.597 Sum_probs=149.2
Q ss_pred cccCCeeEeeeecccCceEEEEEEEc--CCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeEEE
Q 005841 502 ILWEDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCI 579 (674)
Q Consensus 502 ~~~~~y~~~~~LG~G~fG~Vy~~~~~--~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 579 (674)
+..++|.+.++||+|+||+||+|.+. +..||+|++.. ........+.+|+.+++.++||||+++++++...+.+|+
T Consensus 7 ~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~--~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 84 (310)
T 3s95_A 7 FRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIR--FDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNF 84 (310)
T ss_dssp ECGGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESC--CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEE
T ss_pred eChhHeeccceecCCCCEEEEEEEECCCCcEEEEEEecc--CCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEE
Confidence 45678999999999999999999984 77899998854 245667789999999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccccCCc
Q 005841 580 VTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETY 659 (674)
Q Consensus 580 V~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~~~ 659 (674)
||||+++++|.+++......+++..++.++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++......
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 162 (310)
T 3s95_A 85 ITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMN--IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEK 162 (310)
T ss_dssp EEECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSTTSEEECTTSCEEECCCTTCEECC---
T ss_pred EEEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCCcCeEEECCCCCEEEeecccceeccccc
Confidence 99999999999999887778999999999999999999999999 9999999999999999999999999998764332
Q ss_pred ccc--------------ccCCCCccccCC
Q 005841 660 LTT--------------KTGKGTVTYLAS 674 (674)
Q Consensus 660 ~~~--------------~~~~GTp~YmAP 674 (674)
... ...+||+.|+||
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aP 191 (310)
T 3s95_A 163 TQPEGLRSLKKPDRKKRYTVVGNPYWMAP 191 (310)
T ss_dssp -----------------CCCCSCGGGCCH
T ss_pred ccccccccccccccccccccCCCcceeCH
Confidence 211 145799999998
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=99.96 E-value=3.3e-29 Score=260.86 Aligned_cols=167 Identities=27% Similarity=0.389 Sum_probs=150.2
Q ss_pred CCeeEeeeecccCceEEEEEEE--cCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeEEEEEe
Q 005841 505 EDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTE 582 (674)
Q Consensus 505 ~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E 582 (674)
++|++.+.||+|+||+||+|.+ ++..||||++............+.+|+.+++.++||||+++++++.....+|||||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 5799999999999999999998 46779999998776666666788899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccccCCcccc
Q 005841 583 FLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTT 662 (674)
Q Consensus 583 ~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~~~~~~ 662 (674)
|+++ +|.+++......+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.........
T Consensus 82 ~~~~-~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~--ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 158 (292)
T 3o0g_A 82 FCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN--VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCY 158 (292)
T ss_dssp CCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCTTCEECCSCCSCC
T ss_pred cCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEEeecccceecCCccccc
Confidence 9975 777777666778999999999999999999999999 9999999999999999999999999998776554455
Q ss_pred ccCCCCccccCC
Q 005841 663 KTGKGTVTYLAS 674 (674)
Q Consensus 663 ~~~~GTp~YmAP 674 (674)
....||+.||||
T Consensus 159 ~~~~~t~~y~aP 170 (292)
T 3o0g_A 159 SAEVVTLWYRPP 170 (292)
T ss_dssp CSCCSCGGGCCH
T ss_pred cCCccccCCcCh
Confidence 556899999998
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=2.6e-29 Score=264.84 Aligned_cols=171 Identities=31% Similarity=0.439 Sum_probs=147.6
Q ss_pred ccccCCeeEeeeecccCceEEEEEEE-cCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeEEE
Q 005841 501 EILWEDLTIGEQIGQGSCGTVYHAVW-YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCI 579 (674)
Q Consensus 501 ~~~~~~y~~~~~LG~G~fG~Vy~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 579 (674)
+...++|++.++||+|+||+||+|.+ .+..||||++............+.+|+.+++.++||||+++++++.....+||
T Consensus 17 q~l~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 96 (311)
T 3niz_A 17 QGLMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTL 96 (311)
T ss_dssp ECSSCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEE
T ss_pred cchHhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEE
Confidence 45568899999999999999999998 57789999997655444456778899999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccccCCc
Q 005841 580 VTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETY 659 (674)
Q Consensus 580 V~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~~~ 659 (674)
||||+++ +|.+++......+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 97 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~ 173 (311)
T 3niz_A 97 VFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHR--ILHRDLKPQNLLINSDGALKLADFGLARAFGIPV 173 (311)
T ss_dssp EEECCSE-EHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEECCCTTCEETTSCC
T ss_pred EEcCCCC-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCchHhEEECCCCCEEEccCcCceecCCCc
Confidence 9999975 899988877777999999999999999999999999 9999999999999999999999999998776544
Q ss_pred cccccCCCCccccCC
Q 005841 660 LTTKTGKGTVTYLAS 674 (674)
Q Consensus 660 ~~~~~~~GTp~YmAP 674 (674)
.......||+.|+||
T Consensus 174 ~~~~~~~~t~~y~aP 188 (311)
T 3niz_A 174 RSYTHEVVTLWYRAP 188 (311)
T ss_dssp C---CCCCCCTTCCH
T ss_pred ccccCCcccCCcCCH
Confidence 444456799999998
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.4e-29 Score=272.40 Aligned_cols=171 Identities=26% Similarity=0.351 Sum_probs=148.4
Q ss_pred ccccCCeeEeeeecccCceEEEEEEEc--CCeEEEEEeecccCC-HHHHHHHHHHHHHHhhC-CCCCeeeEEEEEecCCe
Q 005841 501 EILWEDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYS-DEVIHSFRQEVSLMKRL-RHPNVLLFMGAVTSPQR 576 (674)
Q Consensus 501 ~~~~~~y~~~~~LG~G~fG~Vy~~~~~--~~~vAvK~i~~~~~~-~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~ 576 (674)
.+...+|++.++||+|+||+||+|.+. +..||||++.+.... ....+.+..|..++..+ +||||+++++++.+.+.
T Consensus 16 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~ 95 (353)
T 2i0e_A 16 RMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDR 95 (353)
T ss_dssp ---CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSE
T ss_pred CCchHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCE
Confidence 345688999999999999999999985 556999999765321 12345678899999988 79999999999999999
Q ss_pred EEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCccccc
Q 005841 577 LCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKH 656 (674)
Q Consensus 577 ~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~ 656 (674)
+||||||++||+|.+++... ..+++..++.++.||+.||.|||+++ ||||||||+||||+.++++||+|||+|+...
T Consensus 96 ~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~g--ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~ 172 (353)
T 2i0e_A 96 LYFVMEYVNGGDLMYHIQQV-GRFKEPHAVFYAAEIAIGLFFLQSKG--IIYRDLKLDNVMLDSEGHIKIADFGMCKENI 172 (353)
T ss_dssp EEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred EEEEEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--EEeccCCHHHEEEcCCCcEEEEeCCcccccc
Confidence 99999999999999999764 46999999999999999999999999 9999999999999999999999999998755
Q ss_pred CCccccccCCCCccccCC
Q 005841 657 ETYLTTKTGKGTVTYLAS 674 (674)
Q Consensus 657 ~~~~~~~~~~GTp~YmAP 674 (674)
.........+||+.||||
T Consensus 173 ~~~~~~~~~~gt~~y~aP 190 (353)
T 2i0e_A 173 WDGVTTKTFCGTPDYIAP 190 (353)
T ss_dssp CTTCCBCCCCSCGGGCCH
T ss_pred cCCcccccccCCccccCh
Confidence 444456667899999998
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.5e-29 Score=271.37 Aligned_cols=171 Identities=28% Similarity=0.428 Sum_probs=147.4
Q ss_pred ccccCCeeEeeeecccCceEEEEEEEc--CCeEEEEEeecccCC-HHHHHHHHHHHHHHhhC-CCCCeeeEEEEEecCCe
Q 005841 501 EILWEDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYS-DEVIHSFRQEVSLMKRL-RHPNVLLFMGAVTSPQR 576 (674)
Q Consensus 501 ~~~~~~y~~~~~LG~G~fG~Vy~~~~~--~~~vAvK~i~~~~~~-~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~ 576 (674)
.+..++|++.++||+|+||+||+|++. +..||||++.+.... ......+..|..++..+ +||||+++++++.+.+.
T Consensus 13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~ 92 (345)
T 1xjd_A 13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKEN 92 (345)
T ss_dssp ---CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCE
Confidence 345689999999999999999999984 667999999765321 12345677899999876 89999999999999999
Q ss_pred EEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCccccc
Q 005841 577 LCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKH 656 (674)
Q Consensus 577 ~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~ 656 (674)
+||||||++||+|.+++... ..+++..+..++.||+.||.|||+++ ||||||||+||||+.++++||+|||+|+...
T Consensus 93 ~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~ 169 (345)
T 1xjd_A 93 LFFVMEYLNGGDLMYHIQSC-HKFDLSRATFYAAEIILGLQFLHSKG--IVYRDLKLDNILLDKDGHIKIADFGMCKENM 169 (345)
T ss_dssp EEEEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred EEEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCChhhEEECCCCCEEEeEChhhhhcc
Confidence 99999999999999999764 46999999999999999999999999 9999999999999999999999999998754
Q ss_pred CCccccccCCCCccccCC
Q 005841 657 ETYLTTKTGKGTVTYLAS 674 (674)
Q Consensus 657 ~~~~~~~~~~GTp~YmAP 674 (674)
.........+||+.||||
T Consensus 170 ~~~~~~~~~~gt~~y~aP 187 (345)
T 1xjd_A 170 LGDAKTNTFCGTPDYIAP 187 (345)
T ss_dssp CTTCCBCCCCSCGGGCCH
T ss_pred cCCCcccCCCCCcccCCh
Confidence 444445567899999998
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.8e-29 Score=274.41 Aligned_cols=170 Identities=25% Similarity=0.398 Sum_probs=150.1
Q ss_pred ccccCCeeEeeeecccCceEEEEEEE--cCCeEEEEEeecccCC-HHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeE
Q 005841 501 EILWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYS-DEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRL 577 (674)
Q Consensus 501 ~~~~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 577 (674)
.+..++|++.+.||+|+||.||+|.+ ++..||||++.+.... ......+.+|+.+++.++||||+++++++.+...+
T Consensus 11 ~v~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~ 90 (384)
T 4fr4_A 11 DVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDM 90 (384)
T ss_dssp CCCGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 56678999999999999999999998 4667999999765421 12346788999999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccccC
Q 005841 578 CIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHE 657 (674)
Q Consensus 578 ~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~ 657 (674)
|+||||+.|++|.+++.. ...+++..+..|+.||+.||.|||+++ ||||||||+||||+.++.+||+|||+|+....
T Consensus 91 ~lv~e~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~LH~~g--ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 167 (384)
T 4fr4_A 91 FMVVDLLLGGDLRYHLQQ-NVHFKEETVKLFICELVMALDYLQNQR--IIHRDMKPDNILLDEHGHVHITDFNIAAMLPR 167 (384)
T ss_dssp EEEECCCTTEEHHHHHHT-TCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EEEEecCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCcHHHeEECCCCCEEEeccceeeeccC
Confidence 999999999999999975 457999999999999999999999999 99999999999999999999999999987654
Q ss_pred CccccccCCCCccccCC
Q 005841 658 TYLTTKTGKGTVTYLAS 674 (674)
Q Consensus 658 ~~~~~~~~~GTp~YmAP 674 (674)
.. .....+||+.||||
T Consensus 168 ~~-~~~~~~gt~~Y~aP 183 (384)
T 4fr4_A 168 ET-QITTMAGTKPYMAP 183 (384)
T ss_dssp TC-CBCCCCSCGGGCCG
T ss_pred CC-ceeccCCCccccCC
Confidence 32 33457899999998
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=4.6e-29 Score=261.24 Aligned_cols=166 Identities=28% Similarity=0.419 Sum_probs=148.6
Q ss_pred ccCCeeEeeeecccCceEEEEEEE--cCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeEEEE
Q 005841 503 LWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIV 580 (674)
Q Consensus 503 ~~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 580 (674)
..++|++.+.||+|+||+||+|.+ ++..||||++....... .+.+.+|+.+++.++||||+++++++...+.+|+|
T Consensus 18 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 95 (297)
T 3fxz_A 18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK--KELIINEILVMRENKNPNIVNYLDSYLVGDELWVV 95 (297)
T ss_dssp GGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSC--HHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccH--HHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEE
Confidence 346899999999999999999986 57789999997654433 35678899999999999999999999999999999
Q ss_pred EecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccccCCcc
Q 005841 581 TEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYL 660 (674)
Q Consensus 581 ~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~~~~ 660 (674)
|||+++++|.+++... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++........
T Consensus 96 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 171 (297)
T 3fxz_A 96 MEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLHSNQ--VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 171 (297)
T ss_dssp EECCTTCBHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC
T ss_pred EECCCCCCHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHhCC--ceeCCCCHHHEEECCCCCEEEeeCCCceecCCccc
Confidence 9999999999999763 5899999999999999999999999 99999999999999999999999999988766555
Q ss_pred ccccCCCCccccCC
Q 005841 661 TTKTGKGTVTYLAS 674 (674)
Q Consensus 661 ~~~~~~GTp~YmAP 674 (674)
.....+||+.||||
T Consensus 172 ~~~~~~gt~~y~aP 185 (297)
T 3fxz_A 172 KRSTMVGTPYWMAP 185 (297)
T ss_dssp CBCCCCSCGGGCCH
T ss_pred ccCCccCCcCccCh
Confidence 55567899999998
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=9.3e-30 Score=279.10 Aligned_cols=170 Identities=25% Similarity=0.361 Sum_probs=147.4
Q ss_pred ccccCCeeEeeeecccCceEEEEEEEc--CCeEEEEEeecccCCH-HHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeE
Q 005841 501 EILWEDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSD-EVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRL 577 (674)
Q Consensus 501 ~~~~~~y~~~~~LG~G~fG~Vy~~~~~--~~~vAvK~i~~~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 577 (674)
.+..++|++.++||+|+||+||+|.+. +..||||++.+..... .....+.+|+.+++.++||||+++++++.+...+
T Consensus 65 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~ 144 (410)
T 3v8s_A 65 RMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYL 144 (410)
T ss_dssp SCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEE
Confidence 455689999999999999999999984 6679999997632211 1123477899999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccccC
Q 005841 578 CIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHE 657 (674)
Q Consensus 578 ~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~ 657 (674)
|||||||+||+|.+++.. ..+++..+..|+.||+.||.|||+++ ||||||||+||||+.++++||+|||+|+....
T Consensus 145 ~lV~E~~~gg~L~~~l~~--~~~~e~~~~~~~~qi~~aL~~LH~~g--ivHrDLKp~NILl~~~g~ikL~DFG~a~~~~~ 220 (410)
T 3v8s_A 145 YMVMEYMPGGDLVNLMSN--YDVPEKWARFYTAEVVLALDAIHSMG--FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNK 220 (410)
T ss_dssp EEEECCCTTEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EEEEeCCCCCcHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCCHHHeeECCCCCEEEeccceeEeecc
Confidence 999999999999999975 36999999999999999999999999 99999999999999999999999999987654
Q ss_pred Cc-cccccCCCCccccCC
Q 005841 658 TY-LTTKTGKGTVTYLAS 674 (674)
Q Consensus 658 ~~-~~~~~~~GTp~YmAP 674 (674)
.. ....+.+||+.||||
T Consensus 221 ~~~~~~~~~~gt~~Y~AP 238 (410)
T 3v8s_A 221 EGMVRCDTAVGTPDYISP 238 (410)
T ss_dssp TSEEECCSCCSCGGGCCH
T ss_pred CCcccccCCcCCccccCH
Confidence 43 234467899999998
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=3.2e-29 Score=266.21 Aligned_cols=171 Identities=26% Similarity=0.382 Sum_probs=138.4
Q ss_pred ccccCCeeEeeeecccCceEEEEEEE-----cCCeEEEEEeecccCC--HHHHHHHHHHHHHHhhCCCCCeeeEEEEEec
Q 005841 501 EILWEDLTIGEQIGQGSCGTVYHAVW-----YGSDVAVKVFSRQEYS--DEVIHSFRQEVSLMKRLRHPNVLLFMGAVTS 573 (674)
Q Consensus 501 ~~~~~~y~~~~~LG~G~fG~Vy~~~~-----~~~~vAvK~i~~~~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~ 573 (674)
.+..++|++.+.||+|+||.||++.. .+..||||++.+.... ......+.+|+.+++.++||||+++++++..
T Consensus 13 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 92 (327)
T 3a62_A 13 KIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQT 92 (327)
T ss_dssp CCCGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEEC
T ss_pred CCCHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEc
Confidence 45567899999999999999999987 4677999999765432 2344567889999999999999999999999
Q ss_pred CCeEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcc
Q 005841 574 PQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSR 653 (674)
Q Consensus 574 ~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~ 653 (674)
.+.+||||||+++++|.+++... ..+++..+..++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++
T Consensus 93 ~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~Dlkp~Nill~~~~~~kl~Dfg~~~ 169 (327)
T 3a62_A 93 GGKLYLILEYLSGGELFMQLERE-GIFMEDTACFYLAEISMALGHLHQKG--IIYRDLKPENIMLNHQGHVKLTDFGLCK 169 (327)
T ss_dssp SSCEEEEEECCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCTTTEEECTTSCEEECCCSCC-
T ss_pred CCEEEEEEeCCCCCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCC--EEcccCCHHHeEECCCCcEEEEeCCccc
Confidence 99999999999999999999764 46899999999999999999999999 9999999999999999999999999998
Q ss_pred cccCCccccccCCCCccccCC
Q 005841 654 LKHETYLTTKTGKGTVTYLAS 674 (674)
Q Consensus 654 ~~~~~~~~~~~~~GTp~YmAP 674 (674)
............+||+.||||
T Consensus 170 ~~~~~~~~~~~~~gt~~y~aP 190 (327)
T 3a62_A 170 ESIHDGTVTHTFCGTIEYMAP 190 (327)
T ss_dssp ---------CTTSSCCTTSCH
T ss_pred ccccCCccccccCCCcCccCH
Confidence 655444444557899999998
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=99.96 E-value=6.2e-29 Score=259.73 Aligned_cols=171 Identities=29% Similarity=0.427 Sum_probs=145.9
Q ss_pred ccccCCeeEeeeecccCceEEEEEEE--cCCeEEEEEeecccC-CHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeE
Q 005841 501 EILWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEY-SDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRL 577 (674)
Q Consensus 501 ~~~~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 577 (674)
.+..++|++.+.||+|+||.||+|.+ .+..||+|++..... .....+.+.+|+.+++.++||||+++++++...+.+
T Consensus 7 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~ 86 (294)
T 4eqm_A 7 KIINERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCY 86 (294)
T ss_dssp SCEETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEE
T ss_pred hHhhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeE
Confidence 45568899999999999999999997 467899999866543 346678899999999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccccC
Q 005841 578 CIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHE 657 (674)
Q Consensus 578 ~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~ 657 (674)
|+||||+++++|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 87 ~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 163 (294)
T 4eqm_A 87 YLVMEYIEGPTLSEYIESH-GPLSVDTAINFTNQILDGIKHAHDMR--IVHRDIKPQNILIDSNKTLKIFDFGIAKALSE 163 (294)
T ss_dssp EEEEECCCSCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTSCEEECCCSSSTTC--
T ss_pred EEEEeCCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCCCCEEEEeCCCcccccc
Confidence 9999999999999999764 47999999999999999999999999 99999999999999999999999999987654
Q ss_pred Cccc-cccCCCCccccCC
Q 005841 658 TYLT-TKTGKGTVTYLAS 674 (674)
Q Consensus 658 ~~~~-~~~~~GTp~YmAP 674 (674)
.... ....+||+.||||
T Consensus 164 ~~~~~~~~~~gt~~y~aP 181 (294)
T 4eqm_A 164 TSLTQTNHVLGTVQYFSP 181 (294)
T ss_dssp -----------CCSSCCH
T ss_pred ccccccCccccCccccCH
Confidence 3322 3345799999998
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.96 E-value=3.3e-29 Score=265.51 Aligned_cols=166 Identities=27% Similarity=0.457 Sum_probs=147.1
Q ss_pred ccCCeeEeeeecccCceEEEEEEE--cCCeEEEEEeecccCCH-HHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeEEE
Q 005841 503 LWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSD-EVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCI 579 (674)
Q Consensus 503 ~~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 579 (674)
..++|++.+.||+|+||+||+|.. ++..||||++.+..... ...+.+.+|+.+++.++||||+++++++.+...+|+
T Consensus 4 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l 83 (318)
T 1fot_A 4 SLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFM 83 (318)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEE
T ss_pred ChHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEE
Confidence 457899999999999999999998 47789999997653211 234567889999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccccCCc
Q 005841 580 VTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETY 659 (674)
Q Consensus 580 V~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~~~ 659 (674)
||||+++++|.+++.. ...+++..+..++.||+.||.|||+++ |+||||||+||||+.++++||+|||+++.....
T Consensus 84 v~e~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~- 159 (318)
T 1fot_A 84 IMDYIEGGELFSLLRK-SQRFPNPVAKFYAAEVCLALEYLHSKD--IIYRDLKPENILLDKNGHIKITDFGFAKYVPDV- 159 (318)
T ss_dssp EECCCCSCBHHHHHHH-TSSCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEECTTSCEEECCCSSCEECSSC-
T ss_pred EEeCCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCChheEEEcCCCCEEEeecCcceecCCc-
Confidence 9999999999999976 457999999999999999999999999 999999999999999999999999999876543
Q ss_pred cccccCCCCccccCC
Q 005841 660 LTTKTGKGTVTYLAS 674 (674)
Q Consensus 660 ~~~~~~~GTp~YmAP 674 (674)
..+.+||+.||||
T Consensus 160 --~~~~~gt~~y~aP 172 (318)
T 1fot_A 160 --TYTLCGTPDYIAP 172 (318)
T ss_dssp --BCCCCSCTTTCCH
T ss_pred --cccccCCccccCH
Confidence 3346899999998
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=5.5e-29 Score=275.79 Aligned_cols=169 Identities=22% Similarity=0.332 Sum_probs=150.4
Q ss_pred ccCCeeEeeeecccCceEEEEEEE--cCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeEEEE
Q 005841 503 LWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIV 580 (674)
Q Consensus 503 ~~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 580 (674)
..++|++.+.||+|+||+||+|.+ ++..||+|++.+........+.+.+|+.+++.++||||+++++++.+.+.+|||
T Consensus 9 ~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv 88 (444)
T 3soa_A 9 FTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLI 88 (444)
T ss_dssp HHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEE
T ss_pred ccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEE
Confidence 346899999999999999999987 577899999988776666677899999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEc---CCCcEEEEecCCcccccC
Q 005841 581 TEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVD---KHWTVKVGDFGLSRLKHE 657 (674)
Q Consensus 581 ~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~---~~~~vkL~DFGla~~~~~ 657 (674)
||||.+++|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++ .++.+||+|||+++....
T Consensus 89 ~E~~~gg~L~~~i~~-~~~~~e~~~~~i~~qil~aL~~lH~~g--ivHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~ 165 (444)
T 3soa_A 89 FDLVTGGELFEDIVA-REYYSEADASHCIQQILEAVLHCHQMG--VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEG 165 (444)
T ss_dssp ECCCBCCBHHHHHHH-CSCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCT
T ss_pred EEeCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEEeccCCCCcEEEccCceeEEecC
Confidence 999999999999976 457999999999999999999999999 99999999999998 467899999999987766
Q ss_pred CccccccCCCCccccCC
Q 005841 658 TYLTTKTGKGTVTYLAS 674 (674)
Q Consensus 658 ~~~~~~~~~GTp~YmAP 674 (674)
........+||+.||||
T Consensus 166 ~~~~~~~~~gt~~Y~AP 182 (444)
T 3soa_A 166 EQQAWFGFAGTPGYLSP 182 (444)
T ss_dssp TCCBCCCSCSCGGGCCH
T ss_pred CCceeecccCCcccCCH
Confidence 55445557899999998
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=2e-29 Score=279.37 Aligned_cols=171 Identities=28% Similarity=0.418 Sum_probs=140.0
Q ss_pred ccccCCeeEeeeecccCceEEEEEEE--cCCeEEEEEeecccC-CHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeE
Q 005841 501 EILWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEY-SDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRL 577 (674)
Q Consensus 501 ~~~~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 577 (674)
.+..++|++.++||+|+||.||+|.+ ++..||||++.+... .......+.+|+.+++.++||||+.+++++...+.+
T Consensus 144 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~ 223 (446)
T 4ejn_A 144 RVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRL 223 (446)
T ss_dssp CCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEE
T ss_pred CCChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEE
Confidence 44567899999999999999999998 467899999976543 234456678899999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCeEEccCCCCCEEEcCCCcEEEEecCCccccc
Q 005841 578 CIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHH-CNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKH 656 (674)
Q Consensus 578 ~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~-~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~ 656 (674)
||||||+++++|.+++... ..+++..+..++.||+.||.|||+ ++ ||||||||+||||+.++.+||+|||+|+...
T Consensus 224 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~g--iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 300 (446)
T 4ejn_A 224 CFVMEYANGGELFFHLSRE-RVFSEDRARFYGAEIVSALDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCKEGI 300 (446)
T ss_dssp EEEECCCSSCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHHTC--CCCCCCCGGGEEECSSSCEEECCCCCCCTTC
T ss_pred EEEEeeCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCC--EEECCCCHHHEEECCCCCEEEccCCCceecc
Confidence 9999999999999999764 479999999999999999999998 88 9999999999999999999999999998765
Q ss_pred CCccccccCCCCccccCC
Q 005841 657 ETYLTTKTGKGTVTYLAS 674 (674)
Q Consensus 657 ~~~~~~~~~~GTp~YmAP 674 (674)
.........+||+.||||
T Consensus 301 ~~~~~~~~~~gt~~y~aP 318 (446)
T 4ejn_A 301 KDGATMKTFCGTPEYLAP 318 (446)
T ss_dssp C-----CCSSSCGGGCCH
T ss_pred CCCcccccccCCccccCH
Confidence 555555567899999998
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=9.2e-29 Score=266.78 Aligned_cols=169 Identities=25% Similarity=0.388 Sum_probs=148.2
Q ss_pred cccCCeeEeeeecccCceEEEEEEE--cCCeEEEEEeecccCCH----HHHHHHHHHHHHHhhCCCCCeeeEEEEEecCC
Q 005841 502 ILWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSD----EVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQ 575 (674)
Q Consensus 502 ~~~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~~~----~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~ 575 (674)
...+.|++.+.||+|+||+||+|.+ ++..||||++.+..... ...+.+.+|+.+++.++||||+++++++.+..
T Consensus 9 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~ 88 (361)
T 2yab_A 9 KVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRT 88 (361)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred ChhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCC
Confidence 3457899999999999999999998 47789999998765432 12467889999999999999999999999999
Q ss_pred eEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCC----cEEEEecCC
Q 005841 576 RLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHW----TVKVGDFGL 651 (674)
Q Consensus 576 ~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~----~vkL~DFGl 651 (674)
.+||||||+++++|.+++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++ .+||+|||+
T Consensus 89 ~~~lv~e~~~gg~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~~g--ivHrDlkp~NIll~~~~~~~~~vkl~DFG~ 165 (361)
T 2yab_A 89 DVVLILELVSGGELFDFLAQ-KESLSEEEATSFIKQILDGVNYLHTKK--IAHFDLKPENIMLLDKNIPIPHIKLIDFGL 165 (361)
T ss_dssp EEEEEEECCCSCBHHHHHTT-CSCCBHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESCTTSSSCCEEECCCSS
T ss_pred EEEEEEEcCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEeCCCCCccCEEEEecCC
Confidence 99999999999999999965 457999999999999999999999999 99999999999998776 799999999
Q ss_pred cccccCCccccccCCCCccccCC
Q 005841 652 SRLKHETYLTTKTGKGTVTYLAS 674 (674)
Q Consensus 652 a~~~~~~~~~~~~~~GTp~YmAP 674 (674)
++...... .....+||+.||||
T Consensus 166 a~~~~~~~-~~~~~~gt~~y~aP 187 (361)
T 2yab_A 166 AHEIEDGV-EFKNIFGTPEFVAP 187 (361)
T ss_dssp CEECCTTC-CCCCCCSCGGGCCH
T ss_pred ceEcCCCC-ccccCCCCccEECc
Confidence 98765532 23446899999998
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=9.4e-29 Score=262.37 Aligned_cols=171 Identities=32% Similarity=0.487 Sum_probs=147.8
Q ss_pred ccccCCeeEeeeecccCceEEEEEEEc-----CCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCC
Q 005841 501 EILWEDLTIGEQIGQGSCGTVYHAVWY-----GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQ 575 (674)
Q Consensus 501 ~~~~~~y~~~~~LG~G~fG~Vy~~~~~-----~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~ 575 (674)
++...+|++.+.||+|+||.||+|.+. +..||||++... ......+.+.+|+.+++.++||||+++++++....
T Consensus 45 ~~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 123 (325)
T 3kul_A 45 EIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAG-YTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGR 123 (325)
T ss_dssp BCCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTT-CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGG
T ss_pred ccChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCC-CCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCC
Confidence 566789999999999999999999983 234999999654 34556678999999999999999999999999999
Q ss_pred eEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccc
Q 005841 576 RLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLK 655 (674)
Q Consensus 576 ~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~ 655 (674)
.+||||||+++++|.+++......+++..++.++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++..
T Consensus 124 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 201 (325)
T 3kul_A 124 LAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLG--YVHRDLAARNVLVDSNLVCKVSDFGLSRVL 201 (325)
T ss_dssp CCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTCCEEECCCSSCEEC
T ss_pred ccEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC--eeCCCCCcceEEECCCCCEEECCCCccccc
Confidence 999999999999999999877778999999999999999999999999 999999999999999999999999999876
Q ss_pred cCCc---cccccCCCCccccCC
Q 005841 656 HETY---LTTKTGKGTVTYLAS 674 (674)
Q Consensus 656 ~~~~---~~~~~~~GTp~YmAP 674 (674)
.... .......||+.||||
T Consensus 202 ~~~~~~~~~~~~~~~t~~y~aP 223 (325)
T 3kul_A 202 EDDPDAAYTTTGGKIPIRWTAP 223 (325)
T ss_dssp C----CCEECC---CCGGGSCH
T ss_pred ccCccceeeccCCCCcccccCH
Confidence 5432 222334578899998
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.96 E-value=1.3e-28 Score=261.09 Aligned_cols=166 Identities=22% Similarity=0.332 Sum_probs=146.9
Q ss_pred ccCCeeEeeeecccCceEEEEEEEc--CCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeEEEE
Q 005841 503 LWEDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIV 580 (674)
Q Consensus 503 ~~~~y~~~~~LG~G~fG~Vy~~~~~--~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 580 (674)
..++|++.+.||+|+||.||+|.+. +..||+|++... ......+.+|+.+++.++||||+++++++.+.+.+|||
T Consensus 3 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 79 (321)
T 1tki_A 3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK---GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMI 79 (321)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC---THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEE
T ss_pred hhhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC---cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEE
Confidence 3578999999999999999999984 667999998643 23345688999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcC--CCcEEEEecCCcccccCC
Q 005841 581 TEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDK--HWTVKVGDFGLSRLKHET 658 (674)
Q Consensus 581 ~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~--~~~vkL~DFGla~~~~~~ 658 (674)
||||++++|.+++......+++..+..++.||+.||.|||+++ |+||||||+|||++. ++.+||+|||+++.....
T Consensus 80 ~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~g--ivH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~ 157 (321)
T 1tki_A 80 FEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHN--IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG 157 (321)
T ss_dssp ECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT
T ss_pred EEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--CCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCC
Confidence 9999999999999776667999999999999999999999999 999999999999986 789999999999876543
Q ss_pred ccccccCCCCccccCC
Q 005841 659 YLTTKTGKGTVTYLAS 674 (674)
Q Consensus 659 ~~~~~~~~GTp~YmAP 674 (674)
.. .....|||.|+||
T Consensus 158 ~~-~~~~~gt~~y~aP 172 (321)
T 1tki_A 158 DN-FRLLFTAPEYYAP 172 (321)
T ss_dssp CE-EEEEESCGGGSCH
T ss_pred Cc-cccccCChhhcCc
Confidence 32 2335799999998
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=99.96 E-value=5.3e-29 Score=267.47 Aligned_cols=167 Identities=26% Similarity=0.364 Sum_probs=148.0
Q ss_pred cccCCeeEeeeecccCceEEEEEEE--cCCeEEEEEeecccCC-HHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeEE
Q 005841 502 ILWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYS-DEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLC 578 (674)
Q Consensus 502 ~~~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 578 (674)
...++|++.+.||+|+||.||+|.+ ++..||||++.+.... ......+.+|+.+++.++||||+++++++.+...+|
T Consensus 38 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 117 (350)
T 1rdq_E 38 AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLY 117 (350)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred CCHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEE
Confidence 3457899999999999999999998 4778999999765431 123467888999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccccCC
Q 005841 579 IVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHET 658 (674)
Q Consensus 579 lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~~ 658 (674)
|||||+++++|.+++.+. ..+++..+..++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++.....
T Consensus 118 lv~e~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~ 194 (350)
T 1rdq_E 118 MVMEYVAGGEMFSHLRRI-GRFSEPHARFYAAQIVLTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR 194 (350)
T ss_dssp EEEECCTTCBHHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred EEEcCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--cccccCccceEEECCCCCEEEcccccceeccCC
Confidence 999999999999999764 46999999999999999999999999 999999999999999999999999999876543
Q ss_pred ccccccCCCCccccCC
Q 005841 659 YLTTKTGKGTVTYLAS 674 (674)
Q Consensus 659 ~~~~~~~~GTp~YmAP 674 (674)
....+||+.||||
T Consensus 195 ---~~~~~gt~~y~aP 207 (350)
T 1rdq_E 195 ---TWTLCGTPEALAP 207 (350)
T ss_dssp ---BCCCEECGGGCCH
T ss_pred ---cccccCCccccCH
Confidence 3346899999998
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.96 E-value=4.1e-29 Score=277.54 Aligned_cols=167 Identities=28% Similarity=0.317 Sum_probs=134.2
Q ss_pred cCCeeEeeeecccCceEEEEEEE--cCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEec-----CCe
Q 005841 504 WEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTS-----PQR 576 (674)
Q Consensus 504 ~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~-----~~~ 576 (674)
.++|++.++||+|+||+||+|.+ ++..||||++.+........+.+.+|+.+|+.++||||+++++++.. ...
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 131 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE 131 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence 47899999999999999999987 47789999997765566667889999999999999999999999843 357
Q ss_pred EEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCccccc
Q 005841 577 LCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKH 656 (674)
Q Consensus 577 ~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~ 656 (674)
+||||||+ +++|.+++.. ...+++..+..|+.||+.||.|||+.+ ||||||||+||||+.++.|||+|||+|+...
T Consensus 132 ~~lv~e~~-~~~L~~~~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~~--iiHrDlKp~NILl~~~~~~kl~DFGla~~~~ 207 (458)
T 3rp9_A 132 LYVVLEIA-DSDFKKLFRT-PVYLTELHIKTLLYNLLVGVKYVHSAG--ILHRDLKPANCLVNQDCSVKVCDFGLARTVD 207 (458)
T ss_dssp EEEEECCC-SEEHHHHHHS-SCCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTCCEEECCCTTCBCTT
T ss_pred EEEEEecc-ccchhhhccc-CCCCCHHHHHHHHHHHHHHHHHHHhCC--cCCCCCChhhEEECCCCCEeecccccchhcc
Confidence 99999998 5699999964 457999999999999999999999999 9999999999999999999999999998764
Q ss_pred CCc---------------------------cccccCCCCccccCC
Q 005841 657 ETY---------------------------LTTKTGKGTVTYLAS 674 (674)
Q Consensus 657 ~~~---------------------------~~~~~~~GTp~YmAP 674 (674)
... ......+||+.||||
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aP 252 (458)
T 3rp9_A 208 YPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAP 252 (458)
T ss_dssp SCTTCCCCCC---------------------------CCCTTCCH
T ss_pred CccccccccccCccccccccccccccccccccccCCcccccccCh
Confidence 221 112345799999998
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=99.96 E-value=1.2e-28 Score=265.72 Aligned_cols=168 Identities=23% Similarity=0.397 Sum_probs=149.8
Q ss_pred ccCCeeEeeeecccCceEEEEEEE--cCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeEEEE
Q 005841 503 LWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIV 580 (674)
Q Consensus 503 ~~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 580 (674)
..++|++.+.||+|+||.||+|.+ ++..||||++..........+.+.+|+.+++.++||||+++++++.+.+.+|||
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv 106 (362)
T 2bdw_A 27 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 106 (362)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 346899999999999999999998 477899999988777777778899999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCC---CcEEEEecCCcccccC
Q 005841 581 TEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKH---WTVKVGDFGLSRLKHE 657 (674)
Q Consensus 581 ~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~---~~vkL~DFGla~~~~~ 657 (674)
||||++++|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+||||+.+ +.+||+|||+++....
T Consensus 107 ~e~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~ 183 (362)
T 2bdw_A 107 FDLVTGGELFEDIVA-REFYSEADASHCIQQILESIAYCHSNG--IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND 183 (362)
T ss_dssp ECCCCSCBHHHHHTT-CSCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTT
T ss_pred EecCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCchHHEEEecCCCCCCEEEeecCcceEecC
Confidence 999999999999965 457999999999999999999999999 9999999999999854 4699999999987664
Q ss_pred CccccccCCCCccccCC
Q 005841 658 TYLTTKTGKGTVTYLAS 674 (674)
Q Consensus 658 ~~~~~~~~~GTp~YmAP 674 (674)
.. .....+||+.||||
T Consensus 184 ~~-~~~~~~gt~~y~aP 199 (362)
T 2bdw_A 184 SE-AWHGFAGTPGYLSP 199 (362)
T ss_dssp CC-SCCCSCSCTTTCCH
T ss_pred Cc-ccccCCCCccccCH
Confidence 33 23346899999998
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=99.96 E-value=4e-29 Score=268.16 Aligned_cols=170 Identities=24% Similarity=0.353 Sum_probs=146.4
Q ss_pred ccCCeeEeeeecccCceEEEEEEE--cCCeEEEEEeecccCC---HHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeE
Q 005841 503 LWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYS---DEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRL 577 (674)
Q Consensus 503 ~~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 577 (674)
..++|++.+.||+|+||+||+|.+ ++..||||++...... ....+.+.+|+.+++.++||||+++++++...+.+
T Consensus 22 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 101 (351)
T 3c0i_A 22 FEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGML 101 (351)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred cccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 346799999999999999999998 4778999999753321 11246788999999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCc---EEEEecCC
Q 005841 578 CIVTEFLPRGSLFRLLQRN---TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWT---VKVGDFGL 651 (674)
Q Consensus 578 ~lV~E~~~ggsL~~~l~~~---~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~---vkL~DFGl 651 (674)
|||||||++++|.+++... ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++. |||+|||+
T Consensus 102 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~ 179 (351)
T 3c0i_A 102 YMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN--IIHRDVKPHCVLLASKENSAPVKLGGFGV 179 (351)
T ss_dssp EEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECSSSTTCCEEECCCTT
T ss_pred EEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCChHHeEEecCCCCCcEEEecCcc
Confidence 9999999999999887643 345899999999999999999999999 999999999999986554 99999999
Q ss_pred cccccCCccccccCCCCccccCC
Q 005841 652 SRLKHETYLTTKTGKGTVTYLAS 674 (674)
Q Consensus 652 a~~~~~~~~~~~~~~GTp~YmAP 674 (674)
++............+||+.||||
T Consensus 180 a~~~~~~~~~~~~~~gt~~y~aP 202 (351)
T 3c0i_A 180 AIQLGESGLVAGGRVGTPHFMAP 202 (351)
T ss_dssp CEECCTTSCBCCCCCSCGGGCCH
T ss_pred eeEecCCCeeecCCcCCcCccCH
Confidence 98876655445556899999998
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=99.96 E-value=3.6e-29 Score=260.30 Aligned_cols=167 Identities=29% Similarity=0.450 Sum_probs=143.4
Q ss_pred CCeeEeeeecccCceEEEEEEE-cCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeEEEEEec
Q 005841 505 EDLTIGEQIGQGSCGTVYHAVW-YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEF 583 (674)
Q Consensus 505 ~~y~~~~~LG~G~fG~Vy~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~ 583 (674)
++|++.+.||+|+||+||+|.+ .+..||||++............+.+|+.+++.++||||+++++++...+.+|+||||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence 5799999999999999999998 477899999976544333345678899999999999999999999999999999999
Q ss_pred CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccccCCccccc
Q 005841 584 LPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTK 663 (674)
Q Consensus 584 ~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~~~~~~~ 663 (674)
+++ +|.+++......+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++..........
T Consensus 82 ~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 158 (288)
T 1ob3_A 82 LDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR--VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYT 158 (288)
T ss_dssp CSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC------
T ss_pred cCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEcCCCCEEEeECccccccCccccccc
Confidence 975 999999877778999999999999999999999999 99999999999999999999999999987654433334
Q ss_pred cCCCCccccCC
Q 005841 664 TGKGTVTYLAS 674 (674)
Q Consensus 664 ~~~GTp~YmAP 674 (674)
...||+.||||
T Consensus 159 ~~~~t~~y~aP 169 (288)
T 1ob3_A 159 HEIVTLWYRAP 169 (288)
T ss_dssp ---CCCTTCCH
T ss_pred cccccccccCc
Confidence 45799999998
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=7.9e-29 Score=258.77 Aligned_cols=169 Identities=30% Similarity=0.468 Sum_probs=142.1
Q ss_pred cccCCeeEeeeecccCceEEEEEEE--cCCeEEEEEeecccCCH------------------------HHHHHHHHHHHH
Q 005841 502 ILWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSD------------------------EVIHSFRQEVSL 555 (674)
Q Consensus 502 ~~~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~~~------------------------~~~~~~~~Ei~i 555 (674)
+..++|++.+.||+|+||.||+|.+ ++..||||++.+..... ...+.+.+|+.+
T Consensus 10 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~ 89 (298)
T 2zv2_A 10 VQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAI 89 (298)
T ss_dssp CEETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHH
T ss_pred eeecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHH
Confidence 3457899999999999999999987 46779999997654321 124568899999
Q ss_pred HhhCCCCCeeeEEEEEec--CCeEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCC
Q 005841 556 MKRLRHPNVLLFMGAVTS--PQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKS 633 (674)
Q Consensus 556 l~~l~HpnIv~l~~~~~~--~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp 633 (674)
++.++||||+++++++.. ...+||||||+++++|.+++. ...+++..+..++.||+.||.|||+.+ |+||||||
T Consensus 90 l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp 165 (298)
T 2zv2_A 90 LKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT--LKPLSEDQARFYFQDLIKGIEYLHYQK--IIHRDIKP 165 (298)
T ss_dssp HHTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC--SSCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCG
T ss_pred HHhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCH
Confidence 999999999999999987 568999999999999987653 346999999999999999999999999 99999999
Q ss_pred CCEEEcCCCcEEEEecCCcccccCCccccccCCCCccccCC
Q 005841 634 SNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTVTYLAS 674 (674)
Q Consensus 634 ~NILi~~~~~vkL~DFGla~~~~~~~~~~~~~~GTp~YmAP 674 (674)
+||||+.++.+||+|||+++.............||+.||||
T Consensus 166 ~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aP 206 (298)
T 2zv2_A 166 SNLLVGEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAP 206 (298)
T ss_dssp GGEEECTTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCG
T ss_pred HHEEECCCCCEEEecCCCccccccccccccCCcCCccccCh
Confidence 99999999999999999998776544444456899999998
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.3e-28 Score=253.04 Aligned_cols=171 Identities=29% Similarity=0.506 Sum_probs=150.9
Q ss_pred ccccccCCeeEeeeecccCceEEEEEEE-cCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeE
Q 005841 499 DYEILWEDLTIGEQIGQGSCGTVYHAVW-YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRL 577 (674)
Q Consensus 499 ~~~~~~~~y~~~~~LG~G~fG~Vy~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 577 (674)
.|.+..++|++.+.||+|+||.||+|.+ .+..||+|++....... +.+.+|+.+++.++||||+++++++.+...+
T Consensus 4 ~~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~---~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 80 (269)
T 4hcu_A 4 KWVIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE---EDFIEEAEVMMKLSHPKLVQLYGVCLEQAPI 80 (269)
T ss_dssp -CBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSBCH---HHHHHHHHHHHTCCCTTBCCEEEEECSSSSE
T ss_pred cEEeChhhceeeheecCCCccEEEEEEecCCCeEEEEEecccccCH---HHHHHHHHHHHhCCCCCEeeEEEEEecCCce
Confidence 4567778999999999999999999998 56679999998665444 4588899999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccccC
Q 005841 578 CIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHE 657 (674)
Q Consensus 578 ~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~ 657 (674)
|+||||+++++|.+++......+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 158 (269)
T 4hcu_A 81 CLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC--VIHRDLAARNCLVGENQVIKVSDFGMTRFVLD 158 (269)
T ss_dssp EEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECGGGCEEECCTTGGGGBCC
T ss_pred EEEEEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCC--eecCCcchheEEEcCCCCEEeccccccccccc
Confidence 9999999999999999877778999999999999999999999999 99999999999999999999999999987654
Q ss_pred Cccc-cccCCCCccccCC
Q 005841 658 TYLT-TKTGKGTVTYLAS 674 (674)
Q Consensus 658 ~~~~-~~~~~GTp~YmAP 674 (674)
.... .....||+.|+||
T Consensus 159 ~~~~~~~~~~~~~~y~aP 176 (269)
T 4hcu_A 159 DQYTSSTGTKFPVKWASP 176 (269)
T ss_dssp HHHHSTTSTTCCGGGCCH
T ss_pred cccccccCcccccccCCH
Confidence 3322 2234678899998
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.6e-28 Score=264.34 Aligned_cols=170 Identities=19% Similarity=0.243 Sum_probs=145.1
Q ss_pred cccccccCCeeEeeeecccCceEEEEEE-------EcCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCC---CCCeeeE
Q 005841 498 LDYEILWEDLTIGEQIGQGSCGTVYHAV-------WYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLR---HPNVLLF 567 (674)
Q Consensus 498 ~~~~~~~~~y~~~~~LG~G~fG~Vy~~~-------~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~---HpnIv~l 567 (674)
..+++..++|.+.++||+|+||+||+|. ..+..||||++.... ...+..|+.++..+. |+||+.+
T Consensus 58 ~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-----~~~~~~e~~~~~~l~~~~~~~iv~~ 132 (365)
T 3e7e_A 58 TEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN-----PWEFYIGTQLMERLKPSMQHMFMKF 132 (365)
T ss_dssp CEEECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC-----HHHHHHHHHHHHHSCGGGGGGBCCE
T ss_pred eeEEECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC-----hhHHHHHHHHHHHhhhhhhhhhhhh
Confidence 3456677899999999999999999994 257789999996542 235667888888876 9999999
Q ss_pred EEEEecCCeEEEEEecCCCCCHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcC---
Q 005841 568 MGAVTSPQRLCIVTEFLPRGSLFRLLQR----NTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDK--- 640 (674)
Q Consensus 568 ~~~~~~~~~~~lV~E~~~ggsL~~~l~~----~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~--- 640 (674)
++++...+..|||||||++|+|.+++.. ....+++..++.|+.||+.||+|||+++ ||||||||+||||+.
T Consensus 133 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~--ivHrDiKp~NIll~~~~~ 210 (365)
T 3e7e_A 133 YSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE--IIHGDIKPDNFILGNGFL 210 (365)
T ss_dssp EEEEECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCSGGGEEECGGGT
T ss_pred heeeecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCC--eecCCCCHHHEEeccccc
Confidence 9999999999999999999999999975 3457999999999999999999999999 999999999999998
Q ss_pred --------CCcEEEEecCCccccc--CCccccccCCCCccccCC
Q 005841 641 --------HWTVKVGDFGLSRLKH--ETYLTTKTGKGTVTYLAS 674 (674)
Q Consensus 641 --------~~~vkL~DFGla~~~~--~~~~~~~~~~GTp~YmAP 674 (674)
++.+||+|||+|+... .........+||+.||||
T Consensus 211 ~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aP 254 (365)
T 3e7e_A 211 EQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCV 254 (365)
T ss_dssp CC------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCH
T ss_pred CccccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCCh
Confidence 8999999999997653 222233446899999998
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.96 E-value=2e-28 Score=258.38 Aligned_cols=167 Identities=25% Similarity=0.380 Sum_probs=140.4
Q ss_pred CCeeEeeeecccCceEEEEEEE--cCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCC-------
Q 005841 505 EDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQ------- 575 (674)
Q Consensus 505 ~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~------- 575 (674)
++|++.+.||+|+||.||+|.+ ++..||||++.... .....+.+.+|+.+++.++||||+++++++.+..
T Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 84 (332)
T 3qd2_B 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPN-RELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE 84 (332)
T ss_dssp HHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCS-TTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred hcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCC-chhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence 5799999999999999999998 47789999997654 3334577899999999999999999999986543
Q ss_pred --------------------------------------------------eEEEEEecCCCCCHHHHHHhcC--CCCCHH
Q 005841 576 --------------------------------------------------RLCIVTEFLPRGSLFRLLQRNT--TKLDWR 603 (674)
Q Consensus 576 --------------------------------------------------~~~lV~E~~~ggsL~~~l~~~~--~~l~~~ 603 (674)
.+|+|||||++++|.+++.... ...++.
T Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~ 164 (332)
T 3qd2_B 85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHG 164 (332)
T ss_dssp HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHH
T ss_pred hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhH
Confidence 3899999999999999997643 235677
Q ss_pred HHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccccCCc------------cccccCCCCccc
Q 005841 604 RRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETY------------LTTKTGKGTVTY 671 (674)
Q Consensus 604 ~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~~~------------~~~~~~~GTp~Y 671 (674)
.++.++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++...... ......+||+.|
T Consensus 165 ~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y 242 (332)
T 3qd2_B 165 VCLHIFIQIAEAVEFLHSKG--LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLY 242 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGGG
T ss_pred HHHHHHHHHHHHHHHHHhCC--eeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcCc
Confidence 78999999999999999999 9999999999999999999999999998765432 122335799999
Q ss_pred cCC
Q 005841 672 LAS 674 (674)
Q Consensus 672 mAP 674 (674)
+||
T Consensus 243 ~aP 245 (332)
T 3qd2_B 243 MSP 245 (332)
T ss_dssp SCH
T ss_pred cCh
Confidence 998
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=99.96 E-value=1.1e-28 Score=279.27 Aligned_cols=171 Identities=22% Similarity=0.302 Sum_probs=150.7
Q ss_pred cccCCeeEeeeecccCceEEEEEEE--cCCeEEEEEeecccCCH-HHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeEE
Q 005841 502 ILWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSD-EVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLC 578 (674)
Q Consensus 502 ~~~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 578 (674)
+..++|.+.++||+|+||+||+|++ ++..||||++.+..... .....+.+|+.+++.++||||+.+++++.....+|
T Consensus 182 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~ 261 (543)
T 3c4z_A 182 MGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLC 261 (543)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred CChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEE
Confidence 3457899999999999999999998 47789999997654322 23456888999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccc
Q 005841 579 IVTEFLPRGSLFRLLQRN---TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLK 655 (674)
Q Consensus 579 lV~E~~~ggsL~~~l~~~---~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~ 655 (674)
|||||++|++|.+++... ...+++..++.|+.||+.||.|||+++ ||||||||+||||+.++++||+|||+++..
T Consensus 262 lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g--IvHrDLKP~NILl~~~g~vkL~DFGla~~~ 339 (543)
T 3c4z_A 262 LVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN--IIYRDLKPENVLLDDDGNVRISDLGLAVEL 339 (543)
T ss_dssp EEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcC--CcccCCChHHEEEeCCCCEEEeecceeeec
Confidence 999999999999999754 346999999999999999999999999 999999999999999999999999999887
Q ss_pred cCCccccccCCCCccccCC
Q 005841 656 HETYLTTKTGKGTVTYLAS 674 (674)
Q Consensus 656 ~~~~~~~~~~~GTp~YmAP 674 (674)
..........+||+.||||
T Consensus 340 ~~~~~~~~~~~GT~~Y~AP 358 (543)
T 3c4z_A 340 KAGQTKTKGYAGTPGFMAP 358 (543)
T ss_dssp CTTCCCBCCCCSCTTTSCH
T ss_pred cCCCcccccccCCccccCh
Confidence 6554445556899999998
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.5e-28 Score=260.28 Aligned_cols=170 Identities=32% Similarity=0.449 Sum_probs=146.7
Q ss_pred cccccccCCeeEeeeecccCceEEEEEEEcCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCC--
Q 005841 498 LDYEILWEDLTIGEQIGQGSCGTVYHAVWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQ-- 575 (674)
Q Consensus 498 ~~~~~~~~~y~~~~~LG~G~fG~Vy~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~-- 575 (674)
.++.+...+|++.++||+|+||+||+|.+.+..||||++.... .....+.+|+.+++.++||||+++++++....
T Consensus 17 ~n~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 93 (322)
T 3soc_A 17 ENLYFQSMPLQLLEVKARGRFGCVWKAQLLNEYVAVKIFPIQD---KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSV 93 (322)
T ss_dssp CCEEETTEEEEEEEEEECSTTCEEEEEEETTEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSS
T ss_pred cccccchhhchhhheecccCceEEEEEEECCCEEEEEEeecCc---hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCC
Confidence 3456777899999999999999999999999999999996542 33345667999999999999999999998754
Q ss_pred --eEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC----------CCCeEEccCCCCCEEEcCCCc
Q 005841 576 --RLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHC----------NPPIIHRDLKSSNLLVDKHWT 643 (674)
Q Consensus 576 --~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~----------~~~IvHrDLKp~NILi~~~~~ 643 (674)
.+||||||+++++|.+++... .+++..++.++.||+.||.|||+. + |+||||||+||||+.++.
T Consensus 94 ~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~--ivH~Dlkp~Nill~~~~~ 169 (322)
T 3soc_A 94 DVDLWLITAFHEKGSLSDFLKAN--VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPA--ISHRDIKSKNVLLKNNLT 169 (322)
T ss_dssp SEEEEEEEECCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECE--EECSCCSGGGEEECTTCC
T ss_pred CceEEEEEecCCCCCHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCC--EEeCCCChHhEEECCCCe
Confidence 479999999999999999763 599999999999999999999998 7 999999999999999999
Q ss_pred EEEEecCCcccccCCcc--ccccCCCCccccCC
Q 005841 644 VKVGDFGLSRLKHETYL--TTKTGKGTVTYLAS 674 (674)
Q Consensus 644 vkL~DFGla~~~~~~~~--~~~~~~GTp~YmAP 674 (674)
+||+|||+|+....... .....+||+.|+||
T Consensus 170 ~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aP 202 (322)
T 3soc_A 170 ACIADFGLALKFEAGKSAGDTHGQVGTRRYMAP 202 (322)
T ss_dssp EEECCCTTCEEECTTSCCCCCTTCCCCGGGCCH
T ss_pred EEEccCCcccccccccCccccccCccCccccCH
Confidence 99999999987654322 23335799999998
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=99.96 E-value=4.4e-28 Score=263.22 Aligned_cols=172 Identities=20% Similarity=0.264 Sum_probs=152.1
Q ss_pred ccccCCeeEeeeeccc--CceEEEEEEEc--CCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCe
Q 005841 501 EILWEDLTIGEQIGQG--SCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQR 576 (674)
Q Consensus 501 ~~~~~~y~~~~~LG~G--~fG~Vy~~~~~--~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 576 (674)
....++|++.++||+| +||.||+|.+. +..||||++............+.+|+.+++.++||||+++++++...+.
T Consensus 21 ~~~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 100 (389)
T 3gni_B 21 LPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNE 100 (389)
T ss_dssp CCCGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTE
T ss_pred cCCCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCE
Confidence 4455789999999999 99999999984 7789999998877777778889999999999999999999999999999
Q ss_pred EEEEEecCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccc
Q 005841 577 LCIVTEFLPRGSLFRLLQRN-TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLK 655 (674)
Q Consensus 577 ~~lV~E~~~ggsL~~~l~~~-~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~ 655 (674)
+|||||||++++|.+++... ...+++..+..|+.||+.||.|||+++ ||||||||+||||+.++.+||+|||++...
T Consensus 101 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivHrDlkp~NIll~~~~~~kl~dfg~~~~~ 178 (389)
T 3gni_B 101 LWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMG--YVHRSVKASHILISVDGKVYLSGLRSNLSM 178 (389)
T ss_dssp EEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred EEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEEcccccceee
Confidence 99999999999999999764 356999999999999999999999999 999999999999999999999999998654
Q ss_pred cCCc-------cccccCCCCccccCC
Q 005841 656 HETY-------LTTKTGKGTVTYLAS 674 (674)
Q Consensus 656 ~~~~-------~~~~~~~GTp~YmAP 674 (674)
.... ......+||+.||||
T Consensus 179 ~~~~~~~~~~~~~~~~~~gt~~y~aP 204 (389)
T 3gni_B 179 ISHGQRQRVVHDFPKYSVKVLPWLSP 204 (389)
T ss_dssp EETTEECSCBCCCCTTCTTTGGGSCH
T ss_pred ccccccccccccccccccccccccCH
Confidence 3211 112234799999998
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=4e-28 Score=249.06 Aligned_cols=170 Identities=32% Similarity=0.550 Sum_probs=150.0
Q ss_pred cccccCCeeEeeeecccCceEEEEEEEcCC-eEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeEE
Q 005841 500 YEILWEDLTIGEQIGQGSCGTVYHAVWYGS-DVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLC 578 (674)
Q Consensus 500 ~~~~~~~y~~~~~LG~G~fG~Vy~~~~~~~-~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 578 (674)
+++..++|++.+.||+|+||.||+|.+.+. .||||++....... ..+.+|+.+++.++||||+++++++.....+|
T Consensus 3 ~~l~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~---~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 79 (268)
T 3sxs_A 3 MELKREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSE---DEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIY 79 (268)
T ss_dssp TBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTBCH---HHHHHHHHHHHHCCCTTBCCEEEEECSSSSEE
T ss_pred eEechhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCCcH---HHHHHHHHHHHhCCCCCEeeEEEEEccCCceE
Confidence 466778999999999999999999998644 69999997665444 45788999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccccCC
Q 005841 579 IVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHET 658 (674)
Q Consensus 579 lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~~ 658 (674)
+||||+++++|.+++......+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~ 157 (268)
T 3sxs_A 80 IVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQ--FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDD 157 (268)
T ss_dssp EEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTT--EEESSCSGGGEEECTTCCEEECCTTCEEECCTT
T ss_pred EEEEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCcCcceEEECCCCCEEEccCccceecchh
Confidence 999999999999999877667999999999999999999999999 999999999999999999999999999876544
Q ss_pred ccc-cccCCCCccccCC
Q 005841 659 YLT-TKTGKGTVTYLAS 674 (674)
Q Consensus 659 ~~~-~~~~~GTp~YmAP 674 (674)
... .....||+.|+||
T Consensus 158 ~~~~~~~~~~~~~y~aP 174 (268)
T 3sxs_A 158 QYVSSVGTKFPVKWSAP 174 (268)
T ss_dssp CEEECCSCCCCGGGCCH
T ss_pred hhhcccCCCcCcccCCH
Confidence 322 2334578889998
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=99.95 E-value=2.3e-28 Score=252.85 Aligned_cols=171 Identities=30% Similarity=0.501 Sum_probs=147.7
Q ss_pred ccccccCCeeEeeeecccCceEEEEEEEcC-CeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeE
Q 005841 499 DYEILWEDLTIGEQIGQGSCGTVYHAVWYG-SDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRL 577 (674)
Q Consensus 499 ~~~~~~~~y~~~~~LG~G~fG~Vy~~~~~~-~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 577 (674)
.+++..++|++.+.||+|+||.||++.+.+ ..||||++....... ..+.+|+.+++.++||||+++++++.....+
T Consensus 18 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~---~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 94 (283)
T 3gen_A 18 SWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE---DEFIEEAKVMMNLSHEKLVQLYGVCTKQRPI 94 (283)
T ss_dssp TTBCCGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSBCH---HHHHHHHHHHHTCCCTTBCCEEEEECSSSSE
T ss_pred CccCCHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCCCH---HHHHHHHHHHhcCCCCCEeeEEEEEecCCCe
Confidence 456777899999999999999999999864 469999998765444 4578899999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccccC
Q 005841 578 CIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHE 657 (674)
Q Consensus 578 ~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~ 657 (674)
|+||||+++++|.+++......+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 95 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 172 (283)
T 3gen_A 95 FIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ--FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD 172 (283)
T ss_dssp EEEECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSSCSGGGEEECTTSCEEECSTTGGGGBCC
T ss_pred EEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCC--ccCCCCccceEEEcCCCCEEEccccccccccc
Confidence 9999999999999999876678999999999999999999999999 99999999999999999999999999987654
Q ss_pred Cccc-cccCCCCccccCC
Q 005841 658 TYLT-TKTGKGTVTYLAS 674 (674)
Q Consensus 658 ~~~~-~~~~~GTp~YmAP 674 (674)
.... .....||+.|+||
T Consensus 173 ~~~~~~~~~~~~~~y~aP 190 (283)
T 3gen_A 173 DEYTSSVGSKFPVRWSPP 190 (283)
T ss_dssp HHHHSTTSTTSCGGGCCH
T ss_pred cccccccCCccCcccCCH
Confidence 3222 2234578999998
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.4e-28 Score=262.72 Aligned_cols=167 Identities=32% Similarity=0.513 Sum_probs=146.1
Q ss_pred ccCCeeEeeeecccCceEEEEEEE--cCCeEEEEEeecccCCH-HHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeEEE
Q 005841 503 LWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSD-EVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCI 579 (674)
Q Consensus 503 ~~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 579 (674)
..++|.+.+.||+|+||+||+|.+ ++..||||++.+..... .....+.+|+.+++.++||||+++++++.....+||
T Consensus 7 ~i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l 86 (336)
T 3h4j_B 7 HIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVM 86 (336)
T ss_dssp EETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ccCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence 457899999999999999999998 57789999997643221 223568899999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccccCCc
Q 005841 580 VTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETY 659 (674)
Q Consensus 580 V~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~~~ 659 (674)
||||+ +|+|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++.......
T Consensus 87 v~E~~-~g~l~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~g--ivH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~ 162 (336)
T 3h4j_B 87 VIEYA-GGELFDYIVEK-KRMTEDEGRRFFQQIICAIEYCHRHK--IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGN 162 (336)
T ss_dssp EECCC-CEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHHT--CCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSB
T ss_pred EEECC-CCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCchhhEEEcCCCCEEEEEeccceeccCCc
Confidence 99999 78999988754 46999999999999999999999999 9999999999999999999999999998765543
Q ss_pred cccccCCCCccccCC
Q 005841 660 LTTKTGKGTVTYLAS 674 (674)
Q Consensus 660 ~~~~~~~GTp~YmAP 674 (674)
. ....+||+.|+||
T Consensus 163 ~-~~~~~gt~~y~aP 176 (336)
T 3h4j_B 163 F-LKTSCGSPNYAAP 176 (336)
T ss_dssp T-TCCCTTSTTTSCG
T ss_pred c-cccccCCcCcCCH
Confidence 2 3346899999998
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.6e-28 Score=266.13 Aligned_cols=173 Identities=31% Similarity=0.498 Sum_probs=151.8
Q ss_pred ccccccCCeeEeeeecccCceEEEEEEEc--CCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCe
Q 005841 499 DYEILWEDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQR 576 (674)
Q Consensus 499 ~~~~~~~~y~~~~~LG~G~fG~Vy~~~~~--~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 576 (674)
.+.+..++|.+.+.||+|+||.||+|.+. +..||||++... ........+.+|+.+++.++||||+++++++...+.
T Consensus 108 ~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 186 (377)
T 3cbl_A 108 KWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRET-LPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQP 186 (377)
T ss_dssp TTBCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTT-SCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred ccEEchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEcccc-CCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCC
Confidence 45677889999999999999999999984 778999998654 345556778899999999999999999999999999
Q ss_pred EEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCccccc
Q 005841 577 LCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKH 656 (674)
Q Consensus 577 ~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~ 656 (674)
+||||||+++++|.+++......+++..++.++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++...
T Consensus 187 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~ 264 (377)
T 3cbl_A 187 IYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKC--CIHRDLAARNCLVTEKNVLKISDFGMSREEA 264 (377)
T ss_dssp CEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTCCEEECCGGGCEECT
T ss_pred cEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--cCCcccCHHHEEEcCCCcEEECcCCCceecC
Confidence 99999999999999999877667999999999999999999999999 9999999999999999999999999998765
Q ss_pred CCccccc--cCCCCccccCC
Q 005841 657 ETYLTTK--TGKGTVTYLAS 674 (674)
Q Consensus 657 ~~~~~~~--~~~GTp~YmAP 674 (674)
....... ...+|+.||||
T Consensus 265 ~~~~~~~~~~~~~~~~y~aP 284 (377)
T 3cbl_A 265 DGVYAASGGLRQVPVKWTAP 284 (377)
T ss_dssp TSEEECCSSCCEEEGGGSCH
T ss_pred CCceeecCCCCCCCcCcCCH
Confidence 4333222 12367889998
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=3.5e-28 Score=256.12 Aligned_cols=170 Identities=21% Similarity=0.196 Sum_probs=144.0
Q ss_pred ccccCCeeEeeeecccCceEEEEEEE--cCCeEEEEEeecccCCHHHHHHHHHHHHHHhhC-CCCCeeeEEEEEecCCeE
Q 005841 501 EILWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRL-RHPNVLLFMGAVTSPQRL 577 (674)
Q Consensus 501 ~~~~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~ 577 (674)
++..++|++.++||+|+||+||+|.+ ++..||||++............+..|+..+..+ .||||+++++++...+.+
T Consensus 53 ~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~ 132 (311)
T 3p1a_A 53 SFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGIL 132 (311)
T ss_dssp CHHHHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred chhhhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEE
Confidence 34457899999999999999999998 477899999876655555445555666666555 899999999999999999
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccccC
Q 005841 578 CIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHE 657 (674)
Q Consensus 578 ~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~ 657 (674)
||||||+ +++|.+++......+++..++.|+.||+.||.|||+.+ ||||||||+||||+.++.+||+|||+++....
T Consensus 133 ~lv~e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~ 209 (311)
T 3p1a_A 133 YLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQG--LVHLDVKPANIFLGPRGRCKLGDFGLLVELGT 209 (311)
T ss_dssp EEEEECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECGGGCEEECCCTTCEECC-
T ss_pred EEEEecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHEEECCCCCEEEccceeeeeccc
Confidence 9999999 77999999887778999999999999999999999999 99999999999999999999999999987654
Q ss_pred CccccccCCCCccccCC
Q 005841 658 TYLTTKTGKGTVTYLAS 674 (674)
Q Consensus 658 ~~~~~~~~~GTp~YmAP 674 (674)
... .....||+.|+||
T Consensus 210 ~~~-~~~~~gt~~y~aP 225 (311)
T 3p1a_A 210 AGA-GEVQEGDPRYMAP 225 (311)
T ss_dssp ------CCCCCGGGCCG
T ss_pred CCC-CcccCCCccccCH
Confidence 432 3345799999998
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=4.7e-28 Score=254.04 Aligned_cols=168 Identities=27% Similarity=0.369 Sum_probs=142.8
Q ss_pred cCCeeEeeeecccCceEEEEEEEc--CCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeEEEEE
Q 005841 504 WEDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVT 581 (674)
Q Consensus 504 ~~~y~~~~~LG~G~fG~Vy~~~~~--~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 581 (674)
.++|++.+.||+|+||+||+|.+. +..||||++..........+.+.+|+.+++.++||||+++++++...+.+|+||
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (311)
T 4agu_A 2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVF 81 (311)
T ss_dssp -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEE
Confidence 368999999999999999999984 778999999776666666778899999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccccCCccc
Q 005841 582 EFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLT 661 (674)
Q Consensus 582 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~~~~~ 661 (674)
||+++++|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++........
T Consensus 82 e~~~~~~l~~~~~~-~~~~~~~~~~~i~~~l~~~l~~lH~~~--ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 158 (311)
T 4agu_A 82 EYCDHTVLHELDRY-QRGVPEHLVKSITWQTLQAVNFCHKHN--CIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDY 158 (311)
T ss_dssp ECCSEEHHHHHHHT-SSCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred EeCCCchHHHHHhh-hcCCCHHHHHHHHHHHHHHHHHHHHCC--CcCCCCChhhEEEcCCCCEEEeeCCCchhccCcccc
Confidence 99999999888864 456999999999999999999999999 999999999999999999999999999877654444
Q ss_pred cccCCCCccccCC
Q 005841 662 TKTGKGTVTYLAS 674 (674)
Q Consensus 662 ~~~~~GTp~YmAP 674 (674)
.....||+.|+||
T Consensus 159 ~~~~~~~~~y~aP 171 (311)
T 4agu_A 159 YDDEVATRWYRSP 171 (311)
T ss_dssp -------GGGCCH
T ss_pred cCCCcCCccccCh
Confidence 4456899999998
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=99.95 E-value=2.1e-28 Score=254.64 Aligned_cols=173 Identities=39% Similarity=0.659 Sum_probs=141.3
Q ss_pred cccccccCCeeEeeeecccCceEEEEEEEcCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeE
Q 005841 498 LDYEILWEDLTIGEQIGQGSCGTVYHAVWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRL 577 (674)
Q Consensus 498 ~~~~~~~~~y~~~~~LG~G~fG~Vy~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 577 (674)
...++..++|++.++||+|+||.||+|.+.+ .||||++..........+.+.+|+.+++.++||||+.+++++ ....+
T Consensus 17 ~~~ei~~~~y~~~~~lG~G~~g~Vy~~~~~~-~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~ 94 (289)
T 3og7_A 17 DDWEIPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQL 94 (289)
T ss_dssp -CCBCCTTSCEEEEEEEECSSEEEEEEESSS-EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSC
T ss_pred CCCccCccceeeeeEecCCCCeEEEEEEEcC-ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCcc
Confidence 3457888999999999999999999998654 599999987766777778899999999999999999999965 56678
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccccC
Q 005841 578 CIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHE 657 (674)
Q Consensus 578 ~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~ 657 (674)
++||||+++++|.+++......+++..++.++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++....
T Consensus 95 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~--i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 172 (289)
T 3og7_A 95 AIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKS--IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSR 172 (289)
T ss_dssp EEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEETTTEEEECCCC-------
T ss_pred EEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC--cccccCccceEEECCCCCEEEccceecccccc
Confidence 9999999999999999877778999999999999999999999999 99999999999999999999999999986543
Q ss_pred C--ccccccCCCCccccCC
Q 005841 658 T--YLTTKTGKGTVTYLAS 674 (674)
Q Consensus 658 ~--~~~~~~~~GTp~YmAP 674 (674)
. ........||+.|+||
T Consensus 173 ~~~~~~~~~~~gt~~y~aP 191 (289)
T 3og7_A 173 WSGSHQFEQLSGSILWMAP 191 (289)
T ss_dssp -----------CCCTTCCH
T ss_pred ccccccccccCCCccccCc
Confidence 1 1222335799999998
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.95 E-value=1.6e-28 Score=260.94 Aligned_cols=173 Identities=27% Similarity=0.491 Sum_probs=150.2
Q ss_pred ccccccCCeeEeeeecccCceEEEEEEEcC-------CeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEE
Q 005841 499 DYEILWEDLTIGEQIGQGSCGTVYHAVWYG-------SDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAV 571 (674)
Q Consensus 499 ~~~~~~~~y~~~~~LG~G~fG~Vy~~~~~~-------~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~ 571 (674)
.+++..++|++.+.||+|+||.||+|.+.+ ..||||++.... .......+.+|+.+++.++||||+++++++
T Consensus 41 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~ 119 (343)
T 1luf_A 41 SLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMAEFDNPNIVKLLGVC 119 (343)
T ss_dssp HTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred eeEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence 456778899999999999999999999864 569999997543 455667899999999999999999999999
Q ss_pred ecCCeEEEEEecCCCCCHHHHHHhcC-----------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEE
Q 005841 572 TSPQRLCIVTEFLPRGSLFRLLQRNT-----------------------TKLDWRRRILMALDIARGVSYLHHCNPPIIH 628 (674)
Q Consensus 572 ~~~~~~~lV~E~~~ggsL~~~l~~~~-----------------------~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvH 628 (674)
...+.+||||||+++++|.+++.... ..+++..++.++.||+.||.|||+++ |+|
T Consensus 120 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~--ivH 197 (343)
T 1luf_A 120 AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK--FVH 197 (343)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT--CCC
T ss_pred ccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eec
Confidence 99999999999999999999997642 56999999999999999999999999 999
Q ss_pred ccCCCCCEEEcCCCcEEEEecCCcccccCCc--cccccCCCCccccCC
Q 005841 629 RDLKSSNLLVDKHWTVKVGDFGLSRLKHETY--LTTKTGKGTVTYLAS 674 (674)
Q Consensus 629 rDLKp~NILi~~~~~vkL~DFGla~~~~~~~--~~~~~~~GTp~YmAP 674 (674)
|||||+||||+.++.+||+|||+++...... .......||+.|+||
T Consensus 198 ~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aP 245 (343)
T 1luf_A 198 RDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPP 245 (343)
T ss_dssp SCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCH
T ss_pred CCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecCh
Confidence 9999999999999999999999998764332 222335689999998
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.9e-28 Score=259.95 Aligned_cols=167 Identities=28% Similarity=0.405 Sum_probs=143.5
Q ss_pred cCCeeEeeeecccCceEEEEEEE--cCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeEEEEE
Q 005841 504 WEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVT 581 (674)
Q Consensus 504 ~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 581 (674)
.++|++.+.||+|+||+||+|.+ ++..||||++...... ...+.+.+|+.+++.++||||+++++++...+..||||
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 84 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV-DCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL 84 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEccccc-chHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEE
Confidence 47899999999999999999998 4778999999755432 23456889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccccCC--c
Q 005841 582 EFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHET--Y 659 (674)
Q Consensus 582 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~~--~ 659 (674)
|||++++|.+++.. ...+++..+..++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++..... .
T Consensus 85 e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~g--ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 161 (323)
T 3tki_A 85 EYCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHGIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 161 (323)
T ss_dssp ECCTTEEGGGGSBT-TTBCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred EcCCCCcHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccccchHHEEEeCCCCEEEEEeeccceeccCCcc
Confidence 99999999999864 446999999999999999999999999 999999999999999999999999999865422 2
Q ss_pred cccccCCCCccccCC
Q 005841 660 LTTKTGKGTVTYLAS 674 (674)
Q Consensus 660 ~~~~~~~GTp~YmAP 674 (674)
......+||+.|+||
T Consensus 162 ~~~~~~~gt~~y~aP 176 (323)
T 3tki_A 162 RLLNKMCGTLPYVAP 176 (323)
T ss_dssp CCBCSCCSCGGGSCH
T ss_pred cccCCCccCcCccCc
Confidence 223346899999998
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=8.8e-28 Score=255.71 Aligned_cols=170 Identities=26% Similarity=0.346 Sum_probs=151.0
Q ss_pred cccCCeeEeeeecccCceEEEEEEEc--CCeEEEEEeecccC-CHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeEE
Q 005841 502 ILWEDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEY-SDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLC 578 (674)
Q Consensus 502 ~~~~~y~~~~~LG~G~fG~Vy~~~~~--~~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 578 (674)
....+|.+.+.||+|+||.||++.+. +..||+|++.+... .....+.+.+|+.+++.++||||+++++++.+.+.+|
T Consensus 38 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 117 (335)
T 2owb_A 38 RSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVF 117 (335)
T ss_dssp TTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred ccCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEE
Confidence 34578999999999999999999984 66799999987654 3456678899999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccccCC
Q 005841 579 IVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHET 658 (674)
Q Consensus 579 lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~~ 658 (674)
|||||+++++|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 118 lv~e~~~~~~L~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 194 (335)
T 2owb_A 118 VVLELCRRRSLLELHKRR-KALTEPEARYYLRQIVLGCQYLHRNR--VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD 194 (335)
T ss_dssp EEECCCTTCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECTTCCEEECCCTTCEECCST
T ss_pred EEEecCCCCCHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC--CEecCCCchhEEEcCCCCEEEeeccCceecccC
Confidence 999999999999998754 47999999999999999999999999 999999999999999999999999999876544
Q ss_pred ccccccCCCCccccCC
Q 005841 659 YLTTKTGKGTVTYLAS 674 (674)
Q Consensus 659 ~~~~~~~~GTp~YmAP 674 (674)
........||+.|+||
T Consensus 195 ~~~~~~~~gt~~y~aP 210 (335)
T 2owb_A 195 GERKKVLCGTPNYIAP 210 (335)
T ss_dssp TCCBCCCCSCCSSCCH
T ss_pred cccccccCCCccccCH
Confidence 4444456899999998
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=6.2e-28 Score=261.34 Aligned_cols=165 Identities=28% Similarity=0.409 Sum_probs=138.7
Q ss_pred CCeeE--eeeecccCceEEEEEEE--cCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeEEEE
Q 005841 505 EDLTI--GEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIV 580 (674)
Q Consensus 505 ~~y~~--~~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 580 (674)
..|.+ .+.||+|+||.||+|.+ ++..||+|++.... ....+.+.+|+.+++.++||||+++++++...+.+|||
T Consensus 87 ~~~~~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 164 (373)
T 2x4f_A 87 SFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRG--MKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLV 164 (373)
T ss_dssp GTEEEEEEEECC-----CEEEEEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cceeeecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccc--cccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEE
Confidence 34444 67899999999999997 47789999997643 23456789999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEE--cCCCcEEEEecCCcccccCC
Q 005841 581 TEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLV--DKHWTVKVGDFGLSRLKHET 658 (674)
Q Consensus 581 ~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi--~~~~~vkL~DFGla~~~~~~ 658 (674)
|||+++++|.+++......+++..++.++.||+.||.|||+.+ |+||||||+|||| +.++.+||+|||+++.....
T Consensus 165 ~E~~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~ 242 (373)
T 2x4f_A 165 MEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMY--ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPR 242 (373)
T ss_dssp EECCTTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEEETTTTEEEECCCSSCEECCTT
T ss_pred EeCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccccCCHHHEEEecCCCCcEEEEeCCCceecCCc
Confidence 9999999999999776667999999999999999999999999 9999999999999 56789999999999876543
Q ss_pred ccccccCCCCccccCC
Q 005841 659 YLTTKTGKGTVTYLAS 674 (674)
Q Consensus 659 ~~~~~~~~GTp~YmAP 674 (674)
.. ....+||+.||||
T Consensus 243 ~~-~~~~~gt~~y~aP 257 (373)
T 2x4f_A 243 EK-LKVNFGTPEFLAP 257 (373)
T ss_dssp CB-CCCCCSSCTTCCH
T ss_pred cc-cccccCCCcEeCh
Confidence 32 2335799999998
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=3.1e-28 Score=249.36 Aligned_cols=169 Identities=26% Similarity=0.505 Sum_probs=151.8
Q ss_pred ccccCCeeEeeeecccCceEEEEEEEcCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecC--CeEE
Q 005841 501 EILWEDLTIGEQIGQGSCGTVYHAVWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSP--QRLC 578 (674)
Q Consensus 501 ~~~~~~y~~~~~LG~G~fG~Vy~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~--~~~~ 578 (674)
.+..++|++.+.||+|+||.||+|.+.+..||||++..........+.+.+|+.+++.++||||+++++++... ..+|
T Consensus 6 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 85 (271)
T 3kmu_A 6 GIDFKQLNFLTKLNENHSGELWKGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPT 85 (271)
T ss_dssp CCCGGGCEEEEEEEEETTEEEEEEEETTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCE
T ss_pred CCCHHHhHHHHHhcCCCcceEEEEEECCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeE
Confidence 56678999999999999999999999999999999988776777778899999999999999999999999887 7899
Q ss_pred EEEecCCCCCHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccccC
Q 005841 579 IVTEFLPRGSLFRLLQRNTT-KLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHE 657 (674)
Q Consensus 579 lV~E~~~ggsL~~~l~~~~~-~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~ 657 (674)
+||||+++++|.+++..... .+++..++.++.||+.||.|||+++.+|+||||||+|||++.++.++|+|||++....
T Consensus 86 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~- 164 (271)
T 3kmu_A 86 LITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQ- 164 (271)
T ss_dssp EEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTS-
T ss_pred eeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEEeccceeeec-
Confidence 99999999999999976543 5899999999999999999999987779999999999999999999999999876432
Q ss_pred CccccccCCCCccccCC
Q 005841 658 TYLTTKTGKGTVTYLAS 674 (674)
Q Consensus 658 ~~~~~~~~~GTp~YmAP 674 (674)
.....||+.|+||
T Consensus 165 ----~~~~~~t~~y~aP 177 (271)
T 3kmu_A 165 ----SPGRMYAPAWVAP 177 (271)
T ss_dssp ----CTTCBSCGGGSCH
T ss_pred ----ccCccCCccccCh
Confidence 2235789999998
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=5e-28 Score=256.90 Aligned_cols=168 Identities=26% Similarity=0.371 Sum_probs=146.9
Q ss_pred ccCCeeEeeeecccCceEEEEEEEc--CCeEEEEEeecccCCH----HHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCe
Q 005841 503 LWEDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSD----EVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQR 576 (674)
Q Consensus 503 ~~~~y~~~~~LG~G~fG~Vy~~~~~--~~~vAvK~i~~~~~~~----~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 576 (674)
..++|.+.+.||+|+||.||+|.+. +..||||++.+..... ...+.+.+|+.+++.++||||+++++++.....
T Consensus 9 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 88 (326)
T 2y0a_A 9 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTD 88 (326)
T ss_dssp HHHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred cccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCE
Confidence 4467999999999999999999984 7789999998754321 124678899999999999999999999999999
Q ss_pred EEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCC----cEEEEecCCc
Q 005841 577 LCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHW----TVKVGDFGLS 652 (674)
Q Consensus 577 ~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~----~vkL~DFGla 652 (674)
+|+||||+++++|.+++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++ .+||+|||++
T Consensus 89 ~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a 165 (326)
T 2y0a_A 89 VILILELVAGGELFDFLAE-KESLTEEEATEFLKQILNGVYYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLA 165 (326)
T ss_dssp EEEEEECCCSCBHHHHHTT-SSCCBHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESCSSSSSCCEEECCCTTC
T ss_pred EEEEEEcCCCCCHHHHHHh-cCCcCHHHHHHHHHHHHHHHHHHHHCC--eEcCCCCHHHEEEecCCCCCCCEEEEECCCC
Confidence 9999999999999999965 457999999999999999999999999 99999999999999877 8999999999
Q ss_pred ccccCCccccccCCCCccccCC
Q 005841 653 RLKHETYLTTKTGKGTVTYLAS 674 (674)
Q Consensus 653 ~~~~~~~~~~~~~~GTp~YmAP 674 (674)
+...... .....+||+.||||
T Consensus 166 ~~~~~~~-~~~~~~gt~~y~aP 186 (326)
T 2y0a_A 166 HKIDFGN-EFKNIFGTPEFVAP 186 (326)
T ss_dssp EECCTTS-CCCCCCSCTTTCCH
T ss_pred eECCCCC-ccccccCCcCcCCc
Confidence 8765432 22346799999998
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=2.9e-28 Score=276.83 Aligned_cols=170 Identities=24% Similarity=0.329 Sum_probs=148.5
Q ss_pred cccCCeeEeeeecccCceEEEEEEE--cCCeEEEEEeecccCCH-HHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeEE
Q 005841 502 ILWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSD-EVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLC 578 (674)
Q Consensus 502 ~~~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 578 (674)
+..++|++.++||+|+||.||+|.+ ++..||||++.+..... .....+.+|+.+|+.++||||+++++++.+.+.+|
T Consensus 181 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~ 260 (576)
T 2acx_A 181 VTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALC 260 (576)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred ccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEE
Confidence 4557899999999999999999998 57789999997653321 22356788999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccccC
Q 005841 579 IVTEFLPRGSLFRLLQRNT-TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHE 657 (674)
Q Consensus 579 lV~E~~~ggsL~~~l~~~~-~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~ 657 (674)
|||||++||+|.+++.... ..+++..++.|+.||+.||.|||+.+ ||||||||+||||+.+++|||+|||+|+....
T Consensus 261 lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~g--IvHrDLKPeNILld~~g~vKL~DFGla~~~~~ 338 (576)
T 2acx_A 261 LVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRER--IVYRDLKPENILLDDHGHIRISDLGLAVHVPE 338 (576)
T ss_dssp EEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC--EeccCCchheEEEeCCCCeEEEecccceeccc
Confidence 9999999999999997643 34999999999999999999999999 99999999999999999999999999987654
Q ss_pred CccccccCCCCccccCC
Q 005841 658 TYLTTKTGKGTVTYLAS 674 (674)
Q Consensus 658 ~~~~~~~~~GTp~YmAP 674 (674)
.. .....+||+.||||
T Consensus 339 ~~-~~~~~~GT~~Y~AP 354 (576)
T 2acx_A 339 GQ-TIKGRVGTVGYMAP 354 (576)
T ss_dssp TC-CEECCCSCGGGCCH
T ss_pred Cc-cccccCCCccccCH
Confidence 32 23346899999998
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=3.4e-28 Score=251.00 Aligned_cols=169 Identities=28% Similarity=0.460 Sum_probs=137.1
Q ss_pred cCCeeEeeeecccCceEEEEEEE--cCCeEEEEEeecccCCH-HHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeEEEE
Q 005841 504 WEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSD-EVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIV 580 (674)
Q Consensus 504 ~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 580 (674)
.++|++.+.||+|+||.||+|.+ .+..||||++....... .....+.+|+.+++.++||||+++++++...+..|+|
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV 89 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence 36799999999999999999997 57789999997543211 2346788999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccccCCcc
Q 005841 581 TEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYL 660 (674)
Q Consensus 581 ~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~~~~ 660 (674)
|||+++++|.+++......+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++........
T Consensus 90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~ 167 (278)
T 3cok_A 90 LEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHG--ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHE 167 (278)
T ss_dssp EECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTT--EECSSCCGGGEEECTTCCEEECCCTTCEECC----
T ss_pred EecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEcCCCCEEEEeecceeeccCCCC
Confidence 9999999999999876678999999999999999999999999 99999999999999999999999999987664444
Q ss_pred ccccCCCCccccCC
Q 005841 661 TTKTGKGTVTYLAS 674 (674)
Q Consensus 661 ~~~~~~GTp~YmAP 674 (674)
......||+.|+||
T Consensus 168 ~~~~~~~~~~y~aP 181 (278)
T 3cok_A 168 KHYTLCGTPNYISP 181 (278)
T ss_dssp --------------
T ss_pred cceeccCCCCcCCc
Confidence 44456799999998
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=99.95 E-value=3.1e-28 Score=253.75 Aligned_cols=170 Identities=30% Similarity=0.548 Sum_probs=143.7
Q ss_pred ccccCCeeEeeeecccCceEEEEEEE------cCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecC
Q 005841 501 EILWEDLTIGEQIGQGSCGTVYHAVW------YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSP 574 (674)
Q Consensus 501 ~~~~~~y~~~~~LG~G~fG~Vy~~~~------~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~ 574 (674)
++..++|++.++||+|+||+||+|.+ .+..||||++... .....+.+.+|+.+++.++||||+++++++...
T Consensus 6 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 83 (295)
T 3ugc_A 6 QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS--TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSA 83 (295)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHH
T ss_pred cCCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccC--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC
Confidence 55668999999999999999999985 4667999998643 345567899999999999999999999998654
Q ss_pred --CeEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCc
Q 005841 575 --QRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLS 652 (674)
Q Consensus 575 --~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla 652 (674)
..+||||||+++++|.+++......+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 84 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dikp~Nil~~~~~~~kl~Dfg~~ 161 (295)
T 3ugc_A 84 GRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR--YIHRDLATRNILVENENRVKIGDFGLT 161 (295)
T ss_dssp HHTSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEEETTEEEECCCCSC
T ss_pred CCCceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCC--cccCCCCHhhEEEcCCCeEEEccCccc
Confidence 5689999999999999999877667999999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCc---cccccCCCCccccCC
Q 005841 653 RLKHETY---LTTKTGKGTVTYLAS 674 (674)
Q Consensus 653 ~~~~~~~---~~~~~~~GTp~YmAP 674 (674)
+...... .......||+.|+||
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~y~aP 186 (295)
T 3ugc_A 162 KVLPQDKEFFKVKEPGESPIFWYAP 186 (295)
T ss_dssp C-------------CTTCGGGGCCH
T ss_pred ccccCCcceeeeccCCCCccceeCc
Confidence 8764332 122334688899998
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=3.8e-28 Score=257.73 Aligned_cols=166 Identities=20% Similarity=0.299 Sum_probs=145.4
Q ss_pred cccCCeeEeeeecccCceEEEEEEE--cCCeEEEEEeecccCCHHHHHHHHHHHHHHhhC-CCCCeeeEEEEEecCCeEE
Q 005841 502 ILWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRL-RHPNVLLFMGAVTSPQRLC 578 (674)
Q Consensus 502 ~~~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~ 578 (674)
+..++|++.+.||+|+||.||+|.+ ++..||||++...... ..+.+|+.+++.+ +||||+++++++...+..|
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~ 81 (330)
T 2izr_A 6 MVGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRA----PQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNA 81 (330)
T ss_dssp EETTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCSS----CCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEE
T ss_pred EEcCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccch----HHHHHHHHHHHHhhCCCCCCEEEEEEecCCccE
Confidence 4567899999999999999999996 5778999999765432 2477899999999 8999999999999999999
Q ss_pred EEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCc-----EEEEecCCcc
Q 005841 579 IVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWT-----VKVGDFGLSR 653 (674)
Q Consensus 579 lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~-----vkL~DFGla~ 653 (674)
|||||+ +++|.+++......+++..++.|+.||+.||.|||+.+ |+||||||+||||+.++. +||+|||+++
T Consensus 82 lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~ 158 (330)
T 2izr_A 82 MVLELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKN--LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158 (330)
T ss_dssp EEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECCGGGTCTTSEEECCCTTCE
T ss_pred EEEEeC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHeeeccCCCCCCceEEEEEcccce
Confidence 999999 99999999877778999999999999999999999999 999999999999998887 9999999998
Q ss_pred cccCCcc-------ccccCCCCccccCC
Q 005841 654 LKHETYL-------TTKTGKGTVTYLAS 674 (674)
Q Consensus 654 ~~~~~~~-------~~~~~~GTp~YmAP 674 (674)
....... .....+||+.||||
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~gt~~y~aP 186 (330)
T 2izr_A 159 EYIDPETKKHIPYREHKSLTGTARYMSI 186 (330)
T ss_dssp ESBCTTTCCBCCCCCCCCCCSCTTTCCH
T ss_pred eeecCCCCccccccccCCcCCCccccCh
Confidence 7644322 12356899999998
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=2.4e-28 Score=258.01 Aligned_cols=167 Identities=29% Similarity=0.432 Sum_probs=131.3
Q ss_pred cCCeeEeeeecccCceEEEEEEE--cCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeEEEEE
Q 005841 504 WEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVT 581 (674)
Q Consensus 504 ~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 581 (674)
..+|++.+.||+|+||.||+|.+ ++..||||++..... ......+.+|+.+++.++||||+++++++...+.+||||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 82 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSE-EGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVF 82 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCST-TCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccc-cccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEE
Confidence 35799999999999999999987 477899999976542 222356778999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCccccc
Q 005841 582 EFLPRGSLFRLLQRNT-----TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKH 656 (674)
Q Consensus 582 E~~~ggsL~~~l~~~~-----~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~ 656 (674)
||++ ++|.+++.... ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 83 e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~--ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 159 (317)
T 2pmi_A 83 EFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK--ILHRDLKPQNLLINKRGQLKLGDFGLARAFG 159 (317)
T ss_dssp ECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred EecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence 9997 59999886532 45899999999999999999999999 9999999999999999999999999998775
Q ss_pred CCccccccCCCCccccCC
Q 005841 657 ETYLTTKTGKGTVTYLAS 674 (674)
Q Consensus 657 ~~~~~~~~~~GTp~YmAP 674 (674)
..........||+.||||
T Consensus 160 ~~~~~~~~~~~t~~y~aP 177 (317)
T 2pmi_A 160 IPVNTFSSEVVTLWYRAP 177 (317)
T ss_dssp SCCCCCCCCCSCCTTCCH
T ss_pred CCcccCCCCcccccccCc
Confidence 444344456799999998
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=6.6e-28 Score=261.59 Aligned_cols=173 Identities=31% Similarity=0.528 Sum_probs=150.8
Q ss_pred ccccccCCeeEeeeecccCceEEEEEEEcC---------CeEEEEEeecccCCHHHHHHHHHHHHHHhhC-CCCCeeeEE
Q 005841 499 DYEILWEDLTIGEQIGQGSCGTVYHAVWYG---------SDVAVKVFSRQEYSDEVIHSFRQEVSLMKRL-RHPNVLLFM 568 (674)
Q Consensus 499 ~~~~~~~~y~~~~~LG~G~fG~Vy~~~~~~---------~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~ 568 (674)
.+++..++|.+.+.||+|+||.||+|.+.+ ..||||++... ........+.+|+.+++.+ +||||++++
T Consensus 63 ~~~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~hpnIv~~~ 141 (382)
T 3tt0_A 63 RWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSD-ATEKDLSDLISEMEMMKMIGKHKNIINLL 141 (382)
T ss_dssp TTBCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTT-CCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred ccccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccc-cCHHHHHHHHHHHHHHHHhcCCchhhhhe
Confidence 346777899999999999999999998732 35999999754 3455667899999999999 899999999
Q ss_pred EEEecCCeEEEEEecCCCCCHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCC
Q 005841 569 GAVTSPQRLCIVTEFLPRGSLFRLLQRNT---------------TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKS 633 (674)
Q Consensus 569 ~~~~~~~~~~lV~E~~~ggsL~~~l~~~~---------------~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp 633 (674)
+++...+.+||||||+++++|.+++.... ..+++..++.|+.||+.||.|||+.+ ||||||||
T Consensus 142 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp 219 (382)
T 3tt0_A 142 GACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK--CIHRDLAA 219 (382)
T ss_dssp EEECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCG
T ss_pred eeeccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCc
Confidence 99999999999999999999999998653 35999999999999999999999999 99999999
Q ss_pred CCEEEcCCCcEEEEecCCcccccCCc--cccccCCCCccccCC
Q 005841 634 SNLLVDKHWTVKVGDFGLSRLKHETY--LTTKTGKGTVTYLAS 674 (674)
Q Consensus 634 ~NILi~~~~~vkL~DFGla~~~~~~~--~~~~~~~GTp~YmAP 674 (674)
+||||+.++.+||+|||+|+...... .......||+.|+||
T Consensus 220 ~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aP 262 (382)
T 3tt0_A 220 RNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAP 262 (382)
T ss_dssp GGEEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCH
T ss_pred ceEEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCH
Confidence 99999999999999999998765432 223345789999998
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.95 E-value=8.3e-28 Score=261.73 Aligned_cols=167 Identities=24% Similarity=0.390 Sum_probs=146.5
Q ss_pred ccCCeeEeeeecccCceEEEEEEE--cCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeEEEE
Q 005841 503 LWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIV 580 (674)
Q Consensus 503 ~~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 580 (674)
..++|++.+.||+|+||.||+|.+ ++..||+|++.... ......+.+|+.+++.++||||+++++++.....+|||
T Consensus 49 ~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~--~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv 126 (387)
T 1kob_A 49 VYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY--PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLI 126 (387)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEE
T ss_pred cccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccc--hhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEE
Confidence 346899999999999999999998 46779999997543 23345788999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcC--CCcEEEEecCCcccccCC
Q 005841 581 TEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDK--HWTVKVGDFGLSRLKHET 658 (674)
Q Consensus 581 ~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~--~~~vkL~DFGla~~~~~~ 658 (674)
||||++++|.+++......+++..++.++.||+.||.|||+++ |+||||||+|||++. .+.+||+|||+++.....
T Consensus 127 ~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g--ivHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~ 204 (387)
T 1kob_A 127 LEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHS--IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD 204 (387)
T ss_dssp EECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred EEcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecccchHHeEEecCCCCceEEEecccceecCCC
Confidence 9999999999999766667999999999999999999999999 999999999999974 578999999999876544
Q ss_pred ccccccCCCCccccCC
Q 005841 659 YLTTKTGKGTVTYLAS 674 (674)
Q Consensus 659 ~~~~~~~~GTp~YmAP 674 (674)
... ...+||+.||||
T Consensus 205 ~~~-~~~~gt~~y~aP 219 (387)
T 1kob_A 205 EIV-KVTTATAEFAAP 219 (387)
T ss_dssp SCE-EEECSSGGGCCH
T ss_pred cce-eeeccCCCccCc
Confidence 322 234799999998
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=6.1e-28 Score=266.39 Aligned_cols=168 Identities=27% Similarity=0.346 Sum_probs=144.3
Q ss_pred ccCCeeEeeeecccCceEEEEEEE--cCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecC-----C
Q 005841 503 LWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSP-----Q 575 (674)
Q Consensus 503 ~~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~-----~ 575 (674)
..++|++.+.||+|+||+||+|.+ ++..||||++.+..........+.+|+.+++.++||||+++++++... .
T Consensus 24 i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~ 103 (432)
T 3n9x_A 24 VPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFD 103 (432)
T ss_dssp CCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCC
T ss_pred ecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCC
Confidence 457899999999999999999998 456799999987655566678899999999999999999999999776 5
Q ss_pred eEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccc
Q 005841 576 RLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLK 655 (674)
Q Consensus 576 ~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~ 655 (674)
.+||||||+. ++|.+++.. ...+++..++.|+.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+|+..
T Consensus 104 ~~~lv~e~~~-~~L~~~~~~-~~~l~~~~~~~i~~qil~aL~~LH~~g--ivHrDlkp~NILl~~~~~~kL~DFGla~~~ 179 (432)
T 3n9x_A 104 ELYIVLEIAD-SDLKKLFKT-PIFLTEEHIKTILYNLLLGENFIHESG--IIHRDLKPANCLLNQDCSVKVCDFGLARTI 179 (432)
T ss_dssp CEEEEEECCS-EEHHHHHHS-SCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred eEEEEEecCC-cCHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCC--CCCCCCCHHHeEECCCCCEEEccCCCcccc
Confidence 7999999996 599999965 457999999999999999999999999 999999999999999999999999999876
Q ss_pred cCCcc----------------------ccccCCCCccccCC
Q 005841 656 HETYL----------------------TTKTGKGTVTYLAS 674 (674)
Q Consensus 656 ~~~~~----------------------~~~~~~GTp~YmAP 674 (674)
..... .....+||+.|+||
T Consensus 180 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~AP 220 (432)
T 3n9x_A 180 NSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAP 220 (432)
T ss_dssp -------------------------------CCCCCTTCCH
T ss_pred cccccccccccccccccccccccchhccccCCCCCccccCH
Confidence 54321 12456899999998
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1e-27 Score=250.20 Aligned_cols=171 Identities=28% Similarity=0.506 Sum_probs=145.2
Q ss_pred ccccCCeeEeeeecccCceEEEEEEE------cCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecC
Q 005841 501 EILWEDLTIGEQIGQGSCGTVYHAVW------YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSP 574 (674)
Q Consensus 501 ~~~~~~y~~~~~LG~G~fG~Vy~~~~------~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~ 574 (674)
.+....|++.+.||+|+||.||+|.+ .+..||||++.... .......+.+|+.+++.++||||+++++++...
T Consensus 17 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 95 (302)
T 4e5w_A 17 HFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES-GGNHIADLKKEIEILRNLYHENIVKYKGICTED 95 (302)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC------CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-
T ss_pred hhhhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccc-cchhHHHHHHHHHHHHhCCCCCeeeeeeEEecC
Confidence 34456799999999999999999984 46679999997543 223346788999999999999999999999877
Q ss_pred --CeEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCc
Q 005841 575 --QRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLS 652 (674)
Q Consensus 575 --~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla 652 (674)
..+|+||||+++++|.+++......+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 96 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dikp~Nil~~~~~~~kl~Dfg~~ 173 (302)
T 4e5w_A 96 GGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQ--YVHRDLAARNVLVESEHQVKIGDFGLT 173 (302)
T ss_dssp --CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEEETTEEEECCCTTC
T ss_pred CCceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCC--cccCCCchheEEEcCCCCEEECccccc
Confidence 6689999999999999999877778999999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCc---cccccCCCCccccCC
Q 005841 653 RLKHETY---LTTKTGKGTVTYLAS 674 (674)
Q Consensus 653 ~~~~~~~---~~~~~~~GTp~YmAP 674 (674)
+...... .......||+.|+||
T Consensus 174 ~~~~~~~~~~~~~~~~~~~~~y~aP 198 (302)
T 4e5w_A 174 KAIETDKEYYTVKDDRDSPVFWYAP 198 (302)
T ss_dssp EECCTTCCEEECCCCTTCCGGGCCH
T ss_pred ccccCCCcceeccCCCCCCccccCC
Confidence 8765432 223345689999998
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=3.2e-28 Score=260.59 Aligned_cols=177 Identities=27% Similarity=0.472 Sum_probs=149.1
Q ss_pred CCccccccccCCeeEeeeecccCceEEEEEEEc-------CCeEEEEEeecccCCHHHHHHHHHHHHHHhhC-CCCCeee
Q 005841 495 NDCLDYEILWEDLTIGEQIGQGSCGTVYHAVWY-------GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRL-RHPNVLL 566 (674)
Q Consensus 495 ~~~~~~~~~~~~y~~~~~LG~G~fG~Vy~~~~~-------~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~ 566 (674)
.....+++..++|++.+.||+|+||.||+|.+. +..||||++.... .....+.+.+|+.++..+ +||||++
T Consensus 12 ~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hpniv~ 90 (359)
T 3vhe_A 12 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVN 90 (359)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred CCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcC-CHHHHHHHHHHHHHHHhhcCCcceee
Confidence 344566788899999999999999999999853 2569999997543 444567899999999999 7899999
Q ss_pred EEEEEecCCe-EEEEEecCCCCCHHHHHHhcCC-----------------------------------------------
Q 005841 567 FMGAVTSPQR-LCIVTEFLPRGSLFRLLQRNTT----------------------------------------------- 598 (674)
Q Consensus 567 l~~~~~~~~~-~~lV~E~~~ggsL~~~l~~~~~----------------------------------------------- 598 (674)
+++++...+. +|+|||||++|+|.+++.....
T Consensus 91 ~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (359)
T 3vhe_A 91 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEE 170 (359)
T ss_dssp EEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-----------------------------------------
T ss_pred eeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccc
Confidence 9999987654 9999999999999999976432
Q ss_pred ------------------CCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccccCC--
Q 005841 599 ------------------KLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHET-- 658 (674)
Q Consensus 599 ------------------~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~~-- 658 (674)
.+++..++.++.||+.||.|||+.+ ||||||||+||||+.++.+||+|||+++.....
T Consensus 171 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~--ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 248 (359)
T 3vhe_A 171 KSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK--CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 248 (359)
T ss_dssp -------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTT
T ss_pred cccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCC--cccCCCChhhEEEcCCCcEEEEeccceeeeccccc
Confidence 1899999999999999999999999 999999999999999999999999999866432
Q ss_pred ccccccCCCCccccCC
Q 005841 659 YLTTKTGKGTVTYLAS 674 (674)
Q Consensus 659 ~~~~~~~~GTp~YmAP 674 (674)
........||+.||||
T Consensus 249 ~~~~~~~~~t~~y~aP 264 (359)
T 3vhe_A 249 YVRKGDARLPLKWMAP 264 (359)
T ss_dssp CEEC--CEECGGGCCH
T ss_pred chhccccCCCceeECh
Confidence 2223345689999998
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=6.2e-28 Score=254.65 Aligned_cols=169 Identities=24% Similarity=0.387 Sum_probs=145.3
Q ss_pred cccCCeeEeeeecccCceEEEEEEEc--CCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCC--eE
Q 005841 502 ILWEDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQ--RL 577 (674)
Q Consensus 502 ~~~~~y~~~~~LG~G~fG~Vy~~~~~--~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~--~~ 577 (674)
...++|++.++||+|+||+||+|.+. +..||||++....... ..+.+.+|+.+++.++||||+++++++.... .+
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 84 (319)
T 4euu_A 6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLR-PVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHK 84 (319)
T ss_dssp CSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGS-CHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCE
T ss_pred CCCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccc-hHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceE
Confidence 44578999999999999999999985 7789999997644322 2456778999999999999999999998765 78
Q ss_pred EEEEecCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEE----cCCCcEEEEecCC
Q 005841 578 CIVTEFLPRGSLFRLLQRNT--TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLV----DKHWTVKVGDFGL 651 (674)
Q Consensus 578 ~lV~E~~~ggsL~~~l~~~~--~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi----~~~~~vkL~DFGl 651 (674)
||||||+++++|.+++.... ..+++..++.++.||+.||.|||+.+ |+||||||+|||| +.++.+||+|||+
T Consensus 85 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~ 162 (319)
T 4euu_A 85 VLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG--IVHRNIKPGNIMRVIGEDGQSVYKLTDFGA 162 (319)
T ss_dssp EEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEEECTTSCEEEEECCCTT
T ss_pred EEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHEEEeccCCCCceEEEccCCC
Confidence 99999999999999997643 23999999999999999999999999 9999999999999 7788899999999
Q ss_pred cccccCCccccccCCCCccccCC
Q 005841 652 SRLKHETYLTTKTGKGTVTYLAS 674 (674)
Q Consensus 652 a~~~~~~~~~~~~~~GTp~YmAP 674 (674)
++....... .....||+.|+||
T Consensus 163 a~~~~~~~~-~~~~~gt~~y~aP 184 (319)
T 4euu_A 163 ARELEDDEQ-FVSLYGTEEYLHP 184 (319)
T ss_dssp CEECCTTCC-BCCCCSCGGGCCH
T ss_pred ceecCCCCc-eeecccCCCccCH
Confidence 987655432 2346799999998
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=99.95 E-value=3.3e-28 Score=282.97 Aligned_cols=171 Identities=26% Similarity=0.355 Sum_probs=148.7
Q ss_pred ccccCCeeEeeeecccCceEEEEEEEc--CCeEEEEEeecccC-CHHHHHHHHHHHHHHhhC-CCCCeeeEEEEEecCCe
Q 005841 501 EILWEDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEY-SDEVIHSFRQEVSLMKRL-RHPNVLLFMGAVTSPQR 576 (674)
Q Consensus 501 ~~~~~~y~~~~~LG~G~fG~Vy~~~~~--~~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~ 576 (674)
.+...+|+++++||+|+||+||+|.+. +..||||++.+... .....+.+..|..++..+ +||||+.+++++.+.+.
T Consensus 337 ~~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~ 416 (674)
T 3pfq_A 337 RMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDR 416 (674)
T ss_dssp ---CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSE
T ss_pred cccccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCE
Confidence 456689999999999999999999984 56799999976432 112345677899999987 69999999999999999
Q ss_pred EEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCccccc
Q 005841 577 LCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKH 656 (674)
Q Consensus 577 ~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~ 656 (674)
+||||||+++|+|.+++... ..|++..++.|+.||+.||.|||+.+ ||||||||+||||+.++++||+|||+|+...
T Consensus 417 ~~lV~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~g--IiHrDLKp~NILl~~~g~ikL~DFGla~~~~ 493 (674)
T 3pfq_A 417 LYFVMEYVNGGDLMYHIQQV-GRFKEPHAVFYAAEIAIGLFFLQSKG--IIYRDLKLDNVMLDSEGHIKIADFGMCKENI 493 (674)
T ss_dssp EEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTS--EECCCCCSTTEEECSSSCEEECCCTTCEECC
T ss_pred EEEEEeCcCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--eEeccCChhhEEEcCCCcEEEeecceeeccc
Confidence 99999999999999999764 47999999999999999999999999 9999999999999999999999999999765
Q ss_pred CCccccccCCCCccccCC
Q 005841 657 ETYLTTKTGKGTVTYLAS 674 (674)
Q Consensus 657 ~~~~~~~~~~GTp~YmAP 674 (674)
.......+++||+.||||
T Consensus 494 ~~~~~~~~~~GT~~Y~AP 511 (674)
T 3pfq_A 494 WDGVTTKTFCGTPDYIAP 511 (674)
T ss_dssp CTTCCBCCCCSCSSSCCH
T ss_pred cCCcccccccCCCcccCH
Confidence 555556678999999998
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=99.95 E-value=5.2e-30 Score=272.76 Aligned_cols=164 Identities=20% Similarity=0.237 Sum_probs=138.0
Q ss_pred cccCCeeEeeeecccCceEEEEEEEcCCeEEEEEeecccC------CHHHHHHHHHHHHHHhhCC---------CCCeee
Q 005841 502 ILWEDLTIGEQIGQGSCGTVYHAVWYGSDVAVKVFSRQEY------SDEVIHSFRQEVSLMKRLR---------HPNVLL 566 (674)
Q Consensus 502 ~~~~~y~~~~~LG~G~fG~Vy~~~~~~~~vAvK~i~~~~~------~~~~~~~~~~Ei~il~~l~---------HpnIv~ 566 (674)
+..++|++.++||+|+||+||+|++++..||||++..... .....+.+.+|+.+++.++ ||||+.
T Consensus 17 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~ 96 (336)
T 2vuw_A 17 LPTEKLQRCEKIGEGVFGEVFQTIADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIG 96 (336)
T ss_dssp SCHHHHHTCEEEEEETTEEEEEEEETTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCC
T ss_pred cccccchheeeecccCceEEEEEEeCCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhh
Confidence 4457899999999999999999999999999999987643 2223466788999888885 777777
Q ss_pred EEEEEe------------------------------cCCeEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHH
Q 005841 567 FMGAVT------------------------------SPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGV 616 (674)
Q Consensus 567 l~~~~~------------------------------~~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L 616 (674)
+++.+. ....+|||||||++|++.+.+.+ ..+++..++.|+.||+.||
T Consensus 97 l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~--~~~~~~~~~~i~~qi~~aL 174 (336)
T 2vuw_A 97 LNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT--KLSSLATAKSILHQLTASL 174 (336)
T ss_dssp EEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT--TCCCHHHHHHHHHHHHHHH
T ss_pred hcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh--cCCCHHHHHHHHHHHHHHH
Confidence 776643 26789999999999977666643 5689999999999999999
Q ss_pred HHHH-hCCCCeEEccCCCCCEEEcCCC--------------------cEEEEecCCcccccCCccccccCCCCccccCC
Q 005841 617 SYLH-HCNPPIIHRDLKSSNLLVDKHW--------------------TVKVGDFGLSRLKHETYLTTKTGKGTVTYLAS 674 (674)
Q Consensus 617 ~yLH-~~~~~IvHrDLKp~NILi~~~~--------------------~vkL~DFGla~~~~~~~~~~~~~~GTp~YmAP 674 (674)
.||| +++ ||||||||+||||+.++ .+||+|||+|+..... ..+||+.||||
T Consensus 175 ~~lH~~~~--ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~-----~~~gt~~y~aP 246 (336)
T 2vuw_A 175 AVAEASLR--FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG-----IVVFCDVSMDE 246 (336)
T ss_dssp HHHHHHHC--CBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-----EEECCCCTTCS
T ss_pred HHHHHhCC--EeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC-----cEEEeecccCh
Confidence 9999 899 99999999999999887 9999999999876543 23799999999
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=5.3e-28 Score=250.34 Aligned_cols=172 Identities=33% Similarity=0.551 Sum_probs=138.1
Q ss_pred ccccccCCeeEeeeecccCceEEEEEEEcC-----CeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEec
Q 005841 499 DYEILWEDLTIGEQIGQGSCGTVYHAVWYG-----SDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTS 573 (674)
Q Consensus 499 ~~~~~~~~y~~~~~LG~G~fG~Vy~~~~~~-----~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~ 573 (674)
++++..++|++.+.||+|+||.||+|.+.. ..||+|++.... .....+.+.+|+.+++.++||||+++++++.
T Consensus 9 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~- 86 (281)
T 1mp8_A 9 DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT-SDSVREKFLQEALTMRQFDHPHIVKLIGVIT- 86 (281)
T ss_dssp CCBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTT-SHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-
T ss_pred ceEEehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCccceEEEEEc-
Confidence 457778899999999999999999998742 349999886532 4556678999999999999999999999984
Q ss_pred CCeEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcc
Q 005841 574 PQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSR 653 (674)
Q Consensus 574 ~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~ 653 (674)
.+..|+||||+++++|.+++......+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++
T Consensus 87 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~kl~Dfg~~~ 164 (281)
T 1mp8_A 87 ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKR--FVHRDIAARNVLVSSNDCVKLGDFGLSR 164 (281)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEEETTEEEECC-----
T ss_pred cCccEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eecccccHHHEEECCCCCEEECcccccc
Confidence 56789999999999999999877667999999999999999999999999 9999999999999999999999999998
Q ss_pred cccCCcc-ccccCCCCccccCC
Q 005841 654 LKHETYL-TTKTGKGTVTYLAS 674 (674)
Q Consensus 654 ~~~~~~~-~~~~~~GTp~YmAP 674 (674)
....... ......||+.|+||
T Consensus 165 ~~~~~~~~~~~~~~~~~~y~aP 186 (281)
T 1mp8_A 165 YMEDSTYYKASKGKLPIKWMAP 186 (281)
T ss_dssp --------------CCGGGCCH
T ss_pred ccCcccccccccCCCcccccCh
Confidence 7654322 23335688999998
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=2.5e-27 Score=245.02 Aligned_cols=168 Identities=23% Similarity=0.393 Sum_probs=149.8
Q ss_pred ccCCeeEeeeecccCceEEEEEEEc--CCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeEEEE
Q 005841 503 LWEDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIV 580 (674)
Q Consensus 503 ~~~~y~~~~~LG~G~fG~Vy~~~~~--~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 580 (674)
..++|++.+.||+|+||.||+|.+. +..||+|++............+.+|+.+++.++||||+++++++......|+|
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 83 (284)
T 3kk8_A 4 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 83 (284)
T ss_dssp TTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEE
Confidence 3578999999999999999999984 67899999988777777778899999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCc---EEEEecCCcccccC
Q 005841 581 TEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWT---VKVGDFGLSRLKHE 657 (674)
Q Consensus 581 ~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~---vkL~DFGla~~~~~ 657 (674)
|||+++++|.+++... ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++. +||+|||++.....
T Consensus 84 ~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~ 160 (284)
T 3kk8_A 84 FDLVTGGELFEDIVAR-EFYSEADASHCIQQILESIAYCHSNG--IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND 160 (284)
T ss_dssp ECCCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEESSSSTTCCEEECCCTTCEECCS
T ss_pred EecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--cCcCCCCHHHEEEecCCCCCcEEEeeceeeEEccc
Confidence 9999999999988764 46999999999999999999999999 999999999999976554 99999999987654
Q ss_pred CccccccCCCCccccCC
Q 005841 658 TYLTTKTGKGTVTYLAS 674 (674)
Q Consensus 658 ~~~~~~~~~GTp~YmAP 674 (674)
... .....||+.|+||
T Consensus 161 ~~~-~~~~~~~~~y~aP 176 (284)
T 3kk8_A 161 SEA-WHGFAGTPGYLSP 176 (284)
T ss_dssp SCB-CCCSCSCGGGCCH
T ss_pred Ccc-ccCCCCCcCCcCc
Confidence 332 2346799999998
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=99.95 E-value=4e-28 Score=271.04 Aligned_cols=170 Identities=30% Similarity=0.563 Sum_probs=149.9
Q ss_pred ccccCCeeEeeeecccCceEEEEEEE--cCCeEEEEEeecccCCH-HHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeE
Q 005841 501 EILWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSD-EVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRL 577 (674)
Q Consensus 501 ~~~~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 577 (674)
.+..++|.+.+.||+|+||+||+|.+ ++..||||++.+..... +....+.+|+.+++.++||||+++++++...+.+
T Consensus 12 ~~~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~ 91 (476)
T 2y94_A 12 RVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDI 91 (476)
T ss_dssp CCEETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred CceecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 34567899999999999999999998 47889999997653321 2356788999999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccccC
Q 005841 578 CIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHE 657 (674)
Q Consensus 578 ~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~ 657 (674)
||||||+++++|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 92 ~lv~E~~~gg~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~~g--ivHrDLkp~NIll~~~~~vkL~DFG~a~~~~~ 168 (476)
T 2y94_A 92 FMVMEYVSGGELFDYICK-NGRLDEKESRRLFQQILSGVDYCHRHM--VVHRDLKPENVLLDAHMNAKIADFGLSNMMSD 168 (476)
T ss_dssp EEEEECCSSEEHHHHTTS-SSSCCHHHHHHHHHHHHHHHHHHHTTT--EECSCCSGGGEEECTTCCEEECCCSSCEECCT
T ss_pred EEEEeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCC--CCcccccHHHEEEecCCCeEEEeccchhhccc
Confidence 999999999999999965 457999999999999999999999999 99999999999999999999999999987654
Q ss_pred CccccccCCCCccccCC
Q 005841 658 TYLTTKTGKGTVTYLAS 674 (674)
Q Consensus 658 ~~~~~~~~~GTp~YmAP 674 (674)
.. .....+||+.|+||
T Consensus 169 ~~-~~~~~~gt~~y~aP 184 (476)
T 2y94_A 169 GE-FLRTSCGSPNYAAP 184 (476)
T ss_dssp TC-CBCCCCSCSTTCCH
T ss_pred cc-cccccCCCcCeECh
Confidence 33 23346899999998
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=99.95 E-value=3.2e-28 Score=263.52 Aligned_cols=171 Identities=29% Similarity=0.488 Sum_probs=138.7
Q ss_pred ccccCCeeEeeeecccCceEEEEEEEc-----CCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCC
Q 005841 501 EILWEDLTIGEQIGQGSCGTVYHAVWY-----GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQ 575 (674)
Q Consensus 501 ~~~~~~y~~~~~LG~G~fG~Vy~~~~~-----~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~ 575 (674)
++...+|.+.+.||+|+||.||+|.+. +..||||++.... .....+.+.+|+.+++.++||||+++++++....
T Consensus 41 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 119 (373)
T 2qol_A 41 ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY-TEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSK 119 (373)
T ss_dssp BCCGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred hcCHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCcc-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCC
Confidence 556678999999999999999999864 4569999996543 4556678999999999999999999999999999
Q ss_pred eEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccc
Q 005841 576 RLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLK 655 (674)
Q Consensus 576 ~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~ 655 (674)
.+||||||+++++|.+++......+++..++.++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++..
T Consensus 120 ~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 197 (373)
T 2qol_A 120 PVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMG--YVHRDLAARNILINSNLVCKVSDFGLGRVL 197 (373)
T ss_dssp SCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTCCEEECCC------
T ss_pred ceEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeCCCCCcceEEEcCCCCEEECcCcccccc
Confidence 999999999999999999877778999999999999999999999999 999999999999999999999999999876
Q ss_pred cCCc---cccccCCCCccccCC
Q 005841 656 HETY---LTTKTGKGTVTYLAS 674 (674)
Q Consensus 656 ~~~~---~~~~~~~GTp~YmAP 674 (674)
.... .......+|+.||||
T Consensus 198 ~~~~~~~~~~~~~~~~~~y~aP 219 (373)
T 2qol_A 198 EDDPEAAYTTRGGKIPIRWTSP 219 (373)
T ss_dssp ----------------CTTSCH
T ss_pred ccCCccceeccCCCcCCCccCh
Confidence 5432 222234578899998
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=2.7e-28 Score=256.65 Aligned_cols=171 Identities=27% Similarity=0.364 Sum_probs=140.3
Q ss_pred ccccCCeeEeeeecccCceEEEEEEE--cCCeEEEEEeecccC-CHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCe-
Q 005841 501 EILWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEY-SDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQR- 576 (674)
Q Consensus 501 ~~~~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~- 576 (674)
....++|++.+.||+|+||.||+|.+ .+..||||++..... .......+.+|+.+++.++||||+++++++.....
T Consensus 8 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 87 (311)
T 3ork_A 8 SHLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPA 87 (311)
T ss_dssp SEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETT
T ss_pred ceecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCC
Confidence 34567899999999999999999997 567799999987544 34566789999999999999999999999876543
Q ss_pred ---EEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcc
Q 005841 577 ---LCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSR 653 (674)
Q Consensus 577 ---~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~ 653 (674)
.||||||+++++|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++
T Consensus 88 ~~~~~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nil~~~~~~~kl~Dfg~a~ 164 (311)
T 3ork_A 88 GPLPYIVMEYVDGVTLRDIVHTE-GPMTPKRAIEVIADACQALNFSHQNG--IIHRDVKPANIMISATNAVKVMDFGIAR 164 (311)
T ss_dssp EEEEEEEEECCCEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEETTSCEEECCCSCC-
T ss_pred CcccEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--CCcCCCCHHHEEEcCCCCEEEeeccCcc
Confidence 49999999999999999764 46999999999999999999999999 9999999999999999999999999998
Q ss_pred cccCCcc---ccccCCCCccccCC
Q 005841 654 LKHETYL---TTKTGKGTVTYLAS 674 (674)
Q Consensus 654 ~~~~~~~---~~~~~~GTp~YmAP 674 (674)
....... ......||+.||||
T Consensus 165 ~~~~~~~~~~~~~~~~gt~~y~aP 188 (311)
T 3ork_A 165 AIADSGNSVTQTAAVIGTAQYLSP 188 (311)
T ss_dssp -----------------CCTTCCH
T ss_pred cccccccccccccccCcCcccCCH
Confidence 7643321 22335799999998
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=6.1e-28 Score=258.86 Aligned_cols=166 Identities=30% Similarity=0.457 Sum_probs=130.4
Q ss_pred ccccCCeeEeeeecccCceEEEEEEEc--CCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeEE
Q 005841 501 EILWEDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLC 578 (674)
Q Consensus 501 ~~~~~~y~~~~~LG~G~fG~Vy~~~~~--~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 578 (674)
+...++|++.+.||+|+||.||+|.+. +..||||++.... ..+.+.+|+.+++.++||||+++++++.....+|
T Consensus 49 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 124 (349)
T 2w4o_A 49 DALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV----DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEIS 124 (349)
T ss_dssp SCGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC--------------CHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred ccccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch----hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEE
Confidence 445678999999999999999999984 5679999997543 2345778999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcC---CCcEEEEecCCcccc
Q 005841 579 IVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDK---HWTVKVGDFGLSRLK 655 (674)
Q Consensus 579 lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~---~~~vkL~DFGla~~~ 655 (674)
|||||+++++|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+||||+. ++.+||+|||+++..
T Consensus 125 lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~ 201 (349)
T 2w4o_A 125 LVLELVTGGELFDRIVE-KGYYSERDAADAVKQILEAVAYLHENG--IVHRDLKPENLLYATPAPDAPLKIADFGLSKIV 201 (349)
T ss_dssp EEECCCCSCBHHHHHTT-CSSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEESSSSTTCCEEECCCC-----
T ss_pred EEEEeCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCcccEEEecCCCCCCEEEccCcccccc
Confidence 99999999999999965 456999999999999999999999999 999999999999975 889999999999876
Q ss_pred cCCccccccCCCCccccCC
Q 005841 656 HETYLTTKTGKGTVTYLAS 674 (674)
Q Consensus 656 ~~~~~~~~~~~GTp~YmAP 674 (674)
..... ....+||+.|+||
T Consensus 202 ~~~~~-~~~~~gt~~y~aP 219 (349)
T 2w4o_A 202 EHQVL-MKTVCGTPGYCAP 219 (349)
T ss_dssp ------------CGGGSCH
T ss_pred Ccccc-cccccCCCCccCH
Confidence 54322 2346799999998
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.9e-27 Score=251.80 Aligned_cols=163 Identities=28% Similarity=0.380 Sum_probs=145.4
Q ss_pred CeeEeeeecccCceEEEEEEE--cCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeEEEEEec
Q 005841 506 DLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEF 583 (674)
Q Consensus 506 ~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~ 583 (674)
.|...+.||+|+||.||+|.+ .+..||||++...... ..+.+.+|+.+++.++||||+++++++...+.+|+||||
T Consensus 46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 123 (321)
T 2c30_A 46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQ--RRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEF 123 (321)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC--SHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchh--HHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEec
Confidence 378888999999999999998 4788999999765432 235688999999999999999999999999999999999
Q ss_pred CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccccCCccccc
Q 005841 584 LPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTK 663 (674)
Q Consensus 584 ~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~~~~~~~ 663 (674)
+++++|.+++.. ..+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++..........
T Consensus 124 ~~~~~L~~~l~~--~~l~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~ 199 (321)
T 2c30_A 124 LQGGALTDIVSQ--VRLNEEQIATVCEAVLQALAYLHAQG--VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRK 199 (321)
T ss_dssp CCSCBHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCCBC
T ss_pred CCCCCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEECCCCcEEEeeeeeeeecccCccccc
Confidence 999999999864 46999999999999999999999999 99999999999999999999999999987765544445
Q ss_pred cCCCCccccCC
Q 005841 664 TGKGTVTYLAS 674 (674)
Q Consensus 664 ~~~GTp~YmAP 674 (674)
...||+.||||
T Consensus 200 ~~~gt~~y~aP 210 (321)
T 2c30_A 200 SLVGTPYWMAP 210 (321)
T ss_dssp CCCSCGGGCCH
T ss_pred cccCCccccCH
Confidence 57899999998
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.2e-27 Score=250.88 Aligned_cols=173 Identities=29% Similarity=0.511 Sum_probs=150.1
Q ss_pred ccccccCCeeEeeeecccCceEEEEEEEc-------CCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEE
Q 005841 499 DYEILWEDLTIGEQIGQGSCGTVYHAVWY-------GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAV 571 (674)
Q Consensus 499 ~~~~~~~~y~~~~~LG~G~fG~Vy~~~~~-------~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~ 571 (674)
.+++..++|.+.+.||+|+||.||+|.+. +..||||++.... .....+.+.+|+.+++.++||||+++++++
T Consensus 17 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~ 95 (314)
T 2ivs_A 17 KWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENA-SPSELRDLLSEFNVLKQVNHPHVIKLYGAC 95 (314)
T ss_dssp TTBCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred ccccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCC-CHHHHHHHHHHHHHHhhCCCCceeeEEEEE
Confidence 45677889999999999999999999872 2569999997543 455667899999999999999999999999
Q ss_pred ecCCeEEEEEecCCCCCHHHHHHhcC-----------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEE
Q 005841 572 TSPQRLCIVTEFLPRGSLFRLLQRNT-----------------------TKLDWRRRILMALDIARGVSYLHHCNPPIIH 628 (674)
Q Consensus 572 ~~~~~~~lV~E~~~ggsL~~~l~~~~-----------------------~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvH 628 (674)
...+.+|+||||+++++|.+++.... ..+++..++.++.||+.||.|||+++ |+|
T Consensus 96 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH 173 (314)
T 2ivs_A 96 SQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK--LVH 173 (314)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT--EEC
T ss_pred ecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC--Ccc
Confidence 99999999999999999999997643 23899999999999999999999999 999
Q ss_pred ccCCCCCEEEcCCCcEEEEecCCcccccCCc--cccccCCCCccccCC
Q 005841 629 RDLKSSNLLVDKHWTVKVGDFGLSRLKHETY--LTTKTGKGTVTYLAS 674 (674)
Q Consensus 629 rDLKp~NILi~~~~~vkL~DFGla~~~~~~~--~~~~~~~GTp~YmAP 674 (674)
|||||+||||+.++.+||+|||+++...... .......||+.|+||
T Consensus 174 ~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aP 221 (314)
T 2ivs_A 174 RDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAI 221 (314)
T ss_dssp CCCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCH
T ss_pred cccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccCh
Confidence 9999999999999999999999998764332 223345689999998
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=99.95 E-value=9.5e-28 Score=258.65 Aligned_cols=166 Identities=28% Similarity=0.399 Sum_probs=136.9
Q ss_pred cccCCeeEeeeecccCceEEEEEEE--cCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeEEE
Q 005841 502 ILWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCI 579 (674)
Q Consensus 502 ~~~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 579 (674)
...++|++.+.||+|+||+||++.+ ++..||||++.+..... ..+.+|+.+++.++||||+++++++.....+||
T Consensus 17 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~---~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 93 (361)
T 3uc3_A 17 HDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAID---ENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 93 (361)
T ss_dssp CCTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSC---HHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred CCCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcccc---HHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEE
Confidence 3457899999999999999999998 57789999997654333 457789999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCc--EEEEecCCcccccC
Q 005841 580 VTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWT--VKVGDFGLSRLKHE 657 (674)
Q Consensus 580 V~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~--vkL~DFGla~~~~~ 657 (674)
||||+++++|.+++... ..+++..+..++.||+.||.|||+++ |+||||||+||||+.++. +||+|||+++....
T Consensus 94 v~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~ql~~~L~~LH~~~--ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~ 170 (361)
T 3uc3_A 94 IMEYASGGELYERICNA-GRFSEDEARFFFQQLLSGVSYCHSMQ--ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 170 (361)
T ss_dssp EEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT--CCSCCCCGGGEEECSSSSCCEEECCCCCC-----
T ss_pred EEEeCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEcCCCCceEEEeecCccccccc
Confidence 99999999999999754 46999999999999999999999999 999999999999987665 99999999985433
Q ss_pred CccccccCCCCccccCC
Q 005841 658 TYLTTKTGKGTVTYLAS 674 (674)
Q Consensus 658 ~~~~~~~~~GTp~YmAP 674 (674)
.. .....+||+.||||
T Consensus 171 ~~-~~~~~~gt~~y~aP 186 (361)
T 3uc3_A 171 HS-QPKSTVGTPAYIAP 186 (361)
T ss_dssp -----------CTTSCH
T ss_pred cC-CCCCCcCCCCcCCh
Confidence 22 23345799999998
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=9.6e-28 Score=250.06 Aligned_cols=165 Identities=35% Similarity=0.564 Sum_probs=139.1
Q ss_pred ccccCCeeEeeeecccCceEEEEEEEcCCeEEEEEeecccCCHHHHHHHHHHHHHHhh--CCCCCeeeEEEEEec----C
Q 005841 501 EILWEDLTIGEQIGQGSCGTVYHAVWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKR--LRHPNVLLFMGAVTS----P 574 (674)
Q Consensus 501 ~~~~~~y~~~~~LG~G~fG~Vy~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~--l~HpnIv~l~~~~~~----~ 574 (674)
....++|++.+.||+|+||+||+|.+++..||||++.... ...+..|.+++.. ++||||+++++++.. .
T Consensus 4 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~-----~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~ 78 (301)
T 3q4u_A 4 RTVARDITLLECVGKGRYGEVWRGSWQGENVAVKIFSSRD-----EKSWFRETELYNTVMLRHENILGFIASDMTSRHSS 78 (301)
T ss_dssp CCCGGGCEEEEEEEECSSEEEEEEEETTEEEEEEEECGGG-----HHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTE
T ss_pred ccccCcEEEEEeeccCCCcEEEEEEECCEEEEEEEecccc-----chhhHHHHHHHHHhhccCcCeeeEEEeeccccCCC
Confidence 3456789999999999999999999999999999986532 2344556666666 789999999998654 3
Q ss_pred CeEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH--------hCCCCeEEccCCCCCEEEcCCCcEEE
Q 005841 575 QRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLH--------HCNPPIIHRDLKSSNLLVDKHWTVKV 646 (674)
Q Consensus 575 ~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH--------~~~~~IvHrDLKp~NILi~~~~~vkL 646 (674)
..+|+||||+++++|.+++.. ..+++..++.++.||+.||.||| +++ |+||||||+||||+.++.+||
T Consensus 79 ~~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~--ivH~Dlkp~Nill~~~~~~kl 154 (301)
T 3q4u_A 79 TQLWLITHYHEMGSLYDYLQL--TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA--IAHRDLKSKNILVKKNGQCCI 154 (301)
T ss_dssp EEEEEEECCCTTCBHHHHHTT--CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCE--EECSCCCGGGEEECTTSCEEE
T ss_pred ceeEEehhhccCCCHHHHHhh--cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC--eecCCCChHhEEEcCCCCEEE
Confidence 568999999999999999954 46999999999999999999999 878 999999999999999999999
Q ss_pred EecCCcccccCCccc----cccCCCCccccCC
Q 005841 647 GDFGLSRLKHETYLT----TKTGKGTVTYLAS 674 (674)
Q Consensus 647 ~DFGla~~~~~~~~~----~~~~~GTp~YmAP 674 (674)
+|||+|+........ ....+||+.|+||
T Consensus 155 ~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aP 186 (301)
T 3q4u_A 155 ADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAP 186 (301)
T ss_dssp CCCTTCEEEETTTTEEECCCCCCCCCGGGCCH
T ss_pred eeCCCeeecccccccccccccccccccceeCh
Confidence 999999876443222 2234799999998
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.95 E-value=7.8e-28 Score=256.24 Aligned_cols=174 Identities=28% Similarity=0.472 Sum_probs=146.6
Q ss_pred cccccccCCeeEeeeecccCceEEEEEEEc-------CCeEEEEEeecccCCHHHHHHHHHHHHHHhhC-CCCCeeeEEE
Q 005841 498 LDYEILWEDLTIGEQIGQGSCGTVYHAVWY-------GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRL-RHPNVLLFMG 569 (674)
Q Consensus 498 ~~~~~~~~~y~~~~~LG~G~fG~Vy~~~~~-------~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~ 569 (674)
..+++..++|++.+.||+|+||.||+|.+. +..||||++.... .......+.+|+.+++.+ .||||+++++
T Consensus 38 ~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~ 116 (344)
T 1rjb_A 38 LKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA-DSSEREALMSELKMMTQLGSHENIVNLLG 116 (344)
T ss_dssp GGGBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred cCcccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEeccccc-CHHHHHHHHHHHHHHHhhcCCCCeeeEEE
Confidence 356788899999999999999999999972 3359999997543 333456788999999999 8999999999
Q ss_pred EEecCCeEEEEEecCCCCCHHHHHHhcCC----------------------CCCHHHHHHHHHHHHHHHHHHHhCCCCeE
Q 005841 570 AVTSPQRLCIVTEFLPRGSLFRLLQRNTT----------------------KLDWRRRILMALDIARGVSYLHHCNPPII 627 (674)
Q Consensus 570 ~~~~~~~~~lV~E~~~ggsL~~~l~~~~~----------------------~l~~~~~~~i~~qi~~~L~yLH~~~~~Iv 627 (674)
++...+.+||||||+++++|.+++..... .+++..++.++.||+.||.|||+.+ |+
T Consensus 117 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--iv 194 (344)
T 1rjb_A 117 ACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS--CV 194 (344)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT--EE
T ss_pred EEeeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC--cc
Confidence 99999999999999999999999976543 3789999999999999999999999 99
Q ss_pred EccCCCCCEEEcCCCcEEEEecCCcccccCCcc--ccccCCCCccccCC
Q 005841 628 HRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYL--TTKTGKGTVTYLAS 674 (674)
Q Consensus 628 HrDLKp~NILi~~~~~vkL~DFGla~~~~~~~~--~~~~~~GTp~YmAP 674 (674)
||||||+||||+.++.+||+|||+++....... ......||+.|+||
T Consensus 195 H~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aP 243 (344)
T 1rjb_A 195 HRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAP 243 (344)
T ss_dssp ETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCH
T ss_pred cCCCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCH
Confidence 999999999999999999999999986643322 22334688999998
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.2e-27 Score=259.97 Aligned_cols=168 Identities=23% Similarity=0.364 Sum_probs=135.6
Q ss_pred cccCCeeEeeeecccCceEEEEEEE--cCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCC-CCCeeeEEEEEecCC--e
Q 005841 502 ILWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLR-HPNVLLFMGAVTSPQ--R 576 (674)
Q Consensus 502 ~~~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~--~ 576 (674)
...++|++.+.||+|+||+||+|.+ ++..||||++.+..........+.+|+.+++.+. ||||+++++++...+ .
T Consensus 6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~ 85 (388)
T 3oz6_A 6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRD 85 (388)
T ss_dssp HHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSC
T ss_pred cccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCE
Confidence 3457899999999999999999987 4778999999766556666778889999999997 999999999997554 6
Q ss_pred EEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCccccc
Q 005841 577 LCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKH 656 (674)
Q Consensus 577 ~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~ 656 (674)
+|||||||+ ++|..++.. ..+++..+..++.||+.||.|||+.+ ||||||||+||||+.++.+||+|||+|+...
T Consensus 86 ~~lv~e~~~-~~L~~~~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~--ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 160 (388)
T 3oz6_A 86 VYLVFDYME-TDLHAVIRA--NILEPVHKQYVVYQLIKVIKYLHSGG--LLHRDMKPSNILLNAECHVKVADFGLSRSFV 160 (388)
T ss_dssp EEEEEECCS-EEHHHHHHH--TCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEECCCTTCEESS
T ss_pred EEEEecccC-cCHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCC--EEeCCCCHHHeEEcCCCCEEecCCccccccc
Confidence 999999997 599999975 46999999999999999999999999 9999999999999999999999999998653
Q ss_pred CC---------------------ccccccCCCCccccCC
Q 005841 657 ET---------------------YLTTKTGKGTVTYLAS 674 (674)
Q Consensus 657 ~~---------------------~~~~~~~~GTp~YmAP 674 (674)
.. .......+||+.||||
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP 199 (388)
T 3oz6_A 161 NIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAP 199 (388)
T ss_dssp SCCCCCCCGGGCCC---------------CCCGGGGCCH
T ss_pred ccccccccccccccccccccccccccccCCcccCCcCCH
Confidence 21 1112335899999998
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=99.95 E-value=1.2e-27 Score=265.48 Aligned_cols=167 Identities=32% Similarity=0.541 Sum_probs=145.5
Q ss_pred ccccccCCeeEeeeecccCceEEEEEEEcCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCC-eE
Q 005841 499 DYEILWEDLTIGEQIGQGSCGTVYHAVWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQ-RL 577 (674)
Q Consensus 499 ~~~~~~~~y~~~~~LG~G~fG~Vy~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~-~~ 577 (674)
.+++..++|++.+.||+|+||.||+|.+.+..||||+++... ..+.+.+|+.+|+.++||||+++++++.... .+
T Consensus 187 ~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 262 (450)
T 1k9a_A 187 GWALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGL 262 (450)
T ss_dssp TCBCCGGGEEEEEEEEECSSEEEEEEEETTEEEEEEEESSCT----TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCE
T ss_pred ccccChHHeEEEeeecCcCCeeEEEEEecCCeEEEEEeCCch----HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCce
Confidence 356778899999999999999999999999999999997653 2356889999999999999999999987665 79
Q ss_pred EEEEecCCCCCHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCccccc
Q 005841 578 CIVTEFLPRGSLFRLLQRNTT-KLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKH 656 (674)
Q Consensus 578 ~lV~E~~~ggsL~~~l~~~~~-~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~ 656 (674)
|||||||++|+|.+++..... .+++..++.++.||+.||.|||+++ ||||||||+||||+.++.+||+|||+++...
T Consensus 263 ~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~ 340 (450)
T 1k9a_A 263 YIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN--FVHRDLAARNVLVSEDNVAKVSDFGLTKEAS 340 (450)
T ss_dssp EEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCCHhhEEECCCCCEEEeeCCCccccc
Confidence 999999999999999987544 3799999999999999999999999 9999999999999999999999999998654
Q ss_pred CCccccccCCCCccccCC
Q 005841 657 ETYLTTKTGKGTVTYLAS 674 (674)
Q Consensus 657 ~~~~~~~~~~GTp~YmAP 674 (674)
.. .....+|+.||||
T Consensus 341 ~~---~~~~~~~~~y~aP 355 (450)
T 1k9a_A 341 ST---QDTGKLPVKWTAP 355 (450)
T ss_dssp ---------CCCTTTSCH
T ss_pred cc---ccCCCCCcceeCH
Confidence 32 2234689999998
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=99.95 E-value=3.5e-27 Score=245.14 Aligned_cols=171 Identities=30% Similarity=0.486 Sum_probs=149.5
Q ss_pred ccccCCeeEeeeecccCceEEEEEEE--cCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEec----C
Q 005841 501 EILWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTS----P 574 (674)
Q Consensus 501 ~~~~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~----~ 574 (674)
......|++.+.||+|+||.||+|.+ ++..||+|++..........+.+.+|+.+++.++||||+++++++.. .
T Consensus 22 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 101 (290)
T 1t4h_A 22 SNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGK 101 (290)
T ss_dssp CTTSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSC
T ss_pred ccCceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCC
Confidence 44556799999999999999999998 45679999998877777778889999999999999999999998875 3
Q ss_pred CeEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEc-CCCcEEEEecCCcc
Q 005841 575 QRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVD-KHWTVKVGDFGLSR 653 (674)
Q Consensus 575 ~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~-~~~~vkL~DFGla~ 653 (674)
..+|+||||+++++|.+++... ..+++..++.++.||+.||.|||+.+.+|+||||||+|||++ .++.+||+|||++.
T Consensus 102 ~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~ 180 (290)
T 1t4h_A 102 KCIVLVTELMTSGTLKTYLKRF-KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT 180 (290)
T ss_dssp EEEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred ceEEEEEEecCCCCHHHHHHHc-cCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCCCcc
Confidence 5689999999999999999764 469999999999999999999999877799999999999998 78999999999997
Q ss_pred cccCCccccccCCCCccccCC
Q 005841 654 LKHETYLTTKTGKGTVTYLAS 674 (674)
Q Consensus 654 ~~~~~~~~~~~~~GTp~YmAP 674 (674)
....... ....||+.|+||
T Consensus 181 ~~~~~~~--~~~~~t~~y~aP 199 (290)
T 1t4h_A 181 LKRASFA--KAVIGTPEFMAP 199 (290)
T ss_dssp GCCTTSB--EESCSSCCCCCG
T ss_pred ccccccc--ccccCCcCcCCH
Confidence 6554432 335799999998
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=3.5e-27 Score=245.60 Aligned_cols=170 Identities=26% Similarity=0.346 Sum_probs=150.8
Q ss_pred cccCCeeEeeeecccCceEEEEEEEc--CCeEEEEEeecccC-CHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeEE
Q 005841 502 ILWEDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEY-SDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLC 578 (674)
Q Consensus 502 ~~~~~y~~~~~LG~G~fG~Vy~~~~~--~~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 578 (674)
...++|.+.+.||+|+||.||++.+. +..||+|++.+... .....+.+.+|+.+++.+.||||+++++++...+.+|
T Consensus 12 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 91 (294)
T 2rku_A 12 RSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVF 91 (294)
T ss_dssp TTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred CcccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEE
Confidence 34578999999999999999999984 66799999987654 3456678899999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccccCC
Q 005841 579 IVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHET 658 (674)
Q Consensus 579 lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~~ 658 (674)
+||||+++++|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 92 lv~e~~~~~~L~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~ 168 (294)
T 2rku_A 92 VVLELCRRRSLLELHKRR-KALTEPEARYYLRQIVLGCQYLHRNR--VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD 168 (294)
T ss_dssp EEEECCTTCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEECCCTTCEECCST
T ss_pred EEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCChHhEEEcCCCCEEEEeccCceecccC
Confidence 999999999999998754 47999999999999999999999999 999999999999999999999999999876544
Q ss_pred ccccccCCCCccccCC
Q 005841 659 YLTTKTGKGTVTYLAS 674 (674)
Q Consensus 659 ~~~~~~~~GTp~YmAP 674 (674)
........||+.|+||
T Consensus 169 ~~~~~~~~~~~~y~aP 184 (294)
T 2rku_A 169 GERKKVLCGTPNYIAP 184 (294)
T ss_dssp TCCBCCCCSCCSSCCH
T ss_pred ccccccccCCCCcCCc
Confidence 4444456799999998
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.95 E-value=1.4e-27 Score=257.85 Aligned_cols=163 Identities=30% Similarity=0.423 Sum_probs=139.5
Q ss_pred cCCeeEeeeecccCceEEEEEEE--cCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCC------
Q 005841 504 WEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQ------ 575 (674)
Q Consensus 504 ~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~------ 575 (674)
.++|++.+.||+|+||.||+|.+ ++..||||++..........+.+.+|+.+++.++||||+++++++....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 103 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 103 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence 47899999999999999999998 4778999999776556666788999999999999999999999998663
Q ss_pred eEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccc
Q 005841 576 RLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLK 655 (674)
Q Consensus 576 ~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~ 655 (674)
.+||||||+ +++|.+++.. ..+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++..
T Consensus 104 ~~~lv~e~~-~~~L~~~~~~--~~l~~~~~~~~~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 178 (367)
T 1cm8_A 104 DFYLVMPFM-GTDLGKLMKH--EKLGEDRIQFLVYQMLKGLRYIHAAG--IIHRDLKPGNLAVNEDCELKILDFGLARQA 178 (367)
T ss_dssp CCEEEEECC-SEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred eEEEEEecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCcCHHHEEEcCCCCEEEEeeeccccc
Confidence 469999999 8899999975 46999999999999999999999999 999999999999999999999999999876
Q ss_pred cCCccccccCCCCccccCC
Q 005841 656 HETYLTTKTGKGTVTYLAS 674 (674)
Q Consensus 656 ~~~~~~~~~~~GTp~YmAP 674 (674)
... ....+||+.|+||
T Consensus 179 ~~~---~~~~~~t~~y~aP 194 (367)
T 1cm8_A 179 DSE---MTGYVVTRWYRAP 194 (367)
T ss_dssp CSS---CCSSCSCGGGCCT
T ss_pred ccc---cCcCcCCCCcCCH
Confidence 542 3346799999999
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=5.3e-28 Score=256.76 Aligned_cols=168 Identities=26% Similarity=0.386 Sum_probs=135.1
Q ss_pred ccCCeeEeeeecccCceEEEEEEE--cCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeEEEE
Q 005841 503 LWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIV 580 (674)
Q Consensus 503 ~~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 580 (674)
..++|++.++||+|+||+||+|.+ ++..||||++............+.+|+.+++.++||||+++++++.....+|||
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 111 (329)
T 3gbz_A 32 SIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLI 111 (329)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEE
T ss_pred chhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEE
Confidence 346899999999999999999987 467799999977655555566788999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEE-----cCCCcEEEEecCCcccc
Q 005841 581 TEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLV-----DKHWTVKVGDFGLSRLK 655 (674)
Q Consensus 581 ~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi-----~~~~~vkL~DFGla~~~ 655 (674)
|||+++ +|.+++... ..+++..+..|+.||+.||.|||+++ |+||||||+|||| +..+.+||+|||+++..
T Consensus 112 ~e~~~~-~L~~~~~~~-~~~~~~~~~~i~~ql~~~l~~LH~~~--ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~ 187 (329)
T 3gbz_A 112 FEYAEN-DLKKYMDKN-PDVSMRVIKSFLYQLINGVNFCHSRR--CLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAF 187 (329)
T ss_dssp EECCSE-EHHHHHHHC-TTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEEC-----CCEEEECCTTHHHHH
T ss_pred EecCCC-CHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--EECCCCCHHHEEEecCCCCccceEEECcCCCcccc
Confidence 999975 999999764 46999999999999999999999999 9999999999999 45556999999999877
Q ss_pred cCCccccccCCCCccccCC
Q 005841 656 HETYLTTKTGKGTVTYLAS 674 (674)
Q Consensus 656 ~~~~~~~~~~~GTp~YmAP 674 (674)
..........+||+.|+||
T Consensus 188 ~~~~~~~~~~~~t~~y~aP 206 (329)
T 3gbz_A 188 GIPIRQFTHEIITLWYRPP 206 (329)
T ss_dssp C-----------CCTTCCH
T ss_pred CCcccccCCCcCCccccCH
Confidence 6544444456799999998
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=2.9e-27 Score=243.94 Aligned_cols=165 Identities=24% Similarity=0.357 Sum_probs=145.6
Q ss_pred cCCeeEeeeecccCceEEEEEEE--cCCeEEEEEeecccCCHHHHHHHHHHHHHHhhC-CCCCeeeEEEEEecCCeEEEE
Q 005841 504 WEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRL-RHPNVLLFMGAVTSPQRLCIV 580 (674)
Q Consensus 504 ~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lV 580 (674)
.++|++.+.||+|+||.||+|.+ ++..||||++............+.+|+.++..+ +||||+++++++...+.+|||
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv 89 (289)
T 1x8b_A 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQ 89 (289)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEE
T ss_pred cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence 46799999999999999999998 478899999987665555567788999999999 899999999999999999999
Q ss_pred EecCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcC-----------------
Q 005841 581 TEFLPRGSLFRLLQRN---TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDK----------------- 640 (674)
Q Consensus 581 ~E~~~ggsL~~~l~~~---~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~----------------- 640 (674)
|||+++++|.+++... ...+++..+..++.||+.||.|||+++ |+||||||+|||++.
T Consensus 90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~ 167 (289)
T 1x8b_A 90 NEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS--LVHMDIKPSNIFISRTSIPNAASEEGDEDDWA 167 (289)
T ss_dssp EECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEC------------------
T ss_pred EEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCC--EeecCCCHHHEEEcCCCCCccccccccccccc
Confidence 9999999999999754 256999999999999999999999999 999999999999984
Q ss_pred --CCcEEEEecCCcccccCCccccccCCCCccccCC
Q 005841 641 --HWTVKVGDFGLSRLKHETYLTTKTGKGTVTYLAS 674 (674)
Q Consensus 641 --~~~vkL~DFGla~~~~~~~~~~~~~~GTp~YmAP 674 (674)
...+||+|||++....... ...||+.|+||
T Consensus 168 ~~~~~~kl~Dfg~~~~~~~~~----~~~gt~~y~aP 199 (289)
T 1x8b_A 168 SNKVMFKIGDLGHVTRISSPQ----VEEGDSRFLAN 199 (289)
T ss_dssp --CCCEEECCCTTCEETTCSC----CCCCCGGGCCH
T ss_pred CCceEEEEcccccccccCCcc----ccCCCccccCh
Confidence 4489999999998765432 24699999998
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.4e-27 Score=253.51 Aligned_cols=170 Identities=29% Similarity=0.353 Sum_probs=145.0
Q ss_pred cccCCeeEeeeecccCceEEEEEEEc--CCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeEEE
Q 005841 502 ILWEDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCI 579 (674)
Q Consensus 502 ~~~~~y~~~~~LG~G~fG~Vy~~~~~--~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 579 (674)
...++|++.+.||+|+||.||+|.+. +..||||++............+.+|+.+++.++||||+++++++...+.+||
T Consensus 22 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 101 (331)
T 4aaa_A 22 QSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYL 101 (331)
T ss_dssp BCGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred hhhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEE
Confidence 34578999999999999999999984 7789999998776666667788899999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccccCCc
Q 005841 580 VTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETY 659 (674)
Q Consensus 580 V~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~~~ 659 (674)
||||+++++|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++......
T Consensus 102 v~e~~~~~~l~~~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 178 (331)
T 4aaa_A 102 VFEFVDHTILDDLELF-PNGLDYQVVQKYLFQIINGIGFCHSHN--IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG 178 (331)
T ss_dssp EEECCSEEHHHHHHHS-TTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTSCEEECCCTTC-------
T ss_pred EEecCCcchHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHHCC--EEccCcChheEEEcCCCcEEEEeCCCceeecCCc
Confidence 9999999888887653 457999999999999999999999999 9999999999999999999999999998766544
Q ss_pred cccccCCCCccccCC
Q 005841 660 LTTKTGKGTVTYLAS 674 (674)
Q Consensus 660 ~~~~~~~GTp~YmAP 674 (674)
.......||+.|+||
T Consensus 179 ~~~~~~~~t~~y~aP 193 (331)
T 4aaa_A 179 EVYDDEVATRWYRAP 193 (331)
T ss_dssp -----CCCCCTTCCH
T ss_pred cccCCCcCCccccCc
Confidence 444456799999998
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.7e-27 Score=249.63 Aligned_cols=175 Identities=27% Similarity=0.431 Sum_probs=151.0
Q ss_pred ccccccccCCeeEeeeecccCceEEEEEEEc-------CCeEEEEEeecccCCHHHHHHHHHHHHHHhhC-CCCCeeeEE
Q 005841 497 CLDYEILWEDLTIGEQIGQGSCGTVYHAVWY-------GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRL-RHPNVLLFM 568 (674)
Q Consensus 497 ~~~~~~~~~~y~~~~~LG~G~fG~Vy~~~~~-------~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~ 568 (674)
...+++..++|++.+.||+|+||.||+|.+. +..||||++.... .....+.+.+|+.+++.+ +||||++++
T Consensus 15 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~i~~~~ 93 (313)
T 1t46_A 15 DHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA-HLTEREALMSELKVLSYLGNHMNIVNLL 93 (313)
T ss_dssp CGGGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred ccccccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcch-hHHHHHHHHHHHHHHhhcccCCCeeeEE
Confidence 3456778889999999999999999999862 3569999997543 344567899999999999 899999999
Q ss_pred EEEecCCeEEEEEecCCCCCHHHHHHhcCC-----------------CCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccC
Q 005841 569 GAVTSPQRLCIVTEFLPRGSLFRLLQRNTT-----------------KLDWRRRILMALDIARGVSYLHHCNPPIIHRDL 631 (674)
Q Consensus 569 ~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~-----------------~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDL 631 (674)
+++...+..|+||||+++++|.+++..... .+++..++.++.||+.||.|||+++ |+||||
T Consensus 94 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl 171 (313)
T 1t46_A 94 GACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN--CIHRDL 171 (313)
T ss_dssp EEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCC
T ss_pred EEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCC--eecCCC
Confidence 999999999999999999999999976543 4899999999999999999999999 999999
Q ss_pred CCCCEEEcCCCcEEEEecCCcccccCCcc--ccccCCCCccccCC
Q 005841 632 KSSNLLVDKHWTVKVGDFGLSRLKHETYL--TTKTGKGTVTYLAS 674 (674)
Q Consensus 632 Kp~NILi~~~~~vkL~DFGla~~~~~~~~--~~~~~~GTp~YmAP 674 (674)
||+|||++.++.+||+|||+++....... ......||+.|+||
T Consensus 172 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aP 216 (313)
T 1t46_A 172 AARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAP 216 (313)
T ss_dssp SGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCH
T ss_pred ccceEEEcCCCCEEEccccccccccccccceeccCCCCcceeeCh
Confidence 99999999999999999999987654322 22234588999998
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=99.95 E-value=1.5e-27 Score=255.36 Aligned_cols=163 Identities=24% Similarity=0.401 Sum_probs=141.5
Q ss_pred ccCCeeEeeeecccCceEEEEEEEc--CCeEEEEEeecccCCHHHHHHHHHHHHHHhhC-CCCCeeeEEEEEecCCeEEE
Q 005841 503 LWEDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRL-RHPNVLLFMGAVTSPQRLCI 579 (674)
Q Consensus 503 ~~~~y~~~~~LG~G~fG~Vy~~~~~--~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~l 579 (674)
..++|++.+.||+|+||+||+|.+. +..||||++.+.... +.+|+.++.++ +||||+++++++.+...+||
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~------~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~l 93 (342)
T 2qr7_A 20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD------PTEEIEILLRYGQHPNIITLKDVYDDGKYVYV 93 (342)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC------CHHHHHHHHHHTTSTTBCCEEEEEECSSEEEE
T ss_pred ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC------hHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEE
Confidence 3467999999999999999999984 667999999765432 34588888887 79999999999999999999
Q ss_pred EEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCC----CcEEEEecCCcccc
Q 005841 580 VTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKH----WTVKVGDFGLSRLK 655 (674)
Q Consensus 580 V~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~----~~vkL~DFGla~~~ 655 (674)
|||||++++|.+++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||+... +.+||+|||+++..
T Consensus 94 v~E~~~gg~L~~~i~~-~~~~~~~~~~~~~~qi~~al~~lH~~g--ivHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~ 170 (342)
T 2qr7_A 94 VTELMKGGELLDKILR-QKFFSEREASAVLFTITKTVEYLHAQG--VVHRDLKPSNILYVDESGNPESIRICDFGFAKQL 170 (342)
T ss_dssp EECCCCSCBHHHHHHT-CTTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEESSSSCSGGGEEECCCTTCEEC
T ss_pred EEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCC--cEeccCCHHHEEEecCCCCcCeEEEEECCCcccC
Confidence 9999999999999975 457999999999999999999999999 9999999999998532 35999999999977
Q ss_pred cCCccccccCCCCccccCC
Q 005841 656 HETYLTTKTGKGTVTYLAS 674 (674)
Q Consensus 656 ~~~~~~~~~~~GTp~YmAP 674 (674)
..........+||+.||||
T Consensus 171 ~~~~~~~~~~~gt~~y~aP 189 (342)
T 2qr7_A 171 RAENGLLMTPCYTANFVAP 189 (342)
T ss_dssp BCTTCCBCCSSCCSSCCCH
T ss_pred cCCCCceeccCCCccccCH
Confidence 6554445567899999998
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=99.95 E-value=1.5e-27 Score=260.67 Aligned_cols=162 Identities=27% Similarity=0.367 Sum_probs=130.7
Q ss_pred ccCCeeEe-eeecccCceEEEEEEE--cCCeEEEEEeecccCCHHHHHHHHHHHHHHh-hCCCCCeeeEEEEEec----C
Q 005841 503 LWEDLTIG-EQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMK-RLRHPNVLLFMGAVTS----P 574 (674)
Q Consensus 503 ~~~~y~~~-~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~-~l~HpnIv~l~~~~~~----~ 574 (674)
..++|.+. ++||+|+||+||+|.+ ++..||||++... ..+.+|+.++. .++||||+++++++.. .
T Consensus 59 ~~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~ 131 (400)
T 1nxk_A 59 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLYAGR 131 (400)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTE
T ss_pred ccccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-------hhHHHHHHHHHHhcCCCCcceEeEEEeecccCC
Confidence 34678776 7899999999999998 4677999999642 24567888874 4589999999998875 5
Q ss_pred CeEEEEEecCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcC---CCcEEEEecC
Q 005841 575 QRLCIVTEFLPRGSLFRLLQRNT-TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDK---HWTVKVGDFG 650 (674)
Q Consensus 575 ~~~~lV~E~~~ggsL~~~l~~~~-~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~---~~~vkL~DFG 650 (674)
..+|||||||++|+|.+++.... ..+++..+..|+.||+.||.|||+++ ||||||||+||||+. ++.+||+|||
T Consensus 132 ~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~Nill~~~~~~~~~kl~DFG 209 (400)
T 1nxk_A 132 KCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFG 209 (400)
T ss_dssp EEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSSSTTCCEEECCCT
T ss_pred cEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCcCcceEEEecCCCCccEEEEecc
Confidence 67999999999999999997643 46999999999999999999999999 999999999999997 7899999999
Q ss_pred CcccccCCccccccCCCCccccCC
Q 005841 651 LSRLKHETYLTTKTGKGTVTYLAS 674 (674)
Q Consensus 651 la~~~~~~~~~~~~~~GTp~YmAP 674 (674)
+++...... .....+||+.||||
T Consensus 210 ~a~~~~~~~-~~~~~~gt~~y~aP 232 (400)
T 1nxk_A 210 FAKETTSHN-SLTTPCYTPYYVAP 232 (400)
T ss_dssp TCEECC------------CTTCCG
T ss_pred cccccCCCC-ccccCCCCCCccCH
Confidence 998765432 23346899999998
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.5e-27 Score=244.30 Aligned_cols=170 Identities=30% Similarity=0.517 Sum_probs=150.1
Q ss_pred cccccCCeeEeeeecccCceEEEEEEE-cCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeEE
Q 005841 500 YEILWEDLTIGEQIGQGSCGTVYHAVW-YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLC 578 (674)
Q Consensus 500 ~~~~~~~y~~~~~LG~G~fG~Vy~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 578 (674)
|.+..++|++.+.||+|+||.||+|.+ .+..||+|++....... +.+.+|+.+++.++||||+++++++...+.+|
T Consensus 3 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~---~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 79 (267)
T 3t9t_A 3 WVIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE---EDFIEEAEVMMKLSHPKLVQLYGVCLEQAPIC 79 (267)
T ss_dssp CBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTBCH---HHHHHHHHHHHTCCCTTBCCEEEEECSSSSCE
T ss_pred eEEchhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCCCH---HHHHHHHHHHHhCCCCCEeeEEEEEccCCCeE
Confidence 456678999999999999999999998 45679999998765443 46888999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccccCC
Q 005841 579 IVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHET 658 (674)
Q Consensus 579 lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~~ 658 (674)
+||||+++++|.+++......+++..+..++.||+.||.|||+.+ |+|+||||+|||++.++.+||+|||+++.....
T Consensus 80 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~ 157 (267)
T 3t9t_A 80 LVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC--VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD 157 (267)
T ss_dssp EEECCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSSCCGGGEEECGGGCEEECCTTGGGGBCCH
T ss_pred EEEeCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCchheEEECCCCCEEEcccccccccccc
Confidence 999999999999999877778999999999999999999999999 999999999999999999999999999876543
Q ss_pred ccc-cccCCCCccccCC
Q 005841 659 YLT-TKTGKGTVTYLAS 674 (674)
Q Consensus 659 ~~~-~~~~~GTp~YmAP 674 (674)
... .....||+.|+||
T Consensus 158 ~~~~~~~~~~~~~y~aP 174 (267)
T 3t9t_A 158 QYTSSTGTKFPVKWASP 174 (267)
T ss_dssp HHHSTTSTTCCGGGCCH
T ss_pred cccccccccccccccCh
Confidence 222 2234688999998
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.7e-27 Score=254.27 Aligned_cols=169 Identities=22% Similarity=0.337 Sum_probs=144.8
Q ss_pred ccccCCeeEeeeecccCceEEEEEEE-cCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCC--CCeeeEEEEEecCCeE
Q 005841 501 EILWEDLTIGEQIGQGSCGTVYHAVW-YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRH--PNVLLFMGAVTSPQRL 577 (674)
Q Consensus 501 ~~~~~~y~~~~~LG~G~fG~Vy~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~H--pnIv~l~~~~~~~~~~ 577 (674)
.+..++|++.+.||+|+||.||++.+ .+..||||++............+.+|+.+++.+.| |||+++++++.....+
T Consensus 5 ~~~~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~ 84 (343)
T 3dbq_A 5 SVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYI 84 (343)
T ss_dssp ESSSCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred eeecCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEE
Confidence 45678899999999999999999987 46679999998777677777889999999999986 9999999999999999
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccccC
Q 005841 578 CIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHE 657 (674)
Q Consensus 578 ~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~ 657 (674)
|||||+ .+++|.+++.. ...+++..+..|+.||+.||.|||+.+ |+||||||+||||+ ++.+||+|||+++....
T Consensus 85 ~lv~e~-~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~lH~~~--iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~ 159 (343)
T 3dbq_A 85 YMVMEC-GNIDLNSWLKK-KKSIDPWERKSYWKNMLEAVHTIHQHG--IVHSDLKPANFLIV-DGMLKLIDFGIANQMQP 159 (343)
T ss_dssp EEEECC-CSEEHHHHHHH-SCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEE-TTEEEECCCSSSCCC--
T ss_pred EEEEeC-CCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCcceEEEE-CCcEEEeecccccccCc
Confidence 999995 58899999976 457999999999999999999999999 99999999999997 57899999999987653
Q ss_pred Ccc--ccccCCCCccccCC
Q 005841 658 TYL--TTKTGKGTVTYLAS 674 (674)
Q Consensus 658 ~~~--~~~~~~GTp~YmAP 674 (674)
... .....+||+.||||
T Consensus 160 ~~~~~~~~~~~gt~~y~aP 178 (343)
T 3dbq_A 160 DTTSVVKDSQVGTVNYMPP 178 (343)
T ss_dssp ----------CCCCSSCCH
T ss_pred ccccccCCCCcCCcCcCCH
Confidence 322 23346799999998
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=4.3e-28 Score=256.88 Aligned_cols=166 Identities=28% Similarity=0.415 Sum_probs=136.8
Q ss_pred CCeeEeeeecccCceEEEEEEE--cCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeEEEEEe
Q 005841 505 EDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTE 582 (674)
Q Consensus 505 ~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E 582 (674)
++|++.+.||+|+||.||+|.+ ++..||||++..... ......+.+|+.+++.++||||+++++++...+.+|||||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHE-EGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFE 80 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC-------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccc-cccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEec
Confidence 5799999999999999999998 467799999865432 1222235579999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccccCCcccc
Q 005841 583 FLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTT 662 (674)
Q Consensus 583 ~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~~~~~~ 662 (674)
|++ ++|.+++......+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.........
T Consensus 81 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~ 157 (324)
T 3mtl_A 81 YLD-KDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQK--VLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTY 157 (324)
T ss_dssp CCS-EEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--EEESSCCGGGEEECTTCCEEECSSSEEECC-------
T ss_pred ccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--ccCCCcCHHHEEECCCCCEEEccCcccccccCCcccc
Confidence 997 5999999887778999999999999999999999999 9999999999999999999999999998766544444
Q ss_pred ccCCCCccccCC
Q 005841 663 KTGKGTVTYLAS 674 (674)
Q Consensus 663 ~~~~GTp~YmAP 674 (674)
....||+.|+||
T Consensus 158 ~~~~~t~~y~aP 169 (324)
T 3mtl_A 158 DNEVVTLWYRPP 169 (324)
T ss_dssp -----CGGGCCH
T ss_pred ccccCcccccCh
Confidence 456799999998
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=3.1e-27 Score=253.46 Aligned_cols=163 Identities=30% Similarity=0.440 Sum_probs=145.8
Q ss_pred CCeeEeeeecccCceEEEEEEE--cCCeEEEEEeecccCC-HHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeEEEEE
Q 005841 505 EDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYS-DEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVT 581 (674)
Q Consensus 505 ~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 581 (674)
+.|.+.+.||+|+||+||+|.+ ++..||||++...... ....+.+.+|+.+++.++||||+++++++......||||
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 133 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 133 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence 5699999999999999999997 5777999999765443 345678899999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccccCCccc
Q 005841 582 EFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLT 661 (674)
Q Consensus 582 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~~~~~ 661 (674)
||+. |+|.+++......+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++.....
T Consensus 134 e~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~--- 207 (348)
T 1u5q_A 134 EYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN--MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA--- 207 (348)
T ss_dssp ECCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB---
T ss_pred ecCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHEEECCCCCEEEeeccCceecCCC---
Confidence 9997 6898888776778999999999999999999999999 999999999999999999999999999866432
Q ss_pred cccCCCCccccCC
Q 005841 662 TKTGKGTVTYLAS 674 (674)
Q Consensus 662 ~~~~~GTp~YmAP 674 (674)
...+||+.||||
T Consensus 208 -~~~~gt~~y~aP 219 (348)
T 1u5q_A 208 -NSFVGTPYWMAP 219 (348)
T ss_dssp -CCCCSCGGGCCH
T ss_pred -CcccCCcceeCH
Confidence 346799999998
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=6.8e-28 Score=260.30 Aligned_cols=171 Identities=26% Similarity=0.395 Sum_probs=145.8
Q ss_pred ccccCCeeEeeeecccCceEEEEEEEc-------CCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEec
Q 005841 501 EILWEDLTIGEQIGQGSCGTVYHAVWY-------GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTS 573 (674)
Q Consensus 501 ~~~~~~y~~~~~LG~G~fG~Vy~~~~~-------~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~ 573 (674)
++..++|++.+.||+|+||+||+|.+. +..||||++... ........+.+|+.+++.++||||+++++++..
T Consensus 67 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~ 145 (367)
T 3l9p_A 67 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV-CSEQDELDFLMEALIISKFNHQNIVRCIGVSLQ 145 (367)
T ss_dssp BCCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSS-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred hcCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccc-cChhhHHHHHHHHHHHHhCCCCCCCeEEEEEec
Confidence 566789999999999999999999853 346999998643 344555678899999999999999999999999
Q ss_pred CCeEEEEEecCCCCCHHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCC---cE
Q 005841 574 PQRLCIVTEFLPRGSLFRLLQRNT------TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHW---TV 644 (674)
Q Consensus 574 ~~~~~lV~E~~~ggsL~~~l~~~~------~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~---~v 644 (674)
....|||||||++++|.+++.... ..+++..++.++.||+.||.|||+++ ||||||||+||||+.++ .+
T Consensus 146 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~~~~~~~ 223 (367)
T 3l9p_A 146 SLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH--FIHRDIAARNCLLTCPGPGRVA 223 (367)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESCSSTTCCE
T ss_pred CCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCC--eeCCCCChhhEEEecCCCCceE
Confidence 999999999999999999998643 45899999999999999999999999 99999999999999544 59
Q ss_pred EEEecCCcccccCC--ccccccCCCCccccCC
Q 005841 645 KVGDFGLSRLKHET--YLTTKTGKGTVTYLAS 674 (674)
Q Consensus 645 kL~DFGla~~~~~~--~~~~~~~~GTp~YmAP 674 (674)
||+|||+|+..... ........||+.||||
T Consensus 224 kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aP 255 (367)
T 3l9p_A 224 KIGDFGMARDIYRAGYYRKGGCAMLPVKWMPP 255 (367)
T ss_dssp EECCCHHHHHHHHHSSCTTCCGGGSCGGGCCH
T ss_pred EECCCccccccccccccccCCCcCCcccEECH
Confidence 99999999865322 2223335689999998
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=99.95 E-value=1.2e-27 Score=257.62 Aligned_cols=171 Identities=20% Similarity=0.287 Sum_probs=139.8
Q ss_pred ccccCCeeEeeeecccCceEEEEEEEc-------CCeEEEEEeecccCCH----HHH-----HHHHHHHHHHhhCCCCCe
Q 005841 501 EILWEDLTIGEQIGQGSCGTVYHAVWY-------GSDVAVKVFSRQEYSD----EVI-----HSFRQEVSLMKRLRHPNV 564 (674)
Q Consensus 501 ~~~~~~y~~~~~LG~G~fG~Vy~~~~~-------~~~vAvK~i~~~~~~~----~~~-----~~~~~Ei~il~~l~HpnI 564 (674)
++..++|++.++||+|+||.||+|.+. +..||||++....... ... ..+..|+..+..++||||
T Consensus 31 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~i 110 (364)
T 3op5_A 31 DMAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGV 110 (364)
T ss_dssp CTTCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCS
T ss_pred ccCCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCC
Confidence 456679999999999999999999884 3569999987653211 001 223456667788899999
Q ss_pred eeEEEEEecC----CeEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEc-
Q 005841 565 LLFMGAVTSP----QRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVD- 639 (674)
Q Consensus 565 v~l~~~~~~~----~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~- 639 (674)
+++++++... ..+||||||+ +++|.+++......+++..++.|+.||+.||.|||+.+ ||||||||+||||+
T Consensus 111 v~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~--iiHrDlkp~Nill~~ 187 (364)
T 3op5_A 111 PKYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHE--YVHGDIKASNLLLNY 187 (364)
T ss_dssp CCEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEES
T ss_pred CeEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--eEEecCCHHHEEEec
Confidence 9999998765 4589999999 99999999887678999999999999999999999999 99999999999999
Q ss_pred -CCCcEEEEecCCcccccCCccc-------cccCCCCccccCC
Q 005841 640 -KHWTVKVGDFGLSRLKHETYLT-------TKTGKGTVTYLAS 674 (674)
Q Consensus 640 -~~~~vkL~DFGla~~~~~~~~~-------~~~~~GTp~YmAP 674 (674)
.++.+||+|||+|+.+...... ....+||+.||||
T Consensus 188 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aP 230 (364)
T 3op5_A 188 KNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSI 230 (364)
T ss_dssp SCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCH
T ss_pred CCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCH
Confidence 8899999999999876433211 1234699999998
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=99.95 E-value=3.3e-27 Score=250.89 Aligned_cols=173 Identities=28% Similarity=0.522 Sum_probs=149.6
Q ss_pred ccccccCCeeEeeeecccCceEEEEEEEc---------CCeEEEEEeecccCCHHHHHHHHHHHHHHhhC-CCCCeeeEE
Q 005841 499 DYEILWEDLTIGEQIGQGSCGTVYHAVWY---------GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRL-RHPNVLLFM 568 (674)
Q Consensus 499 ~~~~~~~~y~~~~~LG~G~fG~Vy~~~~~---------~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~ 568 (674)
.+++..++|++.+.||+|+||.||+|.+. +..||||++.... .......+.+|+.+++.+ +||||++++
T Consensus 29 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~ 107 (334)
T 2pvf_A 29 KWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINLL 107 (334)
T ss_dssp TTBCCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred cccCCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCC-cHHHHHHHHHHHHHHHHhhcCCCEeeEE
Confidence 45677889999999999999999999863 3469999997543 455667899999999999 899999999
Q ss_pred EEEecCCeEEEEEecCCCCCHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCC
Q 005841 569 GAVTSPQRLCIVTEFLPRGSLFRLLQRNT---------------TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKS 633 (674)
Q Consensus 569 ~~~~~~~~~~lV~E~~~ggsL~~~l~~~~---------------~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp 633 (674)
+++...+.+||||||+++++|.+++.... ..+++..++.++.||+.||.|||+.+ |+||||||
T Consensus 108 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp 185 (334)
T 2pvf_A 108 GACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK--CIHRDLAA 185 (334)
T ss_dssp EEECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSG
T ss_pred EEEccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCcc
Confidence 99999999999999999999999997643 24899999999999999999999999 99999999
Q ss_pred CCEEEcCCCcEEEEecCCcccccCCcc--ccccCCCCccccCC
Q 005841 634 SNLLVDKHWTVKVGDFGLSRLKHETYL--TTKTGKGTVTYLAS 674 (674)
Q Consensus 634 ~NILi~~~~~vkL~DFGla~~~~~~~~--~~~~~~GTp~YmAP 674 (674)
+||||+.++.+||+|||+++....... ......||+.|+||
T Consensus 186 ~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aP 228 (334)
T 2pvf_A 186 RNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAP 228 (334)
T ss_dssp GGEEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCH
T ss_pred ceEEEcCCCCEEEccccccccccccccccccCCCCcccceeCh
Confidence 999999999999999999987654322 23335689999998
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=99.95 E-value=2.5e-27 Score=249.77 Aligned_cols=173 Identities=32% Similarity=0.495 Sum_probs=149.4
Q ss_pred ccccccCCeeEeeeecccCceEEEEEEEc-------CCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEE
Q 005841 499 DYEILWEDLTIGEQIGQGSCGTVYHAVWY-------GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAV 571 (674)
Q Consensus 499 ~~~~~~~~y~~~~~LG~G~fG~Vy~~~~~-------~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~ 571 (674)
.+++..++|++.+.||+|+||.||+|.+. +..||||++.... .......+.+|+.+++.++||||+++++++
T Consensus 19 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~ 97 (322)
T 1p4o_A 19 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA-SMRERIEFLNEASVMKEFNCHHVVRLLGVV 97 (322)
T ss_dssp TTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS-CHHHHHHHHHHHHHGGGCCCTTBCCEEEEE
T ss_pred hhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEeccccc-CHHHHHHHHHHHHHHHhcCCCCEeeeEEEE
Confidence 45777889999999999999999999864 4569999997543 344556789999999999999999999999
Q ss_pred ecCCeEEEEEecCCCCCHHHHHHhcC---------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCC
Q 005841 572 TSPQRLCIVTEFLPRGSLFRLLQRNT---------TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHW 642 (674)
Q Consensus 572 ~~~~~~~lV~E~~~ggsL~~~l~~~~---------~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~ 642 (674)
......|+||||+++++|.+++.... ..+++..++.++.||+.||.|||+++ |+||||||+||||+.++
T Consensus 98 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dikp~NIli~~~~ 175 (322)
T 1p4o_A 98 SQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK--FVHRDLAARNCMVAEDF 175 (322)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT--CBCSCCSGGGEEECTTC
T ss_pred ccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC--CccCCCccceEEEcCCC
Confidence 99999999999999999999997532 45789999999999999999999999 99999999999999999
Q ss_pred cEEEEecCCcccccCCcc--ccccCCCCccccCC
Q 005841 643 TVKVGDFGLSRLKHETYL--TTKTGKGTVTYLAS 674 (674)
Q Consensus 643 ~vkL~DFGla~~~~~~~~--~~~~~~GTp~YmAP 674 (674)
.+||+|||+++....... ......||+.|+||
T Consensus 176 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aP 209 (322)
T 1p4o_A 176 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSP 209 (322)
T ss_dssp CEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCH
T ss_pred eEEECcCccccccccccccccccCCCCCCCccCh
Confidence 999999999987644322 22334689999998
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=2.9e-27 Score=245.14 Aligned_cols=169 Identities=33% Similarity=0.582 Sum_probs=145.8
Q ss_pred ccccCCeeEeeeecccCceEEEEEEE--cCCeEEEEEeecccCCH--HHH---HHHHHHHHHHhhCCCCCeeeEEEEEec
Q 005841 501 EILWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSD--EVI---HSFRQEVSLMKRLRHPNVLLFMGAVTS 573 (674)
Q Consensus 501 ~~~~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~~~--~~~---~~~~~Ei~il~~l~HpnIv~l~~~~~~ 573 (674)
.+..++|++.+.||+|+||.||+|.+ .+..||||++....... ... +.+.+|+.+++.++||||+++++++..
T Consensus 15 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 94 (287)
T 4f0f_A 15 TLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHN 94 (287)
T ss_dssp BCCSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETT
T ss_pred hhhhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecC
Confidence 35568899999999999999999998 57789999987654322 211 678899999999999999999999876
Q ss_pred CCeEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCc-----EEEEe
Q 005841 574 PQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWT-----VKVGD 648 (674)
Q Consensus 574 ~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~-----vkL~D 648 (674)
.. ++||||+++++|.+++......+++..++.++.||+.||.|||+.+++|+||||||+||||+.++. +||+|
T Consensus 95 ~~--~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~D 172 (287)
T 4f0f_A 95 PP--RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVAD 172 (287)
T ss_dssp TT--EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEECC
T ss_pred CC--eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEeCC
Confidence 55 799999999999999987777899999999999999999999998877999999999999987776 99999
Q ss_pred cCCcccccCCccccccCCCCccccCC
Q 005841 649 FGLSRLKHETYLTTKTGKGTVTYLAS 674 (674)
Q Consensus 649 FGla~~~~~~~~~~~~~~GTp~YmAP 674 (674)
||+++..... .....||+.|+||
T Consensus 173 fg~~~~~~~~---~~~~~g~~~y~aP 195 (287)
T 4f0f_A 173 FGLSQQSVHS---VSGLLGNFQWMAP 195 (287)
T ss_dssp CTTCBCCSSC---EECCCCCCTTSCG
T ss_pred CCcccccccc---ccccCCCccccCc
Confidence 9999855442 3346799999998
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=99.95 E-value=5.8e-27 Score=251.30 Aligned_cols=165 Identities=24% Similarity=0.407 Sum_probs=145.1
Q ss_pred ccccCCeeEeeeecccCceEEEEEEE--cCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCC-----CCCeeeEEEEEec
Q 005841 501 EILWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLR-----HPNVLLFMGAVTS 573 (674)
Q Consensus 501 ~~~~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~-----HpnIv~l~~~~~~ 573 (674)
.+..++|++.++||+|+||+||+|.+ ++..||||++.. .......+..|+.+++.+. ||||+++++++..
T Consensus 31 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~---~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~ 107 (360)
T 3llt_A 31 MLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRN---IKKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMY 107 (360)
T ss_dssp CEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS---CHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEE
T ss_pred eEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEecc---chhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeE
Confidence 56678999999999999999999998 577899999964 2344566788999999986 9999999999999
Q ss_pred CCeEEEEEecCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcC------------
Q 005841 574 PQRLCIVTEFLPRGSLFRLLQRNT-TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDK------------ 640 (674)
Q Consensus 574 ~~~~~lV~E~~~ggsL~~~l~~~~-~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~------------ 640 (674)
.+.+||||||+ +++|.+++.... ..+++..+..++.||+.||.|||+++ ||||||||+||||+.
T Consensus 108 ~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~~~~~~~~~~~~ 184 (360)
T 3llt_A 108 YDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMS--LTHTDLKPENILLDDPYFEKSLITVRR 184 (360)
T ss_dssp TTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEESCTTCCEEEEEEEC
T ss_pred CCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCcccEEEccccccccccchhc
Confidence 99999999999 999999997654 45999999999999999999999999 999999999999975
Q ss_pred -------------CCcEEEEecCCcccccCCccccccCCCCccccCC
Q 005841 641 -------------HWTVKVGDFGLSRLKHETYLTTKTGKGTVTYLAS 674 (674)
Q Consensus 641 -------------~~~vkL~DFGla~~~~~~~~~~~~~~GTp~YmAP 674 (674)
++.+||+|||+|+..... .....||+.||||
T Consensus 185 ~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~---~~~~~gt~~y~aP 228 (360)
T 3llt_A 185 VTDGKKIQIYRTKSTGIKLIDFGCATFKSDY---HGSIINTRQYRAP 228 (360)
T ss_dssp TTTCCEEEEEEESCCCEEECCCTTCEETTSC---CCSCCSCGGGCCH
T ss_pred ccccccccccccCCCCEEEEeccCceecCCC---CcCccCcccccCc
Confidence 789999999999875543 2346799999998
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=99.95 E-value=2.3e-27 Score=251.70 Aligned_cols=162 Identities=26% Similarity=0.408 Sum_probs=128.4
Q ss_pred CCeeEe---eeecccCceEEEEEEEc--CCeEEEEEeecccCCHHHHHHHHHHHHHHhhCC-CCCeeeEEEEEecCCeEE
Q 005841 505 EDLTIG---EQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLR-HPNVLLFMGAVTSPQRLC 578 (674)
Q Consensus 505 ~~y~~~---~~LG~G~fG~Vy~~~~~--~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~ 578 (674)
.+|.+. +.||+|+||+||+|.+. +..||||++.+.. ...+.+|+.+++.+. ||||+++++++.+....|
T Consensus 8 ~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~ 82 (325)
T 3kn6_A 8 QHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRM-----EANTQKEITALKLCEGHPNIVKLHEVFHDQLHTF 82 (325)
T ss_dssp HHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGGG-----HHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred hccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChhh-----hhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEE
Confidence 456664 78999999999999984 6789999997542 345778999999997 999999999999999999
Q ss_pred EEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCC---cEEEEecCCcccc
Q 005841 579 IVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHW---TVKVGDFGLSRLK 655 (674)
Q Consensus 579 lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~---~vkL~DFGla~~~ 655 (674)
|||||+++++|.+++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++ .+||+|||+++..
T Consensus 83 lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~--ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~ 159 (325)
T 3kn6_A 83 LVMELLNGGELFERIKK-KKHFSETEASYIMRKLVSAVSHMHDVG--VVHRDLKPENLLFTDENDNLEIKIIDFGFARLK 159 (325)
T ss_dssp EEECCCCSCBHHHHHHH-CSCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEEC----CEEEECCCTTCEEC
T ss_pred EEEEccCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCC--CeecCCCHHHEEEecCCCcccEEEeccccceec
Confidence 99999999999999976 457999999999999999999999999 99999999999998665 8999999999877
Q ss_pred cCCccccccCCCCccccCC
Q 005841 656 HETYLTTKTGKGTVTYLAS 674 (674)
Q Consensus 656 ~~~~~~~~~~~GTp~YmAP 674 (674)
..........+||+.||||
T Consensus 160 ~~~~~~~~~~~~t~~y~aP 178 (325)
T 3kn6_A 160 PPDNQPLKTPCFTLHYAAP 178 (325)
T ss_dssp CC-----------------
T ss_pred CCCCCcccccCCCcCccCH
Confidence 6554445556899999998
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=99.95 E-value=2.4e-27 Score=266.21 Aligned_cols=171 Identities=33% Similarity=0.561 Sum_probs=150.3
Q ss_pred ccccccCCeeEeeeecccCceEEEEEEEc--CCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCe
Q 005841 499 DYEILWEDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQR 576 (674)
Q Consensus 499 ~~~~~~~~y~~~~~LG~G~fG~Vy~~~~~--~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 576 (674)
.+++...+|++.++||+|+||.||+|.+. +..||||++...... .+.|.+|+.+|+.++||||+++++++.....
T Consensus 214 ~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~ 290 (495)
T 1opk_A 214 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME---VEEFLKEAAVMKEIKHPNLVQLLGVCTREPP 290 (495)
T ss_dssp CCBCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred ccccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccc---hHHHHHHHHHHHhcCCCCEeeEEEEEecCCc
Confidence 45777889999999999999999999985 677999999765433 4568899999999999999999999999999
Q ss_pred EEEEEecCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccc
Q 005841 577 LCIVTEFLPRGSLFRLLQRN-TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLK 655 (674)
Q Consensus 577 ~~lV~E~~~ggsL~~~l~~~-~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~ 655 (674)
+|||||||++++|.+++... ...+++..++.|+.||+.||.|||+++ ||||||||+||||+.++.+||+|||+++..
T Consensus 291 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivHrDlkp~NIll~~~~~~kl~DFG~a~~~ 368 (495)
T 1opk_A 291 FYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN--FIHRNLAARNCLVGENHLVKVADFGLSRLM 368 (495)
T ss_dssp CEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECGGGCEEECCTTCEECC
T ss_pred EEEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCChhhEEECCCCcEEEeecccceec
Confidence 99999999999999999864 356999999999999999999999999 999999999999999999999999999876
Q ss_pred cCCccc-cccCCCCccccCC
Q 005841 656 HETYLT-TKTGKGTVTYLAS 674 (674)
Q Consensus 656 ~~~~~~-~~~~~GTp~YmAP 674 (674)
...... .....+|+.||||
T Consensus 369 ~~~~~~~~~~~~~~~~y~aP 388 (495)
T 1opk_A 369 TGDTYTAHAGAKFPIKWTAP 388 (495)
T ss_dssp TTCCEECCTTCCCCGGGCCH
T ss_pred cCCceeecCCCcCCcceeCH
Confidence 543333 2234578899998
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.8e-27 Score=267.11 Aligned_cols=167 Identities=28% Similarity=0.423 Sum_probs=140.9
Q ss_pred cCCeeEeeeecccCceEEEEEEE--cCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeEEEEE
Q 005841 504 WEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVT 581 (674)
Q Consensus 504 ~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 581 (674)
.++|++.++||+|+||+||+|.+ ++..||||++.+..........+.+|+.+++.++||||+++++++.....+||||
T Consensus 36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 115 (494)
T 3lij_A 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVM 115 (494)
T ss_dssp HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 45799999999999999999998 4677999999876544434567889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcC---CCcEEEEecCCcccccCC
Q 005841 582 EFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDK---HWTVKVGDFGLSRLKHET 658 (674)
Q Consensus 582 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~---~~~vkL~DFGla~~~~~~ 658 (674)
|||++++|.+++... ..+++..+..++.||+.||.|||+++ ||||||||+||||+. ++.+||+|||+|+.....
T Consensus 116 e~~~~g~L~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~ 192 (494)
T 3lij_A 116 ECYKGGELFDEIIHR-MKFNEVDAAVIIKQVLSGVTYLHKHN--IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQ 192 (494)
T ss_dssp ECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTT
T ss_pred ecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCC
Confidence 999999999988754 46999999999999999999999999 999999999999975 456999999999876544
Q ss_pred ccccccCCCCccccCC
Q 005841 659 YLTTKTGKGTVTYLAS 674 (674)
Q Consensus 659 ~~~~~~~~GTp~YmAP 674 (674)
. .....+||+.||||
T Consensus 193 ~-~~~~~~gt~~y~aP 207 (494)
T 3lij_A 193 K-KMKERLGTAYYIAP 207 (494)
T ss_dssp B-CBCCCCSCTTTCCH
T ss_pred c-cccccCCCcCeeCH
Confidence 3 23346799999998
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=99.95 E-value=3.1e-27 Score=265.81 Aligned_cols=168 Identities=30% Similarity=0.509 Sum_probs=143.4
Q ss_pred ccCCeeEeeeecccCceEEEEEEEc--CCeEEEEEeecccCCH-----------HHHHHHHHHHHHHhhCCCCCeeeEEE
Q 005841 503 LWEDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSD-----------EVIHSFRQEVSLMKRLRHPNVLLFMG 569 (674)
Q Consensus 503 ~~~~y~~~~~LG~G~fG~Vy~~~~~--~~~vAvK~i~~~~~~~-----------~~~~~~~~Ei~il~~l~HpnIv~l~~ 569 (674)
..++|.+.++||+|+||+||+|.+. +..||||++.+..... ...+.+.+|+.+++.++||||+++++
T Consensus 34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~ 113 (504)
T 3q5i_A 34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD 113 (504)
T ss_dssp GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 4578999999999999999999984 6679999998654321 23467889999999999999999999
Q ss_pred EEecCCeEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCC---cEEE
Q 005841 570 AVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHW---TVKV 646 (674)
Q Consensus 570 ~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~---~vkL 646 (674)
++.+...+|||||||++++|.+++... ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++ .+||
T Consensus 114 ~~~~~~~~~lv~e~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~kl 190 (504)
T 3q5i_A 114 VFEDKKYFYLVTEFYEGGELFEQIINR-HKFDECDAANIMKQILSGICYLHKHN--IVHRDIKPENILLENKNSLLNIKI 190 (504)
T ss_dssp EEECSSEEEEEEECCTTCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEESSTTCCSSEEE
T ss_pred EEEcCCEEEEEEecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCcHHHEEEecCCCCccEEE
Confidence 999999999999999999999999764 46999999999999999999999999 99999999999998765 6999
Q ss_pred EecCCcccccCCccccccCCCCccccCC
Q 005841 647 GDFGLSRLKHETYLTTKTGKGTVTYLAS 674 (674)
Q Consensus 647 ~DFGla~~~~~~~~~~~~~~GTp~YmAP 674 (674)
+|||+|+...... .....+||+.|+||
T Consensus 191 ~Dfg~a~~~~~~~-~~~~~~gt~~y~aP 217 (504)
T 3q5i_A 191 VDFGLSSFFSKDY-KLRDRLGTAYYIAP 217 (504)
T ss_dssp CCCTTCEECCTTS-CBCCCCSCTTTCCH
T ss_pred EECCCCEEcCCCC-ccccccCCcCCCCH
Confidence 9999998765543 23346799999998
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.1e-27 Score=248.35 Aligned_cols=166 Identities=24% Similarity=0.401 Sum_probs=145.3
Q ss_pred ccccCCeeEeeeecccCceEEEEEEEc--C-------CeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEE
Q 005841 501 EILWEDLTIGEQIGQGSCGTVYHAVWY--G-------SDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAV 571 (674)
Q Consensus 501 ~~~~~~y~~~~~LG~G~fG~Vy~~~~~--~-------~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~ 571 (674)
++..++|.+.+.||+|+||+||+|.+. + ..||+|++.... ....+.+.+|+.+++.++||||+++++++
T Consensus 4 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 81 (289)
T 4fvq_A 4 KIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAH--RNYSESFFEAASMMSKLSHKHLVLNYGVC 81 (289)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGG--GGGHHHHHHHHHHHHTSCCTTBCCEEEEE
T ss_pred EechhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhccccc--HHHHHHHHHHHHHHHhCCCCCEeEEEEEE
Confidence 456689999999999999999999874 2 359999986543 23346788999999999999999999999
Q ss_pred ecCCeEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCc--------
Q 005841 572 TSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWT-------- 643 (674)
Q Consensus 572 ~~~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~-------- 643 (674)
...+..||||||+++++|.+++......+++..++.++.||+.||.|||+++ |+||||||+||||+.++.
T Consensus 82 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~~~~~~~~~~~~ 159 (289)
T 4fvq_A 82 VCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENT--LIHGNVCAKNILLIREEDRKTGNPPF 159 (289)
T ss_dssp CCTTCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEEECCBGGGTBCCE
T ss_pred EeCCCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCC--eECCCcCcceEEEecCCcccccccce
Confidence 9999999999999999999999876666999999999999999999999999 999999999999998877
Q ss_pred EEEEecCCcccccCCccccccCCCCccccCC
Q 005841 644 VKVGDFGLSRLKHETYLTTKTGKGTVTYLAS 674 (674)
Q Consensus 644 vkL~DFGla~~~~~~~~~~~~~~GTp~YmAP 674 (674)
+||+|||++...... ....||+.|+||
T Consensus 160 ~kl~Dfg~~~~~~~~----~~~~~~~~y~aP 186 (289)
T 4fvq_A 160 IKLSDPGISITVLPK----DILQERIPWVPP 186 (289)
T ss_dssp EEECCCCSCTTTSCH----HHHHHTTTTSCH
T ss_pred eeeccCcccccccCc----cccCCcCcccCH
Confidence 999999999765432 223589999998
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.3e-27 Score=252.37 Aligned_cols=174 Identities=30% Similarity=0.432 Sum_probs=132.4
Q ss_pred ccccccCCeeEeeeecccCceEEEEEEEcCC-----eEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEec
Q 005841 499 DYEILWEDLTIGEQIGQGSCGTVYHAVWYGS-----DVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTS 573 (674)
Q Consensus 499 ~~~~~~~~y~~~~~LG~G~fG~Vy~~~~~~~-----~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~ 573 (674)
...+..++|++.+.||+|+||.||+|.+... .||||++..........+.+.+|+.+++.++||||+++++++..
T Consensus 17 ~~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 96 (323)
T 3qup_A 17 DVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLR 96 (323)
T ss_dssp TTBCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEEC
T ss_pred hcccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeec
Confidence 3456778999999999999999999986432 69999998765555667889999999999999999999999987
Q ss_pred CCeE------EEEEecCCCCCHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCC
Q 005841 574 PQRL------CIVTEFLPRGSLFRLLQRNT-----TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHW 642 (674)
Q Consensus 574 ~~~~------~lV~E~~~ggsL~~~l~~~~-----~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~ 642 (674)
.... |+||||+++++|.+++.... ..+++..++.++.||+.||.|||+.+ |+||||||+||||+.++
T Consensus 97 ~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~--ivH~Dikp~NIli~~~~ 174 (323)
T 3qup_A 97 SRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN--FIHRDLAARNCMLAEDM 174 (323)
T ss_dssp C-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECTTS
T ss_pred cccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCC--cccCCCCcceEEEcCCC
Confidence 7665 99999999999999986432 25899999999999999999999999 99999999999999999
Q ss_pred cEEEEecCCcccccCCcc--ccccCCCCccccCC
Q 005841 643 TVKVGDFGLSRLKHETYL--TTKTGKGTVTYLAS 674 (674)
Q Consensus 643 ~vkL~DFGla~~~~~~~~--~~~~~~GTp~YmAP 674 (674)
.+||+|||+++....... ......||+.|+||
T Consensus 175 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aP 208 (323)
T 3qup_A 175 TVCVADFGLSRKIYSGDYYRQGCASKLPVKWLAL 208 (323)
T ss_dssp CEEECCCCC-----------------CCGGGCCH
T ss_pred CEEEeeccccccccccccccccccccCcccccCc
Confidence 999999999987644322 22234578899998
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.95 E-value=3.2e-27 Score=251.27 Aligned_cols=172 Identities=30% Similarity=0.465 Sum_probs=143.4
Q ss_pred cccccCCeeEeeeecccCceEEEEEEEcCC------eEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEec
Q 005841 500 YEILWEDLTIGEQIGQGSCGTVYHAVWYGS------DVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTS 573 (674)
Q Consensus 500 ~~~~~~~y~~~~~LG~G~fG~Vy~~~~~~~------~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~ 573 (674)
.++...+|.+.+.||+|+||.||+|.+... .||||++.... .......+.+|+.+++.++||||+++++++..
T Consensus 39 ~~i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 117 (333)
T 1mqb_A 39 TEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY-TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISK 117 (333)
T ss_dssp CBCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred ccCChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEec
Confidence 367778999999999999999999987422 49999997543 44556678999999999999999999999999
Q ss_pred CCeEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcc
Q 005841 574 PQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSR 653 (674)
Q Consensus 574 ~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~ 653 (674)
.+.+||||||+++++|.+++......+++..++.++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++
T Consensus 118 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~NIl~~~~~~~kl~Dfg~~~ 195 (333)
T 1mqb_A 118 YKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMN--YVHRDLAARNILVNSNLVCKVSDFGLSR 195 (333)
T ss_dssp SSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred CCCcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCChheEEECCCCcEEECCCCcch
Confidence 99999999999999999999877778999999999999999999999999 9999999999999999999999999998
Q ss_pred cccCCc---cccccCCCCccccCC
Q 005841 654 LKHETY---LTTKTGKGTVTYLAS 674 (674)
Q Consensus 654 ~~~~~~---~~~~~~~GTp~YmAP 674 (674)
...... .......||+.|+||
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~y~aP 219 (333)
T 1mqb_A 196 VLEDDPEATYTTSGGKIPIRWTAP 219 (333)
T ss_dssp ---------------CCCGGGSCH
T ss_pred hhccccccccccCCCCccccccCc
Confidence 765432 122234578999998
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=2.7e-27 Score=257.82 Aligned_cols=169 Identities=21% Similarity=0.336 Sum_probs=145.1
Q ss_pred ccccCCeeEeeeecccCceEEEEEEE-cCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCC--CCCeeeEEEEEecCCeE
Q 005841 501 EILWEDLTIGEQIGQGSCGTVYHAVW-YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLR--HPNVLLFMGAVTSPQRL 577 (674)
Q Consensus 501 ~~~~~~y~~~~~LG~G~fG~Vy~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~--HpnIv~l~~~~~~~~~~ 577 (674)
.+...+|++.+.||+|+||+||+|.+ .+..||||++............+.+|+.+++.+. ||||+++++++...+.+
T Consensus 52 ~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~ 131 (390)
T 2zmd_A 52 SVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYI 131 (390)
T ss_dssp EETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred cccCCceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEE
Confidence 34456799999999999999999987 4667999999887767777788999999999996 59999999999999999
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccccC
Q 005841 578 CIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHE 657 (674)
Q Consensus 578 ~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~ 657 (674)
||||| +.+++|.+++... ..+++..+..|+.||+.||.|||+++ ||||||||+||||+ ++.+||+|||+++....
T Consensus 132 ~lv~E-~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~lH~~~--ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~ 206 (390)
T 2zmd_A 132 YMVME-CGNIDLNSWLKKK-KSIDPWERKSYWKNMLEAVHTIHQHG--IVHSDLKPANFLIV-DGMLKLIDFGIANQMQP 206 (390)
T ss_dssp EEEEE-CCSEEHHHHHHHC-SSCCHHHHHHHHHHHHHHHHHHHTTT--CCCCCCCGGGEEES-SSCEEECCCSSSCCC--
T ss_pred EEEEe-cCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHEEEE-CCeEEEEecCccccccC
Confidence 99999 5688999999764 47899999999999999999999999 99999999999996 57999999999987653
Q ss_pred Cc--cccccCCCCccccCC
Q 005841 658 TY--LTTKTGKGTVTYLAS 674 (674)
Q Consensus 658 ~~--~~~~~~~GTp~YmAP 674 (674)
.. ......+||+.||||
T Consensus 207 ~~~~~~~~~~~gt~~y~aP 225 (390)
T 2zmd_A 207 DTTSVVKDSQVGAVNYMPP 225 (390)
T ss_dssp -------CCSCCCGGGCCH
T ss_pred CCccccCCCCCcCCCccCh
Confidence 32 223346799999998
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.95 E-value=3.4e-28 Score=261.39 Aligned_cols=170 Identities=23% Similarity=0.353 Sum_probs=145.3
Q ss_pred cccCCeeEeeeecccCceEEEEEEE-----cCCeEEEEEeecccCC--HHHHHHHHHHHHHHhhC-CCCCeeeEEEEEec
Q 005841 502 ILWEDLTIGEQIGQGSCGTVYHAVW-----YGSDVAVKVFSRQEYS--DEVIHSFRQEVSLMKRL-RHPNVLLFMGAVTS 573 (674)
Q Consensus 502 ~~~~~y~~~~~LG~G~fG~Vy~~~~-----~~~~vAvK~i~~~~~~--~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~ 573 (674)
+..++|++.++||+|+||.||+|.+ .+..||||++.+.... ......+.+|+.+++.+ .||||+++++++..
T Consensus 51 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 130 (355)
T 1vzo_A 51 VGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT 130 (355)
T ss_dssp CCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEE
T ss_pred ccccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEee
Confidence 4457899999999999999999997 5678999998654321 12234466799999999 69999999999999
Q ss_pred CCeEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcc
Q 005841 574 PQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSR 653 (674)
Q Consensus 574 ~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~ 653 (674)
...+||||||+++++|.+++... ..+++..+..++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++
T Consensus 131 ~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~kl~DfG~a~ 207 (355)
T 1vzo_A 131 ETKLHLILDYINGGELFTHLSQR-ERFTEHEVQIYVGEIVLALEHLHKLG--IIYRDIKLENILLDSNGHVVLTDFGLSK 207 (355)
T ss_dssp TTEEEEEECCCCSCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred CceEEEEeecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCCCcEEEeeCCCCe
Confidence 99999999999999999999764 46999999999999999999999999 9999999999999999999999999998
Q ss_pred cccCC-ccccccCCCCccccCC
Q 005841 654 LKHET-YLTTKTGKGTVTYLAS 674 (674)
Q Consensus 654 ~~~~~-~~~~~~~~GTp~YmAP 674 (674)
..... .......+||+.||||
T Consensus 208 ~~~~~~~~~~~~~~gt~~y~aP 229 (355)
T 1vzo_A 208 EFVADETERAYDFCGTIEYMAP 229 (355)
T ss_dssp ECCGGGGGGGCGGGSCCTTCCH
T ss_pred ecccCCCCcccCcccCcCccCh
Confidence 65432 2223346799999998
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=99.95 E-value=1.8e-27 Score=245.97 Aligned_cols=169 Identities=33% Similarity=0.537 Sum_probs=143.8
Q ss_pred ccccCCeeEeeeecccCceEEEEEEEc--CCeEEEEEeecccCCH-HHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeE
Q 005841 501 EILWEDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSD-EVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRL 577 (674)
Q Consensus 501 ~~~~~~y~~~~~LG~G~fG~Vy~~~~~--~~~vAvK~i~~~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 577 (674)
.+..++|++.+.||+|+||.||+|.+. +..||||++.+..... .....+.+|+.+++.++||||+++++++......
T Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 84 (279)
T 3fdn_A 5 QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRV 84 (279)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred eeecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEE
Confidence 345688999999999999999999984 5569999997644322 2345688999999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccccC
Q 005841 578 CIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHE 657 (674)
Q Consensus 578 ~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~ 657 (674)
|+||||+++++|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||++.....
T Consensus 85 ~lv~e~~~~~~l~~~l~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~--i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~ 161 (279)
T 3fdn_A 85 YLILEYAPLGTVYRELQKL-SKFDEQRTATYITELANALSYCHSKR--VIHRDIKPENLLLGSAGELKIADFGWSVHAPS 161 (279)
T ss_dssp EEEECCCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTTT--CEECCCCGGGEEECTTSCEEECSCCEESCC--
T ss_pred EEEEecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--EecccCChHhEEEcCCCCEEEEeccccccCCc
Confidence 9999999999999999764 46999999999999999999999998 99999999999999999999999999865544
Q ss_pred CccccccCCCCccccCC
Q 005841 658 TYLTTKTGKGTVTYLAS 674 (674)
Q Consensus 658 ~~~~~~~~~GTp~YmAP 674 (674)
.. .....||+.|+||
T Consensus 162 ~~--~~~~~~~~~y~aP 176 (279)
T 3fdn_A 162 SR--RTDLCGTLDYLPP 176 (279)
T ss_dssp --------CCCCTTCCH
T ss_pred cc--ccccCCCCCccCH
Confidence 32 2335799999998
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=7.8e-28 Score=256.56 Aligned_cols=168 Identities=25% Similarity=0.405 Sum_probs=145.7
Q ss_pred ccCCeeEeeeecccCceEEEEEEE--cCCeEEEEEeecccCCHH------HHHHHHHHHHHHhhCCCCCeeeEEEEEecC
Q 005841 503 LWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDE------VIHSFRQEVSLMKRLRHPNVLLFMGAVTSP 574 (674)
Q Consensus 503 ~~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~~~~------~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~ 574 (674)
..++|++.+.||+|+||.||+|.+ ++..||||++.+...... ....+.+|+.+++.++||||+++++++...
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~ 101 (335)
T 3dls_A 22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ 101 (335)
T ss_dssp HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence 346899999999999999999987 567799999987643221 234567799999999999999999999999
Q ss_pred CeEEEEEecCCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcc
Q 005841 575 QRLCIVTEFLPRG-SLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSR 653 (674)
Q Consensus 575 ~~~~lV~E~~~gg-sL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~ 653 (674)
+.+|+||||+.+| +|.+++.. ...+++..+..|+.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++
T Consensus 102 ~~~~lv~e~~~~g~~l~~~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~~~~~kL~Dfg~a~ 178 (335)
T 3dls_A 102 GFFQLVMEKHGSGLDLFAFIDR-HPRLDEPLASYIFRQLVSAVGYLRLKD--IIHRDIKDENIVIAEDFTIKLIDFGSAA 178 (335)
T ss_dssp SEEEEEEECCTTSCBHHHHHHT-CCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTSCEEECCCTTCE
T ss_pred CEEEEEEEeCCCCccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCC--eEEeccCHHHEEEcCCCcEEEeecccce
Confidence 9999999999766 99999975 446999999999999999999999999 9999999999999999999999999998
Q ss_pred cccCCccccccCCCCccccCC
Q 005841 654 LKHETYLTTKTGKGTVTYLAS 674 (674)
Q Consensus 654 ~~~~~~~~~~~~~GTp~YmAP 674 (674)
....... ....+||+.||||
T Consensus 179 ~~~~~~~-~~~~~gt~~y~aP 198 (335)
T 3dls_A 179 YLERGKL-FYTFCGTIEYCAP 198 (335)
T ss_dssp ECCTTCC-BCEECSCGGGCCH
T ss_pred ECCCCCc-eeccCCCccccCh
Confidence 7655432 2335799999998
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=5.9e-27 Score=245.77 Aligned_cols=170 Identities=25% Similarity=0.426 Sum_probs=136.9
Q ss_pred ccCCeeEeeeecccCceEEEEEEE--cCCeEEEEEeecccC-CHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeEEE
Q 005841 503 LWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEY-SDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCI 579 (674)
Q Consensus 503 ~~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 579 (674)
...+|++.+.||+|+||.||+|.+ .+..||||++..... .......+.+|+.+++.++||||+++++++...+.+|+
T Consensus 30 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 109 (310)
T 2wqm_A 30 TLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNI 109 (310)
T ss_dssp SGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred cccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEE
Confidence 346899999999999999999997 577899999976443 44566789999999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCccccc
Q 005841 580 VTEFLPRGSLFRLLQR---NTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKH 656 (674)
Q Consensus 580 V~E~~~ggsL~~~l~~---~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~ 656 (674)
||||+++++|.+++.. ....+++..++.++.||+.||.|||+.+ |+|+||||+||||+.++.+||+|||+++...
T Consensus 110 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~ 187 (310)
T 2wqm_A 110 VLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR--VMHRDIKPANVFITATGVVKLGDLGLGRFFS 187 (310)
T ss_dssp EEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTSCEEECCC-------
T ss_pred EEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCC--eeCCCCcHHHEEEcCCCCEEEEeccceeeec
Confidence 9999999999999864 3566999999999999999999999999 9999999999999999999999999998766
Q ss_pred CCccccccCCCCccccCC
Q 005841 657 ETYLTTKTGKGTVTYLAS 674 (674)
Q Consensus 657 ~~~~~~~~~~GTp~YmAP 674 (674)
..........||+.|+||
T Consensus 188 ~~~~~~~~~~~~~~y~aP 205 (310)
T 2wqm_A 188 SKTTAAHSLVGTPYYMSP 205 (310)
T ss_dssp -----------CCSSCCH
T ss_pred CCCccccccCCCeeEeCh
Confidence 544444456799999998
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.8e-27 Score=254.51 Aligned_cols=168 Identities=24% Similarity=0.342 Sum_probs=144.1
Q ss_pred cCCeeEeeeecccCceEEEEEEE--cCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEec--------
Q 005841 504 WEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTS-------- 573 (674)
Q Consensus 504 ~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~-------- 573 (674)
..+|++.+.||+|+||+||+|.+ ++..||||++............+.+|+.+++.++||||+++++++..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 95 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 95 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence 36899999999999999999998 47789999987665444444567789999999999999999999987
Q ss_pred CCeEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcc
Q 005841 574 PQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSR 653 (674)
Q Consensus 574 ~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~ 653 (674)
.+.+||||||+++ +|.+.+......+++..+..++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+|+
T Consensus 96 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~ 172 (351)
T 3mi9_A 96 KGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNK--ILHRDMKAANVLITRDGVLKLADFGLAR 172 (351)
T ss_dssp -CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred CceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC--eeCCCCCHHHEEEcCCCCEEEccchhcc
Confidence 3468999999975 888888776678999999999999999999999999 9999999999999999999999999998
Q ss_pred cccCC----ccccccCCCCccccCC
Q 005841 654 LKHET----YLTTKTGKGTVTYLAS 674 (674)
Q Consensus 654 ~~~~~----~~~~~~~~GTp~YmAP 674 (674)
..... ........||+.|+||
T Consensus 173 ~~~~~~~~~~~~~~~~~gt~~y~aP 197 (351)
T 3mi9_A 173 AFSLAKNSQPNRYTNRVVTLWYRPP 197 (351)
T ss_dssp ECCCCSSSSCCCCCSSCSCGGGCCH
T ss_pred cccccccccccccCCcccccCccCc
Confidence 75421 1222345799999998
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.95 E-value=9e-28 Score=256.79 Aligned_cols=169 Identities=27% Similarity=0.349 Sum_probs=141.4
Q ss_pred ccCCeeEeeeecccCceEEEEEEEc--CCeEEEEEeecccCCH---HHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeE
Q 005841 503 LWEDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSD---EVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRL 577 (674)
Q Consensus 503 ~~~~y~~~~~LG~G~fG~Vy~~~~~--~~~vAvK~i~~~~~~~---~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 577 (674)
..++|++.+.||+|+||.||+|.+. +..||||++....... .....+.+|+.+++.++||||+++++++.....+
T Consensus 8 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 87 (346)
T 1ua2_A 8 RAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNI 87 (346)
T ss_dssp -----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCC
T ss_pred HhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCce
Confidence 4578999999999999999999974 7789999997543321 2234678899999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccccC
Q 005841 578 CIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHE 657 (674)
Q Consensus 578 ~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~ 657 (674)
|+||||+++ +|.+++......+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 88 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~ 164 (346)
T 1ua2_A 88 SLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW--ILHRDLKPNNLLLDENGVLKLADFGLAKSFGS 164 (346)
T ss_dssp EEEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTCCEEECCCGGGSTTTS
T ss_pred EEEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCC--EECCCCCHHHEEEcCCCCEEEEecccceeccC
Confidence 999999976 899999877777999999999999999999999999 99999999999999999999999999987765
Q ss_pred CccccccCCCCccccCC
Q 005841 658 TYLTTKTGKGTVTYLAS 674 (674)
Q Consensus 658 ~~~~~~~~~GTp~YmAP 674 (674)
........+||+.|+||
T Consensus 165 ~~~~~~~~~~t~~y~aP 181 (346)
T 1ua2_A 165 PNRAYTHQVVTRWYRAP 181 (346)
T ss_dssp CCCCCCCSCCCCTTCCH
T ss_pred CcccCCcccccccccCc
Confidence 54444456899999998
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.5e-27 Score=265.75 Aligned_cols=165 Identities=30% Similarity=0.412 Sum_probs=138.3
Q ss_pred ccCCeeEeeeecccCceEEEEEEE--cCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecC------
Q 005841 503 LWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSP------ 574 (674)
Q Consensus 503 ~~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~------ 574 (674)
..++|+++++||+|+||+||+|.+ ++..||||++.+..........+.+|+.+++.++||||+++++++...
T Consensus 60 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~ 139 (464)
T 3ttj_A 60 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEF 139 (464)
T ss_dssp EETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTC
T ss_pred ecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccC
Confidence 357899999999999999999988 467799999987665666778899999999999999999999999655
Q ss_pred CeEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCccc
Q 005841 575 QRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL 654 (674)
Q Consensus 575 ~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~ 654 (674)
..+||||||+++ +|.+.+.. .+++..+..++.||+.||.|||+.+ ||||||||+||||+.++.+||+|||+|+.
T Consensus 140 ~~~~lv~E~~~~-~l~~~~~~---~l~~~~~~~~~~qil~aL~~lH~~~--iiHrDlkp~NIll~~~~~~kl~DFG~a~~ 213 (464)
T 3ttj_A 140 QDVYLVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLART 213 (464)
T ss_dssp CEEEEEEECCSE-EHHHHHTS---CCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTSCEEECCCCCC--
T ss_pred CeEEEEEeCCCC-CHHHHHhh---cCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCChHhEEEeCCCCEEEEEEEeeee
Confidence 457999999966 57777743 5899999999999999999999999 99999999999999999999999999987
Q ss_pred ccCCccccccCCCCccccCC
Q 005841 655 KHETYLTTKTGKGTVTYLAS 674 (674)
Q Consensus 655 ~~~~~~~~~~~~GTp~YmAP 674 (674)
..... .....+||+.|+||
T Consensus 214 ~~~~~-~~~~~~gt~~y~aP 232 (464)
T 3ttj_A 214 AGTSF-MMTPYVVTRYYRAP 232 (464)
T ss_dssp ---CC-CC----CCCTTCCH
T ss_pred cCCCc-ccCCCcccccccCH
Confidence 65533 23346899999998
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.4e-27 Score=267.44 Aligned_cols=168 Identities=29% Similarity=0.480 Sum_probs=145.0
Q ss_pred ccCCeeEeeeecccCceEEEEEEE--cCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeEEEE
Q 005841 503 LWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIV 580 (674)
Q Consensus 503 ~~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 580 (674)
..++|++.++||+|+||+||+|.+ ++..||||++.+..........+.+|+.+++.++||||+++++++.....+|+|
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 99 (486)
T 3mwu_A 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV 99 (486)
T ss_dssp HHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEE
Confidence 346899999999999999999998 477899999976543333346788999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEc---CCCcEEEEecCCcccccC
Q 005841 581 TEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVD---KHWTVKVGDFGLSRLKHE 657 (674)
Q Consensus 581 ~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~---~~~~vkL~DFGla~~~~~ 657 (674)
||||.+++|.+++... ..+++..+..++.||+.||.|||+++ ||||||||+||||+ .++.+||+|||+++....
T Consensus 100 ~e~~~~~~L~~~~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~ 176 (486)
T 3mwu_A 100 GELYTGGELFDEIIKR-KRFSEHDAARIIKQVFSGITYMHKHN--IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ 176 (486)
T ss_dssp ECCCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCC
T ss_pred EEcCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCchHHEEEecCCCCCCEEEEECCcCeECCC
Confidence 9999999999998764 47999999999999999999999999 99999999999995 456899999999987654
Q ss_pred CccccccCCCCccccCC
Q 005841 658 TYLTTKTGKGTVTYLAS 674 (674)
Q Consensus 658 ~~~~~~~~~GTp~YmAP 674 (674)
.. .....+||+.||||
T Consensus 177 ~~-~~~~~~gt~~y~aP 192 (486)
T 3mwu_A 177 NT-KMKDRIGTAYYIAP 192 (486)
T ss_dssp C-----CCTTGGGGCCG
T ss_pred CC-ccCCCcCCCCCCCH
Confidence 32 23346799999998
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=5.1e-27 Score=248.49 Aligned_cols=169 Identities=30% Similarity=0.490 Sum_probs=146.8
Q ss_pred cccCCeeEeeeecccCceEEEEEEE------cCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEe--c
Q 005841 502 ILWEDLTIGEQIGQGSCGTVYHAVW------YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVT--S 573 (674)
Q Consensus 502 ~~~~~y~~~~~LG~G~fG~Vy~~~~------~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~--~ 573 (674)
+..++|++.+.||+|+||.||+|.+ .+..||||++... .....+.+.+|+.+++.++||||+++++++. .
T Consensus 20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 97 (327)
T 3lxl_A 20 FEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHS--GPDQQRDFQREIQILKALHSDFIVKYRGVSYGPG 97 (327)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred hchhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccC--CHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCC
Confidence 4557899999999999999999985 4566999998754 3455677999999999999999999999886 4
Q ss_pred CCeEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcc
Q 005841 574 PQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSR 653 (674)
Q Consensus 574 ~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~ 653 (674)
...+||||||+++++|.+++......+++..++.++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++
T Consensus 98 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dikp~NIl~~~~~~~kl~Dfg~~~ 175 (327)
T 3lxl_A 98 RQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRR--CVHRDLAARNILVESEAHVKIADFGLAK 175 (327)
T ss_dssp SCEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEEETTEEEECCGGGCE
T ss_pred CceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCChhhEEECCCCCEEEcccccce
Confidence 56699999999999999999876667999999999999999999999999 9999999999999999999999999998
Q ss_pred cccCCcc---ccccCCCCccccCC
Q 005841 654 LKHETYL---TTKTGKGTVTYLAS 674 (674)
Q Consensus 654 ~~~~~~~---~~~~~~GTp~YmAP 674 (674)
....... ......||+.|+||
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~y~aP 199 (327)
T 3lxl_A 176 LLPLDKDYYVVREPGQSPIFWYAP 199 (327)
T ss_dssp ECCTTCSEEECSSCCCSCGGGSCH
T ss_pred ecccCCccceeeccCCccccccCH
Confidence 7643321 22335689999998
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=8.8e-28 Score=253.72 Aligned_cols=170 Identities=30% Similarity=0.532 Sum_probs=147.0
Q ss_pred ccccCCeeEeeeecccCceEEEEEEEc-CCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeEEE
Q 005841 501 EILWEDLTIGEQIGQGSCGTVYHAVWY-GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCI 579 (674)
Q Consensus 501 ~~~~~~y~~~~~LG~G~fG~Vy~~~~~-~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 579 (674)
+...++|.+.+.||+|+||.||+|.+. +..||||++..... ...+.+.+|+.+++.++||||+++++++...+.+|+
T Consensus 35 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 112 (321)
T 2qkw_B 35 EEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESS--QGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMIL 112 (321)
T ss_dssp CCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCS--SHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEE
T ss_pred HHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccCh--HHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEE
Confidence 445678999999999999999999974 77899998876532 335678899999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCccccc
Q 005841 580 VTEFLPRGSLFRLLQRNT---TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKH 656 (674)
Q Consensus 580 V~E~~~ggsL~~~l~~~~---~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~ 656 (674)
||||+++++|.+++.... ..+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 113 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 190 (321)
T 2qkw_B 113 IYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA--IIHRDVKSINILLDENFVPKITDFGISKKGT 190 (321)
T ss_dssp EEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCSTTEEECTTCCEEECCCTTCEECS
T ss_pred EEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCC--eecCCCCHHHEEECCCCCEEEeecccccccc
Confidence 999999999999986533 35899999999999999999999999 9999999999999999999999999998654
Q ss_pred CCc--cccccCCCCccccCC
Q 005841 657 ETY--LTTKTGKGTVTYLAS 674 (674)
Q Consensus 657 ~~~--~~~~~~~GTp~YmAP 674 (674)
... .......||+.|+||
T Consensus 191 ~~~~~~~~~~~~gt~~y~aP 210 (321)
T 2qkw_B 191 ELDQTHLSTVVKGTLGYIDP 210 (321)
T ss_dssp SSSCCCCBCCCEEETTTCCH
T ss_pred cccccccccccCCCccccCH
Confidence 321 122334699999998
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=99.95 E-value=2.5e-27 Score=243.29 Aligned_cols=170 Identities=39% Similarity=0.636 Sum_probs=136.0
Q ss_pred ccccCCeeEeeeecccCceEEEEEEEcCCeEEEEEeecccCC--HHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeEE
Q 005841 501 EILWEDLTIGEQIGQGSCGTVYHAVWYGSDVAVKVFSRQEYS--DEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLC 578 (674)
Q Consensus 501 ~~~~~~y~~~~~LG~G~fG~Vy~~~~~~~~vAvK~i~~~~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 578 (674)
++..++|++.+.||+|+||.||+|.+.+..||||++...... ....+.+.+|+.+++.++||||+++++++...+.+|
T Consensus 3 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (271)
T 3dtc_A 3 EIDFAELTLEEIIGIGGFGKVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLC 82 (271)
T ss_dssp BCCTTSEEEEEEEEEETTEEEEEEEETTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CE
T ss_pred ccchhheeeeeeeccCCCeEEEEEEEcCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceE
Confidence 456789999999999999999999999999999998764332 234567889999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCC-CeEEccCCCCCEEEcC--------CCcEEEEec
Q 005841 579 IVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNP-PIIHRDLKSSNLLVDK--------HWTVKVGDF 649 (674)
Q Consensus 579 lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~-~IvHrDLKp~NILi~~--------~~~vkL~DF 649 (674)
+||||+++++|.+++. ...+++..++.++.||+.||.|||+.+. +|+||||||+|||++. ++.+||+||
T Consensus 83 lv~e~~~~~~L~~~~~--~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Df 160 (271)
T 3dtc_A 83 LVMEFARGGPLNRVLS--GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDF 160 (271)
T ss_dssp EEEECCTTEEHHHHHT--SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCC
T ss_pred EEEEcCCCCCHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccC
Confidence 9999999999999985 3579999999999999999999999873 3889999999999986 778999999
Q ss_pred CCcccccCCccccccCCCCccccCC
Q 005841 650 GLSRLKHETYLTTKTGKGTVTYLAS 674 (674)
Q Consensus 650 Gla~~~~~~~~~~~~~~GTp~YmAP 674 (674)
|+++........ ...||+.|+||
T Consensus 161 g~~~~~~~~~~~--~~~~~~~y~aP 183 (271)
T 3dtc_A 161 GLAREWHRTTKM--SAAGAYAWMAP 183 (271)
T ss_dssp CC---------------CCGGGSCH
T ss_pred Cccccccccccc--CCCCccceeCH
Confidence 999876543322 35799999998
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=99.95 E-value=2.2e-27 Score=245.93 Aligned_cols=171 Identities=25% Similarity=0.319 Sum_probs=135.1
Q ss_pred cccccCCeeEeeeecccCceEEEEEEE--cCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeE
Q 005841 500 YEILWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRL 577 (674)
Q Consensus 500 ~~~~~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 577 (674)
+++..++|++.+.||+|+||.||+|.+ ++..||||++............+..+...++.+.||||+++++++...+..
T Consensus 2 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~ 81 (290)
T 3fme_A 2 MEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDV 81 (290)
T ss_dssp CCCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSE
T ss_pred CcccHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCE
Confidence 356778999999999999999999998 577899999976544444445555666668889999999999999999999
Q ss_pred EEEEecCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCeEEccCCCCCEEEcCCCcEEEEecCCcc
Q 005841 578 CIVTEFLPRGSLFRLLQR---NTTKLDWRRRILMALDIARGVSYLHHC-NPPIIHRDLKSSNLLVDKHWTVKVGDFGLSR 653 (674)
Q Consensus 578 ~lV~E~~~ggsL~~~l~~---~~~~l~~~~~~~i~~qi~~~L~yLH~~-~~~IvHrDLKp~NILi~~~~~vkL~DFGla~ 653 (674)
|+||||+++ +|.+++.. ....+++..++.++.||+.||.|||+. + |+||||||+|||++.++.+||+|||+++
T Consensus 82 ~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~--i~H~dlkp~Nil~~~~~~~kl~Dfg~~~ 158 (290)
T 3fme_A 82 WICMELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS--VIHRDVKPSNVLINALGQVKMCDFGISG 158 (290)
T ss_dssp EEEEECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSC--CCCCCCSGGGCEECTTCCEEBCCC----
T ss_pred EEEEehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCC--eecCCCCHHHEEECCCCCEEEeecCCcc
Confidence 999999975 88877754 456799999999999999999999997 8 9999999999999999999999999998
Q ss_pred cccCCccccccCCCCccccCC
Q 005841 654 LKHETYLTTKTGKGTVTYLAS 674 (674)
Q Consensus 654 ~~~~~~~~~~~~~GTp~YmAP 674 (674)
....... .....||+.|+||
T Consensus 159 ~~~~~~~-~~~~~~t~~y~aP 178 (290)
T 3fme_A 159 YLVDDVA-KDIDAGCKPYMAP 178 (290)
T ss_dssp ------------CCCCCCSCH
T ss_pred ccccccc-ccccCCCccccCh
Confidence 7655432 2334799999998
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=7.6e-27 Score=240.71 Aligned_cols=165 Identities=28% Similarity=0.405 Sum_probs=145.2
Q ss_pred cCCeeEeeeecccCceEEEEEEEc--CCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeEEEEE
Q 005841 504 WEDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVT 581 (674)
Q Consensus 504 ~~~y~~~~~LG~G~fG~Vy~~~~~--~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 581 (674)
.++|++.+.||+|+||.||+|.+. +..||+|++.+..... .+.+.+|+.+++.++||||+++++++.....+|+||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~--~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 85 (277)
T 3f3z_A 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVED--VDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVM 85 (277)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSC--HHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccch--HHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEE
Confidence 467999999999999999999984 4579999997654332 456889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEE---cCCCcEEEEecCCcccccCC
Q 005841 582 EFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLV---DKHWTVKVGDFGLSRLKHET 658 (674)
Q Consensus 582 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi---~~~~~vkL~DFGla~~~~~~ 658 (674)
||+++++|.+++... ..+++..+..++.||+.||.|||+++ |+||||||+|||+ +.++.+||+|||++......
T Consensus 86 e~~~~~~L~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~ 162 (277)
T 3f3z_A 86 ELCTGGELFERVVHK-RVFRESDAARIMKDVLSAVAYCHKLN--VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPG 162 (277)
T ss_dssp ECCCSCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTT
T ss_pred eccCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--ccCCCCCHHHEEEecCCCCCcEEEEecccceeccCc
Confidence 999999999998764 46999999999999999999999999 9999999999999 78899999999999876543
Q ss_pred ccccccCCCCccccCC
Q 005841 659 YLTTKTGKGTVTYLAS 674 (674)
Q Consensus 659 ~~~~~~~~GTp~YmAP 674 (674)
. ......||+.|+||
T Consensus 163 ~-~~~~~~~t~~y~aP 177 (277)
T 3f3z_A 163 K-MMRTKVGTPYYVSP 177 (277)
T ss_dssp S-CBCCCCSCTTTCCH
T ss_pred c-chhccCCCCCccCh
Confidence 3 23346799999998
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=8e-27 Score=245.02 Aligned_cols=168 Identities=27% Similarity=0.433 Sum_probs=143.7
Q ss_pred ccccCCeeEeeeecccCceEEEEEEEc--CCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeEE
Q 005841 501 EILWEDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLC 578 (674)
Q Consensus 501 ~~~~~~y~~~~~LG~G~fG~Vy~~~~~--~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 578 (674)
....++|++.+.||+|+||.||+|.+. +..||||++..... ...+.+|+.+++.++||||+++++++.....+|
T Consensus 25 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 100 (314)
T 3com_A 25 KQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESD----LQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLW 100 (314)
T ss_dssp -----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTSC----CHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred hcchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchHH----HHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEE
Confidence 345678999999999999999999984 77899999976542 245778999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccccCC
Q 005841 579 IVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHET 658 (674)
Q Consensus 579 lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~~ 658 (674)
+||||+++++|.+++......+++..+..++.||+.||.|||+.+ |+|+||||+|||++.++.+||+|||++......
T Consensus 101 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~ 178 (314)
T 3com_A 101 IVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMR--KIHRDIKAGNILLNTEGHAKLADFGVAGQLTDT 178 (314)
T ss_dssp EEEECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTCCEEECCCTTCEECBTT
T ss_pred EEeecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--CcCCCcCHHHEEECCCCCEEEeecccchhhhhh
Confidence 999999999999999866778999999999999999999999999 999999999999999999999999999877655
Q ss_pred ccccccCCCCccccCC
Q 005841 659 YLTTKTGKGTVTYLAS 674 (674)
Q Consensus 659 ~~~~~~~~GTp~YmAP 674 (674)
........||+.|+||
T Consensus 179 ~~~~~~~~~~~~y~aP 194 (314)
T 3com_A 179 MAKRNTVIGTPFWMAP 194 (314)
T ss_dssp BSCBCCCCSCGGGCCH
T ss_pred ccccCccCCCCCccCh
Confidence 4444556799999998
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=7.8e-27 Score=242.82 Aligned_cols=167 Identities=22% Similarity=0.319 Sum_probs=145.7
Q ss_pred ccccCCeeEeeeecccCceEEEEEEE--cCCeEEEEEeecccCCHHHHHHHHHHHHHHhhC-CCCCeeeEEEEEecCCeE
Q 005841 501 EILWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRL-RHPNVLLFMGAVTSPQRL 577 (674)
Q Consensus 501 ~~~~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~ 577 (674)
.+..++|++.+.||+|+||.||+|.+ .+..||||++...... ..+.+|+.+++.+ .|+||+.+++++......
T Consensus 6 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~ 81 (298)
T 1csn_A 6 NVVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA----PQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHN 81 (298)
T ss_dssp CEETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS----CCHHHHHHHHHHTTTCTTCCCEEEEEEETTEE
T ss_pred cccccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCcc----HHHHHHHHHHHHHhcCCCCCeEEeecCCCcee
Confidence 45678899999999999999999996 5778999998754432 3467799999999 799999999999999999
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCc-----EEEEecCCc
Q 005841 578 CIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWT-----VKVGDFGLS 652 (674)
Q Consensus 578 ~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~-----vkL~DFGla 652 (674)
|+||||+ +++|.+++......+++..++.++.||+.||.|||+++ |+||||||+||||+.++. +||+|||++
T Consensus 82 ~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~ 158 (298)
T 1csn_A 82 VLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS--LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMV 158 (298)
T ss_dssp EEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEECCSSSTTTTCEEECCCTTC
T ss_pred EEEEEec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEeccCCCCCCCeEEEEECccc
Confidence 9999999 99999999877777999999999999999999999999 999999999999987765 999999999
Q ss_pred ccccCCcc-------ccccCCCCccccCC
Q 005841 653 RLKHETYL-------TTKTGKGTVTYLAS 674 (674)
Q Consensus 653 ~~~~~~~~-------~~~~~~GTp~YmAP 674 (674)
+....... ......||+.|+||
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aP 187 (298)
T 1csn_A 159 KFYRDPVTKQHIPYREKKNLSGTARYMSI 187 (298)
T ss_dssp EESBCTTTCCBCCCCCCCCCCSCTTTCCH
T ss_pred cccccccccccccccCccCCCCCcccCCc
Confidence 87654322 23346799999998
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=99.95 E-value=3.2e-27 Score=262.35 Aligned_cols=170 Identities=31% Similarity=0.552 Sum_probs=147.4
Q ss_pred ccccccCCeeEeeeecccCceEEEEEEEc-CCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeE
Q 005841 499 DYEILWEDLTIGEQIGQGSCGTVYHAVWY-GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRL 577 (674)
Q Consensus 499 ~~~~~~~~y~~~~~LG~G~fG~Vy~~~~~-~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 577 (674)
.+++..++|++.+.||+|+||.||+|.+. +..||||++...... .+.+.+|+.+|+.++||||+++++++. ...+
T Consensus 182 ~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~ 257 (454)
T 1qcf_A 182 AWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMS---VEAFLAEANVMKTLQHDKLVKLHAVVT-KEPI 257 (454)
T ss_dssp CSBCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTSBC---HHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSC
T ss_pred ceeechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCCcc---HHHHHHHHHHHhhCCCCCEeeEEEEEe-CCcc
Confidence 45788899999999999999999999985 567999999765433 457889999999999999999999986 6679
Q ss_pred EEEEecCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCccccc
Q 005841 578 CIVTEFLPRGSLFRLLQRNT-TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKH 656 (674)
Q Consensus 578 ~lV~E~~~ggsL~~~l~~~~-~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~ 656 (674)
|||||||++|+|.+++.... ..+++..++.++.||+.||.|||+++ ||||||||+||||+.++.+||+|||+++...
T Consensus 258 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~ 335 (454)
T 1qcf_A 258 YIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN--YIHRDLRAANILVSASLVCKIADFGLARVIE 335 (454)
T ss_dssp EEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSSCSGGGEEECTTCCEEECSTTGGGGBC
T ss_pred EEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCCHHHEEECCCCcEEEeeCCCceEcC
Confidence 99999999999999997532 36889999999999999999999999 9999999999999999999999999998765
Q ss_pred CCccc-cccCCCCccccCC
Q 005841 657 ETYLT-TKTGKGTVTYLAS 674 (674)
Q Consensus 657 ~~~~~-~~~~~GTp~YmAP 674 (674)
..... .....+|+.||||
T Consensus 336 ~~~~~~~~~~~~~~~y~aP 354 (454)
T 1qcf_A 336 DNEYTAREGAKFPIKWTAP 354 (454)
T ss_dssp CHHHHTTCSSSSCGGGSCH
T ss_pred CCceeccCCCcccccccCH
Confidence 43322 2234578899998
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=99.95 E-value=2.4e-27 Score=245.74 Aligned_cols=172 Identities=33% Similarity=0.547 Sum_probs=150.4
Q ss_pred cccccccCCeeEeeeecccCceEEEEEEEc--CCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCC
Q 005841 498 LDYEILWEDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQ 575 (674)
Q Consensus 498 ~~~~~~~~~y~~~~~LG~G~fG~Vy~~~~~--~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~ 575 (674)
..+++...+|++.+.||+|+||.||+|.+. +..||||++.... ...+.+.+|+.+++.++||||+++++++....
T Consensus 6 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 82 (288)
T 3kfa_A 6 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT---MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREP 82 (288)
T ss_dssp CTTBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS---THHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred hcccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH---HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCC
Confidence 356778899999999999999999999985 6679999996543 23467889999999999999999999999999
Q ss_pred eEEEEEecCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCccc
Q 005841 576 RLCIVTEFLPRGSLFRLLQRN-TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL 654 (674)
Q Consensus 576 ~~~lV~E~~~ggsL~~~l~~~-~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~ 654 (674)
.+|+||||+++++|.+++... ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++..
T Consensus 83 ~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--i~H~dikp~Nil~~~~~~~~l~Dfg~~~~ 160 (288)
T 3kfa_A 83 PFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN--FIHRDLAARNCLVGENHLVKVADFGLSRL 160 (288)
T ss_dssp SEEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHT--CCCSCCSGGGEEECGGGCEEECCCCGGGT
T ss_pred CEEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCC--ccCCCCCcceEEEcCCCCEEEccCcccee
Confidence 999999999999999999764 345999999999999999999999999 99999999999999999999999999987
Q ss_pred ccCCccc-cccCCCCccccCC
Q 005841 655 KHETYLT-TKTGKGTVTYLAS 674 (674)
Q Consensus 655 ~~~~~~~-~~~~~GTp~YmAP 674 (674)
....... .....||+.|+||
T Consensus 161 ~~~~~~~~~~~~~~~~~y~aP 181 (288)
T 3kfa_A 161 MTGDTYTAHAGAKFPIKWTAP 181 (288)
T ss_dssp SCSSSSEEETTEEECGGGCCH
T ss_pred ccCCccccccCCccccCcCCh
Confidence 6544332 2234578999998
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.94 E-value=4.8e-27 Score=248.79 Aligned_cols=165 Identities=33% Similarity=0.504 Sum_probs=138.2
Q ss_pred ccccCCeeEeeeecccCceEEEEEEEcCCeEEEEEeecccCCHHHHHHHHHHHHHHhhC--CCCCeeeEEEEEecC----
Q 005841 501 EILWEDLTIGEQIGQGSCGTVYHAVWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRL--RHPNVLLFMGAVTSP---- 574 (674)
Q Consensus 501 ~~~~~~y~~~~~LG~G~fG~Vy~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l--~HpnIv~l~~~~~~~---- 574 (674)
....++|++.++||+|+||.||+|.+++..||||++.... ...+.+|..++..+ +||||+++++++...
T Consensus 33 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~-----~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~ 107 (337)
T 3mdy_A 33 RTIAKQIQMVKQIGKGRYGEVWMGKWRGEKVAVKVFFTTE-----EASWFRETEIYQTVLMRHENILGFIAADIKGTGSW 107 (337)
T ss_dssp TTHHHHCEEEEEEEEETTEEEEEEEETTEEEEEEEEEGGG-----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGG
T ss_pred cccccceEEEeEeecCCCeEEEEEEECCceEEEEEEeccc-----cchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCC
Confidence 4455789999999999999999999999999999986432 12344455555554 899999999999887
Q ss_pred CeEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC--------CCCeEEccCCCCCEEEcCCCcEEE
Q 005841 575 QRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHC--------NPPIIHRDLKSSNLLVDKHWTVKV 646 (674)
Q Consensus 575 ~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~--------~~~IvHrDLKp~NILi~~~~~vkL 646 (674)
..+||||||+++++|.+++... .+++..++.++.|++.||.|||+. + ||||||||+||||+.++.+||
T Consensus 108 ~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~--ivH~Dikp~Nill~~~~~~kl 183 (337)
T 3mdy_A 108 TQLYLITDYHENGSLYDYLKST--TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPA--IAHRDLKSKNILVKKNGTCCI 183 (337)
T ss_dssp CEEEEEECCCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCC--EECSCCCGGGEEECTTSCEEE
T ss_pred CceEEEEeccCCCcHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCC--EEecccchHHEEECCCCCEEE
Confidence 7899999999999999999653 699999999999999999999988 7 999999999999999999999
Q ss_pred EecCCcccccCCccc----cccCCCCccccCC
Q 005841 647 GDFGLSRLKHETYLT----TKTGKGTVTYLAS 674 (674)
Q Consensus 647 ~DFGla~~~~~~~~~----~~~~~GTp~YmAP 674 (674)
+|||+++........ .....||+.||||
T Consensus 184 ~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aP 215 (337)
T 3mdy_A 184 ADLGLAVKFISDTNEVDIPPNTRVGTKRYMPP 215 (337)
T ss_dssp CCCTTCEECC---------CCSSCSCGGGCCH
T ss_pred EeCCCceeeccccccccCCCCCCccCcceeCh
Confidence 999999766433222 2245799999998
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=2.4e-27 Score=258.46 Aligned_cols=169 Identities=24% Similarity=0.388 Sum_probs=145.1
Q ss_pred cccCCeeEeeeecccCceEEEEEEEc--CCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCC--eE
Q 005841 502 ILWEDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQ--RL 577 (674)
Q Consensus 502 ~~~~~y~~~~~LG~G~fG~Vy~~~~~--~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~--~~ 577 (674)
...++|.+.++||+|+||+||+|.+. +..||||++...... .....+.+|+.+++.++||||+++++++.... .+
T Consensus 6 ~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~ 84 (396)
T 4eut_A 6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFL-RPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHK 84 (396)
T ss_dssp CSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGG-SCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCE
T ss_pred CCCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEecccccc-chHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCee
Confidence 44578999999999999999999984 778999999764432 22456778999999999999999999998765 78
Q ss_pred EEEEecCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEE----cCCCcEEEEecCC
Q 005841 578 CIVTEFLPRGSLFRLLQRNT--TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLV----DKHWTVKVGDFGL 651 (674)
Q Consensus 578 ~lV~E~~~ggsL~~~l~~~~--~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi----~~~~~vkL~DFGl 651 (674)
|||||||++++|.+++.... ..+++..++.++.||+.||.|||+++ |+||||||+|||| +.++.+||+|||+
T Consensus 85 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~ 162 (396)
T 4eut_A 85 VLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG--IVHRNIKPGNIMRVIGEDGQSVYKLTDFGA 162 (396)
T ss_dssp EEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEEECTTSCEEEEECCGGG
T ss_pred EEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCC--EEECCcCHHHEEEeecCCCceeEEEecCCC
Confidence 99999999999999997543 23999999999999999999999999 9999999999999 7788899999999
Q ss_pred cccccCCccccccCCCCccccCC
Q 005841 652 SRLKHETYLTTKTGKGTVTYLAS 674 (674)
Q Consensus 652 a~~~~~~~~~~~~~~GTp~YmAP 674 (674)
++....... ....+||+.|+||
T Consensus 163 a~~~~~~~~-~~~~~gt~~y~aP 184 (396)
T 4eut_A 163 ARELEDDEQ-FVSLYGTEEYLHP 184 (396)
T ss_dssp CEECCCGGG-SSCSSSCCTTCCH
T ss_pred ceEccCCCc-cccccCCccccCH
Confidence 987655432 2346799999998
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.94 E-value=3e-27 Score=245.57 Aligned_cols=167 Identities=22% Similarity=0.377 Sum_probs=140.7
Q ss_pred cCCeeEeeeecccCceEEEEEEE--cCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeEEEEE
Q 005841 504 WEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVT 581 (674)
Q Consensus 504 ~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 581 (674)
.++|.+.+.||+|+||.||+|.+ .+..||+|++...... ...+.+.+|+.+++.++||||+++++++.....+|+||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 99 (285)
T 3is5_A 21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQ-VPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVM 99 (285)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCC-SCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccc-hhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEE
Confidence 36799999999999999999998 4678999999765432 22467889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEE---cCCCcEEEEecCCcccc
Q 005841 582 EFLPRGSLFRLLQRN---TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLV---DKHWTVKVGDFGLSRLK 655 (674)
Q Consensus 582 E~~~ggsL~~~l~~~---~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi---~~~~~vkL~DFGla~~~ 655 (674)
||+++++|.+++... ...+++..++.++.||+.||.|||+.+ |+||||||+|||+ +.++.+||+|||+++..
T Consensus 100 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~ 177 (285)
T 3is5_A 100 ETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH--VVHKDLKPENILFQDTSPHSPIKIIDFGLAELF 177 (285)
T ss_dssp CCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-
T ss_pred EeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC--EEECCCCHHHEEEecCCCCCCEEEEeeecceec
Confidence 999999999988542 467999999999999999999999999 9999999999999 45688999999999876
Q ss_pred cCCccccccCCCCccccCC
Q 005841 656 HETYLTTKTGKGTVTYLAS 674 (674)
Q Consensus 656 ~~~~~~~~~~~GTp~YmAP 674 (674)
..... .....||+.|+||
T Consensus 178 ~~~~~-~~~~~~t~~y~aP 195 (285)
T 3is5_A 178 KSDEH-STNAAGTALYMAP 195 (285)
T ss_dssp ----------CTTGGGCCH
T ss_pred CCccc-CcCcccccCcCCh
Confidence 54322 3345799999998
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=9.8e-28 Score=253.55 Aligned_cols=173 Identities=31% Similarity=0.534 Sum_probs=147.1
Q ss_pred ccccccCCeeEeeeecccCceEEEEEEE-cCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeE
Q 005841 499 DYEILWEDLTIGEQIGQGSCGTVYHAVW-YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRL 577 (674)
Q Consensus 499 ~~~~~~~~y~~~~~LG~G~fG~Vy~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 577 (674)
......++|.+.+.||+|+||.||+|.+ .+..||||++....... ....+.+|+.+++.++||||+++++++......
T Consensus 24 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 102 (326)
T 3uim_A 24 ELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQG-GELQFQTEVEMISMAVHRNLLRLRGFCMTPTER 102 (326)
T ss_dssp HHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC------CCCHHHHHHHGGGTCCCTTBCCCCEEECCSSCC
T ss_pred HHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCch-HHHHHHHHHHHHHhccCCCccceEEEEecCCce
Confidence 3466778999999999999999999987 47789999987643221 123578899999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhC---CCCeEEccCCCCCEEEcCCCcEEEEecCC
Q 005841 578 CIVTEFLPRGSLFRLLQRNT---TKLDWRRRILMALDIARGVSYLHHC---NPPIIHRDLKSSNLLVDKHWTVKVGDFGL 651 (674)
Q Consensus 578 ~lV~E~~~ggsL~~~l~~~~---~~l~~~~~~~i~~qi~~~L~yLH~~---~~~IvHrDLKp~NILi~~~~~vkL~DFGl 651 (674)
|+||||+++++|.+++.... ..+++..+..++.||+.||.|||+. + |+||||||+|||++.++.+||+|||+
T Consensus 103 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~--ivH~Dlkp~Nil~~~~~~~kl~Dfg~ 180 (326)
T 3uim_A 103 LLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPK--IIHRDVKAANILLDEEFEAVVGDFGL 180 (326)
T ss_dssp EEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSC--EECCCCSGGGEEECTTCCEEECCCSS
T ss_pred EEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC--eEeCCCchhhEEECCCCCEEeccCcc
Confidence 99999999999999997643 3499999999999999999999998 8 99999999999999999999999999
Q ss_pred cccccCCc-cccccCCCCccccCC
Q 005841 652 SRLKHETY-LTTKTGKGTVTYLAS 674 (674)
Q Consensus 652 a~~~~~~~-~~~~~~~GTp~YmAP 674 (674)
++...... .......||+.|+||
T Consensus 181 ~~~~~~~~~~~~~~~~gt~~y~aP 204 (326)
T 3uim_A 181 AKLMDYKDTHVTTAVRGTIGHIAP 204 (326)
T ss_dssp CEECCSSSSCEECCCCSCGGGCCH
T ss_pred ccccCcccccccccccCCcCccCH
Confidence 98765332 223345699999998
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=99.94 E-value=4.6e-27 Score=248.40 Aligned_cols=168 Identities=25% Similarity=0.376 Sum_probs=147.1
Q ss_pred ccCCeeEeeeecccCceEEEEEEE--cCCeEEEEEeecccCCH----HHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCe
Q 005841 503 LWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSD----EVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQR 576 (674)
Q Consensus 503 ~~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~~~----~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 576 (674)
..++|++.+.||+|+||.||+|.+ ++..||||++....... ...+.+.+|+.+++.++||||+++++++.....
T Consensus 10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 89 (321)
T 2a2a_A 10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTD 89 (321)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred hhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCE
Confidence 456799999999999999999998 47789999997654322 124678899999999999999999999999999
Q ss_pred EEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCC----cEEEEecCCc
Q 005841 577 LCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHW----TVKVGDFGLS 652 (674)
Q Consensus 577 ~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~----~vkL~DFGla 652 (674)
+|+||||+++++|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++ .+||+|||++
T Consensus 90 ~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~lH~~~--ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~ 166 (321)
T 2a2a_A 90 VVLILELVSGGELFDFLAQ-KESLSEEEATSFIKQILDGVNYLHTKK--IAHFDLKPENIMLLDKNIPIPHIKLIDFGLA 166 (321)
T ss_dssp EEEEECCCCSCBHHHHHHT-CSCEEHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESCTTSSSCCEEECCCTTC
T ss_pred EEEEEEcCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCChHHEEEecCCCCcCCEEEccCccc
Confidence 9999999999999999975 457899999999999999999999999 99999999999999887 8999999999
Q ss_pred ccccCCccccccCCCCccccCC
Q 005841 653 RLKHETYLTTKTGKGTVTYLAS 674 (674)
Q Consensus 653 ~~~~~~~~~~~~~~GTp~YmAP 674 (674)
+...... ......||+.|+||
T Consensus 167 ~~~~~~~-~~~~~~gt~~y~aP 187 (321)
T 2a2a_A 167 HEIEDGV-EFKNIFGTPEFVAP 187 (321)
T ss_dssp EECCTTC-CCCCCCSCGGGCCH
T ss_pred eecCccc-cccccCCCCCccCc
Confidence 8765432 22345799999998
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=9.9e-27 Score=245.63 Aligned_cols=165 Identities=30% Similarity=0.515 Sum_probs=142.1
Q ss_pred CCeeEeeeecccCceEEEEEEE------cCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecC--Ce
Q 005841 505 EDLTIGEQIGQGSCGTVYHAVW------YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSP--QR 576 (674)
Q Consensus 505 ~~y~~~~~LG~G~fG~Vy~~~~------~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~--~~ 576 (674)
+.|++.+.||+|+||+||++.+ ++..||||++... ........+.+|+.+++.++||||+++++++... ..
T Consensus 31 r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 109 (318)
T 3lxp_A 31 RYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKAD-AGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAAS 109 (318)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTT-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTE
T ss_pred HHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccc-cChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCce
Confidence 3459999999999999999875 4567999999765 3455667899999999999999999999999874 67
Q ss_pred EEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCccccc
Q 005841 577 LCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKH 656 (674)
Q Consensus 577 ~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~ 656 (674)
+||||||+++++|.+++... .+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 110 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~i~~~l~~~l~~LH~~~--ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~ 185 (318)
T 3lxp_A 110 LQLVMEYVPLGSLRDYLPRH--SIGLAQLLLFAQQICEGMAYLHAQH--YIHRDLAARNVLLDNDRLVKIGDFGLAKAVP 185 (318)
T ss_dssp EEEEECCCTTCBHHHHGGGS--CCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTCCEEECCGGGCEECC
T ss_pred EEEEEecccCCcHHHHHhhC--CCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCchheEEEcCCCCEEECCcccccccc
Confidence 89999999999999999754 4999999999999999999999999 9999999999999999999999999998765
Q ss_pred CCcc---ccccCCCCccccCC
Q 005841 657 ETYL---TTKTGKGTVTYLAS 674 (674)
Q Consensus 657 ~~~~---~~~~~~GTp~YmAP 674 (674)
.... ......||+.|+||
T Consensus 186 ~~~~~~~~~~~~~~~~~y~aP 206 (318)
T 3lxp_A 186 EGHEYYRVREDGDSPVFWYAP 206 (318)
T ss_dssp TTCSEEEC---CCCCGGGCCH
T ss_pred ccccccccccCCCCCceeeCh
Confidence 4321 23335689999998
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=7.8e-27 Score=244.04 Aligned_cols=166 Identities=31% Similarity=0.479 Sum_probs=148.6
Q ss_pred cCCeeEeeeecccCceEEEEEEE--cCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeEEEEE
Q 005841 504 WEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVT 581 (674)
Q Consensus 504 ~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 581 (674)
.+.|++.+.||+|+||.||+|.+ .+..||||++...... ...+.+.+|+.+++.+.||||+++++++.....+|+||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 99 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAE-DEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIM 99 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCS-TTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccH-HHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEE
Confidence 36799999999999999999987 4678999999765433 33567889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccccCCccc
Q 005841 582 EFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLT 661 (674)
Q Consensus 582 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~~~~~ 661 (674)
||+++++|.+++.. ..+++..+..++.||+.||.|||+.+ |+|+||||+|||++.++.+||+|||++.........
T Consensus 100 e~~~~~~L~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 175 (303)
T 3a7i_A 100 EYLGGGSALDLLEP--GPLDETQIATILREILKGLDYLHSEK--KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIK 175 (303)
T ss_dssp ECCTTEEHHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCTTCEECBTTBCC
T ss_pred EeCCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC--CccCCCChheEEECCCCCEEEeecccceecCccccc
Confidence 99999999999964 46999999999999999999999999 999999999999999999999999999877665555
Q ss_pred cccCCCCccccCC
Q 005841 662 TKTGKGTVTYLAS 674 (674)
Q Consensus 662 ~~~~~GTp~YmAP 674 (674)
.....||+.|+||
T Consensus 176 ~~~~~~~~~y~aP 188 (303)
T 3a7i_A 176 RNTFVGTPFWMAP 188 (303)
T ss_dssp BCCCCSCGGGCCH
T ss_pred cCccCCCcCccCH
Confidence 5567899999998
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.94 E-value=1.1e-26 Score=241.30 Aligned_cols=170 Identities=25% Similarity=0.433 Sum_probs=146.6
Q ss_pred ccccCCeeEee-eecccCceEEEEEEE----cCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCC
Q 005841 501 EILWEDLTIGE-QIGQGSCGTVYHAVW----YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQ 575 (674)
Q Consensus 501 ~~~~~~y~~~~-~LG~G~fG~Vy~~~~----~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~ 575 (674)
.+..++|.+.+ .||+|+||.||+|.+ .+..||||++.... .....+.+.+|+.+++.++||||+++++++ ..+
T Consensus 5 ~~~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~ 82 (287)
T 1u59_A 5 FLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT-EKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAE 82 (287)
T ss_dssp BCCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESS
T ss_pred cccHHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCcc-chhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCC
Confidence 45567888887 999999999999986 35569999997643 455667899999999999999999999999 456
Q ss_pred eEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccc
Q 005841 576 RLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLK 655 (674)
Q Consensus 576 ~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~ 655 (674)
.+|+||||+++++|.+++......+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 83 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~ 160 (287)
T 1u59_A 83 ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN--FVHRDLAARNVLLVNRHYAKISDFGLSKAL 160 (287)
T ss_dssp SEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred CcEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCC--EeeCCCchheEEEcCCCCEEECcccceeee
Confidence 799999999999999999876777999999999999999999999999 999999999999999999999999999876
Q ss_pred cCCcc---ccccCCCCccccCC
Q 005841 656 HETYL---TTKTGKGTVTYLAS 674 (674)
Q Consensus 656 ~~~~~---~~~~~~GTp~YmAP 674 (674)
..... ......||+.|+||
T Consensus 161 ~~~~~~~~~~~~~~~~~~y~aP 182 (287)
T 1u59_A 161 GADDSYYTARSAGKWPLKWYAP 182 (287)
T ss_dssp TTCSCEECCCCSSCCCGGGCCH
T ss_pred ccCcceeeccccccccccccCH
Confidence 43221 12234679999998
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=4.2e-27 Score=249.55 Aligned_cols=165 Identities=32% Similarity=0.493 Sum_probs=135.3
Q ss_pred ccccCCeeEeeeecccCceEEEEEEEcCCeEEEEEeecccCCHHHHHHHH--HHHHHHhhCCCCCeeeEEEEEec-----
Q 005841 501 EILWEDLTIGEQIGQGSCGTVYHAVWYGSDVAVKVFSRQEYSDEVIHSFR--QEVSLMKRLRHPNVLLFMGAVTS----- 573 (674)
Q Consensus 501 ~~~~~~y~~~~~LG~G~fG~Vy~~~~~~~~vAvK~i~~~~~~~~~~~~~~--~Ei~il~~l~HpnIv~l~~~~~~----- 573 (674)
.+..++|++.+.||+|+||.||+|.+++..||||++..... ..+. .|+..+..++||||+++++.+..
T Consensus 9 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~-----~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~ 83 (336)
T 3g2f_A 9 SLDLDNLKLLELIGRGRYGAVYKGSLDERPVAVKVFSFANR-----QNFINEKNIYRVPLMEHDNIARFIVGDERVTADG 83 (336)
T ss_dssp CCCTTSEEEEEEEEECSSEEEEEEEETTEEEEEEEEEGGGH-----HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTS
T ss_pred CcChHHhheeeecccCCCeEEEEEEECCeEEEEEEeeccch-----hhHHHHHHHHHHHhccCcchhhheecccccccCC
Confidence 45668999999999999999999999999999999975431 2233 34444556899999999975532
Q ss_pred CCeEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---------CCCeEEccCCCCCEEEcCCCcE
Q 005841 574 PQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHC---------NPPIIHRDLKSSNLLVDKHWTV 644 (674)
Q Consensus 574 ~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~---------~~~IvHrDLKp~NILi~~~~~v 644 (674)
...+|||||||++++|.+++... .+++..+..++.||+.||.|||+. + ||||||||+||||+.++.+
T Consensus 84 ~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~--ivH~Dikp~Nill~~~~~~ 159 (336)
T 3g2f_A 84 RMEYLLVMEYYPNGSLXKYLSLH--TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPA--ISHRDLNSRNVLVKNDGTC 159 (336)
T ss_dssp CEEEEEEECCCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCC--EECSSCSGGGEEECTTSCE
T ss_pred CceEEEEEecCCCCcHHHHHhhc--ccchhHHHHHHHHHHHHHHHHHhhhccccccccc--eeecccccceEEEcCCCcE
Confidence 23579999999999999999754 458999999999999999999998 7 9999999999999999999
Q ss_pred EEEecCCcccccCCc--------cccccCCCCccccCC
Q 005841 645 KVGDFGLSRLKHETY--------LTTKTGKGTVTYLAS 674 (674)
Q Consensus 645 kL~DFGla~~~~~~~--------~~~~~~~GTp~YmAP 674 (674)
||+|||+++...... ......+||+.|+||
T Consensus 160 kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP 197 (336)
T 3g2f_A 160 VISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAP 197 (336)
T ss_dssp EECCCTTCEECSSSSCC---------CCTTSCGGGCCH
T ss_pred EEeeccceeecccccccCccccccccccCCCccceeCc
Confidence 999999998764321 122245799999998
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=5.4e-27 Score=246.41 Aligned_cols=180 Identities=29% Similarity=0.418 Sum_probs=141.3
Q ss_pred CCCCccccccccCCeeEeeeecccCceEEEEEEEcC-----CeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeE
Q 005841 493 LDNDCLDYEILWEDLTIGEQIGQGSCGTVYHAVWYG-----SDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLF 567 (674)
Q Consensus 493 ~~~~~~~~~~~~~~y~~~~~LG~G~fG~Vy~~~~~~-----~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l 567 (674)
+......+.+..++|.+.+.||+|+||.||+|.+.. ..||||++..........+.+.+|+.+++.++||||+++
T Consensus 22 l~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~ 101 (313)
T 3brb_A 22 LQNKLEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRL 101 (313)
T ss_dssp --CCTTTTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCC
T ss_pred hhhhHHhcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeee
Confidence 444445567778899999999999999999998732 269999998776667777889999999999999999999
Q ss_pred EEEEecCC-----eEEEEEecCCCCCHHHHHHh-----cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEE
Q 005841 568 MGAVTSPQ-----RLCIVTEFLPRGSLFRLLQR-----NTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLL 637 (674)
Q Consensus 568 ~~~~~~~~-----~~~lV~E~~~ggsL~~~l~~-----~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NIL 637 (674)
++++.... ..|+||||+++++|.+++.. ....+++..++.++.||+.||.|||+++ |+||||||+|||
T Consensus 102 ~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dikp~NIl 179 (313)
T 3brb_A 102 LGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN--FLHRDLAARNCM 179 (313)
T ss_dssp CEEEEC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTT--CCCCCCSGGGEE
T ss_pred eEEEeeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCcceEE
Confidence 99998765 35999999999999999853 2356999999999999999999999999 999999999999
Q ss_pred EcCCCcEEEEecCCcccccCCc--cccccCCCCccccCC
Q 005841 638 VDKHWTVKVGDFGLSRLKHETY--LTTKTGKGTVTYLAS 674 (674)
Q Consensus 638 i~~~~~vkL~DFGla~~~~~~~--~~~~~~~GTp~YmAP 674 (674)
|+.++.+||+|||+++...... .......||+.|+||
T Consensus 180 i~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aP 218 (313)
T 3brb_A 180 LRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAI 218 (313)
T ss_dssp ECTTSCEEECSCSCC----------------CCGGGSCH
T ss_pred EcCCCcEEEeecCcceecccccccCcccccCCCccccCc
Confidence 9999999999999998764332 122234688999998
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=7e-27 Score=247.71 Aligned_cols=173 Identities=27% Similarity=0.486 Sum_probs=148.9
Q ss_pred ccccccCCeeEeeeecccCceEEEEEEEcC-------CeEEEEEeecccCCHHHHHHHHHHHHHHhhC-CCCCeeeEEEE
Q 005841 499 DYEILWEDLTIGEQIGQGSCGTVYHAVWYG-------SDVAVKVFSRQEYSDEVIHSFRQEVSLMKRL-RHPNVLLFMGA 570 (674)
Q Consensus 499 ~~~~~~~~y~~~~~LG~G~fG~Vy~~~~~~-------~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~ 570 (674)
.+++..++|.+.+.||+|+||.||+|.+.+ ..||+|++.... .......+.+|+.+++.+ +||||++++++
T Consensus 40 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~ 118 (333)
T 2i1m_A 40 KWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA-HADEKEALMSELKIMSHLGQHENIVNLLGA 118 (333)
T ss_dssp GGBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred cccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhccccc-ChHHHHHHHHHHHHHHhhcCCCCeeeEEEE
Confidence 457778999999999999999999999742 259999996543 445567899999999999 89999999999
Q ss_pred EecCCeEEEEEecCCCCCHHHHHHhc-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEE
Q 005841 571 VTSPQRLCIVTEFLPRGSLFRLLQRN-------------TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLL 637 (674)
Q Consensus 571 ~~~~~~~~lV~E~~~ggsL~~~l~~~-------------~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NIL 637 (674)
+...+.+||||||+++++|.+++... ...+++..++.++.||+.||.|||+.+ |+||||||+|||
T Consensus 119 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~NIl 196 (333)
T 2i1m_A 119 CTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN--CIHRDVAARNVL 196 (333)
T ss_dssp ECSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGCE
T ss_pred EecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC--cccCCcccceEE
Confidence 99999999999999999999999753 346899999999999999999999999 999999999999
Q ss_pred EcCCCcEEEEecCCcccccCCcc--ccccCCCCccccCC
Q 005841 638 VDKHWTVKVGDFGLSRLKHETYL--TTKTGKGTVTYLAS 674 (674)
Q Consensus 638 i~~~~~vkL~DFGla~~~~~~~~--~~~~~~GTp~YmAP 674 (674)
|+.++.+||+|||+++....... ......||+.|+||
T Consensus 197 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aP 235 (333)
T 2i1m_A 197 LTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAP 235 (333)
T ss_dssp EEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCH
T ss_pred ECCCCeEEECccccccccccccceeecCCCCCCccccCH
Confidence 99999999999999986543221 22234578999998
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=99.94 E-value=3.2e-27 Score=250.48 Aligned_cols=169 Identities=25% Similarity=0.484 Sum_probs=138.4
Q ss_pred cccCCeeEeeeecccCceEEEEEEEc--CCe----EEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCC
Q 005841 502 ILWEDLTIGEQIGQGSCGTVYHAVWY--GSD----VAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQ 575 (674)
Q Consensus 502 ~~~~~y~~~~~LG~G~fG~Vy~~~~~--~~~----vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~ 575 (674)
+...+|++.++||+|+||+||+|.+. +.. ||+|.+.... .......+.+|+.+++.++||||+++++++....
T Consensus 12 l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 90 (327)
T 3poz_A 12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLTST 90 (327)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC--------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS
T ss_pred cCHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeeccccc-CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC
Confidence 45578999999999999999999973 333 5777775432 2334567889999999999999999999998754
Q ss_pred eEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccc
Q 005841 576 RLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLK 655 (674)
Q Consensus 576 ~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~ 655 (674)
.++||||+.+++|.+++......+++..++.++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+|+..
T Consensus 91 -~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~ 167 (327)
T 3poz_A 91 -VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR--LVHRDLAARNVLVKTPQHVKITDFGLAKLL 167 (327)
T ss_dssp -EEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEEETTEEEECCTTHHHHH
T ss_pred -eEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCC--eeCCCCChheEEECCCCCEEEccCcceeEc
Confidence 88999999999999999887788999999999999999999999999 999999999999999999999999999876
Q ss_pred cCCcc--ccccCCCCccccCC
Q 005841 656 HETYL--TTKTGKGTVTYLAS 674 (674)
Q Consensus 656 ~~~~~--~~~~~~GTp~YmAP 674 (674)
..... ......||+.||||
T Consensus 168 ~~~~~~~~~~~~~~t~~y~aP 188 (327)
T 3poz_A 168 GAEEKEYHAEGGKVPIKWMAL 188 (327)
T ss_dssp TTTCC-------CCCGGGSCH
T ss_pred cCCcccccccCCCccccccCh
Confidence 43322 23335679999998
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=6.4e-27 Score=243.09 Aligned_cols=173 Identities=28% Similarity=0.455 Sum_probs=144.9
Q ss_pred cccccccCCeeEeeeecccCceEEEEEEE--cCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCC
Q 005841 498 LDYEILWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQ 575 (674)
Q Consensus 498 ~~~~~~~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~ 575 (674)
..+.+..++|....+||+|+||.||+|.+ ++..||||++.... ....+.+.+|+.+++.++||||+++++++...+
T Consensus 15 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 92 (295)
T 2clq_A 15 LEYDYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERD--SRYSQPLHEEIALHKHLKHKNIVQYLGSFSENG 92 (295)
T ss_dssp CCEEECBCTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCC--C---HHHHHHHHHHHTCCCTTBCCEEEEEEETT
T ss_pred ccccccccCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCc--hHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCC
Confidence 34455556677777999999999999998 46679999997653 234567889999999999999999999999999
Q ss_pred eEEEEEecCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcC-CCcEEEEecCCc
Q 005841 576 RLCIVTEFLPRGSLFRLLQRNT--TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDK-HWTVKVGDFGLS 652 (674)
Q Consensus 576 ~~~lV~E~~~ggsL~~~l~~~~--~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~-~~~vkL~DFGla 652 (674)
.+++||||+++++|.+++.... ..+++..+..++.||+.||.|||+.+ |+|+||||+|||++. ++.+||+|||++
T Consensus 93 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~~kl~Dfg~~ 170 (295)
T 2clq_A 93 FIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ--IVHRDIKGDNVLINTYSGVLKISDFGTS 170 (295)
T ss_dssp EEEEEEECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEETTTCCEEECCTTTC
T ss_pred cEEEEEEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCC--EEccCCChhhEEEECCCCCEEEeecccc
Confidence 9999999999999999997653 34678999999999999999999999 999999999999987 899999999999
Q ss_pred ccccCCccccccCCCCccccCC
Q 005841 653 RLKHETYLTTKTGKGTVTYLAS 674 (674)
Q Consensus 653 ~~~~~~~~~~~~~~GTp~YmAP 674 (674)
+.............||+.|+||
T Consensus 171 ~~~~~~~~~~~~~~~~~~y~aP 192 (295)
T 2clq_A 171 KRLAGINPCTETFTGTLQYMAP 192 (295)
T ss_dssp EESCC-----CCCCCCGGGCCH
T ss_pred cccCCCCCcccccCCCccccCh
Confidence 8766544344456799999998
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=6.9e-27 Score=246.84 Aligned_cols=169 Identities=29% Similarity=0.420 Sum_probs=140.0
Q ss_pred ccccCCeeEeeeecccCceEEEEEEE--cCCeEEEEEeecccCCHHHHHHHHHHHHHHhhC-CCCCeeeEEEEEec----
Q 005841 501 EILWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRL-RHPNVLLFMGAVTS---- 573 (674)
Q Consensus 501 ~~~~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~---- 573 (674)
....++|++.+.||+|+||.||+|.+ .+..||||++...... ...+.+|+.+++.+ +||||+++++++..
T Consensus 20 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~---~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~ 96 (326)
T 2x7f_A 20 RDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE---EEEIKQEINMLKKYSHHRNIATYYGAFIKKNPP 96 (326)
T ss_dssp CCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSST---THHHHHHHHHHHHHCCSTTBCCEEEEEEECC--
T ss_pred cCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCccc---HHHHHHHHHHHHhccCCCCeeeeeeEEeeccCc
Confidence 34567899999999999999999998 5778999999765432 24677899999998 79999999999987
Q ss_pred --CCeEEEEEecCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecC
Q 005841 574 --PQRLCIVTEFLPRGSLFRLLQRNT-TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFG 650 (674)
Q Consensus 574 --~~~~~lV~E~~~ggsL~~~l~~~~-~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFG 650 (674)
...+||||||+++++|.+++.... ..+++..+..++.||+.||.|||+.+ |+|+||||+||||+.++.+||+|||
T Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~dlkp~NIl~~~~~~~kl~Dfg 174 (326)
T 2x7f_A 97 GMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHK--VIHRDIKGQNVLLTENAEVKLVDFG 174 (326)
T ss_dssp CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEECTTCCEEECCCT
T ss_pred cccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCcHHHEEEcCCCCEEEeeCc
Confidence 468999999999999999997643 56999999999999999999999999 9999999999999999999999999
Q ss_pred CcccccCCccccccCCCCccccCC
Q 005841 651 LSRLKHETYLTTKTGKGTVTYLAS 674 (674)
Q Consensus 651 la~~~~~~~~~~~~~~GTp~YmAP 674 (674)
++..............||+.|+||
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~y~aP 198 (326)
T 2x7f_A 175 VSAQLDRTVGRRNTFIGTPYWMAP 198 (326)
T ss_dssp TTC-------------CCGGGCCH
T ss_pred CceecCcCccccccccCCccccCh
Confidence 998765543334456799999998
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=3.8e-27 Score=247.19 Aligned_cols=169 Identities=31% Similarity=0.384 Sum_probs=137.3
Q ss_pred cccCCeeEeeeecccCceEEEEEEE--cCCeEEEEEeecccCCH---HHHHHHHHHHHHHhhC---CCCCeeeEEEEEec
Q 005841 502 ILWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSD---EVIHSFRQEVSLMKRL---RHPNVLLFMGAVTS 573 (674)
Q Consensus 502 ~~~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~~~---~~~~~~~~Ei~il~~l---~HpnIv~l~~~~~~ 573 (674)
+..++|++.+.||+|+||+||+|.+ ++..||||++....... .....+.+|+.+++.+ .||||+++++++..
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~ 85 (308)
T 3g33_A 6 MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCAT 85 (308)
T ss_dssp ----CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEE
T ss_pred ccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeec
Confidence 4567899999999999999999996 57789999997543211 1123455677777666 49999999999987
Q ss_pred CC-----eEEEEEecCCCCCHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEE
Q 005841 574 PQ-----RLCIVTEFLPRGSLFRLLQRNTT-KLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVG 647 (674)
Q Consensus 574 ~~-----~~~lV~E~~~ggsL~~~l~~~~~-~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~ 647 (674)
.. .+|+||||+. ++|.+++..... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+
T Consensus 86 ~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dlkp~Nil~~~~~~~kl~ 162 (308)
T 3g33_A 86 SRTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANC--IVHRDLKPENILVTSGGTVKLA 162 (308)
T ss_dssp CCSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCTTTEEECTTSCEEEC
T ss_pred cCCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEcCCCCEEEe
Confidence 65 5899999996 599999976543 3999999999999999999999999 9999999999999999999999
Q ss_pred ecCCcccccCCccccccCCCCccccCC
Q 005841 648 DFGLSRLKHETYLTTKTGKGTVTYLAS 674 (674)
Q Consensus 648 DFGla~~~~~~~~~~~~~~GTp~YmAP 674 (674)
|||+++....... ....+||+.||||
T Consensus 163 Dfg~a~~~~~~~~-~~~~~gt~~y~aP 188 (308)
T 3g33_A 163 DFGLARIYSYQMA-LTPVVVTLWYRAP 188 (308)
T ss_dssp SCSCTTTSTTCCC-SGGGGCCCSSCCH
T ss_pred eCccccccCCCcc-cCCccccccccCc
Confidence 9999987654332 2346799999998
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.9e-27 Score=245.33 Aligned_cols=171 Identities=26% Similarity=0.400 Sum_probs=145.9
Q ss_pred cCCeeEeeeecccCceEEEEEEE--cCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEe--cCCeEEE
Q 005841 504 WEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVT--SPQRLCI 579 (674)
Q Consensus 504 ~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~--~~~~~~l 579 (674)
.++|++.+.||+|+||.||++.+ ++..||+|++..........+.+.+|+.+++.++||||+++++++. ....+|+
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 84 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 84 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence 46899999999999999999998 4778999999887767777788999999999999999999999874 4678999
Q ss_pred EEecCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---CCeEEccCCCCCEEEcCCCcEEEEecCCcc
Q 005841 580 VTEFLPRGSLFRLLQRN---TTKLDWRRRILMALDIARGVSYLHHCN---PPIIHRDLKSSNLLVDKHWTVKVGDFGLSR 653 (674)
Q Consensus 580 V~E~~~ggsL~~~l~~~---~~~l~~~~~~~i~~qi~~~L~yLH~~~---~~IvHrDLKp~NILi~~~~~vkL~DFGla~ 653 (674)
||||+++++|.+++... ...+++..++.++.||+.||.|||+.+ .+|+||||||+|||++.++.+||+|||+++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~ 164 (279)
T 2w5a_A 85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 164 (279)
T ss_dssp EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHH
T ss_pred EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchhe
Confidence 99999999999999753 345999999999999999999999866 349999999999999999999999999998
Q ss_pred cccCCccccccCCCCccccCC
Q 005841 654 LKHETYLTTKTGKGTVTYLAS 674 (674)
Q Consensus 654 ~~~~~~~~~~~~~GTp~YmAP 674 (674)
.............||+.|+||
T Consensus 165 ~~~~~~~~~~~~~~~~~y~aP 185 (279)
T 2w5a_A 165 ILNHDTSFAKTFVGTPYYMSP 185 (279)
T ss_dssp HC---CHHHHHHHSCCTTCCH
T ss_pred eeccccccccccCCCccccCh
Confidence 765443333345799999998
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=99.94 E-value=1.6e-26 Score=244.38 Aligned_cols=159 Identities=21% Similarity=0.396 Sum_probs=139.5
Q ss_pred cCCeeEeeeecccCceEEEEEEE--cCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCC-CCCeeeEEEEEec--CCeEE
Q 005841 504 WEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLR-HPNVLLFMGAVTS--PQRLC 578 (674)
Q Consensus 504 ~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~--~~~~~ 578 (674)
.++|++.+.||+|+||.||+|.+ .+..||||++.... ...+.+|+.+++.+. ||||+++++++.. ....+
T Consensus 35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~ 109 (330)
T 3nsz_A 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK-----KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPA 109 (330)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC-----HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEE
T ss_pred CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc-----hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceE
Confidence 47899999999999999999987 57789999986432 256888999999997 9999999999988 66799
Q ss_pred EEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCC-cEEEEecCCcccccC
Q 005841 579 IVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHW-TVKVGDFGLSRLKHE 657 (674)
Q Consensus 579 lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~-~vkL~DFGla~~~~~ 657 (674)
+||||+++++|.+++. .+++..+..++.||+.||.|||+++ |+||||||+||||+.++ .+||+|||+|+....
T Consensus 110 lv~e~~~~~~l~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~ 183 (330)
T 3nsz_A 110 LVFEHVNNTDFKQLYQ----TLTDYDIRFYMYEILKALDYCHSMG--IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP 183 (330)
T ss_dssp EEEECCCCCCHHHHGG----GCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEETTTTEEEECCCTTCEECCT
T ss_pred EEEeccCchhHHHHHH----hCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCC
Confidence 9999999999999885 3889999999999999999999999 99999999999999766 899999999987654
Q ss_pred CccccccCCCCccccCC
Q 005841 658 TYLTTKTGKGTVTYLAS 674 (674)
Q Consensus 658 ~~~~~~~~~GTp~YmAP 674 (674)
... .....||+.|+||
T Consensus 184 ~~~-~~~~~~~~~y~aP 199 (330)
T 3nsz_A 184 GQE-YNVRVASRYFKGP 199 (330)
T ss_dssp TCC-CCSCCSCGGGCCH
T ss_pred CCc-cccccccccccCh
Confidence 332 3345799999998
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=99.94 E-value=4.7e-27 Score=252.17 Aligned_cols=168 Identities=24% Similarity=0.408 Sum_probs=147.6
Q ss_pred ccccCCeeEeeeecccCceEEEEEEEc--CCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeEE
Q 005841 501 EILWEDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLC 578 (674)
Q Consensus 501 ~~~~~~y~~~~~LG~G~fG~Vy~~~~~--~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 578 (674)
++..++|++.+.||+|+||.||+|.+. +..||+|++.... .......+.+|+.+++.++||||+++++++...+.+|
T Consensus 29 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 107 (360)
T 3eqc_A 29 ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEIS 107 (360)
T ss_dssp CCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCC-CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEE
T ss_pred ccccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEecccc-CHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEE
Confidence 455688999999999999999999985 7789999997653 4556678999999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCeEEccCCCCCEEEcCCCcEEEEecCCcccccC
Q 005841 579 IVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHC-NPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHE 657 (674)
Q Consensus 579 lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~-~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~ 657 (674)
|||||+++++|.+++... ..+++..+..++.||+.||.|||+. + |+||||||+||||+.++.+||+|||+++....
T Consensus 108 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~~--i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 184 (360)
T 3eqc_A 108 ICMEHMDGGSLDQVLKKA-GRIPEQILGKVSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 184 (360)
T ss_dssp EEECCCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHHHC--CCCSCCSGGGEEECTTCCEEECCCCCCHHHHH
T ss_pred EEEECCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHhCC--EEcCCccHHHEEECCCCCEEEEECCCCccccc
Confidence 999999999999999764 4699999999999999999999985 8 99999999999999999999999999976543
Q ss_pred CccccccCCCCccccCC
Q 005841 658 TYLTTKTGKGTVTYLAS 674 (674)
Q Consensus 658 ~~~~~~~~~GTp~YmAP 674 (674)
.. .....||+.|+||
T Consensus 185 ~~--~~~~~gt~~y~aP 199 (360)
T 3eqc_A 185 SM--ANSFVGTRSYMSP 199 (360)
T ss_dssp HC------CCCCTTCCH
T ss_pred cc--ccCCCCCCCeECH
Confidence 32 2345799999998
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=99.94 E-value=7.4e-27 Score=241.07 Aligned_cols=170 Identities=33% Similarity=0.572 Sum_probs=146.5
Q ss_pred ccccccCCeeEeeeecccCceEEEEEEEcC-CeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeE
Q 005841 499 DYEILWEDLTIGEQIGQGSCGTVYHAVWYG-SDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRL 577 (674)
Q Consensus 499 ~~~~~~~~y~~~~~LG~G~fG~Vy~~~~~~-~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 577 (674)
+|++..++|++.+.||+|+||.||+|.+.+ ..||||++...... .+.+.+|+.+++.++||||+++++++. .+..
T Consensus 7 ~~~v~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~ 82 (279)
T 1qpc_A 7 EWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS---PDAFLAEANLMKQLQHQRLVRLYAVVT-QEPI 82 (279)
T ss_dssp TTBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSC---HHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSC
T ss_pred hcccCHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCccc---HHHHHHHHHHHHhCCCcCcceEEEEEc-CCCc
Confidence 467788999999999999999999999854 47999999765443 356888999999999999999999886 4568
Q ss_pred EEEEecCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCccccc
Q 005841 578 CIVTEFLPRGSLFRLLQRNT-TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKH 656 (674)
Q Consensus 578 ~lV~E~~~ggsL~~~l~~~~-~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~ 656 (674)
|+||||+++++|.+++.... ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 83 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~ 160 (279)
T 1qpc_A 83 YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN--YIHRDLRAANILVSDTLSCKIADFGLARLIE 160 (279)
T ss_dssp EEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred EEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHhhEEEcCCCCEEECCCccccccc
Confidence 99999999999999996532 26899999999999999999999999 9999999999999999999999999998775
Q ss_pred CCccc-cccCCCCccccCC
Q 005841 657 ETYLT-TKTGKGTVTYLAS 674 (674)
Q Consensus 657 ~~~~~-~~~~~GTp~YmAP 674 (674)
..... .....||+.|+||
T Consensus 161 ~~~~~~~~~~~~~~~y~aP 179 (279)
T 1qpc_A 161 DNEYTAREGAKFPIKWTAP 179 (279)
T ss_dssp SSCEECCTTCCCCTTTSCH
T ss_pred CcccccccCCCCccCccCh
Confidence 54332 2234578899998
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=7e-27 Score=247.03 Aligned_cols=173 Identities=29% Similarity=0.405 Sum_probs=135.8
Q ss_pred ccccccCCeeEeeeecccCceEEEEEEE--cCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCC-CCCeeeEEEEEe---
Q 005841 499 DYEILWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLR-HPNVLLFMGAVT--- 572 (674)
Q Consensus 499 ~~~~~~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~--- 572 (674)
..++...+|++.++||+|+||.||+|.+ ++..||||++... .......+.+|+.+++.+. ||||+++++++.
T Consensus 22 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~ 99 (337)
T 3ll6_A 22 TVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSN--EEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGK 99 (337)
T ss_dssp EEEETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEES--SHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECT
T ss_pred eeeccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCC--chHHHHHHHHHHHHHHHhccCCChhhccccccccc
Confidence 3456667899999999999999999998 6778999998654 3445567889999999996 999999999994
Q ss_pred -----cCCeEEEEEecCCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEE
Q 005841 573 -----SPQRLCIVTEFLPRGSLFRLLQR--NTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVK 645 (674)
Q Consensus 573 -----~~~~~~lV~E~~~ggsL~~~l~~--~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vk 645 (674)
....+|+||||+. |+|.+++.. ....+++..++.++.||+.||.|||+.+++|+||||||+||||+.++.+|
T Consensus 100 ~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~~k 178 (337)
T 3ll6_A 100 EESDTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIK 178 (337)
T ss_dssp TTSTTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSCEE
T ss_pred cccccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCCEE
Confidence 3345899999995 699998865 34569999999999999999999999877799999999999999999999
Q ss_pred EEecCCcccccCCccc------------cccCCCCccccCC
Q 005841 646 VGDFGLSRLKHETYLT------------TKTGKGTVTYLAS 674 (674)
Q Consensus 646 L~DFGla~~~~~~~~~------------~~~~~GTp~YmAP 674 (674)
|+|||+++........ .....||+.|+||
T Consensus 179 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aP 219 (337)
T 3ll6_A 179 LCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTP 219 (337)
T ss_dssp BCCCTTCBCCSSCC---------------------------
T ss_pred EecCccceeccccCcccccccccccchhhccccCCCCcCCh
Confidence 9999999876542211 1134699999998
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=99.94 E-value=5.8e-27 Score=244.19 Aligned_cols=168 Identities=30% Similarity=0.457 Sum_probs=142.1
Q ss_pred cCCeeEeeeecccCceEEEEEEEcC-----CeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEe-cCCeE
Q 005841 504 WEDLTIGEQIGQGSCGTVYHAVWYG-----SDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVT-SPQRL 577 (674)
Q Consensus 504 ~~~y~~~~~LG~G~fG~Vy~~~~~~-----~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~-~~~~~ 577 (674)
..+|++.++||+|+||.||+|.+.. ..||+|.+... ......+.+.+|+.+++.++||||+++++++. .....
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 102 (298)
T 3f66_A 24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI-TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSP 102 (298)
T ss_dssp GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTC-CSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCC
T ss_pred ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccC-CCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCce
Confidence 3569999999999999999998632 24899988653 24456678999999999999999999999854 55678
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccccC
Q 005841 578 CIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHE 657 (674)
Q Consensus 578 ~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~ 657 (674)
|+||||+++++|.+++......+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 103 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~--i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~ 180 (298)
T 3f66_A 103 LVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKK--FVHRDLAARNCMLDEKFTVKVADFGLARDMYD 180 (298)
T ss_dssp EEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECTTCCEEECSCGGGCCCSC
T ss_pred EEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCchheEEECCCCCEEECcccccccccc
Confidence 9999999999999999877778999999999999999999999999 99999999999999999999999999987644
Q ss_pred Ccc----ccccCCCCccccCC
Q 005841 658 TYL----TTKTGKGTVTYLAS 674 (674)
Q Consensus 658 ~~~----~~~~~~GTp~YmAP 674 (674)
... ......||+.|+||
T Consensus 181 ~~~~~~~~~~~~~~~~~y~aP 201 (298)
T 3f66_A 181 KEYYSVHNKTGAKLPVKWMAL 201 (298)
T ss_dssp GGGCBC-----CCBCGGGSCH
T ss_pred cchhccccccCCCCCccccCh
Confidence 321 22334688999998
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... | Back alignment and structure |
|---|
Probab=99.94 E-value=4.6e-27 Score=244.90 Aligned_cols=168 Identities=29% Similarity=0.451 Sum_probs=142.9
Q ss_pred cCCeeEeeeecccCceEEEEEEE--cCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeEEEEE
Q 005841 504 WEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVT 581 (674)
Q Consensus 504 ~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 581 (674)
.++|++.+.||+|+||.||+|.+ ++..||||++............+.+|+.+++.++||||+++++++...+.+|+||
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (299)
T 2r3i_A 2 MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVF 81 (299)
T ss_dssp CTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC--------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cchhhhhhhhccCCCeeEEEEEEcCCCceEEEEEeecCccchhhHHHHHHHHHHHHHcCCCCeeeEEEEEecCCceEEEE
Confidence 36899999999999999999998 4778999998765443334467888999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccccCCcc
Q 005841 582 EFLPRGSLFRLLQRNT-TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYL 660 (674)
Q Consensus 582 E~~~ggsL~~~l~~~~-~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~~~~ 660 (674)
||+. ++|.+++.... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++........
T Consensus 82 e~~~-~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~ 158 (299)
T 2r3i_A 82 EFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR 158 (299)
T ss_dssp ECCS-EEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTSCEEECSTTHHHHHCCCSB
T ss_pred Eccc-CCHHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHHHCC--ccCCCCCHHHeEEcCCCCEEECcchhhhhccCCcc
Confidence 9997 59999987643 46899999999999999999999999 99999999999999999999999999987655433
Q ss_pred ccccCCCCccccCC
Q 005841 661 TTKTGKGTVTYLAS 674 (674)
Q Consensus 661 ~~~~~~GTp~YmAP 674 (674)
......||+.|+||
T Consensus 159 ~~~~~~~~~~y~aP 172 (299)
T 2r3i_A 159 TYTHEVVTLWYRAP 172 (299)
T ss_dssp CTTSCBCCCTTCCH
T ss_pred ccCcccccccccCc
Confidence 44445799999998
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=99.94 E-value=6.6e-27 Score=242.26 Aligned_cols=169 Identities=32% Similarity=0.544 Sum_probs=146.9
Q ss_pred ccccCCeeEeeeecccCceEEEEEEEc--CCeEEEEEeecccCCH-HHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeE
Q 005841 501 EILWEDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSD-EVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRL 577 (674)
Q Consensus 501 ~~~~~~y~~~~~LG~G~fG~Vy~~~~~--~~~vAvK~i~~~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 577 (674)
.+..++|++.+.||+|+||.||+|.+. +..||||++.+..... .....+.+|+.+++.++||||+++++++...+.+
T Consensus 10 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 89 (284)
T 2vgo_A 10 KFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRI 89 (284)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred chhhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEE
Confidence 345578999999999999999999984 5579999997543221 2235688999999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccccC
Q 005841 578 CIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHE 657 (674)
Q Consensus 578 ~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~ 657 (674)
|+||||+++++|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 90 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~ 166 (284)
T 2vgo_A 90 YLMLEFAPRGELYKELQKH-GRFDEQRSATFMEELADALHYCHERK--VIHRDIKPENLLMGYKGELKIADFGWSVHAPS 166 (284)
T ss_dssp EEEECCCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCSGGGEEECTTCCEEECCCTTCEECSS
T ss_pred EEEEEeCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCHHHEEEcCCCCEEEecccccccCcc
Confidence 9999999999999999764 46999999999999999999999999 99999999999999999999999999976554
Q ss_pred CccccccCCCCccccCC
Q 005841 658 TYLTTKTGKGTVTYLAS 674 (674)
Q Consensus 658 ~~~~~~~~~GTp~YmAP 674 (674)
.. .....||+.|+||
T Consensus 167 ~~--~~~~~~~~~y~aP 181 (284)
T 2vgo_A 167 LR--RRTMCGTLDYLPP 181 (284)
T ss_dssp SC--BCCCCSCGGGCCH
T ss_pred cc--cccccCCCCcCCH
Confidence 32 3346799999998
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=7.3e-27 Score=241.57 Aligned_cols=171 Identities=30% Similarity=0.535 Sum_probs=144.7
Q ss_pred cccccCCeeEeeeecccCceEEEEEEEcCC-----eEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecC
Q 005841 500 YEILWEDLTIGEQIGQGSCGTVYHAVWYGS-----DVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSP 574 (674)
Q Consensus 500 ~~~~~~~y~~~~~LG~G~fG~Vy~~~~~~~-----~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~ 574 (674)
+.+..++|++.+.||+|+||+||+|.+.+. .||+|++.... .....+.+.+|+.+++.++||||+++++++..
T Consensus 7 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~- 84 (281)
T 3cc6_A 7 YGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDC-TLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE- 84 (281)
T ss_dssp CSCCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTS-CHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-
T ss_pred ceecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEeccccc-CchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-
Confidence 356678999999999999999999987422 39999987643 44556789999999999999999999999865
Q ss_pred CeEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCccc
Q 005841 575 QRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL 654 (674)
Q Consensus 575 ~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~ 654 (674)
+..|+||||+++++|.+++......+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.
T Consensus 85 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 162 (281)
T 3cc6_A 85 EPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESIN--CVHRDIAVRNILVASPECVKLGDFGLSRY 162 (281)
T ss_dssp SSCEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEEEETTEEEECCCCGGGC
T ss_pred CCCEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCccceEEECCCCcEEeCccCCCcc
Confidence 4579999999999999999887778999999999999999999999999 99999999999999999999999999987
Q ss_pred ccCCcc-ccccCCCCccccCC
Q 005841 655 KHETYL-TTKTGKGTVTYLAS 674 (674)
Q Consensus 655 ~~~~~~-~~~~~~GTp~YmAP 674 (674)
...... ......||+.|+||
T Consensus 163 ~~~~~~~~~~~~~~~~~y~aP 183 (281)
T 3cc6_A 163 IEDEDYYKASVTRLPIKWMSP 183 (281)
T ss_dssp C---------CCCCCGGGCCH
T ss_pred cccccccccccCCCCcceeCc
Confidence 654322 22334689999998
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=99.94 E-value=6.2e-27 Score=243.43 Aligned_cols=166 Identities=29% Similarity=0.431 Sum_probs=139.2
Q ss_pred cCCeeEeeeecccCceEEEEEEE--cCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEec--------
Q 005841 504 WEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTS-------- 573 (674)
Q Consensus 504 ~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~-------- 573 (674)
.++|++.+.||+|+||.||+|.+ .+..||||++... ......+.+|+.+++.++||||+++++++..
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 81 (303)
T 1zy4_A 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT---EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPM 81 (303)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE---HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC--
T ss_pred cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc---HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhh
Confidence 35799999999999999999997 5778999999643 3456778999999999999999999998865
Q ss_pred -----CCeEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEe
Q 005841 574 -----PQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGD 648 (674)
Q Consensus 574 -----~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~D 648 (674)
...+|+||||+++++|.+++......+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|
T Consensus 82 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dlkp~Nil~~~~~~~kl~d 159 (303)
T 1zy4_A 82 TAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQG--IIHRDLKPMNIFIDESRNVKIGD 159 (303)
T ss_dssp ----CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTSCEEECC
T ss_pred cccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCC--eecccCCHHhEEEcCCCCEEEee
Confidence 35689999999999999999876667899999999999999999999999 99999999999999999999999
Q ss_pred cCCcccccCC--------------ccccccCCCCccccCC
Q 005841 649 FGLSRLKHET--------------YLTTKTGKGTVTYLAS 674 (674)
Q Consensus 649 FGla~~~~~~--------------~~~~~~~~GTp~YmAP 674 (674)
||+++..... ........||+.|+||
T Consensus 160 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aP 199 (303)
T 1zy4_A 160 FGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVAT 199 (303)
T ss_dssp CCCCSCTTC-------------------------CTTSCH
T ss_pred CcchhhcccccchhccccccccccccccccCCCcccccCc
Confidence 9999865432 1122345799999998
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=2.7e-27 Score=246.96 Aligned_cols=168 Identities=26% Similarity=0.403 Sum_probs=142.5
Q ss_pred ccCCeeEeeeecccCceEEEEEEEc--CCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeEEEE
Q 005841 503 LWEDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIV 580 (674)
Q Consensus 503 ~~~~y~~~~~LG~G~fG~Vy~~~~~--~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 580 (674)
..++|++.+.||+|+||.||+|.+. +..||+|++..... .....+.+|+.+++.++||||+++++++...+.+|+|
T Consensus 17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 94 (302)
T 2j7t_A 17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSE--EELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIM 94 (302)
T ss_dssp GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC------CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEE
T ss_pred CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCH--HHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEE
Confidence 3478999999999999999999984 67899999865432 2346788899999999999999999999999999999
Q ss_pred EecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccccCCcc
Q 005841 581 TEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYL 660 (674)
Q Consensus 581 ~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~~~~ 660 (674)
|||+++++|.+++......+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++........
T Consensus 95 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 172 (302)
T 2j7t_A 95 IEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKR--IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQ 172 (302)
T ss_dssp EECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHHH
T ss_pred EEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCC--cccCCCCHHHEEECCCCCEEEEECCCCcccccccc
Confidence 9999999999999877778999999999999999999999999 99999999999999999999999999865433323
Q ss_pred ccccCCCCccccCC
Q 005841 661 TTKTGKGTVTYLAS 674 (674)
Q Consensus 661 ~~~~~~GTp~YmAP 674 (674)
......||+.|+||
T Consensus 173 ~~~~~~~~~~y~aP 186 (302)
T 2j7t_A 173 KRDSFIGTPYWMAP 186 (302)
T ss_dssp C-----CCGGGCCH
T ss_pred ccccccCChhhcCC
Confidence 33446799999998
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=2.6e-27 Score=264.79 Aligned_cols=169 Identities=29% Similarity=0.436 Sum_probs=147.9
Q ss_pred cccCCeeEeeeecccCceEEEEEEE--cCCeEEEEEeecccCC-HHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeEE
Q 005841 502 ILWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYS-DEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLC 578 (674)
Q Consensus 502 ~~~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 578 (674)
...++|++.++||+|+||.||+|.+ ++..||||++.+.... ......+.+|+.+++.++||||+++++++.....+|
T Consensus 23 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 102 (484)
T 3nyv_A 23 IFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFY 102 (484)
T ss_dssp CHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred cccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 4457899999999999999999998 4778999999766543 233567889999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEE---cCCCcEEEEecCCcccc
Q 005841 579 IVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLV---DKHWTVKVGDFGLSRLK 655 (674)
Q Consensus 579 lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi---~~~~~vkL~DFGla~~~ 655 (674)
+|||||.+++|.+++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||| +.++.+||+|||+++..
T Consensus 103 lv~e~~~~~~L~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~ 179 (484)
T 3nyv_A 103 LVGEVYTGGELFDEIIS-RKRFSEVDAARIIRQVLSGITYMHKNK--IVHRDLKPENLLLESKSKDANIRIIDFGLSTHF 179 (484)
T ss_dssp EEECCCCSCBHHHHHHT-CSCCBHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESSSSTTCCEEECCTTHHHHB
T ss_pred EEEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEc
Confidence 99999999999999965 457999999999999999999999999 9999999999999 56789999999999876
Q ss_pred cCCccccccCCCCccccCC
Q 005841 656 HETYLTTKTGKGTVTYLAS 674 (674)
Q Consensus 656 ~~~~~~~~~~~GTp~YmAP 674 (674)
..... ....+||+.||||
T Consensus 180 ~~~~~-~~~~~gt~~y~aP 197 (484)
T 3nyv_A 180 EASKK-MKDKIGTAYYIAP 197 (484)
T ss_dssp CCCCS-HHHHTTGGGTCCH
T ss_pred ccccc-cccCCCCccccCc
Confidence 54332 2335799999998
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=5.9e-27 Score=241.22 Aligned_cols=170 Identities=28% Similarity=0.529 Sum_probs=140.7
Q ss_pred ccccCCeeEeeeecccCceEEEEEEE--cCCeEEEEEeecccCC-HHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeE
Q 005841 501 EILWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYS-DEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRL 577 (674)
Q Consensus 501 ~~~~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 577 (674)
.+..++|.+.+.||+|+||.||+|.+ ++..||||++...... ......+.+|+.+++.++||||+++++++...+.+
T Consensus 7 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 86 (276)
T 2h6d_A 7 RVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDF 86 (276)
T ss_dssp CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred cceeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeE
Confidence 45668999999999999999999998 4778999999764321 12346788999999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccccC
Q 005841 578 CIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHE 657 (674)
Q Consensus 578 ~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~ 657 (674)
|+||||+++++|.+++... ..+++..+..++.||+.||.|||+.+ |+|+||||+|||++.++.+||+|||++.....
T Consensus 87 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~ 163 (276)
T 2h6d_A 87 FMVMEYVSGGELFDYICKH-GRVEEMEARRLFQQILSAVDYCHRHM--VVHRDLKPENVLLDAHMNAKIADFGLSNMMSD 163 (276)
T ss_dssp EEEEECCCSCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHHC--SSCCCCCGGGEEECTTSCEEECCCCGGGCCCC
T ss_pred EEEEeccCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC--CccCCCChhhEEECCCCCEEEeecccccccCC
Confidence 9999999999999999764 46899999999999999999999999 99999999999999999999999999987654
Q ss_pred CccccccCCCCccccCC
Q 005841 658 TYLTTKTGKGTVTYLAS 674 (674)
Q Consensus 658 ~~~~~~~~~GTp~YmAP 674 (674)
... .....||+.|+||
T Consensus 164 ~~~-~~~~~~~~~y~aP 179 (276)
T 2h6d_A 164 GEF-LRTSCGSPNYAAP 179 (276)
T ss_dssp --------------CCT
T ss_pred Ccc-eecccCCccccCH
Confidence 332 2335799999998
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=99.94 E-value=9.7e-27 Score=240.46 Aligned_cols=167 Identities=25% Similarity=0.407 Sum_probs=143.1
Q ss_pred cCCeeEeeeecccCceEEEEEEEc--CCeEEEEEeecccCCH----HHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeE
Q 005841 504 WEDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSD----EVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRL 577 (674)
Q Consensus 504 ~~~y~~~~~LG~G~fG~Vy~~~~~--~~~vAvK~i~~~~~~~----~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 577 (674)
.++|++.+.||+|+||.||+|.+. +..||+|++....... ...+.+.+|+.+++.++||||+++++++......
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 83 (283)
T 3bhy_A 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDV 83 (283)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeE
Confidence 357999999999999999999984 7789999998764432 1346788999999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCC----cEEEEecCCcc
Q 005841 578 CIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHW----TVKVGDFGLSR 653 (674)
Q Consensus 578 ~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~----~vkL~DFGla~ 653 (674)
|+||||+++++|.+++... ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++ .+||+|||++.
T Consensus 84 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~ 160 (283)
T 3bhy_A 84 VLILELVSGGELFDFLAEK-ESLTEDEATQFLKQILDGVHYLHSKR--IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAH 160 (283)
T ss_dssp EEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred EEEEeecCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCChHHEEEecCCCCCCceEEEecccce
Confidence 9999999999999999753 46999999999999999999999999 99999999999998776 89999999998
Q ss_pred cccCCccccccCCCCccccCC
Q 005841 654 LKHETYLTTKTGKGTVTYLAS 674 (674)
Q Consensus 654 ~~~~~~~~~~~~~GTp~YmAP 674 (674)
....... .....||+.|+||
T Consensus 161 ~~~~~~~-~~~~~~~~~y~aP 180 (283)
T 3bhy_A 161 KIEAGNE-FKNIFGTPEFVAP 180 (283)
T ss_dssp ECC---------CCCGGGCCH
T ss_pred eccCCCc-ccccCCCcCccCc
Confidence 7654322 2335799999998
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.5e-27 Score=252.66 Aligned_cols=170 Identities=25% Similarity=0.423 Sum_probs=139.7
Q ss_pred ccccCCeeEeeeecccCceEEEEEEEc--CCe----EEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecC
Q 005841 501 EILWEDLTIGEQIGQGSCGTVYHAVWY--GSD----VAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSP 574 (674)
Q Consensus 501 ~~~~~~y~~~~~LG~G~fG~Vy~~~~~--~~~----vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~ 574 (674)
.+...+|++.++||+|+||+||+|.+. +.. ||+|++..... ......+.+|+.+++.++||||+++++++. .
T Consensus 9 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~ 86 (325)
T 3kex_A 9 IFKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSG-RQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-G 86 (325)
T ss_dssp BCCTTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTS-CSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-B
T ss_pred hcCHhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEecccccc-HHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-C
Confidence 345678999999999999999999974 343 77777754322 122345667999999999999999999886 5
Q ss_pred CeEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCccc
Q 005841 575 QRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL 654 (674)
Q Consensus 575 ~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~ 654 (674)
...|+||||+++++|.+++......+++..++.++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++.
T Consensus 87 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~ 164 (325)
T 3kex_A 87 SSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHG--MVHRNLAARNVLLKSPSQVQVADFGVADL 164 (325)
T ss_dssp SSEEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTT--CCCSCCSSTTEEESSSSCEEECSCSGGGG
T ss_pred CccEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCC--CCCCccchheEEECCCCeEEECCCCcccc
Confidence 6799999999999999999876668999999999999999999999999 99999999999999999999999999987
Q ss_pred ccCCcc--ccccCCCCccccCC
Q 005841 655 KHETYL--TTKTGKGTVTYLAS 674 (674)
Q Consensus 655 ~~~~~~--~~~~~~GTp~YmAP 674 (674)
...... ......||+.||||
T Consensus 165 ~~~~~~~~~~~~~~~~~~y~aP 186 (325)
T 3kex_A 165 LPPDDKQLLYSEAKTPIKWMAL 186 (325)
T ss_dssp SCCCTTCCC-----CCTTTSCH
T ss_pred cCcccccccccCCCCcccccCh
Confidence 643322 22335688999998
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=99.94 E-value=2.5e-27 Score=252.21 Aligned_cols=172 Identities=28% Similarity=0.391 Sum_probs=141.3
Q ss_pred ccccCCeeEeeeecccCceEEEEEEE--cCCeEEEEEeecccC---CHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCC
Q 005841 501 EILWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEY---SDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQ 575 (674)
Q Consensus 501 ~~~~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~---~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~ 575 (674)
....++|++.+.||+|+||.||+|.+ .+..||||++.+... .....+.+.+|+.+++.++||||+++++++.+.+
T Consensus 22 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 101 (345)
T 3hko_A 22 LELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQ 101 (345)
T ss_dssp HHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred hhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCC
Confidence 34457899999999999999999998 456799999976532 2345678999999999999999999999999999
Q ss_pred eEEEEEecCCCCCHHHHHHhc---------------------------------------CCCCCHHHHHHHHHHHHHHH
Q 005841 576 RLCIVTEFLPRGSLFRLLQRN---------------------------------------TTKLDWRRRILMALDIARGV 616 (674)
Q Consensus 576 ~~~lV~E~~~ggsL~~~l~~~---------------------------------------~~~l~~~~~~~i~~qi~~~L 616 (674)
.+|||||||++++|.+++... ...+++..+..++.||+.||
T Consensus 102 ~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l 181 (345)
T 3hko_A 102 YICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSAL 181 (345)
T ss_dssp EEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHH
T ss_pred eEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHH
Confidence 999999999999999988421 11246788899999999999
Q ss_pred HHHHhCCCCeEEccCCCCCEEEcCCC--cEEEEecCCcccccCC----ccccccCCCCccccCC
Q 005841 617 SYLHHCNPPIIHRDLKSSNLLVDKHW--TVKVGDFGLSRLKHET----YLTTKTGKGTVTYLAS 674 (674)
Q Consensus 617 ~yLH~~~~~IvHrDLKp~NILi~~~~--~vkL~DFGla~~~~~~----~~~~~~~~GTp~YmAP 674 (674)
.|||+.+ |+||||||+||||+.++ .+||+|||+++..... ........||+.|+||
T Consensus 182 ~~LH~~~--ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aP 243 (345)
T 3hko_A 182 HYLHNQG--ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAP 243 (345)
T ss_dssp HHHHHTT--EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCH
T ss_pred HHHHHCC--ccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCc
Confidence 9999999 99999999999998766 8999999999865432 1123345799999998
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=7.5e-27 Score=244.44 Aligned_cols=166 Identities=34% Similarity=0.584 Sum_probs=144.4
Q ss_pred eeEeeeecccCceEEEEEEEcCCeEEEEEeecccC--CHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeEEEEEecC
Q 005841 507 LTIGEQIGQGSCGTVYHAVWYGSDVAVKVFSRQEY--SDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFL 584 (674)
Q Consensus 507 y~~~~~LG~G~fG~Vy~~~~~~~~vAvK~i~~~~~--~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 584 (674)
|...+.||+|+||.||+|.+.+..||||++..... .....+.+.+|+.+++.++||||+++++++...+..|+||||+
T Consensus 33 ~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 112 (307)
T 2nru_A 33 SVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYM 112 (307)
T ss_dssp TTTCCEEEECSSEEEEEEESSSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred cccCCccccCCCeEEEEEEECCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCceEEEEEec
Confidence 34458999999999999999999999999875432 2345678999999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccccCCcc--
Q 005841 585 PRGSLFRLLQRN--TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYL-- 660 (674)
Q Consensus 585 ~ggsL~~~l~~~--~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~~~~-- 660 (674)
++++|.+++... ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 113 ~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~ 190 (307)
T 2nru_A 113 PNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENH--HIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTV 190 (307)
T ss_dssp TTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECTTCCEEECCCTTCEECCSCSSCE
T ss_pred CCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCC--eecCCCCHHHEEEcCCCcEEEeecccccccccccccc
Confidence 999999999743 346999999999999999999999999 99999999999999999999999999987654222
Q ss_pred ccccCCCCccccCC
Q 005841 661 TTKTGKGTVTYLAS 674 (674)
Q Consensus 661 ~~~~~~GTp~YmAP 674 (674)
......||+.|+||
T Consensus 191 ~~~~~~g~~~y~aP 204 (307)
T 2nru_A 191 MTSRIVGTTAYMAP 204 (307)
T ss_dssp ECSSCCSCGGGCCH
T ss_pred cccccCCCcCcCCh
Confidence 23345799999998
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=99.94 E-value=2e-26 Score=248.58 Aligned_cols=168 Identities=27% Similarity=0.482 Sum_probs=147.7
Q ss_pred ccCCeeEeeeecccCceEEEEEEEc--CCeEEEEEeecccC--C----HHHHHHHHHHHHHHhhC-CCCCeeeEEEEEec
Q 005841 503 LWEDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEY--S----DEVIHSFRQEVSLMKRL-RHPNVLLFMGAVTS 573 (674)
Q Consensus 503 ~~~~y~~~~~LG~G~fG~Vy~~~~~--~~~vAvK~i~~~~~--~----~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~ 573 (674)
..++|.+.+.||+|+||.||+|.+. +..||||++..... . ....+.+.+|+.+++.+ .||||+.+++++..
T Consensus 92 ~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 171 (365)
T 2y7j_A 92 FYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYES 171 (365)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEB
T ss_pred hhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEee
Confidence 4468999999999999999999984 77899999976542 1 13456788999999999 79999999999999
Q ss_pred CCeEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcc
Q 005841 574 PQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSR 653 (674)
Q Consensus 574 ~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~ 653 (674)
....||||||+++++|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||++.
T Consensus 172 ~~~~~lv~e~~~g~~L~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~g--i~H~Dlkp~NIl~~~~~~ikl~DfG~~~ 248 (365)
T 2y7j_A 172 SSFMFLVFDLMRKGELFDYLTEK-VALSEKETRSIMRSLLEAVSFLHANN--IVHRDLKPENILLDDNMQIRLSDFGFSC 248 (365)
T ss_dssp SSEEEEEECCCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred CCEEEEEEEeCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEECCCCCEEEEecCccc
Confidence 99999999999999999999754 46999999999999999999999999 9999999999999999999999999998
Q ss_pred cccCCccccccCCCCccccCC
Q 005841 654 LKHETYLTTKTGKGTVTYLAS 674 (674)
Q Consensus 654 ~~~~~~~~~~~~~GTp~YmAP 674 (674)
.+.... .....+||+.|+||
T Consensus 249 ~~~~~~-~~~~~~gt~~y~aP 268 (365)
T 2y7j_A 249 HLEPGE-KLRELCGTPGYLAP 268 (365)
T ss_dssp ECCTTC-CBCCCCSCGGGCCH
T ss_pred ccCCCc-ccccCCCCCCccCh
Confidence 765432 23346899999998
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=99.94 E-value=4.4e-27 Score=246.81 Aligned_cols=174 Identities=26% Similarity=0.461 Sum_probs=147.7
Q ss_pred cccccccCCeeEeeeecccCceEEEEEEEc-------CCeEEEEEeecccCCHHHHHHHHHHHHHHhhC-CCCCeeeEEE
Q 005841 498 LDYEILWEDLTIGEQIGQGSCGTVYHAVWY-------GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRL-RHPNVLLFMG 569 (674)
Q Consensus 498 ~~~~~~~~~y~~~~~LG~G~fG~Vy~~~~~-------~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~ 569 (674)
..+++..++|++.+.||+|+||.||+|.+. +..||||++.... .......+.+|+.+++.+ +||||+++++
T Consensus 20 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~ 98 (316)
T 2xir_A 20 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLG 98 (316)
T ss_dssp HHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred cceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCC-CcHHHHHHHHHHHHHHhcccCCCeeeEEE
Confidence 345677889999999999999999999863 3569999997543 445567889999999999 6899999999
Q ss_pred EEecCC-eEEEEEecCCCCCHHHHHHhcCCC---------------CCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCC
Q 005841 570 AVTSPQ-RLCIVTEFLPRGSLFRLLQRNTTK---------------LDWRRRILMALDIARGVSYLHHCNPPIIHRDLKS 633 (674)
Q Consensus 570 ~~~~~~-~~~lV~E~~~ggsL~~~l~~~~~~---------------l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp 633 (674)
++...+ .+|+||||+++++|.+++...... +++..++.++.||+.||.|||+.+ |+||||||
T Consensus 99 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--i~H~dikp 176 (316)
T 2xir_A 99 ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK--CIHRDLAA 176 (316)
T ss_dssp EECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSG
T ss_pred EEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC--cccccCcc
Confidence 988765 599999999999999999765432 899999999999999999999999 99999999
Q ss_pred CCEEEcCCCcEEEEecCCcccccCCc--cccccCCCCccccCC
Q 005841 634 SNLLVDKHWTVKVGDFGLSRLKHETY--LTTKTGKGTVTYLAS 674 (674)
Q Consensus 634 ~NILi~~~~~vkL~DFGla~~~~~~~--~~~~~~~GTp~YmAP 674 (674)
+||||+.++.+||+|||+++...... .......||+.|+||
T Consensus 177 ~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aP 219 (316)
T 2xir_A 177 RNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAP 219 (316)
T ss_dssp GGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCH
T ss_pred ceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCc
Confidence 99999999999999999998764322 223334689999998
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=99.94 E-value=1.2e-26 Score=250.75 Aligned_cols=165 Identities=30% Similarity=0.407 Sum_probs=135.4
Q ss_pred ccCCeeEeeeecccCceEEEEEEE--cCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCC-----
Q 005841 503 LWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQ----- 575 (674)
Q Consensus 503 ~~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~----- 575 (674)
..++|++.+.||+|+||.||+|.+ .+..||||++............+.+|+.+++.++||||+++++++....
T Consensus 23 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~ 102 (371)
T 2xrw_A 23 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 102 (371)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTC
T ss_pred hhhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccc
Confidence 357899999999999999999987 4677999999876656666778899999999999999999999998765
Q ss_pred -eEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCccc
Q 005841 576 -RLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL 654 (674)
Q Consensus 576 -~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~ 654 (674)
.+||||||+++ +|.+++. ..+++..+..++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++.
T Consensus 103 ~~~~lv~e~~~~-~l~~~~~---~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~ 176 (371)
T 2xrw_A 103 QDVYIVMELMDA-NLCQVIQ---MELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLART 176 (371)
T ss_dssp CEEEEEEECCSE-EHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTSCEEECCCCC---
T ss_pred cceEEEEEcCCC-CHHHHHh---hccCHHHHHHHHHHHHHHHHHHHHCC--eecccCCHHHEEEcCCCCEEEEEeecccc
Confidence 78999999965 7888885 35899999999999999999999999 99999999999999999999999999987
Q ss_pred ccCCccccccCCCCccccCC
Q 005841 655 KHETYLTTKTGKGTVTYLAS 674 (674)
Q Consensus 655 ~~~~~~~~~~~~GTp~YmAP 674 (674)
..... .....+||+.||||
T Consensus 177 ~~~~~-~~~~~~gt~~y~aP 195 (371)
T 2xrw_A 177 AGTSF-MMTPYVVTRYYRAP 195 (371)
T ss_dssp --------------CTTCCH
T ss_pred ccccc-ccCCceecCCccCH
Confidence 65432 23346799999998
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=99.94 E-value=1.3e-26 Score=243.65 Aligned_cols=169 Identities=22% Similarity=0.296 Sum_probs=140.6
Q ss_pred ccCCeeEeeeecccCceEEEEEEE--cCCeEEEEEeecccC-CHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeEEE
Q 005841 503 LWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEY-SDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCI 579 (674)
Q Consensus 503 ~~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 579 (674)
..++|++.+.||+|+||.||+|.+ .+..||||++..... .......+.+|+.+++.++||||+++++++...+.+|+
T Consensus 32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 111 (309)
T 2h34_A 32 QFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYV 111 (309)
T ss_dssp --CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEE
T ss_pred EeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEE
Confidence 347899999999999999999997 467799999976543 34556789999999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccccCCc
Q 005841 580 VTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETY 659 (674)
Q Consensus 580 V~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~~~ 659 (674)
||||+++++|.+++... ..+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++.......
T Consensus 112 v~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~ 188 (309)
T 2h34_A 112 DMRLINGVDLAAMLRRQ-GPLAPPRAVAIVRQIGSALDAAHAAG--ATHRDVKPENILVSADDFAYLVDFGIASATTDEK 188 (309)
T ss_dssp EEECCCCEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTSCEEECSCCC--------
T ss_pred EEEecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCc--CCcCCCChHHEEEcCCCCEEEecCccCccccccc
Confidence 99999999999999764 46999999999999999999999999 9999999999999999999999999998765432
Q ss_pred c-ccccCCCCccccCC
Q 005841 660 L-TTKTGKGTVTYLAS 674 (674)
Q Consensus 660 ~-~~~~~~GTp~YmAP 674 (674)
. ......||+.|+||
T Consensus 189 ~~~~~~~~~~~~y~aP 204 (309)
T 2h34_A 189 LTQLGNTVGTLYYMAP 204 (309)
T ss_dssp --------CCGGGCCG
T ss_pred cccccccCCCcCccCH
Confidence 2 22345799999998
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.94 E-value=1.3e-26 Score=241.08 Aligned_cols=166 Identities=30% Similarity=0.518 Sum_probs=142.8
Q ss_pred CeeEeeeecccCceEEEEEEEc--CC---eEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeE-EE
Q 005841 506 DLTIGEQIGQGSCGTVYHAVWY--GS---DVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRL-CI 579 (674)
Q Consensus 506 ~y~~~~~LG~G~fG~Vy~~~~~--~~---~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~-~l 579 (674)
.|.+.++||+|+||.||+|.+. +. .||+|++... ......+.+.+|+.+++.++||||+++++++...+.. ++
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 100 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRI-TEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHV 100 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTC-CSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeecccc-ccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEE
Confidence 4677899999999999999862 22 5999998653 3445667899999999999999999999999877665 99
Q ss_pred EEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccccCCc
Q 005841 580 VTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETY 659 (674)
Q Consensus 580 V~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~~~ 659 (674)
||||+.+++|.+++......+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 101 v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 178 (298)
T 3pls_A 101 LLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQK--FVHRDLAARNCMLDESFTVKVADFGLARDILDRE 178 (298)
T ss_dssp EECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGG
T ss_pred EEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCcceEEEcCCCcEEeCcCCCcccccCCc
Confidence 99999999999999876778999999999999999999999999 9999999999999999999999999998654322
Q ss_pred ----cccccCCCCccccCC
Q 005841 660 ----LTTKTGKGTVTYLAS 674 (674)
Q Consensus 660 ----~~~~~~~GTp~YmAP 674 (674)
.......||+.|+||
T Consensus 179 ~~~~~~~~~~~~~~~y~aP 197 (298)
T 3pls_A 179 YYSVQQHRHARLPVKWTAL 197 (298)
T ss_dssp GGCSCCSSCTTCGGGGSCH
T ss_pred ccccccCcCCCCCccccCh
Confidence 122335689999998
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=99.94 E-value=3.7e-27 Score=259.21 Aligned_cols=169 Identities=30% Similarity=0.508 Sum_probs=136.2
Q ss_pred ccccCCeeEeeeecccCceEEEEEEE--cCCeEEEEEeecccCC------HHHHHHHHHHHHHHhhCCCCCeeeEEEEEe
Q 005841 501 EILWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYS------DEVIHSFRQEVSLMKRLRHPNVLLFMGAVT 572 (674)
Q Consensus 501 ~~~~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~~------~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~ 572 (674)
....++|.+.+.||+|+||+||+|.+ ++..||||++.+.... ......+.+|+.+++.++||||+++++++.
T Consensus 131 ~~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~ 210 (419)
T 3i6u_A 131 KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD 210 (419)
T ss_dssp HHHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE
T ss_pred hhhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe
Confidence 34568899999999999999999998 4678999999875432 122345788999999999999999999985
Q ss_pred cCCeEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCC---CcEEEEec
Q 005841 573 SPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKH---WTVKVGDF 649 (674)
Q Consensus 573 ~~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~---~~vkL~DF 649 (674)
...+||||||+++++|.+++.. ...+++..+..++.||+.||.|||+++ |+||||||+||||+.+ +.+||+||
T Consensus 211 -~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~--ivHrDlkp~NIll~~~~~~~~~kl~DF 286 (419)
T 3i6u_A 211 -AEDYYIVLELMEGGELFDKVVG-NKRLKEATCKLYFYQMLLAVQYLHENG--IIHRDLKPENVLLSSQEEDCLIKITDF 286 (419)
T ss_dssp -SSEEEEEEECCTTCBGGGGTSS-SCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESSSSSSCCEEECCS
T ss_pred -cCceEEEEEcCCCCcHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCChHhEEEecCCCcceEEEeec
Confidence 4568999999999999998864 457999999999999999999999999 9999999999999754 45999999
Q ss_pred CCcccccCCccccccCCCCccccCC
Q 005841 650 GLSRLKHETYLTTKTGKGTVTYLAS 674 (674)
Q Consensus 650 Gla~~~~~~~~~~~~~~GTp~YmAP 674 (674)
|+|+....... ....+||+.||||
T Consensus 287 G~a~~~~~~~~-~~~~~gt~~y~aP 310 (419)
T 3i6u_A 287 GHSKILGETSL-MRTLCGTPTYLAP 310 (419)
T ss_dssp STTTSCC------------CTTCCT
T ss_pred ccceecCCCcc-ccccCCCCCccCc
Confidence 99987765432 3346899999999
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=2.3e-27 Score=247.20 Aligned_cols=173 Identities=25% Similarity=0.425 Sum_probs=129.3
Q ss_pred ccccccCCeeEeeeecccCceEEEEEEE--cCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCe
Q 005841 499 DYEILWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQR 576 (674)
Q Consensus 499 ~~~~~~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 576 (674)
.+.+..++|++.+.||+|+||.||+|.+ ++..||||++..... ......+.+|+.+++.++||||+++++++...+.
T Consensus 9 p~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 87 (303)
T 2vwi_A 9 PWSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKC-QTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDE 87 (303)
T ss_dssp ----CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC-----------------CCCCCCCTTBCCEEEEEESSSC
T ss_pred ccccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhc-chhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCC
Confidence 3467778999999999999999999986 577899999865432 2345678889999999999999999999999999
Q ss_pred EEEEEecCCCCCHHHHHHh-------cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEec
Q 005841 577 LCIVTEFLPRGSLFRLLQR-------NTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDF 649 (674)
Q Consensus 577 ~~lV~E~~~ggsL~~~l~~-------~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DF 649 (674)
.|+||||+++++|.+++.. ....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+||
T Consensus 88 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~kl~df 165 (303)
T 2vwi_A 88 LWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG--QIHRDVKAGNILLGEDGSVQIADF 165 (303)
T ss_dssp EEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEECTTCCEEECCC
T ss_pred cEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC--CCCCCCChhhEEEcCCCCEEEEec
Confidence 9999999999999999874 2456999999999999999999999999 999999999999999999999999
Q ss_pred CCcccccCCc-----cccccCCCCccccCC
Q 005841 650 GLSRLKHETY-----LTTKTGKGTVTYLAS 674 (674)
Q Consensus 650 Gla~~~~~~~-----~~~~~~~GTp~YmAP 674 (674)
|++....... .......||+.|+||
T Consensus 166 g~~~~~~~~~~~~~~~~~~~~~~~~~y~aP 195 (303)
T 2vwi_A 166 GVSAFLATGGDITRNKVRKTFVGTPCWMAP 195 (303)
T ss_dssp HHHHHCC---------------CCCTTCCH
T ss_pred cchheeccCCCccchhhhcccCCCccccCH
Confidence 9997654321 112335799999998
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.7e-26 Score=240.31 Aligned_cols=171 Identities=25% Similarity=0.412 Sum_probs=142.8
Q ss_pred cccccCCeeEee-eecccCceEEEEEEEc----CCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecC
Q 005841 500 YEILWEDLTIGE-QIGQGSCGTVYHAVWY----GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSP 574 (674)
Q Consensus 500 ~~~~~~~y~~~~-~LG~G~fG~Vy~~~~~----~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~ 574 (674)
..+...+|.+.+ .||+|+||.||+|.+. +..||||++..........+.+.+|+.+++.++||||+++++++ ..
T Consensus 11 ~~~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~ 89 (291)
T 1xbb_A 11 VYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EA 89 (291)
T ss_dssp CBCCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ES
T ss_pred eeecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CC
Confidence 355667899998 9999999999999652 45699999977655556678899999999999999999999999 56
Q ss_pred CeEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCccc
Q 005841 575 QRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL 654 (674)
Q Consensus 575 ~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~ 654 (674)
+.+|+||||+++++|.+++.. ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 90 ~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dikp~Nil~~~~~~~kl~Dfg~~~~ 166 (291)
T 1xbb_A 90 ESWMLVMEMAELGPLNKYLQQ-NRHVKDKNIIELVHQVSMGMKYLEESN--FVHRDLAARNVLLVTQHYAKISDFGLSKA 166 (291)
T ss_dssp SSEEEEEECCTTEEHHHHHHH-CTTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred CCcEEEEEeCCCCCHHHHHHh-CcCCCHHHHHHHHHHHHHHHHHHHhCC--eEcCCCCcceEEEeCCCcEEEccCCccee
Confidence 779999999999999999976 456999999999999999999999999 99999999999999999999999999987
Q ss_pred ccCCccc---cccCCCCccccCC
Q 005841 655 KHETYLT---TKTGKGTVTYLAS 674 (674)
Q Consensus 655 ~~~~~~~---~~~~~GTp~YmAP 674 (674)
....... .....||+.|+||
T Consensus 167 ~~~~~~~~~~~~~~~~~~~y~aP 189 (291)
T 1xbb_A 167 LRADENYYKAQTHGKWPVKWYAP 189 (291)
T ss_dssp CCTTCSEEEC----CCCGGGCCH
T ss_pred eccCCCcccccccCCCCceeeCh
Confidence 6443221 2224578999998
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=1.3e-26 Score=266.95 Aligned_cols=171 Identities=24% Similarity=0.427 Sum_probs=141.0
Q ss_pred cccccCCeeEee-eecccCceEEEEEEEc----CCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecC
Q 005841 500 YEILWEDLTIGE-QIGQGSCGTVYHAVWY----GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSP 574 (674)
Q Consensus 500 ~~~~~~~y~~~~-~LG~G~fG~Vy~~~~~----~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~ 574 (674)
+.+..+++.+.+ .||+|+||.||+|.+. +..||||++.... .....+.+.+|+.+|+.++||||+++++++..
T Consensus 330 ~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~- 407 (613)
T 2ozo_A 330 LFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT-EKADTEEMMREAQIMHQLDNPYIVRLIGVCQA- 407 (613)
T ss_dssp SBCCTTSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCC-SSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-
T ss_pred eeccccceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCC-ChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-
Confidence 345566777777 8999999999999873 3459999997653 22345678999999999999999999999976
Q ss_pred CeEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCccc
Q 005841 575 QRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL 654 (674)
Q Consensus 575 ~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~ 654 (674)
+.+|||||||++|+|.+++......+++..++.|+.||+.||.|||+++ ||||||||+||||+.++.+||+|||+++.
T Consensus 408 ~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--iiHrDlkp~NILl~~~~~vkL~DFGla~~ 485 (613)
T 2ozo_A 408 EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN--FVHRNLAARNVLLVNRHYAKISDFGLSKA 485 (613)
T ss_dssp SSEEEEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEEETTEEEECCCSTTTT
T ss_pred CCeEEEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC--EEcCcCCHHHEEEcCCCcEEEeeccCccc
Confidence 5699999999999999999877777999999999999999999999999 99999999999999999999999999987
Q ss_pred ccCCcc---ccccCCCCccccCC
Q 005841 655 KHETYL---TTKTGKGTVTYLAS 674 (674)
Q Consensus 655 ~~~~~~---~~~~~~GTp~YmAP 674 (674)
...... ......+|+.||||
T Consensus 486 ~~~~~~~~~~~~~~~~~~~y~AP 508 (613)
T 2ozo_A 486 LGADDSYYTARSAGKWPLKWYAP 508 (613)
T ss_dssp CC--------------CCTTSCH
T ss_pred ccCCCceeeeccCCCCccceeCH
Confidence 643211 12234577999998
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=99.94 E-value=5.9e-27 Score=260.08 Aligned_cols=170 Identities=34% Similarity=0.598 Sum_probs=141.8
Q ss_pred ccccccCCeeEeeeecccCceEEEEEEEcC-CeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeE
Q 005841 499 DYEILWEDLTIGEQIGQGSCGTVYHAVWYG-SDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRL 577 (674)
Q Consensus 499 ~~~~~~~~y~~~~~LG~G~fG~Vy~~~~~~-~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 577 (674)
.+++..++|++.+.||+|+||.||+|.+.+ ..||||++....... +.+.+|+.+|+.++||||+++++++.. +.+
T Consensus 178 ~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~---~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~ 253 (452)
T 1fmk_A 178 AWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP---EAFLQEAQVMKKLRHEKLVQLYAVVSE-EPI 253 (452)
T ss_dssp CSBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSCH---HHHHHHHHHHHHCCCTTBCCEEEEECS-SSC
T ss_pred ccccChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCCCCH---HHHHHHHHHHHhCCCCCEeeEEEEEcC-Cce
Confidence 457788899999999999999999999965 469999997655432 568899999999999999999999876 779
Q ss_pred EEEEecCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCccccc
Q 005841 578 CIVTEFLPRGSLFRLLQRN-TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKH 656 (674)
Q Consensus 578 ~lV~E~~~ggsL~~~l~~~-~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~ 656 (674)
||||||+++|+|.+++... ...+++..++.++.||+.||.|||+++ ||||||||+||||+.++.+||+|||+++...
T Consensus 254 ~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~ 331 (452)
T 1fmk_A 254 YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN--YVHRDLRAANILVGENLVCKVADFGLARLIE 331 (452)
T ss_dssp EEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECGGGCEEECCCCTTC---
T ss_pred EEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCChhhEEECCCCCEEECCCccceecC
Confidence 9999999999999999753 346899999999999999999999999 9999999999999999999999999998765
Q ss_pred CCccc-cccCCCCccccCC
Q 005841 657 ETYLT-TKTGKGTVTYLAS 674 (674)
Q Consensus 657 ~~~~~-~~~~~GTp~YmAP 674 (674)
..... .....+|+.||||
T Consensus 332 ~~~~~~~~~~~~~~~y~aP 350 (452)
T 1fmk_A 332 DNEYTARQGAKFPIKWTAP 350 (452)
T ss_dssp -----------CCGGGSCH
T ss_pred CCceecccCCcccccccCH
Confidence 43322 2234578999998
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=3.2e-26 Score=238.43 Aligned_cols=168 Identities=26% Similarity=0.427 Sum_probs=147.1
Q ss_pred ccCCeeEeeeecccCceEEEEEEE--cCCeEEEEEeecccC---C----HHHHHHHHHHHHHHhhCC-CCCeeeEEEEEe
Q 005841 503 LWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEY---S----DEVIHSFRQEVSLMKRLR-HPNVLLFMGAVT 572 (674)
Q Consensus 503 ~~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~---~----~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~ 572 (674)
..++|++.+.||+|+||.||+|.+ ++..||||++..... . ....+.+.+|+.+++.+. ||||+++++++.
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 94 (298)
T 1phk_A 15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE 94 (298)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred hhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeec
Confidence 457899999999999999999998 467899999976531 1 234567889999999996 999999999999
Q ss_pred cCCeEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCc
Q 005841 573 SPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLS 652 (674)
Q Consensus 573 ~~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla 652 (674)
....+|+||||+++++|.+++... ..+++..+..++.||+.||.|||+++ |+|+||||+|||++.++.+||+|||++
T Consensus 95 ~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~kl~dfg~~ 171 (298)
T 1phk_A 95 TNTFFFLVFDLMKKGELFDYLTEK-VTLSEKETRKIMRALLEVICALHKLN--IVHRDLKPENILLDDDMNIKLTDFGFS 171 (298)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred cCCeEEEEEeccCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCcceEEEcCCCcEEEecccch
Confidence 999999999999999999999764 46999999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCccccccCCCCccccCC
Q 005841 653 RLKHETYLTTKTGKGTVTYLAS 674 (674)
Q Consensus 653 ~~~~~~~~~~~~~~GTp~YmAP 674 (674)
....... ......||+.|+||
T Consensus 172 ~~~~~~~-~~~~~~~~~~y~aP 192 (298)
T 1phk_A 172 CQLDPGE-KLREVCGTPSYLAP 192 (298)
T ss_dssp EECCTTC-CBCCCCSCGGGCCH
T ss_pred hhcCCCc-ccccccCCccccCH
Confidence 8765432 23346799999998
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=7.2e-27 Score=248.06 Aligned_cols=170 Identities=25% Similarity=0.476 Sum_probs=136.9
Q ss_pred ccccCCeeEeeeecccCceEEEEEEE--cCCe----EEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecC
Q 005841 501 EILWEDLTIGEQIGQGSCGTVYHAVW--YGSD----VAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSP 574 (674)
Q Consensus 501 ~~~~~~y~~~~~LG~G~fG~Vy~~~~--~~~~----vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~ 574 (674)
.+...+|++.++||+|+||.||+|.+ .+.. ||+|.+.... .......+.+|+.+++.++||||+++++++...
T Consensus 11 ~l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 89 (327)
T 3lzb_A 11 ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLTS 89 (327)
T ss_dssp ECCTTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCS-SCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESS
T ss_pred ccCHhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeecccc-CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecC
Confidence 34568899999999999999999997 3444 4666664332 223346788999999999999999999999875
Q ss_pred CeEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCccc
Q 005841 575 QRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL 654 (674)
Q Consensus 575 ~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~ 654 (674)
. .++||||+.+++|.+++......+++..++.++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++.
T Consensus 90 ~-~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~NIl~~~~~~~kL~DfG~a~~ 166 (327)
T 3lzb_A 90 T-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR--LVHRDLAARNVLVKTPQHVKITDFGLAKL 166 (327)
T ss_dssp S-EEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEEETTEEEECCTTC---
T ss_pred C-ceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCC--CcCCCCCHHHEEEcCCCCEEEccCcceeE
Confidence 4 88999999999999999887778999999999999999999999999 99999999999999999999999999987
Q ss_pred ccCCc--cccccCCCCccccCC
Q 005841 655 KHETY--LTTKTGKGTVTYLAS 674 (674)
Q Consensus 655 ~~~~~--~~~~~~~GTp~YmAP 674 (674)
..... .......||+.||||
T Consensus 167 ~~~~~~~~~~~~~~~t~~y~aP 188 (327)
T 3lzb_A 167 LGAEEKEYHAEGGKVPIKWMAL 188 (327)
T ss_dssp -------------CCCGGGSCH
T ss_pred ccCccccccccCCCccccccCH
Confidence 64322 223334688999998
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=5.3e-27 Score=242.21 Aligned_cols=166 Identities=33% Similarity=0.536 Sum_probs=137.6
Q ss_pred cccccCCeeEeeeecccCceEEEEEEEcCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecC-CeEE
Q 005841 500 YEILWEDLTIGEQIGQGSCGTVYHAVWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSP-QRLC 578 (674)
Q Consensus 500 ~~~~~~~y~~~~~LG~G~fG~Vy~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~-~~~~ 578 (674)
+.+..++|++.+.||+|+||.||++.+.+..||||++.... ..+.+.+|+.+++.++||||+++++++... +.+|
T Consensus 16 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (278)
T 1byg_A 16 WALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLY 91 (278)
T ss_dssp CBCCGGGEEEEEEEEECSSCEEEEEEETTEEEEEEECCCCC------HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCE
T ss_pred ccCChhhceEEeEEecCCCceEEEEEEcCCEEEEEEecchh----HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceE
Confidence 45667899999999999999999999999999999997543 345688999999999999999999987654 4799
Q ss_pred EEEecCCCCCHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccccC
Q 005841 579 IVTEFLPRGSLFRLLQRNTT-KLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHE 657 (674)
Q Consensus 579 lV~E~~~ggsL~~~l~~~~~-~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~ 657 (674)
+||||+++++|.+++..... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 92 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~ 169 (278)
T 1byg_A 92 IVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN--FVHRDLAARNVLVSEDNVAKVSDFGLTKEASS 169 (278)
T ss_dssp EEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECTTSCEEECCCCC------
T ss_pred EEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCCcceEEEeCCCcEEEeeccccccccc
Confidence 99999999999999976432 3889999999999999999999999 99999999999999999999999999986554
Q ss_pred CccccccCCCCccccCC
Q 005841 658 TYLTTKTGKGTVTYLAS 674 (674)
Q Consensus 658 ~~~~~~~~~GTp~YmAP 674 (674)
.. ....+|+.|+||
T Consensus 170 ~~---~~~~~~~~y~aP 183 (278)
T 1byg_A 170 TQ---DTGKLPVKWTAP 183 (278)
T ss_dssp ---------CCTTTSCH
T ss_pred cc---cCCCccccccCH
Confidence 32 234689999998
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.4e-26 Score=239.06 Aligned_cols=164 Identities=29% Similarity=0.450 Sum_probs=142.5
Q ss_pred cccCCeeEeeeecccCceEEEEEEEc--CCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEec------
Q 005841 502 ILWEDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTS------ 573 (674)
Q Consensus 502 ~~~~~y~~~~~LG~G~fG~Vy~~~~~--~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~------ 573 (674)
....+|++.+.||+|+||.||+|.+. +..||||++.... ..+.+|+.+++.++||||+++++++..
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (284)
T 2a19_B 8 RFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN------EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPE 81 (284)
T ss_dssp HHHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS------GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC--
T ss_pred hhccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc------HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcc
Confidence 34568999999999999999999984 7889999997543 246679999999999999999998864
Q ss_pred ----------CCeEEEEEecCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCC
Q 005841 574 ----------PQRLCIVTEFLPRGSLFRLLQRN-TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHW 642 (674)
Q Consensus 574 ----------~~~~~lV~E~~~ggsL~~~l~~~-~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~ 642 (674)
...+|+||||+++++|.+++... ...+++..++.++.||+.||.|||+.+ |+|+||||+|||++.++
T Consensus 82 ~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~~ 159 (284)
T 2a19_B 82 TSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKK--LINRDLKPSNIFLVDTK 159 (284)
T ss_dssp -------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEEETT
T ss_pred cccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeccCCHHHEEEcCCC
Confidence 34589999999999999999754 357999999999999999999999999 99999999999999999
Q ss_pred cEEEEecCCcccccCCccccccCCCCccccCC
Q 005841 643 TVKVGDFGLSRLKHETYLTTKTGKGTVTYLAS 674 (674)
Q Consensus 643 ~vkL~DFGla~~~~~~~~~~~~~~GTp~YmAP 674 (674)
.+||+|||+++....... .....||+.|+||
T Consensus 160 ~~kl~Dfg~~~~~~~~~~-~~~~~~~~~y~aP 190 (284)
T 2a19_B 160 QVKIGDFGLVTSLKNDGK-RTRSKGTLRYMSP 190 (284)
T ss_dssp EEEECCCTTCEESSCCSC-CCCCCSCCTTSCH
T ss_pred CEEECcchhheecccccc-ccccCCcccccCh
Confidence 999999999987655432 2335799999998
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=99.94 E-value=2.1e-26 Score=242.09 Aligned_cols=166 Identities=23% Similarity=0.346 Sum_probs=137.5
Q ss_pred cCCeeEe-eeecccCceEEEEEEE--cCCeEEEEEeecccCCHHHHHHHHHHHHHHhhC-CCCCeeeEEEEEecCCeEEE
Q 005841 504 WEDLTIG-EQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRL-RHPNVLLFMGAVTSPQRLCI 579 (674)
Q Consensus 504 ~~~y~~~-~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~l 579 (674)
.+.|.+. ++||+|+||.||+|.+ ++..||||++...... ....+.+|+.++.++ +||||+++++++...+.+||
T Consensus 11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~l 88 (316)
T 2ac3_A 11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGH--IRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYL 88 (316)
T ss_dssp TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSC--CHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcch--hHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEE
Confidence 3678885 7899999999999987 5778999999765432 245688899999985 79999999999999999999
Q ss_pred EEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCc---EEEEecCCccccc
Q 005841 580 VTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWT---VKVGDFGLSRLKH 656 (674)
Q Consensus 580 V~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~---vkL~DFGla~~~~ 656 (674)
||||+++++|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++. +||+|||+++...
T Consensus 89 v~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~ 165 (316)
T 2ac3_A 89 VFEKMRGGSILSHIHKR-RHFNELEASVVVQDVASALDFLHNKG--IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIK 165 (316)
T ss_dssp EEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEESCSSSSCSEEECCTTCCC---
T ss_pred EEEcCCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCC--ceeCCCCHHHEEEccCCCcCceEEEEccCccccc
Confidence 99999999999999764 46999999999999999999999999 999999999999987765 9999999997653
Q ss_pred CCc-------cccccCCCCccccCC
Q 005841 657 ETY-------LTTKTGKGTVTYLAS 674 (674)
Q Consensus 657 ~~~-------~~~~~~~GTp~YmAP 674 (674)
... ......+||+.|+||
T Consensus 166 ~~~~~~~~~~~~~~~~~gt~~y~aP 190 (316)
T 2ac3_A 166 LNGDCSPISTPELLTPCGSAEYMAP 190 (316)
T ss_dssp ----------------CCSGGGCCH
T ss_pred cCCccccccccccccccCCcCccCh
Confidence 211 112234699999998
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=2.7e-26 Score=242.93 Aligned_cols=170 Identities=30% Similarity=0.542 Sum_probs=146.1
Q ss_pred ccccCCeeEeeeecccCceEEEEEEE------cCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecC
Q 005841 501 EILWEDLTIGEQIGQGSCGTVYHAVW------YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSP 574 (674)
Q Consensus 501 ~~~~~~y~~~~~LG~G~fG~Vy~~~~------~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~ 574 (674)
.+..++|++.+.||+|+||.||+|.+ .+..||||++... .....+.+.+|+.+++.++||||+++++++...
T Consensus 37 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 114 (326)
T 2w1i_A 37 QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS--TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSA 114 (326)
T ss_dssp CCCGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSC--CSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC-
T ss_pred ccCHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEec
Confidence 34557899999999999999999985 4667999998754 345567899999999999999999999998765
Q ss_pred C--eEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCc
Q 005841 575 Q--RLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLS 652 (674)
Q Consensus 575 ~--~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla 652 (674)
+ .+++||||+++++|.+++......+++..++.++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||++
T Consensus 115 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dikp~NIli~~~~~~kL~Dfg~~ 192 (326)
T 2w1i_A 115 GRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR--YIHRDLATRNILVENENRVKIGDFGLT 192 (326)
T ss_dssp ---CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEEEETTEEEECCCTTC
T ss_pred CCCceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC--EeccCCCcceEEEcCCCcEEEecCcch
Confidence 4 789999999999999999887778999999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCcc---ccccCCCCccccCC
Q 005841 653 RLKHETYL---TTKTGKGTVTYLAS 674 (674)
Q Consensus 653 ~~~~~~~~---~~~~~~GTp~YmAP 674 (674)
+....... ......||+.|+||
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~~y~aP 217 (326)
T 2w1i_A 193 KVLPQDKEYYKVKEPGESPIFWYAP 217 (326)
T ss_dssp EECCSSCSEEECSSCCSCCGGGCCH
T ss_pred hhccccccccccccCCCCceeEECc
Confidence 87654322 12234688899998
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=1.7e-26 Score=242.92 Aligned_cols=170 Identities=21% Similarity=0.265 Sum_probs=143.2
Q ss_pred ccccCCeeEeeeecccCceEEEEEEE--cCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEe----cC
Q 005841 501 EILWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVT----SP 574 (674)
Q Consensus 501 ~~~~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~----~~ 574 (674)
.+..++|++.+.||+|+||.||++.+ .+..||||++... .....+.+.+|+.+++.++||||+++++++. ..
T Consensus 25 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 102 (317)
T 2buj_A 25 IIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCH--EQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAK 102 (317)
T ss_dssp EETTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEES--SHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTE
T ss_pred EECCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecC--CHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCC
Confidence 45567899999999999999999997 5778999998653 3455678899999999999999999999986 34
Q ss_pred CeEEEEEecCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCC
Q 005841 575 QRLCIVTEFLPRGSLFRLLQR---NTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGL 651 (674)
Q Consensus 575 ~~~~lV~E~~~ggsL~~~l~~---~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGl 651 (674)
..+|+||||+++++|.+++.. ....+++..++.++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+
T Consensus 103 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~dlkp~NIl~~~~~~~kl~dfg~ 180 (317)
T 2buj_A 103 HEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG--YAHRDLKPTNILLGDEGQPVLMDLGS 180 (317)
T ss_dssp EEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTSCEEECCCSS
T ss_pred ceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEEcCCCCEEEEecCc
Confidence 578999999999999999876 3567999999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCccc---------cccCCCCccccCC
Q 005841 652 SRLKHETYLT---------TKTGKGTVTYLAS 674 (674)
Q Consensus 652 a~~~~~~~~~---------~~~~~GTp~YmAP 674 (674)
+......... .....||+.|+||
T Consensus 181 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP 212 (317)
T 2buj_A 181 MNQACIHVEGSRQALTLQDWAAQRCTISYRAP 212 (317)
T ss_dssp CEESCEEEESHHHHHHHHHHHHHHSCGGGCCG
T ss_pred chhcccccccccccccccccccccCCcccCCH
Confidence 8765321110 1123589999998
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=99.94 E-value=1.3e-26 Score=238.38 Aligned_cols=167 Identities=28% Similarity=0.408 Sum_probs=146.0
Q ss_pred cCCeeEeeeecccCceEEEEEEEc--CCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeEEEEE
Q 005841 504 WEDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVT 581 (674)
Q Consensus 504 ~~~y~~~~~LG~G~fG~Vy~~~~~--~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 581 (674)
.++|++.+.||+|+||.||+|.+. +..||||++...... ...+.+.+|+.+++.++||||+++++++......|+||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 84 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV-DCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL 84 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCT-THHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccch-hhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEE
Confidence 367999999999999999999984 778999999765432 34567889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccccCCc--
Q 005841 582 EFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETY-- 659 (674)
Q Consensus 582 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~~~-- 659 (674)
||+++++|.+++.. ...+++..+..++.||+.||.|||+++ |+|+||||+|||++.++.+||+|||++.......
T Consensus 85 e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~ 161 (276)
T 2yex_A 85 EYCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHGIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 161 (276)
T ss_dssp ECCTTEEGGGGSBT-TTBCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred EecCCCcHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCChHHEEEccCCCEEEeeCCCccccCCCcch
Confidence 99999999998864 456999999999999999999999999 9999999999999999999999999998654321
Q ss_pred cccccCCCCccccCC
Q 005841 660 LTTKTGKGTVTYLAS 674 (674)
Q Consensus 660 ~~~~~~~GTp~YmAP 674 (674)
.......||+.|+||
T Consensus 162 ~~~~~~~~~~~y~aP 176 (276)
T 2yex_A 162 RLLNKMCGTLPYVAP 176 (276)
T ss_dssp CCBCCCCSCGGGCCG
T ss_pred hcccCCccccCccCh
Confidence 123346799999998
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=2.8e-27 Score=269.87 Aligned_cols=158 Identities=16% Similarity=0.146 Sum_probs=126.4
Q ss_pred eeecccCceEEEEEEE--cCCeEEEEEeecccCC--------HHHHHHHHHHHHHHhhC-CCCCeeeEEEEEecCCeEEE
Q 005841 511 EQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYS--------DEVIHSFRQEVSLMKRL-RHPNVLLFMGAVTSPQRLCI 579 (674)
Q Consensus 511 ~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~~--------~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~l 579 (674)
..++.|++|.+..++. .+..|+||++.+.... ....+.|.+|+.+|+++ .|+||+++++++++...+||
T Consensus 240 ~~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yL 319 (569)
T 4azs_A 240 NQPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWL 319 (569)
T ss_dssp CC-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEE
T ss_pred hccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEE
Confidence 3567777777766553 7899999999865321 23456799999999999 69999999999999999999
Q ss_pred EEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccccCCc
Q 005841 580 VTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETY 659 (674)
Q Consensus 580 V~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~~~ 659 (674)
|||||+|++|.++|.. ...+++. .|+.||+.||+|||++| ||||||||+||||+.+|+|||+|||+|+......
T Consensus 320 VMEyv~G~~L~d~i~~-~~~l~~~---~I~~QIl~AL~ylH~~G--IIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~ 393 (569)
T 4azs_A 320 VMEKLPGRLLSDMLAA-GEEIDRE---KILGSLLRSLAALEKQG--FWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDC 393 (569)
T ss_dssp EEECCCSEEHHHHHHT-TCCCCHH---HHHHHHHHHHHHHHHTT--CEESCCCGGGEEECTTSCEEECCCTTEESCC---
T ss_pred EEecCCCCcHHHHHHh-CCCCCHH---HHHHHHHHHHHHHHHCC--ceeccCchHhEEECCCCCEEEeecccCeeCCCCC
Confidence 9999999999999976 4567664 47899999999999999 9999999999999999999999999999876655
Q ss_pred cccccCCCCccccCC
Q 005841 660 LTTKTGKGTVTYLAS 674 (674)
Q Consensus 660 ~~~~~~~GTp~YmAP 674 (674)
....+.+|||.||||
T Consensus 394 ~~~~t~vGTp~YmAP 408 (569)
T 4azs_A 394 SWPTNLVQSFFVFVN 408 (569)
T ss_dssp CCSHHHHHHHHHHHH
T ss_pred ccccCceechhhccH
Confidence 555567899999998
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=1.2e-26 Score=243.66 Aligned_cols=173 Identities=25% Similarity=0.383 Sum_probs=133.7
Q ss_pred cccccccCCeeEeeeecccCceEEEEEEE--cCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCC
Q 005841 498 LDYEILWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQ 575 (674)
Q Consensus 498 ~~~~~~~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~ 575 (674)
..+....++|++.+.||+|+||.||+|.+ ++..||||++............+..+..+++.++||||+++++++...+
T Consensus 18 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~ 97 (318)
T 2dyl_A 18 QRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNT 97 (318)
T ss_dssp SEEECCGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS
T ss_pred hhhhhhhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCC
Confidence 45566778999999999999999999998 4778999999876544444455555666788889999999999999999
Q ss_pred eEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCeEEccCCCCCEEEcCCCcEEEEecCCccc
Q 005841 576 RLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHC-NPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL 654 (674)
Q Consensus 576 ~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~-~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~ 654 (674)
.+||||||+ ++.+..++......+++..+..++.||+.||.|||+. + |+|+||||+|||++.++.+||+|||++..
T Consensus 98 ~~~lv~e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~--i~H~dlkp~Nil~~~~~~~kl~dfg~~~~ 174 (318)
T 2dyl_A 98 DVFIAMELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHG--VIHRDVKPSNILLDERGQIKLCDFGISGR 174 (318)
T ss_dssp EEEEEECCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHC--CCCCCCCGGGEEECTTSCEEECCCTTC--
T ss_pred cEEEEEecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCC--EEeCCCCHHHEEECCCCCEEEEECCCchh
Confidence 999999999 6677777766567899999999999999999999984 8 99999999999999999999999999976
Q ss_pred ccCCccccccCCCCccccCC
Q 005841 655 KHETYLTTKTGKGTVTYLAS 674 (674)
Q Consensus 655 ~~~~~~~~~~~~GTp~YmAP 674 (674)
...... .....||+.|+||
T Consensus 175 ~~~~~~-~~~~~~~~~y~aP 193 (318)
T 2dyl_A 175 LVDDKA-KDRSAGCAAYMAP 193 (318)
T ss_dssp -------------CCTTCCH
T ss_pred ccCCcc-ccccCCCccccCh
Confidence 654322 2235799999998
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=5.8e-27 Score=248.55 Aligned_cols=171 Identities=23% Similarity=0.382 Sum_probs=143.7
Q ss_pred ccccCCeeEe-eeecccCceEEEEEEEc--CCeEEEEEeecccCCHHHHHHHHHHHHHHhhCC-CCCeeeEEEEEecCCe
Q 005841 501 EILWEDLTIG-EQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLR-HPNVLLFMGAVTSPQR 576 (674)
Q Consensus 501 ~~~~~~y~~~-~~LG~G~fG~Vy~~~~~--~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~ 576 (674)
+...+.|.+. +.||+|+||.||+|.+. +..||||++.+..........+.+|+.+++.+. ||||+++++++.....
T Consensus 24 ~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~ 103 (327)
T 3lm5_A 24 ENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSE 103 (327)
T ss_dssp HHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred HhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCe
Confidence 4455678887 89999999999999984 778999999876554444567889999999995 6999999999999999
Q ss_pred EEEEEecCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcC---CCcEEEEecCCc
Q 005841 577 LCIVTEFLPRGSLFRLLQRN-TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDK---HWTVKVGDFGLS 652 (674)
Q Consensus 577 ~~lV~E~~~ggsL~~~l~~~-~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~---~~~vkL~DFGla 652 (674)
+|+||||+++++|.+++... ...+++..++.++.||+.||.|||+++ |+||||||+||||+. ++.+||+|||++
T Consensus 104 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~g--ivH~Dikp~NIl~~~~~~~~~~kL~Dfg~a 181 (327)
T 3lm5_A 104 IILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNN--IVHLDLKPQNILLSSIYPLGDIKIVDFGMS 181 (327)
T ss_dssp EEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEESCBTTBCCEEECCGGGC
T ss_pred EEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC--eecCcCChHHEEEecCCCCCcEEEeeCccc
Confidence 99999999999999988543 357999999999999999999999999 999999999999987 789999999999
Q ss_pred ccccCCccccccCCCCccccCC
Q 005841 653 RLKHETYLTTKTGKGTVTYLAS 674 (674)
Q Consensus 653 ~~~~~~~~~~~~~~GTp~YmAP 674 (674)
+....... ....+||+.|+||
T Consensus 182 ~~~~~~~~-~~~~~gt~~y~aP 202 (327)
T 3lm5_A 182 RKIGHACE-LREIMGTPEYLAP 202 (327)
T ss_dssp EEC----------CCCGGGCCH
T ss_pred cccCCccc-cccccCCcCccCC
Confidence 87654322 2346799999998
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=99.94 E-value=7.6e-27 Score=264.70 Aligned_cols=170 Identities=34% Similarity=0.594 Sum_probs=147.3
Q ss_pred ccccccCCeeEeeeecccCceEEEEEEEcC-CeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeE
Q 005841 499 DYEILWEDLTIGEQIGQGSCGTVYHAVWYG-SDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRL 577 (674)
Q Consensus 499 ~~~~~~~~y~~~~~LG~G~fG~Vy~~~~~~-~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 577 (674)
.+++..++|++.++||+|+||.||+|.+.+ ..||||++...... .+.|.+|+.+|+.++||||+++++++.. ..+
T Consensus 261 ~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~ 336 (535)
T 2h8h_A 261 AWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS---PEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPI 336 (535)
T ss_dssp CSBCCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECS-SSC
T ss_pred ceecchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCCCC---HHHHHHHHHHHHhCCCCCEeeEEEEEee-ccc
Confidence 457788899999999999999999999965 46999999765543 2568899999999999999999999876 779
Q ss_pred EEEEecCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCccccc
Q 005841 578 CIVTEFLPRGSLFRLLQRN-TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKH 656 (674)
Q Consensus 578 ~lV~E~~~ggsL~~~l~~~-~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~ 656 (674)
|||||||.+++|.++|... ...+++..++.|+.||+.||.|||+++ ||||||||+||||+.++.+||+|||+++...
T Consensus 337 ~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 414 (535)
T 2h8h_A 337 YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN--YVHRDLRAANILVGENLVCKVADFGLARLIE 414 (535)
T ss_dssp EEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECGGGCEEECCTTSTTTCC
T ss_pred eEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCCHhhEEEcCCCcEEEcccccceecC
Confidence 9999999999999999753 346899999999999999999999999 9999999999999999999999999998765
Q ss_pred CCccc-cccCCCCccccCC
Q 005841 657 ETYLT-TKTGKGTVTYLAS 674 (674)
Q Consensus 657 ~~~~~-~~~~~GTp~YmAP 674 (674)
..... .....+|+.||||
T Consensus 415 ~~~~~~~~~~~~~~~y~aP 433 (535)
T 2h8h_A 415 DNEYTARQGAKFPIKWTAP 433 (535)
T ss_dssp CHHHHTTCSTTSCGGGSCH
T ss_pred CCceecccCCcCcccccCH
Confidence 43322 2234578899998
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=6.9e-27 Score=249.80 Aligned_cols=170 Identities=21% Similarity=0.263 Sum_probs=136.5
Q ss_pred ccccCCeeEeeeecccCceEEEEEEEc-----CCeEEEEEeecccCCH----H-----HHHHHHHHHHHHhhCCCCCeee
Q 005841 501 EILWEDLTIGEQIGQGSCGTVYHAVWY-----GSDVAVKVFSRQEYSD----E-----VIHSFRQEVSLMKRLRHPNVLL 566 (674)
Q Consensus 501 ~~~~~~y~~~~~LG~G~fG~Vy~~~~~-----~~~vAvK~i~~~~~~~----~-----~~~~~~~Ei~il~~l~HpnIv~ 566 (674)
++..++|++.+.||+|+||.||+|.+. +..||||++....... . ....+.+|+.+++.+.||||++
T Consensus 33 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~ 112 (345)
T 2v62_A 33 DMEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPL 112 (345)
T ss_dssp CTTSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCC
T ss_pred cccCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcce
Confidence 456688999999999999999999984 4569999987653211 0 1123667889999999999999
Q ss_pred EEEEEec----CCeEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCC
Q 005841 567 FMGAVTS----PQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHW 642 (674)
Q Consensus 567 l~~~~~~----~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~ 642 (674)
+++++.. ...+||||||+ +++|.+++.... .+++..++.|+.||+.||.|||+.+ |+||||||+||||+.++
T Consensus 113 ~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~ 188 (345)
T 2v62_A 113 FYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNG-TFKKSTVLQLGIRMLDVLEYIHENE--YVHGDIKAANLLLGYKN 188 (345)
T ss_dssp EEEEEEEESSSCEEEEEEEECE-EEEHHHHCBGGG-BCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEESSS
T ss_pred eecccccccCCCcEEEEEEecc-CCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCcCHHHEEEccCC
Confidence 9999988 77899999999 999999997654 7999999999999999999999999 99999999999999877
Q ss_pred --cEEEEecCCcccccCCcc-------ccccCCCCccccCC
Q 005841 643 --TVKVGDFGLSRLKHETYL-------TTKTGKGTVTYLAS 674 (674)
Q Consensus 643 --~vkL~DFGla~~~~~~~~-------~~~~~~GTp~YmAP 674 (674)
.+||+|||+|+.+..... ......||+.||||
T Consensus 189 ~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aP 229 (345)
T 2v62_A 189 PDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSL 229 (345)
T ss_dssp TTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCH
T ss_pred CCcEEEEeCCCceecccccccccchhccccccCCCccccCH
Confidence 999999999987643211 11345799999998
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=2e-26 Score=243.93 Aligned_cols=170 Identities=31% Similarity=0.568 Sum_probs=140.9
Q ss_pred ccccCCeeEeeeecccCceEEEEEEEc--CCe--EEEEEeecccCCHHHHHHHHHHHHHHhhC-CCCCeeeEEEEEecCC
Q 005841 501 EILWEDLTIGEQIGQGSCGTVYHAVWY--GSD--VAVKVFSRQEYSDEVIHSFRQEVSLMKRL-RHPNVLLFMGAVTSPQ 575 (674)
Q Consensus 501 ~~~~~~y~~~~~LG~G~fG~Vy~~~~~--~~~--vAvK~i~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~ 575 (674)
.+..++|++.+.||+|+||.||+|.+. +.. ||||.+.... .......+.+|+.+++.+ +||||+++++++...+
T Consensus 21 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 99 (327)
T 1fvr_A 21 VLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA-SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG 99 (327)
T ss_dssp BCCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-------CHHHHHHHHHTTCCCCTTBCCEEEEEEETT
T ss_pred cccHHHccceeeeecCCCceEEEEEEccCCcccceeeeeecccc-chHHHHHHHHHHHHHHhccCCCchhhhceeeeeCC
Confidence 355688999999999999999999873 443 5999886432 334456788999999999 8999999999999999
Q ss_pred eEEEEEecCCCCCHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcC
Q 005841 576 RLCIVTEFLPRGSLFRLLQRNT---------------TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDK 640 (674)
Q Consensus 576 ~~~lV~E~~~ggsL~~~l~~~~---------------~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~ 640 (674)
.+||||||+++++|.+++.... ..+++..++.++.||+.||.|||+++ |+||||||+||||+.
T Consensus 100 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~NIl~~~ 177 (327)
T 1fvr_A 100 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ--FIHRDLAARNILVGE 177 (327)
T ss_dssp EEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECG
T ss_pred ceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCccceEEEcC
Confidence 9999999999999999997543 46999999999999999999999999 999999999999999
Q ss_pred CCcEEEEecCCcccccCCccccccCCCCccccCC
Q 005841 641 HWTVKVGDFGLSRLKHETYLTTKTGKGTVTYLAS 674 (674)
Q Consensus 641 ~~~vkL~DFGla~~~~~~~~~~~~~~GTp~YmAP 674 (674)
++.+||+|||+++..... .......+|+.|+||
T Consensus 178 ~~~~kL~Dfg~~~~~~~~-~~~~~~~~~~~y~aP 210 (327)
T 1fvr_A 178 NYVAKIADFGLSRGQEVY-VKKTMGRLPVRWMAI 210 (327)
T ss_dssp GGCEEECCTTCEESSCEE-CCC----CCTTTCCH
T ss_pred CCeEEEcccCcCcccccc-ccccCCCCCccccCh
Confidence 999999999999754332 222334689999998
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=99.94 E-value=3.4e-26 Score=246.24 Aligned_cols=165 Identities=29% Similarity=0.424 Sum_probs=142.7
Q ss_pred cCCeeEeeeecccCceEEEEEEE--cCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecC-----Ce
Q 005841 504 WEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSP-----QR 576 (674)
Q Consensus 504 ~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~-----~~ 576 (674)
..+|++.+.||+|+||.||+|.+ ++..||||++.... .......+.+|+.+++.++||||+++++++... ..
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 104 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFE-HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD 104 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTT-CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEecccc-CcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccce
Confidence 46899999999999999999998 46679999997533 445567889999999999999999999999765 46
Q ss_pred EEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCccccc
Q 005841 577 LCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKH 656 (674)
Q Consensus 577 ~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~ 656 (674)
+|+||||+. ++|.+++.. ..+++..+..++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++...
T Consensus 105 ~~iv~e~~~-~~L~~~l~~--~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~ 179 (364)
T 3qyz_A 105 VYIVQDLME-TDLYKLLKT--QHLSNDHICYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVAD 179 (364)
T ss_dssp EEEEEECCS-EEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEEEEcccC-cCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCChHhEEECCCCCEEEEeCcceEecC
Confidence 899999996 599999965 35999999999999999999999999 9999999999999999999999999998765
Q ss_pred CCccc---cccCCCCccccCC
Q 005841 657 ETYLT---TKTGKGTVTYLAS 674 (674)
Q Consensus 657 ~~~~~---~~~~~GTp~YmAP 674 (674)
..... ....+||+.|+||
T Consensus 180 ~~~~~~~~~~~~~gt~~y~aP 200 (364)
T 3qyz_A 180 PDHDHTGFLTEYVATRWYRAP 200 (364)
T ss_dssp GGGCBCCTTCCCCSCGGGCCH
T ss_pred CCCCccccccccccccCCCCC
Confidence 43221 2345899999998
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=2.1e-26 Score=244.61 Aligned_cols=165 Identities=35% Similarity=0.559 Sum_probs=143.7
Q ss_pred ccccCCeeEeeeecccCceEEEEEEEcCCeEEEEEeecccCCHHHHHHHHHHHHHHhh--CCCCCeeeEEEEEecCC---
Q 005841 501 EILWEDLTIGEQIGQGSCGTVYHAVWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKR--LRHPNVLLFMGAVTSPQ--- 575 (674)
Q Consensus 501 ~~~~~~y~~~~~LG~G~fG~Vy~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~--l~HpnIv~l~~~~~~~~--- 575 (674)
....++|.+.+.||+|+||.||+|.+++..||||++.... ...+.+|+.++.. ++||||+++++++....
T Consensus 38 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~-----~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~ 112 (342)
T 1b6c_B 38 RTIARTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSRE-----ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTW 112 (342)
T ss_dssp HHHHHHCEEEEEEEEETTEEEEEEEETTEEEEEEEECGGG-----HHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSC
T ss_pred ccccccEEEEeeecCCCCcEEEEEEEcCccEEEEEeCchh-----HHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCcc
Confidence 4456789999999999999999999999999999996432 2456778888887 78999999999998876
Q ss_pred -eEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH--------hCCCCeEEccCCCCCEEEcCCCcEEE
Q 005841 576 -RLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLH--------HCNPPIIHRDLKSSNLLVDKHWTVKV 646 (674)
Q Consensus 576 -~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH--------~~~~~IvHrDLKp~NILi~~~~~vkL 646 (674)
.+|+||||+++++|.+++.. ..+++..++.++.||+.||.||| +.+ |+||||||+||||+.++++||
T Consensus 113 ~~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~--ivH~Dlkp~NIll~~~~~~kL 188 (342)
T 1b6c_B 113 TQLWLVSDYHEHGSLFDYLNR--YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA--IAHRDLKSKNILVKKNGTCCI 188 (342)
T ss_dssp CCEEEEECCCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE--EECSCCSGGGEEECTTSCEEE
T ss_pred ceeEEEEeecCCCcHHHHHhc--cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCC--eeeCCCCHHHEEECCCCCEEE
Confidence 79999999999999999975 36899999999999999999999 777 999999999999999999999
Q ss_pred EecCCcccccCCcc----ccccCCCCccccCC
Q 005841 647 GDFGLSRLKHETYL----TTKTGKGTVTYLAS 674 (674)
Q Consensus 647 ~DFGla~~~~~~~~----~~~~~~GTp~YmAP 674 (674)
+|||+++....... ......||+.|+||
T Consensus 189 ~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aP 220 (342)
T 1b6c_B 189 ADLGLAVRHDSATDTIDIAPNHRVGTKRYMAP 220 (342)
T ss_dssp CCCTTCEEEETTTTEEEECCCSCCCCGGGCCH
T ss_pred EECCCceeccccccccccccccCCcCcccCCH
Confidence 99999987654322 22345799999998
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1e-26 Score=245.64 Aligned_cols=168 Identities=31% Similarity=0.505 Sum_probs=139.3
Q ss_pred cccCCeeEeeeecccCceEEEEEEEc--CCeEEEEEeecccCC------HHHHHHHHHHHHHHhhCCCCCeeeEEEEEec
Q 005841 502 ILWEDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYS------DEVIHSFRQEVSLMKRLRHPNVLLFMGAVTS 573 (674)
Q Consensus 502 ~~~~~y~~~~~LG~G~fG~Vy~~~~~--~~~vAvK~i~~~~~~------~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~ 573 (674)
...++|++.+.||+|+||.||+|.+. +..||||++.+.... ......+.+|+.+++.++||||+++++++..
T Consensus 7 ~l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 86 (322)
T 2ycf_A 7 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA 86 (322)
T ss_dssp HHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEES
T ss_pred hhhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcC
Confidence 34568999999999999999999984 567999999765431 1233458899999999999999999999876
Q ss_pred CCeEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCc---EEEEecC
Q 005841 574 PQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWT---VKVGDFG 650 (674)
Q Consensus 574 ~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~---vkL~DFG 650 (674)
.. +|+||||+++++|.+++.. ...+++..+..++.||+.||.|||+++ |+||||||+||||+.++. +||+|||
T Consensus 87 ~~-~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~NIl~~~~~~~~~~kl~Dfg 162 (322)
T 2ycf_A 87 ED-YYIVLELMEGGELFDKVVG-NKRLKEATCKLYFYQMLLAVQYLHENG--IIHRDLKPENVLLSSQEEDCLIKITDFG 162 (322)
T ss_dssp SS-EEEEEECCTTEETHHHHST-TCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESSSSSSCCEEECCCT
T ss_pred Cc-eEEEEecCCCCcHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHEEEecCCCCCeEEEccCc
Confidence 55 8999999999999999864 457999999999999999999999999 999999999999986654 9999999
Q ss_pred CcccccCCccccccCCCCccccCC
Q 005841 651 LSRLKHETYLTTKTGKGTVTYLAS 674 (674)
Q Consensus 651 la~~~~~~~~~~~~~~GTp~YmAP 674 (674)
+++....... .....||+.|+||
T Consensus 163 ~~~~~~~~~~-~~~~~gt~~y~aP 185 (322)
T 2ycf_A 163 HSKILGETSL-MRTLCGTPTYLAP 185 (322)
T ss_dssp TCEECCCCHH-HHHHHSCCTTCCH
T ss_pred cceecccccc-cccccCCcCccCc
Confidence 9987655432 2235699999998
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=99.94 E-value=3e-26 Score=248.50 Aligned_cols=164 Identities=25% Similarity=0.379 Sum_probs=135.7
Q ss_pred ccccCCeeEeeeecccCceEEEEEEE--cCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEec-----
Q 005841 501 EILWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTS----- 573 (674)
Q Consensus 501 ~~~~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~----- 573 (674)
+...++|++.+.||+|+||+||+|.+ ++..||||++...... ..+|+.+++.++||||+++++++..
T Consensus 3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~------~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 76 (383)
T 3eb0_A 3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY------KNRELDIMKVLDHVNIIKLVDYFYTTGDEE 76 (383)
T ss_dssp ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS------CCHHHHHHTTCCCTTBCCEEEEEEEC----
T ss_pred ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch------HHHHHHHHHHcCCCCccchhheeeecCccc
Confidence 44567899999999999999999998 5778999998654321 2369999999999999999999843
Q ss_pred ---------------------------------CCeEEEEEecCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHH
Q 005841 574 ---------------------------------PQRLCIVTEFLPRGSLFRLLQR---NTTKLDWRRRILMALDIARGVS 617 (674)
Q Consensus 574 ---------------------------------~~~~~lV~E~~~ggsL~~~l~~---~~~~l~~~~~~~i~~qi~~~L~ 617 (674)
...+||||||++ ++|.+.+.. ....+++..+..|+.||+.||.
T Consensus 77 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~ 155 (383)
T 3eb0_A 77 PKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVG 155 (383)
T ss_dssp ---------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHH
Confidence 345899999997 488777653 4567999999999999999999
Q ss_pred HHHhCCCCeEEccCCCCCEEEc-CCCcEEEEecCCcccccCCccccccCCCCccccCC
Q 005841 618 YLHHCNPPIIHRDLKSSNLLVD-KHWTVKVGDFGLSRLKHETYLTTKTGKGTVTYLAS 674 (674)
Q Consensus 618 yLH~~~~~IvHrDLKp~NILi~-~~~~vkL~DFGla~~~~~~~~~~~~~~GTp~YmAP 674 (674)
|||+++ |+||||||+||||+ .++.+||+|||+|+....... .....||+.|+||
T Consensus 156 ~LH~~g--i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~-~~~~~~t~~y~aP 210 (383)
T 3eb0_A 156 FIHSLG--ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP-SVAYICSRFYRAP 210 (383)
T ss_dssp HHHTTT--EECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC-CCCCCCCSSCCCH
T ss_pred HHHHCc--CccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC-CcCcccCCCccCH
Confidence 999999 99999999999998 688999999999987654332 3345789999998
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.94 E-value=7.4e-27 Score=252.94 Aligned_cols=167 Identities=29% Similarity=0.464 Sum_probs=133.4
Q ss_pred CCeeEeeeecccCceEEEEEEEc--C---CeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEec-CCeEE
Q 005841 505 EDLTIGEQIGQGSCGTVYHAVWY--G---SDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTS-PQRLC 578 (674)
Q Consensus 505 ~~y~~~~~LG~G~fG~Vy~~~~~--~---~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~-~~~~~ 578 (674)
..|.+.++||+|+||+||+|.+. + ..||||.+.... .......+.+|+.+++.++||||+++++++.. .+..|
T Consensus 89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~ 167 (373)
T 3c1x_A 89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT-DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL 167 (373)
T ss_dssp EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCS-CSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCE
T ss_pred ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeE
Confidence 35888999999999999999873 1 248999886533 34556789999999999999999999998754 56789
Q ss_pred EEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccccCC
Q 005841 579 IVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHET 658 (674)
Q Consensus 579 lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~~ 658 (674)
+||||+++++|.+++......+++..++.++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++.....
T Consensus 168 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~ 245 (373)
T 3c1x_A 168 VVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKK--FVHRDLAARNCMLDEKFTVKVADFGLARDMYDK 245 (373)
T ss_dssp EEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred EEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCC--EecCccchheEEECCCCCEEEeecccccccccc
Confidence 999999999999999877777999999999999999999999999 999999999999999999999999999866432
Q ss_pred cc----ccccCCCCccccCC
Q 005841 659 YL----TTKTGKGTVTYLAS 674 (674)
Q Consensus 659 ~~----~~~~~~GTp~YmAP 674 (674)
.. ......||+.||||
T Consensus 246 ~~~~~~~~~~~~~~~~y~aP 265 (373)
T 3c1x_A 246 EFDSVHNKTGAKLPVKWMAL 265 (373)
T ss_dssp ------------CCGGGSCH
T ss_pred ccccccccCCCCCcccccCh
Confidence 21 12234688999998
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=1.2e-27 Score=251.59 Aligned_cols=174 Identities=34% Similarity=0.604 Sum_probs=146.0
Q ss_pred ccccccccCCeeEeeeecccCceEEEEEEEcCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCe
Q 005841 497 CLDYEILWEDLTIGEQIGQGSCGTVYHAVWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQR 576 (674)
Q Consensus 497 ~~~~~~~~~~y~~~~~LG~G~fG~Vy~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 576 (674)
...+++..++|++.+.||+|+||.||+|.+.+ .||+|++..........+.+.+|+.+++.++||||+++++++.....
T Consensus 25 ~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~-~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 103 (319)
T 2y4i_B 25 LQEWDIPFEQLEIGELIGKGRFGQVYHGRWHG-EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPH 103 (319)
T ss_dssp GGGSSSCCSCEECCCBCCCSSSSEEEEEEESS-SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSC
T ss_pred cccccCCHHHeEEeeEeccCCceEEEEEEEcC-eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCc
Confidence 34567788999999999999999999999865 59999997654433334557789999999999999999999999999
Q ss_pred EEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCccccc
Q 005841 577 LCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKH 656 (674)
Q Consensus 577 ~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~ 656 (674)
+|+||||+++++|.+++......+++..++.++.||+.||.|||+.+ |+||||||+|||++ ++.+||+|||+++...
T Consensus 104 ~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~ 180 (319)
T 2y4i_B 104 LAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKG--ILHKDLKSKNVFYD-NGKVVITDFGLFSISG 180 (319)
T ss_dssp EEEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTT--CCCCCCCSTTEEEC---CCEECCCSCCC---
T ss_pred eEEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCChhhEEEe-CCCEEEeecCCccccc
Confidence 99999999999999999876667999999999999999999999999 99999999999998 6799999999987643
Q ss_pred CC-----ccccccCCCCccccCC
Q 005841 657 ET-----YLTTKTGKGTVTYLAS 674 (674)
Q Consensus 657 ~~-----~~~~~~~~GTp~YmAP 674 (674)
.. ........||+.|+||
T Consensus 181 ~~~~~~~~~~~~~~~g~~~y~aP 203 (319)
T 2y4i_B 181 VLQAGRREDKLRIQNGWLCHLAP 203 (319)
T ss_dssp -------CCSCBCCSGGGGTSCH
T ss_pred cccccccccccccCCCcccccCh
Confidence 21 1122234699999998
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=1.4e-26 Score=243.37 Aligned_cols=163 Identities=31% Similarity=0.547 Sum_probs=134.7
Q ss_pred ccccCCeeEeeeecccCceEEEEEEEcCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeEEEE
Q 005841 501 EILWEDLTIGEQIGQGSCGTVYHAVWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIV 580 (674)
Q Consensus 501 ~~~~~~y~~~~~LG~G~fG~Vy~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 580 (674)
.+..++|++.+.||+|+||.||++.+.+..||||++... ...+.+.+|+.+++.++||||+++++++. +..|+|
T Consensus 4 ~i~~~~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~----~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~lv 77 (307)
T 2eva_A 4 MIDYKEIEVEEVVGRGAFGVVCKAKWRAKDVAIKQIESE----SERKAFIVELRQLSRVNHPNIVKLYGACL--NPVCLV 77 (307)
T ss_dssp BCCGGGEEEEEEEECCSSSEEEEEEETTEEEEEEECSST----THHHHHHHHHHHHHHCCCTTBCCEEEBCT--TTTEEE
T ss_pred cCCHhHeeeeeEeecCCCceEEEEEECCeeEEEEEecCh----hHHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCcEEE
Confidence 345678999999999999999999999999999998643 23467889999999999999999999876 458999
Q ss_pred EecCCCCCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHh---CCCCeEEccCCCCCEEEcCCCc-EEEEecCCccc
Q 005841 581 TEFLPRGSLFRLLQRNTT--KLDWRRRILMALDIARGVSYLHH---CNPPIIHRDLKSSNLLVDKHWT-VKVGDFGLSRL 654 (674)
Q Consensus 581 ~E~~~ggsL~~~l~~~~~--~l~~~~~~~i~~qi~~~L~yLH~---~~~~IvHrDLKp~NILi~~~~~-vkL~DFGla~~ 654 (674)
|||+++++|.+++..... .+++..++.++.||+.||.|||+ .+ |+||||||+||||+.++. +||+|||++..
T Consensus 78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~--ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~ 155 (307)
T 2eva_A 78 MEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKA--LIHRDLKPPNLLLVAGGTVLKICDFGTACD 155 (307)
T ss_dssp EECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSC--CCCCCCSGGGEEEETTTTEEEECCCCC---
T ss_pred EEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCC--eecCCCChhHEEEeCCCCEEEEcccccccc
Confidence 999999999999975432 47899999999999999999999 66 999999999999998876 79999999976
Q ss_pred ccCCccccccCCCCccccCC
Q 005841 655 KHETYLTTKTGKGTVTYLAS 674 (674)
Q Consensus 655 ~~~~~~~~~~~~GTp~YmAP 674 (674)
.... .....||+.|+||
T Consensus 156 ~~~~---~~~~~gt~~y~aP 172 (307)
T 2eva_A 156 IQTH---MTNNKGSAAWMAP 172 (307)
T ss_dssp ------------CCTTSSCH
T ss_pred cccc---cccCCCCCceECh
Confidence 5432 2234699999998
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.6e-26 Score=239.68 Aligned_cols=171 Identities=34% Similarity=0.492 Sum_probs=136.6
Q ss_pred ccccCCeeEeeeecccCceEEEEEEEc---CC--eEEEEEeecccCC-HHHHHHHHHHHHHHhhCCCCCeeeEEEEEecC
Q 005841 501 EILWEDLTIGEQIGQGSCGTVYHAVWY---GS--DVAVKVFSRQEYS-DEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSP 574 (674)
Q Consensus 501 ~~~~~~y~~~~~LG~G~fG~Vy~~~~~---~~--~vAvK~i~~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~ 574 (674)
.+..++|++.+.||+|+||.||+|.+. +. .||||++...... ....+.+.+|+.+++.++||||+++++++...
T Consensus 14 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 93 (291)
T 1u46_A 14 LIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP 93 (291)
T ss_dssp ECCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred ccchhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccC
Confidence 455678999999999999999999863 22 4899998765432 35667899999999999999999999999876
Q ss_pred CeEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCccc
Q 005841 575 QRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL 654 (674)
Q Consensus 575 ~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~ 654 (674)
. .++||||+++++|.+++......+++..+..++.||+.||.|||+++ |+|+||||+|||++.++.+||+|||+++.
T Consensus 94 ~-~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dikp~Nili~~~~~~kl~Dfg~~~~ 170 (291)
T 1u46_A 94 P-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKR--FIHRDLAARNLLLATRDLVKIGDFGLMRA 170 (291)
T ss_dssp S-CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred C-ceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCC--cccCCCchheEEEcCCCCEEEcccccccc
Confidence 5 89999999999999999876667999999999999999999999999 99999999999999999999999999987
Q ss_pred ccCCcc---ccccCCCCccccCC
Q 005841 655 KHETYL---TTKTGKGTVTYLAS 674 (674)
Q Consensus 655 ~~~~~~---~~~~~~GTp~YmAP 674 (674)
...... ......||+.|+||
T Consensus 171 ~~~~~~~~~~~~~~~~~~~y~aP 193 (291)
T 1u46_A 171 LPQNDDHYVMQEHRKVPFAWCAP 193 (291)
T ss_dssp CCC-CCEEEC-----CCGGGCCH
T ss_pred ccccccchhhhccCCCCceeeCc
Confidence 644322 22234688999998
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=99.94 E-value=4.7e-27 Score=250.44 Aligned_cols=170 Identities=24% Similarity=0.391 Sum_probs=148.6
Q ss_pred ccccCCeeEeeeecccCceEEEEEEEcCCeEEEEEeecccCCH---------------HHHHHHHHHHHHHhhCCCCCee
Q 005841 501 EILWEDLTIGEQIGQGSCGTVYHAVWYGSDVAVKVFSRQEYSD---------------EVIHSFRQEVSLMKRLRHPNVL 565 (674)
Q Consensus 501 ~~~~~~y~~~~~LG~G~fG~Vy~~~~~~~~vAvK~i~~~~~~~---------------~~~~~~~~Ei~il~~l~HpnIv 565 (674)
....++|++.+.||+|+||.||+|.+.+..||||++....... .....+.+|+.+++.++||||+
T Consensus 27 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~ 106 (348)
T 2pml_X 27 DKYINDYRIIRTLNQGKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCL 106 (348)
T ss_dssp CEEETTEEEEEEEECCSSCCEEEEEETTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBC
T ss_pred ccccCceEEEEEEcCCCCeEEEEEEcCCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcc
Confidence 3456899999999999999999999988899999997543221 1126788999999999999999
Q ss_pred eEEEEEecCCeEEEEEecCCCCCHHHH------HHhc-CCCCCHHHHHHHHHHHHHHHHHHHh-CCCCeEEccCCCCCEE
Q 005841 566 LFMGAVTSPQRLCIVTEFLPRGSLFRL------LQRN-TTKLDWRRRILMALDIARGVSYLHH-CNPPIIHRDLKSSNLL 637 (674)
Q Consensus 566 ~l~~~~~~~~~~~lV~E~~~ggsL~~~------l~~~-~~~l~~~~~~~i~~qi~~~L~yLH~-~~~~IvHrDLKp~NIL 637 (674)
++++++...+.+|+||||+++++|.++ +... ...+++..++.++.||+.||.|||+ ++ |+||||||+|||
T Consensus 107 ~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~--i~H~dl~p~Nil 184 (348)
T 2pml_X 107 TCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKN--ICHRDVKPSNIL 184 (348)
T ss_dssp CCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSC--EECCCCCGGGEE
T ss_pred eEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCC--EeecCCChHhEE
Confidence 999999999999999999999999998 5432 5679999999999999999999998 88 999999999999
Q ss_pred EcCCCcEEEEecCCcccccCCccccccCCCCccccCC
Q 005841 638 VDKHWTVKVGDFGLSRLKHETYLTTKTGKGTVTYLAS 674 (674)
Q Consensus 638 i~~~~~vkL~DFGla~~~~~~~~~~~~~~GTp~YmAP 674 (674)
++.++.+||+|||++...... ......||+.|+||
T Consensus 185 ~~~~~~~kl~dfg~~~~~~~~--~~~~~~~~~~y~aP 219 (348)
T 2pml_X 185 MDKNGRVKLSDFGESEYMVDK--KIKGSRGTYEFMPP 219 (348)
T ss_dssp ECTTSCEEECCCTTCEECBTT--EECSSCSCGGGCCG
T ss_pred EcCCCcEEEeccccccccccc--cccCCCCCcCccCc
Confidence 999999999999999876554 23346799999998
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=99.94 E-value=1.1e-26 Score=255.48 Aligned_cols=161 Identities=27% Similarity=0.364 Sum_probs=133.4
Q ss_pred cCCeeEeeeecccCceEEEEEEE--cCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecC------C
Q 005841 504 WEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSP------Q 575 (674)
Q Consensus 504 ~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~------~ 575 (674)
..+|++.++||+|+||+||+|.+ ++..||||++..... .+.+|+.+++.++||||+++++++... .
T Consensus 53 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~------~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~ 126 (420)
T 1j1b_A 53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEV 126 (420)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT------SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEE
T ss_pred cceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch------hHHHHHHHHHHcCCCCccceeeEEeccCCCCcce
Confidence 35799999999999999999998 477899999865432 133699999999999999999988532 2
Q ss_pred eEEEEEecCCCCCHHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcC-CCcEEEEecCC
Q 005841 576 RLCIVTEFLPRGSLFRLLQ---RNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDK-HWTVKVGDFGL 651 (674)
Q Consensus 576 ~~~lV~E~~~ggsL~~~l~---~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~-~~~vkL~DFGl 651 (674)
++++||||+++ +|.+++. .....+++..+..|+.||+.||.|||+++ ||||||||+||||+. ++.+||+|||+
T Consensus 127 ~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NILl~~~~~~~kl~DFG~ 203 (420)
T 1j1b_A 127 YLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGS 203 (420)
T ss_dssp EEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT--EECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred eEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCChhhEEEeCCCCeEEeccchh
Confidence 47899999976 6766654 34567999999999999999999999999 999999999999995 46789999999
Q ss_pred cccccCCccccccCCCCccccCC
Q 005841 652 SRLKHETYLTTKTGKGTVTYLAS 674 (674)
Q Consensus 652 a~~~~~~~~~~~~~~GTp~YmAP 674 (674)
|+....... ....+||+.||||
T Consensus 204 a~~~~~~~~-~~~~~~t~~y~aP 225 (420)
T 1j1b_A 204 AKQLVRGEP-NVSYICSRYYRAP 225 (420)
T ss_dssp CEECCTTCC-CCSCCSCTTSCCH
T ss_pred hhhcccCCC-ceeeeeCCCcCCH
Confidence 987654322 2346799999998
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=99.94 E-value=7.7e-27 Score=252.23 Aligned_cols=163 Identities=31% Similarity=0.408 Sum_probs=126.7
Q ss_pred cCCeeEeeeecccCceEEEEEEE--cCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecC------C
Q 005841 504 WEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSP------Q 575 (674)
Q Consensus 504 ~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~------~ 575 (674)
.++|++.+.||+|+||.||+|.+ ++..||||++............+.+|+.+++.++||||+++++++... .
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 107 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 107 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence 47899999999999999999987 467899999977655556677889999999999999999999998754 5
Q ss_pred eEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccc
Q 005841 576 RLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLK 655 (674)
Q Consensus 576 ~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~ 655 (674)
.+|+||||+ +++|.+++.. ..+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++..
T Consensus 108 ~~~lv~e~~-~~~L~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~g--ivH~Dlkp~NIll~~~~~~kL~DFG~a~~~ 182 (367)
T 2fst_X 108 DVYLVTHLM-GADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHT 182 (367)
T ss_dssp CCEEEEECC-CEECC-------CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTCCEEECC-------
T ss_pred eEEEEeccc-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCHhhEEECCCCCEEEeeccccccc
Confidence 689999999 7899998864 56999999999999999999999999 999999999999999999999999999875
Q ss_pred cCCccccccCCCCccccCC
Q 005841 656 HETYLTTKTGKGTVTYLAS 674 (674)
Q Consensus 656 ~~~~~~~~~~~GTp~YmAP 674 (674)
... .....||+.|+||
T Consensus 183 ~~~---~~~~~~t~~y~aP 198 (367)
T 2fst_X 183 ADE---MTGYVATRWYRAP 198 (367)
T ss_dssp -----------CCCTTCCH
T ss_pred ccc---CCCcCcCcCccCh
Confidence 543 2346799999998
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.9e-26 Score=247.37 Aligned_cols=170 Identities=22% Similarity=0.310 Sum_probs=137.6
Q ss_pred ccccCCeeEeeeecccCceEEEEEEE-cCCeEEEEEeecccC---------CHHHHHHHHHHHHHHhhCCCCCeeeEEEE
Q 005841 501 EILWEDLTIGEQIGQGSCGTVYHAVW-YGSDVAVKVFSRQEY---------SDEVIHSFRQEVSLMKRLRHPNVLLFMGA 570 (674)
Q Consensus 501 ~~~~~~y~~~~~LG~G~fG~Vy~~~~-~~~~vAvK~i~~~~~---------~~~~~~~~~~Ei~il~~l~HpnIv~l~~~ 570 (674)
....++|.+.+.||+|+||.||+|.+ .+..||||++..... .....+.+.+|+.+++.++||||++++++
T Consensus 18 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 97 (362)
T 3pg1_A 18 HAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDI 97 (362)
T ss_dssp HHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEE
T ss_pred HHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeee
Confidence 45668999999999999999999987 577899999865432 22345789999999999999999999999
Q ss_pred Eec-----CCeEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEE
Q 005841 571 VTS-----PQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVK 645 (674)
Q Consensus 571 ~~~-----~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vk 645 (674)
+.. ...+|+||||+. ++|.+++......+++..+..++.||+.||.|||+++ |+||||||+||||+.++.+|
T Consensus 98 ~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~NIl~~~~~~~k 174 (362)
T 3pg1_A 98 FVHFEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAG--VVHRDLHPGNILLADNNDIT 174 (362)
T ss_dssp EEECCTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTCCEE
T ss_pred EEeccCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCc--CEecCCChHHEEEcCCCCEE
Confidence 843 346899999997 6899988876678999999999999999999999999 99999999999999999999
Q ss_pred EEecCCcccccCCccccccCCCCccccCC
Q 005841 646 VGDFGLSRLKHETYLTTKTGKGTVTYLAS 674 (674)
Q Consensus 646 L~DFGla~~~~~~~~~~~~~~GTp~YmAP 674 (674)
|+|||+++....... .....||+.|+||
T Consensus 175 l~Dfg~~~~~~~~~~-~~~~~~t~~y~aP 202 (362)
T 3pg1_A 175 ICDFNLAREDTADAN-KTHYVTHRWYRAP 202 (362)
T ss_dssp ECCTTC----------------CGGGCCH
T ss_pred EEecCcccccccccc-cceecccceecCc
Confidence 999999986544332 2335799999998
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=99.94 E-value=5.7e-27 Score=253.67 Aligned_cols=163 Identities=17% Similarity=0.201 Sum_probs=134.5
Q ss_pred cCCeeEeeeecccCceEEEEEEE--cCCeEEEEEeecccC-CHHHHHHHHHHHH---HHhhCCCCCeeeEE-------EE
Q 005841 504 WEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEY-SDEVIHSFRQEVS---LMKRLRHPNVLLFM-------GA 570 (674)
Q Consensus 504 ~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~-~~~~~~~~~~Ei~---il~~l~HpnIv~l~-------~~ 570 (674)
.++|++.+.||+|+||+||+|.+ ++..||||++.+... .....+.+.+|+. +++.++||||++++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 46899999999999999999996 478899999986533 3345678899994 55555799999988 66
Q ss_pred EecCC-----------------eEEEEEecCCCCCHHHHHHhcCCCCC-------HHHHHHHHHHHHHHHHHHHhCCCCe
Q 005841 571 VTSPQ-----------------RLCIVTEFLPRGSLFRLLQRNTTKLD-------WRRRILMALDIARGVSYLHHCNPPI 626 (674)
Q Consensus 571 ~~~~~-----------------~~~lV~E~~~ggsL~~~l~~~~~~l~-------~~~~~~i~~qi~~~L~yLH~~~~~I 626 (674)
+...+ ..||||||+ +|+|.+++.... .++ +..++.|+.||+.||.|||+++ |
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~-~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--i 227 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLL-SHSSTHKSLVHHARLQLTLQVIRLLASLHHYG--L 227 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHH-HTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTT--E
T ss_pred hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhcc-ccccccccccHHHHHHHHHHHHHHHHHHHhCC--e
Confidence 66553 289999999 679999997642 233 4888889999999999999999 9
Q ss_pred EEccCCCCCEEEcCCCcEEEEecCCcccccCCccccccCCCCccccCC
Q 005841 627 IHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTVTYLAS 674 (674)
Q Consensus 627 vHrDLKp~NILi~~~~~vkL~DFGla~~~~~~~~~~~~~~GTp~YmAP 674 (674)
|||||||+||||+.++.+||+|||+|+.... .....+| +.||||
T Consensus 228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~---~~~~~~g-~~y~aP 271 (377)
T 3byv_A 228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA---RVVSSVS-RGFEPP 271 (377)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETTC---EEECCCC-TTCCCH
T ss_pred ecCCCCHHHEEEcCCCCEEEEechhheecCC---cccCCCC-cCccCh
Confidence 9999999999999999999999999986443 2334578 999998
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.7e-26 Score=244.51 Aligned_cols=171 Identities=25% Similarity=0.390 Sum_probs=142.3
Q ss_pred ccccCCeeEeeeecccCceEEEEEEE-------cCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEec
Q 005841 501 EILWEDLTIGEQIGQGSCGTVYHAVW-------YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTS 573 (674)
Q Consensus 501 ~~~~~~y~~~~~LG~G~fG~Vy~~~~-------~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~ 573 (674)
++..++|++.+.||+|+||.||+|.+ .+..||||++... ........+.+|+.+++.++||||+++++++..
T Consensus 26 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 104 (327)
T 2yfx_A 26 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV-CSEQDELDFLMEALIISKFNHQNIVRCIGVSLQ 104 (327)
T ss_dssp BCCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSS-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cCChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccc-cchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcC
Confidence 56678999999999999999999984 3456999999643 344556678899999999999999999999999
Q ss_pred CCeEEEEEecCCCCCHHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEc---CCCcE
Q 005841 574 PQRLCIVTEFLPRGSLFRLLQRNT------TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVD---KHWTV 644 (674)
Q Consensus 574 ~~~~~lV~E~~~ggsL~~~l~~~~------~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~---~~~~v 644 (674)
....||||||+++++|.+++.... ..+++..++.++.||+.||.|||+.+ |+||||||+||||+ .+..+
T Consensus 105 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~--i~H~dlkp~NIli~~~~~~~~~ 182 (327)
T 2yfx_A 105 SLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH--FIHRDIAARNCLLTCPGPGRVA 182 (327)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESCSSTTCCE
T ss_pred CCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC--eecCcCCHhHEEEecCCCcceE
Confidence 999999999999999999998653 35899999999999999999999999 99999999999998 45569
Q ss_pred EEEecCCcccccCCcc--ccccCCCCccccCC
Q 005841 645 KVGDFGLSRLKHETYL--TTKTGKGTVTYLAS 674 (674)
Q Consensus 645 kL~DFGla~~~~~~~~--~~~~~~GTp~YmAP 674 (674)
||+|||+++....... ......||+.|+||
T Consensus 183 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aP 214 (327)
T 2yfx_A 183 KIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 214 (327)
T ss_dssp EECCCHHHHHHHC------CCGGGSCGGGCCH
T ss_pred EECccccccccccccccccCCCcCCCcceeCH
Confidence 9999999986543222 22234689999998
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=99.94 E-value=3.2e-26 Score=239.64 Aligned_cols=165 Identities=25% Similarity=0.429 Sum_probs=142.3
Q ss_pred ccCCeeEeeeecccCceEEEEEEE--cCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeEEEE
Q 005841 503 LWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIV 580 (674)
Q Consensus 503 ~~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 580 (674)
..++|.+.+.||+|+||.||+|.+ .+..||||++..... .....+.+|+.+++.++||||+++++++.....+|+|
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (304)
T 2jam_A 7 IRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPA--FRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLV 84 (304)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC--------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccc--cchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEE
Confidence 346899999999999999999998 477899999975432 2235688899999999999999999999999999999
Q ss_pred EecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEE---cCCCcEEEEecCCcccccC
Q 005841 581 TEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLV---DKHWTVKVGDFGLSRLKHE 657 (674)
Q Consensus 581 ~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi---~~~~~vkL~DFGla~~~~~ 657 (674)
|||+++++|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||+ +.++.+||+|||+++....
T Consensus 85 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~ 161 (304)
T 2jam_A 85 MQLVSGGELFDRILER-GVYTEKDASLVIQQVLSAVKYLHENG--IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN 161 (304)
T ss_dssp ECCCCSCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCC
T ss_pred EEcCCCccHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEEecCCCCCCEEEccCCcceecCC
Confidence 9999999999998754 46999999999999999999999999 9999999999999 7889999999999986554
Q ss_pred CccccccCCCCccccCC
Q 005841 658 TYLTTKTGKGTVTYLAS 674 (674)
Q Consensus 658 ~~~~~~~~~GTp~YmAP 674 (674)
... ....||+.|+||
T Consensus 162 ~~~--~~~~~~~~y~aP 176 (304)
T 2jam_A 162 GIM--STACGTPGYVAP 176 (304)
T ss_dssp BTT--HHHHSCCCBCCT
T ss_pred Ccc--ccccCCCCccCh
Confidence 322 234699999999
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=8.4e-26 Score=241.20 Aligned_cols=166 Identities=27% Similarity=0.403 Sum_probs=141.4
Q ss_pred ccCCeeEeeeecccCceEEEEEEEc--CCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecC-----C
Q 005841 503 LWEDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSP-----Q 575 (674)
Q Consensus 503 ~~~~y~~~~~LG~G~fG~Vy~~~~~--~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~-----~ 575 (674)
..++|.+.+.||+|+||.||+|.+. +..||||++.... .......+.+|+.+++.++||||+++++++... .
T Consensus 9 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 87 (353)
T 2b9h_A 9 ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFD-KPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFN 87 (353)
T ss_dssp SCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCS-SHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCC
T ss_pred cccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccc-cchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccc
Confidence 4578999999999999999999984 7789999996432 445567788999999999999999999988754 6
Q ss_pred eEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccc
Q 005841 576 RLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLK 655 (674)
Q Consensus 576 ~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~ 655 (674)
..|+||||+. ++|.+++.. ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 88 ~~~lv~e~~~-~~L~~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~--ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~ 162 (353)
T 2b9h_A 88 EVYIIQELMQ-TDLHRVIST--QMLSDDHIQYFIYQTLRAVKVLHGSN--VIHRDLKPSNLLINSNCDLKVCDFGLARII 162 (353)
T ss_dssp CEEEEECCCS-EEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred eEEEEEeccC-ccHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEEcCCCcEEEEeccccccc
Confidence 7999999996 599999875 46999999999999999999999999 999999999999999999999999999876
Q ss_pred cCCcc----------ccccCCCCccccCC
Q 005841 656 HETYL----------TTKTGKGTVTYLAS 674 (674)
Q Consensus 656 ~~~~~----------~~~~~~GTp~YmAP 674 (674)
..... .....+||+.|+||
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aP 191 (353)
T 2b9h_A 163 DESAADNSEPTGQQSGMVEFVATRWYRAP 191 (353)
T ss_dssp C----------------CCCCCCGGGCCH
T ss_pred ccccccccCccccccchhhccccccccCC
Confidence 43221 12235799999998
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=1.8e-26 Score=249.07 Aligned_cols=164 Identities=16% Similarity=0.149 Sum_probs=124.9
Q ss_pred CCeeEeeeecccCceEEEEEEE--cCCeEEEEEeecccCCH-HHHHHHHHHHHHHhhC--CCCCeeeEE-------EEEe
Q 005841 505 EDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSD-EVIHSFRQEVSLMKRL--RHPNVLLFM-------GAVT 572 (674)
Q Consensus 505 ~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~~~-~~~~~~~~Ei~il~~l--~HpnIv~l~-------~~~~ 572 (674)
.+|++.+.||+|+||.||+|.+ ++..||||++....... .....+.+|+.+++.| +||||++++ +++.
T Consensus 62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~ 141 (371)
T 3q60_A 62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVA 141 (371)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEE
T ss_pred eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhee
Confidence 4599999999999999999997 46779999998866533 4556778885544444 699988755 4443
Q ss_pred cC-----------------CeEEEEEecCCCCCHHHHHHhcCCCCCHHHH------HHHHHHHHHHHHHHHhCCCCeEEc
Q 005841 573 SP-----------------QRLCIVTEFLPRGSLFRLLQRNTTKLDWRRR------ILMALDIARGVSYLHHCNPPIIHR 629 (674)
Q Consensus 573 ~~-----------------~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~------~~i~~qi~~~L~yLH~~~~~IvHr 629 (674)
.. ..+|||||||+ ++|.+++......+.+..+ ..++.||+.||.|||+++ ||||
T Consensus 142 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~--ivHr 218 (371)
T 3q60_A 142 VQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKG--LVHG 218 (371)
T ss_dssp ETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTT--EEET
T ss_pred cCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCC--CccC
Confidence 32 34899999998 8999999875545566666 788899999999999999 9999
Q ss_pred cCCCCCEEEcCCCcEEEEecCCcccccCCccccccCCCCccccCC
Q 005841 630 DLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTVTYLAS 674 (674)
Q Consensus 630 DLKp~NILi~~~~~vkL~DFGla~~~~~~~~~~~~~~GTp~YmAP 674 (674)
||||+||||+.++.+||+|||+|+....... ...||+.||||
T Consensus 219 Dikp~NIll~~~~~~kL~DFG~a~~~~~~~~---~~~~t~~y~aP 260 (371)
T 3q60_A 219 HFTPDNLFIMPDGRLMLGDVSALWKVGTRGP---ASSVPVTYAPR 260 (371)
T ss_dssp TCSGGGEEECTTSCEEECCGGGEEETTCEEE---GGGSCGGGCCH
T ss_pred cCCHHHEEECCCCCEEEEecceeeecCCCcc---CccCCcCCcCh
Confidence 9999999999999999999999987654321 34577999998
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=99.93 E-value=3.6e-26 Score=246.97 Aligned_cols=163 Identities=27% Similarity=0.423 Sum_probs=140.2
Q ss_pred ccCCeeEeeeecccCceEEEEEEE--cCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeE---
Q 005841 503 LWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRL--- 577 (674)
Q Consensus 503 ~~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~--- 577 (674)
..++|.+.+.||+|+||.||+|.+ ++..||||++............+.+|+.+++.++||||+++++++......
T Consensus 40 l~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 119 (371)
T 4exu_A 40 LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF 119 (371)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTC
T ss_pred ccccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccc
Confidence 347899999999999999999998 477899999987666666778899999999999999999999999877655
Q ss_pred ---EEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCccc
Q 005841 578 ---CIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL 654 (674)
Q Consensus 578 ---~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~ 654 (674)
|+||||+. ++|.+++. ..+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++.
T Consensus 120 ~~~~lv~e~~~-~~l~~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~NIll~~~~~~kL~Dfg~a~~ 193 (371)
T 4exu_A 120 YDFYLVMPFMQ-TDLQKIMG---MEFSEEKIQYLVYQMLKGLKYIHSAG--VVHRDLKPGNLAVNEDCELKILDFGLARH 193 (371)
T ss_dssp CCCEEEEECCC-EEHHHHTT---SCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTCCEEECSTTCC--
T ss_pred eeEEEEEcccc-ccHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHHCC--CcCCCcCHHHeEECCCCCEEEEecCcccc
Confidence 99999996 58888773 35999999999999999999999999 99999999999999999999999999986
Q ss_pred ccCCccccccCCCCccccCC
Q 005841 655 KHETYLTTKTGKGTVTYLAS 674 (674)
Q Consensus 655 ~~~~~~~~~~~~GTp~YmAP 674 (674)
.... ....+||+.|+||
T Consensus 194 ~~~~---~~~~~~t~~y~aP 210 (371)
T 4exu_A 194 ADAE---MTGYVVTRWYRAP 210 (371)
T ss_dssp ---------CTTCCCTTSCH
T ss_pred cccC---cCCcccCccccCH
Confidence 6543 2346799999998
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=99.93 E-value=7.1e-26 Score=235.09 Aligned_cols=165 Identities=25% Similarity=0.352 Sum_probs=135.9
Q ss_pred ccCCeeEeeeecccCceEEEEEEE--cCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEE-EEecCCeEEE
Q 005841 503 LWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMG-AVTSPQRLCI 579 (674)
Q Consensus 503 ~~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~-~~~~~~~~~l 579 (674)
..++|++.+.||+|+||+||+|.+ .+..||||++...... ..+.+|+.+++.+.|++++..+. ++...+..||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~l 82 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVM 82 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---C----CCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEE
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccc----hHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEE
Confidence 347899999999999999999996 5678999987654432 34677999999999877665544 4567788999
Q ss_pred EEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEE---cCCCcEEEEecCCccccc
Q 005841 580 VTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLV---DKHWTVKVGDFGLSRLKH 656 (674)
Q Consensus 580 V~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi---~~~~~vkL~DFGla~~~~ 656 (674)
||||+ +++|.+++......+++..++.++.||+.||.|||+++ |+||||||+|||| +.++.+||+|||+++...
T Consensus 83 v~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~ 159 (296)
T 4hgt_A 83 VMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN--FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR 159 (296)
T ss_dssp EEECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred EEEcc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeeeeccCCCCeEEEecCccceecc
Confidence 99999 99999999877778999999999999999999999999 9999999999999 788999999999998765
Q ss_pred CCcc-------ccccCCCCccccCC
Q 005841 657 ETYL-------TTKTGKGTVTYLAS 674 (674)
Q Consensus 657 ~~~~-------~~~~~~GTp~YmAP 674 (674)
.... ......||+.|+||
T Consensus 160 ~~~~~~~~~~~~~~~~~gt~~y~aP 184 (296)
T 4hgt_A 160 DARTHQHIPYRENKNLTGTARYASI 184 (296)
T ss_dssp CTTTCCBCCCCCSCCCCSCGGGCCH
T ss_pred CcccCccCCCCcccccCCCccccch
Confidence 4322 22345799999998
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=99.93 E-value=1.3e-25 Score=233.37 Aligned_cols=165 Identities=25% Similarity=0.347 Sum_probs=140.1
Q ss_pred ccCCeeEeeeecccCceEEEEEEE--cCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEE-EEEecCCeEEE
Q 005841 503 LWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFM-GAVTSPQRLCI 579 (674)
Q Consensus 503 ~~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~-~~~~~~~~~~l 579 (674)
..++|++.+.||+|+||.||+|.+ .+..||||++....... .+.+|+.+++.+.|++++..+ .++......|+
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~----~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~l 82 (296)
T 3uzp_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHP----QLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVM 82 (296)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSCC----HHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEE
T ss_pred eccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcchh----HHHHHHHHHHHhhcCCCCCccccccCCCCceEE
Confidence 457899999999999999999997 57789999987654432 477899999999987755444 44467788999
Q ss_pred EEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEE---cCCCcEEEEecCCccccc
Q 005841 580 VTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLV---DKHWTVKVGDFGLSRLKH 656 (674)
Q Consensus 580 V~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi---~~~~~vkL~DFGla~~~~ 656 (674)
||||+ +++|.+++......+++..++.++.||+.||.|||+++ |+||||||+|||| +.++.+||+|||+++...
T Consensus 83 v~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~ 159 (296)
T 3uzp_A 83 VMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN--FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR 159 (296)
T ss_dssp EEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred EEEec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHeEEecCCCCCeEEEeeCCCccccc
Confidence 99999 99999999877778999999999999999999999999 9999999999999 488999999999998765
Q ss_pred CCcc-------ccccCCCCccccCC
Q 005841 657 ETYL-------TTKTGKGTVTYLAS 674 (674)
Q Consensus 657 ~~~~-------~~~~~~GTp~YmAP 674 (674)
.... ......||+.|+||
T Consensus 160 ~~~~~~~~~~~~~~~~~gt~~y~aP 184 (296)
T 3uzp_A 160 DARTHQHIPYRENKNLTGTARYASI 184 (296)
T ss_dssp CTTTCCBCCCCCSCCCCSCTTTCCH
T ss_pred ccccccccccccccccccccccCCh
Confidence 4322 12346799999998
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=1.5e-25 Score=247.20 Aligned_cols=165 Identities=26% Similarity=0.351 Sum_probs=142.0
Q ss_pred ccccCCeeEeeeecccCceEEEEEEEc--CCeEEEEEeecccCCHHHHHHHHHHHHHHhhC------CCCCeeeEEEEEe
Q 005841 501 EILWEDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRL------RHPNVLLFMGAVT 572 (674)
Q Consensus 501 ~~~~~~y~~~~~LG~G~fG~Vy~~~~~--~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l------~HpnIv~l~~~~~ 572 (674)
+....+|++.++||+|+||+||+|.+. +..||||++... ......+.+|+.+++.+ .|+||+.+++++.
T Consensus 93 ~~~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~ 169 (429)
T 3kvw_A 93 DHVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE---KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFT 169 (429)
T ss_dssp CEETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEE
T ss_pred CcccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc---cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecc
Confidence 445678999999999999999999984 567999999653 34455677788888876 5779999999999
Q ss_pred cCCeEEEEEecCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCc--EEEEec
Q 005841 573 SPQRLCIVTEFLPRGSLFRLLQRNT-TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWT--VKVGDF 649 (674)
Q Consensus 573 ~~~~~~lV~E~~~ggsL~~~l~~~~-~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~--vkL~DF 649 (674)
....+||||||+. ++|.+++.... ..+++..+..|+.||+.||.|||+.+ ||||||||+||||+.++. |||+||
T Consensus 170 ~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlKp~NILl~~~~~~~vkL~DF 246 (429)
T 3kvw_A 170 FRNHICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNR--IIHCDLKPENILLKQQGRSGIKVIDF 246 (429)
T ss_dssp ETTEEEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHT--EECSCCSGGGEEESSTTSCCEEECCC
T ss_pred cCCeEEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEEccCCCcceEEeec
Confidence 9999999999995 69999987654 45999999999999999999999999 999999999999999887 999999
Q ss_pred CCcccccCCccccccCCCCccccCC
Q 005841 650 GLSRLKHETYLTTKTGKGTVTYLAS 674 (674)
Q Consensus 650 Gla~~~~~~~~~~~~~~GTp~YmAP 674 (674)
|+|+..... ....+||+.||||
T Consensus 247 G~a~~~~~~---~~~~~gt~~y~aP 268 (429)
T 3kvw_A 247 GSSCYEHQR---VYTYIQSRFYRAP 268 (429)
T ss_dssp TTCEETTCC---CCSSCSCGGGCCH
T ss_pred ccceecCCc---ccccCCCCCccCh
Confidence 999865543 2346899999998
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=7.2e-26 Score=238.01 Aligned_cols=170 Identities=22% Similarity=0.332 Sum_probs=143.6
Q ss_pred cccccCCeeEeeeecccCceEEEEEEE-cCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCC--CCCeeeEEEEEecCCe
Q 005841 500 YEILWEDLTIGEQIGQGSCGTVYHAVW-YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLR--HPNVLLFMGAVTSPQR 576 (674)
Q Consensus 500 ~~~~~~~y~~~~~LG~G~fG~Vy~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~--HpnIv~l~~~~~~~~~ 576 (674)
..+..++|++.+.||+|+||.||++.+ .+..||||++............+.+|+.+++.+. ||||+++++++.....
T Consensus 23 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~ 102 (313)
T 3cek_A 23 MSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQY 102 (313)
T ss_dssp EEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSE
T ss_pred eeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCE
Confidence 456678899999999999999999987 4667999999877767777788999999999997 5999999999999999
Q ss_pred EEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCccccc
Q 005841 577 LCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKH 656 (674)
Q Consensus 577 ~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~ 656 (674)
+||||| +.+++|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||+++ +.+||+|||+++...
T Consensus 103 ~~lv~e-~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~~ 177 (313)
T 3cek_A 103 IYMVME-CGNIDLNSWLKKK-KSIDPWERKSYWKNMLEAVHTIHQHG--IVHSDLKPANFLIVD-GMLKLIDFGIANQMQ 177 (313)
T ss_dssp EEEEEC-CCSEEHHHHHHHC-SSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEET-TEEEECCCSSSCC--
T ss_pred EEEEEe-cCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCcccEEEEC-CeEEEeecccccccc
Confidence 999999 5588999999764 57899999999999999999999999 999999999999975 799999999998764
Q ss_pred CCcc--ccccCCCCccccCC
Q 005841 657 ETYL--TTKTGKGTVTYLAS 674 (674)
Q Consensus 657 ~~~~--~~~~~~GTp~YmAP 674 (674)
.... ......||+.|+||
T Consensus 178 ~~~~~~~~~~~~gt~~y~aP 197 (313)
T 3cek_A 178 PDTTSVVKDSQVGTVNYMPP 197 (313)
T ss_dssp ------------CCGGGCCH
T ss_pred CccccccccCCCCCCCcCCH
Confidence 3321 22345799999998
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=3.9e-26 Score=238.56 Aligned_cols=168 Identities=24% Similarity=0.407 Sum_probs=140.0
Q ss_pred cCCeeEeeeecccCceEEEEEEE--cCCeEEEEEeecccCC--HHHHHHHHHHHHHHhhCCCCCeeeEEEEEe--cCCeE
Q 005841 504 WEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYS--DEVIHSFRQEVSLMKRLRHPNVLLFMGAVT--SPQRL 577 (674)
Q Consensus 504 ~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~--~~~~~ 577 (674)
.++|++.+.||+|+||.||+|.+ ++..||||++...... ......+.+|+.+++.++||||+++++++. ....+
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM 83 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence 46899999999999999999998 4667999999765321 234567899999999999999999999984 45679
Q ss_pred EEEEecCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCccccc
Q 005841 578 CIVTEFLPRGSLFRLLQRN-TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKH 656 (674)
Q Consensus 578 ~lV~E~~~ggsL~~~l~~~-~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~ 656 (674)
||||||++++ |.+++... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++....
T Consensus 84 ~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~--i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~ 160 (305)
T 2wtk_C 84 YMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQG--IVHKDIKPGNLLLTTGGTLKISALGVAEALH 160 (305)
T ss_dssp EEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCcccEEEcCCCcEEeeccccccccC
Confidence 9999999876 77777653 456999999999999999999999999 9999999999999999999999999998764
Q ss_pred CC--ccccccCCCCccccCC
Q 005841 657 ET--YLTTKTGKGTVTYLAS 674 (674)
Q Consensus 657 ~~--~~~~~~~~GTp~YmAP 674 (674)
.. ........||+.|+||
T Consensus 161 ~~~~~~~~~~~~~~~~y~aP 180 (305)
T 2wtk_C 161 PFAADDTCRTSQGSPAFQPP 180 (305)
T ss_dssp TTCSSCEECCCCSCGGGCCH
T ss_pred ccccccccccCCCCCCCcCh
Confidence 32 2223345799999998
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=5.1e-26 Score=246.21 Aligned_cols=165 Identities=22% Similarity=0.328 Sum_probs=139.4
Q ss_pred ccccCCeeEeeeecccCceEEEEEEE--cCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCC--------CCCeeeEEEE
Q 005841 501 EILWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLR--------HPNVLLFMGA 570 (674)
Q Consensus 501 ~~~~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~--------HpnIv~l~~~ 570 (674)
++..++|++.++||+|+||+||+|.+ .+..||||++... ......+.+|+.+++.+. |+||++++++
T Consensus 33 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~ 109 (397)
T 1wak_A 33 DLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA---EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDD 109 (397)
T ss_dssp CEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEE
T ss_pred hhcCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC---CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecc
Confidence 34568899999999999999999987 4667999999643 345567889999999985 7889999999
Q ss_pred Ee----cCCeEEEEEecCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhC-CCCeEEccCCCCCEEEcCCC--
Q 005841 571 VT----SPQRLCIVTEFLPRGSLFRLLQRN-TTKLDWRRRILMALDIARGVSYLHHC-NPPIIHRDLKSSNLLVDKHW-- 642 (674)
Q Consensus 571 ~~----~~~~~~lV~E~~~ggsL~~~l~~~-~~~l~~~~~~~i~~qi~~~L~yLH~~-~~~IvHrDLKp~NILi~~~~-- 642 (674)
+. ....+||||||+ +++|.+++... ...+++..++.|+.||+.||.|||+. + ||||||||+||||+.++
T Consensus 110 ~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~g--ivHrDikp~NIll~~~~~~ 186 (397)
T 1wak_A 110 FKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCR--IIHTDIKPENILLSVNEQY 186 (397)
T ss_dssp EEEEETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC--EECCCCSGGGEEECCCHHH
T ss_pred eeecCCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHeeEeccchh
Confidence 87 556899999999 56666666543 36799999999999999999999997 8 99999999999998775
Q ss_pred -----------------------------------------------cEEEEecCCcccccCCccccccCCCCccccCC
Q 005841 643 -----------------------------------------------TVKVGDFGLSRLKHETYLTTKTGKGTVTYLAS 674 (674)
Q Consensus 643 -----------------------------------------------~vkL~DFGla~~~~~~~~~~~~~~GTp~YmAP 674 (674)
.+||+|||+++..... ....+||+.||||
T Consensus 187 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~---~~~~~gt~~y~aP 262 (397)
T 1wak_A 187 IRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH---FTEDIQTRQYRSL 262 (397)
T ss_dssp HHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC---SCSCCSCGGGCCH
T ss_pred hhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc---CccCCCCCcccCC
Confidence 7999999999876543 2335799999998
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=99.93 E-value=8.2e-26 Score=263.48 Aligned_cols=163 Identities=25% Similarity=0.314 Sum_probs=140.8
Q ss_pred ccccCCeeEeeeecccCceEEEEEEEc---CCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCe-
Q 005841 501 EILWEDLTIGEQIGQGSCGTVYHAVWY---GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQR- 576 (674)
Q Consensus 501 ~~~~~~y~~~~~LG~G~fG~Vy~~~~~---~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~- 576 (674)
++..++|++.++||+|+||+||+|.+. +..||||++.... .......+.+|+.+++.++||||+++++++...+.
T Consensus 76 ~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 154 (681)
T 2pzi_A 76 DIVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSG-DAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRH 154 (681)
T ss_dssp CEETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSC-CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTT
T ss_pred CEeCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccC-CHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCC
Confidence 456689999999999999999999983 5779999986532 44556778999999999999999999999987665
Q ss_pred ----EEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCc
Q 005841 577 ----LCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLS 652 (674)
Q Consensus 577 ----~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla 652 (674)
.||||||++|++|.+++.. .+++..++.|+.||+.||.|||+++ ||||||||+||||+.+ .+||+|||++
T Consensus 155 ~~~~~~lv~E~~~g~~L~~~~~~---~l~~~~~~~~~~qi~~aL~~lH~~g--iiHrDlkp~NIll~~~-~~kl~DFG~a 228 (681)
T 2pzi_A 155 GDPVGYIVMEYVGGQSLKRSKGQ---KLPVAEAIAYLLEILPALSYLHSIG--LVYNDLKPENIMLTEE-QLKLIDLGAV 228 (681)
T ss_dssp SCEEEEEEEECCCCEECC----C---CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECSS-CEEECCCTTC
T ss_pred CCceeEEEEEeCCCCcHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHCC--CeecccChHHeEEeCC-cEEEEecccc
Confidence 7999999999999988753 6999999999999999999999999 9999999999999986 9999999999
Q ss_pred ccccCCccccccCCCCccccCC
Q 005841 653 RLKHETYLTTKTGKGTVTYLAS 674 (674)
Q Consensus 653 ~~~~~~~~~~~~~~GTp~YmAP 674 (674)
+..... ....||+.||||
T Consensus 229 ~~~~~~----~~~~gt~~y~aP 246 (681)
T 2pzi_A 229 SRINSF----GYLYGTPGFQAP 246 (681)
T ss_dssp EETTCC----SCCCCCTTTSCT
T ss_pred hhcccC----CccCCCccccCH
Confidence 876543 335799999999
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=99.93 E-value=9e-26 Score=252.45 Aligned_cols=166 Identities=23% Similarity=0.327 Sum_probs=142.9
Q ss_pred cccCCeeEeeeecccCceEEEEEEE--cCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCC-CCeeeEEEEEecCCeEE
Q 005841 502 ILWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRH-PNVLLFMGAVTSPQRLC 578 (674)
Q Consensus 502 ~~~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~H-pnIv~l~~~~~~~~~~~ 578 (674)
...++|++.++||+|+||.||+|.+ .+..||||++....... .+.+|+.+++.|.| ++|..+..++...+..|
T Consensus 4 ~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~----~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~ 79 (483)
T 3sv0_A 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHP----QLLYESKIYRILQGGTGIPNVRWFGVEGDYNV 79 (483)
T ss_dssp EETTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSSC----CHHHHHHHHHHTTTSTTCCCEEEEEEETTEEE
T ss_pred CcCCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccccH----HHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEE
Confidence 3467899999999999999999997 47789999987654432 36779999999986 66777777778888999
Q ss_pred EEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEE---cCCCcEEEEecCCcccc
Q 005841 579 IVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLV---DKHWTVKVGDFGLSRLK 655 (674)
Q Consensus 579 lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi---~~~~~vkL~DFGla~~~ 655 (674)
|||||+ +++|.+++......+++..++.|+.||+.||.|||+++ ||||||||+|||| +.++.|||+|||+++..
T Consensus 80 lvme~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g--IvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~ 156 (483)
T 3sv0_A 80 LVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS--FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKY 156 (483)
T ss_dssp EEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred EEEECC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccCcceEEEecCCCCCeEEEEeCCcceec
Confidence 999999 99999999877778999999999999999999999999 9999999999999 68899999999999876
Q ss_pred cCCcc-------ccccCCCCccccCC
Q 005841 656 HETYL-------TTKTGKGTVTYLAS 674 (674)
Q Consensus 656 ~~~~~-------~~~~~~GTp~YmAP 674 (674)
..... .....+||+.||||
T Consensus 157 ~~~~~~~~~~~~~~~~~~gt~~Y~aP 182 (483)
T 3sv0_A 157 RDTSTHQHIPYRENKNLTGTARYASV 182 (483)
T ss_dssp BCTTTCCBCCCCCCCCCCSCTTTCCH
T ss_pred cCCccccccccccccccCCCccccCH
Confidence 54322 12256899999998
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=6.2e-26 Score=262.12 Aligned_cols=169 Identities=25% Similarity=0.429 Sum_probs=138.6
Q ss_pred cccCCeeEe-eeecccCceEEEEEEEc----CCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCe
Q 005841 502 ILWEDLTIG-EQIGQGSCGTVYHAVWY----GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQR 576 (674)
Q Consensus 502 ~~~~~y~~~-~~LG~G~fG~Vy~~~~~----~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 576 (674)
+....+.+. ++||+|+||.||+|.+. +..||||++..........+.+.+|+.+|+.++||||+++++++.. +.
T Consensus 365 ~~~~~~~l~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~ 443 (635)
T 4fl3_A 365 LDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ES 443 (635)
T ss_dssp CCGGGEEEEEEEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SS
T ss_pred ccchhccccCCEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CC
Confidence 334445554 48999999999999762 3569999998765555556789999999999999999999999864 56
Q ss_pred EEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCccccc
Q 005841 577 LCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKH 656 (674)
Q Consensus 577 ~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~ 656 (674)
+|||||||++++|.+++.. ...+++..++.|+.||+.||.|||+++ ||||||||+||||+.++.+||+|||+|+.+.
T Consensus 444 ~~lv~E~~~~g~L~~~l~~-~~~l~~~~~~~i~~qi~~~L~yLH~~~--iiHrDLkp~NILl~~~~~~kL~DFGla~~~~ 520 (635)
T 4fl3_A 444 WMLVMEMAELGPLNKYLQQ-NRHVKDKNIIELVHQVSMGMKYLEESN--FVHRDLAARNVLLVTQHYAKISDFGLSKALR 520 (635)
T ss_dssp EEEEEECCTTEEHHHHHHH-CTTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEEETTEEEECCTTHHHHTT
T ss_pred EEEEEEccCCCCHHHHHhh-CCCCCHHHHHHHHHHHHHHHHHHHHCC--EeCCCCChHhEEEeCCCCEEEEEcCCccccc
Confidence 8999999999999999975 457999999999999999999999999 9999999999999999999999999998764
Q ss_pred CCc---cccccCCCCccccCC
Q 005841 657 ETY---LTTKTGKGTVTYLAS 674 (674)
Q Consensus 657 ~~~---~~~~~~~GTp~YmAP 674 (674)
... .......||+.||||
T Consensus 521 ~~~~~~~~~~~~~~t~~y~AP 541 (635)
T 4fl3_A 521 ADENYYKAQTHGKWPVKWYAP 541 (635)
T ss_dssp C-------------CGGGSCH
T ss_pred cCccccccccCCCCceeeeCh
Confidence 332 122234688999998
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=1e-25 Score=261.24 Aligned_cols=173 Identities=32% Similarity=0.541 Sum_probs=145.6
Q ss_pred cccccccCCeeEeeeecccCceEEEEEEEcC-----CeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEe
Q 005841 498 LDYEILWEDLTIGEQIGQGSCGTVYHAVWYG-----SDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVT 572 (674)
Q Consensus 498 ~~~~~~~~~y~~~~~LG~G~fG~Vy~~~~~~-----~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~ 572 (674)
..+++..++|++.+.||+|+||.||+|.+.. ..||||++... ......+.+.+|+.+++.++||||+++++++.
T Consensus 383 ~~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~ 461 (656)
T 2j0j_A 383 RDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNC-TSDSVREKFLQEALTMRQFDHPHIVKLIGVIT 461 (656)
T ss_dssp GGTBCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSST-TCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cccccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEeccc-CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe
Confidence 3456777899999999999999999999842 34899988643 34556678999999999999999999999985
Q ss_pred cCCeEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCc
Q 005841 573 SPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLS 652 (674)
Q Consensus 573 ~~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla 652 (674)
.+.+||||||+++++|.+++......+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 462 -~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g--ivHrDikp~NILl~~~~~vkL~DFG~a 538 (656)
T 2j0j_A 462 -ENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKR--FVHRDIAARNVLVSSNDCVKLGDFGLS 538 (656)
T ss_dssp -SSSCEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEEETTEEEECCCCCC
T ss_pred -cCceEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccccchHhEEEeCCCCEEEEecCCC
Confidence 56789999999999999999876667999999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCcc-ccccCCCCccccCC
Q 005841 653 RLKHETYL-TTKTGKGTVTYLAS 674 (674)
Q Consensus 653 ~~~~~~~~-~~~~~~GTp~YmAP 674 (674)
+....... ......||+.||||
T Consensus 539 ~~~~~~~~~~~~~~~~t~~y~aP 561 (656)
T 2j0j_A 539 RYMEDSTYYKASKGKLPIKWMAP 561 (656)
T ss_dssp CSCCC----------CCGGGCCH
T ss_pred eecCCCcceeccCCCCCcceeCH
Confidence 87654322 23335688999998
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=2.7e-26 Score=245.78 Aligned_cols=164 Identities=16% Similarity=0.211 Sum_probs=138.9
Q ss_pred ccccCCeeEeeeecccCceEEEEEEEc----------CCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeee----
Q 005841 501 EILWEDLTIGEQIGQGSCGTVYHAVWY----------GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLL---- 566 (674)
Q Consensus 501 ~~~~~~y~~~~~LG~G~fG~Vy~~~~~----------~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~---- 566 (674)
....++|++.+.||+|+||.||+|.+. +..||||++... ..+.+|+.+++.++||||++
T Consensus 38 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~ 110 (352)
T 2jii_A 38 DKSGRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-------GRLFNEQNFFQRAAKPLQVNKWKK 110 (352)
T ss_dssp CTTSCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-------STHHHHHHHHHHHCCHHHHHHHHH
T ss_pred cccCCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-------chHHHHHHHHHHhcccchhhhhhh
Confidence 344578999999999999999999974 567999999754 35778999999999999887
Q ss_pred -----------EEEEEec-CCeEEEEEecCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCC
Q 005841 567 -----------FMGAVTS-PQRLCIVTEFLPRGSLFRLLQRN-TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKS 633 (674)
Q Consensus 567 -----------l~~~~~~-~~~~~lV~E~~~ggsL~~~l~~~-~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp 633 (674)
+++++.. ...+||||||+ +++|.+++... ...+++..++.|+.||+.||.|||+++ |+||||||
T Consensus 111 ~~~~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dikp 187 (352)
T 2jii_A 111 LYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENE--YVHGNVTA 187 (352)
T ss_dssp HTTCTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTT--CBCSCCCG
T ss_pred hccCCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCCH
Confidence 5667765 67899999999 99999999864 357999999999999999999999999 99999999
Q ss_pred CCEEEcCCC--cEEEEecCCcccccCCcc-------ccccCCCCccccCC
Q 005841 634 SNLLVDKHW--TVKVGDFGLSRLKHETYL-------TTKTGKGTVTYLAS 674 (674)
Q Consensus 634 ~NILi~~~~--~vkL~DFGla~~~~~~~~-------~~~~~~GTp~YmAP 674 (674)
+|||++.++ .+||+|||+++....... ......||+.|+||
T Consensus 188 ~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aP 237 (352)
T 2jii_A 188 ENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISM 237 (352)
T ss_dssp GGEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCH
T ss_pred HHEEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCH
Confidence 999999988 999999999987653221 11234799999998
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=8.6e-26 Score=238.91 Aligned_cols=172 Identities=24% Similarity=0.351 Sum_probs=131.8
Q ss_pred cccccccCCeeEeeeecccCceEEEEEEEc--CCeEEEEEeecccCCHHHHHHHHHHHH-HHhhCCCCCeeeEEEEEecC
Q 005841 498 LDYEILWEDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVS-LMKRLRHPNVLLFMGAVTSP 574 (674)
Q Consensus 498 ~~~~~~~~~y~~~~~LG~G~fG~Vy~~~~~--~~~vAvK~i~~~~~~~~~~~~~~~Ei~-il~~l~HpnIv~l~~~~~~~ 574 (674)
..+.+..++|++.+.||+|+||.||+|.+. +..||||++.... .......+..|+. +++.++||||+++++++...
T Consensus 15 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~ 93 (327)
T 3aln_A 15 QHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTV-DEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFRE 93 (327)
T ss_dssp EEECCCSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCC-CHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECS
T ss_pred HhcccCHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeeccc-CchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeC
Confidence 345677899999999999999999999985 7789999997654 3333445555665 77788999999999999999
Q ss_pred CeEEEEEecCCCCCHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCeEEccCCCCCEEEcCCCcEEEEec
Q 005841 575 QRLCIVTEFLPRGSLFRLLQR----NTTKLDWRRRILMALDIARGVSYLHHC-NPPIIHRDLKSSNLLVDKHWTVKVGDF 649 (674)
Q Consensus 575 ~~~~lV~E~~~ggsL~~~l~~----~~~~l~~~~~~~i~~qi~~~L~yLH~~-~~~IvHrDLKp~NILi~~~~~vkL~DF 649 (674)
+..||||||+++ +|.+++.. ....+++..+..++.|++.||.|||+. + |+||||||+||||+.++.+||+||
T Consensus 94 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~--ivH~dlkp~NIll~~~~~~kl~Df 170 (327)
T 3aln_A 94 GDCWICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK--IIHRDIKPSNILLDRSGNIKLCDF 170 (327)
T ss_dssp SEEEEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHS--CCCSCCCGGGEEEETTTEEEECCC
T ss_pred CceEEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCC--EeECCCCHHHEEEcCCCCEEEccC
Confidence 999999999975 88887753 256799999999999999999999998 8 999999999999999999999999
Q ss_pred CCcccccCCccccccCCCCccccCC
Q 005841 650 GLSRLKHETYLTTKTGKGTVTYLAS 674 (674)
Q Consensus 650 Gla~~~~~~~~~~~~~~GTp~YmAP 674 (674)
|+++....... .....||+.|+||
T Consensus 171 g~~~~~~~~~~-~~~~~gt~~y~aP 194 (327)
T 3aln_A 171 GISGQLVDSIA-KTRDAGCRPYMAP 194 (327)
T ss_dssp SSSCC--------------------
T ss_pred CCceecccccc-cccCCCCccccCc
Confidence 99987654332 2234799999998
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=4.6e-26 Score=236.45 Aligned_cols=170 Identities=28% Similarity=0.462 Sum_probs=146.6
Q ss_pred ccccCCeeEeeeecccCceEEEEEEE--cCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeEE
Q 005841 501 EILWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLC 578 (674)
Q Consensus 501 ~~~~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 578 (674)
....++|++.+.||+|+||.||+|.+ .+..||||++............+.+|+.+++.++||||+++++++.....+|
T Consensus 18 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 97 (287)
T 2wei_A 18 GTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFY 97 (287)
T ss_dssp HHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred HHHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEE
Confidence 34457899999999999999999998 4778999999876554444567889999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCC---CcEEEEecCCcccc
Q 005841 579 IVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKH---WTVKVGDFGLSRLK 655 (674)
Q Consensus 579 lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~---~~vkL~DFGla~~~ 655 (674)
+||||+++++|.+++... ..+++..++.++.||+.||.|||+++ |+|+||||+||||+.+ +.+||+|||++...
T Consensus 98 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~ 174 (287)
T 2wei_A 98 IVGELYTGGELFDEIIKR-KRFSEHDAARIIKQVFSGITYMHKHN--IVHRDLKPENILLESKEKDCDIKIIDFGLSTCF 174 (287)
T ss_dssp EEECCCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESCSSTTCCEEECSTTGGGTB
T ss_pred EEEEccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCChhhEEEecCCCcccEEEeccCcceee
Confidence 999999999999988754 46999999999999999999999999 9999999999999753 47999999999866
Q ss_pred cCCccccccCCCCccccCC
Q 005841 656 HETYLTTKTGKGTVTYLAS 674 (674)
Q Consensus 656 ~~~~~~~~~~~GTp~YmAP 674 (674)
..... .....||+.|+||
T Consensus 175 ~~~~~-~~~~~~~~~y~aP 192 (287)
T 2wei_A 175 QQNTK-MKDRIGTAYYIAP 192 (287)
T ss_dssp CCCSS-CSCHHHHHTTCCH
T ss_pred cCCCc-cccccCcccccCh
Confidence 54322 2234589999998
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=2.5e-26 Score=241.20 Aligned_cols=170 Identities=25% Similarity=0.367 Sum_probs=136.3
Q ss_pred cccccCCeeEeeeecccCceEEEEEEE--cCCeEEEEEeecccCCH----HHHHHHHHHHHHHhhC----CCCCeeeEEE
Q 005841 500 YEILWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSD----EVIHSFRQEVSLMKRL----RHPNVLLFMG 569 (674)
Q Consensus 500 ~~~~~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~~~----~~~~~~~~Ei~il~~l----~HpnIv~l~~ 569 (674)
.+...++|++.+.||+|+||.||+|.+ .+..||||++....... .....+.+|+.++..+ +||||+++++
T Consensus 26 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~ 105 (312)
T 2iwi_A 26 REAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLD 105 (312)
T ss_dssp -------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEE
T ss_pred hhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEE
Confidence 355668899999999999999999987 56789999997654322 1233456789999988 8999999999
Q ss_pred EEecCCeEEEEEec-CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEc-CCCcEEEE
Q 005841 570 AVTSPQRLCIVTEF-LPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVD-KHWTVKVG 647 (674)
Q Consensus 570 ~~~~~~~~~lV~E~-~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~-~~~~vkL~ 647 (674)
++...+..|+|||| +.+++|.+++... ..+++..++.++.||+.||.|||+.+ |+||||||+|||++ .++.+||+
T Consensus 106 ~~~~~~~~~~v~e~~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~~kl~ 182 (312)
T 2iwi_A 106 WFETQEGFMLVLERPLPAQDLFDYITEK-GPLGEGPSRCFFGQVVAAIQHCHSRG--VVHRDIKDENILIDLRRGCAKLI 182 (312)
T ss_dssp EC-----CEEEEECCSSEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHHT--EECCCCSGGGEEEETTTTEEEEC
T ss_pred EEecCCeEEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCChhhEEEeCCCCeEEEE
Confidence 99999999999999 7899999999764 46999999999999999999999999 99999999999999 88999999
Q ss_pred ecCCcccccCCccccccCCCCccccCC
Q 005841 648 DFGLSRLKHETYLTTKTGKGTVTYLAS 674 (674)
Q Consensus 648 DFGla~~~~~~~~~~~~~~GTp~YmAP 674 (674)
|||+++....... ....||+.|+||
T Consensus 183 dfg~~~~~~~~~~--~~~~~~~~y~aP 207 (312)
T 2iwi_A 183 DFGSGALLHDEPY--TDFDGTRVYSPP 207 (312)
T ss_dssp CCSSCEECCSSCB--CCCCSCTTTSCH
T ss_pred EcchhhhcccCcc--cccCCcccccCc
Confidence 9999987765432 345799999998
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=1.9e-25 Score=235.98 Aligned_cols=165 Identities=27% Similarity=0.404 Sum_probs=142.6
Q ss_pred ccccCCeeEeeeecccCceEEEEEEE---cCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCC------CeeeEEEEE
Q 005841 501 EILWEDLTIGEQIGQGSCGTVYHAVW---YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHP------NVLLFMGAV 571 (674)
Q Consensus 501 ~~~~~~y~~~~~LG~G~fG~Vy~~~~---~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp------nIv~l~~~~ 571 (674)
+...++|++.+.||+|+||.||+|.+ .+..||||++... ......+.+|+.+++.++|+ +|+++++++
T Consensus 10 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~ 86 (339)
T 1z57_A 10 DVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV---DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWF 86 (339)
T ss_dssp CEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS---HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEE
T ss_pred CCccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC---CchhHHHHHHHHHHHHhhhcCCCCceeeEeeeccc
Confidence 45678999999999999999999987 3667999999643 34556788899999988655 599999999
Q ss_pred ecCCeEEEEEecCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcC----------
Q 005841 572 TSPQRLCIVTEFLPRGSLFRLLQRNT-TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDK---------- 640 (674)
Q Consensus 572 ~~~~~~~lV~E~~~ggsL~~~l~~~~-~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~---------- 640 (674)
...+.+||||||+ +++|.+++.... ..+++..+..++.||+.||.|||+++ |+||||||+||||+.
T Consensus 87 ~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~~~~ 163 (339)
T 1z57_A 87 EHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNK--LTHTDLKPENILFVQSDYTEAYNPK 163 (339)
T ss_dssp EETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESCCCEEEEEC--
T ss_pred ccCCcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCC--CcCCCCCHHHEEEeccccccccCCc
Confidence 9999999999999 889999997654 36899999999999999999999999 999999999999987
Q ss_pred ---------CCcEEEEecCCcccccCCccccccCCCCccccCC
Q 005841 641 ---------HWTVKVGDFGLSRLKHETYLTTKTGKGTVTYLAS 674 (674)
Q Consensus 641 ---------~~~vkL~DFGla~~~~~~~~~~~~~~GTp~YmAP 674 (674)
++.+||+|||+++..... .....||+.|+||
T Consensus 164 ~~~~~~~~~~~~~kl~Dfg~~~~~~~~---~~~~~gt~~y~aP 203 (339)
T 1z57_A 164 IKRDERTLINPDIKVVDFGSATYDDEH---HSTLVSTRHYRAP 203 (339)
T ss_dssp --CEEEEESCCCEEECCCSSCEETTSC---CCSSCSCGGGCCH
T ss_pred cccccccccCCCceEeeCcccccCccc---cccccCCccccCh
Confidence 678999999999875543 2345799999998
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=99.93 E-value=7e-26 Score=238.92 Aligned_cols=167 Identities=28% Similarity=0.393 Sum_probs=139.2
Q ss_pred cCCeeEeeeecccCceEEEEEEEc---CCeEEEEEeecccCCHHHHHHHHHHHHHHhhC---CCCCeeeEEEEEe-----
Q 005841 504 WEDLTIGEQIGQGSCGTVYHAVWY---GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRL---RHPNVLLFMGAVT----- 572 (674)
Q Consensus 504 ~~~y~~~~~LG~G~fG~Vy~~~~~---~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l---~HpnIv~l~~~~~----- 572 (674)
.++|++.+.||+|+||.||+|.+. +..||||++............+.+|+.+++.+ .||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~ 89 (326)
T 1blx_A 10 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 89 (326)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred hhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecccC
Confidence 478999999999999999999983 56799999976543322223455677777666 8999999999987
Q ss_pred cCCeEEEEEecCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCC
Q 005841 573 SPQRLCIVTEFLPRGSLFRLLQRNT-TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGL 651 (674)
Q Consensus 573 ~~~~~~lV~E~~~ggsL~~~l~~~~-~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGl 651 (674)
....+|+||||++ ++|.+++.... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 90 ~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g--i~H~dlkp~Nili~~~~~~kl~Dfg~ 166 (326)
T 1blx_A 90 RETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR--VVHRDLKPQNILVTSSGQIKLADFGL 166 (326)
T ss_dssp SEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTCCEEECSCCS
T ss_pred CCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCHHHeEEcCCCCEEEecCcc
Confidence 5567999999997 59999997653 35999999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCccccccCCCCccccCC
Q 005841 652 SRLKHETYLTTKTGKGTVTYLAS 674 (674)
Q Consensus 652 a~~~~~~~~~~~~~~GTp~YmAP 674 (674)
++...... ......||+.|+||
T Consensus 167 ~~~~~~~~-~~~~~~~~~~y~aP 188 (326)
T 1blx_A 167 ARIYSFQM-ALTSVVVTLWYRAP 188 (326)
T ss_dssp CCCCCGGG-GGCCCCCCCTTCCH
T ss_pred cccccCCC-CccccccccceeCH
Confidence 98765432 23346799999998
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=99.93 E-value=6.5e-26 Score=239.72 Aligned_cols=169 Identities=25% Similarity=0.388 Sum_probs=145.0
Q ss_pred ccccCCeeEeeeecccCceEEEEEEE--cCCeEEEEEeecccCCH----HHHHHHHHHHHHHhhCC--CCCeeeEEEEEe
Q 005841 501 EILWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSD----EVIHSFRQEVSLMKRLR--HPNVLLFMGAVT 572 (674)
Q Consensus 501 ~~~~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~~~----~~~~~~~~Ei~il~~l~--HpnIv~l~~~~~ 572 (674)
+...++|++.+.||+|+||.||+|.+ ++..||||++....... .....+.+|+.+++.+. |+||+++++++.
T Consensus 39 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~ 118 (320)
T 3a99_A 39 EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFE 118 (320)
T ss_dssp -CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEE
T ss_pred CCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEe
Confidence 45668899999999999999999987 56779999997654322 12234667999999996 599999999999
Q ss_pred cCCeEEEEEecCCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEc-CCCcEEEEecC
Q 005841 573 SPQRLCIVTEFLPR-GSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVD-KHWTVKVGDFG 650 (674)
Q Consensus 573 ~~~~~~lV~E~~~g-gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~-~~~~vkL~DFG 650 (674)
..+.+++||||+.+ ++|.+++... ..+++..++.++.||+.||.|||+.+ |+||||||+||||+ .++.+||+|||
T Consensus 119 ~~~~~~lv~e~~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~~~~~~kL~Dfg 195 (320)
T 3a99_A 119 RPDSFVLILERPEPVQDLFDFITER-GALQEELARSFFWQVLEAVRHCHNCG--VLHRDIKDENILIDLNRGELKLIDFG 195 (320)
T ss_dssp CSSEEEEEEECCSSEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEETTTTEEEECCCT
T ss_pred cCCcEEEEEEcCCCCccHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC--cEeCCCCHHHEEEeCCCCCEEEeeCc
Confidence 99999999999976 8999999764 47999999999999999999999999 99999999999999 78999999999
Q ss_pred CcccccCCccccccCCCCccccCC
Q 005841 651 LSRLKHETYLTTKTGKGTVTYLAS 674 (674)
Q Consensus 651 la~~~~~~~~~~~~~~GTp~YmAP 674 (674)
+++....... ....||+.|+||
T Consensus 196 ~~~~~~~~~~--~~~~gt~~y~aP 217 (320)
T 3a99_A 196 SGALLKDTVY--TDFDGTRVYSPP 217 (320)
T ss_dssp TCEECCSSCB--CCCCSCGGGSCH
T ss_pred cccccccccc--cCCCCCccCCCh
Confidence 9987765432 235799999998
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=2e-25 Score=234.18 Aligned_cols=166 Identities=27% Similarity=0.442 Sum_probs=134.8
Q ss_pred cccCCeeEeeeecccCceEEEEEEEc--CCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEe-------
Q 005841 502 ILWEDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVT------- 572 (674)
Q Consensus 502 ~~~~~y~~~~~LG~G~fG~Vy~~~~~--~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~------- 572 (674)
...++|++.+.||+|+||.||+|.+. +..||||++... .....+.+.+|+.+++.++||||+++++++.
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 85 (320)
T 2i6l_A 8 DLGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLT--DPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLT 85 (320)
T ss_dssp EETTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECC--SHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCC
T ss_pred ccCCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecC--ChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccc
Confidence 34578999999999999999999984 678999998754 3455678899999999999999999999874
Q ss_pred -------cCCeEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEc-CCCcE
Q 005841 573 -------SPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVD-KHWTV 644 (674)
Q Consensus 573 -------~~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~-~~~~v 644 (674)
....+|+||||+. ++|.+++.. ..+++..+..++.||+.||.|||+++ |+||||||+|||++ .++.+
T Consensus 86 ~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~~ 160 (320)
T 2i6l_A 86 DDVGSLTELNSVYIVQEYME-TDLANVLEQ--GPLLEEHARLFMYQLLRGLKYIHSAN--VLHRDLKPANLFINTEDLVL 160 (320)
T ss_dssp C----CCSCSEEEEEEECCS-EEHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCSGGGEEEETTTTEE
T ss_pred cccccccccCceeEEeeccC-CCHHHHhhc--CCccHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEEcCCCCeE
Confidence 3467899999997 599999964 46999999999999999999999999 99999999999997 56799
Q ss_pred EEEecCCcccccCCcc---ccccCCCCccccCC
Q 005841 645 KVGDFGLSRLKHETYL---TTKTGKGTVTYLAS 674 (674)
Q Consensus 645 kL~DFGla~~~~~~~~---~~~~~~GTp~YmAP 674 (674)
||+|||+++....... ......||+.|+||
T Consensus 161 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aP 193 (320)
T 2i6l_A 161 KIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSP 193 (320)
T ss_dssp EECCCTTCBCC--------CCCGGGSCCTTCCH
T ss_pred EEccCccccccCCCcccccccccccccccccCc
Confidence 9999999987643211 12234689999998
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=99.93 E-value=1.1e-25 Score=245.28 Aligned_cols=163 Identities=26% Similarity=0.343 Sum_probs=133.6
Q ss_pred cccCCeeEeeeecccCceEEEEEEEc-CCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCC-----
Q 005841 502 ILWEDLTIGEQIGQGSCGTVYHAVWY-GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQ----- 575 (674)
Q Consensus 502 ~~~~~y~~~~~LG~G~fG~Vy~~~~~-~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~----- 575 (674)
....+|++.++||+|+||+||+|.+. +..||+|.+...... ..+|+.+++.++||||+++++++....
T Consensus 37 ~~~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~------~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~ 110 (394)
T 4e7w_A 37 QREIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRF------KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDE 110 (394)
T ss_dssp EEEEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTTS------CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSC
T ss_pred cccceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcch------HHHHHHHHHhCCCCCcceEEEEEEecCCCCCc
Confidence 34567999999999999999999984 445899887654321 235999999999999999999996543
Q ss_pred -eEEEEEecCCCCCHHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEc-CCCcEEEEecC
Q 005841 576 -RLCIVTEFLPRGSLFRLLQ---RNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVD-KHWTVKVGDFG 650 (674)
Q Consensus 576 -~~~lV~E~~~ggsL~~~l~---~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~-~~~~vkL~DFG 650 (674)
.+||||||++++ |...+. .....+++..+..|+.||+.||.|||+++ |+||||||+||||+ .++.+||+|||
T Consensus 111 ~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~Nill~~~~~~~kL~DFG 187 (394)
T 4e7w_A 111 VFLNLVLEYVPET-VYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG--ICHRDIKPQNLLLDPPSGVLKLIDFG 187 (394)
T ss_dssp EEEEEEEECCSEE-HHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEETTTTEEEECCCT
T ss_pred eEEEEEeeccCcc-HHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccCCCCCHHHEEEcCCCCcEEEeeCC
Confidence 388999999774 444332 23567999999999999999999999999 99999999999999 79999999999
Q ss_pred CcccccCCccccccCCCCccccCC
Q 005841 651 LSRLKHETYLTTKTGKGTVTYLAS 674 (674)
Q Consensus 651 la~~~~~~~~~~~~~~GTp~YmAP 674 (674)
+|+....... .....||+.|+||
T Consensus 188 ~a~~~~~~~~-~~~~~~t~~y~aP 210 (394)
T 4e7w_A 188 SAKILIAGEP-NVSYICSRYYRAP 210 (394)
T ss_dssp TCEECCTTCC-CCSSCSCGGGCCH
T ss_pred CcccccCCCC-CcccccCcCccCH
Confidence 9987654332 3346799999998
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=6.1e-26 Score=242.98 Aligned_cols=162 Identities=27% Similarity=0.416 Sum_probs=139.1
Q ss_pred cCCeeEeeeecccCceEEEEEEE--cCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCe-----
Q 005841 504 WEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQR----- 576 (674)
Q Consensus 504 ~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~----- 576 (674)
.++|.+.+.||+|+||.||+|.+ ++..||||++............+.+|+.+++.++||||+++++++.....
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 102 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 102 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence 47899999999999999999998 47789999998766566667889999999999999999999999987654
Q ss_pred -EEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccc
Q 005841 577 -LCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLK 655 (674)
Q Consensus 577 -~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~ 655 (674)
+|+||||+. ++|.+++. ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 103 ~~~lv~e~~~-~~l~~~~~---~~~~~~~~~~i~~qi~~al~~LH~~~--ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~ 176 (353)
T 3coi_A 103 DFYLVMPFMQ-TDLQKIMG---LKFSEEKIQYLVYQMLKGLKYIHSAG--VVHRDLKPGNLAVNEDCELKILDFGLARHA 176 (353)
T ss_dssp CCEEEEECCS-EEGGGTTT---SCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSSCCGGGEEECTTCCEEECSTTCTTC-
T ss_pred eEEEEecccc-CCHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEeECCCCcEEEeecccccCC
Confidence 499999997 58877764 35999999999999999999999999 999999999999999999999999999865
Q ss_pred cCCccccccCCCCccccCC
Q 005841 656 HETYLTTKTGKGTVTYLAS 674 (674)
Q Consensus 656 ~~~~~~~~~~~GTp~YmAP 674 (674)
... .....||+.|+||
T Consensus 177 ~~~---~~~~~~t~~y~aP 192 (353)
T 3coi_A 177 DAE---MTGYVVTRWYRAP 192 (353)
T ss_dssp ----------CCSBCCSCH
T ss_pred CCC---ccccccCcCcCCH
Confidence 433 2335799999998
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=8.8e-26 Score=246.68 Aligned_cols=163 Identities=26% Similarity=0.427 Sum_probs=124.0
Q ss_pred CCeeE-eeeecccCceEEEEEEEc----CCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEe--cCCeE
Q 005841 505 EDLTI-GEQIGQGSCGTVYHAVWY----GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVT--SPQRL 577 (674)
Q Consensus 505 ~~y~~-~~~LG~G~fG~Vy~~~~~----~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~--~~~~~ 577 (674)
+.|++ +++||+|+||+||+|.+. +..||||++....... .+.+|+.+|+.++||||+++++++. ....+
T Consensus 20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~~----~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~ 95 (405)
T 3rgf_A 20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISM----SACREIALLRELKHPNVISLQKVFLSHADRKV 95 (405)
T ss_dssp HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSCCH----HHHHHHHHHHHCCCTTBCCCCEEEEETTTTEE
T ss_pred hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCCCH----HHHHHHHHHHhcCCCCeeeEeeEEecCCCCeE
Confidence 45666 558999999999999964 5679999997655443 4678999999999999999999995 46789
Q ss_pred EEEEecCCCCCHHHHHHhc--------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEE----cCCCcEE
Q 005841 578 CIVTEFLPRGSLFRLLQRN--------TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLV----DKHWTVK 645 (674)
Q Consensus 578 ~lV~E~~~ggsL~~~l~~~--------~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi----~~~~~vk 645 (674)
||||||+. ++|.+++... ...+++..++.|+.||+.||.|||+++ ||||||||+|||| +.++.||
T Consensus 96 ~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~--ivH~Dlkp~NIll~~~~~~~~~~k 172 (405)
T 3rgf_A 96 WLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW--VLHRDLKPANILVMGEGPERGRVK 172 (405)
T ss_dssp EEEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECCSSTTTTCEE
T ss_pred EEEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC--EeCCCcCHHHeEEecCCCCCCcEE
Confidence 99999996 5888877532 224999999999999999999999999 9999999999999 6788999
Q ss_pred EEecCCcccccCCc---cccccCCCCccccCC
Q 005841 646 VGDFGLSRLKHETY---LTTKTGKGTVTYLAS 674 (674)
Q Consensus 646 L~DFGla~~~~~~~---~~~~~~~GTp~YmAP 674 (674)
|+|||+|+...... ......+||+.||||
T Consensus 173 l~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aP 204 (405)
T 3rgf_A 173 IADMGFARLFNSPLKPLADLDPVVVTFWYRAP 204 (405)
T ss_dssp ECCTTCCC----------------CCCTTCCH
T ss_pred EEECCCceecCCCCcccccCCCceecCcccCc
Confidence 99999998765321 223346799999998
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=5.3e-26 Score=251.02 Aligned_cols=166 Identities=26% Similarity=0.350 Sum_probs=134.7
Q ss_pred ccccCCeeEeeeecccCceE-EEEEEEcCCeEEEEEeecccCCHHHHHHHHHHHHHHhhC-CCCCeeeEEEEEecCCeEE
Q 005841 501 EILWEDLTIGEQIGQGSCGT-VYHAVWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRL-RHPNVLLFMGAVTSPQRLC 578 (674)
Q Consensus 501 ~~~~~~y~~~~~LG~G~fG~-Vy~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~ 578 (674)
.+...+|.+.++||+|+||+ ||.+...+..||||++.+.... .+.+|+.+++.+ +||||+++++++.+...+|
T Consensus 20 ~i~~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~~-----~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~ 94 (432)
T 3p23_A 20 IVGKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFS-----FADREVQLLRESDEHPNVIRYFCTEKDRQFQY 94 (432)
T ss_dssp EETTEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTEE-----ECHHHHHHHHHSCCCTTBCCEEEEEEETTEEE
T ss_pred EEccEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHHH-----HHHHHHHHHHhccCCCCcCeEEEEEecCCEEE
Confidence 44556799999999999998 4555568899999999754332 245799999999 7999999999999999999
Q ss_pred EEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcC-----CCcEEEEecCCcc
Q 005841 579 IVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDK-----HWTVKVGDFGLSR 653 (674)
Q Consensus 579 lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~-----~~~vkL~DFGla~ 653 (674)
||||||. ++|.+++......+.+..++.++.||+.||.|||+++ ||||||||+||||+. ...+||+|||+|+
T Consensus 95 lv~E~~~-g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~ 171 (432)
T 3p23_A 95 IAIELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLN--IVHRDLKPHNILISMPNAHGKIKAMISDFGLCK 171 (432)
T ss_dssp EEEECCS-EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTT--CCCCCCSTTSEEECCCBTTTBCCEEECCTTEEE
T ss_pred EEEECCC-CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCc--CEeCCCCHHHEEEecCCCCCceeEEEeccccee
Confidence 9999996 5999999876666777778899999999999999999 999999999999953 3368899999998
Q ss_pred cccCCc---cccccCCCCccccCC
Q 005841 654 LKHETY---LTTKTGKGTVTYLAS 674 (674)
Q Consensus 654 ~~~~~~---~~~~~~~GTp~YmAP 674 (674)
...... ......+||+.||||
T Consensus 172 ~~~~~~~~~~~~~~~~gt~~y~AP 195 (432)
T 3p23_A 172 KLAVGRHSFSRRSGVPGTEGWIAP 195 (432)
T ss_dssp CC------------CCSCTTSCCG
T ss_pred eccCCCcceeeccccCCCcCccCh
Confidence 765321 223346799999998
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=5.5e-25 Score=234.42 Aligned_cols=162 Identities=23% Similarity=0.362 Sum_probs=121.0
Q ss_pred ccCCeeEee-eecccCceEEEEEEEc--CCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEec----CC
Q 005841 503 LWEDLTIGE-QIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTS----PQ 575 (674)
Q Consensus 503 ~~~~y~~~~-~LG~G~fG~Vy~~~~~--~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~----~~ 575 (674)
..++|.+.+ +||+|+||+||+|.+. +..||||++... .... ......++.+.||||+++++++.. ..
T Consensus 26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~---~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~ 99 (336)
T 3fhr_A 26 VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS---PKAR---QEVDHHWQASGGPHIVCILDVYENMHHGKR 99 (336)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS---HHHH---HHHHHHHHHTTSTTBCCEEEEEEEEETTEE
T ss_pred ccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc---HHHH---HHHHHHHHhcCCCChHHHHHHHhhccCCCc
Confidence 446799865 6999999999999985 778999999653 2211 222334566789999999999876 45
Q ss_pred eEEEEEecCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcC---CCcEEEEecCC
Q 005841 576 RLCIVTEFLPRGSLFRLLQRNT-TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDK---HWTVKVGDFGL 651 (674)
Q Consensus 576 ~~~lV~E~~~ggsL~~~l~~~~-~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~---~~~vkL~DFGl 651 (674)
.+||||||+++++|.+++.... ..+++..++.++.||+.||.|||+++ |+||||||+||||+. ++.+||+|||+
T Consensus 100 ~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~--ivH~dlkp~NIll~~~~~~~~~kl~Dfg~ 177 (336)
T 3fhr_A 100 CLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHN--IAHRDVKPENLLYTSKEKDAVLKLTDFGF 177 (336)
T ss_dssp EEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred eEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEEecCCCceEEEecccc
Confidence 5899999999999999998653 46999999999999999999999999 999999999999975 45699999999
Q ss_pred cccccCCccccccCCCCccccCC
Q 005841 652 SRLKHETYLTTKTGKGTVTYLAS 674 (674)
Q Consensus 652 a~~~~~~~~~~~~~~GTp~YmAP 674 (674)
++...... ....+||+.|+||
T Consensus 178 ~~~~~~~~--~~~~~~t~~y~aP 198 (336)
T 3fhr_A 178 AKETTQNA--LQTPCYTPYYVAP 198 (336)
T ss_dssp CEEC-------------------
T ss_pred ceeccccc--cccCCCCcCccCh
Confidence 98765433 2335789999998
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=99.92 E-value=3.1e-25 Score=237.46 Aligned_cols=167 Identities=24% Similarity=0.295 Sum_probs=126.7
Q ss_pred ccccCCeeEeeeecccCceEEEEEEEc--CCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCe--
Q 005841 501 EILWEDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQR-- 576 (674)
Q Consensus 501 ~~~~~~y~~~~~LG~G~fG~Vy~~~~~--~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~-- 576 (674)
....++|++.+.||+|+||+||+|.+. +..||||++....... ..+.+++..+..++||||+++++++.....
T Consensus 19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~ 95 (360)
T 3e3p_A 19 RKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFR---NRELQIMQDLAVLHHPNIVQLQSYFYTLGERD 95 (360)
T ss_dssp HHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTCC---CHHHHHHHHHHHHCCTTBCCEEEEEEEECSSC
T ss_pred hhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCcccc---HHHHHHHHHHHhcCCCCcccHHHhhhcccccc
Confidence 445688999999999999999999984 7789999986543222 245567888888999999999999965433
Q ss_pred -----EEEEEecCCCCCHHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHHH--hCCCCeEEccCCCCCEEEcC-CCcEE
Q 005841 577 -----LCIVTEFLPRGSLFRLLQ---RNTTKLDWRRRILMALDIARGVSYLH--HCNPPIIHRDLKSSNLLVDK-HWTVK 645 (674)
Q Consensus 577 -----~~lV~E~~~ggsL~~~l~---~~~~~l~~~~~~~i~~qi~~~L~yLH--~~~~~IvHrDLKp~NILi~~-~~~vk 645 (674)
+||||||+++ +|...+. .....+++..+..++.||+.||.||| +++ |+||||||+||||+. ++.+|
T Consensus 96 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~--ivH~Dlkp~NIll~~~~~~~k 172 (360)
T 3e3p_A 96 RRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVN--VCHRDIKPHNVLVNEADGTLK 172 (360)
T ss_dssp TTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTC--CBCSCCCGGGEEEETTTTEEE
T ss_pred ccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCC--eecCcCCHHHEEEeCCCCcEE
Confidence 8999999976 5555443 24567899999999999999999999 877 999999999999996 89999
Q ss_pred EEecCCcccccCCccccccCCCCccccCC
Q 005841 646 VGDFGLSRLKHETYLTTKTGKGTVTYLAS 674 (674)
Q Consensus 646 L~DFGla~~~~~~~~~~~~~~GTp~YmAP 674 (674)
|+|||+++....... .....||+.|+||
T Consensus 173 l~Dfg~a~~~~~~~~-~~~~~gt~~y~aP 200 (360)
T 3e3p_A 173 LCDFGSAKKLSPSEP-NVAYICSRYYRAP 200 (360)
T ss_dssp ECCCTTCBCCCTTSC-CCSTTSCGGGCCH
T ss_pred EeeCCCceecCCCCC-cccccCCcceeCH
Confidence 999999987654332 2345799999998
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=1.1e-24 Score=231.84 Aligned_cols=165 Identities=26% Similarity=0.428 Sum_probs=140.6
Q ss_pred ccccCCeeEeeeecccCceEEEEEEEc--C-CeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCC------eeeEEEEE
Q 005841 501 EILWEDLTIGEQIGQGSCGTVYHAVWY--G-SDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPN------VLLFMGAV 571 (674)
Q Consensus 501 ~~~~~~y~~~~~LG~G~fG~Vy~~~~~--~-~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hpn------Iv~l~~~~ 571 (674)
+...++|++.+.||+|+||+||+|.+. + ..||||++... ......+.+|+.+++.+.|++ |+.+++++
T Consensus 15 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~ 91 (355)
T 2eu9_A 15 DWLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV---GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWF 91 (355)
T ss_dssp CEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEE
T ss_pred ceecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc---ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeee
Confidence 456789999999999999999999983 3 57999999643 344567888999999987655 89999999
Q ss_pred ecCCeEEEEEecCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEE------------
Q 005841 572 TSPQRLCIVTEFLPRGSLFRLLQRNT-TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLV------------ 638 (674)
Q Consensus 572 ~~~~~~~lV~E~~~ggsL~~~l~~~~-~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi------------ 638 (674)
...+.+||||||+ +++|.+++.... ..+++..++.++.||+.||.|||+++ |+||||||+||||
T Consensus 92 ~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~--ivH~Dlkp~NIll~~~~~~~~~~~~ 168 (355)
T 2eu9_A 92 NFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQ--LTHTDLKPENILFVNSEFETLYNEH 168 (355)
T ss_dssp EETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEESCCCEEEEECCC
T ss_pred eeCCeEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEeccccccccccc
Confidence 9999999999999 667777776543 57999999999999999999999998 9999999999999
Q ss_pred -------cCCCcEEEEecCCcccccCCccccccCCCCccccCC
Q 005841 639 -------DKHWTVKVGDFGLSRLKHETYLTTKTGKGTVTYLAS 674 (674)
Q Consensus 639 -------~~~~~vkL~DFGla~~~~~~~~~~~~~~GTp~YmAP 674 (674)
+.++.+||+|||+++..... .....||+.|+||
T Consensus 169 ~~~~~~~~~~~~~kl~Dfg~~~~~~~~---~~~~~gt~~y~aP 208 (355)
T 2eu9_A 169 KSCEEKSVKNTSIRVADFGSATFDHEH---HTTIVATRHYRPP 208 (355)
T ss_dssp -CCCEEEESCCCEEECCCTTCEETTSC---CCSSCSCGGGCCH
T ss_pred ccccccccCCCcEEEeecCcccccccc---ccCCcCCCcccCC
Confidence 67889999999999875443 2345799999998
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=1.3e-24 Score=235.49 Aligned_cols=167 Identities=25% Similarity=0.318 Sum_probs=140.2
Q ss_pred ccccCCeeEeeeecccCceEEEEEEEc--CCeEEEEEeecccCCHHHHHHHHHHHHHHhhCC-CC-----CeeeEEEEEe
Q 005841 501 EILWEDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLR-HP-----NVLLFMGAVT 572 (674)
Q Consensus 501 ~~~~~~y~~~~~LG~G~fG~Vy~~~~~--~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~-Hp-----nIv~l~~~~~ 572 (674)
+...++|++.++||+|+||+||+|.+. +..||||++... ......+..|+.+++.+. |+ +|+.+++++.
T Consensus 50 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~ 126 (382)
T 2vx3_A 50 EKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK---KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFM 126 (382)
T ss_dssp CEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS---HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEE
T ss_pred CEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc---HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeec
Confidence 445689999999999999999999984 667999999643 344566778898888875 44 4999999999
Q ss_pred cCCeEEEEEecCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEc--CCCcEEEEec
Q 005841 573 SPQRLCIVTEFLPRGSLFRLLQRNT-TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVD--KHWTVKVGDF 649 (674)
Q Consensus 573 ~~~~~~lV~E~~~ggsL~~~l~~~~-~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~--~~~~vkL~DF 649 (674)
..+.+||||||++ ++|.+++.... ..+++..+..++.||+.||.|||....+||||||||+||||+ .++.+||+||
T Consensus 127 ~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~DF 205 (382)
T 2vx3_A 127 FRNHLCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDF 205 (382)
T ss_dssp ETTEEEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEECCC
T ss_pred cCCceEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEEec
Confidence 9999999999996 49999997654 569999999999999999999995323399999999999994 5788999999
Q ss_pred CCcccccCCccccccCCCCccccCC
Q 005841 650 GLSRLKHETYLTTKTGKGTVTYLAS 674 (674)
Q Consensus 650 Gla~~~~~~~~~~~~~~GTp~YmAP 674 (674)
|+|+..... ....+||+.||||
T Consensus 206 G~a~~~~~~---~~~~~~t~~y~aP 227 (382)
T 2vx3_A 206 GSSCQLGQR---IYQYIQSRFYRSP 227 (382)
T ss_dssp TTCEETTCC---CCSSCSCGGGCCH
T ss_pred cCceecccc---cccccCCccccCh
Confidence 999876543 2346799999998
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=99.92 E-value=1.2e-24 Score=226.79 Aligned_cols=147 Identities=16% Similarity=0.076 Sum_probs=132.5
Q ss_pred cccCCeeEeeeecccCceEEEEEEEc--CCeEEEEEeecccCC-HHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeEE
Q 005841 502 ILWEDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYS-DEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLC 578 (674)
Q Consensus 502 ~~~~~y~~~~~LG~G~fG~Vy~~~~~--~~~vAvK~i~~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 578 (674)
+..++|++.+.||+|+||.||+|.+. +..||||++...... ....+.+.+|+.++..++||||+++++++...+.+|
T Consensus 28 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~ 107 (286)
T 3uqc_A 28 IANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGL 107 (286)
T ss_dssp ETTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred EecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEE
Confidence 55678999999999999999999985 778999999876543 466788999999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcc
Q 005841 579 IVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSR 653 (674)
Q Consensus 579 lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~ 653 (674)
|||||++|++|.+++.. ......+..|+.||+.||.|||+++ |+||||||+||||+.++.+||+++|...
T Consensus 108 lv~e~~~g~~L~~~l~~---~~~~~~~~~i~~ql~~aL~~lH~~g--ivH~Dikp~NIll~~~g~~kl~~~~~~~ 177 (286)
T 3uqc_A 108 VVAEWIRGGSLQEVADT---SPSPVGAIRAMQSLAAAADAAHRAG--VALSIDHPSRVRVSIDGDVVLAYPATMP 177 (286)
T ss_dssp EEEECCCEEEHHHHHTT---CCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEEETTSCEEECSCCCCT
T ss_pred EEEEecCCCCHHHHHhc---CCChHHHHHHHHHHHHHHHHHHHCC--CccCCCCcccEEEcCCCCEEEEeccccC
Confidence 99999999999999954 2466788999999999999999999 9999999999999999999999888754
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=99.91 E-value=1e-24 Score=234.33 Aligned_cols=165 Identities=20% Similarity=0.310 Sum_probs=139.9
Q ss_pred ccccCCeeEeeeecccCceEEEEEEE--cCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCC-----------CCCeeeE
Q 005841 501 EILWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLR-----------HPNVLLF 567 (674)
Q Consensus 501 ~~~~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~-----------HpnIv~l 567 (674)
.+...+|++.+.||+|+||+||+|.+ .+..||||++... ......+.+|+.+++.+. ||||+++
T Consensus 15 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~ 91 (373)
T 1q8y_A 15 PYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD---KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKL 91 (373)
T ss_dssp EETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCC
T ss_pred cccCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC---ccchhhhhHHHHHHHHhhcccccchhccccchHHHH
Confidence 34557899999999999999999997 5678999999643 334566788999999886 8899999
Q ss_pred EEEEecCC----eEEEEEecCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhC-CCCeEEccCCCCCEEEc--
Q 005841 568 MGAVTSPQ----RLCIVTEFLPRGSLFRLLQRN-TTKLDWRRRILMALDIARGVSYLHHC-NPPIIHRDLKSSNLLVD-- 639 (674)
Q Consensus 568 ~~~~~~~~----~~~lV~E~~~ggsL~~~l~~~-~~~l~~~~~~~i~~qi~~~L~yLH~~-~~~IvHrDLKp~NILi~-- 639 (674)
++++...+ .+++||||+ +++|.+++... ...+++..+..++.||+.||.|||+. + |+||||||+||||+
T Consensus 92 ~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~--ivH~Dikp~NIll~~~ 168 (373)
T 1q8y_A 92 LDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG--IIHTDIKPENVLMEIV 168 (373)
T ss_dssp CEEEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC--EECSCCSGGGEEEEEE
T ss_pred HHHhhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCC--EEecCCChHHeEEecc
Confidence 99988654 789999999 88999999764 34599999999999999999999997 8 99999999999995
Q ss_pred ----CCCcEEEEecCCcccccCCccccccCCCCccccCC
Q 005841 640 ----KHWTVKVGDFGLSRLKHETYLTTKTGKGTVTYLAS 674 (674)
Q Consensus 640 ----~~~~vkL~DFGla~~~~~~~~~~~~~~GTp~YmAP 674 (674)
..+.+||+|||+++..... .....||+.||||
T Consensus 169 ~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~~t~~y~aP 204 (373)
T 1q8y_A 169 DSPENLIQIKIADLGNACWYDEH---YTNSIQTREYRSP 204 (373)
T ss_dssp ETTTTEEEEEECCCTTCEETTBC---CCSCCSCGGGCCH
T ss_pred CCCcCcceEEEcccccccccCCC---CCCCCCCccccCc
Confidence 3448999999999876543 2235799999998
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=3.3e-25 Score=251.25 Aligned_cols=154 Identities=19% Similarity=0.221 Sum_probs=123.0
Q ss_pred eEeeeecccCceEEEEEEEcCCeEEEEEeecccCCHH------HHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeEEEEE
Q 005841 508 TIGEQIGQGSCGTVYHAVWYGSDVAVKVFSRQEYSDE------VIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVT 581 (674)
Q Consensus 508 ~~~~~LG~G~fG~Vy~~~~~~~~vAvK~i~~~~~~~~------~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 581 (674)
...++||+|+||+||+|.+.+..+++|.+........ ..+.+.+|+.+++.++||||+.+..++...+..||||
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVm 418 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSYLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMM 418 (540)
T ss_dssp ---------CCEEEEEEECSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEE
T ss_pred CCCCEEeeCCCEEEEEEEECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEE
Confidence 3466899999999999988899999998765544321 2456899999999999999996655566777889999
Q ss_pred ecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccccCCccc
Q 005841 582 EFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLT 661 (674)
Q Consensus 582 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~~~~~ 661 (674)
|||++++|.+++.. +..|+.||+.||.|||+++ |+||||||+|||++. ++||+|||+|+........
T Consensus 419 E~~~ggsL~~~l~~---------~~~i~~qi~~aL~~LH~~g--IiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~~ 485 (540)
T 3en9_A 419 SYINGKLAKDVIED---------NLDIAYKIGEIVGKLHKND--VIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDEDK 485 (540)
T ss_dssp ECCCSEEHHHHSTT---------CTHHHHHHHHHHHHHHHTT--EECTTCCTTSEEESS--SEEECCCTTCEECCCHHHH
T ss_pred ECCCCCCHHHHHHH---------HHHHHHHHHHHHHHHHHCc--CccCCCCHHHEEECC--eEEEEECccCEECCCcccc
Confidence 99999999999964 5689999999999999999 999999999999999 9999999999987653221
Q ss_pred -------cccCCCCccccCC
Q 005841 662 -------TKTGKGTVTYLAS 674 (674)
Q Consensus 662 -------~~~~~GTp~YmAP 674 (674)
...++||+.||||
T Consensus 486 ~~~~~~~~~~~~GT~~y~AP 505 (540)
T 3en9_A 486 AVDLIVFKKAVLSTHHEKFD 505 (540)
T ss_dssp HHHHHHHHHHHHHHCGGGHH
T ss_pred ccchhhhhhhhcCCCCcCCH
Confidence 2356899999998
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=1.5e-24 Score=239.50 Aligned_cols=164 Identities=29% Similarity=0.351 Sum_probs=126.7
Q ss_pred ccCCeeEeeeecccCceEEEEEE-EcCCeEEEEEeecccCCHHHHHHHHHHHHHHhhC-CCCCeeeEEEEEecCCeEEEE
Q 005841 503 LWEDLTIGEQIGQGSCGTVYHAV-WYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRL-RHPNVLLFMGAVTSPQRLCIV 580 (674)
Q Consensus 503 ~~~~y~~~~~LG~G~fG~Vy~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lV 580 (674)
..+.|.+.++||+|+||+||.+. ..+..||||++.... ...+.+|+.+++.+ +||||+++++++.....+|||
T Consensus 13 l~~~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~~-----~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv 87 (434)
T 2rio_A 13 LKNLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF-----CDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIA 87 (434)
T ss_dssp CSSCEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGGG-----HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEE
T ss_pred hhheeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHHH-----HHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEE
Confidence 34556778899999999997543 478899999986542 24567899999876 899999999999999999999
Q ss_pred EecCCCCCHHHHHHhcCCC------CCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCC-------------
Q 005841 581 TEFLPRGSLFRLLQRNTTK------LDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKH------------- 641 (674)
Q Consensus 581 ~E~~~ggsL~~~l~~~~~~------l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~------------- 641 (674)
||||. ++|.+++...... ..+..++.++.||+.||.|||+++ ||||||||+||||+.+
T Consensus 88 ~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDLkp~NILl~~~~~~~~~~~~~~~~ 164 (434)
T 2rio_A 88 LELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK--IIHRDLKPQNILVSTSSRFTADQQTGAEN 164 (434)
T ss_dssp ECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEECCHHHHSCCTTCCCS
T ss_pred EecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCC--ccccCCChHhEEEecCcccccccccCCCc
Confidence 99996 5999999754321 133345789999999999999999 9999999999999754
Q ss_pred CcEEEEecCCcccccCCcc----ccccCCCCccccCC
Q 005841 642 WTVKVGDFGLSRLKHETYL----TTKTGKGTVTYLAS 674 (674)
Q Consensus 642 ~~vkL~DFGla~~~~~~~~----~~~~~~GTp~YmAP 674 (674)
+.+||+|||+|+....... .....+||+.||||
T Consensus 165 ~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aP 201 (434)
T 2rio_A 165 LRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAP 201 (434)
T ss_dssp CEEEECCCTTCEECCC--------------CCTTSCH
T ss_pred eEEEEcccccceecCCCCccceeeecCCCCCCCccCH
Confidence 4899999999987654321 12235799999998
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=7.1e-25 Score=251.94 Aligned_cols=167 Identities=27% Similarity=0.367 Sum_probs=142.4
Q ss_pred cCCeeEeeeecccCceEEEEEEE--cCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEec------CC
Q 005841 504 WEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTS------PQ 575 (674)
Q Consensus 504 ~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~------~~ 575 (674)
.++|++.+.||+|+||.||+|.+ .+..||||++... ........+.+|+.+++.++||||+.+++++.. .+
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~-~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~ 91 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQE-LSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPND 91 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSC-CCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTS
T ss_pred CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEeccc-CCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCC
Confidence 37899999999999999999987 4778999998654 355667789999999999999999999998765 67
Q ss_pred eEEEEEecCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCc---EEEEecC
Q 005841 576 RLCIVTEFLPRGSLFRLLQRNT--TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWT---VKVGDFG 650 (674)
Q Consensus 576 ~~~lV~E~~~ggsL~~~l~~~~--~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~---vkL~DFG 650 (674)
..|||||||++++|.+++.... ..+++..++.++.||+.||.|||+.+ |+||||||+|||++.++. +||+|||
T Consensus 92 ~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~g--IVHrDLKP~NILl~~~g~~~~vKL~DFG 169 (676)
T 3qa8_A 92 LPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENR--IIHRDLKPENIVLQPGPQRLIHKIIDLG 169 (676)
T ss_dssp SCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTT--BCCCCCCSTTEEEECCSSSCEEEECSCC
T ss_pred eEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC--CccCCCCHHHeEeecCCCceeEEEcccc
Confidence 7899999999999999997643 26899999999999999999999999 999999999999997664 9999999
Q ss_pred CcccccCCccccccCCCCccccCC
Q 005841 651 LSRLKHETYLTTKTGKGTVTYLAS 674 (674)
Q Consensus 651 la~~~~~~~~~~~~~~GTp~YmAP 674 (674)
++........ .....||+.|+||
T Consensus 170 ~a~~~~~~~~-~~~~~gt~~Y~AP 192 (676)
T 3qa8_A 170 YAKELDQGEL-CTEFVGTLQYLAP 192 (676)
T ss_dssp CCCBTTSCCC-CCCCCSCCTTCSS
T ss_pred cccccccccc-cccccCCcccCCh
Confidence 9987655433 2346899999999
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=1.6e-23 Score=218.98 Aligned_cols=147 Identities=27% Similarity=0.407 Sum_probs=127.6
Q ss_pred ccCCeeEe-eeecccCceEEEEEEE--cCCeEEEEEeecccCCHHHHHHHHHHHHHH-hhCCCCCeeeEEEEEec----C
Q 005841 503 LWEDLTIG-EQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLM-KRLRHPNVLLFMGAVTS----P 574 (674)
Q Consensus 503 ~~~~y~~~-~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il-~~l~HpnIv~l~~~~~~----~ 574 (674)
..++|.+. ++||+|+||.||+|.+ ++..||||++... ..+.+|+.++ +.+.||||+++++++.. .
T Consensus 15 ~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~ 87 (299)
T 3m2w_A 15 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLYAGR 87 (299)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTE
T ss_pred cccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-------HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCC
Confidence 34567777 7899999999999998 5678999999642 3456788887 56689999999999886 6
Q ss_pred CeEEEEEecCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcC---CCcEEEEecC
Q 005841 575 QRLCIVTEFLPRGSLFRLLQRNT-TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDK---HWTVKVGDFG 650 (674)
Q Consensus 575 ~~~~lV~E~~~ggsL~~~l~~~~-~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~---~~~vkL~DFG 650 (674)
..+||||||+++++|.+++.... ..+++..++.++.||+.||.|||+++ |+||||||+||||+. ++.+||+|||
T Consensus 88 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~~~~kl~Dfg 165 (299)
T 3m2w_A 88 KCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFG 165 (299)
T ss_dssp EEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESSSSTTCCEEECCCT
T ss_pred ceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEEecCCCCCcEEEeccc
Confidence 77999999999999999998653 46999999999999999999999999 999999999999997 7899999999
Q ss_pred CcccccCC
Q 005841 651 LSRLKHET 658 (674)
Q Consensus 651 la~~~~~~ 658 (674)
++......
T Consensus 166 ~a~~~~~~ 173 (299)
T 3m2w_A 166 FAKETTGE 173 (299)
T ss_dssp TCEECTTC
T ss_pred cccccccc
Confidence 99876543
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.89 E-value=1.6e-23 Score=229.76 Aligned_cols=164 Identities=18% Similarity=0.200 Sum_probs=125.6
Q ss_pred cCCeeEeeeecccCceEEEEEEEc--CCeEEEEEeecccC-CHHHHHHHHHHHHHHhhCCC-CCe---------e-----
Q 005841 504 WEDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEY-SDEVIHSFRQEVSLMKRLRH-PNV---------L----- 565 (674)
Q Consensus 504 ~~~y~~~~~LG~G~fG~Vy~~~~~--~~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~H-pnI---------v----- 565 (674)
...|.+.++||+|+||+||+|.+. +..||||++..... .....+.+.+|+.+++.+.| +|+ +
T Consensus 77 ~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 156 (413)
T 3dzo_A 77 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 156 (413)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEE
T ss_pred ceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhh
Confidence 356889999999999999999985 88899999874332 22345678899999999987 221 1
Q ss_pred -------eEEEEEec-----CCeEEEEEecCCCCCHHHHHHh------cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeE
Q 005841 566 -------LFMGAVTS-----PQRLCIVTEFLPRGSLFRLLQR------NTTKLDWRRRILMALDIARGVSYLHHCNPPII 627 (674)
Q Consensus 566 -------~l~~~~~~-----~~~~~lV~E~~~ggsL~~~l~~------~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~Iv 627 (674)
.++.++.. ...+|++|+++ +++|.+++.. ....+++..++.|+.||+.||.|||+++ ||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ii 233 (413)
T 3dzo_A 157 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG--LV 233 (413)
T ss_dssp EECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT--EE
T ss_pred cccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC--cc
Confidence 11111111 23467888876 6799998852 2345788899999999999999999999 99
Q ss_pred EccCCCCCEEEcCCCcEEEEecCCcccccCCccccccCCCCccccCC
Q 005841 628 HRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTVTYLAS 674 (674)
Q Consensus 628 HrDLKp~NILi~~~~~vkL~DFGla~~~~~~~~~~~~~~GTp~YmAP 674 (674)
||||||+||||+.++.+||+|||+++..... ....+| +.||||
T Consensus 234 HrDiKp~NILl~~~~~~kL~DFG~a~~~~~~---~~~~~g-~~y~aP 276 (413)
T 3dzo_A 234 HTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS---AVSPIG-RGFAPP 276 (413)
T ss_dssp CSCCCGGGEEECTTCCEEECCGGGCEETTEE---ECCCCC-TTTCCH
T ss_pred cCCcccceEEEecCCeEEEEeccceeecCCc---cccCCC-CceeCc
Confidence 9999999999999999999999999876543 334678 999998
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.85 E-value=7.7e-22 Score=205.36 Aligned_cols=137 Identities=22% Similarity=0.212 Sum_probs=109.8
Q ss_pred CCeeEeeeecccCceEEEEEEE-cCCeEEEEEeecccCCH----------------HHHHHHHHHHHHHhhCCCCCeeeE
Q 005841 505 EDLTIGEQIGQGSCGTVYHAVW-YGSDVAVKVFSRQEYSD----------------EVIHSFRQEVSLMKRLRHPNVLLF 567 (674)
Q Consensus 505 ~~y~~~~~LG~G~fG~Vy~~~~-~~~~vAvK~i~~~~~~~----------------~~~~~~~~Ei~il~~l~HpnIv~l 567 (674)
..|.+.+.||+|+||.||+|.+ .+..||||++....... .....+.+|+.+++.++| +.+
T Consensus 90 ~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~~---~~v 166 (282)
T 1zar_A 90 KVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQG---LAV 166 (282)
T ss_dssp SCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTT---SSS
T ss_pred eEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhccC---CCc
Confidence 4566779999999999999998 46789999996533211 235678899999999984 455
Q ss_pred EEEEecCCeEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEE
Q 005841 568 MGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVG 647 (674)
Q Consensus 568 ~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~ 647 (674)
++++.. +..|+||||++|++|.+ +.. .....++.||+.||.|||+++ ||||||||+||||+ ++.+||+
T Consensus 167 ~~~~~~-~~~~lvmE~~~g~~L~~-l~~-------~~~~~i~~qi~~~l~~lH~~g--iiHrDlkp~NILl~-~~~vkl~ 234 (282)
T 1zar_A 167 PKVYAW-EGNAVLMELIDAKELYR-VRV-------ENPDEVLDMILEEVAKFYHRG--IVHGDLSQYNVLVS-EEGIWII 234 (282)
T ss_dssp CCEEEE-ETTEEEEECCCCEEGGG-CCC-------SCHHHHHHHHHHHHHHHHHTT--EECSCCSTTSEEEE-TTEEEEC
T ss_pred CeEEec-cceEEEEEecCCCcHHH-cch-------hhHHHHHHHHHHHHHHHHHCC--CEeCCCCHHHEEEE-CCcEEEE
Confidence 554433 56799999999999987 421 234579999999999999999 99999999999999 9999999
Q ss_pred ecCCccccc
Q 005841 648 DFGLSRLKH 656 (674)
Q Consensus 648 DFGla~~~~ 656 (674)
|||+|+...
T Consensus 235 DFG~a~~~~ 243 (282)
T 1zar_A 235 DFPQSVEVG 243 (282)
T ss_dssp CCTTCEETT
T ss_pred ECCCCeECC
Confidence 999998554
|
| >4hia_A LOV protein; PAS, HTH, signaling protein; HET: FMN; 1.95A {Rhodobacter sphaeroides} PDB: 4hnb_A* 4hj4_A* 4hj6_A* 4hj3_A* | Back alignment and structure |
|---|
Probab=99.82 E-value=2e-20 Score=177.88 Aligned_cols=137 Identities=12% Similarity=0.079 Sum_probs=125.9
Q ss_pred HHHHHHHHHHhcceeEEEcCC---CcEEeecHHHHHHhCCChhhHcCCCccccccccccchhHHHHHHHHHhCceeEEEE
Q 005841 129 DRQYLNILQSMGQSVHIFDLS---DRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGERWTGQF 205 (674)
Q Consensus 129 e~~l~~ilds~~d~I~v~D~~---GrIi~~N~a~e~llGys~eEviG~~~~~l~~~~~~~~~~~~i~~~l~~g~~~~~e~ 205 (674)
.+.|+.+|++++++|+++|.+ |+|++||+++++++||+.++++|+++.+++++.........+...+..+..+..++
T Consensus 6 ~~~~~~~~~~~~~~i~~~d~~~~~g~i~~~N~a~~~~~G~~~~e~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~ 85 (176)
T 4hia_A 6 FEKIRAVFDRSGVALTLVDMSLPEQPVVLANPPFLRMTGYTEGQILGFNCRFLQRGDENAQARADIRDALKLGRELQVVL 85 (176)
T ss_dssp HHHHHHHHHHCSSCCEEEETTSTTCCEEEECHHHHHHHTCCHHHHTTSCGGGGCCTTCCHHHHHHHHHHHHHTCCEEEEE
T ss_pred HHHHHHHHhcCCCcEEEEecCCCCCcEEEECHHHHHHHCcCHHHHcCCCcceeeCCCCCHHHHHHHHHHHHcCCceEEEE
Confidence 457899999999999999999 99999999999999999999999999988887776666777788888999999999
Q ss_pred EEEcCCCCEEEEEEEEEEEECCCCCEEEEEEEEEchHHHHHHHHHHHHhhhcCCccCcCCc
Q 005841 206 PAKTKTEERVLVVATNTPFYDDDGTLVGIVCVSTDSRPFQETRAALWDTKNSDTDSNINRP 266 (674)
Q Consensus 206 ~~~~kdG~~~~v~~s~sPi~d~dG~ivg~i~i~rDITe~k~~e~~L~~la~~d~lt~~nr~ 266 (674)
...+++|..+|+.+++.|+++.+|.+++++++++|||++|++|++ .+++++|.+|++.++
T Consensus 86 ~~~~~dG~~~~~~~~~~pi~~~~g~~~~~~~~~~DITe~k~~e~~-~~~a~~d~LtgL~NR 145 (176)
T 4hia_A 86 RNYRANDEPFDNLLFLHPVGGRPDAPDYFLGSQFELGRSGNSEEA-AAAGHAGALTGELAR 145 (176)
T ss_dssp EEECTTCCEEEEEEEEEEESSBTTBCSEEEEEEEEESSSGGGHHH-HHHHHHHHHHHHHHH
T ss_pred EEEcCCCCEEEEEEEEEEeeCCCCCeEEEEEEEEECcHhhHHHHH-HHHhhhhHHhhhhhh
Confidence 999999999999999999999999999999999999999999999 889999999984443
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.81 E-value=3.8e-20 Score=189.88 Aligned_cols=140 Identities=20% Similarity=0.213 Sum_probs=109.7
Q ss_pred CeeEeeeecccCceEEEEEEE--cCCe--EEEEEeecccCC----------------------HHHHHHHHHHHHHHhhC
Q 005841 506 DLTIGEQIGQGSCGTVYHAVW--YGSD--VAVKVFSRQEYS----------------------DEVIHSFRQEVSLMKRL 559 (674)
Q Consensus 506 ~y~~~~~LG~G~fG~Vy~~~~--~~~~--vAvK~i~~~~~~----------------------~~~~~~~~~Ei~il~~l 559 (674)
-|.+.+.||+|+||.||+|.+ .+.. ||||++...... ......+.+|+.++..+
T Consensus 48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 127 (258)
T 1zth_A 48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA 127 (258)
T ss_dssp EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence 378999999999999999998 7888 999997543211 01224678899999999
Q ss_pred CCCCe--eeEEEEEecCCeEEEEEecCCC-C----CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH-hCCCCeEEccC
Q 005841 560 RHPNV--LLFMGAVTSPQRLCIVTEFLPR-G----SLFRLLQRNTTKLDWRRRILMALDIARGVSYLH-HCNPPIIHRDL 631 (674)
Q Consensus 560 ~HpnI--v~l~~~~~~~~~~~lV~E~~~g-g----sL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH-~~~~~IvHrDL 631 (674)
.|++| +.++.. ...||||||+.+ | +|.+++.. +++..+..++.||+.+|.||| +++ ||||||
T Consensus 128 ~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~----~~~~~~~~i~~qi~~~l~~lH~~~g--ivHrDl 197 (258)
T 1zth_A 128 KEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE----LKELDVEGIFNDVVENVKRLYQEAE--LVHADL 197 (258)
T ss_dssp HHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG----GGGSCHHHHHHHHHHHHHHHHHTSC--EECSSC
T ss_pred HhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc----cChHHHHHHHHHHHHHHHHHHHHCC--EEeCCC
Confidence 88754 344432 357999999942 3 77776532 235567889999999999999 999 999999
Q ss_pred CCCCEEEcCCCcEEEEecCCcccccC
Q 005841 632 KSSNLLVDKHWTVKVGDFGLSRLKHE 657 (674)
Q Consensus 632 Kp~NILi~~~~~vkL~DFGla~~~~~ 657 (674)
||+|||++. .++|+|||+|.....
T Consensus 198 kp~NILl~~--~~~liDFG~a~~~~~ 221 (258)
T 1zth_A 198 SEYNIMYID--KVYFIDMGQAVTLRH 221 (258)
T ss_dssp STTSEEESS--SEEECCCTTCEETTS
T ss_pred CHHHEEEcC--cEEEEECcccccCCC
Confidence 999999998 999999999987643
|
| >2gj3_A Nitrogen fixation regulatory protein; PAS domain, FAD, redox sensor, atomic resolution, transferase; HET: FAD; 1.04A {Azotobacter vinelandii} | Back alignment and structure |
|---|
Probab=99.79 E-value=1.3e-18 Score=155.17 Aligned_cols=118 Identities=20% Similarity=0.320 Sum_probs=106.8
Q ss_pred cHHHHHHHHHHhcceeEEEcCCCcEEeecHHHHHHhCCChhhHcCCCccccccccccchhHHHHHHHHHhCceeEEEEEE
Q 005841 128 TDRQYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGERWTGQFPA 207 (674)
Q Consensus 128 se~~l~~ilds~~d~I~v~D~~GrIi~~N~a~e~llGys~eEviG~~~~~l~~~~~~~~~~~~i~~~l~~g~~~~~e~~~ 207 (674)
.++.|+.++++++++|+++|.+|+|+|||++|++++||+.+|++|+++.++.++.........++..+..+..+..++..
T Consensus 3 ~~~~~~~~~~~~~~~i~~~d~~g~i~~~N~a~~~~~G~~~~elig~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~e~~~ 82 (120)
T 2gj3_A 3 LPEIFRQTVEHAPIAISITDLKANILYANRAFRTITGYGSEEVLGKNESILSNGTTPRLVYQALWGRLAQKKPWSGVLVN 82 (120)
T ss_dssp CHHHHHHHHHHCSSEEEEECTTCBEEEECHHHHHHHCCCTTGGGGCBGGGGCCTTSCHHHHHHHHHHHHTTCCEEEEEEE
T ss_pred hHHHHHHHHHhCCCeEEEECCCCCEEeehHHHHHHHCcCHHHHcCCCHHHcCCCCCCHHHHHHHHHHHHcCCCEEEEEEE
Confidence 46789999999999999999999999999999999999999999999888877665544555677788888899999999
Q ss_pred EcCCCCEEEEEEEEEEEECCCCCEEEEEEEEEchHHHH
Q 005841 208 KTKTEERVLVVATNTPFYDDDGTLVGIVCVSTDSRPFQ 245 (674)
Q Consensus 208 ~~kdG~~~~v~~s~sPi~d~dG~ivg~i~i~rDITe~k 245 (674)
.+++|..+|+.+++.|++|.+|.+.+++++++|||++|
T Consensus 83 ~~~dG~~~~~~~~~~pi~~~~g~~~~~v~~~~DITe~k 120 (120)
T 2gj3_A 83 RRKDKTLYLAELTVAPVLNEAGETIYYLGMHRDTSELH 120 (120)
T ss_dssp ECTTSCEEEEEEEEEEEECTTSCEEEEEEEEEECCSCC
T ss_pred EcCCCCEEEEEEEEEEEECCCCCEEEEEEEeccCcccC
Confidence 99999999999999999999999999999999999763
|
| >2pr5_A Blue-light photoreceptor; light-oxygen-voltage, LOV, PER-ARNT-SIM, PAS, flavoprotein, protein; HET: FMN; 1.45A {Bacillus subtilis} PDB: 2pr6_A* | Back alignment and structure |
|---|
Probab=99.76 E-value=1.4e-17 Score=151.04 Aligned_cols=120 Identities=23% Similarity=0.174 Sum_probs=103.8
Q ss_pred HHHHHhcceeEEEcCCC---cEEeecHHHHHHhCCChhhHcCCCccccccccccchhHHHHHHHHHhCceeEEEEEEEcC
Q 005841 134 NILQSMGQSVHIFDLSD---RIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGERWTGQFPAKTK 210 (674)
Q Consensus 134 ~ilds~~d~I~v~D~~G---rIi~~N~a~e~llGys~eEviG~~~~~l~~~~~~~~~~~~i~~~l~~g~~~~~e~~~~~k 210 (674)
.++++++++|+++|.+| +|+|||++|++++||+.+|++|+++..+.++.........+...+..+..+..++.+.++
T Consensus 3 ~~~~~~~~~i~~~d~~g~~~~i~~~N~a~~~~~G~~~~el~g~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~k 82 (132)
T 2pr5_A 3 HMLDHVRVGVVITDPALEDNPIVYVNQGFVQMTGYETEEILGKNCRFLQGKHTDPAEVDNIRTALQNKEPVTVQIQNYKK 82 (132)
T ss_dssp ---CCCCCEEEEECTTSTTCCEEEECHHHHHHHSCCHHHHTTSCGGGGCCTTCCHHHHHHHHHHHHHTCCEEEEEEEECT
T ss_pred hHHhcCCCcEEEEeCCCCCCcEEEECHHHHHHhCcCHHHHcCCChhhhCCCCCCHHHHHHHHHHHHcCCCeEEEEEEEec
Confidence 57899999999999976 999999999999999999999999887776655555555667778888889999999999
Q ss_pred CCCEEEEEEEEEEEECCCCCEEEEEEEEEchHHHHHHHHHHHHhh
Q 005841 211 TEERVLVVATNTPFYDDDGTLVGIVCVSTDSRPFQETRAALWDTK 255 (674)
Q Consensus 211 dG~~~~v~~s~sPi~d~dG~ivg~i~i~rDITe~k~~e~~L~~la 255 (674)
||..+|+.+++.|+++++ +.+++++++|||++|++|++|+++.
T Consensus 83 dG~~~~~~~~~~~~~~~~--~~~~~~~~~DITe~k~~e~~l~~~~ 125 (132)
T 2pr5_A 83 DGTMFWNELNIDPMEIED--KTYFVGIQNDITKQKEYEKLLEDSL 125 (132)
T ss_dssp TSCEEEEEEEEEEEEETT--EEEEEEEEEECHHHHHHHHHHHHHH
T ss_pred CCCeeeeEEEEEeccCCC--eeEEEEEEEeCcHHHHHHHHHHHHH
Confidence 999999999999999755 8899999999999999999998763
|
| >3p7n_A Sensor histidine kinase; LOV domain, light-activated transcription factor, DNA bindin; HET: FMN; 2.10A {Erythrobacter litoralis} | Back alignment and structure |
|---|
Probab=99.75 E-value=1.1e-17 Score=170.31 Aligned_cols=152 Identities=16% Similarity=0.153 Sum_probs=121.2
Q ss_pred CcccccHHHHHHHHHHhcceeEEEcC---CCcEEeecHHHHHHhCCChhhHcCCCccccccccccchhHHHHHHHHHhCc
Q 005841 123 SAFNFTDRQYLNILQSMGQSVHIFDL---SDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGE 199 (674)
Q Consensus 123 ~~~~~se~~l~~ilds~~d~I~v~D~---~GrIi~~N~a~e~llGys~eEviG~~~~~l~~~~~~~~~~~~i~~~l~~g~ 199 (674)
..+...++.|+.+|++++++|+++|. +|+|+|||++|++++||+.+|++|+++.+++++.........+...+..+.
T Consensus 56 ~~l~~~~~~~~~i~~~~~~~i~~~d~~~~~g~i~~~N~a~~~l~G~~~~el~g~~~~~l~~~~~~~~~~~~~~~~l~~~~ 135 (258)
T 3p7n_A 56 VEVQPPAQWVLDLIEASPIASVVSDPRLADNPLIAINQAFTDLTGYSEEECVGRNCRFLAGSGTEPWLTDKIRQGVREHK 135 (258)
T ss_dssp -----CCHHHHHHHHTCSSEEEEECTTSTTCCEEEECHHHHHHHCCCGGGTTTSCGGGGCCTTCCHHHHHHHHHHHHHTC
T ss_pred HHHHhHHHHHHHHHhcCCccEEEEcCCCCCCcEEEEhHHHHHHcCCCHHHHCCCChhhccCCCCchhHHHHHHHHHHcCC
Confidence 34556778899999999999999999 999999999999999999999999999988888777777777888899999
Q ss_pred eeEEEEEEEcCCCCEEEEEEEEEEEECCCCCEEEEEEEEEchHHHHHHHHHHHHhhhcCCccCcCCchhHHHHHh
Q 005841 200 RWTGQFPAKTKTEERVLVVATNTPFYDDDGTLVGIVCVSTDSRPFQETRAALWDTKNSDTDSNINRPRNTVTAKL 274 (674)
Q Consensus 200 ~~~~e~~~~~kdG~~~~v~~s~sPi~d~dG~ivg~i~i~rDITe~k~~e~~L~~la~~d~lt~~nr~~~~~~~kl 274 (674)
.+..++...+++|..+|+.+++.|++|++|.+++++++++|||++|..+.+....+..+.++.+.++...++..+
T Consensus 136 ~~~~e~~~~~~dG~~~~~~~~~~pi~d~~g~~~~~v~~~~DITerk~~~~e~~~~~~~~~l~~L~~r~~~i~~~~ 210 (258)
T 3p7n_A 136 PVLVEILNYKKDGTPFRNAVLVAPIYDDDDELLYFLGSQVEVDDDQPNMGMARRERAAEMLKTLSPRQLEVTTLV 210 (258)
T ss_dssp CEEEEEEEECTTSCEEEEEEEEEEEECTTSCSEEEEEEEEEC-------CHHHHHHHHHHHTTSCHHHHHHHHHH
T ss_pred CeEEEEEEEcCCCCEEEEeeEEEEEEcCCCCEEEEEEEeeecchhhhhhhHHHHHHHHHHHhhcCHHHHHHHHHH
Confidence 999999999999999999999999999999999999999999999555555555555666666555544444433
|
| >3ue6_A Aureochrome1; PAS/LOV domain, FMN-binding blue-light photoreceptor, signal protein; HET: FMN; 2.75A {Vaucheria frigida} PDB: 3ulf_A* | Back alignment and structure |
|---|
Probab=99.72 E-value=1.1e-16 Score=149.44 Aligned_cols=127 Identities=20% Similarity=0.135 Sum_probs=114.1
Q ss_pred ccHHHHHHHHHHhcceeEEEcC---CCcEEeecHHHHHHhCCChhhHcCCCccccccccccchhHHHHHHHHHhCceeEE
Q 005841 127 FTDRQYLNILQSMGQSVHIFDL---SDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGERWTG 203 (674)
Q Consensus 127 ~se~~l~~ilds~~d~I~v~D~---~GrIi~~N~a~e~llGys~eEviG~~~~~l~~~~~~~~~~~~i~~~l~~g~~~~~ 203 (674)
.....+..++++++++|+++|. +|+|++||+++++++||+.++++|+++.+++++.........+...+..+..+..
T Consensus 32 ~~~~~~~~~~~~~~~~i~~~d~~~~~g~i~~~N~~~~~l~G~~~~e~~g~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 111 (166)
T 3ue6_A 32 DPDYSLVKALQMAQQNFVITDASLPDNPIVYASRGFLTLTGYSLDQILGRNCRFLQGPETDPRAVDKIRNAITKGVDTSV 111 (166)
T ss_dssp CCCCHHHHHHHHTTSCEEEEETTSTTCCEEEECHHHHHHHCCCHHHHTTSCGGGGCCTTSCHHHHHHHHHHHHHTCCEEE
T ss_pred HHHHHHHHHHhcCCceEEEEEccCCCCcEEEECHHHHHHhCcCHHHHcCCCHhheeCCCCCHHHHHHHHHHHhcCCceEE
Confidence 3445899999999999999999 7999999999999999999999999998888777666666677788889999999
Q ss_pred EEEEEcCCCCEEEEEEEEEEEECCCCCEEEEEEEEEchHHHHHHHHHHHH
Q 005841 204 QFPAKTKTEERVLVVATNTPFYDDDGTLVGIVCVSTDSRPFQETRAALWD 253 (674)
Q Consensus 204 e~~~~~kdG~~~~v~~s~sPi~d~dG~ivg~i~i~rDITe~k~~e~~L~~ 253 (674)
++.+.+++|..+|+.++..|+++++|.++|++++++|||++++.+...+.
T Consensus 112 e~~~~~~~g~~~~~~~~~~~i~~~~g~~~~~~~~~~DITe~k~~~~~~e~ 161 (166)
T 3ue6_A 112 CLLNYRQDGTTFWNLFFVAGLRDSKGNIVNYVGVQSKVSEDYAKLLVNEQ 161 (166)
T ss_dssp EEEEECTTSCEEEEEEEEEEEECTTSCEEEEEEECCBCCHHHHHHHHHHH
T ss_pred EEEEEcCCCCEEEEEEEEEeeeCCCCCEEEEEEEEEechHHHHHHHHHhh
Confidence 99999999999999999999999999999999999999999987766443
|
| >1n9l_A PHOT-LOV1, putative blue light receptor; phototropin, flavin, electron transport; HET: FMN; 1.90A {Chlamydomonas reinhardtii} SCOP: d.110.3.6 PDB: 1n9n_A* 1n9o_A* | Back alignment and structure |
|---|
Probab=99.72 E-value=6.9e-17 Score=142.03 Aligned_cols=106 Identities=23% Similarity=0.285 Sum_probs=95.7
Q ss_pred HhcceeEEEcC---CCcEEeecHHHHHHhCCChhhHcCCCccccccccccchhHHHHHHHHHhCceeEEEEEEEcCCCCE
Q 005841 138 SMGQSVHIFDL---SDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGERWTGQFPAKTKTEER 214 (674)
Q Consensus 138 s~~d~I~v~D~---~GrIi~~N~a~e~llGys~eEviG~~~~~l~~~~~~~~~~~~i~~~l~~g~~~~~e~~~~~kdG~~ 214 (674)
+++++|+++|. +|+|+|+|++|++++||+.+|++|+++..+.++.........++..+..++.+..++..+++||..
T Consensus 1 ~~~~~i~i~d~~~~~g~i~~~N~a~~~l~Gy~~~e~~G~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~kdG~~ 80 (109)
T 1n9l_A 1 GLRHTFVVADATLPDCPLVYASEGFYAMTGYGPDEVLGHNCRFLQGEGTDPKEVQKIRDAIKKGEACSVRLLNYRKDGTP 80 (109)
T ss_dssp CCSCEEEEEETTSTTCCEEEECHHHHHHHCCCHHHHTTSCGGGGCCTTCCHHHHHHHHHHHHHTCCEEEEEEEECTTSCE
T ss_pred CCccEEEEEcCCCCCCeEEEEchHHHHHHCcCHHHHcCCCchhcCCCCCCHHHHHHHHHHHHcCCcEEEEEEEEcCCCCE
Confidence 36889999994 799999999999999999999999998777666555555667888899999999999999999999
Q ss_pred EEEEEEEEEEECCCCCEEEEEEEEEchHH
Q 005841 215 VLVVATNTPFYDDDGTLVGIVCVSTDSRP 243 (674)
Q Consensus 215 ~~v~~s~sPi~d~dG~ivg~i~i~rDITe 243 (674)
+|+.+++.|++|++|++.+++++++|||+
T Consensus 81 ~~~~~~~~pi~d~~G~~~~~v~~~~DITe 109 (109)
T 1n9l_A 81 FWNLLTVTPIKTPDGRVSKFVGVQVDVTS 109 (109)
T ss_dssp EEEEEEEEEEECTTSCEEEEEEEEEECCC
T ss_pred EEEEEEEEEEECCCCCEEEEEEEEEeCCC
Confidence 99999999999999999999999999984
|
| >3t50_A Blue-light-activated histidine kinase; PAS superfamily, blue-light photoreceptor, FMN binding, TRAN; HET: FMN; 1.64A {Brucella melitensis} | Back alignment and structure |
|---|
Probab=99.71 E-value=6.9e-17 Score=143.93 Aligned_cols=120 Identities=19% Similarity=0.141 Sum_probs=103.8
Q ss_pred HHHHhcceeEEEcC---CCcEEeecHHHHHHhCCChhhHcCCCccccccccccchhHHHHHHHHHhCceeEEEEEEEcCC
Q 005841 135 ILQSMGQSVHIFDL---SDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGERWTGQFPAKTKT 211 (674)
Q Consensus 135 ilds~~d~I~v~D~---~GrIi~~N~a~e~llGys~eEviG~~~~~l~~~~~~~~~~~~i~~~l~~g~~~~~e~~~~~kd 211 (674)
+|++++++|+++|. +|+|++||+++++++||+.++++|+++.+++++.........+...+..+..+..++.+.+++
T Consensus 2 ~~~~~~~~i~~~d~~~~~g~i~~~N~~~~~l~g~~~~e~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~ 81 (128)
T 3t50_A 2 ASEFTLMPMLITNPHLPDNPIVFANPAFLKLTGYEADEVMGRNCRFLQGHGTDPAHVRAIKSAIAAEKPIDIDIINYKKS 81 (128)
T ss_dssp CCCCCSSCEEEECTTSTTCCEEEECHHHHHHHCCCHHHHTTSCGGGGCCTTSCHHHHHHHHHHHHTTCCEEEEEEEECTT
T ss_pred ccccCcccEEEecCCCCCCcEEEEcHHHHHHhCcCHHHHcCCCHhhhcCCccCHHHHHHHHHHHHcCCCceeEEEEEcCC
Confidence 46788999999999 999999999999999999999999999988887776666677778888898899999999999
Q ss_pred CCEEEEEEEEEEEECCCCCEEEEEEEEEchHHHHHHHHHHHHh
Q 005841 212 EERVLVVATNTPFYDDDGTLVGIVCVSTDSRPFQETRAALWDT 254 (674)
Q Consensus 212 G~~~~v~~s~sPi~d~dG~ivg~i~i~rDITe~k~~e~~L~~l 254 (674)
|..+|+.++..|+++.+|.+.+++++++|||++|+++++..+.
T Consensus 82 g~~~~~~~~~~~i~~~~g~~~~~~~~~~DITe~k~~e~~~~~~ 124 (128)
T 3t50_A 82 GEAFWNRLHISPVHNANGRLQHFVSSQLDVTLELVPRGSLEHH 124 (128)
T ss_dssp CCEEEEEEEEEEEECTTSCEEEEEEEEEECHHHHC--------
T ss_pred CCEEEEEEEEEEEECCCCCEEEEEEEEEEcchhhhhhhhhhhc
Confidence 9999999999999999999999999999999999999876543
|
| >3sw1_A Sensory box protein; light-oxygen-voltage, LOV, PAS, signaling protein; HET: FMN; 2.63A {Pseudomonas putida} | Back alignment and structure |
|---|
Probab=99.71 E-value=2.6e-16 Score=146.43 Aligned_cols=130 Identities=19% Similarity=0.165 Sum_probs=120.2
Q ss_pred ccHHHHHHHHHHhcceeEEEcCCC---cEEeecHHHHHHhCCChhhHcCCCccccccccccchhHHHHHHHHHhCceeEE
Q 005841 127 FTDRQYLNILQSMGQSVHIFDLSD---RIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGERWTG 203 (674)
Q Consensus 127 ~se~~l~~ilds~~d~I~v~D~~G---rIi~~N~a~e~llGys~eEviG~~~~~l~~~~~~~~~~~~i~~~l~~g~~~~~ 203 (674)
.+++.++.+++.++++|+++|.+| +|+++|+++++++||+.++++|+.+.+++++.........+...+..+..+..
T Consensus 22 ~~~~~~~~i~~~~~~~i~~~d~~~~~~~i~~~N~~~~~~~g~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 101 (162)
T 3sw1_A 22 INAQLLQSMVDASNDGIVVAEKEGDDTILIYVNAAFEYLTGYSRDEILYQDCRFLQGDDRDQLGRARIRKAMAEGRPCRE 101 (162)
T ss_dssp CCHHHHHHHHHTCSSEEEEEEEETTEEEEEEECHHHHHHHTCCHHHHTTSBGGGGTTTCCCCHHHHHHHHHHHHTCCEEE
T ss_pred chHHHHHHHHhhccCcEEEEeCCCCccEEEEECHHHHHHHCCCHHHHcCCCcceecCCCcCHHHHHHHHHHHhcCCCCcc
Confidence 678899999999999999999999 99999999999999999999999999888877766777777888889999999
Q ss_pred EEEEEcCCCCEEEEEEEEEEEECCCCCEEEEEEEEEchHHHHHHHHHHHHhhh
Q 005841 204 QFPAKTKTEERVLVVATNTPFYDDDGTLVGIVCVSTDSRPFQETRAALWDTKN 256 (674)
Q Consensus 204 e~~~~~kdG~~~~v~~s~sPi~d~dG~ivg~i~i~rDITe~k~~e~~L~~la~ 256 (674)
++.+.+++|..+|+.++..|+++.+|.+.+++++++|||++++++++|+++..
T Consensus 102 ~~~~~~~~g~~~~~~~~~~~i~~~~g~~~~~~~~~~DiTe~k~~e~~l~~~~~ 154 (162)
T 3sw1_A 102 VLRNYRKDGSAFWNELSITPVKSDFDQRTYFIGIQKDVSRQVELERELAELRA 154 (162)
T ss_dssp EEEEECTTCCEEEEEEEEEEEECSSSSCEEEEEEEEECHHHHHHHHHHHHHTC
T ss_pred eEEEECCCCCEEEEEEEEEEeecCCCCEEEEEEEEEeCcHHHHHHHHHHHHHH
Confidence 99999999999999999999999999999999999999999999999987743
|
| >3k3c_A Protein RV1364C/MT1410; sensor, PAS, signal transduction, fatty-acid binding, sigma regulator, signaling protein; HET: PLM; 1.62A {Mycobacterium tuberculosis} PDB: 3k3d_A | Back alignment and structure |
|---|
Probab=99.68 E-value=3.5e-16 Score=145.49 Aligned_cols=128 Identities=15% Similarity=0.087 Sum_probs=107.9
Q ss_pred ccHHHHHHHHHHhcceeEEEc-CCCcEEeecHHHHHHhCCChhhHcCCCccccccccccchhHHHHHHHHHhCceeEEEE
Q 005841 127 FTDRQYLNILQSMGQSVHIFD-LSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGERWTGQF 205 (674)
Q Consensus 127 ~se~~l~~ilds~~d~I~v~D-~~GrIi~~N~a~e~llGys~eEviG~~~~~l~~~~~~~~~~~~i~~~l~~g~~~~~e~ 205 (674)
-+++.|+.+|++++++|+++| .+|+|+++|+++++++|++ +++|+++.+++++.........+..++.+|++...+.
T Consensus 14 ~~~~~~~~~~~~~~~~i~~~d~~~~~i~~~N~~~~~~~g~~--~~~G~~~~~~~~~~~~~~~~~~~~~~~~~g~~~~~~~ 91 (158)
T 3k3c_A 14 GAAEDVRRIFEHIPAILVGLEGPDHRFVAVNAAYRGFSPLL--DTVGQPAREVYPELEGQQIYEMLDRVYQTGEPQSGSE 91 (158)
T ss_dssp CCHHHHHHHHHHCSSEEEEEETTTTEEEEECHHHHHHCTTC--CSTTSBHHHHSGGGGGTTHHHHHHHHHHHCCCEEEEE
T ss_pred HHHHHHHHHHhcCCceEEEEECCCcEeHHHHHHHHHHcCCc--hhcCCcHHHhCCchhHHHHHHHHHHHHHhCCcccccc
Confidence 345689999999999999999 9999999999999999999 9999999999987665555566667778888854432
Q ss_pred E-E--EcC-C-CCEEEEEEEEEEEECCCCCEEEEEEEEEchHHHHHHHHHHHHhhh
Q 005841 206 P-A--KTK-T-EERVLVVATNTPFYDDDGTLVGIVCVSTDSRPFQETRAALWDTKN 256 (674)
Q Consensus 206 ~-~--~~k-d-G~~~~v~~s~sPi~d~dG~ivg~i~i~rDITe~k~~e~~L~~la~ 256 (674)
. + ... + |..+|+.++..|+++.+|.+.|++++++|||++++++++|++++.
T Consensus 92 ~~~~~~~~~~~g~~~~~~~~~~pi~~~~g~~~g~~~~~~DITe~k~~e~~l~~~~~ 147 (158)
T 3k3c_A 92 WRLQTDYDGSGVEERYFDFVVTPRRRADGSIEGVQLIVDDVTSRVRARQAAEARVE 147 (158)
T ss_dssp EEEEEESSSSCEEEEEEEEEEEEEECTTSCEEEEEEEEEECHHHHHHHHHHHHHHH
T ss_pred eeEEeccCCCCcceEEEEEEEEEeECCCCCEEEEEEEEEehhHHHHHHHHHHHHHH
Confidence 2 2 222 2 778999999999999999999999999999999999999976643
|
| >3f1p_B ARYL hydrocarbon receptor nuclear translocator; PAS domain, heterodimer, internal cavity, activator, angiogenesis, congenital erythrocytosis; 1.17A {Homo sapiens} SCOP: d.110.3.0 PDB: 3f1o_B* 3f1n_B 3h7w_B* 3h82_B* 1x0o_A 2hv1_A 4h6j_B 2b02_A* 2k7s_A 2a24_B | Back alignment and structure |
|---|
Probab=99.68 E-value=5.5e-17 Score=144.32 Aligned_cols=116 Identities=13% Similarity=0.192 Sum_probs=97.2
Q ss_pred HHHHHHHHhcceeEEEcCCCcEEeecHHHHHHhCCChhhHcCCCccccccccccchhHHHHHHHHH-hCceeEEEEEEEc
Q 005841 131 QYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIK-MGERWTGQFPAKT 209 (674)
Q Consensus 131 ~l~~ilds~~d~I~v~D~~GrIi~~N~a~e~llGys~eEviG~~~~~l~~~~~~~~~~~~i~~~l~-~g~~~~~e~~~~~ 209 (674)
++..+++++++.|+++|.+|+|+|||+++++++||+++|++|+++.+++++++.......+...+. .+..+..++++++
T Consensus 3 ~~~ll~e~~~d~i~~~d~~g~i~~~n~~~~~~~G~~~~el~g~~~~~~i~p~d~~~~~~~~~~~~~~~~~~~~~e~r~~~ 82 (121)
T 3f1p_B 3 FKGLNVCQPTRFISRHNIEGIFTFVDHRCVATVGYQPQELLGKNIVEFCHPEDQQLLRDSFQQVVKLKGQVLSVMFRFRS 82 (121)
T ss_dssp -----CCCCCEEEEEECTTSBEEEECTTHHHHHSCCGGGTTTSBGGGGBCTTTHHHHHHHHHHHTTSTTCCEEEEEEEEC
T ss_pred cccceecCCCceEEEECCCceEEEECcchhhhhCCChHHHcCCCHHHeECHHHHHHHHHHHHHHHhcCCCcccEEEEEEe
Confidence 455688999999999999999999999999999999999999999999988776555445555553 4556888999999
Q ss_pred CCCCEEEEEEEEEEEECC-CCCEEEEEEEEEchHHHHH
Q 005841 210 KTEERVLVVATNTPFYDD-DGTLVGIVCVSTDSRPFQE 246 (674)
Q Consensus 210 kdG~~~~v~~s~sPi~d~-dG~ivg~i~i~rDITe~k~ 246 (674)
++|..+|+.++..|++|+ +|.+.+++++++|||++|+
T Consensus 83 ~dG~~~w~~~~~~~~~~~~~g~~~~iv~~~~DIT~~kq 120 (121)
T 3f1p_B 83 KNQEWLWMRTSSFTFQNPYSDEIEYIICTNTNVKNSSQ 120 (121)
T ss_dssp TTSCEEEEEEEEEEECCTTCCCCCEEEEEEEECCCC--
T ss_pred cCCCEEEEEEEEEEEECCCCCceeEEEEEeEEcccccC
Confidence 999999999999999987 7899999999999999875
|
| >2wkq_A NPH1-1, RAS-related C3 botulinum toxin substrate 1; transferase, cell adhesion, nucleotide-binding, protein engineering, RAS superfamily LOV2; HET: GTP FMN; 1.60A {Avena sativa} PDB: 2wkr_A* 2wkp_A* | Back alignment and structure |
|---|
Probab=99.68 E-value=3e-16 Score=165.68 Aligned_cols=151 Identities=20% Similarity=0.185 Sum_probs=127.3
Q ss_pred HHHHHhcceeEEEcC---CCcEEeecHHHHHHhCCChhhHcCCCccccccccccchhHHHHHHHHHhCceeEEEEEEEcC
Q 005841 134 NILQSMGQSVHIFDL---SDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGERWTGQFPAKTK 210 (674)
Q Consensus 134 ~ilds~~d~I~v~D~---~GrIi~~N~a~e~llGys~eEviG~~~~~l~~~~~~~~~~~~i~~~l~~g~~~~~e~~~~~k 210 (674)
.+++.++++|+++|. +|+|+|||+++++++||+.+|++|+++.+++++.........+...+..+..+..++++.++
T Consensus 15 ~~~~~~~~~i~~~D~~~~~g~i~~~N~a~~~l~G~~~~el~G~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~ 94 (332)
T 2wkq_A 15 TTLERIEKNFVITDPRLPDNPIIFASDSFLQLTEYSREEILGRNARFLQGPETDRATVRKIRDAIDNQTEVTVQLINYTK 94 (332)
T ss_dssp CCGGGCCSEEEEECTTSTTCCEEEECHHHHHHHCCCHHHHTTSCGGGGCCTTCCHHHHHHHHHHHHTTCCEEEEEEEECT
T ss_pred hHhhcCCCcEEEecCCCCCCCEEEeehHHHHHhCCCHHHHcCCCchhhcCCCCCHHHHHHHHHHHHcCCeeEEEEEEEcC
Confidence 368999999999999 99999999999999999999999999999888777666677788889999999999999999
Q ss_pred CCCEEEEEEEEEEEECCCCCEEEEEEEEEchHHHHHHHHHHHHhhhcCCccCcCCchhHHHHHhcCCccchhhHHHHHHH
Q 005841 211 TEERVLVVATNTPFYDDDGTLVGIVCVSTDSRPFQETRAALWDTKNSDTDSNINRPRNTVTAKLGLDSQQPLQATIASKI 290 (674)
Q Consensus 211 dG~~~~v~~s~sPi~d~dG~ivg~i~i~rDITe~k~~e~~L~~la~~d~lt~~nr~~~~~~~kl~~~~~qpl~~~iassi 290 (674)
+|..+|+.++..|++|++|.++|++++++|||+++++++++..... +.. +
T Consensus 95 dG~~~~~~~~~~pi~d~~g~~~~~v~~~~DITe~k~~e~~~~~~~~-------------------------~~~-----~ 144 (332)
T 2wkq_A 95 SGKKFWNLFHLQPMRDQKGDVQYFIGVQLDGTEHVRDAAEREGVML-------------------------IKK-----T 144 (332)
T ss_dssp TCCEEEEEEEEEEEECTTSCEEEEEEEEEEESSCCCHHHHHHHHHH-------------------------HHH-----H
T ss_pred CCCEEEEeeEEEEeEcCCCCEEEEEEEeccCchhhhhhhhccchhh-------------------------Hhh-----h
Confidence 9999999999999999999999999999999999888776543311 011 2
Q ss_pred HHHHHHHHhhhccccccCCCCCcc
Q 005841 291 SNLATKVSNKVKSRIRTGDNFMDR 314 (674)
Q Consensus 291 ~~LA~kva~~~~svLi~Gesg~~~ 314 (674)
......+......+++.|..|+||
T Consensus 145 ~~~~~~~~~~~~~i~i~G~~~~GK 168 (332)
T 2wkq_A 145 AENIDEAAKELIKCVVVGDGAVGK 168 (332)
T ss_dssp HHHHHHHHTTCEEEEEEESTTSSH
T ss_pred cccchhcccceeEEEEECCCCCCh
Confidence 222234556667799999998876
|
| >3mr0_A Sensory box histidine kinase/response regulator; PAS fold, structural genomics, PSI-2; HET: PG5; 1.49A {Burkholderia thailandensis} | Back alignment and structure |
|---|
Probab=99.67 E-value=8.1e-16 Score=141.53 Aligned_cols=131 Identities=9% Similarity=0.174 Sum_probs=111.8
Q ss_pred ccccHHHHHHHHHHhcceeEEEcCCCcEEeecHHHHHHhCCChhhHcCC--CccccccccccchhHHHHHHHHHhCceeE
Q 005841 125 FNFTDRQYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQ--DAIELLTDGRDFDVAYDIVHRIKMGERWT 202 (674)
Q Consensus 125 ~~~se~~l~~ilds~~d~I~v~D~~GrIi~~N~a~e~llGys~eEviG~--~~~~l~~~~~~~~~~~~i~~~l~~g~~~~ 202 (674)
+..+++.|+.+++++++++|..|.++.+++||+++++++||+.+++.+. .+.++++|++...+...+...+..+..+.
T Consensus 4 L~~se~rl~~~~~~~~~g~w~~d~~~~~~~~s~~~~~~~G~~~~~~~~~~~~~~~~ihpdD~~~~~~~~~~~~~~~~~~~ 83 (142)
T 3mr0_A 4 LSASEERFQLAVSGASAGLWDWNPKTGAMYLSPHFKKIMGYEDHELPDEITGHRESIHPDDRARVLAALKAHLEHRDTYD 83 (142)
T ss_dssp -----CCHHHHHHHTTCEEEEECTTTCCEEECHHHHHHTTCCGGGSCSEEC---CCBCTTTHHHHHHHHHHHHHHCCCEE
T ss_pred HHHHHHHHHHHHHhCCcEEEEEEcCCCeEEECHHHHHHhCCCccccCCCHHHHHhhcCHHHHHHHHHHHHHHHhCCCceE
Confidence 4456678999999999999999999999999999999999999998873 45677888776666666667788888899
Q ss_pred EEEEEEcCCCCEEEEEEEEEEEECCCCCEEEEEEEEEchHHHHHHHHHHHHhh
Q 005841 203 GQFPAKTKTEERVLVVATNTPFYDDDGTLVGIVCVSTDSRPFQETRAALWDTK 255 (674)
Q Consensus 203 ~e~~~~~kdG~~~~v~~s~sPi~d~dG~ivg~i~i~rDITe~k~~e~~L~~la 255 (674)
.++++.+++|..+|+.....|++|++|.+++++++++|||++|++|++|+...
T Consensus 84 ~e~r~~~~~G~~~w~~~~~~~~~d~~g~~~~~~G~~~DITerk~~E~~L~~~~ 136 (142)
T 3mr0_A 84 VEYRVRTRSGDFRWIQSRGQALWNSAGEPYRMVGWIMDVTDRKRDEDALRVSR 136 (142)
T ss_dssp EEEEEECTTSCEEEEEEEEEEEECTTSCEEEEEEEEEECHHHHHHHHHHHHHH
T ss_pred EEEEEECCCCCEEEEEEEEEEEECCCCCEEEEEEEEEcCchHHHHHHHHHHHH
Confidence 99999999999999999999999999999999999999999999999998763
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.67 E-value=7.2e-17 Score=173.83 Aligned_cols=137 Identities=17% Similarity=0.140 Sum_probs=101.8
Q ss_pred CeeEeeeecccCceEEEEEEE-cCCeEEEEEeecccCC---------------H-----HHHHHHHHHHHHHhhCCCCCe
Q 005841 506 DLTIGEQIGQGSCGTVYHAVW-YGSDVAVKVFSRQEYS---------------D-----EVIHSFRQEVSLMKRLRHPNV 564 (674)
Q Consensus 506 ~y~~~~~LG~G~fG~Vy~~~~-~~~~vAvK~i~~~~~~---------------~-----~~~~~~~~Ei~il~~l~HpnI 564 (674)
-|.++.+||.|+||.||+|.. .|..||||+++..... . .......+|...|.++.+.+|
T Consensus 96 iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv 175 (397)
T 4gyi_A 96 VYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF 175 (397)
T ss_dssp CSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred EEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence 389999999999999999987 6788999987542110 0 011123457778888765544
Q ss_pred e--eEEEEEecCCeEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCC
Q 005841 565 L--LFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHW 642 (674)
Q Consensus 565 v--~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~ 642 (674)
. ..+.+ ...+|||||++|..|..++. ......++.||+.+|.|||++| ||||||||.|||+++++
T Consensus 176 ~vp~p~~~----~~~~LVME~i~G~~L~~l~~-------~~~~~~l~~qll~~l~~lH~~g--IVHrDLKp~NILl~~dg 242 (397)
T 4gyi_A 176 PVPEPIAQ----SRHTIVMSLVDALPMRQVSS-------VPDPASLYADLIALILRLAKHG--LIHGDFNEFNILIREEK 242 (397)
T ss_dssp SCCCEEEE----ETTEEEEECCSCEEGGGCCC-------CSCHHHHHHHHHHHHHHHHHTT--EECSCCSTTSEEEEEEE
T ss_pred CCCeeeec----cCceEEEEecCCccHhhhcc-------cHHHHHHHHHHHHHHHHHHHCC--CcCCCCCHHHEEEeCCC
Confidence 3 33332 23489999999988755432 2234677899999999999999 99999999999998776
Q ss_pred ----------cEEEEecCCcccc
Q 005841 643 ----------TVKVGDFGLSRLK 655 (674)
Q Consensus 643 ----------~vkL~DFGla~~~ 655 (674)
.+.|+||+-+...
T Consensus 243 d~~d~~~~~~~~~iID~~Q~V~~ 265 (397)
T 4gyi_A 243 DAEDPSSITLTPIIIXFPQMVSM 265 (397)
T ss_dssp CSSCTTSEEEEEEECCCTTCEET
T ss_pred CcccccccccceEEEEeCCcccC
Confidence 4899999988654
|
| >2vv6_A FIXL, sensor protein FIXL; signaling protein, transferase, phosphoprotein, nitrogen FIX PER-ARNT-SIM, metal-binding, PAS, iron, heme; HET: HEM; 1.5A {Bradyrhizobium japonicum} PDB: 1xj6_A* 1xj4_A* 2vv7_A* 2vv8_A* 1lsw_A* 1dp8_A* 1dp9_A* 1drm_A* 1lsv_A* 1dp6_A* 1lsx_A* 1lt0_A* 1y28_A* 2cmn_A* 1xj3_A* 1xj2_A* 2owh_A* 2owj_A* | Back alignment and structure |
|---|
Probab=99.66 E-value=5.1e-16 Score=137.73 Aligned_cols=115 Identities=17% Similarity=0.135 Sum_probs=80.5
Q ss_pred HhcceeEEEcCCCcEEeecHHHHHHhCCChhhHcCCCccccccccccchhHHHHHHHHHhCce----eEEEEEEEcCCCC
Q 005841 138 SMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGER----WTGQFPAKTKTEE 213 (674)
Q Consensus 138 s~~d~I~v~D~~GrIi~~N~a~e~llGys~eEviG~~~~~l~~~~~~~~~~~~i~~~l~~g~~----~~~e~~~~~kdG~ 213 (674)
+++++|+++|.+|+|++||+++++++||+.+|++|+++.+++++.........+......+.. ...++...++||.
T Consensus 1 ~~~d~i~~~d~~g~i~~~N~a~~~l~G~~~~el~G~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dG~ 80 (119)
T 2vv6_A 1 TIPDAMIVIDGHGIIQLFSTAAERLFGWSELEAIGQNVNILMPEPDRSRHDSYISRYRTTSDPHIIGIGRIVTGKRRDGT 80 (119)
T ss_dssp -CCCEEEEEETTSBEEEECHHHHHHHCCCHHHHTTSBGGGGSCTTHHHHHHHHHHHHHHHCCCSSTTTCEEEEEECTTSC
T ss_pred CCcceEEEECCCCeEEEEhHHHHHHhCCCHHHHcCCCHHHhCCchHHHHHHHHHHHHhcCCCcccCCCceEEEEEeCCCC
Confidence 368899999999999999999999999999999999998887665433222223333444443 2346678899999
Q ss_pred EEEEEEEEEEEECCCCCEEEEEEEEEchHHHHHHHHHHHHh
Q 005841 214 RVLVVATNTPFYDDDGTLVGIVCVSTDSRPFQETRAALWDT 254 (674)
Q Consensus 214 ~~~v~~s~sPi~d~dG~ivg~i~i~rDITe~k~~e~~L~~l 254 (674)
.+|+.++++|+.+. ...+++++++|||++|++|++|+++
T Consensus 81 ~~~~~~~~~~~~~~--~~~~~~~~~~DITerk~~e~~l~~l 119 (119)
T 2vv6_A 81 TFPMHLSIGEMQSG--GEPYFTGFVRDLTEHQQTQARLQEL 119 (119)
T ss_dssp EEEEEEEEEEEEET--TEEEEEEEEEECC------------
T ss_pred EEEEEEEEEEEEEC--CeEEEEEEEEEcHHHHHHHHHHHhC
Confidence 99999999999863 3456899999999999999988653
|
| >4eet_B Phototropin-2; LOV, blue light photoreceptor, signaling protein, flavoprote; HET: FMN; 1.20A {Arabidopsis thaliana} PDB: 4ees_A* 4eer_A* 4eep_A* 4eeu_A* 1jnu_A* 1g28_A* | Back alignment and structure |
|---|
Probab=99.66 E-value=6.3e-16 Score=133.80 Aligned_cols=110 Identities=24% Similarity=0.197 Sum_probs=98.9
Q ss_pred HHHHhcceeEEEcC---CCcEEeecHHHHHHhCCChhhHcCCCccccccccccchhHHHHHHHHHhCceeEEEEEEEcCC
Q 005841 135 ILQSMGQSVHIFDL---SDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGERWTGQFPAKTKT 211 (674)
Q Consensus 135 ilds~~d~I~v~D~---~GrIi~~N~a~e~llGys~eEviG~~~~~l~~~~~~~~~~~~i~~~l~~g~~~~~e~~~~~kd 211 (674)
.|++++++|+++|. +|+|+++|+++++++||+.++++|+++..++++.........+...+..+..+..++...+++
T Consensus 2 ~l~~~~~~i~~~d~~~~~g~i~~~N~~~~~~~g~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 81 (115)
T 4eet_B 2 SPEFIEKNFVITDPRLPDNPIIFASDGFLELTEYSREEILGRNARFLQGPETDQATVQKIRDAIRDQRETTVQLINYTKS 81 (115)
T ss_dssp ---CCCCSEEEECTTSTTCCEEEECHHHHHHHCCCHHHHTTSCGGGGCCTTSCHHHHHHHHHHHHTTCCEEEEEEEECTT
T ss_pred ccccCCCcEEEEcCCCCCCcEEEEcHHHHHHHCcCHHHHhCCCHHHhcCCCCChHHHHHHHHHHHcCCCcceEEEEecCC
Confidence 57899999999999 999999999999999999999999998888877766666667778888898899999999999
Q ss_pred CCEEEEEEEEEEEECCCCCEEEEEEEEEchHHH
Q 005841 212 EERVLVVATNTPFYDDDGTLVGIVCVSTDSRPF 244 (674)
Q Consensus 212 G~~~~v~~s~sPi~d~dG~ivg~i~i~rDITe~ 244 (674)
|..+|+.++..|+++.+|.+.+++++++|||++
T Consensus 82 g~~~~~~~~~~~~~~~~g~~~~~~~~~~DITer 114 (115)
T 4eet_B 82 GKKFWNLLHLQPVRDQKGELQYFIGVQLDGSDH 114 (115)
T ss_dssp CCEEEEEEEEEEEECTTSCEEEEEEEEEECSCC
T ss_pred CCEEEEEEEEEEEECCCCCEEEEEEEEEeeccc
Confidence 999999999999999999999999999999975
|
| >3lyx_A Sensory BOX/ggdef domain protein; structural genomics, PSI- 2, protein structure initiative, northeast structural genomics consortium; 2.00A {Colwellia psychrerythraea} | Back alignment and structure |
|---|
Probab=99.66 E-value=9.3e-16 Score=133.01 Aligned_cols=120 Identities=23% Similarity=0.410 Sum_probs=105.3
Q ss_pred cHHHHHHHHHHhcceeEEEcCCCcEEeecHHHHHHhCCChhhHcCCCccccccccccchhHHHHHHHHHhCceeEEEEEE
Q 005841 128 TDRQYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGERWTGQFPA 207 (674)
Q Consensus 128 se~~l~~ilds~~d~I~v~D~~GrIi~~N~a~e~llGys~eEviG~~~~~l~~~~~~~~~~~~i~~~l~~g~~~~~e~~~ 207 (674)
..+.++.++++++++|+++|.+|+|+++|+++++++|++.++++|+++..+.++.........+...+..+..+..++.+
T Consensus 5 ~~~~~~~~~~~~~~~i~~~d~~~~i~~~N~~~~~~~g~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 84 (124)
T 3lyx_A 5 ILKQRAKAFDYVFDAIVVTDLQGFIIDWNKGSETLYGYSKEQAIGQPVNMLHVPGDTEHITSEVISAVENQGKWTGEIRM 84 (124)
T ss_dssp HHHHHHHGGGTCSSEEEEEETTCBEEEECHHHHHHHCCCHHHHTTSBGGGGSCTTTHHHHHHHHHHHHHHTSCEEEEEEE
T ss_pred HHHHHHHHHhhcCceEEEECCCCcEeehhhHHHHHhCCCHHHHcCCCHHHhcCcchhhHHHHHHHHHHHcCCcccceEEE
Confidence 46789999999999999999999999999999999999999999999886666555445555667778889888889999
Q ss_pred EcCCCCEEEEEEEEEEEECCCCCEEEEEEEEEchHHHHHH
Q 005841 208 KTKTEERVLVVATNTPFYDDDGTLVGIVCVSTDSRPFQET 247 (674)
Q Consensus 208 ~~kdG~~~~v~~s~sPi~d~dG~ivg~i~i~rDITe~k~~ 247 (674)
..++|..+|+.++..|+++.+|.+.|++++++|||+++++
T Consensus 85 ~~~~g~~~~~~~~~~~~~~~~g~~~~~~~~~~Dit~~~~l 124 (124)
T 3lyx_A 85 LHKDGHIGWIESMCVPIYGENYQMVGALGINRDITKRKKE 124 (124)
T ss_dssp ECTTSCEEEEEEEEEEEECSTTCEEEEEEEEEECSCC---
T ss_pred EccCCCEEEEEEEEEEEECCCCCEEEEEEEEecchhhhcC
Confidence 9999999999999999999999999999999999998753
|
| >2r78_A Sensor protein; sensory box sensor histidine kinase/response regulator, structural genomics, PSI, MCSG; 1.60A {Geobacter sulfurreducens pca} | Back alignment and structure |
|---|
Probab=99.65 E-value=1.5e-15 Score=135.10 Aligned_cols=115 Identities=20% Similarity=0.211 Sum_probs=93.9
Q ss_pred CCcccccHHHHHHHHHHhcceeEEEcCCCcEEeecHHHHHHhCCChhhHcCCCccccccccccchhHHHHHHHHHhCcee
Q 005841 122 PSAFNFTDRQYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGERW 201 (674)
Q Consensus 122 ~~~~~~se~~l~~ilds~~d~I~v~D~~GrIi~~N~a~e~llGys~eEviG~~~~~l~~~~~~~~~~~~i~~~l~~g~~~ 201 (674)
...+..+++.|+.+|++++++|+++|.+|+|++||+++++++||+.+|++|+++.++.++. ...........+..+..+
T Consensus 3 ~~~l~~se~~~~~l~e~~~d~i~~~d~~g~i~~vN~a~~~l~Gy~~~el~g~~~~~~~~~~-~~~~~~~~~~~~~~~~~~ 81 (117)
T 2r78_A 3 TENLYFQSNAYRALFEHAIDGIFIMDAEGHYLDVNPAICSAIGYTRDEFLALDWGVLSRGV-DSGWAAASLARIVGGEPL 81 (117)
T ss_dssp CCSHHHHHHHHHHHHHHCSSEEEEECTTSBEEEECHHHHHHHCCCHHHHTTCBTTTTTTCS-TTSHHHHHHHHHHTTCCE
T ss_pred hhHHHHhHHHHHHHHhcCCceEEEECCCCCEEEecHHHHHHHCcCHHHHcCCCHHHhCCcc-chhHHHHHHHHHHcCCcE
Confidence 4556678899999999999999999999999999999999999999999999876654332 222233455667777778
Q ss_pred EEEEEEEcCCCCEEEEEEEEEEEECCCCCEEEEEEEEEchH
Q 005841 202 TGQFPAKTKTEERVLVVATNTPFYDDDGTLVGIVCVSTDSR 242 (674)
Q Consensus 202 ~~e~~~~~kdG~~~~v~~s~sPi~d~dG~ivg~i~i~rDIT 242 (674)
..+.++.++||..+|+.++..|+. +|. ++++++|||
T Consensus 82 ~~e~~~~~kdG~~~~v~~~~~~~~--~g~---~~~i~~DIT 117 (117)
T 2r78_A 82 REERTVWTRNGDQLTVELSAHLLP--DGK---ILGIARDVS 117 (117)
T ss_dssp EEEEEEECTTSCEEEEEEEEEECT--TSC---EEEEEEC--
T ss_pred EEEEEEEecCCCEEEEEEEEEEec--CCe---EEEEEEeCC
Confidence 888999999999999999999985 566 578899997
|
| >2z6d_A Phototropin-2; PAS-fold, LOV-fold, alternative splicing, ATP-binding, chromophore, flavoprotein, FMN, kinase, membrane, nucleotide-binding; HET: FMN; 2.00A {Arabidopsis thaliana} PDB: 2z6c_A* | Back alignment and structure |
|---|
Probab=99.65 E-value=1.8e-15 Score=132.10 Aligned_cols=122 Identities=20% Similarity=0.278 Sum_probs=106.1
Q ss_pred HHHHHHHHHHhcceeEEEc---CCCcEEeecHHHHHHhCCChhhHcCCCccccccccccchhHHHHHHHHHhCceeEEEE
Q 005841 129 DRQYLNILQSMGQSVHIFD---LSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGERWTGQF 205 (674)
Q Consensus 129 e~~l~~ilds~~d~I~v~D---~~GrIi~~N~a~e~llGys~eEviG~~~~~l~~~~~~~~~~~~i~~~l~~g~~~~~e~ 205 (674)
++.++.++++++++|+++| .+|+|+++|+++++++|++.++++|+++.+++++.........+...+..+..+..++
T Consensus 5 ~~~~~~~~~~~~~~i~~~d~~d~~~~i~~~N~~~~~~~g~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 84 (130)
T 2z6d_A 5 SQELKTALSTLQQTFVVSDATQPHCPIVYASSGFFTMTGYSSKEIVGRNCRFLQGPDTDKNEVAKIRDCVKNGKSYCGRL 84 (130)
T ss_dssp --CHHHHHHHTTCEEEEEETTSTTCCEEEECHHHHHHHCCCHHHHTTSCGGGGCCTTSCHHHHHHHHHHHHTTCCEEEEE
T ss_pred HHHHHHHHHhcccceeeeeccCCCCcEEEecHHHHHHhCcCHHHHcCCChhhccCCCCCchHHHHHHHHHHcCCcceeEE
Confidence 4568999999999999999 9999999999999999999999999999988887666666666777888888888888
Q ss_pred EEEcCCCCEEEEEEEEEEEECCCCCEEEEEEEEEchHHHHHHHHH
Q 005841 206 PAKTKTEERVLVVATNTPFYDDDGTLVGIVCVSTDSRPFQETRAA 250 (674)
Q Consensus 206 ~~~~kdG~~~~v~~s~sPi~d~dG~ivg~i~i~rDITe~k~~e~~ 250 (674)
...+++|..+|+.++..|+++.+|.+.+++++++|||++++++++
T Consensus 85 ~~~~~~g~~~~~~~~~~~~~~~~g~~~~~~~~~~Dit~~~~~e~e 129 (130)
T 2z6d_A 85 LNYKKDGTPFWNLLTVTPIKDDQGNTIKFIGMQVEVSKYTEGVND 129 (130)
T ss_dssp EEECTTSCEEEEEEEEEEEECTTSCEEEEEEEEEECCTTC-----
T ss_pred EEEcCCCcEEEEEEEEEEEECCCCCeeEEEEEEecchHHHHhhcc
Confidence 889999999999999999999999999999999999999887653
|
| >3nja_A Probable ggdef family protein; structural genomics, PSI-2, protein structure initiative, MI center for structural genomics, MCSG; 2.37A {Chromobacterium violaceum} | Back alignment and structure |
|---|
Probab=99.65 E-value=6.5e-16 Score=135.79 Aligned_cols=121 Identities=6% Similarity=0.099 Sum_probs=92.8
Q ss_pred cccHHHHHHHHHHhcceeEEEcCCCcEEeecHHHHHHhCCChhhHcC--CCccccccccccchhHHHHHHHHHhCceeEE
Q 005841 126 NFTDRQYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALG--QDAIELLTDGRDFDVAYDIVHRIKMGERWTG 203 (674)
Q Consensus 126 ~~se~~l~~ilds~~d~I~v~D~~GrIi~~N~a~e~llGys~eEviG--~~~~~l~~~~~~~~~~~~i~~~l~~g~~~~~ 203 (674)
..+++.|+.+++.++++||++|.+|++++||+++++++||+.++++| ..+.+++++++.......+...+..+..+..
T Consensus 3 ~~~~~~l~~~~~~~~~~i~~~d~~~~~~~~n~~~~~~~G~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~ 82 (125)
T 3nja_A 3 AMAEKLLHTAESDAGIGSWVLHMESGRLEWSQAVHDIFGTDSATFDATEDAYFQRVHPDDRARVRRELDRHVLGDRPFDV 82 (125)
T ss_dssp --------------CCEEEEEETTTTEEEECHHHHHHHTCCTTTCCCBHHHHHHHBCTTTHHHHHHHHHHHHHSCCCEEE
T ss_pred HHHHHHHHHHHHhCCeeEEEEEcCCCcEEECHHHHHHhCCCcccccccHHHHHhhcChhHHHHHHHHHHHHHhcCCCceE
Confidence 35667899999999999999999999999999999999999999999 5566677776655555556667778888888
Q ss_pred EEEEEcCCCCEEEEEEEEEEEECCCCCEEEEEEEEEchHHHHH
Q 005841 204 QFPAKTKTEERVLVVATNTPFYDDDGTLVGIVCVSTDSRPFQE 246 (674)
Q Consensus 204 e~~~~~kdG~~~~v~~s~sPi~d~dG~ivg~i~i~rDITe~k~ 246 (674)
++++.+++|..+|+.++..|+++.+|.+++++++++|||++|+
T Consensus 83 e~~~~~~~g~~~~~~~~~~~~~~~~g~~~~~~g~~~DITe~k~ 125 (125)
T 3nja_A 83 EYRIVRPDGQVRELLERNHIQRQASGQVDHLWGTVIDMTEHKQ 125 (125)
T ss_dssp EEEEECTTSCEEEEEEEEEEEECTTSCEEEEEEEEEECCC---
T ss_pred EEEEECCCCCEEEEEEeeEEEECCCCCEEEEEEEEEecccccC
Confidence 9999999999999999999999999999999999999999874
|
| >3f1p_A Endothelial PAS domain-containing protein 1; PAS domain, heterodimer, internal cavity, activator, angiogenesis, congenital erythrocytosis; 1.17A {Homo sapiens} SCOP: d.110.3.7 PDB: 3f1o_A* 3f1n_A 3h7w_A* 3h82_A* 1p97_A 2a24_A 4h6j_A | Back alignment and structure |
|---|
Probab=99.64 E-value=3.9e-16 Score=137.71 Aligned_cols=108 Identities=19% Similarity=0.228 Sum_probs=97.2
Q ss_pred hcceeEEEcCCCcEEeecHHHHHHhCCChhhHcCCCccccccccccchhHHHHHHHHHhCceeEEEEEEEcCCCCEEEEE
Q 005841 139 MGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGERWTGQFPAKTKTEERVLVV 218 (674)
Q Consensus 139 ~~d~I~v~D~~GrIi~~N~a~e~llGys~eEviG~~~~~l~~~~~~~~~~~~i~~~l~~g~~~~~e~~~~~kdG~~~~v~ 218 (674)
.++.|+++|.+|+|+|+|+++++++||+++|++|+++.+++++++.......+...+..+..+..++++++++|..+|+.
T Consensus 8 ~~~~i~~~d~~g~i~~~n~~~~~~~Gy~~~el~g~~~~~~~~p~d~~~~~~~~~~~~~~~~~~~~e~r~~~~dG~~~w~~ 87 (117)
T 3f1p_A 8 SKTFLSEHSMDMKFTYCDDRITELIGYHPEELLGRSAYEFYHALDSENMTKSHQNLCTKGQVVSGQYRMLAKHGGYVWLE 87 (117)
T ss_dssp GGEEEEEECTTCBEEEECTHHHHHHCCCHHHHTTSBGGGGBCGGGHHHHHHHHHHHHHHSEEECCCEEEECTTSSEEEEE
T ss_pred CccEEEEECCCceEEEECcChhhhhCCCHHHHcCCchhheECHHHHHHHHHHHHHHHhCCCeeeeEEEEEecCCCEEEEE
Confidence 36789999999999999999999999999999999999999988766665666677788888888999999999999999
Q ss_pred EEEEEEECC-CCCEEEEEEEEEchHHHHH
Q 005841 219 ATNTPFYDD-DGTLVGIVCVSTDSRPFQE 246 (674)
Q Consensus 219 ~s~sPi~d~-dG~ivg~i~i~rDITe~k~ 246 (674)
++..|++|+ +|.+.+++++.+|||++++
T Consensus 88 ~~~~~~~d~~~g~~~~iv~~~~DITer~~ 116 (117)
T 3f1p_A 88 TQGTVIYNPRNLQPQCIMCVNYVLSEIEK 116 (117)
T ss_dssp EEEEEEEETTTTEEEEEEEEEEECSCCBC
T ss_pred EeeEEEECCCCCCceEEEEEeeecccccc
Confidence 999999987 8899999999999998764
|
| >3mqq_A Transcriptional regulator, LUXR family; PAS domain, PSI, MCSG, structural genomics, center for structural genomics; 1.65A {Burkholderia thailandensis} PDB: 3mqo_A | Back alignment and structure |
|---|
Probab=99.64 E-value=3.7e-16 Score=138.65 Aligned_cols=115 Identities=11% Similarity=0.076 Sum_probs=94.5
Q ss_pred HHHHHHHHhcceeEEEcCCCcEEeecHHHHHHhCCChhhHcCCCcccccccccc-chhHHHHHHHHHhCceeEEEEEEEc
Q 005841 131 QYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRD-FDVAYDIVHRIKMGERWTGQFPAKT 209 (674)
Q Consensus 131 ~l~~ilds~~d~I~v~D~~GrIi~~N~a~e~llGys~eEviG~~~~~l~~~~~~-~~~~~~i~~~l~~g~~~~~e~~~~~ 209 (674)
.|+.+|++++++|+ +|.+|+|++||+++++|+||+.++++|+++.+++++... ......+...+..+..+..++.+.+
T Consensus 4 ~~~~~~~~~~~~i~-~~~~g~i~~~N~a~~~l~G~~~~el~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~ 82 (120)
T 3mqq_A 4 DYKTAFHLAPIGLV-LSRDRVIEDCNDELAAIFRCARADLIGRSFEVLYPSSDEFERIGERISPVMIAHGSYADDRIMKR 82 (120)
T ss_dssp CHHHHHHHCSSEEE-EEETTEEEEECHHHHHHTTSCHHHHTTCBGGGGSSSHHHHHHHHHHHHHHHHHHSCEEEEEEEEC
T ss_pred hHHHHHhcCCceEE-EecCCEEHHHHHHHHHHhCcCHHHhCCCchhhccCChhhHHHHHHHHHHHHhcCCcceEEEEEEe
Confidence 48899999999996 578999999999999999999999999998888765433 2333445566777788889999999
Q ss_pred CCCCEEEEEEEEEEEECCCCCEEEEEEEEEchHHHHHH
Q 005841 210 KTEERVLVVATNTPFYDDDGTLVGIVCVSTDSRPFQET 247 (674)
Q Consensus 210 kdG~~~~v~~s~sPi~d~dG~ivg~i~i~rDITe~k~~ 247 (674)
++|..+|+.++..|+ +.+|...+++++++|||++|++
T Consensus 83 ~dG~~~~~~~~~~~~-~~~~~~~~~v~~~~DITerk~~ 119 (120)
T 3mqq_A 83 AGGELFWCHVTGRAL-DRTAPLAAGVWTFEDLSATRRV 119 (120)
T ss_dssp TTSCEEEEEEEEEES-STTSTTSSEEEEEEESCC----
T ss_pred CCCCEEEEEEEEEEC-CCCCCceeEEEEEEcccHhhcc
Confidence 999999999999999 5566677889999999999875
|
| >3mxq_A Sensor protein; PSI2, MCSG, structural genomics, protein structure initiativ midwest center for structural genomics; 2.78A {Vibrio cholerae o1 biovar el tor} | Back alignment and structure |
|---|
Probab=99.64 E-value=4.4e-16 Score=146.74 Aligned_cols=120 Identities=15% Similarity=0.141 Sum_probs=94.7
Q ss_pred cHHHHHHHHHHhcceeEEEcCCCcEEeecHHHHHHhCCChhhHcCCCccccccccccchhHHHHHHHHHhCceeEEE---
Q 005841 128 TDRQYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGERWTGQ--- 204 (674)
Q Consensus 128 se~~l~~ilds~~d~I~v~D~~GrIi~~N~a~e~llGys~eEviG~~~~~l~~~~~~~~~~~~i~~~l~~g~~~~~e--- 204 (674)
.+..|++||++++++|+++|.+|+|++||+++++++|++.+|++|+++.+++++ ....+...+..++.+|.+....
T Consensus 20 ~~~~l~~il~~~~~gi~v~D~~g~I~~~N~a~~~~~G~~~~eviG~~~~~~~p~-~~~~~~~~l~~vl~~G~~~~~~~~~ 98 (152)
T 3mxq_A 20 SRLLLSELLDQLSFALCIVRNDYVIVKVNEYFESRVIFDGETMQGKNILELFPE-SADYLKRKIDTALVIESSSFSSWEQ 98 (152)
T ss_dssp HHHHHHHHHHHHCCEEEEEETTSBEEEECHHHHHTSSSCHHHHTTSBHHHHSGG-GHHHHHHHHHHHHHHTSCEEEECCS
T ss_pred HHHHHHHHHhcCCCCEEEEcCCCEEEEECHHHHHHHCcCHHHHCCCCHHHhcCC-hHHHHHHHHHHHHhcCCceeeeccc
Confidence 445679999999999999999999999999999999999999999999999988 4444455567778888763321
Q ss_pred ------E---EEEcCCCCEEEEEEEEEEEECCCCCEEEEEEEEEchHHHHHHH
Q 005841 205 ------F---PAKTKTEERVLVVATNTPFYDDDGTLVGIVCVSTDSRPFQETR 248 (674)
Q Consensus 205 ------~---~~~~kdG~~~~v~~s~sPi~d~dG~ivg~i~i~rDITe~k~~e 248 (674)
+ ....++|..+++.++++|+.|++|++.|++.+++|||++..+.
T Consensus 99 ~~~~~~~~~~~~~~~~~~~~~~~~ti~Pl~d~~G~v~gv~~ii~DVTe~~~a~ 151 (152)
T 3mxq_A 99 KPHLLPFKSSRPVSGEEEQMYQNLEVIPIHSEDGTIEHVCLCVYDVTIQASQQ 151 (152)
T ss_dssp SSCSSCC----------CCEEEEEEEEEEECTTSCEEEEEEEEEEEECC----
T ss_pred ccccccccccCCCCCCCcEEEEEEEEEEEECCCCCEEEEEEEEEECCHHHhcc
Confidence 1 1123567788999999999999999999999999999987643
|
| >3luq_A Sensor protein; PAS, histidine, kinase, PSI, MCSG, structural genomics, midwest center for structural genomics; HET: PGE; 2.49A {Geobacter sulfurreducens} | Back alignment and structure |
|---|
Probab=99.63 E-value=2.9e-15 Score=129.61 Aligned_cols=112 Identities=16% Similarity=0.196 Sum_probs=93.2
Q ss_pred HHHHHHHHHHhcceeEEEcCCCcEEeecHHHHHHhCCChhhHcCCCccccccccccchhHHHHHHHHHhCceeEEEE-EE
Q 005841 129 DRQYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGERWTGQF-PA 207 (674)
Q Consensus 129 e~~l~~ilds~~d~I~v~D~~GrIi~~N~a~e~llGys~eEviG~~~~~l~~~~~~~~~~~~i~~~l~~g~~~~~e~-~~ 207 (674)
+++|+.++++++++|+++|.+|+|+++|+++++++|++.++++|+++.++++. .. .........+..++....+. .+
T Consensus 2 e~~~~~~~~~~~~~i~~~d~~g~i~~~N~~~~~~~g~~~~~~~g~~~~~~~~~-~~-~~~~~~~~~~~~~~~~~~~~~~~ 79 (114)
T 3luq_A 2 DERLRLFTEHAPAALAMFDREMRYLAVSRRWREDYGLGDGDILGMSHYDIFPE-IG-EEWKSVHRRGLAGEVIRVEEDCF 79 (114)
T ss_dssp CHHHHHHHHTCSSEEEEEETTCBEEEECHHHHHHTTCCSSCCTTCBHHHHCTT-CC-HHHHHHHHHHHTTCCEEEEEEEE
T ss_pred hHHHHHHHhcCCceEEEEcCCcEEEEECHHHHHHHCCCHHHHcCCcHHHHCCc-cH-HHHHHHHHHHhcCCcceeeeeEE
Confidence 45799999999999999999999999999999999999999999999998843 32 33334445555566654443 77
Q ss_pred EcCCCCEEEEEEEEEEEECCCCCEEEEEEEEEchH
Q 005841 208 KTKTEERVLVVATNTPFYDDDGTLVGIVCVSTDSR 242 (674)
Q Consensus 208 ~~kdG~~~~v~~s~sPi~d~dG~ivg~i~i~rDIT 242 (674)
.+++|..+|+.++..|+++.+|.+.|++++++|||
T Consensus 80 ~~~~g~~~~~~~~~~p~~~~~g~~~~~~~~~~DIT 114 (114)
T 3luq_A 80 VRADGRTQWLRWEVRPWYEGEGRVGGVVIFTEDIT 114 (114)
T ss_dssp EC--CCEEEEEEEEEEEECTTSCEEEEEEEEEECC
T ss_pred EcCCCcEEEEEEEEEEeECCCCCEEEEEEEEeeCC
Confidence 88999999999999999999999999999999997
|
| >3ewk_A Sensor protein; PAS domain, alpha/beta fold, kinase, phosphoprotein, transfe flavoprotein; HET: FAD; 2.34A {Methylococcus capsulatus} | Back alignment and structure |
|---|
Probab=99.62 E-value=3.3e-15 Score=149.09 Aligned_cols=113 Identities=27% Similarity=0.342 Sum_probs=103.3
Q ss_pred eeEEEcCCCcEEeecHHHHHHhCCChhhHcCCCccccccccccchhHHHHHHHHHhCceeEEEEEEEcCCCCEEEEEEEE
Q 005841 142 SVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGERWTGQFPAKTKTEERVLVVATN 221 (674)
Q Consensus 142 ~I~v~D~~GrIi~~N~a~e~llGys~eEviG~~~~~l~~~~~~~~~~~~i~~~l~~g~~~~~e~~~~~kdG~~~~v~~s~ 221 (674)
.|+++|.+|+|++||++|++++||+.+|++|+++..+.++.........++..+..|..+..++.+.++||..+|+.++.
T Consensus 1 ~i~i~D~~g~i~~~N~a~~~l~Gy~~~el~G~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~dG~~~~~~~~~ 80 (227)
T 3ewk_A 1 LVSITDLQGRILYANDNFCAVSRYGREELVGQDHRIVNSGYHGKAYIRDMWRTISRGNIWQGEFCNRRKDGTRYWVDSTI 80 (227)
T ss_dssp CEEEEETTCBEEEECHHHHHHTTCCHHHHTTSBGGGGCCSCSCHHHHHHHHHHHTTTCCEEEEEEEECSSSCEEEEEEEE
T ss_pred CEEEECCCCcEEehHHHHHHHHCcCHHHHcCCCHHHcCCCCCCHHHHHHHHHHHHcCCeEEEEEEEEcCCCCEEeeeeEE
Confidence 37899999999999999999999999999999988887666656666677888889999999999999999999999999
Q ss_pred EEEECCCCCEEEEEEEEEchHHHHHHHHHHHHh
Q 005841 222 TPFYDDDGTLVGIVCVSTDSRPFQETRAALWDT 254 (674)
Q Consensus 222 sPi~d~dG~ivg~i~i~rDITe~k~~e~~L~~l 254 (674)
.|++|.+|++.+++++++|||++|+++++|+++
T Consensus 81 ~p~~d~~g~~~~~~~~~~DIT~~k~~e~~l~~~ 113 (227)
T 3ewk_A 81 VPLMDNAGKPRQYISIRRDITAQKEAEAQLARL 113 (227)
T ss_dssp EEEECSSSCEEEEEEEEEECTTTTHHHHHHHHH
T ss_pred EEEEcCCCCEEEEEEEEEehhhHHHHHHHHHHH
Confidence 999999999999999999999999999988665
|
| >3kx0_X Uncharacterized protein RV1364C/MT1410; PAS domain, sensory domain, mycobacteium tuberculos molecule binding domain; 2.30A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=99.61 E-value=3e-15 Score=144.37 Aligned_cols=122 Identities=16% Similarity=0.097 Sum_probs=102.3
Q ss_pred ccHHHHHHHHHHhcceeEEEc-CCCcEEeecHHHHHHhCCChhhHcCCCccccccccccchhHHHHHHHHHhCceeEEEE
Q 005841 127 FTDRQYLNILQSMGQSVHIFD-LSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGERWTGQF 205 (674)
Q Consensus 127 ~se~~l~~ilds~~d~I~v~D-~~GrIi~~N~a~e~llGys~eEviG~~~~~l~~~~~~~~~~~~i~~~l~~g~~~~~e~ 205 (674)
.+++.|+.+|++++++|+++| .+|+|++||++|++++||+ +++|+++.+++++.........+..++.+|+....+.
T Consensus 34 ~~~~~l~~l~~~~~~~i~~~d~~~g~i~~~N~a~~~l~G~~--~~~G~~~~~~~~~~~~~~~~~~~~~~~~~g~~~~~~~ 111 (185)
T 3kx0_X 34 GAAEDVRRIFEHIPAILVGLEGPDHRFVAVNAAYRGFSPLL--DTVGQPAREVYPELEGQQIYEMLDRVYQTGEPQSGSE 111 (185)
T ss_dssp CCHHHHHHHHHHCSSEEEEEETTTTEEEEECHHHHHHCCCC--SCTTSBHHHHCTTSCSSSSHHHHHHHHHHCCCEEEEE
T ss_pred hhHHHHHHHHhcCCceEEEEECCCcEEEEEcHHHHHHcCCc--cccCCcHHHHCCchhhhhHHHHHHHHHHcCCcccccc
Confidence 456789999999999999999 9999999999999999999 9999999999987765555566677788888865542
Q ss_pred EEE---cCC--CCEEEEEEEEEEEECCCCCEEEEEEEEEchHHHHHHHHH
Q 005841 206 PAK---TKT--EERVLVVATNTPFYDDDGTLVGIVCVSTDSRPFQETRAA 250 (674)
Q Consensus 206 ~~~---~kd--G~~~~v~~s~sPi~d~dG~ivg~i~i~rDITe~k~~e~~ 250 (674)
... .++ |..+|+.++..|+++.+|.+.|++++++|||++++++++
T Consensus 112 ~~~~~~~~~~gg~~~~~~~~~~pi~~~~g~~~g~~~~~~DITerk~~e~~ 161 (185)
T 3kx0_X 112 WRLQTDYDGSGVEERYFDFVVTPRRRADGSIEGVQLIVDDVTSRVRARQA 161 (185)
T ss_dssp EEEC--------CCEEEEEEEEEEECTTSCEEEEEEEEEECHHHHTTCC-
T ss_pred eeEEeeccCCCCccEEEEEEEEEEECCCCCEEEEEEEEEeCCHHHHHHHH
Confidence 222 222 778999999999999999999999999999999999988
|
| >1d06_A Nitrogen fixation regulatory protein FIXL; oxygen sensor, histidine kinase, PAS, high-resolution, two-C system, signaling protein; HET: HEM; 1.40A {Sinorhizobium meliloti} SCOP: d.110.3.2 PDB: 1ew0_A* | Back alignment and structure |
|---|
Probab=99.59 E-value=4.4e-15 Score=133.94 Aligned_cols=112 Identities=15% Similarity=0.167 Sum_probs=89.1
Q ss_pred HHHHHHHHHHhcceeEEEcCCCcEEeecHHHHHHhCCChhhHcCCCccccccccccchhHHHHHHHHHhCce----eEEE
Q 005841 129 DRQYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGER----WTGQ 204 (674)
Q Consensus 129 e~~l~~ilds~~d~I~v~D~~GrIi~~N~a~e~llGys~eEviG~~~~~l~~~~~~~~~~~~i~~~l~~g~~----~~~e 204 (674)
+..|+.++++++++|+++|.+|+|++||+++++++||+.+|++|+++.+++++.........+......+.. ...+
T Consensus 15 ~~~~~~l~~~~~d~i~~~d~~g~i~~~N~a~~~l~Gy~~~eliG~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e 94 (130)
T 1d06_A 15 DAHLRSILDTVPDATVVSATDGTIVSFNAAAVRQFGYAEEEVIGQNLRILMPEPYRHEHDGYLQRYMATGEKRIIGIDRV 94 (130)
T ss_dssp TSCHHHHHTTCSSEEEEEETTSBEEEECHHHHHHHCCCHHHHTTSBGGGGSCTTHHHHHHHHHHHHHHHCCCSSTTSCEE
T ss_pred HHHHHHHHhhCcCeEEEECCCCeEEEEcHHHHHHHCCCHHHHcCCcHHHHCCchhHHHHHHHHHHHHhcCCccccCCeeE
Confidence 346899999999999999999999999999999999999999999998888765433222223333444443 2346
Q ss_pred EEEEcCCCCEEEEEEEEEEEECCCCCEEEEEEEEEchH
Q 005841 205 FPAKTKTEERVLVVATNTPFYDDDGTLVGIVCVSTDSR 242 (674)
Q Consensus 205 ~~~~~kdG~~~~v~~s~sPi~d~dG~ivg~i~i~rDIT 242 (674)
+...++||..+|+.+++.|+.+. ...+++++++|||
T Consensus 95 ~~~~~kdG~~~~~~~~~~~~~~~--~~~~~~~~~~DIT 130 (130)
T 1d06_A 95 VSGQRKDGSTFPMKLAVGEMRSG--GERFFTGFIRDLT 130 (130)
T ss_dssp EEEECTTSCEEEEEEEEEEEEET--TEEEEEEEEEECC
T ss_pred EEEEeCCCCEEEEEEEEEEEEEC--CeEEEEEEEEECc
Confidence 67889999999999999999763 3456889999997
|
| >2v0u_A NPH1-1, LOV2; kinase, transferase, ATP-binding, serine/threonine-protein kinase, light-induced signal trans phototropin1, nucleotide-binding; HET: FMN; 1.40A {Avena sativa} PDB: 2v0w_A* 2v1b_A* 2v1a_A* 1jnu_A* 1g28_A* | Back alignment and structure |
|---|
Probab=99.56 E-value=1.3e-14 Score=129.81 Aligned_cols=117 Identities=22% Similarity=0.201 Sum_probs=105.9
Q ss_pred HHHHHHHhcceeEEEcC---CCcEEeecHHHHHHhCCChhhHcCCCccccccccccchhHHHHHHHHHhCceeEEEEEEE
Q 005841 132 YLNILQSMGQSVHIFDL---SDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGERWTGQFPAK 208 (674)
Q Consensus 132 l~~ilds~~d~I~v~D~---~GrIi~~N~a~e~llGys~eEviG~~~~~l~~~~~~~~~~~~i~~~l~~g~~~~~e~~~~ 208 (674)
|+.++++++++|+++|. +|+|+++|+++++++||+.++++|+++..++++.........+...+..+..+..++...
T Consensus 4 l~~~~~~~~~~i~~~d~~~~~~~i~~~N~~~~~~~g~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 83 (146)
T 2v0u_A 4 LATTLERIEKNFVITDPRLPDNPIIFASDSFLQLTEYSREEILGRNCRFLQGPETDRATVRKIRDAIDNQTEVTVQLINY 83 (146)
T ss_dssp CCCTGGGSSSCEEEECTTSTTCCEEEECHHHHHHHCCCHHHHTTSCGGGGCCTTSCHHHHHHHHHHHHTTCCEEEEEEEE
T ss_pred HHHHHhcCCCcEEEEcCCCCCceEEEEcHHHHHHHCcCHHHHcCCCHHHhcCCcCChHHHHHHHHHHhcCCCcceEEEEE
Confidence 45688999999999999 999999999999999999999999999888877766666667777888888888899999
Q ss_pred cCCCCEEEEEEEEEEEECCCCCEEEEEEEEEchHHHHHHH
Q 005841 209 TKTEERVLVVATNTPFYDDDGTLVGIVCVSTDSRPFQETR 248 (674)
Q Consensus 209 ~kdG~~~~v~~s~sPi~d~dG~ivg~i~i~rDITe~k~~e 248 (674)
+++|..+|+.++..|+++.+|.+.+++++++|||++++.+
T Consensus 84 ~~~g~~~~~~~~~~~~~~~~g~~~~~~~~~~Dit~~~~~~ 123 (146)
T 2v0u_A 84 TKSGKKFWNLFHLQPMRDQKGDVQYFIGVQLDGTEHVRDA 123 (146)
T ss_dssp CTTCCEEEEEEEEEEEECTTSCEEEEEEEEEEESSCCCHH
T ss_pred ecCCcEEEEEEEEEEeECCCCCEEEEEEEEeechHHHHHH
Confidence 9999999999999999999999999999999999998833
|
| >2qkp_A Uncharacterized protein; structural genomics, unknown function, PSI-2, protein struct initiative; 1.75A {Streptococcus mutans} | Back alignment and structure |
|---|
Probab=99.56 E-value=5.5e-15 Score=139.08 Aligned_cols=125 Identities=18% Similarity=0.223 Sum_probs=102.4
Q ss_pred ccccHHHHHHHHHHhcceeEEEcCCCcEEeecHH---HHHHhCCChhhHcCCCccccccccccchhHHHHHHHHHhCcee
Q 005841 125 FNFTDRQYLNILQSMGQSVHIFDLSDRIIYWNRS---AELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGERW 201 (674)
Q Consensus 125 ~~~se~~l~~ilds~~d~I~v~D~~GrIi~~N~a---~e~llGys~eEviG~~~~~l~~~~~~~~~~~~i~~~l~~g~~~ 201 (674)
..++.++|.+||++|+++|+++|.+|+|+|||++ +++++| ..++++|+++.++.++. .....+.+...+++|+..
T Consensus 14 g~l~~~~l~~IL~~~~~gI~~vD~~g~I~~~N~a~~~~~~i~g-~~~~~iGr~v~~~~~~~-~~~~v~~i~~~l~~g~~~ 91 (151)
T 2qkp_A 14 GYLSVEQANLILNHLPLEITFVNKDDIFQYYNDSVPAAEMVFK-RTPSQVGRNVELCHPPK-VLDKVKKVFELLRNGQRD 91 (151)
T ss_dssp EEECHHHHHHHHHHSSSEEEEEETTSBEEEECCCSCGGGCSSC-CCGGGTTSBGGGSSCHH-HHHHHHHHHHHHHTTSBS
T ss_pred cEecHHHHHHHHHhCCCceEEEcCCCeEEEEeCCCchhhhhcC-CCHHHcCCCHHHhCCHH-HHHHHHHHHHHHHcCCcc
Confidence 3477889999999999999999999999999999 999999 66789999999887643 344456678888999887
Q ss_pred EEEEEEEcCCCCEEEEEEEEEEEECCCCCEEEEEEEEEchHHHHHHHHHHH
Q 005841 202 TGQFPAKTKTEERVLVVATNTPFYDDDGTLVGIVCVSTDSRPFQETRAALW 252 (674)
Q Consensus 202 ~~e~~~~~kdG~~~~v~~s~sPi~d~dG~ivg~i~i~rDITe~k~~e~~L~ 252 (674)
..+++....+ ...++.++..||+|++|+++|++.+++|||+.++++++..
T Consensus 92 ~~~~~~~~~~-~~~~v~v~~~Pi~d~~G~~~G~vev~~Dit~l~~le~~r~ 141 (151)
T 2qkp_A 92 KVNMWFQSER-LGKFVYVTYAAVRDQAGDFQGVLEYVQDIKPFFELDSEFN 141 (151)
T ss_dssp EEEEEEEETT-TTEEEEEEEEEEECTTCCEEEEEEEEEECGGGGGGGGC--
T ss_pred EEEEEEecCC-CCeEEEEEEEEEECCCCCEEEEEEEEEECHHHHhhhhhhh
Confidence 7776664332 1245688999999989999999999999999988776543
|
| >3ewk_A Sensor protein; PAS domain, alpha/beta fold, kinase, phosphoprotein, transfe flavoprotein; HET: FAD; 2.34A {Methylococcus capsulatus} | Back alignment and structure |
|---|
Probab=99.54 E-value=4.9e-14 Score=140.58 Aligned_cols=111 Identities=23% Similarity=0.336 Sum_probs=103.0
Q ss_pred HHHHHHHHHhcceeEEEcCCCcEEeecHHHHHHhCCChhhHcCCCccccccccccchhHHHHHHHHHhCceeEEEEEEEc
Q 005841 130 RQYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGERWTGQFPAKT 209 (674)
Q Consensus 130 ~~l~~ilds~~d~I~v~D~~GrIi~~N~a~e~llGys~eEviG~~~~~l~~~~~~~~~~~~i~~~l~~g~~~~~e~~~~~ 209 (674)
+.++.++++++++|+++|.+|+|+++|+++++++||+.+|++|+++..+.++.........+++.+..|+.|.+++...+
T Consensus 111 ~~~~~~~~~~~~~i~~~d~~g~i~~~N~~~~~~~G~~~~e~~g~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~ 190 (227)
T 3ewk_A 111 ARLKQAMDANSEMILLTDRAGRIIYANPALCRFSGMAEGELLGQSPSILDSPLADQETLAAMQEALQAGQPWSGRLLNRR 190 (227)
T ss_dssp HHHHHHHHTCCSEEEEECTTSCEEEECHHHHHHHTCCTHHHHSSCGGGGBCTTSCHHHHHHHHHHHHHTCCEECCEEEEE
T ss_pred HHHHHHHhcCcCeEEEEcCCCcEEEEchHHHHHhCCCHHHHcCCChhhccCCCCCHHHHHHHHHHHHcCCceeEEEEEEC
Confidence 35778899999999999999999999999999999999999999999888877777777788889999999999999999
Q ss_pred CCCC------EEEEEEEEEEEECCCCCEEEEEEEEEc
Q 005841 210 KTEE------RVLVVATNTPFYDDDGTLVGIVCVSTD 240 (674)
Q Consensus 210 kdG~------~~~v~~s~sPi~d~dG~ivg~i~i~rD 240 (674)
++|. .+|+.++++|++|.+|.+++++++++|
T Consensus 191 k~G~~~~dg~~~~~~~~~~pi~d~~g~~~~~v~i~~D 227 (227)
T 3ewk_A 191 RTGPAPHDAEDYWAEISTTPIHTDGNGLVGYVQIQHD 227 (227)
T ss_dssp ECCSSSSCEEEEEEEEEEEEEECSSSCEEEEEEEEEC
T ss_pred CCCCcCcccceEEEEEEEEEEECCCCCEEEEEEEecC
Confidence 9987 899999999999999999999999998
|
| >3icy_A Sensor protein; sensory box histidine kinase/response regulator domain, kinase, chlorobium tepidum TLS, PSI-2; 2.68A {Chlorobaculum tepidum} | Back alignment and structure |
|---|
Probab=99.54 E-value=1.1e-14 Score=127.03 Aligned_cols=115 Identities=11% Similarity=0.119 Sum_probs=102.3
Q ss_pred cHHHHHHHHHHhcceeEEEcCCCcEEeecHHHHHHhCCChhhHcCCCc--cccccccccchhHHHHHHHHHhCceeEEEE
Q 005841 128 TDRQYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDA--IELLTDGRDFDVAYDIVHRIKMGERWTGQF 205 (674)
Q Consensus 128 se~~l~~ilds~~d~I~v~D~~GrIi~~N~a~e~llGys~eEviG~~~--~~l~~~~~~~~~~~~i~~~l~~g~~~~~e~ 205 (674)
++++|+.++++++++|+++|.+|+++++|+++++++||+.++++|... .+++++++.......+...+..+..+..++
T Consensus 2 s~~~~~~l~~~~~~~i~~~d~~~~~~~~n~~~~~~~G~~~~~~~~~~~~~~~~i~p~d~~~~~~~~~~~~~~~~~~~~e~ 81 (118)
T 3icy_A 2 NAEELQALVDNIPAAIYHLDVSGQATIRFRPPAFLKTLVSEHAGTTRLNTLSMIHHDDRHMLSNAYSKLREAKHSLTLVY 81 (118)
T ss_dssp HHHHHHHHHTTCCCCCEEECTTSCEEECCCCCGGGGGGEEEETTEEEEGGGGGBCGGGHHHHHHHHHHHHHSCCEEEEEE
T ss_pred cHHHHHHHHhcCCceEEEEEcCCCceEEechhHhhcCCCHHHccCChhHHHHHcCHHHHHHHHHHHHHHHhcCCCceEEE
Confidence 467899999999999999999999999999999999999999988753 567777765555556666678888889999
Q ss_pred EEEcCCCCEEEEEEEEEEEECCCCCEEEEEEEEEchH
Q 005841 206 PAKTKTEERVLVVATNTPFYDDDGTLVGIVCVSTDSR 242 (674)
Q Consensus 206 ~~~~kdG~~~~v~~s~sPi~d~dG~ivg~i~i~rDIT 242 (674)
++.+++|..+|+.....|+++++|.+++++++++|||
T Consensus 82 r~~~~~g~~~w~~~~~~~~~~~~g~~~~~~g~~~DIT 118 (118)
T 3icy_A 82 RIVTPEGKLHWIEDHMRSSFSDDGLFSGIDGILCEVT 118 (118)
T ss_dssp EEECTTCCEEEEEEEEEEEECTTSCEEEEEEEEEECC
T ss_pred EEECCCCCEEEEEEEEEEEECCCCCEEEEEEEEEecC
Confidence 9999999999999999999999999999999999997
|
| >3mjq_A Uncharacterized protein; NESG, structural genomics, PSI-2, protein structure initiati northeast structural genomics consortium; 2.60A {Desulfitobacterium hafniense} | Back alignment and structure |
|---|
Probab=99.54 E-value=1.4e-14 Score=127.84 Aligned_cols=121 Identities=13% Similarity=0.158 Sum_probs=87.4
Q ss_pred HHHHHHhcceeEEEcCCCcEEeecHHHHHHhCCChhhHcCCCccccccccccchhHHHHHHHHHhCceeEEEEEEEcCCC
Q 005841 133 LNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGERWTGQFPAKTKTE 212 (674)
Q Consensus 133 ~~ilds~~d~I~v~D~~GrIi~~N~a~e~llGys~eEviG~~~~~l~~~~~~~~~~~~i~~~l~~g~~~~~e~~~~~kdG 212 (674)
+.++++++++|+++|.+|+|+++|+++++++||+.++++|+++.+++++....... ..+..+..+.....++.+.+++|
T Consensus 2 ~~l~~~~~~~i~~~d~~g~i~~~N~~~~~~~g~~~~~~~g~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~g 80 (126)
T 3mjq_A 2 KNFLETIEDMILIINREGRLLYANTAVPKKLGYTHEELMSMHILTITSAGKMAEGE-KILAELFAGKKESLPLSLEKKEG 80 (126)
T ss_dssp CTTGGGCSSEEEEEETTSBEEEECTHHHHHHSCCHHHHHHSBHHHHHCTTCHHHHH-HHHHHHHHTCCSEEEEEEECTTS
T ss_pred hhHHhhCCceEEEEeCCCcEEEEcHHHHHHHCCCHHHHcCCCHHHHcCchhHHHHH-HHHHHHHhCCCceeEEEEEccCC
Confidence 45789999999999999999999999999999999999999999988766543333 33333444444477788889999
Q ss_pred CEEEEEEEEEEEECCCCCEEEEEEEEEchHHHHHHHHHHHHhhh
Q 005841 213 ERVLVVATNTPFYDDDGTLVGIVCVSTDSRPFQETRAALWDTKN 256 (674)
Q Consensus 213 ~~~~v~~s~sPi~d~dG~ivg~i~i~rDITe~k~~e~~L~~la~ 256 (674)
..+|+.++..|+.+ +...+++++++|||+++++++++.....
T Consensus 81 ~~~~~~~~~~~~~~--~~~~~~~~~~~DITe~k~a~~~~~~~~~ 122 (126)
T 3mjq_A 81 TSIPAKARIWQGKW--HNEPCLFAIIKDLSKEERASSPPFLEHH 122 (126)
T ss_dssp CEEEEEEEEEEEES--SSSEEEEEEEEECC--------------
T ss_pred CEEEEEEEEEeeeE--CCceEEEEEEEechHHHHhhcccchhhc
Confidence 99999999998764 3356889999999999999998876644
|
| >3h9w_A Diguanylate cyclase with PAS/PAC sensor; alpha-beta protein., structural genomics, PSI-2, protein STR initiative; 1.90A {Marinobacter aquaeolei} | Back alignment and structure |
|---|
Probab=99.53 E-value=2.5e-14 Score=125.76 Aligned_cols=111 Identities=12% Similarity=0.048 Sum_probs=94.0
Q ss_pred hcceeEEEc-CCCcEEeecHHHHHHhCCChhhHcCCC-ccccccccccchhHHHHHHHHHhCceeEEEEEEEcCCCCEEE
Q 005841 139 MGQSVHIFD-LSDRIIYWNRSAELLYGYSAEEALGQD-AIELLTDGRDFDVAYDIVHRIKMGERWTGQFPAKTKTEERVL 216 (674)
Q Consensus 139 ~~d~I~v~D-~~GrIi~~N~a~e~llGys~eEviG~~-~~~l~~~~~~~~~~~~i~~~l~~g~~~~~e~~~~~kdG~~~~ 216 (674)
++++||.+| .+|+++|+|+++++++||+.++++|.. +.+++++++.......+...+..+..+..++++++++|..+|
T Consensus 2 a~~giw~~d~~~~~~~~~n~~~~~l~G~~~~e~~~~~~~~~~ihpdd~~~~~~~~~~~~~~~~~~~~e~r~~~~dG~~~w 81 (115)
T 3h9w_A 2 TKAIPWKINWQTMAFEYIGPQIEALLGWPQGSWKSVEDWATRMHPEDQEWVVNFCVKQSECGVDHEADYRALHRDGHYVW 81 (115)
T ss_dssp -CCEEEEEETTTTEEEEECTHHHHHHCSCGGGCCBHHHHHHSBCHHHHHHHHHHHHHHHHTTCCEEEEEEEECTTSCEEE
T ss_pred cceEEEEEEcCCCcEEEEChhHHHHhCCChHHccCHHHHHHhcCHHHHHHHHHHHHHHHhcCCcccEEEEEEcCCCCEEE
Confidence 467999999 689999999999999999999999932 345677776555555666777888888999999999999999
Q ss_pred EEEEEEEEECCCCCEEEEEEEEEchHHHHHHHH
Q 005841 217 VVATNTPFYDDDGTLVGIVCVSTDSRPFQETRA 249 (674)
Q Consensus 217 v~~s~sPi~d~dG~ivg~i~i~rDITe~k~~e~ 249 (674)
+..+..|++|++|++++++++..|||++|+.|+
T Consensus 82 ~~~~~~~~~d~~G~~~~~~G~~~Dit~~k~~~~ 114 (115)
T 3h9w_A 82 IRDVVHVVRDDSGEVEALIGFMFDISLEHHHHH 114 (115)
T ss_dssp EEEEEEEEECTTSCEEEEEEEEEECGGGGC---
T ss_pred EEEEEEEEECCCCCEEEEEEEEeccCccccccc
Confidence 999999999999999999999999999998765
|
| >3eeh_A Putative light and redox sensing histidine kinase; structural genomic MCSG, protein structure initiative, midwest center for STRU genomics; HET: PG5; 1.95A {Haloarcula marismortui} | Back alignment and structure |
|---|
Probab=99.52 E-value=3.2e-14 Score=123.85 Aligned_cols=118 Identities=14% Similarity=0.140 Sum_probs=97.9
Q ss_pred cccccHHHHHHHHHHhcceeEEEcCC-CcEEeecHHHHHHhCCChhhHcCCC--ccccccccccchhHHHHHHHHHhCce
Q 005841 124 AFNFTDRQYLNILQSMGQSVHIFDLS-DRIIYWNRSAELLYGYSAEEALGQD--AIELLTDGRDFDVAYDIVHRIKMGER 200 (674)
Q Consensus 124 ~~~~se~~l~~ilds~~d~I~v~D~~-GrIi~~N~a~e~llGys~eEviG~~--~~~l~~~~~~~~~~~~i~~~l~~g~~ 200 (674)
++...++.|+.++++++++|+++|.+ |+|+++|+++++++||+.++++|+. +.+++++++... ....+..+..+..
T Consensus 5 ~l~~~~~~~~~~~~~~~~~i~~~d~~~~~i~~~n~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 83 (125)
T 3eeh_A 5 QAAKSERRVRELTEATNDILWEFTADLSEVLVINSAYEDIWGRSVAKLRENPHDFLNGIHPEDREL-MKDTMQSLMDGES 83 (125)
T ss_dssp -----CHHHHHHHSCCCCEEEEEETTSSCEEEECTHHHHHHSSCHHHHHHCGGGGGGGBCHHHHHH-HHHHHHHHHTTCC
T ss_pred HHHHHHHHHHHHHhcCCceEEEEEcCCCcEEEecHHHHHHHCCCHHHHccCcHHHHHhcCHHHHHH-HHHHHHHHHcCCC
Confidence 34456778999999999999999999 9999999999999999999999987 555665544333 3334444778888
Q ss_pred eEEEEEEEcCCCCEEEEEEEEEEEECCCCCEEEEEEEEEchH
Q 005841 201 WTGQFPAKTKTEERVLVVATNTPFYDDDGTLVGIVCVSTDSR 242 (674)
Q Consensus 201 ~~~e~~~~~kdG~~~~v~~s~sPi~d~dG~ivg~i~i~rDIT 242 (674)
+..++.+.+++|..+|+.++..|+++++|.+.+++++++|||
T Consensus 84 ~~~e~~~~~~~g~~~~~~~~~~~~~~~~g~~~~~~~~~~DIT 125 (125)
T 3eeh_A 84 ADVECRVNATEEYQRWVWIQGEPITNDAGETVRVAGFARDIT 125 (125)
T ss_dssp EEEEEEECGGGTTCEEEEEEEEEEECTTSCEEEEEEEEEECC
T ss_pred ccEEEEEEcCCCCEEEEEEecEEEECCCCCEEEEEEEEEecC
Confidence 888999999999999999999999999999999999999997
|
| >3vol_A Aerotaxis transducer AER2; heme, oxygen sensor protein, PAS, HAMP, cyanoMet, CN-bound, protein; HET: HEM; 2.40A {Pseudomonas aeruginosa} | Back alignment and structure |
|---|
Probab=99.52 E-value=6e-14 Score=141.48 Aligned_cols=121 Identities=13% Similarity=0.146 Sum_probs=96.0
Q ss_pred cccHHHHHHHHHHhcceeEEEcCCCcEEeecHHHHHHh------------CCChhhHcCCCccccccccccchhHHHHHH
Q 005841 126 NFTDRQYLNILQSMGQSVHIFDLSDRIIYWNRSAELLY------------GYSAEEALGQDAIELLTDGRDFDVAYDIVH 193 (674)
Q Consensus 126 ~~se~~l~~ilds~~d~I~v~D~~GrIi~~N~a~e~ll------------Gys~eEviG~~~~~l~~~~~~~~~~~~i~~ 193 (674)
.....++..+|++++++|+++|.+|+|+|+|++|++++ ||+.++++|+++.++++.+. ....++.
T Consensus 18 ~~e~~~l~~iLd~~~~~vii~D~~g~I~~~N~a~~~ll~~~~~~~~~~l~G~~~~eliG~~~~~~~~~~~---~~~~~~~ 94 (233)
T 3vol_A 18 GSHMARIKSALDNVSANVMIADNDLNIIYMNRTVSEMLGRAEADIRKQLPNFDAGRLMGANIDVFHKNPA---HQRHLLA 94 (233)
T ss_dssp CTHHHHHHHHHTTSSSEEEEEETTSBEEEECHHHHHHHHHTHHHHHTTCTTCCTTSCTTCBGGGGSSSHH---HHHHHHH
T ss_pred HHHHHHHHHHHhcCCCcEEEECCCCcEEEecHHHHHHHHHHHHHHHhhcCCCCHHHHcCCCHHHHcCCHH---HHHHHHH
Confidence 34556899999999999999999999999999999999 89999999999988876432 2222333
Q ss_pred HHHhCceeEEEEEEEcCCCCEEEEEEEEEEEECCCCCEEEEEEEEEchHHHHHHHHHHHHhhh
Q 005841 194 RIKMGERWTGQFPAKTKTEERVLVVATNTPFYDDDGTLVGIVCVSTDSRPFQETRAALWDTKN 256 (674)
Q Consensus 194 ~l~~g~~~~~e~~~~~kdG~~~~v~~s~sPi~d~dG~ivg~i~i~rDITe~k~~e~~L~~la~ 256 (674)
.+. ..+..++. .+| .|+.++++|++|++|+++|++++++|||+++++++++.+++.
T Consensus 95 ~~~--~~~~~~~~---~~g--~~~~~~~~Pi~d~~G~~~g~v~~~~DITe~~~~e~ei~~l~~ 150 (233)
T 3vol_A 95 NLT--GVHKAELN---LGG--RRFSLDVVPVFNDANERLGSAVQWTDRTEEHRAEQEVSQLVQ 150 (233)
T ss_dssp TCC--SCEEEEEE---ETT--EEEEEEEEEEECTTCCEEEEEEEEEECHHHHHHHHHHHHHHH
T ss_pred hcc--cceeEEEE---ECC--EEEEEEEEEEECCCCCEEEEEEEEehhhHHHHHHHHHHHHHH
Confidence 221 23444433 245 367899999999999999999999999999999998876644
|
| >3olo_A Two-component sensor histidine kinase; structural genomics, PSI-2, protein structure initiative, MI center for structural genomics, MCSG, TRA; 2.09A {Nostoc SP} | Back alignment and structure |
|---|
Probab=99.52 E-value=1.2e-13 Score=120.44 Aligned_cols=109 Identities=13% Similarity=0.063 Sum_probs=90.6
Q ss_pred ccHHHHHHHHHHhcceeEEEcCCCcEEeecHHHHHHhCCChhhHcCCCccccccccccchhHHHHHHHHHhCceeEEEEE
Q 005841 127 FTDRQYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGERWTGQFP 206 (674)
Q Consensus 127 ~se~~l~~ilds~~d~I~v~D~~GrIi~~N~a~e~llGys~eEviG~~~~~l~~~~~~~~~~~~i~~~l~~g~~~~~e~~ 206 (674)
...+.++.++++++++|+++|.+|+|++||+++++++||+.++++|+++.++++...... +..+..+..+..+..
T Consensus 10 ~~~~~~~~~~~~~~~~i~~~d~~g~i~~~N~~~~~l~G~~~~el~g~~~~~~~~~~~~~~-----~~~~~~~~~~~~e~~ 84 (118)
T 3olo_A 10 LEFKFAHYLINNAVEASFCLGDNWQFLYVNDATCRMTEYSREQLLSMNLQDIDVDFALHD-----WEEIRQKNNYTFKTR 84 (118)
T ss_dssp HHHHHHHHHHHHCSSEEEEECTTSBEEEECHHHHHHHCCCHHHHTTCBGGGTBTTGGGSC-----HHHHHHHSEEEEEEE
T ss_pred HHHHHHHHHHhcCCceEEEECCCCcEEEEHHHHHHHHCCCHHHHhCCChhhcccccCHHH-----HHHHHhcCcEEEEEE
Confidence 345678899999999999999999999999999999999999999999998886543222 344555667888889
Q ss_pred EEcCCCCEEEEEEEEEEEECCCCCEEEEEEEEEchH
Q 005841 207 AKTKTEERVLVVATNTPFYDDDGTLVGIVCVSTDSR 242 (674)
Q Consensus 207 ~~~kdG~~~~v~~s~sPi~d~dG~ivg~i~i~rDIT 242 (674)
+.+++|..+|+.++..|+.+. | ..+++++++|||
T Consensus 85 ~~~~~g~~~~~~~~~~~~~~~-~-~~~~~~~~~DIT 118 (118)
T 3olo_A 85 YRSQSGRIFLVEMSLTFLEDQ-E-RRFSCVFVREKS 118 (118)
T ss_dssp EECTTCCEEEEEEEEEEEEET-T-EEEEEEEEEEC-
T ss_pred EEccCCCEEEEEEEEEEEEEC-C-ccEEEEEEEeCC
Confidence 999999999999999999764 3 346789999997
|
| >1v9y_A Heme PAS sensor protein; signaling protein; HET: HEM; 1.32A {Escherichia coli} SCOP: d.110.3.2 PDB: 1v9z_A* 1vb6_A* 1s67_L* 1s66_L* | Back alignment and structure |
|---|
Probab=99.52 E-value=4.9e-14 Score=130.69 Aligned_cols=127 Identities=15% Similarity=0.222 Sum_probs=86.1
Q ss_pred ccHHHHHHHHHHhcceeEEEcCCCcEEeecHHHHHHhCCChhhHcCCCccccccccccchhHHHHHHHHHhCce----eE
Q 005841 127 FTDRQYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGER----WT 202 (674)
Q Consensus 127 ~se~~l~~ilds~~d~I~v~D~~GrIi~~N~a~e~llGys~eEviG~~~~~l~~~~~~~~~~~~i~~~l~~g~~----~~ 202 (674)
..+..|..+++.++++|+++|.+|+|++||+++++++||+.++++|+++.+++++.........+......+.. +.
T Consensus 37 ~~~~~~~~~l~~~~~~i~~~d~~g~i~~~N~~~~~l~g~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 116 (167)
T 1v9y_A 37 AADGIFFPALEQNMMGAVLINENDEVMFFNPAAEKLWGYKREEVIGNNIDMLIPRDLRPAHPEYIRHNREGGKARVEGMS 116 (167)
T ss_dssp ---CCHHHHHHTCSSEEEEECTTSBEEEECHHHHHHHSCCGGGTTTSBGGGGSCGGGTTTHHHHHHHHHC----------
T ss_pred hhhHHHHHHHHhCCCCEEEECCCCcEEEECHHHHHHhCCCHHHHcCCChhhccCccccchHHHHHHHHhhcCCCcccccc
Confidence 44556999999999999999999999999999999999999999999999888766544433333333333322 44
Q ss_pred EEEEEEcCCCCEEEEEEEEEEEECCCCCEEEEEEEEEchHHHHHHHHHHHHhh
Q 005841 203 GQFPAKTKTEERVLVVATNTPFYDDDGTLVGIVCVSTDSRPFQETRAALWDTK 255 (674)
Q Consensus 203 ~e~~~~~kdG~~~~v~~s~sPi~d~dG~ivg~i~i~rDITe~k~~e~~L~~la 255 (674)
.++.+..++|..+|+.++..|+ +.+|.+ +++++++|||++++++++|++++
T Consensus 117 ~~~~~~~~~g~~~~~~~~~~~~-~~~g~~-~~~~~~~DiT~~~~~e~~l~~la 167 (167)
T 1v9y_A 117 RELQLEKKDGSKIWTRFALSKV-SAEGKV-YYLALVRDASVEMAQKEQTRQLI 167 (167)
T ss_dssp CEEEEECTTSCEEEEEEEEEEE-EETTEE-EEEEEEEC---------------
T ss_pred eEEEEEcCCCcEEEEEEEEEEE-ecCCCE-EEEEEEecCcHHHHHHHHHHhhC
Confidence 5677889999999999999999 446665 48999999999999999887763
|
| >2l0w_A Potassium voltage-gated channel, subfamily H (EAG member 2, isoform CRA_B; HERG, PAS domain, voltage-gated potassium channel, membrane; NMR {Homo sapiens} PDB: 2l1m_A 2l4r_A | Back alignment and structure |
|---|
Probab=99.49 E-value=2.9e-13 Score=119.91 Aligned_cols=112 Identities=16% Similarity=0.174 Sum_probs=93.6
Q ss_pred HHHHHHHhcceeEEEcC---CCcEEeecHHHHHHhCCChhhHcCCCc-cc-cccccccchhHHHHHHHHHhCceeEEEEE
Q 005841 132 YLNILQSMGQSVHIFDL---SDRIIYWNRSAELLYGYSAEEALGQDA-IE-LLTDGRDFDVAYDIVHRIKMGERWTGQFP 206 (674)
Q Consensus 132 l~~ilds~~d~I~v~D~---~GrIi~~N~a~e~llGys~eEviG~~~-~~-l~~~~~~~~~~~~i~~~l~~g~~~~~e~~ 206 (674)
+...++.++++|+++|. +|+|+++|+++++++||+.++++|+++ .. +.++.........+...+..+..+..++.
T Consensus 21 ~~~~~~~~~~~i~~~d~~~~~g~i~~~N~~~~~l~g~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 100 (138)
T 2l0w_A 21 IIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQRRAAAQIAQALLGAEERKVEIA 100 (138)
T ss_dssp HHHHHTTTTSEEEEEESSSTTCBEEEECSHHHHHHSCCHHHHTTSBTTCGGGCCTTCCHHHHHHHHHHTTCSSCEEEEEE
T ss_pred HHHHHhcCCCCEEEEecCCCCCEEEEeCHHHHHHhCCCHHHHcCCCCcccccCCcccchhHHHHHHHHHhhcCCceeEEE
Confidence 44455569999999999 999999999999999999999999983 44 44444434444556666777777888888
Q ss_pred EEcCCCCEEEEEEEEEEEECCCCCEEEEEEEEEchHH
Q 005841 207 AKTKTEERVLVVATNTPFYDDDGTLVGIVCVSTDSRP 243 (674)
Q Consensus 207 ~~~kdG~~~~v~~s~sPi~d~dG~ivg~i~i~rDITe 243 (674)
..+++|..+|+.++..|+++.+|.+.+++++++|||+
T Consensus 101 ~~~~~g~~~~~~~~~~~~~~~~g~~~~~~~~~~Dit~ 137 (138)
T 2l0w_A 101 FYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVME 137 (138)
T ss_dssp EECTTSCEEEEEEEEEEEECTTSCEEEEEEEEEEEEE
T ss_pred EECCCCCEEEEEEEEEEEeCCCCCEEEEEEEEEeccC
Confidence 8899999999999999999999999999999999986
|
| >2kdk_A ARYL hydrocarbon receptor nuclear translocator-LI 2; circadian clock, PAS domain, transcription, activator, biolo rhythms, DNA-binding, nucleus; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.48 E-value=1.5e-13 Score=121.39 Aligned_cols=111 Identities=18% Similarity=0.215 Sum_probs=92.3
Q ss_pred HHHHHhcceeEEEcCCCcEEeecHHHHHHhCCChhhHcCCCccccccccccchhHHHHHHHHHh-CceeEEEEEEEcCCC
Q 005841 134 NILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKM-GERWTGQFPAKTKTE 212 (674)
Q Consensus 134 ~ilds~~d~I~v~D~~GrIi~~N~a~e~llGys~eEviG~~~~~l~~~~~~~~~~~~i~~~l~~-g~~~~~e~~~~~kdG 212 (674)
.++++++++|+++|.+|+|+|+|+++++++||+.+|++|+.+.+++++++.......+...+.. +.....++++.+++|
T Consensus 7 ~~~~~~~~~i~~~d~~g~i~~~N~~~~~~~G~~~~el~g~~~~~~~~p~d~~~~~~~~~~~~~~~~~~~~~e~r~~~~dG 86 (121)
T 2kdk_A 7 EINVKPTEFITRFAVNGKFVYVDQRATAILGYLPQELLGTSCYEYFHQDDHNNLTDKHKAVLQSKEKILTDSYKFRAKDG 86 (121)
T ss_dssp CCCCCSSEEEEEECTTSBEEEECTHHHHHTCCCTTTSBTSBTTTTBCSSSHHHHHHHHHHHHTSSSCEEEEEEEEECSSS
T ss_pred ccccCCccEEEEECCCeeEEEEChhHHHHHCCCHHHHcCCcHHHeeCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCC
Confidence 3677889999999999999999999999999999999999999988876654444444444554 344677889999999
Q ss_pred CEEEEEEEEEEEECCC-CCEEEEEEEEEchHHH
Q 005841 213 ERVLVVATNTPFYDDD-GTLVGIVCVSTDSRPF 244 (674)
Q Consensus 213 ~~~~v~~s~sPi~d~d-G~ivg~i~i~rDITe~ 244 (674)
..+|+.++..|++|.+ +.+.+++++.+||++.
T Consensus 87 ~~~~~~~~~~~~~d~~~~~~~~~v~~~~~i~~~ 119 (121)
T 2kdk_A 87 SFVTLKSQWFSFTNPDTKELEYIVSVNTLVLGH 119 (121)
T ss_dssp CEEEEEEEEEEEECCSSSCEEEEEEEEECCSSC
T ss_pred CEEEEEEEEEEEECCCCCeeeEEEEEEEecccc
Confidence 9999999999999875 5677788999999864
|
| >1byw_A Protein (human ERG potassium channel); PAS domain, potassium channel domain, membrane protein; 2.60A {Homo sapiens} SCOP: d.110.3.6 | Back alignment and structure |
|---|
Probab=99.46 E-value=7.5e-13 Score=111.84 Aligned_cols=103 Identities=17% Similarity=0.189 Sum_probs=87.4
Q ss_pred ceeEEEcC---CCcEEeecHHHHHHhCCChhhHcCCCc-ccccc-ccccchhHHHHHHHHHhCceeEEEEEEEcCCCCEE
Q 005841 141 QSVHIFDL---SDRIIYWNRSAELLYGYSAEEALGQDA-IELLT-DGRDFDVAYDIVHRIKMGERWTGQFPAKTKTEERV 215 (674)
Q Consensus 141 d~I~v~D~---~GrIi~~N~a~e~llGys~eEviG~~~-~~l~~-~~~~~~~~~~i~~~l~~g~~~~~e~~~~~kdG~~~ 215 (674)
++|+++|. +|+|+++|+++++++||+.++++|+++ ..++. +.........+...+..+..+..++...+++|..+
T Consensus 2 ~~i~i~d~~~~~g~i~~~N~~~~~~~g~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~ 81 (110)
T 1byw_A 2 RKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPCTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCF 81 (110)
T ss_dssp CEEEEEETTSSSCBEEEECHHHHHHHTCCHHHHTTSBTTCGGGCCTTCCHHHHHHHHHHHHTTCCEEEEEEEECTTSCEE
T ss_pred CCEEEEeccCCCCcEEEECHHHHHHhCCCHHHHccCCCccccccCCcCCHHHHHHHHHHHhcCCCceEEEEEEcCCCCEE
Confidence 57899997 599999999999999999999999982 44444 43334445566677788888888888899999999
Q ss_pred EEEEEEEEEECCCCCEEEEEEEEEchHH
Q 005841 216 LVVATNTPFYDDDGTLVGIVCVSTDSRP 243 (674)
Q Consensus 216 ~v~~s~sPi~d~dG~ivg~i~i~rDITe 243 (674)
|+.++..|+++.+|.+.+++++++|||+
T Consensus 82 ~~~~~~~~~~~~~g~~~~~~~~~~DiTe 109 (110)
T 1byw_A 82 LCLVDVVPVKNEDGAVIMFILNFEVVME 109 (110)
T ss_dssp EEEEEEEEEECTTCCEEEEEEEEEEEEE
T ss_pred EEEEEEEEeecCCCCEEEEEEEEEeccC
Confidence 9999999999999999999999999986
|
| >4hi4_A Aerotaxis transducer AER2; PAS domain, diatomic GAS sensor, signaling protein; HET: HEM GOL; 2.30A {Pseudomonas aeruginosa} | Back alignment and structure |
|---|
Probab=99.45 E-value=3.6e-13 Score=120.37 Aligned_cols=105 Identities=16% Similarity=0.223 Sum_probs=80.7
Q ss_pred HHHHHHHHHhcceeEEEcCCCcEEeecHHHHHHhC------------CChhhHcCCCccccccccccchhHHHHHHHHHh
Q 005841 130 RQYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYG------------YSAEEALGQDAIELLTDGRDFDVAYDIVHRIKM 197 (674)
Q Consensus 130 ~~l~~ilds~~d~I~v~D~~GrIi~~N~a~e~llG------------ys~eEviG~~~~~l~~~~~~~~~~~~i~~~l~~ 197 (674)
.+++++|++++++|+++|.+|+|+|+|++|++++| |+.++++|+++.++++.+. ....++....
T Consensus 5 ~rl~~il~~~~~gviv~D~~g~I~~~N~a~~~llg~~~~~i~~~~~g~~~~~~~G~~~~~~~~~~~---~~~~~~~~~~- 80 (121)
T 4hi4_A 5 ARIASALDNVSANVMIADNDLNIIYMNRTVSEMLGRAEADIRKQLPNFDAGRLMGANIDVFHKNPA---HQRHLLANLT- 80 (121)
T ss_dssp HHHHHHHTTSSSEEEEEETTCBEEEECHHHHHHHHHTHHHHHHHCTTCCGGGCTTCBGGGGCSSHH---HHHHHHHHCS-
T ss_pred HHHHHHHhcCCccEEEEcCCCeEEEecHHHHHHHHHHHHHHHHhcCCCChHHhcCCCHHHhcCCHH---HHHHHHhCcC-
Confidence 57999999999999999999999999999999995 8999999999988876432 1122222221
Q ss_pred CceeEEEEEEEcCCCCEEEEEEEEEEEECCCCCEEEEEEEEEchHHH
Q 005841 198 GERWTGQFPAKTKTEERVLVVATNTPFYDDDGTLVGIVCVSTDSRPF 244 (674)
Q Consensus 198 g~~~~~e~~~~~kdG~~~~v~~s~sPi~d~dG~ivg~i~i~rDITe~ 244 (674)
..+..++.. +|. ++.++++|++|++|+++|++++++|||++
T Consensus 81 -~~~~~~~~~---~~~--~~~~~~~pi~~~~g~~~g~v~~~~DiTee 121 (121)
T 4hi4_A 81 -GVHKAELNL---GGR--RFSLDVVPVFNDANARLGSAVQWTDRTEE 121 (121)
T ss_dssp -SCEEEEEEE---TTE--EEEEEEEEEECTTSCEEEEEEEEEECC--
T ss_pred -CCcEEEEEE---CCE--EEEEEEEEEECCCCCEEEEEEEEEEecCC
Confidence 234443332 443 45789999999999999999999999974
|
| >3d72_A Vivid PAS protein VVD; circadian, photoreceptor, blue-light, LOV, signaling protein; HET: FAD; 1.65A {Neurospora crassa} PDB: 3is2_A* 2pd8_A* 3hjk_A* 2pdr_A* 2pd7_A* 2pdt_A* 3hji_A* 3rh8_B* | Back alignment and structure |
|---|
Probab=99.45 E-value=4.7e-13 Score=122.68 Aligned_cols=105 Identities=17% Similarity=0.205 Sum_probs=92.6
Q ss_pred HHHHhcceeEEEc---CCCcEEeecHHHHHHhCCChhhHcCCCccccccccc-----------cchhHHHHHHHHHhCce
Q 005841 135 ILQSMGQSVHIFD---LSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGR-----------DFDVAYDIVHRIKMGER 200 (674)
Q Consensus 135 ilds~~d~I~v~D---~~GrIi~~N~a~e~llGys~eEviG~~~~~l~~~~~-----------~~~~~~~i~~~l~~g~~ 200 (674)
++++ +++|+++| .+|+|++||+++++++||+.+|++|+++.+++++.. .......+...+..+..
T Consensus 31 ~~~~-~~~i~~~d~~d~~g~i~~~N~a~~~l~G~~~~el~g~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 109 (149)
T 3d72_A 31 PVDT-SVALILCDLKQKDTPIVYASEAFLYMTGYSNAEVLGRNCRFLQSPDGMVKPKSTRKYVDSNTINTMRKAIDRNAE 109 (149)
T ss_dssp SCCT-TSCEEEEETTSTTCCEEEECHHHHHHHCCCHHHHTTSCGGGGGSTTSCCCTTCCCSSSCHHHHHHHHHHHHHTCC
T ss_pred hhcC-CccEEEEeccCCCCcEEEECHHHHHHHCcCHHHHcCCChhHhCCccccccccccccccChHHHHHHHHHHHCCCc
Confidence 4556 48999999 799999999999999999999999999988877653 45555667778888888
Q ss_pred eEEEEEEEcCCCCEEEEEEEEEEEECCCCCEEEEEEEEEc
Q 005841 201 WTGQFPAKTKTEERVLVVATNTPFYDDDGTLVGIVCVSTD 240 (674)
Q Consensus 201 ~~~e~~~~~kdG~~~~v~~s~sPi~d~dG~ivg~i~i~rD 240 (674)
+..++...+++|..+|+.++.+|+++++|++.+++++++|
T Consensus 110 ~~~e~~~~~~dG~~~~~~~~~~~i~~~~g~~~~~v~~~~D 149 (149)
T 3d72_A 110 VQVEVVNFKKNGQRFVNFLTMIPVRDETGEYRYSMGFQCE 149 (149)
T ss_dssp EEEEEEEECTTCCEEEEEEEEEEEECTTSSEEEEEEECCC
T ss_pred eEEEEEEECCCCCEEEEEEEEEEEEcCCCCEEEEEEEEeC
Confidence 9999999999999999999999999999999999999887
|
| >3mfx_A Sensory BOX/ggdef family protein; alpha-beta protein, structural genomics, PSI-2, protein structure initiative; 2.40A {Shewanella oneidensis} | Back alignment and structure |
|---|
Probab=99.45 E-value=3.7e-13 Score=122.92 Aligned_cols=111 Identities=14% Similarity=0.074 Sum_probs=84.1
Q ss_pred HHHHHHHHHhcceeEEEcCCCcEEeecHHHHHHhCCChhhHcCCCccccccccccchhHHHHHHHHHhCc-------eeE
Q 005841 130 RQYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGE-------RWT 202 (674)
Q Consensus 130 ~~l~~ilds~~d~I~v~D~~GrIi~~N~a~e~llGys~eEviG~~~~~l~~~~~~~~~~~~i~~~l~~g~-------~~~ 202 (674)
..+.+++++++++|+++|.+|+|+++|+++++++||+.++++|+++.+++++.........+......+. .+.
T Consensus 7 ~~l~~i~~~~~d~i~~~D~~g~I~~~N~aa~~l~G~~~~el~G~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 86 (129)
T 3mfx_A 7 ETIELFIQHLTEAMILVNANGFIRSCNQRSAELLDCPQVSLKGQDWRNFLTEHHQARYDNLLSHDVQLGTNCGQPVQHPA 86 (129)
T ss_dssp HHHHHHHTTCSSEEEEEETTSBEEEECHHHHHHTTSCHHHHTTSBGGGGBCTTCCGGGGCTTC----------CCSCEEE
T ss_pred HHHHHHHhcCCceEEEECCCCEEEeEhHHHHHHHCcCHHHHcCCcHHHHcChHhHHHHHHHHHHHHhcCcccccccCCCc
Confidence 5689999999999999999999999999999999999999999999999887653321111111112222 245
Q ss_pred EEEEEEcCCCCEEEEEEEEEEEECCCCCEEEEEEEEEchHH
Q 005841 203 GQFPAKTKTEERVLVVATNTPFYDDDGTLVGIVCVSTDSRP 243 (674)
Q Consensus 203 ~e~~~~~kdG~~~~v~~s~sPi~d~dG~ivg~i~i~rDITe 243 (674)
.++.+.++||..+|++++++|+.+ ++. -++++++|+..
T Consensus 87 ~E~~~~rkdG~~~~velsis~i~~-~~~--~~v~~~~~~~~ 124 (129)
T 3mfx_A 87 QETTLICASGKAKDVELSISYIPG-HEP--MFVMVMHDLEH 124 (129)
T ss_dssp EEEEEECTTSCEEEEEEEEEEECS-SSC--EEEEEEEEC--
T ss_pred eEEEEEcCCCCEEEEEEEEEEecC-CCc--EEEEEEechhh
Confidence 788899999999999999999973 332 25788899754
|
| >3bwl_A Sensor protein; structural genomics, APC87707.1, PAS domain, HTR-like protei protein structure initiative; HET: MSE I3A; 1.73A {Haloarcula marismortui atcc 43049} | Back alignment and structure |
|---|
Probab=99.44 E-value=7.2e-13 Score=117.77 Aligned_cols=113 Identities=13% Similarity=0.113 Sum_probs=84.8
Q ss_pred ccccHHHHHHHHHHhcceeEEEcCCCcEEeecHHHHHHhCCChhhH--cCCCccccccccccchhHHHHHHHHHhCceeE
Q 005841 125 FNFTDRQYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEA--LGQDAIELLTDGRDFDVAYDIVHRIKMGERWT 202 (674)
Q Consensus 125 ~~~se~~l~~ilds~~d~I~v~D~~GrIi~~N~a~e~llGys~eEv--iG~~~~~l~~~~~~~~~~~~i~~~l~~g~~~~ 202 (674)
+..+++.|+.++++++++|+++|.+|+|++||+++++++||+.+|+ +|+++.++++ +. ......+.....+....
T Consensus 12 L~~~~~~~~~l~e~~~~~i~~~d~~g~i~~~N~a~~~~~G~~~~el~g~g~~~~~~~~--~~-~~~~~~~~~~~~~~~~~ 88 (126)
T 3bwl_A 12 LEETSSRLEALFENSPDMIDVLDADGTICEVNQRFCAELGYDESEVLGRSIWEFDLMF--DA-EDVQTQLSGFSVDERRK 88 (126)
T ss_dssp HHHHHHHHHHHHHHCSSEEEEECTTCBEEEECHHHHHHHTCCGGGTTTSBGGGTBTTC--CH-HHHHHHHHTCCTTCEEE
T ss_pred HHHHHHHHHHHHhhCCcEEEEEcCCCCEEEEcHHHHHHhCCCHHHHhhCCCchhhccC--CH-HHHHHHHHHHhcCCCcc
Confidence 4456778999999999999999999999999999999999999999 5677777766 21 11111111122344455
Q ss_pred EEEEEEcCCCCEEEEEEEEEEEECCCCCEEEEEEEEEchH
Q 005841 203 GQFPAKTKTEERVLVVATNTPFYDDDGTLVGIVCVSTDSR 242 (674)
Q Consensus 203 ~e~~~~~kdG~~~~v~~s~sPi~d~dG~ivg~i~i~rDIT 242 (674)
.+..+.+++|..+|+.++..|+.+ +|. .+++++++|||
T Consensus 89 ~e~~~~~~dG~~~~~~~~~~~~~~-~~~-~~~~~~~~DIT 126 (126)
T 3bwl_A 89 FEGLYERRDGSTMSVEVHLLRFNL-EGE-DRFLAISRDIT 126 (126)
T ss_dssp EEEEEECTTSCEEEEEEEEEEEEE-TTE-EEEEEEEEEC-
T ss_pred eEEEEEeCCCCEEEEEEEeEEEec-CCc-EEEEEEEEeCC
Confidence 566778999999999999888753 454 35788999997
|
| >3b33_A Sensor protein; structural genomics, PAS domain, nitrogen regulation protein APC91440.4, PSI-2; HET: MSE; 1.83A {Vibrio parahaemolyticus rimd 2210633} | Back alignment and structure |
|---|
Probab=99.40 E-value=1.2e-12 Score=114.59 Aligned_cols=107 Identities=18% Similarity=0.148 Sum_probs=86.9
Q ss_pred HHHHHHHHhcceeEEEcCCCcEEeecHHHHHHhCCChhhHcCCCccccccccccchhHHHHHHHHHhCcee-EEEEEEEc
Q 005841 131 QYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGERW-TGQFPAKT 209 (674)
Q Consensus 131 ~l~~ilds~~d~I~v~D~~GrIi~~N~a~e~llGys~eEviG~~~~~l~~~~~~~~~~~~i~~~l~~g~~~-~~e~~~~~ 209 (674)
....+|++++++|+++|.+|+|+++|+++++++|++.++++|+++.+++++... ....+...+..+... ..+..+.
T Consensus 8 l~~~il~~~~~~i~~~D~~g~I~~~N~aa~~l~g~~~~~~~g~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~- 84 (115)
T 3b33_A 8 LPSAILNNMVTATLILDDGLAIRYANPAAELLFSQSAKRIVEQSLSQLIQHASL--DLALLTQPLQSGQSITDSDVTFV- 84 (115)
T ss_dssp HHHHHHHHCSSEEEEECTTCBEEEECHHHHHHTTSCHHHHTTCBHHHHCSEEEC--CTHHHHHHHHHCCCEEEEEEEEE-
T ss_pred cHHHHHhhcCceEEEECCCCcEEEECHHHHHHhCCCHHHHhCCCHHHHhCccch--hhHHHHHHHHcCCcccCCceEEe-
Confidence 566799999999999999999999999999999999999999999988765332 122344566667653 3455555
Q ss_pred CCCCEEEEEEEEEEEECCCCCEEEEEEEEEchH
Q 005841 210 KTEERVLVVATNTPFYDDDGTLVGIVCVSTDSR 242 (674)
Q Consensus 210 kdG~~~~v~~s~sPi~d~dG~ivg~i~i~rDIT 242 (674)
++|..+|+.++.+|+++ +|. .+++.+++||+
T Consensus 85 ~~g~~~~~~~~~~pi~~-~g~-~~~l~~~~Di~ 115 (115)
T 3b33_A 85 VDGRPLMLEVTVSPITW-QRQ-LMLLVEMRKID 115 (115)
T ss_dssp ETTEEEEEEEEEEEEEE-TTE-EEEEEEEEEC-
T ss_pred cCCCEEEEEEEEEEeec-CCc-eEEEEEEEeCC
Confidence 78999999999999998 776 68999999985
|
| >3fc7_A HTR-like protein, sensor protein; APC87712.1, HTR-like protein,haloarcula marismortui ATCC 430 structural genomics, PSI-2; 2.65A {Haloarcula marismortui} | Back alignment and structure |
|---|
Probab=99.37 E-value=2.7e-13 Score=119.66 Aligned_cols=107 Identities=11% Similarity=0.109 Sum_probs=76.2
Q ss_pred cHHHHHHHHHHhcceeEEEcCCCcEEeecHHHHHHhCCChhhHcCCCccccccccccchhHHHH-HHHHHhCceeEEEEE
Q 005841 128 TDRQYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDI-VHRIKMGERWTGQFP 206 (674)
Q Consensus 128 se~~l~~ilds~~d~I~v~D~~GrIi~~N~a~e~llGys~eEviG~~~~~l~~~~~~~~~~~~i-~~~l~~g~~~~~e~~ 206 (674)
.+++|+.++++++++|+++|.+|+|+++|+++++++||+.++++|+++.++++ .......... ...+..++..
T Consensus 17 ~~~~~~~i~~~~~~~i~~~d~~g~i~~~N~~~~~~~g~~~~~~~g~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~----- 90 (125)
T 3fc7_A 17 TRKKFESLVSDSPDGIVHLTTNGTILSVNPSMAGRLGADPDTLVGQQLSAVMD-SEAANQRLEAGKSAVENGTAT----- 90 (125)
T ss_dssp ---------CCSCCEEEEEETTSBEEEECHHHHHHHTSCHHHHTTSBGGGSSC-HHHHHHHHHHHHHHHHHTSCE-----
T ss_pred HHHHHHHHHhcCCCeEEEEcCCCeEEEECHHHHHHhCCCHHHHcCccHHHhCC-HHHHHHHHHHHHHHhcCCCeE-----
Confidence 45679999999999999999999999999999999999999999999999883 3222222222 3445566543
Q ss_pred EEcCCCC-EEEEEEEEEEEECCCCCEEEEEEEEEchH
Q 005841 207 AKTKTEE-RVLVVATNTPFYDDDGTLVGIVCVSTDSR 242 (674)
Q Consensus 207 ~~~kdG~-~~~v~~s~sPi~d~dG~ivg~i~i~rDIT 242 (674)
...+|. .+|+.++..|+++ +|...|++++++|||
T Consensus 91 -~~~~~~~~~~~~~~~~p~~~-~~~~~~~~~~~~DIT 125 (125)
T 3fc7_A 91 -RSEDAVGGRHYHNQYIPVDS-HRKSDTFQLVSRDIT 125 (125)
T ss_dssp -EEEEEETTEEEEEEEEESST-TTTTTEEEEEEEECC
T ss_pred -EeEcCCCcEEEEEEEEeEec-CCCeEEEEEEEecCC
Confidence 122344 6888999999876 466789999999997
|
| >3fg8_A Uncharacterized protein RHA05790; PAS domain, structural genomics, PS protein structure initiative, midwest center for structural genomics, MCSG; HET: 3PB; 1.80A {Rhodococcus SP} | Back alignment and structure |
|---|
Probab=99.36 E-value=4e-13 Score=119.38 Aligned_cols=109 Identities=17% Similarity=0.078 Sum_probs=86.9
Q ss_pred cHHHHHHHHHHhcceeEEEcCCCcEEeecHHHHHHhCCChhhHcCCCccccccccccchhHHHHHHHHHhCceeEEEEEE
Q 005841 128 TDRQYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGERWTGQFPA 207 (674)
Q Consensus 128 se~~l~~ilds~~d~I~v~D~~GrIi~~N~a~e~llGys~eEviG~~~~~l~~~~~~~~~~~~i~~~l~~g~~~~~e~~~ 207 (674)
.+..++++|++++++|+++|.+|+|+++|+++++++|++.++++|+++.+++++.........+...+.+|+....++..
T Consensus 10 ~~~~~~~il~~~~~~i~~~D~~g~i~~~N~a~~~l~g~~~~e~~G~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 89 (118)
T 3fg8_A 10 HSSGRENLYFQGGLGFMALDEDLRIIYVNSGCLRHVRRSRDELLGRVVTEVLPETQGSYFDALCRKVLATGREQQTRVDS 89 (118)
T ss_dssp ---CCCCSSSCTTCEEEEECTTCBEEEECHHHHHHHTCCHHHHTTSBHHHHCGGGTTSHHHHHHHHHHHHCCCEEEEEEC
T ss_pred ccchHHHHHhhCCceEEEECCCCeEEEECHHHHHHhCCCHHHHcCCcHHHHcCccchHHHHHHHHHHHHcCCceEEEEEE
Confidence 34567789999999999999999999999999999999999999999999998766555556667788889887764333
Q ss_pred EcCCCCEEEEEEEEEEEECCCCCEEEEEEEEEchHHH
Q 005841 208 KTKTEERVLVVATNTPFYDDDGTLVGIVCVSTDSRPF 244 (674)
Q Consensus 208 ~~kdG~~~~v~~s~sPi~d~dG~ivg~i~i~rDITe~ 244 (674)
...+| .|+.++..|+.+ |++++++|||++
T Consensus 90 ~~~~g--~~~~~~~~p~~~------g~v~~~~DITer 118 (118)
T 3fg8_A 90 LYSPG--MTIEVTAAADSG------ALVVHFRDVTAE 118 (118)
T ss_dssp SSSTT--CEEEEEEEEETT------EEEEEEEECSCC
T ss_pred EcCCC--eEEEEEEEEcCC------cEEEEEEeccCC
Confidence 33356 577888889853 378899999973
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.34 E-value=3.3e-12 Score=130.19 Aligned_cols=143 Identities=15% Similarity=0.036 Sum_probs=113.5
Q ss_pred CCeeEeeeecccCceEEEEEEEcCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCC-CCCeeeEEEEEecCCeEEEEEec
Q 005841 505 EDLTIGEQIGQGSCGTVYHAVWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLR-HPNVLLFMGAVTSPQRLCIVTEF 583 (674)
Q Consensus 505 ~~y~~~~~LG~G~fG~Vy~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~lV~E~ 583 (674)
..|++...++.|+++.||++...+..+++|+........ ...+.+|+.+++.+. +..+.++++++...+..|+||||
T Consensus 14 ~~~~~~~~~~g~s~~~v~~~~~~~~~~vlK~~~~~~~~~--~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~ 91 (263)
T 3tm0_A 14 EKYRCVKDTEGMSPAKVYKLVGENENLYLKMTDSRYKGT--TYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSE 91 (263)
T ss_dssp TTSEEEECCSCCSSSEEEEEECSSCEEEEEEECGGGTTS--TTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEEC
T ss_pred ccceeEeeccCCCCCeEEEEECCCCcEEEEeCCcccCCC--HHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEe
Confidence 568999999999999999998778889999986532111 124778999999885 67788999999988999999999
Q ss_pred CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC----------------------------------------
Q 005841 584 LPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCN---------------------------------------- 623 (674)
Q Consensus 584 ~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~---------------------------------------- 623 (674)
++|.+|.+.+. +......++.+++.+|..||+..
T Consensus 92 i~G~~l~~~~~------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (263)
T 3tm0_A 92 ADGVLCSEEYE------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFK 165 (263)
T ss_dssp CSSEEHHHHCC------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSS
T ss_pred cCCeehhhccC------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccCC
Confidence 99999877531 12233467889999999999810
Q ss_pred -----------------CCeEEccCCCCCEEEcCCCcEEEEecCCcccc
Q 005841 624 -----------------PPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLK 655 (674)
Q Consensus 624 -----------------~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~ 655 (674)
..++|+|++|.|||++.+..+.|+||+.+...
T Consensus 166 ~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~g 214 (263)
T 3tm0_A 166 DPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGRA 214 (263)
T ss_dssp SHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEEE
T ss_pred CHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcccC
Confidence 23899999999999987666789999998653
|
| >3cax_A Uncharacterized protein PF0695; structural genomics, unknown function, PSI-2, protein struct initiative; 2.43A {Pyrococcus furiosus dsm 3638} | Back alignment and structure |
|---|
Probab=99.30 E-value=5.6e-12 Score=135.84 Aligned_cols=122 Identities=16% Similarity=0.305 Sum_probs=101.3
Q ss_pred CcccccHHHHHHHHHHhcceeEEEcCCCcEEeecHHHHHHhCCChhhHcCCCccccccccccchhHHHHHHHHHhCceeE
Q 005841 123 SAFNFTDRQYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGERWT 202 (674)
Q Consensus 123 ~~~~~se~~l~~ilds~~d~I~v~D~~GrIi~~N~a~e~llGys~eEviG~~~~~l~~~~~~~~~~~~i~~~l~~g~~~~ 202 (674)
....+....+.+||++++++|+++|.+|+|+|||++ ++++ ++.++++|+++.+++++.. ....+.+...+.+|+...
T Consensus 232 ~~g~~~~~~l~~IL~~l~dgIivvD~~g~I~~~N~a-e~i~-~~~~e~iGr~v~~~~p~~~-~~~~~~l~~~l~~g~~~~ 308 (369)
T 3cax_A 232 GTGYLNIEELKAIFEALPVDVTFIDKDDRVRFFSPG-ERIF-TRTPSVLGRPVQLCHPPKS-VYVVNKILKAFKEGRKKE 308 (369)
T ss_dssp SSCEECHHHHHHHHHHSSSEEEEECTTSBEEEECCS-SCSS-CCCGGGTTCBTTTSSCGGG-HHHHHHHHHHHHHTSCSC
T ss_pred CcchhhHHHHHHHHHhCCCcEEEECCCCcEEEEcCH-HHcc-CChHHHcCCcHHHHCChhh-HHHHHHHHHHHHcCCceE
Confidence 344477889999999999999999999999999999 9999 9999999999999887532 344456777888898766
Q ss_pred EEEEEEcCCCCEEEEEEEEEEEECCCCCEEEEEEEEEchHHHHHHHHH
Q 005841 203 GQFPAKTKTEERVLVVATNTPFYDDDGTLVGIVCVSTDSRPFQETRAA 250 (674)
Q Consensus 203 ~e~~~~~kdG~~~~v~~s~sPi~d~dG~ivg~i~i~rDITe~k~~e~~ 250 (674)
.++.+. .+| .++.++.+||+|.+|+++|++.+++|||++++++++
T Consensus 309 ~~~~~~-~~g--~~v~v~~~PI~d~~G~~~G~v~v~~DITe~~~le~~ 353 (369)
T 3cax_A 309 ATFWLR-LRE--KYVYIKYVPLFNEKGEYIGTLEMTMDIAPYKKIEGE 353 (369)
T ss_dssp EEEEEE-ETT--EEEEEEEEEEECTTSCEEEEEEEEEECHHHHTCCSC
T ss_pred EEEEEe-eCC--EEEEEEEEEEECCCCCEEEEEEEEEcCHHHHHHHHH
Confidence 555543 345 577889999999999999999999999998876543
|
| >3a0r_A Sensor protein; four helix bundle, PAS fold, kinase, phosphoprotein, transfe two-component regulatory system; 3.80A {Thermotoga maritima} | Back alignment and structure |
|---|
Probab=99.25 E-value=5.2e-13 Score=141.40 Aligned_cols=143 Identities=17% Similarity=0.213 Sum_probs=102.7
Q ss_pred cHHHHHHHHHHhcceeEEEcCCCcEEeecHHHHHHhCCChhhHcCCCccccccccccchhHHHHHHHHHhCceeEEEEEE
Q 005841 128 TDRQYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGERWTGQFPA 207 (674)
Q Consensus 128 se~~l~~ilds~~d~I~v~D~~GrIi~~N~a~e~llGys~eEviG~~~~~l~~~~~~~~~~~~i~~~l~~g~~~~~e~~~ 207 (674)
.+++++.++++++++|+++|.+|+|++||+++++++||+.++++|+++.++.... .....+...+..+.......
T Consensus 6 ~~~~~~~i~~~~~~~i~~~d~~g~i~~~N~a~~~l~G~~~~e~~G~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~-- 80 (349)
T 3a0r_A 6 LRNFSESILESLETAIITLSKDGRITEWNKKAEQLFGLKKENVLGRRLKDLPDFE---EIGSVAESVFENKEPVFLNF-- 80 (349)
T ss_dssp ---CCCSSGGGSSSEEEEEESSSBCSCBCHHHHHHHSCCSTTTTTCBSTTSTTTT---HHHHHHHHHHHHCCCCEEEC--
T ss_pred HHHHHHHHHhhhcCeEEEECCCCCEEeeHHHHHHHhCCCHHHHcCcCHHHCcChh---HHHHHHHHHHhcCCceeecc--
Confidence 3446778999999999999999999999999999999999999999988873322 22233444556666543321
Q ss_pred EcCCCCEEEEEEEEEEEECCCCCE-EEEEEEEEchHHHHHHHHHHHHhhhcCCccCcCCchhHHHHHhcCCccchhhH
Q 005841 208 KTKTEERVLVVATNTPFYDDDGTL-VGIVCVSTDSRPFQETRAALWDTKNSDTDSNINRPRNTVTAKLGLDSQQPLQA 284 (674)
Q Consensus 208 ~~kdG~~~~v~~s~sPi~d~dG~i-vg~i~i~rDITe~k~~e~~L~~la~~d~lt~~nr~~~~~~~kl~~~~~qpl~~ 284 (674)
..+...|+.++..|+++.+|.. .|++++++|||+++++++++.+.... .....+...++|+...||+.
T Consensus 81 --~~~~~~~~~~~~~~~~~~~~~~~~g~~~~~~DiTe~~~~e~~~~~~~~~-------~~~~~~~~~i~Helr~pL~~ 149 (349)
T 3a0r_A 81 --YKFGERYFNIRFSPFRNAKTQLLEGVIITIDDVTELYKYEEERKRRERL-------SILGEMTARVAHEIRNPITI 149 (349)
T ss_dssp --CCBTTBCCEEEEEEECCTTTTSSCEEEEEEECCSTTTTTTTTTTHHHHH-------HHHHHHHHHHHHHHHHHHHH
T ss_pred --cccCceEEEEEEEEEEcCCCceeeEEEEEEEechHHHHHHHHHHHHHHH-------HHHHHHHHHHHHHhcchHHH
Confidence 2223457788999999887765 58999999999999888766543221 12335666677777777766
|
| >2vlg_A Sporulation kinase A; histidine kinase, two-component regulatory system, two-component signal transduction, transferase, phosphorylation, SCOD; 1.7A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=99.25 E-value=1.4e-11 Score=109.42 Aligned_cols=92 Identities=21% Similarity=0.167 Sum_probs=68.7
Q ss_pred HHHHHhcceeEEEcCCCcEEeecHHHHHHhCCChhhHcCCCccccccccccchhHHHHHHHHH-hCceeEEEEEEEcCCC
Q 005841 134 NILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIK-MGERWTGQFPAKTKTE 212 (674)
Q Consensus 134 ~ilds~~d~I~v~D~~GrIi~~N~a~e~llGys~eEviG~~~~~l~~~~~~~~~~~~i~~~l~-~g~~~~~e~~~~~kdG 212 (674)
.+|+++++.|+++|.+|+|+|+|+++++++||+++|++|+.+.+++++++..... ..+. .+.....+++++++||
T Consensus 3 ~lle~~~d~i~v~d~~G~i~yvn~~~~~~lGy~~~el~G~~~~~~ihp~D~~~~~----~~~~~~~~~~~~e~r~~~kdG 78 (111)
T 2vlg_A 3 FPLQTKTDIHAVLASNGRIIYISANSKLHLGYLQGEMIGSFLKTFLHEEDQFLVE----SYFYNEHHLMPCTFRFIKKDH 78 (111)
T ss_dssp ------CCEEEEECTTSBEEEECTTHHHHHSCCHHHHTTSBGGGGBCGGGHHHHH----HHHHCSCCSSCEEEEEECTTS
T ss_pred chhhcCCCEEEEEcCCCeEEEEChHHHHHhCCCHHHHcCCcHHHeECHhHHHHHH----HHHhccCCCccEEEEEEcCCC
Confidence 4799999999999999999999999999999999999999999999887744332 2222 2333456788999999
Q ss_pred CEEEEEEEEEEEECCCC
Q 005841 213 ERVLVVATNTPFYDDDG 229 (674)
Q Consensus 213 ~~~~v~~s~sPi~d~dG 229 (674)
..+|++++++++.+.++
T Consensus 79 ~~~wve~~~~~v~~~~~ 95 (111)
T 2vlg_A 79 TIVWVEAAVEIVTTRAE 95 (111)
T ss_dssp CEEEEEEEEEEC-----
T ss_pred CEEEEEEEEEEEecccC
Confidence 99999999999987654
|
| >4f3l_A Mclock, circadian locomoter output cycles protein kaput; BHLH, PAS, circadian rhythm proteins, transcription-activato; 2.27A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.25 E-value=1.5e-11 Score=132.15 Aligned_cols=109 Identities=16% Similarity=0.138 Sum_probs=97.2
Q ss_pred cceeEEEcCCCcEEeecHHHHHHhCCChhhHcCCCccccccccccchhHHHHHHHHHhCceeEEEEEEEcCCCCEEEEEE
Q 005841 140 GQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGERWTGQFPAKTKTEERVLVVA 219 (674)
Q Consensus 140 ~d~I~v~D~~GrIi~~N~a~e~llGys~eEviG~~~~~l~~~~~~~~~~~~i~~~l~~g~~~~~e~~~~~kdG~~~~v~~ 219 (674)
.+.++..|.+|+|+|||++++.++||+++|++|+++.+++++++.......+...+..|+....++++++++|..+|+..
T Consensus 251 ~~f~~~~~~dg~~~~vn~~~~~ilGY~~eEl~g~~~~~~iHpdD~~~~~~~~~~~l~~g~~~~~eyR~~~kdG~~vWv~~ 330 (361)
T 4f3l_A 251 EEFTSRHSLEWKFLFLDHRAPPIIGYLPFEVLGTSGYDYYHVDDLENLAKCHEHLMQYGKGKSCYYRFLTKGQQWIWLQT 330 (361)
T ss_dssp CEEEEEECTTSBEEEECTTSHHHHCCCHHHHTTSBGGGGBCHHHHHHHHHHHHHHHHHSEEECCCEEEECTTSEEEEEEE
T ss_pred ceeEEEEcCCceEEEECChhhhhhCcCHHHHcCCCHHHeECHHHHHHHHHHHHHHHhCCCcceEEEEEEecCCCEEEEEE
Confidence 45667789999999999999999999999999999999999887666656666777888888888999999999999999
Q ss_pred EEEEEECC-CCCEEEEEEEEEchHHHHHHH
Q 005841 220 TNTPFYDD-DGTLVGIVCVSTDSRPFQETR 248 (674)
Q Consensus 220 s~sPi~d~-dG~ivg~i~i~rDITe~k~~e 248 (674)
+..|++|+ +|++.+++++.+|||+++..+
T Consensus 331 ~~~~v~~~~~g~~~~iv~~~~dITe~~~~~ 360 (361)
T 4f3l_A 331 HYYITYHQWNSRPEFIVCTHTVVSYAEVRA 360 (361)
T ss_dssp EEEEEECTTTCCEEEEEEEEEECCHHHHHH
T ss_pred EEEEEEcCCCCCeeEEEEEEEECChhHhhc
Confidence 99999998 799999999999999987654
|
| >1nwz_A PYP, photoactive yellow protein; PAS, LOV, GAF, domains fold, signaling protein; HET: HC4; 0.82A {Halorhodospira halophila} SCOP: d.110.3.1 PDB: 1kou_A* 1ot9_A* 1otb_A* 1s4r_A* 1s4s_A* 1ts0_A* 1ts6_A* 1ts7_A* 1ts8_A* 1uwn_X* 1uwp_X* 2d01_A* 2phy_A* 2pyp_A* 2pyr_A* 2qj5_A* 2qj7_A* 2qws_A* 2zoh_A* 2zoi_A* ... | Back alignment and structure |
|---|
Probab=99.17 E-value=2.6e-10 Score=102.76 Aligned_cols=100 Identities=9% Similarity=0.031 Sum_probs=80.6
Q ss_pred HHHHHHhcceeEEEcCCCcEEeecHHHHHHhCCChhhHcCCCccccc-cccccchhHHHHHHHHHhCceeEEEEEEE-cC
Q 005841 133 LNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELL-TDGRDFDVAYDIVHRIKMGERWTGQFPAK-TK 210 (674)
Q Consensus 133 ~~ilds~~d~I~v~D~~GrIi~~N~a~e~llGys~eEviG~~~~~l~-~~~~~~~~~~~i~~~l~~g~~~~~e~~~~-~k 210 (674)
..+||+++.||+++|.+|+|++||++++++.||++++++|+++.+.+ +......+...+.+.+.+|. +..++.++ ++
T Consensus 20 ~~~ld~l~~Gii~lD~~g~I~~~N~~~e~~sG~~~~eviGk~~f~~~~~~~~~~~f~~rf~~~~~~g~-l~~~~~~v~~~ 98 (125)
T 1nwz_A 20 DGQLDGLAFGAIQLDGDGNILQYNAAEGDITGRDPKQVIGKNFFKDVAPCTDSPEFYGKFKEGVASGN-LNTMFEYTFDY 98 (125)
T ss_dssp HHHHTTCSSEEEEEETTCBEEEECHHHHHHHCCCHHHHTTSBCCCCCCGGGCSTTTHHHHHHHHHHTC-CEEEEEEEECT
T ss_pred HHHHhccCceEEEECCCCEEEEEHHHHHHHhCCCHHHHcCCchhhhccchhcccHHHHHHHHHHhcCc-eeEEEEEEEcC
Confidence 45799999999999999999999999999999999999999998754 44445666667777788887 55555554 89
Q ss_pred CCCEEEEEEEEEEEECCCCCEEEEE
Q 005841 211 TEERVLVVATNTPFYDDDGTLVGIV 235 (674)
Q Consensus 211 dG~~~~v~~s~sPi~d~dG~ivg~i 235 (674)
+|+ ++.++++++.+++|..++++
T Consensus 99 ~~~--p~~v~i~l~~~~~~~~~~i~ 121 (125)
T 1nwz_A 99 QMT--PTKVKVHMKKALSGDSYWVF 121 (125)
T ss_dssp TSC--CEEEEEEEEECSSSSEEEEE
T ss_pred CCC--EEEEEEEEEEcCCCCEEEEE
Confidence 998 55667777888899877654
|
| >3a0s_A Sensor protein; PAS-fold, kinase, phosphoprotein, transferase, two-component regulatory system; HET: PG4 PGE; 1.47A {Thermotoga maritima} PDB: 3a0v_A* | Back alignment and structure |
|---|
Probab=99.16 E-value=2.2e-10 Score=94.18 Aligned_cols=95 Identities=21% Similarity=0.259 Sum_probs=72.7
Q ss_pred hcceeEEEcCCCcEEeecHHHHHHhCCChhhHcCCCccccccccccchhHHHHHHHHHhCceeEEEEEEEcCCCCEEEEE
Q 005841 139 MGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGERWTGQFPAKTKTEERVLVV 218 (674)
Q Consensus 139 ~~d~I~v~D~~GrIi~~N~a~e~llGys~eEviG~~~~~l~~~~~~~~~~~~i~~~l~~g~~~~~e~~~~~kdG~~~~v~ 218 (674)
++++|+++|.+|+|+++|+++++++|++.++++|+++.++ +. .......+...+..+..+... .. +|...|+.
T Consensus 1 ~~~~i~~~d~~g~i~~~N~~~~~l~g~~~~~~~g~~~~~~-~~--~~~~~~~~~~~~~~~~~~~~~--~~--~~~~~~~~ 73 (96)
T 3a0s_A 1 METAIITLSKDGRITEWNKKAEQLFGLKKENVLGRRLKDL-PD--FEEIGSVAESVFENKEPVFLN--FY--KFGERYFN 73 (96)
T ss_dssp CCCEEEEEETTSBEEEECHHHHHHHCCCHHHHTTSBGGGS-TT--CHHHHHHHHHHHHHTCCEEEE--EE--EETTEEEE
T ss_pred CCceEEEEcCCCCEeehhHHHHHHhCCCHHHhcCCCHHHC-cc--hHHHHHHHHHHhccCCeEEEE--EE--cCCcEEEE
Confidence 5789999999999999999999999999999999998887 32 223333445556666655322 22 34446889
Q ss_pred EEEEEEECCCCC-EEEEEEEEEc
Q 005841 219 ATNTPFYDDDGT-LVGIVCVSTD 240 (674)
Q Consensus 219 ~s~sPi~d~dG~-ivg~i~i~rD 240 (674)
++..|+++.+|. +.|++++++|
T Consensus 74 ~~~~p~~~~~~~~~~g~v~~~~D 96 (96)
T 3a0s_A 74 IRFSPFRNAKTQLLEGVIITIDD 96 (96)
T ss_dssp EEEEEEECTTTCCEEEEEEEEEC
T ss_pred EEEEEeEcCCCCeeeEEEEEecC
Confidence 999999987654 6799999987
|
| >2w0n_A Sensor protein DCUS; signal transduction, two-component regulatory system, PAS, kinase, membrane, transferase, solid state cell inner membrane; NMR {Escherichia coli} | Back alignment and structure |
|---|
Probab=99.15 E-value=6e-12 Score=109.28 Aligned_cols=106 Identities=18% Similarity=0.216 Sum_probs=84.6
Q ss_pred ccccHHHHHHHHHHhcceeEEEcCCCcEEeecHHHHHHhCC---ChhhHcCCCccccccccccchhHHHHHHHHHhCcee
Q 005841 125 FNFTDRQYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGY---SAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGERW 201 (674)
Q Consensus 125 ~~~se~~l~~ilds~~d~I~v~D~~GrIi~~N~a~e~llGy---s~eEviG~~~~~l~~~~~~~~~~~~i~~~l~~g~~~ 201 (674)
+....+.++.++++++++|+++|.+|+|+++|+++++++|| +.++++|+++.+++++.. +...+..+...
T Consensus 10 l~~~~~~~~~il~~~~~~i~~~d~~g~i~~~N~~~~~~~g~~~~~~~~~~g~~~~~~~~~~~-------~~~~~~~~~~~ 82 (118)
T 2w0n_A 10 ISTLFEQRQAMLQSIKEGVVAVDDRGEVTLINDAAQELLNYRKSQDDEKLSTLSHSWSQVVD-------VSEVLRDGTPR 82 (118)
T ss_dssp HCTTHHHHHHHHHCCCCCCEEEBTTTBCCCBCHHHHHHHCSCTTTTTSSCCCTTCCCSCTHH-------HHHHHHTTCCC
T ss_pred HHHHHHHHHHHHhhccccEEEECCCCcEeehhHHHHHHhCCCccChhhhhccCcccccCchh-------HHHHhccCcee
Confidence 44567789999999999999999999999999999999998 889999999998876542 44555666543
Q ss_pred EEEEEEEcCCCCEEEEEEEEEEEECCCCCEEEEEEEEEchH
Q 005841 202 TGQFPAKTKTEERVLVVATNTPFYDDDGTLVGIVCVSTDSR 242 (674)
Q Consensus 202 ~~e~~~~~kdG~~~~v~~s~sPi~d~dG~ivg~i~i~rDIT 242 (674)
.... ...+| .|+.++..|+++ +|++.|++++++|||
T Consensus 83 ~~~~--~~~~~--~~~~~~~~p~~~-~g~~~g~v~~~~DiT 118 (118)
T 2w0n_A 83 RDEE--ITIKD--RLLLINTVPVRS-NGVIIGAISTFRDKT 118 (118)
T ss_dssp CCCC--EESSS--CEECCCEECCCC-SSCCCCEEECCCCCC
T ss_pred ccEE--EEECC--EEEEEeeceeee-CCEEEEEEEEEEeCC
Confidence 2221 12345 467888999987 888899999999997
|
| >4f3l_B BMAL1B; BHLH, PAS, circadian rhythm proteins, transcription-activato; 2.27A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.15 E-value=7e-11 Score=128.06 Aligned_cols=108 Identities=15% Similarity=0.112 Sum_probs=88.7
Q ss_pred hcceeEEEcCCCcEEeecHHHHHHhCCChhhHcCCCccccccccccchhHHHHHHHHHhCce-eEEEEEEEcCCCCEEEE
Q 005841 139 MGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGER-WTGQFPAKTKTEERVLV 217 (674)
Q Consensus 139 ~~d~I~v~D~~GrIi~~N~a~e~llGys~eEviG~~~~~l~~~~~~~~~~~~i~~~l~~g~~-~~~e~~~~~kdG~~~~v 217 (674)
..+.++..|.+|+|+|||++++.++||+++|++|+.+.+++++++.......+...+..+.. ...+++++++||..+|+
T Consensus 277 ~~~fi~~~~~dg~~~~vn~~~~~ilGY~~eEl~g~~~~~~iHpdD~~~~~~~~~~~l~~~~~~~~~eyR~~~kdG~~vWv 356 (387)
T 4f3l_B 277 SMEYVSRHAIDGKFVFVDQRATAILAYLPQELLGTSCYEYFHQDDIGHLAECHRQVLQTREKITTNCYKFKIKDGSFITL 356 (387)
T ss_dssp CCEEEEEECTTSBEEEECTHHHHHHCCCHHHHTTSBGGGTBCHHHHHHHHHHHHHHTTCSSCEECCCEEEECTTSCEEEE
T ss_pred CceEEEEECCCCEEEEECCCcccccCCCHHHHcCCcHHHeeCHHHHHHHHHHHHHHHhcCCCeeeEEEEEEccCCCEEEE
Confidence 45577788999999999999999999999999999999999987755444444444555444 56789999999999999
Q ss_pred EEEEEEEECC-CCCEEEEEEEEEchHHHHH
Q 005841 218 VATNTPFYDD-DGTLVGIVCVSTDSRPFQE 246 (674)
Q Consensus 218 ~~s~sPi~d~-dG~ivg~i~i~rDITe~k~ 246 (674)
+.+..+++|. +|++.++|++.+|||++|.
T Consensus 357 ~~~~~~~~~~~~g~~~~ivg~~~dIT~Rk~ 386 (387)
T 4f3l_B 357 RSRWFSFMNPWTKEVEYIVSTNTVVLANVL 386 (387)
T ss_dssp EEEEEEEEETTTTEEEEEEEEEEECC----
T ss_pred EEEEEEEECCCCCCEEEEEEEEEEcchhhc
Confidence 9999999987 7899999999999999874
|
| >1ll8_A PAS kinase; PAS domain, ligand binding, ligand screening, kinase regulation, transferase; NMR {Homo sapiens} SCOP: d.110.3.5 | Back alignment and structure |
|---|
Probab=99.15 E-value=1.2e-11 Score=108.24 Aligned_cols=101 Identities=17% Similarity=0.212 Sum_probs=75.7
Q ss_pred hcceeEEEcCC-CcEEeecHHHHHHhCCChhhHcCCCccccccccccchhHHHHHHHH-H-hCcee---EEEEEEEcCCC
Q 005841 139 MGQSVHIFDLS-DRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRI-K-MGERW---TGQFPAKTKTE 212 (674)
Q Consensus 139 ~~d~I~v~D~~-GrIi~~N~a~e~llGys~eEviG~~~~~l~~~~~~~~~~~~i~~~l-~-~g~~~---~~e~~~~~kdG 212 (674)
.+++|+++|.+ |+|++||+++++||||+.+|++|+++.+++++... .....+...+ . .+... ..++.+++++|
T Consensus 7 ~~~~i~~~d~~~g~I~~~N~aa~~l~G~~~~el~g~~~~~l~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dG 85 (114)
T 1ll8_A 7 FNKAIFTVDAKTTEILVANDKACGLLGYSSQDLIGQKLTQFFLRSDS-DVVEALSEEHMEADGHAAVVFGTVVDIISRSG 85 (114)
T ss_dssp TTCEEEEEETTTCBEEEECTTHHHHHTCCTTTTTTSBGGGGSSCTTT-HHHHHTTSSTTSSSSCSSCCCSSSEEECCTTC
T ss_pred CCceEEEEECCCCeEEEehHHHHHHhCCCHHHHcCCCHHHhcCcchh-HHHHHHHHHhhccCCcceeccCcEEEEEecCC
Confidence 45799999998 99999999999999999999999999999876542 2122222111 1 12211 23466789999
Q ss_pred CEEEEEEEEEEEECCCCCEEEEEEEEEchH
Q 005841 213 ERVLVVATNTPFYDDDGTLVGIVCVSTDSR 242 (674)
Q Consensus 213 ~~~~v~~s~sPi~d~dG~ivg~i~i~rDIT 242 (674)
..+|+.++++|+.+.++ .+++++++|++
T Consensus 86 ~~~~v~~~~~~~~~~~~--~~~v~~~~~~~ 113 (114)
T 1ll8_A 86 EKIPVSVWMKRMRQERR--LCCVVVLEPVE 113 (114)
T ss_dssp CCEEEECCEECCBSSSS--BEEEEEEEECC
T ss_pred CEEEEEEEEEeeccCCc--cEEEEEEeecC
Confidence 99999999999986554 36788999875
|
| >1mzu_A PPR; photoactive yellow protein, PAS, PYP, signaling protein; HET: HC4; 2.00A {Rhodospirillum centenum} SCOP: d.110.3.1 | Back alignment and structure |
|---|
Probab=99.14 E-value=3.7e-10 Score=101.98 Aligned_cols=99 Identities=13% Similarity=0.023 Sum_probs=79.6
Q ss_pred HHHHHhcceeEEEcCCCcEEeecHHHHHHhCCChhhHcCCCcccccc-ccccchhHHHHHHHHHhCceeEEEEEEE-cCC
Q 005841 134 NILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLT-DGRDFDVAYDIVHRIKMGERWTGQFPAK-TKT 211 (674)
Q Consensus 134 ~ilds~~d~I~v~D~~GrIi~~N~a~e~llGys~eEviG~~~~~l~~-~~~~~~~~~~i~~~l~~g~~~~~e~~~~-~kd 211 (674)
.+|++++.||+++|.+|+|++||++++++.||++++++|+++.+++. ......+...+.+.+.+|. +..++.++ +++
T Consensus 26 ~~ld~l~~GiivlD~dg~I~~~N~~~e~isG~s~eeviGk~~f~~~~p~~~~~~f~grf~~~~~~G~-l~~~~~yv~~~~ 104 (129)
T 1mzu_A 26 AEFDALPVGAIQVDGSGVIHRYNRTESRLSGRIPERVIGRNFFTEVAPCTNIPAFSGRFMDGVTSGT-LDARFDFVFDFQ 104 (129)
T ss_dssp TTGGGCSSEEEEEETTCBEEEECHHHHHHHCCCHHHHTTSBCCCCCCGGGCSTTTHHHHHHHHHTSC-CEEEEEEEEECS
T ss_pred HHHhccCceEEEECCCCeEEEEHHHHHHHhCCCHHHHcCCchhhhccchhcccHHHHHHHHHHhcCc-eeEEEEEEEcCC
Confidence 36999999999999999999999999999999999999999987544 4444566667777788777 55555554 889
Q ss_pred CCEEEEEEEEEEEECCCCCEEEEE
Q 005841 212 EERVLVVATNTPFYDDDGTLVGIV 235 (674)
Q Consensus 212 G~~~~v~~s~sPi~d~dG~ivg~i 235 (674)
|+ ++.++++++.+++|..++++
T Consensus 105 ~~--p~~v~i~l~~~~~~~~~~i~ 126 (129)
T 1mzu_A 105 MA--PVRVQIRMQNAGVPDRYWIF 126 (129)
T ss_dssp SC--EEEEEEEEEECSSTTEEEEE
T ss_pred CC--EEEEEEEEEEcCCCCEEEEE
Confidence 98 55667777788899877654
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.11 E-value=6.6e-11 Score=119.54 Aligned_cols=137 Identities=16% Similarity=0.103 Sum_probs=100.2
Q ss_pred CCeeEeeeecccCceEEEEEEEc-CCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCC--eeeEEEEEecCCeEEEEE
Q 005841 505 EDLTIGEQIGQGSCGTVYHAVWY-GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPN--VLLFMGAVTSPQRLCIVT 581 (674)
Q Consensus 505 ~~y~~~~~LG~G~fG~Vy~~~~~-~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hpn--Iv~l~~~~~~~~~~~lV~ 581 (674)
..|.+..+.+.|..+.||++... +..|++|+..... ...+.+|+.+++.+.+.+ +.+++.++...+..|+||
T Consensus 20 ~~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~~-----~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~ 94 (264)
T 1nd4_A 20 FGYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSGA-----LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLL 94 (264)
T ss_dssp TTCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSCT-----TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEE
T ss_pred CCCceEecccCCCCceEEEEecCCCCeEEEEeCCccc-----chhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEE
Confidence 45666555456677999999753 5679999976531 134667899998886444 567888888888899999
Q ss_pred ecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--------------------------------------
Q 005841 582 EFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCN-------------------------------------- 623 (674)
Q Consensus 582 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~-------------------------------------- 623 (674)
||++|.+|. .. ... ...++.+++..|..||...
T Consensus 95 e~i~G~~l~--~~----~~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (264)
T 1nd4_A 95 GEVPGQDLL--SS----HLA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGL 165 (264)
T ss_dssp ECCSSEETT--TS----CCC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTC
T ss_pred EecCCcccC--cC----cCC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCc
Confidence 999998873 21 111 2255667777788887643
Q ss_pred ------------------CCeEEccCCCCCEEEcCCCcEEEEecCCcccc
Q 005841 624 ------------------PPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLK 655 (674)
Q Consensus 624 ------------------~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~ 655 (674)
..++|+|++|.|||++.++.+.|+|||.+...
T Consensus 166 ~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~g 215 (264)
T 1nd4_A 166 APAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGVA 215 (264)
T ss_dssp CHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEEE
T ss_pred cHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcccC
Confidence 12999999999999988766779999998754
|
| >2jhe_A Transcription regulator TYRR; aromatic hydrocarbons catabolism, TYRR protei nucleotide-binding, transcription regulation, activator; HET: PG4; 2.30A {Escherichia coli} | Back alignment and structure |
|---|
Probab=99.11 E-value=4.8e-11 Score=114.94 Aligned_cols=106 Identities=14% Similarity=0.211 Sum_probs=82.6
Q ss_pred cHHHHHHHHHHhcceeEEEcCCCcEEeecHHHHHHhCCChhhHcCCCccccccccccchhHHHHHHHHHhCc-e-eEEEE
Q 005841 128 TDRQYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGE-R-WTGQF 205 (674)
Q Consensus 128 se~~l~~ilds~~d~I~v~D~~GrIi~~N~a~e~llGys~eEviG~~~~~l~~~~~~~~~~~~i~~~l~~g~-~-~~~e~ 205 (674)
....++.+|++++++|+++|.+|+|+++|+++++++|++.++++|+++.+++++.. +...+..+. . +..++
T Consensus 78 ~~~~l~~il~~~~~gvi~~D~~g~I~~~N~aa~~llg~~~~~~~g~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~ 150 (190)
T 2jhe_A 78 EHLALSALLEALPEPVLSVDMKSKVDMANPASCQLFGQKLDRLRNHTAAQLINGFN-------FLRWLESEPQDSHNEHV 150 (190)
T ss_dssp HHHHHHHHHHHCSSCEEEECTTCBEEEECHHHHHHHTSCHHHHTTSBGGGTSTTCC-------HHHHHHTCCCSCEEEEE
T ss_pred HHHHHHHHHHhCCCcEEEEcCCCCEEEEcHHHHHHhCCCHHHhcCccHHHHhCCCC-------HHHHHhcCCCCCcceEE
Confidence 34579999999999999999999999999999999999999999999999887643 233455554 2 33333
Q ss_pred EEEcCCCCEEEEEEEEEEEECCCCC----EEEEEEEEEchHHHH
Q 005841 206 PAKTKTEERVLVVATNTPFYDDDGT----LVGIVCVSTDSRPFQ 245 (674)
Q Consensus 206 ~~~~kdG~~~~v~~s~sPi~d~dG~----ivg~i~i~rDITe~k 245 (674)
.. +|.. +.++.+|+++++|+ +.|++++++|||+++
T Consensus 151 ~~---~g~~--~~~~~~pi~~~~~~~~~~~~g~v~~~~DiTe~~ 189 (190)
T 2jhe_A 151 VI---NGQN--FLMEITPVYLQDENDQHVLTGAVVMLRSTIRMG 189 (190)
T ss_dssp EE---TTEE--EEEEEEEETTTTEEEEEEEE-HHHHHHHHTTTC
T ss_pred EE---CCeE--EEEEEEEEEecCCCCcceEEeEEEEEeccchhc
Confidence 32 5643 56788999876666 788899999999864
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.10 E-value=1.5e-10 Score=123.62 Aligned_cols=144 Identities=19% Similarity=0.237 Sum_probs=108.2
Q ss_pred eEeeeecccCceEEEEEEEcCCeEEEEEee--cccCCHHHHHHHHHHHHHHhhCC--CCCeeeEEEEEecC---CeEEEE
Q 005841 508 TIGEQIGQGSCGTVYHAVWYGSDVAVKVFS--RQEYSDEVIHSFRQEVSLMKRLR--HPNVLLFMGAVTSP---QRLCIV 580 (674)
Q Consensus 508 ~~~~~LG~G~fG~Vy~~~~~~~~vAvK~i~--~~~~~~~~~~~~~~Ei~il~~l~--HpnIv~l~~~~~~~---~~~~lV 580 (674)
...+.|+.|.++.||++...+..+++|+.. ..... .....+.+|+.+++.|. +..+.+++.++.+. +..|+|
T Consensus 41 ~~~~~l~~G~sn~~y~v~~~~~~~vlr~~~~p~~~~~-~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~v 119 (359)
T 3dxp_A 41 LSVEQFKGGQSNPTFKLVTPGQTYVMRAKPGPKSKLL-PSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYI 119 (359)
T ss_dssp CEEEECCC-CCSCEEEEECSSCEEEEECCCC-----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEE
T ss_pred ceEEEcCCcccceEEEEEECCceEEEEeCCCCCCCCC-CcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEE
Confidence 346789999999999998877889999775 32211 12346778999999987 45678888888766 458999
Q ss_pred EecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC--------------------------------------
Q 005841 581 TEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHC-------------------------------------- 622 (674)
Q Consensus 581 ~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~-------------------------------------- 622 (674)
|||++|..+.+.. ...++......++.+++..|..||..
T Consensus 120 me~v~G~~l~~~~---~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (359)
T 3dxp_A 120 MEFVSGRVLWDQS---LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPA 196 (359)
T ss_dssp EECCCCBCCCCTT---CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHH
T ss_pred EEecCCeecCCCc---cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChH
Confidence 9999997764311 22467888889999999999999973
Q ss_pred ------------------CCCeEEccCCCCCEEEcCCCc--EEEEecCCcccc
Q 005841 623 ------------------NPPIIHRDLKSSNLLVDKHWT--VKVGDFGLSRLK 655 (674)
Q Consensus 623 ------------------~~~IvHrDLKp~NILi~~~~~--vkL~DFGla~~~ 655 (674)
...+||+|++|.|||++.++. +.|+||++|..-
T Consensus 197 ~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~g 249 (359)
T 3dxp_A 197 MDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTLG 249 (359)
T ss_dssp HHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEEE
T ss_pred HHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccccC
Confidence 134899999999999997653 699999999753
|
| >3rty_A Period circadian protein; PAS domain, signalling, timeless, circadian clock protein; 2.85A {Drosophila melanogaster} PDB: 1wa9_A 3gec_A | Back alignment and structure |
|---|
Probab=98.84 E-value=1.2e-08 Score=108.10 Aligned_cols=104 Identities=13% Similarity=0.046 Sum_probs=87.6
Q ss_pred cceeEEEcCCCcEEeecHHHHHHhCCChhhHcCCCccccccccccchhHHHHHHHHHhCce-----eEEEEEEEcCCCCE
Q 005841 140 GQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGER-----WTGQFPAKTKTEER 214 (674)
Q Consensus 140 ~d~I~v~D~~GrIi~~N~a~e~llGys~eEviG~~~~~l~~~~~~~~~~~~i~~~l~~g~~-----~~~e~~~~~kdG~~ 214 (674)
.+.|+..|.+|+|+|+|+++..++||+++|++|+++.+++++++.......+...+..|+. ...+++++++||..
T Consensus 154 ~~fi~r~~~dG~~~yvn~~~~~lLGY~peELiG~s~~~~vHPdD~~~~~~~~~~~l~~G~~~~~~~~s~~yR~~~kdG~~ 233 (339)
T 3rty_A 154 PKFAIRHTATGIISHVDSAAVSALGYLPQDLIGRSIMDFYHHEDLSVMKETYETVMKKGQTAGASFCSKPYRFLIQNGCY 233 (339)
T ss_dssp CEEEEEEETTCBEEEECTTHHHHHCCCHHHHTTSBGGGGBCGGGHHHHHHHHHHHHHHTTSTTCCCBCCCEEEECTTSCE
T ss_pred ceEEEEECCCCeEEEcChhhhcccCCCHHHHcCCcHHHEECHHHHHHHHHHHHHHHHcCCcccccccceEEEEEccCCCE
Confidence 5678889999999999999999999999999999999999988765555555566777774 35689999999999
Q ss_pred EEEEEEEEEEECCC-CCEEEEEEEEEchHH
Q 005841 215 VLVVATNTPFYDDD-GTLVGIVCVSTDSRP 243 (674)
Q Consensus 215 ~~v~~s~sPi~d~d-G~ivg~i~i~rDITe 243 (674)
+|++.+.++++|+. +++..+|++.+.|+.
T Consensus 234 vWlet~~~~~~np~s~~~~~II~~h~vi~~ 263 (339)
T 3rty_A 234 VLLETEWTSFVNPWSRKLEFVVGHHRVFQG 263 (339)
T ss_dssp EEEEEEEEEEECTTTCSEEEEEEEEEEEEC
T ss_pred EEEEEEEEEEECCCCCCeeEEEEEEEECCC
Confidence 99999999999875 577788887775553
|
| >2ykf_A Pdtas, probable sensor histidine kinase pdtas; transferase, two-component system, GAF domain, PAS domain; 2.00A {Mycobacterium tuberculosis} PDB: 2ykh_A | Back alignment and structure |
|---|
Probab=98.20 E-value=1.2e-09 Score=114.59 Aligned_cols=112 Identities=16% Similarity=0.127 Sum_probs=80.4
Q ss_pred HHHHhcceeEEEcCCCcEEeecHHHHHHhC---CChhhHcCCCcccccccc---ccc--hhHHHHHHHHHh-CceeEEEE
Q 005841 135 ILQSMGQSVHIFDLSDRIIYWNRSAELLYG---YSAEEALGQDAIELLTDG---RDF--DVAYDIVHRIKM-GERWTGQF 205 (674)
Q Consensus 135 ilds~~d~I~v~D~~GrIi~~N~a~e~llG---ys~eEviG~~~~~l~~~~---~~~--~~~~~i~~~l~~-g~~~~~e~ 205 (674)
+++.+++||+++|.+|+|+|+|++|+++|+ +. ++++|+++.++++.. ... .+...+...+.. +..+..++
T Consensus 175 ~~~~~~dGIivvD~~G~Ii~~N~aA~~ll~~lG~~-~~~iGk~l~el~~~~~~~~~~~~~~~~~l~~vl~~~~~~~~~ei 253 (305)
T 2ykf_A 175 SSPRAGDGFIRLDVDGVVSYASPNALSAYHRMGLT-TELEGVNLIDATRPLISDPFEAHEVDEHVQDLLAGDGKGMRMEV 253 (305)
Confidence 456899999999999999999999999985 54 789999999988653 100 111111223333 33332222
Q ss_pred EEEcCCCCEEEEEEEEEEEECCCCCEEEEEEEEEchHHHHHHHHHHHH
Q 005841 206 PAKTKTEERVLVVATNTPFYDDDGTLVGIVCVSTDSRPFQETRAALWD 253 (674)
Q Consensus 206 ~~~~kdG~~~~v~~s~sPi~d~dG~ivg~i~i~rDITe~k~~e~~L~~ 253 (674)
. ..| .++.++..|+++ +|++.|++.+++|||++++++++|..
T Consensus 254 ~---~~~--~~l~v~~~Pi~~-~g~~~G~Vvv~rDITE~~~lE~eL~~ 295 (305)
T 2ykf_A 254 D---AGG--ATVLLRTLPLVV-AGRNVGAAILIRDVTEVKRRDRALIS 295 (305)
Confidence 1 123 556788899986 68899999999999999999998854
|
| >4dj3_A Period circadian protein homolog 3; PAS domain, circadian rhythm, protein binding; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=98.64 E-value=1.6e-07 Score=98.64 Aligned_cols=100 Identities=12% Similarity=0.043 Sum_probs=82.7
Q ss_pred ceeEEEcCCCcEEeecHHHHHHhCCChhhHcCCCccccccccccchhHHHHHHHHHhCce---eEEEEEEEcCCCCEEEE
Q 005841 141 QSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGER---WTGQFPAKTKTEERVLV 217 (674)
Q Consensus 141 d~I~v~D~~GrIi~~N~a~e~llGys~eEviG~~~~~l~~~~~~~~~~~~i~~~l~~g~~---~~~e~~~~~kdG~~~~v 217 (674)
+-+...|.+|+|+|+|+++..++||.++|++|+.+.+++++++.......+...+..+.. ...+++++++||..+|+
T Consensus 175 ~Fitrh~~dG~~~yvs~~~~~lLGY~peELig~s~~~~vHPdD~~~~~~~~~~~l~~~~~~~f~s~~yR~~~kdG~~vwv 254 (317)
T 4dj3_A 175 IFTTTHTPGCVFLEVDERAVPLLGYLPQDLIGTSILTYLHPEDRPLMVAIHQKVLKYAGHPPFEHSPVRFCTQNGEYVIL 254 (317)
T ss_dssp EEEEEECTTSBEEEECTTHHHHHSCCHHHHTTSBGGGGBCTTTTTHHHHHHHHHHHTTTSCCEECCCEEEECTTSCEEEE
T ss_pred ceEEEecCCCeEEEEChHHhhhcCcChHHHcCCCHHHeECHHHHHHHHHHHHHHHHcCCCccccceEEEEEccCCCEEEE
Confidence 456667889999999999999999999999999999999988766555555555665554 35789999999999999
Q ss_pred EEEEEEEECC-CCCEEEEEEEEEc
Q 005841 218 VATNTPFYDD-DGTLVGIVCVSTD 240 (674)
Q Consensus 218 ~~s~sPi~d~-dG~ivg~i~i~rD 240 (674)
+...++++|. .+++..+|++.+-
T Consensus 255 et~~~~~~np~s~~~e~II~~h~v 278 (317)
T 4dj3_A 255 DSSWSSFVNPWSRKVSFIIGRHKV 278 (317)
T ss_dssp EEEEEEEECSSSCCEEEEEEEEEE
T ss_pred EEEEEEEECCCCCcccEEEEEEEe
Confidence 9999999986 4677777777763
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.60 E-value=8.6e-08 Score=99.77 Aligned_cols=136 Identities=24% Similarity=0.228 Sum_probs=99.8
Q ss_pred eeeecccCceEEEEEEEcCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCC-CCC--eeeEEEEEecCC---eEEEEEec
Q 005841 510 GEQIGQGSCGTVYHAVWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLR-HPN--VLLFMGAVTSPQ---RLCIVTEF 583 (674)
Q Consensus 510 ~~~LG~G~fG~Vy~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~-Hpn--Iv~l~~~~~~~~---~~~lV~E~ 583 (674)
.+.++.|.+..||++. ..+++|+.... .....+.+|+.+++.+. +.. +..++....... ..|+||++
T Consensus 25 i~~~~~G~~n~v~~v~---~~~vlR~~~~~----~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~ 97 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN---RDFIFKFPKHS----RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTK 97 (304)
T ss_dssp CCEEEECSSEEEEEST---TSEEEEEESSH----HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEEC
T ss_pred eEecCCCCcceEEEEC---CEEEEEecCCc----chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcc
Confidence 3458999999999864 67999986432 34567889999998873 332 445555543333 34899999
Q ss_pred CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC----------------------------------------
Q 005841 584 LPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCN---------------------------------------- 623 (674)
Q Consensus 584 ~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~---------------------------------------- 623 (674)
++|..|..... ..++..+...++.+++..|..||+..
T Consensus 98 i~G~~l~~~~~---~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 174 (304)
T 3sg8_A 98 IKGVPLTPLLL---NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVD 174 (304)
T ss_dssp CCCEECCHHHH---HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHH
T ss_pred cCCeECCcccc---ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHH
Confidence 99988765332 13677777888888888888888511
Q ss_pred ----------------CCeEEccCCCCCEEEcC--CCcEEEEecCCcccc
Q 005841 624 ----------------PPIIHRDLKSSNLLVDK--HWTVKVGDFGLSRLK 655 (674)
Q Consensus 624 ----------------~~IvHrDLKp~NILi~~--~~~vkL~DFGla~~~ 655 (674)
+.++|+|++|.|||++. +..+.|+||+.+...
T Consensus 175 ~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~ 224 (304)
T 3sg8_A 175 DFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAIS 224 (304)
T ss_dssp HHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEE
T ss_pred HHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccC
Confidence 23799999999999998 566899999998754
|
| >3gdi_A Period circadian protein homolog 2; tandem PAS domains, biological rhythms, cytoplasm, nucleus, phosphoprotein, transcription; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=98.59 E-value=2.7e-07 Score=96.48 Aligned_cols=103 Identities=10% Similarity=0.034 Sum_probs=84.0
Q ss_pred ceeEEEcCCCcEEeecHHHHHHhCCChhhHcCCCccccccccccchhHHHHHHHHHhCce-eE-EEEEEEcCCCCEEEEE
Q 005841 141 QSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGER-WT-GQFPAKTKTEERVLVV 218 (674)
Q Consensus 141 d~I~v~D~~GrIi~~N~a~e~llGys~eEviG~~~~~l~~~~~~~~~~~~i~~~l~~g~~-~~-~e~~~~~kdG~~~~v~ 218 (674)
.-+...|.+|+|+|+|+++..++||.++|++|+.+.+++++++...........+..+.. .. .+++++++||..+|++
T Consensus 166 ~Fitrh~~dG~~~yvd~~~~~lLGY~peELig~s~~~~iHpdD~~~~~~~~~~~l~~~g~~~~~~~yR~~~kdG~~vwve 245 (309)
T 3gdi_A 166 IFTTTHTPNCLFQAVDERAVPLLGYLPQDLIETPVLVQLHPSDRPLMLAIHKKILQAGGQPFDYSPIRFRTRNGEYITLD 245 (309)
T ss_dssp EEEEEECTTCBEEEECTTHHHHHSCCHHHHTTSBHHHHBCTTSHHHHHHHHHHHHHTTTCCEEEEEEEEECTTSCEEEEE
T ss_pred eEEEEecCCCeEEEECcccccccCcCHHHHcCCCHHHhCCHHHHHHHHHHHHHHHhcCCceeeceEEEEEccCCCEEEEE
Confidence 456678899999999999999999999999999999999988754444444445554443 44 5899999999999999
Q ss_pred EEEEEEECC-CCCEEEEEEEEEchHH
Q 005841 219 ATNTPFYDD-DGTLVGIVCVSTDSRP 243 (674)
Q Consensus 219 ~s~sPi~d~-dG~ivg~i~i~rDITe 243 (674)
...++++|. .+++..+||+.+-|+.
T Consensus 246 t~~~~~~np~s~~~e~ii~~h~v~~g 271 (309)
T 3gdi_A 246 TSWSSFINPWSRKISFIIGRHKVRVG 271 (309)
T ss_dssp EEEEEEECTTTCCEEEEEEEEEEEEC
T ss_pred EEEEEEECCCCCcccEEEEEEEEccC
Confidence 999999886 5778888888776654
|
| >4dj2_A Period circadian protein homolog 1; PAS domains, circadian clock protein, protein binding; 2.75A {Mus musculus} | Back alignment and structure |
|---|
Probab=98.54 E-value=2.4e-07 Score=97.41 Aligned_cols=105 Identities=11% Similarity=0.036 Sum_probs=84.1
Q ss_pred hcceeEEEcCCCcEEeecHHHHHHhCCChhhHcCCCccccccccccchhHHHHHHHHHh-Ccee-EEEEEEEcCCCCEEE
Q 005841 139 MGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKM-GERW-TGQFPAKTKTEERVL 216 (674)
Q Consensus 139 ~~d~I~v~D~~GrIi~~N~a~e~llGys~eEviG~~~~~l~~~~~~~~~~~~i~~~l~~-g~~~-~~e~~~~~kdG~~~~ 216 (674)
..+-+...|.+|+|+|+|+++..++||.++|++|+.+.+++++++...........+.. |... ..+++++++||..+|
T Consensus 175 ~~~Fitrh~~dG~~~yvd~~~~~lLGY~peELig~s~~~~vHPdD~~~~~~~~~~~l~~~g~~~~~~~yR~~~kdG~~vw 254 (320)
T 4dj2_A 175 KRIFTTRHTPSCLFQDVDERAAPLLGYLPQDLLGAPVLLFLHPEDRPLMLAIHKKILQLAGQPFDHSPIRFCARNGEYVT 254 (320)
T ss_dssp GCEEEEEECTTCBEEEECTTHHHHHSCCHHHHTTSBGGGGBCGGGHHHHHHHHHHHTTSSSCCEECCCEEEECSSSCEEE
T ss_pred CceEEEEecCCceEEEcCcceeccCCcChHHHcCCcHHHhCCHHHHHHHHHHHHHHHhcCCCcccceEEEEEccCCCEEE
Confidence 34566778899999999999999999999999999999999988754443333344443 4444 358999999999999
Q ss_pred EEEEEEEEECC-CCCEEEEEEEEEchHH
Q 005841 217 VVATNTPFYDD-DGTLVGIVCVSTDSRP 243 (674)
Q Consensus 217 v~~s~sPi~d~-dG~ivg~i~i~rDITe 243 (674)
++...++++|. .+++.++|+..+-|+.
T Consensus 255 vet~~~~~~np~s~~~e~II~~h~v~~g 282 (320)
T 4dj2_A 255 MDTSWAGFVHPWSRKVAFVLGRHKVRTA 282 (320)
T ss_dssp EECEEEEEECTTTCSEEEEEEEEEESSC
T ss_pred EEEEEEEEECCCCCCccEEEEEEEEccC
Confidence 99999999986 5788888888776654
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.54 E-value=8.5e-07 Score=92.60 Aligned_cols=136 Identities=18% Similarity=0.149 Sum_probs=94.3
Q ss_pred eeeecccCceEEEEEEEcCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCC---CeeeEEEEEe-cCCeEEEEEecCC
Q 005841 510 GEQIGQGSCGTVYHAVWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHP---NVLLFMGAVT-SPQRLCIVTEFLP 585 (674)
Q Consensus 510 ~~~LG~G~fG~Vy~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp---nIv~l~~~~~-~~~~~~lV~E~~~ 585 (674)
.+.++.|....||+. +..+++|+.. .......+.+|+.+|..|.+. .|..++.+.. ..+..|+||||++
T Consensus 24 v~~l~~G~~n~v~~v---g~~~VlR~~~----~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~ 96 (306)
T 3tdw_A 24 VESLGEGFRNYAILV---NGDWVFRFPK----SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQ 96 (306)
T ss_dssp EEEEEECSSEEEEEE---TTTEEEEEES----SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCC
T ss_pred eeecCCCcceeEEEE---CCEEEEEecC----CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccC
Confidence 346788888999987 6889999852 234456788999999998742 3556676664 4556789999999
Q ss_pred CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC-------------------------------------------
Q 005841 586 RGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHC------------------------------------------- 622 (674)
Q Consensus 586 ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~------------------------------------------- 622 (674)
|..|....-. .++......++.++...|..||+.
T Consensus 97 G~~l~~~~~~---~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~ 173 (306)
T 3tdw_A 97 GQILGEDGMA---VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLT 173 (306)
T ss_dssp SEECHHHHHT---TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHH
T ss_pred CeECchhhhh---hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHH
Confidence 9877653211 233444444445555555544432
Q ss_pred ---------------CCCeEEccCCCCCEEEcC---CCc-EEEEecCCcccc
Q 005841 623 ---------------NPPIIHRDLKSSNLLVDK---HWT-VKVGDFGLSRLK 655 (674)
Q Consensus 623 ---------------~~~IvHrDLKp~NILi~~---~~~-vkL~DFGla~~~ 655 (674)
.+.++|+|+.|.|||++. ++. +.|+||+.+...
T Consensus 174 ~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~g 225 (306)
T 3tdw_A 174 LRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAIS 225 (306)
T ss_dssp HHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEE
T ss_pred HHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCC
Confidence 123699999999999987 355 589999998754
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.40 E-value=3.2e-06 Score=85.84 Aligned_cols=133 Identities=17% Similarity=0.180 Sum_probs=94.2
Q ss_pred ecccCc-eEEEEEEEc--CCeEEEEEeecccCCHHHHHHHHHHHHHHhhCC-CCCeeeEEEEEecCCeEEEEEecCCCCC
Q 005841 513 IGQGSC-GTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLR-HPNVLLFMGAVTSPQRLCIVTEFLPRGS 588 (674)
Q Consensus 513 LG~G~f-G~Vy~~~~~--~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~lV~E~~~ggs 588 (674)
+..|.- ..||+.... +..+.+|+-... ....+.+|..+|+.+. +--|.+++.++.+.+..|+|||+++|.+
T Consensus 32 ~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~-----~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~ 106 (272)
T 4gkh_A 32 DNVGQSGATIYRLYGKPNAPELFLKHGKGS-----VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKT 106 (272)
T ss_dssp EECSSSSCEEEEEECCTTCCCEEEEEEETH-----HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEE
T ss_pred ccCCCcCCeEEEEEecCCCeEEEEEECCCC-----CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCcc
Confidence 333433 478987653 456999986532 2345778999988875 3346788899999999999999999988
Q ss_pred HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---------------------------------------------
Q 005841 589 LFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCN--------------------------------------------- 623 (674)
Q Consensus 589 L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~--------------------------------------------- 623 (674)
+.+..... ......+..++...|.-||...
T Consensus 107 ~~~~~~~~-----~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 181 (272)
T 4gkh_A 107 AFQVLEEY-----PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWK 181 (272)
T ss_dssp HHHHHHHC-----GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHH
T ss_pred ccccccCC-----HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHH
Confidence 87765431 1222345555666666666421
Q ss_pred -----------CCeEEccCCCCCEEEcCCCcEEEEecCCcccc
Q 005841 624 -----------PPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLK 655 (674)
Q Consensus 624 -----------~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~ 655 (674)
+.++|+|+.+.|||++.++.+-|+||+.+...
T Consensus 182 ~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~g 224 (272)
T 4gkh_A 182 EMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGIA 224 (272)
T ss_dssp HHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEEE
T ss_pred HHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccccC
Confidence 02789999999999998877789999998754
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.20 E-value=1.3e-06 Score=92.88 Aligned_cols=80 Identities=8% Similarity=0.015 Sum_probs=54.8
Q ss_pred eEeeee-cccCceEEEEEEEc--------CCeEEEEEeeccc---CCHHHHHHHHHHHHHHhhCC-C--CCeeeEEEEEe
Q 005841 508 TIGEQI-GQGSCGTVYHAVWY--------GSDVAVKVFSRQE---YSDEVIHSFRQEVSLMKRLR-H--PNVLLFMGAVT 572 (674)
Q Consensus 508 ~~~~~L-G~G~fG~Vy~~~~~--------~~~vAvK~i~~~~---~~~~~~~~~~~Ei~il~~l~-H--pnIv~l~~~~~ 572 (674)
...+.| +.|....+|+.... +..+++|+..... ... ...+.+|+.+++.|. + ..+.+++.++.
T Consensus 23 ~~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~--~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~ 100 (357)
T 3ats_A 23 TVESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFP--TYRLDHQFEVIRLVGELTDVPVPRVRWIET 100 (357)
T ss_dssp EEEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSS--CCCHHHHHHHHHHHHHHCCSCCCCEEEEEC
T ss_pred EEEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCc--hhHHHHHHHHHHHHhhcCCCCCCcEEEEcc
Confidence 345677 88889999998765 6679999865432 100 124567888888774 2 35667887776
Q ss_pred cC---CeEEEEEecCCCCCH
Q 005841 573 SP---QRLCIVTEFLPRGSL 589 (674)
Q Consensus 573 ~~---~~~~lV~E~~~ggsL 589 (674)
+. +..|+||||++|..+
T Consensus 101 ~~~~~g~~~~v~e~l~G~~l 120 (357)
T 3ats_A 101 TGDVLGTPFFLMDYVEGVVP 120 (357)
T ss_dssp SSTTTSSCEEEEECCCCBCC
T ss_pred CCCccCCceEEEEecCCCCh
Confidence 55 357899999988654
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.19 E-value=1.3e-05 Score=83.94 Aligned_cols=139 Identities=16% Similarity=0.130 Sum_probs=79.6
Q ss_pred eeeecccCceEEEEEEEcCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCC-----CCCeeeEE-E--EEecCCeEEEEE
Q 005841 510 GEQIGQGSCGTVYHAVWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLR-----HPNVLLFM-G--AVTSPQRLCIVT 581 (674)
Q Consensus 510 ~~~LG~G~fG~Vy~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~-----HpnIv~l~-~--~~~~~~~~~lV~ 581 (674)
.+.|+.|..+.||++...+..+++|+.... .. .+..|+.++..|. .|.++... + +....+..|+||
T Consensus 37 ~~~l~gG~~n~~~~v~~~~~~~vlk~~~~~---~~---~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~ 110 (346)
T 2q83_A 37 IDVIQGNQMALVWKVHTDSGAVCLKRIHRP---EK---KALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVY 110 (346)
T ss_dssp EEECC----CEEEEEEETTEEEEEEEECSC---HH---HHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEE
T ss_pred eeeccccccCcEEEEEeCCCCEEEEecCCC---HH---HHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEE
Confidence 345666778999999876667999998652 22 2333455555442 24433210 0 123467789999
Q ss_pred ecCCCCCHH-----------HH---HHhcCCC-------------CCHHH------------------------------
Q 005841 582 EFLPRGSLF-----------RL---LQRNTTK-------------LDWRR------------------------------ 604 (674)
Q Consensus 582 E~~~ggsL~-----------~~---l~~~~~~-------------l~~~~------------------------------ 604 (674)
+|++|..+. .. |+..... ..|..
T Consensus 111 ~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 190 (346)
T 2q83_A 111 DWIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQ 190 (346)
T ss_dssp ECCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHH
T ss_pred EeecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHH
Confidence 999985431 11 1111000 11211
Q ss_pred -HHHHHHHHHHHHHHHHh-----------CCCCeEEccCCCCCEEEcCCCcEEEEecCCccc
Q 005841 605 -RILMALDIARGVSYLHH-----------CNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL 654 (674)
Q Consensus 605 -~~~i~~qi~~~L~yLH~-----------~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~ 654 (674)
...+..++..++.+|+. ....+||+|+.+.|||++.++.+.|+||+.+..
T Consensus 191 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~ 252 (346)
T 2q83_A 191 EIDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVSF 252 (346)
T ss_dssp HHHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred HHHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence 01111223345666652 234499999999999998788999999999864
|
| >4f3l_A Mclock, circadian locomoter output cycles protein kaput; BHLH, PAS, circadian rhythm proteins, transcription-activato; 2.27A {Mus musculus} | Back alignment and structure |
|---|
Probab=98.04 E-value=3e-05 Score=82.85 Aligned_cols=65 Identities=14% Similarity=0.162 Sum_probs=56.0
Q ss_pred cHHHHHHHHHHhcceeEEEcCCCcEEeecHHHHHHhCCChhhHcCCCccccccccccchhHHHHH
Q 005841 128 TDRQYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIV 192 (674)
Q Consensus 128 se~~l~~ilds~~d~I~v~D~~GrIi~~N~a~e~llGys~eEviG~~~~~l~~~~~~~~~~~~i~ 192 (674)
.+++...+++++++.|+++|.+|+|+|+|+++++++||+.+|++|+++.+++++++...+...+.
T Consensus 84 ~~~~~~~~l~a~~~~i~v~~~~G~i~yvs~~~~~~lGy~~~el~g~~~~~~ihp~D~~~~~~~l~ 148 (361)
T 4f3l_A 84 NEEFTQLMLEALDGFFLAIMTDGSIIYVSESVTSLLEHLPSDLVDQSIFNFIPEGEHSEVYKILS 148 (361)
T ss_dssp HHHHHHHHHHHTTEEEEEEETTSBEEEECTTHHHHHCCCHHHHTTSBGGGGSCGGGHHHHHHHHH
T ss_pred HHHHHHHHHHhcCceEEEEcCCccEEEEechhhhhcCCCHHHhcCCcHHHhcCHHHHHHHHHHhc
Confidence 34566778899999999999999999999999999999999999999999999887555444443
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.97 E-value=1.9e-05 Score=85.08 Aligned_cols=76 Identities=21% Similarity=0.157 Sum_probs=48.9
Q ss_pred eeeecccCceEEEEEEE--cCCeEEEEEeecccC--CH---HHHHHHHHHHHHHhhCCC--C-CeeeEEEEEecCCeEEE
Q 005841 510 GEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEY--SD---EVIHSFRQEVSLMKRLRH--P-NVLLFMGAVTSPQRLCI 579 (674)
Q Consensus 510 ~~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~--~~---~~~~~~~~Ei~il~~l~H--p-nIv~l~~~~~~~~~~~l 579 (674)
.+.||.|.++.||++.. .+..|+||....... .. ....++..|..+++.+.. + .+..++.+ +.+..++
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l 112 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 112 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence 56799999999999964 457899998653211 00 012345678888887642 3 34456644 3455789
Q ss_pred EEecCCCC
Q 005841 580 VTEFLPRG 587 (674)
Q Consensus 580 V~E~~~gg 587 (674)
||||+++.
T Consensus 113 vmE~l~g~ 120 (397)
T 2olc_A 113 VMEDLSHL 120 (397)
T ss_dssp EECCCTTS
T ss_pred EEEeCCCc
Confidence 99999764
|
| >4f3l_B BMAL1B; BHLH, PAS, circadian rhythm proteins, transcription-activato; 2.27A {Mus musculus} | Back alignment and structure |
|---|
Probab=97.88 E-value=2.8e-05 Score=83.89 Aligned_cols=61 Identities=18% Similarity=0.238 Sum_probs=53.0
Q ss_pred HHHHHHHHHHhcceeEEEcCC-CcEEeecHHHHHHhCCChhhHcCCCccccccccccchhHH
Q 005841 129 DRQYLNILQSMGQSVHIFDLS-DRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAY 189 (674)
Q Consensus 129 e~~l~~ilds~~d~I~v~D~~-GrIi~~N~a~e~llGys~eEviG~~~~~l~~~~~~~~~~~ 189 (674)
+++...+++++...|++++.+ |+|+|+|++++.+|||+.+|++|+.+.+++++++...+..
T Consensus 85 ~~~~~~ll~~~~gfi~v~~~~~G~i~yvs~~~~~~lG~~~~el~g~~~~~~ihp~D~~~~~~ 146 (387)
T 4f3l_B 85 DELKHLILRAADGFLFVVGCDRGKILFVSESVFKILNYSQNDLIGQSLFDYLHPKDIAKVKE 146 (387)
T ss_dssp HHHHHHHHHTCCSEEEEEETTTCBEEEECTTHHHHHSCCHHHHTTSBGGGGBCGGGHHHHHH
T ss_pred HHHHHHHHhcCCCEEEEEecCCeEEEEEchhhHHHcCCCHHHHCCCcHHHhcCCCCHHHHHH
Confidence 345566789999999999997 9999999999999999999999999999999887555443
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.75 E-value=0.00011 Score=76.94 Aligned_cols=77 Identities=22% Similarity=0.166 Sum_probs=61.0
Q ss_pred eEeeeecccCceEEEEEEEcCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCC---CCCeeeEEEEEecCCeEEEEEecC
Q 005841 508 TIGEQIGQGSCGTVYHAVWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLR---HPNVLLFMGAVTSPQRLCIVTEFL 584 (674)
Q Consensus 508 ~~~~~LG~G~fG~Vy~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~---HpnIv~l~~~~~~~~~~~lV~E~~ 584 (674)
.-.+.|+.|....+|+....+..+++|+..... ...+..|..+|+.|. ...|.+++.+....+..|+||||+
T Consensus 39 ~~~~~l~gG~~n~~y~v~~~~~~~vlK~~~~~~-----~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l 113 (312)
T 3jr1_A 39 KHKEKLYSGEMNEIWLINDEVQTVFVKINERSY-----RSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEAL 113 (312)
T ss_dssp CEEEEECCSSSSEEEEEESSSCEEEEEEEEGGG-----HHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECC
T ss_pred eeeEEeCCccceeeeEEEECCCeEEEEeCCccc-----HHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEec
Confidence 345678999999999998777889999876431 356778988888874 356788888888888999999999
Q ss_pred CCCCH
Q 005841 585 PRGSL 589 (674)
Q Consensus 585 ~ggsL 589 (674)
+|..+
T Consensus 114 ~G~~~ 118 (312)
T 3jr1_A 114 NKSKN 118 (312)
T ss_dssp CCCCC
T ss_pred cCCCC
Confidence 98753
|
| >3rty_A Period circadian protein; PAS domain, signalling, timeless, circadian clock protein; 2.85A {Drosophila melanogaster} PDB: 1wa9_A 3gec_A | Back alignment and structure |
|---|
Probab=97.65 E-value=0.00012 Score=77.48 Aligned_cols=98 Identities=15% Similarity=0.129 Sum_probs=66.5
Q ss_pred eEEEc-CCCcEEeecHHHHHHhCCChhhHcCCCccccccccccchhHHHHHHHHHhCcee------------EEEEEEEc
Q 005841 143 VHIFD-LSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGERW------------TGQFPAKT 209 (674)
Q Consensus 143 I~v~D-~~GrIi~~N~a~e~llGys~eEviG~~~~~l~~~~~~~~~~~~i~~~l~~g~~~------------~~e~~~~~ 209 (674)
++|++ .+|+|+|+|+.+..++||+.+|++|+++.+++++.+... ++..+..|.++ ..-.++++
T Consensus 6 ~~vv~~~~G~i~yvS~~~~~~LGy~~~el~G~s~~d~ihp~D~~~----f~~~L~~gl~~~~~~~~~~~~~rsffcR~~r 81 (339)
T 3rty_A 6 CCVISMHDGIVLYTTPSITDVLGYPRDMWLGRSFIDFVHLKDRAT----FASQITTGIPIAESRGSVPKDAKSTFCVMLR 81 (339)
T ss_dssp EEEEETTTCBEEEECTTHHHHHCCCTTSSTTSBGGGGBCHHHHHH----HHHHHHTTSCCC----------CCEEEEEEE
T ss_pred EEEEECCCcEEEEEChHHHHHcCCCHHHHCCCcHHHhcCHHHHHH----HHHHHhcCCCCCccccCCCCCCceEEEEEEe
Confidence 56778 699999999999999999999999999999999877444 44455555332 11112111
Q ss_pred ----------------CCCCEEEEEEEEEEEECC---------CCCEEEEEEEEEchHHH
Q 005841 210 ----------------KTEERVLVVATNTPFYDD---------DGTLVGIVCVSTDSRPF 244 (674)
Q Consensus 210 ----------------kdG~~~~v~~s~sPi~d~---------dG~ivg~i~i~rDITe~ 244 (674)
++...+|+..+..++.++ +|..++++++..+|+..
T Consensus 82 r~~~l~s~gy~v~~~~~~~~p~~l~~~~~~~~~e~~~~~~~~~~g~~~~lv~~a~~i~s~ 141 (339)
T 3rty_A 82 RYRGLKSGGFGVIGRPVSYEPFRLGLTFREAPEEARPDNYMVSNGTNMLLVICATPIKSS 141 (339)
T ss_dssp CCC-------------CCEEEEEEEEEEEECCCC----------CCCEEEEEEEEECCCS
T ss_pred ccCCCCcCCcceecccccceeEEEEEEEeccccccccccccccCCceEEEEEEcccCCcc
Confidence 122234555555555544 56677888889999853
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.64 E-value=0.00018 Score=78.27 Aligned_cols=76 Identities=14% Similarity=0.093 Sum_probs=45.1
Q ss_pred EeeeecccCceEEEEEEEcCCeEEEEEeecccC--CH-----HHHHHHHHHHHHHhh-CCCCCeeeEEEEEecCCeEEEE
Q 005841 509 IGEQIGQGSCGTVYHAVWYGSDVAVKVFSRQEY--SD-----EVIHSFRQEVSLMKR-LRHPNVLLFMGAVTSPQRLCIV 580 (674)
Q Consensus 509 ~~~~LG~G~fG~Vy~~~~~~~~vAvK~i~~~~~--~~-----~~~~~~~~Ei~il~~-l~HpnIv~l~~~~~~~~~~~lV 580 (674)
-.+.||.|....||++...+..|+||....... .. .....+..|+..+.. .....+.+++.+. ....++|
T Consensus 38 ~i~~l~~G~~n~vyrv~~~~~~~vvK~~~p~~~~~~~~~~~~~~~~~~E~e~l~~~~~~~~~~vP~v~~~~--~~~~~lv 115 (420)
T 2pyw_A 38 VIKEVGDGNLNFVFIVVGSSGSLVIKQALPYIRCIGESWPMTKERAYFEATTLRKHGNLSPDHVPEVYHFD--RTMALIG 115 (420)
T ss_dssp EEEECCCSSSCEEEEEECSSCEEEEEECCSBCTTTCTTSBCCTTHHHHHHHHHHHHHHHSGGGSCCEEEEE--TTTTEEE
T ss_pred EEEEccCCCcEEEEEEEcCCceEEEEECchhhcccCcccccchhHHHHHHHHHHHHHhhCCCCCCeEEEEC--CCccEEE
Confidence 356789999999999976677899994321100 00 011223333332221 1234566777665 5678999
Q ss_pred EecC-CC
Q 005841 581 TEFL-PR 586 (674)
Q Consensus 581 ~E~~-~g 586 (674)
|||+ ++
T Consensus 116 ~e~l~~g 122 (420)
T 2pyw_A 116 MRYLEPP 122 (420)
T ss_dssp ECCCCTT
T ss_pred EeecCCc
Confidence 9999 77
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.38 E-value=0.00081 Score=68.93 Aligned_cols=81 Identities=15% Similarity=0.117 Sum_probs=56.6
Q ss_pred cccCCeeEeeeecccCceEEEEEEE-cCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCC---CCeeeEEEEEecCCeE
Q 005841 502 ILWEDLTIGEQIGQGSCGTVYHAVW-YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRH---PNVLLFMGAVTSPQRL 577 (674)
Q Consensus 502 ~~~~~y~~~~~LG~G~fG~Vy~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~H---pnIv~l~~~~~~~~~~ 577 (674)
.......-.+.+|.|..+.||+.+. .|+.|.+|+........ ...|..|+..|+.|.- -.+.+++.+. .-
T Consensus 12 l~G~~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~--~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~ 85 (288)
T 3f7w_A 12 LTGREVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPAL--DGLFRAEALGLDWLGRSFGSPVPQVAGWD----DR 85 (288)
T ss_dssp HHCCCEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCC--TTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TT
T ss_pred hcCCCeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcch--hhHHHHHHHHHHHHHhhCCCCcceEEecc----Cc
Confidence 4455667788999999999999987 57889999865433221 1346779988888742 2345566543 24
Q ss_pred EEEEecCCCCC
Q 005841 578 CIVTEFLPRGS 588 (674)
Q Consensus 578 ~lV~E~~~ggs 588 (674)
++||||++++.
T Consensus 86 ~lv~e~l~~~~ 96 (288)
T 3f7w_A 86 TLAMEWVDERP 96 (288)
T ss_dssp EEEEECCCCCC
T ss_pred eEEEEeecccC
Confidence 78999998754
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.38 E-value=0.00035 Score=72.18 Aligned_cols=136 Identities=13% Similarity=0.090 Sum_probs=75.1
Q ss_pred eeeecccCceEEEEEEEcCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCe-eeEEEEEecCCeEEEEEecC-CCC
Q 005841 510 GEQIGQGSCGTVYHAVWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNV-LLFMGAVTSPQRLCIVTEFL-PRG 587 (674)
Q Consensus 510 ~~~LG~G~fG~Vy~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnI-v~l~~~~~~~~~~~lV~E~~-~gg 587 (674)
.+.|+.|....+|++ ..+++|+...... ......+|+.+++.+...++ .+++.+ +.+.-++|+||+ +|.
T Consensus 23 i~~l~gG~tN~~~~~----~~~vlR~~~~~~~---~~~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e~i~~g~ 93 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA----GDLCLRIPGKGTE---EYINRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTRYIAGAQ 93 (301)
T ss_dssp CEEEESCSSEEEEEE----TTEEEEEECC-------CCCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEECCTTCE
T ss_pred eeEcCCcccccccee----eeEEEECCCCCcc---ceeCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEeecCCCc
Confidence 567888999999998 6799998764311 11123457777776642222 355543 344457899999 664
Q ss_pred CHHH---------------HH---HhcCCCC----CH-HHHHHHHHH--------------HHHHHHH----HH--hCCC
Q 005841 588 SLFR---------------LL---QRNTTKL----DW-RRRILMALD--------------IARGVSY----LH--HCNP 624 (674)
Q Consensus 588 sL~~---------------~l---~~~~~~l----~~-~~~~~i~~q--------------i~~~L~y----LH--~~~~ 624 (674)
+|.. .| +.....+ .. ..+..+... +...+.. |. ....
T Consensus 94 ~l~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~~~~~~~ 173 (301)
T 3dxq_A 94 TMSPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALAAHPLPL 173 (301)
T ss_dssp ECCHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHHSSCCCC
T ss_pred cCCHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCc
Confidence 4321 01 1111111 11 111111111 1111111 11 1122
Q ss_pred CeEEccCCCCCEEEcCCCcEEEEecCCcccc
Q 005841 625 PIIHRDLKSSNLLVDKHWTVKVGDFGLSRLK 655 (674)
Q Consensus 625 ~IvHrDLKp~NILi~~~~~vkL~DFGla~~~ 655 (674)
.++|+|+.+.||| ..++.+.|+||..+..-
T Consensus 174 ~l~HgDl~~~Nil-~~~~~~~lID~e~a~~g 203 (301)
T 3dxq_A 174 AACHCDPLCENFL-DTGERMWIVDWEYSGMN 203 (301)
T ss_dssp EEECSCCCGGGEE-ECSSCEEECCCTTCEEE
T ss_pred eeeccCCCcCCEE-ECCCCEEEEecccccCC
Confidence 3799999999999 55668899999998753
|
| >1oj5_A Steroid receptor coactivator 1A; transcriptional coactivator, complex, LXXLL motif, transcriptional regulation; 2.2A {Mus musculus} SCOP: d.110.3.8 | Back alignment and structure |
|---|
Probab=97.34 E-value=0.00042 Score=62.18 Aligned_cols=98 Identities=8% Similarity=-0.036 Sum_probs=76.6
Q ss_pred ceeEEEcCCCcEEeecHHHHHHhCCCh--hhHcCCCccccccccccc--hhHHHHHHHHHhCceeEEEEEEEcCCCCEEE
Q 005841 141 QSVHIFDLSDRIIYWNRSAELLYGYSA--EEALGQDAIELLTDGRDF--DVAYDIVHRIKMGERWTGQFPAKTKTEERVL 216 (674)
Q Consensus 141 d~I~v~D~~GrIi~~N~a~e~llGys~--eEviG~~~~~l~~~~~~~--~~~~~i~~~l~~g~~~~~e~~~~~kdG~~~~ 216 (674)
.-+.-.|.+|+|+++..... ..+|.. +|++|+.+.+++++.+.. .+.....+++..|+.....+++..++|..+|
T Consensus 8 ~F~sRh~~dGKf~~vDq~~~-r~~~~~g~qdLlGrsiy~f~H~~D~~~s~l~~h~~~vl~~Gq~~S~~YRfr~k~g~~V~ 86 (132)
T 1oj5_A 8 SFMTKQDTTGKIISIDTSSL-RAAGRTGWEDLVRKCIYAFFQPQGREPSYARQLFQEVMTRGTASSPSYRFILNDGTMLS 86 (132)
T ss_dssp EEEEEECTTCCEEEEECHHH-HTTCCSCHHHHHHHHHHHHTSCBTTBCCHHHHHHHHHHHHSEEECCCEEEECTTSCEEE
T ss_pred eeEEeecCCCcEEEEecccc-cccccccHHHHHHHHHHHHhCcccchHHHHHHHHHHHHHcCCccccceEEEecCCcEEE
Confidence 34556789999999999887 477877 999999999999988854 5555566778888888888999999999999
Q ss_pred EEEEEEEEECCC-CCEEEEEEEEE
Q 005841 217 VVATNTPFYDDD-GTLVGIVCVST 239 (674)
Q Consensus 217 v~~s~sPi~d~d-G~ivg~i~i~r 239 (674)
+......+++.- .++-.+|++-.
T Consensus 87 ~qT~sk~f~np~t~e~e~Ivs~n~ 110 (132)
T 1oj5_A 87 AHTRCKLCYPQSPDMQPFIMGIHI 110 (132)
T ss_dssp EEEEEEEECC----CCCEEEEEEE
T ss_pred EEEEEEEecCCCCCCCCEEEEEEE
Confidence 999999988752 34445555433
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.33 E-value=0.001 Score=69.04 Aligned_cols=143 Identities=16% Similarity=0.153 Sum_probs=80.1
Q ss_pred eEeeeecccCceEEEEEEEcCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCC--eeeEEEE------EecCCeEEE
Q 005841 508 TIGEQIGQGSCGTVYHAVWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPN--VLLFMGA------VTSPQRLCI 579 (674)
Q Consensus 508 ~~~~~LG~G~fG~Vy~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hpn--Iv~l~~~------~~~~~~~~l 579 (674)
.-.+.|+.|....||++...+..+++|+....... ..+..|+.++..|...+ +..++.. ....+..++
T Consensus 25 ~~~~~i~~G~~n~~~~v~~~~g~~vlk~~~~~~~~----~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~ 100 (322)
T 2ppq_A 25 TSYKGIAEGVENSNFLLHTTKDPLILTLYEKRVEK----NDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAA 100 (322)
T ss_dssp EEEEEECC---EEEEEEEESSCCEEEEEECC---C----CHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEE
T ss_pred eEeeccCCCcccceEEEEeCCccEEEEEeCCCCCH----HHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEE
Confidence 34566788888999999876668999988653111 23445777776663211 2333311 123466799
Q ss_pred EEecCCCCCHH-----------HH---HHhcCCC--------CC---HHHHHH------------HHHHHHHHHHHHHhC
Q 005841 580 VTEFLPRGSLF-----------RL---LQRNTTK--------LD---WRRRIL------------MALDIARGVSYLHHC 622 (674)
Q Consensus 580 V~E~~~ggsL~-----------~~---l~~~~~~--------l~---~~~~~~------------i~~qi~~~L~yLH~~ 622 (674)
||+|++|..+. .. ++..... .. |..... +...+...+.++...
T Consensus 101 l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~ 180 (322)
T 2ppq_A 101 LISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAH 180 (322)
T ss_dssp EEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHH
T ss_pred EEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhh
Confidence 99999885421 11 1111101 11 111000 001133445555531
Q ss_pred -----CCCeEEccCCCCCEEEcCCCcEEEEecCCccc
Q 005841 623 -----NPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL 654 (674)
Q Consensus 623 -----~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~ 654 (674)
...+||+|+.+.|||++.++.+.|+||+.+..
T Consensus 181 ~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~ 217 (322)
T 2ppq_A 181 WPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 217 (322)
T ss_dssp CCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred CcccCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence 12489999999999999876668999999865
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.24 E-value=0.00052 Score=71.82 Aligned_cols=138 Identities=16% Similarity=0.124 Sum_probs=71.7
Q ss_pred eeecccCceE-EEEEEEc-CCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCC--CCeeeEEEEEecCCeEEEEEecCCC
Q 005841 511 EQIGQGSCGT-VYHAVWY-GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRH--PNVLLFMGAVTSPQRLCIVTEFLPR 586 (674)
Q Consensus 511 ~~LG~G~fG~-Vy~~~~~-~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~H--pnIv~l~~~~~~~~~~~lV~E~~~g 586 (674)
+.|..|.... +|+.... +..+++|....... ..+..|+.++..+.. -.+.+++.+....+ ++|||++.+
T Consensus 24 ~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~~-----~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~l~~ 96 (333)
T 3csv_A 24 TPLAGDASSRRYQRLRSPTGAKAVLMDWSPEEG-----GDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIEDLGD 96 (333)
T ss_dssp CC--------CCEEEECTTCCEEEEEECCTTTT-----CCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECCCCS
T ss_pred eECCCCCCCceEEEEEcCCCCeEEEEECCCCCC-----ccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEeeCCC
Confidence 3454454443 6676653 66788886544321 123346666666532 23556666543333 789999977
Q ss_pred CCHHHHHHhcC-------------------------CCCCHHHHH--------HHH------------HHHHHHHHHHH-
Q 005841 587 GSLFRLLQRNT-------------------------TKLDWRRRI--------LMA------------LDIARGVSYLH- 620 (674)
Q Consensus 587 gsL~~~l~~~~-------------------------~~l~~~~~~--------~i~------------~qi~~~L~yLH- 620 (674)
..+.+.+.... ..++..... .+. ..+...+..|-
T Consensus 97 ~~l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~ 176 (333)
T 3csv_A 97 ALFTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILS 176 (333)
T ss_dssp CBHHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHH
T ss_pred cchHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHH
Confidence 67654432110 112221110 000 01112222331
Q ss_pred ---hCCCCeEEccCCCCCEEEcCC----CcEEEEecCCcccc
Q 005841 621 ---HCNPPIIHRDLKSSNLLVDKH----WTVKVGDFGLSRLK 655 (674)
Q Consensus 621 ---~~~~~IvHrDLKp~NILi~~~----~~vkL~DFGla~~~ 655 (674)
.....+||+|+.+.|||++.+ +.+.|+||+.+..-
T Consensus 177 ~~~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 177 AQLEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp HHCCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred hcccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 112348999999999999874 68999999998754
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.02 E-value=0.0013 Score=71.82 Aligned_cols=71 Identities=14% Similarity=0.224 Sum_probs=47.3
Q ss_pred EeeeecccCceEEEEEEEc---------CCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCe-eeEEEEEecCCeEE
Q 005841 509 IGEQIGQGSCGTVYHAVWY---------GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNV-LLFMGAVTSPQRLC 578 (674)
Q Consensus 509 ~~~~LG~G~fG~Vy~~~~~---------~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnI-v~l~~~~~~~~~~~ 578 (674)
-.+.|+.|-...||++... +..|++|+..... . ...+..|+.++..|...+| .++++.+.. .
T Consensus 77 ~v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~-~---~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g 148 (429)
T 1nw1_A 77 RISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE-T---ESHLVAESVIFTLLSERHLGPKLYGIFSG----G 148 (429)
T ss_dssp EEEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC-C---HHHHHHHHHHHHHHHHTTSSSCEEEEETT----E
T ss_pred EEEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCC-c---HHHHHHHHHHHHHHHhCCCCCcEEEEeCC----C
Confidence 3457888888999999864 3679999884321 2 1234468888888753333 566665542 3
Q ss_pred EEEecCCCC
Q 005841 579 IVTEFLPRG 587 (674)
Q Consensus 579 lV~E~~~gg 587 (674)
+||||++|.
T Consensus 149 ~v~e~l~G~ 157 (429)
T 1nw1_A 149 RLEEYIPSR 157 (429)
T ss_dssp EEECCCCEE
T ss_pred EEEEEeCCc
Confidence 899999863
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.82 E-value=0.0036 Score=65.93 Aligned_cols=31 Identities=23% Similarity=0.370 Sum_probs=27.8
Q ss_pred CeEEccCCCCCEEEcCCCcEEEEecCCcccc
Q 005841 625 PIIHRDLKSSNLLVDKHWTVKVGDFGLSRLK 655 (674)
Q Consensus 625 ~IvHrDLKp~NILi~~~~~vkL~DFGla~~~ 655 (674)
.++|+|+.+.|||++.++.+.|+||+.+...
T Consensus 207 ~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~~ 237 (339)
T 3i1a_A 207 VLCHSDIHAGNVLVGNEESIYIIDWDEPMLA 237 (339)
T ss_dssp EEECSCCCGGGEEECGGGCEEECCCSSCEEE
T ss_pred eeEeCCCCcCCEEEeCCCeEEEEECCCCeeC
Confidence 4899999999999998888999999988753
|
| >4dj2_A Period circadian protein homolog 1; PAS domains, circadian clock protein, protein binding; 2.75A {Mus musculus} | Back alignment and structure |
|---|
Probab=96.73 E-value=0.00069 Score=70.93 Aligned_cols=66 Identities=18% Similarity=0.107 Sum_probs=55.9
Q ss_pred cccccHHHHHHH-----HHHhcceeEEEcCC-CcEEeecHHHHHHhCCChhhHcCCCccccccccccchhHH
Q 005841 124 AFNFTDRQYLNI-----LQSMGQSVHIFDLS-DRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAY 189 (674)
Q Consensus 124 ~~~~se~~l~~i-----lds~~d~I~v~D~~-GrIi~~N~a~e~llGys~eEviG~~~~~l~~~~~~~~~~~ 189 (674)
...++.+.|..+ |+++..-++|+..+ |+|+|+++.+..+|||+.+|++|+.+.+++++.+...+..
T Consensus 15 ~~~~s~eel~~l~~e~lLqaldGF~~vvs~~~G~i~yvS~sv~~~Lg~~~~~l~g~s~~d~iHp~D~~~f~~ 86 (320)
T 4dj2_A 15 MSTYTLEELEHITSEYTLRNQDTFSVAVSFLTGRIVYISEQAGVLLRCKRDVFRGARFSELLAPQDVGVFYG 86 (320)
T ss_dssp CSEECHHHHHHHHHHHTTSCSSEEEEEEETTTCBEEEECTHHHHHHTSCSTTTTTSBGGGGBCHHHHHHHHH
T ss_pred ccccCHHHHHHHHHHHHHhccCCEEEEEECCCceEEEECcHHHHHhCcCHHHHcCCcHHHhcCHHHHHHHHH
Confidence 345788888887 67777778888885 9999999999999999999999999999999887554443
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.72 E-value=0.0071 Score=62.75 Aligned_cols=138 Identities=11% Similarity=0.050 Sum_probs=77.5
Q ss_pred eecccCceEEEEEEEc-CCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCC--CCeeeEEEE-----EecCCeEEEEEec
Q 005841 512 QIGQGSCGTVYHAVWY-GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRH--PNVLLFMGA-----VTSPQRLCIVTEF 583 (674)
Q Consensus 512 ~LG~G~fG~Vy~~~~~-~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~H--pnIv~l~~~-----~~~~~~~~lV~E~ 583 (674)
.|+ |....||++... +..+++|+........ ..+..|..++..+.. -.++.++.. ....+..++||+|
T Consensus 33 ~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~~~~---~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~ 108 (328)
T 1zyl_A 33 PLN-SYENRVYQFQDEDRRRFVVKFYRPERWTA---DQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPS 108 (328)
T ss_dssp EEC-CSSSEEEEECCTTCCCEEEEEECTTTSCH---HHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEEC
T ss_pred eec-CcccceEEEEcCCCCEEEEEEcCCCCCCH---HHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEe
Confidence 456 777899988753 5579999986443333 234557777776642 123344332 2234567899999
Q ss_pred CCCCCH-----HH------HH---Hhc--------CCCCCHHHH----HHHH---------------HHHHHHHHHHHh-
Q 005841 584 LPRGSL-----FR------LL---QRN--------TTKLDWRRR----ILMA---------------LDIARGVSYLHH- 621 (674)
Q Consensus 584 ~~ggsL-----~~------~l---~~~--------~~~l~~~~~----~~i~---------------~qi~~~L~yLH~- 621 (674)
++|..+ .. .| +.. ...+++... ..++ ..+-..+..+..
T Consensus 109 i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 188 (328)
T 1zyl_A 109 VGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAH 188 (328)
T ss_dssp CCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHH
T ss_pred cCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHH
Confidence 987432 11 11 110 011222111 0010 011112233321
Q ss_pred ----CCCCeEEccCCCCCEEEcCCCcEEEEecCCcccc
Q 005841 622 ----CNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLK 655 (674)
Q Consensus 622 ----~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~ 655 (674)
....+||+|+++.|||++ + .+.|+||+.+..-
T Consensus 189 ~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~g 224 (328)
T 1zyl_A 189 WREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARNG 224 (328)
T ss_dssp CCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCEE
T ss_pred hhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCcC
Confidence 223378999999999999 4 8999999988753
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.67 E-value=0.0049 Score=67.74 Aligned_cols=73 Identities=14% Similarity=0.114 Sum_probs=46.8
Q ss_pred EeeeecccCceEEEEEEEcC--CeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCe-eeEEEEEecCCeEEEEEecCC
Q 005841 509 IGEQIGQGSCGTVYHAVWYG--SDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNV-LLFMGAVTSPQRLCIVTEFLP 585 (674)
Q Consensus 509 ~~~~LG~G~fG~Vy~~~~~~--~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnI-v~l~~~~~~~~~~~lV~E~~~ 585 (674)
-.+.|+.|-...+|++...+ ..|++|+...... ..+ ...+|..++..|...++ .++++.+. + .+||||++
T Consensus 112 ~i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~--~~i-dR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~ 184 (458)
T 2qg7_A 112 EFQIINGGITNILIKVKDMSKQAKYLIRLYGPKTD--EII-NREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMD 184 (458)
T ss_dssp EEEEECC--CEEEEEEEETTTTEEEEEEEECC-CC--SCS-CHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCC
T ss_pred EEEEcCCCeEeEEEEEEECCCCceEEEEECCCChh--hhc-CHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeC
Confidence 34578888889999998865 6799998754321 111 12468888888864444 46777663 2 35999998
Q ss_pred CCC
Q 005841 586 RGS 588 (674)
Q Consensus 586 ggs 588 (674)
|..
T Consensus 185 G~~ 187 (458)
T 2qg7_A 185 GYA 187 (458)
T ss_dssp SEE
T ss_pred Ccc
Confidence 743
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.63 E-value=0.0016 Score=69.32 Aligned_cols=72 Identities=11% Similarity=0.152 Sum_probs=42.9
Q ss_pred eeeecccCceEEEEEEEcC----------CeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCC-eeeEEEEEecCCeEE
Q 005841 510 GEQIGQGSCGTVYHAVWYG----------SDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPN-VLLFMGAVTSPQRLC 578 (674)
Q Consensus 510 ~~~LG~G~fG~Vy~~~~~~----------~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hpn-Iv~l~~~~~~~~~~~ 578 (674)
.+.|+.|....+|++...+ ..|++|+..... ........|..+++.+...+ +.++++.+ . -+
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~---~~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~ 110 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHV---DELYNTISEFEVYKTMSKYKIAPQLLNTF--N--GG 110 (369)
T ss_dssp EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTG---GGTSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TE
T ss_pred EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCc---cceecHHHHHHHHHHHHhcCCCCceEEec--C--Cc
Confidence 4567888888999998753 678999875421 11112356788887775323 34666544 2 26
Q ss_pred EEEecCCCCC
Q 005841 579 IVTEFLPRGS 588 (674)
Q Consensus 579 lV~E~~~ggs 588 (674)
+||||++|..
T Consensus 111 ~v~e~i~G~~ 120 (369)
T 3c5i_A 111 RIEEWLYGDP 120 (369)
T ss_dssp EEEECCCSEE
T ss_pred EEEEEecCCc
Confidence 8999998753
|
| >4dj3_A Period circadian protein homolog 3; PAS domain, circadian rhythm, protein binding; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=96.49 E-value=0.00074 Score=70.61 Aligned_cols=55 Identities=11% Similarity=0.077 Sum_probs=48.9
Q ss_pred HHHHhcceeEEEcCC-CcEEeecHHHHHHhCCChhhHcCCCccccccccccchhHH
Q 005841 135 ILQSMGQSVHIFDLS-DRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAY 189 (674)
Q Consensus 135 ilds~~d~I~v~D~~-GrIi~~N~a~e~llGys~eEviG~~~~~l~~~~~~~~~~~ 189 (674)
+|+++..-++|++.+ |+|+|+++++..+|||+.+|++|+.+.+++++.+...+..
T Consensus 31 ~L~aldgF~~vvs~~~G~i~yvS~~~~~~Lg~~~~el~g~s~~d~ihp~D~~~f~~ 86 (317)
T 4dj3_A 31 TSKNTDTFAAVFSFLSGRLVHISEQAALILNSKRGFLKSVHFVDLLAPQDVRAFYA 86 (317)
T ss_dssp HTSCTTEEEEEEETTTCBEEEECTTHHHHTTCCHHHHHTSBGGGGBCGGGHHHHHH
T ss_pred HHhccCCEEEEEEcCCcEEEEECCHHHHHcCCCHHHHcCCchhhhcChhhHHHHHH
Confidence 488888888999985 9999999999999999999999999999999988555443
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.41 E-value=0.0076 Score=64.55 Aligned_cols=137 Identities=12% Similarity=0.159 Sum_probs=79.8
Q ss_pred eeecccCceEEEEEEEc---------CCeEEEEEeecccCCHHHHHHHHHHHHHHhhCC-CCCeeeEEEEEecCCeEEEE
Q 005841 511 EQIGQGSCGTVYHAVWY---------GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLR-HPNVLLFMGAVTSPQRLCIV 580 (674)
Q Consensus 511 ~~LG~G~fG~Vy~~~~~---------~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~lV 580 (674)
+.|..|-...+|++... +..|++|+..... .....+.+|..+++.|. +.-..++++++.. .+|
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~---~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v 128 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAIL---QGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRL 128 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC------CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEE
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCcc---chHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccE
Confidence 46767777889998763 3579999863321 11344567999888875 2223566666543 299
Q ss_pred EecCCCCCHH--------------HHHH---hcC----CCCC--HHHHHHHHHHHHH-------------------HHHH
Q 005841 581 TEFLPRGSLF--------------RLLQ---RNT----TKLD--WRRRILMALDIAR-------------------GVSY 618 (674)
Q Consensus 581 ~E~~~ggsL~--------------~~l~---~~~----~~l~--~~~~~~i~~qi~~-------------------~L~y 618 (674)
|||++|..|. +.|. ... .... +..+..+..++-. .+.+
T Consensus 129 ~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 208 (379)
T 3feg_A 129 EQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGN 208 (379)
T ss_dssp EECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHH
T ss_pred EEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHH
Confidence 9999875432 1111 111 1122 3455555544321 2333
Q ss_pred HH----hC--CCCeEEccCCCCCEEEcCC----CcEEEEecCCccc
Q 005841 619 LH----HC--NPPIIHRDLKSSNLLVDKH----WTVKVGDFGLSRL 654 (674)
Q Consensus 619 LH----~~--~~~IvHrDLKp~NILi~~~----~~vkL~DFGla~~ 654 (674)
|. .. ...++|+|+.+.|||++.+ +.+.|+||..|..
T Consensus 209 L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 209 LRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 32 22 1248999999999999876 7899999999975
|
| >3gdi_A Period circadian protein homolog 2; tandem PAS domains, biological rhythms, cytoplasm, nucleus, phosphoprotein, transcription; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=96.24 E-value=0.0012 Score=68.91 Aligned_cols=56 Identities=11% Similarity=0.122 Sum_probs=40.0
Q ss_pred HHHHHhcceeEEEcCC-CcEEeecHHHHHHhCCChhhHcCCCccccccccccchhHH
Q 005841 134 NILQSMGQSVHIFDLS-DRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAY 189 (674)
Q Consensus 134 ~ilds~~d~I~v~D~~-GrIi~~N~a~e~llGys~eEviG~~~~~l~~~~~~~~~~~ 189 (674)
-+|+++..-++|++.+ |+|+|+++++..+|||+.+|++|+.+.+++++++...+..
T Consensus 19 lll~a~dgF~~vvs~~~G~i~yvS~s~~~~Lg~~~~el~g~s~~d~iHp~D~~~~~~ 75 (309)
T 3gdi_A 19 YIVKNADMFAVAVSLVSGKILYISNQVASIFHCKKDAFSDAKFVEFLAPHDVSVFHS 75 (309)
T ss_dssp ----CTTEEEEEECTTTCBEEEECTTTTTTC-------CCSBGGGGBCTTTHHHHHH
T ss_pred HHHHhcCCEEEEEECCCceEEEECCHHHHHcCCCHHHHcCCchhhccCHhHHHHHHH
Confidence 4688888889999986 9999999999999999999999999999999988554443
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=95.19 E-value=0.018 Score=62.50 Aligned_cols=72 Identities=10% Similarity=0.133 Sum_probs=46.1
Q ss_pred eeeecccCceEEEEEEEc---------CCeEEEEEeecccCCHHHHHHHHHHHHHHhhCC-CCCeeeEEEEEecCCeEEE
Q 005841 510 GEQIGQGSCGTVYHAVWY---------GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLR-HPNVLLFMGAVTSPQRLCI 579 (674)
Q Consensus 510 ~~~LG~G~fG~Vy~~~~~---------~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~l 579 (674)
.+.|..|-...+|++... +..|++|+..... +......+|..+++.+. +.-..++++.+. -++
T Consensus 75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t---~~~idR~~E~~~l~~L~~~gi~P~l~~~~~----~~~ 147 (424)
T 3mes_A 75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV---GKFYDSKVELDVFRYLSNINIAPNIIADFP----EGR 147 (424)
T ss_dssp EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC----CCCCHHHHHHHHHHHHHTTSSCCEEEEET----TEE
T ss_pred EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc---chhcCHHHHHHHHHHHHhcCCCCCEEEEcC----CCE
Confidence 456777888899999875 5779999865432 11112346788887774 222345555432 278
Q ss_pred EEecCCCCC
Q 005841 580 VTEFLPRGS 588 (674)
Q Consensus 580 V~E~~~ggs 588 (674)
||||++|..
T Consensus 148 I~efI~G~~ 156 (424)
T 3mes_A 148 IEEFIDGEP 156 (424)
T ss_dssp EEECCCSEE
T ss_pred EEEEeCCcc
Confidence 999999854
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=92.90 E-value=0.22 Score=53.39 Aligned_cols=29 Identities=24% Similarity=0.394 Sum_probs=25.3
Q ss_pred eEEccCCCCCEEE------cCCCcEEEEecCCccc
Q 005841 626 IIHRDLKSSNLLV------DKHWTVKVGDFGLSRL 654 (674)
Q Consensus 626 IvHrDLKp~NILi------~~~~~vkL~DFGla~~ 654 (674)
++|.|+.+.|||+ +.+..|+|+||.+|..
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 5799999999999 4567899999999975
|
| >2ool_A Sensor protein; bacteriophytochrome, photoconversion, photoreceptor, biliver signaling protein; HET: LBV; 2.20A {Rhodopseudomonas palustris} SCOP: d.110.2.1 d.110.3.9 | Back alignment and structure |
|---|
Probab=92.59 E-value=0.18 Score=52.76 Aligned_cols=75 Identities=15% Similarity=0.085 Sum_probs=49.3
Q ss_pred eEEEcC-CCcEEeecHHHHHHhCCChhhHcCCCccccccccccchhHHHHHHHHHhCce---eEEEEEEEcC-CCCEEEE
Q 005841 143 VHIFDL-SDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGER---WTGQFPAKTK-TEERVLV 217 (674)
Q Consensus 143 I~v~D~-~GrIi~~N~a~e~llGys~eEviG~~~~~l~~~~~~~~~~~~i~~~l~~g~~---~~~e~~~~~k-dG~~~~v 217 (674)
++++|. +++|+++|..+++++|+++++++|+++.+++++.... .+...+..+.. ....+.+... +|..+|+
T Consensus 45 Ll~~~~~~~~i~~~S~N~~~~lg~~~~~llG~~l~~ll~~~~~~----~l~~~l~~~~~~~~~p~~~~~~~~~~~~~f~~ 120 (337)
T 2ool_A 45 LFVVSETDLRIASVSANVEDLLRQPPASLLNVPIAHYLTAASAA----RLTHALHGGDPAAINPIRLDVVTPDGERAFNG 120 (337)
T ss_dssp EEEECTTTCBEEEEETTHHHHHSSCGGGGTTCBGGGGBCHHHHH----HHHHHHCC----CCCSEEEEEEETTEEEEEEE
T ss_pred EEEEECCCCEEEEEehhHHHHHCcCHHHHcCCCHHHHcCHHHHH----HHHHHHhcCCccccCcEEEEEeccCCCeEEEE
Confidence 456776 5999999999999999999999999999999864422 23333433221 2223344333 3556776
Q ss_pred EEEE
Q 005841 218 VATN 221 (674)
Q Consensus 218 ~~s~ 221 (674)
.+..
T Consensus 121 ~~Hr 124 (337)
T 2ool_A 121 ILHR 124 (337)
T ss_dssp EEEE
T ss_pred EEEE
Confidence 5554
|
| >1p0z_A Sensor kinase CITA; transferase; HET: FLC MO7; 1.60A {Klebsiella pneumoniae} SCOP: d.110.6.1 PDB: 2v9a_A 2j80_A* | Back alignment and structure |
|---|
Probab=91.84 E-value=1.4 Score=38.95 Aligned_cols=87 Identities=15% Similarity=0.164 Sum_probs=51.3
Q ss_pred HHHHHHHHhc-ceeEEEcCCCcEEeecHHHHHHhCCChhhHcCCCccccccccccchhHHHHHHHHHhCceeEEEEEEEc
Q 005841 131 QYLNILQSMG-QSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGERWTGQFPAKT 209 (674)
Q Consensus 131 ~l~~ilds~~-d~I~v~D~~GrIi~~N~a~e~llGys~eEviG~~~~~l~~~~~~~~~~~~i~~~l~~g~~~~~e~~~~~ 209 (674)
.++.+-+... +.|+++|.+|.+++... .+.+|+++.. .+. +..++ .|+.+.... ..
T Consensus 40 ~~~~~~~~~~~~~i~v~d~~G~~~a~~~----------~~~iG~~~~~---~~~-------~~~al-~G~~~~~~~--~g 96 (131)
T 1p0z_A 40 LIDPMRSFSDATYITVGDASGQRLYHVN----------PDEIGKSMEG---GDS-------DEALI-NAKSYVSVR--KG 96 (131)
T ss_dssp HHHHHHHHSCCSEEEEEETTSBEEECSS----------GGGTTSBCCS---SCC-------HHHHH-HCCCEEEEE--EE
T ss_pred HHHHHHHhcCCCEEEEEcCCCcEEEecC----------hhhCCCcccC---CCc-------HHHHh-CCCeEEEEE--Ec
Confidence 3444444333 47889999998876542 3457764321 111 23334 576655432 11
Q ss_pred CCCCEEEEEEEEEEEECCCCCEEEEEEEEEchHH
Q 005841 210 KTEERVLVVATNTPFYDDDGTLVGIVCVSTDSRP 243 (674)
Q Consensus 210 kdG~~~~v~~s~sPi~d~dG~ivg~i~i~rDITe 243 (674)
..| . ......||++++|+++|++++..++..
T Consensus 97 ~~g--~-~~~~~~PV~~~~g~viGvv~vg~~l~~ 127 (131)
T 1p0z_A 97 SLG--S-SLRGKSPIQDATGKVIGIVSVGYTIEQ 127 (131)
T ss_dssp TTE--E-EEEEEEEEECTTCCEEEEEEEEEEGGG
T ss_pred cce--e-eEEEEEeEECCCCCEEEEEEEEEEhHH
Confidence 112 2 233445999888999999999888764
|
| >3ra3_B P2F; coiled coil domain, fiber, KIH interactions, synthetic biolo helical reconstruction, de novo protein; HET: PHI; 2.31A {Synthetic} | Back alignment and structure |
|---|
Probab=89.58 E-value=0.11 Score=31.67 Aligned_cols=20 Identities=40% Similarity=0.609 Sum_probs=14.1
Q ss_pred HHHHHHHhHHHHHHhhcccc
Q 005841 14 KIQELEAGQEHLKQELSKLK 33 (674)
Q Consensus 14 ~~~~l~~~~~~l~~~~~~~~ 33 (674)
||++|.+..+.||||++.|.
T Consensus 1 kirrlkqknarlkqeiaale 20 (28)
T 3ra3_B 1 KIRRLKQKNARLKQEIAALE 20 (28)
T ss_dssp --CHHHHHHHHHHHHHHHHH
T ss_pred ChhHHHHhhhHHHHHHHHHH
Confidence 57788888888888887663
|
| >3by8_A Sensor protein DCUS; histidine kinase sensor domain, inner membrane, membrane, phosphoprotein, transferase, transmembrane; 1.45A {Escherichia coli} SCOP: d.110.6.1 PDB: 1ojg_A | Back alignment and structure |
|---|
Probab=89.19 E-value=1.6 Score=39.20 Aligned_cols=91 Identities=14% Similarity=0.196 Sum_probs=54.9
Q ss_pred HHHHHHHHHHhc-ceeEEEcCCCcEEeecHHHHHHhCCChhhHcCCCccccccccccchhHHHHHHHHHhCceeEEEEEE
Q 005841 129 DRQYLNILQSMG-QSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGERWTGQFPA 207 (674)
Q Consensus 129 e~~l~~ilds~~-d~I~v~D~~GrIi~~N~a~e~llGys~eEviG~~~~~l~~~~~~~~~~~~i~~~l~~g~~~~~e~~~ 207 (674)
...++.+-+... +.|+++|.+|.+++... .+.+|+++.. + . +..++ .|+.+....
T Consensus 44 ~~~~~~~~~~~~~~~i~v~d~~G~~~~~~~----------~~~iG~~~~~---~-~-------~~~al-~G~~~~~~~-- 99 (142)
T 3by8_A 44 QAIAEAVRKRNDLLFIVVTDMQSLRYSHPE----------AQRIGQPFKG---D-D-------ILKAL-NGEENVAIN-- 99 (142)
T ss_dssp HHHHHHHHHHTTCSEEEEEETTCBBSCCSS----------GGGTTSBCCC---G-G-------GTGGG-GTCCEEEEE--
T ss_pred HHHHHHHHhhcCCcEEEEECCCCcEEECCC----------hHHCCCcCCC---C-C-------HHHHh-CCCeEEEEe--
Confidence 345555554443 47889999998776432 3468875431 1 1 11222 566554421
Q ss_pred EcCCCCEEEEEEEEEEEECCCCCEEEEEEEEEchHHHHH
Q 005841 208 KTKTEERVLVVATNTPFYDDDGTLVGIVCVSTDSRPFQE 246 (674)
Q Consensus 208 ~~kdG~~~~v~~s~sPi~d~dG~ivg~i~i~rDITe~k~ 246 (674)
....|.. .....||++++|+++|++++..++.....
T Consensus 100 ~~~~g~~---~~~~~PV~~~~g~viGvv~vg~~~~~~~~ 135 (142)
T 3by8_A 100 RGFLAQA---LRVFTPIYDENHKQIGVVAIGLELSRVTQ 135 (142)
T ss_dssp CSSSSCE---EEEEEEEECTTSCEEEEEEEEEEHHHHHH
T ss_pred cCccEEE---EEEEEeEEcCCCCEEEEEEEeEEHHHHHH
Confidence 2222322 23344999878999999999999887654
|
| >3lif_A Putative diguanylate cyclase (ggdef) with PAS/PAC; PDC fold, signaling protein; HET: CIT; 2.70A {Rhodopseudomonas palustris} | Back alignment and structure |
|---|
Probab=84.55 E-value=11 Score=36.63 Aligned_cols=96 Identities=14% Similarity=0.138 Sum_probs=56.6
Q ss_pred HHHHHHHHHHhcc--eeEEEcCCCcEEeecHHHHHHhCCChhhHcCCCccccccccccchhHHHHHHHHH--hCceeEEE
Q 005841 129 DRQYLNILQSMGQ--SVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIK--MGERWTGQ 204 (674)
Q Consensus 129 e~~l~~ilds~~d--~I~v~D~~GrIi~~N~a~e~llGys~eEviG~~~~~l~~~~~~~~~~~~i~~~l~--~g~~~~~e 204 (674)
...|..++...+. .|+++|.+|+ ++.... . ...+.+ + ..... +...+. .++.+..+
T Consensus 57 ~~~L~~~~~~~~~~~~i~i~d~~G~-~~~s~~------~---~~~~~~---~----~~r~~---f~~a~~~~~~~~~is~ 116 (254)
T 3lif_A 57 NERLRALADNLPQLSDVAILDADGQ-LTYASV------K---PVPALD---N----SDRSY---FRYHRANDDHTLLITG 116 (254)
T ss_dssp HHHHHHHHHHCTTEEEEEEECTTSB-EEEESS------S---SEECCB---C----TTSHH---HHHHHHCCCCCCEEEE
T ss_pred HHHHHHHHhcCCccceEEEECCCCC-EecCCC------C---CCCCCC---c----ccHHH---HHHHHhCCCCCeEECC
Confidence 4467777776664 7899999999 554321 0 011111 1 11111 233344 45555554
Q ss_pred EEEEcCCCCEEEEEEEEEEEECCCCCEEEEEEEEEchHHHHH
Q 005841 205 FPAKTKTEERVLVVATNTPFYDDDGTLVGIVCVSTDSRPFQE 246 (674)
Q Consensus 205 ~~~~~kdG~~~~v~~s~sPi~d~dG~ivg~i~i~rDITe~k~ 246 (674)
...-...|. |+..-..||++.+|+++|++++..|+....+
T Consensus 117 p~~~~~~g~--~~i~~~~pi~~~~g~~~Gvl~~~i~l~~l~~ 156 (254)
T 3lif_A 117 PIQSRTSGV--WVFVVSRRLETTDGKFFGVVVATIESEYFST 156 (254)
T ss_dssp EEECTTTCC--EEEEEEEEEECTTCCEEEEEEEEECHHHHHH
T ss_pred ceecCCCCc--EEEEEEeeeeCCCCCEeEEEEEEECHHHHHH
Confidence 433333454 4456677999989999999999999866543
|
| >4e04_A Bacteriophytochrome (light-regulated signal trans histidine kinase), PHYB1; bacteriophytochrome chromophore binding domain; HET: LBV; 1.79A {Rhodopseudomonas palustris} | Back alignment and structure |
|---|
Probab=81.62 E-value=3.5 Score=42.73 Aligned_cols=41 Identities=12% Similarity=0.156 Sum_probs=36.9
Q ss_pred eeEEEcCCCcEEeecHHHHHHhCCChhhHcCCCcccccccc
Q 005841 142 SVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDG 182 (674)
Q Consensus 142 ~I~v~D~~GrIi~~N~a~e~llGys~eEviG~~~~~l~~~~ 182 (674)
+++++|.+++|+.+...++.++|.+.++++|+++.+++.+.
T Consensus 31 ~Ll~~~~~~~I~~~S~N~~~~lg~~~~~~lG~~l~~ll~~~ 71 (327)
T 4e04_A 31 LLLALAADMTIVAGSDNLPELTGLAIGALIGRSAADVFDSE 71 (327)
T ss_dssp EEEEECTTCBEEEEETTHHHHHSCCHHHHTTCBHHHHBCHH
T ss_pred EEEEEcCCCeEEEEcccHHHHhCCChHhhcCCCHHHHcCHH
Confidence 45678888999999999999999999999999999998654
|
| >1dip_A Delta-sleep-inducing peptide immunoreactive peptide; structure, leucine zipper, PIG, acetylation; NMR {Sus scrofa} SCOP: h.1.12.1 | Back alignment and structure |
|---|
Probab=81.42 E-value=4.4 Score=31.78 Aligned_cols=28 Identities=32% Similarity=0.356 Sum_probs=24.3
Q ss_pred chHHHHHHHHHHHHhHHHHHHhhccccc
Q 005841 7 PAEELLRKIQELEAGQEHLKQELSKLKI 34 (674)
Q Consensus 7 ~~~~l~~~~~~l~~~~~~l~~~~~~~~~ 34 (674)
.-|.|-.+|.||++.+.+|++|++-|+.
T Consensus 16 EVevLKe~I~EL~e~~~qLE~EN~~Lk~ 43 (78)
T 1dip_A 16 EVEILKEQIRELVEKNSQLERENTLLKT 43 (78)
T ss_dssp SCHHHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHHH
Confidence 3467778999999999999999998875
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=81.30 E-value=2.2 Score=41.59 Aligned_cols=86 Identities=14% Similarity=0.069 Sum_probs=63.2
Q ss_pred CCCCeeeEEEEEecCCeEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHH-HHHhCCCCeEEccCCCCCEEE
Q 005841 560 RHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVS-YLHHCNPPIIHRDLKSSNLLV 638 (674)
Q Consensus 560 ~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~-yLH~~~~~IvHrDLKp~NILi 638 (674)
.||.+ --.+-.+.+.+.|.++.-+++.=+..++ .++....+.++.+|+.... +++ . -+|--|.|+||++
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i~----~~~~~eKlrll~nl~~L~~~~~~--~--r~tf~l~P~NL~f 117 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAIR----KTTLLSRIRAAIHLVSKVKHHSA--R--RLIFIVCPENLMF 117 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHHH----TSCHHHHHHHHHHHHHHHSSCCS--S--SEECCCCGGGEEE
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHHH----hcCHHHHHHHHHHHHHHHHHhhh--C--ceeEEEeCceEEE
Confidence 47777 4444467788888888664544344453 3678888988888877666 443 2 5888999999999
Q ss_pred cCCCcEEEEecCCcccc
Q 005841 639 DKHWTVKVGDFGLSRLK 655 (674)
Q Consensus 639 ~~~~~vkL~DFGla~~~ 655 (674)
+.++.++|.-.|+-..+
T Consensus 118 ~~~~~p~i~hRGi~~~l 134 (219)
T 4ano_A 118 NRALEPFFLHVGVKESL 134 (219)
T ss_dssp CTTCCEEESCCEETTTB
T ss_pred eCCCcEEEEEcCCcccC
Confidence 99999999999975544
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| 674 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 6e-56 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 5e-47 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 4e-46 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 5e-46 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 5e-46 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 8e-46 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 2e-45 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 3e-45 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 3e-44 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 4e-44 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 8e-44 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 1e-43 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 2e-43 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 4e-43 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 6e-43 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 9e-43 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 1e-42 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 4e-42 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 6e-42 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 1e-41 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 2e-41 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 2e-41 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 3e-41 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 2e-40 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 3e-40 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 3e-39 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 3e-39 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 1e-38 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 1e-38 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 2e-38 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 4e-38 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 8e-38 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 1e-37 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 5e-37 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 1e-36 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 1e-35 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 2e-35 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 2e-35 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 4e-35 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 4e-34 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 1e-33 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 2e-33 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 6e-33 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 1e-32 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 1e-32 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 2e-31 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 3e-31 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 4e-31 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 2e-30 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 3e-30 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 5e-30 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 7e-30 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 6e-29 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 7e-29 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 1e-27 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 2e-27 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 2e-26 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 2e-26 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 4e-26 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 1e-25 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 3e-25 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 1e-19 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 9e-17 | |
| d1n9la_ | 109 | d.110.3.6 (A:) Putative blue light receptor, phot- | 9e-15 | |
| d1jnua_ | 104 | d.110.3.6 (A:) Photoreceptor phy3 flavin-binding d | 2e-12 | |
| d1mzua_ | 110 | d.110.3.1 (A:) PYP domain of sensor histidine kina | 5e-07 | |
| d1xj3a1 | 106 | d.110.3.2 (A:154-259) Histidine kinase FixL heme d | 2e-05 | |
| d1ll8a_ | 114 | d.110.3.5 (A:) N-terminal PAS domain of Pas kinase | 2e-05 | |
| d1p97a_ | 114 | d.110.3.7 (A:) Hypoxia-inducible factor Hif2a, C-t | 5e-05 | |
| d1bywa_ | 110 | d.110.3.6 (A:) Erg potassium channel, N-terminal d | 8e-05 | |
| d1ew0a_ | 130 | d.110.3.2 (A:) Histidine kinase FixL heme domain { | 1e-04 | |
| d1v9ya_ | 113 | d.110.3.2 (A:) Direct oxygen sensor protein, DOS { | 3e-04 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (481), Expect = 6e-56
Identities = 70/177 (39%), Positives = 109/177 (61%), Gaps = 6/177 (3%)
Query: 499 DYEILWEDLTIGEQIGQGSCGTVYHAVWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKR 558
D+EI +T+G++IG GS GTVY W+G DVAVK+ + + + + +F+ EV ++++
Sbjct: 2 DWEIPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRK 60
Query: 559 LRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSY 618
RH N+LLFMG T+PQ L IVT++ SL+ L TK + + I +A A+G+ Y
Sbjct: 61 TRHVNILLFMGYSTAPQ-LAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDY 119
Query: 619 LHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHE--TYLTTKTGKGTVTYLA 673
LH IIHRDLKS+N+ + + TVK+GDFGL+ +K + G++ ++A
Sbjct: 120 LHA--KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMA 174
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (422), Expect = 5e-47
Identities = 42/175 (24%), Positives = 88/175 (50%), Gaps = 7/175 (4%)
Query: 501 EILWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKR 558
E+ +D ++G G+ G V+ G +A K+ E + + +E+ ++
Sbjct: 2 ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLI-HLEIKPAIRNQIIRELQVLHE 60
Query: 559 LRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSY 618
P ++ F GA S + I E + GSL ++L++ ++ + +++ + +G++Y
Sbjct: 61 CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKA-GRIPEQILGKVSIAVIKGLTY 119
Query: 619 LHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTVTYLA 673
L + I+HRD+K SN+LV+ +K+ DFG+S ++ + GT +Y++
Sbjct: 120 LREKH-KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--MANSFVGTRSYMS 171
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (411), Expect = 4e-46
Identities = 58/181 (32%), Positives = 91/181 (50%), Gaps = 10/181 (5%)
Query: 499 DYEILWEDLTIGEQIGQGSCGTVYHAVWYGSD-----VAVKVFSRQEYSDEVIHSFRQEV 553
DYEI E + +G IG+G G V+ ++ + VA+K + SD V F QE
Sbjct: 1 DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTC-KNCTSDSVREKFLQEA 59
Query: 554 SLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIA 613
M++ HP+++ +G +T + I+ E G L LQ LD IL A ++
Sbjct: 60 LTMRQFDHPHIVKLIGVITENP-VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLS 118
Query: 614 RGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSR-LKHETYLTTKTGKGTVTYL 672
++YL +HRD+ + N+LV + VK+GDFGLSR ++ TY GK + ++
Sbjct: 119 TALAYLESKR--FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWM 176
Query: 673 A 673
A
Sbjct: 177 A 177
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (410), Expect = 5e-46
Identities = 56/176 (31%), Positives = 87/176 (49%), Gaps = 11/176 (6%)
Query: 500 YEILWEDLTIGEQIGQGSCGTVYHAVWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRL 559
+ + ++L + + IG+G G V + G+ VAVK + F E S+M +L
Sbjct: 2 WALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDATAQA----FLAEASVMTQL 57
Query: 560 RHPNVLLFMGA-VTSPQRLCIVTEFLPRGSLFRLLQ-RNTTKLDWRRRILMALDIARGVS 617
RH N++ +G V L IVTE++ +GSL L+ R + L + +LD+ +
Sbjct: 58 RHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAME 117
Query: 618 YLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTVTYLA 673
YL N +HRDL + N+LV + KV DFGL++ T TGK V + A
Sbjct: 118 YLEGNN--FVHRDLAARNVLVSEDNVAKVSDFGLTKEASS---TQDTGKLPVKWTA 168
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (409), Expect = 5e-46
Identities = 51/174 (29%), Positives = 82/174 (47%), Gaps = 7/174 (4%)
Query: 502 ILWEDLTIGEQIGQGSCGTVYHAVWY-GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLR 560
I +DLT +++G G G V + W DVA+K+ S++ F +E +M L
Sbjct: 1 IDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED---EFIEEAKVMMNLS 57
Query: 561 HPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLH 620
H ++ G T + + I+TE++ G L L+ + ++ + M D+ + YL
Sbjct: 58 HEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE 117
Query: 621 HCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTG-KGTVTYLA 673
+HRDL + N LV+ VKV DFGLSR + T+ G K V +
Sbjct: 118 S--KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSP 169
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (409), Expect = 8e-46
Identities = 55/178 (30%), Positives = 95/178 (53%), Gaps = 9/178 (5%)
Query: 499 DYEILWEDLTIGEQIGQGSCGTVYHAVWY-GSDVAVKVFSRQEYSDEVIHSFRQEVSLMK 557
++E+ E L + E++G G G V+ + + VAVK + S + +F E +LMK
Sbjct: 7 EWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD---AFLAEANLMK 63
Query: 558 RLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNT-TKLDWRRRILMALDIARGV 616
+L+H ++ VT + I+TE++ GSL L+ + KL + + MA IA G+
Sbjct: 64 QLQHQRLVRLYAVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGM 122
Query: 617 SYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHET-YLTTKTGKGTVTYLA 673
+++ N IHRDL+++N+LV + K+ DFGL+RL + Y + K + + A
Sbjct: 123 AFIEERN--YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTA 178
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (408), Expect = 2e-45
Identities = 44/171 (25%), Positives = 76/171 (44%), Gaps = 6/171 (3%)
Query: 505 EDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHP 562
+ I ++G G+ G VY A A KV + S+E + + E+ ++ HP
Sbjct: 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTK--SEEELEDYMVEIDILASCDHP 69
Query: 563 NVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHC 622
N++ + A L I+ EF G++ ++ L + ++ ++YLH
Sbjct: 70 NIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDN 129
Query: 623 NPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTVTYLA 673
IIHRDLK+ N+L +K+ DFG+S T + GT ++A
Sbjct: 130 K--IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMA 178
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (405), Expect = 3e-45
Identities = 45/179 (25%), Positives = 78/179 (43%), Gaps = 10/179 (5%)
Query: 505 EDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHP 562
ED + IG GS G G + K ++ EV+L++ L+HP
Sbjct: 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 63
Query: 563 NVLLFMGAVT--SPQRLCIVTEFLPRGSLFRLLQRNTTK---LDWRRRILMALDIARGVS 617
N++ + + + L IV E+ G L ++ + T + LD + + + +
Sbjct: 64 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 123
Query: 618 YLH---HCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTVTYLA 673
H ++HRDLK +N+ +D VK+GDFGL+R+ + K GT Y++
Sbjct: 124 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMS 182
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (402), Expect = 3e-44
Identities = 57/228 (25%), Positives = 95/228 (41%), Gaps = 39/228 (17%)
Query: 482 STSSSAVNKVDLDNDCLDYEILWE----DLTIGEQIGQGSCGTVYHAVWYGSD------- 530
T SS +D +Y++ WE +L G+ +G G+ G V +A YG
Sbjct: 10 VTGSSDNEYFYVDFREYEYDLKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQ 69
Query: 531 VAVKVFSRQEYSDEVIHSFRQEVSLMKRL-RHPNVLLFMGAVTSPQRLCIVTEFLPRGSL 589
VAVK+ + S E E+ +M +L H N++ +GA T + ++ E+ G L
Sbjct: 70 VAVKMLKEKADSSEREA-LMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDL 128
Query: 590 FRLLQRNTTK----------------------LDWRRRILMALDIARGVSYLHHCNPPII 627
L+ K L + + A +A+G+ +L + +
Sbjct: 129 LNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS--CV 186
Query: 628 HRDLKSSNLLVDKHWTVKVGDFGLSRL--KHETYLTTKTGKGTVTYLA 673
HRDL + N+LV VK+ DFGL+R Y+ + V ++A
Sbjct: 187 HRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMA 234
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (400), Expect = 4e-44
Identities = 58/183 (31%), Positives = 84/183 (45%), Gaps = 19/183 (10%)
Query: 505 EDLTIGEQIGQGSCGTVYHAVWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNV 564
+ + E IG+G G V+ W G +VAVK+FS +E E+ LRH N+
Sbjct: 3 RTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSREERSWF---REAEIYQTVMLRHENI 59
Query: 565 LLFMGAVTSPQ----RLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLH 620
L F+ A +L +V+++ GSLF L R + I +AL A G+++LH
Sbjct: 60 LGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLH 117
Query: 621 H------CNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL----KHETYLTTKTGKGTVT 670
P I HRDLKS N+LV K+ T + D GL+ + GT
Sbjct: 118 MEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKR 177
Query: 671 YLA 673
Y+A
Sbjct: 178 YMA 180
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (394), Expect = 8e-44
Identities = 51/174 (29%), Positives = 83/174 (47%), Gaps = 7/174 (4%)
Query: 502 ILWEDLTIGEQIGQGSCGTVYHAVWY-GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLR 560
I +LT ++IG G G V+ W VA+K S+E F +E +M +L
Sbjct: 2 IDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEE---DFIEEAEVMMKLS 58
Query: 561 HPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLH 620
HP ++ G +C+V EF+ G L L+ + M LD+ G++YL
Sbjct: 59 HPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE 118
Query: 621 HCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSR-LKHETYLTTKTGKGTVTYLA 673
+IHRDL + N LV ++ +KV DFG++R + + Y ++ K V + +
Sbjct: 119 E--ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWAS 170
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (393), Expect = 1e-43
Identities = 52/174 (29%), Positives = 86/174 (49%), Gaps = 10/174 (5%)
Query: 507 LTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNV 564
L +IG+GS TVY + +VA ++ + F++E ++K L+HPN+
Sbjct: 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNI 70
Query: 565 LLFMGAVTSPQR----LCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLH 620
+ F + S + + +VTE + G+L L+R + + I +G+ +LH
Sbjct: 71 VRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFK-VMKIKVLRSWCRQILKGLQFLH 129
Query: 621 HCNPPIIHRDLKSSN-LLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTVTYLA 673
PPIIHRDLK N + +VK+GD GL+ LK ++ K GT ++A
Sbjct: 130 TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASF--AKAVIGTPEFMA 181
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 155 bits (393), Expect = 2e-43
Identities = 61/179 (34%), Positives = 89/179 (49%), Gaps = 9/179 (5%)
Query: 499 DYEILWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLM 556
+E+ D+T+ ++G G G VY VW Y VAVK E F +E ++M
Sbjct: 11 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE---EFLKEAAVM 67
Query: 557 KRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLL-QRNTTKLDWRRRILMALDIARG 615
K ++HPN++ +G T I+TEF+ G+L L + N ++ + MA I+
Sbjct: 68 KEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSA 127
Query: 616 VSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTG-KGTVTYLA 673
+ YL N IHRDL + N LV ++ VKV DFGLSRL T G K + + A
Sbjct: 128 MEYLEKKN--FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTA 184
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (389), Expect = 4e-43
Identities = 57/172 (33%), Positives = 86/172 (50%), Gaps = 8/172 (4%)
Query: 505 EDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDE-VIHSFRQEVSLMKRLRH 561
ED IG +G+G G VY A +A+KV + + V H R+EV + LRH
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65
Query: 562 PNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHH 621
PN+L G R+ ++ E+ P G+++R LQ+ +K D +R ++A +SY H
Sbjct: 66 PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL-SKFDEQRTATYITELANALSYCHS 124
Query: 622 CNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTVTYLA 673
+IHRD+K NLL+ +K+ DFG S + T GT+ YL
Sbjct: 125 KR--VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS--RRTTLCGTLDYLP 172
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (392), Expect = 6e-43
Identities = 56/216 (25%), Positives = 92/216 (42%), Gaps = 34/216 (15%)
Query: 489 NKVDLDNDCLDYEILWE----DLTIGEQIGQGSCGTVYHAVWYGSD-------VAVKVFS 537
N V +D L Y+ WE L+ G+ +G G+ G V A YG VAVK+
Sbjct: 3 NYVYIDPTQLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLK 62
Query: 538 RQEYSDEVIHSFRQEVSLMKRL-RHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQR- 595
+ E + E+ ++ L H N++ +GA T ++TE+ G L L+R
Sbjct: 63 PSAHLTER-EALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRK 121
Query: 596 ----------------NTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVD 639
+ LD + + +A+G+++L N IHRDL + N+L+
Sbjct: 122 RDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN--CIHRDLAARNILLT 179
Query: 640 KHWTVKVGDFGLSRL--KHETYLTTKTGKGTVTYLA 673
K+ DFGL+R Y+ + V ++A
Sbjct: 180 HGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMA 215
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (388), Expect = 9e-43
Identities = 62/178 (34%), Positives = 97/178 (54%), Gaps = 9/178 (5%)
Query: 499 DYEILWEDLTIGEQIGQGSCGTVYHAVWYGSD-VAVKVFSRQEYSDEVIHSFRQEVSLMK 557
+EI E L + ++GQG G V+ W G+ VA+K S E +F QE +MK
Sbjct: 11 AWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE---AFLQEAQVMK 67
Query: 558 RLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLD-WRRRILMALDIARGV 616
+LRH ++ V S + + IVTE++ +GSL L+ T K + + MA IA G+
Sbjct: 68 KLRHEKLVQLYA-VVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGM 126
Query: 617 SYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTG-KGTVTYLA 673
+Y+ N +HRDL+++N+LV ++ KV DFGL+RL + T + G K + + A
Sbjct: 127 AYVERMN--YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTA 182
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 154 bits (389), Expect = 1e-42
Identities = 59/183 (32%), Positives = 86/183 (46%), Gaps = 13/183 (7%)
Query: 501 EILWEDLTIGEQIGQGSCGTVYHAVWYGSD-----VAVKVFSRQEYSDEVIHSFRQEVSL 555
EI + I + IG G G V VA+K + Y+++ F E S+
Sbjct: 22 EIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTL-KSGYTEKQRRDFLSEASI 80
Query: 556 MKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARG 615
M + HPNV+ G VT + I+TEF+ GSL L++N + + + M IA G
Sbjct: 81 MGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAG 140
Query: 616 VSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL-----KHETYLTTKTGKGTVT 670
+ YL N +HRDL + N+LV+ + KV DFGLSR TY + GK +
Sbjct: 141 MKYLADMN--YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIR 198
Query: 671 YLA 673
+ A
Sbjct: 199 WTA 201
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 152 bits (385), Expect = 4e-42
Identities = 50/209 (23%), Positives = 89/209 (42%), Gaps = 33/209 (15%)
Query: 493 LDNDCLDYEILWEDLTIGEQIGQGSCGTVYHAVWYGSD-------VAVKVFSRQEYSDEV 545
L+ L E ++ IG+G+ G V+ A G VAVK+ ++E S ++
Sbjct: 1 LNPKLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKML-KEEASADM 59
Query: 546 IHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNT-------- 597
F++E +LM +PN++ +G + +C++ E++ G L L+ +
Sbjct: 60 QADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLS 119
Query: 598 ---------------TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHW 642
L ++ +A +A G++YL +HRDL + N LV ++
Sbjct: 120 HSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK--FVHRDLATRNCLVGENM 177
Query: 643 TVKVGDFGLSRLKHETYLTTKTGKGTVTY 671
VK+ DFGLSR + G +
Sbjct: 178 VVKIADFGLSRNIYSADYYKADGNDAIPI 206
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (382), Expect = 6e-42
Identities = 47/173 (27%), Positives = 79/173 (45%), Gaps = 8/173 (4%)
Query: 505 EDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHP 562
ED + + +G+G+ G V AV VAVK+ + + + + ++E+ + K L H
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIV-DMKRAVDCPENIKKEICINKMLNHE 63
Query: 563 NVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHC 622
NV+ F G + E+ G LF ++ + + + GV YLH
Sbjct: 64 NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPD-IGMPEPDAQRFFHQLMAGVVYLHGI 122
Query: 623 NPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL--KHETYLTTKTGKGTVTYLA 673
I HRD+K NLL+D+ +K+ DFGL+ + + GT+ Y+A
Sbjct: 123 G--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVA 173
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 151 bits (383), Expect = 1e-41
Identities = 52/178 (29%), Positives = 82/178 (46%), Gaps = 13/178 (7%)
Query: 499 DYEILWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQ-EYSDEVIHSFRQEVSL 555
D E L+ DL +IG GS G VY A VA+K S + S+E +EV
Sbjct: 12 DPEKLFSDL---REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRF 68
Query: 556 MKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARG 615
+++LRHPN + + G +V E+ + L L + +G
Sbjct: 69 LQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHK-KPLQEVEIAAVTHGALQG 127
Query: 616 VSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTVTYLA 673
++YLH N +IHRD+K+ N+L+ + VK+GDFG + + + GT ++A
Sbjct: 128 LAYLHSHN--MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP----ANSFVGTPYWMA 179
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (378), Expect = 2e-41
Identities = 58/181 (32%), Positives = 83/181 (45%), Gaps = 12/181 (6%)
Query: 502 ILWEDLTIGEQIGQGSCGTVYHAVWYGSD-----VAVKVFSRQEYSD-EVIHSFRQEVSL 555
I +DL + E++G GS G V W VAVK S E + F +EV+
Sbjct: 5 IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNA 64
Query: 556 MKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARG 615
M L H N++ G V +P + +VTE P GSL L+++ A+ +A G
Sbjct: 65 MHSLDHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEG 123
Query: 616 VSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL---KHETYLTTKTGKGTVTYL 672
+ YL IHRDL + NLL+ VK+GDFGL R + Y+ + K +
Sbjct: 124 MGYLESKR--FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWC 181
Query: 673 A 673
A
Sbjct: 182 A 182
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (378), Expect = 2e-41
Identities = 45/177 (25%), Positives = 79/177 (44%), Gaps = 12/177 (6%)
Query: 505 EDLTIGE-QIGQGSCGTVYHAVWY----GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRL 559
++L I + ++G G+ G+V V+ DVA+KV +Q +E +M +L
Sbjct: 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVL-KQGTEKADTEEMMREAQIMHQL 66
Query: 560 RHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYL 619
+P ++ +G V + L +V E G L + L ++ + ++ G+ YL
Sbjct: 67 DNPYIVRLIG-VCQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYL 125
Query: 620 HHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL---KHETYLTTKTGKGTVTYLA 673
N +HRDL + N+L+ K+ DFGLS+ Y GK + + A
Sbjct: 126 EEKN--FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYA 180
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (379), Expect = 3e-41
Identities = 54/193 (27%), Positives = 92/193 (47%), Gaps = 24/193 (12%)
Query: 501 EILWEDLTIGEQIGQGSCGTVYHAVWYGS----DVAVKVFSRQEYSDEVIHSFRQEVSLM 556
+ W D+ + IG+G+ G V A D A+K ++ S + F E+ ++
Sbjct: 6 VLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRM-KEYASKDDHRDFAGELEVL 64
Query: 557 KRL-RHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNT---------------TKL 600
+L HPN++ +GA L + E+ P G+L L+++ + L
Sbjct: 65 CKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTL 124
Query: 601 DWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYL 660
++ + A D+ARG+ YL IHRDL + N+LV +++ K+ DFGLSR E Y+
Sbjct: 125 SSQQLLHFAADVARGMDYL--SQKQFIHRDLAARNILVGENYVAKIADFGLSRG-QEVYV 181
Query: 661 TTKTGKGTVTYLA 673
G+ V ++A
Sbjct: 182 KKTMGRLPVRWMA 194
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (373), Expect = 2e-40
Identities = 59/189 (31%), Positives = 92/189 (48%), Gaps = 19/189 (10%)
Query: 499 DYEILWEDLTIGEQIGQGSCGTVYHAVWYGSD-------VAVKVFSRQEYSDEVIHSFRQ 551
++E+ E +T+ ++GQGS G VY V G VA+K + E I F
Sbjct: 14 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIE-FLN 72
Query: 552 EVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRN---------TTKLDW 602
E S+MK +V+ +G V+ Q ++ E + RG L L+
Sbjct: 73 EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSL 132
Query: 603 RRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTT 662
+ I MA +IA G++YL+ +HRDL + N +V + +TVK+GDFG++R +ET
Sbjct: 133 SKMIQMAGEIADGMAYLNANK--FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYR 190
Query: 663 KTGKGTVTY 671
K GKG +
Sbjct: 191 KGGKGLLPV 199
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (369), Expect = 3e-40
Identities = 45/177 (25%), Positives = 81/177 (45%), Gaps = 12/177 (6%)
Query: 505 EDLTIGE-QIGQGSCGTVYHAVW----YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRL 559
+ LT+ + ++G G+ GTV + VAVK+ + + E ++M++L
Sbjct: 6 KLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQL 65
Query: 560 RHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYL 619
+P ++ +G + + +V E G L + LQ+N + + I + ++ G+ YL
Sbjct: 66 DNPYIVRMIG-ICEAESWMLVMEMAELGPLNKYLQQN-RHVKDKNIIELVHQVSMGMKYL 123
Query: 620 HHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL---KHETYLTTKTGKGTVTYLA 673
N +HRDL + N+L+ K+ DFGLS+ Y GK V + A
Sbjct: 124 EESN--FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYA 178
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (364), Expect = 3e-39
Identities = 51/200 (25%), Positives = 85/200 (42%), Gaps = 27/200 (13%)
Query: 499 DYEILWEDLTIGEQIGQGSCGTVYHAVWYGSD-------VAVKVFSRQEYSDEVIHSFRQ 551
+E + L +G+ +G+G+ G V A +G D VAVK+ E +
Sbjct: 7 KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSE 66
Query: 552 EVSLMKRLRHPNVLLFMGAVTSP-QRLCIVTEFLPRGSLFRLLQRNTTK----------- 599
L+ H NV+ +GA T P L ++ EF G+L L+ +
Sbjct: 67 LKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDL 126
Query: 600 ----LDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL- 654
L I + +A+G+ +L IHRDL + N+L+ + VK+ DFGL+R
Sbjct: 127 YKDFLTLEHLICYSFQVAKGMEFLASRK--CIHRDLAARNILLSEKNVVKICDFGLARDI 184
Query: 655 -KHETYLTTKTGKGTVTYLA 673
K Y+ + + ++A
Sbjct: 185 YKDPDYVRKGDARLPLKWMA 204
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 145 bits (368), Expect = 3e-39
Identities = 42/175 (24%), Positives = 79/175 (45%), Gaps = 9/175 (5%)
Query: 503 LWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLR 560
+++ I E++G G+ G V+ V G K + D+ ++ + E+S+M +L
Sbjct: 27 VYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDK--YTVKNEISIMNQLH 84
Query: 561 HPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLH 620
HP ++ A + ++ EFL G LF + K+ I G+ ++H
Sbjct: 85 HPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMH 144
Query: 621 HCNPPIIHRDLKSSNLLVD--KHWTVKVGDFGLSRLKHETYLTTKTGKGTVTYLA 673
+ I+H D+K N++ + K +VK+ DFGL+ + + T T + A
Sbjct: 145 EHS--IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTT-ATAEFAA 196
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (358), Expect = 1e-38
Identities = 52/182 (28%), Positives = 86/182 (47%), Gaps = 12/182 (6%)
Query: 501 EILWEDLTIGEQIGQGSCGTVYHAVWYGSD------VAVKVFSRQEYSDEVIHSFRQEVS 554
EI +T + IG G G VY + S VA+K + Y+++ F E
Sbjct: 3 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTL-KAGYTEKQRVDFLGEAG 61
Query: 555 LMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIAR 614
+M + H N++ G ++ + + I+TE++ G+L + L+ + + + M IA
Sbjct: 62 IMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAA 121
Query: 615 GVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKH---ETYLTTKTGKGTVTY 671
G + N +HRDL + N+LV+ + KV DFGLSR+ E TT GK + +
Sbjct: 122 G--MKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRW 179
Query: 672 LA 673
A
Sbjct: 180 TA 181
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (359), Expect = 1e-38
Identities = 45/171 (26%), Positives = 82/171 (47%), Gaps = 8/171 (4%)
Query: 505 EDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHP 562
+ T E+IGQG+ GTVY A+ G +VA++ + Q+ + E+ +M+ ++P
Sbjct: 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKK--ELIINEILVMRENKNP 77
Query: 563 NVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHC 622
N++ ++ + L +V E+L GSL ++ + + + + +LH
Sbjct: 78 NIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAV--CRECLQALEFLHSN 135
Query: 623 NPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTVTYLA 673
+IHRD+KS N+L+ +VK+ DFG T GT ++A
Sbjct: 136 Q--VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMA 184
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 143 bits (361), Expect = 2e-38
Identities = 42/173 (24%), Positives = 76/173 (43%), Gaps = 9/173 (5%)
Query: 505 EDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHP 562
+ I E++G G+ G V+ G++ A K SD+ + R+E+ M LRHP
Sbjct: 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDK--ETVRKEIQTMSVLRHP 83
Query: 563 NVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHC 622
++ A + ++ EF+ G LF + K+ + + +G+ ++H
Sbjct: 84 TLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHEN 143
Query: 623 NPPIIHRDLKSSNLLV--DKHWTVKVGDFGLSRLKHETYLTTKTGKGTVTYLA 673
N +H DLK N++ + +K+ DFGL+ + K GT + A
Sbjct: 144 N--YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ-SVKVTTGTAEFAA 193
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (357), Expect = 4e-38
Identities = 44/177 (24%), Positives = 84/177 (47%), Gaps = 12/177 (6%)
Query: 505 EDLTIGEQIGQGSCGTVYHAVWYGSD------VAVKVFSRQEYSDEVIHSFRQEVSLMKR 558
+ + +G G+ GTVY +W VA+K R+ S + E +M
Sbjct: 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL-REATSPKANKEILDEAYVMAS 67
Query: 559 LRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSY 618
+ +P+V +G + + ++T+ +P G L ++ + + + + + IA+G++Y
Sbjct: 68 VDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNY 126
Query: 619 LHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL--KHETYLTTKTGKGTVTYLA 673
L ++HRDL + N+LV VK+ DFGL++L E + GK + ++A
Sbjct: 127 LEDRR--LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 181
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (353), Expect = 8e-38
Identities = 41/174 (23%), Positives = 75/174 (43%), Gaps = 8/174 (4%)
Query: 505 EDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDE-VIHSFRQEVSLMKRLRH 561
ED G+ +G+GS TV A + A+K+ ++ E + +E +M RL H
Sbjct: 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 67
Query: 562 PNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHH 621
P + ++L + G L + +++ D +I + YLH
Sbjct: 68 PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKI-GSFDETCTRFYTAEIVSALEYLHG 126
Query: 622 CNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKH--ETYLTTKTGKGTVTYLA 673
IIHRDLK N+L+++ +++ DFG +++ + GT Y++
Sbjct: 127 --KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVS 178
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (354), Expect = 1e-37
Identities = 37/173 (21%), Positives = 72/173 (41%), Gaps = 10/173 (5%)
Query: 503 LWEDLTIGEQIGQGSCGTVYHAVWYGSD--VAVKVFSRQEYSDEVIHSFRQEVSLMKRLR 560
L+E I E +G+G G V+ V S K + ++E+S++ R
Sbjct: 3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQV---LVKKEISILNIAR 59
Query: 561 HPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLH 620
H N+L + S + L ++ EF+ +F + + +L+ R + + + +LH
Sbjct: 60 HRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLH 119
Query: 621 HCNPPIIHRDLKSSNLLVD--KHWTVKVGDFGLSRLKHETYLTTKTGKGTVTY 671
N I H D++ N++ + T+K+ +FG +R + Y
Sbjct: 120 SHN--IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD-NFRLLFTAPEY 169
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (347), Expect = 5e-37
Identities = 55/202 (27%), Positives = 96/202 (47%), Gaps = 30/202 (14%)
Query: 499 DYEILWEDLTIGEQIGQGSCGTVYHAVWYGSD---------VAVKVFSRQEYSDEVIHSF 549
+E+ + L +G+ +G+G+ G V A G D VAVK+ + + +++ +
Sbjct: 7 RWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKML-KSDATEKDLSDL 65
Query: 550 RQEVSLMKRL-RHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRN------------ 596
E+ +MK + +H N++ +GA T L ++ E+ +G+L LQ
Sbjct: 66 ISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPS 125
Query: 597 ---TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSR 653
+L + + A +ARG+ YL IHRDL + N+LV + +K+ DFGL+R
Sbjct: 126 HNPEEQLSSKDLVSCAYQVARGMEYLASKK--CIHRDLAARNVLVTEDNVMKIADFGLAR 183
Query: 654 LKHE--TYLTTKTGKGTVTYLA 673
H Y T G+ V ++A
Sbjct: 184 DIHHIDYYKKTTNGRLPVKWMA 205
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (346), Expect = 1e-36
Identities = 55/194 (28%), Positives = 85/194 (43%), Gaps = 15/194 (7%)
Query: 492 DLDNDCLDYEILWEDLTI--GEQIGQGSCGTVYHAVWYGSD-----VAVKVFSRQEYSDE 544
+L I L + E IG+G G VYH +D AVK +R E
Sbjct: 12 ELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE 71
Query: 545 VIHSFRQEVSLMKRLRHPNVLLFMGA-VTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWR 603
V F E +MK HPNVL +G + S +V ++ G L ++ T +
Sbjct: 72 VSQ-FLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVK 130
Query: 604 RRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHE----TY 659
I L +A+G+ + +HRDL + N ++D+ +TVKV DFGL+R ++ +
Sbjct: 131 DLIGFGLQVAKGMK--FLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSV 188
Query: 660 LTTKTGKGTVTYLA 673
K V ++A
Sbjct: 189 HNKTGAKLPVKWMA 202
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (339), Expect = 1e-35
Identities = 49/173 (28%), Positives = 78/173 (45%), Gaps = 7/173 (4%)
Query: 505 EDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYS--DEVIHSFRQEVSLMKRLR 560
ED + + +G+GS G V+ A + A+K + D+V + ++ L
Sbjct: 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61
Query: 561 HPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLH 620
HP + + + L V E+L G L +Q K D R A +I G+ +LH
Sbjct: 62 HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSC-HKFDLSRATFYAAEIILGLQFLH 120
Query: 621 HCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTVTYLA 673
I++RDLK N+L+DK +K+ DFG+ + T T GT Y+A
Sbjct: 121 SKG--IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIA 171
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 134 bits (337), Expect = 2e-35
Identities = 42/174 (24%), Positives = 77/174 (44%), Gaps = 10/174 (5%)
Query: 505 EDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHP 562
+ + +G G+ V A VA+K +++ + S E++++ +++HP
Sbjct: 9 DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKE-GSMENEIAVLHKIKHP 67
Query: 563 NVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHC 622
N++ S L ++ + + G LF + R + + V YLH
Sbjct: 68 NIVALDDIYESGGHLYLIMQLVSGGELFDRIVEK-GFYTERDASRLIFQVLDAVKYLHDL 126
Query: 623 NPPIIHRDLKSSNLLV---DKHWTVKVGDFGLSRLKHETYLTTKTGKGTVTYLA 673
I+HRDLK NLL D+ + + DFGLS+++ + + T GT Y+A
Sbjct: 127 G--IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLS-TACGTPGYVA 177
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 132 bits (334), Expect = 2e-35
Identities = 43/180 (23%), Positives = 76/180 (42%), Gaps = 14/180 (7%)
Query: 504 WEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQ-------EYSDEVIHSFRQEVS 554
+E+ E +G+G V + + AVK+ E E+ + +EV
Sbjct: 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVD 61
Query: 555 LMKRLR-HPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIA 613
+++++ HPN++ + +V + + +G LF L L + + +
Sbjct: 62 ILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKV-TLSEKETRKIMRALL 120
Query: 614 RGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTVTYLA 673
+ LH N I+HRDLK N+L+D +K+ DFG S + GT +YLA
Sbjct: 121 EVICALHKLN--IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREV-CGTPSYLA 177
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 134 bits (338), Expect = 4e-35
Identities = 41/175 (23%), Positives = 79/175 (45%), Gaps = 11/175 (6%)
Query: 505 EDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDE----VIHSFRQEVSLMKR 558
D ++ IG+G G VY G A+K ++ + + + R +SL+
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 559 LRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSY 618
P ++ A +P +L + + + G L L ++ + R A +I G+ +
Sbjct: 64 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAA-EIILGLEH 122
Query: 619 LHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTVTYLA 673
+H+ +++RDLK +N+L+D+H V++ D GL+ + GT Y+A
Sbjct: 123 MHNRF--VVYRDLKPANILLDEHGHVRISDLGLACDFSKK--KPHASVGTHGYMA 173
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (326), Expect = 4e-34
Identities = 48/171 (28%), Positives = 82/171 (47%), Gaps = 4/171 (2%)
Query: 505 EDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHP 562
E+ E+IG+G+ G VY A G VA+K ++ V + +E+SL+K L HP
Sbjct: 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 563 NVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHC 622
N++ + + + +L +V EFL + + T + + +G+++ H
Sbjct: 62 NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 121
Query: 623 NPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTVTYLA 673
++HRDLK NLL++ +K+ DFGL+R T T+ Y A
Sbjct: 122 R--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRA 170
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (325), Expect = 1e-33
Identities = 50/187 (26%), Positives = 85/187 (45%), Gaps = 17/187 (9%)
Query: 490 KVDLDNDCLDYEILWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEY-SDEVI 546
KV ++ D++ L + +G+G+ G V G A+K+ ++ + + +
Sbjct: 1 KVTMN----DFDYL-------KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEV 49
Query: 547 HSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRI 606
E +++ RHP + A + RLC V E+ G LF L R + R R
Sbjct: 50 AHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARF 109
Query: 607 LMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGK 666
A +I + + + +++RD+K NL++DK +K+ DFGL + T KT
Sbjct: 110 YGA-EIVSALE--YLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFC 166
Query: 667 GTVTYLA 673
GT YLA
Sbjct: 167 GTPEYLA 173
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 128 bits (323), Expect = 2e-33
Identities = 44/172 (25%), Positives = 82/172 (47%), Gaps = 9/172 (5%)
Query: 505 EDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSD-EVIHSFRQEVSLMKRLRH 561
+D I +G GS G V+ G A+KV ++ + + E ++ + H
Sbjct: 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63
Query: 562 PNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHH 621
P ++ G Q++ ++ +++ G LF LL+++ + + A ++ + YLH
Sbjct: 64 PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAA-EVCLALEYLHS 122
Query: 622 CNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTVTYLA 673
II+RDLK N+L+DK+ +K+ DFG ++ + T GT Y+A
Sbjct: 123 --KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT---YTLCGTPDYIA 169
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 126 bits (316), Expect = 6e-33
Identities = 47/181 (25%), Positives = 76/181 (41%), Gaps = 13/181 (7%)
Query: 503 LWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDE-VIHSFRQEVSLMKRL 559
L + +GE +G G V+ A DVAVKV D FR+E L
Sbjct: 5 LSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAAL 64
Query: 560 RHPNVLLFMGAVTSP----QRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARG 615
HP ++ + IV E++ +L ++ + +R I + D +
Sbjct: 65 NHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG-PMTPKRAIEVIADACQA 123
Query: 616 VSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL---KHETYLTTKTGKGTVTYL 672
+++ H IIHRD+K +N+++ VKV DFG++R + T GT YL
Sbjct: 124 LNFSHQNG--IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYL 181
Query: 673 A 673
+
Sbjct: 182 S 182
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 125 bits (315), Expect = 1e-32
Identities = 49/170 (28%), Positives = 83/170 (48%), Gaps = 4/170 (2%)
Query: 505 EDLTIGEQIGQGSCGTVYHAVW-YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPN 563
E E+IG+G+ G VY A YG A+K ++ + + + +E+S++K L+H N
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 564 VLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCN 623
++ + + +RL +V E L L +LL L+ L + G++Y H
Sbjct: 62 IVKLYDVIHTKKRLVLVFEHLD-QDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR 120
Query: 624 PPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTVTYLA 673
++HRDLK NLL+++ +K+ DFGL+R T+ Y A
Sbjct: 121 --VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRA 168
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 125 bits (314), Expect = 1e-32
Identities = 47/168 (27%), Positives = 79/168 (47%), Gaps = 8/168 (4%)
Query: 511 EQIGQGSCGTVYHAVW--YGSDVAVKVFS---RQEYSDEVIHSFRQEVSLMKRLRHPNVL 565
+ +G+G TVY A VA+K R E D + + +E+ L++ L HPN++
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 566 LFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPP 625
+ A + +V +F+ L +++ N+ L L +G+ YLH
Sbjct: 64 GLLDAFGHKSNISLVFDFME-TDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW-- 120
Query: 626 IIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTVTYLA 673
I+HRDLK +NLL+D++ +K+ DFGL++ T Y A
Sbjct: 121 ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRA 168
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (309), Expect = 2e-31
Identities = 46/186 (24%), Positives = 70/186 (37%), Gaps = 27/186 (14%)
Query: 499 DYEILWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLM 556
DY++ + +G G G V A+K+ R+EV L
Sbjct: 12 DYKVT------SQVLGLGINGKVLQIFNKRTQEKFALKMLQDCP-------KARREVELH 58
Query: 557 KRL-RHPNVL----LFMGAVTSPQRLCIVTEFLPRGSLFRLLQ-RNTTKLDWRRRILMAL 610
R + P+++ ++ + L IV E L G LF +Q R R +
Sbjct: 59 WRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMK 118
Query: 611 DIARGVSYLHHCNPPIIHRDLKSSNLLVDKHW---TVKVGDFGLSRLKHETYLTTKTGKG 667
I + YLH N I HRD+K NLL +K+ DFG ++ + T
Sbjct: 119 SIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN-SLTTPCY 175
Query: 668 TVTYLA 673
T Y+A
Sbjct: 176 TPYYVA 181
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 122 bits (307), Expect = 3e-31
Identities = 48/175 (27%), Positives = 75/175 (42%), Gaps = 14/175 (8%)
Query: 508 TIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVL 565
T IG+G+ G V A VA+K S E +E+ ++ R RH N++
Sbjct: 11 TNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE-HQTYCQRTLREIKILLRFRHENII 69
Query: 566 LFMGAVTSP----QRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHH 621
+ +P + + L L++LL+ L I RG+ Y+H
Sbjct: 70 GINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQ--HLSNDHICYFLYQILRGLKYIHS 127
Query: 622 CNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL---KHETYLTTKTGKGTVTYLA 673
N ++HRDLK SNLL++ +K+ DFGL+R+ H+ T Y A
Sbjct: 128 AN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 180
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 120 bits (302), Expect = 4e-31
Identities = 39/175 (22%), Positives = 64/175 (36%), Gaps = 13/175 (7%)
Query: 508 TIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSD----EVIHSFRQEVSLMKRLR- 560
+G +G G G+VY + VA+K + SD EV L+K++
Sbjct: 7 QVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSS 66
Query: 561 -HPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYL 619
V+ + P ++ E L + V +
Sbjct: 67 GFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHC 126
Query: 620 HHCNPPIIHRDLKSSNLLVDKH-WTVKVGDFGLSRLKHETYLTTKTGKGTVTYLA 673
H+C ++HRD+K N+L+D + +K+ DFG L +T T GT Y
Sbjct: 127 HNCG--VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFD--GTRVYSP 177
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (300), Expect = 2e-30
Identities = 42/189 (22%), Positives = 77/189 (40%), Gaps = 24/189 (12%)
Query: 499 DYEILWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLM 556
YE L +IGQG+ G V+ A G VA+K + + + +E+ ++
Sbjct: 11 KYEKL-------AKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKIL 63
Query: 557 KRLRHPNVLLFMGAVTSPQ--------RLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILM 608
+ L+H NV+ + + + +V +F L K +
Sbjct: 64 QLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLV-KFTLSEIKRV 122
Query: 609 ALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL----KHETYLTTKT 664
+ G+ Y+H I+HRD+K++N+L+ + +K+ DFGL+R K+
Sbjct: 123 MQMLLNGLYYIHRNK--ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTN 180
Query: 665 GKGTVTYLA 673
T+ Y
Sbjct: 181 RVVTLWYRP 189
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 118 bits (297), Expect = 3e-30
Identities = 46/180 (25%), Positives = 81/180 (45%), Gaps = 14/180 (7%)
Query: 505 EDLTIGEQIGQGSCGTVYHAVWY---GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRL-- 559
+ +IG+G+ G V+ A G VA+K Q + + S +EV++++ L
Sbjct: 7 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLET 66
Query: 560 -RHPNVLLFMGAVTSPQ-----RLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIA 613
HPNV+ T + +L +V E + + L + + M +
Sbjct: 67 FEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLL 126
Query: 614 RGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTVTYLA 673
RG+ +LH ++HRDLK N+LV +K+ DFGL+R+ + + + T+ Y A
Sbjct: 127 RGLDFLHSHR--VVHRDLKPQNILVTSSGQIKLADFGLARI-YSFQMALTSVVVTLWYRA 183
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 119 bits (299), Expect = 5e-30
Identities = 38/160 (23%), Positives = 69/160 (43%), Gaps = 6/160 (3%)
Query: 505 EDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSD-EVIHSFRQEVSLMKRLRH 561
+ + +G GS G V G+ A+K+ +Q+ + I E +++ +
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 562 PNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHH 621
P ++ + L +V E++ G +F L+R + A I YLH
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIG-RFSEPHARFYAAQIVLTFEYLHS 159
Query: 622 CNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLT 661
+ +I+RDLK NLL+D+ ++V DFG ++ T
Sbjct: 160 LD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWT 197
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 117 bits (294), Expect = 7e-30
Identities = 43/172 (25%), Positives = 79/172 (45%), Gaps = 5/172 (2%)
Query: 505 EDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHP 562
+ E+IG+G+ GTV+ A VA+K + + V S +E+ L+K L+H
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61
Query: 563 NVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHC 622
N++ + S ++L +V EF + N + + + +G+ + H
Sbjct: 62 NIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLF-QLLKGLGFCHSR 120
Query: 623 NPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTKTGKGTVTYLAS 674
N ++HRDLK NLL++++ +K+ +FGL+R T+ Y
Sbjct: 121 N--VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPP 170
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 114 bits (287), Expect = 6e-29
Identities = 39/176 (22%), Positives = 64/176 (36%), Gaps = 14/176 (7%)
Query: 508 TIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDE----VIHSFRQEVSLMKRLRH 561
GE++G G V G A K ++ +EVS++K ++H
Sbjct: 13 DTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQH 72
Query: 562 PNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHH 621
PNV+ + + ++ E + G LF L L I GV +
Sbjct: 73 PNVITLHEVYENKTDVILILELVAGGELFDFLAEK-ESLTEEEATEFLKQILNGVY--YL 129
Query: 622 CNPPIIHRDLKSSNLLVDKHWT----VKVGDFGLSRLKHETYLTTKTGKGTVTYLA 673
+ I H DLK N+++ +K+ DFGL+ GT ++A
Sbjct: 130 HSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNI-FGTPEFVA 184
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 114 bits (287), Expect = 7e-29
Identities = 42/178 (23%), Positives = 72/178 (40%), Gaps = 18/178 (10%)
Query: 508 TIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVL 565
+G +IG GS G +Y G +VA+K+ + + E + K ++ +
Sbjct: 10 RLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQ----LHIESKIYKMMQGGVGI 65
Query: 566 LFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPP 625
+ + ++ L SL L + K + +L+A + + Y+H N
Sbjct: 66 PTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN-- 123
Query: 626 IIHRDLKSSNLLV---DKHWTVKVGDFGLSRL-------KHETYLTTKTGKGTVTYLA 673
IHRD+K N L+ K V + DFGL++ +H Y K GT Y +
Sbjct: 124 FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYAS 181
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 112 bits (281), Expect = 1e-27
Identities = 45/161 (27%), Positives = 72/161 (44%), Gaps = 11/161 (6%)
Query: 508 TIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVL 565
+ +G G+ G V AV G+ VA+K R S+ +E+ L+K +RH NV+
Sbjct: 21 RDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVI 80
Query: 566 LFMGAVTSPQRLCIVTEF-----LPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLH 620
+ T + L T+F L +L++ KL R + + +G+ Y+H
Sbjct: 81 GLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHE--KLGEDRIQFLVYQMLKGLRYIH 138
Query: 621 HCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLT 661
HRDLK NL V++ +K+ DFGL+R
Sbjct: 139 AAGII--HRDLKPGNLAVNEDCELKILDFGLARQADSEMTG 177
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 110 bits (275), Expect = 2e-27
Identities = 38/180 (21%), Positives = 68/180 (37%), Gaps = 20/180 (11%)
Query: 508 TIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVL 565
+G +IG+GS G ++ VA+K R+ + + R E K L +
Sbjct: 8 KVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQ----LRDEYRTYKLLAGCTGI 63
Query: 566 LFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPP 625
+ ++ L SL LL K + + A + V +H +
Sbjct: 64 PNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS-- 121
Query: 626 IIHRDLKSSNLLVDKHW-----TVKVGDFGLSRL-------KHETYLTTKTGKGTVTYLA 673
+++RD+K N L+ + + V DFG+ + +H Y K GT Y++
Sbjct: 122 LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMS 181
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 108 bits (270), Expect = 2e-26
Identities = 36/156 (23%), Positives = 70/156 (44%), Gaps = 11/156 (7%)
Query: 505 EDLTIGEQIGQGSCGTVYHAV-----WYGSDVAVKVFSRQEYSD--EVIHSFRQEVSLMK 557
E+ + + +G G+ G V+ G A+KV + + R E +++
Sbjct: 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83
Query: 558 RLRH-PNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGV 616
+R P ++ A + +L ++ +++ G LF L + + + +I +
Sbjct: 84 HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRE-RFTEHEVQIYVGEIVLAL 142
Query: 617 SYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLS 652
+LH II+RD+K N+L+D + V + DFGLS
Sbjct: 143 EHLHKLG--IIYRDIKLENILLDSNGHVVLTDFGLS 176
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 108 bits (271), Expect = 2e-26
Identities = 41/160 (25%), Positives = 66/160 (41%), Gaps = 19/160 (11%)
Query: 506 DLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPN 563
T + IG GS G VY A G VA+K + + +E+ +M++L H N
Sbjct: 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK------RFKNRELQIMRKLDHCN 74
Query: 564 VLLFMGAVTSPQR------LCIVTEFLPRGSLFRLLQ--RNTTKLDWRRRILMALDIARG 615
++ S L +V +++P R L L + R
Sbjct: 75 IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRS 134
Query: 616 VSYLHHCNPPIIHRDLKSSNLLVDKH-WTVKVGDFGLSRL 654
++Y+H I HRD+K NLL+D +K+ DFG ++
Sbjct: 135 LAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ 172
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 107 bits (268), Expect = 4e-26
Identities = 37/185 (20%), Positives = 76/185 (41%), Gaps = 21/185 (11%)
Query: 496 DCLDYEILW---EDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFR 550
D + + W +D + ++G+G V+ A+ V VK+ + +
Sbjct: 23 DYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKK-----IK 77
Query: 551 QEVSLMKRLR-HPNVLLFMGAVTSP--QRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRIL 607
+E+ +++ LR PN++ V P + +V E + +L Q L
Sbjct: 78 REIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT----LTDYDIRF 133
Query: 608 MALDIARGVSYLHHCNPPIIHRDLKSSNLLVD-KHWTVKVGDFGLSRLKHETYLTTKTGK 666
+I + + Y H I+HRD+K N+++D +H +++ D+GL+ H
Sbjct: 134 YMYEILKALDYCHSMG--IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRV- 190
Query: 667 GTVTY 671
+ +
Sbjct: 191 ASRYF 195
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 106 bits (265), Expect = 1e-25
Identities = 44/172 (25%), Positives = 74/172 (43%), Gaps = 15/172 (8%)
Query: 499 DYEILWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLM 556
+ +L + + IG G+ G V A +VA+K SR + +E+ LM
Sbjct: 12 TFTVL-KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLM 70
Query: 557 KRLRHPNVLLFMGAVTSP------QRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMAL 610
K + H N++ + T Q + +V E + + D R +
Sbjct: 71 KCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL----DHERMSYLLY 126
Query: 611 DIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTT 662
+ G+ +LH IHRDLK SN++V T+K+ DFGL+R +++ T
Sbjct: 127 QMLCGIKHLHSAGI--IHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMT 176
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 105 bits (262), Expect = 3e-25
Identities = 49/171 (28%), Positives = 76/171 (44%), Gaps = 14/171 (8%)
Query: 501 EILWE---DLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSL 555
+ +WE +G G+ G+V A G VAVK SR S +E+ L
Sbjct: 11 KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 70
Query: 556 MKRLRHPNVLLFMGAVTSPQRLC-----IVTEFLPRGSLFRLLQRNTTKLDWRRRILMAL 610
+K ++H NV+ + T + L + L L +++ KL +
Sbjct: 71 LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ--KLTDDHVQFLIY 128
Query: 611 DIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLT 661
I RG+ Y+H + IIHRDLK SNL V++ +K+ DFGL+R +
Sbjct: 129 QILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTG 177
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 85.2 bits (210), Expect = 1e-19
Identities = 29/162 (17%), Positives = 55/162 (33%), Gaps = 32/162 (19%)
Query: 509 IGEQIGQGSCGTVYHAVWY-GSDVAVKVF----------------SRQEYSDEVIHSFRQ 551
IG+ +G+G V++ + VK +S I S R
Sbjct: 4 IGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARN 63
Query: 552 EVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALD 611
E +++L+ V ++ E + + +++ +L
Sbjct: 64 EFRALQKLQGLAVPKVYAWE----GNAVLMELIDAK------ELYRVRVENPDEVL--DM 111
Query: 612 IARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSR 653
I V+ +H I+H DL N+LV + + + DF S
Sbjct: 112 ILEEVAKFYHRG--IVHGDLSQYNVLVSEEG-IWIIDFPQSV 150
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 80.1 bits (196), Expect = 9e-17
Identities = 32/175 (18%), Positives = 64/175 (36%), Gaps = 27/175 (15%)
Query: 508 TIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVL 565
+ ++G G TV+ A + VA+K+ + E + E+ L++R+ +
Sbjct: 16 ILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTE---AAEDEIKLLQRVNDADNT 72
Query: 566 L---------------FMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMAL 610
F + + +V E L L + + + ++
Sbjct: 73 KEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISK 132
Query: 611 DIARGVSYLHHCNPPIIHRDLKSSNLLVD------KHWTVKVGDFGLSRLKHETY 659
+ G+ Y+H IIH D+K N+L++ +K+ D G + E Y
Sbjct: 133 QLLLGLDYMH-RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHY 186
|
| >d1n9la_ d.110.3.6 (A:) Putative blue light receptor, phot-lov1 domain {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} Length = 109 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: Flavin-binding PAS domain domain: Putative blue light receptor, phot-lov1 domain species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Score = 68.7 bits (167), Expect = 9e-15
Identities = 24/105 (22%), Positives = 39/105 (37%), Gaps = 3/105 (2%)
Query: 139 MGQSVHIFDLSD---RIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRI 195
+ + + D + ++Y + + GY +E LG + L +G D I I
Sbjct: 2 LRHTFVVADATLPDCPLVYASEGFYAMTGYGPDEVLGHNCRFLQGEGTDPKEVQKIRDAI 61
Query: 196 KMGERWTGQFPAKTKTEERVLVVATNTPFYDDDGTLVGIVCVSTD 240
K GE + + K + T TP DG + V V D
Sbjct: 62 KKGEACSVRLLNYRKDGTPFWNLLTVTPIKTPDGRVSKFVGVQVD 106
|
| >d1jnua_ d.110.3.6 (A:) Photoreceptor phy3 flavin-binding domain, lov2 {Maidenhair fern (Adiantum capillus-veneris) [TaxId: 13818]} Length = 104 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: Flavin-binding PAS domain domain: Photoreceptor phy3 flavin-binding domain, lov2 species: Maidenhair fern (Adiantum capillus-veneris) [TaxId: 13818]
Score = 61.5 bits (148), Expect = 2e-12
Identities = 20/90 (22%), Positives = 31/90 (34%)
Query: 151 RIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGERWTGQFPAKTK 210
II+ + L Y+ EE LG + L G D I +K T Q TK
Sbjct: 14 PIIFASDRFLELTEYTREEVLGNNCRFLQGRGTDRKAVQLIRDAVKEQRDVTVQVLNYTK 73
Query: 211 TEERVLVVATNTPFYDDDGTLVGIVCVSTD 240
+ D++G + + V +
Sbjct: 74 GGRAFWNLFHLQVMRDENGDVQYFIGVQQE 103
|
| >d1mzua_ d.110.3.1 (A:) PYP domain of sensor histidine kinase Ppr {Rhodospirillum centenum [TaxId: 34018]} Length = 110 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: PYP-like domain: PYP domain of sensor histidine kinase Ppr species: Rhodospirillum centenum [TaxId: 34018]
Score = 46.6 bits (110), Expect = 5e-07
Identities = 13/99 (13%), Positives = 24/99 (24%), Gaps = 1/99 (1%)
Query: 135 ILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHR 194
++ D S I +NR+ L G E +G++ + +
Sbjct: 8 EFDALPVGAIQVDGSGVIHRYNRTESRLSGRIPERVIGRNFFTEVAPCTNIPAFSGRFMD 67
Query: 195 IKMGERWTGQFP-AKTKTEERVLVVATNTPFYDDDGTLV 232
+F V V D +
Sbjct: 68 GVTSGTLDARFDFVFDFQMAPVRVQIRMQNAGVPDRYWI 106
|
| >d1xj3a1 d.110.3.2 (A:154-259) Histidine kinase FixL heme domain {Bradyrhizobium japonicum [TaxId: 375]} Length = 106 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: Heme-binding PAS domain domain: Histidine kinase FixL heme domain species: Bradyrhizobium japonicum [TaxId: 375]
Score = 42.0 bits (97), Expect = 2e-05
Identities = 15/102 (14%), Positives = 29/102 (28%), Gaps = 6/102 (5%)
Query: 143 VHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIK----MG 198
+ + D I ++ +AE L+G+S EA+GQ+ L+ + I
Sbjct: 3 MIVIDGHGIIQLFSTAAERLFGWSELEAIGQNVNILMPEPDRSRHDSYISRYRTTSDPHI 62
Query: 199 ERWTGQFPAKTKTEERVLVVATNTPFYDDDGTLVGIVCVSTD 240
K + + + D
Sbjct: 63 IGIGRIVTGKRRDGTTFPMHLSIGEMQSGGEP--YFTGFVRD 102
|
| >d1ll8a_ d.110.3.5 (A:) N-terminal PAS domain of Pas kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 114 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: N-terminal PAS domain of Pas kinase domain: N-terminal PAS domain of Pas kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.1 bits (98), Expect = 2e-05
Identities = 14/107 (13%), Positives = 35/107 (32%), Gaps = 6/107 (5%)
Query: 135 ILQSMGQSVHIFDLSD-RIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVH 193
+ +++ D I+ N A L GYS+++ +GQ + V
Sbjct: 3 MDPEFNKAIFTVDAKTTEILVANDKACGLLGYSSQDLIGQKLTQFFLRSDSDVVEALSEE 62
Query: 194 RIKMGER----WTGQFPAKTKTEERVLVVATNTPFYDDDGT-LVGIV 235
++ + +++ E++ V + V ++
Sbjct: 63 HMEADGHAAVVFGTVVDIISRSGEKIPVSVWMKRMRQERRLCCVVVL 109
|
| >d1p97a_ d.110.3.7 (A:) Hypoxia-inducible factor Hif2a, C-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 114 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: Hypoxia-inducible factor Hif2a, C-terminal domain domain: Hypoxia-inducible factor Hif2a, C-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.8 bits (94), Expect = 5e-05
Identities = 20/99 (20%), Positives = 36/99 (36%), Gaps = 1/99 (1%)
Query: 143 VHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGERWT 202
+ + + Y + L GY EE LG+ A E ++ + G+ +
Sbjct: 9 LSRHSMDMKFTYCDDRITELIGYHPEELLGRSAYEFYHALDSENMTKSHQNLCTKGQVVS 68
Query: 203 GQFPAKTKTEERVLVVATNTPFYDD-DGTLVGIVCVSTD 240
GQ+ K V + T Y+ + I+CV+
Sbjct: 69 GQYRMLAKHGGYVWLETQGTVIYNPRNLQPQCIMCVNYV 107
|
| >d1bywa_ d.110.3.6 (A:) Erg potassium channel, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 110 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: Flavin-binding PAS domain domain: Erg potassium channel, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.1 bits (92), Expect = 8e-05
Identities = 17/92 (18%), Positives = 28/92 (30%), Gaps = 2/92 (2%)
Query: 151 RIIYWNRSAELLYGYSAEEALGQDAIELLTDGRD--FDVAYDIVHRIKMGERWTGQFPAK 208
+IY N L GYS E + + G A I + E +
Sbjct: 15 AVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPCTQRRAAAQIAQALLGAEERKVEIAFY 74
Query: 209 TKTEERVLVVATNTPFYDDDGTLVGIVCVSTD 240
K L + P ++DG ++ +
Sbjct: 75 RKDGSCFLCLVDVVPVKNEDGAVIMFILNFEV 106
|
| >d1ew0a_ d.110.3.2 (A:) Histidine kinase FixL heme domain {Rhizobium meliloti [TaxId: 382]} Length = 130 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: Heme-binding PAS domain domain: Histidine kinase FixL heme domain species: Rhizobium meliloti [TaxId: 382]
Score = 40.0 bits (92), Expect = 1e-04
Identities = 17/116 (14%), Positives = 37/116 (31%), Gaps = 6/116 (5%)
Query: 129 DRQYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVA 188
D +IL ++ + + I+ +N +A +GY+ EE +GQ+ L+ + +
Sbjct: 15 DAHLRSILDTVPDATVVSATDGTIVSFNAAAVRQFGYAEEEVIGQNLRILMPEPYRHEHD 74
Query: 189 YDIVHRIKMGER----WTGQFPAKTKTEERVLVVATNTPFYDDDGTLVGIVCVSTD 240
+ + GE+ + K + D
Sbjct: 75 GYLQRYMATGEKRIIGIDRVVSGQRKDGSTFPMKLAVGEMRSGGER--FFTGFIRD 128
|
| >d1v9ya_ d.110.3.2 (A:) Direct oxygen sensor protein, DOS {Escherichia coli [TaxId: 562]} Length = 113 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: Heme-binding PAS domain domain: Direct oxygen sensor protein, DOS species: Escherichia coli [TaxId: 562]
Score = 38.6 bits (88), Expect = 3e-04
Identities = 18/113 (15%), Positives = 42/113 (37%), Gaps = 6/113 (5%)
Query: 132 YLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDI 191
+ L+ + + +D ++++N +AE L+GY EE +G + L+ I
Sbjct: 3 FFPALEQNMMGAVLINENDEVMFFNPAAEKLWGYKREEVIGNNIDMLIPRDLRPAHPEYI 62
Query: 192 VHRIKMG----ERWTGQFPAKTKTEERVLVVATNTPFYDDDGTLVGIVCVSTD 240
H + G E + + + K ++ + + + + D
Sbjct: 63 RHNREGGKARVEGMSRELQLEKKDGSKIWTRFALSKVSAEGKVYY--LALVRD 113
|
Homologous Domains Detected by HHsearch 
Original result of HHsearch against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 674 | |||
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 99.98 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 99.98 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 99.98 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 99.98 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 99.98 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 99.97 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 99.97 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 99.97 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 99.97 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 99.97 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 99.97 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 99.97 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 99.97 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 99.97 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 99.97 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 99.97 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 99.97 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 99.97 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 99.97 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 99.97 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 99.97 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 99.97 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 99.96 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 99.96 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 99.96 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 99.96 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 99.96 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 99.96 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 99.96 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 99.96 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 99.96 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 99.96 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 99.96 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 99.9 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.87 | |
| d1n9la_ | 109 | Putative blue light receptor, phot-lov1 domain {Gr | 99.79 | |
| d1jnua_ | 104 | Photoreceptor phy3 flavin-binding domain, lov2 {Ma | 99.69 | |
| d1bywa_ | 110 | Erg potassium channel, N-terminal domain {Human (H | 99.69 | |
| d1ew0a_ | 130 | Histidine kinase FixL heme domain {Rhizobium melil | 99.65 | |
| d1xj3a1 | 106 | Histidine kinase FixL heme domain {Bradyrhizobium | 99.59 | |
| d1p97a_ | 114 | Hypoxia-inducible factor Hif2a, C-terminal domain | 99.59 | |
| d1v9ya_ | 113 | Direct oxygen sensor protein, DOS {Escherichia col | 99.59 | |
| d1nwza_ | 125 | Photoactive yellow protein, PYP {Ectothiorhodospir | 99.4 | |
| d1mzua_ | 110 | PYP domain of sensor histidine kinase Ppr {Rhodosp | 99.38 | |
| d1ll8a_ | 114 | N-terminal PAS domain of Pas kinase {Human (Homo s | 99.2 | |
| d1oj5a_ | 109 | PAS domain of steroid receptor coactivator 1A, NCo | 98.92 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.49 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.88 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.41 | |
| d2oola2 | 114 | Sensor protein PhyB2 {Rhodopseudomonas palustris [ | 97.02 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.63 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.15 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.03 | |
| d2o9ca2 | 127 | Bacteriophytochrome BphP {Deinococcus radiodurans | 93.83 | |
| d2veaa3 | 127 | Phytochrome-like protein Cph1 {Synechocystis sp. p | 92.75 | |
| d1p0za_ | 131 | Sensor kinase CitA {Klebsiella pneumoniae [TaxId: | 90.08 | |
| d3c2wa3 | 113 | Bacteriophytochrome BphP {Pseudomonas aeruginosa [ | 81.09 |
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.8e-36 Score=307.89 Aligned_cols=167 Identities=28% Similarity=0.408 Sum_probs=145.1
Q ss_pred cCCeeEeeeecccCceEEEEEEEc--CCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeEEEEE
Q 005841 504 WEDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVT 581 (674)
Q Consensus 504 ~~~y~~~~~LG~G~fG~Vy~~~~~--~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 581 (674)
.++|+++++||+|+||+||+|++. +..||||++.+.... +..+.+.+|+.+++.++||||+++++++.+.+.+||||
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~-~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivm 82 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV-DCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL 82 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcc-hHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEE
Confidence 368999999999999999999984 778999999765432 33467889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccccCCc--
Q 005841 582 EFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETY-- 659 (674)
Q Consensus 582 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~~~-- 659 (674)
|||++|+|.++|.. ...+++..+..|+.||+.||+|||+++ ||||||||+||||+.++++||+|||+|+......
T Consensus 83 Ey~~gg~L~~~l~~-~~~l~e~~~~~i~~qi~~al~ylH~~~--IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~ 159 (271)
T d1nvra_ 83 EYCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHGIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 159 (271)
T ss_dssp ECCTTEEGGGGSBT-TTBCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred eccCCCcHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHcC--CccCcccHHHEEECCCCCEEEccchhheeeccCCcc
Confidence 99999999999964 457999999999999999999999999 9999999999999999999999999998764322
Q ss_pred cccccCCCCccccCC
Q 005841 660 LTTKTGKGTVTYLAS 674 (674)
Q Consensus 660 ~~~~~~~GTp~YmAP 674 (674)
......+|||.||||
T Consensus 160 ~~~~~~~GT~~Y~AP 174 (271)
T d1nvra_ 160 RLLNKMCGTLPYVAP 174 (271)
T ss_dssp CCBCCCCSCGGGSCT
T ss_pred ccccceeeCcCccCH
Confidence 223456899999999
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-36 Score=309.25 Aligned_cols=172 Identities=39% Similarity=0.649 Sum_probs=149.3
Q ss_pred ccccccCCeeEeeeecccCceEEEEEEEcCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeEE
Q 005841 499 DYEILWEDLTIGEQIGQGSCGTVYHAVWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLC 578 (674)
Q Consensus 499 ~~~~~~~~y~~~~~LG~G~fG~Vy~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 578 (674)
+|++..++|++.++||+|+||+||+|++. ..||||+++.........+.|.+|+.++++++|||||++++++. .+.+|
T Consensus 2 dwei~~~~~~~~~~lG~G~fg~Vy~~~~~-~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~-~~~~~ 79 (276)
T d1uwha_ 2 DWEIPDGQITVGQRIGSGSFGTVYKGKWH-GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST-APQLA 79 (276)
T ss_dssp CCBCCTTCCCCCSEEEECSSCEEEEEESS-SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCE
T ss_pred CcccccccEEEEEEEeeCCCcEEEEEEEC-CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEe-ccEEE
Confidence 57888899999999999999999999865 46999999877666666788999999999999999999999875 46789
Q ss_pred EEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccccCC
Q 005841 579 IVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHET 658 (674)
Q Consensus 579 lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~~ 658 (674)
||||||++|+|.+++......+++..++.|+.||+.||+|||+++ ||||||||+||||+.++.+||+|||+|+.....
T Consensus 80 lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~--ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~ 157 (276)
T d1uwha_ 80 IVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKS--IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRW 157 (276)
T ss_dssp EEEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEETTSSEEECCCCCSCC----
T ss_pred EEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCC--EeccccCHHHEEEcCCCCEEEccccceeecccc
Confidence 999999999999999877778999999999999999999999998 999999999999999999999999999876532
Q ss_pred --ccccccCCCCccccCC
Q 005841 659 --YLTTKTGKGTVTYLAS 674 (674)
Q Consensus 659 --~~~~~~~~GTp~YmAP 674 (674)
........||+.||||
T Consensus 158 ~~~~~~~~~~gt~~y~AP 175 (276)
T d1uwha_ 158 SGSHQFEQLSGSILWMAP 175 (276)
T ss_dssp --------CCCCGGGCCH
T ss_pred CCcccccccccCcccCCH
Confidence 2233456899999998
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.2e-36 Score=309.12 Aligned_cols=166 Identities=26% Similarity=0.382 Sum_probs=149.7
Q ss_pred CCeeEeeeecccCceEEEEEEE--cCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeEEEEEe
Q 005841 505 EDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTE 582 (674)
Q Consensus 505 ~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E 582 (674)
+.|++++.||+|+||+||+|++ ++..||||++.+... ...+.+.+|+.+|+.++|||||++++++.+.+.+|||||
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~--~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmE 89 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSE--EELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIE 89 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSS--GGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCH--HHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEe
Confidence 4699999999999999999998 466799999976532 334678899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccccCCcccc
Q 005841 583 FLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTT 662 (674)
Q Consensus 583 ~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~~~~~~ 662 (674)
||++|+|.+++.+....+++..+..|+.||+.||.|||+++ ||||||||+||||+.++++||+|||+|+.........
T Consensus 90 y~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~--ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~~~~ 167 (288)
T d2jfla1 90 FCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNK--IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRR 167 (288)
T ss_dssp CCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCTTCEECHHHHHHH
T ss_pred cCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--EEEeecChhheeECCCCCEEEEechhhhccCCCcccc
Confidence 99999999998776778999999999999999999999999 9999999999999999999999999998776554445
Q ss_pred ccCCCCccccCC
Q 005841 663 KTGKGTVTYLAS 674 (674)
Q Consensus 663 ~~~~GTp~YmAP 674 (674)
.+.+||+.||||
T Consensus 168 ~~~~Gt~~y~AP 179 (288)
T d2jfla1 168 DSFIGTPYWMAP 179 (288)
T ss_dssp TCCCSCCTTCCH
T ss_pred cccccccccCCH
Confidence 567899999998
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-35 Score=306.23 Aligned_cols=164 Identities=29% Similarity=0.439 Sum_probs=148.6
Q ss_pred CCeeEeeeecccCceEEEEEEE--cCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeEEEEEe
Q 005841 505 EDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTE 582 (674)
Q Consensus 505 ~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E 582 (674)
++|++.++||+|+||+||+|.+ ++..||||++....... .+.+.+|+.+++.++||||+++++++.+.+.+|||||
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~--~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE 97 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK--KELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME 97 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSC--HHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChH--HHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEE
Confidence 5799999999999999999997 47889999998665433 3568899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccccCCcccc
Q 005841 583 FLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTT 662 (674)
Q Consensus 583 ~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~~~~~~ 662 (674)
||+||+|.+++.+ ..+++..+..|+.||+.||.|||++| ||||||||+||||+.+++|||+|||+|+.+.......
T Consensus 98 y~~gg~L~~~~~~--~~l~~~~~~~i~~qi~~aL~yLH~~~--iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~ 173 (293)
T d1yhwa1 98 YLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHSNQ--VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR 173 (293)
T ss_dssp CCTTCBHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCCB
T ss_pred ecCCCcHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHCC--CcccCCcHHHeEECCCCcEeeccchhheeeccccccc
Confidence 9999999998865 36999999999999999999999999 9999999999999999999999999999876655555
Q ss_pred ccCCCCccccCC
Q 005841 663 KTGKGTVTYLAS 674 (674)
Q Consensus 663 ~~~~GTp~YmAP 674 (674)
...+||+.||||
T Consensus 174 ~~~~gt~~Y~aP 185 (293)
T d1yhwa1 174 STMVGTPYWMAP 185 (293)
T ss_dssp CCCCSCGGGCCH
T ss_pred cccccCCCccCh
Confidence 667899999998
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-35 Score=305.09 Aligned_cols=170 Identities=26% Similarity=0.405 Sum_probs=138.2
Q ss_pred CCeeEeeeecccCceEEEEEEE--cCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEec--CCeEEEE
Q 005841 505 EDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTS--PQRLCIV 580 (674)
Q Consensus 505 ~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~--~~~~~lV 580 (674)
++|++.+.||+|+||+||+|++ ++..||||++.+....+...+.+.+|+.+++.++||||+++++++.+ ...+|||
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv 83 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 83 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence 6899999999999999999998 47789999998887777777889999999999999999999999865 4568999
Q ss_pred EecCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---CCeEEccCCCCCEEEcCCCcEEEEecCCccc
Q 005841 581 TEFLPRGSLFRLLQR---NTTKLDWRRRILMALDIARGVSYLHHCN---PPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL 654 (674)
Q Consensus 581 ~E~~~ggsL~~~l~~---~~~~l~~~~~~~i~~qi~~~L~yLH~~~---~~IvHrDLKp~NILi~~~~~vkL~DFGla~~ 654 (674)
||||++|+|.+++.+ ....+++..++.++.||+.||.|||+.+ .+||||||||+||||+.++.|||+|||+|+.
T Consensus 84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~ 163 (269)
T d2java1 84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 163 (269)
T ss_dssp EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence 999999999999864 3567999999999999999999999854 2499999999999999999999999999998
Q ss_pred ccCCccccccCCCCccccCC
Q 005841 655 KHETYLTTKTGKGTVTYLAS 674 (674)
Q Consensus 655 ~~~~~~~~~~~~GTp~YmAP 674 (674)
...........+|||.||||
T Consensus 164 ~~~~~~~~~~~~gt~~Y~AP 183 (269)
T d2java1 164 LNHDTSFAKAFVGTPYYMSP 183 (269)
T ss_dssp C-----------CCCSCCCH
T ss_pred cccCCCccccCCCCcccCCH
Confidence 76655455567899999998
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-35 Score=302.02 Aligned_cols=166 Identities=34% Similarity=0.554 Sum_probs=148.0
Q ss_pred cCCeeEeeeecccCceEEEEEEEc--CCeEEEEEeecccCCH-HHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeEEEE
Q 005841 504 WEDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSD-EVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIV 580 (674)
Q Consensus 504 ~~~y~~~~~LG~G~fG~Vy~~~~~--~~~vAvK~i~~~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 580 (674)
.++|++++.||+|+||+||+|++. +..||||++.+..... .....+.+|+.+++.++||||+++++++.+++.+|||
T Consensus 5 l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~iv 84 (263)
T d2j4za1 5 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI 84 (263)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEE
Confidence 468999999999999999999984 6679999997654322 3346788999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccccCCcc
Q 005841 581 TEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYL 660 (674)
Q Consensus 581 ~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~~~~ 660 (674)
||||++|+|.+++.+. ..+++..+..|+.||+.||+|||+++ ||||||||+||||+.++.+||+|||+|+......
T Consensus 85 mEy~~~g~L~~~l~~~-~~l~e~~~~~i~~qi~~al~~lH~~~--ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~~- 160 (263)
T d2j4za1 85 LEYAPLGTVYRELQKL-SKFDEQRTATYITELANALSYCHSKR--VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR- 160 (263)
T ss_dssp EECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTSCEEECCCCSCSCCCCCC-
T ss_pred EeecCCCcHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eeeeeeccccceecCCCCEeecccceeeecCCCc-
Confidence 9999999999999764 46999999999999999999999999 9999999999999999999999999998766543
Q ss_pred ccccCCCCccccCC
Q 005841 661 TTKTGKGTVTYLAS 674 (674)
Q Consensus 661 ~~~~~~GTp~YmAP 674 (674)
....+||+.||||
T Consensus 161 -~~~~~Gt~~Y~AP 173 (263)
T d2j4za1 161 -RTTLCGTLDYLPP 173 (263)
T ss_dssp -CEETTEEGGGCCH
T ss_pred -ccccCCCCcccCH
Confidence 3346899999998
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-35 Score=310.68 Aligned_cols=169 Identities=28% Similarity=0.413 Sum_probs=152.0
Q ss_pred ccCCeeEeeeecccCceEEEEEEE--cCCeEEEEEeecccCC-HHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeEEE
Q 005841 503 LWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYS-DEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCI 579 (674)
Q Consensus 503 ~~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 579 (674)
..++|+++++||+|+||+||+|++ ++..||||++.+.... ......+.+|+.+|+.++||||+++++++.+.+.+||
T Consensus 3 ~l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~i 82 (337)
T d1o6la_ 3 TMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCF 82 (337)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEE
T ss_pred chHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeecccccccc
Confidence 446899999999999999999998 5778999999875432 2345678899999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccccCCc
Q 005841 580 VTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETY 659 (674)
Q Consensus 580 V~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~~~ 659 (674)
|||||+||+|.+++.+. ..+++..+..++.||+.||+|||+++ ||||||||+||||+.+|+|||+|||+|+......
T Consensus 83 v~ey~~gg~L~~~~~~~-~~~~e~~~~~~~~qil~al~ylH~~~--iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~ 159 (337)
T d1o6la_ 83 VMEYANGGELFFHLSRE-RVFTEERARFYGAEIVSALEYLHSRD--VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG 159 (337)
T ss_dssp EEECCTTCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT
T ss_pred ceeccCCCchhhhhhcc-cCCcHHHHHHHHHHHhhhhhhhhhcC--ccccccCHHHeEecCCCCEEEeecccccccccCC
Confidence 99999999999999764 47999999999999999999999999 9999999999999999999999999999876655
Q ss_pred cccccCCCCccccCC
Q 005841 660 LTTKTGKGTVTYLAS 674 (674)
Q Consensus 660 ~~~~~~~GTp~YmAP 674 (674)
......+|||.||||
T Consensus 160 ~~~~~~~GT~~Y~aP 174 (337)
T d1o6la_ 160 ATMKTFCGTPEYLAP 174 (337)
T ss_dssp CCBCCCEECGGGCCG
T ss_pred cccccceeCHHHhhh
Confidence 566668999999999
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-34 Score=297.38 Aligned_cols=166 Identities=31% Similarity=0.525 Sum_probs=146.5
Q ss_pred CeeEeeeecccCceEEEEEEEc--CCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEec----CCeEEE
Q 005841 506 DLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTS----PQRLCI 579 (674)
Q Consensus 506 ~y~~~~~LG~G~fG~Vy~~~~~--~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~----~~~~~l 579 (674)
.|++.++||+|+||+||+|.+. +..||+|++..........+.+.+|+.+|++++||||+++++++.. ...+||
T Consensus 10 y~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~i 89 (270)
T d1t4ha_ 10 FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL 89 (270)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEE
T ss_pred EEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEE
Confidence 3578889999999999999984 6679999998877777777889999999999999999999999865 356899
Q ss_pred EEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEc-CCCcEEEEecCCcccccCC
Q 005841 580 VTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVD-KHWTVKVGDFGLSRLKHET 658 (674)
Q Consensus 580 V~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~-~~~~vkL~DFGla~~~~~~ 658 (674)
|||||++|+|.+++.+. ..+++..+..++.||+.||+|||+++++||||||||+||||+ +++.+||+|||+|+.....
T Consensus 90 vmE~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~~ 168 (270)
T d1t4ha_ 90 VTELMTSGTLKTYLKRF-KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS 168 (270)
T ss_dssp EEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTT
T ss_pred EEeCCCCCcHHHHHhcc-ccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCcceeccCC
Confidence 99999999999999764 479999999999999999999999887899999999999997 5789999999999876544
Q ss_pred ccccccCCCCccccCC
Q 005841 659 YLTTKTGKGTVTYLAS 674 (674)
Q Consensus 659 ~~~~~~~~GTp~YmAP 674 (674)
. ..+.+|||.||||
T Consensus 169 ~--~~~~~GT~~Y~aP 182 (270)
T d1t4ha_ 169 F--AKAVIGTPEFMAP 182 (270)
T ss_dssp S--BEESCSSCCCCCG
T ss_pred c--cCCcccCccccCH
Confidence 3 3346899999999
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-35 Score=310.18 Aligned_cols=168 Identities=24% Similarity=0.411 Sum_probs=148.1
Q ss_pred ccccCCeeEeeeecccCceEEEEEEE--cCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeEE
Q 005841 501 EILWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLC 578 (674)
Q Consensus 501 ~~~~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 578 (674)
++..++|+++++||+|+||+||+|++ ++..||||++.+.. .......+.+|+.+|+.++|||||+++++|.+.+.+|
T Consensus 2 el~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 80 (322)
T d1s9ja_ 2 ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEIS 80 (322)
T ss_dssp CCCGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCC-CTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEE
T ss_pred CCCccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhh-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 45567899999999999999999998 46779999997653 3444577899999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCeEEccCCCCCEEEcCCCcEEEEecCCcccccC
Q 005841 579 IVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHH-CNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHE 657 (674)
Q Consensus 579 lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~-~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~ 657 (674)
||||||+||+|.+++.+. ..+++..+..++.||+.||.|||+ ++ ||||||||+||||+.++++||+|||+|+....
T Consensus 81 iVmEy~~gg~L~~~l~~~-~~l~~~~~~~~~~qil~aL~yLH~~~~--IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~ 157 (322)
T d1s9ja_ 81 ICMEHMDGGSLDQVLKKA-GRIPEQILGKVSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 157 (322)
T ss_dssp EEEECCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHHHC--CCCSCCSGGGEEECTTCCEEECCCCCCHHHHH
T ss_pred EEEEcCCCCcHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHhCC--EEccccCHHHeeECCCCCEEEeeCCCccccCC
Confidence 999999999999999764 469999999999999999999997 58 99999999999999999999999999997654
Q ss_pred CccccccCCCCccccCC
Q 005841 658 TYLTTKTGKGTVTYLAS 674 (674)
Q Consensus 658 ~~~~~~~~~GTp~YmAP 674 (674)
.. ..+.+||+.||||
T Consensus 158 ~~--~~~~~GT~~Y~AP 172 (322)
T d1s9ja_ 158 SM--ANSFVGTRSYMSP 172 (322)
T ss_dssp HT--C---CCSSCCCCH
T ss_pred Cc--cccccCCccccCc
Confidence 32 2346899999998
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.7e-35 Score=303.05 Aligned_cols=168 Identities=24% Similarity=0.415 Sum_probs=145.6
Q ss_pred cCCeeEeeeecccCceEEEEEEE--cCCeEEEEEeecccCC-HHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeEEEE
Q 005841 504 WEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYS-DEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIV 580 (674)
Q Consensus 504 ~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 580 (674)
.++|+++++||+|+||+||+|.+ ++..||||++.+.... ....+.+.+|+.++++++||||+++++++.+.+.+|||
T Consensus 7 p~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~iv 86 (288)
T d1uu3a_ 7 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFG 86 (288)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEE
T ss_pred CCCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEE
Confidence 36899999999999999999998 4778999999765432 23446788999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccccCC--
Q 005841 581 TEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHET-- 658 (674)
Q Consensus 581 ~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~~-- 658 (674)
||||+||+|.+++... ..+++..+..++.||+.||+|||+++ ||||||||+||||+.++.+||+|||+|+.+...
T Consensus 87 mEy~~gg~L~~~~~~~-~~l~e~~~~~~~~qi~~al~ylH~~~--iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~ 163 (288)
T d1uu3a_ 87 LSYAKNGELLKYIRKI-GSFDETCTRFYTAEIVSALEYLHGKG--IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK 163 (288)
T ss_dssp ECCCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTSCEEECCCTTCEECC----
T ss_pred EEccCCCCHHHhhhcc-CCCCHHHHHHHHHHHHHHHHhhcccc--EEcCcCCccccccCCCceEEecccccceecccCCc
Confidence 9999999999998754 57999999999999999999999999 999999999999999999999999999976532
Q ss_pred ccccccCCCCccccCC
Q 005841 659 YLTTKTGKGTVTYLAS 674 (674)
Q Consensus 659 ~~~~~~~~GTp~YmAP 674 (674)
.....+.+||+.||||
T Consensus 164 ~~~~~~~~GT~~Y~AP 179 (288)
T d1uu3a_ 164 QARANSFVGTAQYVSP 179 (288)
T ss_dssp ------CCCCGGGCCH
T ss_pred ccccccccCCccccCc
Confidence 2233456899999998
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1e-34 Score=301.11 Aligned_cols=171 Identities=33% Similarity=0.570 Sum_probs=151.6
Q ss_pred ccccccCCeeEeeeecccCceEEEEEEEc--CCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCe
Q 005841 499 DYEILWEDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQR 576 (674)
Q Consensus 499 ~~~~~~~~y~~~~~LG~G~fG~Vy~~~~~--~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 576 (674)
.|++..++|++.++||+|+||+||+|.+. +..||||+++..... .+.|.+|+.+|+.++|||||++++++.+.+.
T Consensus 11 ~wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~---~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~ 87 (287)
T d1opja_ 11 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME---VEEFLKEAAVMKEIKHPNLVQLLGVCTREPP 87 (287)
T ss_dssp TTBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSC---HHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred ccEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccch---HHHHHHHHHHHHhCCCCCEecCCccEeeCCe
Confidence 46788899999999999999999999984 667999999765443 3568899999999999999999999999999
Q ss_pred EEEEEecCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccc
Q 005841 577 LCIVTEFLPRGSLFRLLQRN-TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLK 655 (674)
Q Consensus 577 ~~lV~E~~~ggsL~~~l~~~-~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~ 655 (674)
+|||||||++|+|.+++... ...+++..++.|+.||+.||+|||+++ ||||||||+||||+.++++||+|||+|+..
T Consensus 88 ~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~--iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~ 165 (287)
T d1opja_ 88 FYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN--FIHRDLAARNCLVGENHLVKVADFGLSRLM 165 (287)
T ss_dssp CEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECGGGCEEECCCCCTTTC
T ss_pred eEEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCC--cccCccccCeEEECCCCcEEEccccceeec
Confidence 99999999999999999753 457899999999999999999999999 999999999999999999999999999987
Q ss_pred cCCccccc-cCCCCccccCC
Q 005841 656 HETYLTTK-TGKGTVTYLAS 674 (674)
Q Consensus 656 ~~~~~~~~-~~~GTp~YmAP 674 (674)
........ ...||+.||||
T Consensus 166 ~~~~~~~~~~~~g~~~y~aP 185 (287)
T d1opja_ 166 TGDTYTAHAGAKFPIKWTAP 185 (287)
T ss_dssp CSSSSEEETTEEECGGGCCH
T ss_pred CCCCceeeccccccccccCh
Confidence 65443333 23589999998
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.4e-34 Score=299.32 Aligned_cols=162 Identities=28% Similarity=0.393 Sum_probs=145.5
Q ss_pred CeeEeeeecccCceEEEEEEE--cCCeEEEEEeecccCCH-HHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeEEEEEe
Q 005841 506 DLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSD-EVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTE 582 (674)
Q Consensus 506 ~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E 582 (674)
.|++++.||+|+||+||+|++ ++..||||++.+..... ...+.+.+|+.+|+.++|||||++++++.+.+.+|||||
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E 95 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEE
Confidence 499999999999999999998 46679999998766543 556789999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccccCCcccc
Q 005841 583 FLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTT 662 (674)
Q Consensus 583 ~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~~~~~~ 662 (674)
||.+|+|..++.. ...+++..+..|+.||+.||.|||+++ ||||||||+||||+.++++||+|||+|+.... .
T Consensus 96 ~~~~g~l~~~~~~-~~~l~e~~~~~i~~qi~~aL~yLH~~~--iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~----~ 168 (309)
T d1u5ra_ 96 YCLGSASDLLEVH-KKPLQEVEIAAVTHGALQGLAYLHSHN--MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP----A 168 (309)
T ss_dssp CCSEEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCSGGGEEEETTTEEEECCCTTCBSSSS----B
T ss_pred ecCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCC--EeccCCCcceEEECCCCCEEEeecccccccCC----C
Confidence 9999998776654 567999999999999999999999999 99999999999999999999999999986554 2
Q ss_pred ccCCCCccccCC
Q 005841 663 KTGKGTVTYLAS 674 (674)
Q Consensus 663 ~~~~GTp~YmAP 674 (674)
...+|||.||||
T Consensus 169 ~~~~GT~~Y~AP 180 (309)
T d1u5ra_ 169 NSFVGTPYWMAP 180 (309)
T ss_dssp CCCCSCGGGCCH
T ss_pred CccccCccccCH
Confidence 346899999998
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=8.2e-34 Score=302.49 Aligned_cols=166 Identities=25% Similarity=0.395 Sum_probs=148.1
Q ss_pred cCCeeEeeeecccCceEEEEEEE--cCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeEEEEE
Q 005841 504 WEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVT 581 (674)
Q Consensus 504 ~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 581 (674)
.++|+++++||+|+||+||+|.+ ++..||||++.+.. ......+.+|+.+|+.|+|||||+++++|.+++.+||||
T Consensus 28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~--~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 105 (352)
T d1koba_ 28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY--PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLIL 105 (352)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcc--hhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 46799999999999999999998 47789999997654 233467889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEc--CCCcEEEEecCCcccccCCc
Q 005841 582 EFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVD--KHWTVKVGDFGLSRLKHETY 659 (674)
Q Consensus 582 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~--~~~~vkL~DFGla~~~~~~~ 659 (674)
|||+||+|.+++......|++..++.|+.||+.||.|||++| ||||||||+||||+ .++.|||+|||+|+.+....
T Consensus 106 E~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~--iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~ 183 (352)
T d1koba_ 106 EFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHS--IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE 183 (352)
T ss_dssp ECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS
T ss_pred EcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecccccccccccccCCCeEEEeecccceecCCCC
Confidence 999999999988776778999999999999999999999999 99999999999998 67899999999999876543
Q ss_pred cccccCCCCccccCC
Q 005841 660 LTTKTGKGTVTYLAS 674 (674)
Q Consensus 660 ~~~~~~~GTp~YmAP 674 (674)
.. ....||+.||||
T Consensus 184 ~~-~~~~gt~~y~aP 197 (352)
T d1koba_ 184 IV-KVTTATAEFAAP 197 (352)
T ss_dssp CE-EEECSSGGGCCH
T ss_pred ce-eeccCcccccCH
Confidence 33 335799999998
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=9.1e-34 Score=301.90 Aligned_cols=166 Identities=24% Similarity=0.421 Sum_probs=148.0
Q ss_pred cCCeeEeeeecccCceEEEEEEE--cCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeEEEEE
Q 005841 504 WEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVT 581 (674)
Q Consensus 504 ~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 581 (674)
.++|+++++||+|+||+||+|.+ ++..||||++.+.. ....+.+.+|+.+|+.++|||||++++++.+.+.+||||
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~--~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 102 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH--ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIY 102 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCS--HHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEE
T ss_pred ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccc--hhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 46899999999999999999998 47789999997543 334567889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEc--CCCcEEEEecCCcccccCCc
Q 005841 582 EFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVD--KHWTVKVGDFGLSRLKHETY 659 (674)
Q Consensus 582 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~--~~~~vkL~DFGla~~~~~~~ 659 (674)
|||+||+|.+++......+++..+..|+.||+.||.|||+++ ||||||||+||||+ .++.|||+|||+|+.+....
T Consensus 103 E~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~--iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~ 180 (350)
T d1koaa2 103 EFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN--YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ 180 (350)
T ss_dssp CCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTS
T ss_pred EcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcC--CeeeeechhHeeeccCCCCeEEEeecchheeccccc
Confidence 999999999999766678999999999999999999999999 99999999999996 46789999999999776543
Q ss_pred cccccCCCCccccCC
Q 005841 660 LTTKTGKGTVTYLAS 674 (674)
Q Consensus 660 ~~~~~~~GTp~YmAP 674 (674)
.. .+.+||+.||||
T Consensus 181 ~~-~~~~gT~~Y~aP 194 (350)
T d1koaa2 181 SV-KVTTGTAEFAAP 194 (350)
T ss_dssp CE-EEECSCTTTCCH
T ss_pred cc-ceecCcccccCH
Confidence 33 346899999998
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-34 Score=292.60 Aligned_cols=167 Identities=29% Similarity=0.508 Sum_probs=139.1
Q ss_pred ccCCeeEeeeecccCceEEEEEEEc-CCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeEEEEE
Q 005841 503 LWEDLTIGEQIGQGSCGTVYHAVWY-GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVT 581 (674)
Q Consensus 503 ~~~~y~~~~~LG~G~fG~Vy~~~~~-~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 581 (674)
..++|++.++||+|+||+||+|.+. +..||||++.+..... +.|.+|+.+++.++||||+++++++...+.+||||
T Consensus 3 dp~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~---~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~ 79 (263)
T d1sm2a_ 3 DPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE---EDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVF 79 (263)
T ss_dssp CCSCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSSSCH---HHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred ChHHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCcCcH---HHHHHHHHHHHhcCCCCcccccceeccCCceEEEE
Confidence 3468999999999999999999984 5579999997655443 46889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccccCCccc
Q 005841 582 EFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLT 661 (674)
Q Consensus 582 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~~~~~ 661 (674)
|||++|+|.+++......+++..++.|+.||+.||.|||+++ |+||||||+||||+.++.+||+|||+|+........
T Consensus 80 E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~--iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~ 157 (263)
T d1sm2a_ 80 EFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC--VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT 157 (263)
T ss_dssp ECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCTTCSGGGEEECGGGCEEECSCC-----------
T ss_pred EecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccc--eeecccchhheeecCCCCeEecccchheeccCCCce
Confidence 999999999999877778999999999999999999999999 999999999999999999999999999877544332
Q ss_pred -cccCCCCccccCC
Q 005841 662 -TKTGKGTVTYLAS 674 (674)
Q Consensus 662 -~~~~~GTp~YmAP 674 (674)
.....||+.||||
T Consensus 158 ~~~~~~gt~~y~aP 171 (263)
T d1sm2a_ 158 SSTGTKFPVKWASP 171 (263)
T ss_dssp -------CTTSCCH
T ss_pred eecceecCcccCCh
Confidence 3345799999998
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.4e-34 Score=292.77 Aligned_cols=171 Identities=32% Similarity=0.540 Sum_probs=148.5
Q ss_pred cccccccCCeeEeeeecccCceEEEEEEEc-CCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCe
Q 005841 498 LDYEILWEDLTIGEQIGQGSCGTVYHAVWY-GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQR 576 (674)
Q Consensus 498 ~~~~~~~~~y~~~~~LG~G~fG~Vy~~~~~-~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 576 (674)
.+|++..++|++.++||+|+||+||+|.+. +..||||++....... +.|.+|+.++.+++|||||++++++. .+.
T Consensus 6 ~~wei~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~---~~~~~E~~~l~~l~HpnIv~~~g~~~-~~~ 81 (272)
T d1qpca_ 6 DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP---DAFLAEANLMKQLQHQRLVRLYAVVT-QEP 81 (272)
T ss_dssp CTTBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSCH---HHHHHHHHHHHHCCCTTBCCEEEEEC-SSS
T ss_pred CCeecCHHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCcCCH---HHHHHHHHHHHhCCCCCEeEEEeeec-cCC
Confidence 457888899999999999999999999986 4579999997655443 46889999999999999999999875 466
Q ss_pred EEEEEecCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccc
Q 005841 577 LCIVTEFLPRGSLFRLLQRN-TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLK 655 (674)
Q Consensus 577 ~~lV~E~~~ggsL~~~l~~~-~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~ 655 (674)
+|||||||++|+|.+++... ...+++..++.|+.||+.||.|||+++ ||||||||+||||+.++.+||+|||+|+..
T Consensus 82 ~~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~--ivHrDiKp~NIll~~~~~~Kl~DFGla~~~ 159 (272)
T d1qpca_ 82 IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN--YIHRDLRAANILVSDTLSCKIADFGLARLI 159 (272)
T ss_dssp CEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred eEEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCccchhheeeecccceeeccccceEEc
Confidence 89999999999999987543 235999999999999999999999999 999999999999999999999999999987
Q ss_pred cCCcc-ccccCCCCccccCC
Q 005841 656 HETYL-TTKTGKGTVTYLAS 674 (674)
Q Consensus 656 ~~~~~-~~~~~~GTp~YmAP 674 (674)
..... ......||+.||||
T Consensus 160 ~~~~~~~~~~~~gt~~y~AP 179 (272)
T d1qpca_ 160 EDNEYTAREGAKFPIKWTAP 179 (272)
T ss_dssp SSSCEECCTTCCCCTTTSCH
T ss_pred cCCccccccccCCcccccCh
Confidence 65433 23345799999998
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=6.5e-34 Score=298.98 Aligned_cols=165 Identities=27% Similarity=0.455 Sum_probs=147.4
Q ss_pred cCCeeEeeeecccCceEEEEEEEc--CCeEEEEEeecccCC-HHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeEEEE
Q 005841 504 WEDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYS-DEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIV 580 (674)
Q Consensus 504 ~~~y~~~~~LG~G~fG~Vy~~~~~--~~~vAvK~i~~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 580 (674)
.++|+++++||+|+||+||+|++. +..||||++.+.... ....+.+.+|+.+++.++||||+++++++.+.+.+|+|
T Consensus 3 l~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv 82 (316)
T d1fota_ 3 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI 82 (316)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred hhHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeE
Confidence 368999999999999999999984 778999999765432 23456788999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccccCCcc
Q 005841 581 TEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYL 660 (674)
Q Consensus 581 ~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~~~~ 660 (674)
||||+||+|..++.. ...+++..+..++.||+.||.|||+++ ||||||||+||||+.++.+||+|||+|+.....
T Consensus 83 mE~~~gg~l~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~--iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~-- 157 (316)
T d1fota_ 83 MDYIEGGELFSLLRK-SQRFPNPVAKFYAAEVCLALEYLHSKD--IIYRDLKPENILLDKNGHIKITDFGFAKYVPDV-- 157 (316)
T ss_dssp ECCCCSCBHHHHHHH-TSSCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEECTTSCEEECCCSSCEECSSC--
T ss_pred eeecCCccccccccc-cccccccHHHHHHHHHHHhhhhhccCc--EEccccCchheeEcCCCCEEEecCccceEeccc--
Confidence 999999999998875 557899999999999999999999999 999999999999999999999999999987654
Q ss_pred ccccCCCCccccCC
Q 005841 661 TTKTGKGTVTYLAS 674 (674)
Q Consensus 661 ~~~~~~GTp~YmAP 674 (674)
..+.+|||.||||
T Consensus 158 -~~~~~Gt~~Y~AP 170 (316)
T d1fota_ 158 -TYTLCGTPDYIAP 170 (316)
T ss_dssp -BCCCCSCTTTCCH
T ss_pred -cccccCcccccCH
Confidence 2346899999998
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=7.2e-34 Score=296.36 Aligned_cols=171 Identities=33% Similarity=0.490 Sum_probs=138.6
Q ss_pred ccccCCeeEeeeecccCceEEEEEEEc--CC---eEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCC
Q 005841 501 EILWEDLTIGEQIGQGSCGTVYHAVWY--GS---DVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQ 575 (674)
Q Consensus 501 ~~~~~~y~~~~~LG~G~fG~Vy~~~~~--~~---~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~ 575 (674)
++..++|++.++||+|+||+||+|.+. +. .||||.+.... .....+.|.+|+.+|++++|||||++++++...+
T Consensus 22 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~ 100 (299)
T d1jpaa_ 22 EIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY-TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKST 100 (299)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred hhChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECccc-CHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCC
Confidence 455678999999999999999999974 22 38888876433 4556678999999999999999999999999999
Q ss_pred eEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccc
Q 005841 576 RLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLK 655 (674)
Q Consensus 576 ~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~ 655 (674)
.+|||||||++|+|.+++......+++..++.|+.||+.||.|||+++ ||||||||+||||+.++++||+|||+|+.+
T Consensus 101 ~~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~--iiHrDlKp~NILl~~~~~~Kl~DFGla~~~ 178 (299)
T d1jpaa_ 101 PVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMN--YVHRDLAARNILVNSNLVCKVSDFGLSRFL 178 (299)
T ss_dssp SCEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTCCEEECCC------
T ss_pred EEEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCC--CccCccccceEEECCCCcEEECCcccceEc
Confidence 999999999999999999877778999999999999999999999999 999999999999999999999999999876
Q ss_pred cCCcc-----ccccCCCCccccCC
Q 005841 656 HETYL-----TTKTGKGTVTYLAS 674 (674)
Q Consensus 656 ~~~~~-----~~~~~~GTp~YmAP 674 (674)
..... ......||+.||||
T Consensus 179 ~~~~~~~~~~~~~~~~~t~~y~aP 202 (299)
T d1jpaa_ 179 EDDTSDPTYTSALGGKIPIRWTAP 202 (299)
T ss_dssp -----------------CGGGSCH
T ss_pred cCCCCcceeeecccccCCccccCH
Confidence 43221 12224689999998
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=5.2e-34 Score=298.51 Aligned_cols=167 Identities=25% Similarity=0.407 Sum_probs=130.3
Q ss_pred ccCCeeEeeeecccCceEEEEEEEc--CCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeEEEE
Q 005841 503 LWEDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIV 580 (674)
Q Consensus 503 ~~~~y~~~~~LG~G~fG~Vy~~~~~--~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 580 (674)
..+.|++.++||+|+||+||+|++. +..||||++.+..... ....+.+|+.+|+.++||||+++++++.+.+.+|||
T Consensus 7 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~-~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv 85 (307)
T d1a06a_ 7 IRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEG-KEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLI 85 (307)
T ss_dssp GGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC-----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhh-HHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 3467999999999999999999984 6779999998765433 235688999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEc---CCCcEEEEecCCcccccC
Q 005841 581 TEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVD---KHWTVKVGDFGLSRLKHE 657 (674)
Q Consensus 581 ~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~---~~~~vkL~DFGla~~~~~ 657 (674)
||||+||+|.++|.. ...+++..+..|+.||+.||+|||+++ ||||||||+|||+. .++.|||+|||+|+....
T Consensus 86 mE~~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~al~ylH~~~--iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~ 162 (307)
T d1a06a_ 86 MQLVSGGELFDRIVE-KGFYTERDASRLIFQVLDAVKYLHDLG--IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDP 162 (307)
T ss_dssp ECCCCSCBHHHHHHT-CSCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESSSSTTCCEEECCC--------
T ss_pred EeccCCCcHHHhhhc-ccCCCHHHHHHHHHHHHHHHHhhhhce--eeeEEecccceeecccCCCceEEEeccceeEEccC
Confidence 999999999999975 457999999999999999999999999 99999999999994 578999999999987654
Q ss_pred CccccccCCCCccccCC
Q 005841 658 TYLTTKTGKGTVTYLAS 674 (674)
Q Consensus 658 ~~~~~~~~~GTp~YmAP 674 (674)
... ..+.+||+.||||
T Consensus 163 ~~~-~~~~~GT~~y~AP 178 (307)
T d1a06a_ 163 GSV-LSTACGTPGYVAP 178 (307)
T ss_dssp -----------CTTSCH
T ss_pred CCe-eeeeeeCccccCc
Confidence 432 3346899999998
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-33 Score=297.88 Aligned_cols=173 Identities=28% Similarity=0.480 Sum_probs=145.5
Q ss_pred ccccccCCeeEeeeecccCceEEEEEEEcCC-------eEEEEEeecccCCHHHHHHHHHHHHHHhhC-CCCCeeeEEEE
Q 005841 499 DYEILWEDLTIGEQIGQGSCGTVYHAVWYGS-------DVAVKVFSRQEYSDEVIHSFRQEVSLMKRL-RHPNVLLFMGA 570 (674)
Q Consensus 499 ~~~~~~~~y~~~~~LG~G~fG~Vy~~~~~~~-------~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~ 570 (674)
.|++..++|+++++||+|+||+||+|++.+. .||+|.+.... .......+.+|+.++..+ +|||||+++++
T Consensus 31 kwei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~ 109 (325)
T d1rjba_ 31 KWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA-DSSEREALMSELKMMTQLGSHENIVNLLGA 109 (325)
T ss_dssp GGBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred cccCCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEecccc-CHHHHHHHHHHHHHHHHhcCCCcEeEEEEE
Confidence 4677889999999999999999999997432 48999886543 233456788999999998 89999999999
Q ss_pred EecCCeEEEEEecCCCCCHHHHHHhcC----------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEE
Q 005841 571 VTSPQRLCIVTEFLPRGSLFRLLQRNT----------------------TKLDWRRRILMALDIARGVSYLHHCNPPIIH 628 (674)
Q Consensus 571 ~~~~~~~~lV~E~~~ggsL~~~l~~~~----------------------~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvH 628 (674)
+.+.+.+|||||||++|+|.++|.... ..+++..++.|+.||+.||+|||+++ |||
T Consensus 110 ~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~--IiH 187 (325)
T d1rjba_ 110 CTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS--CVH 187 (325)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT--EEE
T ss_pred EeeCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC--eee
Confidence 999999999999999999999997543 24889999999999999999999999 999
Q ss_pred ccCCCCCEEEcCCCcEEEEecCCcccccCCcc--ccccCCCCccccCC
Q 005841 629 RDLKSSNLLVDKHWTVKVGDFGLSRLKHETYL--TTKTGKGTVTYLAS 674 (674)
Q Consensus 629 rDLKp~NILi~~~~~vkL~DFGla~~~~~~~~--~~~~~~GTp~YmAP 674 (674)
|||||+|||++.++++||+|||+|+....... ...+..||+.||||
T Consensus 188 RDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aP 235 (325)
T d1rjba_ 188 RDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAP 235 (325)
T ss_dssp TTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCH
T ss_pred ccCchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCCh
Confidence 99999999999999999999999987654322 22345689999998
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=5.9e-33 Score=286.26 Aligned_cols=167 Identities=25% Similarity=0.418 Sum_probs=149.3
Q ss_pred cCCeeEeeeecccCceEEEEEEE--cCCeEEEEEeecccCC-------HHHHHHHHHHHHHHhhCC-CCCeeeEEEEEec
Q 005841 504 WEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYS-------DEVIHSFRQEVSLMKRLR-HPNVLLFMGAVTS 573 (674)
Q Consensus 504 ~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~~-------~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~ 573 (674)
.++|++.+.||+|+||+||+|++ +++.||||++.+.... ....+.+.+|+.+++.+. ||||+++++++.+
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 81 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 81 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence 47899999999999999999998 5678999999876542 134457889999999997 9999999999999
Q ss_pred CCeEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcc
Q 005841 574 PQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSR 653 (674)
Q Consensus 574 ~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~ 653 (674)
++.+|||||||++|+|.++|... ..+++..+..|+.||+.||+|||+++ ||||||||+||||+.++.+||+|||+|+
T Consensus 82 ~~~~~ivmE~~~~g~L~~~l~~~-~~l~e~~~~~~~~qi~~al~~lH~~~--ivHrDlkp~Nill~~~~~~kl~DFG~a~ 158 (277)
T d1phka_ 82 NTFFFLVFDLMKKGELFDYLTEK-VTLSEKETRKIMRALLEVICALHKLN--IVHRDLKPENILLDDDMNIKLTDFGFSC 158 (277)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred CcceEEEEEcCCCchHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcC--CcccccccceEEEcCCCCeEEccchhee
Confidence 99999999999999999999764 47999999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCccccccCCCCccccCC
Q 005841 654 LKHETYLTTKTGKGTVTYLAS 674 (674)
Q Consensus 654 ~~~~~~~~~~~~~GTp~YmAP 674 (674)
....... ....+||+.|+||
T Consensus 159 ~~~~~~~-~~~~~gt~~y~~P 178 (277)
T d1phka_ 159 QLDPGEK-LREVCGTPSYLAP 178 (277)
T ss_dssp ECCTTCC-BCCCCSCGGGCCH
T ss_pred EccCCCc-eeeeeccCCCCCH
Confidence 8765433 3346899999998
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-33 Score=289.23 Aligned_cols=167 Identities=26% Similarity=0.366 Sum_probs=147.5
Q ss_pred cCCeeEeeeecccCceEEEEEEEc--CCeEEEEEeecccCCH----HHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeE
Q 005841 504 WEDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSD----EVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRL 577 (674)
Q Consensus 504 ~~~y~~~~~LG~G~fG~Vy~~~~~--~~~vAvK~i~~~~~~~----~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 577 (674)
.++|+++++||+|+||+||+|++. +..||||++.+..... ...+.+.+|+.+|+.++|||||++++++.+.+.+
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 88 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 88 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 467999999999999999999984 7789999998765432 2356789999999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCC----cEEEEecCCcc
Q 005841 578 CIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHW----TVKVGDFGLSR 653 (674)
Q Consensus 578 ~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~----~vkL~DFGla~ 653 (674)
|||||||++|+|.++|... ..+++..+..++.||+.||+|||+++ ||||||||+|||++.++ .+||+|||+|+
T Consensus 89 ~iv~E~~~gg~L~~~i~~~-~~l~~~~~~~~~~qi~~al~yLH~~~--ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~ 165 (293)
T d1jksa_ 89 ILILELVAGGELFDFLAEK-ESLTEEEATEFLKQILNGVYYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH 165 (293)
T ss_dssp EEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred EEEEEcCCCccccchhccc-cccchhHHHHHHHHHHHHHHhhhhcc--eeecccccceEEEecCCCcccceEecchhhhh
Confidence 9999999999999999764 47999999999999999999999999 99999999999998766 59999999998
Q ss_pred cccCCccccccCCCCccccCC
Q 005841 654 LKHETYLTTKTGKGTVTYLAS 674 (674)
Q Consensus 654 ~~~~~~~~~~~~~GTp~YmAP 674 (674)
....... ..+..||+.||||
T Consensus 166 ~~~~~~~-~~~~~~t~~y~AP 185 (293)
T d1jksa_ 166 KIDFGNE-FKNIFGTPEFVAP 185 (293)
T ss_dssp ECTTSCB-CSCCCCCGGGCCH
T ss_pred hcCCCcc-ccccCCCCcccCH
Confidence 7755432 3346799999998
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2e-33 Score=299.38 Aligned_cols=164 Identities=26% Similarity=0.386 Sum_probs=147.6
Q ss_pred CCeeEeeeecccCceEEEEEEE--cCCeEEEEEeecccCCH-HHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeEEEEE
Q 005841 505 EDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSD-EVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVT 581 (674)
Q Consensus 505 ~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 581 (674)
++|+++++||+|+||+||+|++ ++..||||++.+..... ...+.+.+|+.+|+.++||||+++++++.....+|+||
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence 6899999999999999999998 47789999997654322 34567889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccccCCccc
Q 005841 582 EFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLT 661 (674)
Q Consensus 582 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~~~~~ 661 (674)
||+.+|+|..++.+. ..+++..++.|+.||+.||.|||+++ ||||||||+||||+.+++|||+|||+|+.....
T Consensus 121 e~~~~g~l~~~l~~~-~~l~e~~~~~i~~qi~~aL~yLH~~~--iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~--- 194 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRRI-GRFSEPHARFYAAQIVLTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR--- 194 (350)
T ss_dssp ECCTTCBHHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCTTCEECSSC---
T ss_pred ccccccchhhhHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--EecCcCCHHHcccCCCCCEEeeeceeeeecccc---
Confidence 999999999999764 47999999999999999999999999 999999999999999999999999999987643
Q ss_pred cccCCCCccccCC
Q 005841 662 TKTGKGTVTYLAS 674 (674)
Q Consensus 662 ~~~~~GTp~YmAP 674 (674)
..+.+|||.||||
T Consensus 195 ~~~~~Gt~~Y~AP 207 (350)
T d1rdqe_ 195 TWTLCGTPEALAP 207 (350)
T ss_dssp BCCCEECGGGCCH
T ss_pred cccccCccccCCH
Confidence 2346899999998
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-33 Score=288.68 Aligned_cols=171 Identities=30% Similarity=0.486 Sum_probs=143.3
Q ss_pred ccccCCeeEeeeecccCceEEEEEEEcC------CeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecC
Q 005841 501 EILWEDLTIGEQIGQGSCGTVYHAVWYG------SDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSP 574 (674)
Q Consensus 501 ~~~~~~y~~~~~LG~G~fG~Vy~~~~~~------~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~ 574 (674)
++...+|++.++||+|+||.||+|.+.. ..||||++... ........|.+|+.+++.++|||||++++++...
T Consensus 3 ei~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~-~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~ 81 (283)
T d1mqba_ 3 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAG-YTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKY 81 (283)
T ss_dssp BCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTT-CCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred cCCHHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcc-cChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecC
Confidence 5566789999999999999999998743 25999999654 3445566799999999999999999999999999
Q ss_pred CeEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCccc
Q 005841 575 QRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL 654 (674)
Q Consensus 575 ~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~ 654 (674)
+.+++|||||.+++|.+++......+++..++.|+.||+.||+|||+++ ||||||||+||||+.++.+||+|||+|+.
T Consensus 82 ~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~--iiHrDlKp~NILl~~~~~~Kl~DFGla~~ 159 (283)
T d1mqba_ 82 KPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMN--YVHRDLAARNILVNSNLVCKVSDFGLSRV 159 (283)
T ss_dssp SSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred CceEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccc--cccCccccceEEECCCCeEEEcccchhhc
Confidence 9999999999999999999887788999999999999999999999999 99999999999999999999999999987
Q ss_pred ccCCc---cccccCCCCccccCC
Q 005841 655 KHETY---LTTKTGKGTVTYLAS 674 (674)
Q Consensus 655 ~~~~~---~~~~~~~GTp~YmAP 674 (674)
+.... .......||+.||||
T Consensus 160 ~~~~~~~~~~~~~~~gt~~Y~AP 182 (283)
T d1mqba_ 160 LEDDPEATYTTSGGKIPIRWTAP 182 (283)
T ss_dssp --------------CCCGGGSCH
T ss_pred ccCCCccceEeccCCCCccccCH
Confidence 64432 223335689999998
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.8e-33 Score=287.44 Aligned_cols=169 Identities=25% Similarity=0.438 Sum_probs=145.9
Q ss_pred cccCCeeEeee-ecccCceEEEEEEEc----CCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCe
Q 005841 502 ILWEDLTIGEQ-IGQGSCGTVYHAVWY----GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQR 576 (674)
Q Consensus 502 ~~~~~y~~~~~-LG~G~fG~Vy~~~~~----~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 576 (674)
+..++|.+.+. ||+|+||+||+|.+. +..||||++++.. .....+.|.+|+.+|++++|||||++++++.. +.
T Consensus 5 l~~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~-~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~ 82 (285)
T d1u59a_ 5 LKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT-EKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EA 82 (285)
T ss_dssp CCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SS
T ss_pred ecccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhc-CHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-Ce
Confidence 44567888885 999999999999863 3359999997543 45567789999999999999999999999865 56
Q ss_pred EEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCccccc
Q 005841 577 LCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKH 656 (674)
Q Consensus 577 ~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~ 656 (674)
+|||||||++|+|.+++...+..+++..++.|+.||+.||+|||+++ ||||||||+||||+.++.+||+|||+|+...
T Consensus 83 ~~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~--iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~ 160 (285)
T d1u59a_ 83 LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN--FVHRDLAARNVLLVNRHYAKISDFGLSKALG 160 (285)
T ss_dssp EEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEEETTEEEECCCTTCEECT
T ss_pred EEEEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCcCchhheeeccCCceeeccchhhhccc
Confidence 89999999999999999777778999999999999999999999999 9999999999999999999999999998765
Q ss_pred CCcc---ccccCCCCccccCC
Q 005841 657 ETYL---TTKTGKGTVTYLAS 674 (674)
Q Consensus 657 ~~~~---~~~~~~GTp~YmAP 674 (674)
.... ......||+.||||
T Consensus 161 ~~~~~~~~~~~~~gt~~y~aP 181 (285)
T d1u59a_ 161 ADDSYYTARSAGKWPLKWYAP 181 (285)
T ss_dssp TCSCEECCCCSSCCCGGGCCH
T ss_pred ccccccccccccccCccccCh
Confidence 4321 22345799999998
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-33 Score=291.97 Aligned_cols=166 Identities=22% Similarity=0.327 Sum_probs=146.4
Q ss_pred ccCCeeEeeeecccCceEEEEEEEc--CCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeEEEE
Q 005841 503 LWEDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIV 580 (674)
Q Consensus 503 ~~~~y~~~~~LG~G~fG~Vy~~~~~--~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 580 (674)
++++|++++.||+|+||+||+|.+. +..||||++.+... ....+.+|+.+|+.++||||+++++++.+.+++|||
T Consensus 3 ~~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~---~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lv 79 (321)
T d1tkia_ 3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT---DQVLVKKEISILNIARHRNILHLHESFESMEELVMI 79 (321)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTH---HHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEE
T ss_pred CccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcc---cHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEE
Confidence 4688999999999999999999984 66799999976532 234578999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcC--CCcEEEEecCCcccccCC
Q 005841 581 TEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDK--HWTVKVGDFGLSRLKHET 658 (674)
Q Consensus 581 ~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~--~~~vkL~DFGla~~~~~~ 658 (674)
||||+|++|.+++......+++.++..|+.||+.||.|||+++ ||||||||+|||++. ...|||+|||+++.....
T Consensus 80 mE~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~--iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~ 157 (321)
T d1tkia_ 80 FEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHN--IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG 157 (321)
T ss_dssp ECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT
T ss_pred EecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcC--CCcccccccceeecCCCceEEEEcccchhhccccC
Confidence 9999999999999876668999999999999999999999999 999999999999984 458999999999876543
Q ss_pred ccccccCCCCccccCC
Q 005841 659 YLTTKTGKGTVTYLAS 674 (674)
Q Consensus 659 ~~~~~~~~GTp~YmAP 674 (674)
.. .....||+.||||
T Consensus 158 ~~-~~~~~~t~~y~ap 172 (321)
T d1tkia_ 158 DN-FRLLFTAPEYYAP 172 (321)
T ss_dssp CE-EEEEESCGGGSCH
T ss_pred Cc-ccccccccccccc
Confidence 32 2335799999998
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-33 Score=293.04 Aligned_cols=168 Identities=29% Similarity=0.409 Sum_probs=144.6
Q ss_pred CCeeEeeeecccCceEEEEEEEc--CCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeEEEEEe
Q 005841 505 EDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTE 582 (674)
Q Consensus 505 ~~y~~~~~LG~G~fG~Vy~~~~~--~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E 582 (674)
++|+++++||+|+||+||+|.+. ++.||||++............+.+|+.+|++++||||+++++++.+.+.+|||||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 68999999999999999999984 7789999997665444455778899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccccCCcccc
Q 005841 583 FLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTT 662 (674)
Q Consensus 583 ~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~~~~~~ 662 (674)
||.++.+..+.......+++..+..|+.||+.||.|||+++ ||||||||+|||++.++.+||+|||+|+.........
T Consensus 82 ~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~--IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~~~ 159 (298)
T d1gz8a_ 82 FLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY 159 (298)
T ss_dssp CCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSBCT
T ss_pred ecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCC--EEccccCchheeecccCcceeccCCcceeccCCcccc
Confidence 99664444444445667999999999999999999999999 9999999999999999999999999999877666566
Q ss_pred ccCCCCccccCC
Q 005841 663 KTGKGTVTYLAS 674 (674)
Q Consensus 663 ~~~~GTp~YmAP 674 (674)
....||+.|+||
T Consensus 160 ~~~~gt~~y~ap 171 (298)
T d1gz8a_ 160 THEVVTLWYRAP 171 (298)
T ss_dssp TCCBCCCTTCCH
T ss_pred eeecccceeeeh
Confidence 667899999998
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=8.9e-33 Score=295.82 Aligned_cols=166 Identities=24% Similarity=0.368 Sum_probs=144.4
Q ss_pred cCCeeEeeeecccCceEEEEEEE--cCCeEEEEEeecccCCH----HHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeE
Q 005841 504 WEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSD----EVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRL 577 (674)
Q Consensus 504 ~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~~~----~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 577 (674)
.++|++.++||+|+||+||+|++ ++..||||++.+..... .......+++.+++.++|||||++++++.+.+.+
T Consensus 3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~ 82 (364)
T d1omwa3 3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 82 (364)
T ss_dssp STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred HHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEE
Confidence 46899999999999999999998 47789999997654322 2223334567888888999999999999999999
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccccC
Q 005841 578 CIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHE 657 (674)
Q Consensus 578 ~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~ 657 (674)
|||||||+||+|.++|.+. ..+++..+..|+.||+.||.|||+++ ||||||||+||||+.++.+||+|||+|+....
T Consensus 83 ~ivmE~~~gg~L~~~l~~~-~~~~e~~~~~~~~qi~~aL~ylH~~~--iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~ 159 (364)
T d1omwa3 83 SFILDLMNGGDLHYHLSQH-GVFSEADMRFYAAEIILGLEHMHNRF--VVYRDLKPANILLDEHGHVRISDLGLACDFSK 159 (364)
T ss_dssp EEEECCCCSCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECSSSCEEECCCTTCEECSS
T ss_pred EEEEEecCCCcHHHHHHhc-ccccHHHHHHHHHHHHHHHHHHHHCC--ccceeeccceeEEcCCCcEEEeeeceeeecCC
Confidence 9999999999999999764 57899999999999999999999999 99999999999999999999999999997765
Q ss_pred CccccccCCCCccccCC
Q 005841 658 TYLTTKTGKGTVTYLAS 674 (674)
Q Consensus 658 ~~~~~~~~~GTp~YmAP 674 (674)
.. ....+||+.||||
T Consensus 160 ~~--~~~~~GT~~y~AP 174 (364)
T d1omwa3 160 KK--PHASVGTHGYMAP 174 (364)
T ss_dssp SC--CCSCCSCGGGCCH
T ss_pred Cc--ccccccccccchh
Confidence 43 3346899999998
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.98 E-value=5.9e-33 Score=285.50 Aligned_cols=172 Identities=33% Similarity=0.566 Sum_probs=138.9
Q ss_pred ccccccCCeeEeeeecccCceEEEEEEEcC-----CeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEec
Q 005841 499 DYEILWEDLTIGEQIGQGSCGTVYHAVWYG-----SDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTS 573 (674)
Q Consensus 499 ~~~~~~~~y~~~~~LG~G~fG~Vy~~~~~~-----~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~ 573 (674)
+|++..++|++++.||+|+||+||+|++.. ..||||.+... ......+.+.+|+.+++.++||||+++++++.
T Consensus 1 ~~ei~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~- 78 (273)
T d1mp8a_ 1 DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC-TSDSVREKFLQEALTMRQFDHPHIVKLIGVIT- 78 (273)
T ss_dssp CCBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT-TSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-
T ss_pred CCCcCHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccc-cCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-
Confidence 478888999999999999999999998742 24788887543 34556678999999999999999999999985
Q ss_pred CCeEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcc
Q 005841 574 PQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSR 653 (674)
Q Consensus 574 ~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~ 653 (674)
.+.+|||||||++|+|.+++......+++..++.++.||+.||.|||+++ ||||||||+|||++.++.+||+|||+|+
T Consensus 79 ~~~~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~--iiHrDlKp~NIll~~~~~~Kl~DfG~a~ 156 (273)
T d1mp8a_ 79 ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKR--FVHRDIAARNVLVSSNDCVKLGDFGLSR 156 (273)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEEETTEEEECC-----
T ss_pred cCeEEEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccC--eeccccchhheeecCCCcEEEccchhhe
Confidence 56799999999999999998877778999999999999999999999999 9999999999999999999999999998
Q ss_pred cccCC-ccccccCCCCccccCC
Q 005841 654 LKHET-YLTTKTGKGTVTYLAS 674 (674)
Q Consensus 654 ~~~~~-~~~~~~~~GTp~YmAP 674 (674)
..... ........||+.||||
T Consensus 157 ~~~~~~~~~~~~~~gt~~y~ap 178 (273)
T d1mp8a_ 157 YMEDSTYYKASKGKLPIKWMAP 178 (273)
T ss_dssp --------------CCGGGCCH
T ss_pred eccCCcceeccceecCcccchh
Confidence 76533 2233445799999998
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.98 E-value=8.4e-33 Score=282.17 Aligned_cols=166 Identities=30% Similarity=0.484 Sum_probs=148.8
Q ss_pred cCCeeEeeeecccCceEEEEEEEc-CCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeEEEEEe
Q 005841 504 WEDLTIGEQIGQGSCGTVYHAVWY-GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTE 582 (674)
Q Consensus 504 ~~~y~~~~~LG~G~fG~Vy~~~~~-~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E 582 (674)
.++|++.++||+|+||+||+|++. +..||||++++..... +.|.+|+.++.+++||||+++++++.+.+.+|+|||
T Consensus 3 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~~---~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~E 79 (258)
T d1k2pa_ 3 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE---DEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITE 79 (258)
T ss_dssp CCCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSSCH---HHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEE
T ss_pred hHHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcCCH---HHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEE
Confidence 368899999999999999999995 4479999998766554 468899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccccCCccc-
Q 005841 583 FLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLT- 661 (674)
Q Consensus 583 ~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~~~~~- 661 (674)
|+++|+|..++......+++..+..|+.||+.||+|||+++ |+||||||+||||+.++.+||+|||+|+........
T Consensus 80 y~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~--iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~ 157 (258)
T d1k2pa_ 80 YMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ--FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTS 157 (258)
T ss_dssp CCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTT--BCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCC
T ss_pred ccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcC--cccccccceeEEEcCCCcEEECcchhheeccCCCcee
Confidence 99999999998877778999999999999999999999999 999999999999999999999999999876554333
Q ss_pred cccCCCCccccCC
Q 005841 662 TKTGKGTVTYLAS 674 (674)
Q Consensus 662 ~~~~~GTp~YmAP 674 (674)
.....||+.||||
T Consensus 158 ~~~~~~t~~y~aP 170 (258)
T d1k2pa_ 158 SVGSKFPVRWSPP 170 (258)
T ss_dssp CCCSCCCGGGCCH
T ss_pred ecccCCCCCcCCc
Confidence 3345799999998
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.98 E-value=1e-32 Score=290.24 Aligned_cols=167 Identities=29% Similarity=0.443 Sum_probs=146.3
Q ss_pred CCeeEeeeecccCceEEEEEEE--cCCeEEEEEeecccCC-HHHHHHHHHHHHHHh-hCCCCCeeeEEEEEecCCeEEEE
Q 005841 505 EDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYS-DEVIHSFRQEVSLMK-RLRHPNVLLFMGAVTSPQRLCIV 580 (674)
Q Consensus 505 ~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~~-~~~~~~~~~Ei~il~-~l~HpnIv~l~~~~~~~~~~~lV 580 (674)
++|+++++||+|+||+||+|.+ ++..||||++.+.... ....+.+..|+.++. .++||||+++++++.+++.+|||
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 6899999999999999999998 5777999999764321 223345666777665 68999999999999999999999
Q ss_pred EecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccccCCcc
Q 005841 581 TEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYL 660 (674)
Q Consensus 581 ~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~~~~ 660 (674)
||||++|+|.+++... ..+++..+..++.||+.||+|||+++ ||||||||+|||+++++++||+|||+|+.......
T Consensus 82 mEy~~~g~L~~~i~~~-~~~~e~~~~~~~~qi~~al~ylH~~~--iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~~ 158 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQSC-HKFDLSRATFYAAEIILGLQFLHSKG--IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDA 158 (320)
T ss_dssp EECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTC
T ss_pred EeecCCCcHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHhCC--eeeccCcccceeecCCCceeccccchhhhcccccc
Confidence 9999999999999754 47999999999999999999999999 99999999999999999999999999987765555
Q ss_pred ccccCCCCccccCC
Q 005841 661 TTKTGKGTVTYLAS 674 (674)
Q Consensus 661 ~~~~~~GTp~YmAP 674 (674)
.....+||+.||||
T Consensus 159 ~~~~~~gt~~y~aP 172 (320)
T d1xjda_ 159 KTNTFCGTPDYIAP 172 (320)
T ss_dssp CBCCCCSCGGGCCH
T ss_pred cccccCCCCCcCCH
Confidence 55567899999998
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.98 E-value=8.8e-33 Score=286.04 Aligned_cols=171 Identities=34% Similarity=0.585 Sum_probs=141.9
Q ss_pred cccccccCCeeEeeeecccCceEEEEEEEcC-CeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCe
Q 005841 498 LDYEILWEDLTIGEQIGQGSCGTVYHAVWYG-SDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQR 576 (674)
Q Consensus 498 ~~~~~~~~~y~~~~~LG~G~fG~Vy~~~~~~-~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 576 (674)
..|++..++|++.+.||+|+||+||+|++.+ ..||||++....... +.|.+|+.++++++|||||++++++. .+.
T Consensus 10 ~~~~i~~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~~~~---~~~~~E~~~l~~l~h~nIv~~~g~~~-~~~ 85 (285)
T d1fmka3 10 DAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP---EAFLQEAQVMKKLRHEKLVQLYAVVS-EEP 85 (285)
T ss_dssp TCSBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSCH---HHHHHHHHHHHHCCCTTBCCEEEEEC-SSS
T ss_pred cceEcCHHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcccCCH---HHHHHHHHHHHhcccCCEeEEEEEEe-cCC
Confidence 3467778899999999999999999999854 469999997655443 56889999999999999999999985 466
Q ss_pred EEEEEecCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccc
Q 005841 577 LCIVTEFLPRGSLFRLLQRN-TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLK 655 (674)
Q Consensus 577 ~~lV~E~~~ggsL~~~l~~~-~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~ 655 (674)
+|+|||||++|+|..++... ...+++..++.|+.||+.||+|||+++ |+||||||+||||+.++++||+|||+|+..
T Consensus 86 ~~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~--ivH~DlKp~NIll~~~~~~kl~DfGla~~~ 163 (285)
T d1fmka3 86 IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN--YVHRDLRAANILVGENLVCKVADFGLARLI 163 (285)
T ss_dssp CEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECGGGCEEECCCCTTC--
T ss_pred eEEEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhh--eecccccceEEEECCCCcEEEcccchhhhc
Confidence 89999999999999888643 356999999999999999999999999 999999999999999999999999999876
Q ss_pred cCCccc-cccCCCCccccCC
Q 005841 656 HETYLT-TKTGKGTVTYLAS 674 (674)
Q Consensus 656 ~~~~~~-~~~~~GTp~YmAP 674 (674)
...... .....||+.||||
T Consensus 164 ~~~~~~~~~~~~gt~~y~aP 183 (285)
T d1fmka3 164 EDNEYTARQGAKFPIKWTAP 183 (285)
T ss_dssp ------------CCGGGSCH
T ss_pred cCCCceeeccccccccccCh
Confidence 543322 3335799999998
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.98 E-value=2.2e-32 Score=282.00 Aligned_cols=160 Identities=26% Similarity=0.445 Sum_probs=134.4
Q ss_pred eeecccCceEEEEEEEc----CCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeEEEEEecCCC
Q 005841 511 EQIGQGSCGTVYHAVWY----GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPR 586 (674)
Q Consensus 511 ~~LG~G~fG~Vy~~~~~----~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~g 586 (674)
++||+|+||+||+|.+. +..||||++..........+.|.+|+.+|++++|||||++++++.. +.+|||||||++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence 47999999999999873 2459999997665555667889999999999999999999999865 467899999999
Q ss_pred CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccccCCcc---ccc
Q 005841 587 GSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYL---TTK 663 (674)
Q Consensus 587 gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~~~~---~~~ 663 (674)
|+|.+++.. ...+++..++.|+.||+.||+|||+++ ||||||||+||||+.++.+||+|||+|+....... ...
T Consensus 92 g~L~~~l~~-~~~l~~~~~~~i~~qi~~gl~ylH~~~--iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~ 168 (277)
T d1xbba_ 92 GPLNKYLQQ-NRHVKDKNIIELVHQVSMGMKYLEESN--FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQT 168 (277)
T ss_dssp EEHHHHHHH-CTTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC--
T ss_pred CcHHHHHhh-ccCCCHHHHHHHHHHHHHHHhhHHhCC--cccCCCcchhhcccccCcccccchhhhhhcccccccccccc
Confidence 999999975 457999999999999999999999999 99999999999999999999999999987643322 223
Q ss_pred cCCCCccccCC
Q 005841 664 TGKGTVTYLAS 674 (674)
Q Consensus 664 ~~~GTp~YmAP 674 (674)
...||+.||||
T Consensus 169 ~~~gt~~y~AP 179 (277)
T d1xbba_ 169 HGKWPVKWYAP 179 (277)
T ss_dssp --CCCGGGCCH
T ss_pred ccCCCceecCc
Confidence 35799999998
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=99.97 E-value=4.3e-32 Score=279.56 Aligned_cols=169 Identities=27% Similarity=0.377 Sum_probs=140.9
Q ss_pred ccCCeeEeeeecccCceEEEEEEE--cCCeEEEEEeecccCC-HHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCC----
Q 005841 503 LWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYS-DEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQ---- 575 (674)
Q Consensus 503 ~~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~---- 575 (674)
+.++|++.+.||+|+||+||+|.+ +++.||||++.+.... ......+.+|+.+++.++||||+++++++...+
T Consensus 5 l~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~ 84 (277)
T d1o6ya_ 5 LSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGP 84 (277)
T ss_dssp ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSE
T ss_pred ccceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCc
Confidence 457899999999999999999998 4778999999876553 456778999999999999999999999997654
Q ss_pred eEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccc
Q 005841 576 RLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLK 655 (674)
Q Consensus 576 ~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~ 655 (674)
.+|||||||+|++|.+++... ..+++.+++.|+.||+.||+|||+++ ||||||||+||||+.++.++|+|||+++..
T Consensus 85 ~~~lvmE~~~g~~L~~~~~~~-~~l~~~~~~~i~~qi~~al~~lH~~~--iiHrDiKP~NIll~~~~~~~l~d~~~~~~~ 161 (277)
T d1o6ya_ 85 LPYIVMEYVDGVTLRDIVHTE-GPMTPKRAIEVIADACQALNFSHQNG--IIHRDVKPANIMISATNAVKVMDFGIARAI 161 (277)
T ss_dssp EEEEEEECCCEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEETTSCEEECCCTTCEEC
T ss_pred eEEEEEECCCCCEehhhhccc-CCCCHHHHHHHHHHHHHHHHHHHhCC--ccCccccCcccccCccccceeehhhhhhhh
Confidence 389999999999999988764 47999999999999999999999999 999999999999999999999999999765
Q ss_pred cCCc---cccccCCCCccccCC
Q 005841 656 HETY---LTTKTGKGTVTYLAS 674 (674)
Q Consensus 656 ~~~~---~~~~~~~GTp~YmAP 674 (674)
.... ......+||+.||||
T Consensus 162 ~~~~~~~~~~~~~~Gt~~Y~aP 183 (277)
T d1o6ya_ 162 ADSGNSVTQTAAVIGTAQYLSP 183 (277)
T ss_dssp C----------------TTCCH
T ss_pred ccccccccccccccCcccccCH
Confidence 4322 233346899999998
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=1.2e-32 Score=286.90 Aligned_cols=163 Identities=27% Similarity=0.348 Sum_probs=139.0
Q ss_pred EeeeecccCceEEEEEEE--cCCeEEEEEeecccCCH---HHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeEEEEEec
Q 005841 509 IGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSD---EVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEF 583 (674)
Q Consensus 509 ~~~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~~~---~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~ 583 (674)
.+++||+|+||+||+|++ ++..||||++....... .....+.+|+.+++.++|||||++++++...+.+||||||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~ 81 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF 81 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence 468999999999999997 47789999997654322 2345688999999999999999999999999999999999
Q ss_pred CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccccCCccccc
Q 005841 584 LPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTK 663 (674)
Q Consensus 584 ~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~~~~~~~ 663 (674)
|.++++..++ .....+++..+..|+.||+.||+|||+++ ||||||||+|||++.++.+||+|||+|+..........
T Consensus 82 ~~~~~~~~~~-~~~~~l~~~~~~~~~~qil~aL~~lH~~~--iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~~~ 158 (299)
T d1ua2a_ 82 METDLEVIIK-DNSLVLTPSHIKAYMLMTLQGLEYLHQHW--ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYT 158 (299)
T ss_dssp CSEEHHHHHT-TCCSSCCSSHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCCCC
T ss_pred hcchHHhhhh-hcccCCCHHHHHHHHHHHHHHHHHhhccc--eecccCCcceEEecCCCccccccCccccccCCCccccc
Confidence 9887666555 45667999999999999999999999999 99999999999999999999999999988776655566
Q ss_pred cCCCCccccCC
Q 005841 664 TGKGTVTYLAS 674 (674)
Q Consensus 664 ~~~GTp~YmAP 674 (674)
..+||+.||||
T Consensus 159 ~~~gt~~y~aP 169 (299)
T d1ua2a_ 159 HQVVTRWYRAP 169 (299)
T ss_dssp CSCCCCTTCCH
T ss_pred ceecChhhccH
Confidence 67899999998
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.97 E-value=6e-32 Score=281.91 Aligned_cols=173 Identities=27% Similarity=0.491 Sum_probs=149.3
Q ss_pred ccccccCCeeEeeeecccCceEEEEEEEcC-------CeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEE
Q 005841 499 DYEILWEDLTIGEQIGQGSCGTVYHAVWYG-------SDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAV 571 (674)
Q Consensus 499 ~~~~~~~~y~~~~~LG~G~fG~Vy~~~~~~-------~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~ 571 (674)
.+++..++|++++.||+|+||+||+|++.+ ..||||++.... ..+..+.|.+|+.+++.++||||+++++++
T Consensus 7 ~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~E~~il~~l~h~niv~~~~~~ 85 (301)
T d1lufa_ 7 SLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMAEFDNPNIVKLLGVC 85 (301)
T ss_dssp HTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred hccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhc-ChHHHHHHHHHHHHHHhcCCCCcccceeee
Confidence 457778899999999999999999999754 469999987543 455667899999999999999999999999
Q ss_pred ecCCeEEEEEecCCCCCHHHHHHhcC-----------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEE
Q 005841 572 TSPQRLCIVTEFLPRGSLFRLLQRNT-----------------------TKLDWRRRILMALDIARGVSYLHHCNPPIIH 628 (674)
Q Consensus 572 ~~~~~~~lV~E~~~ggsL~~~l~~~~-----------------------~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvH 628 (674)
.....+++||||+++|+|.++|.... ..+++..++.|+.||+.||+|||+++ |||
T Consensus 86 ~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~--ivH 163 (301)
T d1lufa_ 86 AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK--FVH 163 (301)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT--CCC
T ss_pred ccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC--eEe
Confidence 99999999999999999999996422 24889999999999999999999999 999
Q ss_pred ccCCCCCEEEcCCCcEEEEecCCcccccCCc--cccccCCCCccccCC
Q 005841 629 RDLKSSNLLVDKHWTVKVGDFGLSRLKHETY--LTTKTGKGTVTYLAS 674 (674)
Q Consensus 629 rDLKp~NILi~~~~~vkL~DFGla~~~~~~~--~~~~~~~GTp~YmAP 674 (674)
|||||+||||+.++.+||+|||+|+...... ....+..||+.||||
T Consensus 164 rDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aP 211 (301)
T d1lufa_ 164 RDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPP 211 (301)
T ss_dssp SCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCH
T ss_pred eEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCH
Confidence 9999999999999999999999998764332 223346799999998
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=5.4e-32 Score=281.82 Aligned_cols=176 Identities=27% Similarity=0.473 Sum_probs=139.0
Q ss_pred CccccccccCCeeEeeeecccCceEEEEEEEcC-------CeEEEEEeecccCCHHHHHHHHHHHHHHhhC-CCCCeeeE
Q 005841 496 DCLDYEILWEDLTIGEQIGQGSCGTVYHAVWYG-------SDVAVKVFSRQEYSDEVIHSFRQEVSLMKRL-RHPNVLLF 567 (674)
Q Consensus 496 ~~~~~~~~~~~y~~~~~LG~G~fG~Vy~~~~~~-------~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l 567 (674)
+...|++..++|++.++||+|+||+||+|.+.+ +.||||++.... .....+.+.+|+.++.++ +|+||+.+
T Consensus 4 ~~~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~-~~~~~~~~~~e~~~l~~~~~h~~iv~~ 82 (299)
T d1ywna1 4 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNL 82 (299)
T ss_dssp CHHHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC-----CHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CCccccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEcccc-CcHHHHHHHHHHHHHHhhcCCCeEEEe
Confidence 445678888999999999999999999998732 359999986543 344456777888888777 58999999
Q ss_pred EEEEecC-CeEEEEEecCCCCCHHHHHHhc---------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccC
Q 005841 568 MGAVTSP-QRLCIVTEFLPRGSLFRLLQRN---------------TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDL 631 (674)
Q Consensus 568 ~~~~~~~-~~~~lV~E~~~ggsL~~~l~~~---------------~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDL 631 (674)
++++... ..+|+|||||++|+|.++|... ...+++..++.|+.||+.||.|||+++ ||||||
T Consensus 83 ~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~--ivHrDl 160 (299)
T d1ywna1 83 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK--CIHRDL 160 (299)
T ss_dssp EEEECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT--CCCSCC
T ss_pred eeeeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC--CcCCcC
Confidence 9988765 4689999999999999999753 235899999999999999999999999 999999
Q ss_pred CCCCEEEcCCCcEEEEecCCcccccCCc--cccccCCCCccccCC
Q 005841 632 KSSNLLVDKHWTVKVGDFGLSRLKHETY--LTTKTGKGTVTYLAS 674 (674)
Q Consensus 632 Kp~NILi~~~~~vkL~DFGla~~~~~~~--~~~~~~~GTp~YmAP 674 (674)
||+||||+.++++||+|||+|+...... .......||+.||||
T Consensus 161 Kp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~AP 205 (299)
T d1ywna1 161 AARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAP 205 (299)
T ss_dssp CGGGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCH
T ss_pred CccceeECCCCcEEEccCcchhhccccccccccCceeeCccccch
Confidence 9999999999999999999998764332 233346799999998
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=9.9e-32 Score=284.47 Aligned_cols=162 Identities=27% Similarity=0.369 Sum_probs=138.2
Q ss_pred ccCCeeEee-eecccCceEEEEEEE--cCCeEEEEEeecccCCHHHHHHHHHHHHHHhh-CCCCCeeeEEEEEec----C
Q 005841 503 LWEDLTIGE-QIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKR-LRHPNVLLFMGAVTS----P 574 (674)
Q Consensus 503 ~~~~y~~~~-~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~-l~HpnIv~l~~~~~~----~ 574 (674)
..++|++.. +||+|+||+||+|++ ++..||||++.+. ..+.+|+.++.+ ++||||++++++|.+ .
T Consensus 9 i~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~ 81 (335)
T d2ozaa1 9 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLYAGR 81 (335)
T ss_dssp GGGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTE
T ss_pred cccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-------HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCC
Confidence 346899875 599999999999998 4678999999643 346679998765 589999999999875 4
Q ss_pred CeEEEEEecCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcC---CCcEEEEecC
Q 005841 575 QRLCIVTEFLPRGSLFRLLQRN-TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDK---HWTVKVGDFG 650 (674)
Q Consensus 575 ~~~~lV~E~~~ggsL~~~l~~~-~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~---~~~vkL~DFG 650 (674)
..+|||||||+||+|.++|.+. ...|++..+..|+.||+.||+|||+++ ||||||||+|||++. .+.+||+|||
T Consensus 82 ~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~--iiHRDiKp~NIll~~~~~~~~~Kl~DFG 159 (335)
T d2ozaa1 82 KCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFG 159 (335)
T ss_dssp EEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESCSSTTCCEEECCCT
T ss_pred CEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcC--Cccccccccccccccccccccccccccc
Confidence 6689999999999999999764 356999999999999999999999999 999999999999985 5679999999
Q ss_pred CcccccCCccccccCCCCccccCC
Q 005841 651 LSRLKHETYLTTKTGKGTVTYLAS 674 (674)
Q Consensus 651 la~~~~~~~~~~~~~~GTp~YmAP 674 (674)
+|+....... ....+|||.||||
T Consensus 160 ~a~~~~~~~~-~~~~~gt~~y~aP 182 (335)
T d2ozaa1 160 FAKETTSHNS-LTTPCYTPYYVAP 182 (335)
T ss_dssp TCEECCCCCC-CCCCSCCCSSCCC
T ss_pred eeeeccCCCc-cccccCCcccCCc
Confidence 9987665433 3346899999999
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=99.97 E-value=5.6e-32 Score=279.79 Aligned_cols=167 Identities=28% Similarity=0.405 Sum_probs=142.9
Q ss_pred CCeeEeeeecccCceEEEEEEE-cCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeEEEEEec
Q 005841 505 EDLTIGEQIGQGSCGTVYHAVW-YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEF 583 (674)
Q Consensus 505 ~~y~~~~~LG~G~fG~Vy~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~ 583 (674)
++|+++++||+|+||+||+|++ ++..||||++..........+.+.+|+.+|+.++||||+++++++...+..|++|||
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence 6899999999999999999998 467899999977655444457788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccccCCccccc
Q 005841 584 LPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTTK 663 (674)
Q Consensus 584 ~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~~~~~~~ 663 (674)
+.++.+..+. .....+++..+..|+.||+.||+|||+++ ||||||||+||||+.++.+||+|||+|.....+.....
T Consensus 82 ~~~~~~~~~~-~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~ 158 (286)
T d1ob3a_ 82 LDQDLKKLLD-VCEGGLESVTAKSFLLQLLNGIAYCHDRR--VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYT 158 (286)
T ss_dssp CSEEHHHHHH-TSTTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC------
T ss_pred ehhhhHHHHH-hhcCCcchhhhHHHHHHHHHHHHHhccCc--EEecCCCCceeeEcCCCCEEecccccceecccCccccc
Confidence 9776555555 45678999999999999999999999999 99999999999999999999999999988776655566
Q ss_pred cCCCCccccCC
Q 005841 664 TGKGTVTYLAS 674 (674)
Q Consensus 664 ~~~GTp~YmAP 674 (674)
...||+.|+||
T Consensus 159 ~~~~~~~y~~p 169 (286)
T d1ob3a_ 159 HEIVTLWYRAP 169 (286)
T ss_dssp ---CCCTTCCH
T ss_pred eecccchhhhH
Confidence 66899999998
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=5.9e-32 Score=276.47 Aligned_cols=166 Identities=33% Similarity=0.542 Sum_probs=138.9
Q ss_pred cccccCCeeEeeeecccCceEEEEEEEcCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEec-CCeEE
Q 005841 500 YEILWEDLTIGEQIGQGSCGTVYHAVWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTS-PQRLC 578 (674)
Q Consensus 500 ~~~~~~~y~~~~~LG~G~fG~Vy~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~-~~~~~ 578 (674)
|++..++|+++++||+|+||.||+|.++++.||||++++.. ..+.+.+|+.++++++||||+++++++.+ .+.+|
T Consensus 2 w~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~vAvK~i~~~~----~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~ 77 (262)
T d1byga_ 2 WALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLY 77 (262)
T ss_dssp CBCCGGGEEEEEEEEECSSCEEEEEEETTEEEEEEECCCCC------HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCE
T ss_pred CccCHHHeEEeEEEecCCCeEEEEEEECCeEEEEEEECcHH----HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEE
Confidence 67788899999999999999999999999999999997543 23568899999999999999999998854 46689
Q ss_pred EEEecCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccccC
Q 005841 579 IVTEFLPRGSLFRLLQRNT-TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHE 657 (674)
Q Consensus 579 lV~E~~~ggsL~~~l~~~~-~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~ 657 (674)
|||||+++|+|.++|.+.. ..+++..++.|+.||+.||.|||+.+ ||||||||+|||++.++.+||+|||+++....
T Consensus 78 lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~--ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~ 155 (262)
T d1byga_ 78 IVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN--FVHRDLAARNVLVSEDNVAKVSDFGLTKEASS 155 (262)
T ss_dssp EEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECTTSCEEECCCCC------
T ss_pred EEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCc--eeccccchHhheecCCCCEeecccccceecCC
Confidence 9999999999999997543 35899999999999999999999998 99999999999999999999999999987654
Q ss_pred CccccccCCCCccccCC
Q 005841 658 TYLTTKTGKGTVTYLAS 674 (674)
Q Consensus 658 ~~~~~~~~~GTp~YmAP 674 (674)
. .....+|+.||||
T Consensus 156 ~---~~~~~~~~~y~aP 169 (262)
T d1byga_ 156 T---QDTGKLPVKWTAP 169 (262)
T ss_dssp ---------CCTTTSCH
T ss_pred C---CccccccccCCCh
Confidence 3 2335789999998
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=1.6e-31 Score=280.84 Aligned_cols=166 Identities=26% Similarity=0.501 Sum_probs=138.0
Q ss_pred CCeeEeeeecccCceEEEEEEEc--CC----eEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeEE
Q 005841 505 EDLTIGEQIGQGSCGTVYHAVWY--GS----DVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLC 578 (674)
Q Consensus 505 ~~y~~~~~LG~G~fG~Vy~~~~~--~~----~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 578 (674)
.+|+++++||+|+||+||+|.+. +. .||+|.+.... ..+..+.+.+|+.++++++|||||++++++.++ ..+
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~ 86 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQ 86 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC-----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-Cee
Confidence 57999999999999999999874 33 48888875432 233456799999999999999999999999864 578
Q ss_pred EEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccccCC
Q 005841 579 IVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHET 658 (674)
Q Consensus 579 lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~~ 658 (674)
++|||+.+++|.+++......+++..++.|+.||+.||.|||+++ ||||||||+||||+.++++||+|||+|+.....
T Consensus 87 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~--iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~ 164 (317)
T d1xkka_ 87 LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR--LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 164 (317)
T ss_dssp EEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEEETTEEEECCCSHHHHTTTT
T ss_pred EEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcC--cccCcchhhcceeCCCCCeEeeccccceecccc
Confidence 889999999999999888888999999999999999999999999 999999999999999999999999999876543
Q ss_pred --ccccccCCCCccccCC
Q 005841 659 --YLTTKTGKGTVTYLAS 674 (674)
Q Consensus 659 --~~~~~~~~GTp~YmAP 674 (674)
........||+.||||
T Consensus 165 ~~~~~~~~~~gt~~y~AP 182 (317)
T d1xkka_ 165 EKEYHAEGGKVPIKWMAL 182 (317)
T ss_dssp CC--------CCTTTSCH
T ss_pred cccccccccccCccccCh
Confidence 2233345799999998
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=9.1e-32 Score=276.66 Aligned_cols=166 Identities=24% Similarity=0.378 Sum_probs=142.5
Q ss_pred cCCeeEeeeecccCceEEEEEEE--cCCeEEEEEeecccCCH----HHHHHHHHHHHHHhhCC--CCCeeeEEEEEecCC
Q 005841 504 WEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSD----EVIHSFRQEVSLMKRLR--HPNVLLFMGAVTSPQ 575 (674)
Q Consensus 504 ~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~~~----~~~~~~~~Ei~il~~l~--HpnIv~l~~~~~~~~ 575 (674)
.++|++.++||+|+||+||+|++ ++..||||++.+..... .....+.+|+.+++.++ ||||+++++++.+.+
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~ 82 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD 82 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence 36799999999999999999998 47789999998654432 11234667999999986 899999999999999
Q ss_pred eEEEEEecCCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcC-CCcEEEEecCCcc
Q 005841 576 RLCIVTEFLPR-GSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDK-HWTVKVGDFGLSR 653 (674)
Q Consensus 576 ~~~lV~E~~~g-gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~-~~~vkL~DFGla~ 653 (674)
.+|+||||+.+ +++.+++.. ...+++..+..++.||+.||.|||+++ ||||||||+|||++. ++.+||+|||+|+
T Consensus 83 ~~~lv~e~~~~~~~l~~~~~~-~~~l~e~~~~~~~~qi~~al~~lH~~~--iiHrDiKp~NIll~~~~~~vkl~DFG~a~ 159 (273)
T d1xwsa_ 83 SFVLILERPEPVQDLFDFITE-RGALQEELARSFFWQVLEAVRHCHNCG--VLHRDIKDENILIDLNRGELKLIDFGSGA 159 (273)
T ss_dssp EEEEEEECCSSEEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred eEEEEEEeccCcchHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCC--CccccCcccceEEecCCCeEEECccccce
Confidence 99999999976 688888865 457999999999999999999999999 999999999999985 5799999999998
Q ss_pred cccCCccccccCCCCccccCC
Q 005841 654 LKHETYLTTKTGKGTVTYLAS 674 (674)
Q Consensus 654 ~~~~~~~~~~~~~GTp~YmAP 674 (674)
....... .+.+||+.||||
T Consensus 160 ~~~~~~~--~~~~GT~~y~aP 178 (273)
T d1xwsa_ 160 LLKDTVY--TDFDGTRVYSPP 178 (273)
T ss_dssp ECCSSCB--CCCCSCGGGSCH
T ss_pred ecccccc--cccccCCCcCCH
Confidence 7655433 346899999998
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=1.9e-31 Score=279.00 Aligned_cols=173 Identities=32% Similarity=0.488 Sum_probs=150.8
Q ss_pred ccccccCCeeEeeeecccCceEEEEEEEc-------CCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEE
Q 005841 499 DYEILWEDLTIGEQIGQGSCGTVYHAVWY-------GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAV 571 (674)
Q Consensus 499 ~~~~~~~~y~~~~~LG~G~fG~Vy~~~~~-------~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~ 571 (674)
.|++..++|++++.||+|+||.||+|.+. +..||||++++.. .......+.+|+.++++++||||+++++++
T Consensus 14 ~~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~-~~~~~~~~~~E~~il~~l~h~nIv~~~~~~ 92 (308)
T d1p4oa_ 14 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA-SMRERIEFLNEASVMKEFNCHHVVRLLGVV 92 (308)
T ss_dssp TTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS-CHHHHHHHHHHHHHGGGCCCTTBCCEEEEE
T ss_pred ceeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECccc-ChHHHHHHHHHHHHHHHcCCCCEeeeeeEE
Confidence 47888999999999999999999999874 3469999997543 445556789999999999999999999999
Q ss_pred ecCCeEEEEEecCCCCCHHHHHHhc---------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCC
Q 005841 572 TSPQRLCIVTEFLPRGSLFRLLQRN---------TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHW 642 (674)
Q Consensus 572 ~~~~~~~lV~E~~~ggsL~~~l~~~---------~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~ 642 (674)
...+..++|||||++|+|.+++... ...+++..+..|+.|++.||.|||+++ ||||||||+||||+.++
T Consensus 93 ~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~--ivHrDlk~~NiLld~~~ 170 (308)
T d1p4oa_ 93 SQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK--FVHRDLAARNCMVAEDF 170 (308)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT--CBCSCCSGGGEEECTTC
T ss_pred ecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC--eeeceEcCCceeecCCc
Confidence 9999999999999999999988642 134789999999999999999999998 99999999999999999
Q ss_pred cEEEEecCCcccccCCc--cccccCCCCccccCC
Q 005841 643 TVKVGDFGLSRLKHETY--LTTKTGKGTVTYLAS 674 (674)
Q Consensus 643 ~vkL~DFGla~~~~~~~--~~~~~~~GTp~YmAP 674 (674)
++||+|||+|+.+.... .......||+.||||
T Consensus 171 ~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aP 204 (308)
T d1p4oa_ 171 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSP 204 (308)
T ss_dssp CEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCH
T ss_pred eEEEeecccceeccCCcceeeccceecccccCCH
Confidence 99999999998765432 233345799999998
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=1.4e-31 Score=275.31 Aligned_cols=170 Identities=33% Similarity=0.470 Sum_probs=136.1
Q ss_pred cccCCeeEeeeecccCceEEEEEEEcC-----CeEEEEEeecccCC-HHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCC
Q 005841 502 ILWEDLTIGEQIGQGSCGTVYHAVWYG-----SDVAVKVFSRQEYS-DEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQ 575 (674)
Q Consensus 502 ~~~~~y~~~~~LG~G~fG~Vy~~~~~~-----~~vAvK~i~~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~ 575 (674)
+..++|++.+.||+|+||+||+|++.. ..||||++.+.... .+..+.|.+|+.+|+.++||||+++++++.+ .
T Consensus 5 i~~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~ 83 (273)
T d1u46a_ 5 IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-P 83 (273)
T ss_dssp CCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-S
T ss_pred EchHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-c
Confidence 445789999999999999999998732 25899999776543 3566789999999999999999999999975 5
Q ss_pred eEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccc
Q 005841 576 RLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLK 655 (674)
Q Consensus 576 ~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~ 655 (674)
.+++|||||++++|.+++......+++..++.++.||+.||.|||+++ |+||||||+||||+.++.|||+|||+++..
T Consensus 84 ~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~--iiHrDikp~NIll~~~~~vkl~DfGl~~~~ 161 (273)
T d1u46a_ 84 PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKR--FIHRDLAARNLLLATRDLVKIGDFGLMRAL 161 (273)
T ss_dssp SCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred chheeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCC--EeeeeecHHHhccccccceeeccchhhhhc
Confidence 789999999999999988877778999999999999999999999999 999999999999999999999999999976
Q ss_pred cCCcc---ccccCCCCccccCC
Q 005841 656 HETYL---TTKTGKGTVTYLAS 674 (674)
Q Consensus 656 ~~~~~---~~~~~~GTp~YmAP 674 (674)
..... ......||+.||||
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~aP 183 (273)
T d1u46a_ 162 PQNDDHYVMQEHRKVPFAWCAP 183 (273)
T ss_dssp CC-CCEEEC-----CCGGGCCH
T ss_pred ccCCCcceecCccccCcccCCH
Confidence 44322 22234688999998
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=3.2e-31 Score=277.46 Aligned_cols=170 Identities=31% Similarity=0.574 Sum_probs=142.2
Q ss_pred ccccCCeeEeeeecccCceEEEEEEEc--CC--eEEEEEeecccCCHHHHHHHHHHHHHHhhC-CCCCeeeEEEEEecCC
Q 005841 501 EILWEDLTIGEQIGQGSCGTVYHAVWY--GS--DVAVKVFSRQEYSDEVIHSFRQEVSLMKRL-RHPNVLLFMGAVTSPQ 575 (674)
Q Consensus 501 ~~~~~~y~~~~~LG~G~fG~Vy~~~~~--~~--~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~ 575 (674)
.+.+++|++.++||+|+||+||+|++. +. .||||.+.... ..+..+.+.+|+.+|+++ +||||+++++++.+.+
T Consensus 6 ~i~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~ 84 (309)
T d1fvra_ 6 VLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA-SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG 84 (309)
T ss_dssp BCCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-------CHHHHHHHHHTTCCCCTTBCCEEEEEEETT
T ss_pred ccCHHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECccc-ChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCC
Confidence 456789999999999999999999984 33 37778775433 334456799999999999 7999999999999999
Q ss_pred eEEEEEecCCCCCHHHHHHhc---------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcC
Q 005841 576 RLCIVTEFLPRGSLFRLLQRN---------------TTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDK 640 (674)
Q Consensus 576 ~~~lV~E~~~ggsL~~~l~~~---------------~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~ 640 (674)
.+||||||+++|+|.++|+.. ...+++..++.++.||+.||.|||+++ ||||||||+|||++.
T Consensus 85 ~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~--iiHrDlkp~NIL~~~ 162 (309)
T d1fvra_ 85 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ--FIHRDLAARNILVGE 162 (309)
T ss_dssp EEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECG
T ss_pred eeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCC--ccccccccceEEEcC
Confidence 999999999999999999753 357999999999999999999999999 999999999999999
Q ss_pred CCcEEEEecCCcccccCCccccccCCCCccccCC
Q 005841 641 HWTVKVGDFGLSRLKHETYLTTKTGKGTVTYLAS 674 (674)
Q Consensus 641 ~~~vkL~DFGla~~~~~~~~~~~~~~GTp~YmAP 674 (674)
++.+||+|||+|+...... ......||+.||||
T Consensus 163 ~~~~kl~DfG~a~~~~~~~-~~~~~~gt~~y~aP 195 (309)
T d1fvra_ 163 NYVAKIADFGLSRGQEVYV-KKTMGRLPVRWMAI 195 (309)
T ss_dssp GGCEEECCTTCEESSCEEC-CC----CCTTTCCH
T ss_pred CCceEEccccccccccccc-cccceecCCcccch
Confidence 9999999999998665432 33345799999998
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=7.9e-31 Score=274.66 Aligned_cols=173 Identities=28% Similarity=0.483 Sum_probs=150.6
Q ss_pred ccccccCCeeEeeeecccCceEEEEEEEcC-------CeEEEEEeecccCCHHHHHHHHHHHHHHhhC-CCCCeeeEEEE
Q 005841 499 DYEILWEDLTIGEQIGQGSCGTVYHAVWYG-------SDVAVKVFSRQEYSDEVIHSFRQEVSLMKRL-RHPNVLLFMGA 570 (674)
Q Consensus 499 ~~~~~~~~y~~~~~LG~G~fG~Vy~~~~~~-------~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~ 570 (674)
.|++..++|+++++||+|+||.||+|++.+ ..||||++++.. .......+.+|+.+++.+ +|||||+++++
T Consensus 17 ~~~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~ 95 (311)
T d1t46a_ 17 KWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA-HLTEREALMSELKVLSYLGNHMNIVNLLGA 95 (311)
T ss_dssp GGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred cccCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECccc-CHHHHHHHHHHHHHHHhccCCCCEEEEEEE
Confidence 567888999999999999999999998732 359999997654 344556789999999999 69999999999
Q ss_pred EecCCeEEEEEecCCCCCHHHHHHhcC-----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCC
Q 005841 571 VTSPQRLCIVTEFLPRGSLFRLLQRNT-----------------TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKS 633 (674)
Q Consensus 571 ~~~~~~~~lV~E~~~ggsL~~~l~~~~-----------------~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp 633 (674)
+.+.+.+|||||||++|+|.+++.... ..+++..++.|+.||+.||+|||+++ ||||||||
T Consensus 96 ~~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~--ivHrDLKp 173 (311)
T d1t46a_ 96 CTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN--CIHRDLAA 173 (311)
T ss_dssp ECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSG
T ss_pred EeeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC--eeeccccc
Confidence 999999999999999999999997532 25899999999999999999999999 99999999
Q ss_pred CCEEEcCCCcEEEEecCCcccccCC--ccccccCCCCccccCC
Q 005841 634 SNLLVDKHWTVKVGDFGLSRLKHET--YLTTKTGKGTVTYLAS 674 (674)
Q Consensus 634 ~NILi~~~~~vkL~DFGla~~~~~~--~~~~~~~~GTp~YmAP 674 (674)
+|||++.++.+||+|||+++..... .......+||+.||||
T Consensus 174 ~NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aP 216 (311)
T d1t46a_ 174 RNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAP 216 (311)
T ss_dssp GGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCH
T ss_pred ccccccccCcccccccchheeccCCCcceEeeecccChHHcCH
Confidence 9999999999999999999876542 2333345799999998
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=8.6e-31 Score=273.43 Aligned_cols=165 Identities=36% Similarity=0.541 Sum_probs=136.8
Q ss_pred CCeeEeeeecccCceEEEEEEEcCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCC----eEEEE
Q 005841 505 EDLTIGEQIGQGSCGTVYHAVWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQ----RLCIV 580 (674)
Q Consensus 505 ~~y~~~~~LG~G~fG~Vy~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~----~~~lV 580 (674)
++|.+.+.||+|+||+||+|++++..||||++.... ........|+..+..++||||+++++++...+ .+|||
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~~g~~vAvK~~~~~~---~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv 79 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLV 79 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEETTEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEECCEEEEEEEECccc---hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEE
Confidence 578999999999999999999999999999996542 21222334666667889999999999997654 58999
Q ss_pred EecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC------CCCeEEccCCCCCEEEcCCCcEEEEecCCccc
Q 005841 581 TEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHC------NPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL 654 (674)
Q Consensus 581 ~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~------~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~ 654 (674)
||||++|+|.++|++. .+++..++.++.|++.||.|||.. .++||||||||+||||+.++++||+|||+++.
T Consensus 80 ~Ey~~~g~L~~~l~~~--~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~ 157 (303)
T d1vjya_ 80 SDYHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVR 157 (303)
T ss_dssp EECCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred EecccCCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCcccc
Confidence 9999999999999764 589999999999999999999974 12399999999999999999999999999987
Q ss_pred ccCCcc----ccccCCCCccccCC
Q 005841 655 KHETYL----TTKTGKGTVTYLAS 674 (674)
Q Consensus 655 ~~~~~~----~~~~~~GTp~YmAP 674 (674)
...... ......||+.||||
T Consensus 158 ~~~~~~~~~~~~~~~~gt~~y~aP 181 (303)
T d1vjya_ 158 HDSATDTIDIAPNHRVGTKRYMAP 181 (303)
T ss_dssp EETTTTEECC----CCSCGGGCCH
T ss_pred ccCCCcceeccccceecccCcCCh
Confidence 654322 23346799999998
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=7.6e-31 Score=273.28 Aligned_cols=172 Identities=31% Similarity=0.540 Sum_probs=144.8
Q ss_pred cccccCCeeEeeeecccCceEEEEEEEcC---------CeEEEEEeecccCCHHHHHHHHHHHHHHhhC-CCCCeeeEEE
Q 005841 500 YEILWEDLTIGEQIGQGSCGTVYHAVWYG---------SDVAVKVFSRQEYSDEVIHSFRQEVSLMKRL-RHPNVLLFMG 569 (674)
Q Consensus 500 ~~~~~~~y~~~~~LG~G~fG~Vy~~~~~~---------~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~ 569 (674)
|++..++|++++.||+|+||.||+|+..+ ..||||++++.. .......+.+|+..+.++ +|||||++++
T Consensus 8 ~~i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~e~~~l~~~~~HpnIv~~~~ 86 (299)
T d1fgka_ 8 WELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA-TEKDLSDLISEMEMMKMIGKHKNIINLLG 86 (299)
T ss_dssp TBCCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred CcccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECccc-ChHHHHHHHHHHHHHHHhcCCCeEEeccc
Confidence 77888999999999999999999998632 259999997644 445567788899999888 7999999999
Q ss_pred EEecCCeEEEEEecCCCCCHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCC
Q 005841 570 AVTSPQRLCIVTEFLPRGSLFRLLQRNT---------------TKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSS 634 (674)
Q Consensus 570 ~~~~~~~~~lV~E~~~ggsL~~~l~~~~---------------~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~ 634 (674)
++.+.+.+|+|||||++|+|.++|.... ..+++..++.++.||+.||+|||+++ ||||||||+
T Consensus 87 ~~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~--ivHrDiKp~ 164 (299)
T d1fgka_ 87 ACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK--CIHRDLAAR 164 (299)
T ss_dssp EECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGG
T ss_pred ccccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC--EEeeeeccc
Confidence 9999999999999999999999997542 45899999999999999999999999 999999999
Q ss_pred CEEEcCCCcEEEEecCCcccccCCcc--ccccCCCCccccCC
Q 005841 635 NLLVDKHWTVKVGDFGLSRLKHETYL--TTKTGKGTVTYLAS 674 (674)
Q Consensus 635 NILi~~~~~vkL~DFGla~~~~~~~~--~~~~~~GTp~YmAP 674 (674)
|||++.++.+||+|||+++....... ......||+.||||
T Consensus 165 NiLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aP 206 (299)
T d1fgka_ 165 NVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAP 206 (299)
T ss_dssp GEEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCH
T ss_pred ceeecCCCCeEeccchhhccccccccccccccCCCChhhhhh
Confidence 99999999999999999987654332 23345799999998
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=2.3e-30 Score=267.76 Aligned_cols=167 Identities=26% Similarity=0.354 Sum_probs=149.7
Q ss_pred CCeeEeeeecccCceEEEEEEE--cCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCeEEEEEe
Q 005841 505 EDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTE 582 (674)
Q Consensus 505 ~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E 582 (674)
++|+++++||+|+||+||+|++ ++..||||+++...........+.+|+.+++.++||||+++++++.....+++||+
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 5899999999999999999998 46679999998776666677889999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccccCCcccc
Q 005841 583 FLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLTT 662 (674)
Q Consensus 583 ~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~~~~~~ 662 (674)
++.+++|..++. ....+++..+..++.|++.||+|||+++ ||||||||+||||+.++.+||+|||+|+.........
T Consensus 82 ~~~~~~l~~~~~-~~~~~~~~~~~~~~~q~~~aL~~lH~~~--IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~~~ 158 (292)
T d1unla_ 82 FCDQDLKKYFDS-CNGDLDPEIVKSFLFQLLKGLGFCHSRN--VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCY 158 (292)
T ss_dssp CCSEEHHHHHHH-TTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTCCEEECCCTTCEECCSCCSCC
T ss_pred eccccccccccc-cccccchhHHHHHHHHHHHHHHHhhcCC--EeeecccCcccccccCCceeeeecchhhcccCCCccc
Confidence 999988888775 4567999999999999999999999999 9999999999999999999999999999877655555
Q ss_pred ccCCCCccccCC
Q 005841 663 KTGKGTVTYLAS 674 (674)
Q Consensus 663 ~~~~GTp~YmAP 674 (674)
....+++.|+||
T Consensus 159 ~~~~~~~~~~~p 170 (292)
T d1unla_ 159 SAEVVTLWYRPP 170 (292)
T ss_dssp CSCCSCGGGCCH
T ss_pred eeeccccchhhh
Confidence 555678888876
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=2.3e-30 Score=274.95 Aligned_cols=163 Identities=30% Similarity=0.419 Sum_probs=139.9
Q ss_pred cCCeeEeeeecccCceEEEEEEEc--CCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCC------
Q 005841 504 WEDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQ------ 575 (674)
Q Consensus 504 ~~~y~~~~~LG~G~fG~Vy~~~~~--~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~------ 575 (674)
.++|+++++||+|+||+||+|.+. +..||||++.+........+.+.+|+.+|+.++|||||+++++|...+
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence 578999999999999999999984 778999999877667777788999999999999999999999998664
Q ss_pred eEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccc
Q 005841 576 RLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLK 655 (674)
Q Consensus 576 ~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~ 655 (674)
.+||||||| +.+|..+++. ..|++..++.|+.||+.||.|||+++ ||||||||+|||++.++.+||+|||+|+..
T Consensus 97 ~~~lv~e~~-~~~l~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~~--IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~ 171 (346)
T d1cm8a_ 97 DFYLVMPFM-GTDLGKLMKH--EKLGEDRIQFLVYQMLKGLRYIHAAG--IIHRDLKPGNLAVNEDCELKILDFGLARQA 171 (346)
T ss_dssp CCEEEEECC-SEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred eEEEEEecc-cccHHHHHHh--ccccHHHHHHHHHHHHHHHHHHHhCC--CcccccCcchhhcccccccccccccceecc
Confidence 579999999 6688887754 46999999999999999999999999 999999999999999999999999999876
Q ss_pred cCCccccccCCCCccccCC
Q 005841 656 HETYLTTKTGKGTVTYLAS 674 (674)
Q Consensus 656 ~~~~~~~~~~~GTp~YmAP 674 (674)
... .....||+.||||
T Consensus 172 ~~~---~~~~~~t~~y~aP 187 (346)
T d1cm8a_ 172 DSE---MTGYVVTRWYRAP 187 (346)
T ss_dssp CSS---CCSSCSCGGGCCT
T ss_pred CCc---cccccccccccCH
Confidence 553 2346799999999
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.96 E-value=6.4e-30 Score=265.45 Aligned_cols=166 Identities=22% Similarity=0.314 Sum_probs=143.3
Q ss_pred cccCCeeEeeeecccCceEEEEEEE--cCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCC-CCeeeEEEEEecCCeEE
Q 005841 502 ILWEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRH-PNVLLFMGAVTSPQRLC 578 (674)
Q Consensus 502 ~~~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~H-pnIv~l~~~~~~~~~~~ 578 (674)
+..++|++.++||+|+||+||+|++ +++.||||++...... ..+.+|+.+++.|.| +||+.+++++......|
T Consensus 2 vig~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~----~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~ 77 (293)
T d1csna_ 2 VVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA----PQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNV 77 (293)
T ss_dssp EETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS----CCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEE
T ss_pred CCCCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCc----HHHHHHHHHHHHhcCCCCCCEEEEEeecCCccE
Confidence 4568999999999999999999998 4678999998765432 235678899999975 89999999999999999
Q ss_pred EEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcC-----CCcEEEEecCCcc
Q 005841 579 IVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDK-----HWTVKVGDFGLSR 653 (674)
Q Consensus 579 lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~-----~~~vkL~DFGla~ 653 (674)
+||||+ +++|.+++......+++..+..++.|++.||+|||+++ ||||||||+||||+. .+.+||+|||+|+
T Consensus 78 ~vme~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~g--iiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~ 154 (293)
T d1csna_ 78 LVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS--LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 154 (293)
T ss_dssp EEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEECCSSSTTTTCEEECCCTTCE
T ss_pred EEEEec-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCC--ceeccCCccceeecCcccccCCceEEcccceeE
Confidence 999999 78999999887778999999999999999999999999 999999999999964 5789999999998
Q ss_pred cccCCc-------cccccCCCCccccCC
Q 005841 654 LKHETY-------LTTKTGKGTVTYLAS 674 (674)
Q Consensus 654 ~~~~~~-------~~~~~~~GTp~YmAP 674 (674)
.+.... ......+|||.||||
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~GT~~y~aP 182 (293)
T d1csna_ 155 FYRDPVTKQHIPYREKKNLSGTARYMSI 182 (293)
T ss_dssp ESBCTTTCCBCCCCCCCCCCSCTTTCCH
T ss_pred EcccCccccceeecccCceEEchhhcCH
Confidence 764321 123346899999998
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=4.1e-30 Score=273.06 Aligned_cols=166 Identities=28% Similarity=0.387 Sum_probs=138.0
Q ss_pred cCCeeEeeeecccCceEEEEEEE--cCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCC----eE
Q 005841 504 WEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSPQ----RL 577 (674)
Q Consensus 504 ~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~----~~ 577 (674)
..+|+++++||+|+||+||+|.+ ++..||||++.+.. .....+.+.+|+.+|+.++||||+++++++.... ..
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~ 85 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE-HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD 85 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTT-CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhc-ChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccce
Confidence 35799999999999999999998 47889999997544 4455678899999999999999999999997653 23
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccccC
Q 005841 578 CIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHE 657 (674)
Q Consensus 578 ~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~ 657 (674)
+++|+|+.+++|.+++.. ..+++..+..++.||+.||+|||+++ ||||||||+||||+.++.+||+|||+|+....
T Consensus 86 ~~l~~~~~~g~L~~~l~~--~~l~~~~i~~i~~qil~al~yLH~~~--iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~ 161 (345)
T d1pmea_ 86 VYLVTHLMGADLYKLLKT--QHLSNDHICYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADP 161 (345)
T ss_dssp EEEEEECCCEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEECCCTTCEECCG
T ss_pred EEEEEeecCCchhhhhhc--CCCCHHHHHHHHHHHHHHHHHHHHCC--CcCCCCCcceEEECCCCCEEEcccCceeeccC
Confidence 444556679999999975 36999999999999999999999999 99999999999999999999999999987644
Q ss_pred Ccc---ccccCCCCccccCC
Q 005841 658 TYL---TTKTGKGTVTYLAS 674 (674)
Q Consensus 658 ~~~---~~~~~~GTp~YmAP 674 (674)
... .....+||+.|+||
T Consensus 162 ~~~~~~~~~~~~gt~~y~aP 181 (345)
T d1pmea_ 162 DHDHTGFLTEYVATRWYRAP 181 (345)
T ss_dssp GGCBCCTTCCCCSCGGGCCG
T ss_pred CCccceeeccccccceechH
Confidence 322 23345799999998
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=1.1e-30 Score=272.38 Aligned_cols=167 Identities=28% Similarity=0.375 Sum_probs=139.3
Q ss_pred CCeeEeeeecccCceEEEEEEEc---CCeEEEEEeecccCCHHHHHHHHHHHHHHhhC---CCCCeeeEEEEEec-----
Q 005841 505 EDLTIGEQIGQGSCGTVYHAVWY---GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRL---RHPNVLLFMGAVTS----- 573 (674)
Q Consensus 505 ~~y~~~~~LG~G~fG~Vy~~~~~---~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l---~HpnIv~l~~~~~~----- 573 (674)
++|+++++||+|+||+||+|++. +..||||++............+.+|+.+++.| +||||++++++|..
T Consensus 7 ~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~~ 86 (305)
T d1blxa_ 7 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 86 (305)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSS
T ss_pred CCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeeccccccc
Confidence 68999999999999999999983 34589999976554433233455677777665 79999999999853
Q ss_pred CCeEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcc
Q 005841 574 PQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSR 653 (674)
Q Consensus 574 ~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~ 653 (674)
...+|++||||.++.+..........+++..+..|+.||+.||+|||+++ ||||||||+|||++..+.+||+|||+++
T Consensus 87 ~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~--ivHrDiKp~NILi~~~~~~kl~dfg~~~ 164 (305)
T d1blxa_ 87 ETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR--VVHRDLKPQNILVTSSGQIKLADFGLAR 164 (305)
T ss_dssp EEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTCCEEECSCCSCC
T ss_pred CceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--EEecCCCccEEEEcCCCCeeecchhhhh
Confidence 34689999999887776666666678999999999999999999999999 9999999999999999999999999998
Q ss_pred cccCCccccccCCCCccccCC
Q 005841 654 LKHETYLTTKTGKGTVTYLAS 674 (674)
Q Consensus 654 ~~~~~~~~~~~~~GTp~YmAP 674 (674)
...... .....+||+.||||
T Consensus 165 ~~~~~~-~~~~~~gT~~Y~AP 184 (305)
T d1blxa_ 165 IYSFQM-ALTSVVVTLWYRAP 184 (305)
T ss_dssp CCCGGG-GGCCCCCCCTTCCH
T ss_pred hhcccc-cCCCcccChhhcCc
Confidence 765433 33456899999998
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=6.3e-30 Score=267.75 Aligned_cols=163 Identities=30% Similarity=0.481 Sum_probs=140.8
Q ss_pred EeeeecccCceEEEEEEEcC-----CeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEec-CCeEEEEEe
Q 005841 509 IGEQIGQGSCGTVYHAVWYG-----SDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTS-PQRLCIVTE 582 (674)
Q Consensus 509 ~~~~LG~G~fG~Vy~~~~~~-----~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~-~~~~~lV~E 582 (674)
+.++||+|+||+||+|++.. ..||||.+++. ......+.|.+|+.+|++++||||+++++++.. +..+++|||
T Consensus 31 ~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E 109 (311)
T d1r0pa_ 31 FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI-TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLP 109 (311)
T ss_dssp EEEEEEEETTEEEEEEEECC----CEEEEEEEECCC-CCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEE
T ss_pred cceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcc-cCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEE
Confidence 46789999999999999732 24899998643 355667889999999999999999999999765 568999999
Q ss_pred cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccccCCccc-
Q 005841 583 FLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKHETYLT- 661 (674)
Q Consensus 583 ~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~~~~~~- 661 (674)
||++++|.+++......+++..++.|+.|++.||.|||+++ |+||||||+||||+.++.+||+|||+++........
T Consensus 110 ~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~--iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~ 187 (311)
T d1r0pa_ 110 YMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKK--FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDS 187 (311)
T ss_dssp CCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCC
T ss_pred EeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccC--cccCCccHHhEeECCCCCEEEecccchhhcccccccc
Confidence 99999999999877778899999999999999999999999 999999999999999999999999999876543222
Q ss_pred ---cccCCCCccccCC
Q 005841 662 ---TKTGKGTVTYLAS 674 (674)
Q Consensus 662 ---~~~~~GTp~YmAP 674 (674)
.....||+.||||
T Consensus 188 ~~~~~~~~gt~~y~aP 203 (311)
T d1r0pa_ 188 VHNKTGAKLPVKWMAL 203 (311)
T ss_dssp TTCTTCSSCCGGGSCH
T ss_pred ceecccccccccccCh
Confidence 2224699999998
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=99.96 E-value=5.8e-30 Score=269.70 Aligned_cols=159 Identities=21% Similarity=0.409 Sum_probs=136.9
Q ss_pred cCCeeEeeeecccCceEEEEEEE--cCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCC-CCCeeeEEEEEecC--CeEE
Q 005841 504 WEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLR-HPNVLLFMGAVTSP--QRLC 578 (674)
Q Consensus 504 ~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~--~~~~ 578 (674)
.++|+++++||+|+||+||+|++ ++..||||++++.. .+.+.+|+.+|+.+. ||||+++++++... ..+|
T Consensus 34 ~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~-----~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~ 108 (328)
T d3bqca1 34 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK-----KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPA 108 (328)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC-----HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEE
T ss_pred CcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH-----HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCcee
Confidence 36899999999999999999998 46779999996543 346788999999996 99999999999744 5699
Q ss_pred EEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCC-CcEEEEecCCcccccC
Q 005841 579 IVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKH-WTVKVGDFGLSRLKHE 657 (674)
Q Consensus 579 lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~-~~vkL~DFGla~~~~~ 657 (674)
+|||||.+++|..+. ..+++..+..|+.||+.||+|||++| ||||||||+||||+.+ +.|||+|||+|+....
T Consensus 109 ~v~e~~~~~~L~~~~----~~l~e~~i~~i~~qil~aL~~LH~~g--IvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~ 182 (328)
T d3bqca1 109 LVFEHVNNTDFKQLY----QTLTDYDIRFYMYEILKALDYCHSMG--IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP 182 (328)
T ss_dssp EEEECCCSCBGGGTT----TSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEETTTTEEEECCGGGCEECCT
T ss_pred EEEeecCCCcHHHHh----cCCCHHHHHHHHHHHHHHHHHHhhcc--cccccccccceEEcCCCCeeeecccccceeccC
Confidence 999999999986654 36999999999999999999999999 9999999999999864 5699999999987654
Q ss_pred CccccccCCCCccccCC
Q 005841 658 TYLTTKTGKGTVTYLAS 674 (674)
Q Consensus 658 ~~~~~~~~~GTp~YmAP 674 (674)
.. .....+||+.|+||
T Consensus 183 ~~-~~~~~~~t~~y~aP 198 (328)
T d3bqca1 183 GQ-EYNVRVASRYFKGP 198 (328)
T ss_dssp TC-CCCSCCSCGGGCCH
T ss_pred CC-cccccccCccccCc
Confidence 43 23346799999998
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=6.4e-30 Score=272.10 Aligned_cols=160 Identities=27% Similarity=0.334 Sum_probs=133.2
Q ss_pred CeeEeeeecccCceEEEEEEE--cCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecC------CeE
Q 005841 506 DLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSP------QRL 577 (674)
Q Consensus 506 ~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~------~~~ 577 (674)
+|+.+++||+|+||+||+|++ ++..||||++.+.... +.+|+.+|++++||||++++++|... .++
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~------~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~ 94 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF------KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYL 94 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS------CCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchH------HHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEE
Confidence 699999999999999999998 4778999999765422 23699999999999999999998543 358
Q ss_pred EEEEecCCCCCHHHHHH--hcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCC-cEEEEecCCccc
Q 005841 578 CIVTEFLPRGSLFRLLQ--RNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHW-TVKVGDFGLSRL 654 (674)
Q Consensus 578 ~lV~E~~~ggsL~~~l~--~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~-~vkL~DFGla~~ 654 (674)
|||||||+++.+..+.. .....+++..+..|+.||+.||+|||++| ||||||||+||||+.++ .+||+|||+|+.
T Consensus 95 ~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~--IiHrDiKp~NILl~~~~~~~kl~DFG~a~~ 172 (350)
T d1q5ka_ 95 NLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ 172 (350)
T ss_dssp EEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEECTTTCCEEECCCTTCEE
T ss_pred EEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcC--CcccCCCcceEEEecCCCceeEecccchhh
Confidence 99999997654433332 34567999999999999999999999999 99999999999999765 899999999987
Q ss_pred ccCCccccccCCCCccccCC
Q 005841 655 KHETYLTTKTGKGTVTYLAS 674 (674)
Q Consensus 655 ~~~~~~~~~~~~GTp~YmAP 674 (674)
..... ...+.+||+.|+||
T Consensus 173 ~~~~~-~~~~~~gt~~y~aP 191 (350)
T d1q5ka_ 173 LVRGE-PNVSYICSRYYRAP 191 (350)
T ss_dssp CCTTS-CCCSCCSCTTSCCH
T ss_pred ccCCc-ccccccccccccCh
Confidence 65433 23346899999998
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=1.2e-29 Score=266.05 Aligned_cols=168 Identities=23% Similarity=0.325 Sum_probs=138.1
Q ss_pred cCCeeEeeeecccCceEEEEEEE--cCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEec--------
Q 005841 504 WEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTS-------- 573 (674)
Q Consensus 504 ~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~-------- 573 (674)
.++|+++++||+|+||+||+|++ ++..||||++.+..........+.+|+.+|+.++||||+.+++++..
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence 37899999999999999999998 47789999997765555455678899999999999999999998865
Q ss_pred CCeEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcc
Q 005841 574 PQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSR 653 (674)
Q Consensus 574 ~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~ 653 (674)
...+|+|||||.++.+. .+......+++..+..|+.||+.||.|||+++ ||||||||+||||+.++.+||+|||+|+
T Consensus 89 ~~~~~iv~e~~~~~~~~-~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~--ivHrDlKp~NILl~~~~~~kl~dfg~~~ 165 (318)
T d3blha1 89 KGSIYLVFDFCEHDLAG-LLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNK--ILHRDMKAANVLITRDGVLKLADFGLAR 165 (318)
T ss_dssp --CEEEEEECCCEEHHH-HHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTSCEEECCCTTCE
T ss_pred CceEEEEEeccCCCccc-hhhhcccccccHHHHHHHHHHHHHHHHhccCC--EEecCcCchheeecCCCcEEeeecceee
Confidence 34689999999766554 44455678999999999999999999999999 9999999999999999999999999998
Q ss_pred cccCCcc----ccccCCCCccccCC
Q 005841 654 LKHETYL----TTKTGKGTVTYLAS 674 (674)
Q Consensus 654 ~~~~~~~----~~~~~~GTp~YmAP 674 (674)
....... ...+.+||+.||||
T Consensus 166 ~~~~~~~~~~~~~~~~~gT~~Y~aP 190 (318)
T d3blha1 166 AFSLAKNSQPNRYTNRVVTLWYRPP 190 (318)
T ss_dssp ECCC-----CCCCCSCCSCGGGCCH
T ss_pred ecccccccccccccceecCHHHhhH
Confidence 6543221 22335799999998
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.96 E-value=6.3e-29 Score=258.30 Aligned_cols=164 Identities=26% Similarity=0.348 Sum_probs=137.6
Q ss_pred cCCeeEeeeecccCceEEEEEEEc--CCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCC-eeeEEEEEecCCeEEEE
Q 005841 504 WEDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPN-VLLFMGAVTSPQRLCIV 580 (674)
Q Consensus 504 ~~~y~~~~~LG~G~fG~Vy~~~~~--~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hpn-Iv~l~~~~~~~~~~~lV 580 (674)
.++|++.++||+|+||+||+|++. +..||||++...... ..+..|+.+++.++|+| |+.+..++...+..++|
T Consensus 6 g~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~----~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~iv 81 (299)
T d1ckia_ 6 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMV 81 (299)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS----CCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEE
T ss_pred CCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccC----HHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEE
Confidence 467999999999999999999984 678999998765433 24678999999998665 56667777888899999
Q ss_pred EecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEc---CCCcEEEEecCCcccccC
Q 005841 581 TEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVD---KHWTVKVGDFGLSRLKHE 657 (674)
Q Consensus 581 ~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~---~~~~vkL~DFGla~~~~~ 657 (674)
|||+ +++|.+.+......+++..+..++.|++.||+|||+++ ||||||||+|||++ .+..|||+|||+|+.+..
T Consensus 82 me~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~ 158 (299)
T d1ckia_ 82 MELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN--FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 158 (299)
T ss_dssp EECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECCGGGTTCEEECCCSSCEECBC
T ss_pred EEEc-CCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCC--eeeccCCHhhccccccCCCceeeeeccCcceeccc
Confidence 9999 66888877777778999999999999999999999999 99999999999986 456799999999997654
Q ss_pred Cc-------cccccCCCCccccCC
Q 005841 658 TY-------LTTKTGKGTVTYLAS 674 (674)
Q Consensus 658 ~~-------~~~~~~~GTp~YmAP 674 (674)
.. ......+||+.||||
T Consensus 159 ~~~~~~~~~~~~~~~~gt~~y~aP 182 (299)
T d1ckia_ 159 ARTHQHIPYRENKNLTGTARYASI 182 (299)
T ss_dssp TTTCCBCCCCBCCSCCCCSSSCCH
T ss_pred cccccceeccccCCcCCCccccCH
Confidence 22 123346899999998
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=1.8e-29 Score=267.95 Aligned_cols=164 Identities=30% Similarity=0.368 Sum_probs=140.2
Q ss_pred cCCeeEeeeecccCceEEEEEEE--cCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecC-----Ce
Q 005841 504 WEDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTSP-----QR 576 (674)
Q Consensus 504 ~~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~-----~~ 576 (674)
.++|+++++||+|+||+||+|++ ++..||||++.+........+.+.+|+.+|+.++||||+++++++... ..
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 47899999999999999999997 477899999987766666677899999999999999999999998643 33
Q ss_pred EEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCccccc
Q 005841 577 LCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLKH 656 (674)
Q Consensus 577 ~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~~ 656 (674)
.++||+|+.+++|.+++.. .++++..+..|+.||+.||+|||+++ ||||||||+|||++.++.+||+|||+|....
T Consensus 97 ~~~i~~~~~gg~L~~~~~~--~~l~e~~~~~i~~qil~aL~~LH~~g--iiHrDiKp~NILi~~~~~~kl~dfg~a~~~~ 172 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTD 172 (348)
T ss_dssp CCEEEEECCSEEHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTCCEEECCC----CCT
T ss_pred eEEEEEeecCCchhhhccc--ccccHHHHHHHHHHHHHHHHHHHhCC--CcccccCCccccccccccccccccchhcccC
Confidence 4666777889999999954 46999999999999999999999999 9999999999999999999999999998665
Q ss_pred CCccccccCCCCccccCC
Q 005841 657 ETYLTTKTGKGTVTYLAS 674 (674)
Q Consensus 657 ~~~~~~~~~~GTp~YmAP 674 (674)
.. ..+..||+.||||
T Consensus 173 ~~---~~~~~g~~~y~ap 187 (348)
T d2gfsa1 173 DE---MTGYVATRWYRAP 187 (348)
T ss_dssp GG---GSSSCHHHHTSCH
T ss_pred cc---cccccccccccCc
Confidence 43 3346799999998
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=8.9e-30 Score=267.92 Aligned_cols=168 Identities=24% Similarity=0.370 Sum_probs=144.9
Q ss_pred cCCeeEeeeecccCceEEEEEEE-----cCCeEEEEEeecccCC--HHHHHHHHHHHHHHhhCCC-CCeeeEEEEEecCC
Q 005841 504 WEDLTIGEQIGQGSCGTVYHAVW-----YGSDVAVKVFSRQEYS--DEVIHSFRQEVSLMKRLRH-PNVLLFMGAVTSPQ 575 (674)
Q Consensus 504 ~~~y~~~~~LG~G~fG~Vy~~~~-----~~~~vAvK~i~~~~~~--~~~~~~~~~Ei~il~~l~H-pnIv~l~~~~~~~~ 575 (674)
.++|++++.||+|+||+||+|.. ++..||||++++.... ....+.+.+|+.++++++| |||+++++++.+..
T Consensus 23 l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~ 102 (322)
T d1vzoa_ 23 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 102 (322)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred hhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCC
Confidence 47899999999999999999986 3567999998765431 1234567789999999976 89999999999999
Q ss_pred eEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccc
Q 005841 576 RLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLK 655 (674)
Q Consensus 576 ~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~ 655 (674)
.+|+||||+.+++|.+++.... .+.+..+..++.||+.||.|||+++ ||||||||+||||+.++.+||+|||+|+..
T Consensus 103 ~~~~v~e~~~~~~L~~~i~~~~-~~~e~~~~~~~~Qi~~al~~lH~~~--ivHrDiKp~Nill~~~~~vkL~DFG~a~~~ 179 (322)
T d1vzoa_ 103 KLHLILDYINGGELFTHLSQRE-RFTEHEVQIYVGEIVLALEHLHKLG--IIYRDIKLENILLDSNGHVVLTDFGLSKEF 179 (322)
T ss_dssp EEEEEECCCCSCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTSCEEESCSSEEEEC
T ss_pred ceeeeeecccccHHHHHHHhcc-cccHHHHHHHHHHHHHHHHHhhcCC--EEeccCCccceeecCCCCEEEeeccchhhh
Confidence 9999999999999999997644 6789999999999999999999999 999999999999999999999999999876
Q ss_pred cCCcc-ccccCCCCccccCC
Q 005841 656 HETYL-TTKTGKGTVTYLAS 674 (674)
Q Consensus 656 ~~~~~-~~~~~~GTp~YmAP 674 (674)
..... ...+..||+.||||
T Consensus 180 ~~~~~~~~~~~~g~~~~~~p 199 (322)
T d1vzoa_ 180 VADETERAYDFCGTIEYMAP 199 (322)
T ss_dssp CGGGGGGGCGGGSCCTTCCH
T ss_pred cccccccccccccccccchh
Confidence 43322 23346799999997
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=4.9e-29 Score=265.71 Aligned_cols=164 Identities=30% Similarity=0.408 Sum_probs=132.7
Q ss_pred cCCeeEeeeecccCceEEEEEEEc--CCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEec------CC
Q 005841 504 WEDLTIGEQIGQGSCGTVYHAVWY--GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNVLLFMGAVTS------PQ 575 (674)
Q Consensus 504 ~~~y~~~~~LG~G~fG~Vy~~~~~--~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~------~~ 575 (674)
.++|+++++||+|+||+||+|.+. +..||||++.+..........+.+|+.+++.++||||++++++|.. ..
T Consensus 16 ~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~ 95 (355)
T d2b1pa1 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 95 (355)
T ss_dssp ETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCc
Confidence 368999999999999999999984 7789999998877777777889999999999999999999999964 36
Q ss_pred eEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEecCCcccc
Q 005841 576 RLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLK 655 (674)
Q Consensus 576 ~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~ 655 (674)
.+|+|||||.+ ++.+.+. ..+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||+++..
T Consensus 96 ~~~iv~Ey~~~-~l~~~~~---~~~~~~~i~~~~~qil~gl~~LH~~g--iiHrDlKP~Nil~~~~~~~kl~df~~~~~~ 169 (355)
T d2b1pa1 96 DVYLVMELMDA-NLCQVIQ---MELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTA 169 (355)
T ss_dssp EEEEEEECCSE-EHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred eeEEEEeccch-HHHHhhh---cCCCHHHHHHHHHHHHHHHHHhhhcc--cccccCCccccccccccceeeechhhhhcc
Confidence 78999999965 5555553 46899999999999999999999999 999999999999999999999999999876
Q ss_pred cCCccccccCCCCccccCC
Q 005841 656 HETYLTTKTGKGTVTYLAS 674 (674)
Q Consensus 656 ~~~~~~~~~~~GTp~YmAP 674 (674)
..... ....+||+.|+||
T Consensus 170 ~~~~~-~~~~~~t~~y~aP 187 (355)
T d2b1pa1 170 GTSFM-MTPYVVTRYYRAP 187 (355)
T ss_dssp ------------CCTTCCH
T ss_pred ccccc-cccccccccccCh
Confidence 65433 3346799999998
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=99.90 E-value=6.8e-24 Score=225.38 Aligned_cols=162 Identities=21% Similarity=0.354 Sum_probs=129.2
Q ss_pred CCeeEeeeecccCceEEEEEEE--cCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCC-----------CCCeeeEEEEE
Q 005841 505 EDLTIGEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLR-----------HPNVLLFMGAV 571 (674)
Q Consensus 505 ~~y~~~~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~-----------HpnIv~l~~~~ 571 (674)
.+|+++++||+|+||+||+|++ ++..||||++++.. ...+.+.+|+.+++.+. |+||+++++++
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~---~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~ 89 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK---VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHF 89 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH---HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc---cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEe
Confidence 4699999999999999999998 47789999997543 33456778999888775 57899998887
Q ss_pred ec--CCeEEEEEecCCCCCHH-H-HHHhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCeEEccCCCCCEEEcCCC----
Q 005841 572 TS--PQRLCIVTEFLPRGSLF-R-LLQRNTTKLDWRRRILMALDIARGVSYLHH-CNPPIIHRDLKSSNLLVDKHW---- 642 (674)
Q Consensus 572 ~~--~~~~~lV~E~~~ggsL~-~-~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~-~~~~IvHrDLKp~NILi~~~~---- 642 (674)
.. ....+++|+++..+... . ........+++..+..++.||+.||.|||+ ++ |+||||||+||||+.++
T Consensus 90 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~--IvHrDlKp~NIll~~~~~~~~ 167 (362)
T d1q8ya_ 90 NHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG--IIHTDIKPENVLMEIVDSPEN 167 (362)
T ss_dssp EEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC--EECSCCSGGGEEEEEEETTTT
T ss_pred eeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcC--cccccCChhHeeeeccCcccc
Confidence 54 45677777776554332 2 233345679999999999999999999997 78 99999999999998654
Q ss_pred --cEEEEecCCcccccCCccccccCCCCccccCC
Q 005841 643 --TVKVGDFGLSRLKHETYLTTKTGKGTVTYLAS 674 (674)
Q Consensus 643 --~vkL~DFGla~~~~~~~~~~~~~~GTp~YmAP 674 (674)
.+||+|||.|....... ...+||+.||||
T Consensus 168 ~~~~kl~dfg~s~~~~~~~---~~~~gt~~y~aP 198 (362)
T d1q8ya_ 168 LIQIKIADLGNACWYDEHY---TNSIQTREYRSP 198 (362)
T ss_dssp EEEEEECCCTTCEETTBCC---CSCCSCGGGCCH
T ss_pred cceeeEeeccccccccccc---ccccccccccCh
Confidence 49999999998765432 346799999998
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.87 E-value=4.2e-22 Score=192.74 Aligned_cols=136 Identities=22% Similarity=0.218 Sum_probs=107.7
Q ss_pred eeEeeeecccCceEEEEEEE-cCCeEEEEEeecccCC----------------HHHHHHHHHHHHHHhhCCCCCeeeEEE
Q 005841 507 LTIGEQIGQGSCGTVYHAVW-YGSDVAVKVFSRQEYS----------------DEVIHSFRQEVSLMKRLRHPNVLLFMG 569 (674)
Q Consensus 507 y~~~~~LG~G~fG~Vy~~~~-~~~~vAvK~i~~~~~~----------------~~~~~~~~~Ei~il~~l~HpnIv~l~~ 569 (674)
+.++++||+|+||+||+|.+ ++..||||++...... ........+|...+.++.|++++..++
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~ 81 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYA 81 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEE
T ss_pred chhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEE
Confidence 46889999999999999987 6788999987532110 112234567889999999999998886
Q ss_pred EEecCCeEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEEccCCCCCEEEcCCCcEEEEec
Q 005841 570 AVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCNPPIIHRDLKSSNLLVDKHWTVKVGDF 649 (674)
Q Consensus 570 ~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~IvHrDLKp~NILi~~~~~vkL~DF 649 (674)
+.. .++||||+++..+. .++...+..++.|++.+|.|||+++ |+||||||+|||++++ .++|+||
T Consensus 82 ~~~----~~lvme~~~~~~~~--------~l~~~~~~~i~~ql~~~l~~lH~~g--iiHrDiKP~NILv~~~-~~~liDF 146 (191)
T d1zara2 82 WEG----NAVLMELIDAKELY--------RVRVENPDEVLDMILEEVAKFYHRG--IVHGDLSQYNVLVSEE-GIWIIDF 146 (191)
T ss_dssp EET----TEEEEECCCCEEGG--------GCCCSCHHHHHHHHHHHHHHHHHTT--EECSCCSTTSEEEETT-EEEECCC
T ss_pred ecC----CEEEEEeecccccc--------chhhHHHHHHHHHHHHHHHHHhhCC--EEEccCChhheeeeCC-CEEEEEC
Confidence 542 37999999885542 2445566789999999999999999 9999999999999965 5999999
Q ss_pred CCcccccC
Q 005841 650 GLSRLKHE 657 (674)
Q Consensus 650 Gla~~~~~ 657 (674)
|+|+....
T Consensus 147 G~a~~~~~ 154 (191)
T d1zara2 147 PQSVEVGE 154 (191)
T ss_dssp TTCEETTS
T ss_pred CCcccCCC
Confidence 99976643
|
| >d1n9la_ d.110.3.6 (A:) Putative blue light receptor, phot-lov1 domain {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: Flavin-binding PAS domain domain: Putative blue light receptor, phot-lov1 domain species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.79 E-value=5e-19 Score=154.82 Aligned_cols=104 Identities=23% Similarity=0.288 Sum_probs=97.3
Q ss_pred hcceeEEEcC---CCcEEeecHHHHHHhCCChhhHcCCCccccccccccchhHHHHHHHHHhCceeEEEEEEEcCCCCEE
Q 005841 139 MGQSVHIFDL---SDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGERWTGQFPAKTKTEERV 215 (674)
Q Consensus 139 ~~d~I~v~D~---~GrIi~~N~a~e~llGys~eEviG~~~~~l~~~~~~~~~~~~i~~~l~~g~~~~~e~~~~~kdG~~~ 215 (674)
+.++++|+|+ ||+|+|||++|++|+||+.+|++|+++..++++.........+...+..|+.+..++.++++||..+
T Consensus 2 i~~~~vi~Da~~pdg~Ii~vN~a~~~~~Gy~~~El~G~~~~~l~~~~~~~~~~~~~~~~l~~~~~~~~e~~~~~kdG~~~ 81 (109)
T d1n9la_ 2 LRHTFVVADATLPDCPLVYASEGFYAMTGYGPDEVLGHNCRFLQGEGTDPKEVQKIRDAIKKGEACSVRLLNYRKDGTPF 81 (109)
T ss_dssp CSCEEEEEETTSTTCCEEEECHHHHHHHCCCHHHHTTSCGGGGCCTTCCHHHHHHHHHHHHHTCCEEEEEEEECTTSCEE
T ss_pred ccceEEEEeCCCCCCeEEEEcHHHHHHHCcCHHHHcCCcceeeecccCCHHHhhhhhhHhhcCCceeeeEEEEecCCeEE
Confidence 5789999994 8999999999999999999999999998888777667777888899999999999999999999999
Q ss_pred EEEEEEEEEECCCCCEEEEEEEEEchH
Q 005841 216 LVVATNTPFYDDDGTLVGIVCVSTDSR 242 (674)
Q Consensus 216 ~v~~s~sPi~d~dG~ivg~i~i~rDIT 242 (674)
|+.++++|++|++|++.+++++++|||
T Consensus 82 w~~~~~~pi~d~~G~v~~~v~~~~DIT 108 (109)
T d1n9la_ 82 WNLLTVTPIKTPDGRVSKFVGVQVDVT 108 (109)
T ss_dssp EEEEEEEEEECTTSCEEEEEEEEEECC
T ss_pred EEEEEEEEEECCCCCEEEEEEEEEECC
Confidence 999999999999999999999999998
|
| >d1jnua_ d.110.3.6 (A:) Photoreceptor phy3 flavin-binding domain, lov2 {Maidenhair fern (Adiantum capillus-veneris) [TaxId: 13818]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: Flavin-binding PAS domain domain: Photoreceptor phy3 flavin-binding domain, lov2 species: Maidenhair fern (Adiantum capillus-veneris) [TaxId: 13818]
Probab=99.69 E-value=8.7e-17 Score=138.70 Aligned_cols=100 Identities=23% Similarity=0.174 Sum_probs=94.0
Q ss_pred eeEEEc---CCCcEEeecHHHHHHhCCChhhHcCCCccccccccccchhHHHHHHHHHhCceeEEEEEEEcCCCCEEEEE
Q 005841 142 SVHIFD---LSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGERWTGQFPAKTKTEERVLVV 218 (674)
Q Consensus 142 ~I~v~D---~~GrIi~~N~a~e~llGys~eEviG~~~~~l~~~~~~~~~~~~i~~~l~~g~~~~~e~~~~~kdG~~~~v~ 218 (674)
.++|+| +||+|+|+|++|++++||+.+|++|+++.+++.+.........+...+..++.+..++++++++|+.+|+.
T Consensus 2 ~fvi~d~~~pd~~I~y~N~a~~~~~G~s~~e~~G~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~dg~~~~~~ 81 (104)
T d1jnua_ 2 SFVITDPRLPDNPIIFASDRFLELTEYTREEVLGNNCRFLQGRGTDRKAVQLIRDAVKEQRDVTVQVLNYTKGGRAFWNL 81 (104)
T ss_dssp EEEEECTTSTTCCEEEECHHHHHHHTCCHHHHTTSCGGGGCCTTSCHHHHHHHHHHHHHTCCEEEEEEEECTTSCEEEEE
T ss_pred eEEEEcCCCCCCEEEEEcHHHHHHHCcCHHHHCCccceeccccccchHHHhhhhhhhhcCceeEeEEEEEecccceEEEE
Confidence 357888 58999999999999999999999999999898888878888888899999999999999999999999999
Q ss_pred EEEEEEECCCCCEEEEEEEEEch
Q 005841 219 ATNTPFYDDDGTLVGIVCVSTDS 241 (674)
Q Consensus 219 ~s~sPi~d~dG~ivg~i~i~rDI 241 (674)
++++|++|++|++++++++++||
T Consensus 82 ~~~~pi~d~~G~v~~~i~i~~DI 104 (104)
T d1jnua_ 82 FHLQVMRDENGDVQYFIGVQQEM 104 (104)
T ss_dssp EEEEEECTTTSSCCEEEEEEEEC
T ss_pred EEEEEEECCCCCEEEEEEEEEcC
Confidence 99999999999999999999997
|
| >d1bywa_ d.110.3.6 (A:) Erg potassium channel, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: Flavin-binding PAS domain domain: Erg potassium channel, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.69 E-value=8.7e-17 Score=140.28 Aligned_cols=102 Identities=17% Similarity=0.129 Sum_probs=90.0
Q ss_pred eEEEcC---CCcEEeecHHHHHHhCCChhhHcCCCccccc--cccccchhHHHHHHHHHhCceeEEEEEEEcCCCCEEEE
Q 005841 143 VHIFDL---SDRIIYWNRSAELLYGYSAEEALGQDAIELL--TDGRDFDVAYDIVHRIKMGERWTGQFPAKTKTEERVLV 217 (674)
Q Consensus 143 I~v~D~---~GrIi~~N~a~e~llGys~eEviG~~~~~l~--~~~~~~~~~~~i~~~l~~g~~~~~e~~~~~kdG~~~~v 217 (674)
.+|+|+ |+.|+|||++|++|+||+.+|++|+++..++ ++.........+...+..++.+..+++.++++|..+|+
T Consensus 4 f~i~~~~~~d~~I~~~N~a~~~l~G~~~~eiiG~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~e~~~~~~~g~~~w~ 83 (110)
T d1bywa_ 4 FIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPCTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFLC 83 (110)
T ss_dssp EEEEETTSSSCBEEEECHHHHHHHTCCHHHHTTSBTTCGGGCCTTCCHHHHHHHHHHHHTTCCEEEEEEEECTTSCEEEE
T ss_pred EEEEcCCCCCCEEEEEcHHHHHHhCCCHHHhcccCcccccceeeheecccccccchhhcccccccceeeeeecccceeee
Confidence 467784 6789999999999999999999999987654 34444566677788899999999999999999999999
Q ss_pred EEEEEEEECCCCCEEEEEEEEEchHHH
Q 005841 218 VATNTPFYDDDGTLVGIVCVSTDSRPF 244 (674)
Q Consensus 218 ~~s~sPi~d~dG~ivg~i~i~rDITe~ 244 (674)
.++++||+|++|+++++|++++|||++
T Consensus 84 ~~~~~pi~d~~G~v~~~i~~~~DITer 110 (110)
T d1bywa_ 84 LVDVVPVKNEDGAVIMFILNFEVVMEK 110 (110)
T ss_dssp EEEEEEEECTTCCEEEEEEEEEEEEEC
T ss_pred eeeEEEEECCCCCEEEEEEEEEECCCC
Confidence 999999999999999999999999974
|
| >d1ew0a_ d.110.3.2 (A:) Histidine kinase FixL heme domain {Rhizobium meliloti [TaxId: 382]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: Heme-binding PAS domain domain: Histidine kinase FixL heme domain species: Rhizobium meliloti [TaxId: 382]
Probab=99.65 E-value=1.6e-16 Score=142.21 Aligned_cols=114 Identities=15% Similarity=0.167 Sum_probs=95.7
Q ss_pred ccHHHHHHHHHHhcceeEEEcCCCcEEeecHHHHHHhCCChhhHcCCCccccccccccchhHHHHHHHHHhCce----eE
Q 005841 127 FTDRQYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGER----WT 202 (674)
Q Consensus 127 ~se~~l~~ilds~~d~I~v~D~~GrIi~~N~a~e~llGys~eEviG~~~~~l~~~~~~~~~~~~i~~~l~~g~~----~~ 202 (674)
.++++|++||++++++|+++|.+|+|++||+++++|+||+.+|++|+++.+++++.........+...+..+.. ..
T Consensus 13 ~~e~~~~~i~~~~~~~i~~~d~~g~i~~~N~~~~~l~Gy~~~el~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 92 (130)
T d1ew0a_ 13 ARDAHLRSILDTVPDATVVSATDGTIVSFNAAAVRQFGYAEEEVIGQNLRILMPEPYRHEHDGYLQRYMATGEKRIIGID 92 (130)
T ss_dssp HHTSCHHHHHTTCSSEEEEEETTSBEEEECHHHHHHHCCCHHHHTTSBGGGGSCTTTGGGHHHHHHHHHHHCCCSSTTSC
T ss_pred HHHHHHHHHHHcCCCeEEEEeCCccEEEEHHHHHHhhcCCHHHhcCCccccccccchhHHHHHHHHHHHHhCCCccccce
Confidence 44557999999999999999999999999999999999999999999998888876655544444455666654 46
Q ss_pred EEEEEEcCCCCEEEEEEEEEEEECCCCCEEEEEEEEEchH
Q 005841 203 GQFPAKTKTEERVLVVATNTPFYDDDGTLVGIVCVSTDSR 242 (674)
Q Consensus 203 ~e~~~~~kdG~~~~v~~s~sPi~d~dG~ivg~i~i~rDIT 242 (674)
.++...++||..+|+.++++|+.+.++ .+++++++|||
T Consensus 93 ~e~~~~~~dG~~~~v~~~~~~i~~~~~--~~~~~i~rDIT 130 (130)
T d1ew0a_ 93 RVVSGQRKDGSTFPMKLAVGEMRSGGE--RFFTGFIRDLT 130 (130)
T ss_dssp EEEEEECTTSCEEEEEEEEEEEEETTE--EEEEEEEEECC
T ss_pred eeEEEEcCCCCEEEEEEEEEEEEECCe--EEEEEEEEECC
Confidence 788889999999999999999987443 45789999997
|
| >d1xj3a1 d.110.3.2 (A:154-259) Histidine kinase FixL heme domain {Bradyrhizobium japonicum [TaxId: 375]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: Heme-binding PAS domain domain: Histidine kinase FixL heme domain species: Bradyrhizobium japonicum [TaxId: 375]
Probab=99.59 E-value=3.2e-15 Score=127.91 Aligned_cols=102 Identities=15% Similarity=0.112 Sum_probs=83.8
Q ss_pred ceeEEEcCCCcEEeecHHHHHHhCCChhhHcCCCccccccccccchhHHHHHHHHHhCce----eEEEEEEEcCCCCEEE
Q 005841 141 QSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGER----WTGQFPAKTKTEERVL 216 (674)
Q Consensus 141 d~I~v~D~~GrIi~~N~a~e~llGys~eEviG~~~~~l~~~~~~~~~~~~i~~~l~~g~~----~~~e~~~~~kdG~~~~ 216 (674)
|||+++|.+|+|++||+++++|+||+.+|++|+++..++++.........+...+..... ...++...++||..+|
T Consensus 1 dgi~~~D~~G~I~~~N~a~~~l~Gy~~~el~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~dg~~~~ 80 (106)
T d1xj3a1 1 DAMIVIDGHGIIQLFSTAAERLFGWSELEAIGQNVNILMPEPDRSRHDSYISRYRTTSDPHIIGIGRIVTGKRRDGTTFP 80 (106)
T ss_dssp CCEEEEETTSBEEEECHHHHHHHCCCHHHHTTSBGGGGSCTTHHHHHHHHHHHHHHHCCCSSTTTCEEEEEECTTSCEEE
T ss_pred CEEEEECCCCcEEEEcHHHHHHhhhchHhhcCCCcccccccccccchhhhhhhhhhhcccccccccceeeeeeccceEEE
Confidence 689999999999999999999999999999999998888876654444444444444433 4567889999999999
Q ss_pred EEEEEEEEECCCCCEEEEEEEEEchHHH
Q 005841 217 VVATNTPFYDDDGTLVGIVCVSTDSRPF 244 (674)
Q Consensus 217 v~~s~sPi~d~dG~ivg~i~i~rDITe~ 244 (674)
+.++++|+++.++ .+++++++||||.
T Consensus 81 v~~~~~~~~~~~~--~~~~~~~~DITE~ 106 (106)
T d1xj3a1 81 MHLSIGEMQSGGE--PYFTGFVRDLTEH 106 (106)
T ss_dssp EEEEEEEEEETTE--EEEEEEEEECHHH
T ss_pred EEEEEEEEEECCe--EEEEEEEEeCCCC
Confidence 9999999997544 4678999999974
|
| >d1p97a_ d.110.3.7 (A:) Hypoxia-inducible factor Hif2a, C-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: Hypoxia-inducible factor Hif2a, C-terminal domain domain: Hypoxia-inducible factor Hif2a, C-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.59 E-value=5.9e-16 Score=135.61 Aligned_cols=105 Identities=19% Similarity=0.243 Sum_probs=90.4
Q ss_pred eeEEEcCCCcEEeecHHHHHHhCCChhhHcCCCccccccccccchhHHHHHHHHHhCceeEEEEEEEcCCCCEEEEEEEE
Q 005841 142 SVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGERWTGQFPAKTKTEERVLVVATN 221 (674)
Q Consensus 142 ~I~v~D~~GrIi~~N~a~e~llGys~eEviG~~~~~l~~~~~~~~~~~~i~~~l~~g~~~~~e~~~~~kdG~~~~v~~s~ 221 (674)
-|+..|.+|+|+|||+++++++||+.+|++|+++.+++++++.......+...+..+..+..++++.++||..+|+.++.
T Consensus 8 fi~r~~~dG~i~~~N~~~~~~~G~~~~el~g~~~~~~~~~ed~~~~~~~~~~~~~~~~~~~~e~~~~~kdG~~~wv~~~~ 87 (114)
T d1p97a_ 8 FLSRHSMDMKFTYCDDRITELIGYHPEELLGRSAYEFYHALDSENMTKSHQNLCTKGQVVSGQYRMLAKHGGYVWLETQG 87 (114)
T ss_dssp EEEEECTTTSCSEECTTHHHHTSSCHHHHTTSCHHHHSCSSSHHHHHHHHHHHTTTSEEEEEEEEEECTTSCEEEEEEEE
T ss_pred EEEEECCCCcEEEECHHHHHHcCCCccccccccccccccccccccceeeeeecccccceeecceeeeeecCcceEEEEEE
Confidence 34446999999999999999999999999999999999887755554445555666666888999999999999999999
Q ss_pred EEEECC-CCCEEEEEEEEEchHHHHH
Q 005841 222 TPFYDD-DGTLVGIVCVSTDSRPFQE 246 (674)
Q Consensus 222 sPi~d~-dG~ivg~i~i~rDITe~k~ 246 (674)
+|++|+ +|++.+++++.+|||++|+
T Consensus 88 ~~~~~~~~~~~~~ii~~~~dite~k~ 113 (114)
T d1p97a_ 88 TVIYNPRNLQPQCIMCVNYVLSEIEK 113 (114)
T ss_dssp EEEECTTTCSEEEEEEEEEEEEEEEC
T ss_pred EEEEeCCCCCEEEEEEEEEECChhhc
Confidence 999986 6899999999999999764
|
| >d1v9ya_ d.110.3.2 (A:) Direct oxygen sensor protein, DOS {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: Heme-binding PAS domain domain: Direct oxygen sensor protein, DOS species: Escherichia coli [TaxId: 562]
Probab=99.59 E-value=4.2e-15 Score=128.82 Aligned_cols=108 Identities=16% Similarity=0.245 Sum_probs=86.0
Q ss_pred HHHHHHHHhcceeEEEcCCCcEEeecHHHHHHhCCChhhHcCCCccccccccccchhHHHHHHHHHhCce----eEEEEE
Q 005841 131 QYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGER----WTGQFP 206 (674)
Q Consensus 131 ~l~~ilds~~d~I~v~D~~GrIi~~N~a~e~llGys~eEviG~~~~~l~~~~~~~~~~~~i~~~l~~g~~----~~~e~~ 206 (674)
.|.++|++.+++|+++|.+|+|++||+++++++||+.+|++|+++..+++..........+...+..+.. ...+..
T Consensus 2 ~~~~~~e~~~d~i~~~d~~g~i~~~N~~~~~l~Gy~~~e~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~ 81 (113)
T d1v9ya_ 2 IFFPALEQNMMGAVLINENDEVMFFNPAAEKLWGYKREEVIGNNIDMLIPRDLRPAHPEYIRHNREGGKARVEGMSRELQ 81 (113)
T ss_dssp CHHHHHHTCSSEEEEECTTSBEEEECHHHHHHHSCCGGGTTTSBGGGGSCGGGTTTHHHHHHHHHC----------CEEE
T ss_pred HHHHHHHcCcCcEEEEeCCCCEEEEchhHhhhhccchhhhcCcceecccccccccccccccccccccccccccccceeee
Confidence 4789999999999999999999999999999999999999999998888766554444444444433322 456778
Q ss_pred EEcCCCCEEEEEEEEEEEECCCCCEEEEEEEEEc
Q 005841 207 AKTKTEERVLVVATNTPFYDDDGTLVGIVCVSTD 240 (674)
Q Consensus 207 ~~~kdG~~~~v~~s~sPi~d~dG~ivg~i~i~rD 240 (674)
..+++|+.+|++++++|+.+++|. .++++++|
T Consensus 82 ~~~~dG~~~~v~~~~~~i~~~~~~--~~~~v~rD 113 (113)
T d1v9ya_ 82 LEKKDGSKIWTRFALSKVSAEGKV--YYLALVRD 113 (113)
T ss_dssp EECTTSCEEEEEEEEEEEEETTEE--EEEEEEEC
T ss_pred eccccceeEEEEEEEEEEEECCeE--EEEEEEEC
Confidence 899999999999999999975553 37888888
|
| >d1nwza_ d.110.3.1 (A:) Photoactive yellow protein, PYP {Ectothiorhodospira halophila [TaxId: 1053]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: PYP-like domain: Photoactive yellow protein, PYP species: Ectothiorhodospira halophila [TaxId: 1053]
Probab=99.40 E-value=1.1e-12 Score=117.01 Aligned_cols=107 Identities=10% Similarity=-0.004 Sum_probs=87.5
Q ss_pred HHHHHHHHhcceeEEEcCCCcEEeecHHHHHHhCCChhhHcCCCcccccccccc-chhHHHHHHHHHhCceeEEEEEEEc
Q 005841 131 QYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRD-FDVAYDIVHRIKMGERWTGQFPAKT 209 (674)
Q Consensus 131 ~l~~ilds~~d~I~v~D~~GrIi~~N~a~e~llGys~eEviG~~~~~l~~~~~~-~~~~~~i~~~l~~g~~~~~e~~~~~ 209 (674)
.+..+||++|+||+++|.+|+|++||+++++++||++++++|+++.+++.+... ..+...+.+.+.+|.....+...++
T Consensus 18 ~~d~~ld~~p~gi~~lD~~G~i~~~N~a~~~l~G~~~~e~iG~~~~~~~~p~~~~~~~~~~~~~~~~~g~~~~~~~~~~~ 97 (125)
T d1nwza_ 18 MDDGQLDGLAFGAIQLDGDGNILQYNAAEGDITGRDPKQVIGKNFFKDVAPCTDSPEFYGKFKEGVASGNLNTMFEYTFD 97 (125)
T ss_dssp CCHHHHTTCSSEEEEEETTCBEEEECHHHHHHHCCCHHHHTTSBCCCCCCGGGCSTTTHHHHHHHHHHTCCEEEEEEEEC
T ss_pred HHHHHHhCCCccEEEEeCCCCEEEEcHHHHHhhccchHhhcCCCHHHccCchhhhhheeeeceeeeecCCcceEEEEEec
Confidence 467899999999999999999999999999999999999999999887755443 4455566777888887777767789
Q ss_pred CCCCEEEEEEEEEEEECCCCCEEEEEEEEEch
Q 005841 210 KTEERVLVVATNTPFYDDDGTLVGIVCVSTDS 241 (674)
Q Consensus 210 kdG~~~~v~~s~sPi~d~dG~ivg~i~i~rDI 241 (674)
++|..+|+.++..++.+ |.-+ ..+++||
T Consensus 98 ~~G~~~~v~v~l~~~~~--g~~~--~v~V~di 125 (125)
T d1nwza_ 98 YQMTPTKVKVHMKKALS--GDSY--WVFVKRV 125 (125)
T ss_dssp TTSCCEEEEEEEEECSS--SSEE--EEEEEEC
T ss_pred cCCcEEEEEEEEEEecC--CCEE--EEEEEEC
Confidence 99999999999888754 4433 3467775
|
| >d1mzua_ d.110.3.1 (A:) PYP domain of sensor histidine kinase Ppr {Rhodospirillum centenum [TaxId: 34018]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: PYP-like domain: PYP domain of sensor histidine kinase Ppr species: Rhodospirillum centenum [TaxId: 34018]
Probab=99.38 E-value=6.2e-13 Score=115.88 Aligned_cols=96 Identities=13% Similarity=-0.058 Sum_probs=78.2
Q ss_pred HHHHHHHHhcceeEEEcCCCcEEeecHHHHHHhCCChhhHcCCCccccccccc-cchhHHHHHHHHHhCceeEEEEEEEc
Q 005841 131 QYLNILQSMGQSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGR-DFDVAYDIVHRIKMGERWTGQFPAKT 209 (674)
Q Consensus 131 ~l~~ilds~~d~I~v~D~~GrIi~~N~a~e~llGys~eEviG~~~~~l~~~~~-~~~~~~~i~~~l~~g~~~~~e~~~~~ 209 (674)
.+.++||++|++|+++|.+|+|++||+++++|+||+++|++|+++.+++.++. ...+...+.+.+.+|+........++
T Consensus 4 ~~~A~ld~~p~gvi~~D~~G~I~~~N~aa~~~~G~~~eellG~~~~~~~~p~~~~~~~~~~~~~~~~~g~~~~~~~~~l~ 83 (110)
T d1mzua_ 4 MGTAEFDALPVGAIQVDGSGVIHRYNRTESRLSGRIPERVIGRNFFTEVAPCTNIPAFSGRFMDGVTSGTLDARFDFVFD 83 (110)
T ss_dssp --CTTGGGCSSEEEEEETTCBEEEECHHHHHHHCCCHHHHTTSBCCCCCCGGGCSTTTHHHHHHHHHTSCCEEEEEEEEE
T ss_pred HHHHHHhCCCcEEEEEcCCCCEEEeHHHHHHHHcCCHHHHcCCCHHHhcCChhhhHHHHHHHHHHHhccccCcceEEEEe
Confidence 46789999999999999999999999999999999999999999987665543 34555567777888886444444467
Q ss_pred CCCCEEEEEEEEEEEEC
Q 005841 210 KTEERVLVVATNTPFYD 226 (674)
Q Consensus 210 kdG~~~~v~~s~sPi~d 226 (674)
++|..++++++..+..+
T Consensus 84 ~~G~~~~v~v~~~~~~~ 100 (110)
T d1mzua_ 84 FQMAPVRVQIRMQNAGV 100 (110)
T ss_dssp CSSCEEEEEEEEEECSS
T ss_pred cCCceEEEEEEEEEecC
Confidence 89999999999988753
|
| >d1ll8a_ d.110.3.5 (A:) N-terminal PAS domain of Pas kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: N-terminal PAS domain of Pas kinase domain: N-terminal PAS domain of Pas kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.20 E-value=2.1e-12 Score=112.74 Aligned_cols=105 Identities=15% Similarity=0.168 Sum_probs=81.0
Q ss_pred HHHhcceeEEEcC-CCcEEeecHHHHHHhCCChhhHcCCCccccccccccchhHHHHHHHHHhCce----eEEEEEEEcC
Q 005841 136 LQSMGQSVHIFDL-SDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGER----WTGQFPAKTK 210 (674)
Q Consensus 136 lds~~d~I~v~D~-~GrIi~~N~a~e~llGys~eEviG~~~~~l~~~~~~~~~~~~i~~~l~~g~~----~~~e~~~~~k 210 (674)
-+.+.++|+++|. +|+|+++|++++++|||+.+|++|+++.+++++.........+...+.++.. +..++..+++
T Consensus 4 ~~~~n~AI~~id~~~G~I~~~N~a~~~l~Gy~~~el~g~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~ 83 (114)
T d1ll8a_ 4 DPEFNKAIFTVDAKTTEILVANDKACGLLGYSSQDLIGQKLTQFFLRSDSDVVEALSEEHMEADGHAAVVFGTVVDIISR 83 (114)
T ss_dssp STTTTCEEEEEETTTCBEEEECTTHHHHHTCCTTTTTTSBGGGGSSCTTTHHHHHTTSSTTSSSSCSSCCCSSSEEECCT
T ss_pred chhcCcEEEEEECCCCEEEEECHHHHHhhcCCHHHHcCCCeeeecCcccHHHHHHHHHHHHhcCCCccceeeEEEEEEcc
Confidence 3567889999995 7999999999999999999999999999999876643332222223333332 3336788999
Q ss_pred CCCEEEEEEEEEEEECCCCCEEEEEEEEEchH
Q 005841 211 TEERVLVVATNTPFYDDDGTLVGIVCVSTDSR 242 (674)
Q Consensus 211 dG~~~~v~~s~sPi~d~dG~ivg~i~i~rDIT 242 (674)
+|..+|++++++++.. +|+.. ++++++||+
T Consensus 84 ~G~~~pvevs~~~i~~-~~~~~-~l~vi~dV~ 113 (114)
T d1ll8a_ 84 SGEKIPVSVWMKRMRQ-ERRLC-CVVVLEPVE 113 (114)
T ss_dssp TCCCEEEECCEECCBS-SSSBE-EEEEEEECC
T ss_pred CCcEEEEEEEEEEEEE-CCeEE-EEEEEEECc
Confidence 9999999999999975 44443 689999994
|
| >d1oj5a_ d.110.3.8 (A:) PAS domain of steroid receptor coactivator 1A, NCo-A1 {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: PAS domain of steroid receptor coactivator 1A, NCo-A1 domain: PAS domain of steroid receptor coactivator 1A, NCo-A1 species: Mouse (Mus musculus) [TaxId: 10090]
Probab=98.92 E-value=1.1e-09 Score=94.75 Aligned_cols=94 Identities=10% Similarity=0.003 Sum_probs=75.3
Q ss_pred eEEEcCCCcEEeecHHHHHHhCCCh-hhHcCCCccccccccccchhH-HH-HHHHHHhCceeEEEEEEEcCCCCEEEEEE
Q 005841 143 VHIFDLSDRIIYWNRSAELLYGYSA-EEALGQDAIELLTDGRDFDVA-YD-IVHRIKMGERWTGQFPAKTKTEERVLVVA 219 (674)
Q Consensus 143 I~v~D~~GrIi~~N~a~e~llGys~-eEviG~~~~~l~~~~~~~~~~-~~-i~~~l~~g~~~~~e~~~~~kdG~~~~v~~ 219 (674)
+...|.+|+|+++|+++.+++||.. +|++|+.+.+++++++..... .. ....+..|+....+++++++||..+|+..
T Consensus 5 ~trh~~~g~~~~vd~~~~~~~gy~~~eelig~s~~~f~HPeD~~~~~~~~~~~~~~~~g~~~~~~yR~~~kdG~~vWv~t 84 (109)
T d1oj5a_ 5 MTKQDTTGKIISIDTSSLRAAGRTGWEDLVRKCIYAFFQPQGREPSYARQLFQEVMTRGTASSPSYRFILNDGTMLSAHT 84 (109)
T ss_dssp EEEECTTCCEEEEECHHHHTTCCSCHHHHHHHHHHHHTSCBTTBCCHHHHHHHHHHHHSEEECCCEEEECTTSCEEEEEE
T ss_pred EEEECCCceEEEECHHHhhHhhcCCHHHHcCCcHHHeECcccchHHHhhHHHHHHHhhcccchhhhhhhhccCcEEEEEE
Confidence 4457999999999999999999985 899999999999998754332 22 34557788889999999999999999999
Q ss_pred EEEEEECCCC-CEEEEEE
Q 005841 220 TNTPFYDDDG-TLVGIVC 236 (674)
Q Consensus 220 s~sPi~d~dG-~ivg~i~ 236 (674)
+..+++|+.| ++..+||
T Consensus 85 ~~~~~~~~~~~~~~~Ii~ 102 (109)
T d1oj5a_ 85 RCKLCYPQSPDMQPFIMG 102 (109)
T ss_dssp EEEEECC----CCCEEEE
T ss_pred EEEEEECCCCCcccEEEE
Confidence 9999998644 4444444
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.49 E-value=2.3e-07 Score=91.45 Aligned_cols=144 Identities=15% Similarity=0.032 Sum_probs=98.1
Q ss_pred cCCeeEeeeecccCceEEEEEEEcCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCC-CCCeeeEEEEEecCCeEEEEEe
Q 005841 504 WEDLTIGEQIGQGSCGTVYHAVWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLR-HPNVLLFMGAVTSPQRLCIVTE 582 (674)
Q Consensus 504 ~~~y~~~~~LG~G~fG~Vy~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~lV~E 582 (674)
.+.|++.+..+.++...||+....+..+.+|+........ ...+.+|..++..+. +--+.+++.+...++..|+||+
T Consensus 13 ~~~~~~~~~~~G~s~~~v~rv~~~~~~~vlk~~~~~~~~~--~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~ 90 (263)
T d1j7la_ 13 IEKYRCVKDTEGMSPAKVYKLVGENENLYLKMTDSRYKGT--TYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMS 90 (263)
T ss_dssp HTTSEEEECSCCCSSSEEEEEECSSCEEEEEEECGGGTTS--TTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEE
T ss_pred hhceEEEEcCCCCCCCcEEEEEeCCCeEEEEEcCCCcccc--hhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEE
Confidence 4677777766656668999988778889999886543221 123556788777664 4346678888888899999999
Q ss_pred cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---------------------------------------
Q 005841 583 FLPRGSLFRLLQRNTTKLDWRRRILMALDIARGVSYLHHCN--------------------------------------- 623 (674)
Q Consensus 583 ~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~--------------------------------------- 623 (674)
+++|..+....... .....++.++...|..||+..
T Consensus 91 ~l~G~~~~~~~~~~------~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (263)
T d1j7la_ 91 EADGVLCSEEYEDE------QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPF 164 (263)
T ss_dssp CCSSEEHHHHTTTC------SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSC
T ss_pred eccccccccccccc------ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccccc
Confidence 99998875543211 111223334444444454311
Q ss_pred ------------------CCeEEccCCCCCEEEcCCCcEEEEecCCcccc
Q 005841 624 ------------------PPIIHRDLKSSNLLVDKHWTVKVGDFGLSRLK 655 (674)
Q Consensus 624 ------------------~~IvHrDLKp~NILi~~~~~vkL~DFGla~~~ 655 (674)
..++|+|+.|.|||++.++.+.|+||+.+...
T Consensus 165 ~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~g 214 (263)
T d1j7la_ 165 KDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGRA 214 (263)
T ss_dssp SSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEEE
T ss_pred hHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcccC
Confidence 12789999999999998766779999998753
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.88 E-value=2.4e-05 Score=76.03 Aligned_cols=138 Identities=18% Similarity=0.116 Sum_probs=81.8
Q ss_pred eecccC-ceEEEEEEEc-CCeEEEEEeecccCCHHHHHHHHHHHHHHhhCC--CCCeeeEEEEEecCCeEEEEEecCCCC
Q 005841 512 QIGQGS-CGTVYHAVWY-GSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLR--HPNVLLFMGAVTSPQRLCIVTEFLPRG 587 (674)
Q Consensus 512 ~LG~G~-fG~Vy~~~~~-~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~--HpnIv~l~~~~~~~~~~~lV~E~~~gg 587 (674)
.+..|. .+.||+.... +..+.+|........ .+..|..+++.+. .-.+.+++.+..+++..|+||+|++|.
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~~-----~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~ 91 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGALN-----ELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQ 91 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSCTTS-----CHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSE
T ss_pred EcCCcccCCeEEEEEeCCCCEEEEEeCCccCHh-----HHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecc
Confidence 344444 4679998875 445888976544322 3556777777664 233667888888888999999999875
Q ss_pred CHHH--------------HHHhc------CCCC--CHHHHHHHHH--------------------HHHHHHHHHHhCC--
Q 005841 588 SLFR--------------LLQRN------TTKL--DWRRRILMAL--------------------DIARGVSYLHHCN-- 623 (674)
Q Consensus 588 sL~~--------------~l~~~------~~~l--~~~~~~~i~~--------------------qi~~~L~yLH~~~-- 623 (674)
++.. .|.+. ...+ .......-.. .....+..+....
T Consensus 92 ~~~~~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 171 (255)
T d1nd4a_ 92 DLLSSHLAPAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKARMPD 171 (255)
T ss_dssp ETTTSCCCHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHTCCS
T ss_pred ccccccccHHHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHHHHHHhCCc
Confidence 5421 11110 0000 0000000000 0122233333211
Q ss_pred ---CCeEEccCCCCCEEEcCCCcEEEEecCCccc
Q 005841 624 ---PPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL 654 (674)
Q Consensus 624 ---~~IvHrDLKp~NILi~~~~~vkL~DFGla~~ 654 (674)
+.+||+|+.|.|||++.+..+.|+||+.+..
T Consensus 172 ~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~ 205 (255)
T d1nd4a_ 172 GEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 205 (255)
T ss_dssp SCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred cCCceEEeCCCCCcceEEeCCceEEEEEchhccc
Confidence 1279999999999999876778999999875
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.41 E-value=0.00014 Score=75.89 Aligned_cols=77 Identities=21% Similarity=0.112 Sum_probs=47.6
Q ss_pred eeeecccCceEEEEEEE--cCCeEEEEEeecccC-----CHHHHHHHHHHHHHHhhCC-C--CCeeeEEEEEecCCeEEE
Q 005841 510 GEQIGQGSCGTVYHAVW--YGSDVAVKVFSRQEY-----SDEVIHSFRQEVSLMKRLR-H--PNVLLFMGAVTSPQRLCI 579 (674)
Q Consensus 510 ~~~LG~G~fG~Vy~~~~--~~~~vAvK~i~~~~~-----~~~~~~~~~~Ei~il~~l~-H--pnIv~l~~~~~~~~~~~l 579 (674)
.+.||.|....||++.. .+..|+||.-..... -+....+...|..+|..+. + ..+.+++.+ +.+..++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence 45689999999999975 355789996532110 0011233456777777663 2 345566654 4556689
Q ss_pred EEecCCCCC
Q 005841 580 VTEFLPRGS 588 (674)
Q Consensus 580 V~E~~~ggs 588 (674)
|||++.+..
T Consensus 109 vmE~L~~~~ 117 (392)
T d2pula1 109 VMEDLSHLK 117 (392)
T ss_dssp EECCCTTSE
T ss_pred EEeccCCcc
Confidence 999997644
|
| >d2oola2 d.110.3.9 (A:26-139) Sensor protein PhyB2 {Rhodopseudomonas palustris [TaxId: 1076]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: BphP N-terminal domain-like domain: Sensor protein PhyB2 species: Rhodopseudomonas palustris [TaxId: 1076]
Probab=97.02 E-value=0.00042 Score=58.92 Aligned_cols=42 Identities=17% Similarity=0.082 Sum_probs=37.8
Q ss_pred eeEEEcC-CCcEEeecHHHHHHhCCChhhHcCCCccccccccc
Q 005841 142 SVHIFDL-SDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGR 183 (674)
Q Consensus 142 ~I~v~D~-~GrIi~~N~a~e~llGys~eEviG~~~~~l~~~~~ 183 (674)
.++++|. +|+|+|+......++|+++++++|+++.+++++..
T Consensus 19 ~Llvld~~d~~I~~vS~N~~~lLG~~~~~llG~~l~dll~~~~ 61 (114)
T d2oola2 19 YLFVVSETDLRIASVSANVEDLLRQPPASLLNVPIAHYLTAAS 61 (114)
T ss_dssp EEEEECTTTCBEEEEETTHHHHHSSCGGGGTTCBGGGGBCHHH
T ss_pred EEEEEECCCCEEEEEcCCHHHHhCCChHHHcCCCHHHhCCHHH
Confidence 4567885 79999999999999999999999999999998755
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.63 E-value=0.0031 Score=63.37 Aligned_cols=66 Identities=12% Similarity=0.081 Sum_probs=42.4
Q ss_pred eEEEEEEE-cCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCe--eeEE-----EEEecCCeEEEEEecCCCC
Q 005841 519 GTVYHAVW-YGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRHPNV--LLFM-----GAVTSPQRLCIVTEFLPRG 587 (674)
Q Consensus 519 G~Vy~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnI--v~l~-----~~~~~~~~~~lV~E~~~gg 587 (674)
-.||++.. .|..|++|+......+.+ .+..|..++..|....| +..+ ..+......+.|+++++|.
T Consensus 36 N~vy~v~~~dg~~~VlK~~rp~~~s~~---~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~ 109 (325)
T d1zyla1 36 NRVYQFQDEDRRRFVVKFYRPERWTAD---QILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGR 109 (325)
T ss_dssp SEEEEECCTTCCCEEEEEECTTTSCHH---HHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCE
T ss_pred ceeEEEEcCCCCEEEEEEeCCCCCCHH---HHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCc
Confidence 58999986 677899999876654543 35567777777642211 1111 1223466789999999763
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.15 E-value=0.0075 Score=62.18 Aligned_cols=75 Identities=16% Similarity=0.234 Sum_probs=49.1
Q ss_pred CCeeEeeeecccCceEEEEEEEcC---------CeEEEEEeecccCCHHHHHHHHHHHHHHhhCC-CCCeeeEEEEEecC
Q 005841 505 EDLTIGEQIGQGSCGTVYHAVWYG---------SDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLR-HPNVLLFMGAVTSP 574 (674)
Q Consensus 505 ~~y~~~~~LG~G~fG~Vy~~~~~~---------~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~ 574 (674)
+++++ +.|+.|-.-.+|++.... ..|.+++.-. ... . ....+|..+++.+. +.-..++++++..
T Consensus 43 ~~l~v-~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~-~~~--~-idr~~E~~i~~~ls~~gl~Pkll~~~~~- 116 (395)
T d1nw1a_ 43 EHLRI-SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFN-PET--E-SHLVAESVIFTLLSERHLGPKLYGIFSG- 116 (395)
T ss_dssp GGEEE-EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECS-CCC--H-HHHHHHHHHHHHHHHTTSSSCEEEEETT-
T ss_pred cceEE-EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCC-cch--h-hHHHHHHHHHHHHHhCCCCCeEEEEcCC-
Confidence 34444 578888889999998632 3477887752 212 1 23557888888875 3334477777643
Q ss_pred CeEEEEEecCCCCC
Q 005841 575 QRLCIVTEFLPRGS 588 (674)
Q Consensus 575 ~~~~lV~E~~~ggs 588 (674)
++||||++|..
T Consensus 117 ---g~I~efi~g~~ 127 (395)
T d1nw1a_ 117 ---GRLEEYIPSRP 127 (395)
T ss_dssp ---EEEECCCCEEE
T ss_pred ---ceEEEEecccc
Confidence 68999998743
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.03 E-value=0.017 Score=57.06 Aligned_cols=144 Identities=15% Similarity=0.030 Sum_probs=73.6
Q ss_pred eeEeeeecccCceEEEEEEEcCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCC-----CCeeeE---EEEEecCCeEE
Q 005841 507 LTIGEQIGQGSCGTVYHAVWYGSDVAVKVFSRQEYSDEVIHSFRQEVSLMKRLRH-----PNVLLF---MGAVTSPQRLC 578 (674)
Q Consensus 507 y~~~~~LG~G~fG~Vy~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~H-----pnIv~l---~~~~~~~~~~~ 578 (674)
+.-.+.|..|---+.|+....+..|++|++...... ..+..|+.++..|.. |..+.. ..+.......+
T Consensus 20 ~~~~~~i~~G~~N~ny~v~t~~g~yVLri~~~~~~~----~~l~~~~~~l~~L~~~g~pvp~pi~~~~g~~~~~~~~~~~ 95 (316)
T d2ppqa1 20 LTSYKGIAEGVENSNFLLHTTKDPLILTLYEKRVEK----NDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPA 95 (316)
T ss_dssp EEEEEEECC---EEEEEEEESSCCEEEEEECC---C----CHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEE
T ss_pred ceEeecCCCCcccCeEEEEECCCcEEEEEcCCCCCH----HHHHHHHHHHHhhhhccccccccceecCCCcceeeecccc
Confidence 333445667777889999887778999998653211 223446666666532 211111 00112245566
Q ss_pred EEEecCCCCCH-----HH------H---HHhcC--------CCCC------------------HHHHHHHHHHHHHHHHH
Q 005841 579 IVTEFLPRGSL-----FR------L---LQRNT--------TKLD------------------WRRRILMALDIARGVSY 618 (674)
Q Consensus 579 lV~E~~~ggsL-----~~------~---l~~~~--------~~l~------------------~~~~~~i~~qi~~~L~y 618 (674)
.++.++.+... .. + ++... .... .......+..+...+.-
T Consensus 96 ~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 175 (316)
T d2ppqa1 96 ALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAA 175 (316)
T ss_dssp EEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHH
T ss_pred eeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcchhHHHHHHHHHHhhhc
Confidence 67777655322 11 1 11000 0000 01111112222222222
Q ss_pred HHh--CCCCeEEccCCCCCEEEcCCCcEEEEecCCccc
Q 005841 619 LHH--CNPPIIHRDLKSSNLLVDKHWTVKVGDFGLSRL 654 (674)
Q Consensus 619 LH~--~~~~IvHrDLKp~NILi~~~~~vkL~DFGla~~ 654 (674)
.+. ...+|||+|+.++|||++.+..+-|+||+.|..
T Consensus 176 ~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~ 213 (316)
T d2ppqa1 176 HWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 213 (316)
T ss_dssp HCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred cCccccccccccCCcchhhhhcccccceeEeccccccc
Confidence 221 122499999999999999887779999999864
|
| >d2o9ca2 d.110.3.9 (A:4-130) Bacteriophytochrome BphP {Deinococcus radiodurans [TaxId: 1299]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: BphP N-terminal domain-like domain: Bacteriophytochrome BphP species: Deinococcus radiodurans [TaxId: 1299]
Probab=93.83 E-value=0.071 Score=45.53 Aligned_cols=75 Identities=12% Similarity=0.061 Sum_probs=51.1
Q ss_pred eeEEEcC-CCcEEeecHHHHHHhCCChhhHcCCCccccccccccchhHHHHHHHHHhCce--eEEEEEEEcCCCCEEEEE
Q 005841 142 SVHIFDL-SDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGER--WTGQFPAKTKTEERVLVV 218 (674)
Q Consensus 142 ~I~v~D~-~GrIi~~N~a~e~llGys~eEviG~~~~~l~~~~~~~~~~~~i~~~l~~g~~--~~~e~~~~~kdG~~~~v~ 218 (674)
+++++|. +++|++++....+++|++.++++|+++.+++.... ..+...+..... ..........++..+++.
T Consensus 37 ~LLald~~~~~I~~~S~N~~~~lG~~~~~llG~~l~~ll~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~f~~~ 111 (127)
T d2o9ca2 37 ALLTADGHSGEVLQMSLNAATFLGQEPTVLRGQTLAALLPEQW-----PALQAALPPGCPDALQYRATLDWPAAGHLSLT 111 (127)
T ss_dssp EEEEEETTTCBEEEEETTHHHHHSSCHHHHTTCBHHHHCTTTH-----HHHHHHSCTTCCTTCCEEEEECCSSSSEEEEE
T ss_pred EEEEEECCCCEEEEECCCHHHHhCCChHHHcCCCHHHHCCHHH-----HHHHHHhhhcCcccccceeeeecCCCceEEEE
Confidence 4566786 89999999999999999999999999999985421 223333332222 233344445567777776
Q ss_pred EEE
Q 005841 219 ATN 221 (674)
Q Consensus 219 ~s~ 221 (674)
+..
T Consensus 112 ~Hr 114 (127)
T d2o9ca2 112 VHR 114 (127)
T ss_dssp EEE
T ss_pred EEE
Confidence 654
|
| >d2veaa3 d.110.3.9 (A:4-130) Phytochrome-like protein Cph1 {Synechocystis sp. pcc 6803 [TaxId: 1148]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: BphP N-terminal domain-like domain: Phytochrome-like protein Cph1 species: Synechocystis sp. pcc 6803 [TaxId: 1148]
Probab=92.75 E-value=0.036 Score=47.46 Aligned_cols=42 Identities=19% Similarity=0.165 Sum_probs=36.6
Q ss_pred eeEEEcC-CCcEEeecHHHHHHhCCChhhHcCCCccccccccc
Q 005841 142 SVHIFDL-SDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGR 183 (674)
Q Consensus 142 ~I~v~D~-~GrIi~~N~a~e~llGys~eEviG~~~~~l~~~~~ 183 (674)
+++++|. +++|+++......++|+++++++|+++.+++.+..
T Consensus 28 ~LLald~~~~~I~~aS~N~~~~lG~~~~~lLG~~l~~ll~~~~ 70 (127)
T d2veaa3 28 LVVVLQEPDLTISQISANCTGILGRSPEDLLGRTLGEVFDSFQ 70 (127)
T ss_dssp EEEEEETTTTEEEEEETTHHHHTSCCTTTSSTTTTTTTSBCC-
T ss_pred EEEEEECCCCEEEEEcCCHHHHhCcChHHHcCCCHHHHCCHHH
Confidence 4566775 89999999999999999999999999999997654
|
| >d1p0za_ d.110.6.1 (A:) Sensor kinase CitA {Klebsiella pneumoniae [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: Sensory domain-like family: Sensory domain of two-component sensor kinase domain: Sensor kinase CitA species: Klebsiella pneumoniae [TaxId: 573]
Probab=90.08 E-value=1.8 Score=36.23 Aligned_cols=87 Identities=14% Similarity=0.182 Sum_probs=54.6
Q ss_pred HHHHHHHHhc-ceeEEEcCCCcEEeecHHHHHHhCCChhhHcCCCccccccccccchhHHHHHHHHHhCceeEEEEEEEc
Q 005841 131 QYLNILQSMG-QSVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGERWTGQFPAKT 209 (674)
Q Consensus 131 ~l~~ilds~~-d~I~v~D~~GrIi~~N~a~e~llGys~eEviG~~~~~l~~~~~~~~~~~~i~~~l~~g~~~~~e~~~~~ 209 (674)
.++.+.+... +-|+++|.+|+++.-... +.+|+++.. .. ....+..|+.+.....
T Consensus 40 ~~~~l~~~~~~~~i~v~D~~G~v~a~~~~----------~~iG~~~~~----~~-------~~~a~~~g~~~~~~~~--- 95 (131)
T d1p0za_ 40 LIDPMRSFSDATYITVGDASGQRLYHVNP----------DEIGKSMEG----GD-------SDEALINAKSYVSVRK--- 95 (131)
T ss_dssp HHHHHHHHSCCSEEEEEETTSBEEECSSG----------GGTTSBCCS----SC-------CHHHHHHCCCEEEEEE---
T ss_pred HHHHHHHHcCCcEEEEECCCCCEEEccCh----------hhcCCcccc----cc-------hHHHHHcCCcEEEEEe---
Confidence 4555555543 367889999998865332 346654332 11 2345667777654322
Q ss_pred CCCCEEEEEEEEEEEECCCCCEEEEEEEEEchHH
Q 005841 210 KTEERVLVVATNTPFYDDDGTLVGIVCVSTDSRP 243 (674)
Q Consensus 210 kdG~~~~v~~s~sPi~d~dG~ivg~i~i~rDITe 243 (674)
..+.. ......||+|++|+++|+|.+..++.+
T Consensus 96 g~~g~--~~~~~~PI~~~~G~viGvV~Vg~~l~~ 127 (131)
T d1p0za_ 96 GSLGS--SLRGKSPIQDATGKVIGIVSVGYTIEQ 127 (131)
T ss_dssp ETTEE--EEEEEEEEECTTCCEEEEEEEEEEGGG
T ss_pred cCCcc--EEEEEEEEECCCCcEEEEEEEEEEhHH
Confidence 12332 235667999999999999999888765
|
| >d3c2wa3 d.110.3.9 (A:5-117) Bacteriophytochrome BphP {Pseudomonas aeruginosa [TaxId: 287]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: BphP N-terminal domain-like domain: Bacteriophytochrome BphP species: Pseudomonas aeruginosa [TaxId: 287]
Probab=81.09 E-value=0.96 Score=37.19 Aligned_cols=74 Identities=9% Similarity=0.083 Sum_probs=47.7
Q ss_pred eeEEEcCCCcEEeecHHHHHHhCCChhhHcCCCccccccccccchhHHHHHHHHHhCceeEEEEEEEcCCCCEEEEEEEE
Q 005841 142 SVHIFDLSDRIIYWNRSAELLYGYSAEEALGQDAIELLTDGRDFDVAYDIVHRIKMGERWTGQFPAKTKTEERVLVVATN 221 (674)
Q Consensus 142 ~I~v~D~~GrIi~~N~a~e~llGys~eEviG~~~~~l~~~~~~~~~~~~i~~~l~~g~~~~~e~~~~~kdG~~~~v~~s~ 221 (674)
+++++|.+++|+.+...++.++|++.+ .+|+.+.+++.... ...+...+.........+. ...+|..+++.+..
T Consensus 24 ~LLald~~~~I~~~S~N~~~~lg~~~~-~L~~~~~~~~~~~~----~~~l~~~~~~~~~~~~~~~-~~~~~~~~d~~~H~ 97 (113)
T d3c2wa3 24 ALVTLRADGMVLAASENIQALLGFVAS-PGSYLTQEQVGPEV----LRMLEEGLTGNGPWSNSVE-TRIGEHLFDVIGHS 97 (113)
T ss_dssp EEEEECTTSBEEEEETTHHHHTSSCCC-TTCBCCHHHHHHHH----HHHHHHHHSCSSCCCCEEE-ECCSSSCEEEEEEE
T ss_pred EEEEEcCCCeEEEEcCCHHHHhCCChh-HhcccHHHHhCHHH----HHHHHhhhhcCCCceeEEE-eccCCeEEEEEEEE
Confidence 456789999999999999999999864 67887777765432 2233333433333333222 34567777765553
|